PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cromie, GL; Chapple, DG				Cromie, Gillian L.; Chapple, David G.			Impact of Tail Loss on the Behaviour and Locomotor Performance of Two Sympatric Lampropholis Skink Species	PLOS ONE			English	Article							CAUDAL AUTOTOMY; RUNNING SPEED; ROCK-LIZARDS; MOVEMENT PATTERNS; VIVIPAROUS SKINK; METALLIC SKINK; SPRINT SPEED; COSTS; REGENERATION; SQUAMATA	Caudal autotomy is an anti-predator behaviour that is used by many lizard species. Although there is an immediate survival benefit, the subsequent absence of the tail may inhibit locomotor performance, alter activity and habitat use, and increase the individuals' susceptibility to future predation attempts. We used laboratory experiments to examine the impact of tail autotomy on locomotor performance, activity and basking site selection in two lizard species, the delicate skink (Lampropholis delicata) and garden skink (L. guichenoti), that occur sympatrically throughout southeastern Australia and are exposed to an identical suite of potential predators. Post-autotomy tail movement did not differ between the two Lampropholis species, although a positive relationship between the shed tail length and distance moved, but not the duration of movement, was observed. Tail autotomy resulted in a substantial decrease in sprint speed in both species (28-39%), although this impact was limited to the optimal performance temperature (30 degrees C). Although L. delicata was more active than L. guichenoti, tail autotomy resulted in decreased activity in both species. Sheltered basking sites were preferred over open sites by both Lampropholis species, although this preference was stronger in L. delicata. Caudal autotomy did not alter the basking site preferences of either species. Thus, both Lampropholis species had similar behavioural responses to autotomy. Our study also indicates that the impact of tail loss on locomotor performance may be temperature-dependent and highlights that future studies should be conducted over a broad thermal range.	[Cromie, Gillian L.; Chapple, David G.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia	Monash University	Cromie, GL (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	David.Chapple@monash.edu	Chapple, David/B-9073-2008	Chapple, David/0000-0002-7720-6280	Australian Research Council [DP0771913]; Hermon Slade Foundation [HSF09/02]; National Geographic Society [CRE8085-06]	Australian Research Council(Australian Research Council); Hermon Slade Foundation; National Geographic Society(National Geographic Society)	This research was funded by grants from the Australian Research Council (DP0771913), Hermon Slade Foundation (HSF09/02), and National Geographic Society (CRE8085-06) (to DGC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2002, J THERM BIOL, V27, P199, DOI 10.1016/S0306-4565(01)00084-5; [Anonymous], 2010, COMPLETE GUIDE REPTI; Arnold E.N., 1988, Biology of Reptilia, V16, P235; BALLINGER RE, 1979, HERPETOLOGICA, V35, P114; Bateman PW, 2009, J ZOOL, V277, P1, DOI 10.1111/j.1469-7998.2008.00484.x; Bellairs A.D., 1985, Biology of Reptilia, V15, P301; Chapple DG, 2011, ECOL EVOL, V1, P278, DOI 10.1002/ece3.22; Chapple DG, 2012, TRENDS ECOL EVOL, V27, P57, DOI 10.1016/j.tree.2011.09.010; Chapple DG, 2012, TRENDS ECOL EVOL, V27, P68, DOI 10.1016/j.tree.2011.11.008; Chapple DG, 2004, J ZOOL, V264, P411, DOI 10.1017/s0952836904005941; Chapple DG, 2004, AMPHIBIA-REPTILIA, V25, P326; Chapple DG, 2004, J HERPETOL, V38, P137, DOI 10.1670/128-03N; Chapple DG, 2002, FUNCT ECOL, V16, P817, DOI 10.1046/j.1365-2435.2002.00687.x; Chapple DG, 2002, AUSTRAL ECOL, V27, P565, DOI 10.1046/j.1442-9993.2002.01217.x; Clause AR, 2006, J EXP ZOOL PART A, V305A, P965, DOI 10.1002/jez.a.346; Cooper WE, 2003, BEHAV ECOL SOCIOBIOL, V54, P179, DOI 10.1007/s00265-003-0619-y; Cooper WE, 2008, BEHAVIOUR, V145, P1085; Cooper WE, 2009, CAN J ZOOL, V87, P400, DOI 10.1139/Z09-024; DIAL BE, 1983, SCIENCE, V219, P391, DOI 10.1126/science.219.4583.391; Doughty P, 2003, COMP BIOCHEM PHYS A, V135, P215, DOI 10.1016/S1095-6433(03)00087-4; Downes S, 2001, ECOLOGY, V82, P1293, DOI 10.1890/0012-9658(2001)082[1293:WDTLIA]2.0.CO;2; FORMANOWICZ DR, 1990, ANIM BEHAV, V40, P782, DOI 10.1016/S0003-3472(05)80710-9; Goodman RM, 2006, J HERPETOL, V40, P99, DOI 10.1670/09-05N.1; HAMLEY T, 1990, Memoirs of the Queensland Museum, V28, P153; Higham TE, 2010, BIOL LETTERS, V6, P70, DOI 10.1098/rsbl.2009.0577; JOSS JMP, 1985, AUST J ZOOL, V33, P699, DOI 10.1071/ZO9850699; Kraus Fred, 2009, V4, P1; Kutt Alex, 1993, P187; Lever C., 2003, NATURALIZED REPTILES; Lin ZH, 2006, COMP BIOCHEM PHYS A, V143, P508, DOI 10.1016/j.cbpa.2006.01.018; Lin ZH, 2005, J COMP PHYSIOL B, V175, P567, DOI 10.1007/s00360-005-0017-z; Losos JB, 2002, J ZOOL, V258, P57, DOI 10.1017/S0952836902001206; Maginnis TL, 2006, BEHAV ECOL, V17, P857, DOI 10.1093/beheco/arl010; MARTIN J, 1993, BEHAVIOUR, V124, P123, DOI 10.1163/156853993X00533; Martin J, 1997, HERPETOLOGICA, V53, P117; MARTIN J, 1992, OIKOS, V65, P328, DOI 10.2307/3545026; Martin J, 1995, COPEIA, P984; Martin J, 1998, FUNCT ECOL, V12, P794, DOI 10.1046/j.1365-2435.1998.00247.x; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Pafilis P, 2008, NATURWISSENSCHAFTEN, V95, P217, DOI 10.1007/s00114-007-0320-5; Prosser C, 2006, J HERPETOL, V40, P151, DOI 10.1670/38-05A.1; PUNZO F, 1982, J HERPETOL, V16, P329, DOI 10.2307/1563731; R Development Core Team, 2010, R VERS 2 10 1 FDN ST; Shine R, 2003, FUNCT ECOL, V17, P526, DOI 10.1046/j.1365-2435.2003.00756.x	44	43	44	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34732	10.1371/journal.pone.0034732	http://dx.doi.org/10.1371/journal.pone.0034732			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523555	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345000026
J	Klick, B; Nishiura, H; Cowling, BJ				Klick, Brendan; Nishiura, Hiroshi; Cowling, Benjamin J.			Optimal Design of Intervention Studies to Prevent Influenza in Healthy Cohorts	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; SEASONAL INFLUENZA; DOUBLE-BLIND; RESPIRATORY-INFECTIONS; VIRUS-INFECTION; FIELD TRIAL; HAND HYGIENE; YOUNG-ADULTS; EFFICACY; VACCINE	Background: Influenza cohort studies, in which participants are monitored for infection over an epidemic period, are invaluable in assessing the effectiveness of control measures such as vaccination, antiviral prophylaxis and non-pharmaceutical interventions (NPIs). Influenza infections and illnesses can be identified through a number of approaches with different costs and logistical requirements. Methodology and Principal Findings: In the context of a randomized controlled trial of an NPI with a constrained budget, we used a simulation approach to examine which approaches to measuring outcomes could provide greater statistical power to identify an effective intervention against confirmed influenza. We found that for a short epidemic season, the optimal design was to collect respiratory specimens at biweekly intervals, as well as following report of acute respiratory illness (ARI), for virologic testing by reverse transcription polymerase chain reaction (RT-PCR). Collection of respiratory specimens only from individuals reporting ARI was also an efficient design particularly for studies in settings with longer periods of influenza activity. Collection of specimens only from individuals reporting a febrile ARI was less efficient. Collection and testing of sera before and after influenza activity appeared to be inferior to collection of respiratory specimens for RT-PCR confirmation of acute infections. The performance of RT-PCR was robust to uncertainty in the costs and diagnostic performance of RT-PCR and serological tests. Conclusions and Significance: Our results suggest that unless the sensitivity or specificity of serology can be increased RTPCR will remain as the preferable outcome measure in NPI studies. Routine collection of specimens for RT-PCR testing even when study participants do not report acute respiratory illness appears to be the most cost efficient design under most scenarios.	[Klick, Brendan; Nishiura, Hiroshi; Cowling, Benjamin J.] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Pokfulam, Hong Kong, Peoples R China; [Nishiura, Hiroshi] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	University of Hong Kong; Japan Science & Technology Agency (JST)	Klick, B (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Infect Dis Epidemiol Grp, Pokfulam, Hong Kong, Peoples R China.	bcowling@hku.hk	Cowling, Benjamin John/C-4263-2009	Cowling, Benjamin John/0000-0002-6297-7154; Nishiura, Hiroshi/0000-0003-0941-8537	Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences [U54 GM088558]; Hong Kong University Grants Committee [AoE/M-12/06]; Research Grants Council, Hong Kong; JST PRESTO; MedImmune Inc.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences; Hong Kong University Grants Committee; Research Grants Council, Hong Kong(Hong Kong Research Grants Council); JST PRESTO(Japan Science & Technology Agency (JST)); MedImmune Inc.(AstraZenecaMedimmune); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received financial support from the Harvard Center for Communicable Disease Dynamics from the National Institute of General Medical Sciences (grant no. U54 GM088558) and the Area of Excellence Scheme of the Hong Kong University Grants Committee (grant no. AoE/M-12/06). BK is supported by a Hong Kong PhD Fellowship from the Research Grants Council, Hong Kong. HN is supported by the JST PRESTO program. The funding bodies were not involved in the collection, analysis and interpretation of data, the writing of the manuscript, or the decision to submit for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.; BJC has received study funding from MedImmune Inc., a manufacturer of influenza vaccines. The authors report no other potential conflicts of interest. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aiello AE, 2010, J INFECT DIS, V201, P491, DOI 10.1086/650396; Allwinn R, 2002, MED MICROBIOL IMMUN, V191, P157, DOI 10.1007/s00430-002-0137-y; Bellei N, 2008, J MED VIROL, V80, P1824, DOI 10.1002/jmv.21295; Belshe RB, 2000, J PEDIATR-US, V136, P168, DOI 10.1016/S0022-3476(00)70097-7; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Beran J, 2009, J INFECT DIS, V200, P1861, DOI 10.1086/648406; Beran J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-2; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; CALLMANDER E, 1968, J CLIN PHARMACOL N D, V8, P186, DOI 10.1002/j.1552-4604.1968.tb00269.x; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Carter NJ, 2011, DRUGS, V71, P1591, DOI 10.2165/11206860-000000000-00000; Cheng CKY, 2009, DIAGN MICR INFEC DIS, V65, P35, DOI 10.1016/j.diagmicrobio.2009.05.003; Cheng PKC, 2010, J CLIN VIROL, V47, P182, DOI 10.1016/j.jcv.2009.11.022; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; DAWKINS AT, 1968, J AMER MED ASSOC, V203, P1095, DOI 10.1001/jama.203.13.1095; DOLIN R, 1982, NEW ENGL J MED, V307, P580, DOI 10.1056/NEJM198209023071002; Ellis JS, 2002, REV MED VIROL, V12, P375, DOI 10.1002/rmv.370; FINKLEA JF, 1967, AM J EPIDEMIOL, V85, P403, DOI 10.1093/oxfordjournals.aje.a120702; Gravenstein Stefan, 2005, J Am Med Dir Assoc, V6, P359, DOI 10.1016/j.jamda.2005.08.006; HAMMOND GW, 1980, J INFECT DIS, V141, P644, DOI 10.1093/infdis/141.5.644; Hayden FG, 1999, JAMA-J AM MED ASSOC, V282, P1240, DOI 10.1001/jama.282.13.1240; HIGGINS PG, 1974, J HYG-CAMBRIDGE, V72, P425, DOI 10.1017/S0022172400023664; Killingley B, 2011, LANCET INFECT DIS, V11, P879, DOI 10.1016/S1473-3099(11)70142-6; Klick B, 2011, EPIDEMIOL INFECT, P1; Larson EL, 2010, PUBLIC HEALTH REP, V125, P178, DOI 10.1177/003335491012500206; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Lehmann E.L., 2006, TESTING STAT HYPOTHE, V3rd ed; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466; LONGINI IM, 1988, AM J EPIDEMIOL, V128, P639, DOI 10.1093/oxfordjournals.aje.a115011; MacIntyre CR, 2011, INFLUENZA OTHER RESP, V5, P170, DOI 10.1111/j.1750-2659.2011.00198.x; Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167; Madhi SA, 2011, CLIN INFECT DIS, V52, P128, DOI 10.1093/cid/ciq004; McClellan K, 2001, DRUGS, V61, P263, DOI 10.2165/00003495-200161020-00011; Miller AE, 1997, NEUROLOGY, V48, P312, DOI 10.1212/WNL.48.2.312; Monto AS, 2004, INT CONGR SER, V1263, P3, DOI 10.1016/j.ics.2004.02.049; Monto AS, 1999, JAMA-J AM MED ASSOC, V282, P31, DOI 10.1001/jama.282.1.31; MONTO AS, 1969, B WORLD HEALTH ORGAN, V41, P537; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; NAFTA I, 1970, B WORLD HEALTH ORGAN, V42, P423; Osterholm MT, 2011, LANCET INFECT DIS; Petrie JG, 2011, J INFECT DIS, V203, P1309, DOI 10.1093/infdis/jir015; PETTERSSON RF, 1980, J INFECT DIS, V142, P377, DOI 10.1093/infdis/142.3.377; Rabie T, 2006, TROP MED INT HEALTH, V11, P258, DOI 10.1111/j.1365-3156.2006.01568.x; Sandora TJ, 2008, PEDIATRICS, V121, pE1555, DOI 10.1542/peds.2007-2597; Sattar SA, 2000, INFECT CONT HOSP EP, V21, P516, DOI 10.1086/501796; Suntarattiwong P, 2009, PEDIAT INFECT DIS J; Turner RB, 2010, ANTIMICROB AGENTS CH, V54, P1363, DOI 10.1128/AAC.01498-09; Watanabe A, 2010, J MED VIROL, V82, P2110, DOI 10.1002/jmv.21914; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908; Zambon M, 2001, ARCH INTERN MED, V161, P2116, DOI 10.1001/archinte.161.17.2116	53	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35166	10.1371/journal.pone.0035166	http://dx.doi.org/10.1371/journal.pone.0035166			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514718	Green Published, gold			2022-12-27	WOS:000305341600124
J	Kotorashvili, A; Ramnauth, A; Liu, C; Lin, J; Ye, K; Kim, R; Hazan, R; Rohan, T; Fineberg, S; Loudig, O				Kotorashvili, Adam; Ramnauth, Andrew; Liu, Christina; Lin, Juan; Ye, Kenny; Kim, Ryung; Hazan, Rachel; Rohan, Thomas; Fineberg, Susan; Loudig, Olivier			Effective DNA/RNA Co-Extraction for Analysis of MicroRNAs, mRNAs, and Genomic DNA from Formalin-Fixed Paraffin-Embedded Specimens	PLOS ONE			English	Article							EXPRESSION ANALYSIS; NUCLEIC-ACIDS; FFPE TISSUES; ARRAY CGH; EXTRACTION; AMPLIFICATION; FORMALDEHYDE; METHYLATION; OPTIMIZATION; RECOVERY	Background: Retrospective studies of archived human specimens, with known clinical follow-up, are used to identify predictive and prognostic molecular markers of disease. Due to biochemical differences, however, formalin-fixed paraffin-embedded (FFPE) DNA and RNA have generally been extracted separately from either different tissue sections or from the same section by dividing the digested tissue. The former limits accurate correlation whilst the latter is impractical when utilizing rare or limited archived specimens. Principal Findings: For effective recovery of genomic DNA and total RNA from a single FFPE specimen, without splitting the proteinase-K digested tissue solution, we optimized a co-extraction method by using TRIzol and purifying DNA from the lower aqueous and RNA from the upper organic phases. Using a series of seven different archived specimens, we evaluated the total amounts of genomic DNA and total RNA recovered by our TRIzol-based co-extraction method and compared our results with those from two commercial kits, the Qiagen AllPrep DNA/RNA FFPE kit, for co-extraction, and the Ambion RecoverAll (TM) Total Nucleic Acid Isolation kit, for separate extraction of FFPE-DNA and -RNA. Then, to accurately assess the quality of DNA and RNA co-extracted from a single FFPE specimen, we used qRT-PCR, gene expression profiling and methylation assays to analyze microRNAs, mRNAs, and genomic DNA recovered from matched fresh and FFPE MCF10A cells. These experiments show that the TRIzol-based co-extraction method provides larger amounts of FFPE-DNA and -RNA than the two other methods, and particularly provides higher quality microRNAs and genomic DNA for subsequent molecular analyses. Significance: We determined that co-extraction of genomic DNA and total RNA from a single FFPE specimen is an effective recovery approach to obtain high-quality material for parallel molecular and high-throughput analyses. Our optimized approach provides the option of collecting DNA, which would otherwise be discarded or degraded, for additional or subsequent studies.	[Kotorashvili, Adam; Ramnauth, Andrew; Liu, Christina; Lin, Juan; Ye, Kenny; Kim, Ryung; Rohan, Thomas; Loudig, Olivier] Yeshiva Univ, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY USA; [Hazan, Rachel; Fineberg, Susan; Loudig, Olivier] Yeshiva Univ, Albert Einstein Coll Med, Dept Pathol, Bronx, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Kotorashvili, A (corresponding author), Yeshiva Univ, Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY USA.	olivier.loudig@einstein.yu.edu	Ye, Kenny/U-2341-2019; Ye, Kenny/GSM-7731-2022	Ye, Kenny/0000-0002-1466-855X; 	Albert Einstein College of Medicine	Albert Einstein College of Medicine	The Albert Einstein College of Medicine funded the research presented in the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitz M, 2008, BIOTECHNIQUES, V44, P417, DOI 10.2144/000112703; April C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008162; Aranyi Tamas, 2007, V402, P385; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bonin S, 2010, VIRCHOWS ARCH, V457, P309, DOI 10.1007/s00428-010-0917-5; Cannon-Albright Lisa A, 2011, BMC Res Notes, V4, P159, DOI 10.1186/1756-0500-4-159; CHAW YFM, 1980, BIOCHEMISTRY-US, V19, P5525, DOI 10.1021/bi00565a010; Dallol A, 2011, METHODS MOL BIOL, V724, P191, DOI 10.1007/978-1-61779-055-3_13; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Gagnon JF, 2010, EXP MOL PATHOL, V88, P184, DOI 10.1016/j.yexmp.2009.09.020; Ghazani AA, 2006, J CLIN PATHOL, V59, P311, DOI 10.1136/jcp.2005.029777; Giricz O, 2011, J PATHOL; Glenn ST, 2010, J BIOMOL SCREEN, V15, P80, DOI 10.1177/1087057109355059; Hamatani K, 2006, J HISTOCHEM CYTOCHEM, V54, P773, DOI 10.1369/jhc.5A6859.2006; Hennig G, 2010, CLIN CHEM, V56, P1845, DOI 10.1373/clinchem.2010.151233; Huang WY, 2010, CANCER EPIDEM BIOMAR, V19, P973, DOI 10.1158/1055-9965.EPI-10-0091; JACKSON V, 1978, CELL, V15, P945, DOI 10.1016/0092-8674(78)90278-7; Johnson NA, 2006, LAB INVEST, V86, P968, DOI 10.1038/labinvest.3700441; Karolchik D, 2011, CURR PROTOC HUM GENE; Klopfleisch R, 2011, HISTOL HISTOPATHOL, V26, P797, DOI 10.14670/HH-26.797; Lehmann U, 2001, METHODS, V25, P409, DOI 10.1006/meth.2001.1263; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Liu AH, 2011, METHODS MOL BIOL, V724, P259, DOI 10.1007/978-1-61779-055-3_16; Loudig O, 2011, HUM PATHOL; Loudig O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm510; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Munoz-Cadavid C, 2010, J CLIN MICROBIOL, V48, P2147, DOI 10.1128/JCM.00459-10; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Penland SK, 2007, LAB INVEST, V87, P383, DOI 10.1038/labinvest.3700529; Qu KB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-S1-P31; Ren ZP, 2000, PATHOBIOLOGY, V68, P215, DOI 10.1159/000055926; Schweiger MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005548; Shi SR, 2004, HISTOCHEM CELL BIOL, V122, P211, DOI 10.1007/s00418-004-0693-x; Stanzer S, 2010, CLIN BIOCHEM, V43, P1443, DOI 10.1016/j.clinbiochem.2010.09.013; Streichert T, 2011, MOL BIOTECHNOL; Thirlwell C, 2010, METHODS, V52, P248, DOI 10.1016/j.ymeth.2010.04.012; Thompson RF, 2009, BIOINFORMATICS, V25, P2164, DOI 10.1093/bioinformatics/btp382; Triant DA, 2009, J HERED, V100, P246, DOI 10.1093/jhered/esn083; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Wu L, 2002, APPL IMMUNOHISTO M M, V10, P269, DOI 10.1097/00022744-200209000-00015	40	52	54	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34683	10.1371/journal.pone.0034683	http://dx.doi.org/10.1371/journal.pone.0034683			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514653	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600059
J	Villalon, A; Sepulveda, M; Guerrero, N; Meynard, MM; Palma, K; Concha, ML				Villalon, Aldo; Sepulveda, Mauricio; Guerrero, Nestor; Meynard, Margarita M.; Palma, Karina; Concha, Miguel L.			Evolutionary Plasticity of Habenular Asymmetry with a Conserved Efferent Connectivity Pattern	PLOS ONE			English	Article							BRAIN ASYMMETRY; CEREBRAL LATERALIZATION; PINEAL COMPLEX; CICHLID FISH; ZEBRAFISH; NUCLEI; DIENCEPHALON; FOREBRAIN; BEHAVIOR; ORGANIZATION	The vertebrate habenulae (Hb) is an evolutionary conserved dorsal diencephalic nuclear complex that relays information from limbic and striatal forebrain regions to the ventral midbrain. One key feature of this bilateral nucleus is the presence of left-right differences in size, cytoarchitecture, connectivity, neurochemistry and/or gene expression. In teleosts, habenular asymmetry has been associated with preferential innervation of left-right habenular efferents into dorso-ventral domains of the midbrain interpeduncular nucleus (IPN). However, the degree of conservation of this trait and its relation to the structural asymmetries of the Hb are currently unknown. To address these questions, we performed the first systematic comparative analysis of structural and connectional asymmetries of the Hb in teleosts. We found striking inter-species variability in the overall shape and cytoarchitecture of the Hb, and in the frequency, strength and to a lesser degree, laterality of habenular volume at the population level. Directional asymmetry of the Hb was either to the left in D. rerio, E. bicolor, O. latipes, P. reticulata, B. splendens, or to the right in F. gardneri females. In contrast, asymmetry was absent in P. scalare and F. gardneri males at the population level, although in these species the Hb displayed volumetric asymmetries at the individual level. Inter-species variability was more pronounced across orders than within a single order, and coexisted with an overall conserved laterotopic representation of left-right habenular efferents into dorso-ventral domains of the IPN. These results suggest that the circuit design involving the Hb of teleosts promotes structural flexibility depending on developmental, cognitive and/or behavioural pressures, without affecting the main midbrain connectivity output, thus unveiling a key conserved role of this connectivity trait in the function of the circuit. We propose that ontogenic plasticity in habenular morphogenesis underlies the observed inter-species variations in habenular asymmetric morphology.	[Villalon, Aldo; Sepulveda, Mauricio; Guerrero, Nestor; Meynard, Margarita M.; Palma, Karina; Concha, Miguel L.] BNI, Santiago, Chile; [Villalon, Aldo; Sepulveda, Mauricio; Guerrero, Nestor; Meynard, Margarita M.; Palma, Karina; Concha, Miguel L.] Univ Chile, Fac Med, Anat & Dev Biol Program, Inst Biomed Sci, Santiago 7, Chile; [Villalon, Aldo] Univ Diego Portales, Fac Med, Santiago, Chile	Universidad de Chile; University Diego Portales	Villalon, A (corresponding author), BNI, Santiago, Chile.	mconcha@med.uchile.cl	Palma, Karina/AAL-7009-2021; Concha, Miguel/I-2551-2013	Palma, Karina/0000-0001-6105-6436; Concha, Miguel/0000-0003-3353-9398	FONDECYT [1090242]; Millennium Initiative [P07-048-F, P09-015-F]; Howard Hughes Medical Institute [INTNL 55005940]; Commission of the European Communities [FP6-2004-NEST-PATH EDCBNL]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Millennium Initiative; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Commission of the European Communities(European Commission)	This work was funded by FONDECYT (1090242), the Millennium Initiative (P07-048-F and P09-015-F), Howard Hughes Medical Institute (INTNL 55005940), and the Commission of the European Communities (FP6-2004-NEST-PATH EDCBNL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Aizawa H, 2007, DEV CELL, V12, P87, DOI 10.1016/j.devcel.2006.10.004; Aizawa H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00138; Amo R, 2010, J NEUROSCI, V30, P1566, DOI 10.1523/JNEUROSCI.3690-09.2010; Andres KH, 1999, J COMP NEUROL, V407, P130, DOI 10.1002/(SICI)1096-9861(19990428)407:1<130::AID-CNE10>3.0.CO;2-8; Bianco IH, 2009, PHILOS T R SOC B, V364, P1005, DOI 10.1098/rstb.2008.0213; Bianco IH, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-9; Bianki V. L., 2001, SEX DIFFERENCES LATE; Bisazza A, 2000, LATERALITY, V5, P269, DOI 10.1080/135765000406111; Bolker JA, 2000, AM ZOOL, V40, P770, DOI 10.1668/0003-1569(2000)040[0770:MIDAWI]2.0.CO;2; BRAITENBERG V, 1970, Journal of Comparative Neurology, V138, P137, DOI 10.1002/cne.901380203; Cerda-Reverter JM, 2001, J MORPHOL, V247, P229, DOI 10.1002/1097-4687(200103)247:3<229::AID-JMOR1014>3.0.CO;2-K; Clotfelter ED, 2007, BRAIN BEHAV EVOLUT, V69, P169, DOI 10.1159/000096985; Concha ML, 2009, SEMIN CELL DEV BIOL, V20, P498, DOI 10.1016/j.semcdb.2008.11.007; Concha ML, 2003, NEURON, V39, P423, DOI 10.1016/S0896-6273(03)00437-9; Concha ML, 2001, J ANAT, V199, P63, DOI 10.1046/j.1469-7580.2001.19910063.x; Concha ML, 2000, NEURON, V28, P399, DOI 10.1016/S0896-6273(00)00120-3; Diaz E, 2011, J COMP NEUROL, V519, P3727, DOI 10.1002/cne.22687; ENGBRETSON GA, 1981, J COMP NEUROL, V198, P155, DOI 10.1002/cne.901980113; EWING AW, 1975, BEHAVIOUR, V52, P172, DOI 10.1163/156853975X00029; Gamse JT, 2003, DEVELOPMENT, V130, P1059, DOI 10.1242/dev.00270; GOMEZSEGADE P, 1988, J MORPHOL, V197, P71, DOI 10.1002/jmor.1051970107; Guglielmotti V, 2006, BRAIN RES BULL, V69, P475, DOI 10.1016/j.brainresbull.2006.03.010; GURUSINGHE CJ, 1985, CELL TISSUE RES, V240, P149; Gutierrez-Ibanez C, 2011, BEHAV BRAIN RES, V221, P189, DOI 10.1016/j.bbr.2011.03.001; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; HOLMGREN N, 1920, ACTA ZOOLOGICA, V1, P137; Jones EG, 2006, THALAMUS, P1315; KEMALI M, 1990, BRAIN RES, V517, P251, DOI 10.1016/0006-8993(90)91034-E; Kuan YS, 2007, J EXP ZOOL PART B, V308B, P669, DOI 10.1002/jez.b.21184; Lee A, 2010, CURR BIOL, V20, P2211, DOI 10.1016/j.cub.2010.11.025; Miller RN, 1940, J COMP NEUROL, V73, P345, DOI 10.1002/cne.900730302; NELSON JS, 2006, FISHES WORLD, pR19; Nieuwenhuys R, 1977, Ann N Y Acad Sci, V299, P97, DOI 10.1111/j.1749-6632.1977.tb41902.x; Nissl F., 1892, ALLG Z PSYCHIAT, V48, P197; Okamoto H, 2011, DEV NEUROBIOL; Reddon AR, 2008, BIOL LETTERS, V4, P338, DOI 10.1098/rsbl.2008.0206; Reddon AR, 2009, BEHAV BRAIN RES, V201, P223, DOI 10.1016/j.bbr.2009.02.015; SCHNITZLEIN HN, 1962, J COMP NEUROL, V118, P225, DOI 10.1002/cne.901180208; Shanklin WM, 1935, PHILOS T R SOC B, V516, P361; Signore IA, 2009, PHILOS T R SOC B, V364, P991, DOI 10.1098/rstb.2008.0260; Stephenson-Jones M, 2011, P NATL ACAD SCI US; STEYN W, 1960, ANAT REC, V136, P79, DOI 10.1002/ar.1091360202; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267; Winther RG, 2001, J EXP ZOOL, V291, P116, DOI 10.1002/jez.1064; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; WREE A, 1981, ANAT EMBRYOL, V161, P419, DOI 10.1007/BF00316052; Zilles K, 1976, J Hirnforsch, V17, P1	49	22	23	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35329	10.1371/journal.pone.0035329	http://dx.doi.org/10.1371/journal.pone.0035329			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514727	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600132
J	Chou, MH; Chuang, JH; Eng, HL; Tsai, PC; Hsieh, CS; Liu, HC; Wang, CH; Lin, CY; Lin, TM				Chou, Ming-Huei; Chuang, Jiin-Haur; Eng, Hock-Liew; Tsai, Po-Chin; Hsieh, Chih-Sung; Liu, Hsiang-Chun; Wang, Chiou-Huey; Lin, Chih-Yun; Lin, Tsun-Mei			Effects of Hepatocyte CD14 Upregulation during Cholestasis on Endotoxin Sensitivity	PLOS ONE			English	Article							HEPATIC MICROVASCULAR DYSFUNCTION; OBSTRUCTIVE-JAUNDICE; LIVER-INJURY; BACTERIAL CLEARANCE; CELL-LINE; MICE; RATS; LPS; LIPOPOLYSACCHARIDE; EXPRESSION	Cholestasis is frequently related to endotoxemia and inflammatory response. Our previous investigation revealed a significant increase in plasma endotoxin and CD14 levels during biliary atresia. We therefore propose that lipopolysacharides (LPS) may stimulate CD14 production in liver cells and promote the removal of endotoxins. The aims of this study are to test the hypothesis that CD14 is upregulated by LPS and investigate the pathophysiological role of CD14 production during cholestasis. Using Western blotting, qRT-PCR, and promoter activity assay, we demonstrated that LPS was associated with a significant increase in CD14 and MD2 protein and mRNA expression and CD14 promoter activity in C9 rat hepatocytes but not in the HSC-T6 hepatic stellate cell line in vitro. To correlate CD14 expression and endotoxin sensitivity, in vivo biliary LPS administration was performed on rats two weeks after they were subjected to bile duct ligation (BDL) or a sham operation. CD14 expression and endotoxin levels were found to significantly increase after LPS administration in BDL rats. These returned to basal levels after 24 h. In contrast, although endotoxin levels were increased in sham-operated rats given LPS, no increase in CD14 expression was observed. However, mortality within 24 h was more frequent in the BDL animals than in the sham-operated group. In conclusion, cholestasis and LPS stimulation were here found to upregulate hepatic CD14 expression, which may have led to increased endotoxin sensitivity and host proinflammatory reactions, causing organ failure and death in BDL rats.	[Chou, Ming-Huei; Liu, Hsiang-Chun; Lin, Tsun-Mei] Natl Chang Kung Univ, Inst Basic Med Sci, Tainan, Taiwan; [Chou, Ming-Huei; Chuang, Jiin-Haur] Chang Gung Univ, Grad Inst Clin Med Sci, Kaohsiung, Taiwan; [Chuang, Jiin-Haur] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Kaohsiung, Taiwan; [Chuang, Jiin-Haur; Eng, Hock-Liew; Tsai, Po-Chin; Lin, Chih-Yun] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Eng, Hock-Liew; Tsai, Po-Chin] Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan; [Hsieh, Chih-Sung] PingTung Christian Hosp, Dept Med Res, Pingtung, Taiwan; [Wang, Chiou-Huey; Lin, Tsun-Mei] I SHOU Univ, Dept Lab Med, E DA Hosp, Kaohsiung, Taiwan; [Lin, Chih-Yun] Kaohsiung Chang Gung Mem Hosp, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Lin, Tsun-Mei] I SHOU Univ, E DA Hosp, Dept Med Res, Kaohsiung, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; E-Da Hospital; I Shou University; Chang Gung Memorial Hospital; E-Da Hospital; I Shou University	Chou, MH (corresponding author), Natl Chang Kung Univ, Inst Basic Med Sci, Tainan, Taiwan.	jhchuang@adm.cgmh.org.tw; ltmei@mail.ncku.edu.tw			National Science Council, Taiwan [NSC 92-2314-B-182-076, NSC 95-2320-B-182A-014-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grant # NSC 92-2314-B-182-076 and # NSC 95-2320-B-182A-014-MY3 from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2004, HEPATOLOGY, V40, P414, DOI 10.1002/hep.20301; Abraham S, 2008, SHOCK, V30, P69, DOI 10.1097/SHK.0b013e31815dceea; Bas S, 2004, J IMMUNOL, V172, P4470, DOI 10.4049/jimmunol.172.7.4470; Brunialti MKC, 2006, SHOCK, V25, P351, DOI 10.1097/01.shk.0000217815.57727.29; Chou MH, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-138; Chuang JH, 2004, J SURG RES, V120, P210, DOI 10.1016/j.jss.2004.03.020; Dory D, 2003, J LEUKOCYTE BIOL, V74, P49, DOI 10.1189/jlb.0302133; Finberg RW, 2004, J ENDOTOXIN RES, V10, P413, DOI 10.1179/096805104225006273; Gheorghiu Mihaela, 2004, Roum Arch Microbiol Immunol, V63, P5; Gluck T, 2001, EUR J MED RES, V6, P351; Hirschfield GM, 2010, GASTROENTEROLOGY, V139, P1481, DOI 10.1053/j.gastro.2010.09.004; Hirschfield GM, 2009, CURR OPIN GASTROEN, V25, P175, DOI 10.1097/MOG.0b013e32832914b4; Hori Y, 1998, PANCREAS, V16, P148, DOI 10.1097/00006676-199803000-00007; Isayama F, 2006, AM J PHYSIOL-GASTR L, V290, pG1318, DOI 10.1152/ajpgi.00405.2005; Ishii K, 2002, SHOCK, V18, P163, DOI 10.1097/00024382-200208000-00013; Kmiec Z, 2001, Adv Anat Embryol Cell Biol, V161, pIII; Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1; Lazar G, 2002, INFLAMM RES, V51, P511, DOI 10.1007/PL00012421; Lee Y, 2010, PROG MOL BIOL TRANSL, V97, P151, DOI 10.1016/B978-0-12-385233-5.00006-4; LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838; Liu SB, 2000, GENE, V250, P137, DOI 10.1016/S0378-1119(00)00179-7; Liu SB, 1998, INFECT IMMUN, V66, P5089, DOI 10.1128/IAI.66.11.5089-5098.1998; Minter RM, 2005, SURGERY, V138, P236, DOI 10.1016/j.surg.2005.04.001; Murphey ED, 2008, SHOCK, V29, P512, DOI 10.1097/SHK.0b013e318150776f; Okaya T, 2008, HEPATO-GASTROENTEROL, V55, P2146; Pan Z, 2000, J BIOL CHEM, V275, P36430, DOI 10.1074/jbc.M003192200; Ramaiah SK, 2007, TOXICOL PATHOL, V35, P757, DOI 10.1080/01926230701584163; Sakrak O, 2003, HEPATO-GASTROENTEROL, V50, P1542; Schutt C, 1999, INT J BIOCHEM CELL B, V31, P545, DOI 10.1016/S1357-2725(98)00153-8; Scott MJ, 2008, J BIOL CHEM, V283, P29433, DOI 10.1074/jbc.M803905200; Sewnath ME, 2000, HEPATOLOGY, V32, P1289, DOI 10.1053/jhep.2000.20525; Shuto Y, 2004, IMMUNOL LETT, V94, P47, DOI 10.1016/j.imlet.2004.03.008; Singer G, 2007, J HEPATOL, V47, P799, DOI 10.1016/j.jhep.2007.07.021; Steib CJ, 2010, LAB INVEST, V90, P1024, DOI 10.1038/labinvest.2010.60; Su GL, 1999, J HEPATOL, V31, P435, DOI 10.1016/S0168-8278(99)80034-8; TRACY TF, 1995, SURGERY, V118, P371, DOI 10.1016/S0039-6060(05)80347-2; VANBOSSUYT H, 1990, J HEPATOL, V10, P274, DOI 10.1016/0168-8278(90)90132-B; Vilstrup Hendrik, 2003, Rom J Gastroenterol, V12, P297; Vogel S, 2000, J LIPID RES, V41, P882; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yasui M, 1995, HEPATO-GASTROENTEROL, V42, P683	41	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34903	10.1371/journal.pone.0034903	http://dx.doi.org/10.1371/journal.pone.0034903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511970	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338600056
J	Sabunciyan, S; Aryee, MJ; Irizarry, RA; Rongione, M; Webster, MJ; Kaufman, WE; Murakami, P; Lessard, A; Yolken, RH; Feinberg, AP; Potash, JB				Sabunciyan, Sarven; Aryee, Martin J.; Irizarry, Rafael A.; Rongione, Michael; Webster, Maree J.; Kaufman, Walter E.; Murakami, Peter; Lessard, Andrew; Yolken, Robert H.; Feinberg, Andrew P.; Potash, James B.			Genome-Wide DNA Methylation Scan in Major Depressive Disorder	PLOS ONE			English	Article							MEMBRANE ANCHOR; RETT-SYNDROME; HUMAN BRAIN; GENE; ACETYLCHOLINESTERASE; DEMETHYLATION; METAANALYSIS; EXPRESSION; RECEPTOR; NEURONS	While genome-wide association studies are ongoing to identify sequence variation influencing susceptibility to major depressive disorder (MDD), epigenetic marks, such as DNA methylation, which can be influenced by environment, might also play a role. Here we present the first genome-wide DNA methylation (DNAm) scan in MDD. We compared 39 postmortem frontal cortex MDD samples to 26 controls. DNA was hybridized to our Comprehensive High-throughput Arrays for Relative Methylation (CHARM) platform, covering 3.5 million CpGs. CHARM identified 224 candidate regions with DNAm differences > 10%. These regions are highly enriched for neuronal growth and development genes. Ten of 17 regions for which validation was attempted showed true DNAm differences; the greatest were in PRIMA1, with 12-15% increased DNAm in MDD (p = 0.0002-0.0003), and a concomitant decrease in gene expression. These results must be considered pilot data, however, as we could only test replication in a small number of additional brain samples (n = 16), which showed no significant difference in PRIMA1. Because PRIMA1 anchors acetylcholinesterase in neuronal membranes, decreased expression could result in decreased enzyme function and increased cholinergic transmission, consistent with a role in MDD. We observed decreased immunoreactivity for acetylcholinesterase in MDD brain with increased PRIMA1 DNAm, nonsignificant at p = 0.08. While we cannot draw firm conclusions about PRIMA1 DNAm in MDD, the involvement of neuronal development genes across the set showing differential methylation suggests a role for epigenetics in the illness. Further studies using limbic system brain regions might shed additional light on this role.	[Sabunciyan, Sarven; Irizarry, Rafael A.; Yolken, Robert H.] Johns Hopkins Univ, Dept Pediat, Stanley Div Dev Neurovirol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Aryee, Martin J.] Johns Hopkins Univ, Dept Oncol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Irizarry, Rafael A.; Kaufman, Walter E.; Murakami, Peter; Feinberg, Andrew P.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Epigenet Ctr, Baltimore, MD USA; [Lessard, Andrew] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Med, Div Mol Med, Baltimore, MD USA; [Aryee, Martin J.; Irizarry, Rafael A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Kaufman, Walter E.] Kennedy Krieger Inst, Ctr Genet Disorders Cognit & Behav, Baltimore, MD USA; [Webster, Maree J.] Univ Hlth Sci, Uniformed Serv, Bethesda, MD USA; [Rongione, Michael; Potash, James B.] Univ Iowa, Dept Psychiat, Iowa City, IA 52242 USA; [Lessard, Andrew] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Kennedy Krieger Institute; University of Iowa; University System of Maryland; University of Maryland Baltimore	Sabunciyan, S (corresponding author), Johns Hopkins Univ, Dept Pediat, Stanley Div Dev Neurovirol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	james-potash@uiowa.edu	yolken, robert/AAW-2556-2021; Feinberg, Andrew/AAY-7666-2020; McInnis, Melvin G/F-6963-2012; Aryee, Martin/AAC-8113-2020	McInnis, Melvin G/0000-0002-0375-6247; Sabunciyan, Sarven/0000-0002-7231-0820; Feinberg, Andrew/0000-0002-8364-1991	NIMH (National Institute of Mental Health) [R01MH074131]; NHGRI (National Human Genome Research Institute) [2P50HG003233]; Margaret Price Investigatorship; Stanley Medical Research Institute (SMRI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH074131] Funding Source: NIH RePORTER; Medical Research Council [G0801418B] Funding Source: researchfish	NIMH (National Institute of Mental Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NHGRI (National Human Genome Research Institute); Margaret Price Investigatorship; Stanley Medical Research Institute (SMRI); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a grant from the NIMH (National Institute of Mental Health) to Dr. Potash (R01MH074131), by the NHGRI (National Human Genome Research Institute) to Dr. Feinberg (2P50HG003233), and by the Margaret Price Investigatorship, and the Stanley Medical Research Institute (SMRI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Aryee MJ, 2011, BIOSTATISTICS, V12, P197, DOI 10.1093/biostatistics/kxq055; Bacher I, 2009, EXPERT OPIN PHARMACO, V10, P2709, DOI 10.1517/14656560903329102; Benjamini Y, 1995, J ROY STAT SOC, V57, P289; Campbell S, 2004, AM J PSYCHIAT, V161, P598, DOI 10.1176/appi.ajp.161.4.598; Cassel S, 2006, MOL PHARMACOL, V70, P487, DOI 10.1124/mol.106.022301; Dempster EL, 2011, HUM MOL GENET, V20, P4786, DOI 10.1093/hmg/ddr416; Dobbertin A, 2009, J NEUROSCI, V29, P4519, DOI 10.1523/JNEUROSCI.3863-08.2009; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Furey ML, 2006, ARCH GEN PSYCHIAT, V63, P1121, DOI 10.1001/archpsyc.63.10.1121; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; JANOWSKY DS, 1972, LANCET, V2, P632; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Kaufmann WE, 2000, CEREB CORTEX, V10, P992, DOI 10.1093/cercor/10.10.992; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lee MG, 2006, CHEM BIOL, V13, P563, DOI 10.1016/j.chembiol.2006.05.004; Levinson DF, 2003, AM J MED GENET B, V119B, P118, DOI 10.1002/ajmg.b.20009; Mayberg HS, 2005, NEURON, V45, P651, DOI 10.1016/j.neuron.2005.02.014; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Mill J, 2007, MOL PSYCHIATR, V12, P799, DOI 10.1038/sj.mp.4001992; Mill J, 2008, AM J HUM GENET, V82, P696, DOI 10.1016/j.ajhg.2008.01.008; Milutinovic S, 2007, CARCINOGENESIS, V28, P560, DOI 10.1093/carcin/bgl167; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; PAYKEL ES, 1969, ARCH GEN PSYCHIAT, V21, P753; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; RISCH SC, 1981, J CLIN PSYCHOPHARM, V1, P186, DOI 10.1097/00004714-198107000-00003; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Schroeder FA, 2007, BIOL PSYCHIAT, V62, P55, DOI 10.1016/j.biopsych.2006.06.036; Shimabukuro Morihiro, 2006, Behav Brain Funct, V2, P37, DOI 10.1186/1744-9081-2-37; Shyn SI, 2011, MOL PSYCHIATR, V16, P202, DOI 10.1038/mp.2009.125; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Sweatt JD, 2009, BIOL PSYCHIAT, V65, P191, DOI 10.1016/j.biopsych.2008.09.002; Torrey EF, 2000, SCHIZOPHR RES, V44, P151, DOI 10.1016/S0920-9964(99)00192-9; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276	41	99	100	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34451	10.1371/journal.pone.0034451	http://dx.doi.org/10.1371/journal.pone.0034451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511943	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305338600029
J	Burri, A; Hysi, P; Clop, A; Rahman, Q; Spector, TD				Burri, Andrea; Hysi, Pirro; Clop, Alex; Rahman, Qazi; Spector, Tim D.			A Genome-Wide Association Study of Female Sexual Dysfunction	PLOS ONE			English	Article							GENETIC EPIDEMIOLOGY; PREVALENCE; POLYMORPHISMS; DEPRESSION; PSORIASIS; VARIANTS; BEHAVIOR; GABA(A); SAMPLE; WOMEN	Background: Female sexual dysfunction (FSD) is an important but controversial problem with serious negative impact on women's quality of life. Data from twin studies have shown a genetic contribution to the development and maintenance of FSD. Methodology/Principal Findings: We performed a genome-wide association study (GWAS) on 2.5 million single-nucleotide polymorphisms (SNPs) in 1,104 female twins (25-81 years of age) in a population-based register and phenotypic data on lifelong sexual functioning. Although none reached conventional genome-wide level of significance (10 x -8), we found strongly suggestive associations with the phenotypic dimension of arousal (rs13202860, P = 1.2 x 10(-7); rs1876525, P = 1.2 x 10(-7); and rs13209281 P = 8.3 x 10(-7)) on chromosome 6, around 500kb upstream of the locus HTR1E (5-hydroxytryptamine receptor 1E) locus, related to the serotonin brain pathways. We could not replicate previously reported candidate SNPs associated with FSD in the DRD4, 5HT2A and IL-1B loci. Conclusions/Significance: We report the first GWAS of FSD symptoms in humans. This has pointed to several "risk alleles" and the implication of the serotonin and GABA pathways. Ultimately, understanding key mechanisms via this research may lead to new FSD treatments and inform clinical practice and developments in psychiatric nosology.	[Burri, Andrea; Rahman, Qazi] Queen Mary Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England; [Burri, Andrea; Hysi, Pirro; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London WC2R 2LS, England; [Clop, Alex] Kings Coll London, Sch Med, Dept Med & Mol Genet, London WC2R 2LS, England	University of London; Queen Mary University London; University of London; King's College London; University of London; King's College London	Burri, A (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, Biol & Expt Psychol Grp, London, England.	andrea.burri@kcl.ac.uk	Clop, Alex/AAH-9231-2021; Clop, Alex/D-1519-2009	Clop, Alex/0000-0001-9238-2728; Clop, Alex/0000-0001-9238-2728; Hysi, Pirro/0000-0001-5752-2510; Rahman, Qazi/0000-0001-8346-4529; Burri, Andrea/0000-0002-4705-3551	Wellcome Trust; National Eye Institute via an National Institutes of Health/Center for Inherited Disease Research (NIH/CIDR); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre to Guy's & St Thomas' National Health Service (NHS) Foundation Trust; King's College London; Chronic Disease Research Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); National Eye Institute via an National Institutes of Health/Center for Inherited Disease Research (NIH/CIDR); Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre to Guy's & St Thomas' National Health Service (NHS) Foundation Trust; King's College London; Chronic Disease Research Foundation	The authors acknowledge financial support from the Wellcome Trust; the National Eye Institute via an National Institutes of Health/Center for Inherited Disease Research (NIH/CIDR) genotyping project; the Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre award to Guy's & St Thomas' National Health Service (NHS) Foundation Trust in partnership with King's College London; and the Chronic Disease Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; BARONE P, 1994, BRAIN RES, V638, P85, DOI 10.1016/0006-8993(94)90636-X; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Basson R, 2000, J UROLOGY, V163, P888, DOI 10.1016/S0022-5347(05)67828-7; Basson R, 2004, J SEX MED, V1, P24, DOI 10.1111/j.1743-6109.2004.10105.x; Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005; Ben Zion IZ, 2006, MOL PSYCHIATR, V11, P782, DOI 10.1038/sj.mp.4001832; Bishop JR, 2006, NEUROPSYCHOPHARMACOL, V31, P2281, DOI 10.1038/sj.npp.1301090; Burri A, 2011, J SEX MED, V8, P2420, DOI 10.1111/j.1743-6109.2011.02341.x; Burri A, 2010, J SEX MED, V7, P3929, DOI 10.1111/j.1743-6109.2010.01970.x; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Dawood K, 2005, TWIN RES HUM GENET, V8, P27, DOI 10.1375/twin.8.1.27; DeRogatis LR, 2008, J SEX MED, V5, P289, DOI 10.1111/j.1743-6109.2007.00668.x; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Dudbridge F, 2008, GENET EPIDEMIOL, V32, P227, DOI 10.1002/gepi.20297; Dunn KM, 2005, BIOL LETT-UK, V1, P260, DOI 10.1098/rsbl.2005.0308; Frazer A., 1999, BASIC NEUROCHEMISTRY; Frohlich PF, 2000, PHYSIOL BEHAV, V71, P383, DOI 10.1016/S0031-9384(00)00344-9; Frye CA, 2011, PSYCHOPHARMACOLOGY, V213, P93, DOI 10.1007/s00213-010-2016-3; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gerber S, 2003, EUR J OBSTET GYN R B, V107, P74, DOI 10.1016/S0301-2115(02)00276-2; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Harismendy O, 2011, NATURE, V470, P264, DOI 10.1038/nature09753; Hawton DM, 2000, ARCH SEX BEHAV, V23, P375; Hettema JM, 2001, AM J PSYCHIAT, V158, P1568, DOI 10.1176/appi.ajp.158.10.1568; Jang KL, 1996, J PERS, V64, P577, DOI 10.1111/j.1467-6494.1996.tb00522.x; Kim JR, 2009, J BIOL CHEM, V284, P16308, DOI 10.1074/jbc.M807725200; Kogan M. I., 2009, Urologiya (Moscow), P8; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Ponholzer A, 2005, EUR UROL, V47, P366, DOI 10.1016/j.eururo.2004.10.005; Rosen R, 2000, J SEX MARITAL THER, V26, P191, DOI 10.1080/009262300278597; ROSEN RC, 1993, J SEX MARITAL THER, V19, P171; SHIMRONABARBANELL D, 1995, MOL BRAIN RES, V29, P387, DOI 10.1016/0169-328X(95)00003-B; Snieder H, 1998, J CLIN ENDOCR METAB, V83, P1875, DOI 10.1210/jc.83.6.1875; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Strange A, 2010, NAT GENET, V42, P985, DOI 10.1038/ng.694; Sullivan PF, 2000, AM J PSYCHIAT, V157, P1552, DOI 10.1176/appi.ajp.157.10.1552; Wada S, 2008, PHARMACOL BIOCHEM BE, V90, P590, DOI 10.1016/j.pbb.2008.04.020; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Witting K, 2008, PSYCHOL MED, V26, P1; Zajecka J, 2001, J CLIN PSYCHIAT, V62, P35	44	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35041	10.1371/journal.pone.0035041	http://dx.doi.org/10.1371/journal.pone.0035041			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509378	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600074
J	Moller, AP; Bonisoli-Alquati, A; Rudolfsen, G; Mousseau, TA				Moller, Anders Pape; Bonisoli-Alquati, Andrea; Rudolfsen, Geir; Mousseau, Timothy A.			Elevated Mortality among Birds in Chernobyl as Judged from Skewed Age and Sex Ratios	PLOS ONE			English	Article							BARN SWALLOWS; RADIATION; ANTIOXIDANTS; ABUNDANCE	Background: Radiation has negative effects on survival of animals including humans, although the generality of this claim is poorly documented under low-dose field conditions. Because females may suffer disproportionately from the effects of radiation on survival due to differences in sex roles during reproduction, radiation-induced mortality may result in male-skewed adult sex ratios. Methodology/Principal Finding: We estimated the effects of low-dose radiation on adult survival rates in birds by determining age ratios of adults captured in mist nets during the breeding season in relation to background radiation levels around Chernobyl and in nearby uncontaminated control areas. Age ratios were skewed towards yearlings, especially in the most contaminated areas, implying that adult survival rates were reduced in contaminated areas, and that populations in such areas could only be maintained through immigration from nearby uncontaminated areas. Differential mortality in females resulted in a strongly male-skewed sex ratio in the most contaminated areas. In addition, males sang disproportionately commonly in the most contaminated areas where the sex ratio was male skewed presumably because males had difficulty finding and acquiring mates when females were rare. The results were not caused by permanent emigration by females from the most contaminated areas because none of the recaptured birds had changed breeding site, and the proportion of individuals with morphological abnormalities did not differ significantly between the sexes for areas with normal and higher levels of contamination. Conclusions/Significance: These findings are consistent with the hypothesis that the adult survival rate of female birds is particularly susceptible to the effects of low-dose radiation, resulting in male skewed sex ratios at high levels of radiation. Such skewed age ratios towards yearlings in contaminated areas are consistent with the hypothesis that an area exceeding 30,000 km(2) in Chernobyl's surroundings constitutes an ecological trap that causes dramatic excess mortality.	[Moller, Anders Pape] Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, F-91405 Orsay, France; [Bonisoli-Alquati, Andrea; Mousseau, Timothy A.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Rudolfsen, Geir] Fram Ctr, Dept Environm Radioact, NRPA, Tromso, Norway	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Moller, AP (corresponding author), Univ Paris 11, CNRS, UMR 8079, Lab Ecol Systemat & Evolut, Batiment 362, F-91405 Orsay, France.	anders.moller@u-psud.fr	Moller, Anders/O-6665-2016; Alquati, Andrea Bonisoli/S-2082-2017; Rudolfsen, Geir/ABD-7777-2020; Mousseau, Timothy A/A-1253-2011	Moller, Anders/0000-0003-3739-4675; Alquati, Andrea Bonisoli/0000-0002-9255-7556; Mousseau, Timothy/0000-0002-2235-4868; Rudolfsen, Geir/0000-0001-7984-8458	US National Science Foundation; University of South Carolina School of the Environment; CNRS; National Geographic Society; NATO; Samuel Freeman Charitable Trust	US National Science Foundation(National Science Foundation (NSF)); University of South Carolina School of the Environment; CNRS(Centre National de la Recherche Scientifique (CNRS)); National Geographic Society(National Geographic Society); NATO(NATO (North Atlantic Treaty Organisation)); Samuel Freeman Charitable Trust	We gratefully acknowledge support from the US National Science Foundation, the University of South Carolina School of the Environment, the CNRS, the National Geographic Society, the NATO Collaborative Linkage Grant program, and the Samuel Freeman Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bibby CJ, 2005, BIRD CENSUS TECHNIQU; Blount JD, 2000, TRENDS ECOL EVOL, V15, P47, DOI 10.1016/S0169-5347(99)01774-7; Bonisoli-Alquati A, 2010, COMP BIOCHEM PHYS A, V155, P205, DOI 10.1016/j.cbpa.2009.10.041; Bromet EJ, 2011, CLIN ONCOL-UK, V23, P297, DOI 10.1016/j.clon.2011.01.501; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; Chernobyl Forum, 2005, CHERN TRUE SCAL ACC; Chernobyl Forum Expert Group `Environment', 2006, ENV CONS CHERN ACC T; Cramp S, 1988, BIRDS W PALEARCTIC, V1-9; Dunn Erica H., 2004, Studies in Avian Biology, P1; European Union, 1998, 16733 EUR EUR UN, P16733; Garamszegi LZ, 2007, BEHAV ECOL, V18, P86, DOI 10.1093/beheco/arl047; Gaschak S. P., 2008, Radiatsionnaya Biologiya Radioekologiya, V48, P28; Moller AP, 2007, BIOLOGY LETT, V3, P483, DOI 10.1098/rsbl.2007.0226; Moller AP, 2007, J APPL ECOL, V44, P909, DOI 10.1111/j.1365-2664.2007.01353.x; Moller AP, 2007, BIOL LETTERS, V3, P414, DOI 10.1098/rsbl.2007.0136; Moller AP, 2006, ECOL APPL, V16, P1696, DOI 10.1890/1051-0761(2006)016[1696:CAAPSF]2.0.CO;2; Moller AP, 2011, BIOL CONSERV, V144, P2787, DOI 10.1016/j.biocon.2011.08.009; Moller AP, 2008, J COMP PHYSIOL B, V178, P735, DOI 10.1007/s00360-008-0262-z; Moller AP, 2011, ECOL INDIC, V11, P424, DOI 10.1016/j.ecolind.2010.06.013; Moller AP, 2009, J ORNITHOL, V150, P239, DOI 10.1007/s10336-008-0343-5; Moller AP, 2005, J ANIM ECOL, V74, P1102, DOI 10.1111/j.1365-2656.2005.01009.x; Moller AP, 2005, P ROY SOC B-BIOL SCI, V272, P247, DOI 10.1098/rspb.2004.2914; Moller AP, 2001, OIKOS, V92, P27, DOI 10.1034/j.1600-0706.2001.920104.x; Moller AP., 1994, SEXUAL SELECTION BAR; Moller AP, 1983, METHODS MONITORING B; Nesterenko AV, 2009, ANN NY ACAD SCI, V1181, P1, DOI 10.1111/j.1749-6632.2009.04819.x; Rahu M, 2003, EUR J CANCER, V39, P295, DOI 10.1016/S0959-8049(02)00764-5; Rankin DJ, 2007, OIKOS, V116, P335, DOI [10.1111/j.2006.0030-1299.15451.x, 10.1111/j.0030-1299.2007.15451.x]; Ricklefs RE, 1997, ECOL MONOGR, V67, P23, DOI 10.1890/0012-9615(1997)067[0023:CDONWP]2.0.CO;2; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; SAS Institute Inc, 2000, JMP; Shestopalov V. M., 1996, ATLAS CHERNOBYL EXCL; SNOW D. W., 1956, BRIT BIRDS, V49, P174; Svensson L.A., 2006, IDENTIFICATION GUIDE; Vorisek P, 2010, BEST PRACTICE GUIDE	36	29	29	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35223	10.1371/journal.pone.0035223	http://dx.doi.org/10.1371/journal.pone.0035223			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22514722	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336600094
J	Pratt, AJ; Rambo, RP; Lau, PW; MacRae, IJ				Pratt, Ashley J.; Rambo, Robert P.; Lau, Pick-Wei; MacRae, Ian J.			Preparation and Characterization of the Extracellular Domain of Human Sid-1	PLOS ONE			English	Article							SYSTEMIC RNA INTERFERENCE; SMALL-ANGLE SCATTERING; TRANSMEMBRANE PROTEIN SID-1; DOUBLE-STRANDED-RNA; X-RAY SOLUTION; CAENORHABDITIS-ELEGANS; CELLS; DSRNA; CHANNEL; GENES	In C. elegans, the cell surface protein Sid-1 imports extracellular dsRNA into the cytosol of most non-neuronal cells, enabling systemic spread of RNA interference (RNAi) throughout the worm. Sid-1 homologs are found in many other animals, although for most a function for the protein has not yet been established. Sid-1 proteins are composed of an N-terminal extracellular domain (ECD) followed by 9-12 predicted transmembrane regions. We developed a baculovirus system to express and purify the ECD of the human Sid-1 protein SidT1. Recombinant SidT1 ECD is glycosylated and spontaneously assembles into a stable and discrete tetrameric structure. Electron microscopy (EM) and small angle x-ray scattering (SAXS) studies reveal that the SidT1 ECD tetramer is a compact, puck-shaped globular particle, which we hypothesize may control access of dsRNA to the transmembrane pore. These characterizations provide inroads towards understanding the mechanism of this unique RNA transport system from structural prospective.	[Pratt, Ashley J.; Lau, Pick-Wei; MacRae, Ian J.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Rambo, Robert P.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA	Scripps Research Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Pratt, AJ (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	macrae@scripps.edu	MacRae, Ian/CAF-5564-2022; Pratt, Ashley/A-1754-2012	Pratt, Ashley/0000-0002-9702-8805	NIH through National Center for Research Resources [RR017573]; National Institute of General Medical Sciences [GM103310]; DOE Office of Biological and Environmental Research; Novartis Research Foundation; National Institutes of Health [R01GM086701]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086701, P41GM103310] Funding Source: NIH RePORTER	NIH through National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); Novartis Research Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by grant R01GM086701 to IJM from the National Institutes of Health and by start-up funds from the Novartis Research Foundation. AJP is a pre-doctoral fellow of the National Science Foundation. PWL is a pre-doctoral fellow of the American Heart Association. IJM is a Pew Scholar in the Biomedical Sciences. EM imaging and reconstruction was conducted at the National Resource for Automated Molecular Microscopy, which is supported by the NIH through the P41 program of the National Center for Research Resources (RR017573) and the National Institute of General Medical Sciences (GM103310). The SAXS data was collected at the Advanced Light Source (ALS), a national user facility operated by the Department of Energy, Office of Basic Energy Sciences, through the Integrated Diffraction Analysis Technologies (IDAT) program, supported by DOE Office of Biological and Environmental Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: This work was partly supported by Novartis Research Foundation. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aronstein K, 2006, J APICULT RES, V45, P20, DOI 10.1080/00218839.2006.11101307; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Duxbury MS, 2005, BIOCHEM BIOPH RES CO, V331, P459, DOI 10.1016/j.bbrc.2005.03.199; Feinberg EH, 2003, SCIENCE, V301, P1545, DOI 10.1126/science.1087117; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Gao JL, 2010, BIOCHEM BIOPH RES CO, V402, P588, DOI 10.1016/j.bbrc.2010.09.133; Gomes D, 2009, BBA-BIOMEMBRANES, V1788, P1213, DOI 10.1016/j.bbamem.2009.03.009; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Han W, 2008, GENETICS, V178, P1875, DOI 10.1534/genetics.107.085472; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jose AM, 2009, P NATL ACAD SCI USA, V106, P2283, DOI 10.1073/pnas.0809760106; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Labreuche Y, 2010, DEV COMP IMMUNOL, V34, P1209, DOI 10.1016/j.dci.2010.06.017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Ren R, 2011, DEV COMP IMMUNOL; Rendic D, 2008, CROAT CHEM ACTA, V81, P7; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shih JD, 2011, RNA, V17, P1057, DOI 10.1261/rna.2596511; Shih JD, 2009, RNA, V15, P384, DOI 10.1261/rna.1286409; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tijsterman M, 2004, CURR BIOL, V14, P111, DOI 10.1016/j.cub.2003.12.029; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Tsang SY, 2007, BIOCHEM BIOPH RES CO, V357, P480, DOI 10.1016/j.bbrc.2007.03.187; Ulvila J, 2006, J BIOL CHEM, V281, P14370, DOI 10.1074/jbc.M513868200; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winston WM, 2007, P NATL ACAD SCI USA, V104, P10565, DOI 10.1073/pnas.0611282104; Winston WM, 2002, SCIENCE, V295, P2456, DOI 10.1126/science.1068836; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3	38	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e33607	10.1371/journal.pone.0033607	http://dx.doi.org/10.1371/journal.pone.0033607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509261	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600014
J	Wang, SW; Wu, HH; Liu, SC; Wang, PC; Ou, WC; Chou, WY; Shen, YS; Tang, CH				Wang, Shih-Wei; Wu, Hsing-Hsien; Liu, Shih-Chia; Wang, Po-Chuan; Ou, Wen-Chieh; Chou, Wen-Yi; Shen, Yung-Shuen; Tang, Chih-Hsin			CCL5 and CCR5 Interaction Promotes Cell Motility in Human Osteosarcoma	PLOS ONE			English	Article							NF-KAPPA-B; SIGNALING PATHWAYS; GLIOMA-CELLS; CANCER; MIGRATION; EXPRESSION; BREAST; RANTES; LYMPHOCYTES; ACTIVATION	Background: Osteosarcoma is characterized by a high malignant and metastatic potential. CCL5 (previously called RANTES) was originally recognized as a product of activated T cells, and plays a crucial role in the migration and metastasis of human cancer cells. It has been reported that the effect of CCL5 is mediated via CCR receptors. However, the effect of CCL5 on migration activity and integrin expression in human osteosarcoma cells is mostly unknown. Methodology/Principal Findings: Here we found that CCL5 increased the migration and expression of alpha v beta 3 integrin in human osteosarcoma cells. Stimulation of cells with CCL5 increased CCR5 but not CCR1 and CCR3 expression. CCR5 mAb, inhibitor, and siRNA reduced the CCL5-enhanced the migration and integrin up-regulation of osteosarcoma cells. Activations of MEK, ERK, and NF-kappa B pathways after CCL5 treatment were demonstrated, and CCL5-induced expression of integrin and migration activity was inhibited by the specific inhibitor and mutant of MEK, ERK, and NF-kappa B cascades. In addition, over-expression of CCL5 shRNA inhibited the migratory ability and integrin expression in osteosarcoma cells. Conclusions/Significance: CCL5 and CCR5 interaction acts through MEK, ERK, which in turn activates NF-kappa B, resulting in the activations of alpha v beta 3 integrin and contributing the migration of human osteosarcoma cells.	[Wang, Shih-Wei] Mackay Med Coll, Dept Med, New Taipei City, Taiwan; [Wu, Hsing-Hsien] Tainan Municipal Hosp, Dept Thorac Surg, Tainan, Taiwan; [Liu, Shih-Chia] Mackay Mem Hosp, Dept Orthopaed, Taipei, Taiwan; [Wang, Po-Chuan] Mackay Mem Hosp, Dept Gastroenterol, Hsinchu, Taiwan; [Ou, Wen-Chieh] Tainan Municipal Hosp, Dept Gen Surg, Tainan, Taiwan; [Chou, Wen-Yi] Kaohsiung Chang Gung Mem Hosp, Med Ctr, Dept Orthoped Surg, Kaohsiung, Taiwan; [Shen, Yung-Shuen] Mackay Med Coll, Holist Educ Ctr, New Taipei City, Taiwan; [Tang, Chih-Hsin] China Med Univ, Sch Med, Dept Pharmacol, Taichung, Taiwan; [Tang, Chih-Hsin] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	Mackay Medical College; Mackay Memorial Hospital; Mackay Memorial Hospital; Chang Gung Memorial Hospital; Mackay Medical College; China Medical University Taiwan; China Medical University Taiwan	Wang, SW (corresponding author), Mackay Med Coll, Dept Med, New Taipei City, Taiwan.	chtang@mail.cmu.edu.tw	Tang, Chih Hsin/O-5212-2015; Wang, Shih-Wei/AAH-1967-2020; Chou, Wen-Yi/GPX-7184-2022	Tang, Chih Hsin/0000-0002-7113-8352; Wang, Shih-Wei/0000-0001-7522-6352; 	National Science Council of Taiwan [NSC99-2632-B-715-001-MY3, NSC100-2320-B-715-001]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the National Science Council of Taiwan NSC99-2632-B-715-001-MY3; NSC100-2320-B-715-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arndt CAS, 1999, NEW ENGL J MED, V341, P342, DOI 10.1056/NEJM199907293410507; Bacci G, 2001, EUR J CANCER, V37, P32, DOI 10.1016/S0959-8049(00)00361-0; Ben-Baruch A, 2006, SEMIN CANCER BIOL, V16, P38, DOI 10.1016/j.semcancer.2005.07.006; Brooks PC, 1996, CELL, V85, P683, DOI 10.1016/S0092-8674(00)81235-0; Chen JH, 2011, J CELL BIOCHEM, V112, P2931, DOI 10.1002/jcb.23209; Chuang JY, 2009, J CELL PHYSIOL, V220, P418, DOI 10.1002/jcp.21783; de la Rosa G, 2003, J LEUKOCYTE BIOL, V73, P639, DOI 10.1189/jlb.1002516; Ek ETH, 2006, EXPERT REV ANTICANC, V6, P225, DOI 10.1586/14737140.6.2.225; Grant S, 2008, J CLIN INVEST, V118, P3003, DOI 10.1172/JCI36898; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Heyder C, 2005, CLIN EXP METASTAS, V22, P99, DOI 10.1007/s10585-005-4335-z; Hsieh MT, 2003, LIFE SCI, V73, P1007, DOI 10.1016/S0024-3205(03)00372-2; Huang CY, 2009, J CELL PHYSIOL, V221, P204, DOI 10.1002/jcp.21846; Huang CY, 2009, BIOCHEM PHARMACOL, V77, P794, DOI 10.1016/j.bcp.2008.11.014; Huang HC, 2003, J BIOL CHEM, V278, P46750, DOI 10.1074/jbc.M305216200; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Kempf-Bielack B, 2005, J CLIN ONCOL, V23, P559, DOI 10.1200/JCO.2005.04.063; Kulbe H, 2004, INT J DEV BIOL, V48, P489, DOI 10.1387/ijdb.041814hk; Luboshits G, 1999, CANCER RES, V59, P4681; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Martin L, 2001, BIOCHEMISTRY-US, V40, P6303, DOI 10.1021/bi002670n; McCormack G, 2001, INFLAMM RES, V50, P491, DOI 10.1007/PL00000223; Niwa Y, 2001, CLIN CANCER RES, V7, P285; Roth SJ, 1995, EUR J IMMUNOL, V25, P3482, DOI 10.1002/eji.1830251241; SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Sliva D, 2004, CURR CANCER DRUG TAR, V4, P327, DOI 10.2174/1568009043332961; Stupack Dwayne G, 2007, Oncology (Williston Park), V21, P6; Takenaka K, 2000, INT J ONCOL, V17, P1187; Tseng CP, 2003, FEBS LETT, V541, P21, DOI 10.1016/S0014-5793(03)00281-3; Tyner JW, 2005, NAT MED, V11, P1180, DOI 10.1038/nm1303; Wang YC, 2003, ANAL BIOCHEM, V319, P206, DOI 10.1016/S0003-2697(03)00330-0; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; Woodhouse EC, 1997, CANCER-AM CANCER SOC, V80, P1529, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1529::AID-CNCR2>3.0.CO;2-F; Yaal-Hahoshen N, 2006, CLIN CANCER RES, V12, P4474, DOI 10.1158/1078-0432.CCR-06-0074; Yeh WL, 2009, GLIA, V57, P454, DOI 10.1002/glia.20773	38	62	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35101	10.1371/journal.pone.0035101	http://dx.doi.org/10.1371/journal.pone.0035101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506069	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500076
J	Stein, M; Pilli, M; Bernauer, S; Habermann, BH; Zerial, M; Wade, RC				Stein, Matthias; Pilli, Manohar; Bernauer, Sabine; Habermann, Bianca H.; Zerial, Marino; Wade, Rebecca C.			The Interaction Properties of the Human Rab GTPase Family - A Comparative Analysis Reveals Determinants of Molecular Binding Selectivity	PLOS ONE			English	Article							PROTEIN-INTERACTION; STRUCTURAL BASIS; KINETIC-PARAMETERS; DOMAIN; LOCALIZATION; SPECIFICITY; PHYLOGENIES; EVOLUTION; REGIONS; SWITCH	Background: Rab GTPases constitute the largest subfamily of the Ras protein superfamily. Rab proteins regulate organelle biogenesis and transport, and display distinct binding preferences for effector and activator proteins, many of which have not been elucidated yet. The underlying molecular recognition motifs, binding partner preferences and selectivities are not well understood. Methodology/Principal Findings: Comparative analysis of the amino acid sequences and the three-dimensional electrostatic and hydrophobic molecular interaction fields of 62 human Rab proteins revealed a wide range of binding properties with large differences between some Rab proteins. This analysis assists the functional annotation of Rab proteins 12, 14, 26, 37 and 41 and provided an explanation for the shared function of Rab3 and 27. Rab7a and 7b have very different electrostatic potentials, indicating that they may bind to different effector proteins and thus, exert different functions. The subfamily V Rab GTPases which are associated with endosome differ subtly in the interaction properties of their switch regions, and this may explain exchange factor specificity and exchange kinetics. Conclusions/Significance: We have analysed conservation of sequence and of molecular interaction fields to cluster and annotate the human Rab proteins. The analysis of three dimensional molecular interaction fields provides detailed insight that is not available from a sequence-based approach alone. Based on our results, we predict novel functions for some Rab proteins and provide insights into their divergent functions and the determinants of their binding partner selectivity.	[Stein, Matthias; Pilli, Manohar; Wade, Rebecca C.] HITS, Mol & Cellular Modeling Grp, Heidelberg, Germany; [Stein, Matthias] Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany; [Bernauer, Sabine; Habermann, Bianca H.; Zerial, Marino] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Habermann, Bianca H.] Max Planck Inst Biol Ageing, Cologne, Germany	Max Planck Society; Max Planck Society; Max Planck Society	Stein, M (corresponding author), HITS, Mol & Cellular Modeling Grp, Heidelberg, Germany.	matthias.stein@mpi-magdeburg.mpg.de; rebecca.wade@h-its.org	Habermann, Bianca/N-4886-2016; Pilli, Manohar/G-6568-2015; Stein, Matthias/A-2865-2011; Wade, Rebecca/L-1489-2019	Habermann, Bianca/0000-0002-2457-7504; Pilli, Manohar/0000-0002-3084-8788; Stein, Matthias/0000-0001-7793-0052; Wade, Rebecca/0000-0001-5951-8670	BMBF HepatoSys Competence Network Systems Biology of Hepatocytes [0313076, 0313078C]; Virtual Liver Network [0315749]; Klaus Tschira Foundation	BMBF HepatoSys Competence Network Systems Biology of Hepatocytes(Federal Ministry of Education & Research (BMBF)); Virtual Liver Network; Klaus Tschira Foundation	Financial support from the BMBF HepatoSys Competence Network Systems Biology of Hepatocytes (grant nos. 0313076 and 0313078C) and Virtual Liver Network (grant 0315749), as well as the Klaus Tschira Foundation is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali BR, 2004, J CELL SCI, V117, P6401, DOI 10.1242/jcs.01542; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Blomberg N, 1999, PROTEINS, V37, P379, DOI 10.1002/(SICI)1097-0134(19991115)37:3<379::AID-PROT6>3.0.CO;2-K; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Collins RN, 2005, METHOD ENZYMOL, V403, P19, DOI 10.1016/S0076-6879(05)03003-X; De Rienzo F, 2000, PROTEIN SCI, V9, P1439, DOI 10.1110/ps.9.8.1439; Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009; Delprato A, 2007, NAT STRUCT MOL BIOL, V14, P406, DOI 10.1038/nsmb1232; Dlugosz M, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2948414; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Gabdoulline RR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-373; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo Z, 2005, BIOCHEMISTRY-US, V44, P15423, DOI 10.1021/bi0518601; HODGKIN EE, 1987, INT J QUANTUM CHEM, P105; Iida H, 2005, MOL REPROD DEV, V71, P178, DOI 10.1002/mrd.20294; Kieslich CA, 2011, BIOTECHNOL PROGR, V27, P316, DOI 10.1002/btpr.541; Mackiewicz P, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-101; MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MATTHEW JB, 1985, ANNU REV BIOPHYS BIO, V14, P387; Merithew E, 2001, J BIOL CHEM, V276, P13982, DOI 10.1074/jbc.M009771200; MOORE I, 1995, TRENDS BIOCHEM SCI, V20, P10, DOI 10.1016/S0968-0004(00)88939-2; Nussbaum M, 2005, METHOD ENZYMOL, V403, P10, DOI 10.1016/S0076-6879(05)03002-8; OLKKONEN VM, 1993, J CELL SCI, V106, P1249; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pereira-Leal JB, 2003, BIOCHEM BIOPH RES CO, V301, P92, DOI 10.1016/S0006-291X(02)02963-7; Pereira-Leal JB, 2000, J MOL BIOL, V301, P1077, DOI 10.1006/jmbi.2000.4010; Recacha R, 2009, STRUCTURE, V17, P21, DOI 10.1016/j.str.2008.10.014; Regazzi R, 2007, MOL MECH EXOCYTOSIS, P28; Richter S, 2008, NUCLEIC ACIDS RES, V36, pW276, DOI 10.1093/nar/gkn181; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schleinkofer K, 2004, J MOL BIOL, V344, P865, DOI 10.1016/j.jmb.2004.09.063; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Stein M, 2008, BIOCHEM SOC T, V36, P51, DOI 10.1042/BST0360051; Stein M, 2010, MOL BIOSYST, V6, P162, DOI 10.1039/b912398a; Stenmark H, 2001, GENOME BIOL, V2; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Terzyan S, 2004, ACTA CRYSTALLOGR D, V60, P54, DOI 10.1107/S0907444903021632; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wade RC, 2001, INT J QUANTUM CHEM, V83, P122, DOI 10.1002/qua.1204; WARSHEL A, 1991, ANNU REV BIOPHYS BIO, V20, P267, DOI 10.1146/annurev.biophys.20.1.267; Weidemann A, 2008, BIOINFORMATICS, V24, P1463, DOI 10.1093/bioinformatics/btn207; Winn PJ, 2007, FRONT BIOSCI-LANDMRK, V12, P3419, DOI 10.2741/2323; Winn PJ, 2004, STRUCTURE, V12, P1563, DOI 10.1016/j.str.2004.06.017; Yang MJ, 2004, BIOCHEM BIOPH RES CO, V318, P792, DOI 10.1016/j.bbrc.2004.04.115; Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	56	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34870	10.1371/journal.pone.0034870	http://dx.doi.org/10.1371/journal.pone.0034870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523562	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000034
J	Terada, M; Kawano, F; Ohira, T; Nakai, N; Nishimoto, N; Ohira, Y				Terada, Masahiro; Kawano, Fuminori; Ohira, Takashi; Nakai, Naoya; Nishimoto, Norihiro; Ohira, Yoshinobu			Effects of Mechanical Over-Loading on the Properties of Soleus Muscle Fibers, with or without Damage, in Wild Type and Mdx Mice	PLOS ONE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; COMPENSATORY ADAPTATIONS; MUSCULAR-DYSTROPHY; FAST-TWITCH; HYPERTROPHY; INJURY; PATHOGENESIS; DIVISION; GROWTH	Effects of mechanical over-loading on the characteristics of regenerating or normal soleus muscle fibers were studied in dystrophin-deficient (mdx) and wild type (WT) mice. Damage was also induced in WT mice by injection of cardiotoxin (CTX) into soleus muscle. Over-loading was applied for 14 days to the left soleus muscle in mdx and intact and CTX-injected WT mouse muscles by ablation of the distal tendons of plantaris and gastrocnemius muscles. All of the myonuclei in normal muscle of WT mice were distributed at the peripheral region. But, central myonuclei were noted in all fibers of WT mice regenerating from CTX-injection-related injury. Further, many fibers of mdx mice possessed central myonuclei and the distribution of such fibers was increased in response to over-loading, suggesting a shift of myonuclei from peripheral to central region. Approximately 1.4% branched fibers were seen in the intact muscle of mdx mice, although these fibers were not detected in WT mice. The percentage of these fibers in mdx, not in WT, mice was increased by over-loading (similar to 51.2%). The fiber CSA in normal WT mice was increased by over-loading (p<0.05), but not in mdx and CTX-injected WT mice. It was suggested that compensatory hypertrophy is induced in normal muscle fibers of WT mice following functional over-loading. But, it was also indicated that muscle fibers in mdx mice are susceptible to mechanical over-loading and fiber splitting and shift of myonuclei from peripheral to central region are induced.	[Terada, Masahiro; Ohira, Takashi; Ohira, Yoshinobu] Osaka Univ, Grad Sch Frontier Biosci, Toyonaka, Osaka 560, Japan; [Kawano, Fuminori; Nakai, Naoya; Ohira, Yoshinobu] Osaka Univ, Grad Sch Med, Toyonaka, Osaka 560, Japan; [Nishimoto, Norihiro] Wakayama Med Univ, Lab Immune Regulat, Ibaragi City, Osaka, Japan	Osaka University; Osaka University	Terada, M (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Toyonaka, Osaka 560, Japan.	ohira@space.hss.osaka-u.ac.jp			Japan Society for the Promotion of Science [19-6885, B-23700856, S-19100009, 20650104]; Ministry of Health, Labor and Welfare of Japan [H23-Immunology-003]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported by the Grant-in-Aid for Research Activity Start-up from Japan Society for the Promotion of Science (19-6885, Dr. Terada), Grant-in-Aid for Young Scientists (B-23700856, Dr. Terada), the Grant-in-Aid for Scientific Research (S-19100009, Dr. Ohira, http://www.jsps.go.jp/j-grantsinaid/index.html) and for Exploratory Research (20650104, Dr. Ohira) from Japan Society for the Promotion of Science, and the grant from the Ministry of Health, Labor and Welfare of Japan (H23-Immunology-003, Dr. Nishmoto). The funders had no roles in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Allen DG, 2004, CLIN EXP PHARMACOL P, V31, P485, DOI 10.1111/j.1440-1681.2004.04032.x; Bigard AX, 2001, AM J PHYSIOL-CELL PH, V281, pC1686, DOI 10.1152/ajpcell.2001.281.5.C1686; Bigard XA, 1996, J APPL PHYSIOL, V81, P2658, DOI 10.1152/jappl.1996.81.6.2658; BINKHORST RA, 1973, PFLUG ARCH EUR J PHY, V342, P145, DOI 10.1007/BF00587845; Chan S, 2011, EXP PHYSIOL, V96, P564, DOI 10.1113/expphysiol.2010.056713; Crisona NJ, 1998, J MUSCLE RES CELL M, V19, P43; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; Deconinck N, 2007, PEDIATR NEUROL, V36, P1, DOI 10.1016/j.pediatrneurol.2006.09.016; DONOVAN CM, 1986, J APPL PHYSIOL, V61, P288, DOI 10.1152/jappl.1986.61.1.288; HALLCRAGGS EC, 1970, Z ZELLFORSCH MIK ANA, V109, P481, DOI 10.1007/BF00343963; HALLCRAGGS EC, 1972, J NEUROL SCI, V15, P27, DOI 10.1016/0022-510X(72)90119-0; Haslett JN, 2005, MAMM GENOME, V16, P739, DOI 10.1007/s00335-005-0053-8; Hosaka Y, 2002, J CELL BIOL, V158, P1097, DOI 10.1083/jcb.200204076; HUBBARD RW, 1975, GROWTH, V39, P85; IANUZZO CD, 1976, LIFE SCI, V19, P1517, DOI 10.1016/0024-3205(76)90096-5; IRINTCHEV A, 1987, CELL TISSUE RES, V249, P509; Iwata Y, 2007, AM J PATHOL, V171, P1576, DOI 10.2353/ajpath.2007.070452; JAMES NT, 1979, J ANAT, V129, P769; KANDARIAN SC, 1992, J APPL PHYSIOL, V72, P1934, DOI 10.1152/jappl.1992.72.5.1934; Kawano F, 2007, AM J PHYSIOL-CELL PH, V293, pC35, DOI 10.1152/ajpcell.00297.2006; Kawano F, 2008, AM J PHYSIOL-CELL PH, V295, pC458, DOI 10.1152/ajpcell.00497.2007; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; McCarter GC, 2000, J MEMBRANE BIOL, V176, P169, DOI 10.1007/s002320001086; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mokhtarian A, 1999, J APPL PHYSIOL, V86, P924, DOI 10.1152/jappl.1999.86.3.924; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Ohira T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021044; Ohira Y, 2001, AM J PHYSIOL-CELL PH, V280, pC1008, DOI 10.1152/ajpcell.2001.280.4.C1008; Richard-Bulteau H, 2008, AM J PHYSIOL-CELL PH, V294, pC467, DOI 10.1152/ajpcell.00355.2007; ROY RR, 1985, J APPL PHYSIOL, V59, P639, DOI 10.1152/jappl.1985.59.2.639; SAITO K, 1981, BRAIN DEV-JPN, V3, P65, DOI 10.1016/S0387-7604(81)80008-3; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Schafer R, 2005, NEUROMUSCULAR DISORD, V15, P57, DOI 10.1016/j.nmd.2004.09.011; SOLA OM, 1973, EXP NEUROL, V41, P76, DOI 10.1016/0014-4886(73)90182-9; SWOAP SJ, 1994, J APPL PHYSIOL, V77, P621, DOI 10.1152/jappl.1994.77.2.621; Terada M, 2010, CELLS TISSUES ORGANS, V191, P248, DOI 10.1159/000240245; TSIKA RW, 1987, J APPL PHYSIOL, V62, P2180, DOI 10.1152/jappl.1987.62.6.2180; VAUGHAN HS, 1979, J ANAT, V129, P293; Wang XD, 2006, AM J PHYSIOL-CELL PH, V290, pC981, DOI 10.1152/ajpcell.00298.2005; Wang YX, 2012, NAT REV MOL CELL BIO, V13, P127, DOI 10.1038/nrm3265; WILLIAMS DA, 1993, J PHYSIOL-LONDON, V460, P51, DOI 10.1113/jphysiol.1993.sp019458; Yablonka-Reuveni Z, 2006, DEV DYNAM, V235, P203, DOI 10.1002/dvdy.20602	42	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34557	10.1371/journal.pone.0034557	http://dx.doi.org/10.1371/journal.pone.0034557			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523551	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345000021
J	Baiden, F; Webster, J; Tivura, M; Delimini, R; Berko, Y; Amenga-Etego, S; Agyeman-Budu, A; Karikari, AB; Bruce, J; Owusu-Agyei, S; Chandramohan, D				Baiden, Frank; Webster, Jayne; Tivura, Mathilda; Delimini, Rupert; Berko, Yvonne; Amenga-Etego, Seeba; Agyeman-Budu, Akua; Karikari, Akosua B.; Bruce, Jane; Owusu-Agyei, Seth; Chandramohan, Daniel			Accuracy of Rapid Tests for Malaria and Treatment Outcomes for Malaria and Non-Malaria Cases among Under-Five Children in Rural Ghana	PLOS ONE			English	Article							DIAGNOSTIC-TESTS; ASYMPTOMATIC PARASITEMIA; MANAGEMENT; FEVER; RISK; AREA; MISDIAGNOSIS; BACTEREMIA; ADHERENCE; TANZANIA	Background: WHO now recommends test-based management of malaria across all transmission settings. The accuracy of rapid diagnostic test (RDT) and the outcome of treatment based on the result of tests will influence acceptability of and adherence to the new guidelines. Method: We conducted a study at the Kintampo hospital in rural Ghana to evaluate the performance of CareStart, a HRP-2 based RDT, using microscopy as reference. We applied IMCI treatment guidelines, restricted ACT to RDT-positive children and followed-up both RDT-positive (malaria) and RDT-negative (non-malaria) cases over 28 days. Results: 436 children were enrolled in the RDT evaluation and 391 (children with haemoglobin >8.0 gm/dl) were followed-up to assess treatment outcomes. Mean age was 25.4 months (s.d. 14.6). Sensitivity and specificity of the RDT were 100.0% and 73.0% respectively. Over the follow-up period, 32 (18.5%) RDT-negative children converted to positive, with 7 (4.0%) of them presenting with fever. More children in the non-malaria group made unscheduled visits than children in the malaria group (13.3% versus 7.7%) On all scheduled follow-up visits, proportion of children having a temperature higher than that recorded on day 0 was higher in the non-malaria group compared to the malaria group. Reports of unfavourable treatment outcomes by caregivers were higher among the non-malaria group than the malaria group. Conclusions: The RDT had good sensitivity and specificity. However a minority of children who will not receive ACT based on RDT results may develop clinical malaria within a short period in high transmission settings. This could undermine caregivers' and health workers' confidence in the new guidelines. Improving the quality of management of non-malarial febrile illnesses should be a priority in the era of test-based management of malaria.	[Baiden, Frank; Tivura, Mathilda; Delimini, Rupert; Berko, Yvonne] Kintampo Hlth Res Ctr, Malaria Grp, Kintampo, Ghana; [Webster, Jayne; Bruce, Jane; Chandramohan, Daniel] London Sch Hyg & Trop Med, Dept Dis Control, London WC1, England; [Amenga-Etego, Seeba] Kintampo Hlth Res Ctr, Ctr Comp, Kintampo, Ghana; [Agyeman-Budu, Akua] Kintampo Hlth Res Ctr, Clin Lab, Kintampo, Ghana; [Karikari, Akosua B.] Univ Dev Studies, Dept Microbiol, Tamale, Ghana	Kintampo Health Research Centre; University of London; London School of Hygiene & Tropical Medicine; Kintampo Health Research Centre; Kintampo Health Research Centre; University for Development Studies	Baiden, F (corresponding author), Kintampo Hlth Res Ctr, Malaria Grp, Kintampo, Ghana.	baidenf@yahoo.co.uk	Baiden, Frank/Q-2018-2019; Baiden, Frank/AAF-7309-2020	Baiden, Frank/0000-0003-0141-6561; Owusu-Agyei, Seth/0000-0002-0807-1781; Webster, Jayne/0000-0002-0498-8883	ACT Consortium through Bill and Melinda Gates Foundation; Robert S. McNamara Fellowship Program at the World Bank	ACT Consortium through Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Robert S. McNamara Fellowship Program at the World Bank	This research was funded by the ACT Consortium (www.actconsortium.org) through a grant from the Bill and Melinda Gates Foundation to the London School of Hygiene and Tropical Medicine. FB is supported by a grant from the Robert S. McNamara Fellowship Program at the World Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amexo M, 2004, LANCET, V364, P1896, DOI 10.1016/S0140-6736(04)17446-1; Animut A, 2009, JPN J INFECT DIS, V62, P107; [Anonymous], COCHRANE DATABASE SY, DOI [10.1002/14651858.CD008122pub, DOI 10.1002/14651858.CD008122PUB]; Baiden F, 2011, TROP MED INT HEALTH, V16, P142, DOI 10.1111/j.1365-3156.2010.02692.x; Bell D, 2006, NAT REV MICROBIOL, pS34, DOI [10.1038/nrmico1524, 10.1038/nrmicro1524]; Birku Y, 1999, ETHIOPIAN MED J, V37, P173; Bisoffi Z, 2008, BRIT MED J, V336, P168, DOI 10.1136/bmj.39401.486655.80; Bisoffi Z, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-226; Brent AJ, 2006, LANCET, V367, P482, DOI 10.1016/S0140-6736(06)68180-4; Chandramohan D, 2002, TROP MED INT HEALTH, V7, P45, DOI 10.1046/j.1365-3156.2002.00827.x; d'Acremont V, 2010, CLIN INFECT DIS, V51, P506, DOI 10.1086/655688; D'Acremont V, 2009, PLOS MED, V6, P4, DOI 10.1371/journal.pmed.0050252; Dery DB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-314; English M, 2009, PLOS MED, V6, P7, DOI 10.1371/journal.pmed.1000015; Evans JA, 2004, QJM-INT J MED, V97, P591, DOI 10.1093/qjmed/hch093; Gerstl S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-28; Gillet P, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-166; Gosling RD, MALAR J, V7, P132; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Ishengoma DS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-176; Lubell Y, 2007, AM J TROP MED HYG, V77, P128, DOI 10.4269/ajtmh.2007.77.128; Luchavez J, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-286; Marks F, 2010, EMERG INFECT DIS, V16, P1796, DOI 10.3201/eid1611.100388; Mayxay M, 2001, T ROY SOC TROP MED H, V95, P179, DOI 10.1016/S0035-9203(01)90156-7; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Moonasar D, 2009, SAMJ S AFR MED J, V99, P810; Msellem MI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000070; Mtove G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-290; Mtove G, 2011, TROP MED INT HEALTH, V16, P545, DOI 10.1111/j.1365-3156.2011.02737.x; Murray CK, 2003, TROP MED INT HEALTH, V8, P876, DOI 10.1046/j.1365-3156.2003.01115.x; Nankabirwa J, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-66; Ndyomugyenyi R, MALAR J, V6, P39; Njama-Meya D, 2004, TROP MED INT HEALTH, V9, P862, DOI 10.1111/j.1365-3156.2004.01277.x; Njama-Meya D, 2007, MALAR J; Nosten F, 2007, AM J TROP MED HYG, V77, P181, DOI 10.4269/ajtmh.2007.77.181; Ochola LB, 2006, LANCET INFECT DIS, V6, P582, DOI 10.1016/S1473-3099(06)70579-5; OLIVAR M, 1991, T ROY SOC TROP MED H, V85, P729, DOI 10.1016/0035-9203(91)90432-X; Olliaro P, 2008, TROP MED INT HEALTH, V13, P83, DOI 10.1111/j.1365-3156.2007.01977.x; Olliaro P, 2009, TROP MED INT HEALTH, V14, P488, DOI 10.1111/j.1365-3156.2009.02272.x; Oundo J O, 2002, East Afr Med J, V79, P633; Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220; Perkins MD, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S5; Reyburn H, 2007, BRIT MED J, V334, P403, DOI 10.1136/bmj.39073.496829.AE; ROOTH I, 1992, T ROY SOC TROP MED H, V86, P479, DOI 10.1016/0035-9203(92)90076-O; Van den Ende J, 2010, AM J TROP MED HYG, V83, P207, DOI 10.4269/ajtmh.2010.10-0114a; WHO, 2010, GUID TREATM MAL, V2nd; World Health Organization, 1993, GLOB STRAT MAL CONTR; World Health Organization, 2005, WHO UNICEF MOD IMCI	48	32	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34073	10.1371/journal.pone.0034073	http://dx.doi.org/10.1371/journal.pone.0034073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514617	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000305341600022
J	Hladun, KR; Smith, BH; Mustard, JA; Morton, RR; Trumble, JT				Hladun, Kristen R.; Smith, Brian H.; Mustard, Julie A.; Morton, Ray R.; Trumble, John T.			Selenium Toxicity to Honey Bee (Apis mellifera L.) Pollinators: Effects on Behaviors and Survival	PLOS ONE			English	Article							CONTACT CHEMORECEPTORS; FEEDING PREFERENCES; SPODOPTERA-EXIGUA; DIFFERENT REGIONS; BRASSICA-JUNCEA; AMINO-ACID; ACCUMULATION; METALS; RESPONSES; HYPERACCUMULATION	We know very little about how soil-borne pollutants such as selenium (Se) can impact pollinators, even though Se has contaminated soils and plants in areas where insect pollination can be critical to the functioning of both agricultural and natural ecosystems. Se can be biotransferred throughout the food web, but few studies have examined its effects on the insects that feed on Se-accumulating plants, particularly pollinators. In laboratory bioassays, we used proboscis extension reflex (PER) and taste perception to determine if the presence of Se affected the gustatory response of honey bee (Apis mellifera L., Hymenoptera: Apidae) foragers. Antennae and proboscises were stimulated with both organic (selenomethionine) and inorganic (selenate) forms of Se that commonly occur in Se-accumulating plants. Methionine was also tested. Each compound was dissolved in 1 M sucrose at 5 concentrations, with sucrose alone as a control. Antennal stimulation with selenomethionine and methionine reduced PER at higher concentrations. Selenate did not reduce gustatory behaviors. Two hours after being fed the treatments, bees were tested for sucrose response threshold. Bees fed selenate responded less to sucrose stimulation. Mortality was higher in bees chronically dosed with selenate compared with a single dose. Selenomethionine did not increase mortality except at the highest concentration. Methionine did not significantly impact survival. Our study has shown that bees fed selenate were less responsive to sucrose, which may lead to a reduction in incoming floral resources needed to support coworkers and larvae in the field. If honey bees forage on nectar containing Se (particularly selenate), reductions in population numbers may occur due to direct toxicity. Given that honey bees are willing to consume food resources containing Se and may not avoid Se compounds in the plant tissues on which they are foraging, they may suffer similar adverse effects as seen in other insect guilds.	[Hladun, Kristen R.; Morton, Ray R.; Trumble, John T.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Smith, Brian H.; Mustard, Julie A.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	University of California System; University of California Riverside; Arizona State University; Arizona State University-Tempe	Hladun, KR (corresponding author), Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA.	kristen.hladun@email.ucr.edu		Mustard, Julie A/0000-0002-1412-1140	Department of Entomology at University of California - Riverside; Environmental Protection Agency Science to Achieve Results (EPA STAR) fellowship; STAR Research Assistance by United States Environmental Protection Agency (EPA) [F08F20896]	Department of Entomology at University of California - Riverside; Environmental Protection Agency Science to Achieve Results (EPA STAR) fellowship; STAR Research Assistance by United States Environmental Protection Agency (EPA)(United States Environmental Protection Agency)	This research was supported by the Department of Entomology at University of California - Riverside and an Environmental Protection Agency Science to Achieve Results (EPA STAR) fellowship to KRH. This publication was developed under a STAR Research Assistance Agreement no. F08F20896 awarded by the United States Environmental Protection Agency (EPA). It has not been formally reviewed by the EPA. The views expressed in this document are solely those of the authors and the EPA does not endorse any products or commercial services mentioned in this publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achudume AC, 2010, AFR J AGR RES, V5, P2608; Aliouane Y, 2009, ENVIRON TOXICOL CHEM, V28, P113, DOI 10.1897/08-110.1; ALM J, 1990, OECOLOGIA, V84, P53, DOI 10.1007/BF00665594; [Anonymous], 2000, CROP POLLINATION BEE; Bernays EA, 2001, J INSECT PHYSIOL, V47, P1029, DOI 10.1016/S0022-1910(01)00079-8; Bibi S, 2008, PAK J BOT, V40, P507; Bogdanov S, 2006, APIDOLOGIE, V37, P1, DOI 10.1051/apido:2005043; Boyd RS, 2007, PLANT SOIL, V293, P153, DOI 10.1007/s11104-007-9240-6; BROMENSHENK JJ, 1985, SCIENCE, V227, P632, DOI 10.1126/science.227.4687.632; Burau R. G., 1985, CALIF AGR, V39, P16; Celli Giorgio, 2003, Bulletin of Insectology, V56, P137; Combs GF, 1998, PHARMACOL THERAPEUT, V79, P179, DOI 10.1016/S0163-7258(98)00014-X; Daniels LA, 1996, BIOL TRACE ELEM RES, V54, P185, DOI 10.1007/BF02784430; de Brito Sanchez MG, 2005, EUR J NEUROSCI, V22, P3161, DOI 10.1111/j.1460-9568.2005.04516.x; De Groot A.P., 1953, PHYSL COMP OECOL, V3, P1, DOI DOI 10.1111/1365-2656.12168; de Souza MP, 1998, PLANT PHYSIOL, V117, P1487, DOI 10.1104/pp.117.4.1487; DEJONG D, 1977, B ENVIRON CONTAM TOX, V18, P442, DOI 10.1007/BF01683714; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; El Hassani AK, 2005, PHARMACOL BIOCHEM BE, V82, P30, DOI 10.1016/j.pbb.2005.07.008; Emmons SF, 1896, US GEOL SURV MONOGR, V27, P527; Franke KW, 1936, SCIENCE, V83, P330, DOI 10.1126/science.83.2153.330-a; Freeman JL, 2006, CURR BIOL, V16, P2181, DOI 10.1016/j.cub.2006.09.015; Galeas ML, 2008, NEW PHYTOL, V177, P715, DOI 10.1111/j.1469-8137.2007.02285.x; Galeas ML, 2007, NEW PHYTOL, V173, P517, DOI 10.1111/j.1469-8137.2006.01943.x; Hanson B, 2004, NEW PHYTOL, V162, P655, DOI 10.1111/j.1469-8137.2004.01067.x; Hanson B, 2003, NEW PHYTOL, V159, P461, DOI 10.1046/j.1469-8137.2003.00786.x; Haupt SS, 2004, J COMP PHYSIOL A, V190, P735, DOI 10.1007/s00359-004-0532-5; HIRAO T, 1991, JPN J APPL ENTOMOL Z, V35, P197, DOI 10.1303/jjaez.35.197; Hladun KR, 2011, ENVIRON EXP BOT, V74, P90, DOI 10.1016/j.envexpbot.2011.05.003; HOGAN GR, 1991, ENVIRON ENTOMOL, V20, P790, DOI 10.1093/ee/20.3.790; INOUYE DW, 1984, ECOLOGY, V65, P618, DOI 10.2307/1941424; Jensen P, 2003, REC RES DEV ENTOMOL, V4, P1; Jensen PD, 2006, ARCH ENVIRON CON TOX, V50, P523, DOI 10.1007/s00244-005-0111-y; JONES KC, 1987, WATER AIR SOIL POLL, V33, P179, DOI 10.1007/BF00191386; Kahakachchi C, 2004, J CHROMATOGR A, V1054, P303, DOI 10.1016/j.chroma.2004.07.083; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kevan PG, 1999, AGR ECOSYST ENVIRON, V74, P373, DOI 10.1016/S0167-8809(99)00044-4; Kim YS, 2000, J INSECT PHYSIOL, V46, P793, DOI 10.1016/S0022-1910(99)00168-7; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kuwabara M., 1957, Journal of the Faculty of Science Hokkaido University Zoology, V13, P458; Leita L, 1996, ENVIRON MONIT ASSESS, V43, P1, DOI 10.1007/BF00399566; Lemly A. Dennis, 1997, Biomedical and Environmental Sciences, V10, P415; Morse RA, 2002, BEE CULTURE, V128, P1; Mustard JA, 2008, NEUROBIOL LEARN MEM, V90, P633, DOI 10.1016/j.nlm.2008.07.017; Ohlendorf HM., 2003, HDB ECOTOXICOLOGY, P465; Page RE, 1998, J COMP PHYSIOL A, V182, P489, DOI 10.1007/s003590050196; Pedrero Z, 2006, J AGR FOOD CHEM, V54, P2412, DOI 10.1021/jf052500n; Popham HJR, 2007, ENTOMOL EXP APPL, V125, P171, DOI 10.1111/j.1570-7458.2007.00609.x; Quinn CF, 2008, OECOLOGIA, V155, P267, DOI 10.1007/s00442-007-0907-8; Quinn CF, 2011, NEW PHYTOL, V192, P727, DOI 10.1111/j.1469-8137.2011.03832.x; Roman A, 2010, POL J ENVIRON STUD, V19, P663; Schrauzer GN, 2000, J NUTR, V130, P1653, DOI 10.1093/jn/130.7.1653; SOUTHWICK EE, 1992, J ECON ENTOMOL, V85, P621, DOI 10.1093/jee/85.3.621; Spallholz JE, 1997, BIOMED ENVIRON SCI, V10, P260; Trumble JT, 1998, ENVIRON POLLUT, V101, P175, DOI 10.1016/S0269-7491(98)00086-4; Tuzen M, 2007, FOOD CHEM, V103, P325, DOI 10.1016/j.foodchem.2006.07.053; Vickerman DB, 2004, ENVIRON SCI TECHNOL, V38, P3581, DOI 10.1021/es049941s; Vickerman DB, 2003, ECOTOXICOLOGY, V12, P497, DOI 10.1023/B:ECTX.0000003036.81351.31; Vickerman DB, 2002, ENVIRON ENTOMOL, V31, P953, DOI 10.1603/0046-225X-31.6.953; Vickerman DB, 1999, ARCH INSECT BIOCHEM, V42, P64, DOI 10.1002/(SICI)1520-6327(199909)42:1&lt;64::AID-ARCH7&gt;3.0.CO;2-Y; WHITEHEAD AT, 1976, J INSECT PHYSIOL, V22, P1609, DOI 10.1016/0022-1910(76)90052-4; WHITEHEAD AT, 1978, PHYSIOL ENTOMOL, V3, P241, DOI 10.1111/j.1365-3032.1978.tb00153.x; WIECZOREK H, 1976, J COMP PHYSIOL, V106, P153, DOI 10.1007/BF00620496; Wright GA, 2010, CURR BIOL, V20, P2234, DOI 10.1016/j.cub.2010.11.040; Wu L, 2004, ECOTOX ENVIRON SAFE, V57, P257, DOI 10.1016/S0147-6513(03)00064-2; Yarsan E, 2007, B ENVIRON CONTAM TOX, V79, P255, DOI 10.1007/s00128-007-9034-9	66	53	55	3	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34137	10.1371/journal.pone.0034137	http://dx.doi.org/10.1371/journal.pone.0034137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514621	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600026
J	Liu, AD; Fang, HS; Dirsch, O; Jin, H; Dahmen, U				Liu, Anding; Fang, Haoshu; Dirsch, Olaf; Jin, Hao; Dahmen, Uta			Oxidation of HMGB1 Causes Attenuation of Its Pro-Inflammatory Activity and Occurs during Liver Ischemia and Reperfusion	PLOS ONE			English	Article							MOBILITY GROUP BOX-1; CHROMATIN PROTEIN HMGB1; ISCHEMIA/REPERFUSION INJURY; SUBCELLULAR-LOCALIZATION; CELLS; RAT; TRANSPLANTATION; RELEASE; DANGER; ACTIVATION	High mobility group box 1 (HMGB1) is a nuclear transcription factor. Once HMGB1 is released by damaged cells or activated immune cells, it acts as danger molecule and triggers the inflammatory signaling cascade. Currently, evidence is accumulating that posttranslational modifications such as oxidation may modulate the pro-inflammatory potential of danger signals. We hypothesized that oxidation of HMGB1 may reduce its pro-inflammatory potential and could take place during prolonged ischemia and upon reperfusion. Liver grafts were cold preserved for 24 h and flushed with saline in hourly intervals to collect the effluent. Liver grafts, cold-preserved for 6 h, were transplanted into syngeneic recipients to obtain serum and liver samples 24 h after initiation of reperfusion. Addition of the effluent to a macrophage culture induced the synthesis of tumor necrosis factor-alpha (TNF-alpha) and interleukin (IL)-6. The stimulatory activity of graft effluent was reduced after depletion of HMGB1 via immunoprecipitation. Oxidation of the effluent HMGB1 using H2O2 attenuated its stimulatory activity as well. Liver transplantation of cold preserved grafts caused HMGB1 translocation and release as determined by immunohistochemistry and ELISA-assay, respectively. Using Western blot with non-reducing conditions revealed the presence of oxidized HMGB1 in liver samples obtained after 12 h and in effluent samples after 16 h of cold preservation as well as in liver and serum samples obtained 24 h after reperfusion. These observations confirm that posttranslational oxidation of HMGB1 attenuates its pro-inflammatory activity. Oxidation of HMGB1 as induced during prolonged ischemia and by reoxygenation during reperfusion in vivo might also attenuate its pro-inflammatory activity. Our findings also call for future studies to investigate the mechanism of the inhibitory effect of oxidized HMGB1 on the pro-inflammatory potential.	[Liu, Anding; Fang, Haoshu; Jin, Hao; Dahmen, Uta] Univ Jena, Dept Gen Visceral & Vasc Surg, Jena, Germany; [Liu, Anding] Shaoxing Univ, Affiliated Hosp 1, Shaoxing Peoples Hosp, Ctr Mol Med, Shaoxing, Peoples R China; [Liu, Anding; Fang, Haoshu; Jin, Hao; Dahmen, Uta] Univ Duisburg & Essen, Univ Hosp Essen, Dept Gen Visceral & Transplantat Surg, Essen, Germany; [Dirsch, Olaf] Univ Hosp Jena, Inst Pathol, Jena, Germany	Friedrich Schiller University of Jena; Shaoxing University; University of Duisburg Essen; Friedrich Schiller University of Jena	Liu, AD (corresponding author), Univ Jena, Dept Gen Visceral & Vasc Surg, Jena, Germany.	uta.dahmen@med.uni-jena.de	Liu, Anding/AAU-2477-2020		DFG grant "Klinische Forschergruppe 117 - Optimierung der Leberlebendspende'' [Da251/4-3, Da251/4-4, Da251/5-3, Da251/5-4, KFO117]; German Federal Ministry for Education and Research (BMBF) Virtual Liver Network	DFG grant "Klinische Forschergruppe 117 - Optimierung der Leberlebendspende''; German Federal Ministry for Education and Research (BMBF) Virtual Liver Network(Federal Ministry of Education & Research (BMBF))	This research is supported partially by the DFG grant "Klinische Forschergruppe 117 - Optimierung der Leberlebendspende'' (grant number: Da251/4-3&4, 5-3&4, KFO117) and the German Federal Ministry for Education and Research (BMBF) Virtual Liver Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abraham E, 2000, J IMMUNOL, V165, P2950, DOI 10.4049/jimmunol.165.6.2950; Abu-Amara M, 2010, LIVER TRANSPLANT, V16, P1016, DOI 10.1002/lt.22117; Andrassy M, 2008, CIRCULATION, V117, P3216, DOI 10.1161/CIRCULATIONAHA.108.769331; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; BIANCHI ME, 1989, SCIENCE, V243, P1056, DOI 10.1126/science.2922595; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Bustin M, 1996, PROG NUCLEIC ACID RE, V54, P35, DOI 10.1016/S0079-6603(08)60360-8; Colletti LM, 1996, HEPATOLOGY, V23, P506; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; Ilmakunnas M, 2008, LIVER TRANSPLANT, V14, P1517, DOI 10.1002/lt.21573; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Jin H., 2011, J SUPERCOMPUT, P1; KAMADA N, 1979, TRANSPLANTATION, V28, P47, DOI 10.1097/00007890-197907000-00011; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Kim JB, 2008, J NEUROSCI RES, V86, P1125, DOI 10.1002/jnr.21555; Klune JR, 2008, MOL MED, V14, P476, DOI 10.2119/2008-00034.Klune; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Liu AD, 2012, CYTOKINE, V57, P150, DOI 10.1016/j.cyto.2011.11.009; Liu AD, 2011, EXP MOL PATHOL, V91, P502, DOI 10.1016/j.yexmp.2011.05.005; Liu AD, 2011, HISTOCHEM CELL BIOL, V135, P443, DOI 10.1007/s00418-011-0802-6; Liu AD, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/436145; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Muller S, 2004, J INTERN MED, V255, P332, DOI 10.1111/j.1365-2796.2003.01296.x; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Peralta C, 2001, TRANSPLANTATION, V71, P529, DOI 10.1097/00007890-200102270-00008; Peter ME, 2008, IMMUNITY, V29, P1, DOI 10.1016/j.immuni.2008.06.006; Piratvisuth T, 1995, Liver Transpl Surg, V1, P296, DOI 10.1002/lt.500010505; Rovere-Querini P, 2004, EMBO REP, V5, P825, DOI 10.1038/sj.embor.7400205; Sahu D, 2008, FEBS LETT, V582, P3973, DOI 10.1016/j.febslet.2008.09.061; STEININGER R, 1994, TRANSPLANTATION, V58, P179, DOI 10.1097/00007890-199407270-00008; Tsung A, 2005, J EXP MED, V201, P1135, DOI 10.1084/jem.20042614; Vardanian AJ, 2008, MOL MED, V14, P337, DOI 10.2119/2007-00134.Vardanian; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Yang HA, 2010, P NATL ACAD SCI USA, V107, P11942, DOI 10.1073/pnas.1003893107; Yang H, 2010, BBA-GENE REGUL MECH, V1799, P149, DOI 10.1016/j.bbagrm.2009.11.019; Youn JH, 2006, J IMMUNOL, V177, P7889, DOI 10.4049/jimmunol.177.11.7889	38	31	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35379	10.1371/journal.pone.0035379	http://dx.doi.org/10.1371/journal.pone.0035379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514737	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600142
J	Zajdowicz, S; Haller, JC; Krafft, AE; Hunsucker, SW; Mant, CT; Duncan, MW; Hodges, RS; Jones, DNM; Holmes, RK				Zajdowicz, Sheryl; Haller, Jon C.; Krafft, Amy E.; Hunsucker, Steve W.; Mant, Colin T.; Duncan, Mark W.; Hodges, Robert S.; Jones, David N. M.; Holmes, Randall K.			Purification and Structural Characterization of Siderophore (Corynebactin) from Corynebacterium diphtheriae	PLOS ONE			English	Article							MICROBIAL IRON TRANSPORT; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; COORDINATION CHEMISTRY; BACILLUS-SUBTILIS; STAPHYLOFERRIN-A; GENE-CLUSTER; GLUTAMICUM; NMR; BIOSYNTHESIS	During infection, Corynebacterium diphtheriae must compete with host iron-sequestering mechanisms for iron. C. diphtheriae can acquire iron by a siderophore-dependent iron-uptake pathway, by uptake and degradation of heme, or both. Previous studies showed that production of siderophore (corynebactin) by C. diphtheriae is repressed under high-iron growth conditions by the iron-activated diphtheria toxin repressor (DtxR) and that partially purified corynebactin fails to react in chemical assays for catecholate or hydroxamate compounds. In this study, we purified corynebactin from supernatants of low-iron cultures of the siderophore-overproducing, DtxR-negative mutant strain C. diphtheriae C7(beta) Delta dtxR by sequential anion-exchange chromatography on AG1-X2 and Source 15Q resins, followed by reverse-phase high-performance liquid chromatography (RP-HPLC) on Zorbax C8 resin. The Chrome Azurol S (CAS) chemical assay for siderophores was used to detect and measure corynebactin during purification, and the biological activity of purified corynebactin was shown by its ability to promote growth and iron uptake in siderophore-deficient mutant strains of C. diphtheriae under iron-limiting conditions. Mass spectrometry and NMR analysis demonstrated that corynebactin has a novel structure, consisting of a central lysine residue linked through its alpha- and epsilon-amino groups by amide bonds to the terminal carboxyl groups of two different citrate residues. Corynebactin from C. diphtheriae is structurally related to staphyloferrin A from Staphylococcus aureus and rhizoferrin from Rhizopus microsporus in which D-ornithine or 1,4-diaminobutane, respectively, replaces the central lysine residue that is present in corynebactin.	[Zajdowicz, Sheryl; Haller, Jon C.; Holmes, Randall K.] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA; [Zajdowicz, Sheryl] Metropolitan State Coll Denver, Dept Biol, Denver, CO USA; [Krafft, Amy E.] NIAID, Resp Dis Branch, Div Microbiol & Infect Dis, NIH,Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Hunsucker, Steve W.; Duncan, Mark W.] Univ Colorado, Sch Med, Dept Endocrinol Metab & Diabet, Aurora, CO USA; [Mant, Colin T.; Hodges, Robert S.] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO USA; [Jones, David N. M.] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Zajdowicz, S (corresponding author), Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO USA.	Randall.Holmes@ucdenver.edu	Jones, David N/C-5764-2013	Duncan, Mark/0000-0001-9256-8274	NIH [R37-AI14107, RO1-GM061855]; John Stewart Endowed Chair in Peptide Chemistry; University of Colorado Cancer Center Support Grant [NIH P30-CA046934]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI014107] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John Stewart Endowed Chair in Peptide Chemistry; University of Colorado Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by NIH grant R37-AI14107 (to RKH) and NIH grant RO1-GM061855 and the John Stewart Endowed Chair in Peptide Chemistry (to RSH). Operation of the NMR spectrometers was supported by the Program in Structural Biology and Biophysics and the University of Colorado Cancer Center Support Grant (NIH P30-CA046934). No other grants contributed to support of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht-Gary AM, 1998, MET IONS BIOL SYST, V35, P239; Arnow LE, 1937, J BIOL CHEM, V118, P531; AUE WP, 1976, J CHEM PHYS, V64, P2229, DOI 10.1063/1.432450; Beasley FC, 2009, MOL MICROBIOL, V72, P947, DOI 10.1111/j.1365-2958.2009.06698.x; Bell CF, 1977, METAL CHELATION PRIN; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Boukhalfa H, 2002, BIOMETALS, V15, P325, DOI 10.1023/A:1020218608266; BRICKMAN TJ, 1992, J BIOL CHEM, V267, P12350; Budzikiewicz H, 2005, MINI-REV ORG CHEM, V2, P119, DOI 10.2174/1570193053544436; Budzikiewicz H, 1997, Z NATURFORSCH C, V52, P551; Challis GL, 2005, CHEMBIOCHEM, V6, P601, DOI 10.1002/cbic.200400283; Cheung J, 2009, MOL MICROBIOL, V74, P594, DOI 10.1111/j.1365-2958.2009.06880.x; Cotton JL, 2009, BIOCHEMISTRY-US, V48, P1025, DOI 10.1021/bi801844c; CSAKY TZ, 1948, ACTA CHEM SCAND, V2, P450, DOI 10.3891/acta.chem.scand.02-0450; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dertz EA, 2006, J BIOL INORG CHEM, V11, P1087, DOI 10.1007/s00775-006-0151-4; DRECHSEL H, 1993, J BACTERIOL, V175, P2727, DOI 10.1128/JB.175.9.2727-2733.1993; Drechsel H, 2005, BIOMETALS, V18, P75, DOI 10.1007/s10534-004-5774-8; Franza T, 2005, MOL MICROBIOL, V55, P261, DOI 10.1111/j.1365-2958.2004.04383.x; FREEMAN VJ, 1951, J BACTERIOL, V61, P675, DOI 10.1128/JB.61.6.675-688.1951; Goddard T. D., 1997, SPARKY, V3; HARRIS WR, 1979, J AM CHEM SOC, V101, P2722, DOI 10.1021/ja00504a038; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; KONETSCHNYRAPP S, 1990, EUR J BIOCHEM, V191, P65, DOI 10.1111/j.1432-1033.1990.tb19094.x; Kunkle CA, 2005, J BACTERIOL, V187, P422, DOI 10.1128/JB.187.2.422-433.2005; Lynch D, 2001, J BACTERIOL, V183, P2576, DOI 10.1128/JB.183.8.2576-2585.2001; MARION D, 1989, J MAGN RESON, V85, P393, DOI 10.1016/0022-2364(89)90152-2; Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449; May JJ, 2001, J BIOL CHEM, V276, P7209, DOI 10.1074/jbc.M009140200; MEIWES J, 1990, FEMS MICROBIOL LETT, V67, P201, DOI 10.1111/j.1574-6968.1990.tb13863.x; Miller DA, 2002, CHEM BIOL, V9, P333, DOI 10.1016/S1074-5521(02)00115-1; Muller K, 1998, EUR J BIOCHEM, V258, P1001, DOI 10.1046/j.1432-1327.1998.2581001.x; MULLER L, 1979, J AM CHEM SOC, V101, P4481; Munzinger M, 1999, BIOMETALS, V12, P189, DOI 10.1023/A:1009259118034; Oram DM, 2006, J BACTERIOL, V188, P2959, DOI 10.1128/JB.188.8.2959-2973.2006; Park W H, 1896, J Exp Med, V1, P164, DOI 10.1084/jem.1.1.164; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; RUSSELL LM, 1985, INFECT IMMUN, V47, P575, DOI 10.1128/IAI.47.2.575-578.1985; RUSSELL LM, 1983, J BACTERIOL, V155, P1439, DOI 10.1128/JB.155.3.1439-1442.1983; RUSSELL LM, 1984, INFECT IMMUN, V45, P143, DOI 10.1128/IAI.45.1.143-149.1984; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; SMITH MJ, 1985, J AM CHEM SOC, V107, P1739, DOI 10.1021/ja00292a047; Stintzi A, SIDEROPHORE CHEM, P273; THIEKEN A, 1992, FEMS MICROBIOL LETT, V94, P37, DOI 10.1111/j.1574-6968.1992.tb05285.x; Winkelmann G, 2002, BIOCHEM SOC T, V30, P691, DOI 10.1042/BST0300691; WINKELMANN G, 1991, HDB MICROBIAL IRON C; Zajdowicz SLW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021523	50	23	23	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34591	10.1371/journal.pone.0034591	http://dx.doi.org/10.1371/journal.pone.0034591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514641	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600047
J	Bassaganya-Riera, J; Viladomiu, M; Pedragosa, M; De Simone, C; Hontecillas, R				Bassaganya-Riera, Josep; Viladomiu, Monica; Pedragosa, Mireia; De Simone, Claudio; Hontecillas, Raquel			Immunoregulatory Mechanisms Underlying Prevention of Colitis-Associated Colorectal Cancer by Probiotic Bacteria	PLOS ONE			English	Article							CONJUGATED LINOLEIC-ACID; TUMOR-NECROSIS-FACTOR; INFLAMMATORY-BOWEL-DISEASE; POLYUNSATURATED FATTY-ACIDS; ACTIVE ULCERATIVE-COLITIS; FACTOR-ALPHA; PPAR-GAMMA; GENE-EXPRESSION; ACTIVATION; CELLS	Background: Inflammatory bowel disease (IBD) increases the risk of colorectal cancer. Probiotic bacteria produce immunoregulatory metabolites in vitro such as conjugated linoleic acid (CLA), a polyunsaturated fatty acid with potent anti-carcinogenic effects. This study aimed to investigate the cellular and molecular mechanisms underlying the efficacy of probiotic bacteria in mouse models of cancer. Methodology/Principal Findings: The immune modulatory mechanisms of VSL#3 probiotic bacteria and CLA were investigated in mouse models of inflammation-driven colorectal cancer. Colonic specimens were collected for histopathology, gene expression and flow cytometry analyses. Immune cell subsets in the mesenteric lymph nodes (MLN), spleen and colonic lamina propria lymphocytes (LPL) were phenotypically and functionally characterized. Mice treated with CLA or VSL#3 recovered faster from the acute inflammatory phase of disease and had lower disease severity in the chronic, tumor-bearing phase of disease. Adenoma and adenocarcinoma formation was also diminished by both treatments. VSL#3 increased the mRNA expression of TNF-alpha, angiostatin and PPAR gamma whereas CLA decreased COX-2 levels. Moreover, VSL#3-treated mice had increased IL-17 expression in MLN CD4+ T cells and accumulation of Treg LPL and memory CD4+ T cells. Conclusions/Significance: Both CLA and VSL#3 suppressed colon carcinogenesis, although VSL#3 showed greater anti-carcinogenic and anti-inflammatory activities than CLA. Mechanistically, CLA modulated expression of COX-2 levels in the colonic mucosa, whereas VSL# 3 targeted regulatory mucosal CD4+ T cell responses.	[Bassaganya-Riera, Josep; Viladomiu, Monica; Pedragosa, Mireia; Hontecillas, Raquel] Virginia Tech, Nutr Immunol & Mol Med Lab, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [De Simone, Claudio] Univ Aquila, I-67100 Laquila, Italy	Virginia Polytechnic Institute & State University; University of L'Aquila	Bassaganya-Riera, J (corresponding author), Virginia Tech, Nutr Immunol & Mol Med Lab, Ctr Modeling Immun Enter Pathogens, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA.	jbassaga@vt.edu	Viladomiu, Monica/GNM-6447-2022					Alonso L, 2003, J DAIRY SCI, V86, P1941, DOI 10.3168/jds.S0022-0302(03)73781-3; Appleyard CB, 2011, AM J PHYSL GASTROINT; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2002, CLIN NUTR, V21, P451, DOI 10.1054/clnu.2002.0594; Bassaganya-Riera J, 2012, PLOS ONE; Bassaganya-Riera J, 2006, CLIN NUTR, V25, P454, DOI 10.1016/j.clnu.2005.12.008; Calder PC, 2008, MOL NUTR FOOD RES, V52, P885, DOI 10.1002/mnfr.200700289; Chichlowski M, 2008, COMPARATIVE MED, V58, P534; Clarke JM, 2011, AM J CLIN NUTR, V94, P1276, DOI 10.3945/ajcn.111.017228; Coakley M, 2003, J APPL MICROBIOL, V94, P138, DOI 10.1046/j.1365-2672.2003.01814.x; Collado MC, 2005, J FOOD PROTECT, V68, P1034, DOI 10.4315/0362-028X-68.5.1034; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Evans NP, 2010, J NUTR, V140, P515, DOI 10.3945/jn.109.115642; Gorissen L, 2010, APPL MICROBIOL BIOTE; HAN SK, 1994, AM J RESP CELL MOL, V11, P270, DOI 10.1165/ajrcmb.11.3.8086165; Hofmanova J, 2011, J NUTR BIOCH; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Ivanov II, 2010, MUCOSAL IMMUNOL, V3, P209, DOI 10.1038/mi.2010.3; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jijon H, 2004, GASTROENTEROLOGY, V126, P1358, DOI 10.1053/j.gastro.2004.02.003; Kohno H, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-46; Lawton EM, 2007, MINI-REV MED CHEM, V7, P1236, DOI 10.2174/138955707782795638; Lee SO, 2003, BIOTECHNOL LETT, V25, P935, DOI 10.1023/A:1024084203052; Lee TY, 2009, BLOOD, V114, P1987, DOI 10.1182/blood-2008-12-197236; Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012; Lewis JD, 2001, AM J GASTROENTEROL, V96, P3323; McConnell BB, 2009, CURR COLORECT CANC R, V5, P69, DOI 10.1007/s11888-009-0011-z; Miller A, 2001, LIPIDS, V36, P1161, DOI 10.1007/s11745-001-0827-0; Miller BA, 2008, CANCER CAUSE CONTROL, V19, P227, DOI 10.1007/s10552-007-9088-3; MOORE WEC, 1974, APPL MICROBIOL, V27, P961, DOI 10.1128/AEM.27.5.961-979.1974; Munkholm P, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.18.s2.2.x; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; OSTENSEN ME, 1989, J BIOL RESP MODIF, V8, P53; OWENSCHAUB LB, 1988, CANCER RES, V48, P788; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; PFIZENMAIER K, 1987, J IMMUNOL, V138, P975; PLAETINCK G, 1987, EUR J IMMUNOL, V17, P1835, DOI 10.1002/eji.1830171224; RANGES GE, 1987, J EXP MED, V166, P991, DOI 10.1084/jem.166.4.991; ROSEN EM, 1991, CANCER RES, V51, P5315; Saubermann LJ, 2000, GASTROENTEROLOGY, V119, P119, DOI 10.1053/gast.2000.9114; Serini S, 2009, APOPTOSIS, V14, P135, DOI 10.1007/s10495-008-0298-2; Shanahan F, 2005, AM J PHYSIOL-GASTR L, V288, pG417, DOI 10.1152/ajpgi.00421.2004; Shanahan F, 2004, ADV DRUG DELIVER REV, V56, P809, DOI 10.1016/j.addr.2003.11.003; Shantha Kumara HM, 2010, SURG ENDOSC; Tuohy KM, 2005, CURR PHARM DESIGN, V11, P75, DOI 10.2174/1381612053382331; Uronis JM, 2011, INFLAMM BOWEL DIS, V17, P289, DOI 10.1002/ibd.21366; Xie JL, 2008, WORLD J GASTROENTERO, V14, P378, DOI 10.3748/wjg.14.378; Yang WL, 2001, CARCINOGENESIS, V22, P1379, DOI 10.1093/carcin/22.9.1379	48	76	78	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34676	10.1371/journal.pone.0034676	http://dx.doi.org/10.1371/journal.pone.0034676			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511958	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600044
J	Bauer, AS; Keller, A; Costello, E; Greenhalf, W; Bier, M; Borries, A; Beier, M; Neoptolemos, J; Buchler, M; Werner, J; Giese, N; Hoheisel, JD				Bauer, Andrea S.; Keller, Andreas; Costello, Eithne; Greenhalf, William; Bier, Melanie; Borries, Anne; Beier, Markus; Neoptolemos, John; Buechler, Markus; Werner, Jens; Giese, Nathalia; Hoheisel, Joerg D.			Diagnosis of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis by Measurement of microRNA Abundance in Blood and Tissue	PLOS ONE			English	Article							FALSE DISCOVERY RATE; CANCER; MICROARRAY	A solid process for diagnosis could have a substantial impact on the successful treatment of pancreatic cancer, for which currently mortality is nearly identical to incidence. Variations in the abundance of all microRNA molecules from peripheral blood cells and pancreas tissues were analyzed on microarrays and in part validated by real-time PCR assays. In total, 245 samples from two clinical centers were studied that were obtained from patients with pancreatic ductal adenocarcinoma or chronic pancreatitis and from healthy donors. Utilizing the minimally invasive blood test, receiver operating characteristic (ROC) curves and the corresponding area under the curve (AUC) analysis demonstrated very high sensitivity and specificity of a distinction between healthy people and patients with either cancer or chronic pancreatitis; respective AUC values of 0.973 and 0.950 were obtained. Confirmative and partly even more discriminative diagnosis could be performed on tissue samples with AUC values of 1.0 and 0.937, respectively. In addition, discrimination between cancer and chronic pancreatitis was achieved (AUC = 0.875). Also, several miRNAs were identified that exhibited abundance variations in both tissue and blood samples. The results could have an immediate diagnostic value for the evaluation of tumor reoccurrence in patients, who have undergone curative surgical resection, and for people with a familial risk of pancreatic cancer.	[Bauer, Andrea S.; Bier, Melanie; Hoheisel, Joerg D.] Deutsch Krebsforschungszentrum, Div Funct Genome Anal, D-6900 Heidelberg, Germany; [Keller, Andreas; Borries, Anne; Beier, Markus] Biomarker Discovery Ctr Heidelberg, Heidelberg, Germany; [Costello, Eithne; Greenhalf, William; Neoptolemos, John] Royal Liverpool Univ Hosp, Natl Inst Hlth Res, Pancreas Biomed Res Unit, Liverpool, Merseyside, England; [Costello, Eithne; Greenhalf, William; Neoptolemos, John] Royal Liverpool Univ Hosp, Liverpool Expt Canc Med Ctr, Liverpool, Merseyside, England; [Buechler, Markus; Werner, Jens; Giese, Nathalia] Heidelberg Univ, Dept Surg, D-6900 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Royal Liverpool & Broadgreen University Hospitals NHS Trust; Royal Liverpool University Hospital; University of Liverpool; Ruprecht Karls University Heidelberg	Bauer, AS (corresponding author), Deutsch Krebsforschungszentrum, Div Funct Genome Anal, D-6900 Heidelberg, Germany.	j.hoheisel@dkfz.de	Neoptolemos, John/HGU-7742-2022; Keller, Andreas/ABB-6412-2021; Greenhalf, William/A-2680-2013	Keller, Andreas/0000-0002-5361-0895; Neoptolemos, John/0000-0002-6201-7399; Costello, Eithne/0000-0002-0104-8992; Bauer, Andrea/0000-0002-7919-0497	European Commission; German Federal Ministry of Education and Research (BMBF), MolDiagPaCa project; German Federal Ministry of Education and Research (BMBF), BioRN project; German Federal Ministry of Education and Research (BMBF), PaCaNet project; National Institute for Health Research Pancreas Biomedical Research Unit; Liverpool Experimental Cancer Medicine Centre; National Institute for Health Research [NF-SI-0510-10126] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); German Federal Ministry of Education and Research (BMBF), MolDiagPaCa project(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF), BioRN project(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF), PaCaNet project(Federal Ministry of Education & Research (BMBF)); National Institute for Health Research Pancreas Biomedical Research Unit; Liverpool Experimental Cancer Medicine Centre; National Institute for Health Research(National Institute for Health Research (NIHR))	The work was financially supported by the European Commission and the German Federal Ministry of Education and Research (BMBF) as part of the MolDiagPaCa, BioRN and PaCaNet projects, and funded by the National Institute for Health Research Pancreas Biomedical Research Unit and the Liverpool Experimental Cancer Medicine Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Brandt R, 2004, PANCREATOLOGY, V4, P587, DOI 10.1159/000082241; Buchholz M, 2005, CLIN CANCER RES, V11, P8048, DOI 10.1158/1078-0432.CCR-05-1274; Bussom S, 2010, J PANCREAS, V11, P128; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Dimitriadou E, WEINGESSEL MISC FUNC, pe1071; Fisher R. A., 1946, Statistical methods for research workers.; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Greither T, 2010, INT J CANCER, V126, P73, DOI 10.1002/ijc.24687; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Keller A, 2011, NAT METHODS, V8, P841, DOI [10.1038/nmeth.1682, 10.1038/NMETH.1682]; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lurje G, 2010, J ONCOL, V2010, DOI 10.1155/2010/392652; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; O'Driscoll L, 2007, ANTICANCER RES, V27, P1257; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Schroder C, 2010, MOL CELL PROTEOMICS, V9, P1271, DOI 10.1074/mcp.M900419-MCP200; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Visone R, 2009, AM J PATHOL, V174, P1131, DOI 10.2353/ajpath.2009.080794; Vorwerk S, 2008, NEW BIOTECHNOL, V25, P142, DOI 10.1016/j.nbt.2008.08.005; Wang J, 2009, CANCER PREV RES, V2, P807, DOI 10.1158/1940-6207.CAPR-09-0094; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Weeks ME, 2008, PROTEOM CLIN APPL, V2, P1047, DOI 10.1002/prca.200780164; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0	31	94	98	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34151	10.1371/journal.pone.0034151	http://dx.doi.org/10.1371/journal.pone.0034151			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511932	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600018
J	Rokah, OH; Granot, G; Ovcharenko, A; Modai, S; Pasmanik-Chor, M; Toren, A; Shomron, N; Shpilberg, O				Rokah, Oshrat Hershkovitz; Granot, Galit; Ovcharenko, Adelina; Modai, Shira; Pasmanik-Chor, Metsada; Toren, Amos; Shomron, Noam; Shpilberg, Ofer			Downregulation of Mir-31, Mir-155, and Mir-564 in Chronic Myeloid Leukemia Cells	PLOS ONE			English	Article							MICRORNA EXPRESSION; SIGNALING PATHWAY; CANCER; MUTATIONS; KINASE; GENES; CBL; NORMALIZATION; INVOLVEMENT; SIGNATURES	Background/Aims: MicroRNAs (miRNAs) are short non-coding regulatory RNAs that control gene expression and play an important role in cancer development and progression. However, little is known about the role of miRNAs in chronic myeloid leukemia (CML). Our objective is to decipher a miRNA expression signature associated with CML and to determine potential target genes and signaling pathways affected by these signature miRNAs. Results: Using miRNA microarrays and miRNA real-time PCR we characterized the miRNAs expression profile of CML cell lines and patients in reference to non-CML cell lines and healthy blood. Of all miRNAs tested, miR-31, miR-155, and miR-564 were down-regulated in CML cells. Down-regulation of these miRNAs was dependent on BCR-ABL activity. We next analyzed predicted targets and affected pathways of the deregulated miRNAs. As expected, in K562 cells, the expression of several of these targets was inverted to that of the miRNA putatively regulating them. Reassuringly, the analysis identified CML as the main disease associated with these miRNAs. MAPK, ErbB, mammalian target of rapamycin (mTOR) and vascular endothelial growth factor (VEGF) were the main molecular pathways related with these expression patterns. Utilizing Venn diagrams we found appreciable overlap between the CML-related miRNAs and the signaling pathways-related miRNAs. Conclusions: The miRNAs identified in this study might offer a pivotal role in CML. Nevertheless, while these data point to a central disease, the precise molecular pathway/s targeted by these miRNAs is variable implying a high level of complexity of miRNA target selection and regulation. These deregulated miRNAs highlight new candidate gene targets allowing for a better understanding of the molecular mechanism underlying the development of CML, and propose possible new avenues for therapeutic treatment.	[Rokah, Oshrat Hershkovitz; Granot, Galit; Ovcharenko, Adelina; Shpilberg, Ofer] Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Felsenstein Med Res Ctr, IL-69978 Tel Aviv, Israel; [Modai, Shira; Shomron, Noam] Tel Aviv Univ, Sackler Sch Med, Dept Cell & Dev Biol, IL-69978 Tel Aviv, Israel; [Pasmanik-Chor, Metsada] Tel Aviv Univ, George S Wise Fac Life Sci, Bioinformat Unit, IL-69978 Tel Aviv, Israel; [Toren, Amos] Safra Childrens Hosp, Dept Pediat Hematol Oncol, Tel Hashomer, Israel; [Shpilberg, Ofer] Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Inst Hematol, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine	Rokah, OH (corresponding author), Tel Aviv Univ, Sackler Sch Med, Beilinson Hosp, Felsenstein Med Res Ctr, IL-69978 Tel Aviv, Israel.	galitg@clalit.org.il	Hershkovitz-Rokah, Oshrat/GVT-8614-2022; Hershkovitz-Rokah, Oshrat/GLR-2539-2022					AFAR DEH, 1995, P NATL ACAD SCI USA, V92, P9540, DOI 10.1073/pnas.92.21.9540; Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Barlund M, 2000, J NATL CANCER I, V92, P1252, DOI 10.1093/jnci/92.15.1252; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beghini A, 2000, BLOOD, V95, P726, DOI 10.1182/blood.V95.2.726; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borze I, 2011, LEUKEMIA RES, V35, P188, DOI 10.1016/j.leukres.2010.08.005; Brehme M, 2009, P NATL ACAD SCI USA, V106, P7414, DOI 10.1073/pnas.0900653106; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; COLLINS SJ, 1989, BLOOD, V73, P1028; Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103; de Groot Rolf P., 2000, Molecular Cell Biology Research Communications, V3, P299, DOI 10.1006/mcbr.2000.0231; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; Eguchi M, 1999, BLOOD, V93, P1355, DOI 10.1182/blood.V93.4.1355; Eiring AM, 2008, BLOOD, V111, P816, DOI 10.1182/blood-2007-05-090472; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; Farazi TA, 2011, J PATHOL, V223, P102, DOI 10.1002/path.2806; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Gougopoulou DM, 1996, STEM CELLS, V14, P725, DOI 10.1002/stem.140725; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grossmann V, 2011, LEUKEMIA, V25, P557, DOI 10.1038/leu.2010.298; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hatfield S, 2008, CELL TISSUE RES, V331, P57, DOI 10.1007/s00441-007-0530-3; Hussein K, 2011, ANN HEMATOL, V90, P307, DOI 10.1007/s00277-010-1072-4; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Johnson KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007439; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawauchi K, 2003, BLOOD CELL MOL DIS, V31, P11, DOI 10.1016/S1079-9796(03)00070-6; Kluiver J, 2006, GENE CHROMOSOME CANC, V45, P147, DOI 10.1002/gcc.20273; Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825; LANGDON WY, 1989, P NATL ACAD SCI USA, V86, P1168, DOI 10.1073/pnas.86.4.1168; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu CJ, 2010, ORAL DIS, V16, P360, DOI 10.1111/j.1601-0825.2009.01646.x; Liu JH, 2004, LEUKEMIA LYMPHOMA, V45, P2419, DOI 10.1080/10428190400003317; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Meltzer PS, 2005, NATURE, V435, P745, DOI 10.1038/435745a; Milella Michele, 2003, Rev Clin Exp Hematol, V7, P160; Moussay E, 2011, P NATL ACAD SCI USA, V108, P6573, DOI 10.1073/pnas.1019557108; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Ozaki K, 2010, BIOCHEM BIOPH RES CO, V391, P1610, DOI 10.1016/j.bbrc.2009.12.086; Patel H, 2006, GENE CHROMOSOME CANC, V45, P1121, DOI 10.1002/gcc.20377; Peters DG, 2001, BLOOD, V97, P1404, DOI 10.1182/blood.V97.5.1404; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Redig AJ, 2011, LEUKEMIA LYMPHOMA, V52, P45, DOI 10.3109/10428194.2010.546919; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Reuter CWM, 2000, BLOOD, V96, P1655, DOI 10.1182/blood.V96.5.1655.h8001655_1655_1669; Savage DG, 2002, NEW ENGL J MED, V346, P683, DOI 10.1056/NEJMra013339; Shomron N, 2009, J BIOMED BIOTECHNOL, P1; Sillaber C, 2004, EUR J CLIN INVEST, V34, P2, DOI 10.1111/j.0960-135X.2004.01365.x; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang WX, 2010, CANCER RES, V70, P9137, DOI 10.1158/0008-5472.CAN-10-1684; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhao HF, 2010, CRIT REV ONCOL HEMAT, V74, P149, DOI 10.1016/j.critrevonc.2009.05.001; Zimmerman AL, 2011, CANCER LETT, V300, P10, DOI 10.1016/j.canlet.2010.09.019	61	81	90	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e35501	10.1371/journal.pone.0035501	http://dx.doi.org/10.1371/journal.pone.0035501			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511990	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338600076
J	Yang, XJ; Baskin, CC; Baskin, JM; Liu, GZ; Huang, ZY				Yang, Xuejun; Baskin, Carol C.; Baskin, Jerry M.; Liu, Guangzheng; Huang, Zhenying			Seed Mucilage Improves Seedling Emergence of a Sand Desert Shrub	PLOS ONE			English	Article							ARTEMISIA-SPHAEROCEPHALA ASTERACEAE; LIGHT PENETRATION; GERMINATION; ESTABLISHMENT; BURIAL; DORMANCY; DUNES; SURVIVAL; ANNUALS; ADAPTATIONS	The success of seedling establishment of desert plants is determined by seedling emergence response to an unpredictable precipitation regime. Sand burial is a crucial and frequent environmental stress that impacts seedling establishment on sand dunes. However, little is known about the ecological role of seed mucilage in seedling emergence in arid sandy environments. We hypothesized that seed mucilage enhances seedling emergence in a low precipitation regime and under conditions of sand burial. In a greenhouse experiment, two types of Artemisia sphaerocephala achenes (intact and demucilaged) were exposed to different combinations of burial depth (0, 5, 10, 20, 40 and 60 mm) and irrigation regimes (low, medium and high, which simulated the precipitation amount and frequency in May, June and July in the natural habitat, respectively). Seedling emergence increased with increasing irrigation. It was highest at 5 mm sand burial depth and ceased at burial depths greater than 20 mm in all irrigation regimes. Mucilage significantly enhanced seedling emergence at 0, 5 and 10 mm burial depths in low irrigation, at 0 and 5 mm burial depths in medium irrigation and at 0 and 10 mm burial depths in high irrigation. Seed mucilage also reduced seedling mortality at the shallow sand burial depths. Moreover, mucilage significantly affected seedling emergence time and quiescence and dormancy percentages. Our findings suggest that seed mucilage plays an ecologically important role in successful seedling establishment of A. sphaerocephala by improving seedling emergence and reducing seedling mortality in stressful habitats of the sandy desert environment.	[Yang, Xuejun; Huang, Zhenying] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Yang, Xuejun; Liu, Guangzheng] Jiangxi Acad Forestry, Nanchang, Peoples R China; [Baskin, Carol C.; Baskin, Jerry M.] Univ Kentucky, Dept Biol, Lexington, KY USA; [Baskin, Carol C.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY USA	Chinese Academy of Sciences; Institute of Botany, CAS; University of Kentucky; University of Kentucky	Huang, ZY (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	zhenying@ibcas.ac.cn	Yang, Xuejun/B-4718-2014	Yang, Xuejun/0000-0002-8595-545X	Key Basic Research and Development Plan of China [2010CB951304, 2012BAC01B05]; National Natural Science Foundation of People's Republic of China [31170383, 30872074, 30970461]	Key Basic Research and Development Plan of China(National Basic Research Program of China); National Natural Science Foundation of People's Republic of China(National Natural Science Foundation of China (NSFC))	Funds for this study were provided by the Key Basic Research and Development Plan of China (2010CB951304, 2012BAC01B05) and the National Natural Science Foundation of the People's Republic of China, (31170383, 30872074, 30970461). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSKY Z, 1983, OECOLOGIA, V57, P328, DOI 10.1007/BF00377176; AHLGREN IF, 1960, BOT REV, V26, P483, DOI 10.1007/BF02940573; Balestri E, 2004, J COASTAL RES, V20, P761, DOI 10.2112/1551-5036(2004)20[761:GAEECO]2.0.CO;2; Baskin CC, 1998, SEEDS ECOLOGY BIOGEO; BASKIN JM, 1985, BIOSCIENCE, V35, P492, DOI 10.2307/1309817; BEATLEY JC, 1967, ECOLOGY, V48, P745, DOI 10.2307/1933732; BENVENUTI S, 1995, WEED SCI, V43, P389, DOI 10.1017/S0043174500081376; Burmeier S, 2010, SEED SCI RES, V20, P189, DOI 10.1017/S0960258510000127; Busse MD, 2005, INT J WILDLAND FIRE, V14, P267, DOI 10.1071/WF04062; Cabin RJ, 2000, J ECOL, V88, P293, DOI 10.1046/j.1365-2745.2000.00444.x; COOLBEAR P, 1984, J EXP BOT, V35, P1609, DOI 10.1093/jxb/35.11.1609; Eckstein RL, 2005, J ECOL, V93, P807, DOI 10.1111/j.1365-2745.2005.01015.x; Editorial Board of the Flora of China of Chinese Academy of Sciences, 1991, FLOR CHIN, V76; Fahn A, 1990, PLANT ANATOMY; Farooq M, 2005, J INTEGR PLANT BIOL, V47, P187, DOI 10.1111/j.1744-7909.2005.00031.x; GARWOOD NC, 1985, AM J BOT, V72, P1095, DOI 10.2307/2443455; Greipsson S, 1996, ANN BOT-LONDON, V78, P611, DOI 10.1006/anbo.1996.0168; Gutterman Y, 1997, ISR J PLANT SCI, V45, P317, DOI 10.1080/07929978.1997.10676695; Gutterman Y., 1993, SEED GERMINATION DES; Gutterman Yitzchak, 2002, P1; HEDGE I C, 1970, Notes from the Royal Botanic Garden Edinburgh, V30, P79; Hodkinson DJ, 1998, FUNCT ECOL, V12, P762, DOI 10.1046/j.1365-2435.1998.00256.x; Huang Z, 1999, S AFR J BOT, V65, P187, DOI 10.1016/S0254-6299(15)30972-8; Huang ZY, 2008, ANN BOT-LONDON, V101, P277, DOI 10.1093/aob/mcm089; Huang ZY, 2004, PLANT SOIL, V259, P231, DOI 10.1023/B:PLSO.0000020971.66784.fc; Huang ZY, 1998, J ARID ENVIRON, V38, P27, DOI 10.1006/jare.1997.0329; Huang ZY, 2000, ACTA BOT SIN, V42, P71; Huang ZY, 2000, ISRAEL J PLANT SCI, V48, P255, DOI 10.1560/49G5-CNE7-H6UD-PWVW; JORDAN PW, 1981, ECOLOGY, V62, P901, DOI 10.2307/1936987; LEE JA, 1985, VEGETATIO, V62, P319, DOI 10.1007/BF00044759; Martinez ML, 2002, CAN J BOT, V80, P416, DOI 10.1139/B02-027; Maun MA, 1998, CAN J BOT, V76, P713, DOI 10.1139/cjb-76-5-713; MAUN MA, 1994, VEGETATIO, V111, P59; MAUN MA, 1986, AM J BOT, V73, P450, DOI 10.2307/2444088; Milberg P, 2000, SEED SCI RES, V10, P99, DOI 10.1017/S0960258500000118; Moles AT, 2004, OIKOS, V106, P193, DOI 10.1111/j.0030-1299.2004.13101.x; Padgett PE, 2000, ENVIRON MANAGE, V26, P427, DOI 10.1007/s002670010100; PEMADASA MA, 1975, J ECOL, V63, P41, DOI 10.2307/2258840; Penfield S, 2001, PLANT CELL, V13, P2777, DOI 10.1105/tpc.13.12.2777; Redondo-Gomez S, 2011, J ARID ENVIRON, V75, P309, DOI 10.1016/j.jaridenv.2010.10.014; SWARBRICK JT, 1971, BOT J LINN SOC, V64, P157, DOI 10.1111/j.1095-8339.1971.tb02142.x; Thapliyal RC, 2008, AUST J BOT, V56, P583, DOI 10.1071/BT08022; THOMPSON K, 1987, NEW PHYTOL, V106, P23; Tobe K, 2005, ANN BOT-LONDON, V95, P649, DOI 10.1093/aob/mci060; VANDERVALK AG, 1974, CAN J BOT, V52, P1057, DOI 10.1139/b74-135; Vleeshouwers LM, 1995, J ECOL, V83, P1031, DOI 10.2307/2261184; WELLER SG, 1985, ECOLOGY, V66, P1893, DOI 10.2307/2937385; WOOLLEY JT, 1978, PLANT PHYSIOL, V61, P597, DOI 10.1104/pp.61.4.597; Yang XJ, 2012, PLANT CELL ENVIRON, V35, P872, DOI 10.1111/j.1365-3040.2011.02459.x; Yang XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024346; Yang XJ, 2010, PLANT PHYSIOL BIOCH, V48, P131, DOI 10.1016/j.plaphy.2009.12.006; ZHANG JH, 1993, CAN J BOT, V71, P551, DOI 10.1139/b93-061; ZHANG JH, 1994, AM J BOT, V81, P387, DOI 10.2307/2445486; Zheng YR, 2005, ANN BOT-LONDON, V95, P1237, DOI 10.1093/aob/mci138; Zhu YJ, 2007, FLORA, V202, P249, DOI 10.1016/j.flora.2006.05.006	55	36	43	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34597	10.1371/journal.pone.0034597	http://dx.doi.org/10.1371/journal.pone.0034597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511952	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338600038
J	Diez, H; Garrido, JJ; Wandosell, F				Diez, Hector; Garrido, Juan Jose; Wandosell, Francisco			Specific Roles of Akt iso Forms in Apoptosis and Axon Growth Regulation in Neurons	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; RIBOSOMAL-PROTEIN S6; CELL-SURVIVAL; MAMMALIAN TARGET; PHYSIOLOGICAL ROLES; PKB/AKT ISOFORMS; RAPAMYCIN MTOR; MICE LACKING; CROSS-TALK; FACTOR-I	Akt is a member of the AGC kinase family and consists of three isoforms. As one of the major regulators of the class I PI3 kinase pathway, it has a key role in the control of cell metabolism, growth, and survival. Although it has been extensively studied in the nervous system, we have only a faint knowledge of the specific role of each isoform in differentiated neurons. Here, we have used both cortical and hippocampal neuronal cultures to analyse their function. We characterized the expression and function of Akt isoforms, and some of their substrates along different stages of neuronal development using a specific shRNA approach to elucidate the involvement of each isoform in neuron viability, axon development, and cell signalling. Our results suggest that three Akt isoforms show substantial compensation in many processes. However, the disruption of Akt2 and Akt3 significantly reduced neuron viability and axon length. These changes correlated with a tendency to increase in active caspase 3 and a decrease in the phosphorylation of some elements of the mTORC1 pathway. Indeed, the decrease of Akt2 and more evident the inhibition of Akt3 reduced the expression and phosphorylation of S6. All these data indicate that Akt2 and Akt3 specifically regulate some aspects of apoptosis and cell growth in cultured neurons and may contribute to the understanding of mechanisms of neuron death and pathologies that show deregulated growth.	[Diez, Hector; Garrido, Juan Jose; Wandosell, Francisco] Univ Autonoma Madrid, CSIC UAM, Ctr Invest Biomed Red Enfermedades Neudenge, Madrid, Spain; [Diez, Hector; Garrido, Juan Jose; Wandosell, Francisco] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Garrido, Juan Jose] CSIC, Dept Mol Cellular & Dev Neurobiol, Lab Neuronal Polar, Inst Cajal, Madrid, Spain	Autonomous University of Madrid; CIBERNED; Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Wandosell, F (corresponding author), Univ Autonoma Madrid, CSIC UAM, Ctr Invest Biomed Red Enfermedades Neudenge, Madrid, Spain.	fwandosell@cbm.uam.es	Wandosell, Francisco/AAV-6391-2020; Garrido, Juan Jose/E-6782-2012; Wandosell, Francisco/G-6105-2015	Garrido, Juan Jose/0000-0002-4499-4487; Wandosell, Francisco/0000-0001-6537-2321	"Online" Center for Biomedical Research on Neurodegenerative Diseases (CIBERNED); "Direccion General" of Science and Technology-DGCYT [SAF2009-12249-C02-01, SAF2009-12249-C02-02, EU-FP7-2009-CT222887]; Areces Foundation; CSIC; European Social Fund; CIBERNED	"Online" Center for Biomedical Research on Neurodegenerative Diseases (CIBERNED); "Direccion General" of Science and Technology-DGCYT; Areces Foundation; CSIC; European Social Fund(European Social Fund (ESF)); CIBERNED(Instituto de Salud Carlos III)	This work was supported by grants from "Online" Center for Biomedical Research on Neurodegenerative Diseases (CIBERNED)(which was an initiative of the ISCIII); National Grants from "Direccion General" of Science and Technology-DGCYT (references: SAF2009-12249-C02-01 to F.W. and SAF2009-12249-C02-02 to J.J.G.) and EU-FP7-2009-CT222887 to F.W.; and by an Institutional grant from the Areces Foundation. H.D. was supported by CSIC through the I3P program (co-funded by the European Social Fund) and by CIBERNED. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Andrieux J, 2008, EUR J MED GENET, V51, P87, DOI 10.1016/j.ejmg.2007.10.004; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Barnes AP, 2009, ANN REV NEUROSCI; Boland E, 2007, AM J HUM GENET, V81, P292, DOI 10.1086/519999; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Calleja V, 2009, PLOS BIOL, V7, P189, DOI 10.1371/journal.pbio.1000017; Cardona-Gomez GP, 2002, J STEROID BIOCHEM, V83, P211, DOI 10.1016/S0960-0760(02)00261-3; Chalhoub N, 2006, BRAIN RES, V1100, P32, DOI 10.1016/j.brainres.2006.05.013; Chalhoub N, 2009, GENE DEV, V23, P1619, DOI 10.1101/gad.1799609; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Crowder RJ, 2000, J BIOL CHEM, V275, P34266, DOI 10.1074/jbc.M006160200; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Dummler B, 2007, BIOCHEM SOC T, V35, P231, DOI 10.1042/BST0350231; Easton RM, 2005, MOL CELL BIOL, V25, P1869, DOI 10.1128/MCB.25.5.1869-1878.2005; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Endersby R, 2011, CANCER RES, V71, P4106, DOI 10.1158/0008-5472.CAN-10-3597; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Fishwick KJ, 2010, DEV BIOL, V338, P215, DOI 10.1016/j.ydbio.2009.12.001; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gericke A, 2006, GENE, V374, P1, DOI 10.1016/j.gene.2006.02.024; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Gottlieb TM, 2002, ONCOGENE, V21, P1299, DOI 10.1038/sj.onc.1205181; Guo W, 2007, DEV BIOL, V306, P457, DOI 10.1016/j.ydbio.2007.03.019; Han J, 2008, MOL CELL NEUROSCI, V39, P118, DOI 10.1016/j.mcn.2008.06.003; Heron-Milhavet L, 2011, HISTOL HISTOPATHOL, V26, P651, DOI 10.14670/HH-26.651; Hou ZB, 2007, J BIOL CHEM, V282, P6922, DOI 10.1074/jbc.M607836200; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Garrido JJ, 2007, FEBS LETT, V581, P1579, DOI 10.1016/j.febslet.2007.03.018; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee-Fruman KK, 1999, ONCOGENE, V18, P5108, DOI 10.1038/sj.onc.1202894; Li YH, 2008, J BIOL CHEM, V283, P33784, DOI 10.1074/jbc.M802431200; Liao FF, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.274pe36; Lintas C, 2009, J MED GENET, V46, P1, DOI 10.1136/jmg.2008.060871; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Mandell JW, 1996, J NEUROSCI, V16, P5727; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Mendez P, 2006, FRONT NEUROENDOCRIN, V27, P391, DOI 10.1016/j.yfrne.2006.09.001; Meyuhas O, 2008, INT REV CEL MOL BIO, V268, P1, DOI 10.1016/S1937-6448(08)00801-0; Morita T, 2009, J BIOL CHEM, V284, P27734, DOI 10.1074/jbc.M109.008177; Ohba N, 2004, NEUROSCI LETT, V359, P159, DOI 10.1016/j.neulet.2004.02.029; Pap M, 1998, J BIOL CHEM, V273, P19929, DOI 10.1074/jbc.273.32.19929; Papst PJ, 1998, J BIOL CHEM, V273, P15077, DOI 10.1074/jbc.273.24.15077; Parcellier A, 2008, CELL SIGNAL, V20, P21, DOI 10.1016/j.cellsig.2007.07.010; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Poot M, 2008, EUR J MED GENET, V51, P689, DOI 10.1016/j.ejmg.2008.07.001; Priya S, 2008, HEPATOL RES, V38, P1221, DOI 10.1111/j.1872-034X.2008.00394.x; Pullen N, 1997, FEBS LETT, V410, P78, DOI 10.1016/S0014-5793(97)00323-2; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Robinson Shenandoah, 2006, Neurosurg Focus, V20, pE6; Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sandsmark DK, 2007, HISTOL HISTOPATHOL, V22, P895, DOI 10.14670/HH-22.895; Santi SA, AM J PHYSL CELL PHYS, V298, pC580; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schultze Simon M., 2011, Archives of Physiology and Biochemistry, V117, P70, DOI 10.3109/13813455.2010.539236; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Slee EA, 1999, CELL DEATH DIFFER, V6, P1067, DOI 10.1038/sj.cdd.4400601; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Warby SC, 2009, MOL CELL NEUROSCI, V40, P121, DOI 10.1016/j.mcn.2008.09.007; Wildonger J, 2008, GENE DEV, V22, P2447, DOI 10.1101/gad.1724108; Yamaguchi H, 2001, ONCOGENE, V20, P7779, DOI 10.1038/sj.onc.1204984; Yan D, 2006, J CELL BIOL, V174, P415, DOI 10.1083/jcb.200511028; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350; Yoshimura T, 2006, BIOCHEM BIOPH RES CO, V340, P62, DOI 10.1016/j.bbrc.2005.11.147; Zala D, 2008, HUM MOL GENET, V17, P3837, DOI 10.1093/hmg/ddn281	96	58	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e32715	10.1371/journal.pone.0032715	http://dx.doi.org/10.1371/journal.pone.0032715			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509246	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600004
J	Drake, AL; Roxby, AC; Kiarie, J; Richardson, BA; Wald, A; John-Stewart, G; Farquhar, C				Drake, Alison L.; Roxby, Alison C.; Kiarie, James; Richardson, Barbra A.; Wald, Anna; John-Stewart, Grace; Farquhar, Carey			Infant Safety during and after Maternal Valacyclovir Therapy in Conjunction with Antiretroviral HIV-1 Prophylaxis in a Randomized Clinical Trial	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; INTRAVENOUS ACYCLOVIR; HERPES; PHARMACOKINETICS; VALACICLOVIR; PREGNANCY; INFECTION; WOMEN; RISK	Background: Maternal administration of the acyclovir prodrug valacyclovir is compatible with pregnancy and breastfeeding. However, the safety profile of prolonged infant and maternal exposure to acyclovir in the context of antiretrovirals (ARVs) for prevention of mother-to-child HIV-1 transmission (PMTCT) has not been described. Methods: Pregnant Kenyan women co-infected with HIV-1/HSV-2 with CD4 counts > 250 cells/mm(3) were enrolled at 34 weeks gestation and randomized to twice daily 500 mg valacyclovir or placebo until 12 months postpartum. Women received zidovudine from 28 weeks gestation and single dose nevirapine was given to women and infants at the time of delivery for PMTCT. Infant blood was collected at 6 weeks for creatinine and ALT. Breast milk specimens were collected at 2 weeks postpartum from 71 women in the valacyclovir arm; acyclovir levels were determined for a random sample of 44 (62%) specimens. Fisher's Exact and Wilcoxon rank-sum tests were used for analysis. Results: One hundred forty-eight women were randomized and 146 mother-infant pairs were followed postpartum. PMTCT ARVs were administered to 98% of infants and all mothers. Valacyclovir was not associated with infant or maternal toxicities or adverse events, and no congenital malformations were observed. Infant creatinine levels were all normal (< 0.83 mg/dl) and median creatinine (median 0.50 mg/dl) and infant growth did not differ between study arms. Acyclovir was detected in 35 (80%) of 44 breast milk samples collected at 2 weeks postpartum. Median and maximum acyclovir levels were 2.62 and 10.15 mg/ml, respectively (interquartile range 0.6-4.19). Conclusions: Exposure to PMTCT ARVs and acyclovir after maternal administration of valacyclovir during pregnancy and postpartum to women co-infected with HIV-1/HSV-2 was not associated with an increase in infant or maternal toxicities or adverse events.	[Drake, Alison L.; Richardson, Barbra A.; John-Stewart, Grace; Farquhar, Carey] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Roxby, Alison C.; John-Stewart, Grace; Farquhar, Carey] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Wald, Anna; John-Stewart, Grace; Farquhar, Carey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Wald, Anna] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [John-Stewart, Grace] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kiarie, James] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya; [Richardson, Barbra A.; Wald, Anna] Fred Hutchinson Canc Res Ctr, Div Vaccine Dis, Seattle, WA 98104 USA; [Richardson, Barbra A.; Wald, Anna] Fred Hutchinson Canc Res Ctr, Div Infect Dis, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Nairobi; Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Drake, AL (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	adrake2@uw.edu	John-Stewart, Grace/L-3650-2019; John-Stewart, Grace/U-3351-2019; Wald, Anna/B-6272-2012	Wald, Anna/0000-0003-3486-6438; Roxby, Alison/0000-0001-9449-8062; John-Stewart, Grace/0000-0002-4301-1573; kiarie, james/0000-0003-4180-7858	National Institutes of Health (NIH) [R03 HD057773, R03 HD057773-02S1, K24 AI087399, K24 HD054314, K24 AI071113, PO1 AI30731]; University of Washington CFAR (UW CFAR) [P30 AI027757, T32 AI0714032]; Fogarty International Center (FIC) [D43-TW00007, FIC R24 TW007988]; University of Washington Center for AIDS Research (UW CFAR) core [AI027757]; University of Washington Department of Epidemiology; Puget Sound Partners for Global Health Research Technology; University of Washington; GlaxoSmithKline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD054314] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD057773] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000007, R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI071113, P30AI027757, K24AI087399, P01AI030731] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington CFAR (UW CFAR); Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); University of Washington Center for AIDS Research (UW CFAR) core; University of Washington Department of Epidemiology(University of Washington); Puget Sound Partners for Global Health Research Technology; University of Washington(University of Washington); GlaxoSmithKline(GlaxoSmithKline); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (NIH) [R03 HD057773, R03 HD057773-02S1, and K24 AI087399 to CF; K24 HD054314 to G.J.S.; K24 AI071113 and PO1 AI30731 to AW; University of Washington CFAR (UW CFAR) P30 AI027757; International AIDS Research and Training Program by the Fogarty International Center (FIC) D43-TW00007; FIC R24 TW007988 to ACR; University of Washington Center for AIDS Research (UW CFAR) core P30 AI027757; UW CFAR T32 AI0714032 to ALD], University of Washington Department of Epidemiology Small Grants Program; Puget Sound Partners for Global Health Research Technology Grant to BAR, and University of Washington Royalty Research Fund Grant [ 4027] to C. F. GlaxoSmithKline donated study drug (http://www.gsk.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ALD, ACR, JK, GJS, BAR, and CF declared that no competing interests exist. AW received grant support from GlaxoSmithKline and has been a consultant for AiCuris. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	*ACOG COMM PRACT B, 2007, OBSTET GYNECOL, V109, P1489; American Academy of Pediatrics, 2009, HERP SIMPL RED BOOK, P363; ANDERSEN PK, 1982, ANN STAT, V10, P1100, DOI 10.1214/aos/1176345976; Andrews WW, 2006, AM J OBSTET GYNECOL, V194, P774, DOI 10.1016/j.ajog.2005.11.051; Brown SD, 2003, ANTIMICROB AGENTS CH, V47, P991, DOI 10.1128/AAC.47.3.991-996.2003; Conant MA, 2002, INT J STD AIDS, V13, P12, DOI 10.1258/0956462021924550; Drake AL, 2007, OBSTET GYNECOL, V109, P403, DOI 10.1097/01.AOG.0000251511.27725.5c; Drake AL, 2012, J INFECT DIS, V205, P366, DOI 10.1093/infdis/jir766; FRENKEL LM, 1991, AM J OBSTET GYNECOL, V164, P569, DOI 10.1016/S0002-9378(11)80023-2; Hitti J, 1997, AM J OBSTET GYNECOL, V177, P450, DOI 10.1016/S0002-9378(97)70214-X; Hollier LM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004946.pub2; Jacquemard F, 2007, BJOG-INT J OBSTET GY, V114, P1113, DOI 10.1111/j.1471-0528.2007.01308.x; John GC, 2001, J INFECT DIS, V183, P206, DOI 10.1086/317918; Kimberlin DW, 2011, NEW ENGL J MED, V365, P1284, DOI 10.1056/NEJMoa1003509; Kimberlin DF, 1998, AM J OBSTET GYNECOL, V179, P846, DOI 10.1016/S0002-9378(98)70176-0; Kimberlin DW, 2001, PEDIATRICS, V108, P230, DOI 10.1542/peds.108.2.230; Lingappa JR, 2010, LANCET, V375, P824, DOI 10.1016/S0140-6736(09)62038-9; Mbopi-Keou FX, 2000, J INFECT DIS, V182, P1090, DOI 10.1086/315836; National Institute for Allergy and Infectious Disease (NIAID), DIV AIDS TOX TABL GR; Pasternak B, 2010, JAMA-J AM MED ASSOC, V304, P859, DOI 10.1001/jama.2010.1206; Sheffield JS, 2002, AM J OBSTET GYNECOL, V186, P100, DOI 10.1067/mob.2002.119183; Stone KM, 2004, BIRTH DEFECTS RES A, V70, P201, DOI 10.1002/bdra.20013; WELLER S, 1993, CLIN PHARMACOL THER, V54, P595, DOI 10.1038/clpt.1993.196; WHO, 2006, WHO CHILD GROWTH STA	24	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34635	10.1371/journal.pone.0034635	http://dx.doi.org/10.1371/journal.pone.0034635			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509337	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600043
J	Kass, DJ; Rattigan, E; Kahloon, R; Loh, K; Yu, LY; Savir, A; Markowski, M; Saqi, A; Rajkumar, R; Ahmad, F; Champion, HC				Kass, Daniel J.; Rattigan, Eileen; Kahloon, Rehan; Loh, Katrina; Yu, Liyang; Savir, Asaf; Markowski, Mark; Saqi, Anjali; Rajkumar, Revathi; Ahmad, Ferhaan; Champion, Hunter C.			Early Treatment with Fumagillin, an Inhibitor of Methionine Aminopeptidase-2, Prevents Pulmonary Hypertension in Monocrotaline-Injured Rats	PLOS ONE			English	Article							ANTI-ANGIOGENIC AGENT; GROWTH-FACTOR EXPRESSION; ARTERIAL-HYPERTENSION; RIGHT VENTRICLE; DNA-SYNTHESIS; TNP-470; PROLIFERATION; DYSFUNCTION; PACLITAXEL; DISCOVERY	Pulmonary Hypertension (PH) is a pathophysiologic condition characterized by hypoxemia and right ventricular strain. Proliferation of fibroblasts, smooth muscle cells, and endothelial cells is central to the pathology of PH in animal models and in humans. Methionine aminopeptidase-2 (MetAP2) regulates proliferation in a variety of cell types including endothelial cells, smooth muscle cells, and fibroblasts. MetAP2 is inhibited irreversibly by the angiogenesis inhibitor fumagillin. We have previously found that inhibition of MetAP2 with fumagillin in bleomycin-injured mice decreased pulmonary fibrosis by selectively decreasing the proliferation of lung myofibroblasts. In this study, we investigated the role of fumagillin as a potential therapy in experimental PH. In vivo, treatment of rats with fumagillin early after monocrotaline injury prevented PH and right ventricular remodeling by decreasing the thickness of the medial layer of the pulmonary arteries. Treatment with fumagillin beginning two weeks after monocrotaline injury did not prevent PH but was associated with decreased right ventricular mass and decreased cardiomyocyte hypertrophy, suggesting a direct effect of fumagillin on right ventricular remodeling. Incubation of rat pulmonary artery smooth muscle cells (RPASMC) with fumagillin and MetAP2-targeting siRNA inhibited proliferation of RPASMC in vitro. Platelet-derived growth factor, a growth factor that is important in the pathogenesis of PH and stimulates proliferation of fibroblasts and smooth muscle cells, strongly increased expression of MetP2. By immunohistochemistry, we found that MetAP2 was expressed in the lesions of human pulmonary arterial hypertension. We propose that fumagillin may be an effective adjunctive therapy for treating PH in patients.	[Kass, Daniel J.; Kahloon, Rehan; Yu, Liyang; Champion, Hunter C.] Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA; [Kass, Daniel J.; Kahloon, Rehan; Yu, Liyang; Champion, Hunter C.] Dorothy P & Richard P Simmons Ctr Interstitial Lu, Pittsburgh, PA USA; [Rattigan, Eileen] Geisinger Hlth Syst, Dept Cardiol, Wilkes Barre, PA USA; [Loh, Katrina; Savir, Asaf; Markowski, Mark] Columbia Univ Coll Phys & Surg, Dept Med, Div Pulm Allergy & Crit Care Med, New York, NY 10032 USA; [Saqi, Anjali] Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA; [Rajkumar, Revathi; Ahmad, Ferhaan; Champion, Hunter C.] Univ Pittsburgh, Sch Med, Dept Med, Cardiovasc Inst, Pittsburgh, PA USA; [Ahmad, Ferhaan; Champion, Hunter C.] Univ Pittsburgh, Sch Med, Vasc Med Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Geisinger Health System; Columbia University; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kass, DJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15260 USA.	kassd2@upmc.edu		Ahmad, Ferhaan/0000-0003-2877-4641	Entelligence Scholars in Pulmonary Hypertension; Actelion Pharmaceuticals; National Institutes of Health (NIH) [UL1 RR024156, 5P30 ES009089-11]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES009089] Funding Source: NIH RePORTER	Entelligence Scholars in Pulmonary Hypertension; Actelion Pharmaceuticals; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded in part by a peer-reviewed grant administered by the Entelligence Scholars in Pulmonary Hypertension and funded by Actelion Pharmaceuticals. This work was also funded by National Institutes of Health (NIH) grants UL1 RR024156 and 5P30 ES009089-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Baisch H, 1990, Methods Cell Biol, V33, P217; Balasubramaniam V, 2003, AM J PHYSIOL-LUNG C, V284, pL826, DOI 10.1152/ajplung.00199.2002; Barst RJ, 2006, EUR RESPIR J, V28, P1195, DOI 10.1183/09031936.06.00044406; Bogaard HJ, 2010, AM J RESP CRIT CARE, V182, P652, DOI 10.1164/rccm.201003-0335OC; Bogaard HJ, 2009, CIRCULATION, V120, P1951, DOI 10.1161/CIRCULATIONAHA.109.883843; Brakenhielm E, 2004, CIRC RES, V94, P1579, DOI 10.1161/01.RES.0000132745.76882.70; Bridges RS, 2009, AM J PATHOL, V175, P2351, DOI 10.2353/ajpath.2009.080954; Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005; Champion HC, 2009, CIRCULATION, V120, P992, DOI 10.1161/CIRCULATIONAHA.106.674028; Daley E, 2008, J EXP MED, V205, P361, DOI 10.1084/jem.20071008; Datta B, 2000, BIOCHIMIE, V82, P95, DOI 10.1016/S0300-9084(00)00383-7; Denton MD, 2004, TRANSPLANTATION, V78, P1218, DOI 10.1097/01.TP.0000137266.30134.02; Faber MJ, 2006, AM J PHYSIOL-HEART C, V291, pH1580, DOI 10.1152/ajpheart.00286.2006; Faber MJ, 2007, J MOL CELL CARDIOL, V43, P197, DOI 10.1016/j.yjmcc.2007.05.002; Griffith EC, 1997, CHEM BIOL, V4, P461, DOI 10.1016/S1074-5521(97)90198-8; Halpern Scott D, 2008, Proc Am Thorac Soc, V5, P631, DOI 10.1513/pats.200802-019SK; Herbst RS, 2002, J CLIN ONCOL, V20, P4440, DOI 10.1200/JCO.2002.04.006; Huang ZH, 2003, WORLD J GASTROENTERO, V9, P281, DOI 10.3748/wjg.v9.i2.281; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Humbert M, 1998, EUR RESPIR J, V11, P554; INGBER D, 1990, NATURE, V348, P555, DOI 10.1038/348555a0; Kass D, 2007, AM J RESP CELL MOL, V37, P193, DOI 10.1165/rcmb.2006-0352OC; Katzenstein HM, 1999, CLIN CANCER RES, V5, P4273; Kim S, 2004, CANCER RES, V64, P2984, DOI 10.1158/0008-5472.CAN-04-0019; Koyama H, 1996, CIRC RES, V79, P757, DOI 10.1161/01.RES.79.4.757; Kudelka AP, 1997, CLIN CANCER RES, V3, P1501; Lappin PB, 1997, TOXICOL PATHOL, V25, P372, DOI 10.1177/019262339702500405; Liu SP, 1998, SCIENCE, V282, P1324, DOI 10.1126/science.282.5392.1324; McLaughlin VV, 2005, EUR RESPIR J, V25, P244, DOI 10.1183/09031936.05.00054804; Ohta Y, 1997, BRIT J CANCER, V75, P512, DOI 10.1038/bjc.1997.89; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC; Rajkumar R, 2010, AM J PHYSIOL-HEART C, V298, pH1235, DOI 10.1152/ajpheart.00254.2009; Rubin Lewis J, 2006, Proc Am Thorac Soc, V3, P111, DOI 10.1513/pats.200510-112JH; Schermuly RT, 2005, J CLIN INVEST, V115, P2811, DOI 10.1172/JCI24838; Sin N, 1997, P NATL ACAD SCI USA, V94, P6099, DOI 10.1073/pnas.94.12.6099; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Tran HT, 2004, CANCER CHEMOTH PHARM, V54, P308, DOI 10.1007/s00280-004-0816-z; Turk BE, 1999, CHEM BIOL, V6, P823, DOI 10.1016/S1074-5521(99)80129-X; Umar S, 2011, AM J RESP CRIT CARE; Wang YQ, 2000, HEPATOLOGY, V32, P980, DOI 10.1053/jhep.2000.18658; Warder SE, 2008, J PROTEOME RES, V7, P4807, DOI 10.1021/pr800388p; Yeh JRJ, 2000, P NATL ACAD SCI USA, V97, P12782, DOI 10.1073/pnas.97.23.12782; Yoshio Y, 2004, KIDNEY INT, V66, P1677, DOI 10.1111/j.1523-1755.2004.00935.x; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P6427, DOI 10.1073/pnas.97.12.6427; Zou YZ, 2011, J MOL CELL CARDIOL, V51, P821, DOI 10.1016/j.yjmcc.2011.07.030; Zuckerbraun BS, 2010, CIRCULATION, V121, P98, DOI 10.1161/CIRCULATIONAHA.109.891077	50	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35388	10.1371/journal.pone.0035388	http://dx.doi.org/10.1371/journal.pone.0035388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509410	Green Published, Green Accepted, gold			2022-12-27	WOS:000305336600104
J	Singh, A				Singh, Ashish			Gender Based Within-Household Inequality in Childhood Immunization in India: Changes over Time and across Regions	PLOS ONE			English	Article							SEX-SELECTIVE ABORTIONS; SON PREFERENCE; HEALTH-CARE; NUTRITIONAL-STATUS; FERTILITY DECLINE; FEMALE-CHILDREN; RURAL INDIA; MORTALITY; FAMILY; BIAS	Background and Objectives: Despite India's substantial economic growth in the past two decades, girls in India are discriminated against in access to preventive healthcare including immunizations. Surprisingly, no study has assessed the contribution of gender based within-household discrimination to the overall inequality in immunization status of Indian children. This study therefore has two objectives: to estimate the gender based within-household inequality (GWHI) in immunization status of Indian children and to examine the inter-regional and inter-temporal variations in the GWHI. Data and Methods: The present study used households with a pair of male-female siblings (aged 1-5 years) from two rounds of National Family Health Survey (NFHS, 1992-93 and 2005-06). The overall inequality in the immunization status (after controlling for age and birth order) of children was decomposed into within-households and between-households components using Mean log deviation to obtain the GWHI component. The analysis was conducted at the all-India level as well as for six specified geographical regions and at two time points (1992-93 and 2005-06). Household fixed-effects models for immunization status of children were also estimated. Results and Conclusions: Findings from household fixed effects analysis indicated that the immunization scores of girls were significantly lower than that of boys. The inequality decompositions revealed that, at the all-India level, the absolute level of GWHI in immunization status decreased from 0.035 in 1992-93 to 0.023 in 2005-06. However, as a percentage of total inequality, it increased marginally (15.5% to 16.5%). In absolute terms, GWHI decreased in all the regions except in the North-East. But, as a percentage of total inequality it increased in the North-Eastern, Western and Southern regions. The main conclusions are the following: GWHI contributes substantially to the overall inequality in immunization status of Indian children; and though the overall inequality in immunization status declined in all the regions, the changes in GWHI were mixed.	Indira Gandhi Inst Dev Res, Bombay, Maharashtra, India		Singh, A (corresponding author), Indira Gandhi Inst Dev Res, Bombay, Maharashtra, India.	aashish.igidr@gmail.com						Abeykoon A T, 1995, Asia Pac Popul J, V10, P5; Agarwal Bina., 1994, FIELD ONES OWN GENDE; Agrahari K, 2009, DEMOGRAPHY INDIA, V38, P117; Ahmad Nisar, 1999, JPMA (Journal of the Pakistan Medical Association), V49, P301; AMIN S, 1990, Genus, V46, P55; [Anonymous], ASIA PACIFIC POPULAT; Arnold F., 1992, International Family Planning Perspectives, V18, P93, DOI 10.2307/2133408; Arnold F, 2002, POPUL DEV REV, V28, P759, DOI 10.1111/j.1728-4457.2002.00759.x; Arnold F, 1998, POP STUD-J DEMOG, V52, P301, DOI 10.1080/0032472031000150486; Arnold F, 2001, FERTILITY TRANSITION; BAIRAGI R, 1986, POPUL DEV REV, V12, P307, DOI 10.2307/1973113; Bardhan P.K., 1988, RURAL POVERTY S ASIA; BASU AM, 1989, POP STUD-J DEMOG, V43, P193, DOI 10.1080/0032472031000144086; Behrman JR, 1998, TOO YOUNG DIE GENES; Bhat BNM, 1999, ECON POLIT WEEKLY, V34, P3008; Bhat PNM, 2003, DEMOGRAPHY, V40, P637, DOI 10.2307/1515201; Borooah VK, 2004, SOC SCI MED, V58, P1719, DOI 10.1016/S0277-9536(03)00342-3; Bose A, 1991, DEMOGRAPHIC DIVERSIT; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; CAIN M, 1979, POPUL DEV REV, V5, P405, DOI 10.2307/1972079; Cain MT, 1993, WOMENS POSITION DEMO; Cain MT, 1988, HOME DIVIDED WOMEN I; Caldwell P., 1990, 7 AUSTR NAT U NAT CT; Checchi D, 2010, J ECON INEQUAL, V8, P429, DOI 10.1007/s10888-009-9118-3; CHEN LC, 1981, POPUL DEV REV, V7, P55, DOI 10.2307/1972764; Choe MK, 1998, TOO YOUNG DIE GENES; Chowdhury AMR, 2003, J HEALTH POPUL NUTR, V21, P193; Chudgar A, 2011, WORLD DEV, V39, P550, DOI 10.1016/j.worlddev.2010.08.021; DAS N, 1987, DEMOGRAPHY, V24, P517, DOI 10.2307/2061389; DasGupta M, 1997, POP STUD-J DEMOG, V51, P307, DOI 10.1080/0032472031000150076; DASGUPTA M, 1987, POPUL DEV REV, V13, P77; Dharmalingam A, 1996, GENUS, V42, P83; DYSON T, 1983, POPUL DEV REV, V9, P35, DOI 10.2307/1972894; Elfindri, 1993, INDONESIAN J DEMOGR, V20, P31; Ferreira FH, 2008, 4659 WORLD BANK; Foster JE, 2000, J ECON THEORY, V91, P199, DOI 10.1006/jeth.1999.2565; Foster JE, 1999, ECON THEOR, V14, P89, DOI 10.1007/s001990050283; GANATRA B, 1994, B WORLD HEALTH ORGAN, V72, P101; Goodkind D, 1996, POPUL DEV REV, V22, P111, DOI 10.2307/2137689; Government of India, 2011, PULS POL IMM PPI IND; Govindswamy P, 1996, MATERNAL ED GENDER B; Griffiths P, 2002, SOC SCI MED, V55, P775, DOI 10.1016/S0277-9536(01)00202-7; Halder AK, 2008, HEALTH SERV INSIGHTS, V1, P5; HILL K, 1995, POPUL DEV REV, V21, P127, DOI 10.2307/2137416; Holmes J, 2006, HEALTH POLICY PLANN, V21, P231, DOI 10.1093/heapol/czl007; IIPS & ORCMacro, 2007, NAT FAM HLTH SURV 20; IIPS & ORCMacro, 1995, NAT FAM HLTH SURV 19; Karve I., 1965, KINSHIP ORG INDIA; Khan MI, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-17; KISHOR S, 1993, AM SOCIOL REV, V58, P247, DOI 10.2307/2095969; Kishor S, 1995, WOMENS HLTH INDIA; KOENIG MA, 1986, SOC SCI MED, V22, P15, DOI 10.1016/0277-9536(86)90303-5; LEVINE NE, 1987, POPUL DEV REV, V13, P281, DOI 10.2307/1973194; MAKINSON C, 1994, INT J GYNECOL OBSTET, V46, P119, DOI 10.1016/0020-7292(94)90226-7; Mandelbaum David G., 1988, WOMENS SECLUSION MEN; MEASURE DHS, 2006, WHO WE AR; Miller BD, 1981, ENDANGERED SEX NEGLE; Mishra V, 2004, POPUL DEV REV, V30, P269, DOI 10.1111/j.1728-4457.2004.013_1.x; Motiram S, 2010, FEM ECON, V16, P141, DOI 10.1080/13545701.2010.504544; MUHURI PK, 1991, POPUL DEV REV, V17, P415, DOI 10.2307/1971948; Murthi M, 1995, POPUL DEV REV, V21, P745, DOI 10.2307/2137773; Nag M., 1991, SEX PREFERENCE BANGL; Niraula BB, 1995, SOC BIOL, V42, P256, DOI 10.1080/19485565.1995.9988906; OLDENBURG P, 1992, ECON POLIT WEEKLY, V27, P2657; Pande RP, 2007, POPUL RES POLICY REV, V26, P1, DOI 10.1007/s11113-006-9017-2; Pande RP, 2003, DEMOGRAPHY, V40, P395, DOI 10.1353/dem.2003.0029; Pathak PK, 2009, POPULATION POVERTY H, P183; Pelletier D, 1998, TOO YOUNG DIE GENES; Praveen V, 1988, INFANT MORTALITY IND; Prinja S, 2010, B WORLD HEALTH ORGAN, V88, P97, DOI 10.2471/BLT.08.059543; Ram F, 2004, POPULATION HLTH DEV, P46; Ravindran TKS, 2000, WHO M GEND AN HLTH; Riley NE, 1997, POPULATION B, V52, P48; SEN A, 1983, ECON POLIT WEEKLY, V18, P855; Sen A, 1988, FAMILY FOOD SEX BIAS; Shorrocks A, 2005, J ECON GEOGR, V5, P59, DOI 10.1093/jnlecg/lbh054; SHORROCKS AF, 1980, ECONOMETRICA, V48, P613, DOI 10.2307/1913126; Singh A, 2011, POPUL RES POLICY REV, V30, P861, DOI 10.1007/s11113-011-9214-5; Singh A, 2010, J LABOR RES, V31, P230, DOI 10.1007/s12122-010-9090-5; Singh K, 1993, HINDUS OTHERS QUESTI; Stash S, 1996, STUD FAMILY PLANN, V27, P107, DOI 10.2307/2138138; Sudha S, 1999, DEV CHANGE, V30, P585, DOI 10.1111/1467-7660.00130; Tabutin D, 1995, Popul Bull UN, P45; The United Nations, 2005, MILL GOALS; The World Bank, 1991, GEND POV IND WORLD B; The World Health Organization, 2011, MILL DEV GOALS IMM C; Timaeus I, 1998, TOO YOUNG DIE GENES; VLASSOFF C, 1990, POP STUD-J DEMOG, V44, P5, DOI 10.1080/0032472031000144356	88	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35045	10.1371/journal.pone.0035045	http://dx.doi.org/10.1371/journal.pone.0035045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TP	22509379	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600075
J	Lin, YC; Chen, HM; Chou, IM; Chen, AN; Chen, CP; Young, GH; Lin, CT; Cheng, CH; Chang, SC; Juang, RH				Lin, Yi-Chen; Chen, Han-Min; Chou, I-Min; Chen, An-Na; Chen, Chia-Pei; Young, Guang-Huar; Lin, Chi-Tsai; Cheng, Chiung-Hsiang; Chang, Shih-Chung; Juang, Rong-Huay			Plastidial Starch Phosphorylase in Sweet Potato Roots Is Proteolytically Modified by Protein-Protein Interaction with the 20S Proteasome	PLOS ONE			English	Article							ALPHA-GLUCAN PHOSPHORYLASE; SITE-SPECIFIC PHOSPHORYLATION; KAPPA-B-ALPHA; SELECTIVE DEGRADATION; EXPRESSION ANALYSIS; INDEPENDENT MANNER; OXIDIZED PROTEINS; SOLANUM-TUBEROSUM; SUCROSE SYNTHASE; PATHWAY	Post-translational regulation plays an important role in cellular metabolism. Earlier studies showed that the activity of plastidial starch phosphorylase (Pho1) may be regulated by proteolytic modification. During the purification of Pho1 from sweet potato roots, we observed an unknown high molecular weight complex (HX) showing Pho1 activity. The two-dimensional gel electrophoresis, mass spectrometry, and reverse immunoprecipitation analyses showed that HX is composed of Pho1 and the 20S proteasome. Incubating sweet potato roots at 45 degrees C triggers a stepwise degradation of Pho1; however, the degradation process can be partially inhibited by specific proteasome inhibitor MG132. The proteolytically modified Pho1 displays a lower binding affinity toward glucose 1-phosphate and a reduced starch-synthesizing activity. This study suggests that the 20S proteasome interacts with Pho1 and is involved in the regulation of the catalytic activity of Pho1 in sweet potato roots under heat stress conditions.	[Lin, Yi-Chen; Chou, I-Min; Chen, An-Na; Chen, Chia-Pei; Chang, Shih-Chung; Juang, Rong-Huay] Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan; [Lin, Yi-Chen; Chou, I-Min; Chen, An-Na; Chen, Chia-Pei; Chang, Shih-Chung; Juang, Rong-Huay] Natl Taiwan Univ, Inst Microbiol & Biochem, Taipei 10764, Taiwan; [Chen, Han-Min] Catholic Fu Jen Univ, Dept Life Sci, Taipei, Taiwan; [Chen, Han-Min] Catholic Fu Jen Univ, Inst Appl Sci & Engn, Taipei, Taiwan; [Young, Guang-Huar] Natl Taiwan Univ Hosp, Dept Internal Med, Div Nephrol, Taipei 100, Taiwan; [Lin, Chi-Tsai] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan; [Lin, Chi-Tsai] Natl Taiwan Ocean Univ, Marine Ctr Biosci & Biotechnol, Keelung, Taiwan; [Cheng, Chiung-Hsiang] Natl Taiwan Univ, Sch Vet Med, Dept Vet Med, Anim Canc Res Ctr, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; Fu Jen Catholic University; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital; National Taiwan Ocean University; National Taiwan Ocean University; National Taiwan University	Lin, YC (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, Taipei 10764, Taiwan.	shihchung@ntu.edu.tw; juang@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013	CHANG, SHIH-CHUNG/0000-0002-5015-8178; Juang, Rong-Huay/0000-0002-9344-0675	National Science Council of the Republic of China [NSC96-2311-B-002-024-MY3, NSC96-2628-B-002-080-MY3]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was jointly supported by grants from the National Science Council of the Republic of China to SCC (NSC96-2311-B-002-024-MY3) and RHJ (NSC96-2628-B-002-080-MY3). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht T, 2001, PLANTA, V213, P602, DOI 10.1007/s004250100525; ALKALAY I, 1995, P NATL ACAD SCI USA, V92, P10599, DOI 10.1073/pnas.92.23.10599; Asher G, 2005, GENE DEV, V19, P316, DOI 10.1101/gad.319905; Asher G, 2006, BIOESSAYS, V28, P844, DOI 10.1002/bies.20447; Ball S, 1996, CELL, V86, P349, DOI 10.1016/S0092-8674(00)80107-5; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Baugh JM, 2004, MOL CELL, V16, P575, DOI 10.1016/j.molcel.2004.10.017; BAUN LC, 1970, PLANT PHYSIOL, V46, P429, DOI 10.1104/pp.46.3.429; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRISSON N, 1989, PLANT CELL, V1, P559, DOI 10.1105/tpc.1.5.559; Brown C Randell, 2009, Commun Integr Biol, V2, P177; Buchczyk DP, 2003, BIOL CHEM, V384, P237, DOI 10.1515/BC.2003.026; Bulteau AL, 2001, J BIOL CHEM, V276, P45662, DOI 10.1074/jbc.M105374200; Chang SC, 2000, BOT BULL ACAD SINICA, V41, P105; CHANG TC, 1987, AGR BIOL CHEM TOKYO, V51, P187, DOI 10.1080/00021369.1987.10867980; Chen HM, 2002, PHYSIOL PLANTARUM, V114, P506, DOI 10.1034/j.1399-3054.2002.1140402.x; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; CHIANG CL, 1991, AGR BIOL CHEM TOKYO, V55, P641, DOI 10.1080/00021369.1991.10870639; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Dauvillee D, 2006, PLANT J, V48, P274, DOI 10.1111/j.1365-313X.2006.02870.x; Davies KJA, 2001, BIOCHIMIE, V83, P301, DOI 10.1016/S0300-9084(01)01250-0; Duwenig E, 1997, PLANTA, V203, P111, DOI 10.1007/s004250050171; Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X; Hanes CS, 1940, PROC R SOC SER B-BIO, V129, P174, DOI 10.1098/rspb.1940.0035; Hanes CS, 1940, PROC R SOC SER B-BIO, V128, P421, DOI 10.1098/rspb.1940.0020; Hardin SC, 2004, PLANT PHYSIOL BIOCH, V42, P197, DOI 10.1016/j.plaphy.2003.12.004; Hardin SC, 2003, PLANT J, V35, P588, DOI 10.1046/j.1365-313X.2003.01831.x; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Hung GC, 2004, J BIOL CHEM, V279, P49138, DOI 10.1074/jbc.M404544200; Hwang SK, 2010, ARCH BIOCHEM BIOPHYS, V495, P82, DOI 10.1016/j.abb.2009.12.023; Ko YT, 2005, J AGR FOOD CHEM, V53, P5708, DOI 10.1021/jf050193f; Kurepa J, 2008, PLANT J, V53, P102, DOI 10.1111/j.1365-313X.2007.03322.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Liu CW, 2003, SCIENCE, V299, P408, DOI 10.1126/science.1079293; LIU TTY, 1981, PLANT PHYSIOL, V67, P525, DOI 10.1104/pp.67.3.525; Machiya Y, 2010, J BIOL CHEM, V285, P40732, DOI 10.1074/jbc.M110.141952; MINGOCASTEL AM, 1976, PLANT CELL PHYSIOL, V17, P557; Moorthy AK, 2006, EMBO J, V25, P1945, DOI 10.1038/sj.emboj.7601081; MORI H, 1993, J BIOL CHEM, V268, P5574; NAKANO K, 1986, J BIOL CHEM, V261, P8230; Ohdan T, 2005, J EXP BOT, V56, P3229, DOI 10.1093/jxb/eri292; Orlowski M, 2003, ARCH BIOCHEM BIOPHYS, V415, P1, DOI 10.1016/S0003-9861(03)00197-8; PACIFICI RE, 1993, J BIOL CHEM, V268, P15405; Poppek D, 2006, ANTIOXID REDOX SIGN, V8, P173, DOI 10.1089/ars.2006.8.173; Saitoh F, 2010, J NEUROSCI, V30, P1204, DOI 10.1523/JNEUROSCI.3591-09.2010; Santt O, 2008, MOL BIOL CELL, V19, P3323, DOI 10.1091/mbc.E08-03-0328; Satoh H, 2008, PLANT CELL, V20, P1833, DOI 10.1105/tpc.107.054007; SATTELMACHER B, 1990, ANN BOT-LONDON, V65, P27, DOI 10.1093/oxfordjournals.aob.a087903; Schupp N, 2004, PLANT CELL PHYSIOL, V45, P1471, DOI 10.1093/pcp/pch170; SHIMOMURA S, 1982, J BIOCHEM-TOKYO, V91, P703, DOI 10.1093/oxfordjournals.jbchem.a133743; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; SISSON TH, 1990, J IMMUNOL METHODS, V127, P215, DOI 10.1016/0022-1759(90)90071-3; SONNEWALD U, 1995, PLANT MOL BIOL, V27, P567, DOI 10.1007/BF00019322; Sorokin AV, 2005, EMBO J, V24, P3602, DOI 10.1038/sj.emboj.7600830; Steup M., 1988, BIOCH PLANTS COMPREH, P255; STPIERRE B, 1995, PLANTA, V195, P339, DOI 10.1007/BF00202590; Tang GQ, 2003, PLANT J, V34, P77, DOI 10.1046/j.1365-313X.2003.01711.x; Tetlow IJ, 2004, PLANT CELL, V16, P694, DOI 10.1105/tpc.017400; VANBERKEL J, 1991, PLANTA, V185, P432, DOI 10.1007/BF00201068; Varshavsky A, 2005, TRENDS BIOCHEM SCI, V30, P283, DOI 10.1016/j.tibs.2005.04.005; Vierstra RD, 2009, NAT REV MOL CELL BIO, V10, P385, DOI 10.1038/nrm2688; Walker J.M., 2002, PROTEIN PROTOCOLS HD, DOI 10.1385/1592591698; Wang HC, 2009, J AGR FOOD CHEM, V57, P7348, DOI 10.1021/jf9020152; Weng JH, 2005, PHOTOSYNTHETICA, V43, P439, DOI 10.1007/s11099-005-0070-6; Wu YT, 2011, J BIOL CHEM, V286, P14190, DOI 10.1074/jbc.M111.219923; Young GH, 2006, PLANTA, V223, P468, DOI 10.1007/s00425-005-0103-1; Yu Y, 2001, PLANT PHYSIOL, V125, P351, DOI 10.1104/pp.125.1.351; Zeeman SC, 2004, PLANT PHYSIOL, V135, P849, DOI 10.1104/pp.103.032631	69	18	18	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35336	10.1371/journal.pone.0035336	http://dx.doi.org/10.1371/journal.pone.0035336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506077	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500085
J	Watts, SD; Suchland, KL; Amara, SG; Ingram, SL				Watts, Spencer D.; Suchland, Katherine L.; Amara, Susan G.; Ingram, Susan L.			A Sensitive Membrane-Targeted Biosensor for Monitoring Changes in Intracellular Chloride in Neuronal Processes	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; RAT NEOCORTICAL NEURONS; LAMINA-I NEURONS; HIPPOCAMPAL-NEURONS; EXCITATORY ACTIONS; NEUROPATHIC PAIN; SUPRACHIASMATIC NUCLEUS; DOPAMINE TRANSPORTER; SUBSTANTIA-NIGRA; CL-ACCUMULATION	Background: Regulation of chloride gradients is a major mechanism by which excitability is regulated in neurons. Disruption of these gradients is implicated in various diseases, including cystic fibrosis, neuropathic pain and epilepsy. Relatively few studies have addressed chloride regulation in neuronal processes because probes capable of detecting changes in small compartments over a physiological range are limited. Methodology/Principal Findings: In this study, a palmitoylation sequence was added to a variant of the yellow fluorescent protein previously described as a sensitive chloride indicator (YFPQS) to target the protein to the plasma membrane (mbYFPQS) of cultured midbrain neurons. The reporter partitions to the cytoplasmic face of the cellular membranes, including the plasma membrane throughout the neurons and fluorescence is stable over 30-40 min of repeated excitation showing less than 10% decrease in mbYFPQS fluorescence compared to baseline. The mbYFPQS has similar chloride sensitivity (k(50) = 41 mM) but has a shifted pKa compared to the unpalmitoylated YFPQS variant ( cytYFPQS) that remains in the cytoplasm when expressed in midbrain neurons. Changes in mbYFPQS fluorescence were induced by the GABA(A) agonist muscimol and were similar in the soma and processes of the midbrain neurons. Amphetamine also increased mbYFPQS fluorescence in a subpopulation of cultured midbrain neurons that was reversed by the selective dopamine transporter (DAT) inhibitor, GBR12909, indicating that mbYFPQS is sensitive enough to detect endogenous DAT activity in midbrain dopamine (DA) neurons. Conclusions/Significance: The mbYFPQS biosensor is a sensitive tool to study modulation of intracellular chloride levels in neuronal processes and is particularly advantageous for simultaneous whole-cell patch clamp and live-cell imaging experiments.	[Watts, Spencer D.; Amara, Susan G.] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15260 USA; [Suchland, Katherine L.; Ingram, Susan L.] Oregon Hlth & Sci Univ, Dept Neurol Surg, Portland, OR 97201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oregon Health & Science University	Watts, SD (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15260 USA.	ingrams@ohsu.edu		Amara, Susan/0000-0001-8914-1106	National Institute of Drug Abuse (NIDA) [R21 DA019879, RO1 DA024041, RO1 DA07595]; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002946] Funding Source: NIH RePORTER	National Institute of Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Drug Abuse (NIDA) R21 DA019879 and RO1 DA024041(SLI) and RO1 DA07595 (Dr. Amara). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilles K, 2007, J NEUROSCI, V27, P8616, DOI 10.1523/JNEUROSCI.5041-06.2007; Amos BJ, 1996, EXP PHYSIOL, V81, P623, DOI 10.1113/expphysiol.1996.sp003963; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762; Bracci E, 2001, J NEUROPHYSIOL, V85, P2412, DOI 10.1152/jn.2001.85.6.2412; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Choi HJ, 2008, J NEUROSCI, V28, P5450, DOI 10.1523/JNEUROSCI.5750-07.2008; Coull JAM, 2005, NATURE, V438, P1017, DOI 10.1038/nature04223; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Dallwig R, 1999, PFLUG ARCH EUR J PHY, V437, P289, DOI 10.1007/s004240050782; Duebel J, 2006, NEURON, V49, P81, DOI 10.1016/j.neuron.2005.10.035; EBIHARA S, 1995, J PHYSIOL-LONDON, V484, P77, DOI 10.1113/jphysiol.1995.sp020649; Elsliger MA, 1999, BIOCHEMISTRY-US, V38, P5296, DOI 10.1021/bi9902182; ENGBLOM AC, 1989, NEUROSCI LETT, V104, P326, DOI 10.1016/0304-3940(89)90597-1; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Galli A, 1996, P NATL ACAD SCI USA, V93, P8671, DOI 10.1073/pnas.93.16.8671; GRACE AA, 1979, EUR J PHARMACOL, V59, P211, DOI 10.1016/0014-2999(79)90283-8; Gulacsi A, 2003, J NEUROSCI, V23, P8237; Gulledge AT, 2003, NEURON, V37, P299, DOI 10.1016/S0896-6273(02)01146-7; HARA M, 1993, ANN NY ACAD SCI, V707, P421, DOI 10.1111/j.1749-6632.1993.tb38087.x; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Ingram SL, 2002, NAT NEUROSCI, V5, P971, DOI 10.1038/nn920; Isomura Y, 2003, J NEUROPHYSIOL, V90, P2752, DOI 10.1152/jn.00142.2003; Jarolimek W, 1999, J NEUROSCI, V19, P4695; Jayaraman S, 2000, J BIOL CHEM, V275, P6047, DOI 10.1074/jbc.275.9.6047; Jedlicka P, 2006, PHYSIOL RES, V55, P139, DOI 10.33549/physiolres.930764; KAILA K, 1993, J PHYSIOL-LONDON, V464, P273, DOI 10.1113/jphysiol.1993.sp019634; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; Kaneko H, 2001, AM J PHYSIOL-CELL PH, V280, pC1387, DOI 10.1152/ajpcell.2001.280.6.C1387; Khalilov I, 2003, NAT NEUROSCI, V6, P1079, DOI 10.1038/nn1125; KRAPF R, 1988, BIOPHYS J, V53, P955, DOI 10.1016/S0006-3495(88)83176-X; Kruger W, 2005, NEUROSCI LETT, V380, P340, DOI 10.1016/j.neulet.2005.01.065; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; LIU YC, 1993, BIOCHEMISTRY-US, V32, P10714, DOI 10.1021/bi00091a023; Marandi N, 2002, PFLUG ARCH EUR J PHY, V445, P357, DOI 10.1007/s00424-002-0933-7; Markova O, 2008, J NEUROSCI METH, V170, P67, DOI 10.1016/j.jneumeth.2007.12.016; Martina M, 2001, J NEUROPHYSIOL, V86, P2887, DOI 10.1152/jn.2001.86.6.2887; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Prescott SA, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-32; RAYPORT S, 1992, J NEUROSCI, V12, P4264; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; Rohrbough J, 1996, J NEUROSCI, V16, P82; Satoh H, 2001, NEUROSCI LETT, V310, P161, DOI 10.1016/S0304-3940(01)02120-6; Shimura M, 2002, AM J PHYSIOL-CELL PH, V282, pC366, DOI 10.1152/ajpcell.00187.2000; Staley KJ, 1999, J PHYSIOL-LONDON, V519, P693, DOI 10.1111/j.1469-7793.1999.0693n.x; Stell B, 2003, NEURON, V39, P729, DOI 10.1016/S0896-6273(03)00528-2; Thoreson WB, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-53; Thoreson WB, 2002, VISUAL NEUROSCI, V19, P235, DOI 10.1017/S0952523802192017; Vardi N, 2000, J NEUROSCI, V20, P7657; Wachter RM, 1999, CURR BIOL, V9, pR628, DOI 10.1016/S0960-9822(99)80408-4; Waseem T, 2010, J NEUROSCI METH, V193, P14, DOI 10.1016/j.jneumeth.2010.08.002; WASZCZAK BL, 1980, BRAIN RES, V188, P185, DOI 10.1016/0006-8993(80)90567-3; Zhang LL, 2006, J NEUROPHYSIOL, V95, P2404, DOI 10.1152/jn.00578.2005	56	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35373	10.1371/journal.pone.0035373	http://dx.doi.org/10.1371/journal.pone.0035373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506078	Green Accepted, gold, Green Published			2022-12-27	WOS:000305297500086
J	Behjousiar, A; Kontoravdi, C; Polizzi, KM				Behjousiar, Alireza; Kontoravdi, Cleo; Polizzi, Karen M.			In Situ Monitoring of Intracellular Glucose and Glutamine in CHO Cell Culture	PLOS ONE			English	Article							TRANSPORT; LACTATE	The development of processes to produce biopharmaceuticals industrially is still largely empirical and relies on optimizing both medium formulation and cell line in a product-specific manner. Current small-scale (well plate-based) process development methods cannot provide sufficient sample volume for analysis, to obtain information on nutrient utilization which can be problematic when processes are scaled to industrial fermenters. We envision a platform where essential metabolites can be monitored non-invasively and in real time in an ultra-low volume assay in order to provide additional information on cellular metabolism in high throughput screens. Towards this end, we have developed a model system of Chinese Hamster Ovary cells stably expressing protein-based biosensors for glucose and glutamine. Herein, we demonstrate that these can accurately reflect changing intracellular metabolite concentrations in vivo during batch and fed-batch culture of CHO cells. The ability to monitor intracellular depletion of essential nutrients in high throughput will allow rapid development of improved bioprocesses.	[Behjousiar, Alireza; Polizzi, Karen M.] Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Dept Life Sci, London, England; [Behjousiar, Alireza; Polizzi, Karen M.] Univ London Imperial Coll Sci Technol & Med, Ctr Synthet Biol & Innovat, London, England; [Behjousiar, Alireza; Kontoravdi, Cleo] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, Ctr Proc Syst Engn, London SW7 2AZ, England	Imperial College London; Imperial College London; Imperial College London	Behjousiar, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Mol Biosci, Dept Life Sci, London, England.	k.polizzi@imperial.ac.uk		Kontoravdi, Cleo/0000-0003-0213-4830; Polizzi, Karen/0000-0001-5435-2667	Biotechnology and Biological Sciences Research Council; Research Councils United Kingdom; LONZA Biologics; Engineering and Physical Sciences Research Council	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Research Councils United Kingdom; LONZA Biologics; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	AB would like to thank the Biotechnology and Biological Sciences Research Council for his studentship. KMP and CK are supported by Research Councils United Kingdom fellowships. CK thanks LONZA Biologics for their financial support. The Centre for Synthetic Biology and Innovation is supported by the Engineering and Physical Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2008, NAT METHODS, V5, P401, DOI [10.1038/nmeth.1207, 10.1038/NMETH.1207]; Altamirano C, 2006, J BIOTECHNOL, V125, P547, DOI 10.1016/j.jbiotec.2006.03.023; Aurilia V, 2009, CELLULAR BIOMOLECULA; Bermejo C, 2010, BIOCHEM J, V432, P399, DOI 10.1042/BJ20100946; Billingsley K, 2010, ANAL CHEM, V82, P3707, DOI 10.1021/ac100042e; Dattelbaum JD, 2001, ANAL BIOCHEM, V291, P89, DOI 10.1006/abio.2001.4998; Deuschle K, 2005, PROTEIN SCI, V14, P2304, DOI 10.1110/ps.051508105; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Fehr M, 2005, MOL CELL BIOL, V25, P11102, DOI 10.1128/MCB.25.24.11102-11112.2005; Han Y, 2006, J BIOSCI BIOENG, V102, P430, DOI 10.1263/jbb.102.430; HANSEN HA, 1994, APPL MICROBIOL BIOT, V41, P560, DOI 10.1007/BF00178489; Hou JJC, 2011, J CHEM TECHNOL BIOT, V86, P895, DOI 10.1002/jctb.2574; Marchant RJ, 2008, MOL BIOTECHNOL, V39, P69, DOI 10.1007/s12033-008-9032-0; MILLER DM, 1980, J BIOL CHEM, V255, P2465; Moser I, 2002, BIOSENS BIOELECTRON, V17, P297, DOI 10.1016/S0956-5663(01)00298-6; Ouyang MX, 2008, P NATL ACAD SCI USA, V105, P14353, DOI 10.1073/pnas.0807537105; Porter AJ, 2010, BIOTECHNOL PROGR, V26, P1446, DOI 10.1002/btpr.442; Yang HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008917	18	29	30	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34512	10.1371/journal.pone.0034512	http://dx.doi.org/10.1371/journal.pone.0034512			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509313	Green Published, gold, Green Submitted			2022-12-27	WOS:000304805900041
J	De Stefano, D; Tommonaro, G; Malik, SA; Iodice, C; De Rosa, S; Maiuri, MC; Carnuccio, R				De Stefano, Daniela; Tommonaro, Giuseppina; Malik, Shoaib Ahmad; Iodice, Carmine; De Rosa, Salvatore; Maiuri, Maria Chiara; Carnuccio, Rosa			Cacospongionolide and Scalaradial, Two Marine Sesterterpenoids as Potent Apoptosis-Inducing Factors in Human Carcinoma Cell Lines	PLOS ONE			English	Article							PHOSPHOLIPASE A(2); KAPPA-B; EXPRESSION; CANCER; INFLAMMATION; INHIBITION	Apoptosis, a form of programmed cell death, is a critical defence mechanism against the formation and progression of cancer and acts by eliminating potentially deleterious cells without causing such adverse effects, as inflammatory response and ensuing scar formation. Therefore, targeting apoptotic pathways becomes an intriguing strategy for the development of chemotherapeutic agents. In last decades, marine natural products, such as sesterterpenoids, have played an important role in the discovery and development of new drugs. Interestingly, many of these compounds have a strong potential as anticancer drugs by inhibiting cell proliferation and/or inducing cell death. In the present study, we investigated the effects of scalaradial and cacospongionolide, two sesterterpenoids from Cacospongia scalaris and Fasciospongia cavernosa marine sponges, on the apoptotic signalling pathway in three different human tumoral cells. Results were obtained by using DNA fragmentation, comet and viability assays, quantification of the mitochondrial transmembrane potential and Western blot. The T47D (human breast carcinoma), A431 (human epidermoid carcinoma), HeLa (human cervix carcinoma) and HCT116 (human colon carcinoma) cells were incubated for 24 h with scalaradial or cacospongionolide. Treatment of T47D cells with scalaradial or cacospongionolide for 24 h brought about a significant increase in DNA migration as well as fragmentation. Moreover, incubation of HCT116 and HeLa cells with scalaradial or cacospongionolide for 24 h caused an increased expression of pro-apoptotic proteins. Furthermore, scalaradial or cacospongionolide, added to HCT116 and HeLa cells overnight, induced a significant and concentration-dependent loss of mitochondrial transmembrane potential, an early apoptosis signalling event. These effects paralleled with those achieved with p50 and p65, NF-kappa B subunits, nuclear level. In conclusion, scalaradial and cacospongionolide, by determining human cancer cell apoptosis, may represent new promising compounds to inhibit cancer cell proliferation.	[De Stefano, Daniela; Maiuri, Maria Chiara; Carnuccio, Rosa] Univ Naples Federico II, Fac Sci Biotecnol, Dipartimento Farmacol Sperimentale, Naples, Italy; [Tommonaro, Giuseppina; Iodice, Carmine; De Rosa, Salvatore] Natl Res Council Italy, Inst Biomol Chem, Pozzuoli, NA, Italy; [Malik, Shoaib Ahmad; Maiuri, Maria Chiara] Inst Gustave Roussy, INSERM, U848, F-94805 Villejuif, France	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	De Stefano, D (corresponding author), Univ Naples Federico II, Fac Sci Biotecnol, Dipartimento Farmacol Sperimentale, Naples, Italy.	dadestef@unina.it	Tommonaro, Giuseppina/C-3005-2015; Malik, Shoaib Ahmad/O-7022-2017; Tommonaro, Giuseppina/AAX-9587-2021	Malik, Shoaib Ahmad/0000-0002-0843-8512; Tommonaro, Giuseppina/0000-0002-9613-1843				Al-Ejeh F, 2010, ONCOGENE, V29, P6085, DOI 10.1038/onc.2010.407; Balasubramanyam M, 2010, METHODS MOL BIOL, V610, P245, DOI 10.1007/978-1-60327-029-8_15; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; De Rosa S, 1998, J NAT PROD, V61, P931, DOI 10.1021/np980122t; De Rosa S, 2005, STUD NAT PROD CHEM, V32, P109; De Stefano D, 2011, J GENE MED, V13, P200, DOI 10.1002/jgm.1546; Demaria S, 2010, J IMMUNOTHER, V33, P335, DOI 10.1097/CJI.0b013e3181d32e74; Deorukhkar A, 2010, BIOCHEM PHARMACOL, V80, P1904, DOI 10.1016/j.bcp.2010.06.039; DEROSA S, 1988, J ORG CHEM, V53, P5020, DOI 10.1021/jo00256a022; deRosa S, 1995, J NAT PROD, V58, P1776, DOI 10.1021/np50125a024; Fedorov SN, 2007, CANCER RES, V67, P5914, DOI 10.1158/0008-5472.CAN-06-3723; Fedorov SN, 2006, PHARM RES-DORDR, V23, P70, DOI 10.1007/s11095-005-8813-4; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Lin XK, 2010, CURR DRUG TARGETS, V11, P708, DOI 10.2174/138945010791170824; Liu JJ, 2011, CANCER LETT, V300, P105, DOI 10.1016/j.canlet.2010.10.001; Liu Y, 1997, BBA-MOL CELL RES, V1355, P270, DOI 10.1016/S0167-4889(96)00148-6; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Messmer UK, 1997, BRIT J PHARMACOL, V121, P625, DOI 10.1038/sj.bjp.0701156; Napolitano JG, 2009, ANTI-CANCER AGENT ME, V9, P122, DOI 10.2174/187152009787313800; Posadas I, 2003, BRIT J PHARMACOL, V138, P1571, DOI 10.1038/sj.bjp.0705189; Richardson Alan, 2008, Curr Mol Pharmacol, V1, P244; Rook GAW, 2011, IMMUNOL REV, V240, P141, DOI 10.1111/j.1600-065X.2010.00987.x; Rueda A, 1997, J ORG CHEM, V62, P1481, DOI 10.1021/jo961975y; Ruiperez V, 2007, J IMMUNOL, V179, P631, DOI 10.4049/jimmunol.179.1.631; Udagawa T, 2010, CURR OPIN PHARMACOL, V10, P369, DOI 10.1016/j.coph.2010.06.010; World Health Organization & International Union against Cancer, 2005, GLOB ACT CANC; Xie YL, 2005, J PHARMACOL EXP THER, V314, P1210, DOI 10.1124/jpet.105.086520; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367	30	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e33031	10.1371/journal.pone.0033031	http://dx.doi.org/10.1371/journal.pone.0033031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509253	Green Published, Green Submitted, gold			2022-12-27	WOS:000304805900005
J	Kono, N; Arakawa, K; Tomita, M				Kono, Nobuaki; Arakawa, Kazuharu; Tomita, Masaru			Validation of Bacterial Replication Termination Models Using Simulation of Genomic Mutations	PLOS ONE			English	Article							ESCHERICHIA-COLI-CHROMOSOME; ASYMMETRIC SUBSTITUTION PATTERNS; SITE-SPECIFIC RECOMBINATION; HORIZONTAL GENE-TRANSFER; DNA-REPLICATION; TERMINUS REGION; BASE COMPOSITION; BIAS SUGGESTS; FORK ARREST; TER SITES	In bacterial circular chromosomes and most plasmids, the replication is known to be terminated when either of the following occurs: the forks progressing in opposite directions meet at the distal end of the chromosome or the replication forks become trapped by Tus proteins bound to Ter sites. Most bacterial genomes have various polarities in their genomic structures. The most notable feature is polar genomic compositional asymmetry of the bases G and C in the leading and lagging strands, called GC skew. This asymmetry is caused by replication-associated mutation bias, and this "footprint" of the replication machinery suggests that, in contrast to the two known mechanisms, replication termination occurs near the chromosome dimer resolution site dif. To understand this difference between the known replication machinery and genomic compositional bias, we undertook a simulation study of genomic mutations, and we report here how different replication termination models contribute to the generation of replication-related genomic compositional asymmetry. Contrary to naive expectations, our results show that a single finite termination site at dif or at the GC skew shift point is not sufficient to reconstruct the genomic compositional bias as observed in published sequences. The results also show that the known replication mechanisms are sufficient to explain the position of the GC skew shift point.	[Kono, Nobuaki; Arakawa, Kazuharu; Tomita, Masaru] Keio Univ, Inst Adv Biosci, Fujisawa, Kanagawa, Japan	Keio University	Kono, N (corresponding author), Keio Univ, Inst Adv Biosci, Fujisawa, Kanagawa, Japan.	gaou@sfc.keio.ac.jp		Arakawa, Kazuharu/0000-0002-2893-4919; Kono, Nobuaki/0000-0001-5960-7956	Japan Society for the Promotion of Science (JSPS) [22.5012]; Yamagata Prefectural Government; Tsuruoka City	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yamagata Prefectural Government; Tsuruoka City(Tsuruoka City Government)	This research was supported partly by the Grant-in-Aid for JSPS Fellows (No.22.5012, 2011) from the Japan Society for the Promotion of Science (JSPS) and by funds from the Yamagata Prefectural Government and Tsuruoka City. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa K, 2003, BIOINFORMATICS, V19, P305, DOI 10.1093/bioinformatics/19.2.305; Arakawa K, 2007, EVOL BIOINFORM ONLIN, P3279; Arakawa K, 2007, EVOL BIOINFORM ONLIN, P3159; Arakawa K, 2006, J PESTIC SCI, P31282; Arakawa K, 2008, GENES GENOMES GENOMI, P21; Arakawa K, 2007, FEBS LETT, V581, P253, DOI 10.1016/j.febslet.2006.12.021; Arakawa K, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-640; Bigot S, 2005, EMBO J, V24, P3770, DOI 10.1038/sj.emboj.7600835; Bigot S, 2006, NAT STRUCT MOL BIOL, V13, P1026, DOI 10.1038/nsmb1159; BLAKELY G, 1993, CELL, V75, P351, DOI 10.1016/0092-8674(93)80076-Q; Breier AM, 2005, P NATL ACAD SCI USA, V102, P3942, DOI 10.1073/pnas.0500812102; Carnoy C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006531; CLERGET M, 1991, NEW BIOL, V3, P780; CoskunAri FF, 1997, J BIOL CHEM, V272, P26448, DOI 10.1074/jbc.272.42.26448; Duggin IG, 2009, J MOL BIOL, V387, P532, DOI 10.1016/j.jmb.2009.02.027; Duggin IG, 2008, MOL MICROBIOL, V70, P1323, DOI 10.1111/j.1365-2958.2008.06500.x; EDLUND T, 1976, J MOL BIOL, V108, P295, DOI 10.1016/S0022-2836(76)80122-2; Fisher R.A., 1948, STAT TABLES BIOL AGR; Francino MP, 1996, SCIENCE, V272, P107, DOI 10.1126/science.272.5258.107; Francino MP, 1997, TRENDS GENET, V13, P240, DOI 10.1016/S0168-9525(97)01118-9; Frank AC, 1999, GENE, V238, P65, DOI 10.1016/S0378-1119(99)00297-8; Frank AC, 2000, BIOINFORMATICS, V16, P560, DOI 10.1093/bioinformatics/16.6.560; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Gao F, 2007, BIOINFORMATICS, V23, P1866, DOI 10.1093/bioinformatics/btm255; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Grigoriev A, 1998, NUCLEIC ACIDS RES, V26, P2286, DOI 10.1093/nar/26.10.2286; Haines AS, 2006, MICROBIOL-SGM, V152, P2689, DOI 10.1099/mic.0.28941-0; HANAWALT PC, 1991, MUTAT RES, V247, P203, DOI 10.1016/0027-5107(91)90016-H; Hendrickson H, 2007, MOL MICROBIOL, V64, P42, DOI 10.1111/j.1365-2958.2007.05596.x; Hendrickson H, 2006, J MOL EVOL, V62, P615, DOI 10.1007/s00239-005-0192-2; Higgins NP, 2007, MOL MICROBIOL, V64, P1, DOI 10.1111/j.1365-2958.2007.05641.x; HILL CW, 1988, GENETICS, V119, P771; HILL TM, 1987, P NATL ACAD SCI USA, V84, P1754, DOI 10.1073/pnas.84.7.1754; Hill TM, 1992, ANNU REV MICROBIOL, P46603; HIROSE S, 1983, MOL GEN GENET, V189, P422, DOI 10.1007/BF00325904; Horiuchi T, 1995, ADV BIOPHYS, P31133; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kamada K, 1996, NATURE, V383, P598, DOI 10.1038/383598a0; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Khan SA, 2000, MOL MICROBIOL, V37, P477, DOI 10.1046/j.1365-2958.2000.02001.x; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kono N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-19; KUEMPEL PL, 1977, P NATL ACAD SCI USA, V74, P3927, DOI 10.1073/pnas.74.9.3927; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Labib K, 2007, EMBO REP, V8, P346, DOI 10.1038/sj.embor.7400940; Lesterlin C, 2004, MOL MICROBIOL, V54, P1151, DOI 10.1111/j.1365-2958.2004.04356.x; Liu GR, 2006, MOL BIOL EVOL, V23, P365, DOI 10.1093/molbev/msj042; Lobry JR, 2002, GENOME BIOL, V3; LOBRY JR, 1995, J MOL EVOL, V40, P326, DOI 10.1007/BF00163237; Lobry JR, 1996, SCIENCE, V272, P745, DOI 10.1126/science.272.5262.745; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; LOUARN J, 1977, J MOL BIOL, V115, P295, DOI 10.1016/0022-2836(77)90156-5; Maisnier-Patin S, 2001, MOL MICROBIOL, V42, P1371, DOI 10.1046/j.1365-2958.2001.02718.x; Marians KJ, 1992, ANNU REV BIOCHEM, P61673; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; McGlynn P, 2008, J MOL BIOL, V381, P249, DOI 10.1016/j.jmb.2008.05.053; McLean MJ, 1998, J MOL EVOL, V47, P691, DOI 10.1007/PL00006428; Michel B, 2007, DNA REPAIR, V6, P967, DOI 10.1016/j.dnarep.2007.02.016; Mirkin EV, 2007, MICROBIOL MOL BIOL R, V71, P13, DOI 10.1128/MMBR.00030-06; Mulcair MD, 2006, CELL, V125, P1309, DOI 10.1016/j.cell.2006.04.040; Neylon C, 2005, MICROBIOL MOL BIOL R, V69, P501, DOI 10.1128/MMBR.69.3.501-526.2005; Possoz C, 2006, EMBO J, V25, P2596, DOI 10.1038/sj.emboj.7601155; PRESCOTT DM, 1972, P NATL ACAD SCI USA, V69, P2842, DOI 10.1073/pnas.69.10.2842; Reyes A, 1998, MOL BIOL EVOL, V15, P957, DOI 10.1093/oxfordjournals.molbev.a026011; Rocha EPC, 2006, GENOME RES, V16, P1537, DOI 10.1101/gr.5525106; Rocha EP, 2008, ANNU REV GENET, P42211; Rocha EPC, 2002, TRENDS MICROBIOL, V10, P393, DOI 10.1016/S0966-842X(02)02420-4; Rocha EPC, 2001, MOL BIOL EVOL, V18, P1789, DOI 10.1093/oxfordjournals.molbev.a003966; SAHOO T, 1995, J BIOL CHEM, V270, P29138, DOI 10.1074/jbc.270.49.29138; Saleh OA, 2004, EMBO J, V23, P2430, DOI 10.1038/sj.emboj.7600242; Salzberg SL, 1998, GENE, V217, P57, DOI 10.1016/S0378-1119(98)00374-6; Schaeffer PM, 2005, IUBMB LIFE, V57, P5, DOI 10.1080/15216540500058956; SCHAPER S, 1995, J BIOL CHEM, V270, P17622, DOI 10.1074/jbc.270.29.17622; Scholefield G, 2011, TRENDS CELL BIOL, V21, P188, DOI 10.1016/j.tcb.2010.10.006; SHARMA B, 1995, MOL MICROBIOL, V18, P45, DOI 10.1111/j.1365-2958.1995.mmi_18010045.x; Sherratt DJ, 2003, SCIENCE, V301, P780, DOI 10.1126/science.1084780; SUEOKA N, 1995, J MOL EVOL, V40, P318, DOI 10.1007/BF00163236; Touchon M, 2008, BIOCHIMIE, V90, P648, DOI 10.1016/j.biochi.2007.09.015; Val ME, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000201; van Passel MWJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-26; Wake RG, 1997, STRUCTURE, V5, P1, DOI 10.1016/S0969-2126(97)00160-3; Wake RG, 1997, FEMS MICROBIOL LETT, V153, P247, DOI 10.1016/S0378-1097(97)00245-0; Wang XD, 2011, P NATL ACAD SCI USA, V108, pE243, DOI 10.1073/pnas.1100874108; Wilce JA, 2001, NAT STRUCT BIOL, V8, P206, DOI 10.1038/84934; Worning P, 2006, ENVIRON MICROBIOL, V8, P353, DOI 10.1111/j.1462-2920.2005.00917.x; Xu LW, 2003, MOL CELL, V11, P817, DOI 10.1016/S1097-2765(03)00061-3	86	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34526	10.1371/journal.pone.0034526	http://dx.doi.org/10.1371/journal.pone.0034526			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509315	Green Published, gold, Green Submitted			2022-12-27	WOS:000304805900043
J	Petrovic, N; Alderson, DL; Carlson, JM				Petrovic, Nada; Alderson, David L.; Carlson, Jean M.			Dynamic Resource Allocation in Disaster Response: Tradeoffs in Wildfire Suppression	PLOS ONE			English	Article							WILDLAND FIRE; RISK-ASSESSMENT; FOREST-FIRES; POWER LAWS; DISTURBANCE; COMPLEXITY; SPREAD	Challenges associated with the allocation of limited resources to mitigate the impact of natural disasters inspire fundamentally new theoretical questions for dynamic decision making in coupled human and natural systems. Wildfires are one of several types of disaster phenomena, including oil spills and disease epidemics, where (1) the disaster evolves on the same timescale as the response effort, and (2) delays in response can lead to increased disaster severity and thus greater demand for resources. We introduce a minimal stochastic process to represent wildfire progression that nonetheless accurately captures the heavy tailed statistical distribution of fire sizes observed in nature. We then couple this model for fire spread to a series of response models that isolate fundamental tradeoffs both in the strength and timing of response and also in division of limited resources across multiple competing suppression efforts. Using this framework, we compute optimal strategies for decision making scenarios that arise in fire response policy.	[Petrovic, Nada] Columbia Univ, Ctr Res Environm Decis, New York, NY 10027 USA; [Alderson, David L.] Naval Postgrad Sch, Dept Operat Res, Monterey, CA USA; [Carlson, Jean M.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA	Columbia University; United States Department of Defense; United States Navy; Naval Postgraduate School; University of California System; University of California Santa Barbara	Petrovic, N (corresponding author), Columbia Univ, Ctr Res Environm Decis, New York, NY 10027 USA.	petrovic@columbia.edu			Office of Naval Research MURI [N000140810747, 0001408WR20242]; Bell Labs Graduate Research Fellowship; David and Lucile Packard Foundation	Office of Naval Research MURI(MURIOffice of Naval Research); Bell Labs Graduate Research Fellowship; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was supported by Office of Naval Research MURI grants N000140810747 (http://www07.grants.gov/search/search.do?oppId = 42747& mode = VIEW) and 0001408WR20242, the Bell Labs Graduate Research Fellowship, and the David and Lucile Packard Foundation (http://www.packard.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson H.E., 1983, PREDICTING WIND DRIV, V305; [Anonymous], FIR HAZ MAPS; [Anonymous], 2010 DIS NUMB; [Anonymous], SURF FUELS MAPS DAT; [Anonymous], STAT EV; [Anonymous], NAT WEATH HAZ MAP; Bak P., 1996, NATURE WORKS SCI SEL; Barabasi A. L., 2002, FORMULA UNIVERSAL LA; Barbour MG, 1987, TERRESTRIAL PLANT EC; BOOKBINDER JH, 1979, INFOR, V17, P58; Calkin DE, 2011, J FOREST, V109, P274; Calkin DE, 2011, INT J WILDLAND FIRE, V20, P78, DOI 10.1071/WF09137; Calkin DE, 2005, J FOREST, V103, P179, DOI 10.1093/jof/103.4.179; Carlson JM, 1999, PHYS REV E, V60, P1412, DOI 10.1103/PhysRevE.60.1412; CHEN K, 1990, PHYS LETT A, V149, P207, DOI 10.1016/0375-9601(90)90328-L; Christensen G. A., 2008, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; Corral A, 2010, NAT PHYS, V6, P693, DOI 10.1038/NPHYS1725; Davis FW, 1995, GLOBAL CHANGE MEDITE, P203; Donovan GH, 2003, FOREST SCI, V49, P331; Doyle J, 2000, PHYS REV LETT, V84, P5656, DOI 10.1103/PhysRevLett.84.5656; DROSSEL B, 1992, PHYS REV LETT, V69, P1629, DOI 10.1103/PhysRevLett.69.1629; Finney MA, 2011, ENVIRON MODEL ASSESS, V16, P153, DOI 10.1007/s10666-010-9241-3; Gebert KM, 2007, WEST J APPL FOR, V22, P188, DOI 10.1093/wjaf/22.3.188; Gutenberg B., 1954, SEISMICITY EARTH ASS; Haight RG, 2007, INFOR, V45, P31, DOI 10.3138/infor.45.1.31; Hergarten S, 2004, NAT HAZARD EARTH SYS, V4, P309, DOI 10.5194/nhess-4-309-2004; Islam KMS, 1998, CAN J FOREST RES, V28, P1448, DOI 10.1139/cjfr-28-10-1448; Kaplan S., 1981, RISK ANAL, V1, P11, DOI [DOI 10.1111/J.1539-6924.1981.TB01350.X, 10.1111/j.1539-6924.1981.tb01350.x]; Malamud BD, 1998, SCIENCE, V281, P1840, DOI 10.1126/science.281.5384.1840; MARTELL DL, 1982, CAN J FOREST RES, V12, P119, DOI 10.1139/x82-020; Martin-Fernandez S, 2002, ENVIRON MANAGE, V30, P352, DOI 10.1007/s00267-002-2430-3; Mitzenmacher M., 2003, INTERNET MATH, V2, P226, DOI [10.1080/15427951.2004.10129088, DOI 10.1080/15427951.2004.10129088]; Moritz MA, 2005, P NATL ACAD SCI USA, V102, P17912, DOI 10.1073/pnas.0508985102; Moritz MA, 1997, ECOL APPL, V7, P1252, DOI 10.1890/1051-0761(1997)007[1252:AEDEFI]2.0.CO;2; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Perry GLW, 1998, PROG PHYS GEOG, V22, P222, DOI 10.1191/030913398675585936; Peterson S.H., 2009, PSWRES259 USDA FOR S, DOI [10.2737/PSW-RP-259, DOI 10.2737/PSW-RP-259]; Peterson SH, 2011, INT J WILDLAND FIRE, V20, P1, DOI 10.1071/WF09102; Pisarenko V, 2010, ADV NAT TECH HAZ RES, V30, P1, DOI 10.1007/978-90-481-9171-0_1; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Rothermel R. C., 1972, USDA Forests Service Research Paper, Intermountain Forest and Range Experiment Station; Rothermel R. C., 1983, GEN TECHNICAL REPORT, DOI DOI 10.2737/INT-GTR-143; Snyder GW, 1999, PSWGTR173 USDA FOR S; Sornette D, 2006, CRITICAL PHENOMENA N; Stauffer D., 1992, INTRO PERCOLATION TH; STRAUSS D, 1989, FOREST SCI, V35, P319; Swetnam TW, 1998, J CLIMATE, V11, P3128, DOI 10.1175/1520-0442(1998)011<3128:MDAERT>2.0.CO;2; WEBER RO, 1991, PROG ENERG COMBUST, V17, P67, DOI 10.1016/0360-1285(91)90003-6; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Westerling AL, 2003, B AM METEOROL SOC, V84, P595, DOI 10.1175/BAMS-84-5-595; Willinger W, 2004, PROCEEDINGS OF THE 2004 WINTER SIMULATION CONFERENCE, VOLS 1 AND 2, P130	53	24	25	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e33285	10.1371/journal.pone.0033285	http://dx.doi.org/10.1371/journal.pone.0033285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514605	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600010
J	Ventelou, B; Arrighi, Y; Greener, R; Lamontagne, E; Carrieri, P; Moatti, JP				Ventelou, Bruno; Arrighi, Yves; Greener, Robert; Lamontagne, Erik; Carrieri, Patrizia; Moatti, Jean-Paul			The Macroeconomic Consequences of Renouncing to Universal Access to Antiretroviral Treatment for HIV in Africa: A Micro-Simulation Model	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; COST-EFFECTIVENESS; HIV/AIDS; PREVENTION; IMPACT; AIDS; THERAPY; POLICY; KENYA	Aim: Previous economic literature on the cost-effectiveness of antiretroviral treatment (ART) programs has been mainly focused on the microeconomic consequences of alternative use of resources devoted to the fight against the HIV pandemic. We rather aim at forecasting the consequences of alternative scenarios for the macroeconomic performance of countries. Methods: We used a micro-simulation model based on individuals aged 15-49 selected from nationally representative surveys (DHS for Cameroon, Tanzania and Swaziland) to compare alternative scenarios : 1-freezing of ART programs to current levels of access, 2-universal access (scaling up to 100% coverage by 2015, with two variants defining ART eligibility according to previous or current WHO guidelines). We introduced an "artificial" ageing process by programming methods. Individuals could evolve through different health states: HIV negative, HIV positive (with different stages of the syndrome). Scenarios of ART procurement determine this dynamics. The macroeconomic impact is obtained using sample weights that take into account the resulting age-structure of the population in each scenario and modeling of the consequences on total growth of the economy. Results: Increased levels of ART coverage result in decreasing HIV incidence and related mortality. Universal access to ART has a positive impact on workers' productivity; the evaluations performed for Swaziland and Cameroon show that universal access would imply net cost-savings at the scale of the society, when the full macroeconomic consequences are introduced in the calculations. In Tanzania, ART access programs imply a net cost for the economy, but 70% of costs are covered by GDP gains at the 2034 horizon, even in the extended coverage option promoted by WHO guidelines initiating ART at levels of 350 cc/mm(3) CD4 cell counts. Conclusion: Universal Access ART scaling-up strategies, which are more costly in the short term, remain the best economic choice in the long term. Renouncing or significantly delaying the achievement of this goal, due to "legitimate" short term budgetary constraints would be a misguided choice.	[Ventelou, Bruno; Arrighi, Yves; Carrieri, Patrizia; Moatti, Jean-Paul] INSERM, SESSTIM U912, F-13258 Marseille, France; [Ventelou, Bruno; Arrighi, Yves] Greqam, Aix Marseille Sch Econ, CNRS, Marseille, France; [Ventelou, Bruno; Arrighi, Yves; Carrieri, Patrizia; Moatti, Jean-Paul] Reg Hlth Observ Provence Alpes Cote dAzur, Marseille, France; [Greener, Robert; Lamontagne, Erik] Joint United Nations Programme HIV & AIDS, Geneva, Switzerland; [Ventelou, Bruno; Arrighi, Yves; Carrieri, Patrizia; Moatti, Jean-Paul] Aix Marseille Univ, IRD, UMR S912, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite	Ventelou, B (corresponding author), INSERM, SESSTIM U912, F-13258 Marseille, France.	yves.arrighi@inserm.fr	Lamontagne, Erik/ADD-5405-2022	Lamontagne, Erik/0000-0002-6394-0070; Carrieri, Patrizia/0000-0002-6794-4837	UMR912 Economics & Social Health and Medical Information Processing Research Unit (French National Institute of Health & Medical Research - French Research Institute on Development - Aix-Marseille University) [EMP/AFE/EDA/2212]; Joint Nations Programme on HIV and AIDS (UNAIDS) [EMP/AFE/EDA/2212]; French Agence Nationale de Recherche sur le Sida	UMR912 Economics & Social Health and Medical Information Processing Research Unit (French National Institute of Health & Medical Research - French Research Institute on Development - Aix-Marseille University); Joint Nations Programme on HIV and AIDS (UNAIDS); French Agence Nationale de Recherche sur le Sida(ANRS)	This paper is a common project between the UMR912 Economics & Social Health and Medical Information Processing Research Unit (French National Institute of Health & Medical Research - French Research Institute on Development - Aix-Marseille University) and The Joint Nations Programme on HIV and AIDS (UNAIDS) (UNAIDS Contract EMP/AFE/EDA/2212). Colleagues from UNAIDS interacted with the authors in the analysis of data and in the preparation of the manuscript; they are authors. The authors would also like to thank the French Agence Nationale de Recherche sur le Sida for its financial and intellectual support. Except this, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann MO, 2006, AIDS CARE, V18, P109, DOI 10.1080/09540120500159334; Bell C, 2006, WORLD BANK ECON REV, V20, P55, DOI 10.1093/wber/lhj006; Bendavid E, 2011, AIDS, V25, P211, DOI 10.1097/QAD.0b013e328340fdf8; Bennett S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1001001; Bodri M, 2006, ANTIVIR THER, V11, P63; Bongaarts J, 2010, SCIENCE, V328, P1359, DOI 10.1126/science.1191804; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Crowley S, 2010, LANCET, V375, P874, DOI 10.1016/S0140-6736(09)62064-X; Dabis F, 2010, LANCET, V375, P2056, DOI 10.1016/S0140-6736(10)60838-0; Dongmo Nguimfack B, 2010, TRANSACTION PRICES A; El-Sadr WM, 2010, JAIDS-J ACQ IMM DEF, V55, pS116, DOI 10.1097/QAI.0b013e3181fbca6e; Fox MP, 2004, TROP MED INT HEALTH, V9, P318, DOI 10.1111/j.1365-3156.2004.01207.x; GFATM, 2010, 22 BOARD M DEC 13 15; GFATM, 2010, 22 BOARD M 2010 DEC; Goenka A, 2010, ECON THEOR, P1; Gostin LO, 2011, JAMA-J AM MED ASSOC, V305, P191, DOI 10.1001/jama.2010.1975; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Habyarimana J, 2010, J HUM RESOUR, V45, P809; Hecht R, 2010, LANCET, V376, P1254, DOI 10.1016/S0140-6736(10)61255-X; Institut National de la Statistique du Cameroon ORC Macro, 2005, ENQ DEM ET DE SANT C; Izazola-Licea JA, 2009, JAIDS-J ACQ IMM DEF, V52, pS119, DOI 10.1097/QAI.0b013e3181baeeda; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, GETT ZER UNAIDS 2011, P16; Katzenstein D, 2010, AIDS, V24, pS1, DOI 10.1097/01.aids.0000366077.37827.0a; Kyereh K, 2008, 5 POSTGR C CONSTR IN; Leclerc PM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005439; Moatti JP, 2008, AIDS, V22, pS59, DOI 10.1097/01.aids.0000327624.69974.41; OECD, 2010, AID STAT; Orsi F, 2010, LANCET, V375, P1693, DOI 10.1016/S0140-6736(10)60737-4; Over M, 2006, SEX TRANSM DIS, V33, pS145, DOI 10.1097/01.olq.0000238457.93426.0d; Resch S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025310; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Stover J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021048; Stover J, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/738271; Swaziland Central Statistical Office ORC Macro, 2008, 2006 2007 SWAZ DEM H; Tanzania National Bureau of Statistics ORC Macro, 2005, 2004 2005 TANZ DEM H; Thirumurthy H, 2008, J HUM RESOUR, V43, P511, DOI 10.3368/jhr.43.3.511; UNAIDS, 2010, MAK SENS MON DOES MO; UNAIDS, 2010, GLOB REP UNAIDS REP; UNAIDS, 2009, COST EST AIDS FIN EC; UNITAID, 2009, NEW PRIC RED KEY DRU; United Nations Statistics Division, 2010, NAT ACC EST MAIN AGG; UNPD, 2010, WORLD POP PROSP; USAID, 2010, US HAPSAT HIV PROGR; Ventelou B, 2008, AIDS, V22, P107, DOI 10.1097/QAD.0b013e3282f1d49f; Walensky RP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000382; Walensky RP, 2010, CLIN INFECT DIS, V50, P272, DOI 10.1086/649214; WHO, 2010, ANT THER HIV INF AD; World Health Organization, 2010, UN ACC SCAL PRIOR HI; World Health Organization, 2006, ANT THER HIV INF AD; Young A, 2005, Q J ECON, V120, P423, DOI 10.1162/0033553053970223	50	16	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34101	10.1371/journal.pone.0034101	http://dx.doi.org/10.1371/journal.pone.0034101			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UT	22514619	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600024
J	Campioli, M; Leblans, N; Michelsen, A				Campioli, Matteo; Leblans, Niki; Michelsen, Anders			Twenty-Two Years of Warming, Fertilisation and Shading of Subarctic Heath Shrubs Promote Secondary Growth and Plasticity but Not Primary Growth	PLOS ONE			English	Article							LONG-TERM NUTRIENT; DWARF SHRUBS; ENVIRONMENTAL PERTURBATIONS; CASSIOPE-TETRAGONA; FOLIAR NITROGEN; RESPONSES; TUNDRA; PLANTS; ECOSYSTEMS; CLIMATE	Most manipulation experiments simulating global change in tundra were short-term or did not measure plant growth directly. Here, we assessed the growth of three shrubs (Cassiope tetragona, Empetrum hermaphroditum and Betula nana) at a subarctic heath in Abisko (Northern Sweden) after 22 years of warming (passive greenhouses), fertilisation (nutrients addition) and shading (hessian fabric), and compare this to observations from the first decade of treatment. We assessed the growth rate of current-year leaves and apical stem (primary growth) and cambial growth (secondary growth), and integrated growth rates with morphological measurements and species coverage. Primary-and total growth of Cassiope and Empetrum were unaffected by manipulations, whereas growth was substantially reduced under fertilisation and shading (but not warming) for Betula. Overall, shrub height and length tended to increase under fertilisation and warming, whereas branching increased mostly in shaded Cassiope. Morphological changes were coupled to increased secondary growth under fertilisation. The species coverage showed a remarkable increase in graminoids in fertilised plots. Shrub response to fertilisation was positive in the short-term but changed over time, likely because of an increased competition with graminoids. More erected postures and large, canopies (requiring enhanced secondary growth for stem reinforcement) likely compensated for the increased light competition in Empetrum and Cassiope but did not avoid growth reduction in the shade intolerant Betula. The impact of warming and shading on shrub growth was more conservative. The lack of growth enhancement under warming suggests the absence of long-term acclimation for processes limiting biomass production. The lack of negative effects of shading on Cassiope was linked to morphological changes increasing the photosynthetic surface. Overall, tundra shrubs showed developmental plasticity over the longer term. However, such plasticity was associated clearly with growth rate trends only in fertilised plots.	[Campioli, Matteo; Leblans, Niki] Univ Instelling Antwerp, Dept Biol, B-2610 Antwerp, Belgium; [Michelsen, Anders] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Michelsen, Anders] Univ Copenhagen, Ctr Permafrost CENPERM, Copenhagen, Denmark	University of Antwerp; University of Copenhagen; University of Copenhagen	Campioli, M (corresponding author), Univ Instelling Antwerp, Dept Biol, B-2610 Antwerp, Belgium.	matteo.campioli@ua.ac.be	Campioli, Matteo/N-9380-2015; Michelsen, Anders/L-5279-2014	Michelsen, Anders/0000-0002-9541-8658; Campioli, Matteo/0000-0002-3427-2368	Methusalem funding (Research Center of Excellence 'Eco', University of Antwerp); Danish Council for Independent Research | Natural Sciences	Methusalem funding (Research Center of Excellence 'Eco', University of Antwerp); Danish Council for Independent Research | Natural Sciences(Det Frie Forskningsrad (DFF))	This work was supported by Methusalem funding (Research Center of Excellence 'Eco', University of Antwerp) and by the Danish Council for Independent Research | Natural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Arnesen G, 2007, ARCT ANTARCT ALP RES, V39, P189, DOI 10.1657/1523-0430(2007)39[189:SACOCA]2.0.CO;2; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; BERRY J, 1980, ANNU REV PLANT PHYS, V31, P491, DOI 10.1146/annurev.pp.31.060180.002423; Bret-Harte MS, 2002, J ECOL, V90, P251, DOI 10.1046/j.1365-2745.2001.00657.x; Callaghan TV, 2004, AMBIO, V33, P436, DOI 10.1639/0044-7447(2004)033[0436:EOTSOA]2.0.CO;2; Callaghan TV, 2004, AMBIO, V33, P404, DOI 10.1639/0044-7447(2004)033[0404:BDAAOA]2.0.CO;2; Callaghan TV, 2004, AMBIO, V33, P459, DOI 10.1639/0044-7447(2004)033[0459:EOCICO]2.0.CO;2; Callaghan TV, 2004, AMBIO, V33, P418, DOI 10.1639/0044-7447(2004)033[0418:RTPCIC]2.0.CO;2; Callaghan TV, 2004, AMBIO, V33, P448, DOI 10.1639/0044-7447(2004)033[0448:EOTFOA]2.0.CO;2; CALLAGHAN TV, 1989, J ECOL, V77, P823, DOI 10.2307/2260988; Campioli M, 2012, ARCT ANTARCT ALP RES, V44, P16, DOI 10.1657/1938-4246-44.1.16; Campioli M, 2009, BOTANY, V87, P431, DOI 10.1139/B09-016; Campioli M, 2009, ECOSYSTEMS, V12, P760, DOI 10.1007/s10021-009-9255-3; Chapin FS, 1996, ECOLOGY, V77, P822, DOI 10.2307/2265504; DeGroot WJ, 1997, J ECOL, V85, P241, DOI 10.2307/2960655; Forbes BC, 2010, GLOBAL CHANGE BIOL, V16, P1542, DOI 10.1111/j.1365-2486.2009.02047.x; Gough L, 2002, ARCT ANTARCT ALP RES, V34, P211, DOI 10.2307/1552473; Graglia E, 1997, ECOSCIENCE, V4, P191, DOI 10.1080/11956860.1997.11682395; Graglia E, 2001, ECOGRAPHY, V24, P5, DOI 10.1034/j.1600-0587.2001.240102.x; Hallinger M, 2010, NEW PHYTOL, V186, P890, DOI 10.1111/j.1469-8137.2010.03223.x; HAVSTROM M, 1993, OIKOS, V66, P389, DOI 10.2307/3544933; Jonasson S, 1999, ECOLOGY, V80, P1828, DOI 10.1890/0012-9658(1999)080[1828:RIMAPT]2.0.CO;2; Jonasson S, 1999, APPL SOIL ECOL, V11, P135, DOI 10.1016/S0929-1393(98)00145-0; Leblans N, 2011, THESIS U ANTWERP WIL; Mack MC, 2004, NATURE, V431, P440, DOI 10.1038/nature02887; Marchand FL, 2006, NEW PHYTOL, V170, P291, DOI 10.1111/j.1469-8137.2006.01659.x; Michelsen A, 1996, OECOLOGIA, V105, P1, DOI 10.1007/BF00328785; Niinemets U, 2002, ANN BOT-LONDON, V89, P191, DOI 10.1093/aob/mcf025; PARSONS AN, 1994, J ECOL, V82, P307, DOI 10.2307/2261298; Press MC, 1998, J ECOL, V86, P315, DOI 10.1046/j.1365-2745.1998.00261.x; Richardson SJ, 2002, J ECOL, V90, P544, DOI 10.1046/j.1365-2745.2002.00681.x; Ruess L, 1999, PLANT SOIL, V212, P63, DOI 10.1023/A:1004567816355; Schmidt IK, 2002, PLANT SOIL, V242, P93, DOI 10.1023/A:1019642007929; Shaver GR, 1996, ARCTIC ALPINE RES, V28, P363, DOI 10.2307/1552116; SHAVER GR, 1991, ECOL MONOGR, V61, P1, DOI 10.2307/1942997; SHAVER GR, 1986, ECOLOGY, V67, P660, DOI 10.2307/1937690; Shaver GR, 2001, TERRESTRIAL GLOBAL P, P189; Solomon S., 2007, PHYS SCI BASIS WORKI; SONESSON M, 1991, ARCTIC, V44, P95; SPRUGEL DG, 1991, ANNU REV ECOL SYST, V22, P309, DOI 10.1146/annurev.es.22.110191.001521; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P141, DOI 10.1111/j.1365-2486.2006.01067.x; Tybirk K, 2000, AMBIO, V29, P90, DOI 10.1639/0044-7447(2000)029[0090:NEDEFA]2.0.CO;2; van Wijk MT, 2004, GLOBAL CHANGE BIOL, V10, P105, DOI 10.1111/j.1365-2486.2003.00719.x; Wookey PA, 2008, PLANT ECOL DIVERS, V1, P299, DOI 10.1080/17550870802338354	46	30	31	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34842	10.1371/journal.pone.0034842	http://dx.doi.org/10.1371/journal.pone.0034842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511968	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338600054
J	Qin, A; Cheng, TS; Lin, Z; Cao, L; Chim, SM; Pavlos, NJ; Xu, JK; Zheng, MH; Dai, KR				Qin, An; Cheng, Tak S.; Lin, Zhen; Cao, Lei; Chim, Shek M.; Pavlos, Nathan J.; Xu, Jiake; Zheng, Ming Hao; Dai, Ke Rong			Prevention of Wear Particle-Induced Osteolysis by a Novel V-ATPase Inhibitor Saliphenylhalamide through Inhibition of Osteoclast Bone Resorption	PLOS ONE			English	Article							VACUOLAR H+-ATPASE; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; TOTAL HIP-REPLACEMENT; MEDIATED EXTRACELLULAR ACIDIFICATION; IN-VITRO; PERIPROSTHETIC OSTEOLYSIS; SUBUNIT-C; RECEPTOR ACTIVATOR; ANTISENSE RNA	Wear particle-induced peri-implant loosening (Aseptic prosthetic loosening) is one of the most common causes of total joint arthroplasty. It is well established that extensive bone destruction (osteolysis) by osteoclasts is responsible for wear particle-induced peri-implant loosening. Thus, inhibition of osteoclastic bone resorption should prevent wear particle induced osteolysis and may serve as a potential therapeutic avenue for prosthetic loosening. Here, we demonstrate for the first time that saliphenylhalamide, a new V-ATPase inhibitor attenuates wear particle-induced osteolysis in a mouse calvarial model. In vitro biochemical and morphological assays revealed that the inhibition of osteolysis is partially attributed to a disruption in osteoclast acidification and polarization, both a prerequisite for osteoclast bone resorption. Interestingly, the V-ATPase inhibitor also impaired osteoclast differentiation via the inhibition of RANKL-induced NF-kappa B and ERK signaling pathways. In conclusion, we showed that saliphenylhalamide affected multiple physiological processes including osteoclast differentiation, acidification and polarization, leading to inhibition of osteoclast bone resorption in vitro and wear particle-induced osteolysis in vivo. The results of the study provide proof that the new generation V-ATPase inhibitors, such as saliphenylhalamide, are potential anti-resorptive agents for treatment of peri-implant osteolysis.	[Qin, An; Cao, Lei; Dai, Ke Rong] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Shanghai Key Lab Orthopaed Implant,Dept Orthopaed, Shanghai 200030, Peoples R China; [Qin, An; Cheng, Tak S.; Lin, Zhen; Pavlos, Nathan J.; Zheng, Ming Hao] Univ Western Australia, Sch Surg, Ctr Orthopaed Res, Nedlands, WA 6009, Australia; [Lin, Zhen] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Surg, Div Orthopaed, Guangzhou, Guangdong, Peoples R China; [Chim, Shek M.; Xu, Jiake] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Dai, Ke Rong] Shanghai Jiao Tong Univ, Chinese Acad Sci, Sch Med, Orthopaed Cellular & Mol Biol Lab,Inst Hlth Sci, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; University of Western Australia; Guangdong Academy of Medical Sciences & Guangdong General Hospital; University of Western Australia; Chinese Academy of Sciences; Shanghai Jiao Tong University	Qin, A (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 9, Shanghai Key Lab Orthopaed Implant,Dept Orthopaed, Shanghai 200030, Peoples R China.	minghao.zheng@uwa.edu.au; krdai@163.com	Chim, Shek Man/AAK-6809-2020	Chim, Shek Man/0000-0002-5116-8394; Zheng, Minghao/0000-0003-1185-4768; Xu, Jiake/0000-0003-2021-8309; /0000-0002-2151-3433; Pavlos, Nathan/0000-0001-7003-188X	National Health and Medical Research Council of Australia (NHMRC) [APP572670]; Key Disciplines of Shanghai Municipal Education Commission of China [J50206]; Ministry of Science and Technology of China [S2011DFA30790, 2010CB945600]; National Natural Science Foundation of China [30900850]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Key Disciplines of Shanghai Municipal Education Commission of China; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants awarded by the National Health and Medical Research Council of Australia (NHMRC) APP572670 (MHZ) and grants awarded by the Key Disciplines of Shanghai Municipal Education Commission of China to Dr. Dai (J50206), grants from The Ministry of Science and Technology of China (No. S2011DFA30790, 2010CB945600) to Dr. Dai, and grants awarded by National Natural Science Foundation of China to Dr. Lin (30900850). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saffar N, 2000, J ORTHOP RES, V18, P800, DOI 10.1002/jor.1100180518; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; BARON R, 1989, ANAT RECORD, V224, P317, DOI 10.1002/ar.1092240220; BARON R, 1985, J CELL BIOL, V101, P2210, DOI 10.1083/jcb.101.6.2210; Bowman BJ, 2002, J BIOL CHEM, V277, P3965, DOI 10.1074/jbc.M109756200; Zhang C, 2007, ACTA PHARMACOL SIN, V28, P1603, DOI 10.1111/j.1745-7254.2007.00638.x; CHIBA J, 1994, CLIN ORTHOP RELAT R, P304; Clohisy JC, 2004, J ORTHOPAED RES, V22, P13, DOI 10.1016/S0736-0266(03)00156-6; Clohisy JC, 2003, J ORTHOPAED RES, V21, P202, DOI 10.1016/S0736-0266(02)00133-X; Clohisy JC, 2002, J ORTHOPAED RES, V20, P174, DOI 10.1016/S0736-0266(01)00088-2; Crotti TN, 2004, BIOMATERIALS, V25, P565, DOI 10.1016/S0142-9612(03)00556-8; Drory O, 2006, BBA-BIOENERGETICS, V1757, P297, DOI 10.1016/j.bbabio.2006.03.011; Feng HT, 2008, J BIOL CHEM, V283, P13194, DOI 10.1074/jbc.M709712200; Feng SM, 2009, BIOCHEM J, V417, P195, DOI 10.1042/BJ20081073; Greenfield EM, 2002, J ORTHOPAED RES, V20, P1, DOI 10.1016/S0736-0266(01)00070-5; Harris WH, 2001, CLIN ORTHOP RELAT R, P66; Haynes DR, 2004, BIOMATERIALS, V25, P4877, DOI 10.1016/j.biomaterials.2004.01.003; Holding CA, 2006, BIOMATERIALS, V27, P5212, DOI 10.1016/j.biomaterials.2006.05.054; Holliday LS, 2000, J BIOL CHEM, V275, P32331, DOI 10.1074/jbc.M004795200; Holt G, 2007, CLIN ORTHOP RELAT R, P240, DOI 10.1097/BLO.0b013e31804b4147; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; JIRANEK WA, 1993, J BONE JOINT SURG AM, V75A, P863, DOI 10.2106/00004623-199306000-00007; Kim JM, 2007, INT J MOL MED, V19, P393; LAITALA T, 1994, J CLIN INVEST, V93, P2311, DOI 10.1172/JCI117235; Laitala-Leinonen T, 1999, J CELL SCI, V112, P3657; Laitala-Leinonen T, 1999, ANTISENSE NUCLEIC A, V9, P155, DOI 10.1089/oli.1.1999.9.155; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Liu FX, 2009, BIOMATERIALS, V30, P1756, DOI 10.1016/j.biomaterials.2008.12.018; Merkel KD, 1999, AM J PATHOL, V154, P203, DOI 10.1016/S0002-9440(10)65266-2; Muller KH, 2011, BRIT J PHARMACOL, V164, P344, DOI 10.1111/j.1476-5381.2011.01346.x; Nakamura I, 1997, FEBS LETT, V401, P207, DOI 10.1016/S0014-5793(96)01454-8; Nakashima T, 2008, ARCH BIOCHEM BIOPHYS, V473, P166, DOI 10.1016/j.abb.2008.04.004; Nakashima Y, 1999, J BONE JOINT SURG AM, V81A, P603, DOI 10.2106/00004623-199905000-00002; Pioletti DP, 2004, BIOMATERIALS, V25, P5803, DOI 10.1016/j.biomaterials.2004.01.053; Purdue PE, 2007, CLIN ORTHOP RELAT R, P251, DOI 10.1097/01.blo.0000238813.95035.1b; Rakshit DS, 2006, J BONE JOINT SURG AM, V88A, P788, DOI 10.2106/JBJS.E.00711; Ryu J, 2005, PROTEOMICS, V5, P4152, DOI 10.1002/pmic.200402035; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; Sobacchi C, 2001, HUM MOL GENET, V10, P1767, DOI 10.1093/hmg/10.17.1767; Sochart DH, 1997, J BONE JOINT SURG AM, V79A, P1181, DOI 10.2106/00004623-199708000-00010; Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902; Teeny SM, 2003, J ARTHROPLASTY, V18, P954, DOI 10.1016/j.arth.2003.09.001; Teplova VV, 2007, J BIOENERG BIOMEMBR, V39, P321, DOI 10.1007/s10863-007-9095-9; Vaananen HK, 2000, J CELL SCI, V113, P377; Wang C, 2003, J BONE MINER RES, V18, P2159, DOI 10.1359/jbmr.2003.18.12.2159; Wedemeyer C, 2007, CALCIFIED TISSUE INT, V81, P394, DOI 10.1007/s00223-007-9077-2; Xie XS, 2004, J BIOL CHEM, V279, P19755, DOI 10.1074/jbc.M313796200; Xu J, 2007, HISTOL HISTOPATHOL, V22, P443, DOI 10.14670/HH-22.443; Xu JK, 2000, J BONE MINER RES, V15, P2178, DOI 10.1359/jbmr.2000.15.11.2178; Xu JW, 1998, SCAND J RHEUMATOL, V27, P363; Xu JW, 1996, CLIN EXP RHEUMATOL, V14, P643; Zuo J, 2006, J BONE MINER RES, V21, P714, DOI 10.1359/JBMR.060201	54	72	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34132	10.1371/journal.pone.0034132	http://dx.doi.org/10.1371/journal.pone.0034132			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509274	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336600021
J	Rouse, R; Siwy, J; Mullen, W; Mischak, H; Metzger, J; Hanig, J				Rouse, Rodney; Siwy, Justyna; Mullen, William; Mischak, Harald; Metzger, Jochen; Hanig, Joseph			Proteomic Candidate Biomarkers of Drug-Induced Nephrotoxicity in the Rat	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; SUPPORT VECTOR MACHINES; CAPILLARY-ELECTROPHORESIS; MASS-SPECTROMETRY; URINARY PROTEOMICS; DISCOVERY; DISEASE; QUALIFICATION; GENTAMICIN; PEPTIDES	Improved biomarkers of acute nephrotoxicity are coveted by the drug development industry, regulatory agencies, and clinicians. In an effort to identify such biomarkers, urinary peptide profiles of rats treated with two different nephrotoxins were investigated. 493 marker candidates were defined that showed a significant response to cis-platin comparing a cisplatin treated cohort to controls. Next, urine samples from rats that received three consecutive daily doses of 150 or 300 mg/kg gentamicin were examined. 557 potential biomarkers were initially identified; 108 of these gentamicin-response markers showed a clear temporal response to treatment. 39 of the cisplatin-response markers also displayed a clear response to gentamicin. Of the combined 147 peptides, 101 were similarly regulated by gentamicin or cis-platin and 54 could be identified by tandem mass spectrometry. Most were collagen type I and type III fragments up-regulated in response to gentamicin treatment. Based on these peptides, classification models were generated and validated in a longitudinal study. In agreement with histopathology, the observed changes in classification scores were transient, initiated after the first dose, and generally persistent over a period of 10-20 days before returning to control levels. The data support the hypothesis that gentamicin-induced renal toxicity up-regulates protease activity, resulting in an increase in several specific urinary collagen fragments. Urinary proteomic biomarkers identified here, especially those common to both nephrotoxins, may serve as a valuable tool to investigate potential new drug candidates for the risk of nephrotoxicity.	[Rouse, Rodney] US FDA, Div Drug Safety Res, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Hanig, Joseph] US FDA, Off Pharmaceut Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Siwy, Justyna; Mischak, Harald; Metzger, Jochen] Mosa Diagnost GmbH, Hannover, Germany; [Mullen, William; Mischak, Harald] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); Modular Open Systems Approach (MOSA) Solutions; University of Glasgow	Rouse, R (corresponding author), US FDA, Div Drug Safety Res, Ctr Drug Evaluat & Res, Silver Spring, MD USA.	rodney.rouse@fda.hhs.gov	Mullen, William/GWC-8078-2022	Siwy, Justyna/0000-0003-1407-2534; Mischak, Harald/0000-0003-0323-0306; Metzger, Jochen/0000-0003-4475-4499; Mullen, William/0000-0002-5685-1563	SysKID [HEALTH-F2-2009-241544]; Food and Drug Administration (FDA) [149-09]	SysKID; Food and Drug Administration (FDA)	This work was supported in part by SysKID (HEALTH-F2-2009-241544), and by the Food and Drug Administration (FDA) Cooperative Research and Development Agreement (CRADA) #149-09. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalaf A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013421; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Bengatta S, 2009, J AM SOC NEPHROL, V20, P787, DOI 10.1681/ASN.2008050515; Benjamini Y, 1995, J R STAT SOC B, V57, P125; Boes E, 2006, J AM SOC NEPHROL, V17, P528, DOI 10.1681/ASN.2005070733; Chang HR, 2006, CLIN CHIM ACTA, V366, P243, DOI 10.1016/j.cca.2005.10.007; Decramer S, 2006, NAT MED, V12, P398, DOI 10.1038/nm1384; Devarajan P, 2007, CONTRIB NEPHROL, V156, P203; Dieterle F, 2010, NAT BIOTECHNOL, V28, P455, DOI 10.1038/nbt.1625; Drube J, 2009, NEPHROL DIAL TRANSPL, V24, P2161, DOI 10.1093/ndt/gfp063; DVERGSTEN J, 1994, KIDNEY INT, V45, P828, DOI 10.1038/ki.1994.109; Fliser D, 2007, J AM SOC NEPHROL, V18, P1057, DOI 10.1681/ASN.2006090956; Forbes JM, 2000, KIDNEY INT, V57, P2375, DOI 10.1046/j.1523-1755.2000.00097.x; Frommberger M, 2007, PROTEOM CLIN APPL, V1, P650, DOI 10.1002/prca.200700195; Girolami Mark, 2006, Drug Discov Today Technol, V3, P13, DOI 10.1016/j.ddtec.2006.03.010; Good DM, 2010, MOL CELL PROTEOMICS, V9, P2424, DOI 10.1074/mcp.M110.001917; Goodsaid FM, 2009, CLIN PHARMACOL THER, V86, P490, DOI 10.1038/clpt.2009.149; Goodsaid FM, 2008, TOXICOLOGY, V245, P219, DOI 10.1016/j.tox.2007.12.023; Harpur E, 2011, TOXICOL SCI, V122, P235, DOI 10.1093/toxsci/kfr112; Haubitz M, 2009, MOL CELL PROTEOMICS, V8, P2296, DOI 10.1074/mcp.M800529-MCP200; Jantos-Siwy J, 2009, J PROTEOME RES, V8, P268, DOI 10.1021/pr800401m; Kolch W, 2005, MASS SPECTROM REV, V24, P959, DOI 10.1002/mas.20051; Krishnamoorthy A, 2011, BLOOD, V118, P1934, DOI 10.1182/blood-2011-02-338061; Kunugi S, 2011, LAB INVEST, V91, P170, DOI 10.1038/labinvest.2010.174; Lee SY, 2011, AM J PHYSIOL-RENAL, V301, pF101, DOI 10.1152/ajprenal.00445.2010; Ling XB, 2010, ADV CLIN CHEM, V51, P181, DOI 10.1016/S0065-2423(10)51007-2; Lopez-Novoa JM, 2011, KIDNEY INT, V79, P33, DOI 10.1038/ki.2010.337; Metzger J, 2010, KIDNEY INT, V78, P1252, DOI 10.1038/ki.2010.322; Mischak H, 2009, PROTEOM CLIN APPL, V3, P1062, DOI 10.1002/prca.200900030; Mischak H, 2009, MASS SPECTROM REV, V28, P703, DOI 10.1002/mas.20205; Nguyen MT, 2008, PEDIATR NEPHROL, V23, P2151, DOI 10.1007/s00467-007-0470-x; Pabla N, 2008, KIDNEY INT, V73, P994, DOI 10.1038/sj.ki.5002786; Rached E, 2008, TOXICOL SCI, V103, P371, DOI 10.1093/toxsci/kfn040; Rosenberg ME, 2002, MOL CELL BIOL, V22, P1893, DOI 10.1128/MCB.22.6.1893-1902.2002; Rossing K, 2008, J AM SOC NEPHROL, V19, P1283, DOI 10.1681/ASN.2007091025; Rouse RL, 2011, KIDNEY INT, V79, P1186, DOI 10.1038/ki.2010.463; Sanchez-Gonzalez PD, 2011, CRIT REV TOXICOL; Shao C, 2011, SCI CHINA LIFE SCI, V54, P409, DOI 10.1007/s11427-011-4162-1; Sieber M, 2009, TOXICOL SCI, V109, P336, DOI 10.1093/toxsci/kfp070; Theodorescu D, 2006, LANCET ONCOL, V7, P230, DOI 10.1016/S1470-2045(06)70584-8; Vaidya VS, 2008, ANNU REV PHARMACOL, V48, P463, DOI 10.1146/annurev.pharmtox.48.113006.094615; Wang EJ, 2008, TOXICOLOGY, V246, P91, DOI 10.1016/j.tox.2007.12.031; Weissinger EM, 2004, KIDNEY INT, V65, P2426, DOI 10.1111/j.1523-1755.2004.00659.x; Wenger CD, 2011, PROTEOMICS, V11, P1064, DOI 10.1002/pmic.201000616; Wittke S, 2003, J CHROMATOGR A, V1013, P173, DOI 10.1016/S0021-9673(03)00713-1; Wu J, 2010, J ZHEJIANG UNIV-SC B, V11, P227, DOI 10.1631/jzus.B0900327; Xie Y, 2001, KIDNEY INT, V59, P959, DOI 10.1046/j.1523-1755.2001.00579.x; Yang ZR, 2004, BRIEF BIOINFORM, V5, P328, DOI 10.1093/bib/5.4.328; Yang ZR, 2004, BIOINFORMATICS, V20, P735, DOI 10.1093/bioinformatics/btg477; Zhang J, 2009, TOXICOL PATHOL, V37, P629, DOI 10.1177/0192623309339605; Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827	51	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34606	10.1371/journal.pone.0034606	http://dx.doi.org/10.1371/journal.pone.0034606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509332	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000305336600038
J	Wang, YC; Huang, SH; Lan, CY; Chen, BS				Wang, Yu-Chao; Huang, Shin-Hao; Lan, Chung-Yu; Chen, Bor-Sen			Prediction of Phenotype-Associated Genes via a Cellular Network Approach: A Candida albicans Infection Case Study	PLOS ONE			English	Article							EPITHELIAL-CELLS; TRANSCRIPTION FACTORS; REGULATORY NETWORKS; STEROL-METABOLISM; DRUG-RESISTANCE; CHITIN SYNTHASE; VIRULENCE; GROWTH; BIOLOGY; EXPRESSION	Candida albicans is the most prevalent opportunistic fungal pathogen in humans causing superficial and serious systemic infections. The infection process can be divided into three stages: adhesion, invasion, and host cell damage. To enhance our understanding of these C. albicans infection stages, this study aimed to predict phenotype-associated genes involved during these three infection stages and their roles in C. albicans-host interactions. In light of the principles that proteins that lie closer to one another in a protein interaction network are more likely to have similar functions, and that genes regulated by the same transcription factors tend to have similar functions, a cellular network approach was proposed to predict the phenotype-associated genes in this study. A total of 4, 12, and 3 genes were predicted as adhesion-, invasion-, and damage-associated genes during C. albicans infection, respectively. These predicted genes highlight the facts that cell surface components are critical for cell adhesion, and that morphogenesis is crucial for cell invasion. In addition, they provide targets for further investigations into the mechanisms of the three C. albicans infection stages. These results give insights into the responses elicited in C. albicans during interaction with the host, possibly instrumental in identifying novel therapies to treat C. albicans infection.	[Wang, Yu-Chao; Huang, Shin-Hao; Chen, Bor-Sen] Natl Tsing Hua Univ, Dept Elect Engn, Lab Control & Syst Biol, Hsinchu, Taiwan; [Lan, Chung-Yu] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Lan, Chung-Yu] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Wang, YC (corresponding author), Natl Tsing Hua Univ, Dept Elect Engn, Lab Control & Syst Biol, Hsinchu, Taiwan.	bschen@ee.nthu.edu.tw	Chen, Bor-Sen/D-9114-2017	Wang, Yu-Chao/0000-0002-1574-1691; Lan, Chung-Yu/0000-0002-1533-3049	National Science Council of Taiwan [NSC 99-2745-E-007-001-ASP, NSC 100-2745-E-007-001-ASP, NSC 100-2627-B-007-002]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	The work was supported by the National Science Council of Taiwan under grants NSC 99-2745-E-007-001-ASP, NSC 100-2745-E-007-001-ASP (to BSC) and NSC 100-2627-B-007-002 (to CYL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 2011, MBIO, V2, DOI 10.1128/mBio.00325-10; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arnaud MB, 2007, NUCLEIC ACIDS RES, V35, pD452, DOI 10.1093/nar/gkl899; Askew C, 2011, MOL MICROBIOL, V79, P940, DOI 10.1111/j.1365-2958.2010.07504.x; Askew C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000612; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Boysen JH, 2009, GENETICS, V182, P33, DOI 10.1534/genetics.109.101162; Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; Chen CB, 2011, CELL HOST MICROBE, V10, P118, DOI 10.1016/j.chom.2011.07.005; Chou H, 2011, EUKARYOT CELL, V10, P696, DOI 10.1128/EC.00263-10; Dalle F, 2010, CELL MICROBIOL, V12, P248, DOI 10.1111/j.1462-5822.2009.01394.x; Emmert-Streib F, 2011, WIRES SYST BIOL MED, V3, P379, DOI 10.1002/wsbm.134; GOTTLIEB S, 1991, MYCOPATHOLOGIA, V115, P197, DOI 10.1007/BF00462227; GOW NAR, 1994, P NATL ACAD SCI USA, V91, P6216, DOI 10.1073/pnas.91.13.6216; Hameed S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018684; Heung LJ, 2006, INFECT IMMUN, V74, P28, DOI 10.1128/IAI.74.1.28-39.2006; Hogues H, 2008, MOL CELL, V29, P552, DOI 10.1016/j.molcel.2008.02.006; Hu L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017668; Hwang CS, 2003, MOL MICROBIOL, V47, P1029, DOI 10.1046/j.1365-2958.2003.03353.x; Jacobsen ID, 2012, EXPERT REV ANTI-INFE, V10, P85, DOI [10.1586/eri.11.152, 10.1586/ERI.11.152]; Johansson R, 1993, SYSTEM MODELING IDEN, Vxiii, P512; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Joyce AR, 2006, NAT REV MOL CELL BIO, V7, P198, DOI 10.1038/nrm1857; Karkowska-Kuleta J, 2009, ACTA BIOCHIM POL, V56, P211; Kitamura A, 2009, ANTIMICROB AGENTS CH, V53, P3963, DOI 10.1128/AAC.00435-09; Kitano H, 2001, FDN SYSTEMS BIOL, Vxv, P297; Kumamoto CA, 2005, P NATL ACAD SCI USA, V102, P5576, DOI 10.1073/pnas.0407097102; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Lavoie H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000329; Leach MD, 2011, MOL MICROBIOL, V79, P1574, DOI 10.1111/j.1365-2958.2011.07542.x; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Liu TT, 2007, EUKARYOT CELL, V6, P2122, DOI 10.1128/EC.00327-07; Martin R, 2011, INT J MED MICROBIOL, V301, P417, DOI 10.1016/j.ijmm.2011.04.009; Martin SW, 2004, EUKARYOT CELL, V3, P675, DOI 10.1128/EC.3.3.675-684.2004; Naglik JR, 2011, MICROBES INFECT, V13, P963, DOI 10.1016/j.micinf.2011.06.009; Nett JE, 2011, EUKARYOT CELL, V10, P1660, DOI 10.1128/EC.05126-11; Nobile CJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000133; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Rizzetto L, 2011, TRENDS MICROBIOL, V19, P509, DOI 10.1016/j.tim.2011.07.007; Rouabhia M, 2011, MED MYCOL, V49, P458, DOI 10.3109/13693786.2010.535031; Schaller M, 2006, NAT PROTOC, V1, P2767, DOI 10.1038/nprot.2006.474; Schubert S, 2011, ANTIMICROB AGENTS CH, V55, P2212, DOI 10.1128/AAC.01343-10; Sellam A, 2009, EUKARYOT CELL, V8, P1174, DOI 10.1128/EC.00074-09; Sellam A, 2009, MOL BIOL CELL, V20, P2389, DOI 10.1091/mbc.E08-11-1093; Selvaggini S, 2004, MICROBIOL-SGM, V150, P921, DOI 10.1099/mic.0.26661-0; Sharan R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100129; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stynen B, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq725; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Teixeira MC, 2006, NUCLEIC ACIDS RES, V34, pD446, DOI 10.1093/nar/gkj013; Tsai PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017755; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Umeyama T, 2005, MOL MICROBIOL, V55, P381, DOI 10.1111/j.1365-2958.2004.04405.x; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Wachtler B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017046; Wang YC, 2010, BMC SYST BIOL, V4, DOI [10.1186/1752-0509-4-S2-S1, 10.1186/1752-0509-4-20]; Wang YC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-53; Zakikhany K, 2007, CELL MICROBIOL, V9, P2938, DOI 10.1111/j.1462-5822.2007.01009.x; Zhu WD, 2010, CELL MICROBIOL, V12, P273, DOI 10.1111/j.1462-5822.2009.01412.x; Znaidi S, 2008, EUKARYOT CELL, V7, P836, DOI 10.1128/EC.00070-08; Znaidi S, 2009, EUKARYOT CELL, V8, P806, DOI 10.1128/EC.00002-09; Zordan RE, 2007, PLOS BIOL, V5, P2166, DOI 10.1371/journal.pbio.0050256	65	7	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35339	10.1371/journal.pone.0035339	http://dx.doi.org/10.1371/journal.pone.0035339			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509408	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600102
J	Cheng, HC; Su, CY; Yen, AMF; Huang, CF				Cheng, Hsin-Chung; Su, Chen-Yi; Yen, Amy Ming-Fang; Huang, Chiung-Fang			Factors Affecting Occupational Exposure to Needlestick and Sharps Injuries among Dentists in Taiwan: A Nationwide Survey	PLOS ONE			English	Article							HEALTH-CARE WORKERS; HEPATITIS-C VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; PERCUTANEOUS INJURIES; B-VIRUS; BLOOD EXPOSURE; INFECTION; PERSONNEL; HIV; PRECAUTIONS	Background: Although the risks of needlestick and sharps injuries (NSIs) for dentists are well recognized, most papers published only described the frequency of occupational exposure to NSIs. Less has been reported assessing factors contributing to exposure to NSIs. The purpose of this study was to update the epidemiology of NSIs among dentists in Taiwan and identify factors affecting NSIs in order to find preventive strategies. Methodology/Principal Findings: A nationwide survey was conducted in dentists at 60 hospitals and 340 clinics in Taiwan. The survey included questions about factors supposedly affecting exposure to NSIs, such as dentist and facility characteristics, knowledge and attitudes about infectious diseases, and practices related to infection control. Univariate and multivariate logistic regression analyses were conducted to determine the association between risk factors and exposure to NSIs. In total, 434 (74.8%) of 580 dentists returned the survey questionnaires, and 100 (23.0%) reported that they had experienced more than one NSI per week. Our data showed that the risk of occupational NSIs is similarly heightened by an older age (odds ratio [OR], 3.18; 95% confidence interval [CI], 1.62-6.25), more years in practice (OR, 2.57; 95% CI, 1.41-4.69), working in clinics (OR, 1.73; 95% CI, 1.08-2.77), exhibiting less compliance with infection-control procedures (OR, 1.82; 95% CI, 1.04-3.18), having insufficient knowledge of blood-borne pathogens (OR, 1.67; 95% CI, 1.04-2.67), and being more worried about being infected by blood-borne pathogens (OR, 1.82; 95% CI, 1.05-3.13). Conclusions/Significance: High rates of NSIs and low compliance with infection-control procedures highly contribute to the chance of acquiring a blood-borne pathogen infection and threaten occupational safety. This study reveals the possible affecting factors and helps in designing prevention strategies for occupational exposure to NSIs.	[Cheng, Hsin-Chung] Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei, Taiwan; [Cheng, Hsin-Chung; Huang, Chiung-Fang] Taipei Med Univ Hosp, Dept Dent, Taipei, Taiwan; [Su, Chen-Yi] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Yen, Amy Ming-Fang] Taipei Med Univ, Sch Oral Hyg, Coll Oral Med, Taipei, Taiwan; [Huang, Chiung-Fang] Taipei Med Univ, Sch Dent Technol, Coll Oral Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Defense Medical Center; Taipei Medical University; Taipei Medical University	Cheng, HC (corresponding author), Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei, Taiwan.	g4808@tmu.edu.tw			Taiwan Institute of Occupational Safety and Health [IOSH-993071]	Taiwan Institute of Occupational Safety and Health	This project was partially sponsored by the Taiwan Institute of Occupational Safety and Health (IOSH-993071). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTER HJ, 1976, NEW ENGL J MED, V295, P909, DOI 10.1056/NEJM197610212951701; ALTER MJ, 1994, INFECT CONT HOSP EP, V15, P742; ARTENSTEIN AW, 1991, REV INFECT DIS, V13, P288; Bellissimo-Rodrigues WT, 2006, INT DENT J, V56, P332, DOI 10.1111/j.1875-595X.2006.tb00337.x; Callan Richard S, 2006, J Dent Educ, V70, P1089; Centers for Disease Control (CDC), 1990, MMWR Morb Mortal Wkly Rep, V39, P489; CHEN DS, 1977, NEW ENGL J MED, V297, P668; Chen KT, 2009, AIDS PATIENT CARE ST, V23, P195, DOI 10.1089/apc.2008.0047; Cheng HC, 2005, EUR J ORTHODONT, V27, P64, DOI 10.1093/ejo/cjh074; CIESIELSKI C, 1992, ANN INTERN MED, V116, P798, DOI 10.7326/0003-4819-116-10-798; Cleveland JL, 2007, J AM DENT ASSOC, V138, P169, DOI 10.14219/jada.archive.2007.0133; Kohn William G, 2003, MMWR Recomm Rep, V52, P1; Doebbeling BN, 2003, CLIN INFECT DIS, V37, P1006, DOI 10.1086/377535; Duffy RE, 2004, INFECT CONT HOSP EP, V25, P570, DOI 10.1086/502441; Falagas ME, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000194; GERBERDING JL, 1987, J INFECT DIS, V156, P1, DOI 10.1093/infdis/156.1.1; Guo YL, 1999, EPIDEMIOL INFECT, V122, P259, DOI 10.1017/S0950268899002186; Ippolito G, 1998, JAMA-J AM MED ASSOC, V280, P28, DOI 10.1001/jama.280.1.28; Ko NY, 2009, AM J INFECT CONTROL, V37, P609, DOI 10.1016/j.ajic.2008.11.008; Lee HC, 2008, J FORMOS MED ASSOC, V107, P404, DOI 10.1016/S0929-6646(08)60106-0; Leggat PA, 2006, AUST DENT J, V51, P158, DOI 10.1111/j.1834-7819.2006.tb00420.x; Leigh JP, 2008, AM J INFECT CONTROL, V36, P414, DOI 10.1016/j.ajic.2007.07.020; McCarthy GM, 1999, INFECT CONT HOSP EP, V20, P331, DOI 10.1086/501626; MITSUI T, 1992, HEPATOLOGY, V16, P1109, DOI 10.1002/hep.1840160502; Nagao M, 2009, AM J INFECT CONTROL, V37, P541, DOI 10.1016/j.ajic.2009.01.009; Ni YH, 2001, ANN INTERN MED, V135, P796, DOI 10.7326/0003-4819-135-9-200111060-00009; Pan WH, 2003, DIABETIC MED, V20, P182, DOI 10.1046/j.1464-5491.2003.00772.x; Panlilio AL, 2004, INFECT CONT HOSP EP, V25, P556, DOI 10.1086/502439; Salehi AS, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-19; Shah SM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-269; Shiao JSC, 2009, J OCCUP HEALTH, V51, P132, DOI 10.1539/joh.L8111; SIEW C, 1995, J AM DENT ASSOC, V126, P1227, DOI 10.14219/jada.archive.1995.0357; Smith DR, 2006, J HOSP INFECT, V64, P44, DOI 10.1016/j.jhin.2006.03.021; Smith DR, 2006, J PROF NURS, V22, P359, DOI 10.1016/j.profnurs.2006.10.003; SUNG JL, 1984, CHINESE J GASTROENTE, V1, P1; Talaat M, 2003, AM J INFECT CONTROL, V31, P469, DOI 10.1016/j.ajic.2003.03.003; Tsai PS, 2006, J ALTERN COMPLEM MED, V12, P549, DOI 10.1089/acm.2006.12.549; van Griensven F, 2010, AIDS, V24, pS30, DOI 10.1097/01.aids.0000390087.22565.b4; Webber L M, 2000, SADJ, V55, P494; Wicker S, 2010, INT ARCH OCC ENV HEA, V83, P77, DOI 10.1007/s00420-009-0452-3; Zhang M, 2009, AM J IND MED, V52, P89, DOI 10.1002/ajim.20645	41	39	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34911	10.1371/journal.pone.0034911	http://dx.doi.org/10.1371/journal.pone.0034911			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509367	Green Published, gold, Green Submitted			2022-12-27	WOS:000304805900062
J	Sirakov, M; Skah, S; Lone, IN; Nadjar, J; Angelov, D; Plateroti, M				Sirakov, Maria; Skah, Seham; Lone, Imtiaz Nisar; Nadjar, Julien; Angelov, Dimitar; Plateroti, Michelina			Multi-Level Interactions between the Nuclear Receptor TR alpha 1 and the WNT Effectors beta-Catenin/Tcf4 in the Intestinal Epithelium	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; BETA-CATENIN; SIGNALING PATHWAYS; HORMONE-RECEPTORS; ANDROGEN RECEPTOR; THYROID-HORMONES; CROSS-REGULATION; MOLECULAR-BASIS; SELF-RENEWAL; STEM-CELLS	Intestinal homeostasis results from complex cross-regulation of signaling pathways; their alteration induces intestinal tumorigenesis. Previously, we found that the thyroid hormone nuclear receptor TR alpha 1 activates and synergizes with the WNT pathway, inducing crypt cell proliferation and promoting tumorigenesis. Here, we investigated the mechanisms and implications of the cross-regulation between these two pathways in gut tumorigenesis in vivo and in vitro. We analyzed TR alpha 1 and WNT target gene expression in healthy mucosae and tumors from mice overexpressing TR alpha 1 in the intestinal epithelium in a WNT-activated genetic background (vil-TR alpha 1/Apc mice). Interestingly, increased levels of beta-catenin/Tcf4 complex in tumors from vil-TR alpha 1/Apc mice blocked TR alpha 1 transcriptional activity. This observation was confirmed in Caco2 cells, in which TR alpha 1 functionality on a luciferase reporter-assay was reduced by the overexpression of beta-catenin/Tcf4. Moreover, TR alpha 1 physically interacted with beta-catenin/Tcf4 in the nuclei of these cells. Using molecular approaches, we demonstrated that the binding of TR alpha 1 to its DNA target sequences within the tumors was impaired, while it was newly recruited to WNT target genes. In conclusion, our observations strongly suggest that increased beta-catenin/Tcf4 levels i) correlated with reduced TR alpha 1 transcriptional activity on its target genes and, ii) were likely responsible for the shift of TR alpha 1 binding on WNT targets. Together, these data suggest a novel mechanism for the tumor-promoting activity of the TR alpha 1 nuclear receptor.	[Sirakov, Maria; Skah, Seham; Nadjar, Julien; Plateroti, Michelina] Inst Genom Fonct Lyon, Lyon, France; [Lone, Imtiaz Nisar; Angelov, Dimitar] Univ Lyon 1, Ecole Normale Super Lyon, Lab Biol Mol Cellule, F-69365 Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet	Sirakov, M (corresponding author), Univ Libre Bruxelles, Inst Biol & Med Mol, Brussels, Belgium.	michela.plateroti@ens-lyon.fr	Lone, Imtiaz Nisar/AAC-6709-2020; Plateroti, Michelina/F-2928-2017; Angelov, Dimitar/K-2004-2017	Lone, Imtiaz Nisar/0000-0002-1137-2569; Angelov, Dimitar/0000-0002-5511-6647	Institut National pour le Cancer [INCA-2009-175]; Ligue contre le Cancer Department du Rhone	Institut National pour le Cancer; Ligue contre le Cancer Department du Rhone	This work was supported by the Institut National pour le Cancer (grant INCA-2009-175) and the Ligue contre le Cancer Department du Rhone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir AL, 2003, J BIOL CHEM, V278, P30828, DOI 10.1074/jbc.M301208200; Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Beildeck ME, 2010, EXP CELL RES, V316, P1763, DOI 10.1016/j.yexcr.2010.02.001; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; Buob D, 2011, DIG DIS SCI IN PRESS; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Cianferotti L, 2007, P NATL ACAD SCI USA, V104, P9428, DOI 10.1073/pnas.0702884104; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de Lau W, 2007, FRONT BIOSCI-LANDMRK, V12, P471, DOI 10.2741/2076; Easwaran V, 1999, CURR BIOL, V9, P1415, DOI 10.1016/S0960-9822(00)80088-3; El-Tanani M, 2001, J BIOL CHEM, V276, P41675, DOI 10.1074/jbc.M103966200; EVANS GS, 1992, J CELL SCI, V101, P219; Flamant F, 2003, TRENDS ENDOCRIN MET, V14, P85, DOI 10.1016/S1043-2760(02)00043-7; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Gaspar C, 2004, INT J DEV BIOL, V48, P377, DOI 10.1387/ijdb.041807cg; Gauthier K, 2001, MOL CELL BIOL, V21, P4748, DOI 10.1128/MCB.21.14.4748-4760.2001; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; Guigon CJ, 2008, MOL CELL BIOL, V28, P4598, DOI 10.1128/MCB.02192-07; Hu MC, 2005, DEVELOPMENT, V132, P215, DOI 10.1242/dev.01573; Humphries A, 2008, NAT REV CANCER, V8, P415, DOI 10.1038/nrc2392; Jansson EA, 2005, P NATL ACAD SCI USA, V102, P1460, DOI 10.1073/pnas.0405928102; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kress E, 2009, MOL CELL ENDOCRINOL; Kress E, 2010, GASTROENTEROLOGY, V138, P1863, DOI 10.1053/j.gastro.2010.01.041; Kress E, 2009, J BIOL CHEM, V284, P1234, DOI 10.1074/jbc.M806548200; Mahmoudi T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000539; Mulholland DJ, 2005, ENDOCR REV, V26, P898, DOI 10.1210/er.2003-0034; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Plateroti M, 2006, MOL CELL BIOL, V26, P3204, DOI 10.1128/MCB.26.8.3204-3214.2006; Puzianowska-Kuznicka M, 2006, ACTA BIOCHIM POL, V53, P641, DOI 10.18388/abp.2006_3292; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Radtke F, 2006, CURR MOL MED, V6, P275, DOI 10.2174/156652406776894527; Rezza A, 2010, J CELL SCI, V123, P3256, DOI 10.1242/jcs.065284; SAMUELS HH, 1979, ENDOCRINOLOGY, V105, P80, DOI 10.1210/endo-105-1-80; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Shah S, 2006, MOL CELL, V21, P799, DOI 10.1016/j.molcel.2006.01.037; Sirakov M, 2011, BBA-MOL BASIS DIS, V1812, P938, DOI 10.1016/j.bbadis.2010.12.020; Song LN, 2003, MOL CELL BIOL, V23, P1674, DOI 10.1128/MCB.23.5.1674-1687.2003; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Stappenbeck TS, 1998, CURR OPIN CELL BIOL, V10, P702, DOI 10.1016/S0955-0674(98)80110-5; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Waterman ML, 2004, CANCER METAST REV, V23, P41, DOI 10.1023/A:1025858928620; Widelitz R, 2005, GROWTH FACTORS, V23, P111, DOI 10.1080/08977190500125746; Yen PM, 2006, MOL CELL ENDOCRINOL, V246, P121, DOI 10.1016/j.mce.2005.11.030; Yokota J, 2000, CARCINOGENESIS, V21, P497, DOI 10.1093/carcin/21.3.497	55	18	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34162	10.1371/journal.pone.0034162	http://dx.doi.org/10.1371/journal.pone.0034162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509275	Green Published, Green Submitted, gold			2022-12-27	WOS:000304805900014
J	Keihaninejad, S; Heckemann, RA; Gousias, IS; Hajnal, JV; Duncan, JS; Aljabar, P; Rueckert, D; Hammers, A				Keihaninejad, Shiva; Heckemann, Rolf A.; Gousias, Ioannis S.; Hajnal, Joseph V.; Duncan, John S.; Aljabar, Paul; Rueckert, Daniel; Hammers, Alexander			Classification and Lateralization of Temporal Lobe Epilepsies with and without Hippocampal Atrophy Based on Whole-Brain Automatic MRI Segmentation	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; MAGNETIC-RESONANCE-SPECTROSCOPY; POSITRON-EMISSION-TOMOGRAPHY; RECEPTOR-BINDING; BASAL GANGLIA; WHITE-MATTER; SURGERY; AMYGDALA; IMAGES; PET	Brain images contain information suitable for automatically sorting subjects into categories such as healthy controls and patients. We sought to identify morphometric criteria for distinguishing controls (n = 28) from patients with unilateral temporal lobe epilepsy (TLE), 60 with and 20 without hippocampal atrophy (TLE-HA and TLE-N, respectively), and for determining the presumed side of seizure onset. The framework employs multi-atlas segmentation to estimate the volumes of 83 brain structures. A kernel-based separability criterion was then used to identify structures whose volumes discriminate between the groups. Next, we applied support vector machines (SVM) to the selected set for classification on the basis of volumes. We also computed pairwise similarities between all subjects and used spectral analysis to convert these into per-subject features. SVM was again applied to these feature data. After training on a subgroup, all TLE-HA patients were correctly distinguished from controls, achieving an accuracy of 96 +/- 2% in both classification schemes. For TLE-N patients, the accuracy was 86 +/- 2% based on structural volumes and 91 +/- 3% using spectral analysis. Structures discriminating between patients and controls were mainly localized ipsilaterally to the presumed seizure focus. For the TLE-HA group, they were mainly in the temporal lobe; for the TLE-N group they included orbitofrontal regions, as well as the ipsilateral substantia nigra. Correct lateralization of the presumed seizure onset zone was achieved using hippocampi and parahippocampal gyri in all TLE-HA patients using either classification scheme; in the TLE-N patients, lateralization was accurate based on structural volumes in 86 +/- 4%, and in 94 +/- 4% with the spectral analysis approach. Unilateral TLE has imaging features that can be identified automatically, even when they are invisible to human experts. Such morphometric image features may serve as classification and lateralization criteria. The technique also detects unsuspected distinguishing features like the substantia nigra, warranting further study.	[Keihaninejad, Shiva; Heckemann, Rolf A.; Gousias, Ioannis S.; Hammers, Alexander] Univ London Imperial Coll Sci Technol & Med, Fac Med, Ctr Neurosci, Div Expt Med, London SW7 2AZ, England; [Heckemann, Rolf A.; Hammers, Alexander] CERMEP Imagerie Vivant, Neurodis Fdn, Lyon, France; [Gousias, Ioannis S.; Hajnal, Joseph V.] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Imaging Sci Dept, London SW7 2AZ, England; [Duncan, John S.] UCL Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Duncan, John S.] Natl Soc Epilepsy MRI Unit, Gerrards Cross, England; [Aljabar, Paul; Rueckert, Daniel] Univ London Imperial Coll Sci Technol & Med, Dept Comp, London SW7 2AZ, England	Imperial College London; Imperial College London; University of London; University College London; Imperial College London	Keihaninejad, S (corresponding author), UCL Inst Neurol, Dementia Res Ctr, London, England.	alexander.hammers@fondation-neurodis.org	Rueckert, Daniel/C-4393-2008; Hammers, Alexander/D-9982-2015; Heckemann, Rolf Andreas/H-9022-2019; Hajnal, Joseph/P-6251-2018	Hammers, Alexander/0000-0001-9530-4848; Heckemann, Rolf Andreas/0000-0003-3582-3683; Hajnal, Joseph/0000-0002-2690-5495; Duncan, John S/0000-0002-1373-0681; Rueckert, Daniel/0000-0002-5683-5889	Medical Research Council [G108/585]; MRC Clinical Sciences Centre; Dunhill Medical Trust; National Institute for Health Research (NIHR) Biomedical Research Centre; Medical Research Council [MR/K006355/1, MC_U120061309] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10161] Funding Source: researchfish; MRC [G108/585, MR/K006355/1, MC_U120061309] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Clinical Sciences Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dunhill Medical Trust(Dunhill Medical Trust); National Institute for Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	SK and AH were supported by the Medical Research Council (grant number G108/585 and core funding from MRC Clinical Sciences Centre). RH was supported by a research grant from the Dunhill Medical Trust. Authors affiliated with Imperial are grateful for support from the National Institute for Health Research (NIHR) Biomedical Research Centre Funding Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhondi-Asl A, 2011, NEUROIMAGE, V54, pS218, DOI 10.1016/j.neuroimage.2010.03.066; Aljabar P, 2008, NEUROIMAGE, V43, P225, DOI 10.1016/j.neuroimage.2008.07.055; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Barnes J, 2007, NEUROBIOL AGING, V28, P1657, DOI 10.1016/j.neurobiolaging.2006.07.008; Belkin M, 2003, NEURAL COMPUT, V15, P1373, DOI 10.1162/089976603321780317; Bernasconi A, 2000, NEUROIMAGE, V12, P739, DOI 10.1006/nimg.2000.0724; Bernasconi N, 2004, NEUROIMAGE, V23, P717, DOI 10.1016/j.neuroimage.2004.06.015; Bernasconi N, 2003, BRAIN, V126, P462, DOI 10.1093/brain/awg034; Bonilha L, 2005, NEUROIMAGE, V25, P1016, DOI 10.1016/j.neuroimage.2004.11.050; Bonilha L, 2009, EPILEPSIA, V50, P228, DOI 10.1111/j.1528-1167.2008.01768.x; Bouilleret V, 2008, NEUROLOGY, V70, P177, DOI 10.1212/01.wnl.0000297514.47695.48; Carne RP, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-16; Carne RP, 2004, BRAIN, V127, P2276, DOI 10.1093/brain/awh257; CASCINO GD, 1991, ANN NEUROL, V30, P31, DOI 10.1002/ana.410300107; CENDES F, 1993, NEUROLOGY, V43, P719, DOI 10.1212/WNL.43.4.719; Chupin M, 2009, NEUROIMAGE, V46, P749, DOI 10.1016/j.neuroimage.2009.02.013; Chupin M, 2007, NEUROIMAGE, V34, P996, DOI 10.1016/j.neuroimage.2006.10.035; Ciumas C, 2008, NEUROLOGY, V71, P788, DOI 10.1212/01.wnl.0000316120.70504.d5; Ciumas C, 2010, NEUROIMAGE, V51, P606, DOI 10.1016/j.neuroimage.2010.02.051; Connelly A, 1998, NEUROLOGY, V51, P61, DOI 10.1212/WNL.51.1.61; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Debets RMC, 1997, J NEUROL NEUROSUR PS, V62, P141, DOI 10.1136/jnnp.62.2.141; DeCarli C, 1998, ANN NEUROL, V43, P41, DOI 10.1002/ana.410430110; Deransart C, 1998, EPILEPSY RES, V32, P213, DOI 10.1016/S0920-1211(98)00053-9; Didelot A, 2008, BRAIN, V131, P2751, DOI 10.1093/brain/awn220; Dreifuss S, 2001, NEUROLOGY, V57, P1636, DOI 10.1212/WNL.57.9.1636; Duchesne S, 2006, NEUROIMAGE, V29, P557, DOI 10.1016/j.neuroimage.2005.07.052; Duchesne S, 2008, IEEE T MED IMAGING, V27, P509, DOI 10.1109/TMI.2007.908685; Duncan JS, 2011, EPILEPSY BEHAV, V20, P230, DOI 10.1016/j.yebeh.2010.06.040; Duzel E, 2004, EUR J NEUROL, V11, P195, DOI 10.1046/j.1351-5101.2003.00737.x; Engel J, 1996, NEW ENGL J MED, V334, P647, DOI 10.1056/NEJM199603073341008; Eriksson SH, 2009, HUM BRAIN MAPP, V30, P3351, DOI 10.1002/hbm.20757; Fan Y, 2005, LECT NOTES COMPUT SC, V3749, P1; Fedi M, 2008, NEUROLOGY, V71, P795, DOI 10.1212/01.wnl.0000316192.52731.77; Focke NK, 2011, NEUROIMAGE IN PRESS; FREE SL, 1995, AM J NEURORADIOL, V16, P637; Freeborough PA, 1997, COMPUT METH PROG BIO, V53, P15, DOI 10.1016/S0169-2607(97)01803-8; Fukunaga K., 1972, INTRO STAT PATTERN R, V2nd; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; HAJNAL JV, 1992, J COMPUT ASSIST TOMO, V16, P841, DOI 10.1097/00004728-199211000-00001; Hamer HM, 2002, NEUROLOGY, V58, P97, DOI 10.1212/WNL.58.1.97; Hammers A, 2004, NEUROIMAG CLIN N AM, V14, P537, DOI 10.1016/j.nic.2004.04.012; Hammers A, 2002, BRAIN, V125, P2257, DOI 10.1093/brain/awf233; Hammers A, 2002, HUM BRAIN MAPP, V15, P165, DOI 10.1002/hbm.10016; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Hammers A, 2007, NEUROIMAGE, V36, P38, DOI 10.1016/j.neuroimage.2007.02.031; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Heckemann RA, 2011, NEUROIMAGE, V56, P2024, DOI 10.1016/j.neuroimage.2011.03.014; Heckemann RA, 2010, NEUROIMAGE, V51, P221, DOI 10.1016/j.neuroimage.2010.01.072; Hua JP, 2005, BIOINFORMATICS, V21, P1509, DOI 10.1093/bioinformatics/bti171; Jutila L, 2001, AM J NEURORADIOL, V22, P1490; Keihaninejad S, 2010, NEUROIMAGE, V50, P1427, DOI 10.1016/j.neuroimage.2010.01.064; Kelemen A, 1999, IEEE T MED IMAGING, V18, P828, DOI 10.1109/42.811260; Keller SS, 2002, NEUROIMAGE, V16, P23, DOI 10.1006/nimg.2001.1072; Kittler J, 1998, IEEE T PATTERN ANAL, V20, P226, DOI 10.1109/34.667881; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Kobayashi E, 2003, NEUROLOGY, V60, P405, DOI 10.1212/WNL.60.3.405; Korja M, 2007, EPILEPSIA, V48, P1768, DOI 10.1111/j.1528-1167.2007.01118.x; Labate A, 2008, NEUROLOGY, V71, P1094, DOI 10.1212/01.wnl.0000326898.05099.04; Landvogt C, 2010, EPILEPSIA, V51, P1699, DOI 10.1111/j.1528-1167.2010.02569.x; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; MARGERISON JH, 1966, BRAIN, V89, P499, DOI 10.1093/brain/89.3.499; McDonald CR, 2008, EPILEPSY RES, V79, P130, DOI 10.1016/j.eplepsyres.2008.01.006; Mehta S, 2003, NEUROIMAGE, V20, P1438, DOI 10.1016/S1053-8119(03)00377-X; Moran NF, 2001, BRAIN, V124, P167, DOI 10.1093/brain/124.1.167; Morra JH, 2010, IEEE T MED IMAGING, V29, P30, DOI 10.1109/TMI.2009.2021941; Natsume J, 2003, NEUROLOGY, V60, P1296, DOI 10.1212/01.WNL.0000058764.34968.C2; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Prechelt L, 1998, NEURAL NETWORKS, V11, P761, DOI 10.1016/S0893-6080(98)00010-0; Rohlfing T, 2004, NEUROIMAGE, V21, P1428, DOI 10.1016/j.neuroimage.2003.11.010; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Shen DG, 2002, NEUROIMAGE, V15, P422, DOI 10.1006/nimg.2001.0987; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Uijl SG, 2007, EPILEPSIA, V48, P2121, DOI 10.1111/j.1528-1167.2007.01197.x; van der Lijn F, 2008, NEUROIMAGE, V43, P708, DOI 10.1016/j.neuroimage.2008.07.058; VanPaesschen W, 1997, ANN NEUROL, V42, P756, DOI 10.1002/ana.410420512; Vapnik VN, 1999, IEEE T NEURAL NETWOR, V10, P988, DOI 10.1109/72.788640; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wang L, 2008, IEEE T PATTERN ANAL, V30, P1534, DOI 10.1109/TPAMI.2007.70799; Wang Y, 2010, NEUROIMAGE, V50, P1519, DOI 10.1016/j.neuroimage.2009.12.092; Webb J, 1999, MAGN RESON IMAGING, V17, P1149, DOI 10.1016/S0730-725X(99)00044-2; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wieshmann UC, 1996, J NEUROL NEUROSUR PS, V61, P357, DOI 10.1136/jnnp.61.4.357; Woermann FG, 1999, ANN NEUROL, V45, P369, DOI 10.1002/1531-8249(199903)45:3<369::AID-ANA13>3.0.CO;2-Q; Woermann FG, 1999, BRAIN, V122, P2101, DOI 10.1093/brain/122.11.2101; Woermann FG, 1999, NEUROIMAGE, V10, P373, DOI 10.1006/nimg.1999.0481; Wolz R, 2010, NEUROIMAGE, V49, P1316, DOI 10.1016/j.neuroimage.2009.09.069; Yakushev IY, 2010, EPILEPSIA, V51, P415, DOI 10.1111/j.1528-1167.2009.02272.x	89	46	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e33096	10.1371/journal.pone.0033096	http://dx.doi.org/10.1371/journal.pone.0033096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523539	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000008
J	Albrecht, P; Muller, AK; Sudmeyer, M; Ferrea, S; Ringelstein, M; Cohn, E; Aktas, O; Dietlein, T; Lappas, A; Foerster, A; Hartung, HP; Schnitzler, A; Methner, A				Albrecht, Philipp; Mueller, Ann-Kristin; Suedmeyer, Martin; Ferrea, Stefano; Ringelstein, Marius; Cohn, Eva; Aktas, Orhan; Dietlein, Thomas; Lappas, Alexandra; Foerster, Andreas; Hartung, Hans-Peter; Schnitzler, Alfons; Methner, Axel			Optical Coherence Tomography in Parkinsonian Syndromes	PLOS ONE			English	Article							PROGRESSIVE SUPRANUCLEAR PALSY; FUNCTIONAL RETINAL IMPAIRMENT; MILD COGNITIVE IMPAIRMENT; VISUAL EVOKED-POTENTIALS; CORTICOBASAL DEGENERATION; CONSENSUS STATEMENT; MULTIPLE-SCLEROSIS; EARLY-DIAGNOSIS; DISEASE; THICKNESS	Background/Objective: Parkinson's disease (PD) and the atypical parkinsonian syndromes multiple system atrophy (MSA), progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS) are movement disorders associated with degeneration of the central nervous system. Degeneration of the retina has not been systematically compared in these diseases. Methods: This cross-sectional study used spectral-domain optical coherence tomography with manual segmentation to measure the peripapillar nerve fiber layer, the macular thickness, and the thickness of all retinal layers in foveal scans of 40 patients with PD, 19 with MSA, 10 with CBS, 15 with PSP, and 35 age-and sex-matched controls. Results: The mean paramacular thickness and volume were reduced in PSP while the mean RNFL did not differ significantly between groups. In PSP patients, the complex of retinal ganglion cell-and inner plexiform layer and the outer nuclear layer was reduced. In PD, the inner nuclear layer was thicker than in controls, MSA and PSP. Using the ratio between the outer nuclear layer and the outer plexiform layer with a cut-off at 3.1 and the additional constraint that the inner nuclear layer be under 46 mu m, we were able to differentiate PSP from PD in our patient sample with a sensitivity of 96% and a specificity of 70%. Conclusion: Different parkinsonian syndromes are associated with distinct changes in retinal morphology. These findings may serve to facilitate the differential diagnosis of parkinsonian syndromes and give insight into the degenerative processes of patients with atypical parkinsonian syndromes.	[Albrecht, Philipp; Mueller, Ann-Kristin; Suedmeyer, Martin; Ferrea, Stefano; Ringelstein, Marius; Cohn, Eva; Aktas, Orhan; Hartung, Hans-Peter; Schnitzler, Alfons; Methner, Axel] Univ Dusseldorf, Dept Neurol, Fac Med, Dusseldorf, Germany; [Foerster, Andreas] Univ Dusseldorf, Dept Ophthalmol, Fac Med, D-40225 Dusseldorf, Germany; [Dietlein, Thomas; Lappas, Alexandra] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany; [Schnitzler, Alfons] Univ Dusseldorf, Fac Med, Inst Clin Neurosci & Med Psychol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Cologne; Heinrich Heine University Dusseldorf	Albrecht, P (corresponding author), Univ Dusseldorf, Dept Neurol, Fac Med, Dusseldorf, Germany.	phil.albrecht@gmail.com	Aktas, Orhan/B-7623-2009; Schnitzler, Alfons/AAT-1054-2021; Ferrea, Stefano/AAP-5169-2020; Schnitzler, Alfons/Q-5520-2019	Aktas, Orhan/0000-0002-2020-9210; Schnitzler, Alfons/0000-0002-6414-7939; Methner, Axel/0000-0002-8774-0057	"Helmholtz Alliance for Mental Health in an Ageing Society'' (HelMA) [HA-215]; Helmholtz Impuls- und Vernetzungsfonds; German "Bundesministerium fur Bildung und Forschung'' (BMBF)	"Helmholtz Alliance for Mental Health in an Ageing Society'' (HelMA); Helmholtz Impuls- und Vernetzungsfonds; German "Bundesministerium fur Bildung und Forschung'' (BMBF)(Federal Ministry of Education & Research (BMBF))	The authors thank the "Helmholtz Alliance for Mental Health in an Ageing Society'' (HelMA, HA-215) and the "Helmholtz Impuls- und Vernetzungsfonds'' funded by the German "Bundesministerium fur Bildung und Forschung'' (BMBF) for the support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaker GD, 2010, CLIN OPHTHALMOL, V4, P1427, DOI 10.2147/OPTH.S15136; Albrecht P, 2007, J NEUROL, V254, P1595, DOI 10.1007/s00415-007-0538-3; Altintas O, 2008, DOC OPHTHALMOL, V116, P137, DOI 10.1007/s10633-007-9091-8; Antal A, 1998, CLIN NEUROSCI, V5, P147; Archibald NK, 2011, PARKINSONISM RELAT D, V17, P431, DOI 10.1016/j.parkreldis.2011.03.004; Bak TH, 2006, J NEUROL NEUROSUR PS, V77, P454, DOI 10.1136/jnnp.2005.068239; Barnes CS, 2009, DOC OPHTHALMOL, V118, P247, DOI 10.1007/s10633-008-9156-3; Berg D, 2010, NEURODEGENER DIS, V7, P291, DOI 10.1159/000314494; Blain CRV, 2006, NEUROLOGY, V67, P2199, DOI 10.1212/01.wnl.0000249307.59950.f8; Bodis-Wollner I, 2009, J NEURAL TRANSM, V116, P1493, DOI 10.1007/s00702-009-0292-z; BODISWOLLNER I, 1978, BRAIN, V101, P661, DOI 10.1093/brain/101.4.661; Boeve BF, 2003, ANN NEUROL, V54, pS15, DOI 10.1002/ana.10570; Brandt AU, 2011, BRAIN, V134, DOI 10.1093/brain/awr095; Brenneis C, 2007, J NEUROL, V254, P191, DOI 10.1007/s00415-006-0325-6; DACEY DM, 1988, SCIENCE, V240, P1196, DOI 10.1126/science.3375811; Dorr J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018132; Fischer MD, 2011, MOVEMENT DISORD, V26, P914, DOI 10.1002/mds.23523; Focke NK, 2011, HUM BRAIN MAPP, V32, P1905, DOI 10.1002/hbm.21161; FREDERICK JM, 1982, J COMP NEUROL, V210, P65, DOI 10.1002/cne.902100108; Gaenslen A, 2010, INT REV NEUROBIOL, V90, P81, DOI 10.1016/S0074-7742(10)90006-8; Gilman S, 2008, NEUROLOGY, V71, P670, DOI 10.1212/01.wnl.0000324625.00404.15; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Hajee ME, 2009, ARCH OPHTHALMOL-CHIC, V127, P737, DOI 10.1001/archophthalmol.2009.106; HARNOIS C, 1990, INVEST OPHTH VIS SCI, V31, P2473; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; IKEDA H, 1994, VISION RES, V34, P2629, DOI 10.1016/0042-6989(94)90248-8; Inzelberg R, 2004, VISION RES, V44, P2793, DOI 10.1016/j.visres.2004.06.009; Kesler A, 2011, CLIN NEUROL NEUROSUR, V113, P523, DOI 10.1016/j.clineuro.2011.02.014; Leger F, 2011, J NEUROPATH EXP NEUR, V70, P63, DOI 10.1097/NEN.0b013e31820376cc; Ling HL, 2010, BRAIN, V133, P2045, DOI 10.1093/brain/awq123; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Lu Y, 2010, NEUROSCI LETT, V480, P69, DOI 10.1016/j.neulet.2010.06.006; Messina D, 2011, PARKINSONISM RELAT D, V17, P172, DOI 10.1016/j.parkreldis.2010.12.010; Moschos MM, 2011, EUR J OPHTHALMOL, V21, P24, DOI 10.5301/EJO.2010.1318; Nassif N, 2004, OPT LETT, V29, P480, DOI 10.1364/OL.29.000480; Oka M, 2001, ACTA NEUROL SCAND, V104, P1, DOI 10.1034/j.1600-0404.2001.00262.x; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Parisi V, 2001, CLIN NEUROPHYSIOL, V112, P1860, DOI 10.1016/S1388-2457(01)00620-4; Paviour DC, 2006, MOVEMENT DISORD, V21, P989, DOI 10.1002/mds.20877; Pfueller CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018019; PRICE MJ, 1992, NEUROLOGY, V42, P887, DOI 10.1212/WNL.42.4.887; Price S, 2004, NEUROIMAGE, V23, P663, DOI 10.1016/j.neuroimage.2004.06.013; Pula JH, 2009, CURR OPIN OPHTHALMOL, V20, P482, DOI 10.1097/ICU.0b013e3283319899; REGAN D, 1984, J NEUROL NEUROSUR PS, V47, P673, DOI 10.1136/jnnp.47.7.673; Sartucci F, 2003, J CLIN NEUROPHYSIOL, V20, P375, DOI 10.1097/00004691-200309000-00010; Schrag A, 2000, NEUROLOGY, V54, P697, DOI 10.1212/WNL.54.3.697; Sitburana O, 2009, PARKINSONISM RELAT D, V15, P165, DOI 10.1016/j.parkreldis.2008.04.033; Sudmeyer M, 2011, J NUCL MED; Tagliati M, 1996, EVOKED POTENTIAL, V100, P1, DOI 10.1016/0168-5597(95)00169-7; Tatrai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030922; Wang LH, 2000, J NEUROL, V247, P356, DOI 10.1007/s004150050602; Warner CV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022947	54	120	123	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34891	10.1371/journal.pone.0034891	http://dx.doi.org/10.1371/journal.pone.0034891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514688	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341600094
J	Chen, YC; Lu, YF; Li, IC; Hwang, SPL				Chen, Yi-Chung; Lu, Yu-Fen; Li, I-Chen; Hwang, Sheng-Ping L.			Zebrafish Agr2 Is Required for Terminal Differentiation of Intestinal Goblet Cells	PLOS ONE			English	Article							XENOPUS CEMENT GLAND; ANTERIOR GRADIENT-2; GENE; DISEASE; PROTEIN; EXPRESSION; HOMOLOG; STRESS; GROWTH	Background: Mammalian Anterior Gradient 2 (AGR2) is a protein disulfide isomerase that is required for the production of intestinal mucus and Paneth and goblet cell homeostasis. However, whether increased endoplasmic reticulum (ER) stress occurs in Agr2(-/-) mice remains a controversial issue. Methodology/Principal Findings: We characterized the function of zebrafish agr2 by both morpholino antisense oligomer-mediated knockdown and agr2 mRNA overexpression. Fluorescent whole-mount double in situ hybridization indicated that in the intestine, agr2 was only expressed in goblet cells. Significantly increased numbers of immature Alcian blue-stained goblet cells were observed in the intestines of 104- and 120-hours post fertilization (hpf) agr2 morphants. Transmission electron microscopy analyses further confirmed the existence of immature pre-goblet cells containing few mucous granules in the mid-intestines of 104- and 120-hpf agr2 morphants. agr2 expression was not significantly induced by an ER stress inducer, tunicamycin. Expression of the ER chaperone gene hspa5, the spliced form of xbp1s, c/enhancer binding protein homologous protein chop, and the activating transcription factor 4b1 atf4b1 were not significantly induced in either 104-hpf agr2 morphants or agr2-overexpressed embryos. Similar percentages of P-Histone H3-stained M phase cells were identified in intestines of 104-hpf agr2 morphants and control embryos. Conclusions/Significance: Our study demonstrates that in contrast to mouse AGR2, zebrafish Agr2 is expressed in only one intestinal secretory cell type - the goblet cells. Agr2 is essential for terminal differentiation of intestinal goblet cells in zebrafish embryos. Either knockdown of agr2 function or agr2 overexpression could not extensively induce expression of members of the unfolded protein response pathway.	[Chen, Yi-Chung; Lu, Yu-Fen; Hwang, Sheng-Ping L.] Acad Sinica, ICOB, Taipei 115, Taiwan; [Li, I-Chen] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University	Chen, YC (corresponding author), Acad Sinica, ICOB, Taipei 115, Taiwan.	zoslh@gate.sinica.edu.tw	Hwang, Sheng-Ping/F-2882-2014	Chen, Yi-Chun/0000-0002-2237-9416	National Science Council (NSC) [NSC 98-2321-B-001-028-MY3]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This study was supported by a grant from the National Science Council (NSC NSC 98-2321-B-001-028-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberger F, 1998, MECH DEVELOP, V72, P115, DOI 10.1016/S0925-4773(98)00021-5; Brychtova V, 2011, CANCER LETT, V304, P1, DOI 10.1016/j.canlet.2010.12.023; Chen YH, 2009, DEV DYNAM, V238, P1021, DOI 10.1002/dvdy.21908; Dong AW, 2011, J BIOL CHEM, V286, P18301, DOI 10.1074/jbc.M110.215707; Einerhand AWC, 2002, EUR J GASTROEN HEPAT, V14, P757, DOI 10.1097/00042737-200207000-00008; Fletcher GC, 2003, BRIT J CANCER, V88, P579, DOI 10.1038/sj.bjc.6600740; Gersemann M, 2009, DIFFERENTIATION, V77, P84, DOI 10.1016/j.diff.2008.09.008; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Higa A, 2011, J BIOL CHEM; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Komiya T, 1999, BBA-GENE STRUCT EXPR, V1444, P434, DOI 10.1016/S0167-4781(99)00010-X; Kumar A, 2007, SCIENCE, V318, P772, DOI 10.1126/science.1147710; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu D, 2005, CANCER RES, V65, P3796, DOI 10.1158/0008-5472.CAN-04-3823; McGuckin MA, 2010, AM J PHYSIOL-GASTR L, V298, pG820, DOI 10.1152/ajpgi.00063.2010; Morrison RN, 2008, J FISH DIS, V31, P699, DOI 10.1111/j.1365-2761.2008.00934.x; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Park SW, 2009, P NATL ACAD SCI USA, V106, P6950, DOI 10.1073/pnas.0808722106; Peng MY, 2002, MOL REPROD DEV, V63, P422, DOI 10.1002/mrd.10201; Persson S, 2005, MOL PHYLOGENET EVOL, V36, P734, DOI 10.1016/j.ympev.2005.04.002; Shih LJ, 2007, GENE EXPR PATTERNS, V7, P452, DOI 10.1016/j.modgep.2006.11.003; Sive H, 1996, DEV DYNAM, V205, P265, DOI 10.1002/(SICI)1097-0177(199603)205:3<265::AID-AJA7>3.0.CO;2-G; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Vanderlaag KE, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2586; Wang Z, 2008, CANCER RES, V68, P492, DOI 10.1158/0008-5472.CAN-07-2930; WESTERFIELD M, 1995, ZEBRAFISH BOOK; Zhao F, 2010, DEV BIOL, V338, P268, DOI 10.1016/j.ydbio.2009.12.008	27	23	24	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34408	10.1371/journal.pone.0034408	http://dx.doi.org/10.1371/journal.pone.0034408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514630	gold, Green Published			2022-12-27	WOS:000305341600035
J	Pan, HP; Chu, D; Yan, WQ; Su, Q; Liu, BM; Wang, SL; Wu, QJ; Xie, W; Jiao, XG; Li, RM; Yang, NN; Yang, X; Xu, BY; Brown, JK; Zhou, XG; Zhang, YJ				Pan, Huipeng; Chu, Dong; Yan, Wenqian; Su, Qi; Liu, Baiming; Wang, Shaoli; Wu, Qingjun; Xie, Wen; Jiao, Xiaoguo; Li, Rumei; Yang, Nina; Yang, Xin; Xu, Baoyun; Brown, Judith K.; Zhou, Xuguo; Zhang, Youjun			Rapid Spread of Tomato Yellow Leaf Curl Virus in China Is Aided Differentially by Two Invasive Whiteflies	PLOS ONE			English	Article							BEMISIA-TABACI HEMIPTERA; SHANDONG PROVINCE; BIOTYPE Q; TRANSMISSION; VECTOR; ALEYRODIDAE; BEGOMOVIRUSES; DNA; HOMOPTERA; PCR	Background: Tomato yellow leaf curl virus (TYLCV) was introduced into China in 2006, approximately 10 years after the introduction of an invasive whitefly, Bemisia tabaci (Genn.) B biotype. Even so the distribution and prevalence of TYLCV remained limited, and the economic damage was minimal. Following the introduction of Q biotype into China in 2003, the prevalence and spread of TYLCV started to accelerate. This has lead to the hypothesis that the two biotypes might not be equally competent vectors of TYLCV. Methodology/Principal Findings: The infection frequency of TYLCV in the field-collected B. tabaci populations was investigated, the acquisition and transmission capability of TYLCV by B and Q biotypes were compared under the laboratory conditions. Analysis of B. tabaci populations from 55 field sites revealed the existence of 12 B and 43 Q biotypes across 18 provinces in China. The acquisition and transmission experiments showed that both B and Q biotypes can acquire and transmit the virus, however, Q biotype demonstrated superior acquisition and transmission capability than its B counterparts. Specifically, Q biotype acquired significantly more viral DNA than the B biotype, and reached the maximum viral load in a substantially shorter period of time. Although TYLCV was shown to be transmitted horizontally by both biotypes, Q biotype exhibited significantly higher viral transmission frequency than B biotype. Vertical transmission result, on the other hand, indicated that TYLCV DNA can be detected in eggs and nymphs, but not in pupae and adults of the first generation progeny. Conclusions/Significance: These combined results suggested that the epidemiology of TYLCV was aided differentially by the two invasive whiteflies (B and Q biotypes) through horizontal but not vertical transmission of the virus. This is consistent with the concomitant eruption of TYLCV in tomato fields following the recent rapid invasion of Q biotype whitefly in China.	[Pan, Huipeng; Yan, Wenqian; Su, Qi; Liu, Baiming; Wang, Shaoli; Wu, Qingjun; Xie, Wen; Jiao, Xiaoguo; Li, Rumei; Yang, Nina; Yang, Xin; Xu, Baoyun; Zhang, Youjun] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China; [Chu, Dong] Shandong Acad Agr Sci, High Tech Res Ctr, Jinan, Peoples R China; [Brown, Judith K.] Univ Arizona, Sch Plant Sci, Tucson, AZ USA; [Zhou, Xuguo] Univ Kentucky, Dept Entomol, Lexington, KY 40546 USA	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Shandong Academy of Agricultural Sciences; University of Arizona; University of Kentucky	Pan, HP (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100193, Peoples R China.	xuguozhou@uky.edu; zhangyj@mail.caas.net.cn	Zhang, Youjun/AAY-7948-2020; Chu, Dong/AAS-3914-2020; Yang, Xin/AAG-5375-2020; CHU, DONG/AAI-1892-2020	Zhang, Youjun/0000-0003-3508-6695; Chu, Dong/0000-0001-5716-4979; 	National Science Fund for Distinguished Young Scholars [31025020]; 973 Program [2009CB119200]; National Natural Science Foundation of China [31171857]; Outstanding Youth Science Foundation of Shandong Province [JQ200811]; Key Laboratory of Vegetable Genetics and Physiology, Ministry of Agriculture	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Youth Science Foundation of Shandong Province; Key Laboratory of Vegetable Genetics and Physiology, Ministry of Agriculture	This research was supported by the National Science Fund for Distinguished Young Scholars (31025020), the 973 Program (2009CB119200), the National Natural Science Foundation of China (31171857), the Outstanding Youth Science Foundation of Shandong Province (JQ200811), and the Key Laboratory of Vegetable Genetics and Physiology, Ministry of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosco D, 2004, VIROLOGY, V323, P276, DOI 10.1016/j.virol.2004.03.010; Boulton MI, 2003, ANN APPL BIOL, V142, P143, DOI 10.1111/j.1744-7348.2003.tb00239.x; Brown J. K., 1994, FAO (Food and Agriculture Organization of the United Nations) Plant Protection Bulletin, V42, P3; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Brown JK, 2002, ADV BOT RES, V36, P65, DOI 10.1016/S0065-2296(02)36059-2; Brown JK, 2000, VIRUS RES, V71, P233, DOI 10.1016/S0168-1702(00)00221-5; Brown Judith K., 2010, P31; Brown Judith K., 2007, P25, DOI 10.1007/978-1-4020-4769-5_3; Chu D, 2007, ENVIRON ENTOMOL, V36, P1290, DOI 10.1603/0046-225X(2007)36[1290:BSADOB]2.0.CO;2; Chu D, 2006, FLA ENTOMOL, V89, P168, DOI 10.1653/0015-4040(2006)89[168:TIOTEQ]2.0.CO;2; Chu D, 2010, FLA ENTOMOL, V93, P203, DOI 10.1653/024.093.0209; Chu D, 2010, ENVIRON ENTOMOL, V39, P1028, DOI 10.1603/EN09161; COHEN S., 1964, ENTOMOL EXP APPL, V7, P155, DOI 10.1007/BF00305053; COSTA HS, 1991, ENVIRON ENTOMOL, V20, P1102, DOI 10.1093/ee/20.4.1102; Czosnek H, 2011, WHITEFLY, BEMISIA TABACI (HOMOPTERA: ALEYRODIDAE) INTERACTION WITH GEMINIVIRUS-INFECTED HOST PLANTS: BEMISIA TABACI, HOST PLANTS AND GEMINIVIRUSES, P51, DOI 10.1007/978-94-007-1524-0_3; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; DeBarro PJ, 1997, AUST J ENTOMOL, V36, P149; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Frohlich DR, 1999, MOL ECOL, V8, P1683, DOI 10.1046/j.1365-294x.1999.00754.x; Ghanim M, 2000, J VIROL, V74, P4738, DOI 10.1128/JVI.74.10.4738-4745.2000; Ghanim M, 1998, VIROLOGY, V240, P295, DOI 10.1006/viro.1997.8937; Ghanim M, 2007, ARTHROPOD-PLANT INTE, V1, P195, DOI 10.1007/s11829-007-9018-z; Gill Raymond J., 2010, P5; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Ji YingHua, 2008, Acta Horticulturae Sinica, V35, P1815; Jiu M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000182; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luan JB, 2011, J VIROL, V85, P3330, DOI 10.1128/JVI.02507-10; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; McKenzie CL, 2002, FLA ENTOMOL, V85, P367, DOI 10.1653/0015-4040(2002)085[0367:EOTMVT]2.0.CO;2; Morin S, 2000, VIROLOGY, V276, P404, DOI 10.1006/viro.2000.0549; Morin S, 1999, VIROLOGY, V256, P75, DOI 10.1006/viro.1999.9631; Mughra RB, 2008, J PHYTOPATHOL, V156, P217, DOI 10.1111/j.1439-0434.2007.01345.x; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Pan HP, 2011, J ECON ENTOMOL, V104, P978, DOI 10.1603/EC11009; Perring TM, 2001, CROP PROT, V20, P725, DOI 10.1016/S0261-2194(01)00109-0; Rao Q, 2011, B ENTOMOL RES, V101, P81, DOI 10.1017/S0007485310000428; Rubinstein G, 1997, J GEN VIROL, V78, P2683, DOI 10.1099/0022-1317-78-10-2683; Seal SE, 2006, CRIT REV PLANT SCI, V25, P23, DOI 10.1080/07352680500365257; Sun ZW, 2009, CHINA VEGETABLES, V21, P5; Teng X, 2010, FLA ENTOMOL, V93, P363, DOI 10.1653/024.093.0307; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; Wang J, 2010, ANN APPL BIOL, V157, P125, DOI 10.1111/j.1744-7348.2010.00403.x; Wu JB, 2006, PLANT DIS, V90, P1359, DOI 10.1094/PD-90-1359C; Xie W, 2011, PEST MANAG SCI, V67, P87, DOI 10.1002/ps.2037; Xie Y, 2002, CHINESE SCI BULL, V47, P197, DOI 10.1360/02tb9047; [张爱红 Zhang Aihong], 2010, [植物保护, Plant Protection], V36, P127; [周涛 Zhou Tao], 2010, [植物保护, Plant Protection], V36, P116; Zhou Y, 1949, CHIN J ENTOMOL, V3, P1	50	101	134	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34817	10.1371/journal.pone.0034817	http://dx.doi.org/10.1371/journal.pone.0034817			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514670	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600076
J	Sandt, C; Feraud, O; Oudrhiri, N; Bonnet, ML; Meunier, MC; Valogne, Y; Bertrand, A; Raphael, M; Griscelli, F; Turhan, AG; Dumas, P; Bennaceur-Griscelli, A				Sandt, Christophe; Feraud, Olivier; Oudrhiri, Noufissa; Bonnet, Marie Laure; Meunier, Marie Claude; Valogne, Yannick; Bertrand, Angelina; Raphael, Martine; Griscelli, Frank; Turhan, Ali G.; Dumas, Paul; Bennaceur-Griscelli, Annelise			Identification of Spectral Modifications Occurring during Reprogramming of Somatic Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; INFRARED MICROSPECTROSCOPY; DIFFERENTIATION; SPECTROSCOPY; MEMORY	Recent technological advances in cell reprogramming by generation of induced pluripotent stem cells (iPSC) offer major perspectives in disease modelling and future hopes for providing novel stem cells sources in regenerative medicine. However, research on iPSC still requires refining the criteria of the pluripotency stage of these cells and exploration of their equivalent functionality to human embryonic stem cells (ESC). We report here on the use of infrared microspectroscopy to follow the spectral modification of somatic cells during the reprogramming process. We show that induced pluripotent stem cells (iPSC) adopt a chemical composition leading to a spectral signature indistinguishable from that of embryonic stem cells (ESC) and entirely different from that of the original somatic cells. Similarly, this technique allows a distinction to be made between partially and fully reprogrammed cells. We conclude that infrared microspectroscopy signature is a novel methodology to evaluate induced pluripotency and can be added to the tests currently used for this purpose.	[Sandt, Christophe; Dumas, Paul] SOLEIL Synchrotron, Gif Sur Yvette, France; [Feraud, Olivier; Oudrhiri, Noufissa; Bonnet, Marie Laure; Meunier, Marie Claude; Valogne, Yannick; Bertrand, Angelina; Griscelli, Frank; Turhan, Ali G.; Bennaceur-Griscelli, Annelise] Univ Paris 11, Inst Andre Lwoff, Stem Cell Core Facil, ESTeam Paris Sud,Inserm UMR 935, Villejuif, France; [Oudrhiri, Noufissa; Raphael, Martine; Bennaceur-Griscelli, Annelise] CHU Bicetre, AP HP, Hematol Lab, Le Kremlin Bicetre, France; [Bonnet, Marie Laure; Meunier, Marie Claude; Bertrand, Angelina; Turhan, Ali G.] Univ Poitiers, Div Lab Hematol & Oncol, CHU Poitiers, Inserm UMR 935, Poitiers, France; [Griscelli, Frank] Univ Paris 05, Paris, France	SOLEIL Synchrotron; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; UDICE-French Research Universities; Universite Paris Cite	Sandt, C (corresponding author), SOLEIL Synchrotron, Gif Sur Yvette, France.	ali.turhan@univ-poitiers.fr	Sandt, Christophe/ABE-6818-2020; Sandt, Christophe/M-9806-2014; Soleil, SMIS/I-3166-2014	Sandt, Christophe/0000-0002-6432-2004; Sandt, Christophe/0000-0002-6432-2004; bennaceur griscelli, annelise/0000-0002-3557-4499; FERAUD, Olivier/0000-0002-5332-600X; griscelli, frank/0000-0003-0318-2754; TURHAN, Ali/0000-0002-4861-0137	INSERM; University Paris Sud 11; Medicen-Paris Region Ile de France (IngeCELL); CHU de Poitiers; University of Poitiers; Association NRB Vaincre le Cancer; Synchrotron Soleil	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University Paris Sud 11; Medicen-Paris Region Ile de France (IngeCELL)(Region Ile-de-France); CHU de Poitiers; University of Poitiers; Association NRB Vaincre le Cancer; Synchrotron Soleil	This study has been supported by INSERM (http://www.inserm.fr/), University Paris Sud 11 (http://www.u-psud.fr/fr/index.html), Medicen-Paris Region Ile de France (IngeCELL) (http://www.medicen.org/), CHU de Poitiers (http://www.chu-poitiers.fr/), University of Poitiers (http://www.univ-poitiers.fr/), Association NRB Vaincre le Cancer (http://nrb-vaincrelecancer.org/), and Synchrotron Soleil (http://www.synchrotron-soleil.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ami D, 2008, BBA-MOL CELL RES, V1783, P98, DOI 10.1016/j.bbamcr.2007.08.003; Bieberich E, 2011, J LIPIDS, V2011, DOI 10.1155/2011/610306; Boydston-White S, 2006, BBA-BIOMEMBRANES, V1758, P908, DOI 10.1016/j.bbamem.2006.04.018; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Dumas P, 2007, TRENDS BIOTECHNOL, V25, P40, DOI 10.1016/j.tibtech.2006.11.002; German MJ, 2006, INVEST OPHTH VIS SCI, V47, P2417, DOI 10.1167/iovs.05-1254; Giuliani M, 2011, BLOOD, V118, P3254, DOI 10.1182/blood-2010-12-325324; Heraud P, 2010, STEM CELL RES, V4, P140, DOI 10.1016/j.scr.2009.11.002; Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Krafft C, 2007, ANALYST, V132, P647, DOI 10.1039/b700368d; Lee MY, 2010, J LIPID RES, V51, P2082, DOI 10.1194/jlr.M001545; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Mourant JR, 2003, BIOPHYS J, V85, P1938, DOI 10.1016/S0006-3495(03)74621-9; Pacifico A, 2003, VIB SPECTROSC, V32, P107, DOI 10.1016/S0924-2031(03)00051-1; Pijanka JK, 2010, ANALYST, V135, P3126, DOI 10.1039/c0an00525h; Salli U, 2009, STEM CELLS DEV, V18, P55, DOI 10.1089/scd.2007.0271; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Walsh MJ, 2008, STEM CELLS, V26, P108, DOI 10.1634/stemcells.2007-0196; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	23	13	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e30743	10.1371/journal.pone.0030743	http://dx.doi.org/10.1371/journal.pone.0030743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514597	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600002
J	Stolting, M; Wiesner, C; van Vliet, V; Butt, E; Pavenstadt, H; Linder, S; Kremerskothen, J				Stoelting, Miriam; Wiesner, Christiane; van Vliet, Vanessa; Butt, Elke; Pavenstaedt, Hermann; Linder, Stefan; Kremerskothen, Joachim			Lasp-1 Regulates Podosome Function	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; DEPENDENT PROTEIN-KINASE; CAMP SIGNALING PATHWAY; DISCRETE MICRODOMAINS; ACTIN CYTOSKELETON; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; CANCER CELLS; PHOSPHORYLATION; INVADOPODIA	Eukaryotic cells form a variety of adhesive structures to connect with their environment and to regulate cell motility. In contrast to classical focal adhesions, podosomes, highly dynamic structures of different cell types, are actively engaged in matrix remodelling and degradation. Podosomes are composed of an actin-rich core region surrounded by a ring-like structure containing signalling molecules, motor proteins as well as cytoskeleton-associated proteins. Lasp-1 is a ubiquitously expressed, actin-binding protein that is known to regulate cytoskeleton architecture and cell migration. This multidomain protein is predominantely present at focal adhesions, however, a second pool of Lasp-1 molecules is also found at lamellipodia and vesicle-like microdomains in the cytosol. In this report, we show that Lasp-1 is a novel component and regulator of podosomes. Immunofluorescence studies reveal a localization of Lasp-1 in the podosome ring structure, where it colocalizes with zyxin and vinculin. Life cell imaging experiments demonstrate that Lasp-1 is recruited in early steps of podosome assembly. A siRNA-mediated Lasp-1 knockdown in human macrophages affects podosome dynamics as well as their matrix degradation capacity. In summary, our data indicate that Lasp-1 is a novel component of podosomes and is involved in the regulation of podosomal function.	[Stoelting, Miriam; Pavenstaedt, Hermann; Kremerskothen, Joachim] Univ Klinikum Munster, Abt Mol Nephrol, Med Klin D, Munster, Germany; [Wiesner, Christiane; van Vliet, Vanessa; Linder, Stefan] Univ Klinikum Eppendorf, Inst Med Mikrobiol Virol & Hyg, Hamburg, Germany; [Butt, Elke] Univ Wurzburg, Inst Klin Biochem, Wurzburg, Germany	University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg	Stolting, M (corresponding author), Univ Klinikum Munster, Abt Mol Nephrol, Med Klin D, Munster, Germany.	kremers@uni-muenster.de			"Innovative Medizinische Forschung'' (University Clinic Munster) [IMF110904]; Wilhelm Sander Stiftung [2007.20.2]	"Innovative Medizinische Forschung'' (University Clinic Munster); Wilhelm Sander Stiftung	This work was supported by "Innovative Medizinische Forschung'' (University Clinic Munster, IMF110904 to JK) and "Wilhelm Sander Stiftung'' (2007.20.2 to SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buccione R, 2004, NAT REV MOL CELL BIO, V5, P647, DOI 10.1038/nrm1436; Burgstaller G, 2005, AM J PHYSIOL-HEART C, V288, pH3001, DOI 10.1152/ajpheart.01002.2004; Burgstaller G, 2004, J CELL SCI, V117, P223, DOI 10.1242/jcs.00839; Butt E, 2003, J BIOL CHEM, V278, P15601, DOI 10.1074/jbc.M209009200; Chew CS, 2008, AM J PHYSIOL-GASTR L, V295, pG37, DOI 10.1152/ajpgi.90247.2008; Chew CS, 2000, J CELL SCI, V113, P2035; Chew CS, 2002, J CELL SCI, V115, P4787, DOI 10.1242/jcs.00174; Chew CS, 1998, AM J PHYSIOL-CELL PH, V275, pC56, DOI 10.1152/ajpcell.1998.275.1.C56; Endlich N, 2009, KIDNEY INT, V75, P214, DOI 10.1038/ki.2008.486; Fultz ME, 2000, J MUSCLE RES CELL M, V21, P775, DOI 10.1023/A:1010396429297; Gimona M, 2003, MOL BIOL CELL, V14, P2482, DOI 10.1091/mbc.E02-11-0743; Gimona M, 2008, CURR OPIN CELL BIOL, V20, P235, DOI 10.1016/j.ceb.2008.01.005; Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003; Goicoechea SM, 2008, EUR J CELL BIOL, V87, P517, DOI 10.1016/j.ejcb.2008.01.010; Grunewald TGP, 2006, EXP CELL RES, V312, P974, DOI 10.1016/j.yexcr.2005.12.016; Grunewald TGP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-31; Grunewald TGP, 2007, BMC CANCER, V7, P1, DOI 10.1186/1471-2407-7-198; Hai CM, 2002, EXP CELL RES, V280, P64, DOI 10.1006/excr.2002.5592; Kaverina I, 2003, J CELL SCI, V116, P4915, DOI 10.1242/jcs.00818; Keicher C, 2004, BIOCHEM BIOPH RES CO, V324, P308, DOI 10.1016/j.bbrc.2004.08.235; Kocher HM, 2009, GUT, V58, P271, DOI 10.1136/gut.2008.159871; Lee S, 2008, MECH DEVELOP, V125, P768, DOI 10.1016/j.mod.2008.06.012; Li B, 2004, J BIOL CHEM, V279, P20401, DOI 10.1074/jbc.M310304200; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Moreau V, 2003, MOL CELL BIOL, V23, P6809, DOI 10.1128/MCB.23.19.6809-6822.2003; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Osiak AE, 2005, EXP CELL RES, V307, P342, DOI 10.1016/j.yexcr.2005.03.035; Panaviene Z, 2007, CELL TISSUE RES, V327, P353, DOI 10.1007/s00441-006-0305-2; Rachlin AS, 2006, J CELL SCI, V119, P995, DOI 10.1242/jcs.02825; Schreiber VR, 1998, MOL MED, V4, P675, DOI 10.1007/BF03401929; Spinardi L, 2004, EXP CELL RES, V295, P360, DOI 10.1016/j.yexcr.2004.01.007; Stoelting M, 2009, BIOCHEM BIOPH RES CO, V379, P81, DOI 10.1016/j.bbrc.2008.12.008; Webb BA, 2006, ARCH BIOCHEM BIOPHYS, V456, P183, DOI 10.1016/j.abb.2006.06.011; Wiesner C, BLOOD, V116, P1559; Wiesner C, BLOOD; Xiao H, 2009, J CELL PHYSIOL, V218, P366, DOI 10.1002/jcp.21609; Zhou ST, 2006, AM J PHYSIOL-CELL PH, V290, pC463, DOI 10.1152/ajpcell.00350.2005	40	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35340	10.1371/journal.pone.0035340	http://dx.doi.org/10.1371/journal.pone.0035340			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514729	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600134
J	Twumasi-Boateng, K; Shapira, M				Twumasi-Boateng, Kwame; Shapira, Michael			Dissociation of Immune Responses from Pathogen Colonization Supports Pattern Recognition in C. elegans	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR; CAENORHABDITIS-ELEGANS; PSEUDOMONAS-AERUGINOSA; INNATE IMMUNITY	Caenorhabditis elegans has been used for over a decade to characterize signaling cascades controlling innate immune responses. However, what initiates these responses in the worm has remained elusive. To gain a better understanding of the initiating events we delineated genome-wide immune responses to the bacterial pathogen Pseudomonas aeruginosa in worms heavily-colonized by the pathogen versus worms visibly not colonized. We found that infection responses in both groups were identical, suggesting that immune responses were not correlated with colonization and its associated damage. Quantitative RT-PCR measurements further showed that pathogen secreted factors were not able to induce an immune response, but exposure to a non-pathogenic Pseudomonas species was. These findings raise the possibility that the C. elegans immune response is initiated by recognition of microbe-associated molecular patterns. In the absence of orthologs of known pattern recognition receptors, C. elegans may rely on novel mechanisms, thus holding the potential to advance our understanding of evolutionarily conserved strategies for pathogen recognition.	[Twumasi-Boateng, Kwame; Shapira, Michael] Univ Calif Berkeley, Grad Grp Microbiol, Berkeley, CA 94720 USA; [Shapira, Michael] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Twumasi-Boateng, K (corresponding author), Univ Calif Berkeley, Grad Grp Microbiol, Berkeley, CA 94720 USA.	mshapira@berkeley.edu			Ellison Medical Foundation; NSERC Postgraduate Scholarship	Ellison Medical Foundation(Lawrence Ellison Foundation); NSERC Postgraduate Scholarship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Ellison Medical Foundation. KTB was additionally supported by an NSERC Postgraduate Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Branicky R, 2006, TRENDS GENET, V22, P571, DOI 10.1016/j.tig.2006.08.006; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Irazoqui JE, 2010, NAT REV IMMUNOL, V10, P47, DOI 10.1038/nri2689; Kanzok SM, 2004, J MOL EVOL, V58, P442, DOI 10.1007/s00239-003-2565-8; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lau GW, 2005, TRENDS MICROBIOL, V13, P389, DOI 10.1016/j.tim.2005.05.011; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lu R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000286; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; ROSETTO M, 1995, BIOCHEM BIOPH RES CO, V209, P111, DOI 10.1006/bbrc.1995.1477; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Ting JPY, 2008, NAT REV IMMUNOL, V8, P372, DOI 10.1038/nri2296; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194	20	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35400	10.1371/journal.pone.0035400	http://dx.doi.org/10.1371/journal.pone.0035400			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514739	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600144
J	Fachal, L; Rodriguez-Pazos, L; Ginarte, M; Toribio, J; Salas, A; Vega, A				Fachal, Laura; Rodriguez-Pazos, Laura; Ginarte, Manuel; Toribio, Jaime; Salas, Antonio; Vega, Ana			Multiple Local and Recent Founder Effects of TGM1 in Spanish Families	PLOS ONE			English	Article							RECESSIVE CONGENITAL ICHTHYOSIS; HAPLOTYPE RECONSTRUCTION; POPULATION; MUTATION; NUCLEOTIDE; SEQUENCES; AGE	Background: Mutations in the TGM1 gene encoding transglutaminase 1 are a major cause of autosomal recessive congenital ichthyosis. In the Galician (NW Spain) population, three mutations, c.2278C>T, c.1223_1227delACAC and c.984+1G>A, were observed at high frequency, representing similar to 46%, similar to 21% and similar to 13% of all TGM1 gene mutations, respectively. Moreover, these mutations were reported only once outside of Galicia, pointing to the existence of historical episodes of local severe genetic drift in this region. Methodology/Principal Findings: In order to determine whether these mutations were inherited from a common ancestor in the Galician population, and to estimate the number of generations since their initial appearance, we carried out a haplotype-based analysis by way of genotyping 21 SNPs within and flanking the TGM1 gene and 10 flanking polymorphic microsatellite markers spanning a region of 12 Mb. Two linkage disequilibrium based methods were used to estimate the time to the most recent common ancestor (TMRCA), while a Bayesian-based procedure was used to estimate the age of the two mutations. Haplotype reconstruction from unphased genotypes of all members of the affected pedigrees indicated that all carriers for each of the two mutations harbored the same haplotypes, indicating common ancestry. Conclusions/Significance: In good agreement with the documentation record and the census, both mutations arose between 2,800-2,900 years ago (y.a.), but their TMRCA was in the range 600-1,290 y.a., pointing to the existence of historical bottlenecks in the region followed by population growth. This demographic scenario finds further support on a Bayesian Coalescent Analysis based on TGM1 haplotypes that allowed estimating the occurrence of a dramatic reduction of effective population size around 900-4,500 y.a. (95% highest posterior density) followed by exponential growth.	[Fachal, Laura; Vega, Ana] Fdn Publ Galega Med Xen SERGAS, Grp Med Xen USC, CIBERER, IDIS, Santiago De Compostela, Spain; [Rodriguez-Pazos, Laura; Ginarte, Manuel; Toribio, Jaime] Complejo Hosp Univ, SERGAS, Fac Med, Dept Dermatol, Santiago De Compostela, Spain; [Salas, Antonio] Univ Santiago de Compostela, Fac Med, Unidade Xenet, Inst Ciencias Forenses, Galicia, Spain; [Salas, Antonio] Univ Santiago de Compostela, Fac Med, Dept Anat Patolox & Ciencias Forenses, Galicia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; Universidade de Santiago de Compostela	Fachal, L (corresponding author), Fdn Publ Galega Med Xen SERGAS, Grp Med Xen USC, CIBERER, IDIS, Santiago De Compostela, Spain.	ana.vega@usc.es	Fachal, Laura/N-5560-2014; Vega, Ana/R-4758-2019; Salas, Antonio/U-2029-2019; Salas, Antonio/E-3977-2012	Fachal, Laura/0000-0002-7256-9752; Salas, Antonio/0000-0002-2336-702X; Salas, Antonio/0000-0002-2336-702X	Isabel Barreto program from Xunta de Galicia; Fondo Social Europeo; project of the Xunta de Galicia [10PXIB 9101297PR]; project of the Instituto de Salud Carlos III [FIS PI10/00164]; project of the Fondo Europeo de Desarrollo Regional [FEDER 2007-2013]; Fundacion Mutua Madrilena; Ministerio de Ciencia e Innovacion [SAF2011-26983]	Isabel Barreto program from Xunta de Galicia; Fondo Social Europeo(European Social Fund (ESF)European Commission); project of the Xunta de Galicia; project of the Instituto de Salud Carlos III; project of the Fondo Europeo de Desarrollo Regional; Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	LF is supported by the Isabel Barreto program from Xunta de Galicia and Fondo Social Europeo. This project was partially supported by projects of the Xunta de Galicia (10PXIB 9101297PR), the Instituto de Salud Carlos III (FIS PI10/00164) and Fondo Europeo de Desarrollo Regional (FEDER 2007-2013) and Fundacion Mutua Madrilena given to AV, SAF2011-26983 and SAF2011-26983 from the Ministerio de Ciencia e Innovacion given to AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Alvarez-Iglesias V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005112; BALE SJ, 1994, J INVEST DERMATOL, V102, pS49, DOI 10.1111/1523-1747.ep12388591; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bergman A, 2001, EUR J HUM GENET, V9, P787, DOI 10.1038/sj.ejhg.5200704; Dodge DR, QUATERNARY INT; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Fernandez Canosa XA, 1996, NOVA HIST GALICIA; Fischer J, 2009, J INVEST DERMATOL, V129, P1319, DOI 10.1038/jid.2009.57; Garcia Alvarez MR, 1975, GALICIA GALLEGOS ALT; Gomez-Carballa A, 2012, PLOS ONE IN PRESS; Herman ML, 2009, HUM MUTAT, V30, P537, DOI 10.1002/humu.20952; Ho SYW, 2011, MOL ECOL RESOUR, V11, P423, DOI 10.1111/j.1755-0998.2011.02988.x; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Labuda D, 1997, AM J HUM GENET, V61, P768, DOI 10.1016/S0002-9297(07)64341-9; Loidi L, 2006, CLIN ENDOCRINOL, V64, P330, DOI 10.1111/j.1365-2265.2006.02465.x; Nachman MW, 2000, GENETICS, V156, P297; Oji V, 2010, J AM ACAD DERMATOL, V63, P607, DOI 10.1016/j.jaad.2009.11.020; Pigg M, 1998, EUR J HUM GENET, V6, P589, DOI 10.1038/sj.ejhg.5200224; Reeve JP, 2002, BIOINFORMATICS, V18, P894, DOI 10.1093/bioinformatics/18.6.894; RISCH N, 1995, NAT GENET, V9, P152, DOI 10.1038/ng0295-152; Rodriguez-Pazos L, 2011, BRIT J DERMATOL, V165, P906, DOI 10.1111/j.1365-2133.2011.10454.x; Salas A, 2017, EUR J HUM GENET, V25, pS33, DOI 10.1038/sj.ejhg.5200202; Shevchenko YO, 2000, HUM GENET, V106, P492, DOI 10.1007/s004390000284; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tremblay M, 2000, AM J HUM GENET, V66, P651, DOI 10.1086/302770; Vega A, 2001, Hum Mutat, V17, P520, DOI 10.1002/humu.1136	29	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e33580	10.1371/journal.pone.0033580	http://dx.doi.org/10.1371/journal.pone.0033580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511925	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338600011
J	Rehan, SM; Leys, R; Schwarz, MP				Rehan, Sandra M.; Leys, Remko; Schwarz, Michael P.			A Mid-Cretaceous Origin of Sociality in Xylocopine Bees with Only Two Origins of True Worker Castes Indicates Severe Barriers to Eusociality	PLOS ONE			English	Article							EXONEURINE ALLODAPINE BEES; LARGE CARPENTER BEES; PHYLOGENETIC ANALYSIS; HYMENOPTERA APIDAE; MANUELIA-POSTICA; NESTING BIOLOGY; SOLITARY BEE; LIFE-CYCLE; EVOLUTION; CERATINA	The origin of sterile worker castes, resulting in eusociality, represents one of the major evolutionary transitions in the history of life. Understanding how eusociality has evolved is therefore an important issue for understanding life on earth. Here we show that in the large bee subfamily Xylocopinae, a simple form of sociality was present in the ancestral lineage and there have been at least four reversions to purely solitary nesting. The ancestral form of sociality did not involve morphological worker castes and maximum colony sizes were very small. True worker castes, entailing a life-time commitment to nonreproductive roles, have evolved only twice, and only one of these resulted in discrete queen-worker morphologies. Our results indicate extremely high barriers to the evolution of eusociality. Its origins are likely to have required very unusual life-history and ecological circumstances, rather than the amount of time that selection can operate on more simple forms of sociality.	[Rehan, Sandra M.; Leys, Remko; Schwarz, Michael P.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA, Australia; [Rehan, Sandra M.] Brock Univ, Dept Biol Sci, St Catharines, ON L2S 3A1, Canada; [Leys, Remko] S Australia Museum, Evolutionary Biol Unit, Adelaide, SA, Australia	Flinders University South Australia; Brock University	Rehan, SM (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	sandra.rehan@gmail.com		Leijs, Remko/0000-0001-6909-5659	Australian Research Council Discovery grants; NSERC award (Natural Sciences and Engineering Research Council); Endeavour Fellowship	Australian Research Council Discovery grants(Australian Research Council); NSERC award (Natural Sciences and Engineering Research Council); Endeavour Fellowship	This study was supported by Australian Research Council Discovery grants to M. Schwarz and S. Cooper and by an NSERC award (Natural Sciences and Engineering Research Council) and an Endeavour Fellowship to S. Rehan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1971, INSECT SOC; BATRA SUZANNE W. T., 1966, UNIV KANS SCI BULL, V46, P359; Brady SG, 2006, P ROY SOC B-BIOL SCI, V273, P1643, DOI 10.1098/rspb.2006.3496; Cardinal S, 2011, PNAS, V107, P16207; Cardinal S, 2007, CLADISTICS, V23, P99, DOI 10.1111/j.1096-0031.2006.00137.x; Cardinal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021086; Chenoweth LB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-246; Chenoweth LB, 2011, J BIOGEOGR, V38, P1471, DOI 10.1111/j.1365-2699.2011.02488.x; Crespi Bernard J., 1996, P253; CRESPI BJ, 1994, INSECT SOC, V41, P395, DOI 10.1007/BF01240642; DALY HV, 1987, PAN-PAC ENTOMOL, V63, P102; Danforth BN, 2002, P NATL ACAD SCI USA, V99, P286, DOI 10.1073/pnas.012387999; Dew RM, 2012, INSECT SOC, V59, P207, DOI 10.1007/s00040-011-0206-6; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Engel MS, 2001, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2001)259<0001:AMOTBA>2.0.CO;2; Flores-Prado L, 2008, NEW ZEAL J ZOOL, V35, P93, DOI 10.1080/03014220809510106; Flores-Prado L, 2008, P ROY SOC B-BIOL SCI, V275, P285, DOI 10.1098/rspb.2007.1151; Flores-Prado L, 2010, MOL PHYLOGENET EVOL, V57, P237, DOI 10.1016/j.ympev.2010.06.019; Gerling D, 1983, CONTRIB ZOOL, P369; HOGENDOORN K, 1995, INSECT SOC, V42, P427, DOI 10.1007/BF01242171; HOGENDOORN K, 1993, BEHAV ECOL SOCIOBIOL, V32, P247, DOI 10.1007/BF00166514; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HURST PS, 2001, THESIS FLINDERS U AD; Kawakita A, 2008, APIDOLOGIE, V39, P163, DOI 10.1051/apido:2007046; Leys R, 2002, BIOL J LINN SOC, V77, P249, DOI 10.1046/j.1095-8312.2002.00108.x; Maeta Y, 2010, CHUKOGU KONTYU, V24, P49; Maeta Y, 2009, CHUKOGU KONTYU, V23, P23; Maeta Y., 2010, CHUKOGU KONTYU, V24, P23; Michener C.D., 1990, P123; Michener C.D., 2007, BEES WORLD, Vsecond; MICHENER CD, 1985, FORTS ZOOL, V31, P293; MICHENER CD, 1974, SOCIAL BEHAV BEES; Michener CD., 1975, B AM MUS NAT HIST, V155, P67; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Rehan SM, 2010, INSECT SOC, V57, P403, DOI 10.1007/s00040-010-0097-y; Rehan SM, 2011, BIOL J LINN SOC, V103, P57, DOI 10.1111/j.1095-8312.2011.01642.x; Rehan SM, 2010, MOL PHYLOGENET EVOL, V55, P1042, DOI 10.1016/j.ympev.2010.01.011; Rehan SM, 2010, CAN ENTOMOL, V142, P65, DOI 10.4039/n09-056; Rehan SM, 2009, J KANSAS ENTOMOL SOC, V82, P194, DOI 10.2317/JKES809.22.1; Rehan SM, 2011, THESIS BROCK U ST CA; Roig-Alsina Arturo, 1993, University of Kansas Science Bulletin, V55, P124; SAKAGAMI S F, 1989, Japanese Journal of Entomology, V57, P417; SAKAGAMI SF, 1977, INSECT SOC, V24, P319, DOI 10.1007/BF02223784; SAKAGAMI SF, 1987, ANN ENTOMOL SOC AM, V80, P439, DOI 10.1093/aesa/80.3.439; SAKAGAMI SF, 1984, J KANSAS ENTOMOL SOC, V57, P639; Sakagami Shoichi F., 1995, Japanese Journal of Entomology, V63, P115; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Schwarz MP, 2007, ANNU REV ENTOMOL, V52, P127, DOI 10.1146/annurev.ento.51.110104.150950; Schwarz MP, 2011, BIOL LETTERS, V7, P277, DOI 10.1098/rsbl.2010.0757; Schwarz MP, 2006, SYST BIOL, V55, P31, DOI 10.1080/10635150500431148; Schwarz MP, 2005, ANN ENTOMOL SOC AM, V98, P126, DOI 10.1603/0013-8746(2005)098[0126:BPACCO]2.0.CO;2; Smith JA, 2006, BEHAV ECOL SOCIOBIOL, V60, P108, DOI 10.1007/s00265-005-0147-z; STARK RE, 1992, ETHOLOGY, V91, P301, DOI 10.1111/j.1439-0310.1992.tb00871.x; Steen Z, 2000, AUST J ENTOMOL, V39, P291, DOI 10.1046/j.1440-6055.2000.00195.x; Steen Z, 1998, T ROY SOC SOUTH AUST, V122, P55; STEEN Z, 2000, THESIS FLINDERS U AD; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; VELTHUIS HHW, 1983, BEHAV ECOL SOCIOBIOL, V12, P209, DOI 10.1007/BF00290773; Vicidomini S, 1996, ITAL J ZOOL, V63, P237, DOI 10.1080/11250009609356139; WATMOUGH RH, 1983, J ANIM ECOL, V52, P111, DOI 10.2307/4591; Wilson EO, 2008, BIOSCIENCE, V58, P17, DOI 10.1641/B580106	64	60	60	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34690	10.1371/journal.pone.0034690	http://dx.doi.org/10.1371/journal.pone.0034690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511959	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338600045
J	Kan-o, M; Takeya, R; Taniguchi, K; Tanoue, Y; Tominaga, R; Sumimoto, H				Kan-o, Meikun; Takeya, Ryu; Taniguchi, Kenichiro; Tanoue, Yoshihisa; Tominaga, Ryuji; Sumimoto, Hideki			Expression and Subcellular Localization of Mammalian Formin Fhod3 in the Embryonic and Adult Heart	PLOS ONE			English	Article							STRIATED-MUSCLE; FILAMENT; NUCLEATOR; PROTEIN; NEBULIN; CELLS	The formin family proteins play pivotal roles in actin filament assembly via the FH2 domain. The mammalian formin Fhod3 is highly expressed in the heart, and its mRNA in the adult heart contains exons 11, 12, and 25, which are absent from nonmuscle Fhod3 isoforms. In cultured neonatal cardiomyocytes, Fhod3 localizes to the middle of the sarcomere and appears to function in its organization, although it is suggested that Fhod3 localizes differently in the adult heart. Here we show, using immunohistochemical analysis with three different antibodies, each recognizing distinct regions of Fhod3, that Fhod3 localizes as two closely spaced bands in middle of the sarcomere in both embryonic and adult hearts. The bands are adjacent to the M-line that crosslinks thick myosin filaments at the center of a sarcomere but distant from the Z-line that forms the boundary of the sarcomere, which localization is the same as that observed in cultured cardiomyocytes. Detailed immunohistochemical and immuno-electron microscopic analyses reveal that Fhod3 localizes not at the pointed ends of thin actin filaments but to a more peripheral zone, where thin filaments overlap with thick myosin filaments. We also demonstrate that the embryonic heart of mice specifically expresses the Fhod3 mRNA isoform harboring the three alternative exons, and that the characteristic localization of Fhod3 in the sarcomere does not require a region encoded by exon 25, in contrast to an essential role of exons 11 and 12. Furthermore, the exon 25-encoded region appears to be dispensable for actin-organizing activities both in vivo and in vitro, albeit it is inserted in the catalytic FH2 domain.	[Kan-o, Meikun; Takeya, Ryu; Taniguchi, Kenichiro; Sumimoto, Hideki] Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Fukuoka 812, Japan; [Tanoue, Yoshihisa; Tominaga, Ryuji] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Surg, Fukuoka 812, Japan	Kyushu University; Kyushu University	Kan-o, M (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Biochem, Fukuoka 812, Japan.	takeya@med.kyushu-u.ac.jp; hsumi@med.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Nakatomi Foundation; Grants-in-Aid for Scientific Research [23590337] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nakatomi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research and Targeted Proteins Research Program (TPRP) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and by the Nakatomi Foundation. The funders had not role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Bai J, 2007, DEV CELL, V13, P828, DOI 10.1016/j.devcel.2007.10.003; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chereau D, 2008, SCIENCE, V320, P239, DOI 10.1126/science.1155313; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840; GOSHIMA K, 1973, EXP CELL RES, V80, P432, DOI 10.1016/0014-4827(73)90316-9; GULICK J, 1991, J BIOL CHEM, V266, P9180; Iskratsch T, 2010, J CELL BIOL, V191, P1159, DOI 10.1083/jcb.201005060; Kanaya H, 2005, GENES CELLS, V10, P665, DOI 10.1111/j.1365-2443.2005.00867.x; Kulandavelu S, 2006, ILAR J, V47, P103, DOI 10.1093/ilar.47.2.103; Littlefield RS, 2008, SEMIN CELL DEV BIOL, V19, P511, DOI 10.1016/j.semcdb.2008.08.009; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Ono S, 2010, CYTOSKELETON, V67, P677, DOI 10.1002/cm.20476; Sanger JW, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/858606; SANGER JW, 1984, CELL MOTIL CYTOSKEL, V4, P405, DOI 10.1002/cm.970040602; Sparrow JC, 2009, NAT REV MOL CELL BIO, V10, P293, DOI 10.1038/nrm2634; Takano K, 2010, SCIENCE, V330, P1536, DOI 10.1126/science.1197767; Taniguchi K, 2009, J BIOL CHEM, V284, P29873, DOI 10.1074/jbc.M109.059303; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x	19	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34765	10.1371/journal.pone.0034765	http://dx.doi.org/10.1371/journal.pone.0034765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509354	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000305336600057
J	Khazen, G; Hill, SL; Schurmann, F; Markram, H				Khazen, Georges; Hill, Sean L.; Schuermann, Felix; Markram, Henry			Combinatorial Expression Rules of Ion Channel Genes in Juvenile Rat (Rattus norvegicus) Neocortical Neurons	PLOS ONE			English	Article							PYRAMIDAL NEURONS; GABAERGIC INTERNEURONS; ALPHA(1A) SUBUNIT; CORTEX; CONSTRUCTION; SYSTEM; CELLS	The electrical diversity of neurons arises from the expression of different combinations of ion channels. The gene expression rules governing these combinations are not known. We examined the expression of twenty-six ion channel genes in a broad range of single neocortical neuron cell types. Using expression data from a subset of twenty-six ion channel genes in ten different neocortical neuronal types, classified according to their electrophysiological properties, morphologies and anatomical positions, we first developed an incremental Support Vector Machine (iSVM) model that prioritizes the predictive value of single and combinations of genes for the rest of the expression pattern. With this approach we could predict the expression patterns for the ten neuronal types with an average 10-fold cross validation accuracy of 87% and for a further fourteen neuronal types not used in building the model, with an average accuracy of 75%. The expression of the genes for HCN4, Kv2.2, Kv3.2 and Ca beta 3 were found to be particularly strong predictors of ion channel gene combinations, while expression of the Kv1.4 and Kv3.3 genes has no predictive value. Using a logic gate analysis, we then extracted a spectrum of observed combinatorial gene expression rules of twenty ion channels in different neocortical neurons. We also show that when applied to a completely random and independent data, the model could not extract any rules and that it is only possible to extract them if the data has consistent expression patterns. This novel strategy can be used for predictive reverse engineering combinatorial expression rules from single-cell data and could help identify candidate transcription regulatory processes.	[Khazen, Georges; Hill, Sean L.; Schuermann, Felix; Markram, Henry] Ecole Polytech Fed Lausanne, Brain Mind Inst, Blue Brain Project, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Khazen, G (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Blue Brain Project, Lausanne, Switzerland.	henry.markram@epfl.ch	Khazen, Georges/AAC-2923-2020	Hill, Sean/0000-0001-8055-860X; Khazen, Geroges/0000-0002-9244-2978				Alpaydin E, 2004, INTRO MACHINE LEARNI; [Anonymous], 2010, R LANG ENV STAT COMP; Arkin A, 1997, SCIENCE, V277, P1275, DOI 10.1126/science.277.5330.1275; ARKIN A, 1995, J PHYS CHEM-US, V99, P970, DOI 10.1021/j100003a020; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Chang C.-C., LIBSVM LIB SUPPORT V; Franz O, 2000, EUR J NEUROSCI, V12, P2685, DOI 10.1046/j.1460-9568.2000.00151.x; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Inda MC, 2006, P NATL ACAD SCI USA, V103, P2920, DOI 10.1073/pnas.0511197103; Kole MHP, 2006, J NEUROSCI, V26, P1677, DOI 10.1523/JNEUROSCI.3664-05.2006; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Lai HC, 2006, NAT REV NEUROSCI, V7, P548, DOI 10.1038/nrn1938; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Magee JC, 1999, J NEUROPHYSIOL, V82, P1895, DOI 10.1152/jn.1999.82.4.1895; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; McCullagh P, 1989, GEN LINEAR MODELS; Patrick M, 1993, IEEE T VERY LARGE SC, P432; Rossner MJ, 2006, J NEUROSCI, V26, P9956, DOI 10.1523/JNEUROSCI.0468-06.2006; Science AIfB, 2011, ALL DEV MOUS BRAIN A; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Subkhankulova T, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00010; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Toledo-Rodriguez M, 2004, CEREB CORTEX, V14, P1310, DOI 10.1093/cercor/bhh092; Trimmer JS, 2004, ANNU REV PHYSIOL, V66, P477, DOI 10.1146/annurev.physiol.66.032102.113328; Walker D, 1999, J BIOL CHEM, V274, P12383, DOI 10.1074/jbc.274.18.12383; Walker D, 1998, J BIOL CHEM, V273, P2361, DOI 10.1074/jbc.273.4.2361; Wang Y, 2002, CEREB CORTEX, V12, P395, DOI 10.1093/cercor/12.4.395	30	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34786	10.1371/journal.pone.0034786	http://dx.doi.org/10.1371/journal.pone.0034786			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509357	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600058
J	Taheri, A; Robinson, SJ; Parkin, I; Gruber, MY				Taheri, Ali; Robinson, Stephen J.; Parkin, Isobel; Gruber, Margaret Y.			Revised Selection Criteria for Candidate Restriction Enzymes in Genome Walking	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; T-DNA; ARABIDOPSIS-THALIANA; PCR; SPECIFICITY; LIGATION; AMPLIFICATION; TOUCHDOWN; GENETICS; GENES	A new method to improve the efficiency of flanking sequence identification by genome walking was developed based on an expanded, sequential list of criteria for selecting candidate enzymes, plus several other optimization steps. These criteria include: step (1) initially choosing the most appropriate restriction enzyme according to the average fragment size produced by each enzyme determined using in silico digestion of genomic DNA, step (2) evaluating the in silico frequency of fragment size distribution between individual chromosomes, step (3) selecting those enzymes that generate fragments with the majority between 100 bp and 3,000 bp, step (4) weighing the advantages and disadvantages of blunt-end sites vs. cohesive-end sites, step (5) elimination of methylation sensitive enzymes with methylation-insensitive isoschizomers, and step (6) elimination of enzymes with recognition sites within the binary vector sequence (T-DNA and plasmid backbone). Step (7) includes the selection of a second restriction enzyme with highest number of recognition sites within regions not covered by the first restriction enzyme. Step (8) considers primer and adapter sequence optimization, selecting the best adapter-primer pairs according to their hairpin/dimers and secondary structure. In step (9), the efficiency of genomic library development was improved by column-filtration of digested DNA to remove restriction enzyme and phosphatase enzyme, and most important, to remove small genomic fragments (<100 bp) lacking the T-DNA insertion, hence improving the chance of ligation between adapters and fragments harbouring a T-DNA. Two enzymes, NsiI and NdeI, fit these criteria for the Arabidopsis thaliana genome. Their efficiency was assessed using 54 T-3 lines from an Arabidopsis SK enhancer population. Over 70% success rate was achieved in amplifying the flanking sequences of these lines. This strategy was also tested with Brachypodium distachyon to demonstrate its applicability to other larger genomes.	[Taheri, Ali; Robinson, Stephen J.; Parkin, Isobel; Gruber, Margaret Y.] Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada	Agriculture & Agri Food Canada	Taheri, A (corresponding author), Agr & Agri Food Canada, Saskatoon Res Ctr, Saskatoon, SK, Canada.	Ali.Taheri@agr.gc.ca; Margie.Gruber@agr.gc.ca	Parkin, Isobel/AAD-6625-2020	Taheri, Ali/0000-0002-4019-7982; Parkin, Isobel/0000-0002-5807-9466	Agriculture and Agri-Food Canada, Canadian Crop Genomics Initiative	Agriculture and Agri-Food Canada, Canadian Crop Genomics Initiative(Agriculture & Agri Food Canada)	This work was supported by funding from the Agriculture and Agri-Food Canada, Canadian Crop Genomics Initiative grants to Margaret Y. Gruber and Isobel A.P. Parkin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JH, 2010, ANAL BIOCHEM, V398, P112, DOI 10.1016/j.ab.2009.11.003; Brown TA, 2010, GENE CLONING DNA ANA, Vxvi; Cronan JE, 1996, MICROBIAL GENETICS; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Dolye JJ, 1990, FOCUS, V12, P13; Hecker KH, 1996, BIOTECHNIQUES, V20, P478; Huang SC, 2007, RUSS J PLANT PHYSL+, V54, P822, DOI 10.1134/S1021443707060155; Ji JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010577; Jung KH, 2008, NAT REV GENET, V9, P91, DOI 10.1038/nrg2286; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Korbie DJ, 2008, NAT PROTOC, V3, P1452, DOI 10.1038/nprot.2008.133; Krysan Patrick J., 2002, OMICS A Journal of Integrative Biology, V6, P163, DOI 10.1089/153623102760092760; Leung J, 1998, METH MOL B, V82, P277; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; MARTINEAU B, 1994, PLANT CELL, V6, P1032, DOI 10.1105/tpc.6.8.1032; OCHMAN H, 1988, GENETICS, V120, P621; OKANE CJ, 1987, P NATL ACAD SCI USA, V84, P9123, DOI 10.1073/pnas.84.24.9123; Padegimas LS, 1998, ANAL BIOCHEM, V260, P149, DOI 10.1006/abio.1998.2719; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson SJ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-101; Sallaud C, 2004, PLANT J, V39, P450, DOI 10.1111/j.1365-313X.2004.02145.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sathees CR, 1999, MUTAT RES-DNA REPAIR, V433, P1, DOI 10.1016/S0921-8777(98)00055-X; SGARAMELLA V, 1978, EUR J BIOCHEM, V86, P531, DOI 10.1111/j.1432-1033.1978.tb12336.x; SHYAMALA V, 1989, GENE, V84, P1, DOI 10.1016/0378-1119(89)90132-7; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; Spertini D, 1999, BIOTECHNIQUES, V27, P308, DOI 10.2144/99272st01; Sterky F, 1998, J BIOTECHNOL, V60, P119, DOI 10.1016/S0168-1656(97)00196-X; Tarasova GV, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-7; Thole V, 2009, NAT PROTOC, V4, P650, DOI 10.1038/nprot.2009.32; Tsuchiya T, 2009, ANAL BIOCHEM, V388, P158, DOI 10.1016/j.ab.2009.02.002; Ukai H, 2002, J BIOTECHNOL, V97, P233, DOI 10.1016/S0168-1656(02)00107-4; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; ZABAROVSKY ER, 1986, GENE, V42, P119, DOI 10.1016/0378-1119(86)90158-7	34	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35117	10.1371/journal.pone.0035117	http://dx.doi.org/10.1371/journal.pone.0035117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509391	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600085
J	Asada, M; Goto, Y; Yahata, K; Yokoyama, N; Kawai, S; Inoue, N; Kaneko, O; Kawazu, S				Asada, Masahito; Goto, Yasuyuki; Yahata, Kazuhide; Yokoyama, Naoaki; Kawai, Satoru; Inoue, Noboru; Kaneko, Osamu; Kawazu, Shin-ichiro			Gliding Motility of Babesia bovis Merozoites Visualized by Time-Lapse Video Microscopy	PLOS ONE			English	Article							RED-BLOOD-CELL; MALARIA PARASITES; PLASMODIUM SPOROZOITES; INVASION; PROTEIN; MECHANISM; PROTOZOA; ACTIN	Background: Babesia bovis is an apicomplexan intraerythrocytic protozoan parasite that induces babesiosis in cattle after transmission by ticks. During specific stages of the apicomplexan parasite lifecycle, such as the sporozoites of Plasmodium falciparum and tachyzoites of Toxoplasma gondii, host cells are targeted for invasion using a unique, active process termed "gliding motility''. However, it is not thoroughly understood how the merozoites of B. bovis target and invade host red blood cells (RBCs), and gliding motility has so far not been observed in the parasite. Methodology/Principal Findings: Gliding motility of B. bovis merozoites was revealed by time-lapse video microscopy. The recorded images revealed that the process included egress of the merozoites from the infected RBC, gliding motility, and subsequent invasion into new RBCs. The gliding motility of B. bovis merozoites was similar to the helical gliding of Toxoplasma tachyzoites. The trails left by the merozoites were detected by indirect immunofluorescence assay using antiserum against B. bovis merozoite surface antigen 1. Inhibition of gliding motility by actin filament polymerization or depolymerization indicated that the gliding motility was driven by actomyosin dependent process. In addition, we revealed the timing of breakdown of the parasitophorous vacuole. Time-lapse image analysis of membrane-stained bovine RBCs showed formation and breakdown of the parasitophorous vacuole within ten minutes of invasion. Conclusions/Significance: This is the first report of the gliding motility of B. bovis. Since merozoites of Plasmodium parasites do not glide on a substrate, the gliding motility of B. bovis merozoites is a notable finding.	[Asada, Masahito; Goto, Yasuyuki; Yokoyama, Naoaki; Inoue, Noboru; Kawazu, Shin-ichiro] Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan; [Goto, Yasuyuki] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Mol Immunol, Bunkyo Ku, Tokyo, Japan; [Yahata, Kazuhide; Kaneko, Osamu] Nagasaki Univ, Dept Protozool, Inst Trop Med NEKKEN, Nagasaki 852, Japan; [Yahata, Kazuhide; Kaneko, Osamu] Nagasaki Univ, Ctr Excellence Program, Nagasaki 852, Japan; [Kawai, Satoru] Dokkyo Univ, Sch Med, Lab Trop Med & Parasitol, Shimotsuga, Tochigi, Japan	Obihiro University of Agriculture & Veterinary Medicine; University of Tokyo; Nagasaki University; Nagasaki University; Dokkyo Medical University	Asada, M (corresponding author), Obihiro Univ Agr & Vet Med, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 080, Japan.	skawazu@obihiro.ac.jp	Goto, Yasuyuki/E-9028-2011	Goto, Yasuyuki/0000-0002-8654-7888; Asada, Masahito/0000-0003-0042-6856	NEKKEN [22-21, 23-8]	NEKKEN	This work was supported by a Cooperative Research Grant of NEKKEN, 2010 (Grant No. 22-21) and 2011 (Grant No. 23-8), to S-i.K. Homepage of NEKKEN: http://www.tm.nagasaki-u.ac.jp/nekken/english/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altangerel K, 2012, VET PARASITOL, V184, P309, DOI 10.1016/j.vetpar.2011.09.021; Amino R, 2005, CURR OPIN MICROBIOL, V8, P407, DOI 10.1016/j.mib.2005.06.019; Asada M, 2012, MOL BIOCHEM PARASIT, V181, P162, DOI 10.1016/j.molbiopara.2011.11.001; Bork S, 2005, PARASITOLOGY, V130, P489, DOI 10.1017/S0031182004006821; Chauvin A, 2009, VET RES, V40, DOI 10.1051/vetres/2009020; de Souza W, 2007, PARASITOL INT, V56, P161, DOI 10.1016/j.parint.2007.02.001; Doran DJ, 1962, J PARASITOL S, V48; Frischknecht F, 2004, CELL MICROBIOL, V6, P687, DOI 10.1111/j.1462-5822.2004.00395.x; Gilson PR, 2009, CELL HOST MICROBE, V6, P499, DOI 10.1016/j.chom.2009.11.011; Gohil S, 2010, TRENDS PARASITOL, V26, P591, DOI 10.1016/j.pt.2010.06.012; GRATZER WB, 1993, SEMIN HEMATOL, V30, P232; Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; KING CA, 1988, PARASITOL TODAY, V4, P315, DOI 10.1016/0169-4758(88)90113-5; LANGRETH SG, 1978, J PROTOZOOL, V25, P443, DOI 10.1111/j.1550-7408.1978.tb04167.x; MORZARIA SP, 1978, Z PARASITENKD, V55, P119, DOI 10.1007/BF00384827; Munter S, 2009, CELL HOST MICROBE, V6, P551, DOI 10.1016/j.chom.2009.11.007; Pinder JC, 2000, PARASITOL TODAY, V16, P240, DOI 10.1016/S0169-4758(00)01664-1; RUSSELL DG, 1981, J CELL SCI, V50, P345; Sibley LD, 1998, CURR BIOL, V8, pR12, DOI 10.1016/S0960-9822(98)70008-9; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Siden-Kiamos I, 2006, MOL BIOCHEM PARASIT, V150, P308, DOI 10.1016/j.molbiopara.2006.09.003; STEWART MJ, 1988, J PROTOZOOL, V35, P389, DOI 10.1111/j.1550-7408.1988.tb04115.x; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; VANDERBERG JP, 1974, J PROTOZOOL, V21, P527, DOI 10.1111/j.1550-7408.1974.tb03693.x; Wetzel DM, 2005, INFECT IMMUN, V73, P5379, DOI 10.1128/IAI.73.9.5379-5387.2005; Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Zhou JL, 2006, MOL BIOCHEM PARASIT, V148, P190, DOI 10.1016/j.molbiopara.2006.03.015	29	42	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35227	10.1371/journal.pone.0035227	http://dx.doi.org/10.1371/journal.pone.0035227			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506073	gold, Green Published, Green Submitted			2022-12-27	WOS:000305297500081
J	Auferkorte, ON; Baden, T; Kaushalya, SK; Zabouri, N; Rudolph, U; Haverkamp, S; Euler, T				Auferkorte, Olivia Nicola; Baden, Tom; Kaushalya, Sanjeev Kumar; Zabouri, Nawal; Rudolph, Uwe; Haverkamp, Silke; Euler, Thomas			GABA(A) Receptors Containing the alpha 2 Subunit Are Critical for Direction-Selective Inhibition in the Retina	PLOS ONE			English	Article							STARBURST AMACRINE CELLS; GANGLION-CELLS; RABBIT RETINA; GLUTAMATE RECEPTORS; IMAGE MOTION; MOUSE RETINA; MECHANISMS; IDENTIFICATION; DIVERSITY; SYNAPSES	Far from being a simple sensor, the retina actively participates in processing visual signals. One of the best understood aspects of this processing is the detection of motion direction. Direction-selective (DS) retinal circuits include several subtypes of ganglion cells (GCs) and inhibitory interneurons, such as starburst amacrine cells (SACs). Recent studies demonstrated a surprising complexity in the arrangement of synapses in the DS circuit, i.e. between SACs and DS ganglion cells. Thus, to fully understand retinal DS mechanisms, detailed knowledge of all synaptic elements involved, particularly the nature and localization of neurotransmitter receptors, is needed. Since inhibition from SACs onto DSGCs is crucial for generating retinal direction selectivity, we investigate here the nature of the GABA receptors mediating this interaction. We found that in the inner plexiform layer (IPL) of mouse and rabbit retina, GABA(A) receptor subunit alpha 2 (GABA(A)R alpha 2) aggregated in synaptic clusters along two bands overlapping the dendritic plexuses of both ON and OFF SACs. On distal dendrites of individually labeled SACs in rabbit, GABA(A)R alpha 2 was aligned with the majority of varicosities, the cell's output structures, and found postsynaptically on DSGC dendrites, both in the ON and OFF portion of the IPL. In GABA(A)R alpha 2 knock-out (KO) mice, light responses of retinal GCs recorded with two-photon calcium imaging revealed a significant impairment of DS responses compared to their wild-type littermates. We observed a dramatic drop in the proportion of cells exhibiting DS phenotype in both the ON and ON-OFF populations, which strongly supports our anatomical findings that alpha 2-containing GABA(A)Rs are critical for mediating retinal DS inhibition. Our study reveals for the first time, to the best of our knowledge, the precise functional localization of a specific receptor subunit in the retinal DS circuit.	[Auferkorte, Olivia Nicola; Zabouri, Nawal; Haverkamp, Silke] Max Planck Inst Brain Res, D-60496 Frankfurt, Germany; [Baden, Tom; Euler, Thomas] Univ Tubingen, BCCN, Tubingen, Germany; [Baden, Tom; Euler, Thomas] Univ Tubingen, Werner Reichardt Ctr Integrat Neurosci CIN, Tubingen, Germany; [Kaushalya, Sanjeev Kumar] Max Planck Inst Med Res, Dept Biomed Opt, Heidelberg, Germany; [Rudolph, Uwe] McLean Hosp, Lab Genet Neuropharmacol, Belmont, MA 02178 USA; [Rudolph, Uwe] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Euler, Thomas] Univ Tubingen Hosp, Inst Ophthalm Res, Tubingen, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Max Planck Society; Harvard University; McLean Hospital; Harvard University; Harvard Medical School; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Auferkorte, ON (corresponding author), Max Planck Inst Brain Res, D-60496 Frankfurt, Germany.	Olivia.Auferkorte@brain.mpg.de		Baden, Tom/0000-0003-2808-4210; Euler, Thomas/0000-0002-4567-6966; Kaushalya, sanjeev/0000-0002-3469-2637	Deutsche Forschungsgemeinschaft (DFG) [HA 5277/3-1, EXC307]; Max Planck Society; German Federal Ministry of Education and Research (BMBF) [FKZ: 01GQ1002]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was funded by Deutsche Forschungsgemeinschaft (DFG) (HA 5277/3-1, EXC307) and the Max Planck Society. This study is part of the research program of the Bernstein Center for Computational Neuroscience, Tubingen, funded by the German Federal Ministry of Education and Research (BMBF; FKZ: 01GQ1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amthor FR, 2002, VISUAL NEUROSCI, V19, P495, DOI 10.1017/S0952523802194119; AMTHOR FR, 1989, J COMP NEUROL, V280, P97, DOI 10.1002/cne.902800108; AMTHOR FR, 1984, BRAIN RES, V298, P187, DOI 10.1016/0006-8993(84)91167-3; Badea TC, 2004, J COMP NEUROL, V480, P331, DOI 10.1002/cne.20304; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; Borg-Graham LJ, 2001, NAT NEUROSCI, V4, P176, DOI 10.1038/84007; Borst A, 2011, NEURON, V71, P974, DOI 10.1016/j.neuron.2011.08.031; Borst A, 2010, ANNU REV NEUROSCI, V33, P49, DOI 10.1146/annurev-neuro-060909-153155; BRANDSTATTER JH, 1995, VISUAL NEUROSCI, V12, P345, DOI 10.1017/S0952523800008026; Brandstatter JH, 1998, VISION RES, V38, P1385, DOI 10.1016/S0042-6989(97)00176-4; BRECHA N, 1988, P NATL ACAD SCI USA, V85, P6187, DOI 10.1073/pnas.85.16.6187; Briggman KL, 2011, J NEUROPHYSIOL, V105, P2601, DOI 10.1152/jn.00722.2010; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Brunig I, 2002, J COMP NEUROL, V443, P43, DOI 10.1002/cne.10102; BUHL EH, 1986, J COMP NEUROL, V253, P163, DOI 10.1002/cne.902530204; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P277, DOI 10.1113/jphysiol.1978.sp012233; Chen MG, 2009, J PHYSIOL-LONDON, V587, P819, DOI 10.1113/jphysiol.2008.161240; Chen YC, 2008, J COMP NEUROL, V508, P175, DOI 10.1002/cne.21677; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dorostkar MM, 2010, J NEUROSCI METH, V188, P141, DOI 10.1016/j.jneumeth.2010.01.033; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; EULER T, 2008, SENSES COMPREHENSIVE, V1, P413; Euler T, 2009, PFLUG ARCH EUR J PHY, V457, P1393, DOI 10.1007/s00424-008-0603-5; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; FAMIGLIETTI EV, 1992, J COMP NEUROL, V324, P322, DOI 10.1002/cne.903240303; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Fritschy JM, 2003, PHARMACOL THERAPEUT, V98, P299, DOI 10.1016/S0163-7258(03)00037-8; Ghosh KK, 2001, J NEUROSCI, V21, P8636, DOI 10.1523/JNEUROSCI.21-21-08636.2001; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; GREFERATH U, 1995, J COMP NEUROL, V353, P553, DOI 10.1002/cne.903530407; Grzywacz NM, 2000, VISUAL NEUROSCI, V17, P229, DOI 10.1017/S0952523800172050; Grzywacz NM, 2007, VISUAL NEUROSCI, V24, P647, DOI 10.1017/S0952523807070666; Hausselt SE, 2008, ENCY NEUROSCIENCE, P3501; Hausselt SE, 2007, PLOS BIOL, V5, P1474, DOI 10.1371/journal.pbio.0050185; Herd MB, 2008, J PHYSIOL-LONDON, V586, P989, DOI 10.1113/jphysiol.2007.146746; Hoshi H, 2011, J COMP NEUROL, V519, P2509, DOI 10.1002/cne.22678; Houston CM, 2008, J NEUROSCI, V28, P7574, DOI 10.1523/JNEUROSCI.5531-07.2008; Huberman AD, 2009, NEURON, V62, P327, DOI 10.1016/j.neuron.2009.04.014; Jeon CJ, 2002, J COMP NEUROL, V449, P195, DOI 10.1002/cne.10288; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kanjhan R, 2010, NEUROSCI LETT, V483, P105, DOI 10.1016/j.neulet.2010.07.071; Kay JN, 2011, J NEUROSCI, V31, P7753, DOI 10.1523/JNEUROSCI.0907-11.2011; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; Kong JH, 2005, J COMP NEUROL, V489, P293, DOI 10.1002/cne.20631; KOSAKA T, 1988, EXP BRAIN RES, V70, P605; Koulen P, 1999, J MEMBRANE BIOL, V171, P97, DOI 10.1007/s002329900562; Lee S, 2006, NEURON, V51, P787, DOI 10.1016/j.neuron.2006.08.007; Lee S, 2010, NEURON, V68, P1159, DOI 10.1016/j.neuron.2010.11.031; Majumdar S, 2007, VISUAL NEUROSCI, V24, P471, DOI 10.1017/S0952523807070174; Masland RH, 2005, TRENDS NEUROSCI, V28, P395, DOI 10.1016/j.tins.2005.06.002; Massey SC, 1997, VISUAL NEUROSCI, V14, P939, DOI 10.1017/S0952523800011652; Nyiri G, 2001, EUR J NEUROSCI, V13, P428, DOI 10.1046/j.1460-9568.2001.01407.x; Oesch NW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012447; OYSTER CW, 1980, J COMP NEUROL, V190, P49, DOI 10.1002/cne.901900105; OYSTER CW, 1967, SCIENCE, V155, P841, DOI 10.1126/science.155.3764.841; Panzanelli P, 2009, J NEUROSCI, V29, P15039, DOI 10.1523/JNEUROSCI.3034-09.2009; Poleg-Polsky A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019463; Rivlin-Etzion M, 2011, J NEUROSCI, V31, P8760, DOI 10.1523/JNEUROSCI.0564-11.2011; Schachter MJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000899; Sun WZ, 2002, J COMP NEUROL, V451, P115, DOI 10.1002/cne.10323; Taylor WR, 2002, J NEUROSCI, V22, P7712; Trenholm S, 2011, NEURON, V71, P683, DOI 10.1016/j.neuron.2011.06.020; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; Volgyi B, 2009, J COMP NEUROL, V512, P664, DOI 10.1002/cne.21912; Vollenweider I, 2011, BEHAV BRAIN RES, V217, P77, DOI 10.1016/j.bbr.2010.10.009; Wassle H, 2009, FRONT MOL NEUROSCI, V2, DOI 10.3389/neuro.02.006.2009; Wassle H, 1998, VISION RES, V38, P1411, DOI 10.1016/s0042-6989(97)00300-3; Wei W, 2011, NATURE, V469, P402, DOI 10.1038/nature09600; Weng SJ, 2005, J PHYSIOL-LONDON, V562, P915, DOI 10.1113/jphysiol.2004.076695; Witschi R, 2011, J NEUROSCI, V31, P8134, DOI 10.1523/JNEUROSCI.6328-10.2011; WYATT HJ, 1976, SCIENCE, V191, P204, DOI 10.1126/science.1857; Yonehara K, 2011, NATURE, V469, P407, DOI 10.1038/nature09711; Yonehara K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004320; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zhang J, 2009, J NEUROSCI, V29, P4274, DOI 10.1523/JNEUROSCI.5602-08.2009; Zheleznova Nadezhda N, 2009, Psychoneuroendocrinology, V34 Suppl 1, pS67, DOI 10.1016/j.psyneuen.2009.08.010	81	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35109	10.1371/journal.pone.0035109	http://dx.doi.org/10.1371/journal.pone.0035109			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506070	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500077
J	Pasarin, M; La Mura, V; Gracia-Sancho, J; Garcia-Caldero, H; Rodriguez-Vilarrupla, A; Garcia-Pagan, JC; Bosch, J; Abraldes, JG				Pasarin, Marcos; La Mura, Vincenzo; Gracia-Sancho, Jorge; Garcia-Caldero, Hector; Rodriguez-Vilarrupla, Aina; Carlos Garcia-Pagan, Juan; Bosch, Jaime; Abraldes, Juan G.			Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD	PLOS ONE			English	Article							FATTY LIVER-DISEASE; STELLATE CELL ACTIVATION; CCL4 CIRRHOTIC RATS; NITRIC-OXIDE; INSULIN-RESISTANCE; METABOLIC SYNDROME; IN-VIVO; NONALCOHOLIC STEATOHEPATITIS; PORTAL-HYPERTENSION; DIABETES-MELLITUS	Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome. Most morbidity associated with the metabolic syndrome is related to vascular complications, in which endothelial dysfunction is a major pathogenic factor. However, whether NAFLD is associated with endothelial dysfunction within the hepatic vasculature is unknown. The aims of this study were to explore, in a model of diet-induced overweight that expresses most features of the metabolic syndrome, whether early NAFLD is associated with liver endothelial dysfunction. Wistar Kyoto rats were fed a cafeteria diet (CafD; 65% of fat, mostly saturated) or a control diet (CD) for 1 month. CafD rats developed features of the metabolic syndrome (overweight, arterial hypertension, hypertryglyceridemia, hyperglucemia and insulin resistance) and liver steatosis without inflammation or fibrosis. CafD rats had a significantly higher in vivo hepatic vascular resistance than CD. In liver perfusion livers from CafD rats had an increased portal perfusion pressure and decreased endothelium-dependent vasodilation. This was associated with a decreased Akt-dependent eNOS phosphorylation and NOS activity. In summary, we demonstrate in a rat model of the metabolic syndrome that shows features of NAFLD, that liver endothelial dysfunction occurs before the development of fibrosis or inflammation.	[Pasarin, Marcos; La Mura, Vincenzo; Gracia-Sancho, Jorge; Garcia-Caldero, Hector; Rodriguez-Vilarrupla, Aina; Carlos Garcia-Pagan, Juan; Bosch, Jaime; Abraldes, Juan G.] Univ Barcelona, Liver Unit, Hosp Clin IDIBAPS, Hepat Hemodynam Lab,CIBERrehd, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Pasarin, M (corresponding author), Univ Barcelona, Liver Unit, Hosp Clin IDIBAPS, Hepat Hemodynam Lab,CIBERrehd, Barcelona, Spain.	jgon@clinic.ub.es	Bosch, Jaime/AFF-8344-2022; García-Calderó, Héctor/AAB-3474-2019; Bosch, Jaime/AAF-1006-2022; Gracia-Sancho, Jordi/C-8920-2014; Garcia-Pagan, Juan-Carlos/P-6291-2015; LA MURA, VINCENZO/M-3949-2016; García-Calderó, Héctor/H-2460-2015	García-Calderó, Héctor/0000-0002-8801-6394; Gracia-Sancho, Jordi/0000-0001-7736-4089; Garcia-Pagan, Juan-Carlos/0000-0001-9032-4954; LA MURA, VINCENZO/0000-0003-4685-7184; García-Calderó, Héctor/0000-0002-8801-6394; Gonzalez-Abraldes, Juan/0000-0003-3421-937X	Instituto de Salud Carlos III [FIS 05/0519, FIS 08/0193, 09/01261]; EU, "Una manera de hacer Europa"	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); EU, "Una manera de hacer Europa"	This study was supported by grants from the Instituto de Salud Carlos III (FIS 05/0519 and FIS 08/0193 to Dr. Abraldes and Dr. Pasarin 09/01261 to Dr. Bosch), and co-financed by FEDER funds (EU, "Una manera de hacer Europa"). Part of this work was carried out at the Esther Koplowitz Centre, Barcelona. Ciberehd is funded by Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraldes JG, 2007, J HEPATOL, V46, P1040, DOI 10.1016/j.jhep.2007.01.020; Abraldes JG, 2009, GASTROENTEROLOGY, V136, P1651, DOI 10.1053/j.gastro.2009.01.043; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Bataller R, 2003, AM J PHYSIOL-GASTR L, V285, pG642, DOI 10.1152/ajpgi.00037.2003; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Claret M, 2005, ENDOCRINOLOGY, V146, P4362, DOI 10.1210/en.2005-0385; Claret M, 2004, OBES RES, V12, P1596, DOI 10.1038/oby.2004.199; COUVELARD A, 1993, AM J PATHOL, V143, P738; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; DeLeve LD, 2008, HEPATOLOGY, V48, P920, DOI 10.1002/hep.22351; DeLeve LD, 2004, AM J PHYSIOL-GASTR L, V287, pG757, DOI 10.1152/ajpgi.00017.2004; DeLeve LD, 2003, HEPATOLOGY, V38, P900, DOI 10.1053/jhep.2003.50383; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Duncan ER, 2007, AM J PHYSIOL-ENDOC M, V293, pE1311, DOI 10.1152/ajpendo.00299.2007; Duncan ER, 2008, DIABETES, V57, P3307, DOI 10.2337/db07-1111; Gallagher EJ, 2010, MT SINAI J MED, V77, P511, DOI 10.1002/msj.20212; Goldberg RB, 1998, CIRCULATION, V98, P2513, DOI 10.1161/01.CIR.98.23.2513; Graupera M, 2002, GASTROENTEROLOGY, V122, P387, DOI 10.1053/gast.2002.31040; Gupta TK, 1998, HEPATOLOGY, V28, P926, DOI 10.1002/hep.510280405; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Huang PL, 2009, TRENDS ENDOCRIN MET, V20, P295, DOI 10.1016/j.tem.2009.03.005; KNOWLES RG, 1990, BIOCHEM J, V270, P833, DOI 10.1042/bj2700833; Langer DA, 2008, HEPATOLOGY, V47, P1983, DOI 10.1002/hep.22285; Leclercq IA, 2007, LAB INVEST, V87, P56, DOI 10.1038/labinvest.3700489; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Lieber CS, 2004, AM J CLIN NUTR, V79, P502; March S, 2009, HEPATOLOGY, V50, P920, DOI 10.1002/hep.23085; Matei V, 2008, J HEPATOL, V49, P192, DOI 10.1016/j.jhep.2008.04.014; Matei V, 2006, HEPATOLOGY, V44, P44, DOI 10.1002/hep.21228; McCuskey RS, 2008, ANAT REC, V291, P661, DOI 10.1002/ar.20663; McCuskey RS, 2004, HEPATOLOGY, V40, P386, DOI 10.1002/hep.20302; Miller AM, 2010, ALCOHOL CLIN EXP RES, V34, P719, DOI 10.1111/j.1530-0277.2009.01141.x; Montagnani M, 2001, J BIOL CHEM, V276, P30392, DOI 10.1074/jbc.M103702200; MURO H, 1993, AM J PATHOL, V143, P105; Neri S, 1998, INT J CLIN LAB RES, V28, P100, DOI 10.1007/s005990050027; Ohmori S, 2001, HUM PATHOL, V32, P1363, DOI 10.1053/hupa.2001.29678; Pasarin M, 2011, J HEPATOL, V55, P1095, DOI 10.1016/j.jhep.2011.01.053; Perlemuter G, 2007, NAT CLIN PRACT ENDOC, V3, P458, DOI 10.1038/ncpendmet0505; Picchi A, 2006, CIRC RES, V99, P69, DOI 10.1161/01.RES.0000229685.37402.80; Reaven G, 2002, CIRCULATION, V106, P286, DOI 10.1161/01.CIR.0000019884.36724.D9; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Schalkwijk CG, 2005, CLIN SCI, V109, P143, DOI 10.1042/CS20050025; Seifalian AM, 1998, LIVER TRANSPLANT SUR, V4, P71, DOI 10.1002/lt.500040110; Straub AC, 2008, J CLIN INVEST, V118, P3980, DOI 10.1172/JCI35092; Villanova N, 2005, HEPATOLOGY, V42, P473, DOI 10.1002/hep.20781; Wanless IR, 2004, SEMIN LIVER DIS, V24, P99; WANLESS IR, 1995, HEPATOLOGY, V21, P1238, DOI 10.1002/hep.1840210505; Wiest R, 2002, HEPATOLOGY, V35, P478, DOI 10.1053/jhep.2002.31432; Witek RP, 2009, GASTROENTEROLOGY, V136, P320, DOI 10.1053/j.gastro.2008.09.066; Zhang DH, 2011, HEPATOLOGY, V53, P1306, DOI 10.1002/hep.24200	51	150	155	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e32785	10.1371/journal.pone.0032785	http://dx.doi.org/10.1371/journal.pone.0032785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509248	Green Published, Green Submitted, gold			2022-12-27	WOS:000304805900003
J	von Lohneysen, K; Scott, TM; Soldau, K; Xu, XL; Friedman, JS				von Loehneysen, Katharina; Scott, Thomas M.; Soldau, Katrin; Xu, Xiuling; Friedman, Jeffrey S.			Assessment of the Red Cell Proteome of Young Patients with Unexplained Hemolytic Anemia by Two-Dimensional Differential In-Gel Electrophoresis (DIGE)	PLOS ONE			English	Article							NUCLEOSIDE-PHOSPHORYLASE-DEFICIENCY; ERYTHROCYTE PYRUVATE-KINASE; RETICULOCYTE MATURATION; MOLECULAR CHAPERONE; RAB GTPASES; BLOOD-CELLS; MEMBRANE; PROTEINS; MUTATIONS; BINDING	Erythrocyte cytosolic protein expression profiles of children with unexplained hemolytic anemia were compared with profiles of close relatives and controls by two-dimensional differential in-gel electrophoresis (2D-DIGE). The severity of anemia in the patients varied from compensated (i.e., no medical intervention required) to chronic transfusion dependence. Common characteristics of all patients included chronic elevation of reticulocyte count and a negative workup for anemia focusing on hemoglobinopathies, morphologic abnormalities that would suggest a membrane defect, immune-mediated red cell destruction, and evaluation of the most common red cell enzyme defects, glucose-6-phosphate dehydrogenase and pyruvate kinase deficiency. Based upon this initial workup and presentation during infancy or early childhood, four patients classified as hereditary nonspherocytic hemolytic anemia (HNSHA) of unknown etiology were selected for proteomic analysis. DIGE analysis of red cell cytosolic proteins clearly discriminated each anemic patient from both familial and unrelated controls, revealing both patient-specific and shared patterns of differential protein expression. Changes in expression pattern shared among the four patients were identified in several protein classes including chaperons, cytoskeletal and proteasome proteins. Elevated expression in patient samples of some proteins correlated with high reticulocyte count, likely identifying a subset of proteins that are normally lost during erythroid maturation, including proteins involved in mitochondrial metabolism and protein synthesis. Proteins identified with patient-specific decreased expression included components of the glutathione synthetic pathway, antioxidant pathways, and proteins involved in signal transduction and nucleotide metabolism. Among the more than 200 proteins identified in this study are 21 proteins not previously described as part of the erythrocyte proteome. These results demonstrate the feasibility of applying a global proteomic approach to aid characterization of red cells from patients with hereditary anemia of unknown cause, including the identification of differentially expressed proteins as potential candidates with a role in disease pathogenesis.	[von Loehneysen, Katharina; Scott, Thomas M.; Soldau, Katrin; Xu, Xiuling; Friedman, Jeffrey S.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	von Lohneysen, K (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	friedman@scripps.edu			Center for AIDS [3 P30 AI036214-13S1];  [1RO1 DK080232]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080232] Funding Source: NIH RePORTER	Center for AIDS; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grant 1RO1 DK080232 awarded to JSF. Center for AIDS Research Support 3 P30 AI036214-13S1, is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200; Banerjee T, 2004, BRIT J HAEMATOL, V124, P391, DOI 10.1046/j.1365-2141.2003.04781.x; Baronciani L, 1996, BLOOD CELL MOL DIS, V22, P259, DOI 10.1006/bcmd.1996.0107; Beutler E., 1984, GLUTATHIONE RED CELL; BEUTLER E, 2006, WILLIAMS HEMATOLOGY, P603; Bhattacharya D, 2010, PROTEOM CLIN APPL, V4, P480, DOI 10.1002/prca.200900073; Bouyssie D, 2007, MOL CELL PROTEOMICS, V6, P1621, DOI 10.1074/mcp.T600069-MCP200; Carpenter PA, 1996, BONE MARROW TRANSPL, V17, P121; CARRELL RW, 1972, BRIT J HAEMATOL, V23, P615, DOI 10.1111/j.1365-2141.1972.tb07096.x; CHASIS JA, 1989, BLOOD, V74, P1112, DOI 10.1182/blood.V74.3.1112.1112; CHEN XY, 1994, P NATL ACAD SCI USA, V91, P9111, DOI 10.1073/pnas.91.19.9111; Clarkson YL, 2010, HUM MOL GENET, V19, P3634, DOI 10.1093/hmg/ddq279; DAVID O, 1990, HAEMATOLOGICA, V75, P313; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fibach E, 2008, CURR MOL MED, V8, P609, DOI 10.2174/156652408786241384; Frezza C, 2011, NATURE, V477, P225, DOI 10.1038/nature10363; Friedman DB, 2009, METHOD ENZYMOL, V463, P515, DOI 10.1016/S0076-6879(09)63030-5; Ghosh N, 2011, FREE RADICAL RES, V45, P888, DOI 10.3109/10715762.2011.574290; GIBLETT ER, 1975, LANCET, V1, P1010, DOI 10.1016/S0140-6736(75)91950-9; Gilligan DM, 2011, BLOOD CELL MOL DIS, V47, P85, DOI 10.1016/j.bcmd.2011.03.008; Goodman SR, 2007, EXP BIOL MED, V232, P1391, DOI 10.3181/0706-MR-156; HALLETT RJ, 1994, ADV EXP MED BIOL, V370, P387; Hamburger AW, 2008, J MAMMARY GLAND BIOL, V13, P225, DOI 10.1007/s10911-008-9077-5; Hattangadi S, 2011, ASH ANN M, V118, P178; Hirono A, 1996, BLOOD, V87, P2071; Hoffbrand AV, 2011, ESSENTIAL HAEMATOLOG, Vxi, P454; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; KANNO H, 1994, BLOOD, V84, P3505; KANNO H, 1994, BLOOD, V83, P2311; Karp NA, 2005, PROTEOMICS, V5, P3105, DOI 10.1002/pmic.200500083; Karp NA, 2004, PROTEOMICS, V4, P1421, DOI 10.1002/pmic.200300681; Khalil AA, 2011, BBA-REV CANCER, V1816, P89, DOI 10.1016/j.bbcan.2011.05.001; Koury MJ, 2005, BLOOD, V105, P2168, DOI 10.1182/blood-2004-02-0616; Kubota H, 2002, VITAM HORM, V65, P313, DOI 10.1016/S0083-6729(02)65069-1; Lee IN, 2005, J PROTEOME RES, V4, P2062, DOI 10.1021/pr0502018; Liu J, 2010, BLOOD, V115, P2021, DOI 10.1182/blood-2009-08-241182; Malygin AA, 2011, BIOCHIMIE, V93, P612, DOI 10.1016/j.biochi.2010.12.005; MARKERT M L, 1991, Immunodeficiency Reviews, V3, P45; Markert ML, 1997, HUM MUTAT, V9, P118, DOI 10.1002/(SICI)1098-1004(1997)9:2<118::AID-HUMU3>3.0.CO;2-5; McCallum CD, 2000, J CELL BIOL, V149, P591, DOI 10.1083/jcb.149.3.591; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Mimnaugh EG, 2006, MOL CANCER RES, V4, P667, DOI 10.1158/1541-7786.MCR-06-0019; Mingot JM, 2004, EMBO J, V23, P3227, DOI 10.1038/sj.emboj.7600338; Miwa S, 1996, AM J HEMATOL, V51, P122, DOI 10.1002/(SICI)1096-8652(199602)51:2<122::AID-AJH5>3.0.CO;2-#; Nelson J, 2008, BIOSCIENCE REP, V28, P33, DOI 10.1042/BSR20070004; Notarangelo Luigi D, 2009, Hematology Am Soc Hematol Educ Program, P139, DOI 10.1182/asheducation-2009.1.139; Origa Raffaella, 2011, Pediatr Endocrinol Rev, V8 Suppl 2, P263; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Patterson ST, 2009, J BIOL CHEM, V284, P14547, DOI 10.1074/jbc.M809076200; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Prchal JT, 2004, HEMATOL J, V5, pS110, DOI 10.1038/sj.thj.6200434; Radoshevich L, 2011, AUTOPHAGY, V7, P109, DOI 10.4161/auto.7.1.13998; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Sharma SK, 2009, CURR PROTEIN PEPT SC, V10, P432, DOI 10.2174/138920309789351930; SIMMONDS HA, 1982, BIOCHEM PHARMACOL, V31, P941, DOI 10.1016/0006-2952(82)90324-0; Sivilotti Marco L A, 2004, Toxicol Rev, V23, P169; Squatrito M, 2004, ONCOGENE, V23, P4454, DOI 10.1038/sj.onc.1207579; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Teumer A, 2011, AM J HUM GENET, V88, P664, DOI 10.1016/j.ajhg.2011.04.015; Valentini G, 2002, J BIOL CHEM, V277, P23807, DOI 10.1074/jbc.M202107200; van Kuilenburg ABP, 2010, NUCLEOS NUCLEOT NUCL, V29, P466, DOI 10.1080/15257771003741455; Wang Q, 2004, J STRUCT BIOL, V146, P44, DOI 10.1016/j.jsb.2003.11.014; YAFFE MB, 1992, NATURE, V358, P245, DOI 10.1038/358245a0; Yates JR, 2006, ANAL CHEM, V78, P493, DOI 10.1021/ac0514624; Zhang YX, 2010, CANCER RES, V70, P240, DOI 10.1158/0008-5472.CAN-09-2904; Zhu K, 2005, ANAL CHEM, V77, P2745, DOI 10.1021/ac048494w	68	11	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34237	10.1371/journal.pone.0034237	http://dx.doi.org/10.1371/journal.pone.0034237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509282	Green Submitted, Green Published, gold			2022-12-27	WOS:000304805900020
J	Blom, RM; Hennekam, RC; Denys, D				Blom, Rianne M.; Hennekam, Raoul C.; Denys, Damiaan			Body Integrity Identity Disorder	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE SCALE; SELF-AMPUTATION; FRONTOPARIETAL DYSFUNCTION; DESIRE; APOTEMNOPHILIA; INVENTORY; LIMB	Introduction: Body Integrity Identity Disorder (BIID) is a rare, infrequently studied and highly secretive condition in which there is a mismatch between the mental body image and the physical body. Subjects suffering from BIID have an intense desire to amputate a major limb or severe the spinal cord in order to become paralyzed. Aim of the study is to broaden the knowledge of BIID amongst medical professionals, by describing all who deal with BIID. Methods: Somatic, psychiatric and BIID characteristic data were collected from 54 BIID individuals using a detailed questionnaire. Subsequently, data of different subtypes of BIID (i.e. wish for amputation or paralyzation) were evaluated. Finally, disruption in work, social and family life due to BIID in subjects with and without amputation were compared. Results: Based on the subjects' reports we found that BIID has an onset in early childhood. The main rationale given for their desire for body modification is to feel complete or to feel satisfied inside. Somatic and severe psychiatric co-morbidity is unusual, but depressive symptoms and mood disorders can be present, possibly secondary to the enormous distress BIID puts upon a person. Amputation and paralyzation variant do not differ in any clinical variable. Surgery is found helpful in all subjects who underwent amputation and those subjects score significantly lower on a disability scale than BIID subjects without body modification. Conclusions: The amputation variant and paralyzation variant of BIID are to be considered as one of the same condition. Amputation of the healthy body part appears to result in remission of BIID and an impressive improvement of quality of life. Knowledge of and respect for the desires of BIID individuals are the first steps in providing care and may decrease the huge burden they experience.	[Blom, Rianne M.; Denys, Damiaan] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Hennekam, Raoul C.] Univ Amsterdam, Acad Med Ctr, Dept Paediat, NL-1105 AZ Amsterdam, Netherlands; [Hennekam, Raoul C.] Univ Amsterdam, Acad Med Ctr, Dept Translat Genet, NL-1105 AZ Amsterdam, Netherlands; [Denys, Damiaan] Netherlands Inst Neurosci, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Blom, RM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	ddenys@gmail.com			Academic Medical Center Amsterdam	Academic Medical Center Amsterdam	The study was supported by the Academic Medical Center Amsterdam (internal funding). The funding agency had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript. There are no current external funding sources for this study.	BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bensler JM, 2003, SOUTH MED J, V96, P674, DOI 10.1097/01.SMJ.0000078367.94479.B9; Berger BD, 2005, COMPR PSYCHIAT, V46, P380, DOI 10.1016/j.comppsych.2004.12.003; Blanke O, 2009, J NEUROPSYCHOL, V3, P181, DOI 10.1348/174866408X318653; Brang D, 2008, NEUROREPORT, V19, P1305, DOI 10.1097/WNR.0b013e32830abc4d; Chan JKK, 2011, J PLAST RECONSTR AES, V64, P4, DOI 10.1016/j.bjps.2010.03.029; Craimer A, 2009, AM J BIOETHICS, V9, P53, DOI 10.1080/15265160802626986; First MB, 2005, PSYCHOL MED, V35, P919, DOI 10.1017/S0033291704003320; First MB, 2012, PSYCHOPATHOLOGY, V45, P3, DOI 10.1159/000330503; Gates G, 2011, MANY PEOPLE ARE LESB; Giummarra MJ, 2011, NEUROPSYCHOL REV, V21, P320, DOI 10.1007/s11065-011-9184-8; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1006; GOODMAN WK, 1989, ARCH GEN PSYCHIAT, V46, P1012; Hennekam RCM, 2011, EUR J MED GENET, V54, P220, DOI 10.1016/j.ejmg.2010.12.001; Karnath HO, 2010, BRAIN STRUCT FUNCT, V214, P411, DOI 10.1007/s00429-010-0250-4; Kasten E, 2009, FORTSCHR NEUROL PSYC, V77, P16, DOI 10.1055/s-0028-1100837; Kasten E, 2009, BODY INTEGRITY IDENTITY DISORDER: PSYCHOLOGICAL, NEUROBIOLOGICAL, ETHICAL AND LEGAL ASPECTS, P20; KERSTEIN MD, 1980, J AM GERIATR SOC, V28, P40, DOI 10.1111/j.1532-5415.1980.tb00122.x; Leon AC, 1997, INT J PSYCHIAT MED, V27, P93, DOI 10.2190/T8EM-C8YH-373N-1UWD; McGeoch PD, 2011, J NEUROL NEUROSUR PS, V82, P1314, DOI 10.1136/jnnp-2011-300224; Money John, 1990, J PSYCHOL HUMAN SEXU, V3, P165; Muller S, 2009, AM J BIOETHICS, V9, P36, DOI 10.1080/15265160802588194; Ramachandran VS, 2007, MED HYPOTHESES, V69, P250, DOI 10.1016/j.mehy.2006.12.013; Schlozman SC, 1998, J CLIN PSYCHIAT, V59, P681, DOI 10.4088/JCP.v59n1207; Sedda A, 2011, NEUROPSYCHOL REV, V21, P334, DOI 10.1007/s11065-011-9186-6; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sorene ED, 2006, J HAND SURG-BRIT EUR, V31B, P593, DOI 10.1016/j.jhsb.2006.05.022; Wilson P, 1999, BRIT J GEN PRACT, V49, P991	29	49	49	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34702	10.1371/journal.pone.0034702	http://dx.doi.org/10.1371/journal.pone.0034702			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514657	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600063
J	Deehan, R; Maerz-Weiss, P; Catlett, NL; Steiner, G; Wong, B; Wright, MB; Blander, G; Elliston, KO; Ladd, W; Bobadilla, M; Mizrahi, J; Haefliger, C; Edgar, A				Deehan, Renee; Maerz-Weiss, Pia; Catlett, Natalie L.; Steiner, Guido; Wong, Ben; Wright, Matthew B.; Blander, Gil; Elliston, Keith O.; Ladd, William; Bobadilla, Maria; Mizrahi, Jacques; Haefliger, Carolina; Edgar, Alan			Comparative Transcriptional Network Modeling of Three PPAR-alpha/gamma Co-Agonists Reveals Distinct Metabolic Gene Signatures in Primary Human Hepatocytes	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; EMERGING ROLE; PROTEIN; INHIBITOR; LIVER; PHOSPHORYLATION; BIOINFORMATICS; PIOGLITAZONE; ALEGLITAZAR; MECHANISMS	Aims: To compare the molecular and biologic signatures of a balanced dual peroxisome proliferator-activated receptor (PPAR)-alpha/gamma agonist, aleglitazar, with tesaglitazar (a dual PPAR-alpha/gamma agonist) or a combination of pioglitazone (Pio; PPAR-gamma agonist) and fenofibrate (Feno; PPAR-alpha agonist) in human hepatocytes. Methods and Results: Gene expression microarray profiles were obtained from primary human hepatocytes treated with EC50-aligned low, medium and high concentrations of the three treatments. A systems biology approach, Causal Network Modeling, was used to model the data to infer upstream molecular mechanisms that may explain the observed changes in gene expression. Aleglitazar, tesaglitazar and Pio/Feno each induced unique transcriptional signatures, despite comparable core PPAR signaling. Although all treatments inferred qualitatively similar PPAR-alpha signaling, aleglitazar was inferred to have greater effects on high- and low-density lipoprotein cholesterol levels than tesaglitazar and Pio/Feno, due to a greater number of gene expression changes in pathways related to high-density and low-density lipoprotein metabolism. Distinct transcriptional and biologic signatures were also inferred for stress responses, which appeared to be less affected by aleglitazar than the comparators. In particular, Pio/Feno was inferred to increase NFE2L2 activity, a key component of the stress response pathway, while aleglitazar had no significant effect. All treatments were inferred to decrease proliferative signaling. Conclusions: Aleglitazar induces transcriptional signatures related to lipid parameters and stress responses that are unique from other dual PPAR-alpha/gamma treatments. This may underlie observed favorable changes in lipid profiles in animal and clinical studies with aleglitazar and suggests a differentiated gene profile compared with other dual PPAR-alpha/gamma agonist treatments.	[Deehan, Renee; Catlett, Natalie L.; Wong, Ben; Blander, Gil; Elliston, Keith O.; Ladd, William] Selventa, Cambridge, MA USA; [Maerz-Weiss, Pia; Steiner, Guido; Wright, Matthew B.; Bobadilla, Maria; Mizrahi, Jacques; Haefliger, Carolina; Edgar, Alan] F Hoffmann La Roche & Cie AG, Basel, Switzerland	Roche Holding	Deehan, R (corresponding author), Selventa, Cambridge, MA USA.	matthew.wright@roche.com		Elliston, Keith/0000-0002-9110-9233; Wright, matthewwright/0000-0002-0532-3381	F. Hoffmann-La Roche AG	F. Hoffmann-La Roche AG(Hoffmann-La Roche)	This work was supported by F. Hoffmann-La Roche AG (www.roche.com). The study design and conduct of the hepatocyte treatments, RNA isolation, microarray hybridizations, and statistical analyses were performed in the laboratories of F. Hoffmann-La Roche, while data analysis was performed at Selventa Laboratories (www.selventa.com). The decision to publish and manuscript preparation was made jointly by scientists and F. Hoffmann-La Roche and Selventa Laboratories. Editorial assistance was funded by F. Hoffmann-La Roche AG.	Abourbih S, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.03.030; Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; Barbier O, 2002, ARTERIOSCL THROM VAS, V22, P717, DOI 10.1161/01.ATV.0000015598.86369.04; Bays Harold, 2007, Diab Vasc Dis Res, V4, P181; Bell M, 2008, DIABETES, V57, P2037, DOI 10.2337/db07-1383; Benardeau A, 2009, BIOORG MED CHEM LETT, V19, P2468, DOI 10.1016/j.bmcl.2009.03.036; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blander G, 2009, J INVEST DERMATOL, V129, P41, DOI 10.1038/jid.2008.179; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chang BHJ, 2007, AM J PHYSIOL-GASTR L, V292, pG1465, DOI 10.1152/ajpgi.00566.2006; Chiquette E, 2004, ARCH INTERN MED, V164, P2097, DOI 10.1001/archinte.164.19.2097; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Delerive P, 2001, J ENDOCRINOL, V169, P453, DOI 10.1677/joe.0.1690453; Duval C, 2007, BBA-MOL CELL BIOL L, V1771, P961, DOI 10.1016/j.bbalip.2007.05.003; Ericsson H, 2004, DRUG METAB DISPOS, V32, P923; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Goke Burkhard, 2007, Diab Vasc Dis Res, V4, P204; Gordon S, 2006, ONCOGENE, V25, P1125, DOI 10.1038/sj.onc.1209080; Grosskopf I, 2005, ARTERIOSCL THROM VAS, V25, P2573, DOI 10.1161/01.ATV.0000186189.26141.12; GRUNDY SM, 1987, AM J MED, V83, P9, DOI 10.1016/0002-9343(87)90866-7; Gupta AK, 2007, NEOPLASIA, V9, P271, DOI 10.1593/neo.07124; Hansen BC, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-7; Henry RR, 2009, LANCET, V374, P126, DOI 10.1016/S0140-6736(09)60870-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang XS, 2009, BRIT J PHARMACOL, V158, P706, DOI 10.1111/j.1476-5381.2009.00350.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kast-Woelbern HR, 2004, J BIOL CHEM, V279, P23908, DOI 10.1074/jbc.M403145200; Katso R, 2001, ANNU REV CELL DEV BI, V17, P615, DOI 10.1146/annurev.cellbio.17.1.615; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Kumar R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-419; Laifenfeld D, 2010, TOXICOL SCI, V113, P254, DOI 10.1093/toxsci/kfp213; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; Nissen SE, 2005, JAMA-J AM MED ASSOC, V294, P2581, DOI 10.1001/JAMA.294.20.JOC50147; Oyaizu T, 1997, EXP TOXICOL PATHOL, V49, P375, DOI 10.1016/S0940-2993(97)80121-2; Pfutzner A, 2005, J AM COLL CARDIOL, V45, P1925, DOI 10.1016/j.jacc.2005.03.041; Ratner Robert E, 2007, Diab Vasc Dis Res, V4, P214; Rogue A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018816; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Sahin F, 2010, INT J BIOL SCI, V6, P116; Schlage WK, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-168; Smith JJ, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-31; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460; Tall AR, 2008, CELL METAB, V7, P365, DOI 10.1016/j.cmet.2008.03.001; Tenenbaum A, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-14; Toedter G, 2012, INFLAMM BOWEL DIS; Vu-Dac N, 2003, J BIOL CHEM, V278, P17982, DOI 10.1074/jbc.M212191200; Westra JW, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-105; Wilding John P H, 2007, Diab Vasc Dis Res, V4, P194; Winkler K, 2003, DIABETES CARE, V26, P2588, DOI 10.2337/diacare.26.9.2588; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	53	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35012	10.1371/journal.pone.0035012	http://dx.doi.org/10.1371/journal.pone.0035012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514701	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341600107
J	Gao, Y; Yu, GR; Luo, CY; Zhou, P				Gao, Yang; Yu, Guirui; Luo, Chunyan; Zhou, Pei			Groundwater Nitrogen Pollution and Assessment of Its Health Risks: A Case Study of a Typical Village in Rural-Urban Continuum, China	PLOS ONE			English	Article							NITRATE CONTAMINATION; HILLSLOPE CROPLAND; SICHUAN BASIN; PHOSPHORUS; TRANSPORT; RAINFALL; REGION; INDIA	Protecting groundwater from nitrogen contamination is an important public-health concern and a major national environmental issue in China. In this study, we monitored water quality in 29 wells from 2009 to 2010 in a village in Shanghai city, whick belong to typical rural-urban continuum in China. The total N and NO3-N exhibited seasonal changes, and there were large fluctuations in NH4-N in residential areas, but without significant seasonal patterns. NO2-N in the water was not stable, but was present at high levels. Total N and NO3-N were significantly lower in residential areas than in agricultural areas. The groundwater quality in most wells belonged to Class III and IV in the Chinese water standard, which defines water that is unsuitable for human consumption. Our health risk assessments showed that NO3-N posed the greatest carcinogenic risk, with risk values ranging from 19x10(-6) to 80x10(-6), which accounted for more than 90% of the total risk in the study area.	[Gao, Yang; Yu, Guirui] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China; [Luo, Chunyan] CAAS, Inst Agr Resources & Reg Planning, Beijing, Peoples R China; [Gao, Yang; Zhou, Pei] Shanghai Jiao Tong Univ, Sch Agr & Biol, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Shanghai Jiao Tong University	Gao, Y (corresponding author), Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Ecosyst Network Observat & Modeling, Beijing, Peoples R China.	gaoyang0898@163.com; yugr@igsnrr.ac.cn	Gao, Yang/A-4128-2017; 于, 贵瑞/C-1768-2014	Gao, Yang/0000-0002-2053-0418; 于, 贵瑞/0000-0002-1859-8966	National Key Basic Research Program [2010CB833504]; National Natural Science Foundation of China [40601097, 30590381]	National Key Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by National Key Basic Research Program (2010CB833504), and National Natural Science Foundation of China (40601097 and 30590381). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary PP, 2010, ENVIRON MONIT ASSESS, V167, P599, DOI 10.1007/s10661-009-1076-5; Akhavan S, 2010, AGR ECOSYST ENVIRON, V139, P675, DOI 10.1016/j.agee.2010.10.015; Cao Jie-jun, 2010, Huanjing Kexue, V31, P2587; Cepuder P, 2002, NUTR CYCL AGROECOSYS, V64, P301, DOI 10.1023/A:1021438310211; Chen SF, 2010, ECOL COMPLEX, V7, P131, DOI 10.1016/j.ecocom.2010.03.003; Chen XM, 2010, ENVIRON MONIT ASSESS, V169, P159, DOI 10.1007/s10661-009-1159-3; *COMM AN METH WAT, 1989, AN METH WAT WAST; FORMAN D, 1985, NATURE, V313, P620, DOI 10.1038/313620a0; Gao Y, 2012, J HYDROL, V420, P373, DOI 10.1016/j.jhydrol.2011.12.029; Gao Y, 2010, ENVIRON MONIT ASSESS, V171, P539, DOI 10.1007/s10661-009-1298-6; Gao Y, 2009, NUTR CYCL AGROECOSYS, V85, P263, DOI 10.1007/s10705-009-9265-8; Gong ZT, CHINESE SOIL TAXONOM; Hu KL, 2005, ENVIRON INT, V31, P896, DOI 10.1016/j.envint.2005.05.028; [黄海波 Huang Haibo], 2010, [水土保持学报, Journal of Soil and Water Conservation], V24, P56; Jackson BM, 2008, ENVIRON SCI POLICY, V11, P125, DOI 10.1016/j.envsci.2007.10.006; Kolluru R., 1996, RISK ASSESSMENT MANA; KOMAR SC, 1993, GROUNDWATER, V31, P250; Li YL, 2010, ENVIRON MONIT ASSESS, V163, P1, DOI 10.1007/s10661-009-0811-2; Means B., 1989, RISK ASSESSMENT GUID; Naik PK, 2008, ENVIRON MONIT ASSESS, V146, P339, DOI 10.1007/s10661-007-0084-6; Payne M. R., 1993, Agriculture and the environment., P63; POINKE HB, 1985, GROUND WATER, V23, P68; Rayment G.E., 1992, AUSTR SOIL LAND SURV; Reddy AGS, 2009, ENVIRON MONIT ASSESS, V148, P463, DOI 10.1007/s10661-008-0176-y; State Environmental Protection Administration of China, 1994, GBT1484893 STAT ENV, P23; Vidal M, 2000, J ENVIRON MANAGE, V60, P215, DOI 10.1006/jema.2000.0379; World Health Organization, 2008, INC 1 2 AG, V1; Yang JL, 2009, SOIL TILL RES, V105, P292, DOI 10.1016/j.still.2009.04.003; Zhu B, 2008, PEDOSPHERE, V18, P257, DOI 10.1016/S1002-0160(08)60015-6; Zhu B, 2009, SOIL SCI SOC AM J, V73, P1419, DOI 10.2136/sssaj2008.0259; Zhu Z.L., 1992, NITROGEN CHINESE SOI	31	55	58	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e33982	10.1371/journal.pone.0033982	http://dx.doi.org/10.1371/journal.pone.0033982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514611	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600016
J	Gazendam, FJ; Kindt, M				Gazendam, Femke J.; Kindt, Merel			Worrying Affects Associative Fear Learning: A Startle Fear Conditioning Study	PLOS ONE			English	Article							MEMORY; RECONSOLIDATION; ACQUISITION; EXTINCTION; MODULATION; ACTIVATION; RUMINATION; RESPONSES; AMYGDALA; THINKING	A valuable experimental model for the pathogenesis of anxiety disorders is that they originate from a learned association between an intrinsically non-aversive event (Conditioned Stimulus, CS) and an anticipated disaster (Unconditioned Stimulus, UCS). Most anxiety disorders, however, do not evolve from a traumatic experience. Insights from neuroscience show that memory can be modified post-learning, which may elucidate how pathological fear can develop after relatively mild aversive events. Worrying - a process frequently observed in anxiety disorders - is a potential candidate to strengthen the formation of fear memory after learning. Here we tested in a discriminative fear conditioning procedure whether worry strengthens associative fear memory. Participants were randomly assigned to either a Worry (n = 23) or Control condition (n = 25). After fear acquisition, the participants in the Worry condition processed six worrisome questions regarding the personal aversive consequences of an electric stimulus (UCS), whereas the Control condition received difficult but neutral questions. Subsequently, extinction, reinstatement and re-extinction of fear were tested. Conditioned responding was measured by fear-potentiated startle (FPS), skin conductance (SCR) and UCS expectancy ratings. Our main results demonstrate that worrying resulted in increased fear responses (FPS) to both the feared stimulus (CS+) and the originally safe stimulus (CS-), whereas FPS remained unchanged in the Control condition. In addition, worrying impaired both extinction and re-extinction learning of UCS expectancy. The implication of our findings is that they show how worry may contribute to the development of anxiety disorders by affecting associative fear learning.	[Gazendam, Femke J.; Kindt, Merel] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands	University of Amsterdam	Gazendam, FJ (corresponding author), Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands.	F.J.Gazendam@UvA.nl			TopTalent grant from the Netherlands Organization for Scientific Research [021.002.099]	TopTalent grant from the Netherlands Organization for Scientific Research	This work was supported by a TopTalent grant (Femke J. Gazendam, # 021.002.099) from the Netherlands Organization for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armfield JM, 2006, CLIN PSYCHOL REV, V26, P746, DOI 10.1016/j.cpr.2006.03.007; Arntz A, 1997, BEHAV RES THER, V35, P591, DOI 10.1016/S0005-7967(97)00020-X; Barlow D. H., 2004, ANXIETY ITS DISORDER; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borkovec TD, 2004, GENERALIZED ANXIETY DISORDER: ADVANCES IN RESEARCH AND PRACTICE, P77; BORKOVEC TD, 1983, BEHAV RES THER, V21, P9, DOI 10.1016/0005-7967(83)90121-3; Bradley MM, 2006, PSYCHOPHYSIOLOGY, V43, P486, DOI 10.1111/j.1469-8986.2006.00412.x; BRADLEY MM, 1993, BEHAV NEUROSCI, V107, P970, DOI 10.1037/0735-7044.107.6.970; Brosschot JF, 2006, J PSYCHOSOM RES, V60, P113, DOI 10.1016/j.jpsychores.2005.06.074; BUSH LK, 1993, PSYCHOL BULL, V113, P566, DOI 10.1037/0033-2909.113.3.566; Calmes CA, 2007, COGNITIVE THER RES, V31, P343, DOI 10.1007/s10608-006-9026-9; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davey GCL, 1997, BEHAV BRAIN SCI, V20, P363, DOI 10.1017/S0140525X97231468; Davis M, 2006, AM PSYCHOL, V61, P741, DOI 10.1037/0003-066X.61.8.741; DEJONG PJ, 1994, ADV BEHAV RES THER, V16, P131, DOI 10.1016/0146-6402(93)E0001-S; Dudai Y, 2000, BRAIN, PERCEPTION, MEMORY, P149; Dunsmoor JE, 2009, LEARN MEMORY, V16, P460, DOI 10.1101/lm.1431609; Effting M, 2007, BEHAV RES THER, V45, P2002, DOI 10.1016/j.brat.2007.02.011; Ehring T, 2008, INT J COGN THER, V1, P192, DOI 10.1680/ijct.2008.1.3.192; Ehring T, 2009, BEHAV RES THER, V47, P285, DOI 10.1016/j.brat.2008.12.011; Hamm AO, 2005, INT J PSYCHOPHYSIOL, V57, P5, DOI 10.1016/j.ijpsycho.2005.01.006; Harvey A.G., 2004, COGNITIVE BEHAV PROC; Hermans D, 2005, BEHAV RES THER, V43, P533, DOI 10.1016/j.brat.2004.03.013; Hertel PT, 1998, J ABNORM PSYCHOL, V107, P166, DOI 10.1037/0021-843X.107.1.166; Hupbach A, 2007, LEARN MEMORY, V14, P47, DOI 10.1101/lm.365707; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Laxmi TR, 2003, BEHAV BRAIN RES, V145, P89, DOI 10.1016/S0166-4328(03)00101-3; Lissek S, 2009, BEHAV RES THER, V47, P111, DOI 10.1016/j.brat.2008.10.017; Llera SJ, 2010, EMOTION, V10, P640, DOI 10.1037/a0019351; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milad MR, 2005, PSYCHOPHYSIOLOGY, V42, P456, DOI 10.1111/j.1469-8986.2005.00302.x; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Newman MG, 2011, CLIN PSYCHOL REV, V31, P371, DOI 10.1016/j.cpr.2011.01.008; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Olatunji BO, APPL PREVEN IN PRESS; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; Peasley-Miklus C, 2000, BEHAV RES THER, V38, P129, DOI 10.1016/S0005-7967(99)00025-X; Pineles SL, 2009, PSYCHOPHYSIOLOGY, V46, P984, DOI 10.1111/j.1469-8986.2009.00852.x; Soeter M, 2011, NEUROBIOL LEARN MEM, V96, P263, DOI 10.1016/j.nlm.2011.05.003; Soeter M, 2011, LEARN MEMORY, V18, P357, DOI 10.1101/lm.2148511; Soeter M, 2010, NEUROBIOL LEARN MEM, V94, P30, DOI 10.1016/j.nlm.2010.03.004; Stapinski LA, 2010, BEHAV RES THER, V48, P1032, DOI 10.1016/j.brat.2010.07.005; Stober J, 1998, BEHAV RES THER, V36, P751, DOI 10.1016/S0005-7967(98)00027-8; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Van der Ploeg HM, 1980, ZBV DUTCH LANGUAGE A; Vrana S.R., 1989, COGNITION EMOTION, V3, P179, DOI [10.1080/02699938908415240, DOI 10.1080/02699938908415240]; VRANA SR, 1986, PSYCHOPHYSIOLOGY, V23, P247, DOI 10.1111/j.1469-8986.1986.tb00626.x; Watkins ER, 2008, PSYCHOL BULL, V134, P163, DOI 10.1037/0033-2909.134.2.163; Weike AI, 2007, PSYCHOPHYSIOLOGY, V44, P170, DOI 10.1111/j.1469-8986.2006.00469.x	49	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34882	10.1371/journal.pone.0034882	http://dx.doi.org/10.1371/journal.pone.0034882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UT	22514684	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600090
J	Ido, Y; Duranton, A; Lan, F; Cacicedo, JM; Chen, TC; Breton, L; Ruderman, NB				Ido, Yasuo; Duranton, Albert; Lan, Fan; Cacicedo, Jose M.; Chen, Tai C.; Breton, Lionel; Ruderman, Neil B.			Acute Activation of AMP-Activated Protein Kinase Prevents H2O2-Induced Premature Senescence in Primary Human Keratinocytes	PLOS ONE			English	Article							VEIN ENDOTHELIAL-CELLS; CULTURED HUMAN KERATINOCYTES; CELLULAR SENESCENCE; DEPENDENT PATHWAY; OXIDATIVE STRESS; PHOSPHORYLATION; HYPERGLYCEMIA; SIRT1; LKB1; LOCALIZATION	We investigated the effects of AMPK on H2O2-induced premature senescence in primary human keratinocytes. Incubation with 50 mu M H2O2 for 2 h resulted in premature senescence with characteristic increases in senescence-associated beta-galactosidase (SA-gal) staining 3 days later and no changes in AMPK or p38 MAPK activity. The increase in SA-gal staining was preceded by increases in both p53 phosphorylation (S15) (1 h) and transactivation (6 h) and the abundance of the cyclin inhibitor p21(CIP1) (16 h). Incubation with AICAR or resveratrol, both of which activated AMPK, prevented the H2O2-induced increases in both SA-Gal staining and p21 abundance. In addition, AICAR diminished the increase in p53 transactivation. The decreases in SA-Gal expression induced by resveratrol and AICAR were prevented by the pharmacological AMPK inhibitor Compound C, expression of a DN-AMPK or AMPK knock-down with shRNA. Likewise, both knockdown of AMPK and expression of DN-AMPK were sufficient to induce senescence, even in the absence of exogenous H2O2. As reported by others, we found that AMPK activation by itself increased p53 phosphorylation at S15 in embryonic fibroblasts (MEF), whereas under the same conditions it decreased p53 phosphorylation in the keratinocytes, human aortic endothelial cells, and human HT1080 fibrosarcoma cells. In conclusion, the results indicate that H2O2 at low concentrations causes premature senescence in human keratinocytes by activating p53-p21(CIP1) signaling and that these effects can be prevented by acute AMPK activation and enhanced by AMPK downregulation. They also suggest that this action of AMPK may be cell or context-specific.	[Ido, Yasuo; Lan, Fan; Cacicedo, Jose M.; Chen, Tai C.; Ruderman, Neil B.] Boston Univ, Sch Med, Dept Med, Endocrinol Sect, Boston, MA 02118 USA; [Ido, Yasuo; Lan, Fan; Cacicedo, Jose M.; Chen, Tai C.; Ruderman, Neil B.] Boston Univ, Sch Med, Dept Med, Diabet Res Unit, Boston, MA 02118 USA; [Duranton, Albert; Breton, Lionel] LOREAL Rech, Ctr Charles Zviak, Clichy, France	Boston University; Boston University; L'Oreal Group	Ido, Y (corresponding author), Boston Univ, Sch Med, Dept Med, Endocrinol Sect, Boston, MA 02118 USA.	yido@bu.edu; nrude@bu.edu		Chen, Tai/0000-0002-5704-5694; Ido, Yasuo/0000-0002-3036-9971; Ruderman, Neil/0000-0002-6589-6587; /0000-0001-8417-9754; Duranton, Albert/0000-0002-4057-7176	NIH [T32DK07201, R0-1 DK019514 R01 DK067509, P01-067508]; L'Oreal; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK019514, T32DK007201, R01DK067509] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); L'Oreal(L'Oreal Group); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by Endocrine training grant T32DK07201 from the NIH (JC), NIH grants R0-1 DK019514 R01 DK067509 and P01-067508 (NR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The L'Oreal Company's role, through the employment of Albert Duranton and Lionel Breton, involved the analysis of the data.; Dr. Duranton and Breton secured support for our research from L'Oreal. They are employees of L'Oreal who helped to fund this study. Dr. Ruderman (NR) is a recipient of a research grant from L'Oreal, however the type of research and its conception and performance were totally the province of the Ruderman-Ido lab. No patentable substances were studied. This does not alter the authors' adherence to all the PLos ONE policies on sharing data and materials.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Amato S, 2011, SCIENCE, V332, P247, DOI 10.1126/science.1201678; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Bernard D, 2004, CANCER RES, V64, P472, DOI 10.1158/0008-5472.CAN-03-0005; Cacicedo JM, 2004, BIOCHEM BIOPH RES CO, V324, P1204, DOI 10.1016/j.bbrc.2004.09.177; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cao C, 2009, J CELL MOL MED, V13, P3632, DOI 10.1111/j.1582-4934.2008.00453.x; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; CHEN TC, 1995, J INVEST DERMATOL, V104, P113, DOI 10.1111/1523-1747.ep12613601; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Fu D, 2010, J CELL SCI, V123, P3294, DOI 10.1242/jcs.068098; Gauthier MS, 2011, BIOCHEM BIOPH RES CO, V404, P382, DOI 10.1016/j.bbrc.2010.11.127; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Hamid R, 2004, TOXICOL IN VITRO, V18, P703, DOI 10.1016/j.tiv.2004.03.012; Hattori Y, 2006, HYPERTENSION, V47, P1183, DOI 10.1161/01.HYP.0000221429.94591.72; Hayashi T, 2006, P NATL ACAD SCI USA, V103, P17018, DOI 10.1073/pnas.0607873103; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Huber M, 2000, J INVEST DERMATOL, V114, P661, DOI 10.1046/j.1523-1747.2000.00942.x; Ido Y, 2002, DIABETES, V51, P159, DOI 10.2337/diabetes.51.1.159; Ido Y, 2002, DIABETES, V51, pA396; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kuilman T, 2008, CELL, V133, P1019, DOI 10.1016/j.cell.2008.03.039; Kukidome D, 2006, DIABETES, V55, P120, DOI 10.2337/diabetes.55.01.06.db05-0943; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Maclaine NJ, 2009, AGING-US, V1, P490, DOI 10.18632/aging.100047; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Oakhill JS, 2009, ACTA PHYSIOL, V196, P3, DOI 10.1111/j.1748-1716.2009.01977.x; Pelle E, 2003, J INVEST DERMATOL, V121, P177, DOI 10.1046/j.1523-1747.2003.12330.x; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; Ruderman N, 2004, NAT REV DRUG DISCOV, V3, P340, DOI 10.1038/nrd1344; Saha AK, 2006, BIOCHEM BIOPH RES CO, V349, P519, DOI 10.1016/j.bbrc.2006.08.107; Shelton DN, 1999, CURR BIOL, V9, P939, DOI 10.1016/S0960-9822(99)80420-5; Sinclair DA, 2006, SCI AM, V294, P48, DOI 10.1038/scientificamerican0306-48; Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Sung JY, 2011, BIOCHEM BIOPH RES CO, V413, P143, DOI 10.1016/j.bbrc.2011.08.071; Wang WG, 2004, J BIOL CHEM, V279, P48376, DOI 10.1074/jbc.M409014200; Wang WG, 2003, J BIOL CHEM, V278, P27016, DOI 10.1074/jbc.M300318200; Xie ZL, 2008, DIABETES, V57, P3222, DOI 10.2337/db08-0610; Zhao MT, 2011, CELL METAB, V13, P119, DOI 10.1016/j.cmet.2011.01.009; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	48	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35092	10.1371/journal.pone.0035092	http://dx.doi.org/10.1371/journal.pone.0035092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514710	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600116
J	Kim, TD; Oh, S; Shin, S; Janknecht, R				Kim, Tae-Dong; Oh, Sangphil; Shin, Sook; Janknecht, Ralf			Regulation of Tumor Suppressor p53 and HCT116 Cell Physiology by Histone Demethylase JMJD2D/KDM4D	PLOS ONE			English	Article							TRANSCRIPTION FACTOR ER81; ETS PROTEIN ER81; ESTROGEN-RECEPTOR-ALPHA; P72 RNA HELICASE; LYSINE METHYLATION; SET9-MEDIATED METHYLATION; CONCERTED ACTIVATION; ANDROGEN RECEPTOR; UP-REGULATION; JMJD2 FAMILY	JMJD2D, also known as KDM4D, is a histone demethylase that removes methyl moieties from lysine 9 on histone 3 and from lysine 26 on histone 1.4. Here, we demonstrate that JMJD2D forms a complex with the p53 tumor suppressor in vivo and interacts with the DNA binding domain of p53 in vitro. A luciferase reporter plasmid driven by the promoter of p21, a cell cycle inhibitor and prominent target gene of p53, was synergistically activated by p53 and JMJD2D, which was dependent on JMJD2D catalytic activity. Likewise, overexpression of JMJD2D induced p21 expression in U2OS osteosarcoma cells in the absence and presence of adriamycin, an agent that induces DNA damage. Furthermore, downregulation of JMJD2D inhibited cell proliferation in wild-type and even more so in p53(-/-) HCT116 colon cancer cells, suggesting that JMJD2D is a pro-proliferative molecule. JMJD2D depletion also induced more strongly apoptosis in p53(-/-) compared to wild-type HCT116 cells. Collectively, our results demonstrate that JMJD2D can stimulate cell proliferation and survival, suggesting that its inhibition may be helpful in the fight against cancer. Furthermore, our data imply that activation of p53 may represent a mechanism by which the pro-oncogenic functions of JMJD2D become dampened.	[Kim, Tae-Dong; Oh, Sangphil; Shin, Sook; Janknecht, Ralf] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Kim, TD (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA.	ralf-janknecht@ouhsc.edu		Janknecht, Ralf/0000-0003-1741-1562	University of Oklahoma Health Sciences Center	University of Oklahoma Health Sciences Center	Financial support provided by University of Oklahoma Health Sciences Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosc DG, 2002, J CELL BIOCHEM, V86, P174, DOI 10.1002/jcb.10205; Bosc DG, 2001, ONCOGENE, V20, P6215, DOI 10.1038/sj.onc.1204820; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chi P, 2010, NAT REV CANCER, V10, P457, DOI 10.1038/nrc2876; Chuikov S, 2004, NATURE, V432, P353, DOI 10.1038/nature03117; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cloos PAC, 2006, NATURE, V442, P307, DOI 10.1038/nature04837; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; De Haro L, 2005, GENOMICS, V85, P493, DOI 10.1016/j.ygeno.2004.12.003; De Haro L, 2002, NUCLEIC ACIDS RES, V30, P2972; Dowdy SC, 2003, J BIOL CHEM, V278, P44377, DOI 10.1074/jbc.M307202200; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; Fodor BD, 2006, GENE DEV, V20, P1557, DOI 10.1101/gad.388206; Gaughan L, 2011, NUCLEIC ACIDS RES, V39, P1266, DOI 10.1093/nar/gkq861; Goel A, 2004, J BIOL CHEM, V279, P14909, DOI 10.1074/jbc.M400036200; Goel A, 2003, MOL CELL BIOL, V23, P6243, DOI 10.1128/MCB.23.17.6243-6254.2003; Goueli BS, 2003, ONCOGENE, V22, P8042, DOI 10.1038/sj.onc.1206847; Goueli BS, 2004, MOL CELL BIOL, V24, P25, DOI 10.1128/MCB.24.1.25-35.2004; Hamada S, 2009, BIOORG MED CHEM LETT, V19, P2852, DOI 10.1016/j.bmcl.2009.03.098; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Italiano A, 2006, CANCER GENET CYTOGEN, V167, P122, DOI 10.1016/j.cancergencyto.2006.01.004; Iwamori N, 2011, BIOL REPROD, V84, P1225, DOI 10.1095/biolreprod.110.088955; Janknecht R, 2003, ONCOGENE, V22, P746, DOI 10.1038/sj.onc.1206185; Janknecht R, 2001, J BIOL CHEM, V276, P41856, DOI 10.1074/jbc.M106630200; Katoh M, 2004, INT J ONCOL, V24, P1623; Kawazu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017830; Kim J, 2010, BIOCHEM BIOPH RES CO, V401, P412, DOI 10.1016/j.bbrc.2010.09.068; Kim TD, 2008, BIOCHEM BIOPH RES CO, V366, P563, DOI 10.1016/j.bbrc.2007.12.013; Kim TD, 2012, J CELL BIOCHEM, V113, P1368, DOI 10.1002/jcb.24009; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Knebel J, 2006, J CELL BIOCHEM, V99, P319, DOI 10.1002/jcb.20945; Kouskouti A, 2004, MOL CELL, V14, P175, DOI 10.1016/S1097-2765(04)00182-0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Li Y, 2008, J BIOL CHEM, V283, P26771, DOI 10.1074/jbc.M802800200; Liu G, 2009, ONCOGENE, V28, P4491, DOI 10.1038/onc.2009.297; Masatsugu T, 2009, BIOCHEM BIOPH RES CO, V381, P22, DOI 10.1016/j.bbrc.2009.01.185; Mooney SM, 2010, J BIOL CHEM, V285, P30443, DOI 10.1074/jbc.M110.143792; Mooney SM, 2010, BIOCHEMISTRY-US, V49, P1, DOI 10.1021/bi901263m; Northcott PA, 2009, NAT GENET, V41, P465, DOI 10.1038/ng.336; Papoutsopoulou S, 2000, MOL CELL BIOL, V20, P7300, DOI 10.1128/MCB.20.19.7300-7310.2000; Parseghian MH, 2000, CHROMOSOME RES, V8, P405, DOI 10.1023/A:1009262819961; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rivlin Noa, 2011, Genes Cancer, V2, P466, DOI 10.1177/1947601911408889; Rossow KL, 2003, ONCOGENE, V22, P151, DOI 10.1038/sj.onc.1206067; Rossow KL, 2001, CANCER RES, V61, P2690; Shi L, 2011, P NATL ACAD SCI USA, V108, P7541, DOI 10.1073/pnas.1017374108; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shin S, 2007, J CELL BIOCHEM, V101, P1252, DOI 10.1002/jcb.21250; Shin S, 2007, CANCER RES, V67, P7572, DOI 10.1158/0008-5472.CAN-06-4652; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Shin S, 2007, BIOCHEM BIOPH RES CO, V353, P973, DOI 10.1016/j.bbrc.2006.12.147; Shin S, 2009, CANCER RES, V69, P8102, DOI 10.1158/0008-5472.CAN-09-0941; Shin S, 2008, J CELL BIOCHEM, V105, P866, DOI 10.1002/jcb.21884; Smith EH, 2007, HUM MOL GENET, V16, P3136, DOI 10.1093/hmg/ddm275; Spannhoff A, 2009, CHEMMEDCHEM, V4, P1568, DOI 10.1002/cmdc.200900301; Subramanian K, 2008, MOL CELL, V30, P336, DOI 10.1016/j.molcel.2008.03.022; Trojer P, 2009, J BIOL CHEM, V284, P8395, DOI 10.1074/jbc.M807818200; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Weiss T, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-7; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wu JM, 2002, J BIOL CHEM, V277, P42669, DOI 10.1074/jbc.M205501200; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413; Yang XD, 2009, EMBO J, V28, P1055, DOI 10.1038/emboj.2009.55; Yang ZQ, 2000, CANCER RES, V60, P4735; Yap KL, 2010, CRIT REV BIOCHEM MOL, V45, P488, DOI 10.3109/10409238.2010.512001	69	51	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34618	10.1371/journal.pone.0034618	http://dx.doi.org/10.1371/journal.pone.0034618			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514644	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341600050
J	Krystal, AD; Sutherland, J; Hochman, DW				Krystal, Andrew D.; Sutherland, Janice; Hochman, Daryl W.			Loop Diuretics Have Anxiolytic Effects in Rat Models of Conditioned Anxiety	PLOS ONE			English	Article							POTENTIATED STARTLE RESPONSE; ELEVATED PLUS-MAZE; K-CL COTRANSPORTER; CONTEXTUAL FEAR; FUROSEMIDE; DISORDERS; PREVALENCE; TRANSPORT; BLOCKADE; KINETICS	A number of antiepileptic medications that modulate GABA(A) mediated synaptic transmission are anxiolytic. The loop diuretics furosemide (Lasix) and bumetanide (Bumex) are thought to have antiepileptic properties. These drugs also modulate GABA(A) mediated signalling through their antagonism of cation-chloride cotransporters. Given that loop diuretics may act as antiepileptic drugs that modulate GABAergic signalling, we sought to investigate whether they also mediate anxiolytic effects. Here we report the first investigation of the anxiolytic effects of these drugs in rat models of anxiety. Furosemide and bumetanide were tested in adult rats for their anxiolytic effects using four standard anxiety models: 1) contextual fear conditioning; 2) fear-potentiated startle; 3) elevated plus maze, and 4) open-field test. Furosemide and bumetanide significantly reduced conditioned anxiety in the contextual fear-conditioning and fear-potentiated startle models. At the tested doses, neither compound had significant anxiolytic effects on unconditioned anxiety in the elevated plus maze and open-field test models. These observations suggest that loop diuretics elicit significant anxiolytic effects in rat models of conditioned anxiety. Since loop diuretics are antagonists of the NKCC1 and KCC2 cotransporters, these results implicate the cation-chloride cotransport system as possible molecular mechanism involved in anxiety, and as novel pharmacological target for the development of anxiolytics. In view of these findings, and since furosemide and bumetanide are safe and well tolerated drugs, the clinical potential of loop diuretics for treating some types of anxiety disorders deserves further investigation.	[Krystal, Andrew D.] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27705 USA; [Sutherland, Janice] Univ Lethbridge, Dept Neurosci, Lethbridge, AB T1K 3M4, Canada; [Sutherland, Janice] NeuroInvestigations Inc, Lethbridge, AB, Canada; [Hochman, Daryl W.] Duke Univ, Med Ctr, Dept Surg Surg Sci, Durham, NC USA; [Hochman, Daryl W.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC USA	Duke University; University of Lethbridge; Duke University; Duke University	Krystal, AD (corresponding author), Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC 27705 USA.	dhochman@duke.edu	Krystal, Andrew D/J-7109-2013	Krystal, Andrew D/0000-0002-6702-781X	Cytoscan LLC., Seattle, WA, USA	Cytoscan LLC., Seattle, WA, USA	This research was funded by a gift to DWH from Cytoscan LLC., Seattle, WA, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD S, 1976, BRIT J CLIN PHARMACO, V3, P621, DOI 10.1111/j.1365-2125.1976.tb04885.x; ANDREASEN F, 1991, COMP BIOCHEM PHYS C, V100, P635, DOI 10.1016/0742-8413(91)90053-V; Association AP DSM-IV APA on, 2000, DIAGN STAT MAN MENT; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; BRATER DC, 1983, CLIN PHARMACOL THER, V34, P207, DOI 10.1038/clpt.1983.154; BRATER DC, 1992, EUR HEART J, V13, P10, DOI 10.1093/eurheartj/13.suppl_G.10; Calabrese EJ, 2008, CRIT REV TOXICOL, V38, P489, DOI 10.1080/10408440802014238; Chen H, 2005, NEUROL RES, V27, P280, DOI 10.1179/016164105X25243; Clark BJ, 2005, BEHAV BRAIN RES, V163, P91, DOI 10.1016/j.bbr.2005.04.007; Davis M, 2001, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0811as14; Deisz RA, 2011, J PHYSIOL-LONDON, V589, P1317, DOI 10.1113/jphysiol.2010.201830; Denys Damiaan, 2005, Curr Psychiatry Rep, V7, P252, DOI 10.1007/s11920-005-0078-4; Dzhala VI, 2005, NAT MED, V11, P1205, DOI 10.1038/nm1301; EVANS MG, 1986, PFLUG ARCH EUR J PHY, V406, P65, DOI 10.1007/BF00582955; Farrant M, 2007, PROG BRAIN RES, V160, P59, DOI 10.1016/S0079-6123(06)60005-8; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Haglund MM, 2005, J NEUROPHYSIOL, V94, P907, DOI 10.1152/jn.00944.2004; Hesdorffer DC, 2001, ANN NEUROL, V50, P458, DOI 10.1002/ana.1136; Hicks D, 2010, MED CLIN N AM, V94, P1127, DOI 10.1016/j.mcna.2010.08.008; HIJZEN TH, 1995, PSYCHOPHARMACOLOGY, V118, P150, DOI 10.1007/BF02245833; Hirschfeld RMA, 2003, J CLIN PSYCHIAT, V64, P20; HOCHMAN DW, 1995, SCIENCE, V270, P99, DOI 10.1126/science.270.5233.99; Hochman DW, 2000, J NEUROPHYSIOL, V83, P406, DOI 10.1152/jn.2000.83.1.406; Hogg S, 1996, PHARMACOL BIOCHEM BE, V54, P21, DOI 10.1016/0091-3057(95)02126-4; Jayakumar AR, 2010, METAB BRAIN DIS, V25, P31, DOI 10.1007/s11011-010-9180-3; JENNINGS ML, 1985, ANNU REV PHYSIOL, V47, P519; Joordens RJE, 1996, PSYCHOPHARMACOLOGY, V126, P104, DOI 10.1007/BF02246344; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Khirug S, 2008, J NEUROSCI, V28, P4635, DOI 10.1523/JNEUROSCI.0908-08.2008; Lehmann H, 2010, NEUROSCIENCE, V167, P974, DOI 10.1016/j.neuroscience.2010.03.005; Lehmann H, 2007, EUR J NEUROSCI, V25, P1278, DOI 10.1111/j.1460-9568.2007.05374.x; Lepine JP, 2002, J CLIN PSYCHIAT, V63, P4; Lydiard RB, 2003, J CLIN PSYCHIAT, V64, P21; MacVicar BA, 2002, GLIA, V37, P114, DOI 10.1002/glia.10023; Montezinho LP, 2010, PSYCHOPHARMACOLOGY, V212, P131, DOI 10.1007/s00213-010-1917-5; Muhammad A, 2011, DEV NEUROSCI-BASEL, V33, P85, DOI 10.1159/000324744; Pain L, 2002, BRIT J ANAESTH, V89, P614, DOI 10.1093/bja/aef228; Pinheiro SH, 2007, AN ACAD BRAS CIENC, V79, P71, DOI 10.1590/S0001-37652007000100010; Prut L, 2003, EUR J PHARMACOL, V463, P3, DOI 10.1016/S0014-2999(03)01272-X; Resstel LBM, 2006, BEHAV BRAIN RES, V172, P294, DOI 10.1016/j.bbr.2006.05.016; Rudolph U, 2011, NAT REV DRUG DISCOV, V10, P685, DOI 10.1038/nrd3502; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Santos JM, 2006, EUR J PHARMACOL, V542, P121, DOI 10.1016/j.ejphar.2006.06.019; SCHWARTZ MA, 1981, J CLIN PHARMACOL, V21, P555, DOI 10.1002/j.1552-4604.1981.tb05664.x; Schwartzkroin PA, 1998, EPILEPSY RES, V32, P275, DOI 10.1016/S0920-1211(98)00058-8; Stein DJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002795.pub2; Stewart J, 1984, TESTED STUDIES LAB T, P13; Szabadics J, 2006, SCIENCE, V311, P233, DOI 10.1126/science.1121325; THOMPSON SM, 1994, PROG NEUROBIOL, V42, P575, DOI 10.1016/0301-0082(94)90044-2; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wargo KA, 2009, ANN PHARMACOTHER, V43, P1836, DOI 10.1345/aph.1M177	52	20	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35417	10.1371/journal.pone.0035417	http://dx.doi.org/10.1371/journal.pone.0035417			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514741	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600146
J	Zhao, XS; Malhotra, GK; Band, H; Band, V				Zhao, Xiangshan; Malhotra, Gautam K.; Band, Hamid; Band, Vimla			Derivation of Myoepithelial Progenitor Cells from Bipotent Mammary Stem/Progenitor Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN BREAST-TUMORS; STEM-CELLS; CANCER; PROGRESSION; METASTASIS; CARCINOMAS; CULTURES; SUBTYPES; GROWTH	There is increasing evidence that breast and other cancers originate from and are maintained by a small fraction of stem/progenitor cells with self-renewal properties. Recent molecular profiling has identified six major subtypes of breast cancer: basal-like, ErbB2-overexpressing, normal breast epithelial-like, luminal A and B, and claudin-low subtypes. To help understand the relationship among mammary stem/progenitor cells and breast cancer subtypes, we have recently derived distinct hTERT-immortalized human mammary stem/progenitor cell lines: a K5(+)/K19(-) type, and a K5(+)/K19(+) type. Under specific culture conditions, bipotent K5(+)/K19(-) stem/progenitor cells differentiated into stable clonal populations that were K5(-)/K19(-) and exhibit self-renewal and unipotent myoepithelial differentiation potential in contrast to the parental K5(+)/K19(-) cells which are bipotent. These K5(-)/K19(-) cells function as myoepithelial progenitor cells and constitutively express markers of an epithelial to mesenchymal transition (EMT) and show high invasive and migratory abilities. In addition, these cells express a microarray signature of claudin-low breast cancers. The EMT characteristics of an un-transformed unipotent mammary myoepithelial progenitor cells together with claudin-low signature suggests that the claudin-low breast cancer subtype may arise from myoepithelial lineage committed progenitors. Availability of immortal MPCs should allow a more definitive analysis of their potential to give rise to claudin-low breast cancer subtype and facilitate biological and molecular/biochemical studies of this disease.	[Zhao, Xiangshan; Malhotra, Gautam K.; Band, Hamid; Band, Vimla] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA; [Band, Hamid] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Band, Hamid] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA; [Band, Hamid] Univ Nebraska Med Ctr, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Band, Hamid; Band, Vimla] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Zhao, XS (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE USA.	vband@unmc.edu	Band, Hamid/AAF-4701-2020; Malhotra, Gautam/GYI-8625-2022	Malhotra, Gautam/0000-0003-4563-0172	NIH [CA96844, CA144027, CA87986, CA99163, CA105489, CA116552]; NCI [5U01CA151806-02]; Department of Defense [W81XWH-07-1-0351, W81XWH-11-1-0171]; UNMC graduate student fellowship; NATIONAL CANCER INSTITUTE [R01CA099163, R01CA116552, U01CA151806, R01CA105489, R01CA096844, R01CA144027, R01CA087986] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); UNMC graduate student fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work in the laboratories was supported by NIH grants CA96844 and CA144027 to VB and CA87986, CA99163, CA105489, CA116552 and NCI 5U01CA151806-02 to HB and Department of Defense grants W81XWH-07-1-0351 and W81XWH-11-1-0171 to VB; and the NCI Core Support Grant to UNMC-Eppley Cancer Center. Gautam Malhotra was supported by a UNMC graduate student fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriance MC, 2005, BREAST CANCER RES, V7, P190, DOI 10.1186/bcr1286; BAND V, 1990, P NATL ACAD SCI USA, V87, P463, DOI 10.1073/pnas.87.1.463; BAND V, 1989, P NATL ACAD SCI USA, V86, P1249, DOI 10.1073/pnas.86.4.1249; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; DEUGNIER MA, 1995, DEV DYNAM, V204, P107, DOI 10.1002/aja.1002040202; Dick JE, 2003, P NATL ACAD SCI USA, V100, P3547, DOI 10.1073/pnas.0830967100; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Herschkowitz JI, 2011, P NATL ACAD SCI US; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Hungermann D, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-92; Keller P. J., 2011, P NATL ACAD SCI US; Malhotra GK, 2010, CANCER BIOL THER, V10, P955, DOI 10.4161/cbt.10.10.13879; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Pandey PR, 2010, FRONT BIOSCI-LANDMRK, V15, P226, DOI 10.2741/3617; Pasic L, 2011, GENE DEV, V25, P1641, DOI 10.1101/gad.2025611; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PETERSEN OW, 1989, IN VITRO CELL DEV B, V25, P259, DOI 10.1007/BF02628464; Polyak K, 2009, BREAST CANCER RES, V11, pS8, DOI 10.1186/bcr2279; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Sarrio D, 2012, STEM CELLS, V30, P292, DOI 10.1002/stem.791; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spaderna S, 2008, CANCER RES, V68, P537, DOI 10.1158/0008-5472.CAN-07-5682; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; THORNER PS, 1986, CANCER, V57, P745, DOI 10.1002/1097-0142(19860215)57:4<745::AID-CNCR2820570411>3.0.CO;2-8; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Zhao X, 2012, J CARCINOGE IN PRESS; Zhao XS, 2010, P NATL ACAD SCI USA, V107, P14146, DOI 10.1073/pnas.1009030107	33	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35338	10.1371/journal.pone.0035338	http://dx.doi.org/10.1371/journal.pone.0035338			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514728	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600133
J	Ziello, C; Sparks, TH; Estrella, N; Belmonte, J; Bergmann, KC; Bucher, E; Brighetti, MA; Damialis, A; Detandt, M; Galan, C; Gehrig, R; Grewling, L; Bustillo, AMG; Hallsdottir, M; Kockhans-Bieda, MC; De Linares, C; Myszkowska, D; Paldy, A; Sanchez, A; Smith, M; Thibaudon, M; Travaglini, A; Uruska, A; Valencia-Barrera, RM; Vokou, D; Wachter, R; de Weger, LA; Menzel, A				Ziello, Chiara; Sparks, Tim H.; Estrella, Nicole; Belmonte, Jordina; Bergmann, Karl C.; Bucher, Edith; Brighetti, Maria Antonia; Damialis, Athanasios; Detandt, Monique; Galan, Carmen; Gehrig, Regula; Grewling, Lukasz; Gutierrez Bustillo, Adela M.; Hallsdottir, Margret; Kockhans-Bieda, Marie-Claire; De Linares, Concepcion; Myszkowska, Dorota; Paldy, Anna; Sanchez, Adriana; Smith, Matthew; Thibaudon, Michel; Travaglini, Alessandro; Uruska, Agnieszka; Valencia-Barrera, Rosa M.; Vokou, Despoina; Wachter, Reinhard; de Weger, Letty A.; Menzel, Annette			Changes to Airborne Pollen Counts across Europe	PLOS ONE			English	Article							AMBROSIA-ARTEMISIIFOLIA L.; CLIMATE-CHANGE; ALLERGENIC POLLEN; ATMOSPHERIC CO2; COMMON RAGWEED; PUBLIC-HEALTH; AEROALLERGENS; URBANIZATION; IMPACTS; SEASONS	A progressive global increase in the burden of allergic diseases has affected the industrialized world over the last half century and has been reported in the literature. The clinical evidence reveals a general increase in both incidence and prevalence of respiratory diseases, such as allergic rhinitis (common hay fever) and asthma. Such phenomena may be related not only to air pollution and changes in lifestyle, but also to an actual increase in airborne quantities of allergenic pollen. Experimental enhancements of carbon dioxide (CO2) have demonstrated changes in pollen amount and allergenicity, but this has rarely been shown in the wider environment. The present analysis of a continental-scale pollen data set reveals an increasing trend in the yearly amount of airborne pollen for many taxa in Europe, which is more pronounced in urban than semi-rural/rural areas. Climate change may contribute to these changes, however increased temperatures do not appear to be a major influencing factor. Instead, we suggest the anthropogenic rise of atmospheric CO2 levels may be influential.	[Ziello, Chiara; Sparks, Tim H.; Estrella, Nicole; Sanchez, Adriana; Menzel, Annette] Tech Univ Munich, Chair Ecoclimatol, Freising Weihenstephan, Germany; [Sparks, Tim H.; Estrella, Nicole; Menzel, Annette] Tech Univ Munich, Inst Adv Study, D-8046 Garching, Germany; [Sparks, Tim H.] Poznan Univ Life Sci, Inst Zool, Poznan, Poland; [Belmonte, Jordina; De Linares, Concepcion] Univ Autonoma Barcelona, Bot Unit, Bellaterra, Spain; [Belmonte, Jordina; De Linares, Concepcion] Univ Autonoma Barcelona, Inst Environm Sci & Technol ICTA, Bellaterra, Spain; [Bergmann, Karl C.] Charite, Allergie Ctr Charite, D-13353 Berlin, Germany; [Bucher, Edith] Agenzia Prov Ambiente, Biol Lab, Laives, BZ, Italy; [Brighetti, Maria Antonia; Travaglini, Alessandro] Univ Roma Tor Vergata, Dipartimento Biol, I-00173 Rome, Italy; [Damialis, Athanasios; Vokou, Despoina] Aristotle Univ Thessaloniki, Sch Biol, Dept Ecol, GR-54006 Thessaloniki, Greece; [Detandt, Monique] Sci Inst Publ Hlth, Sect Mycol & Aerobiol, Brussels, Belgium; [Galan, Carmen] Univ Cordoba, Dept Bot Ecol & Plant Physiol, Cordoba, Spain; [Gehrig, Regula] Fed Off Meteorol & Climatol MeteoSwiss, Zurich, Switzerland; [Grewling, Lukasz] Adam Mickiewicz Univ, Lab Aeropalynol, Poznan, Poland; [Gutierrez Bustillo, Adela M.] Univ Complutense Madrid, Dept Plant Biol 2, Madrid, Spain; [Hallsdottir, Margret] Iceland Inst Nat Hist, Gardabaer, Iceland; [Kockhans-Bieda, Marie-Claire] Ctr Hosp Luxembourg, Stn Aerobiol, Luxembourg, Luxembourg; [Myszkowska, Dorota] Jagiellonian Univ, Coll Med, Dept Clin & Environm Allergol, Krakow, Poland; [Paldy, Anna] Natl Inst Environm Hlth, Dept Biol, Budapest, Hungary; [Smith, Matthew] Univ Worcester, Natl Pollen & Aerobiol Res Unit, Worcester, England; [Thibaudon, Michel] Reseau Natl Surveillance Aerobiol, Brussieu, France; [Uruska, Agnieszka] Univ Gdansk, Lab Palaeoecol & Archaeobot, PL-80952 Gdansk, Poland; [Valencia-Barrera, Rosa M.] Univ Leon, Dept Biodivers & Environm Management, E-24071 Leon, Spain; [Wachter, Reinhard] Polleninformat Dienst Deutschland PID, Ganderkesee, Germany; [de Weger, Letty A.] Leiden Univ, Med Ctr, Dept Pulmonol, Leiden, Netherlands	Technical University of Munich; Technical University of Munich; Poznan University of Life Sciences; Autonomous University of Barcelona; Autonomous University of Barcelona; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Rome Tor Vergata; Aristotle University of Thessaloniki; Universidad de Cordoba; Federal Office of Meteorology & Climatology (MeteoSwiss); Adam Mickiewicz University; Complutense University of Madrid; Luxembourg Hospital Center; Jagiellonian University; Collegium Medicum Jagiellonian University; University of Worcester; Fahrenheit Universities; University of Gdansk; Universidad de Leon; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ziello, C (corresponding author), Tech Univ Munich, Chair Ecoclimatol, Freising Weihenstephan, Germany.	ziello@wzw.tum.de	Belmonte, Jordina/AAD-9687-2020; de Weger, Letty/GLN-7644-2022; Galan, Carmen Mrs/M-1377-2015; Bergmann, Karl-Christian/AAA-4104-2019; Valencia-Barrera, Rosa María/M-4282-2018; Damialis, Athanasios/P-9072-2018; De Linares, Concepcion/F-9313-2016; Vokou, Despoina/N-5988-2015; Gutiérrez-Bustillo, Adela Montserrat/L-7250-2014; Damialis, Athanasios/C-6109-2013; Smith, Matt R/C-3911-2014; Menzel, Annette/B-1105-2013	Belmonte, Jordina/0000-0002-6419-9595; Galan, Carmen Mrs/0000-0002-6849-1219; Valencia-Barrera, Rosa María/0000-0002-6014-9961; Damialis, Athanasios/0000-0003-2917-5667; De Linares, Concepcion/0000-0002-2047-3337; Vokou, Despoina/0000-0002-9734-6707; Gutiérrez-Bustillo, Adela Montserrat/0000-0002-6782-0527; Damialis, Athanasios/0000-0001-6400-384X; Smith, Matt R/0000-0002-4170-2960; Menzel, Annette/0000-0002-7175-2512; Estrella, Nicole/0000-0002-1028-0048; Myszkowska, Dorota/0000-0002-1493-3990; Sparks, Tim/0000-0003-4382-7051; Bergmann, Karl-Christian/0000-0002-0306-9922	Technische Universitat Munchen - Institute for AdvancedStudy; German Excellence Initiative; Bavarian State Ministry of the Environment and Public Health [U119]	Technische Universitat Munchen - Institute for AdvancedStudy; German Excellence Initiative; Bavarian State Ministry of the Environment and Public Health	This study is supported by the Technische Universitat Munchen - Institute for AdvancedStudy, funded by the German Excellence Initiative. The Ph.D. project of the first author is supported by Grant U119 from Bavarian State Ministry of the Environment and Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Bartra J, 2007, J INVEST ALLERG CLIN, V17, P3; Beggs PJ, 2005, ENVIRON HEALTH PERSP, V113, P915, DOI 10.1289/ehp.7724; Beggs PJ, 2004, CLIN EXP ALLERGY, V34, P1507, DOI 10.1111/j.1365-2222.2004.02061.x; Chuine I, 1999, PLANT CELL ENVIRON, V22, P1, DOI 10.1046/j.1365-3040.1999.00395.x; Clot Bernard, 2003, Aerobiologia, V19, P227, DOI 10.1023/B:AERO.0000006572.53105.17; D'Amato G, 2008, CLIN EXP ALLERGY, V38, P1264, DOI 10.1111/j.1365-2222.2008.03033.x; D'Amato G, 2007, ALLERGY, V62, P976, DOI 10.1111/j.1398-9995.2007.01393.x; Dahl uO., 1996, AEROBIOLOGIA, V12, P97, DOI [10.1007/BF02446601, DOI 10.1007/BF02446601]; Damialis A, 2007, ATMOS ENVIRON, V41, P7011, DOI 10.1016/j.atmosenv.2007.05.009; Darbah JNT, 2008, ENVIRON POLLUT, V155, P446, DOI 10.1016/j.envpol.2008.01.033; Emberlin J, 2002, INT J BIOMETEOROL, V46, P159, DOI 10.1007/s00484-002-0139-x; EMBERLIN J, 1994, ALLERGY, V49, P15, DOI 10.1111/j.1398-9995.1994.tb04233.x; Emberlin J, 2007, INT J BIOMETEOROL, V51, P181, DOI 10.1007/s00484-006-0059-2; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Garcia-Mozo H, 2010, AEROBIOLOGIA, V26, P157, DOI 10.1007/s10453-009-9153-3; Gregg JW, 2003, NATURE, V424, P183, DOI 10.1038/nature01728; Haylock MR, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010201; Huynen M, 2003, WHO M; Jato V, 2006, AEROBIOLOGIA, V22, P13, DOI 10.1007/s10453-005-9011-x; Luedeling E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020155; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Parry M. L., 2007, CLIMATE CHANGE 2007; Reid CE, 2009, ECOHEALTH, V6, P458, DOI 10.1007/s10393-009-0261-x; Rogers CA, 2006, ENVIRON HEALTH PERSP, V114, P865, DOI 10.1289/ehp.8549; Rosenzweig C, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P79; Singer BD, 2005, FUNCT PLANT BIOL, V32, P667, DOI 10.1071/FP05039; Smith M, 2009, AEROBIOLOGIA, V25, P321, DOI 10.1007/s10453-009-9136-4; Spieksma F. Th. M., 2003, Aerobiologia, V19, P171, DOI 10.1023/B:AERO.0000006528.37447.15; Wayne P, 2002, ANN ALLERG ASTHMA IM, V88, P279, DOI 10.1016/S1081-1206(10)62009-1; Ziska LH, 2008, MITIG ADAPT STRAT GL, V13, P607, DOI 10.1007/s11027-007-9134-1; Ziska LH, 2009, ENVIRON HEALTH PERSP, V117, P155, DOI 10.1289/ehp.11501; Ziska LH, 2003, J ALLERGY CLIN IMMUN, V111, P290, DOI 10.1067/mai.2003.53; [No title captured]	34	222	229	3	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34076	10.1371/journal.pone.0034076	http://dx.doi.org/10.1371/journal.pone.0034076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514618	Green Published, gold			2022-12-27	WOS:000305341600023
J	Klerman, H; St Hilaire, MA; Kronauer, RE; Gooley, JJ; Gronfier, C; Hull, JT; Lockley, SW; Santhi, N; Wang, W; Klerman, EB				Klerman, Hadassa; St Hilaire, Melissa A.; Kronauer, Richard E.; Gooley, Joshua J.; Gronfier, Claude; Hull, Joseph T.; Lockley, Steven W.; Santhi, Nayantara; Wang, Wei; Klerman, Elizabeth B.			Analysis Method and Experimental Conditions Affect Computed Circadian Phase from Melatonin Data	PLOS ONE			English	Article							MATHEMATICAL-MODEL; PLASMA MELATONIN; LIGHT EXPOSURE; BRIGHT LIGHT; PACEMAKER; RHYTHMS; HUMANS; SLEEP; TEMPERATURE; SUPPRESSION	Accurate determination of circadian phase is necessary for research and clinical purposes because of the influence of the master circadian pacemaker on multiple physiologic functions. Melatonin is presently the most accurate marker of the activity of the human circadian pacemaker. Current methods of analyzing the plasma melatonin rhythm can be grouped into three categories: curve-fitting, threshold-based and physiologically-based linear differential equations. To determine which method provides the most accurate assessment of circadian phase, we compared the ability to fit the data and the variability of phase estimates for seventeen different markers of melatonin phase derived from these methodological categories. We used data from three experimental conditions under which circadian rhythms - and therefore calculated melatonin phase - were expected to remain constant or progress uniformly. Melatonin profiles from older subjects and subjects with lower melatonin amplitude were less likely to be fit by all analysis methods. When circadian drift over multiple study days was algebraically removed, there were no significant differences between analysis methods of melatonin onsets (P = 0.57), but there were significant differences between those of melatonin offsets (P<0.0001). For a subset of phase assessment methods, we also examined the effects of data loss on variability of phase estimates by systematically removing data in 2-hour segments. Data loss near onset of melatonin secretion differentially affected phase estimates from the methods, with some methods incorrectly assigning phases too early while other methods assigning phases too late; missing data at other times did not affect analyses of the melatonin profile. We conclude that melatonin data set characteristics, including amplitude and completeness of data collection, differentially affect the results depending on the melatonin analysis method used.	[Klerman, Hadassa; St Hilaire, Melissa A.; Gooley, Joshua J.; Gronfier, Claude; Hull, Joseph T.; Lockley, Steven W.; Santhi, Nayantara; Wang, Wei; Klerman, Elizabeth B.] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA; [St Hilaire, Melissa A.; Kronauer, Richard E.; Gooley, Joshua J.; Gronfier, Claude; Hull, Joseph T.; Lockley, Steven W.; Santhi, Nayantara; Wang, Wei; Klerman, Elizabeth B.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA; [Kronauer, Richard E.] Harvard Univ, Grad Sch Arts & Sci, Cambridge, MA 02138 USA; [Gooley, Joshua J.] Natl Univ Singapore, Duke Univ, Sch Med, Singapore 117548, Singapore; [Gronfier, Claude] INSERM, U846, Stem Cell & Brain Res Inst, F-69008 Lyon, France	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; National University of Singapore; Institut National de la Sante et de la Recherche Medicale (Inserm)	Klerman, H (corresponding author), Brigham & Womens Hosp, Div Sleep Med, 75 Francis St, Boston, MA 02115 USA.	ebklerman@hms.harvard.edu	Gronfier, Claude/C-1243-2008	Gronfier, Claude/0000-0002-6549-799X; Lockley, Steven/0000-0001-5209-2881; Santhi, Nayantara/0000-0003-4568-1447	NIH [P01-AG-09975, K01-AG00661, K02-HD045459, K24-HL105663, T32-HL07901, R01-MH45130, R01-AG06072, R01-NS36590, R01-AT002129, R01-HL52992, R01-HL081761, M01-RR0263, R01 NS40982]; NASA [NAG9-524, NAG5-3952, NAGW-4033]; NSBRI through NASA [NCC9-58]; Wellcome Trust [060018/B/99/Z]; FP6-EUCLOCK; Vanda Pharmaceuticals; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K02HD045459] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT002129] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002635] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081761, T32HL007901, R01HL114088, K24HL105664, R00HL105663, R01HL052992, K99HL105663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036590, R01NS040982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG053952, P01AG009524, K01AG000661, Z01AG000661, R01AG006072, P01AG009975] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NASA(National Aeronautics & Space Administration (NASA)); NSBRI through NASA; Wellcome Trust(Wellcome TrustEuropean Commission); FP6-EUCLOCK; Vanda Pharmaceuticals; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	NIH P01-AG-09975, K01-AG00661 (EBK), K02-HD045459 (EBK), K24-HL105663 (EBK), T32-HL07901 (MSH), R01-MH45130, R01-AG06072, R01-NS36590, R01-AT002129, R01-HL52992, R01-HL081761, M01-RR0263, R01 NS40982. NASA NAG9-524, NAG5-3952 and NAGW-4033. NSBRI through NASA NCC9-58, Wellcome Trust 060018/B/99/Z (SWL), FP6-EUCLOCK (CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Potential conflicts of interest for EBK are Respironics (principal investigator, investigator-initiated project), Vanda Pharmaceuticals (principal investigator, investigator-initiated project; non-principal investigator on another project), Sepracor (non-principal investigator, investigator-initiated project), and Takeda Pharmaceuticals (principal investigator, investigator-initiated project). Potential conflicts of interest not directly related to the work for SWL are: American Family (consultant), Naturebright (consultant), Sound Oasis (consultant), Thomas Jefferson University (consultant), Wyle Integrated Science and Engineering (consultant), Armstrong Management Lawyers (expert testimony), Hicks Morley Hamilton Stewart Storie LLP (expert testimony), Proskauer Rose LLC (expert testimony), Rothstein Law Firm (expert testimony), Bionetics Corporation (unrestricted equipment gift), Philips Lighting (unrestricted equipment gift), ResMed Inc (unrestricted equipment gift), Optalert Pty (unrestricted gift), Swinburne University (unrestricted gift), Vanda Pharmaceuticals (service agreement and sponsored clinical trial), Alcon, Inc. (investigator-initiated research), Apollo Lighting (investigator-initiated research), Philips Lighting (investigator-initiated research), Philips-Respironics (investigator-initiated research), Elsevier (editing), Oxford University Press (advance and royalties). The following authors report no conflicts of interest: HK, MSH, REK, JJG, CG, JTH, WW. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Arendt J, 2005, J BIOL RHYTHM, V20, P291, DOI 10.1177/0748730405277492; Benloucif S, 2005, J BIOL RHYTHM, V20, P178, DOI 10.1177/0748730404273983; Benloucif S, 2008, J CLIN SLEEP MED, V4, P66; Brown EN, 1997, AM J PHYSIOL-ENDOC M, V272, pE506, DOI 10.1152/ajpendo.1997.272.3.E506; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; Czeisler CA, 2000, PRINCIPLES PRACTICE, P353; DEACON S, 1994, NEUROSCI LETT, V167, P191, DOI 10.1016/0304-3940(94)91059-6; Dijk DJ, 1999, J PHYSIOL-LONDON, V516, P611, DOI 10.1111/j.1469-7793.1999.0611v.x; Duffy JE, 2002, J BIOL RHYTHM, V17, P4, DOI 10.1177/074873002129002294; Duffy JF, 1996, J PHYSIOL-LONDON, V495, P289, DOI 10.1113/jphysiol.1996.sp021593; Duffy JF, 2011, P NAT ACAD SCI; Gooley JJ, 2011, J CLIN ENDOCR METAB, V96, pE463, DOI 10.1210/jc.2010-2098; Gooley JJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000741; Gronfier C, 2007, P NATL ACAD SCI USA, V104, P9081, DOI 10.1073/pnas.0702835104; Hull JT, PHOTIC NONPHOTIC EFF; Klerman EB, 2002, J BIOL RHYTHM, V17, P181, DOI 10.1177/074873002129002474; Klerman EB, 2002, J BIOL RHYTHM, V17, P548, DOI 10.1177/0748730402238237; Klerman EB, 2001, J INVEST MED, V49, P30, DOI 10.2310/6650.2001.34088; St Hilaire MA, 2007, J PINEAL RES, V43, P294, DOI 10.1111/j.1600-079X.2007.00477.x; van Someren EJW, 2007, SLEEP MED, V8, P590, DOI 10.1016/j.sleep.2007.03.012; Voultsios A, 1997, J BIOL RHYTHM, V12, P457, DOI 10.1177/074873049701200507; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034; Zeitzer JM, 2000, J CLIN ENDOCR METAB, V85, P2189, DOI 10.1210/jc.85.6.2189; Zeitzer JM, 2005, J SPINAL CORD MED, V28, P55, DOI 10.1080/10790268.2005.11753798	25	18	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e33836	10.1371/journal.pone.0033836	http://dx.doi.org/10.1371/journal.pone.0033836			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511928	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338600014
J	Mohan, M; Kaushal, D; Aye, PP; Alvarez, X; Veazey, RS; Lackner, AA				Mohan, Mahesh; Kaushal, Deepak; Aye, Pyone P.; Alvarez, Xavier; Veazey, Ronald S.; Lackner, Andrew A.			Focused Examination of the Intestinal lamina Propria Yields Greater Molecular Insight into Mechanisms Underlying SIV Induced Immune Dysfunction	PLOS ONE			English	Article							T-CELL DEPLETION; IMMUNODEFICIENCY-VIRUS-INFECTION; ARYL-HYDROCARBON RECEPTOR; TRANSCRIPTIONAL MEDIATOR; GASTROINTESTINAL-TRACT; SIGNALING PATHWAYS; VIRAL REPLICATION; CYCLE PROGRESSION; MUCOSAL REPAIR; HIV-INFECTION	Background: The Gastrointestinal (GI) tract is critical to AIDS pathogenesis as it is the primary site for viral transmission and a major site of viral replication and CD4(+) T cell destruction. Consequently GI disease, a major complication of HIV/SIV infection can facilitate translocation of lumenal bacterial products causing localized/systemic immune activation leading to AIDS progression. Methodology/Principal Findings: To better understand the molecular mechanisms underlying GI disease we analyzed global gene expression profiles sequentially in the intestine of the same animals prior to and at 21 and 90d post SIV infection (PI). More importantly we maximized information gathering by examining distinct mucosal components (intraepithelial lymphocytes, lamina propria leukocytes [LPL], epithelium and fibrovascular stroma) separately. The use of sequential intestinal resections combined with focused examination of distinct mucosal compartments represents novel approaches not previously attempted. Here we report data pertaining to the LPL. A significant increase (+/- 1.7-fold) in immune defense/inflammation, cell adhesion/migration, cell signaling, transcription and cell division/differentiation genes were observed at 21 and 90d PI. Genes associated with the JAK-STAT pathway (IL21, IL12R, STAT5A, IL10, SOCS1) and T-cell activation (NFATc1, CDK6, Gelsolin, Moesin) were notably upregulated at 21d PI. Markedly downregulated genes at 21d PI included IL17D/IL27 and IL28B/IFN gamma 3 (anti-HIV/viral), activation induced cytidine deaminase (B-cell function) and approximately 57 genes regulating oxidative phosphorylation, a critical metabolic shift associated with T-cell activation. The 90d transcriptome revealed further augmentation of inflammation (CXCL11, chitinase-1, JNK3), immune activation (CD38, semaphorin7A, CD109), B-cell dysfunction (CD70), intestinal microbial translocation (Lipopolysaccharide binding protein) and mitochondrial antiviral signaling (NLRX1) genes. Reduced expression of CD28, CD4, CD86, CD93, NFATc1 (T-cells), TLR8, IL8, CCL18, DECTIN1 (macrophages), HLA-DOA and GPR183 (B-cells) at 90d PI suggests further deterioration of overall immune function. Conclusions/Significance: The reported transcriptional signatures provide significant new details on the molecular pathology of HIV/SIV induced GI disease and provide new opportunity for future investigation.	[Mohan, Mahesh; Aye, Pyone P.; Alvarez, Xavier; Veazey, Ronald S.; Lackner, Andrew A.] Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA; [Kaushal, Deepak] Tulane Natl Primate Res Ctr, Div Bacteriol Parasitol, Covington, LA USA	Tulane University; Tulane University	Lackner, AA (corresponding author), Tulane Natl Primate Res Ctr, Div Comparat Pathol, Covington, LA USA.	alackner@tulane.edu			National Institutes of Health [DK083929, DK50550, RR00164, RR16930]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000164, G20RR016930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083929, R01DK050550] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by National Institutes of Health grants: DK083929, DK50550, RR00164, and RR16930. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari AA, 2010, J IMMUNOL; Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074; Bofill M, 1996, AIDS, V10, P827, DOI 10.1097/00002030-199607000-00005; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brown C, 2004, J BIOL CHEM, V279, P12794, DOI 10.1074/jbc.M308593200; Caetano MS, 2002, FASEB J, V16, P1940, DOI 10.1096/fj.02-0282fje; Cello JP, 2009, GASTROENTEROLOGY, V136, P1952, DOI 10.1053/j.gastro.2008.12.073; Choi KC, 2006, NAT IMMUNOL, V7, P1057, DOI 10.1038/ni1383; Chun TW, 2004, P NATL ACAD SCI USA, V101, P2464, DOI 10.1073/pnas.0307328101; Coquet JM, 2007, J IMMUNOL, V178, P2827, DOI 10.4049/jimmunol.178.5.2827; de Aquino SG, 2009, LIFE SCI, V84, P745, DOI 10.1016/j.lfs.2009.03.001; De Maria A, 2009, INT IMMUNOL, V21, P245, DOI 10.1093/intimm/dxn144; Dekker FJ, 2009, DRUG DISCOV TODAY, V14, P942, DOI 10.1016/j.drudis.2009.06.008; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dimitriou ID, 2008, IMMUNOL REV, V224, P265, DOI 10.1111/j.1600-065X.2008.00659.x; Doisne JM, 2004, J IMMUNOL, V173, P2410, DOI 10.4049/jimmunol.173.4.2410; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Drexler SK, 2010, INT J BIOCHEM CELL B, V42, P506, DOI 10.1016/j.biocel.2009.10.009; Eurich K, 2009, WORLD J GASTROENTERO, V15, P5249, DOI 10.3748/wjg.15.5249; Foley JF, 2005, J IMMUNOL, V174, P4892, DOI 10.4049/jimmunol.174.8.4892; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Geiben-Lynn R, 2003, J BIOL CHEM, V278, P1569, DOI 10.1074/jbc.M209964200; George MD, 2005, J VIROL, V79, P2709, DOI 10.1128/JVI.79.5.2709-2719.2005; George MD, 2003, VIROLOGY, V312, P84, DOI 10.1016/S0042-6822(03)00207-1; Giblin PA, 2006, CURR PHARM DESIGN, V12, P2771, DOI 10.2174/138161206777947731; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Grall FT, 2005, FEBS J, V272, P1676, DOI 10.1111/j.1742-4658.2005.04592.x; Grimaldi CM, 2002, J CLIN INVEST, V109, P1625, DOI 10.1172/JCI200214873; Guadalupe M, 2006, J VIROL, V80, P8236, DOI 10.1128/JVI.00120-06; Head JL, 2009, BIOCHEM PHARMACOL, V77, P642, DOI 10.1016/j.bcp.2008.10.031; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iannello A, 2008, VIRAL IMMUNOL, V21, P385, DOI 10.1089/vim.2008.0025; Imamichi T, 2008, AIDS, V22, P39, DOI 10.1097/QAD.0b013e3282f3356c; Izquierdo JM, 2007, J BIOL CHEM, V282, P1539, DOI 10.1074/jbc.C600198200; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Jones RG, 2007, IMMUNITY, V27, P173, DOI 10.1016/j.immuni.2007.07.008; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kewenig S, 1999, GASTROENTEROLOGY, V116, P1115, DOI 10.1016/S0016-5085(99)70014-4; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; LACKNER AA, 1994, AM J PATHOL, V145, P428; Lackner AA, 2009, GASTROENTEROLOGY, V136, P1966, DOI 10.1053/j.gastro.2008.12.071; Lee PT, 2000, AM J RESP CELL MOL, V23, P652, DOI 10.1165/ajrcmb.23.5.4016; Li QS, 2009, J IMMUNOL, V183, P1975, DOI 10.4049/jimmunol.0803222; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Marcus RS, 1998, J PHARMACOL EXP THER, V287, P1113; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McGowan I, 2004, JAIDS-J ACQ IMM DEF, V37, P1228, DOI 10.1097/01.qai.0000131846.12453.29; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mitsuyama K, 2006, CLIN EXP IMMUNOL, V143, P24, DOI 10.1111/j.1365-2249.2005.02959.x; Mohan M, 2008, AM J PATHOL, V173, P106, DOI 10.2353/ajpath.2008.080108; Mohan M, 2007, AM J PATHOL, V171, P1952, DOI 10.2353/ajpath.2007.070017; Monteleone G, 2009, TRENDS PHARMACOL SCI, V30, P441, DOI 10.1016/j.tips.2009.05.006; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Moriggl R, 1999, IMMUNITY, V10, P249, DOI 10.1016/S1074-7613(00)80025-4; Morrow MP, 2010, MOL THER, V18, P1714, DOI 10.1038/mt.2010.118; Mzali R, 2005, FASEB J, V19, P1911, DOI 10.1096/fj.05-4030fje; Nagase H, 2001, CLIN IMMUNOL, V100, P250, DOI 10.1006/clim.2001.5054; Ning Q, 2003, J BIOL CHEM, V278, P15541, DOI 10.1074/jbc.M212806200; Pavlick KP, 2006, INT IMMUNOL, V18, P389, DOI 10.1093/intimm/dxh378; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Rollenhagen C, 2010, JAIDS-J ACQ IMM DEF, V54, P463, DOI 10.1097/QAI.0b013e3181e5e12c; Rudders S, 2001, J BIOL CHEM, V276, P3302, DOI 10.1074/jbc.M006507200; Sanchez AL, 2003, J INTERF CYTOK RES, V23, P193, DOI 10.1089/107999003765027393; Sankaran S, 2005, P NATL ACAD SCI USA, V102, P9860, DOI 10.1073/pnas.0503463102; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Schlaepfer E, 2006, J IMMUNOL, V176, P2888, DOI 10.4049/jimmunol.176.5.2888; Schutyser E, 2005, J LEUKOCYTE BIOL, V78, P14, DOI 10.1189/jlb.1204712; Senaldi G, 2002, J IMMUNOL, V168, P5690, DOI 10.4049/jimmunol.168.11.5690; Shaffer MH, 2009, J IMMUNOL, V182, P1021, DOI 10.4049/jimmunol.182.2.1021; Smit-McBride Z, 1998, J VIROL, V72, P6646, DOI 10.1128/JVI.72.8.6646-6656.1998; Smith GW, 2007, J ANIM SCI, V85, pE20, DOI 10.2527/jas.2006-479; Sondergaard H, 2009, TISSUE ANTIGENS, V74, P467, DOI 10.1111/j.1399-0039.2009.01382.x; Souwer Y, 2009, BRIT J HAEMATOL, V145, P334, DOI 10.1111/j.1365-2141.2009.07625.x; Starnes T, 2002, J IMMUNOL, V169, P642, DOI 10.4049/jimmunol.169.2.642; Stelzer GHA, 2008, FISEB ILANIT; Sun HQ, 1999, J BIOL CHEM, V274, P33179, DOI 10.1074/jbc.274.47.33179; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876; Tesselaar K, 2002, NATURE IMMUNOL, V4, P49; Vainer B, 2000, CLIN EXP IMMUNOL, V121, P242, DOI 10.1046/j.1365-2249.2000.01296.x; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Veazey RS, 1998, SCIENCE, V280, P427, DOI 10.1126/science.280.5362.427; Wang KS, 2000, BLOOD, V95, P3183, DOI 10.1182/blood.V95.10.3183.010k36_3183_3190; Weninger W, 2001, J EXP MED, V194, P953, DOI 10.1084/jem.194.7.953; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018	87	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34561	10.1371/journal.pone.0034561	http://dx.doi.org/10.1371/journal.pone.0034561			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511950	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600036
J	Mutua, G; Sanders, E; Mugo, P; Anzala, O; Haberer, JE; Bangsberg, D; Barin, B; Rooney, JF; Mark, D; Chetty, P; Fast, P; Priddy, FH				Mutua, Gaudensia; Sanders, Eduard; Mugo, Peter; Anzala, Omu; Haberer, Jessica E.; Bangsberg, David; Barin, Burc; Rooney, James F.; Mark, David; Chetty, Paramesh; Fast, Patricia; Priddy, Frances H.			Safety and Adherence to Intermittent Pre-Exposure Prophylaxis (PrEP) for HIV-1 in African Men Who Have Sex with Men and Female Sex Workers	PLOS ONE			English	Article							IMMUNODEFICIENCY VIRUS-INFECTION; ANTIRETROVIRAL THERAPY ADHERENCE; POSTEXPOSURE PROPHYLAXIS; IMMUNE-RESPONSES; RISK BEHAVIOR; SELF-REPORT; SUPPRESSION; PROTECTION; MACAQUES; EMTRICITABINE	Background: Little is known about safety of and adherence to intermittent HIV PrEP regimens, which may be more feasible than daily dosing in some settings. We present safety and adherence data from the first trial of an intermittent PrEP regimen among Kenyan men who have sex with men (MSM) and female sex workers (FSW). Methods/Principal Findings: MSM and FSW were randomized to daily oral FTC/TDF or placebo, or intermittent (Monday, Friday and within 2 hours after sex, not to exceed one dose per day) oral FTC/TDF or placebo in a 2: 1: 2: 1 ratio; volunteers were followed monthly for 4 months. Adherence was assessed with the medication event monitoring system (MEMS). Sexual activity data were collected via daily text message (SMS) queries and timeline followback interviews with a one-month recall period. Sixty-seven men and 5 women were randomized into the study. Safety was similar among all groups. Median MEMS adherence rates were 83% [IQR: 63-92] for daily dosing and 55% [IQR: 28-78] for fixed intermittent dosing (p = 0.003), while adherence to any post-coital doses was 26% [IQR: 14-50]. SMS response rates were low, which may have impaired measurement of post-coital dosing adherence. Acceptability of PrEP was high, regardless of dosing regimen. Conclusions/Significance: Adherence to intermittent dosing regimens, fixed doses, and in particular coitally-dependent doses, may be more difficult than adherence to daily dosing. However, intermittent dosing may still be appropriate for PrEP if intracellular drug levels, which correlate with prevention of HIV acquisition, can be attained with less than daily dosing and if barriers to adherence can be addressed. Additional drug level data, qualitative data on adherence barriers, and better methods to measure sexual activity are necessary to determine whether adherence to post-coital PrEP could be comparable to more standard regimens.	[Mutua, Gaudensia; Anzala, Omu] Univ Nairobi, Kenya AIDS Vaccine Initiat, Nairobi, Kenya; [Sanders, Eduard; Mugo, Peter] Kenya Govt Med Res Ctr, Kilifi, Kenya; [Sanders, Eduard] Univ Oxford, Nuffield Dept Med, Headington, England; [Haberer, Jessica E.; Bangsberg, David] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Barin, Burc] EMMES Corp, Rockville, MD USA; [Rooney, James F.] Gilead Sci Inc, Foster City, CA 94404 USA; [Mark, David; Fast, Patricia; Priddy, Frances H.] Int AIDS Vaccine Initiat, New York, NY USA; [Chetty, Paramesh] Int AIDS Vaccine Initiat, Johannesburg, South Africa	University of Nairobi; Kenya Medical Research Institute; University of Oxford; Harvard University; Massachusetts General Hospital; Emmes Corporation; Gilead Sciences; International AIDS Vaccine Initiative; International AIDS Vaccine Initiative	Mutua, G (corresponding author), Univ Nairobi, Kenya AIDS Vaccine Initiat, Nairobi, Kenya.	fpriddy@iavi.org	Haberer, Jessica/AAH-7976-2019	Haberer, Jessica/0000-0001-5845-3190	International AIDS Vaccine Initiative (IAVI); Gilead Sciences; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087227, K23MH087228] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative (IAVI); Gilead Sciences(Gilead Sciences); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The study was funded and sponsored by the International AIDS Vaccine Initiative (IAVI). Support in the form of study medication was provided by Gilead Sciences. As the sponsor, IAVI reviewed and approved the study design, data collection and analysis, decision to publish and the manuscript. As Gilead Sciences employ James F. Rooney, they have participated in study design and preparation of the manuscript but played no role in data collection and analysis or decision to publish.; Burc Barin is employed by a commercial statistical group, The EMMES Corporation. James F. Rooney is employed by a commercial funder of this study, Gilead Sciences, which supplied the active drug and placebo tablets used in this study. Gilead Sciences developed and markets the drug, Truvada, used in this trial for HIV treatment. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], MTN003; [Anonymous], 067 HPTN; [Anonymous], 2011, GUID US ANT AG HIV 1, P1; Arnsten JH, 2001, CLIN INFECT DIS, V33, P1417, DOI 10.1086/323201; Beyrer C, 2010, EPIDEMIOL REV, V32, P137, DOI 10.1093/epirev/mxq011; Boaz MJ, 2009, CLIN VACCINE IMMUNOL, V16, P147, DOI 10.1128/CVI.00326-08; Carey MP, 2001, INT J STD AIDS, V12, P365, DOI 10.1258/0956462011923309; Cranage M, 2008, PLOS MED, V5, P1238, DOI 10.1371/journal.pmed.0050157; Derdelinckx I, 2006, PLOS MED, V3, P1999, DOI 10.1371/journal.pmed.0030454; *FHI, FHI STAT FEM PREP HI; Foss AM, 2007, SEX TRANSM INFECT, V83, P510, DOI 10.1136/sti.2007.027144; Gallo MF, 2006, SEX TRANSM DIS, V33, P476, DOI 10.1097/01.olq.0000231960.92850.75; Garcia-Lerma JG, 2008, PLOS MED, V5, P291, DOI 10.1371/journal.pmed.0050028; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hugen PWH, 2002, J ACQ IMMUN DEF SYND, V30, P324, DOI [10.1097/00126334-200207010-00009, 10.1097/01.QAI.0000014768.35851.DB]; Jacob ST, 2011, AIDS BEHAV, V15, P897, DOI 10.1007/s10461-010-9853-2; Kearney BP, 2004, CLIN PHARMACOKINET, V43, P595, DOI 10.2165/00003088-200443090-00003; Kenya National AIDS Control Council (NACC), 2005, FIN FRAM RES REQ KEN; Lansky A, 1998, FAM PLANN PERSPECT, V30, P93, DOI 10.2307/2991666; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Lifson JD, 2000, J VIROL, V74, P2584, DOI 10.1128/JVI.74.6.2584-2593.2000; McClelland RS, 2011, SEX TRANSM DIS, V38, P429, DOI 10.1097/OLQ.0b013e31820369f6; Mori K, 2000, J VIROL, V74, P5747, DOI 10.1128/JVI.74.13.5747-5753.2000; Plummer ML, 2010, AIDS CARE, V22, P499, DOI 10.1080/09540120903202889; Richens J, 2005, SEX TRANSM INFECT, V81, P190, DOI 10.1136/sti.2005.014886; Rosenwirth B, 2000, J VIROL, V74, P1704, DOI 10.1128/JVI.74.4.1704-1711.2000; Sanders EJ, 2007, AIDS, V21, P2513, DOI 10.1097/QAD.0b013e3282f2704a; Simoni JM, 2006, AIDS BEHAV, V10, P227, DOI 10.1007/s10461-006-9078-6; Sirivongrangson P, 2011, AIDS BEHAV      0128; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Sobell L. C., 1996, TIMELINE FOLLOWBACK; Spring M, 2001, VIROLOGY, V279, P221, DOI 10.1006/viro.2000.0720; Stiles T, 2011, GOOD CLIN LAB PRACTI; Tsai CC, 2000, J MED PRIMATOL, V29, P248, DOI 10.1034/j.1600-0684.2000.290318.x; van der Elst EM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005340; Wang LH, 2004, AIDS RES HUM RETROV, V20, P1173, DOI 10.1089/aid.2004.20.1173; Ware NC, 2012, JAIDS-J ACQ IMM DEF, V59, P463, DOI 10.1097/QAI.0b013e31824a060b; Weinhardt LS, 1998, ANN BEHAV MED, V20, P25, DOI 10.1007/BF02893805; Wodarz D, 2000, PHILOS T R SOC B, V355, P1021, DOI 10.1098/rstb.2000.0639	40	110	114	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e33103	10.1371/journal.pone.0033103	http://dx.doi.org/10.1371/journal.pone.0033103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TZ	22511916	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338600002
J	Brown, BK; Wieczorek, L; Kijak, G; Lombardi, K; Currier, J; Wesberry, M; Kappes, JC; Ngauy, V; Marovich, M; Michael, N; Ochsenbauer, C; Montefiori, DC; Polonis, VR				Brown, Bruce K.; Wieczorek, Lindsay; Kijak, Gustavo; Lombardi, Kara; Currier, Jeffrey; Wesberry, Maggie; Kappes, John C.; Ngauy, Viseth; Marovich, Mary; Michael, Nelson; Ochsenbauer, Christina; Montefiori, David C.; Polonis, Victoria R.			The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HLA CLASS-I; MONOCLONAL-ANTIBODIES; EFFECTOR-CELLS; SUBTYPE-B; VACCINE DEVELOPMENT; CANDIDATE VACCINE; MOLECULAR CLONES; BETA-CHEMOKINES; CHIMERIC VIRUS	The importance of innate immune cells in HIV-1 pathogenesis and protection has been highlighted by the role of natural killer (NK) cells in the containment of viral replication. Use of peripheral blood mononuclear cells (PBMC) in immunologic studies provides both HIV-1 target cells (ie. CD4+ T cells), as well as anti-HIV-1 effector cells, such as NK cells. In this study, NK and other immune cell populations were analyzed in HIV-negative donor PBMC for an impact on the anti-HIV activity of polyclonal and monoclonal antibodies. NK cell percentages were significantly higher in donor PBMC that supported lower levels of viral replication. While the percentage of NK cells was not directly associated with neutralization titers, NK cell-depletion significantly diminished the antiviral antibody activity by up to three logs, and polymorphisms in NK killer immunoglobulin receptor (KIR) and Fc gamma RIIIa alleles appear to be associated with this affect. These findings demonstrate that NK cells and NK cell receptor polymorphisms may influence assessment of traditional HIV-1 neutralization in a platform where antibody is continuously present. This format appears to simultaneously assess conventional entry inhibition (neutralization) and non-neutralizing antibody-dependent HIV inhibition, which may provide the opportunity to delineate the dominant antibody function(s) in polyclonal vaccine responses.	[Brown, Bruce K.; Wieczorek, Lindsay; Kijak, Gustavo; Lombardi, Kara; Currier, Jeffrey; Wesberry, Maggie; Ngauy, Viseth; Marovich, Mary; Michael, Nelson; Polonis, Victoria R.] MHRP, Rockville, MD USA; [Brown, Bruce K.; Wieczorek, Lindsay; Kijak, Gustavo; Lombardi, Kara; Currier, Jeffrey; Wesberry, Maggie] Henry M Jackson Fdn, Rockville, MD USA; [Kappes, John C.; Ochsenbauer, Christina] Univ Alabama Birmingham, Birmingham, AL USA; [Ngauy, Viseth] Armed Forces Res Inst Med Sci, Bangkok 10400, Thailand; [Marovich, Mary; Michael, Nelson; Polonis, Victoria R.] Walter Reed Army Inst Res, Rockville, MD USA; [Montefiori, David C.] Duke Univ, Durham, NC USA	Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; University of Alabama System; University of Alabama Birmingham; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Duke University	Brown, BK (corresponding author), MHRP, Rockville, MD USA.	vpolonis@hivresearch.org			Bill & Melinda Gates Foundation [38619]; UAB Center for HIV/AIDS Vaccine Immunology (CHAVI) [AI067854]; facilities of the Virology and Genetic Sequencing cores of the UAB Center for AIDS Research [P30-AI-27767]; Genetically Defined Microbe and Expression Core of the UAB Mucosal HIV and Immunobiology Center [R24 DK-64400]; Department of Veterans Affairs Medical Center, Research Service; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI067854, U19AI067854, P30AI027767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064400] Funding Source: NIH RePORTER	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UAB Center for HIV/AIDS Vaccine Immunology (CHAVI); facilities of the Virology and Genetic Sequencing cores of the UAB Center for AIDS Research; Genetically Defined Microbe and Expression Core of the UAB Mucosal HIV and Immunobiology Center; Department of Veterans Affairs Medical Center, Research Service(US Department of Veterans Affairs); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by a Collaboration for AIDS Vaccine Discovery (CAVD) grant from the Bill & Melinda Gates Foundation (Grant ID: 38619), the UAB Center for HIV/AIDS Vaccine Immunology (CHAVI) (Grant ID AI067854), facilities of the Virology and Genetic Sequencing cores of the UAB Center for AIDS Research (P30-AI-27767); and the Genetically Defined Microbe and Expression Core of the UAB Mucosal HIV and Immunobiology Center (R24 DK-64400). The research was also supported by a Merit Review Award (JCK), from the Department of Veterans Affairs Medical Center, Research Service, and by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2009, J INTERN MED, V265, P29, DOI 10.1111/j.1365-2796.2008.02045.x; Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Alter G, 2009, J VIROL, V83, P6798, DOI 10.1128/JVI.00256-09; Altfeld M, 2011, NAT REV IMMUNOL, V11, P176, DOI 10.1038/nri2935; An P, 2004, J VIROL, V78, P11070, DOI 10.1128/JVI.78.20.11070-11076.2004; Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Barbour JD, 2007, PLOS PATHOG, V3, P471, DOI 10.1371/journal.ppat.0030043; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Boulet S, 2008, AIDS, V22, P595, DOI 10.1097/QAD.0b013e3282f56b23; Brackenridge S, 2011, J VIROL, V85, P5415, DOI 10.1128/JVI.00238-11; Brouwer KC, 2004, AIDS, V18, P1187, DOI 10.1097/00002030-200405210-00012; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; BURNS DPW, 1992, AIDS RES HUM RETROV, V8, P1189, DOI 10.1089/aid.1992.8.1189; Carrington M, 2008, TRENDS MICROBIOL, V16, P620, DOI 10.1016/j.tim.2008.09.002; Darden JM, 2000, CYTOMETRY, V40, P141, DOI 10.1002/(SICI)1097-0320(20000601)40:2<141::AID-CYTO8>3.3.CO;2-6; Edmonds TG, 2010, VIROLOGY, V408, P1, DOI 10.1016/j.virol.2010.08.028; Fadda L, 2011, J VIROL, V85, P5970, DOI 10.1128/JVI.00412-11; Fehniger TA, 1998, J IMMUNOL, V161, P6433; Ferrari G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001273; Forthal DN, 1998, J IMMUNOL METHODS, V220, P129, DOI 10.1016/S0022-1759(98)00152-5; Forthal DN, 2005, J VIROL, V79, P2042, DOI 10.1128/JVI.79.4.2042-2049.2005; Forthal DN, 2001, J VIROL, V75, P6953, DOI 10.1128/JVI.75.15.6953-6961.2001; Forthal DN, 2007, J IMMUNOL, V179, P7916, DOI 10.4049/jimmunol.179.11.7916; Forthal DN, 2007, J IMMUNOL, V178, P6596, DOI 10.4049/jimmunol.178.10.6596; Forthal DN, 2006, J VIROL, V80, P9217, DOI 10.1128/JVI.02746-05; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Holl V, 2006, J VIROL, V80, P6177, DOI 10.1128/JVI.02625-05; Jennes W, 2006, J IMMUNOL, V177, P6588, DOI 10.4049/jimmunol.177.10.6588; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Koehler RN, 2009, TISSUE ANTIGENS, V74, P73, DOI 10.1111/j.1399-0039.2009.01265.x; Koup RA, 2011, NAT REV IMMUNOL, V11, P65, DOI 10.1038/nri2890; Long BR, 2008, J VIROL, V82, P4785, DOI 10.1128/JVI.02449-07; Mascola JR, 2005, J VIROL, V79, P10103, DOI 10.1128/JVI.79.16.10103-10107.2005; Mascola JR, 2002, VACCINE, V20, P1922, DOI 10.1016/S0264-410X(02)00068-3; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Matyas GR, 2010, BIOCHEM BIOPH RES CO, V402, P808, DOI 10.1016/j.bbrc.2010.10.124; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Moody MA, 2010, J EXP MED, V207, P763, DOI 10.1084/jem.20091281; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Nishimura Y, 2003, P NATL ACAD SCI USA, V100, P15131, DOI 10.1073/pnas.2436476100; Ochsenbauer C, 2009, CURR OPIN HIV AIDS, V4, P418, DOI 10.1097/COH.0b013e32832f011e; Oliva A, 1998, J CLIN INVEST, V102, P223, DOI 10.1172/JCI2323; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Paul S, 2010, EXPERT REV VACCINES, V9, P1027, DOI 10.1586/ERV.10.77; Pillay V, 2011, N BIOTECHNOL; Pitisuttithum P, 2004, JAIDS-J ACQ IMM DEF, V37, P1160, DOI 10.1097/01.qai.0000136091.72955.4b; Pitisuttithum P, 2003, J INFECT DIS, V188, P219, DOI 10.1086/376506; Polonis VR, 2008, VIROLOGY, V375, P315, DOI 10.1016/j.virol.2008.02.007; Polonis VR, 2009, CURR OPIN HIV AIDS, V4, P400, DOI 10.1097/COH.0b013e32832edc50; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; ROBERTGUROFF M, 1985, NATURE, V316, P72, DOI 10.1038/316072a0; ROOK AH, 1987, J IMMUNOL, V138, P1064; Salminen MO, 2000, VIROLOGY, V278, P103, DOI 10.1006/viro.2000.0640; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; SPEAR GT, 1990, J VIROL, V64, P5869, DOI 10.1128/JVI.64.12.5869-5873.1990; Speelmon EC, 2006, J VIROL, V80, P2463, DOI 10.1128/JVI.80.5.2463-2471.2006; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Thongcharoen P, 2007, JAIDS-J ACQ IMM DEF, V46, P48; ZollaPazner S, 1996, IMMUNOL LETT, V51, P89, DOI 10.1016/0165-2478(96)02560-6	59	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e29454	10.1371/journal.pone.0029454	http://dx.doi.org/10.1371/journal.pone.0029454			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509241	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600001
J	Qin, BD; Liang, Y; Yang, ZX; Zhong, RQ				Qin, Baodong; Liang, Yan; Yang, Zaixing; Zhong, Renqian			Scientific Publications on Primary Biliary Cirrhosis from 2000 through 2010: An 11-Year Survey of the Literature	PLOS ONE			English	Article							IMPACT FACTOR	Background: Primary biliary cirrhosis (PBC) is a chronic liver disease characterized by intrahepatic bile-duct destruction, cholestasis, and fibrosis. It can lead to cirrhosis and eventually liver failure. PBC also shows some regional differences with respect to incidence and prevalence that are becoming more pronounced each year. Recently, researchers have paid more attention to PBC. To evaluate the development of PBC research during the past 11 years, we determined the quantity and quality of articles on this subject. We also compared the contributions of scientists from the US, UK, Japan, Italy, Germany, and China. Methods: The English-language papers covering PBC published in journals from 2000 through 2010 were retrieved from the PubMed database. We recorded the number of papers published each year, analyzed the publication type, and calculated the accumulated, average impact factors (IFs) and citations from every country. The quantity and quality of articles on PBC were compared by country. We also contrasted the level of PBC research in China and other countries. Results: The total number of articles did not significantly increase during the past 11 years. The number of articles from the US exceeded those from any other country; the publications from the US also had the highest IFs and the most citations. Four other countries showed complex trends with respect to the quantity and quality of articles about PBC. Conclusion: The researchers from the US have contributed the most to the development of PBC research. They currently represent the highest level of research. Some high-level studies, such as RCTs, meta-analyses, and in-depth basic studies should be launched. The gap between China and the advanced level is still enormous. Chinese investigators still have a long way to go.	[Qin, Baodong; Liang, Yan; Yang, Zaixing; Zhong, Renqian] Second Mil Med Univ, Changzheng Hosp, Dept Lab Diagnost, Shanghai, Peoples R China	Naval Medical University	Qin, BD (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Lab Diagnost, Shanghai, Peoples R China.	yangzaixingdiyi@163.com; rqzhong@yahoo.com	Qin, Baodong/ABA-3303-2021; Yang, Zaixing/H-9334-2019		China National Natural Science Foundation Council [81001333, 81072479]	China National Natural Science Foundation Council	This study was supported by two grants from the China National Natural Science Foundation Council (81001333 and 81072479). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bollen J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006022; Hohenester S, 2009, SEMIN IMMUNOPATHOL, V31, P283, DOI 10.1007/s00281-009-0164-5; Institute for Scientific Information, ISI J CITATION REPOR; Kaplan MM, 2005, NEW ENGL J MED, V353, P1261, DOI 10.1056/NEJMra043898; Ray-Chadhuri D, 2001, GUT, V48, P42; Rizkallah J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010204; Saha S, 2003, J MED LIBR ASSOC, V91, P42; Seglen PO, 1997, BRIT MED J, V314, P498; Selmi C, 2005, SEMIN LIVER DIS, V25, P265, DOI 10.1055/s-2005-916319; TRIGER DR, 1980, BRIT MED J, V281, P772, DOI 10.1136/bmj.281.6243.772; Weale Andy R, 2004, BMC Med Res Methodol, V4, P14, DOI 10.1186/1471-2288-4-14	11	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35366	10.1371/journal.pone.0035366	http://dx.doi.org/10.1371/journal.pone.0035366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509409	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336600103
J	Wachter, R; Lahno, R; Haase, B; Weber-Kruger, M; Seegers, J; Edelmann, F; Wohlfahrt, J; Gelbrich, G; Gorlitz, A; Kermer, P; Vollmann, D; Hasenfss, G; Groschel, K; Stahrenberg, R				Wachter, Rolf; Lahno, Rosine; Haase, Beatrice; Weber-Krueger, Mark; Seegers, Joachim; Edelmann, Frank; Wohlfahrt, Janin; Gelbrich, Goetz; Goerlitz, Anke; Kermer, Pawel; Vollmann, Dirk; Hasenfss, Gerd; Groeschel, Klaus; Stahrenberg, Raoul			Natriuretic Peptides for the Detection of Paroxysmal Atrial Fibrillation in Patients with Cerebral Ischemia - the Find-AF Study	PLOS ONE			English	Article							ORAL ANTICOAGULATION; SINUS RHYTHM; STROKE; RISK; PREVENTION; SURGERY	Background and Purpose: Diagnosis of paroxysmal atrial fibrillation (AF) can be challenging, but it is highly relevant in patients presenting with sinus rhythm and acute cerebral ischemia. We aimed to evaluate prospectively whether natriuretic peptide levels and kinetics identify patients with paroxysmal AF. Methods: Patients with acute cerebral ischemia were included into the prospective observational Find-AF study. N-terminal pro brain-type natriuretic peptide (NT-proBNP), brain-type natriuretic peptide (BNP) and N-terminal pro atrial-type natriuretic peptide (NT-proANP) plasma levels were measured on admission, after 6 and 24 hours. Patients free from AF at presentation received 7 day Holter monitoring. We prospectively hypothesized that patients presenting in sinus rhythm with NT-proBNP>median were more likely to have paroxysmal AF than patients with NT-proBNP<median. Results: 281 patients were included, of whom 237 (84.3%) presented in sinus rhythm. 220 patients naive to AF with an evaluable prolonged Holter ECG were analysed. In patients with NT-proBNP>median (239 pg/ml), 17.9% had paroxysmal AF in contrast to 7.4% with NT-proBNP<239 pg/ml (p = 0.025). The ratio of early (0 h) to late (24 h) plasma levels of NT-proBNP showed no difference between both groups. For the detection of paroxysmal atrial fibrillation, BNP, NT-proBNP and NT-proANP at admission had an area under the curve in ROC analysis of 0.747 (0.663-0.831), 0.638 (0.531-0.744) and 0.663 (0.566-0.761), respectively. In multivariate analysis, BNP was the only biomarker to be independently predictive for paroxysmal atrial fibrillation. Conclusions: BNP is independently predictive of paroxysmal AF detected by prolonged ECG monitoring in patients with cerebral ischemia and may be used to effectively select patients for prolonged Holter monitoring.	[Wachter, Rolf; Lahno, Rosine; Haase, Beatrice; Weber-Krueger, Mark; Seegers, Joachim; Edelmann, Frank; Vollmann, Dirk; Hasenfss, Gerd; Stahrenberg, Raoul] Univ Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany; [Wohlfahrt, Janin; Kermer, Pawel] Univ Gottingen, Dept Neurol, D-3400 Gottingen, Germany; [Gelbrich, Goetz] Univ Leipzig, Ctr Clin Trials, Leipzig, Germany; [Goerlitz, Anke] Univ Gottingen, Inst Clin Trials, Gottingen, Germany; [Groeschel, Klaus] Johannes Gutenberg Univ Mainz, Dept Neurol, Mainz, Germany	University of Gottingen; University of Gottingen; Leipzig University; University of Gottingen; Johannes Gutenberg University of Mainz	Wachter, R (corresponding author), Univ Gottingen, Dept Cardiol & Pneumol, Gottingen, Germany.	wachter@med.uni-goettingen.de	Wachter, Rolf/AAA-4037-2020; Gröschel, Klaus/ABC-4777-2021	Gröschel, Klaus/0000-0002-0244-6116; Seegers, Joachim/0000-0002-5299-2334; Edelmann, Frank/0000-0003-4401-5936; Vollmann, Dirk/0000-0002-3679-1700; Wachter, Rolf/0000-0003-2231-2200	Roche Diagnostics; German Federal Ministry of Education and Research (German Heart Failure Network) [TP 7 (FKZ 01GI0205)]; Deutsche Forschungsgemeinschaft (DFG); University of Goettingen; Roche Diagnostics, Mannheim, Germany	Roche Diagnostics; German Federal Ministry of Education and Research (German Heart Failure Network)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Goettingen; Roche Diagnostics, Mannheim, Germany	This study was supported by an unrestricted grant from Roche Diagnostics. This work was supported by grants from the German Federal Ministry of Education and Research (German Heart Failure Network, TP 7 (FKZ 01GI0205)). This publication was financially supported by the open-access support program of the Deutsche Forschungsgemeinschaft (DFG) and the fund for publication of the University of Goettingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the German Federal Ministry of Education and Research (German Heart Failure Network, TP 7 (FKZ 01GI0205)). This study was supported by an unrestricted grant from Roche Diagnostics, Mannheim, Germany. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. There has been no employment, consultancy, patents with Roche Diagnostics.	Crystal E, 2004, HEART, V90, P813, DOI 10.1136/hrt.2003.021642; Giannakoulas G, 2005, ANGIOLOGY, V56, P723, DOI 10.1177/000331970505600610; Grau AJ, 2001, STROKE, V32, P2559, DOI 10.1161/hs1101.098524; Hart RG, 2003, ANN INTERN MED, V138, P831, DOI 10.7326/0003-4819-138-10-200305200-00011; Healey JS, 2008, STROKE, V39, P1482, DOI 10.1161/STROKEAHA.107.500199; Hohnloser SH, 2007, J AM COLL CARDIOL, V50, P2156, DOI 10.1016/j.jacc.2007.07.076; Hou JL, 2008, WORLD J GASTROENTERO, V14, P2582, DOI 10.3748/wjg.14.2582; Inoue S, 2000, J CARD FAIL, V6, P92, DOI 10.1016/S1071-9164(00)90010-1; Liao J, 2007, STROKE, V38, P2935, DOI 10.1161/STROKEAHA.106.478685; Nakamura M, 1997, AM J CARDIOL, V79, P966, DOI 10.1016/S0002-9149(97)00023-4; Naya T, 2008, CEREBROVASC DIS, V26, P434, DOI 10.1159/000155640; Okada Y, 2010, EUR J NEUROL, V17, P326, DOI 10.1111/j.1468-1331.2009.02813.x; Omran H, 1997, J AM COLL CARDIOL, V29, P131, DOI 10.1016/S0735-1097(96)00439-1; Patton KK, 2009, CIRCULATION, V120, P1768, DOI 10.1161/CIRCULATIONAHA.109.873265; Schnabel RB, 2010, CIRCULATION, V121, P200, DOI 10.1161/CIRCULATIONAHA.109.882241; Silvet H, 2003, AM J CARDIOL, V92, P1124, DOI 10.1016/j.amjcard.2003.07.010; Sinha AM, 2010, AM HEART J, V160, P36, DOI 10.1016/j.ahj.2010.03.032; Stahrenberg R, 2010, STROKE, V41, P2884, DOI 10.1161/STROKEAHA.110.591958; Vinch CS, 2004, CARDIOLOGY, V102, P188, DOI 10.1159/000081009; Wazni OM, 2004, CIRCULATION, V110, P124, DOI 10.1161/01.CIR.0000134481.24511.BC; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wozakowska-Kaplon B, 2004, AM J CARDIOL, V93, P1555, DOI 10.1016/j.amjcard.2004.03.013	22	44	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34351	10.1371/journal.pone.0034351	http://dx.doi.org/10.1371/journal.pone.0034351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509292	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600027
J	Wong, PCM; Ciocca, V; Chan, AHD; Ha, LYY; Tan, LH; Peretz, I				Wong, Patrick C. M.; Ciocca, Valter; Chan, Alice H. D.; Ha, Louisa Y. Y.; Tan, Li-Hai; Peretz, Isabelle			Effects of Culture on Musical Pitch Perception	PLOS ONE			English	Article							TONE-LANGUAGE SPEAKERS; CONGENITAL AMUSIA; SPEAKING MUSICIANS; BRAIN; CHINESE; FREQUENCY; IDENTIFICATION; COGNITION; PATTERNS; ENGLISH	The strong association between music and speech has been supported by recent research focusing on musicians' superior abilities in second language learning and neural encoding of foreign speech sounds. However, evidence for a double association-the influence of linguistic background on music pitch processing and disorders-remains elusive. Because languages differ in their usage of elements (e.g., pitch) that are also essential for music, a unique opportunity for examining such language-to-music associations comes from a cross-cultural (linguistic) comparison of congenital amusia, a neurogenetic disorder affecting the music (pitch and rhythm) processing of about 5% of the Western population. In the present study, two populations (Hong Kong and Canada) were compared. One spoke a tone language in which differences in voice pitch correspond to differences in word meaning (in Hong Kong Cantonese, /si/ means 'teacher' and 'to try' when spoken in a high and mid pitch pattern, respectively). Using the On-line Identification Test of Congenital Amusia, we found Cantonese speakers as a group tend to show enhanced pitch perception ability compared to speakers of Canadian French and English (non-tone languages). This enhanced ability occurs in the absence of differences in rhythmic perception and persists even after relevant factors such as musical background and age were controlled. Following a common definition of amusia (5% of the population), we found Hong Kong pitch amusics also show enhanced pitch abilities relative to their Canadian counterparts. These findings not only provide critical evidence for a double association of music and speech, but also argue for the reconceptualization of communicative disorders within a cultural framework. Along with recent studies documenting cultural differences in visual perception, our auditory evidence challenges the common assumption of universality of basic mental processes and speaks to the domain generality of culture-to-perception influences.	[Wong, Patrick C. M.; Ha, Louisa Y. Y.] Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA; [Wong, Patrick C. M.; Ha, Louisa Y. Y.] Northwestern Univ, Knowles Hearing Ctr, Evanston, IL USA; [Wong, Patrick C. M.] Northwestern Univ, Dept Otolaryngol Head & Neck Surg, Chicago, IL 60611 USA; [Ciocca, Valter] Univ British Columbia, Sch Audiol & Speech Sci, Vancouver, BC V5Z 1M9, Canada; [Chan, Alice H. D.] Nanyang Technol Univ, Dept Linguist & Multilingual Studies, Singapore, Singapore; [Tan, Li-Hai] Univ Hong Kong, Sch Humanities, Hong Kong, Hong Kong, Peoples R China; [Peretz, Isabelle] Univ Montreal, Int Lab Brain Mus & Sound Res BRAMS, Montreal, PQ, Canada	Northwestern University; Northwestern University; Northwestern University; University of British Columbia; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of Hong Kong; Universite de Montreal	Wong, PCM (corresponding author), Northwestern Univ, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA.	pwong@northwestern.edu; tanlh@hku.hk	Wong, Patrick/A-8102-2012	Wong, Patrick/0000-0002-6105-5027	National Science Foundation [BCS-0719666]; National Institutes of Health [R01DC008333, R21DC007468, R03HD051827, R21DC009652]; Natural Sciences and Engineering Research Council of Canada; Canada Institute of Health Research; Canada Research Chair; College of Humanities, Arts & Social Sciences, Nanyang Technological University [M58100050]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD051827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC009652, R01DC008333, R21DC007468] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); College of Humanities, Arts & Social Sciences, Nanyang Technological University(Nanyang Technological University); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work is supported by grants from the National Science Foundation (BCS-0719666) and the National Institutes of Health (R01DC008333, R21DC007468, R03HD051827, and R21DC009652) awarded to PW, by grants from the Natural Sciences and Engineering Research Council of Canada, Canada Institute of Health Research and a Canada Research Chair to IP, and by a grant from College of Humanities, Arts & Social Sciences, Nanyang Technological University (M58100050), awarded to AHDC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bent T, 2006, J EXP PSYCHOL HUMAN, V32, P97, DOI 10.1037/0096-1523.32.1.97; Bidelman GM, 2011, BRAIN COGNITION, V77, P1, DOI 10.1016/j.bandc.2011.07.006; Bidelman GM, 2011, J COGNITIVE NEUROSCI, V23, P425, DOI 10.1162/jocn.2009.21362; Brugge JF, 1992, MAMMALIAN AUDITORY P; Cheung H, 2000, PSYCHOL REC, V50, P373, DOI 10.1007/BF03395361; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Dediu D, 2007, P NATL ACAD SCI USA, V104, P10944, DOI 10.1073/pnas.0610848104; Deutsch D, 2006, J ACOUST SOC AM, V119, P719, DOI 10.1121/1.2151799; Drayna D, 2001, SCIENCE, V291, P1969, DOI 10.1126/science.291.5510.1969; Ettlinger M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00211; Fry DB, 1948, SPEECH, P1; Giuliano RJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00146; Green DM, 1966, SIGNAL DETECTION THE; Han SH, 2008, NAT REV NEUROSCI, V9, P646, DOI 10.1038/nrn2456; Hays W.L., 1994, STATISTICS-ABINGDON, V5th ed.; Hedden T, 2008, PSYCHOL SCI, V19, P12, DOI 10.1111/j.1467-9280.2008.02038.x; Hoch L, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00112; Hove MJ, 2010, PSYCHON B REV, V17, P310, DOI 10.3758/PBR.17.3.310; Hyde KL, 2007, J NEUROSCI, V27, P13028, DOI 10.1523/JNEUROSCI.3039-07.2007; Hyde KL, 2006, BRAIN, V129, P2562, DOI 10.1093/brain/awl204; Jeng FC, 2011, EAR HEARING, V32, P699, DOI 10.1097/AUD.0b013e31821cc0df; Jiang CM, 2010, NEUROPSYCHOLOGIA, V48, P2630, DOI 10.1016/j.neuropsychologia.2010.05.009; KALMUS H, 1980, ANN HUM GENET, V43, P369, DOI 10.1111/j.1469-1809.1980.tb01571.x; KAY P, 1984, AM ANTHROPOL, V86, P65, DOI 10.1525/aa.1984.86.1.02a00050; Kleinman A., 1981, PATIENTS HEALERS CON; Lee CY, 2008, J ACOUST SOC AM, V124, P3235, DOI 10.1121/1.2990713; Lee CY, 2010, J ACOUST SOC AM, V127, P481, DOI 10.1121/1.3266683; Mandell J, 2007, RESTOR NEUROL NEUROS, V25, P323; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; Milovanov R, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00321; Nan Y, 2010, BRAIN, V133, P2635, DOI 10.1093/brain/awq178; Nisbett RE, 2001, PSYCHOL REV, V108, P291, DOI 10.1037//0033-295X.108.2.291; Nisbett RE, 2003, P NATL ACAD SCI USA, V100, P11163, DOI 10.1073/pnas.1934527100; Patel AD, 2003, NAT NEUROSCI, V6, P674, DOI 10.1038/nn1082; Patel AD, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00142; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Peretz I, 2008, MUSIC PERCEPT, V25, P331, DOI 10.1525/MP.2008.25.4.331; Peretz I, 2007, AM J HUM GENET, V81, P582, DOI 10.1086/521337; Peretz I, 2006, COGNITION, V100, P1, DOI 10.1016/j.cognition.2005.11.004; Peretz I, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00145; Pfordresher PQ, 2009, ATTEN PERCEPT PSYCHO, V71, P1385, DOI 10.3758/APP.71.6.1385; PIERREHUMBERT J, 1979, J ACOUST SOC AM, V66, P363, DOI 10.1121/1.383670; Schon D, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00167; SINGELIS TM, 1994, PERS SOC PSYCHOL B, V20, P580, DOI 10.1177/0146167294205014; Siok WT, 2008, P NATL ACAD SCI USA, V105, P5561, DOI 10.1073/pnas.0801750105; Siok WT, 2004, NATURE, V431, P71, DOI 10.1038/nature02865; STIGLER JW, 1986, COGNITION, V23, P1, DOI 10.1016/0010-0277(86)90051-X; Tan LH, 2008, P NATL ACAD SCI USA, V105, P4004, DOI 10.1073/pnas.0800055105; Tillmann B, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00120; Trehub SE, 2006, COGNITION, V100, P73, DOI 10.1016/j.cognition.2005.11.006; Triandis H. C., 1995, INDIVIDUALISM COLLEC, DOI 10.4324/9780429499845; Whorf BL, LANGUAGE THOUGHT REA; Williams, 1983, KEY WORDS VOCABULARY; Winawer J, 2007, P NATL ACAD SCI USA, V104, P7780, DOI 10.1073/pnas.0701644104; Wong PCM, 2008, CEREB CORTEX, V18, P828, DOI 10.1093/cercor/bhm115; Wong PCM, 2007, APPL PSYCHOLINGUIST, V28, P565, DOI 10.1017/S0142716407070312; Wong PCM, 2007, NAT NEUROSCI, V10, P420, DOI 10.1038/nn1872; Wong PCM, 2003, J SPEECH LANG HEAR R, V46, P413, DOI 10.1044/1092-4388(2003/034); Yip M., 2002, TONE	60	56	57	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e33424	10.1371/journal.pone.0033424	http://dx.doi.org/10.1371/journal.pone.0033424			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	959TP	22509257	Green Published, gold			2022-12-27	WOS:000305336600011
J	Yang, YN; Xie, X; Ma, YT; Li, XM; Fu, ZY; Ma, X; Huang, D; Chen, BD; Liu, F; Huang, Y; Liu, C; Zheng, YY; Baituola, G; Yu, ZX; Chen, Y				Yang, Yi-Ning; Xie, Xiang; Ma, Yi-Tong; Li, Xiao-Mei; Fu, Zhen-Yan; Ma, Xiang; Huang, Ding; Chen, Bang-Dang; Liu, Fen; Huang, Ying; Liu, Cheng; Zheng, Ying-Ying; Baituola, Gulinaer; Yu, Zi-Xiang; Chen, You			Type 2 Diabetes in Xinjiang Uygur Autonomous Region, China	PLOS ONE			English	Article							IMPAIRED FASTING GLUCOSE; ADULT-POPULATION; HIGH PREVALENCE; RISK-FACTORS; MELLITUS; INDIA; BURDEN	Background: The aim of this study was to estimate the prevalence and distribution of type 2 diabetes and to determine the status of type 2 diabetes awareness, treatment, and control in Xinjiang, China. Our data came from the Cardiovascular Risk Survey (CRS) study designed to investigate the prevalence and risk factors for cardiovascular diseases in Xinjiang from October 2007 to March 2010. A total of 14 122 persons (5583 Hans, 4620 Uygurs, and 3919 Kazaks) completed the survey and examination. Diabetes was defined by the American Diabetes Association 2009 criteria. Methodology/Principal Findings: Overall, 9.26% of the Han, 6.23% of the Uygur, and 3.65% of the Kazak adults aged >= 35 years had diabetes. Among diabetes patients, only 53.0% were aware of their blood glucose level, 26.7% were taking hypoglycemic agents, and 10.4% achieved blood glucose control in Han, 35.8% were aware of their blood glucose level, 7.3% were taking hypoglycemic agents, and 3.13% achieved blood glucose control in Uygur, and 23.8% were aware of their blood glucose level, 6.3% were taking hypoglycemic agents, and 1.4% achieved blood glucose control in Kazak, respectively. Conclusions/Significance: Our results indicate that diabetes is highly prevalent in Xinjiang. The percentages of those with diabetes who are aware, treated, and controlled are unacceptably low. These results underscore the urgent need to develop national strategies to improve prevention, detection, and treatment of diabetes in Xinjiang, the west China.	[Yang, Yi-Ning; Xie, Xiang; Ma, Yi-Tong; Li, Xiao-Mei; Fu, Zhen-Yan; Ma, Xiang; Huang, Ding; Huang, Ying; Liu, Cheng; Zheng, Ying-Ying; Baituola, Gulinaer; Yu, Zi-Xiang; Chen, You] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Chen, Bang-Dang; Liu, Fen] Xinjiang Key Lab Cardiovasc Dis Res, Urumqi, Peoples R China	Xinjiang Medical University	Ma, YT (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.	myt-xj@163.com	xie, xiang/AAG-2128-2021		National Natural Science Foundation of China [81160017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant number 81160017 and website: http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuSayeed M, 1997, DIABETES RES CLIN PR, V34, P149, DOI 10.1016/S0168-8227(96)01337-X; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Awuti G, 2012, EXP DIABETES RES, DOI 10.1155/2012/758921; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Gu D, 2003, DIABETOLOGIA, V46, P1190, DOI 10.1007/s00125-003-1167-8; Hussain A, 2005, DIABETIC MED, V22, P931, DOI 10.1111/j.1464-5491.2005.01558.x; *INT DIAB FED, 2006, DIAB ATL; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Kim SM, 2006, DIABETES CARE, V29, P226, DOI 10.2337/diacare.29.02.06.dc05-0481; Liu SQ, 2011, PREV CHRONIC DIS, V8; Mohan V, 2008, DIABETES RES CLIN PR, V80, P159, DOI 10.1016/j.diabres.2007.11.018; National Center for Health Statistics. Centers for Disease Control and Prevention, 2008, NAT HLTH NUTR EX SUR; Pan XR, 1997, DIABETES CARE, V20, P1664, DOI 10.2337/diacare.20.11.1664; Rahim MA, 2007, DIABETES RES CLIN PR, V77, P300, DOI 10.1016/j.diabres.2006.11.010; Rajpathak SN, 2011, J IMMIGR MINOR HEALT, V13, P181, DOI 10.1007/s10903-010-9356-2; Ramachandran A, 2005, J Assoc Physicians India, V53, P34; Roglic G, 2005, DIABETES CARE, V28, P2130, DOI 10.2337/diacare.28.9.2130; Sadikot SM, 2004, DIABETES RES CLIN PR, V66, P293, DOI 10.1016/j.diabres.2004.04.007; Sasaki H, 2005, DIABETES RES CLIN PR, V67, P167, DOI 10.1016/j.diabres.2004.06.012; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shera AS, 2007, DIABETES RES CLIN PR, V76, P219, DOI 10.1016/j.diabres.2006.08.011; Singh DL, 2003, DIABETIC MED, V20, P170, DOI 10.1046/j.1464-5491.2003.00829_4.x; Tao YC, 2008, CARDIOVASC TOXICOL, V8, P155, DOI 10.1007/s12012-008-9024-0; Thomas JS, 1995, NIH PUBLICATION; Tsalikian E, 2004, DIABETES CARE, V27, P722; Wang K, 1998, Zhonghua Liu Xing Bing Xue Za Zhi, V19, P282; Wong KC, 2006, DIABETES RES CLIN PR, V73, P126, DOI 10.1016/j.diabres.2006.01.007; Xie X, 2011, BLOOD PRESSURE, V20, P232, DOI 10.3109/08037051.2011.566244; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015181; Xie X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013997; ZHONG XL, 1982, CHINESE MED J-PEKING, V95, P423	32	34	40	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35270	10.1371/journal.pone.0035270	http://dx.doi.org/10.1371/journal.pone.0035270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506076	gold, Green Published, Green Submitted			2022-12-27	WOS:000305297500084
J	Alff, F; Markert, J; Zschaler, S; Gausche, R; Kiess, W; Bluher, S				Alff, Franziska; Markert, Jana; Zschaler, Silke; Gausche, Ruth; Kiess, Wieland; Blueher, Susann			Reasons for (Non)Participating in a Telephone-Based Intervention Program for Families with Overweight Children	PLOS ONE			English	Article							BODY-MASS INDEX; QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; CHILDHOOD OBESITY; WEIGHT STATUS; BARRIERS; PARENTS; ADOLESCENTS; PREVENTION; HEALTH	Objective: Willingness to participate in obesity prevention programs is low; underlying reasons are poorly understood. We evaluated reasons for (non) participating in a novel telephone-based obesity prevention program for overweight children and their families. Method: Overweight children and adolescents (BMI>90th percentile) aged 3.5-17.4 years were screened via the CrescNet database, a representative cohort of German children, and program participation (repetitive computer aided telephone counseling) was offered by their local pediatrician. Identical questionnaires to collect baseline data on anthropometrics, lifestyle, eating habits, sociodemographic and psychosocial parameters were analyzed from 433 families (241 participants, 192 nonparticipants). Univariate analyses and binary logistic regression were used to identify factors associated with nonparticipation. Results: The number of overweight children (BMI>90th percentile) was higher in nonparticipants than participants (62% vs. 41.1%, p<0.001), whereas the number of obese children (BMI>97th percentile) was higher in participants (58.9% vs. 38%, p<0.001). Participating girls were younger than boys (8.8 vs. 10.4 years, p<0.001). 87.3% and 40% of participants, but only 72.2% and 24.7% of nonparticipants, respectively, reported to have regular breakfasts (p = 0.008) and 5 regular daily meals (p = 0.003). Nonparticipants had a lower household-net-income (p<0.001), but higher subjective physical wellbeing than participants (p = 0.018) and believed that changes in lifestyle can be made easily (p = 0.05). Conclusion: An important reason for nonparticipation was non-awareness of their child's weight status by parents. Nonparticipants, who were often low-income families, believed that they already perform a healthy lifestyle and had a higher subjective wellbeing. We hypothesize that even a low-threshold intervention program does not reach the families who really need it.	[Alff, Franziska; Markert, Jana; Zschaler, Silke; Kiess, Wieland; Blueher, Susann] Univ Hosp Leipzig, Dept Women & Child Hlth, Hosp Children & Adolescents, Leipzig, Germany; [Markert, Jana; Kiess, Wieland; Blueher, Susann] Univ Leipzig, Integrated Res & Treatment Ctr IFB, Leipzig, Germany; [Gausche, Ruth] Univ Leipzig, CrescNet gGmbH, Leipzig, Germany	Leipzig University; Leipzig University; Leipzig University	Alff, F (corresponding author), Univ Hosp Leipzig, Dept Women & Child Hlth, Hosp Children & Adolescents, Leipzig, Germany.	susann.blueher@medizin.uni-leipzig.de		Weihrauch-Bluher, Susann/0000-0001-7399-223X	Federal Ministry of Education and Research (BMBF), Germany (Integrated Research and Treatment Center IFB "Adiposity Diseases") [FKZ: 01E01001]; Saxonian Ministry of Social Affairs (Sachsisches Ministerium fur Soziales), Dresden, Germany; Roland-Ernst-Stiftung fur Gesundheitsforschung, Dresden, Germany; German National Forum for Diabetes Mellitus (NAFDM); Medical Faculty of the University of Leipzig [NBL Formel1-125]; Federal Ministry of Education and Research BMBF, Kompetenznetz "Adipositas", Konsortium 'LARGE'	Federal Ministry of Education and Research (BMBF), Germany (Integrated Research and Treatment Center IFB "Adiposity Diseases"); Saxonian Ministry of Social Affairs (Sachsisches Ministerium fur Soziales), Dresden, Germany; Roland-Ernst-Stiftung fur Gesundheitsforschung, Dresden, Germany; German National Forum for Diabetes Mellitus (NAFDM); Medical Faculty of the University of Leipzig; Federal Ministry of Education and Research BMBF, Kompetenznetz "Adipositas", Konsortium 'LARGE'	This work was supported by the Federal Ministry of Education and Research (BMBF), Germany (Integrated Research and Treatment Center IFB "Adiposity Diseases", FKZ: 01E01001) (to SB), the Saxonian Ministry of Social Affairs (Sachsisches Ministerium fur Soziales), Dresden, Germany (to SB and WK), the Roland-Ernst-Stiftung fur Gesundheitsforschung, Dresden, Germany, and the German National Forum for Diabetes Mellitus (NAFDM) (SB and WK). The present study was also supported by a junior research grant by the Medical Faculty of the University of Leipzig (NBL Formel1-125; to FA). WK is being supported by a grant from the Federal Ministry of Education and Research BMBF, Kompetenznetz "Adipositas", Konsortium 'LARGE') and the LIFE program of the Medical Faculty of the University of Leipzig. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, J PRIMARY PREVENTION, DOI [DOI 10.1023/A:1007039421026, 10.1023/a:1007039421026]; [Anonymous], 1995, PHYS STAT US INT ANT; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Beckman Heidi, 2006, J Pediatr Nurs, V21, P266, DOI 10.1016/j.pedn.2006.02.012; Benton D, 2004, INT J OBESITY, V28, P858, DOI 10.1038/sj.ijo.0802532; Beyerlein A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015739; Bluher S, 2011, INT J PEDIATR OBES, V6, pE199, DOI 10.3109/17477166.2010.526305; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Danielzik S, 2005, INT J OBESITY, V29, pS78, DOI 10.1038/sj.ijo.0803099; Eakin EG, 2007, AM J PREV MED, V32, P419, DOI 10.1016/j.amepre.2007.01.004; EPSTEIN LH, 1994, HEALTH PSYCHOL, V13, P373, DOI 10.1037/0278-6133.13.5.373; Finne E, 2009, INT J PUBLIC HEALTH, V54, P112, DOI 10.1007/s00038-009-8004-x; Golan M, 2006, INT J PEDIATR OBES, V1, P66, DOI 10.1080/17477160600644272; Hamzaid H, 2011, INT J PEDIATR OBES, V6, P450, DOI 10.3109/17477166.2011.590206; Han JC, 2010, LANCET, V375, P1737, DOI 10.1016/S0140-6736(10)60171-7; Heinberg LJ, 2010, CLIN PEDIATR, V49, P457, DOI 10.1177/0009922809337531; Heinrichs N, 2005, PREV SCI, V6, P275, DOI 10.1007/s11121-005-0006-1; Huffman FG, 2010, INT J ENV RES PUB HE, V7, P2800, DOI 10.3390/ijerph7072800; Huybrechts I, 2010, BUNDESGESUNDHEITSBLA, V53, P716, DOI 10.1007/s00103-010-1085-0; Jansen W, 2006, EUR J PUBLIC HEALTH, V16, P645, DOI 10.1093/eurpub/ckl100; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Lindstrom J, 2010, HORM METAB RES, V42, pS37, DOI 10.1055/s-0029-1240975; Magarey AM, 2011, PEDIATRICS, V127, P214, DOI 10.1542/peds.2009-1432; Melgen C, 2008, METABOLISM, V57, P934, DOI 10.1016/j.metabol.2008.02.008; Nyberg G, 2011, INT J PEDIATR OBES, V6, P244, DOI 10.3109/17477166.2011.575226; Oude Luttikhuis H, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001872.pub2; Paulweber B, 2010, HORM METAB RES, V42, pS3, DOI 10.1055/s-0029-1240928; Plachta-Danielzik S, 2010, PUBLIC HEALTH NUTR, V26, P1; Pott W, 2009, INT J EAT DISORDER, V42, P284, DOI 10.1002/eat.20655; Ravens-Sieberer U, 1998, QUAL LIFE RES, V7, P399, DOI 10.1023/A:1008853819715; Rhee KE, 2005, PEDIATRICS, V116, pE94, DOI 10.1542/peds.2004-2479; Rudolph H, 2010, OBESITY FACTS, V3, P83, DOI 10.1159/000295495; SCHWARZ PE, 2012, NAT REV ENDOCRINOL, V8, P363, DOI [DOI 10.1038/NRENDO.2011.232, DOI 10.1038/nrendo.2011.232]; Schwarzer R., 1992, SELF EFFICACY THOUGH, P217; Shepherd J, 2006, HEALTH EDUC RES, V21, P239, DOI 10.1093/her/cyh060; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Sonneville KR, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-81; Stewart L, 2008, ARCH DIS CHILD, V93, P35, DOI 10.1136/adc.2007.125146; Timperio A, 2008, INT J PEDIATR OBES, V3, P160, DOI 10.1080/17477160801970385; Toschke AM, 2009, INT J PEDIATR OBES, V4, P242, DOI 10.3109/17477160902763341; Wake M, 2007, PEDIATRICS, V120, pE1520, DOI 10.1542/peds.2006-3707; Warschburger P, 2009, PEDIATRICS, V124, pE60, DOI 10.1542/peds.2008-1845; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Williams JW, 2011, INT J PEDIATR OBES, V6, pE442, DOI 10.3109/17477166.2010.526226	45	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34580	10.1371/journal.pone.0034580	http://dx.doi.org/10.1371/journal.pone.0034580			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	952PZ	22509327	Green Published, gold, Green Submitted			2022-12-27	WOS:000304805900050
J	Bullwinkle, TJ; Samorodnitsky, D; Rosati, RC; Koudelka, GB				Bullwinkle, Tammy J.; Samorodnitsky, Daniel; Rosati, Rayna C.; Koudelka, Gerald B.			Determinants of Bacteriophage 933W Repressor DNA Binding Specificity	PLOS ONE			English	Article							TOXIN-CONVERTING PHAGES; ESCHERICHIA-COLI; SHIGA-TOXIN; LAC REPRESSOR; NONCONTACTED BASES; CRYSTAL-STRUCTURE; SITE SEQUENCE; OPERATOR DNA; RECOGNITION; AFFINITY	We reported previously that 933W repressor apparently does not cooperatively bind to adjacent sites on DNA and that the relative affinities of 933W repressor for its operators differ significantly from that of any other lambdoid bacteriophage. These findings indicate that the operational details of the lysis-lysogeny switch of bacteriophage 933W are unique among lambdoid bacteriophages. Since the functioning of the lysis-lysogeny switch in 933W bacteriophage uniquely and solely depends on the order of preference of 933W repressor for its operators, we examined the details of how 933W repressor recognizes its DNA sites. To identify the specificity determinants, we first created a molecular model of the 933W repressor-DNA complex and tested the predicted protein-DNA interactions. These results of these studies provide a picture of how 933W repressor recognizes its DNA sites. We also show that, opposite of what is normally observed for lambdoid phages, 933W operator sequences have evolved in such a way that the presence of the most commonly found base sequences at particular operator positions serves to decrease, rather than increase, the affinity of the protein for the site. This finding cautions against assuming that a consensus sequence derived from sequence analysis defines the optimal, highest affinity DNA binding site for a protein.	[Bullwinkle, Tammy J.; Samorodnitsky, Daniel; Rosati, Rayna C.; Koudelka, Gerald B.] SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Bullwinkle, TJ (corresponding author), SUNY Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	koudelka@buffalo.edu	Koudelka, Gerald B./AAI-3738-2020	Koudelka, Gerald B./0000-0001-6280-0837	National Science Foundation [MCB-0956454]; College of Arts & Sciences at the University at Buffalo; Direct For Biological Sciences [0956454] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); College of Arts & Sciences at the University at Buffalo; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The work in this manuscript was supported by a grant (MCB-0956454) from the National Science Foundation (www.nsf.gov) to GBK and funds provided by the College of Arts & Sciences at the University at Buffalo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; ALEXEEV DG, 1987, NATURE, V325, P821, DOI 10.1038/325821a0; BEAMER LJ, 1992, J MOL BIOL, V227, P177, DOI 10.1016/0022-2836(92)90690-L; BECKETT D, 1991, ANAL BIOCHEM, V196, P69, DOI 10.1016/0003-2697(91)90118-D; BELL AC, 1993, J MOL BIOL, V234, P542, DOI 10.1006/jmbi.1993.1610; BELL AC, 1995, J BIOL CHEM, V270, P1205, DOI 10.1074/jbc.270.3.1205; BRENOWITZ M, 1986, METHOD ENZYMOL, V130, P132; Bullwinkle TJ, 2011, J BACTERIOL, V193, P3313, DOI 10.1128/JB.00119-11; BURKHOFF AM, 1987, CELL, V48, P935, DOI 10.1016/0092-8674(87)90702-1; Carmel AB, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-48; CESKA TA, 1993, EMBO J, V12, P1805, DOI 10.1002/j.1460-2075.1993.tb05828.x; Ciubotaru M, 2003, BIOCHEMISTRY-US, V42, P4253, DOI 10.1021/bi027318j; Ciubotaru M, 1999, J MOL BIOL, V294, P859, DOI 10.1006/jmbi.1999.3269; Datz M, 1996, APPL ENVIRON MICROB, V62, P791, DOI 10.1128/AEM.62.3.791-797.1996; DICKERSON RE, 1981, J MOL BIOL, V149, P761, DOI 10.1016/0022-2836(81)90357-0; Fattah KR, 2000, GENES GENET SYST, V75, P223, DOI 10.1266/ggs.75.223; FISHER EF, 1979, NUCLEIC ACIDS RES, V7, P401, DOI 10.1093/nar/7.2.401; Frank DE, 1997, J MOL BIOL, V267, P1186, DOI 10.1006/jmbi.1997.0920; GUNASEKERA A, 1992, J BIOL CHEM, V267, P14713; HAGERMAN PJ, 1986, NATURE, V321, P449, DOI 10.1038/321449a0; Heddi B, 2010, J MOL BIOL, V395, P123, DOI 10.1016/j.jmb.2009.10.023; Hellman LM, 2007, NAT PROTOC, V2, P1849, DOI 10.1038/nprot.2007.249; Hilchey SP, 1997, J BIOL CHEM, V272, P19898, DOI 10.1074/jbc.272.32.19898; HUANG A, 1987, J BACTERIOL, V169, P4308, DOI 10.1128/jb.169.9.4308-4312.1987; Hud NV, 2001, CURR OPIN STRUC BIOL, V11, P293, DOI 10.1016/S0959-440X(00)00205-0; JenJacobson L, 1997, BIOPOLYMERS, V44, P153; KOBLAN KS, 1991, BIOCHEMISTRY-US, V30, P7822, DOI 10.1021/bi00245a023; KOLB A, 1983, NUCLEIC ACIDS RES, V11, P7833, DOI 10.1093/nar/11.22.7833; Koudelka AP, 2004, J BACTERIOL, V186, P7659, DOI 10.1128/JB.186.22.7659-7669.2004; KOUDELKA GB, 1987, NATURE, V326, P886, DOI 10.1038/326886a0; Koudelka GB, 1996, BIOL STRUCTURE DYNAM, V1, P135; Koudelka GB, 2006, PROG NUCLEIC ACID RE, V81, P143, DOI 10.1016/S0079-6603(06)81004-4; LADBURY JE, 1994, J MOL BIOL, V238, P669, DOI 10.1006/jmbi.1994.1328; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIN S, 1972, J MOL BIOL, V72, P671, DOI 10.1016/0022-2836(72)90184-2; MARINI JC, 1982, P NATL ACAD SCI-BIOL, V79, P7664, DOI 10.1073/pnas.79.24.7664; Maxam A M, 1980, Methods Enzymol, V65, P499; Meijsing SH, 2009, SCIENCE, V324, P407, DOI 10.1126/science.1164265; MESSING J, 1983, METHOD ENZYMOL, V101, P20; Mizutani S, 1999, DNA Res, V6, P141, DOI 10.1093/dnares/6.2.141; Naseem R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002336; NEWLAND JW, 1988, J CLIN MICROBIOL, V26, P1292, DOI 10.1128/JCM.26.7.1292-1297.1988; OBRIEN AD, 1984, SCIENCE, V226, P694, DOI 10.1126/science.6387911; Plunkett G, 1999, J BACTERIOL, V181, P1767, DOI 10.1128/JB.181.6.1767-1778.1999; PRICE MA, 1992, METHOD ENZYMOL, V212, P194; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; SENEAR DF, 1990, BIOCHEMISTRY-US, V29, P6568, DOI 10.1021/bi00480a004; SENEAR DF, 1991, BIOCHEMISTRY-US, V30, P6677, DOI 10.1021/bi00241a007; Sowers LC, 2000, BIOCHEMISTRY-US, V39, P7613, DOI 10.1021/bi992388k; Stonehouse EA, 2011, J BACTERIOL, V193, P979, DOI 10.1128/JB.01343-09; TAKEDA Y, 1989, P NATL ACAD SCI USA, V86, P439, DOI 10.1073/pnas.86.2.439; Tyler JS, 2004, J BACTERIOLOGY; Unkmeir A, 2000, INFECT IMMUN, V68, P4856, DOI 10.1128/IAI.68.9.4856-4864.2000; Wagner PL, 2001, J BACTERIOL, V183, P2081, DOI 10.1128/JB.183.6.2081-2085.2001; Wagner PL, 2002, MOL MICROBIOL, V44, P957, DOI 10.1046/j.1365-2958.2002.02950.x; Watkins D, 2008, BIOCHEMISTRY-US, V47, P2325, DOI 10.1021/bi701826f; Watkins D, 2010, J MOL BIOL, V396, P1145, DOI 10.1016/j.jmb.2009.12.050; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WEEKS KM, 1991, CELL, V66, P577, DOI 10.1016/0092-8674(81)90020-9; WHARTON RP, 1984, CELL, V38, P361, DOI 10.1016/0092-8674(84)90491-4; WING R, 1980, NATURE, V287, P755, DOI 10.1038/287755a0; WOLBERGER C, 1988, NATURE, V335, P789, DOI 10.1038/335789a0; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; WU L, 1992, J BIOL CHEM, V267, P9134; Xu J, 2000, DNA CELL BIOL, V19, P621, DOI 10.1089/104454900750019380; Xu J, 1998, J BIOL CHEM, V273, P24165, DOI 10.1074/jbc.273.37.24165; Zhang J, 2011, NAT STRUCT MOL BIOL, V18, P556, DOI 10.1038/nsmb.2046; ZHANG XL, 1995, NUCLEIC ACIDS RES, V23, P1502, DOI 10.1093/nar/23.9.1502; ZINKEL SS, 1987, NATURE, V328, P178, DOI 10.1038/328178a0	70	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34563	10.1371/journal.pone.0034563	http://dx.doi.org/10.1371/journal.pone.0034563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509323	gold, Green Published, Green Submitted			2022-12-27	WOS:000304805900047
J	Danova-Alt, R; Heider, A; Egger, D; Cross, M; Alt, R				Danova-Alt, Ralitza; Heider, Andreas; Egger, Dietmar; Cross, Michael; Alt, Ruediger			Very Small Embryonic-Like Stem Cells Purified from Umbilical Cord Blood Lack Stem Cell Characteristics	PLOS ONE			English	Article							HEMATOPOIETIC STEM; PROGENITOR CELLS; EXPRESSION; POPULATION; DIFFERENTIATION; EXPANSION; TRANSPLANTATION; IDENTIFICATION; PLURIPOTENCY; GENERATION	Very small embryonic-like (VSEL) cells have been described as putatively pluripotent stem cells present in murine bone marrow and human umbilical cord blood (hUCB) and as such are of high potential interest for regenerative medicine. However, there remain some questions concerning the precise identity and properties of VSEL cells, particularly those derived from hUCB. For this reason, we have carried out an extensive characterisation of purified populations of VSEL cells from a large number of UCB samples. Consistent with a previous report, we find that VSEL cells are CXCR4(+), have a high density, are indeed significantly smaller than HSC and have an extremely high nuclear/cytoplasmic ratio. Their nucleoplasm is unstructured and stains strongly with Hoechst 33342. A comprehensive FACS screen for surface markers characteristic of embryonic, mesenchymal, neuronal or hematopoietic stem cells revealed negligible expression on VSEL cells. These cells failed to expand in vitro under a wide range of culture conditions known to support embryonic or adult stem cell types and a microarray analysis revealed the transcriptional profile of VSEL cells to be clearly distinct both from well-defined populations of pluripotent and adult stem cells and from the mature hematopoietic lineages. Finally, we detected an aneuploid karyotype in the majority of purified VSEL cells by fluorescence in situ hybridisation. These data support neither an embryonic nor an adult stem cell like phenotype, suggesting rather that hUCB VSEL cells are an aberrant and inactive population that is not comparable to murine VSEL cells.	[Danova-Alt, Ralitza; Egger, Dietmar] Vita 34 AG, Leipzig, Germany; [Danova-Alt, Ralitza; Heider, Andreas; Alt, Ruediger] Univ Leipzig, Translat Ctr Regenerat Med TRM, Leipzig, Germany; [Cross, Michael] Univ Leipzig, Dept Hematol Oncol & Hemostaseol, Leipzig, Germany	Leipzig University; Leipzig University	Danova-Alt, R (corresponding author), Vita 34 AG, Leipzig, Germany.	ralt@trm.uni-leipzig.de		Cross, Michael/0000-0002-8815-7621	German Federal Ministry of Education and Research (BMBF, PtJ-Bio) [0315883]; Vita 34 AG, Leipzig; Vita 34 AG; Universitat Leipzig	German Federal Ministry of Education and Research (BMBF, PtJ-Bio)(Federal Ministry of Education & Research (BMBF)); Vita 34 AG, Leipzig; Vita 34 AG; Universitat Leipzig	The work presented in this paper was made possible by funding from the German Federal Ministry of Education and Research (BMBF, PtJ-Bio, 0315883) and Vita 34 AG, Leipzig (www.vita34.de). The BMBF had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Vita 34 AG contributed to the study design and approved publication of the manuscript, but had no role in data collection and analysis or preparation of the manuscript.; Ralitza Danova-Alt was employed by Vita34 AG during the course of this project. Dietmar Egger is employed by Vita 34 AG. Rudiger Alt received co-funding and cord blood samples from Vita 34 AG while working on this project at the Universitat Leipzig and is now employed by Vita 34. Co-funding and common scientific standards and goals for this project were defined in a formal agreement between Vita 34 AG and the Universitat Leipzig. Vita 34 AG is a private cord blood bank. However, as the results of this study demonstrates cord blood derived VSEL cells to be devoid of stem cell potential, there is no obvious application of VSEL cells, and hence, no conceivable financial conflict of interest. There are no patents, products in development, or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Allen JB, 2010, STEM CELLS, V28, P318, DOI 10.1002/stem.275; Alt R, 2009, EXP HEMATOL, V37, P294, DOI 10.1016/j.exphem.2008.09.015; Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620; Battula VL, 2007, DIFFERENTIATION, V75, P279, DOI 10.1111/j.1432-0436.2006.00139.x; Battula VL, 2009, HAEMATOL-HEMATOL J, V94, P173, DOI 10.3324/haematol.13740; BERENSON RJ, 1988, J CLIN INVEST, V81, P951, DOI 10.1172/JCI113409; Bhartiya D, 2012, STEM CELLS DEV, V21, P1, DOI 10.1089/scd.2011.0311; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Bunting KD, 2000, BLOOD, V96, P902, DOI 10.1182/blood.V96.3.902.015k40_902_909; Check E, 2007, NATURE, V446, P485, DOI 10.1038/446485a; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Cooling LL, 2001, TRANSFUSION, V41, P898, DOI 10.1046/j.1537-2995.2001.41070898.x; D'Ippolito G, 2004, J CELL SCI, V117, P2971, DOI 10.1242/jcs.01103; Doetsch F, 1997, J NEUROSCI, V17, P5046; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ElMarsafy S, 1996, LEUKEMIA, V10, P1340; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones EA, 2006, CYTOM PART B-CLIN CY, V70B, P391, DOI 10.1002/cyto.b.20118; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Ko K, 2010, NATURE, V465, pE1, DOI 10.1038/nature09089; Koehl U, 2002, BONE MARROW TRANSPL, V29, P927, DOI 10.1038/sj.bmt.1703558; Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440; Kucia M, 2008, CELL TISSUE RES, V331, P125, DOI 10.1007/s00441-007-0485-4; Kucia M, 2007, LEUKEMIA, V21, P297, DOI 10.1038/sj.leu.2404470; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Li L, 2010, STEM CELLS, V28, P247, DOI 10.1002/stem.289; LOETSCHER M, 1994, J BIOL CHEM, V269, P232; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; MURRAY L, 1995, BLOOD, V85, P368; Nakayama F, 2001, J BIOL CHEM, V276, P16100, DOI 10.1074/jbc.M007272200; Peterson SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023018; Peterson Suzanne E., 2008, V438, P197, DOI 10.1007/978-1-59745-133-8_16; Pierelli L, 2001, LEUKEMIA LYMPHOMA, V42, P1195, DOI 10.3109/10428190109097744; Quirici N, 2001, BRIT J HAEMATOL, V115, P186, DOI 10.1046/j.1365-2141.2001.03077.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ratajczak J, 2011, LEUKEMIA, V25, P1278, DOI 10.1038/leu.2011.73; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Rehen SK, 2001, P NATL ACAD SCI USA, V98, P13361, DOI 10.1073/pnas.231487398; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Safran M, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq020; Shin DM, 2009, LEUKEMIA; Taichman RS, 2010, STEM CELLS DEV, V19, P1557, DOI 10.1089/scd.2009.0445; TESTA N G, 1991, Current Opinion in Oncology, V3, P272, DOI 10.1097/00001622-199104000-00006; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vanneste E, 2009, NAT MED, V15, P577, DOI 10.1038/nm.1924; WATT SM, 1995, LEUKEMIA LYMPHOMA, V17, P229, DOI 10.3109/10428199509056827; Zaiss M, 2003, EXP HEMATOL, V31, P798, DOI 10.1016/S0301-472X(03)00187-5; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Zuba-Surma EK, 2011, J CELL MOL MED, V15, P1319, DOI 10.1111/j.1582-4934.2010.01126.x; Zuba-Surma EK, 2010, EUR J HAEMATOL, V84, P34, DOI 10.1111/j.1600-0609.2009.01352.x	57	46	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34899	10.1371/journal.pone.0034899	http://dx.doi.org/10.1371/journal.pone.0034899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509366	gold, Green Published, Green Submitted			2022-12-27	WOS:000304805900061
J	Skinner-Adams, TS; Butterworth, AS; Porter, KA; D'Amico, R; Sawe, F; Shaffer, D; Siika, A; Hosseinipour, MC; Stringer, E; Currier, JS; Chipato, T; Salata, R; Lockman, S; Eron, JJ; Meshnick, SR; McCarthy, JS				Skinner-Adams, Tina S.; Butterworth, Alice S.; Porter, Kimberly A.; D'Amico, Ronald; Sawe, Fred; Shaffer, Doug; Siika, Abraham; Hosseinipour, Mina C.; Stringer, Elizabeth; Currier, Judith S.; Chipato, Tsungai; Salata, Robert; Lockman, Shahin; Eron, Joseph J.; Meshnick, Steven R.; McCarthy, James S.			The Frequency of Malaria Is Similar among Women Receiving either Lopinavir/Ritonavir or Nevirapine-based Antiretroviral Treatment	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; PROTEASE INHIBITORS; IN-VITRO; HIV; COINFECTION; CLEARANCE; RITONAVIR; DIAGNOSIS; THERAPY; AGENTS	HIV protease inhibitors (PIs) show antimalarial activity in vitro and in animals. Whether this translates into a clinical benefit in HIV-infected patients residing in malaria-endemic regions is unknown. We studied the incidence of malaria, as defined by blood smear positivity or a positive Plasmodium falciparum histidine-rich protein 2 antigen test, among 444 HIV-infected women initiating antiretroviral treatment (ART) in the OCTANE trial (A5208; ClinicalTrials.gov: NCT00089505). Participants were randomized to treatment with PI-containing vs. PI-sparing ART, and were followed prospectively for >= 48 weeks; 73% also received cotrimoxazole prophylaxis. PI-containing treatment was not associated with protection against malaria in this study population.	[Skinner-Adams, Tina S.; Butterworth, Alice S.; McCarthy, James S.] Queensland Inst Med Res, Div Infect Dis, Brisbane, Qld 4006, Australia; [Skinner-Adams, Tina S.; McCarthy, James S.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Porter, Kimberly A.; Meshnick, Steven R.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [D'Amico, Ronald] Abbott Labs, Global Med Affairs, New York, NY USA; [Sawe, Fred; Shaffer, Doug] Kenya Govt Med Res Ctr, Walter Reed Project, Kericho, Kenya; [Siika, Abraham] Moi Univ, Fac Hlth Sci, Dept Internal Med, Eldoret, Kenya; [Hosseinipour, Mina C.] Univ N Carolina Project, Kamuzu Cent Hosp, Lilongwe, Malawi; [Stringer, Elizabeth] Univ Alabama Birmingham, CIDRZ, Birmingham, AL USA; [Currier, Judith S.] Univ Calif Los Angeles, UCLA CARE Ctr, Los Angeles, CA USA; [Chipato, Tsungai] Univ Zimbabwe, Harare, Zimbabwe; [Salata, Robert] Case Western Reserve Univ, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA; [Lockman, Shahin] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Eron, Joseph J.] Univ N Carolina, Sch Med, Div Infect Dis, Chapel Hill, NC USA	QIMR Berghofer Medical Research Institute; University of Queensland; University of North Carolina; University of North Carolina Chapel Hill; Abbott Laboratories; Kenya Medical Research Institute; Moi University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; University of Zimbabwe; Case Western Reserve University; Harvard University; Brigham & Women's Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Skinner-Adams, TS (corresponding author), Queensland Inst Med Res, Div Infect Dis, Brisbane, Qld 4006, Australia.	tinaS@qimr.edu.au	Skinner-Adams, Tina S/A-9798-2012; McCarthy, James S/C-1681-2009	Skinner-Adams, Tina S/0000-0001-7011-3850; McCarthy, James/0000-0001-6596-9718	Abbott Pharmaceuticals; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI070114, P30AI050410, UM1AI069423] Funding Source: NIH RePORTER	Abbott Pharmaceuticals(Abbott Laboratories); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from Abbott Pharmaceuticals. One of the authors RDA is an employee of the funder. The funder therefore had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Abu-Raddad LJ, 2006, SCIENCE, V314, P1603, DOI 10.1126/science.1132338; Andrews KT, 2006, ANTIMICROB AGENTS CH, V50, P639, DOI 10.1128/AAC.50.2.639-648.2006; Bell D, 2006, NAT REV MICROBIOL, V4, P682, DOI 10.1038/nrmicro1474; Dooley KE, 2008, J INFECT DIS, V198, P948, DOI 10.1086/591459; German P, 2007, CLIN INFECT DIS, V44, P889, DOI 10.1086/511882; Iqbal J, 2004, J CLIN MICROBIOL, V42, P4237, DOI 10.1128/JCM.42.9.4237-4241.2004; Lockman S, 2010, NEW ENGL J MED, V363, P1499, DOI 10.1056/NEJMoa0906626; Lucia MB, 2005, JAIDS-J ACQ IMM DEF, V39, P635; Mermin J, 2006, LANCET, V367, P1256, DOI 10.1016/S0140-6736(06)68541-3; Nathoo S, 2003, LANCET, V362, P1039, DOI 10.1016/S0140-6736(03)14414-5; Otieno RO, 2006, AIDS, V20, P275, DOI 10.1097/01.aids.0000200533.56490.b7; Peatey CL, 2009, ANTIMICROB AGENTS CH; Pisell TL, 2002, AIDS, V16, P1503, DOI 10.1097/00002030-200207260-00007; Redmond AM, 2007, AIDS, V21, P763, DOI 10.1097/QAD.0b013e328031f41a; Skinner-Adams TS, 2008, TRENDS PARASITOL, V24, P264, DOI 10.1016/j.pt.2008.03.008; Skinner-Adams TS, 2007, ANTIMICROB AGENTS CH, V51, P759, DOI 10.1128/AAC.00840-06; Skinner-Adams TS, 2004, J INFECT DIS, V190, P1998, DOI 10.1086/425584; Soyinka JO, 2010, BRIT J CLIN PHARMACO, V69, P262, DOI 10.1111/j.1365-2125.2009.03566.x; Swarthout TD, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-58; Whitworth JAG, 2005, LANCET, V365, P196	20	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34399	10.1371/journal.pone.0034399	http://dx.doi.org/10.1371/journal.pone.0034399			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509297	Green Published, gold			2022-12-27	WOS:000304805900028
J	Yang, XM; Sun, JT; Xue, XF; Li, JB; Hong, XY				Yang, Xian-Ming; Sun, Jing-Tao; Xue, Xiao-Feng; Li, Jin-Bo; Hong, Xiao-Yue			Invasion Genetics of the Western Flower Thrips in China: Evidence for Genetic Bottleneck, Hybridization and Bridgehead Effect	PLOS ONE			English	Article							MULTIPLE TRANSATLANTIC INTRODUCTIONS; FRANKLINIELLA-OCCIDENTALIS; POPULATION-STRUCTURE; GEOGRAPHICAL-DISTRIBUTION; THYSANOPTERA THRIPIDAE; MUTATIONAL PROCESSES; COMPUTER-PROGRAM; MITOCHONDRIAL; INTROGRESSION; SOFTWARE	The western flower thrips, Frankliniella occidentalis (Pergande), is an invasive species and the most economically important pest within the insect order Thysanoptera. F. occidentalis, which is endemic to North America, was initially detected in Kunming in southwestern China in 2000 and since then it has rapidly invaded several other localities in China where it has greatly damaged greenhouse vegetables and ornamental crops. Controlling this invasive pest in China requires an understanding of its genetic makeup and migration patterns. Using the mitochondrial COI gene and 10 microsatellites, eight of which were newly isolated and are highly polymorphic, we investigated the genetic structure and the routes of range expansion of 14 F. occidentalis populations in China. Both the mitochondrial and microsatellite data revealed that the genetic diversity of F. occidentalis of the Chinese populations is lower than that in its native range. Two previously reported cryptic species (or ecotypes) were found in the study. The divergence in the mitochondrial COI of two Chinese cryptic species (or ecotypes) was about 3.3% but they cannot be distinguished by nuclear markers. Hybridization might produce such substantial mitochondrial-nuclear discordance. Furthermore, we found low genetic differentiation (global F-ST = 0.043, P<0.001) among all the populations and strong evidence for gene flow, especially from the three southwestern populations (Baoshan, Dali and Kunming) to the other Chinese populations. The directional gene flow was further supported by the higher genetic diversity of these three southwestern populations. Thus, quarantine and management of F. occidentalis should focus on preventing it from spreading from the putative source populations to other parts of China.	[Yang, Xian-Ming; Sun, Jing-Tao; Xue, Xiao-Feng; Li, Jin-Bo; Hong, Xiao-Yue] Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Yang, XM (corresponding author), Nanjing Agr Univ, Dept Entomol, Nanjing, Jiangsu, Peoples R China.	xyhong@njau.edu.cn	Xue, Xiao-Feng/P-2046-2015; Hong, Xiao-Yue/AAF-4759-2020	Xue, Xiao-Feng/0000-0002-6374-8601; 	Ministry of Science and Technology of China [2009CB119200]; Ministry of Agriculture of China [201103026, 200803025]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs)	This work was supported by grants from the National Key Basic Research Program (973 Program, No. 2009CB119200) from the Ministry of Science and Technology of China and the Special Fund for Agro-Scientific Research in the Public Interest of China (No. 201103026, 200803025) from the Ministry of Agriculture of China. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern RG, 2009, BIOL INVASIONS, V11, P959, DOI 10.1007/s10530-008-9308-0; Allendorf FW, 2003, CONSERV BIOL, V17, P24, DOI 10.1046/j.1523-1739.2003.02365.x; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; Bachtrog D, 2006, EVOLUTION, V60, P292, DOI 10.1111/j.0014-3820.2006.tb01107.x; Behura SK, 2006, MOL ECOL, V15, P3087, DOI 10.1111/j.1365-294X.2006.03014.x; BERNATCHEZ L, 1995, CAN J FISH AQUAT SCI, V52, P179, DOI 10.1139/f95-018; Berthier P, 2006, P ROY SOC B-BIOL SCI, V273, P3101, DOI 10.1098/rspb.2006.3680; BRODSGAARD HF, 1994, J ECON ENTOMOL, V87, P1141, DOI 10.1093/jee/87.5.1141; Brunner PC, 2010, J EVOLUTION BIOL, V23, P797, DOI 10.1111/j.1420-9101.2010.01946.x; Brunner PC, 2004, MOL ECOL NOTES, V4, P599, DOI 10.1111/j.1471-8286.2004.00749.x; BRYAN DOUGLAS E., 1956, UNIV CALIFORNIA PUBL ENT, V10, P359; Chan KMA, 2005, EVOLUTION, V59, P720; Choudhury R., 2006, UNPUB; Ciosi M, 2008, MOL ECOL, V17, P3614, DOI 10.1111/j.1365-294X.2008.03866.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 1996, GENETICS, V144, P2001; Cox GW, 2004, ALIEN SPECIES EVOLUT; Darling JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017828; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; deKogel WJ, 1997, ENTOMOL EXP APPL, V83, P73, DOI 10.1046/j.1570-7458.1997.00158.x; Delatte H, 2009, BIOL INVASIONS, V11, P1059, DOI 10.1007/s10530-008-9328-9; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; ESTOUP A, 1995, MOL BIOL EVOL, V12, P1074; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Facon B, 2006, TRENDS ECOL EVOL, V21, P130, DOI 10.1016/j.tree.2005.10.012; Falush D, 2003, GENETICS, V164, P1567; Floerl O, 2009, J APPL ECOL, V46, P37, DOI 10.1111/j.1365-2664.2008.01540.x; Funderburk J, 2007, IFAS EDIS PUBLICATIO; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Goudet J, 1996, GENETICS, V144, P1933; Holzman JP, 2009, J EVOLUTION BIOL, V22, P1076, DOI 10.1111/j.1420-9101.2009.01722.x; IMMARAJU JA, 1992, J ECON ENTOMOL, V85, P9, DOI 10.1093/jee/85.1.9; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Jensen Sten E., 2000, Integrated Pest Management Reviews, V5, P131, DOI 10.1023/A:1009600426262; Jiang XL, 2001, PLANT QUARANTINE, V15, P115; Khamis FM, 2009, MOL ECOL, V18, P4798, DOI 10.1111/j.1365-294X.2009.04391.x; Kirk WDJ, 2003, AGR FOREST ENTOMOL, V5, P301, DOI 10.1046/j.1461-9563.2003.00192.x; Kolbe JJ, 2004, NATURE, V431, P177, DOI 10.1038/nature02807; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CE, 2002, TRENDS ECOL EVOL, V17, P386, DOI 10.1016/S0169-5347(02)02554-5; Lian C, 2002, MOL ECOL NOTES, V2, P211, DOI 10.1046/j.1471-8278.2002.00213.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Linnen CR, 2007, EVOLUTION, V61, P1417, DOI 10.1111/j.1558-5646.2007.00114.x; Lockwood JL, 2007, INVASION ECOLOGY; Lombaert E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009743; Loomans AJM, 1995, WAGENINGEN AGR PAPER, V1, P201; Lozier JD, 2009, BIOL INVASIONS, V11, P299, DOI 10.1007/s10530-008-9248-8; Luikart G, 1998, CONSERV BIOL, V12, P228, DOI 10.1046/j.1523-1739.1998.96388.x; Lv Yao-Bin, 2011, Chinese Journal of Applied Entomology, V48, P488; McLeish MJ, 2006, J HERED, V97, P31, DOI 10.1093/jhered/esj001; Miller N, 2005, SCIENCE, V310, P992, DOI 10.1126/science.1115871; MORITZ G., 2004, PEST THRIPS WORLD VI; Morse JG, 2006, ANNU REV ENTOMOL, V51, P67, DOI 10.1146/annurev.ento.51.110104.151044; MOUND LA, 1983, J BIOGEOGR, V10, P119, DOI 10.2307/2844623; Mound LA, 2002, THRIPS TOSPOVIRUSES, P3; Mound LA, 2007, ZOOTAXA, P395; Myers JH, 1998, ANNU REV ENTOMOL, V43, P471, DOI 10.1146/annurev.ento.43.1.471; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Puillandre N, 2008, BIOL INVASIONS, V10, P319, DOI 10.1007/s10530-007-9132-y; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Reitz SR, 2009, FLA ENTOMOL, V92, P7, DOI 10.1653/024.092.0102; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robb, 1991, UNDERSTANDING THYSAN, P343; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rugman-Jones PF, 2010, J ECON ENTOMOL, V103, P877, DOI 10.1603/EC09300; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Tsutsui ND, 2000, P NATL ACAD SCI USA, V97, P5948, DOI 10.1073/pnas.100110397; Valade R, 2009, MOL ECOL, V18, P3458, DOI 10.1111/j.1365-294X.2009.04290.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilson GA, 2003, GENETICS, V163, P1177; Wilson JRU, 2009, TRENDS ECOL EVOL, V24, P136, DOI 10.1016/j.tree.2008.10.007; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144; Wu Xiao-yun, 2009, Zhejiang Daxue Xuebao Nongye Yu Shengming Kexue Ban, V35, P355; Zheng CY, 2007, J QINGDAO AGR U NAT, V24, P172; Zhou Wei-Chuan, 2006, Chinese Bulletin of Entomology, V43, P798; 张友军, 2003, [植物保护, Plant Protection], V29, P58	89	47	55	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34567	10.1371/journal.pone.0034567	http://dx.doi.org/10.1371/journal.pone.0034567			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509325	Green Published, gold, Green Submitted			2022-12-27	WOS:000304805900048
J	Lubarsky, HV; Gerbersdorf, SU; Hubas, C; Behrens, S; Ricciardi, F; Paterson, DM				Lubarsky, Helen V.; Gerbersdorf, Sabine U.; Hubas, Cedric; Behrens, Sebastian; Ricciardi, Francesco; Paterson, David M.			Impairment of the Bacterial Biofilm Stability by Triclosan	PLOS ONE			English	Article							EXTRACELLULAR POLYMERIC SUBSTANCES; CHROMATOGRAPHY MASS-SPECTROMETRY; GRADIENT GEL-ELECTROPHORESIS; WIDELY USED BIOCIDE; SURFACE WATERS; SEASONAL VARIABILITY; AQUATIC ENVIRONMENT; METHYL-TRICLOSAN; TOXICITY; COMMUNITIES	The accumulation of the widely-used antibacterial and antifungal compound triclosan (TCS) in freshwaters raises concerns about the impact of this harmful chemical on the biofilms that are the dominant life style of microorganisms in aquatic systems. However, investigations to-date rarely go beyond effects at the cellular, physiological or morphological level. The present paper focuses on bacterial biofilms addressing the possible chemical impairment of their functionality, while also examining their substratum stabilization potential as one example of an important ecosystem service. The development of a bacterial assemblage of natural composition - isolated from sediments of the Eden Estuary (Scotland, UK) - on non-cohesive glass beads (<63 mu m) and exposed to a range of triclosan concentrations (control, 2 - 100 mu g L-1) was monitored over time by Magnetic Particle Induction (MagPI). In parallel, bacterial cell numbers, division rate, community composition (DGGE) and EPS (extracellular polymeric substances: carbohydrates and proteins) secretion were determined. While the triclosan exposure did not prevent bacterial settlement, biofilm development was increasingly inhibited by increasing TCS levels. The surface binding capacity (MagPI) of the assemblages was positively correlated to the microbial secreted EPS matrix. The EPS concentrations and composition (quantity and quality) were closely linked to bacterial growth, which was affected by enhanced TCS exposure. Furthermore, TCS induced significant changes in bacterial community composition as well as a significant decrease in bacterial diversity. The impairment of the stabilization potential of bacterial biofilm under even low, environmentally relevant TCS levels is of concern since the resistance of sediments to erosive forces has large implications for the dynamics of sediments and associated pollutant dispersal. In addition, the surface adhesive capacity of the biofilm acts as a sensitive measure of ecosystem effects.	[Lubarsky, Helen V.; Gerbersdorf, Sabine U.] Univ Stuttgart, Inst Hydraul Engn, Stuttgart, Germany; [Lubarsky, Helen V.; Paterson, David M.] Univ St Andrews, Sediment Ecol Res Grp, Scottish Ocean Inst, Sch Biol, St Andrews, Fife, Scotland; [Hubas, Cedric] UPMC, IRD, DMPA, UMR BOREA Biol Organismes & Ecosyst Aquat,MNHN, Paris, France; [Behrens, Sebastian] Univ Tubingen, Geomicrobiol Microbial Ecol Grp, Ctr Appl Geosci ZAG, Tubingen, Germany; [Ricciardi, Francesco] Univ Girona, Inst Aquat Ecol, Girona, Spain	University of Stuttgart; University of St Andrews; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Eberhard Karls University of Tubingen; Universitat de Girona	Lubarsky, HV (corresponding author), Univ Stuttgart, Inst Hydraul Engn, Stuttgart, Germany.	sabine.gerbersdorf@iws.uni-stuttgart.de	BOREA, UMR BOREA/C-6165-2008; Paterson, David M/D-5202-2013; Gerbersdorf, Sabine U/B-7875-2009; Hubas, Cédric/P-4200-2019; Ricciardi, Francesco/B-3977-2008	BOREA, UMR BOREA/0000-0002-9110-9292; Paterson, David M/0000-0003-1174-6476; Hubas, Cédric/0000-0002-9110-9292; Lubarsky, Helen/0000-0001-8247-3618; Ricciardi, Francesco/0000-0002-0163-8861	Marie Curie Research Training Network [RTN-CT-2006-035695]; Margarete-von-Wrangell Fellowship for postdoctoral lecture qualification; Ministry of Science, Research and the Arts (MSK); European Social Fund (ESF) of Baden-Wurttemberg; MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland, Scottish Funding Council) [HR09011]	Marie Curie Research Training Network(European Commission); Margarete-von-Wrangell Fellowship for postdoctoral lecture qualification; Ministry of Science, Research and the Arts (MSK); European Social Fund (ESF) of Baden-Wurttemberg(European Social Fund (ESF)); MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland, Scottish Funding Council)	The authors are grateful for the financial support of this study. Dr. Lubarsky was funded by Marie Curie Research Training Network (RTN-CT-2006-035695, Project KEYBIOEFFECT). Dr. Gerbersdorf currently holds a Margarete-von-Wrangell Fellowship for postdoctoral lecture qualification, financed by the Ministry of Science, Research and the Arts (MSK) and the European Social Fund (ESF) of Baden-Wurttemberg. This work also received funding from the MASTS pooling initiative (The Marine Alliance for Science and Technology for Scotland, Scottish Funding Council, grant reference HR09011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson-Erici M, 2002, CHEMOSPHERE, V46, P1485, DOI 10.1016/S0045-6535(01)00255-7; Aguera A, 2003, ANAL CHIM ACTA, V480, P193, DOI 10.1016/S0003-2670(03)00040-0; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Brummer IHM, 2003, APPL ENVIRON MICROB, V69, P4463, DOI 10.1128/AEM.69.8.4463-4473.2003; Brusetti L, 2006, FEMS MICROBIOL ECOL, V56, P154, DOI 10.1111/j.1574-6941.2005.00059.x; Chalew TEA, 2009, J AM WATER RESOUR AS, V45, P4, DOI 10.1111/j.1752-1688.2008.00284.x; CHO BC, 1990, MAR ECOL PROG SER, V63, P253, DOI 10.3354/meps063253; Czaczyk K, 2007, POL J ENVIRON STUD, V16, P799; DECHO AW, 1990, OCEANOGR MAR BIOL, V28, P73; DeLorenzo ME, 2008, ENVIRON TOXICOL, V23, P224, DOI 10.1002/tox.20327; Dobretsov S, 2007, FEMS MICROBIOL ECOL, V60, P177, DOI 10.1111/j.1574-6941.2007.00285.x; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Escalada MG, 2005, LETT APPL MICROBIOL, V41, P476, DOI 10.1111/j.1472-765X.2005.01790.x; Escalada MG, 2005, J ANTIMICROB CHEMOTH, V55, P879, DOI 10.1093/jac/dki123; Farre M, 2008, ANAL BIOANAL CHEM, V390, P1999, DOI 10.1007/s00216-007-1779-9; Fernandez AS, 2000, APPL ENVIRON MICROB, V66, P4058, DOI 10.1128/AEM.66.9.4058-4067.2000; Flemming HC, 2001, WATER SCI TECHNOL, V43, P1; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Garet MJ, 1996, J MICROBIOL METH, V25, P1, DOI 10.1016/0167-7012(95)00071-2; Gerbersdorf SU, 2008, FEMS MICROBIOL ECOL, V66, P282, DOI 10.1111/j.1574-6941.2008.00586.x; Gerbersdorf SU, 2011, J SOIL SEDIMENT, V11, P1099, DOI 10.1007/s11368-011-0373-0; Gerbersdorf SU, 2009, J SOIL SEDIMENT, V9, P640, DOI 10.1007/s11368-009-0142-5; Halden RU, 2005, ENVIRON SCI TECHNOL, V39, P1420, DOI 10.1021/es049071e; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Heidler J, 2007, CHEMOSPHERE, V66, P362, DOI 10.1016/j.chemosphere.2006.04.066; Hubas C, 2007, MAR ECOL PROG SER, V344, P39, DOI 10.3354/meps06947; Hubas C, 2007, MAR BIOL, V151, P41, DOI 10.1007/s00227-006-0446-6; Jain A, 2007, BIOFOULING, V23, P171, DOI 10.1080/08927010701269641; Johnson DR, 2009, ENVIRON MICROBIOL, V11, P1682, DOI 10.1111/j.1462-2920.2009.01893.x; Kolpin DW, 2002, ENVIRON SCI TECHNOL, V36, P1202, DOI 10.1021/es011055j; Larson F, 2009, LIMNOL OCEANOGR-METH, V7, P490, DOI 10.4319/lom.2009.7.490; Lawrence JR, 2009, SCI TOTAL ENVIRON, V407, P3307, DOI 10.1016/j.scitotenv.2009.01.060; Lawrence JR, 2007, ENVIRON TOXICOL CHEM, V26, P573, DOI 10.1897/06-340R.1; LEE S, 1987, APPL ENVIRON MICROB, V53, P1298, DOI 10.1128/AEM.53.6.1298-1303.1987; Levy CW, 1999, NATURE, V398, P383, DOI 10.1038/18803; Lindstrom A, 2002, ENVIRON SCI TECHNOL, V36, P2322, DOI 10.1021/es0114254; Lubarsky HV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013794; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; McAvoy DC, 2002, ENVIRON TOXICOL CHEM, V21, P1323, DOI 10.1897/1551-5028(2002)021<1323:MOTIWT>2.0.CO;2; McMurry LM, 1998, NATURE, V394, P531, DOI 10.1038/28970; McMurry LM, 1999, ANTIMICROB AGENTS CH, V43, P711, DOI 10.1128/AAC.43.3.711; McMurry LM, 1998, FEMS MICROBIOL LETT, V166, P305, DOI 10.1016/S0378-1097(98)00347-4; Mezcua M, 2004, ANAL CHIM ACTA, V524, P241, DOI 10.1016/j.aca.2004.05.050; Muyzer G, 1995, WATER SCI TECHNOL, V32, P1, DOI 10.1016/0273-1223(96)00001-7; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Okumura T, 1996, ANAL CHIM ACTA, V325, P175, DOI 10.1016/0003-2670(96)00027-X; Onbasli D, 2009, J HAZARD MATER, V168, P64, DOI 10.1016/j.jhazmat.2009.01.131; Orvos DR, 2002, ENVIRON TOXICOL CHEM, V21, P1338, DOI 10.1897/1551-5028(2002)021<1338:ATOT>2.0.CO;2; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Pennisi E, 2002, SCIENCE, V296, P250, DOI 10.1126/science.296.5566.250; Peplies J, 2008, SYST APPL MICROBIOL, V31, P251, DOI 10.1016/j.syapm.2008.08.003; Priester JH, 2006, APPL ENVIRON MICROB, V72, P1988, DOI 10.1128/AEM.72.3.1988-1996.2006; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; RAUNKJAER K, 1994, WATER RES, V28, P251, DOI 10.1016/0043-1354(94)90261-5; Ricart M, 2010, J HYDROL, V383, P52, DOI 10.1016/j.jhydrol.2009.08.014; Russell AD, 2004, J ANTIMICROB CHEMOTH, V53, P693, DOI 10.1093/jac/dkh171; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schreiber F, 2008, AQUAT TOXICOL, V87, P227, DOI 10.1016/j.aquatox.2008.02.002; Schweizer HP, 2001, FEMS MICROBIOL LETT, V202, P1, DOI 10.1111/j.1574-6968.2001.tb10772.x; Shannon CE, 1997, M D COMPUT, V14, P306; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Singer H, 2002, ENVIRON SCI TECHNOL, V36, P4998, DOI 10.1021/es025750i; Solan M, 2008, AQUAT BIOL, V2, P289, DOI 10.3354/ab00058; Stal LJ, 2003, GEOMICROBIOL J, V20, P463, DOI 10.1080/713851126; Tabak M, 2007, FEMS MICROBIOL LETT, V267, P200, DOI 10.1111/j.1574-6968.2006.00547.x; Underwood GJC, 2003, ADV BOT RES, V40, P183, DOI 10.1016/S0065-2296(05)40005-1; Villalain J, 2001, ARCH BIOCHEM BIOPHYS, V390, P128, DOI 10.1006/abbi.2001.2356; Wilson BA, 2003, ENVIRON SCI TECHNOL, V37, P1713, DOI 10.1021/es0259741; Wittebolle L, 2009, WATER RES, V43, P4149, DOI 10.1016/j.watres.2009.06.034; Yazdankhah SP, 2006, MICROB DRUG RESIST, V12, P83, DOI 10.1089/mdr.2006.12.83	73	35	35	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e31183	10.1371/journal.pone.0031183	http://dx.doi.org/10.1371/journal.pone.0031183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523534	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345000003
J	Warrander, LK; Batra, G; Bernatavicius, G; Greenwood, SL; Dutton, P; Jones, RL; Sibley, CP; Heazell, AEP				Warrander, Lynne K.; Batra, Gauri; Bernatavicius, Giovanna; Greenwood, Susan L.; Dutton, Philip; Jones, Rebecca L.; Sibley, Colin P.; Heazell, Alexander E. P.			Maternal Perception of Reduced Fetal Movements Is Associated with Altered Placental Structure and Function	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; APOPTOSIS; PREGNANCIES; MANAGEMENT; WOMEN; PREECLAMPSIA; EXPRESSION; TRANSPORT; FETUSES; SYSTEM	Background: Maternal perception of reduced fetal movement (RFM) is associated with increased risk of stillbirth and fetal growth restriction (FGR). DFM is thought to represent fetal compensation to conserve energy due to insufficient oxygen and nutrient transfer resulting from placental insufficiency. To date there have been no studies of placental structure in cases of DFM. Objective: To determine whether maternal perception of reduced fetal movements (RFM) is associated with abnormalities in placental structure and function. Design: Placentas were collected from women with RFM after 28 weeks gestation if delivery occurred within 1 week. Women with normal movements served as a control group. Placentas were weighed and photographs taken. Microscopic structure was evaluated by immunohistochemical staining and image analysis. System A amino acid transporter activity was measured as a marker of placental function. Placentas from all pregnancies with RFM (irrespective of outcome) had greater area with signs of infarction (3.5% vs. 0.6%; p<0.01), a higher density of syncytial knots (p<0.001) and greater proliferation index (p<0.01). Villous vascularity (p<0.001), trophoblast area (p<0.01) and system A activity (p<0.01) were decreased in placentas from RFM compared to controls irrespective of outcome of pregnancy. Conclusions: This study provides evidence of abnormal placental morphology and function in women with RFM and supports the proposition of a causal association between placental insufficiency and RFM. This suggests that women presenting with RFM require further investigation to identify those with placental insufficiency.	[Warrander, Lynne K.; Greenwood, Susan L.; Dutton, Philip; Jones, Rebecca L.; Sibley, Colin P.; Heazell, Alexander E. P.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Biomed, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England; [Batra, Gauri] Royal Manchester Childrens Hosp, Dept Paediat Histopathol, Manchester M27 1HA, Lancs, England; [Bernatavicius, Giovanna] Cent Manchester Univ Hosp NHS Fdn Trust, St Marys Hosp, Manchester, Lancs, England	University of Manchester; Royal Manchester Children's Hospital; University of Manchester	Warrander, LK (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Biomed, Maternal & Fetal Hlth Res Ctr, Manchester, Lancs, England.	alexander.heazell@manchester.ac.uk	Jones, Rebecca/E-4481-2011	Jones, Rebecca/0000-0002-8871-0589; Warrander, Lynne/0000-0001-9529-8935; Greenwood, Susan/0000-0003-2867-4368; Heazell, Alexander/0000-0002-4303-7845	Manchester Wellcome Trust Clinical Research Facility; Greater Manchester Clinical Local Research Network; Wolfson Foundation; National Institutes of Health Research; National Institute for Health Research [CL-2009-06-002] Funding Source: researchfish	Manchester Wellcome Trust Clinical Research Facility(Wellcome Trust); Greater Manchester Clinical Local Research Network; Wolfson Foundation; National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Manchester Wellcome Trust Clinical Research Facility and the Greater Manchester Clinical Local Research Network. It was underpinned by the National Institutes of Health Research Manchester Biomedical Research Centre and an Action Research Endowment Fund. LW was supported by a studentship from the Wolfson Foundation. AH is funded by a Clinical Lectureship from the National Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, CONF ENQ STILLB DEAT; APELSARID L, 2009, ARCH GYNECOL OBSTET; Biswas S, 2008, EARLY HUM DEV, V84, P357, DOI 10.1016/j.earlhumdev.2007.09.017; CEMACE, 2010, PER MORT 2008; Chen CP, 2002, AM J OBSTET GYNECOL, V187, P764, DOI 10.1067/mob.2002.125243; Crocker IP, 2003, AM J PATHOL, V162, P637, DOI 10.1016/S0002-9440(10)63857-6; Daayana S, 2004, J SOC GYNECOL INVEST, V11, P545, DOI 10.1016/j.jsgi.2004.06.009; DICKE JM, 1988, AM J MED SCI, V295, P223, DOI 10.1097/00000441-198803000-00012; Efkarpidis Savvas, 2004, MedGenMed, V6, P53; Flenady V, 2009, AUST NZ J OBSTET GYN, V49, P358, DOI 10.1111/j.1479-828X.2009.01026.x; Froen JF, 2008, SEMIN PERINATOL, V32, P307, DOI 10.1053/j.semperi.2008.04.015; Froen JF, 2008, SEMIN PERINATOL, V32, P243, DOI 10.1053/j.semperi.2008.04.004; Froen JF, 2001, AM J OBSTET GYNECOL, V184, P694, DOI 10.1067/mob.2001.110697; Glazier JD, 1997, PEDIATR RES, V42, P514, DOI 10.1203/00006450-199710000-00016; Greenwood SL, 2006, METH MOLEC MED, V122, P253; Haws RA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S5; Heazell AEP, 2008, J OBSTET GYNAECOL, V28, P147, DOI 10.1080/01443610801912618; Heazell AEP, 2008, PLACENTA, V29, P175, DOI 10.1016/j.placenta.2007.11.002; Heazell AEP, 2007, PLACENTA, V28, pS33, DOI 10.1016/j.placenta.2006.10.007; Heazell AEP, 2009, J OBSTET GYNAECOL, V29, P225, DOI 10.1080/01443610802716042; Heazell AEP, 2008, ACTA OBSTET GYN SCAN, V87, P331, DOI 10.1080/00016340801902034; Heazell AEP, 2011, APOPTOSIS, V16, P135, DOI 10.1007/s10495-010-0551-3; Jansson T, 2002, PLACENTA, V23, P392, DOI 10.1053/plac.2002.0826; Levy R, 2002, AM J OBSTET GYNECOL, V186, P1056, DOI 10.1067/mob.2002.122250; Macara L, 1996, PLACENTA, V17, P37, DOI 10.1016/S0143-4004(05)80642-3; O'Sullivan O, 2009, J OBSTET GYNAECOL, V29, P705, DOI 10.3109/01443610903229598; Parast MM, 2008, HUM PATHOL, V39, P948, DOI 10.1016/j.humpath.2007.10.032; PEARSON JF, 1976, BRIT MED J, V1, P1305, DOI 10.1136/bmj.1.6021.1305; RAYBURN WF, 1982, AM J OBSTET GYNECOL, V144, P967, DOI 10.1016/0002-9378(82)90192-2; Salafia CM, 2009, PLACENTA, V30, P468, DOI 10.1016/j.placenta.2008.12.013; Sinha D, 2007, J OBSTET GYNAECOL, V27, P41, DOI 10.1080/01443610601016909; Smith SC, 1997, AM J OBSTET GYNECOL, V177, P1395, DOI 10.1016/S0002-9378(97)70081-4; Unterscheider J, 2009, OBSTET GYNAECOL, V11, P245, DOI 10.1576/toag.11.4.245.27527; VINTZILEOS AM, 1991, AM J OBSTET GYNECOL, V165, P707, DOI 10.1016/0002-9378(91)90314-H; Warrander LK, 2010, MED HYPOTHESES; Yampolsky M, 2009, PLACENTA, V30, P1058, DOI 10.1016/j.placenta.2009.10.001	36	80	82	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34851	10.1371/journal.pone.0034851	http://dx.doi.org/10.1371/journal.pone.0034851			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523561	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345000033
J	Karim, L; Vashishth, D				Karim, Lamya; Vashishth, Deepak			Heterogeneous Glycation of Cancellous Bone and Its Association with Bone Quality and Fragility	PLOS ONE			English	Article							COLLAGEN CROSS-LINKS; NONENZYMATIC GLYCATION; BIOMECHANICAL PROPERTIES; CORTICAL BONE; TRABECULAR MICROARCHITECTURE; MECHANICAL-PROPERTIES; BIOCHEMICAL MARKERS; MINERAL DENSITY; MICRODAMAGE; FRACTURE	Non-enzymatic glycation (NEG) and enzymatic biochemical processes create crosslinks that modify the extracellular matrix (ECM) and affect the turnover of bone tissue. Because NEG affects turnover and turnover at the local level affects microarchitecture and formation and removal of microdamage, we hypothesized that NEG in cancellous bone is heterogeneous and accounts partly for the contribution of microarchitecture and microdamage on bone fragility. Human trabecular bone cores from 23 donors were subjected to compression tests. Mechanically tested cores as well as an additional 19 cores were stained with lead-uranyl acetate and imaged to determine microarchitecture and measure microdamage. Post-yield mechanical properties were measured and damaged trabeculae were extracted from a subset of specimens and characterized for the morphology of induced microdamage. Tested specimens and extracted trabeculae were quantified for enzymatic and non-enzymatic crosslink content using a colorimetric assay and Ultra-high Performance Liquid Chromatography (UPLC). Results show that an increase in enzymatic crosslinks was beneficial for bone where they were associated with increased toughness and decreased microdamage. Conversely, bone with increased NEG required less strain to reach failure and were less tough. NEG heterogeneously modified trabecular microarchitecture where high amounts of NEG crosslinks were found in trabecular rods and with the mechanically deleterious form of microdamage (linear microcracks). The extent of NEG in tibial cancellous bone was the dominant predictor of bone fragility and was associated with changes in microarchitecture and microdamage.	[Karim, Lamya; Vashishth, Deepak] Rensselaer Polytech Inst, Dept Biomed Engn, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA	Rensselaer Polytechnic Institute	Karim, L (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Boston, MA 02215 USA.	vashid@rpi.edu	Karim, Lamya/V-9875-2019	Karim, Lamya/0000-0002-4558-0884; Vashishth, Deepak/0000-0001-5712-0167	United States National Institutes of Health [AG20618, T32GM067545]; NIH [5 U42 RR006042]; NATIONAL CENTER FOR RESEARCH RESOURCES [U42RR006042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020618, R56AG020618] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The study was supported by United States National Institutes of Health grants AG20618 and T32GM067545. We acknowledge National Disease Research Interchange for providing human tissue with support from NIH grant 5 U42 RR006042 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed N, 2002, BIOCHEM J, V364, P1; Allen MJ, 2003, VET CLIN PATH, V32, P101, DOI 10.1111/j.1939-165X.2003.tb00323.x; Bailey AJ, 1998, MECH AGEING DEV, V106, P1, DOI 10.1016/S0047-6374(98)00119-5; Banse X, 2002, BONE, V31, P70, DOI 10.1016/S8756-3282(02)00800-1; Banse X, 2002, J BONE MINER RES, V17, P1621, DOI 10.1359/jbmr.2002.17.9.1621; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; Chevalley T, 2011, OSTEOPOROS IN PRESS; Fazzalari NL, 1998, BONE, V22, P381, DOI 10.1016/S8756-3282(97)00298-6; Felsenberg D, 2005, CLIN THER, V27, P1, DOI 10.1016/j.clinthera.2004.12.020; Fyhrie DP, 2000, BONE, V26, P169, DOI 10.1016/S8756-3282(99)00246-X; GROSS J, 1958, J EXP MED, V107, P247, DOI 10.1084/jem.107.2.247; Hernandez CJ, 2005, BONE, V37, P825, DOI 10.1016/j.bone.2005.07.019; HUI SL, 1988, J CLIN INVEST, V81, P1804, DOI 10.1172/JCI113523; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Karim L, 2011, J ORTHOP RES, V29, P1739, DOI 10.1002/jor.21448; Keaveny TM, 1997, J ORTHOPAED RES, V15, P101, DOI 10.1002/jor.1100150115; KNOTT L, 1995, BIOCHEM J, V310, P1045, DOI 10.1042/bj3101045; Knott L, 1998, BONE, V22, P181, DOI 10.1016/S8756-3282(97)00279-2; Kuster MS, 1997, J BONE JOINT SURG BR, V79B, P109, DOI 10.1302/0301-620X.79B1.6978; Liu XS, 2008, J BONE MINER RES, V23, P223, DOI 10.1359/JBMR.071009; Nazarian A, 2006, BONE, V39, P1196, DOI 10.1016/j.bone.2006.06.013; Odetti P, 2005, ANN NY ACAD SCI, V1043, P710, DOI 10.1196/annals.1333.082; Parfitt AM, 2002, J BONE MINER RES, V17, P1558, DOI 10.1359/jbmr.2002.17.8.1558; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Paschalis EP, 2004, J BONE MINER RES, V19, P2000, DOI 10.1359/JBMR.040820; Paul RG, 1996, INT J BIOCHEM CELL B, V28, P1297, DOI 10.1016/S1357-2725(96)00079-9; Rath NC, 1999, POULTRY SCI, V78, P1232, DOI 10.1093/ps/78.8.1232; Robins SP, 1996, CLIN CHEM, V42, P1621; Saito M, 2006, CALCIFIED TISSUE INT, V79, P160, DOI 10.1007/s00223-006-0035-1; Schaffler MB, 1995, BONE, V17, P521, DOI 10.1016/8756-3282(95)00370-3; SCHAFFLER MB, 1994, BONE, V15, P483, DOI 10.1016/8756-3282(94)90271-2; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Schwartz AV, 2009, J CLIN ENDOCR METAB, V94, P2380, DOI 10.1210/jc.2008-2498; Shi XT, 2010, BONE, V46, P1260, DOI 10.1016/j.bone.2010.02.005; Silva MJ, 2009, J BONE MINER RES, V24, P1618, DOI [10.1359/jbmr.090316, 10.1359/JBMR.090316]; Singer BR, 1998, J BONE JOINT SURG BR, V80B, P243, DOI 10.1302/0301-620X.80B2.7762; Sroga GE, 2011, J CHROMAT B IN PRESS; Sroga GE, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006718; Tang SY, 2007, BONE, V40, P1259, DOI 10.1016/j.bone.2006.10.031; Tang SY, 2007, BONE, V40, P1144, DOI 10.1016/j.bone.2006.12.056; Tang SY, 2010, BONE, V46, P148, DOI 10.1016/j.bone.2009.09.003; Tang SY, 2009, OSTEOPOROSIS INT, V20, P887, DOI 10.1007/s00198-008-0754-4; Valcourt U, 2007, J BIOL CHEM, V282, P5691, DOI 10.1074/jbc.M610536200; Vashishth D, 1997, J BIOMECH, V30, P763, DOI 10.1016/S0021-9290(97)00029-8; Vashishth D, 2001, BONE, V28, P195, DOI 10.1016/S8756-3282(00)00434-8; Vashishth D, 2005, CRIT REV EUKAR GENE, V15, P343, DOI 10.1615/CritRevEukarGeneExpr.v15.i4.40; Vashishth D, 2007, INT J FATIGUE, V29, P1024, DOI 10.1016/j.ijfatigue.2006.09.010; Viguet-Carrin S, 2006, OSTEOPOROSIS INT, V17, P319, DOI 10.1007/s00198-005-2035-9; Viguet-Carrin S, 2006, BONE, V39, P1073, DOI 10.1016/j.bone.2006.05.013; Viguet-Carrin S, 2010, BONE, V46, P342, DOI 10.1016/j.bone.2009.10.001; Wang X, 2002, BONE, V31, P1, DOI 10.1016/S8756-3282(01)00697-4; Wenzel TE, 1996, BONE, V19, P89, DOI 10.1016/8756-3282(96)88871-5	52	65	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35047	10.1371/journal.pone.0035047	http://dx.doi.org/10.1371/journal.pone.0035047			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514706	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600112
J	Tyan, SW; Hsu, CH; Peng, KL; Chen, CC; Kuo, WH; Lee, EYHP; Shew, JY; Chang, KJ; Juan, LJ; Lee, WH				Tyan, Shiaw-Wei; Hsu, Chih-Hung; Peng, Kai-Lin; Chen, Chun-Chin; Kuo, Wen-Hung; Lee, Eva Y. -H. P.; Shew, Jin-Yuh; Chang, King-Jen; Juan, Li-Jung; Lee, Wen-Hwa			Breast Cancer Cells Induce Stromal Fibroblasts to Secrete ADAMTS1 for Cancer Invasion through an Epigenetic Change	PLOS ONE			English	Article							DNA METHYLATION PATTERNS; H3K27 DEMETHYLASES; TUMOR STROMA; IN-VIVO; CHROMATIN; TUMORIGENESIS; EXPRESSION	Microenvironment plays an important role in cancer development. We have reported that the cancer-associated stromal cells exhibit phenotypic and functional changes compared to stromal cells neighboring to normal tissues. However, the molecular mechanisms as well as the maintenance of these changes remain elusive. Here we showed that through co-culture with breast cancer cells for at least three to four passages, breast normal tissue-associated fibroblasts (NAFs) gained persistent activity for promoting cancer cell invasion, partly via up-regulating ADAM metallopeptidase with thrombospondin type 1 motif, 1 (ADAMTS1). Furthermore, we demonstrated that the DNA methylation pattern in the ADAMTS1 promoter has no alteration. Instead, the loss of EZH2 binding to the ADAMTS1 promoter and the resulting decrease of promoter-associated histone H3K27 methylation may account for the up-regulation of ADAMTS1. Importantly, the lack of EZH2 binding and the H3K27 methylation on the ADAMTS1 promoter were sustained in cancer cell-precocultured NAFs after removal of cancer cells. These results suggest that cancer cells are capable of inducing stromal fibroblasts to secrete ADAMTS1 persistently for their invasion and the effect is epigenetically inheritable.	[Tyan, Shiaw-Wei; Hsu, Chih-Hung; Peng, Kai-Lin; Chen, Chun-Chin; Lee, Eva Y. -H. P.; Shew, Jin-Yuh; Juan, Li-Jung; Lee, Wen-Hwa] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Peng, Kai-Lin] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Kuo, Wen-Hung; Chang, King-Jen] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Chang, King-Jen] Cheng Ching Gen Hosp, Taichung, Taiwan; [Lee, Eva Y. -H. P.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Lee, Eva Y. -H. P.; Lee, Wen-Hwa] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA	Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; University of California System; University of California Irvine; University of California System; University of California Irvine	Tyan, SW (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan.	kingjen@ntu.edu.tw; ljjuan@gate.sinica.edu.tw; whlee@uci.edu	Hsu, Chih-Hung/AEM-8298-2022; Juan, Li-Jung/H-6631-2015; Lee, Wen-Hwa/C-2519-2014	Hsu, Chih-Hung/0000-0001-8071-0122; KUO, WEN-HUNG/0000-0002-9881-4605; Chang, King jen/0000-0001-9811-3422	Academia Sinica	Academia Sinica(Academia Sinica - Taiwan)	This work was supported by grants from Academia Sinica to WHL and LJJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Canals F, 2006, PROTEOMICS, V6, pS28, DOI 10.1002/pmic.200500446; Rodriguez-Manzaneque JC, 2009, INT J BIOCHEM CELL B, V41, P800, DOI 10.1016/j.biocel.2008.08.014; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Hsu CH, 2004, EMBO J, V23, P2269, DOI 10.1038/sj.emboj.7600239; Hu M, 2008, CURR OPIN GENET DEV, V18, P27, DOI 10.1016/j.gde.2007.12.006; Koken MHM, 1996, DEV BIOL, V173, P119, DOI 10.1006/dbio.1996.0011; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuno K, 2000, FEBS LETT, V478, P241, DOI 10.1016/S0014-5793(00)01854-8; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lind GE, 2006, CELL ONCOL, V28, P259; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Longpre JM, 2004, J BIOL CHEM, V279, P33237, DOI 10.1074/jbc.M313151200; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Rocks N, 2008, CANCER RES, V68, P9541, DOI 10.1158/0008-5472.CAN-08-0548; Sandy JD, 2001, J BIOL CHEM, V276, P13372, DOI 10.1074/jbc.M009737200; Sorensen AL, 2010, MOL BIOL CELL, V21, P2066, DOI 10.1091/mbc.E10-01-0018; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Tyan SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015313; Wang GG, 2007, TRENDS MOL MED, V13, P363, DOI 10.1016/j.molmed.2007.07.003; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yao JY, 2010, J BIOL CHEM, V285, P18828, DOI 10.1074/jbc.M109.077974; Zhu B, 2011, CELL RES, V21, P435, DOI 10.1038/cr.2011.26	30	51	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35128	10.1371/journal.pone.0035128	http://dx.doi.org/10.1371/journal.pone.0035128			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514714	Green Published, gold			2022-12-27	WOS:000305341600120
J	Wang, YF; Whittall, T; Rahman, D; Bunnik, EM; Vaughan, R; Scholler, J; Bergmeier, LA; Montefiori, D; Singh, M; Schuitemaker, H; Lehner, T				Wang, Yufei; Whittall, Trevor; Rahman, Durdana; Bunnik, Evelien M.; Vaughan, Robert; Scholler, Jorgen; Bergmeier, Lesley A.; Montefiori, David; Singh, Mahavir; Schuitemaker, Hanneke; Lehner, Thomas			The Role of Innate APOBEC3G and Adaptive AID Immune Responses in HLA-HIV/SIV Immunized SHIV Infected Macaques	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FOLLICULAR DENDRITIC CELLS; CYTIDINE DEAMINASE AID; CD4(+) T-CELLS; B-CELLS; EXOSOME RELEASE; HIV-1; PROTECTION; DIVERSIFICATION; EXPRESSION	The AID/APOBEC family (activation induced deaminase/apolipoprotein B mRNA editing cytokine deaminase) in B cells play important roles in adaptive and innate immunity. Whereas APOBEC3G has been studied in CD4+ T cells and myeloid cells its functional potential in B cells has received little attention. AID combines two critical functions of antibodies, class switching and affinity maturation and may serve as a functional surrogate of protection. These functions were studied following systemic immunization of rhesus macaques with recombinant HLA constructs, linked with HIV and SIV antigens and HSP70 to dextran. The results showed significant upregulation of AID in CD20+ B cells, APOBEC 3G in CD27+ memory B cells and CD4+ effector memory T cells. After immunization the upregulated APOBEC 3G and AID were directly correlated in B cells (p<0.0001). Following challenge with SHIV SF162. P4 the viral load was inversely correlated with AID in B cells and APOBEC 3G in B and T cells, suggesting that both deaminases may have protective functions. Investigation of major interactions between DC, T cells and B cells showed significant increase in membrane associated IL-15 in DC and CD40L in CD4+ T cells. IL-15 binds the IL-15 receptor complex in CD4+ T and B cells, which may reactivate the DC, T and B cell interactions. The overall results are consistent with AID inhibiting pre-entry SHIV by eliciting IgG and IgA antibodies, whereas APOBEC 3G may contribute to the post-entry control of SHIV replication and cellular spread.	[Wang, Yufei; Whittall, Trevor; Rahman, Durdana; Lehner, Thomas] Kings Coll London, Mucosal Immunol Unit, Guys Hosp, London WC2R 2LS, England; [Vaughan, Robert] Kings Coll London, Dept Tissue Typing, Guys Hosp, London WC2R 2LS, England; [Bunnik, Evelien M.; Schuitemaker, Hanneke] AMC Med Res, Amsterdam, Netherlands; [Scholler, Jorgen] Immudex, Copenhagen, Denmark; [Montefiori, David] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Singh, Mahavir] Lionex GmbH, Braunschweig, Germany; [Bergmeier, Lesley A.] Univ London, Barts Sch Med & Dent, Ctr Clin & Diagnost Oral Sci, London, England; [Bergmeier, Lesley A.] Univ London, London Sch Med & Dent, Ctr Clin & Diagnost Oral Sci, London, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Amsterdam; Academic Medical Center Amsterdam; Duke University; University of London; University of London; Queen Mary University London	Wang, YF (corresponding author), Kings Coll London, Mucosal Immunol Unit, Guys Hosp, London WC2R 2LS, England.	thomas.lehner@kcl.ac.uk		Bunnik, Evelien/0000-0003-4003-3053; Whittall, Trevor/0000-0002-2189-3675	Bill & Melinda Gates Foundation [38608]; European Union [280873]; Medical Research Council [G0600698B] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by Bill & Melinda Gates Foundation grant 38608 as part of the Collaboration for AIDS Vaccine Discovery. Parts of the work was also funded by the European Union grant ADITEC (No. 280873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR LO, 1995, J VIROL, V69, P3117, DOI 10.1128/JVI.69.5.3117-3124.1995; Babaahmady K, 2007, J VIROL, P407; Bartlett A, 2000, CLIN TRANSPLANT, V14, P520, DOI 10.1034/j.1399-0012.2000.140602.x; BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; Bevan MJ, 2011, NAT IMMUNOL, V12, P463, DOI 10.1038/ni.2041; Chiu YL, 2006, TRENDS IMMUNOL, V27, P291, DOI 10.1016/j.it.2006.04.003; Conticello SG, 2008, MOL CELL, V31, P474, DOI 10.1016/j.molcel.2008.07.009; DESROSIERS RC, 1989, P NATL ACAD SCI USA, V86, P6353, DOI 10.1073/pnas.86.16.6353; Di Noia JM, 2007, J EXP MED, V204, P3209, DOI 10.1084/jem.20071768; DORMONT D, 1995, VACCINE, V13, P295; Forthal DN, 2009, CURR OPIN HIV AIDS, V4, P388, DOI 10.1097/COH.0b013e32832f0a89; Gilbert P, 2010, J INFECT DIS, V202, P595, DOI 10.1086/654816; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2004, NAT REV IMMUNOL, V4, P868, DOI 10.1038/nri1489; HEATH SL, 1995, NATURE, V377, P740, DOI 10.1038/377740a0; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; Huber M, 2007, J INTERN MED, V262, P5, DOI 10.1111/j.1365-2796.2007.01819.x; Jakubik JJ, 2000, J VIROL, V74, P552, DOI 10.1128/JVI.74.1.552-555.2000; Jeffrey PL, 2009, EUR J IMMUNOL, V39, P1956, DOI 10.1002/eji.200939228; JOLING P, 1993, J IMMUNOL, V150, P1065; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Khatua AK, 2009, J VIROL, V83, P512, DOI 10.1128/JVI.01658-08; Kim EY, 2010, J VIROL, V84, P10402, DOI 10.1128/JVI.01223-10; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; McLellan AD, 2009, CRIT REV IMMUNOL, V29, P203, DOI 10.1615/CritRevImmunol.v29.i3.20; Moir S, 2000, J EXP MED, V192, P637, DOI 10.1084/jem.192.5.637; Morner A, 2011, J VIROL, V85, P6442, DOI 10.1128/JVI.00129-11; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; MURPHEYCORB M, 1989, SCIENCE, V246, P1293, DOI 10.1126/science.2555923; Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Pido-Lopez J, 2007, J IMMUNOL, V178, P1671, DOI 10.4049/jimmunol.178.3.1671; Rappocciolo G, 2006, PLOS PATHOG, V2, P691, DOI 10.1371/journal.ppat.0020070; Sadler HA, 2010, J VIROL, V84, P7396, DOI 10.1128/JVI.00056-10; Santiago ML, 2008, SCIENCE, V321, P1343, DOI 10.1126/science.1161121; Saunderson SC, 2008, J IMMUNOL, V180, P8146, DOI 10.4049/jimmunol.180.12.8146; Scholler J, 2010, J IMMUNOL METHODS, V360, P1, DOI 10.1016/j.jim.2010.05.008; Seidl T, 2011, IMMUNOLOGY; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; STOTT EJ, 1990, LANCET, V336, P1538, DOI 10.1016/0140-6736(90)93310-L; Sugiyama R, 2011, J BIOL CHEM, V286, P10051, DOI 10.1074/jbc.M110.166108; Sui YJ, 2010, P NATL ACAD SCI USA, V107, P9843, DOI 10.1073/pnas.0911932107; Wang YF, 1999, NAT MED, V5, P1004, DOI 10.1038/12440; Wang YF, 2010, EUR J IMMUNOL, V40, P1628, DOI 10.1002/eji.200940251; Wang Y, 2009, VACCINE, V27, P870, DOI 10.1016/j.vaccine.2008.11.084; Xu WF, 2009, NAT IMMUNOL, V10, P1008, DOI 10.1038/ni.1753	51	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34433	10.1371/journal.pone.0034433	http://dx.doi.org/10.1371/journal.pone.0034433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514633	Green Published, gold			2022-12-27	WOS:000305341600038
J	Willner, D; Daly, J; Whiley, D; Grimwood, K; Wainwright, CE; Hugenholtz, P				Willner, Dana; Daly, Joshua; Whiley, David; Grimwood, Keith; Wainwright, Claire E.; Hugenholtz, Philip			Comparison of DNA Extraction Methods for Microbial Community Profiling with an Application to Pediatric Bronchoalveolar Lavage Samples	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; BROAD-RANGE PCR; CYSTIC-FIBROSIS; MOLECULAR-IDENTIFICATION; OROPHARYNGEAL CULTURES; CLINICAL SPECIMENS; STORAGE-CONDITIONS; SPECIES RICHNESS; TAQ POLYMERASE; BACTERIAL	Barcoded amplicon sequencing is rapidly becoming a standard method for profiling microbial communities, including the human respiratory microbiome. While this approach has less bias than standard cultivation, several steps can introduce variation including the type of DNA extraction method used. Here we assessed five different extraction methods on pediatric bronchoalveolar lavage (BAL) samples and a mock community comprised of nine bacterial genera to determine method reproducibility and detection limits for these typically low complexity communities. Additionally, using the mock community, we were able to evaluate contamination and select a relative abundance cut-off threshold based on the geometric distribution that optimizes the trade off between detecting bona fide operational taxonomic units and filtering out spurious ones. Using this threshold, the majority of genera in the mock community were predictably detected by all extraction methods including the hard-to-lyse Gram-positive genus Staphylococcus. Differences between extraction methods were significantly greater than between technical replicates for both the mock community and BAL samples emphasizing the importance of using a standardized methodology for microbiome studies. However, regardless of method used, individual patients retained unique diagnostic profiles. Furthermore, despite being stored as raw frozen samples for over five years, community profiles from BAL samples were consistent with historical culturing results. The culture-independent profiling of these samples also identified a number of anaerobic genera that are gaining acceptance as being part of the respiratory microbiome. This study should help guide researchers to formulate sampling, extraction and analysis strategies for respiratory and other human microbiome samples.	[Willner, Dana; Daly, Joshua; Hugenholtz, Philip] Univ Queensland, Australian Ctr Ecogen, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Willner, Dana; Daly, Joshua; Hugenholtz, Philip] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Willner, Dana] Univ Queensland, Diamatina Inst, St Lucia, Qld, Australia; [Whiley, David; Grimwood, Keith] Royal Childrens Hosp, Infect Management & Prevent Serv, Queensland Paediat Infect Dis Lab, Brisbane, Qld, Australia; [Whiley, David; Grimwood, Keith; Wainwright, Claire E.] Univ Queensland, Queensland Childrens Med Res Inst, Royal Childrens Hosp, St Lucia, Qld, Australia; [Wainwright, Claire E.] Royal Childrens Hosp, Queensland Childrens Resp Ctr, Herston, Qld, Australia	University of Queensland; University of Queensland; University of Queensland; Royal Children's Hospital Brisbane; University of Queensland; Royal Children's Hospital Brisbane	Willner, D (corresponding author), Univ Queensland, Australian Ctr Ecogen, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.	d.willner@uq.edu.au	Wainwright, Claire E/G-4218-2013; Hugenholtz, Philip/AAD-9138-2019; Grimwood, Keith/F-9334-2011	Wainwright, Claire E/0000-0001-8389-3809; Hugenholtz, Philip/0000-0001-5386-7925; Grimwood, Keith/0000-0003-3174-9834	Children's Health Foundation Queensland [50046]	Children's Health Foundation Queensland	Children's Health Foundation Queensland (http://www.workingwonders.com.au) helped fund this work (project grant 50046). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angly F, TYSON GGRIN IN PRESS; Armstrong DS, 1996, PEDIATR PULM, V21, P267, DOI 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K; Balzer S, 2010, BIOINFORMATICS, V26, pi420, DOI 10.1093/bioinformatics/btq365; Baughman RP, 1997, AM J RESP CRIT CARE, V156, P286, DOI 10.1164/ajrccm.156.1.9610059; Binks MJ, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-161; BOTTGER EC, 1990, CLIN CHEM, V36, P1258; Bragg L, FAST HIGH S IN PRESS; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Charlson ES, 2011, AM J RESP CRITICAL C; Christensen JJ, 2001, J CLIN MICROBIOL, V39, P3520, DOI 10.1128/JCM.39.10.3520-3523.2001; Contreras M, 2010, MICROBIOL-SGM, V156, P3282, DOI 10.1099/mic.0.043174-0; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; CREETH JM, 1978, BRIT MED BULL, V34, P17, DOI 10.1093/oxfordjournals.bmb.a071454; Cuiv PO, 2011, MICROB ECOL, V61, P353, DOI 10.1007/s00248-010-9771-x; de Boer R, 2010, J MICROBIOL METH, V80, P209, DOI 10.1016/j.mimet.2009.11.009; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Fredricks DN, 2005, J CLIN MICROBIOL, V43, P5122, DOI 10.1128/JCM.43.10.5122-5128.2005; Gilchrist FJ, 2011, ARCH DIS CHILD, V96, P215, DOI 10.1136/adc.2009.177618; Grahn N, 2003, FEMS MICROBIOL LETT, V219, P87, DOI 10.1016/S0378-1097(02)01190-4; Griffen AL, 2011, ISME J; Guss AM, 2011, ISME J, V5, P20, DOI 10.1038/ismej.2010.88; Gutierrez JP, 2001, EUR RESPIR J, V17, P281, DOI 10.1183/09031936.01.17202810; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Harris JK, 2007, P NATL ACAD SCI USA, V104, P20529, DOI 10.1073/pnas.0709804104; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hodkinson BP, 2012, ENVIRON MICROBIOL, V14, P147, DOI 10.1111/j.1462-2920.2011.02560.x; Hugenholtz P, 2008, NATURE, V455, P481, DOI 10.1038/455481a; HUGHES MS, 1994, J CLIN MICROBIOL, V32, P2007, DOI 10.1128/JCM.32.8.2007-2008.1994; Khot PD, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-73; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; La Duc MT, 2009, J RAPID METH AUT MIC, V17, P350, DOI 10.1111/j.1745-4581.2009.00153.x; Lauber CL, 2010, FEMS MICROBIOL LETT, V307, P80, DOI 10.1111/j.1574-6968.2010.01965.x; Lensmar C, 1998, EUR RESPIR J, V12, P595, DOI 10.1183/09031936.98.12030595; Loonen AJM, 2011, EUR J CLIN MICROBIOL, V30, P337, DOI 10.1007/s10096-010-1090-0; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Momozawa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016952; Morgan JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010209; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; Nasidze I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023352; Nasidze I, 2009, ANAL BIOCHEM, V391, P64, DOI 10.1016/j.ab.2009.04.034; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; Niimi H, 2011, J CLIN MICROBIOL, V49, P3316, DOI 10.1128/JCM.00584-11; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Ochman H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000546; Quince C, 2008, ISME J, V2, P997, DOI 10.1038/ismej.2008.69; Quinque D, 2006, ANAL BIOCHEM, V353, P272, DOI 10.1016/j.ab.2006.03.021; Rabodonirina M, 1997, J CLIN MICROBIOL, V35, P2748, DOI 10.1128/JCM.35.11.2748-2751.1997; Rantakokko-Jalava K, 2002, J CLIN MICROBIOL, V40, P4211, DOI 10.1128/JCM.40.11.4211-4217.2002; Ray Katrina, 2011, Nat Rev Gastroenterol Hepatol, V8, P662, DOI 10.1038/nrgastro.2011.208; Rosenfeld M, 1999, PEDIATR PULM, V28, P321, DOI 10.1002/(SICI)1099-0496(199911)28:5<321::AID-PPUL3>3.0.CO;2-V; Rudkjobing VB, 2011, J CLIN MICROBIOLOGY; Salonen A, 2010, J MICROBIOL METH, V81, P127, DOI 10.1016/j.mimet.2010.02.007; Sambrook J., 2001, MOL CLONING LAB MANU; Sekhon J.S., 2011, MULTIVARIATE PROPENS; Shields MD, 2000, AM J RESP CRIT CARE, V162, pS15, DOI 10.1164/ajrccm.162.supplement_1.maic-4; Silkie SS, 2008, J MICROBIOL METH, V72, P275, DOI 10.1016/j.mimet.2007.12.011; Spangler R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007010; Tanner MA, 1998, APPL ENVIRON MICROB, V64, P3110; Teletchea F, 2005, TRENDS BIOTECHNOL, V23, P359, DOI 10.1016/j.tibtech.2005.05.006; Tringe SG, 2008, CURR OPIN MICROBIOL, V11, P442, DOI 10.1016/j.mib.2008.09.011; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wainwright CE, 2011, JAMA-J AM MED ASSOC, V306, P163, DOI 10.1001/jama.2011.954; Warnes G., GPLOTS VARIOUS R PRO; Willner D, 2011, ISME J; Willner D, 2010, P NATL ACAD SCI; Wu GD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-206; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zhao JC, 2011, J CLIN MICROBIOL, V49, P3717, DOI 10.1128/JCM.01189-11	76	98	100	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34605	10.1371/journal.pone.0034605	http://dx.doi.org/10.1371/journal.pone.0034605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514642	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600048
J	Hertzen, E; Johansson, L; Kansal, R; Hecht, A; Dahesh, S; Janos, M; Nizet, V; Kotb, M; Norrby-Teglund, A				Hertzen, Erika; Johansson, Linda; Kansal, Rita; Hecht, Alexander; Dahesh, Samira; Janos, Marton; Nizet, Victor; Kotb, Malak; Norrby-Teglund, Anna			Intracellular Streptococcus pyogenes in Human Macrophages Display an Altered Gene Expression Profile	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; HYALURONIC-ACID CAPSULE; 2-COMPONENT SIGNAL-TRANSDUCTION; VIRULENCE FACTOR REGULATION; SOFT-TISSUE INFECTION; REGULATORY SYSTEM; SALMONELLA-ENTERICA; BACTERIAL PATHOGENS; HUMAN NEUTROPHILS; GENOME SEQUENCE	Streptococcus pyogenes is an important human pathogen, which has recently gained recognition as an intracellular microorganism during the course of severe invasive infections such as necrotizing fasciitis. Although the surface anchored M protein has been identified as a pivotal factor affecting phagosomal maturation and S. pyogenes survival within macrophages, the overall transcriptional profile required for the pathogen to adapt and persist intracellularly is as of yet unknown. To address this, the gene expression profile of S. pyogenes within human macrophages was determined and compared to that of extracellular bacteria using customized microarrays and real-time qRT-PCR. In order to model the early phase of infection involving adaptation to the intracellular compartment, samples were collected 2h post-infection. Microarray analysis revealed that the expression of 145 streptococcal genes was significantly altered in the intracellular environment. The majority of differentially regulated genes were associated with metabolic and energy-dependent processes. Key up-regulated genes in early phase intracellular bacteria were ihk and irr, encoding a two-component gene regulatory system (TCS). Comparison of gene expression of selected genes at 2h and 6h post-infection revealed a dramatic shift in response regulators over time with a down-regulation of ihk/irr genes concurring with an up-regulation of the covR/S TCS. In re-infection assays, intracellular bacteria from the 6h time point exhibited significantly greater survival within macrophages than did bacteria collected at the 2h time point. An isogenic S. pyogenes mutant deficient in ihk/irr displayed significantly reduced bacterial counts when compared to wild-type bacteria following infection of macrophages. The findings illustrate how gene expression of S. pyogenes during the intracellular life cycle is fine-tuned by temporal expression of specific two-component systems.	[Hertzen, Erika; Johansson, Linda; Hecht, Alexander; Janos, Marton; Norrby-Teglund, Anna] Karolinska Inst, Ctr Infect Med, Stockholm, Sweden; [Kansal, Rita; Kotb, Malak] Univ Cincinnati, Cincinnati Med Ctr A, Cincinnati, OH USA; [Kansal, Rita; Kotb, Malak] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH USA; [Dahesh, Samira; Nizet, Victor] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Dahesh, Samira; Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	Karolinska Institutet; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of California System; University of California San Diego; University of California System; University of California San Diego	Hertzen, E (corresponding author), Karolinska Inst, Ctr Infect Med, Stockholm, Sweden.	anna.norrby-teglund@ki.se	Nizet, Victor/AAF-3190-2019	Nizet, Victor/0000-0003-3847-0422; Janos, Marton/0000-0003-1266-1466	Swedish research Council [12610, 522-2010-2868]; European Society for Clinical Microbiology and Infectiouos Diseases; Swedish Society for Medicine; Karolinska Institutet; Karolinska University Hospital; National Institute of Health [ROI AI092049, ROIAI085196]; Research and Development Office, Medical research Service, Dept. of Veterans Affairs [1IO1BX001198-01]; Veterans Affairs [I01BX001198] Funding Source: NIH RePORTER	Swedish research Council(Swedish Research CouncilEuropean Commission); European Society for Clinical Microbiology and Infectiouos Diseases; Swedish Society for Medicine; Karolinska Institutet(Karolinska Institutet); Karolinska University Hospital(Karolinska Institutet); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research and Development Office, Medical research Service, Dept. of Veterans Affairs; Veterans Affairs(US Department of Veterans Affairs)	Swedish research Council (12610, Norrby-Teglund; 522-2010-2868, Johansson), European Society for Clinical Microbiology and Infectiouos Diseases (Johansson), Swedish Society for Medicine (Johansson), Karolinska Institutet and Karolinska University Hospital (ALF). National Institute of Health (ROI AI092049 and ROIAI085196, Kotb), and by the Research and Development Office, Medical research Service, Dept. of Veterans Affairs (1IO1BX001198-01 Merit Award, Kotb). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; Aziz RK, 2005, J BACTERIOL, V187, P3311, DOI 10.1128/JB.187.10.3311-3318.2005; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Bijlsma JJE, 2005, MOL MICROBIOL, V57, P85, DOI 10.1111/j.1365-2958.2005.04668.x; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Buchanan JT, 2006, CURR BIOL, V16, P396, DOI 10.1016/j.cub.2005.12.039; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Cotter PD, 1999, J BACTERIOL, V181, P6840, DOI 10.1128/JB.181.21.6840-6843.1999; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dalton TL, 2006, MICROB PATHOGENESIS, V40, P221, DOI 10.1016/j.micpath.2006.01.005; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Faucher SP, 2006, P NATL ACAD SCI USA, V103, P1906, DOI 10.1073/pnas.0509183103; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Graham MR, 2006, AM J PATHOL, V169, P927, DOI 10.2353/ajpath.2006.060112; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Hertzen E, 2010, J INNATE IMMUN, V2, P534, DOI 10.1159/000317635; Hollands A, J INFECT DIS, V202, P11; Hulett FM, 1996, MOL MICROBIOL, V19, P933, DOI 10.1046/j.1365-2958.1996.421953.x; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Johansson L, 2010, CLIN INFECT DIS, V51, P58, DOI 10.1086/653116; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kreikemeyer B, 2001, MOL MICROBIOL, V39, P392, DOI 10.1046/j.1365-2958.2001.02226.x; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Muller C, 2008, J MOL MICROB BIOTECH, V14, P59, DOI 10.1159/000106083; Olsen RJ, 2010, ANNU REV PATHOL-MECH, V5, P1, DOI 10.1146/annurev-pathol-121808-102135; Schrager HM, 1998, J CLIN INVEST, V101, P1708, DOI 10.1172/JCI2121; Schrager HM, 1996, J CLIN INVEST, V98, P1954, DOI 10.1172/JCI118998; Shelburne SA, 2005, P NATL ACAD SCI USA, V102, P16037, DOI 10.1073/pnas.0505839102; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Staali L, 2006, CELL MICROBIOL, V8, P690, DOI 10.1111/j.1462-5822.2005.00662.x; Staali L, 2003, CELL MICROBIOL, V5, P253, DOI 10.1046/j.1462-5822.2003.00272.x; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Thulin P, 2006, PLOS MED, V3, P371, DOI 10.1371/journal.pmed.0030053; Voyich JM, 2004, J IMMUNOL, V173, P1194, DOI 10.4049/jimmunol.173.2.1194; Voyich JM, 2003, P NATL ACAD SCI USA, V100, P1996, DOI 10.1073/pnas.0337370100; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612	42	27	28	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e35218	10.1371/journal.pone.0035218	http://dx.doi.org/10.1371/journal.pone.0035218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511985	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338600071
J	Gueguen, M; Vuillerme, N; Isableu, B				Gueguen, Marc; Vuillerme, Nicolas; Isableu, Brice			Does the Integration of Haptic and Visual Cues Reduce the Effect of a Biased Visual Reference Frame on the Subjective Head Orientation?	PLOS ONE			English	Article							CENTER-OF-MASS; SPACE ORIENTATION; LIMB ORIENTATION; POSTURAL CONTROL; BODY TILT; SOMATOSENSORY CORTEX; SPATIAL ORIENTATION; INERTIA TENSOR; PERCEPTION; ROD	Background: The selection of appropriate frames of reference (FOR) is a key factor in the elaboration of spatial perception and the production of robust interaction with our environment. The extent to which we perceive the head axis orientation (subjective head orientation, SHO) with both accuracy and precision likely contributes to the efficiency of these spatial interactions. A first goal of this study was to investigate the relative contribution of both the visual and egocentric FOR (centre-of-mass) in the SHO processing. A second goal was to investigate humans' ability to process SHO in various sensory response modalities (visual, haptic and visuo-haptic), and the way they modify the reliance to either the visual or egocentric FORs. A third goal was to question whether subjects combined visual and haptic cues optimally to increase SHO certainty and to decrease the FORs disruption effect. Methodology/Principal Findings: Thirteen subjects were asked to indicate their SHO while the visual and/or egocentric FORs were deviated. Four results emerged from our study. First, visual rod settings to SHO were altered by the tilted visual frame but not by the egocentric FOR alteration, whereas no haptic settings alteration was observed whether due to the egocentric FOR alteration or the tilted visual frame. These results are modulated by individual analysis. Second, visual and egocentric FOR dependency appear to be negatively correlated. Third, the response modality enrichment appears to improve SHO. Fourth, several combination rules of the visuo-haptic cues such as the Maximum Likelihood Estimation (MLE), Winner-Take-All (WTA) or Unweighted Mean (UWM) rule seem to account for SHO improvements. However, the UWM rule seems to best account for the improvement of visuo-haptic estimates, especially in situations with high FOR incongruence. Finally, the data also indicated that FOR reliance resulted from the application of UWM rule. This was observed more particularly, in the visual dependent subject. Conclusions: Taken together, these findings emphasize the importance of identifying individual spatial FOR preferences to assess the efficiency of our interaction with the environment whilst performing spatial tasks.	[Gueguen, Marc; Isableu, Brice] Univ Paris Sud, URCIAMS Motor Control & Percept Team, Orsay, France; [Vuillerme, Nicolas; Isableu, Brice] CNRS UJF UPMF EPHE, FRE 3405, AGIM, Grenoble, France	UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Gueguen, M (corresponding author), Univ Paris Sud, URCIAMS Motor Control & Percept Team, Orsay, France.	marc.gueguen@u-psud.fr	Nicolas, Vuillerme/C-6692-2009; VUILLERME, Nicolas/U-5767-2019	Nicolas, Vuillerme/0000-0002-5202-4173; ISABLEU, Brice/0000-0002-5399-1405; VUILLERME, Nicolas/0000-0003-3773-393X	Ministere de la Recherche et de l'Enseignement Superieur	Ministere de la Recherche et de l'Enseignement Superieur	This research was funded by the Ministere de la Recherche et de l'Enseignement Superieur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasopoulos D, 1999, ANN NY ACAD SCI, V871, P379, DOI 10.1111/j.1749-6632.1999.tb09199.x; ASCH SE, 1948, J EXP PSYCHOL, V38, P455, DOI 10.1037/h0054121; ASCH SE, 1948, J EXP PSYCHOL, V38, P325, DOI 10.1037/h0057855; Aubert H., 1861, ARCH PATHOL ANAT PH, V20, P381, DOI [10.1007/BF02355256, DOI 10.1007/BF02355256]; Avillac M, 2005, NAT NEUROSCI, V8, P941, DOI 10.1038/nn1480; Barra J, 2010, BRAIN, V133, P3552, DOI 10.1093/brain/awq311; Bernardin D, 2005, EXP BRAIN RES, V167, P487, DOI 10.1007/s00221-005-0161-4; Bock O, 1997, EXP BRAIN RES, V115, P507, DOI 10.1007/PL00005720; Brandt T, 1998, BRAIN, V121, P1749, DOI 10.1093/brain/121.9.1749; Bray A, 2004, CURR BIOL, V14, pR609, DOI 10.1016/j.cub.2004.07.040; Bresciani JP, 2006, J VISION, V6, P554, DOI 10.1167/6.5.2; Bringoux L, 2008, EXP BRAIN RES, V185, P673, DOI 10.1007/s00221-007-1194-7; Bringoux L, 2009, PERCEPTION, V38, P1053, DOI 10.1068/p6089; Clark B, 1968, Acta Otolaryngol, V65, P373, DOI 10.3109/00016486809120978; Coq JO, 2001, NEUROSCIENCE, V104, P705, DOI 10.1016/S0306-4522(01)00123-3; Deneve S, 2004, J PHYSIOLOGY-PARIS, V98, P249, DOI 10.1016/j.jphysparis.2004.03.011; Deutschlander A, 2002, HUM BRAIN MAPP, V16, P92, DOI 10.1002/hbm.10030; Dieterich M, 2000, CURR OPIN NEUROL, V13, P13, DOI 10.1097/00019052-200002000-00004; Dyde RT, 2002, EXP BRAIN RES, V144, P518, DOI 10.1007/s00221-002-1065-1; Elbert T, 1998, NEUROREPORT, V9, P3571, DOI 10.1097/00001756-199811160-00006; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Ernst MO, 2004, TRENDS COGN SCI, V8, P162, DOI 10.1016/j.tics.2004.02.002; Fourre B, 2009, NEUROSCI LETT, V465, P230, DOI 10.1016/j.neulet.2009.07.005; GOODENOUGH DR, 1979, PERCEPT PSYCHOPHYS, V25, P419, DOI 10.3758/BF03199851; GRAYBIEL A, 1952, AMA ARCH OPHTHALMOL, V48, P605; Guerraz M, 1998, PERCEPT PSYCHOPHYS, V60, P287, DOI 10.3758/BF03206037; Guerraz M, 1998, PERCEPT MOTOR SKILL, V87, P643, DOI 10.2466/pms.1998.87.2.643; Guerraz M, 2000, ACTA OTO-LARYNGOL, V120, P735, DOI 10.1080/000164800750000261; Guerraz M, 2001, BRAIN, V124, P1646, DOI 10.1093/brain/124.8.1646; Hanavan EP, 1964, MATH MODEL HUMAN BOD, P1; Howard I. P., 1982, HUMAN VISUAL ORIENTA; Howard IP, 1986, HDB PERCEPTION HUMAN; Isableu B, 1997, EXP BRAIN RES, V114, P584, DOI 10.1007/PL00005667; Isableu B, 2010, NEUROSCIENCE, V169, P1199, DOI 10.1016/j.neuroscience.2010.05.072; Isableu B, 2009, NEUROSCIENCE, V164, P1632, DOI 10.1016/j.neuroscience.2009.08.065; Isableu B, 2008, J VESTIBUL RES-EQUIL, V18, P239; KWON Y, 2002, INT RES SPORT BIOMEC, P44; Lopez C, 2006, NEUROREPORT, V17, P797, DOI 10.1097/01.wnr.0000221843.58373.c8; Luyat M, 2001, PERCEPT PSYCHOPHYS, V63, P541, DOI 10.3758/BF03194419; MARENDAZ C, 1989, PERCEPTION, V18, P739, DOI 10.1068/p180739; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; McGuire LMM, 2009, NAT NEUROSCI, V12, P1056, DOI 10.1038/nn.2357; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; NYBORG H, 1974, SCAND J PSYCHOL, V15, P119, DOI 10.1111/j.1467-9450.1974.tb00563.x; OHLMANN T, 1991, FIELD DEPENDENCE-INDEPENDENCE, P105; OHLMANN T, 1988, THESIS U PARIS 8; Ohlmann T, 1985, FONCTIONNEMENT COGNI, P185; OLTMAN PK, 1968, PERCEPT MOTOR SKILL, V26, P503, DOI 10.2466/pms.1968.26.2.503; Oruc I, 2003, VISION RES, V43, P2451, DOI 10.1016/S0042-6989(03)00435-8; PAGANO CC, 1995, J EXP PSYCHOL HUMAN, V21, P1070, DOI 10.1037/0096-1523.21.5.1070; Pantev C, 2001, ANN NY ACAD SCI, V930, P300, DOI 10.1111/j.1749-6632.2001.tb05740.x; Reuchlin M., 1978, J PSYCHOL NORMALE PA, V2, P133; SCHONE H, 1964, AEROSPACE MED, V35, P764; Van Beuzekom AD, 2001, VISION RES, V41, P3229, DOI 10.1016/S0042-6989(01)00144-4; van de Langenberg R, 2008, J EXP PSYCHOL HUMAN, V34, P624, DOI 10.1037/0096-1523.34.3.624; van de Langenberg R, 2007, EXP BRAIN RES, V180, P595, DOI 10.1007/s00221-007-0891-6; Vingerhoets RAA, 2009, J NEUROPHYSIOL, V101, P1321, DOI 10.1152/jn.90725.2008; Witkin H A, 1981, Psychol Issues, P1; WITKIN HA, 1948, J EXP PSYCHOL, V38, P603, DOI 10.1037/h0055372; WITKIN HA, 1948, J EXP PSYCHOL, V38, P762, DOI 10.1037/h0053671; YARDLEY L, 1990, PERCEPT PSYCHOPHYS, V48, P131, DOI 10.3758/BF03207079; ZOCCOLOTTI P, 1993, PERCEPT PSYCHOPHYS, V54, P14, DOI 10.3758/BF03206933	62	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34380	10.1371/journal.pone.0034380	http://dx.doi.org/10.1371/journal.pone.0034380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509295	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600028
J	Zschenker, O; Streichert, T; Hehlgans, S; Cordes, N				Zschenker, Oliver; Streichert, Thomas; Hehlgans, Stephanie; Cordes, Nils			Genome-Wide Gene Expression Analysis in Cancer Cells Reveals 3D Growth to Affect ECM and Processes Associated with Cell Adhesion but Not DNA Repair	PLOS ONE			English	Article							BREAST-CANCER; EXTRACELLULAR-MATRIX; EPITHELIAL-CELLS; IN-VIVO; 3-DIMENSIONAL CULTURE; BASEMENT-MEMBRANE; TISSUE; PHENOTYPE; MICROENVIRONMENT; DIFFERENTIATION	Cell morphology determines cell behavior, signal transduction, protein-protein interaction, and responsiveness to external stimuli. In cancer, these functions profoundly contribute to resistance mechanisms to radio- and chemotherapy. With regard to this aspect, this study compared the genome wide gene expression in exponentially growing cell lines from different tumor entities, lung carcinoma and squamous cell carcinoma, under more physiological three-dimensional (3D) versus monolayer cell culture conditions. Whole genome cDNA microarray analysis was accomplished using the Affymetrix HG U133 Plus 2.0 gene chip. Significance analysis of microarray (SAM) and t-test analysis revealed significant changes in gene expression profiles of 3D relative to 2D cell culture conditions. These changes affected the extracellular matrix and were mainly associated with biological processes like tissue development, cell adhesion, immune system and defense response in contrast to terms related to DNA repair, which lacked significant alterations. Selected genes were verified by semi-quantitative RT-PCR and Western blotting. Additionally, we show that 3D growth mediates a significant increase in tumor cell radio- and chemoresistance relative to 2D. Our findings show significant gene expression differences between 3D and 2D cell culture systems and indicate that cellular responsiveness to external stress such as ionizing radiation and chemotherapeutics is essentially influenced by differential expression of genes involved in the regulation of integrin signaling, cell shape and cell-cell contact.	[Zschenker, Oliver; Hehlgans, Stephanie; Cordes, Nils] Tech Univ Dresden, Med Fac Carl Gustav Carus, OncoRay Natl Ctr Radiat Res Oncol, Dresden, Germany; [Streichert, Thomas] Univ Hosp Hamburg Eppendorf, Cent Labs, Dept Clin Chem, Hamburg, Germany; [Cordes, Nils] Tech Univ Dresden, Univ Hosp, Dept Radiat Oncol, Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Zschenker, O (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, OncoRay Natl Ctr Radiat Res Oncol, Dresden, Germany.	Nils.Cordes@OncoRay.de		Cordes, Nils/0000-0001-5684-629X	Federal Ministry of Education and Research, Germany (BMBF) [03ZIK041]; EFRE (European Regional Development Fund) Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen [100066308]	Federal Ministry of Education and Research, Germany (BMBF)(Federal Ministry of Education & Research (BMBF)); EFRE (European Regional Development Fund) Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen	The research and authors were in part supported by a grant from the Federal Ministry of Education and Research, Germany (BMBF Contract 03ZIK041 to N.C.) and by the EFRE (European Regional Development Fund) Europaische Fonds fur regionale Entwicklung, Europa fordert Sachsen (100066308). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARCELLOSHOFF MH, 1989, DEVELOPMENT, V105, P223; Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009; BISSELL MJ, 1987, J CELL SCI, P327; Chang TT, 2009, TISSUE ENG PT A, V15, P559, DOI 10.1089/ten.tea.2007.0434; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cheng K, 2008, BIOMATERIALS, V29, P2802, DOI 10.1016/j.biomaterials.2008.03.015; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Eke I, 2010, J CLIN INVEST, P41078, DOI 41010.41172/JCI41078; Eke I, 2012, J CLIN INVEST; Eke I, 2011, RADIOTHER ONCOL, V99, P271, DOI 10.1016/j.radonc.2011.06.007; Eke I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006434; Fournier MV, 2006, CANCER RES, V66, P7095, DOI 10.1158/0008-5472.CAN-06-0515; Ghosh S, 2005, J CELL PHYSIOL, V204, P522, DOI 10.1002/jcp.20320; Hehigans S, 2008, RADIOTHER ONCOL, V86, P329, DOI 10.1016/j.radonc.2007.09.007; Hehlgans S, 2012, INT J RAD O IN PRESS; Hehlgans S, 2009, RADIOTHER ONCOL, V92, P371, DOI 10.1016/j.radonc.2009.08.001; Hehlgans S, 2009, RADIOTHER ONCOL, V92, P362, DOI 10.1016/j.radonc.2009.07.004; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Le Beyec J, 2007, EXP CELL RES, V313, P3066, DOI 10.1016/j.yexcr.2007.04.022; Lee J, 2008, TISSUE ENG PART B-RE, V14, P61, DOI 10.1089/teb.2007.0150; Li GN, 2007, TISSUE ENG, V13, P1035, DOI 10.1089/ten.2006.0251; Martin KJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002994; Nelson CM, 2008, NAT PROTOC, V3, P674, DOI 10.1038/nprot.2008.35; NICKOLOFF BJ, 1994, J AM ACAD DERMATOL, V30, P535, DOI 10.1016/S0190-9622(94)70059-1; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Park CC, 2008, CANCER RES, V68, P4398, DOI 10.1158/0008-5472.CAN-07-6390; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Puigvert JC, 2009, MOL PHARMACOL, V75, P947, DOI 10.1124/mol.108.051649; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Sandberg R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r65; Schmeichel KL, 1998, J MAMMARY GLAND BIOL, V3, P201, DOI 10.1023/A:1018751124382; Schmeichel KL, 2003, J CELL SCI, V116, P2377, DOI 10.1242/jcs.00503; Schulze J, 2011, CANC LETT; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242; Spencer VA, 2007, ADV CANCER RES, V97, P275, DOI 10.1016/S0065-230X(06)97012-2; Storch K, 2010, CANC RES IN PRESS; Strober W, 2001, MONITORING CELL GROW; Tong L, 2009, GENE EXPRESSION, V14, P265, DOI 10.3727/105221609788681231; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231	44	93	94	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34279	10.1371/journal.pone.0034279	http://dx.doi.org/10.1371/journal.pone.0034279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509286	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600024
J	Leake, K; Singhal, J; Nagaprashantha, LD; Awasthi, S; Singhal, SS				Leake, Kathryn; Singhal, Jyotsana; Nagaprashantha, Lokesh Dalasanur; Awasthi, Sanjay; Singhal, Sharad S.			RLIP76 Regulates PI3K/Akt Signaling and Chemo-Radiotherapy Resistance in Pancreatic Cancer	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; MEDIATES DRUG-RESISTANCE; LUNG-CANCER; K-RAS; EPITHELIAL-CELLS; PROSTATE-CANCER; KIDNEY CANCER; EXPRESSION; GENE; ACTIVATION	Purpose: Pancreatic cancer is an aggressive malignancy with characteristic metastatic course of disease and resistance to conventional chemo-radiotherapy. RLIP76 is a multi-functional cell membrane protein that functions as a major mercapturic acid pathway transporter as well as key regulator of receptor-ligand complexes. In this regard, we investigated the significance of targeting RLIP76 on PI3K/Akt pathway and mechanisms regulating response to chemo-radiotherapy. Research Design and Methods: Cell survival was assessed by MTT and colony forming assays. Cellular levels of proteins and phosphorylation was determined by Western blot analyses. The impact on apoptosis was determined by TUNEL assay. The anti-cancer effects of RLIP76 targeted interventions in vivo were determined using mice xenograft model of the pancreatic cancer. The regulation of doxorubicin transport and radiation sensitivity were determined by transport studies and colony forming assays, respectively. Results: Our current studies reveal an encompassing model for the role of RLIP76 in regulating the levels of fundamental proteins like PI3K, Akt, E-cadherin, CDK4, Bcl2 and PCNA which are of specific importance in the signal transduction from critical upstream signaling cascades that determine the proliferation, apoptosis and differentiation of pancreatic cancer cells. RLIP76 depletion also caused marked and sustained regression of established human BxPC-3 pancreatic cancer tumors in nude mouse xenograft model. RLIP76 turned out to be a major regulator of drug transport along with contributing to the radiation resistance in pancreatic cancer. Conclusions/Significance: RLIP76 represents a mechanistically significant target for developing effective interventions in aggressive and refractory pancreatic cancers.	[Leake, Kathryn; Singhal, Jyotsana; Nagaprashantha, Lokesh Dalasanur; Awasthi, Sanjay; Singhal, Sharad S.] City Hope Natl Med Ctr, Beckman Res Inst, Ctr Comprehens Canc, Dept Diabet & Metab Dis Res, Duarte, CA USA	City of Hope; Beckman Research Institute of City of Hope	Leake, K (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Ctr Comprehens Canc, Dept Diabet & Metab Dis Res, Duarte, CA USA.	ssinghal@coh.org	Awasthi, Sanjay/R-4904-2019	Awasthi, Sanjay/0000-0002-5214-5717; Dalasanur Nagaprashantha, Lokesh PG/0000-0001-7041-1970	NIH [CA 77495]; Cancer Research Foundation of North Texas; NATIONAL CANCER INSTITUTE [R01CA077495] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Foundation of North Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH Grant CA 77495 and the Cancer Research Foundation of North Texas. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbunag C, 2004, CANCER RES, V64, P5659, DOI 10.1158/0008-5472.CAN-04-0807; Aguirre D, 2004, APOPTOSIS, V9, P797, DOI 10.1023/B:APPT.0000045781.46314.e2; Awasthi S, 2000, BIOCHEMISTRY-US, V39, P9327, DOI 10.1021/bi992964c; Awasthi S, 2005, CANCER RES, V65, P6022, DOI 10.1158/0008-5472.CAN-05-0968; Awasthi S, 2003, INT J CANCER, V106, P635, DOI 10.1002/ijc.11260; Awasthi S, 2002, DRUG METAB DISPOS, V30, P1300, DOI 10.1124/dmd.30.12.1300; Awasthi S, 2001, BIOCHEMISTRY-US, V40, P4159, DOI 10.1021/bi002182f; Awasthi S, 2008, CLIN CANCER RES, V14, P4372, DOI 10.1158/1078-0432.CCR-08-0145; Awasthi YC, 2004, FREE RADICAL BIO MED, V37, P607, DOI 10.1016/j.freeradbiomed.2004.05.033; AWASTHI YC, 1981, BLOOD, V58, P733; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Chen XF, 2001, ONCOGENE, V20, P6073, DOI 10.1038/sj.onc.1204736; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; Falasca M, 2011, ANTI-CANCER AGENT ME, V11, P455, DOI 10.2174/187152011795677382; FLAKS B, 1984, ENVIRON HEALTH PERSP, V56, P187, DOI 10.2307/3429845; FREEMAN JW, 1995, J CELL PHYSIOL, V165, P155, DOI 10.1002/jcp.1041650118; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; Hipfner DR, 1999, J BIOL CHEM, V274, P15420, DOI 10.1074/jbc.274.22.15420; Howlader N, 2011, SEER CANC STAT REV 1; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Karayiannakis AJ, 1998, ANTICANCER RES, V18, P4177; Kokubu N, 1997, BIOCHEM BIOPH RES CO, V230, P398, DOI 10.1006/bbrc.1996.5970; Korc M, 1998, Surg Oncol Clin N Am, V7, P25; Lautier D, 1996, BIOCHEM PHARMACOL, V52, P967, DOI 10.1016/0006-2952(96)00450-9; MARCHAND DH, 1985, BIOCHEM BIOPH RES CO, V128, P360, DOI 10.1016/0006-291X(85)91687-0; Matsumoto J, 2002, JPN J CANCER RES, V93, P1317, DOI 10.1111/j.1349-7006.2002.tb01240.x; Miller KA, 2009, CANCER RES, V69, P3689, DOI 10.1158/0008-5472.CAN-09-0024; Nagaprashantha LD, 2011, BIOCHEM PHARMACOL, V82, P1100, DOI 10.1016/j.bcp.2011.07.078; Nagaprashantha LD, 2011, CARCINOGENESIS, V32, P568, DOI 10.1093/carcin/bgr021; PELLEGATA NS, 1994, CANCER RES, V54, P1556; Perugini RA, 2000, J SURG RES, V90, P39, DOI 10.1006/jsre.2000.5833; POUR PM, 1984, ENVIRON HEALTH PERSP, V56, P229, DOI 10.2307/3429849; Sheikh R, 2010, EXPERT REV ANTICANC, V10, P1647, DOI [10.1586/era.10.148, 10.1586/ERA.10.148]; Singhal J, 2011, CANCER PREV RES, V4, P879, DOI 10.1158/1940-6207.CAPR-11-0025; Singhal SS, 2007, CANCER RES, V67, P4382, DOI 10.1158/0008-5472.CAN-06-4124; Singhal SS, 2011, MOL CANCER THER, V10, P16, DOI 10.1158/1535-7163.MCT-10-0699; Singhal SS, 2010, INT J CANCER, V126, P1327, DOI 10.1002/ijc.24767; Singhal SS, 2009, CANCER RES, V69, P4244, DOI 10.1158/0008-5472.CAN-08-3521; Singhal SS, 2009, BIOCHEM PHARMACOL, V77, P1074, DOI 10.1016/j.bcp.2008.11.013; Singhal SS, 2006, CANCER RES, V66, P2354, DOI 10.1158/0008-5472.CAN-05-3534; Singhal SS, 2005, BIOCHEM PHARMACOL, V70, P481, DOI 10.1016/j.bcp.2005.05.005; Singhal SS, 2003, INT J ONCOL, V22, P365; Strobel K, 2008, J NUCL MED, V49, P1408, DOI 10.2967/jnumed.108.051466; Stuckler D, 2005, CANCER RES, V65, P991; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; West KA, 2002, DRUG RESIST UPDATE, V5, P234, DOI 10.1016/S1368-7646(02)00120-6; Winter JM, 2008, CLIN CANCER RES, V14, P412, DOI 10.1158/1078-0432.CCR-07-0487; Yadav S, 2007, CANCER METAST REV, V26, P59, DOI 10.1007/s10555-007-9043-5	50	38	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34582	10.1371/journal.pone.0034582	http://dx.doi.org/10.1371/journal.pone.0034582			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509328	Green Submitted, Green Published, gold			2022-12-27	WOS:000304805900051
J	Nishiyama, T; Kishino, H; Suzuki, S; Ando, R; Niimura, H; Uemura, H; Horita, M; Ohnaka, K; Kuriyama, N; Mikami, H; Takashima, N; Mastuo, K; Guang, Y; Wakai, K; Hamajima, N; Tanaka, H				Nishiyama, Takeshi; Kishino, Hirohisa; Suzuki, Sadao; Ando, Ryosuke; Niimura, Hideshi; Uemura, Hirokazu; Horita, Mikako; Ohnaka, Keizo; Kuriyama, Nagato; Mikami, Haruo; Takashima, Naoyuki; Mastuo, Keitaro; Guang, Yin; Wakai, Kenji; Hamajima, Nobuyuki; Tanaka, Hideo		J-MICC Study Grp	Detailed Analysis of Japanese Population Substructure with a Focus on the Southwest Islands of Japan	PLOS ONE			English	Article							MULTIINSTITUTIONAL COLLABORATIVE COHORT; GENOME-WIDE ASSOCIATION; F-STATISTICS; R-PACKAGE; STRATIFICATION; GENOTYPES; ORIGINS; ASIA	Uncovering population structure is important for properly conducting association studies and for examining the demographic history of a population. Here, we examined the Japanese population substructure using data from the Japan Multi-Institutional Collaborative Cohort (J-MICC), which covers all but the northern region of Japan. Using 222 autosomal loci from 4502 subjects, we investigated population substructure by estimating FST among populations, testing population differentiation, and performing principal component analysis (PCA) and correspondence analysis (CA). All analyses revealed a low but significant differentiation between the Amami Islanders and the mainland Japanese population. Furthermore, we examined the genetic differentiation between the mainland population, Amami Islanders and Okinawa Islanders using six loci included in both the Pan-Asian SNP (PASNP) consortium data and the J-MICC data. This analysis revealed that the Amami and Okinawa Islanders were differentiated from the mainland population. In conclusion, we revealed a low but significant level of genetic differentiation between the mainland population and populations in or to the south of the Amami Islands, although genetic variation between both populations might be clinal. Therefore, the possibility of population stratification must be considered when enrolling the islander population of this area, such as in the J-MICC study.	[Nishiyama, Takeshi] Nagoya City Univ Hosp, Clin Trial Management Ctr, Nagoya, Aichi, Japan; [Kishino, Hirohisa] Univ Tokyo, Lab Biometry & Bioinformat, Grad Sch Agr & Life Sci, Tokyo, Japan; [Suzuki, Sadao] Nagoya City Univ, Grad Sch Med, Dept Publ Hlth, Nagoya, Aichi, Japan; [Ando, Ryosuke] Nagoya City Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi, Japan; [Niimura, Hideshi] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Int Isl & Community Med, Kagoshima 890, Japan; [Uemura, Hirokazu] Univ Tokushima, Grad Sch, Dept Prevent Med, Inst Hlth Biosci, Tokushima, Japan; [Horita, Mikako] Saga Univ, Fac Med, Dept Prevent Med, Saga 840, Japan; [Ohnaka, Keizo] Kyushu Univ, Dept Geriatr Med, Grad Sch Med Sci, Fukuoka 812, Japan; [Kuriyama, Nagato] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Epidemiol Community Hlth & Med, Kyoto, Japan; [Mikami, Haruo] Chiba Canc Ctr, Div Canc Registry Prevent & Epidemiol, Chiba 2608717, Japan; [Takashima, Naoyuki] Shiga Univ Med Sci, Dept Hlth Sci, Otsu, Shiga 52021, Japan; [Mastuo, Keitaro; Tanaka, Hideo] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan; [Guang, Yin; Wakai, Kenji; Hamajima, Nobuyuki] Nagoya Univ, Grad Sch Med, Dept Prevent Med, Nagoya, Aichi 4648601, Japan	Nagoya City University; University of Tokyo; Nagoya City University; Nagoya City University; Kagoshima University; Tokushima University; Saga University; Kyushu University; Kyoto Prefectural University of Medicine; Chiba Cancer Center; Shiga University of Medical Science; Aichi Cancer Center; Nagoya University	Nishiyama, T (corresponding author), Nagoya City Univ Hosp, Clin Trial Management Ctr, Nagoya, Aichi, Japan.	nishiyama@minos.ocn.ne.jp	Kishino, Hirohisa/U-9311-2019; Hamajima, Nobuyuki/I-7237-2014; Takashima, Naoyuki/AAG-8978-2021; Tanaka, Hideo/A-8145-2016; Wakai, Kenji/I-7248-2014	Wakai, Kenji/0000-0001-7388-7157	Ministry of Education, Culture, Sports, Science and Technology in Japan [221S0001, 17015018, 22300095]; Grants-in-Aid for Scientific Research [221S0001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Scientific Support Programs for Cancer Research, a Grant-in-Aid (No. 221S0001) for Scientific Research on Innovative Areas and by a Grants-in-Aid (No. 17015018) for Scientific Research on the Special Priority Areas of Cancer and Scientific Research (B) (No. 22300095) from the Ministry of Education, Culture, Sports, Science and Technology in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Excoffier, 2007, HDB STAT GENETICS, P980; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Goudet J, 1996, GENETICS, V144, P1933; Hamajima N, 2007, ASIAN PAC J CANCER P, V8, P317; Hammer MF, 2006, J HUM GENET, V51, P47, DOI 10.1007/s10038-005-0322-0; HAMMER MF, 1995, AM J HUM GENET, V56, P951; Horai S, 1996, AM J HUM GENET, V59, P579; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Manabe Y, INT J OSTEO IN PRESS; Manabe Y, 2008, ANTHROPOL SCI, V116, P49, DOI 10.1537/ase.070309; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Omoto K, 1997, AM J PHYS ANTHROPOL, V102, P437; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; R Core Team, 2020, R LANG ENV STAT COMP; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Tian C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003862; Wakai K, 2011, J EPIDEMIOL, V21, P223, DOI 10.2188/jea.JE20100139; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Yamaguchi-Kabata Y, 2008, AM J HUM GENET, V83, P445, DOI 10.1016/j.ajhg.2008.08.019; [No title captured]	27	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e35000	10.1371/journal.pone.0035000	http://dx.doi.org/10.1371/journal.pone.0035000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509376	gold, Green Submitted, Green Published			2022-12-27	WOS:000304805900064
J	Rutten, N; Gonzales, JL; Elbers, ARW; Velthuis, AGJ				Rutten, Niels; Gonzales, Jose L.; Elbers, Armin R. W.; Velthuis, Annet G. J.			Cost Analysis of Various Low Pathogenic Avian Influenza Surveillance Systems in the Dutch Egg Layer Sector	PLOS ONE			English	Article							RISK; POULTRY; EPIDEMIOLOGY; VALIDATION; CHICKENS; VIRUSES	Background: As low pathogenic avian influenza viruses can mutate into high pathogenic viruses the Dutch poultry sector implemented a surveillance system for low pathogenic avian influenza (LPAI) based on blood samples. It has been suggested that egg yolk samples could be sampled instead of blood samples to survey egg layer farms. To support future decision making about AI surveillance economic criteria are important. Therefore a cost analysis is performed on systems that use either blood or eggs as sampled material. Methodology/Principal Findings: The effectiveness of surveillance using egg or blood samples was evaluated using scenario tree models. Then an economic model was developed that calculates the total costs for eight surveillance systems that have equal effectiveness. The model considers costs for sampling, sample preparation, sample transport, testing, communication of test results and for the confirmation test on false positive results. The surveillance systems varied in sampled material (eggs or blood), sampling location (farm or packing station) and location of sample preparation (laboratory or packing station). It is shown that a hypothetical system in which eggs are sampled at the packing station and samples prepared in a laboratory had the lowest total costs (i.e. (sic) 273,393) a year. Compared to this a hypothetical system in which eggs are sampled at the farm and samples prepared at a laboratory, and the currently implemented system in which blood is sampled at the farm and samples prepared at a laboratory have 6% and 39% higher costs respectively. Conclusions/Significance: This study shows that surveillance for avian influenza on egg yolk samples can be done at lower costs than surveillance based on blood samples. The model can be used in future comparison of surveillance systems for different pathogens and hazards.	[Rutten, Niels; Velthuis, Annet G. J.] Wageningen Univ, Wageningen, Netherlands; [Gonzales, Jose L.; Elbers, Armin R. W.] Cent Vet Inst, Dept Epidemiol Crisis Org & Diagnost, Wageningen, Netherlands; [Gonzales, Jose L.] Univ Utrecht, Fac Vet Med, Dept Farm Anim Hlth, Utrecht, Netherlands	Wageningen University & Research; Wageningen University & Research; Utrecht University	Rutten, N (corresponding author), Wageningen Univ, Wageningen, Netherlands.	Niels.Rutten@wur.nl	Rutten, Cornelis/L-1911-2013	Rutten, Cornelis/0000-0003-2152-1596; Gonzales, Jose L/0000-0002-7889-5380; Velthuis, Annet/0000-0002-5869-8144	Central Veterinary Institute (CVI), part of Wageningen University & Research Centre, The Netherlands (WOT project) [01-001-004]; Foundation for Economic Structure Strengthening (FES) in The Netherlands: FES Program on Avian Influenza	Central Veterinary Institute (CVI), part of Wageningen University & Research Centre, The Netherlands (WOT project)(Netherlands Government); Foundation for Economic Structure Strengthening (FES) in The Netherlands: FES Program on Avian Influenza	Central Veterinary Institute (CVI), part of Wageningen University & Research Centre, The Netherlands (WOT project # 01-001-004: Veterinary Epidemiology and Risk Analysis of Notifiable Contagious Animal Diseases) and partly by the Foundation for Economic Structure Strengthening (FES) in The Netherlands: FES Program on Avian Influenza. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; [Anonymous], 2010, PLUIMVEEVLEES EIEREN, p[4, 25]; BEAN WJ, 1985, J VIROL, V54, P151, DOI 10.1128/JVI.54.1.151-160.1985; Beck JR, 2003, AVIAN DIS, V47, P1196, DOI 10.1637/0005-2086-47.s3.1196; Boender GJ, 2007, PLOS COMPUT BIOL, V3, P704, DOI 10.1371/journal.pcbi.0030071; Bowes VA, 2004, AVIAN DIS, V48, P928, DOI 10.1637/7218-060304R; Capua I, 2000, AVIAN PATHOL, V29, P289, DOI 10.1080/03079450050118403; Capua I, 2000, AVIAN PATHOL, V29, P537, DOI 10.1080/03079450020016779; de Wit E, 2008, J CLIN VIROL, V41, P1, DOI 10.1016/j.jcv.2007.10.017; Dekker SEM, 2011, LIVEST SCI, V139, P109, DOI 10.1016/j.livsci.2011.03.011; DeLiberto TJ, 2009, INTEGR ZOOL, V4, P426, DOI 10.1111/j.1749-4877.2009.00180.x; Dijkhuizen A. A., 1997, ANIMAL HLTH EC PRINC; Drummond MF, 2015, METHODS EC EVALUATIO; Elbers ARW, 2004, AVIAN DIS, V48, P691, DOI 10.1637/7149; Elbers ARW, 2007, AVIAN INFLUENZA SURV; European Commission (EC), OFFICIAL J EUROPEAN; Fischer EAJ, 2005, PREV VET MED, V67, P283, DOI 10.1016/j.prevetmed.2004.12.002; Fouchier RAM, 2004, P NATL ACAD SCI USA, V101, P1356, DOI 10.1073/pnas.0308352100; Garcia M, 1996, J GEN VIROL, V77, P1493, DOI 10.1099/0022-1317-77-7-1493; Gonzales JL, 2010, INFLUENZA OTHER RESP, V4, P91, DOI 10.1111/j.1750-2659.2009.00126.x; Gonzales JL, BAYESIAN EVALU UNPUB; Gonzales JL, 2011, VET MICROBIOLOGY; Hasler B, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-225; Harris K., 2010, ANN REPORT SURVEILLA; Henzler DJ, 2003, AVIAN DIS, V47, P1022, DOI 10.1637/0005-2086-47.s3.1022; Jeong OM, 2010, VET MICROBIOL, V144, P287, DOI 10.1016/j.vetmic.2010.01.022; Jonassen CM, 2007, AVIAN DIS, V51, P425, DOI 10.1637/7555-033106R1.1; Koch G, 2006, NJAS-WAGEN J LIFE SC, V54, P179, DOI 10.1016/S1573-5214(06)80021-7; Lewis PD, 2009, BIOL BREEDING POULTR; Martin RAJ, 2007, PREV VET MED, V79, P71, DOI 10.1016/j.prevetmed.2006.09.008; Palisade-Corporation, 2010, RISK; Perdue ML, 2005, AVIAN DIS, V49, P317, DOI 10.1637/7390-060305R.1; Rojas H, 2002, VET REC, V151, P188; Thomas ME, 2010, PREV VET MED, V95, P137, DOI 10.1016/j.prevetmed.2010.02.003; van Asseldonk MAPM, 2005, PREV VET MED, V69, P39, DOI 10.1016/j.prevetmed.2005.01.012; Velthuis AGJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019612; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA	37	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e33930	10.1371/journal.pone.0033930	http://dx.doi.org/10.1371/journal.pone.0033930			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523543	Green Published, gold			2022-12-27	WOS:000305345000012
J	Zaborin, A; Gerdes, S; Holbrook, C; Liu, DC; Zaborina, OY; Alverdy, JC				Zaborin, Alexander; Gerdes, Svetlana; Holbrook, Christopher; Liu, Donald C.; Zaborina, Olga Y.; Alverdy, John C.			Pseudomonas aeruginosa Overrides the Virulence Inducing Effect of Opioids When It Senses an Abundance of Phosphate	PLOS ONE			English	Article							GUT-DERIVED SEPSIS; ANTIBIOTIC-RESISTANCE RESERVOIR; SENSING SIGNAL MOLECULES; FUNCTIONAL-CHARACTERIZATION; HOMOSERINE LACTONES; QUINOLONE SIGNAL; HUMAN MICROFLORA; IRON; GENES; MVFR	The gut during critical illness represents a complex ecology dominated by the presence of healthcare associated pathogens, nutrient scarce conditions, and compensatory host stress signals. We have previously identified key environmental cues, opioids and phosphate depletion that independently activate the virulence of Pseudomonas aeruginosa. Opioids induce quinolone signal production (PQS), whereas phosphate depletion leads to a triangulated response between MvfR-PQS, pyoverdin, and phosphosensory/phosphoregulatory systems (PstS-PhoB). Yet how P. aeruginosa manages its response to opioids during nutrient scarce conditions when growth is limited and a quorum is unlikely to be achieved is important in the context of pathogenesis in gut during stress. To mimic this environment, we created nutrient poor conditions and exposed P. aeruginosa PAO1 to the specific k-opioid receptor agonist U-50,488. Bacterial cells exposed to the k-opioid expressed a striking increase in virulence-and multi-drug resistance-related genes that correlated to a lethal phenotype in C. elegans killing assays. Under these conditions, HHQ, a precursor of PQS, rather than PQS itself, became the main inducer for pqsABCDE operon expression. P. aeruginosa virulence expression in response to k-opioids required PqsE since Delta PqsE was attenuated in its ability to activate virulence-and efflux pumps-related genes. Extracellular inorganic phosphate completely changed the transcriptional response of PAO1 to the k-opioid preventing pqsABCDE expression, the activation of multiple virulence-and efflux pumps-related genes, and the ability of P. aeruginosa to kill C. elegans. These results indicate that when P. aeruginosa senses resource abundance in the form of phosphate, it overrides its response to compensatory host signals such as opioids to express a virulent and lethal phenotype. These studies confirm a central role for phosphate in P. aeruginosa virulence that might be exploited to design novel anti-virulence strategies.	[Zaborin, Alexander; Holbrook, Christopher; Liu, Donald C.; Zaborina, Olga Y.; Alverdy, John C.] Univ Chicago, Med Ctr, Dept Surg, Chicago, IL 60637 USA; [Gerdes, Svetlana] Fellowship Interpretat Genomes, Burr Ridge, IL USA	University of Chicago; University of Chicago Medical Center	Zaborin, A (corresponding author), Univ Chicago, Med Ctr, Dept Surg, Chicago, IL 60637 USA.	jalverdy@surgery.bsd.uchicago.edu	Zaborina, Olga/AAQ-6977-2021		National Institutes of Health [5R01GM062344-11]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant 5R01GM062344-11 (JCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babrowski T, 2012, ANN SURG, V255, P386, DOI 10.1097/SLA.0b013e3182331870; Chakraborty S, 2011, J BIOL CHEM, V286, P39417, DOI 10.1074/jbc.M111.295188; Chugani S, 2010, P NATL ACAD SCI USA, V107, P10673, DOI 10.1073/pnas.1005909107; Coleman JP, 2008, J BACTERIOL, V190, P1247, DOI 10.1128/JB.01140-07; Deziel E, 2005, MOL MICROBIOL, V55, P998, DOI 10.1111/j.1365-2958.2004.04448.x; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Dietrich LEP, 2006, MOL MICROBIOL, V61, P1308, DOI 10.1111/j.1365-2958.2006.05306.x; Diggle SP, 2003, MOL MICROBIOL, V50, P29, DOI 10.1046/j.1365-2958.2003.03672.x; Diggle SP, 2007, CHEM BIOL, V14, P87, DOI 10.1016/j.chembiol.2006.11.014; Falcone M, 2011, LANCET INFECT DIS, V11, P11, DOI 10.1016/S1473-3099(10)70301-7; Farrow JM, 2008, J BACTERIOL, V190, P7043, DOI 10.1128/JB.00753-08; Fletcher MP, 2007, NAT PROTOC, V2, P1254, DOI 10.1038/nprot.2007.158; Fletcher MP, 2007, ENVIRON MICROBIOL, V9, P2683, DOI 10.1111/j.1462-2920.2007.01380.x; Glattard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008791; Hazan R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000810; Hernandez ME, 2004, APPL ENVIRON MICROB, V70, P921, DOI 10.1128/AEM.70.2.921-928.2004; Hirsch EB, 2010, EXPERT REV PHARM OUT, V10, P441, DOI [10.1586/erp.10.49, 10.1586/ERP.10.49]; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lamarche MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024310; Lepine F, 2004, J AM SOC MASS SPECTR, V15, P862; Lepine F, 2007, BIOL CHEM, V388, P839, DOI 10.1515/BC.2007.100; Long J, 2008, SURGERY, V144, P189, DOI 10.1016/j.surg.2008.03.045; Moss J, 2008, MAYO CLIN PROC, V83, P1116, DOI 10.4065/83.10.1116; Oglesby AG, 2008, J BIOL CHEM, V283, P15558, DOI 10.1074/jbc.M707840200; Patel NJ, 2007, AM J PHYSIOL-GASTR L, V292, pG134, DOI 10.1152/ajpgi.00276.2006; Rampioni G, 2010, ENVIRON MICROBIOL, V12, P1659, DOI 10.1111/j.1462-2920.2010.02214.x; Romanowski K, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-212; Shor R, 2006, ANN CLIN LAB SCI, V36, P67; Sommer MOA, 2010, VIRULENCE, V1, P299, DOI 10.4161/viru.1.4.12010; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Trillis F, 2008, INFECT CONT HOSP EP, V29, P1074, DOI 10.1086/591863; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Xiao GP, 2006, MOL MICROBIOL, V62, P1689, DOI 10.1111/j.1365-2958.2006.05462.x; Xiao GP, 2006, MICROBIOL-SGM, V152, P1679, DOI 10.1099/mic.0.28605-0; Zaborin A, 2009, P NATL ACAD SCI USA, V106, P6327, DOI 10.1073/pnas.0813199106; Zaborina O, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040043; Zaborina O, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030035; Zhang YM, 2008, J BIOL CHEM, V283, P28788, DOI 10.1074/jbc.M804555200	39	50	53	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34883	10.1371/journal.pone.0034883	http://dx.doi.org/10.1371/journal.pone.0034883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514685	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600091
J	Alonso-Peral, MM; Sun, C; Millar, AA				Alonso-Peral, Maria M.; Sun, Cheng; Millar, Anthony A.			MicroRNA159 Can Act as a Switch or Tuning MicroRNA Independently of Its Abundance in Arabidopsis	PLOS ONE			English	Article							GAMYB-LIKE GENES; TRANSLATIONAL REPRESSION; MESSENGER-RNA; BIOGENESIS; DEATH; CELLS; DECAY	The efficacy of gene silencing by plant microRNAs (miRNAs) is generally assumed to be predominantly determined by their abundance. In Arabidopsis the highly abundant miRNA, miR159, acts as a molecular "switch'' in vegetative tissues completely silencing the expression of two GAMYB-like genes, MYB33 and MYB65. Here, we show that miR159 has a diminished silencing efficacy in the seed. Using reporter gene constructs, we determined that MIR159 and MYB33 are co-transcribed in the aleurone and embryo of germinating seeds. However in contrast to vegetative tissues, MYB33 is not completely silenced. Instead, miR159 appears to shape the spatio-temporal expression pattern of MYB33 during seed germination. Transcript profiling in a time course during seed germination in wild-type and a mir159 mutant in which miR159 is almost absent, revealed that transcript levels of the GAMYB-like genes were similar between these two genotypes during germination, but much higher in the mir159 mutant once germination had completed. This attenuation in the silencing of the GAMYB-like genes was not explained by a decrease in mature miR159 levels, which remained constant at all time points during seed germination. We propose that miR159 acts as a tuner of GAMYB-like levels in Arabidopsis germinating seeds and that the activity of this miRNA is attenuated in the seed compared to vegetative tissues. This implies that the efficacy of miRNA-mediated silencing is not solely determined by miRNA abundance and target transcript levels, but is being determined through additional mechanisms.	[Alonso-Peral, Maria M.; Sun, Cheng; Millar, Anthony A.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Alonso-Peral, Maria M.] CSIRO, Plant Ind, Canberra, ACT, Australia	Australian National University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Alonso-Peral, MM (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	tony.millar@anu.edu.au	Millar, Anthony A/C-9323-2009; Alonso Peral, Maria/C-5123-2011	Millar, Anthony/0000-0002-6668-1326	Australian Research Council [DP0773270]	Australian Research Council(Australian Research Council)	This research was supported by an Australian Research Council (http://www.arc.gov.au/default.htm) grant DP0773270. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen RS, 2007, P NATL ACAD SCI USA, V104, P16371, DOI 10.1073/pnas.0707653104; Allen Robert S, 2010, Silence, V1, P18, DOI 10.1186/1758-907X-1-18; Alonso-Peral MM, 2010, PLANT PHYSIOL, V154, P757, DOI 10.1104/pp.110.160630; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bethke PC, 2007, PLANT PHYSIOL, V143, P1173, DOI 10.1104/pp.106.093435; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Ma J, 2010, CURR BIOL, V20, P265, DOI 10.1016/j.cub.2009.12.042; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Zhu HL, 2011, CELL, V145, P242, DOI 10.1016/j.cell.2011.03.024	18	39	41	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34751	10.1371/journal.pone.0034751	http://dx.doi.org/10.1371/journal.pone.0034751			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511963	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600049
J	Bouchery, T; Denece, G; Attout, T; Ehrhardt, K; Lhermitte-Vallarino, N; Hachet-Haas, M; Galzi, JL; Brotin, E; Bachelerie, F; Gavotte, L; Moulia, C; Bain, O; Martin, C				Bouchery, Tiffany; Denece, Gaelle; Attout, Tarik; Ehrhardt, Katharina; Lhermitte-Vallarino, Nathaly; Hachet-Haas, Muriel; Galzi, Jean Luc; Brotin, Emilie; Bachelerie, Francoise; Gavotte, Laurent; Moulia, Catherine; Bain, Odile; Martin, Coralie			The Chemokine CXCL12 Is Essential for the Clearance of the Filaria Litomosoides sigmodontis in Resistant Mice	PLOS ONE			English	Article							CELL-DERIVED FACTOR-1; MESOTHELIAL CELLS; MURINE FILARIASIS; FACTOR-I; HUMAN ONCHOCERCIASIS; IMMUNE-RESPONSES; EPITHELIAL-CELLS; RECEPTOR CXCR4; WHIM SYNDROME; BONE-MARROW	Litomosoides sigmodontis is a cause of filarial infection in rodents. Once infective larvae overcome the skin barrier, they enter the lymphatic system and then settle in the pleural cavity, causing soft tissue infection. The outcome of infection depends on the parasite's modulatory ability and also on the immune response of the infected host, which is influenced by its genetic background. The goal of this study was to determine whether host factors such as the chemokine axis CXCL12/CXCR4, which notably participates in the control of immune surveillance, can influence the outcome of the infection. We therefore set up comparative analyses of subcutaneous infection by L. sigmodontis in two inbred mouse strains with different outcomes: one susceptible strain (BALB/c) and one resistant strain (C57BL/6). We showed that rapid parasite clearance was associated with a L. sigmodontis-specific CXCL12-dependent cell response in C57BL/6 mice. CXCL12 was produced mainly by pleural mesothelial cells during infection. Conversely, the delayed parasite clearance in BALB/c mice was neither associated with an increase in CXCL12 levels nor with cell influx into the pleural cavity. Remarkably, interfering with the CXCL12/CXCR4 axis in both strains of mice delayed filarial development, as evidenced by the postponement of the fourth molting process. Furthermore, the in vitro growth of stage 4 filariae was favored by the addition of low amounts of CXCL12. The CXCL12/CXCR4 axis thus appears to have a dual effect on the L. sigmodontis life cycle: by acting as a host-cell restriction factor for infection, and as a growth factor for worms.	[Bouchery, Tiffany; Denece, Gaelle; Attout, Tarik; Ehrhardt, Katharina; Lhermitte-Vallarino, Nathaly; Bain, Odile; Martin, Coralie] Museum Natl Hist Nat, MCAM MNHN CNRS UMR 7245, F-75231 Paris, France; [Bouchery, Tiffany; Denece, Gaelle; Attout, Tarik; Ehrhardt, Katharina; Lhermitte-Vallarino, Nathaly; Bain, Odile; Martin, Coralie] Museum Natl Hist Nat, OSEB MNHN CNRS UMR 7205, F-75231 Paris, France; [Hachet-Haas, Muriel; Galzi, Jean Luc] Ecole Super Biotechnol Strasbourg, UMR 7242, IREBS, Illkirch Graffenstaden, France; [Bachelerie, Francoise] Univ Paris 11, INSERM UMR S 996, LabEx LERMIT, Clamart, France; [Gavotte, Laurent; Moulia, Catherine] Univ Montpellier 2, ISEM CNRS, UMR 5554, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Bouchery, T (corresponding author), Museum Natl Hist Nat, MCAM MNHN CNRS UMR 7245, F-75231 Paris, France.	cmartin@mnhn.fr	Gavotte, Laurent/T-1987-2019; Martin, Coralie/N-6293-2018; martin, coralie/O-3983-2019; BROTIN, Emilie/L-2042-2015; BACHELERIE, FRANCOISE/F-8823-2013	Gavotte, Laurent/0000-0002-6730-0767; martin, coralie/0000-0003-3801-2595; BACHELERIE, FRANCOISE/0000-0002-0399-3277; bouchery, tiffany/0000-0003-3743-7356	European Community [INCO-CT-2006-032321, FP7-HEALTH-2010-243121]; Agence Nationale de Recherche [ANR-07-MRAR-029]; Region Ile de France	European Community(European Commission); Agence Nationale de Recherche(French National Research Agency (ANR)); Region Ile de France(Region Ile-de-France)	This work was supported by European Community grants INCO-CT-2006-032321 and FP7-HEALTH-2010-243121 and Agence Nationale de Recherche ANR-07-MRAR-029. T. Attout was supported by a postdoctoral fellowship from Region Ile de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Qaoud KM, 2000, INT IMMUNOL, V12, P899, DOI 10.1093/intimm/12.6.899; Allen JE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000217; AlQaoud KM, 1997, INFECT IMMUN, V65, P2457, DOI 10.1128/IAI.65.6.2457-2461.1997; Amara A, 1999, J BIOL CHEM, V274, P23916, DOI 10.1074/jbc.274.34.23916; Anderson C. R, 2009, KEYS NEMATODE PARASI; Antony VB, 2003, EUR RESPIR J, V21, P539, DOI 10.1183/09031936.03.00403902; Attout T, 2008, PARASITOL INT, V57, P201, DOI 10.1016/j.parint.2008.01.001; Babayan S, 2005, MED MICROBIOL IMMUN, V194, P151, DOI 10.1007/s00430-004-0226-1; Babayan S, 2003, INFECT IMMUN, V71, P6820, DOI 10.1128/IAI.71.12.6820-6829.2003; Babayan SA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000525; Babu S, 2005, J INFECT DIS, V191, P1018, DOI 10.1086/427658; Bachelerie F, 2010, DIS MARKERS, V29, P189, DOI [10.3233/DMA-2010-0736, 10.1155/2010/475104]; BAIN O, 2003, FILARIA J, V2, P16, DOI DOI 10.1186/1475-2883-2-16; Balabanian K, 2003, J IMMUNOL, V170, P3392, DOI 10.4049/jimmunol.170.6.3392; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Brattig NW, 2004, MICROBES INFECT, V6, P113, DOI 10.1016/j.micinf.2003.11.003; Choi EH, 2003, EXPERT REV MOL DIAGN, V3, P367, DOI 10.1586/14737159.3.3.367; Colmont CS, 2011, NEPHROL DIAL TRANSPL; Coulomb-L'Hermine A, 1999, P NATL ACAD SCI USA, V96, P8585, DOI 10.1073/pnas.96.15.8585; Negrete-Garcia MC, 2010, CHEST, V138, P100, DOI 10.1378/chest.09-2104; DeVries ME, 2006, J IMMUNOL, V176, P401, DOI 10.4049/jimmunol.176.1.401; DIAGNE M, 1990, ANN PARASIT HUM COMP, V65, P193, DOI 10.1051/parasite/1990654193; Doyle TM, 2010, EUR RESP J; Ferri E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020843; Forster R, 1998, J IMMUNOL, V160, P1522; Foussat A, 2001, EUR J IMMUNOL, V31, P350, DOI 10.1002/1521-4141(200102)31:2<350::AID-IMMU350>3.0.CO;2-0; Fredriksson R, 2005, MOL PHARMACOL, V67, P1414, DOI 10.1124/mol.104.009001; Garnica MR, 2002, IMMUNOL LETT, V83, P47, DOI 10.1016/S0165-2478(02)00067-6; Goostrey A, 2005, DEV COMP IMMUNOL, V29, P229, DOI 10.1016/j.dci.2004.06.012; Hachet-Haas M, 2008, J BIOL CHEM, V283, P23189, DOI 10.1074/jbc.M803947200; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hartmann W, 2011, J IMMUNOL, V186, P2472, DOI 10.4049/jimmunol.0902157; Hoerauf A, 2002, TRENDS PARASITOL, V18, P25, DOI 10.1016/S1471-4922(01)02173-0; Hu JS, 2006, AM J PATHOL, V169, P424, DOI 10.2353/ajpath.2006.051234; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Kajiyama H, 2008, INT J CANCER, V122, P91, DOI 10.1002/ijc.23083; Karin N, 2010, J LEUKOCYTE BIOL, V88, P463, DOI 10.1189/jlb.0909602; Katayama H, 2002, AM J RESP CELL MOL, V26, P398, DOI 10.1165/ajrcmb.26.4.4613; Khan A, 2007, CURR MED CHEM, V14, P2257, DOI 10.2174/092986707781696618; Kowalska MA, 1999, BRIT J HAEMATOL, V104, P220, DOI 10.1046/j.1365-2141.1999.01169.x; Kucia M, 2004, J MOL HISTOL, V35, P233; Kuroda N, 2003, IMMUNOGENETICS, V54, P884, DOI 10.1007/s00251-002-0531-z; Lee DL, BIOL NEMATODES; Liekens S, 2010, CURR PHARM DESIGN, V16, P3903, DOI 10.2174/138161210794455003; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Machelon V, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-97; MAIZELS RM, 1995, PARASITOL TODAY, V11, P50, DOI 10.1016/0169-4758(95)80116-2; Mancardi S, 2003, IMMUNOLOGY, V108, P523, DOI 10.1046/j.1365-2567.2003.01613.x; Marechal P, 1996, PARASITE, V3, P25, DOI 10.1051/parasite/1996031025; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Martin C, 2010, PARASITE, V17, P79, DOI 10.1051/parasite/2010172079; Martin C, 2000, INFECT IMMUN, V68, P3651, DOI 10.1128/IAI.68.6.3651-3656.2000; Martin C, 2000, MED MICROBIOL IMMUN, V189, P67, DOI 10.1007/PL00008258; Martin C, 2006, BRIT J HAEMATOL, V134, P326, DOI 10.1111/j.1365-2141.2006.06181.x; McCormick PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008102; Mohle R, 1998, BLOOD, V91, P4523, DOI 10.1182/blood.V91.12.4523.412k04_4523_4530; Nagasawa T, 1996, P NATL ACAD SCI USA, V93, P14726, DOI 10.1073/pnas.93.25.14726; Park JH, 2007, J IMMUNOL, V179, P514, DOI 10.4049/jimmunol.179.1.514; Park JS, 2003, SCAND J IMMUNOL, V57, P463, DOI 10.1046/j.1365-3083.2003.01201.x; PETIT G, 1992, ANN PARASIT HUM COMP, V67, P144, DOI 10.1051/parasite/1992675144; Salvatore P, 2010, CURR MED CHEM, V17, P3019, DOI 10.2174/092986710791959792; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Topley N, 1996, IMMUNOBIOLOGY, V195, P563, DOI 10.1016/S0171-2985(96)80022-2; Turner JD, 2009, J BIOL CHEM, V284, P22364, DOI 10.1074/jbc.M901528200; Volkmann L, 2003, MED MICROBIOL IMMUN, V192, P23, DOI 10.1007/S00430-002-0155-9; Zlotnik A, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-243; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	70	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34971	10.1371/journal.pone.0034971	http://dx.doi.org/10.1371/journal.pone.0034971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511975	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600061
J	Greenall, SA; Gherardi, E; Liu, ZQ; Donoghue, JF; Vitali, AA; Li, Q; Murphy, R; Iamele, L; Scott, AM; Johns, TG				Greenall, Sameer A.; Gherardi, Ermanno; Liu, Zhanqi; Donoghue, Jacqueline F.; Vitali, Angela A.; Li, Qian; Murphy, Roger; Iamele, Luisa; Scott, Andrew M.; Johns, Terrance G.			Non-Agonistic Bivalent Antibodies That Promote c-MET Degradation and Inhibit Tumor Growth and Others Specific for Tumor Related c-MET	PLOS ONE			English	Article							FACTOR-RECEPTOR; MONOCLONAL-ANTIBODIES; ONCOGENE ADDICTION; ANTITUMOR-ACTIVITY; TYROSINE KINASE; IN-VIVO; HEPATOCYTE; CANCER; PROTOONCOGENE; HGF	The c-MET receptor has a function in many human cancers and is a proven therapeutic target. Generating antagonistic or therapeutic monoclonal antibodies (mAbs) targeting c-MET has been difficult because bivalent, intact anti-Met antibodies frequently display agonistic activity, necessitating the use of monovalent antibody fragments for therapy. By using a novel strategy that included immunizing with cells expressing c-MET, we obtained a range of mAbs. These c-MET mAbs were tested for binding specificity and anti-tumor activity using a range of cell-based techniques and in silico modeling. The LMH 80 antibody bound an epitope, contained in the small cysteine-rich domain of c-MET (amino acids 519-561), that was preferentially exposed on the c-MET precursor. Since the c-MET precursor is only expressed on the surface of cancer cells and not normal cells, this antibody is potentially tumor specific. An interesting subset of our antibodies displayed profound activities on c-MET internalization and degradation. LMH 87, an antibody binding the loop connecting strands 3d and 4a of the 7-bladed beta-propeller domain of c-MET, displayed no intrinsic agonistic activity but promoted receptor internalization and degradation. LMH 87 inhibited HGF/SF-induced migration of SK-OV-3 ovarian carcinoma cells, the proliferation of A549 lung cancer cells and the growth of human U87MG glioma cells in a mouse xenograft model. These results indicate that c-MET antibodies targeting epitopes controlling receptor internalization and degradation provide new ways of controlling c-MET expression and activity and may enable the therapeutic targeting of c-MET by intact, bivalent antibodies.	[Greenall, Sameer A.; Donoghue, Jacqueline F.; Li, Qian; Johns, Terrance G.] Monash Univ, Oncogen Signaling Lab, Monash Inst Med Res, Clayton, Vic, Australia; [Gherardi, Ermanno; Iamele, Luisa] MRC Ctr, Cambridge, England; [Liu, Zhanqi; Vitali, Angela A.; Murphy, Roger; Scott, Andrew M.] Ludwig Inst Canc Res, Tumour Targeting Lab, Heidelberg, Vic, Australia	Monash University; MRC Laboratory Molecular Biology; Ludwig Institute for Cancer Research	Greenall, SA (corresponding author), CSIRO, Div Mat Sci & Engn, Parkville, Vic, Australia.	terry.johns@monash.edu	Johns, Terrance/C-2441-2008; Gherardi, Ermanno/AAB-9608-2022	Johns, Terrance/0000-0002-8874-4543; Greenall, Sameer/0000-0002-1461-7111; GHERARDI, ERMANNO/0000-0002-0016-2945; Scott, Andrew/0000-0002-6656-295X; Donoghue, Jacqueline/0000-0003-1370-2469	National Health and Medical Research Council of Australia [1012020, 280912, 487922]; James S. McDonnell Foundation [220020173]; Victorian Government's Operational Infrastructure Support Program; Victorian Cancer Agency; MRC [G0800858] Funding Source: UKRI; Medical Research Council [G0800858] Funding Source: researchfish	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); James S. McDonnell Foundation; Victorian Government's Operational Infrastructure Support Program; Victorian Cancer Agency; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funding from the National Health and Medical Research Council of Australia (#1012020, #280912 and #487922), the James S. McDonnell Foundation (#220020173) and the Victorian Government's Operational Infrastructure Support Program. T. G. J. is a recipient of a Clinical Fellowship from the Victorian Cancer Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abounader R, 2005, NEURO-ONCOLOGY, V7, P436, DOI 10.1215/S1152851705000050; Adams TE, 2009, GROWTH FACTORS, V27, P141, DOI 10.1080/08977190902843565; Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Bates PA, 2001, PROTEINS, P39; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bu R, 2011, LAB INVEST, V91, P124, DOI 10.1038/labinvest.2010.136; Burgess T, 2006, CANCER RES, V66, P1721, DOI 10.1158/0008-5472.CAN-05-3329; Cao B, 2001, P NATL ACAD SCI USA, V98, P7443, DOI 10.1073/pnas.131200498; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Eder JP, 2009, CLIN CANCER RES, V15, P2207, DOI 10.1158/1078-0432.CCR-08-1306; FALETTO DL, 1992, ONCOGENE, V7, P1149; Garrett TPJ, 2009, P NATL ACAD SCI USA, V106, P5082, DOI 10.1073/pnas.0811559106; Giacobini P, 2002, ENDOCRINOLOGY, V143, P3306, DOI 10.1210/en.2002-220146; Giordano S, 2009, CURR OPIN MOL THER, V11, P448; Gomes DA, 2008, J BIOL CHEM, V283, P4344, DOI 10.1074/jbc.M706550200; Jin HK, 2008, CANCER RES, V68, P4360, DOI 10.1158/0008-5472.CAN-07-5960; Kim KJ, 2006, CLIN CANCER RES, V12, P1292, DOI 10.1158/1078-0432.CCR-05-1793; KOMADA M, 1993, FEBS LETT, V328, P25, DOI 10.1016/0014-5793(93)80958-W; Kong DS, 2009, CANCER-AM CANCER SOC, V115, P140, DOI 10.1002/cncr.23972; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liu W, 2011, J CLIN NEUROSCI, V18, P119, DOI 10.1016/j.jocn.2010.05.010; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Martens T, 2006, CLIN CANCER RES, V12, P6144, DOI 10.1158/1078-0432.CCR-05-1418; MIZUNO K, 1993, J BIOCHEM-TOKYO, V114, P96, DOI 10.1093/oxfordjournals.jbchem.a124147; MONDINO A, 1991, MOL CELL BIOL, V11, P6084, DOI 10.1128/MCB.11.12.6084; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Okamoto W, 2010, MOL CANCER THER, V9, P2785, DOI 10.1158/1535-7163.MCT-10-0481; Pacchiana G, 2010, J BIOL CHEM, V285, P36149, DOI 10.1074/jbc.M110.134031; Petrelli A, 2006, P NATL ACAD SCI USA, V103, P5090, DOI 10.1073/pnas.0508156103; Pillay V, 2009, NEOPLASIA, V11, P448, DOI 10.1593/neo.09230; Prat M, 1998, J CELL SCI, V111, P237; RODRIGUES GA, 1991, MOL CELL BIOL, V11, P2962, DOI 10.1128/MCB.11.6.2962; RONG S, 1992, MOL CELL BIOL, V12, P5152, DOI 10.1128/MCB.12.11.5152; Schelter F, 2010, J BIOL CHEM, V285, P26335, DOI 10.1074/jbc.M110.106435; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Stella GM, 2010, EXPERT OPIN INV DRUG, V19, P1381, DOI 10.1517/13543784.2010.522988; Yu YL, 2002, CANCER RES, V62, P2951	38	26	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34658	10.1371/journal.pone.0034658	http://dx.doi.org/10.1371/journal.pone.0034658			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511956	Green Published, gold			2022-12-27	WOS:000305338600042
J	Cheng, J; Xue, HP; Zhao, X				Cheng, Jing; Xue, Huping; Zhao, Xin			Variation of Serine-Aspartate Repeats in Membrane Proteins Possibly Contributes to Staphylococcal Microevolution	PLOS ONE			English	Article							CLUMPING FACTOR; DNA REPEATS; ESCHERICHIA-COLI; CONTINGENCY LOCI; HUMAN INFECTIONS; SURFACE PROTEIN; AUREUS; REPLICATION; MINISATELLITE; MISALIGNMENT	Tandem repeats (either as microsatellites or minisatellites) in eukaryotic and prokaryotic organisms are mutation-prone DNA. While minisatellites in prokaryotic genomes are underrepresented, the cell surface adhesins of bacteria often contain the minisatellite SD repeats, encoding the amino acid pair of serine-asparatate, especially in Staphylococcal strains. However, their relationship to biological functions is still elusive. In this study, effort was made to uncover the copy number variations of SD repeats by bioinformatic analysis and to detect changes in SD repeats during a plasmid-based assay, as a first step to understand its biological functions. The SD repeats were found to be mainly present in the cell surface proteins. The SD repeats were genetically unstable and polymorphic in terms of copy numbers and sequence compositions. Unlike SNPs, the change of its copy number was reversible, without frame shifting. More significantly, a rearrangement hot spot, the ATTC/AGRT site, was found to be mainly responsible for the instability and reversibility of SD repeats. These characteristics of SD repeats may facilitate bacteria to respond to environmental changes, with low cost, low risk and high efficiency.	[Cheng, Jing; Xue, Huping; Zhao, Xin] McGill Univ, Dept Anim Sci, Montreal, PQ, Canada; [Xue, Huping] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	McGill University; Fudan University	Cheng, J (corresponding author), McGill Univ, Dept Anim Sci, Montreal, PQ, Canada.	xin.zhao@mcgill.ca	Zhao, Xin/M-4312-2015	Zhao, Xin/0000-0002-1078-7332	Natural Science and Engineering Research Council of Canada (NSERC)	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by funding from a discovery grant from Natural Science and Engineering Research Council of Canada (NSERC) to X. Zhao. H. Xue is a recipient of a scholarship from China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrecubieta C, 2007, J BIOL CHEM, V282, P18767, DOI 10.1074/jbc.M610940200; Barlow Miriam, 2009, V532, P397, DOI 10.1007/978-1-60327-853-9_23; Bayliss CD, 2001, J CLIN INVEST, V107, P657, DOI 10.1172/JCI12557; Bowen S, 2005, YEAST, V22, P659, DOI 10.1002/yea.1240; Bzymek M, 1999, J BACTERIOL, V181, P477, DOI 10.1128/JB.181.2.477-482.1999; Bzymek M, 2001, P NATL ACAD SCI USA, V98, P8319, DOI 10.1073/pnas.111008398; Cederberg H, 2006, MUTAT RES-FUND MOL M, V598, P132, DOI 10.1016/j.mrfmmm.2006.01.010; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Coulson RMR, 2003, NUCLEIC ACIDS RES, V31, P653, DOI 10.1093/nar/gkg156; DIAZLAZCOZ Y, 1995, J MOL BIOL, V250, P123, DOI 10.1006/jmbi.1995.0363; FOSTER TJ, 1994, FEMS MICROBIOL LETT, V118, P199, DOI 10.1016/0378-1097(94)90504-5; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Hartford O, 1997, MOL MICROBIOL, V25, P1065, DOI 10.1046/j.1365-2958.1997.5291896.x; Hashem VI, 2002, MUTAT RES-FUND MOL M, V502, P39, DOI 10.1016/S0027-5107(02)00027-1; HULL RA, 1981, INFECT IMMUN, V33, P933, DOI 10.1128/IAI.33.3.933-938.1981; Kashi Y, 2006, TRENDS GENET, V22, P253, DOI 10.1016/j.tig.2006.03.005; Laing CR, 2011, VET MICROBIOLOGY; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; Li YC, 2004, MOL BIOL EVOL, V21, P991, DOI 10.1093/molbev/msh073; Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004; Lovett ST, 2004, MOL MICROBIOL, V52, P1243, DOI 10.1111/j.1365-2958.2004.04076.x; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Missler M, 2003, TRENDS NEUROSCI, V26, P176, DOI 10.1016/S0166-2236(03)00066-3; Monk AB, 2007, J CLIN MICROBIOL, V45, P730, DOI 10.1128/JCM.02317-06; Morag AS, 1999, J MOL BIOL, V289, P21, DOI 10.1006/jmbi.1999.2763; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Pages V, 2003, SCIENCE, V300, P1300, DOI 10.1126/science.1083964; Richard GF, 2008, MICROBIOL MOL BIOL R, V72, P686, DOI 10.1128/MMBR.00011-08; Said KB, 2010, J CLIN MICROBIOL, V48, P375, DOI 10.1128/JCM.01768-09; Said KB, 2010, FOODBORNE PATHOG DIS, V7, P111, DOI 10.1089/fpd.2009.0334; Said KB, 2009, DIAGN MICR INFEC DIS, V63, P24, DOI 10.1016/j.diagmicrobio.2008.09.004; SHIELDS DC, 1995, MOL BIOL EVOL, V12, P963; VANROOIJEN RJ, 1992, J BACTERIOL, V174, P2273, DOI 10.1128/JB.174.7.2273-2280.1992; Vergnaud G, 2000, GENOME RES, V10, P899, DOI 10.1101/gr.10.7.899; Viguera E, 2001, EMBO J, V20, P2587, DOI 10.1093/emboj/20.10.2587; Vogan AA, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-1; Xue HP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020332	37	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34756	10.1371/journal.pone.0034756	http://dx.doi.org/10.1371/journal.pone.0034756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509353	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336600056
J	Bettaieb, A; Matsuo, K; Matsuo, I; Wang, S; Melhem, R; Koromilas, AE; Haj, FG				Bettaieb, Ahmed; Matsuo, Kosuke; Matsuo, Izumi; Wang, Shuo; Melhem, Ramzi; Koromilas, Antonis E.; Haj, Fawaz G.			Protein Tyrosine Phosphatase 1B Deficiency Potentiates PERK/eIF2 alpha Signaling in Brown Adipocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ADIPOSE-TISSUE; MESSENGER-RNA; INSULIN SENSITIVITY; MICE LACKING; KINASE PERK; CELL-DEATH; ER STRESS; OBESITY; TRANSLATION	Background: Protein-tyrosine phosphatase 1B (PTP1B) is a physiological regulator of glucose homeostasis and body mass, and has been implicated in endoplasmic reticulum (ER) stress. Herein, we assess the role of PTP1B in ER stress in brown adipocytes, which are key regulators of thermogenesis and metabolic response. Methodology/Principal Findings: To determine the role of PTP1B in ER stress, we utilized brown adipose tissue (BAT) from mice with adipose-specific PTP1B deletion, and brown adipocytes deficient in PTP1B and reconstituted with PTP1B wild type (WT) or the substrate-trapping PTP1B D181A (D/A) mutant. PTP1B deficiency led to upregulation of PERK-eIF2 alpha phosphorylation and IRE1 alpha-XBP1 sub-arms of the unfolded protein response. In addition, PTP1B deficiency sensitized differentiated brown adipocytes to chemical-induced ER stress. Moreover, PERK activation and tyrosine phosphorylation were increased in BAT and adipocytes lacking PTP1B. Increased PERK activity resulted in the induction of eIF2 alpha phosphorylation at Ser51 and better translatability of ATF4 mRNA in response to ER stress. At the molecular level, we demonstrate direct interaction between PTP1B and PERK and identify PERK Tyr615 as a mediator of this association. Conclusions: Collectively, the data demonstrate that PTP1B is a physiologically-relevant modulator of ER stress in brown adipocytes and that PTP1B deficiency modulates PERK-eIF2 alpha phosphorylation and protein synthesis.	[Bettaieb, Ahmed; Matsuo, Kosuke; Matsuo, Izumi; Melhem, Ramzi; Haj, Fawaz G.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Wang, Shuo; Koromilas, Antonis E.] Sir Mortimer Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Koromilas, Antonis E.] McGill Univ, Dept Oncol, Fac Med, Montreal, PQ, Canada	University of California System; University of California Davis; Lady Davis Institute; McGill University; McGill University	Bettaieb, A (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	fghaj@ucdavis.edu			Juvenile Diabetes Research Foundation [1-2009-337]; National Institutes of Health (NIH) [R56DK084317, R01DK090492]; Canadian Institutes of Health Research (CIHR) [MOP-3816]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090492, R56DK084317] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23791653] Funding Source: KAKEN	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Research Grant from the Juvenile Diabetes Research Foundation (1-2009-337), National Institutes of Health (NIH) grants R56DK084317 and R01DK090492 to F.H., and a grant from the Canadian Institutes of Health Research (CIHR) (MOP-3816) to A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. check symbols	Agouni A, 2011, BIOCH J; Baltzis D, 2007, J BIOL CHEM, V282, P31675, DOI 10.1074/jbc.M704491200; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bettaieb A, 2011, J BIOL CHEM; Biddinger SB, 2006, ANNU REV PHYSIOL, V68, P123, DOI 10.1146/annurev.physiol.68.040104.124723; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Delibegovic M, 2009, DIABETES, V58, P590, DOI 10.2337/db08-0913; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Farmer SR, 2008, GENE DEV, V22, P1269, DOI 10.1101/gad.1681308; Fasshauer M, 2000, J BIOL CHEM, V275, P25494, DOI 10.1074/jbc.M004046200; Fasshauer M, 2001, MOL CELL BIOL, V21, P319, DOI 10.1128/MCB.21.1.319-329.2001; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1992, CELL, V68, P545, DOI 10.1016/0092-8674(92)90190-N; Gu F, 2004, J BIOL CHEM, V279, P49689, DOI 10.1074/jbc.C400261200; Haj FG, 2003, J BIOL CHEM, V278, P739, DOI 10.1074/jbc.M210194200; Haj FG, 2002, SCIENCE, V295, P1708, DOI 10.1126/science.1067566; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Kopecky J, 1995, J CLIN INVEST, V96, P2914, DOI 10.1172/JCI118363; Krishnan N, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002329; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Ma YL, 2001, RAPID COMMUN MASS SP, V15, P1693, DOI 10.1002/rcm.426; Mangus DA, 1999, METHODS, V17, P28, DOI 10.1006/meth.1998.0704; Matsuo K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016446; Nair S, 2007, TOXICOL LETT, V168, P21, DOI 10.1016/j.toxlet.2006.10.012; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Parker RA, 2005, MOL PHARMACOL, V67, P1909, DOI 10.1124/mol.104.010165; Raven JF, 2008, J BIOL CHEM, V283, P3097, DOI 10.1074/jbc.M709677200; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Sood R, 2000, BIOCHEM J, V346, P281, DOI 10.1042/0264-6021:3460281; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Su Q, 2008, J BIOL CHEM, V283, P469, DOI 10.1074/jbc.M704612200; Tseng YH, 2004, MOL CELL BIOL, V24, P1918, DOI 10.1128/MCB.24.5.1918-1929.2004; Tsukiyama-Kohara K, 2001, NAT MED, V7, P1128, DOI 10.1038/nm1001-1128; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang S, 2006, J BIOL CHEM, V281, P9439, DOI 10.1074/jbc.M504977200; WOODFORDTHOMAS TA, 1992, J CELL BIOL, V117, P401, DOI 10.1083/jcb.117.2.401; Xu C, 2004, J BIOL CHEM, V279, P17973, DOI 10.1074/jbc.M313263200; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	61	35	38	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34412	10.1371/journal.pone.0034412	http://dx.doi.org/10.1371/journal.pone.0034412			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509299	gold, Green Published, Green Submitted			2022-12-27	WOS:000304805900029
J	Dai, QY; Gao, Q; Wu, CS; Chesters, D; Zhu, CD; Zhang, AB				Dai, Qing-Yan; Gao, Qiang; Wu, Chun-Sheng; Chesters, Douglas; Zhu, Chao-Dong; Zhang, Ai-Bing			Phylogenetic Reconstruction and DNA Barcoding for Closely Related Pine Moth Species (Dendrolimus) in China with Multiple Gene Markers	PLOS ONE			English	Article							INTEGRATED SOFTWARE; DIVERGENCE TIMES; SEQUENCES; TAXONOMY; DIPTERA; IDENTIFICATION; EVOLUTIONARY; LEPIDOPTERA; ABSENCE; LIFE	Unlike distinct species, closely related species offer a great challenge for phylogeny reconstruction and species identification with DNA barcoding due to their often overlapping genetic variation. We tested a sibling species group of pine moth pests in China with a standard cytochrome c oxidase subunit I (COI) gene and two alternative internal transcribed spacer (ITS) genes (ITS1 and ITS2). Five different phylogenetic/DNA barcoding analysis methods (Maximum likelihood (ML)/Neighborjoining (NJ), "best close match" (BCM), Minimum distance (MD), and BP-based method (BP)), representing commonly used methodology (tree-based and non-tree based) in the field, were applied to both single-gene and multiple-gene analyses. Our results demonstrated clear reciprocal species monophyly for three relatively distant related species, Dendrolimus superans, D. houi, D. kikuchii, as recovered by both single and multiple genes while the phylogenetic relationship of three closely related species, D. punctatus, D. tabulaeformis, D. spectabilis, could not be resolved with the traditional tree-building methods. Additionally, we find the standard COI barcode outperforms two nuclear ITS genes, whatever the methods used. On average, the COI barcode achieved a success rate of 94.10-97.40%, while ITS1 and ITS2 obtained a success rate of 64.70-81.60%, indicating ITS genes are less suitable for species identification in this case. We propose the use of an overall success rate of species identification that takes both sequencing success and assignation success into account, since species identification success rates with multiple-gene barcoding system were generally overestimated, especially by tree-based methods, where only successfully sequenced DNA sequences were used to construct a phylogenetic tree. Non-tree based methods, such as MD, BCM, and BP approaches, presented advantages over tree-based methods by reporting the overall success rates with statistical significance. In addition, our results indicate that the most closely related species D. punctatus, D. tabulaeformis, and D. spectabilis, may be still in the process of incomplete lineage sorting, with occasional hybridizations occurring among them.	[Dai, Qing-Yan; Gao, Qiang; Zhang, Ai-Bing] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Wu, Chun-Sheng; Chesters, Douglas; Zhu, Chao-Dong] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China	Capital Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS	Dai, QY (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	zhangab2008@mail.cnu.edu.cn	ZHU, Chao-Dong/E-5961-2011; Chesters, Douglas/AAF-7926-2019	ZHU, Chao-Dong/0000-0002-9347-3178; ZHANG, Ai-bing/0000-0003-3450-5421; Gao, Qiang/0000-0002-9323-1101; zhang, ai bing/0000-0002-6580-5462	Beijing Municipal Natural Science Foundation [KZ201010028028]; Natural Science Foundation of China [31071963]; Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality [PHR201107120]; Research Fund for the Doctoral Program of Higher Education [20101108120002]; Chinese Academy of Sciences [13914G1001]; Ministry of Agriculture, China [201103024]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality; Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Agriculture, China(Ministry of Agriculture & Rural Affairs)	This study was supported by Beijing Municipal Natural Science Foundation Key Projects (No.KZ201010028028 to ZHANG) and by Natural Science Foundation of China (to ZHANG, Grant No. 31071963), by Funding Project for Academic Human Resources Development in Institutions of Higher Learning Under the Jurisdiction of Beijing Municipality (to ZHANG, Grant No. PHR201107120), by The Research Fund for the Doctoral Program of Higher Education (to ZHANG, Grant No. 20101108120002), by Grant from Chinese Academy of Sciences (Grant No. 13914G1001) and a Grant from Public Welfare Project from the Ministry of Agriculture, China (Grant No. 201103024) to ZHU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Arnheim N., 1983, P38; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Brower AVZ, 2006, SYST BIODIVERS, V4, P127, DOI 10.1017/S147720000500191X; Butler AG, 1877, ANN MAGAZINE NATURAL, V20, P473, DOI DOI 10.1080/00222937708682268; Cai BH, 1965, ACTA ENTOMOL SINICA, V14, P347; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Chu KH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S8; Ebach MC, 2005, NATURE, V434, P697, DOI 10.1038/434697b; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feliner GN, 2007, MOL PHYLOGENET EVOL, V44, P911, DOI 10.1016/j.ympev.2007.01.013; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gao T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-324; Gregory TR, 2005, NATURE, V434, P1067, DOI 10.1038/4341067b; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hajibabaei M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-24; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hendrich L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014448; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kollar V, 1844, HUGEL C F KASCHMIR R, V4, P393; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lajonquiere Yde, 1979, B SOC ENTOMOL FR, V84, P184; Lou M, 2010, MOL PHYLOGENET EVOL, V56, P187, DOI 10.1016/j.ympev.2010.01.002; Luo AR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-84; Marshall E, 2005, SCIENCE, V307, P1037, DOI 10.1126/science.307.5712.1037; MATSUMURA S., 1927, JOUR COLL AGRIC HOKKAIDO IMP UNIV, V19, P1; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meusnier I, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-214; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Nielsen R, 2006, SYST BIOL, V55, P162, DOI 10.1080/10635150500431239; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Prendini L, 2005, CAN J ZOOL, V83, P498, DOI 10.1139/Z05-025; Roe AD, 2007, MOL PHYLOGENET EVOL, V44, P325, DOI 10.1016/j.ympev.2006.12.005; Rojo S, 2006, EUR J ENTOMOL, V103, P443, DOI 10.14411/eje.2006.058; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schindel DE, 2005, NATURE, V435, P17, DOI 10.1038/435017b; Silva-Brandao KL, 2009, NEOTROP ENTOMOL, V38, P441, DOI 10.1590/S1519-566X2009000400001; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Tamhane AC, 2000, STAT DATA ANAL ELEME; Templeton A.R., 1994, Experientia Supplementum (Basel), V69, P455; Templeton AR, 2001, MOL ECOL, V10, P779, DOI 10.1046/j.1365-294x.2001.01199.x; TEMPLETON AR, 1995, GENETICS, V140, P403; Tsai Pang hua, 1962, Acta Entomologica Sinica, V11, P237; Van Houdt JKJ, 2010, MOL ECOL RESOUR, V10, P459, DOI 10.1111/j.1755-0998.2009.02800.x; Walker F, 1855, LONDON BR MUS, V6, P1418; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waugh J, 2008, BIOESSAYS, V30, P92, DOI 10.1002/bies.20698; Whitworth TL, 2007, P ROY SOC B-BIOL SCI, V274, P1731, DOI 10.1098/rspb.2007.0062; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; Zhang AB, 2008, SYST BIOL, V57, P202, DOI 10.1080/10635150802032982; Zhang AB, 2012, MOL ECOL, V21, P1848, DOI 10.1111/j.1365-294X.2011.05235.x; Zhang AB, 2009, MOL ECOL RESOUR, V9, P104, DOI 10.1111/j.1755-0998.2008.02372.x; Zhang AB, 2003, APPL ENTOMOL ZOOL, V38, P177, DOI 10.1303/aez.2003.177; Zhang AB, 2004, CHINESE BULL ENTOMOL, V2, P146, DOI DOI 10.3969/j.issn.0452-8255.2004.02.011; Zhang Ai-Binge, 2004, Acta Entomologica Sinica, V47, P236; Zhang Aibing, 2004, Journal of Beijing Forestry University, V26, P54; ZHAO Q-S, 1992, Acta Entomologica Sinica, V35, P28; Zhao Qingshan, 1999, Scientia Silvae Sinicae, V35, P45; Zimmer EA, 1980, P NATL ACAD SCI USA, V77, P2518	75	43	49	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e32544	10.1371/journal.pone.0032544	http://dx.doi.org/10.1371/journal.pone.0032544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509245	Green Published, Green Submitted, gold			2022-12-27	WOS:000304805900002
J	Richardson, TE; Yu, AE; Wen, Y; Yang, SH; Simpkins, JW				Richardson, Timothy E.; Yu, Amanda E.; Wen, Yi; Yang, Shao-Hua; Simpkins, James W.			Estrogen Prevents Oxidative Damage to the Mitochondria in Friedreich's Ataxia Skin Fibroblasts	PLOS ONE			English	Article							PRENATAL-DIAGNOSIS; FRATAXIN; PROTEIN; STRESS; BRAIN; NEUROPROTECTION; MECHANISMS; ACONITASE; LINKAGE; DISEASE	Estrogen and estrogen-related compounds have been shown to have very potent cytoprotective properties in a wide range of disease models, including an in vitro model of Friedreich's ataxia (FRDA). This study describes a potential estrogen receptor (ER)-independent mechanism by which estrogens act to protect human FRDA skin fibroblasts from a BSO-induced oxidative insult resulting from inhibition of de novo glutathione (GSH) synthesis. We demonstrate that phenolic estrogens, independent of any known ER, are able to prevent lipid peroxidation and mitochondrial membrane potential (Delta Psi m) collapse, maintain ATP at near control levels, increase oxidative phosphorylation and maintain activity of aconitase. Estrogens did not, however, prevent BSO from depleting GSH or induce an increased expression level of GSH. The cytoprotective effects of estrogen appear to be due to a direct overall reduction in oxidative damage to the mitochondria, enabling the FRDA fibroblast mitochondria to generate sufficient ATP for energy requirements and better survive oxidative stress. These data support the hypothesis that phenol ring containing estrogens are possible candidate drugs for the delay and/or prevention of FRDA symptoms.	[Richardson, Timothy E.; Yu, Amanda E.; Wen, Yi; Yang, Shao-Hua; Simpkins, James W.] Univ N Texas, Hlth Sci Ctr, Inst Aging & Alzheimers Dis Res, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Health Science Center	Richardson, TE (corresponding author), Univ N Texas, Hlth Sci Ctr, Inst Aging & Alzheimers Dis Res, Dept Pharmacol & Neurosci, Ft Worth, TX 76107 USA.	james.simpkins@unthsc.edu	Yang, Shaohua/D-1738-2013		NIH [P01 AG100485, P01 AG22550, P01 AG027956]; NIA [T32 AG020494]; NATIONAL INSTITUTE ON AGING [P01AG027956, P01AG022550, T32AG020494] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported in part by NIH Grants P01 AG100485, P01 AG22550, and P01 AG027956 and NIA Grant T32 AG020494. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mahdawi S, 2006, GENOMICS, V88, P580, DOI 10.1016/j.ygeno.2006.06.015; ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Behl C, 2002, FREE RADICAL BIO MED, V33, P182, DOI 10.1016/S0891-5849(02)00883-3; Behl C, 2000, J NEUROCYTOL, V29, P351, DOI 10.1023/A:1007109222673; BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647; BISHOP J, 1994, MOL CELL NEUROSCI, V5, P303, DOI 10.1006/mcne.1994.1036; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Bulteau AL, 2004, SCIENCE, V305, P242, DOI 10.1126/science.1098991; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Chantrel-Groussard K, 2001, HUM MOL GENET, V10, P2061, DOI 10.1093/hmg/10.19.2061; Delatycki MB, 2000, J MED GENET, V37, P1, DOI 10.1136/jmg.37.1.1; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Dykens JA, 2002, MITOCHONDRION, V1, P461, DOI 10.1016/S1567-7249(02)00011-9; Dykens JA, 2001, METHOD CELL BIOL, V65, P285, DOI 10.1016/S0091-679X(01)65018-0; Friedreich N., 1863, VIRCHOWS ARCH PATHOL, V26, P433; FRIEDREICH N, 1863, VIRCHOWS ARCH PATHOL, V27, P1; Friedreich N, 1863, VIRCHOWS ARCH PATHOL, V26, P391, DOI 10.1515/9783112391280-017; FUJITA R, 1989, GENOMICS, V4, P110, DOI 10.1016/0888-7543(89)90323-6; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gille G, 2011, J NEURAL TRANSM, V118, P349, DOI 10.1007/s00702-010-0503-7; Gonzalez-Cabo P, 2005, HUM MOL GENET, V14, P2091, DOI 10.1093/hmg/ddi214; HANAUER A, 1990, AM J HUM GENET, V46, P133; HARDING AE, 1983, LANCET, V1, P1151; HARDING AE, 1981, J MED GENET, V18, P285, DOI 10.1136/jmg.18.4.285; Isnard R, 1997, CIRCULATION, V95, P2247, DOI 10.1161/01.CIR.95.9.2247; Jauslin ML, 2007, MOL CELL BIOCHEM, V302, P79, DOI 10.1007/s11010-007-9429-2; Jauslin ML, 2003, FASEB J, V17, P1972, DOI 10.1096/fj.03-0240fje; Jauslin ML, 2002, HUM MOL GENET, V11, P3055, DOI 10.1093/hmg/11.24.3055; Krishnamoorthy RR, 1999, J BIOL CHEM, V274, P3734, DOI 10.1074/jbc.274.6.3734; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; Lodi R, 2006, ANTIOXID REDOX SIGN, V8, P438, DOI 10.1089/ars.2006.8.438; MONROS E, 1995, PRENATAL DIAG, V15, P551, DOI 10.1002/pd.1970150608; Montermini L, 1997, HUM MOL GENET, V6, P1261, DOI 10.1093/hmg/6.8.1261; Nilsen J, 2003, P NATL ACAD SCI USA, V100, P2842, DOI 10.1073/pnas.0438041100; Nilsen J, 2007, J NEUROSCI, V27, P14069, DOI 10.1523/JNEUROSCI.4391-07.2007; Pandolfo M, 1998, PRENATAL DIAG, V18, P831; Perez E, 2005, DRUG DEVELOP RES, V66, P78, DOI 10.1002/ddr.20047; Prokai L, 2005, DRUG DEVELOP RES, V66, P118, DOI 10.1002/ddr.20050; Prokai L, 2003, P NATL ACAD SCI USA, V100, P11741, DOI 10.1073/pnas.2032621100; Prokai L, 2007, J MASS SPECTROM, V42, P1583, DOI 10.1002/jms.1345; Prokai L, 2007, PHARMACOL THERAPEUT, V114, P1, DOI 10.1016/j.pharmthera.2007.01.006; Razmara A, 2008, J PHARMACOL EXP THER, V325, P782, DOI 10.1124/jpet.107.134072; Richardson TE, 2011, ENDOCRINOLOGY, V152, P2742, DOI 10.1210/en.2011-0184; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Rupprecht R, 1999, TRENDS NEUROSCI, V22, P410, DOI 10.1016/S0166-2236(99)01399-5; Sakamoto N, 2001, J BIOL CHEM, V276, P27171, DOI 10.1074/jbc.M101879200; Santos R, 2010, ANTIOXID REDOX SIGN, V13, P651, DOI 10.1089/ars.2009.3015; Sarkar SN, 2008, P NATL ACAD SCI USA, V105, P15148, DOI 10.1073/pnas.0802379105; Simpkins JW, 2008, MOL CELL ENDOCRINOL, V290, P51, DOI 10.1016/j.mce.2008.04.013; Simpkins JW, 2008, BRAIN RES REV, V57, P421, DOI 10.1016/j.brainresrev.2007.04.007; Simpkins JW, 2010, BBA-GEN SUBJECTS, V1800, P1113, DOI 10.1016/j.bbagen.2009.11.013; Stirone C, 2005, MOL PHARMACOL, V68, P959, DOI 10.1124/mol.105.014662; Toran-Allerand CD, 1999, FRONT NEUROENDOCRIN, V20, P97, DOI 10.1006/frne.1999.0177; WALLIS J, 1989, AM J MED GENET, V34, P458, DOI 10.1002/ajmg.1320340327; Wang XF, 2006, MOL PHARMACOL, V70, P395, DOI 10.1124/mol.106.022384; Yang SH, 2004, P NATL ACAD SCI USA, V101, P4130, DOI 10.1073/pnas.0306948101; Yao J, 2011, BRAIN RES, V1379, P2, DOI 10.1016/j.brainres.2010.11.090; Yi KD, 2008, J PHARMACOL EXP THER, V324, P1188, DOI 10.1124/jpet.107.132308	60	42	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34600	10.1371/journal.pone.0034600	http://dx.doi.org/10.1371/journal.pone.0034600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509330	Green Submitted, Green Published, gold			2022-12-27	WOS:000304805900053
J	Clarke, NE; Fisher, MJ; Porter, KE; Lambert, DW; Turner, AJ				Clarke, Nicola E.; Fisher, Martin J.; Porter, Karen E.; Lambert, Daniel W.; Turner, Anthony J.			Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CARDIAC FIBROBLASTS; GENE-EXPRESSION; SARS-COV; RECEPTOR; HEART; PROTEIN; DYSFUNCTION; INHIBITOR; THROMBIN	The angiotensin converting enzymes (ACEs) are the key catalytic components of the renin-angiotensin system, mediating precise regulation of blood pressure by counterbalancing the effects of each other. Inhibition of ACE has been shown to improve pathology in cardiovascular disease, whilst ACE2 is cardioprotective in the failing heart. However, the mechanisms by which ACE2 mediates its cardioprotective functions have yet to be fully elucidated. Here we demonstrate that both ACE and ACE2 bind integrin subunits, in an RGD-independent manner, and that they can act as cell adhesion substrates. We show that cellular expression of ACE2 enhanced cell adhesion. Furthermore, we present evidence that soluble ACE2 (sACE2) is capable of suppressing integrin signalling mediated by FAK. In addition, sACE2 increases the expression of Akt, thereby lowering the proportion of the signalling molecule phosphorylated Akt. These results suggest that ACE2 plays a role in cell-cell interactions, possibly acting to fine-tune integrin signalling. Hence the expression and cleavage of ACE2 at the plasma membrane may influence cell-extracellular matrix interactions and the signalling that mediates cell survival and proliferation. As such, ectodomain shedding of ACE2 may play a role in the process of pathological cardiac remodelling.	[Clarke, Nicola E.; Turner, Anthony J.] Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England; [Fisher, Martin J.] Univ Leeds, Dept Chem, Leeds LS2 9JT, W Yorkshire, England; [Porter, Karen E.] Univ Leeds, Multidisciplinary Cardiovasc Res Ctr, Leeds, W Yorkshire, England; [Lambert, Daniel W.] Univ Sheffield, Oral Dis Res Grp, Sheffield, S Yorkshire, England	University of Leeds; University of Leeds; University of Leeds; University of Sheffield	Clarke, NE (corresponding author), Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds, W Yorkshire, England.	a.j.turner@leeds.ac.uk			U.K. Biotechnology and Biological Sciences Research Council (BBSRC)	U.K. Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	NEC was supported by a U.K. Biotechnology and Biological Sciences Research Council (BBSRC; http://www.bbsrc.ac.uk/) Ph.D. research studentship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balyasnikova IV, 2008, TISSUE ANTIGENS, V72, P354, DOI 10.1111/j.1399-0039.2008.01112.x; Balyasnikova IV, 2003, TISSUE ANTIGENS, V61, P49, DOI 10.1034/j.1399-0039.2003.610104.x; BARSHAVIT R, 1993, J CELL BIOL, V123, P1279, DOI 10.1083/jcb.123.5.1279; BARSHAVIT R, 1991, J CELL BIOL, V112, P335, DOI 10.1083/jcb.112.2.335; BODE W, 1992, PROTEIN SCI, V1, P426; Burrell LM, 2005, EUR HEART J, V26, P369, DOI 10.1093/eurheartj/ehi114; Camargo SMR, 2009, GASTROENTEROLOGY, V136, P872, DOI 10.1053/j.gastro.2008.10.055; Chen H, 1999, CHEM BIOL, V6, P1, DOI 10.1016/S1074-5521(99)80015-5; Clarke NE, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/307315; Epelman S, 2009, J CARD FAIL, V15, P565, DOI 10.1016/j.cardfail.2009.01.014; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Goulter AB, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-19; Grobe JL, 2007, CLIN SCI, V113, P357, DOI 10.1042/CS20070160; Grobe JL, 2006, AM J PHYSIOL-HEART C, V290, pH2417, DOI 10.1152/ajpheart.01170.2005; Guy JL, 2008, EXP PHYSIOL, V93, P579, DOI 10.1113/expphysiol.2007.040139; Haga S, 2008, P NATL ACAD SCI USA, V105, P7809, DOI 10.1073/pnas.0711241105; HANKS SK, 1992, P NATL ACAD SCI USA, V89, P8487, DOI 10.1073/pnas.89.18.8487; Iwata M, 2005, AM J PHYSIOL-HEART C, V289, pH2356, DOI 10.1152/ajpheart.00317.2005; Ji YY, 2009, CELL PHYSIOL BIOCHEM, V23, P265, DOI 10.1159/000218173; Jimenez E, 2009, BIOCHEM BIOPH RES CO, V380, P769, DOI 10.1016/j.bbrc.2009.01.142; Jin H, 2001, CIRCULATION, V103, P736; Kassiri Z, 2009, CIRC-HEART FAIL, V2, P446, DOI 10.1161/CIRCHEARTFAILURE.108.840124; KERJASCHKI D, 1989, AM J PATHOL, V134, P481; Krishnamurthy P, 2006, HEART, V92, P1309, DOI 10.1136/hrt.2005.071001; Lambert DW, 2008, FEBS LETT, V582, P385, DOI 10.1016/j.febslet.2007.11.085; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Lambert DW, 2009, CELL MOL LIFE SCI; Lin QS, 2004, BBA-MOL BASIS DIS, V1689, P175, DOI 10.1016/j.bbadis.2004.05.005; Long EO, 2011, J IMMUNOL, V186, P5021, DOI 10.4049/jimmunol.1100646; Mercure C, 2008, CIRC RES, V103, P1319, DOI 10.1161/CIRCRESAHA.108.184911; Mores A, 2008, J MED CHEM, V51, P2216, DOI 10.1021/jm701275z; Nakamura Y, 2003, CARDIOVASC RES, V57, P48, DOI 10.1016/S0008-6363(02)00644-2; Ocaranza MP, 2006, HYPERTENSION, V48, P572, DOI 10.1161/01.HYP.0000237862.94083.45; Passier RCJJ, 1996, AM J PHYSIOL-HEART C, V271, pH1040, DOI 10.1152/ajpheart.1996.271.3.H1040; Pola S, 2003, J BIOL CHEM, V278, P40601, DOI 10.1074/jbc.M306510200; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Porter KE, 2004, CARDIOVASC RES, V61, P745, DOI 10.1016/j.cardiores.2003.11.032; Qi Y, 2011, EXP PHYSL; ROMAN J, 1992, AM J RESP CELL MOL, V6, P472, DOI 10.1165/ajrcmb/6.5.472; Rosenow Felix, 2008, Neoplasia, V10, P168, DOI 10.1593/neo.07898; Rushworth CA, 2008, FEBS J, V275, P6033, DOI 10.1111/j.1742-4658.2008.06733.x; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Sarkissian SD, 2008, HYPERTENSION, V51, P712, DOI 10.1161/HYPERTENSIONAHA.107.100693; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soro-Paavonen A, 2012, J HYPERTENS, V30, P375, DOI 10.1097/HJH.0b013e32834f04b6; Sun M, 2003, CIRCULATION, V107, P1046, DOI 10.1161/01.CIR.0000051363.86009.3C; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; Takeda S, 2006, EMBO J, V25, P2388, DOI 10.1038/sj.emboj.7601131; Tallant EA, 2005, AM J PHYSIOL-HEART C, V289, pH1560, DOI 10.1152/ajpheart.00941.2004; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Turner NA, 2003, CARDIOVASC RES, V57, P784, DOI 10.1016/S0008-6363(02)00729-0; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Yamamoto K, 2006, HYPERTENSION, V47, P718, DOI 10.1161/01.HYP.0000205833.89478.5b; Yoshiyama M, 2005, HEART, V91, P1080, DOI 10.1136/hrt.2004.035618; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zhang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012323; Zigrino P, 2011, J BIOL CHEM, V286, P6801, DOI 10.1074/jbc.M110.168617; Zisman LS, 2003, CIRCULATION, V108, P1679, DOI 10.1161/01.CIR.0000094733.61689.D4	60	54	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34747	10.1371/journal.pone.0034747	http://dx.doi.org/10.1371/journal.pone.0034747			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523556	gold, Green Published, Green Accepted			2022-12-27	WOS:000305345000027
J	Huffman, KM; Redman, LM; Landerman, LR; Pieper, CF; Stevens, RD; Muehlbauer, MJ; Wenner, BR; Bain, JR; Kraus, VB; Newgard, CB; Ravussin, E; Kraus, WE				Huffman, Kim M.; Redman, Leanne M.; Landerman, Lawrence R.; Pieper, Carl F.; Stevens, Robert D.; Muehlbauer, Michael J.; Wenner, Brett R.; Bain, James R.; Kraus, Virginia B.; Newgard, Christopher B.; Ravussin, Eric; Kraus, William E.			Caloric Restriction Alters the Metabolic Response to a Mixed-Meal: Results from a Randomized, Controlled Trial	PLOS ONE			English	Article							INSULIN-RESISTANCE; SKELETAL-MUSCLE; WEIGHT-LOSS; SENSITIVITY; EXERCISE; OVERWEIGHT; OBESITY; INDIVIDUALS; FLEXIBILITY; INTENSITY	Objectives: To determine if caloric restriction (CR) would cause changes in plasma metabolic intermediates in response to a mixed meal, suggestive of changes in the capacity to adapt fuel oxidation to fuel availability or metabolic flexibility, and to determine how any such changes relate to insulin sensitivity (S-I). Methods: Forty-six volunteers were randomized to a weight maintenance diet (Control), 25% CR, or 12.5% CR plus 12.5% energy deficit from structured aerobic exercise (CR+EX), or a liquid calorie diet (890 kcal/d until 15% reduction in body weight) for six months. Fasting and postprandial plasma samples were obtained at baseline, three, and six months. A targeted mass spectrometry-based platform was used to measure concentrations of individual free fatty acids (FFA), amino acids (AA), and acylcarnitines (AC). S-I was measured with an intravenous glucose tolerance test. Results: Over three and six months, there were significantly larger differences in fasting-to-postprandial (FPP) concentrations of medium and long chain AC (byproducts of FA oxidation) in the CR relative to Control and a tendency for the same in CR+EX (CR-3 month P = 0.02; CR-6 month P = 0.002; CR+EX-3 month P = 0.09; CR+EX-6 month P = 0.08). After three months of CR, there was a trend towards a larger difference in FPP FFA concentrations (P = 0.07; CR-3 month P = 0.08). Time-varying differences in FPP concentrations of AC and AA were independently related to time-varying S-I (P<0.05 for both). Conclusions: Based on changes in intermediates of FA oxidation following a food challenge, CR imparted improvements in metabolic flexibility that correlated with improvements in S-I.	[Huffman, Kim M.] Vet Affairs Med Ctr, Durham, NC USA; [Huffman, Kim M.; Kraus, Virginia B.] Duke Univ, Med Ctr, Dept Med, Div Rheumatol, Durham, NC 27710 USA; [Huffman, Kim M.; Landerman, Lawrence R.; Pieper, Carl F.; Kraus, Virginia B.; Kraus, William E.] Duke Univ, Med Ctr, Ctr Aging & Human Dev, Durham, NC USA; [Redman, Leanne M.; Ravussin, Eric] Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Stevens, Robert D.; Muehlbauer, Michael J.; Wenner, Brett R.; Bain, James R.; Newgard, Christopher B.; Kraus, William E.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC USA; [Stevens, Robert D.; Muehlbauer, Michael J.; Wenner, Brett R.; Bain, James R.; Newgard, Christopher B.; Kraus, William E.] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA; [Stevens, Robert D.; Muehlbauer, Michael J.; Wenner, Brett R.; Bain, James R.; Newgard, Christopher B.; Kraus, William E.] Duke Univ, Med Ctr, Dept Canc Biol & Med, Durham, NC USA; [Kraus, William E.] Duke Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Durham, NC 27710 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; Duke University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Duke University; Duke University; Duke University; Duke University	Huffman, KM (corresponding author), Vet Affairs Med Ctr, Durham, NC USA.	huffm007@mc.duke.edu	Redman, Leanne M/N-1986-2017; Ravussin, Eric/N-1985-2017	Ravussin, Eric/0000-0003-2129-547X; Bain, James R./0000-0002-8917-9187; Pieper, Carl/0000-0003-4809-1725; Kraus, William E/0000-0003-1930-9684	National Institute on Aging (NIA) [U01-AG20478, P30AG028716]; ACR-REF/ASP - Junior Career Development Award in Geriatric Medicine; Atlantic Philanthropies; John A. Hartford Foundation; NIH/NIAMS [K23AR054904]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR054904] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028716, U01AG020478] Funding Source: NIH RePORTER	National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ACR-REF/ASP - Junior Career Development Award in Geriatric Medicine; Atlantic Philanthropies; John A. Hartford Foundation; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The project described was supported by U01-AG20478 (PI: E Ravussin) and Award Number P30AG028716 (PI: HJ Cohen) from the National Institute on Aging (NIA). Dr. Huffman was supported by the ACR-REF/ASP - Junior Career Development Award in Geriatric Medicine funded via Atlantic Philanthropies, John A. Hartford Foundation as well as NIH/NIAMS K23AR054904. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, PRACTICAL ASSESSMENT; Bajpeyi S, 2009, J APPL PHYSIOL, V106, P1079, DOI 10.1152/japplphysiol.91262.2008; Bergman RN, 2007, DIABETES, V56, P1489, DOI 10.2337/db07-9903; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Galgani JE, 2008, DIABETES, V57, P841, DOI 10.2337/db08-0043; Goodpaster BH, 2003, DIABETES, V52, P2191, DOI 10.2337/diabetes.52.9.2191; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Houmard JA, 2004, J APPL PHYSIOL, V96, P101, DOI 10.1152/japplphysiol.00707.2003; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Kelley DE, 1999, AM J PHYSIOL-ENDOC M, V277, pE1130; KELLEY DE, 1994, J CLIN INVEST, V94, P2349, DOI 10.1172/JCI117600; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Larson-Meyer DE, 2006, DIABETES CARE, V29, P1337, DOI 10.2337/dc05-2565; Lefevre M, 2009, ATHEROSCLEROSIS, V203, P206, DOI 10.1016/j.atherosclerosis.2008.05.036; Mingrone G, 2005, DIABETOLOGIA, V48, P2108, DOI 10.1007/s00125-005-1918-9; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Redman LM, 2007, J CLIN ENDOCR METAB, V92, P865, DOI 10.1210/jc.2006-2184; Redman LM, 2011, J CLIN ENDOCR METAB, V96, pE312, DOI 10.1210/jc.2010-1971; Redman LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004377; Shah SH, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.11; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Speakman JR, 2007, J NUTR, V137, P1078, DOI 10.1093/jn/137.4.1078; Tai ES, 2010, DIABETOLOGIA, V53, P757, DOI 10.1007/s00125-009-1637-8	26	28	33	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e28190	10.1371/journal.pone.0028190	http://dx.doi.org/10.1371/journal.pone.0028190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523532	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000001
J	Garmyn, A; Van Rooij, P; Pasmans, F; Hellebuyck, T; Van den Broeck, W; Haesebrouck, F; Martel, A				Garmyn, An; Van Rooij, Pascale; Pasmans, Frank; Hellebuyck, Tom; Van den Broeck, Wim; Haesebrouck, Freddy; Martel, An			Waterfowl: Potential Environmental Reservoirs of the Chytrid Fungus Batrachochytrium dendrobatidis	PLOS ONE			English	Article							AMPHIBIAN DECLINES; CHYTRIDIOMYCOSIS; PATHOGENESIS; DISEASE	Infections with Batrachochytrium dendrobatidis (B. dendrobatidis), the causal agent of chytridiomycosis, have been shown to play an important role in the decline of amphibians worldwide. Spread of the fungus is poorly understood. Bird movement might possibly contribute to the spread of B. dendrobatidis in the environment. Therefore, 397 wild geese in Belgium were screened for presence of B. dendrobatidis on their toes using real-time quantitative PCR (qPCR). In addition, chemotaxis towards, adhesion, survival after desiccation and proliferation of B. dendrobatidis on keratinous toe scales from waterfowl were examined in vitro. qPCR revealed that 76 geese (15%) were positive for B. dendrobatidis. Results of the in vitro tests showed that B. dendrobatidis is attracted to the keratinous toes of aquatic birds on which they can adhere and even proliferate. However, desiccation is poorly tolerated. This suggests waterfowl are potential environmental reservoirs for B. dendrobatidis.	[Garmyn, An; Van Rooij, Pascale; Pasmans, Frank; Hellebuyck, Tom; Haesebrouck, Freddy; Martel, An] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [Van den Broeck, Wim] Univ Ghent, Fac Vet Med, Dept Morphol, Merelbeke, Belgium	Ghent University; Ghent University	Garmyn, A (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	an.garmyn@UGent.be	Pasmans, Frank/D-3667-2014; Martel, An/D-3713-2014; Haesebrouck, Freddy/M-3857-2014	Haesebrouck, Freddy/0000-0002-1709-933X				Bellrose FC, 1982, WILSON B, V93, P121; Berger L, 2004, AUST VET J, V82, P434, DOI 10.1111/j.1751-0813.2004.tb11137.x; Berger Lee, 2009, Amphibian Biology, V8, P2986; BFIS, 2012, BELGIAN FORUM INVASI; Daszak P, 2004, HERPETOL J, V14, P201; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Hyla, 2012, AMF REPT NAT; Johnson ML, 2003, EMERG INFECT DIS, V9, P922; Johnson ML, 2005, DIS AQUAT ORGAN, V65, P181, DOI 10.3354/dao065181; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Moss AS, 2008, MYCOLOGIA, V100, P1, DOI 10.3852/mycologia.100.1.1; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Picco AM, 2008, CONSERV BIOL, V22, P1582, DOI 10.1111/j.1523-1739.2008.01025.x; POWELL MJ, 1993, MYCOLOGIA, V85, P1, DOI 10.2307/3760471; Shapard EJ, 2011, MYCOPATHOLOGIA; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Van Rooij P, 2010, ATLA-ALTERN LAB ANIM, V38, P519, DOI 10.1177/026119291003800614; Voyles J, 2011, MICROBES INFECT, V13, P25, DOI 10.1016/j.micinf.2010.09.015; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804	20	81	81	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35038	10.1371/journal.pone.0035038	http://dx.doi.org/10.1371/journal.pone.0035038			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514705	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600111
J	Han, L; Zhang, YH; Lou, YX; Xiong, Y				Han, Lei; Zhang, Yonghai; Lou, Yunxiao; Xiong, Ying			Thalamic Activation Modulates the Responses of Neurons in Rat Primary Auditory Cortex: An In Vivo Intracellular Recording Study	PLOS ONE			English	Article							THALAMOCORTICAL SYNAPTIC-TRANSMISSION; LONG-TERM POTENTIATION; CORTICAL-NEURONS; RECEPTIVE-FIELD; VISUAL-CORTEX; STIMULATION; DEPRESSION; PLASTICITY; INFORMATION; SYNAPSES	Auditory cortical plasticity can be induced through various approaches. The medial geniculate body (MGB) of the auditory thalamus gates the ascending auditory inputs to the cortex. The thalamocortical system has been proposed to play a critical role in the responses of the auditory cortex (AC). In the present study, we investigated the cellular mechanism of the cortical activity, adopting an in vivo intracellular recording technique, recording from the primary auditory cortex (AI) while presenting an acoustic stimulus to the rat and electrically stimulating its MGB. We found that low-frequency stimuli enhanced the amplitudes of sound-evoked excitatory postsynaptic potentials (EPSPs) in AI neurons, whereas high-frequency stimuli depressed these auditory responses. The degree of this modulation depended on the intensities of the train stimuli as well as the intervals between the electrical stimulations and their paired sound stimulations. These findings may have implications regarding the basic mechanisms of MGB activation of auditory cortical plasticity and cortical signal processing.	[Han, Lei; Zhang, Yonghai] Third Mil Med Univ, Chongqing Key Lab Neurobiol, Dept Physiol, Chongqing, Peoples R China; [Lou, Yunxiao; Xiong, Ying] Third Mil Med Univ, Chongqing Key Lab Neurobiol, Dept Neurobiol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Han, L (corresponding author), Third Mil Med Univ, Chongqing Key Lab Neurobiol, Dept Physiol, Chongqing, Peoples R China.	xiongying2001@163.com			National Natural Foundation of China [30770681, 31070970]; China-Canada Joint Health Research Initiative [30911120490]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); China-Canada Joint Health Research Initiative	This work was supported by grants of the National Natural Foundation of China (30770681, 31070970) and China-Canada Joint Health Research Initiative (30911120490). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Boudreau CE, 2005, J NEUROSCI, V25, P7179, DOI 10.1523/JNEUROSCI.1445-05.2005; Bruno RM, 2006, SCIENCE, V312, P1622, DOI 10.1126/science.1124593; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Chung S, 2002, NEURON, V34, P437, DOI 10.1016/S0896-6273(02)00659-1; Cruikshank SJ, 2007, NAT NEUROSCI, V10, P462, DOI 10.1038/nn1861; Cruikshank SJ, 2010, NEURON, V65, P230, DOI 10.1016/j.neuron.2009.12.025; Cruikshank SJ, 2002, J NEUROPHYSIOL, V87, P361, DOI 10.1152/jn.00549.2001; Doron NN, 2002, J COMP NEUROL, V453, P345, DOI 10.1002/cne.10412; Dringenberg HC, 2007, CEREB CORTEX, V17, P839, DOI 10.1093/cercor/bhk038; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Fortune ES, 2001, TRENDS NEUROSCI, V24, P381, DOI 10.1016/S0166-2236(00)01835-X; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Fuentealba P, 2004, J NEUROPHYSIOL, V91, P1990, DOI 10.1152/jn.01105.2003; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Heynen AJ, 2001, J NEUROSCI, V21, P9801, DOI 10.1523/JNEUROSCI.21-24-09801.2001; Hirata A, 2006, J NEUROPHYSIOL, V95, P2479, DOI 10.1152/jn.01145.2005; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; Hull C, 2009, J NEUROSCI, V29, P9127, DOI 10.1523/JNEUROSCI.5971-08.2009; IMIG TJ, 1983, ANNU REV NEUROSCI, V6, P95, DOI 10.1146/annurev.ne.06.030183.000523; Iremonger KJ, 2006, J NEUROPHYSIOL, V96, P613, DOI 10.1152/jn.00105.2006; Jaaskelainen IP, 2007, TRENDS NEUROSCI, V30, P653, DOI 10.1016/j.tins.2007.09.003; Jafari MR, 2007, CEREB CORTEX, V17, P71, DOI 10.1093/cercor/bhj125; Khatri V, 2004, J NEUROPHYSIOL, V92, P3244, DOI 10.1152/jn.00257.2004; Kohn A, 2004, NAT NEUROSCI, V7, P764, DOI 10.1038/nn1267; Liu XP, 2011, NEUROSCI BIOBEHAV R, V35, P2155, DOI 10.1016/j.neubiorev.2011.02.010; Ma XF, 2009, J NEUROSCI, V29, P4888, DOI 10.1523/JNEUROSCI.0167-09.2009; Mao BQ, 2001, NEURON, V32, P883, DOI 10.1016/S0896-6273(01)00518-9; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; Metherate R, 2005, HEARING RES, V206, P146, DOI 10.1016/j.heares.2005.01.014; METHERATE R, 1993, SYNAPSE, V14, P132, DOI 10.1002/syn.890140206; Middleton JW, 2010, EXP BRAIN RES, V200, P239, DOI 10.1007/s00221-009-1977-0; Miller LM, 2001, NEURON, V32, P151, DOI 10.1016/S0896-6273(01)00445-7; Ojima H, 2002, CEREB CORTEX, V12, P1079, DOI 10.1093/cercor/12.10.1079; Ojima H, 2011, NEUROSCI BIOBEHAV R, V35, P2084, DOI 10.1016/j.neubiorev.2010.11.009; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pinault D, 2005, J NEUROSCI METH, V141, P231, DOI 10.1016/j.jneumeth.2004.06.015; Poulet JF, 2012, NAT NEUROSCI; PRIETO JJ, 1994, J COMP NEUROL, V344, P383, DOI 10.1002/cne.903440305; Rigas P, 2009, J NEUROPHYSIOL, V102, P119, DOI 10.1152/jn.00126.2009; Rose HJ, 2005, J NEUROPHYSIOL, V94, P2019, DOI 10.1152/jn.00860.2004; Rutkowski RG, 2003, HEARING RES, V181, P116, DOI 10.1016/S0378-5955(03)00182-5; SALLY SL, 1988, J NEUROPHYSIOL, V59, P1627, DOI 10.1152/jn.1988.59.5.1627; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Steriade M, 1998, J NEUROSCI, V18, P6425; Suga N, 2008, J COMP PHYSIOL A, V194, P169, DOI 10.1007/s00359-007-0274-2; Sun YJ, 2010, NATURE, V465, P927, DOI 10.1038/nature09079; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wang X, 2008, NEUROSCIENCE, V157, P483, DOI 10.1016/j.neuroscience.2008.06.041; Wilson MT, 2010, J BIOL PHYS, V36, P245, DOI 10.1007/s10867-009-9180-x; Winer JA, 1996, P NATL ACAD SCI USA, V93, P3083, DOI 10.1073/pnas.93.7.3083; Winer JA, 2005, TRENDS NEUROSCI, V28, P255, DOI 10.1016/j.tins.2005.03.009; Wu Y, 2007, J NEUROSCI, V27, P10651, DOI 10.1523/JNEUROSCI.1320-07.2007; Xiong Y, 2004, J PHYSIOL-LONDON, V560, P207, DOI 10.1113/jphysiol.2004.067686; Xiong Y, 2011, NEUROSCI BIOBEHAV R, V35, P2114, DOI 10.1016/j.neubiorev.2011.02.005; Yu YQ, 2004, J NEUROSCI, V24, P3060, DOI 10.1523/JNEUROSCI.4897-03.2004; Zhang Y, 2011, PHYSIOL RES, V60, P687, DOI 10.33549/physiolres.932086; Zhang YF, 2008, CEREB CORTEX, V18, P1521, DOI 10.1093/cercor/bhm188	60	3	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34837	10.1371/journal.pone.0034837	http://dx.doi.org/10.1371/journal.pone.0034837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514672	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600078
J	Verrier, ER; Langevin, C; Tohry, C; Houel, A; Ducrocq, V; Benmansour, A; Quillet, E; Boudinot, P				Verrier, Eloi R.; Langevin, Christelle; Tohry, Corinne; Houel, Armel; Ducrocq, Vincent; Benmansour, Abdenour; Quillet, Edwige; Boudinot, Pierre			Genetic Resistance to Rhabdovirus Infection in Teleost Fish Is Paralleled to the Derived Cell Resistance Status	PLOS ONE			English	Article							VIRAL HEMORRHAGIC SEPTICEMIA; TROUT ONCORHYNCHUS-MYKISS; HEMATOPOIETIC NECROSIS VIRUS; SALMON SALMO-SALAR; RAINBOW-TROUT; ATLANTIC SALMON; PANCREATIC NECROSIS; HIV-1 INFECTION; PROTECTIVE IMMUNITY; GLYCOPROTEIN GENE	Genetic factors of resistance and predisposition to viral diseases explain a significant part of the clinical variability observed within host populations. Predisposition to viral diseases has been associated to MHC haplotypes and T cell immunity, but a growing repertoire of innate/intrinsic factors are implicated in the genetic determinism of the host susceptibility to viruses. In a long-term study of the genetics of host resistance to fish rhabdoviruses, we produced a collection of double-haploid rainbow trout clones showing a wide range of susceptibility to Viral Hemorrhagic Septicemia Virus (VHSV) waterborne infection. The susceptibility of fibroblastic cell lines derived from these clonal fish was fully consistent with the susceptibility of the parental fish clones. The mechanisms determining the host resistance therefore did not associate with specific host immunity, but rather with innate or intrinsic factors. One cell line was resistant to rhabdovirus infection due to the combination of an early interferon IFN induction - that was not observed in the susceptible cells - and of yet unknown factors that hamper the first steps of the viral cycle. The implication of IFN was well consistent with the wide range of resistance of this genetic background to VSHV and IHNV, to the birnavirus IPNV and the orthomyxovirus ISAV. Another cell line was even more refractory to the VHSV infection through different antiviral mechanisms. This collection of clonal fish and isogenic cell lines provides an interesting model to analyze the relative contribution of antiviral pathways to the resistance to different viruses.	[Verrier, Eloi R.; Langevin, Christelle; Tohry, Corinne; Houel, Armel; Benmansour, Abdenour; Boudinot, Pierre] INRA, Mol Virol & Immunol, Jouy En Josas, France; [Verrier, Eloi R.; Ducrocq, Vincent; Quillet, Edwige] INRA, GABI UMR Anim Genet & Integrat Biol 1313, Jouy En Josas, France; [Verrier, Eloi R.] AgroParisTech, Paris, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech	Verrier, ER (corresponding author), INRA, GABI UMR Anim Genet & Integrat Biol 1313, Jouy En Josas, France.	Pierre.Boudinot@jouy.inra.fr	Verrier, Eloi/AAH-3249-2021; boudinot, pierre/L-4246-2016	boudinot, pierre/0000-0002-7490-9677; Langevin, Christelle/0000-0002-6013-4460; Verrier, Eloi/0000-0002-9022-5611	Animal Health and Animal Genetics divisions of the Institut National de la Recherche Agronomique; European Community's Seventh Framework Programme [228393]	Animal Health and Animal Genetics divisions of the Institut National de la Recherche Agronomique; European Community's Seventh Framework Programme	This work was supported by the Animal Health and Animal Genetics divisions of the Institut National de la Recherche Agronomique. The research leading to these results has received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement nu 228393. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel L, 2000, AM J HUM GENET, V67, P274, DOI 10.1086/303033; Aggad D, 2009, J IMMUNOL, V183, P3924, DOI 10.4049/jimmunol.0901495; Alcais A, 2009, J CLIN INVEST, V119, P2506, DOI 10.1172/JCI38111; Altmann SM, 2003, J VIROL, V77, P1992, DOI 10.1128/JVI.77.3.1992-2002.2003; BASURCO B, 1995, VIROLOGY, V212, P741, DOI 10.1006/viro.1995.1534; Bearzotti M, 1999, J VIROL, V73, P7703, DOI 10.1128/JVI.73.9.7703-7709.1999; BENMANSOUR A, 1994, VIROLOGY, V198, P602, DOI 10.1006/viro.1994.1072; BERNARD J, 1990, J GEN VIROL, V71, P1669, DOI 10.1099/0022-1317-71-8-1669; Biacchesi S, 2007, J FISH DIS, V30, P631, DOI 10.1111/j.1365-2761.2007.00854.x; Biacchesi S, 2009, J VIROL, V83, P7815, DOI 10.1128/JVI.00404-09; Boudinot P, 1999, J VIROL, V73, P1846, DOI 10.1128/JVI.73.3.1846-1852.1999; Boudinot P, 1998, VIROLOGY, V249, P297, DOI 10.1006/viro.1998.9322; Boudinot P, 2001, J IMMUNOL, V167, P6202, DOI 10.4049/jimmunol.167.11.6202; Boudinot P, 2001, FISH SHELLFISH IMMUN, V11, P383, DOI 10.1006/fsim.2000.0326; BROWN KE, 1994, NEW ENGL J MED, V330, P1192, DOI 10.1056/NEJM199404283301704; BRUTON OC, 1962, J PEDIATR-US, V60, P672, DOI 10.1016/S0022-3476(62)80092-4; Chang MX, 2011, J VIROL, V85, P8403, DOI 10.1128/JVI.00445-10; Chiou PP, 2000, J VIROL, V74, P7619, DOI 10.1128/JVI.74.16.7619-7627.2000; COLE RK, 1968, AVIAN DIS, V12, P9, DOI 10.2307/1588081; COX DR, 1972, J R STAT SOC B, V34, P187; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; DORSON M, 1995, VET RES, V26, P361; Ducrocq V, 2010, 9 WORLD C GEN APPL L; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fischer A, 2005, IMMUNOL REV, V203, P98, DOI 10.1111/j.0105-2896.2005.00223.x; Fuji K, 2006, AQUACULTURE, V254, P203, DOI 10.1016/j.aquaculture.2005.11.024; Goff SP, 2004, MOL CELL, V16, P849, DOI 10.1016/j.molcel.2004.12.001; Guy DR, 2006, J FISH DIS, V29, P637, DOI 10.1111/j.1365-2761.2006.00758.x; Hamming OJ, 2011, J VIROL, V85, P8181, DOI 10.1128/JVI.00521-11; Hansen JD, 1999, J IMMUNOL, V163, P774; HANSEN MP, 1967, POULTRY SCI, V46, P1268; Harmache A, 2006, J VIROL, V80, P3655, DOI 10.1128/JVI.80.7.3655-3659.2006; Houston RD, 2008, DEV BIOLOGICALS, V132, P199, DOI 10.1159/000317160; Jorgensen HBH, 2011, MOL IMMUNOL, V48, P1046, DOI 10.1016/j.molimm.2011.01.014; KIRPICHNIKOV VS, 1993, AQUACULTURE, V111, P7, DOI 10.1016/0044-8486(93)90020-Y; Kjoglum S, 2006, FISH SHELLFISH IMMUN, V21, P431, DOI 10.1016/j.fsi.2006.02.001; Koop BF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-545; Lauksund S, 2009, DEV COMP IMMUNOL, V33, P1196, DOI 10.1016/j.dci.2009.06.012; le Berre M, 1977, Bulletin Off int Epizoot, V87, P391; Levraud JP, 2007, J IMMUNOL, V178, P4385, DOI 10.4049/jimmunol.178.7.4385; Li JY, 2011, MAR BIOTECHNOL, V13, P232, DOI 10.1007/s10126-010-9284-0; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Lopez-Munoz A, 2009, J IMMUNOL, V182, P3440, DOI 10.4049/jimmunol.0802528; Lorenzen N, 1998, FISH SHELLFISH IMMUN, V8, P261, DOI 10.1006/fsim.1997.0134; Lutfalla G, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-29; Matsuo A, 2008, J IMMUNOL, V181, P3474, DOI 10.4049/jimmunol.181.5.3474; Moen T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-368; Norris A, 2008, J FISH DIS, V31, P913, DOI 10.1111/j.1365-2761.2008.00982.x; O'Farrell C, 2002, J VIROL, V76, P8040, DOI 10.1128/JVI.76.16.8040-8049.2002; Odegard J, 2010, AQUACULTURE, V304, P7, DOI 10.1016/j.aquaculture.2010.03.017; Oshiumi H, 2008, CURR GENOMICS, V9, P488, DOI 10.2174/138920208786241234; Overgard AC, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-36; Ozaki A, 2001, MOL GENET GENOMICS, V265, P23, DOI 10.1007/s004380000392; Palti Y, 1999, AQUACULTURE, V173, P81, DOI 10.1016/S0044-8486(98)00471-2; Phillips RB, 2003, IMMUNOGENETICS, V55, P561, DOI 10.1007/s00251-003-0615-4; Purcell MK, 2011, FISH SHELLFISH IMMUN, V30, P84, DOI 10.1016/j.fsi.2010.09.007; Purcell MK, 2010, FISH SHELLFISH IMMUN, V28, P98, DOI 10.1016/j.fsi.2009.10.005; Quillet E, 2001, DIS AQUAT ORGAN, V45, P171, DOI 10.3354/dao045171; Quillet E, 2007, FISH SHELLFISH IMMUN, V22, P510, DOI 10.1016/j.fsi.2006.07.002; Rigaud S, 2006, NATURE, V444, P110, DOI 10.1038/nature05257; Robertsen B, 2006, FISH SHELLFISH IMMUN, V20, P172, DOI 10.1016/j.fsi.2005.01.010; Robertsen B, 2008, FISH SHELLFISH IMMUN, V25, P351, DOI 10.1016/j.fsi.2008.02.004; Samson M, 1996, NATURE, V382, P722, DOI 10.1038/382722a0; Shapira Y, 2005, AQUACULTURE, V245, P1, DOI 10.1016/j.aquaculture.2004.11.038; Slierendrecht WJ, 2001, FISH SHELLFISH IMMUN, V11, P155, DOI 10.1006/fsim.2000.0302; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Sun BJ, 2009, DEV COMP IMMUNOL, V33, P547, DOI 10.1016/j.dci.2008.10.001; THIRY M, 1991, BIOCHIM BIOPHYS ACTA, V1090, P345, DOI 10.1016/0167-4781(91)90200-6; TROBRIDGE GD, 1995, J INTERF CYTOK RES, V15, P691, DOI 10.1089/jir.1995.15.691; Trobridge GD, 1997, J VIROL, V71, P5304, DOI 10.1128/JVI.71.7.5304-5311.1997; van der Aa LM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-7; Verrier ER, 2011, DEV COMP IMMUNOL, V35, P1204, DOI 10.1016/j.dci.2011.03.012; Wolf K, 1988, INFECT PANCREATIC NE, P115; Zou J, 2007, J IMMUNOL, V179, P3859, DOI 10.4049/jimmunol.179.6.3859	75	34	34	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e33935	10.1371/journal.pone.0033935	http://dx.doi.org/10.1371/journal.pone.0033935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514610	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600015
J	Xu, N; Li, Y; Zhao, YT; Guo, L; Fang, YY; Zhao, JH; Wang, XJ; Huang, L; Guo, HS				Xu, Ning; Li, Yan; Zhao, Ying-Tao; Guo, Li; Fang, Yuan-Yuan; Zhao, Jian-Hua; Wang, Xiu-Jie; Huang, Li; Guo, Hui-Shan			Identification and Characterization of Small RNAs in the Hyperthermophilic Archaeon Sulfolobus solfataricus	PLOS ONE			English	Article							NONCODING RNAS; ACQUIRED-RESISTANCE; ANTIVIRAL DEFENSE; REGULATORY ROLES; IMMUNE-SYSTEM; CRISPR RNAS; MICRORNAS; BIOGENESIS; COMPLEX; PROTEIN	The term RNA silencing (RNA interference, RNAi) describes a set of mechanisms that regulate gene expression in eukaryotes. Small interfering RNAs (siRNA) and microRNAs (miRNAs) are two major types of RNAi-associated small RNAs (smRNAs) found in most eukaryotic organisms. Despite the presence of a plethora of non-coding RNAs longer than 50-nucleotide (nt) in length in various species of Archaea, little is known about smRNAs in archaea that resemble the 20-24-nt long smRNAs found in eukaryotes, which have been implicated in the post-transcriptional control of gene expression. Here, we report the finding of a large number of smRNAs approximatelly 20-nt in length, including phased smRNAs and potential miRNAs, from the hyperthermophilic archaeon Sulfolobus solfataricus p2 (Ssp2) based on deep sequencing. The expression of some of the miRNA candidates in Ssp2 was confirmed. Consistent with the Ssp2 hyperthermophilic properties, we found that higher temperatures more efficiently induced the production of the miRNA candidates in an in vitro system using the putative foldback precursor transcripts incubated with Ssp2 extract. Although we initially predicted putative target genes of some miRNA candidates, further analysis mapped the cleavage sites downstream of the miRNA candidate complementary regions, similar to those involved in plant miRNA-mediated TAS transcript cleavage. We also identified smRNAs from clustered, regularly interspaced, short palindromic repeat (CRISPR) loci, which play important roles in prokaryotic microbial defense systems. Archaea represent a unique life form next to Bacteria and Eukarya, and our results may provide a useful resource for further in-depth study on the regulation and evolution of smRNAs in this special organism.	[Xu, Ning; Li, Yan; Zhao, Ying-Tao; Fang, Yuan-Yuan; Zhao, Jian-Hua; Wang, Xiu-Jie; Guo, Hui-Shan] Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Natl Ctr Plant Gene Res, Beijing, Peoples R China; [Guo, Li; Huang, Li] Chinese Acad Sci, Inst Microbiol, State Key Lab Microbial Resources, Beijing, Peoples R China; [Xu, Ning; Fang, Yuan-Yuan; Zhao, Jian-Hua] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, N (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Plant Genom, Natl Ctr Plant Gene Res, Beijing, Peoples R China.	guohs@im.ac.cn	Zhao, Ying-Tao/L-2288-2016; Wang, Xiu-Jie/L-1312-2019	Zhao, Yingtao/0000-0003-3748-8428; Zhao, Jian-Hua/0000-0003-2554-1930	National Science Foundation of China [31101423]; Chinese Academy of Sciences (Knowledge Innovation Program) [KSCX2-EW-N-06]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences (Knowledge Innovation Program)(Knowledge Innovation Program of the Chinese Academy of SciencesChinese Academy of Sciences)	This research was supported by grants from the National Science Foundation of China (grant 31101423) and the Chinese Academy of Sciences (Knowledge Innovation Program (KSCX2-EW-N-06)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Bourc'his D, 2010, SCIENCE, V330, P617, DOI 10.1126/science.1194776; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Dennis PP, 2005, CURR OPIN MICROBIOL, V8, P685, DOI 10.1016/j.mib.2005.10.013; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Edgell DR, 1997, CELL, V89, P995, DOI 10.1016/S0092-8674(00)80285-8; Felippes FF, 2009, EMBO REP, V10, P264, DOI 10.1038/embor.2008.247; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; GOGARTEN JP, 1989, Z NATURFORSCH C, V44, P641; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2012, MOL CELL, V45, P292, DOI 10.1016/j.molcel.2011.10.023; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; IWABE N, 1989, P NATL ACAD SCI USA, V86, P9355, DOI 10.1073/pnas.86.23.9355; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Lapidot M, 2006, EMBO REP, V7, P1216, DOI 10.1038/sj.embor.7400857; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Li Y, 2010, J GENET GENOMICS, V37, P493, DOI 10.1016/S1673-8527(09)60069-2; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Lintner NG, 2011, J BIOL CHEM, V286, P21643, DOI 10.1074/jbc.M111.238485; Lintner NG, 2011, J MOL BIOL, V405, P939, DOI 10.1016/j.jmb.2010.11.019; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Londei P, 2005, FEMS MICROBIOL REV, V29, P185, DOI 10.1016/j.femsre.2004.10.002; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29; Mallory AC, 2008, TRENDS PLANT SCI, V13, P359, DOI 10.1016/j.tplants.2008.03.007; Manica A, 2011, MOL MICROBIOL, V80, P481, DOI 10.1111/j.1365-2958.2011.07586.x; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Mcafee JG, 1995, BIOCHEMISTRY, P34; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Montgomery TA, 2008, CELL, V133, P128, DOI 10.1016/j.cell.2008.02.033; Montgomery TA, 2008, P NATL ACAD SCI USA, V105, P20055, DOI 10.1073/pnas.0810241105; Ohtani N, 2004, NUCLEIC ACIDS RES, V32, P5809, DOI 10.1093/nar/gkh917; Omer AD, 2000, SCIENCE, V288, P517, DOI 10.1126/science.288.5465.517; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Rubio-Somoza I, 2009, CURR OPIN PLANT BIOL, V12, P622, DOI 10.1016/j.pbi.2009.07.003; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Oost J, 2009, CELL, V139, P863, DOI 10.1016/j.cell.2009.11.018; Vaucheret H, 2006, GENE DEV, V20, P759, DOI 10.1101/gad.1410506; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang H, 2011, PLANT J, pno; Wang XJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r65; Wang XJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r30; WOESE CR, 1990, SYST APPL MICROBIOL, V13, P19, DOI 10.1016/S0723-2020(11)80175-X; Wurtzel O, 2010, GENOME RES, V20, P133, DOI 10.1101/gr.100396.109; Zago MA, 2005, MOL MICROBIOL, V55, P1812, DOI 10.1111/j.1365-2958.2005.04505.x; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507; ZILLIG W, 1994, SYST APPL MICROBIOL, V16, P609; ZILLIG W, 1989, CAN J MICROBIOL, V35, P73, DOI 10.1139/m89-011; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	78	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35306	10.1371/journal.pone.0035306	http://dx.doi.org/10.1371/journal.pone.0035306			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514725	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600130
J	Kohane, IS; McMurry, A; Weber, G; MacFadden, D; Rappaport, L; Kunkel, L; Bickel, J; Wattanasin, N; Spence, S; Murphy, S; Churchill, S				Kohane, Isaac S.; McMurry, Andrew; Weber, Griffin; MacFadden, Douglas; Rappaport, Leonard; Kunkel, Louis; Bickel, Jonathan; Wattanasin, Nich; Spence, Sarah; Murphy, Shawn; Churchill, Susanne			The Co-Morbidity Burden of Children and Young Adults with Autism Spectrum Disorders	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; DISINTEGRATIVE PSYCHOSIS; INFANTILE-AUTISM; NEUROPSYCHIATRIC DISORDERS; DISCOVERY RESEARCH; DIABETES-MELLITUS; RISK; COMMUNITY; ASSOCIATION; PREVALENCE	Objectives: Use electronic health records Autism Spectrum Disorder (ASD) to assess the comorbidity burden of ASD in children and young adults. Study Design: A retrospective prevalence study was performed using a distributed query system across three general hospitals and one pediatric hospital. Over 14,000 individuals under age 35 with ASD were characterized by their comorbidities and conversely, the prevalence of ASD within these comorbidities was measured. The comorbidity prevalence of the younger (Age, 18 years) and older (Age 18-34 years) individuals with ASD was compared. Results: 19.44% of ASD patients had epilepsy as compared to 2.19% in the overall hospital population (95% confidence interval for difference in percentages 13.58-14.69%), 2.43% of ASD with schizophrenia vs. 0.24% in the hospital population (95% CI 1.89-2.39%), inflammatory bowel disease (IBD) 0.83% vs. 0.54% (95% CI 0.13-0.43%), bowel disorders (without IBD) 11.74% vs. 4.5% (95% CI 5.72-6.68%), CNS/cranial anomalies 12.45% vs. 1.19% (95% CI 9.41-10.38%), diabetes mellitus type I (DM1) 0.79% vs. 0.34% (95% CI 0.3-0.6%), muscular dystrophy 0.47% vs 0.05% (95% CI 0.26-0.49%), sleep disorders 1.12% vs. 0.14% (95% CI 0.79-1.14%). Autoimmune disorders (excluding DM1 and IBD) were not significantly different at 0.67% vs. 0.68% (95% CI 20.14-0.13%). Three of the studied comorbidities increased significantly when comparing ages 0-17 vs 1834 with p<0.001: Schizophrenia (1.43% vs. 8.76%), diabetes mellitus type I (0.67% vs. 2.08%), IBD (0.68% vs. 1.99%) whereas sleeping disorders, bowel disorders (without IBD) and epilepsy did not change significantly. Conclusions: The comorbidities of ASD encompass disease states that are significantly overrepresented in ASD with respect to even the patient populations of tertiary health centers. This burden of comorbidities goes well beyond those routinely managed in developmental medicine centers and requires broad multidisciplinary management that payors and providers will have to plan for.	[Kohane, Isaac S.; McMurry, Andrew; MacFadden, Douglas] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02114 USA; [Kohane, Isaac S.; McMurry, Andrew; Bickel, Jonathan] Childrens Hosp, Childrens Hosp Informat Program, Boston, MA 02115 USA; [Kohane, Isaac S.; Weber, Griffin; Murphy, Shawn; Churchill, Susanne] Brigham & Womens Hosp, Natl Ctr Biomed Comp I2b2, Boston, MA 02115 USA; [Weber, Griffin] Harvard Med Sch Informat Technol, Beth Israel Deaconess Med Ctr, Boston, MA USA; [Rappaport, Leonard] Childrens Hosp, Ctr Dev Med, Boston, MA 02115 USA; [Kunkel, Louis] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Bickel, Jonathan] Childrens Hosp, Dept Informat Syst, Boston, MA 02115 USA; [Wattanasin, Nich; Murphy, Shawn] Partners Healthcare Syst Informat Technol, Boston, MA USA; [Spence, Sarah] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Murphy, Shawn] Massachusetts Gen Hosp, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Partners Healthcare System; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital	Kohane, IS (corresponding author), Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02114 USA.	Isaac_kohane@harvard.edu	Kohane, Isaac Kohane/K-3716-2012; Rappaport, Leonard/HGD-6175-2022	Kohane, Isaac Kohane/0000-0003-2192-5160; Weber, Griffin/0000-0002-2597-881X; mcmurry, andy/0000-0001-5604-0704	CTSA award (National Institutes of Health/National Center for Research Resources) [NIH/NCRR 1UL1RR025758-01]; i2b2 National Center for Biomedical Computing [NIH/NLM U54 LM008748]; Conte Center for Computational System Genomics of Neuropsychiatric Phenotypes [NIH P50MH94267]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094267] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	CTSA award (National Institutes of Health/National Center for Research Resources); i2b2 National Center for Biomedical Computing; Conte Center for Computational System Genomics of Neuropsychiatric Phenotypes; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was funded in part by the CTSA award (National Institutes of Health/National Center for Research Resources NIH/NCRR 1UL1RR025758-01) and the i2b2 National Center for Biomedical Computing (NIH/NLM U54 LM008748) and the Conte Center for Computational System Genomics of Neuropsychiatric Phenotypes (NIH P50MH94267). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Bauman ML, 2010, NEUROTHERAPEUTICS, V7, P320, DOI 10.1016/j.nurt.2010.06.001; Berlin KS, 2011, J DEV BEHAV PEDIATR, V32, P41, DOI 10.1097/DBP.0b013e318203e06d; Black C, 2002, BRIT MED J, V325, P419, DOI 10.1136/bmj.325.7361.419; Boyer GS, 1997, ARCH INTERN MED, V157, P2111, DOI 10.1001/archinte.157.18.2111; Brownstein JS, 2010, DIABETES CARE, V33, P526, DOI 10.2337/dc09-1506; Brugha TS, 2011, ARCH GEN PSYCHIAT, V68, P459, DOI 10.1001/archgenpsychiatry.2011.38; Buizer-Voskamp JE, 2009, AJP LUNG CELLULAR MO, V18, P588; Campbell PG, 2011, J NEUROSURG-SPINE, V14, P16, DOI 10.3171/2010.9.SPINE10151; Charlot L, 2011, J INTELL DISABIL RES, V55, P199, DOI 10.1111/j.1365-2788.2010.01294.x; Coury D, 2010, CURR OPIN NEUROL, V23, P131, DOI 10.1097/WCO.0b013e32833722fa; Dismuke CE, 2005, MED CARE, V43, P713, DOI 10.1097/01.mlr.0000167175.72130.a7; Eagleson KL, 2010, NEUROSCIENCE, V168, P797, DOI 10.1016/j.neuroscience.2010.03.066; Forsen L, 1999, DIABETOLOGIA, V42, P920, DOI 10.1007/s001250051248; Gabbay V, 2008, PEDIATRICS, V122, P273, DOI 10.1542/peds.2007-1307; Gainer V, 2007, AMIA ANN S P; Grannis Shaun J, 2003, AMIA Annu Symp Proc, P259; Grannis SJ, 2002, AMIA 2002 SYMPOSIUM, PROCEEDINGS, P305; Guterman S, 2009, HEALTH AFFAIR, V28, pW238, DOI 10.1377/hlthaff.28.2.w238; Harrington JW, 2010, PEDIATRICS, V126, pE1257, DOI 10.1542/peds.2010-2305; Hendriksen JGM, 2008, J CHILD NEUROL, V23, P477, DOI 10.1177/0883073807309775; Hinton VJ, 2009, PEDIATR NEUROL, V41, P339, DOI 10.1016/j.pediatrneurol.2009.05.011; Horvath K, 2002, CURR OPIN PEDIATR, V14, P583, DOI 10.1097/00008480-200210000-00004; Horvath K, 1999, J PEDIATR-US, V135, P559, DOI 10.1016/S0022-3476(99)70052-1; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; Kim SY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3107; Kohane I, 2008, J AM MED INFORM ASSN, V15, P708, DOI 10.1197/jamia.M2781; Liao KP, 2010, ARTHRIT CARE RES, V62, P1120, DOI 10.1002/acr.20184; Ming X, 2008, J CHILD NEUROL, V23, P6, DOI 10.1177/0883073807307102; Moreno-De-Luca D, 2010, AM J HUM GENET, V87, P618, DOI 10.1016/j.ajhg.2010.10.004; Morgan C.N., 2003, PSYCHIAT B, V27, P378, DOI [DOI 10.1192/PB.27.10.378, 10.1192/pb.27.10.378]; Mouridsen SE, 1999, DEV MED CHILD NEUROL, V41, P110, DOI 10.1017/S0012162299000213; Mouridsen SE, 1999, BRAIN DEV-JPN, V21, P447, DOI 10.1016/S0387-7604(99)00045-5; Mouridsen SE, 1999, PSYCHOPATHOLOGY, V32, P177, DOI 10.1159/000029087; Murphy S, 2009, GENOME RES, V19, P1675, DOI 10.1101/gr.094615.109; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Murphy SN, 2006, AMIA ANN S P; Richdale AL, 2009, SLEEP MED REV, V13, P403, DOI 10.1016/j.smrv.2009.02.003; SMITH RD, 1981, DEV MED CHILD NEUROL, V23, P626; TAYLOR MA, 1978, AM J PSYCHIAT, V135, P945; Tuchman R, 2002, LANCET NEUROL, V1, P352, DOI 10.1016/S1474-4422(02)00160-6; Tyler CV, 2011, AJIDD-AM J INTELLECT, V116, P371, DOI 10.1352/1944-7558-116.5.371; Uzuner O, 2008, J AM MED INFORM ASSN, V15, P14, DOI 10.1197/jamia.M2408; Uzuner O, 2007, J AM MED INFORM ASSN, V14, P550, DOI 10.1197/jamia.M2444; Weber GM, 2009, J AM MED INFORM ASSN, V16, P624, DOI 10.1197/jamia.M3191; World Health Organization, 2019, INT STAT CLASS DIS R, V11th Edn; Wu JY, 2005, J CHILD NEUROL, V20, P790, DOI 10.1177/08830738050200100201; Young HK, 2008, J CHILD NEUROL, V23, P155, DOI 10.1177/0883073807307975	50	328	335	4	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e33224	10.1371/journal.pone.0033224	http://dx.doi.org/10.1371/journal.pone.0033224			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TZ	22511918	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600004
J	Korhonen, A; Seaghdha, DO; Silins, I; Sun, L; Hogberg, J; Stenius, U				Korhonen, Anna; Seaghdha, Diarmuid O.; Silins, Ilona; Sun, Lin; Hogberg, Johan; Stenius, Ulla			Text Mining for Literature Review and Knowledge Discovery in Cancer Risk Assessment and Research	PLOS ONE			English	Article							HIGH AGREEMENT; LOW KAPPA; TECHNOLOGY	Research in biomedical text mining is starting to produce technology which can make information in biomedical literature more accessible for bio-scientists. One of the current challenges is to integrate and refine this technology to support real-life scientific tasks in biomedicine, and to evaluate its usefulness in the context of such tasks. We describe CRAB - a fully integrated text mining tool designed to support chemical health risk assessment. This task is complex and time-consuming, requiring a thorough review of existing scientific data on a particular chemical. Covering human, animal, cellular and other mechanistic data from various fields of biomedicine, this is highly varied and therefore difficult to harvest from literature databases via manual means. Our tool automates the process by extracting relevant scientific data in published literature and classifying it according to multiple qualitative dimensions. Developed in close collaboration with risk assessors, the tool allows navigating the classified dataset in various ways and sharing the data with other users. We present a direct and user-based evaluation which shows that the technology integrated in the tool is highly accurate, and report a number of case studies which demonstrate how the tool can be used to support scientific discovery in cancer risk assessment and research. Our work demonstrates the usefulness of a text mining pipeline in facilitating complex research tasks in biomedicine. We discuss further development and application of our technology to other types of chemical risk assessment in the future.	[Korhonen, Anna; Seaghdha, Diarmuid O.; Sun, Lin] Univ Cambridge, Comp Lab, Cambridge CB2 3QG, England; [Silins, Ilona; Hogberg, Johan; Stenius, Ulla] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	University of Cambridge; Karolinska Institutet	Korhonen, A (corresponding author), Univ Cambridge, Comp Lab, Pembroke St, Cambridge CB2 3QG, England.	Anna.Korhonen@cl.cam.ac.uk			Engineering and Physical Sciences Research Council [EP/G051070/1]; Dorothy Hodgkin Postgraduate Award; Swedish Research Council; EPSRC [EP/G051070/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Dorothy Hodgkin Postgraduate Award; Swedish Research Council(Swedish Research CouncilEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	AK and DOS are supported by Engineering and Physical Sciences Research Council (www.epsrc.ac.uk) grant EP/G051070/1 to AK. LS is supported by a Dorothy Hodgkin Postgraduate Award. IS, US and JH are supported by the Swedish Research Council (http://www.vr.se/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex B, 2008, P PAC S BIOC; Altman RB, 2008, GENOME BIOL S2, V9; Ananiadou S, 2006, TEXT MINING BIOL AND; Apache OpenNLP, AP OPENNLP; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Bouker KB, 2000, ENVIRON HEALTH PERSP, V108, P701, DOI 10.2307/3434722; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cohen KB, 2008, P PAC S BIOC; Cohen SM, 2006, CRIT REV TOXICOL, V36, P803, DOI 10.1080/10408440600977651; Copestake A, 2008, P 22 INT C COMP LING; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cristianini Nello, 2000, INTRO SUPPORT VECTOR; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; EFSA Panel on Plant Protection Products their Residues (PPR Panel), 2009, SCI OP RISK ASS SEL; FEINSTEIN AR, 1990, J CLIN EPIDEMIOL, V43, P543, DOI 10.1016/0895-4356(90)90158-L; Frijters R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000943; Guo Y, 2011, BMC BIOINFORMATICS, V12; Hattis D, 2009, CRIT REV TOXICOL, V39, P97, DOI 10.1080/10408440802307467 ; Hein M, 2005, P 10 INT WORKSH ART; Hunter L, 2006, MOL CELL, V21, P589, DOI 10.1016/j.molcel.2006.02.012; Jackson MA, 2000, MUTAT RES-REV MUTAT, V463, P181, DOI 10.1016/S1383-5742(00)00056-9; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Joachims T., 1998, EUROPEAN C MACHINE L, V1398, P137, DOI [DOI 10.1007/BFB0026683, 10.1007/BFb0026683]; Judson Richard, 2009, Environ Health Perspect, V117, P685, DOI 10.1289/ehp.0800168; Karamanis N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-193; Keselman A, 2010, J AM SOC INF SCI TEC, V61, P2531, DOI 10.1002/asi.21414; Kolman A, 2002, MUTAT RES-REV MUTAT, V512, P173, DOI 10.1016/S1383-5742(02)00067-4; Korhonen A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-303; Leslie C, 2002, P PAC S BIOC PSB 02; Lin J, 1991, IEEE T INFORM THEORY, V52, P4394; McGregor DB, 1998, ENVIRON HEALTH PERSP, V106, P755, DOI 10.2307/3433830; Morgan KT, 1997, TOXICOL PATHOL, V25, P291, DOI 10.1177/019262339702500307; Rindflesch Thomas C., 2011, Information Services & Use, V31, P15, DOI 10.3233/ISU-2011-0627; Shawe-Taylor J, 2004, KERNEL METHODS PATTE; US EPA, 2005, GUID CARC RISK ASS; US National Academy of Science, 2007, TOX TEST 21 CENT VIS; Wang HN, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S3-S4; Wang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017243; Zweigenbaum P, 2007, BRIEF BIOINFORM, V8, P358, DOI 10.1093/bib/bbm045	43	41	42	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e33427	10.1371/journal.pone.0033427	http://dx.doi.org/10.1371/journal.pone.0033427			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511921	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338600007
J	Yunta, M; Nieto-Diaz, M; Esteban, FJ; Caballero-Lopez, M; Navarro-Ruiz, R; Reigada, D; Pita-Thomas, DW; del Aguila, A; Munoz-Galdeano, T; Maza, RM				Yunta, Monica; Nieto-Diaz, Manuel; Esteban, Francisco J.; Caballero-Lopez, Marcos; Navarro-Ruiz, Rosa; Reigada, David; Pita-Thomas, D. Wolfgang; del Aguila, Angela; Munoz-Galdeano, Teresa; Maza, Rodrigo M.			MicroRNA Dysregulation in the Spinal Cord following Traumatic Injury	PLOS ONE			English	Article							NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; DOWN-REGULATION; MULTIDRUG-RESISTANCE; PROTEIN EXPRESSION; INDUCED APOPTOSIS; MIRNA EXPRESSION; CELL SURVIVAL; UP-REGULATION; RAT	Spinal cord injury (SCI) triggers a multitude of pathophysiological events that are tightly regulated by the expression levels of specific genes. Recent studies suggest that changes in gene expression following neural injury can result from the dysregulation of microRNAs, short non-coding RNA molecules that repress the translation of target mRNA. To understand the mechanisms underlying gene alterations following SCI, we analyzed the microRNA expression patterns at different time points following rat spinal cord injury. The microarray data reveal the induction of a specific microRNA expression pattern following moderate contusive SCI that is characterized by a marked increase in the number of down-regulated microRNAs, especially at 7 days after injury. MicroRNA downregulation is paralleled by mRNA upregulation, strongly suggesting that microRNAs regulate transcriptional changes following injury. Bioinformatic analyses indicate that changes in microRNA expression affect key processes in SCI physiopathology, including inflammation and apoptosis. MicroRNA expression changes appear to be influenced by an invasion of immune cells at the injury area and, more importantly, by changes in microRNA expression specific to spinal cord cells. Comparisons with previous data suggest that although microRNA expression patterns in the spinal cord are broadly similar among vertebrates, the results of studies assessing SCI are much less congruent and may depend on injury severity. The results of the present study demonstrate that moderate spinal cord injury induces an extended microRNA downregulation paralleled by an increase in mRNA expression that affects key processes in the pathophysiology of this injury.	[Yunta, Monica; Nieto-Diaz, Manuel; Caballero-Lopez, Marcos; Navarro-Ruiz, Rosa; Reigada, David; del Aguila, Angela; Munoz-Galdeano, Teresa; Maza, Rodrigo M.] Hosp Nacl Paraplejicos SESCAM, Expt Neurol Unit, Mol Neuroprotect Grp, Toledo, OH USA; [Esteban, Francisco J.] Univ Jaen, Fac Expt & Hlth Sci, Expt Biol Dept, Syst Biol Unit, Jaen, Spain; [Pita-Thomas, D. Wolfgang] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA	Universidad de Jaen; Bascom Palmer Eye Institute; University of Miami	Yunta, M (corresponding author), Hosp Nacl Paraplejicos SESCAM, Expt Neurol Unit, Mol Neuroprotect Grp, Toledo, OH USA.	rodrigom@sescam.jccm.es	Reigada, David/AAU-5910-2020; Nieto-Diaz, Manuel/R-5163-2017; Muñoz-Galdeano, Teresa/ABF-8881-2020; Esteban, Francisco J./H-5504-2015; Díaz, Manuel Nieto/ABD-7144-2020; Maza, Rodrigo Martínez/ABH-3989-2020	Reigada, David/0000-0001-9041-0705; Nieto-Diaz, Manuel/0000-0002-7244-794X; Muñoz-Galdeano, Teresa/0000-0003-3526-819X; Esteban, Francisco J./0000-0002-7135-2973; Maza, Rodrigo Martínez/0000-0002-7249-9205; Yunta, Monica/0000-0002-8060-9582; del Aguila Sanchez, Maria de los Angeles/0000-0002-6814-1753	Fundacion para la Investigacion Sanitaria en Castilla-La Mancha, Spain [FISCAM PI 2008/48]; MAPFRE Foundation; Fondo de Investigacion Sanitaria, Ministry of Health, Spain [FIS PI-081941]	Fundacion para la Investigacion Sanitaria en Castilla-La Mancha, Spain; MAPFRE Foundation; Fondo de Investigacion Sanitaria, Ministry of Health, Spain(Spanish GovernmentInstituto de Salud Carlos III)	This work was supported by a grant from the Fundacion para la Investigacion Sanitaria en Castilla-La Mancha, Spain (FISCAM PI 2008/48), the MAPFRE Foundation and by a grant from the Fondo de Investigacion Sanitaria, Ministry of Health, Spain (FIS PI-081941). The funders had no role in study design, data collection, analysis, the decision to publish or the preparation of the manuscript.	Aimone JB, 2004, EXP NEUROL, V189, P204, DOI 10.1016/j.expneurol.2004.05.042; Allan SM, 2001, NAT REV NEUROSCI, V2, P734, DOI 10.1038/35094583; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Andersson T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013453; Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Bareyre FM, 2003, TRENDS NEUROSCI, V26, P555, DOI 10.1016/j.tins.2003.08.004; Bareyre FM, 2002, J NEUROSCI, V22, P7097; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bazzoni F, 2009, P NATL ACAD SCI USA, V106, P5282, DOI 10.1073/pnas.0810909106; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bethea JR, 1998, J NEUROSCI, V18, P3251; Bhaumik D, 2008, ONCOGENE, V27, P5643, DOI 10.1038/onc.2008.171; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Casha S, 2001, NEUROSCIENCE, V103, P203, DOI 10.1016/S0306-4522(00)00538-8; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Citron BA, 2000, EXP NEUROL, V166, P213, DOI 10.1006/exnr.2000.7523; Crawford M, 2009, BIOCHEM BIOPH RES CO, V388, P483, DOI 10.1016/j.bbrc.2009.07.143; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; De Biase A, 2005, PHYSIOL GENOMICS, V22, P368, DOI 10.1152/physiolgenomics.00081.2005; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Di Giovanni S, 2003, ANN NEUROL, V53, P454, DOI 10.1002/ana.10472; Dudoit S, 2003, BIOCONDUCTOR R PACKA, P73; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Elyakim E, 2010, CANCER RES, V70, P8077, DOI 10.1158/0008-5472.CAN-10-1313; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Fiore R, 2008, BBA-GENE REGUL MECH, V1779, P471, DOI 10.1016/j.bbagrm.2007.12.006; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Gabriely G, 2011, CANCER RES, V71, P3563, DOI 10.1158/0008-5472.CAN-10-3568; Gao FB, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-25; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Gusev Y, 2008, METHODS, V44, P61, DOI 10.1016/j.ymeth.2007.10.005; Gusev Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S16; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hebert SS, 2010, HUM MOL GENET, V19, P3959, DOI 10.1093/hmg/ddq311; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Ho J, 2011, J AM SOC NEPHROL, V22, P1053, DOI 10.1681/ASN.2010080841; Hohjoh H, 2007, BIOCHEM BIOPH RES CO, V362, P360, DOI 10.1016/j.bbrc.2007.07.189; Hua YJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-214; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Hutchison ER, 2009, NEUROMOL MED, V11, P153, DOI 10.1007/s12017-009-8086-x; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Izumi B, 2011, NEUROSCI LETT, V492, P114, DOI 10.1016/j.neulet.2011.01.068; Izzotti A, 2009, FASEB J, V23, P806, DOI 10.1096/fj.08-121384; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Li GR, 2011, INVEST OPHTH VIS SCI, V52, P2999, DOI 10.1167/iovs.10-6708; Li JY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3006; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Li J, 2010, BMC EVOL BIOL, V10, DOI [10.1186/1471-2148-10-68, 10.1186/1471-2407-10-354]; Li T, 2010, NAT IMMUNOL, V11, P799, DOI 10.1038/ni.1918; Lindenblatt C, 2009, CELL CYCLE, V8, P2019, DOI 10.4161/cc.8.13.8816; Lindsay MA, 2008, TRENDS IMMUNOL, V29, P343, DOI 10.1016/j.coph.2009.05.003; Linsen SEV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-249; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luna C, 2009, MOL VIS, V15, P2488; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Matsubara H, 2007, ONCOGENE, V26, P6099, DOI 10.1038/sj.onc.1210425; McTigue DM, 2008, PPAR RES, V2008, DOI 10.1155/2008/517162; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Mestdagh P, 2010, MOL CELL, V40, P762, DOI 10.1016/j.molcel.2010.11.038; Moncini S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020038; Mor E, 2011, NUCLEIC ACIDS RES, V39, P3710, DOI 10.1093/nar/gkq1325; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nakanishi K, 2010, SPINAL CORD, V48, P192, DOI 10.1038/sc.2009.89; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Ostenfeld MS, 2010, ONCOGENE, V29, P1073, DOI 10.1038/onc.2009.395; Ovcharenko D, 2007, CANCER RES, V67, P10782, DOI 10.1158/0008-5472.CAN-07-1484; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pogue AI, 2010, NEUROSCI LETT, V476, P18, DOI 10.1016/j.neulet.2010.03.054; Ponomarev ED, 2011, NAT MED, V17, P64, DOI 10.1038/nm.2266; Profyris C, 2004, NEUROBIOL DIS, V15, P415, DOI 10.1016/j.nbd.2003.11.015; Qiu JX, 2001, J NEUROTRAUM, V18, P1267, DOI 10.1089/089771501317095304; Rasmussen KD, 2010, J EXP MED, V207, P1351, DOI 10.1084/jem.20100458; Rau CS, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-181; Rowland JW, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.11.E2; Sachdeva M, 2009, P NATL ACAD SCI USA, V106, P3207, DOI 10.1073/pnas.0808042106; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010; Saito N, 2000, J NEUROTRAUM, V17, P173, DOI 10.1089/neu.2000.17.173; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Santoscopy C, 2002, NEUROSCI LETT, V330, P94, DOI 10.1016/S0304-3940(02)00716-4; Saugstad JA, 2010, J CEREBR BLOOD F MET, V30, P1564, DOI 10.1038/jcbfm.2010.101; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schnell L, 1997, EUR J NEUROSCI, V9, P1000, DOI 10.1111/j.1460-9568.1997.tb01450.x; Schonrock N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011070; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Shafi G, 2010, CAN J NEUROL SCI, V37, P177, DOI 10.1017/S0317167100009902; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Sharma A, 2009, P NATL ACAD SCI USA, V106, P5761, DOI 10.1073/pnas.0808743106; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024; Shin D, 2009, ANN NEUROL, V66, P843, DOI 10.1002/ana.21927; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sonkoly E, 2009, INT REV IMMUNOL, V28, P535, DOI 10.3109/08830180903208303; Spizzo R, 2010, CELL DEATH DIFFER, V17, P246, DOI 10.1038/cdd.2009.117; Strickland ER, 2011, NEUROSCIENCE, V186, P146, DOI 10.1016/j.neuroscience.2011.03.063; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Sugawara T, 2002, FASEB J, V16, P1997, DOI 10.1096/fj.02-0251fje; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Suzuki Y, 2010, AM J PHYSIOL-HEART C, V299, pH1077, DOI 10.1152/ajpheart.00212.2010; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang XQ, 2007, RNA, V13, P1803, DOI 10.1261/rna.498607; Tang YH, 2009, INT HEART J, V50, P377, DOI 10.1536/ihj.50.377; Tao JF, 2011, J NEUROSCI, V31, P8306, DOI 10.1523/JNEUROSCI.0567-11.2011; Thomas Sterling, 2010, Human Genomics, V4, P353; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tjoa T, 2003, J NEUROSCI METH, V129, P49, DOI 10.1016/S0165-0270(03)00205-X; Tsang WP, 2008, APOPTOSIS, V13, P1215, DOI 10.1007/s10495-008-0256-z; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Tyor WR, 2002, J NEUROL SCI, V200, P33, DOI 10.1016/S0022-510X(02)00113-2; Wang JY, 2011, NUCLEIC ACIDS RES, V39, P6440, DOI 10.1093/nar/gkr302; Wang M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-328; Wang S, 2011, GENES IMMUN, V12, P149, DOI 10.1038/gene.2010.53; Wang Zhiguo, 2010, World J Biol Chem, V1, P41, DOI 10.4331/wjbc.v1.i4.41; Weng LP, 1998, CURR BIOL, V8, P247, DOI 10.1016/S0960-9822(98)70106-X; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xia HF, 2009, CELL PHYSIOL BIOCHEM, V23, P347, DOI 10.1159/000218181; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yao J, 2007, MOL CELL BIOCHEM, V297, P81, DOI 10.1007/s11010-006-9332-2; Ye YM, 2010, CARDIOVASC RES, V87, P535, DOI 10.1093/cvr/cvq053; Young MR, 2010, MOL INTERV, V10, P76, DOI 10.1124/mi.10.2.5; Yu XY, 2008, BIOCHEM BIOPH RES CO, V376, P548, DOI 10.1016/j.bbrc.2008.09.025; Yu YM, 2011, EUR J NEUROSCI, V33, P1587, DOI 10.1111/j.1460-9568.2011.07643.x; Yuan Y, 2010, J CLIN NEUROSCI, V17, P774, DOI 10.1016/j.jocn.2009.10.009; Zhang XW, 2010, J MOL CELL CARDIOL, V49, P841, DOI 10.1016/j.yjmcc.2010.08.007; Zhao XH, 2010, NEURON, V65, P612, DOI 10.1016/j.neuron.2010.02.018; Zhao XH, 2010, LEUKEMIA RES, V34, P1078, DOI 10.1016/j.leukres.2009.10.002; Zheng K, 2010, J NEUROSCI, V30, P8245, DOI 10.1523/JNEUROSCI.1169-10.2010; Zhou R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000681	156	106	118	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34534	10.1371/journal.pone.0034534	http://dx.doi.org/10.1371/journal.pone.0034534			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511948	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338600034
J	Cho, SH; Oh, SY; Zhu, Z; Lee, J; Lane, AP				Cho, Seok Hyun; Oh, Sun Young; Zhu, Zhou; Lee, Joan; Lane, Andrew P.			Spontaneous Eosinophilic Nasal Inflammation in a Genetically-Mutant Mouse: Comparative Study with an Allergic Inflammation Model	PLOS ONE			English	Article							CHRONIC RHINOSINUSITIS; AIRWAY INFLAMMATION; IMMUNODEFICIENT MUTANT; INNATE IMMUNITY; MURINE MODEL; MOTH-EATEN; BACTERIAL; RHINITIS; PATHOLOGY; RECEPTOR	Background: Eosinophilic inflammation is a hallmark of chronic rhinosinusitis with nasal polyps. To model this disease process experimentally, nasal sensitization of mice with ovalbumin or aspergillus has been described. Here, we describe a genetically mutant mouse that develops robust spontaneous nasal eosinophilic inflammation. These mice lack the enzyme SHP-1 that down-regulates the IL-4R alpha/stat6 signaling pathway. We compared nasal inflammation and inflammatory mediators in SHP-1 deficient mice (mev) and an ovalbumin-induced nasal allergy model. Methods: A novel technique of trans-pharyngeal nasal lavage was developed to obtain samples of inflammatory cells from the nasal passages of allergic and mev mice. Total and differential cell counts were performed on cytospin preparations. Expression of tissue mRNA for IL-4, IL-13, and mouse beta-defensin-1 (MBD-1) was determined by quantitative PCR. Eotaxin in the lavage fluid was assessed by ELISA. Results: Allergic and mev mice had increased total cells and eosinophils compared with controls. Expression of IL-4 was similarly increased in both allergic and mev mice, but expression of IL-13 and eotaxin was significantly greater in the allergic mice than mev mice. Eotaxin was significantly up-regulated in both allergic rhinitis and mev mice. In both models of eosinophilic inflammation, down-regulation of the innate immune marker MBD-1 was observed. Conclusions: The mev mice display spontaneous chronic nasal eosinophilic inflammation with potential utility for chronic rhinosinusitis with nasal polyps research. The eosinophilic infiltrate is more robust in the mev mice than allergic mice, but Th2 cytokine expression is not as pronounced. Decreased MBD-1 expression in both models supports the concept that Th2-cytokines down-regulate sinonasal innate immunity in humans, and suggests a role for mouse models in investigating the interaction between adaptive and innate immunity in the sinonasal mucosa.	[Cho, Seok Hyun; Lee, Joan; Lane, Andrew P.] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Cho, Seok Hyun] Hanyang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Seoul 133791, South Korea; [Oh, Sun Young; Zhu, Zhou] Johns Hopkins Univ, Sch Med, Div Allergy & Clin Immunol, Baltimore, MD USA	Johns Hopkins University; Hanyang University; Johns Hopkins University	Cho, SH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	alane3@jhmi.edu	Cho, Seok Hyun/F-6753-2017	Cho, Seok Hyun/0000-0001-8218-5894	National Institutes of Health, National Institute of Allergy and Infectious Disease [AI072502]; National Heart, Lung, and Blood Institute [HL079349]	National Institutes of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by the National Institutes of Health, National Institute of Allergy and Infectious Disease AI072502 (A.P.L.), and National Heart, Lung, and Blood Institute HL079349 (Z.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beisswenger C, 2006, J IMMUNOL, V177, P1833, DOI 10.4049/jimmunol.177.3.1833; Blair C, 2001, J ALLERGY CLIN IMMUN, V108, P424, DOI 10.1067/mai.2001.117793; Cho YS, 2008, AM J RESP CELL MOL, V39, P412, DOI 10.1165/rcmb.2007-0229OC; Ferguson BJ, 2009, IMMUNOL ALLERGY CLIN, V29, P719, DOI 10.1016/j.iac.2009.07.009; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; Ha KR, 2007, AM J RHINOL, V21, P339, DOI 10.2500/ajr.2007.21.3032; Hiratsuka T, 1998, BIOCHEM BIOPH RES CO, V249, P943, DOI 10.1006/bbrc.1998.9239; Khalid AN, 2008, OTOLARYNG HEAD NECK, V139, P695, DOI 10.1016/j.otohns.2008.07.018; Lane AP, 2009, CURR ALLERGY ASTHM R, V9, P205, DOI 10.1007/s11882-009-0030-5; McCusker C, 2002, J ALLERGY CLIN IMMUN, V110, P891, DOI 10.1067/mai.2002.130048; Naclerio R, 2006, AM J RHINOL, V20, P524, DOI 10.2500/ajr.2006.20.2920; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; Oh SY, 2009, AM J RESP CELL MOL, V40, P568, DOI 10.1165/rcmb.2008-0225OC; Ramanathan M, 2007, AM J RHINOL, V21, P110, DOI 10.2500/ajr.2007.21.2997; Ramanathan M, 2008, AM J RHINOL, V22, P115, DOI 10.2500/ajr.2008.22.3136; Ramanathan M, 2007, OTOLARYNG HEAD NECK, V136, P348, DOI 10.1016/j.otohns.2006.11.011; Saito H, 2001, IMMUNOLOGY, V104, P226, DOI 10.1046/j.1365-2567.2001.01253.x; Schleimer Robert P, 2009, Proc Am Thorac Soc, V6, P288, DOI 10.1513/pats.200808-088RM; SHULTZ LD, 1976, J IMMUNOL, V116, P936; Takahashi Y, 2009, INT IMMUNOPHARMACOL, V9, P734, DOI 10.1016/j.intimp.2009.02.011; Tieu DD, 2010, J ALLERGY CLIN IMMUN, V125, P667, DOI 10.1016/j.jaci.2009.11.045; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Wang H, 2008, AM J RHINOL, V22, P343, DOI 10.2500/ajr.2008.22.3184; WARD JM, 1978, VET PATHOL, V15, P170, DOI 10.1177/030098587801500203	24	23	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35114	10.1371/journal.pone.0035114	http://dx.doi.org/10.1371/journal.pone.0035114			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509389	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600083
J	Diekstra, FP; Saris, CGJ; van Rheenen, W; Franke, L; Jansen, RC; van Es, MA; van Vught, PWJ; Blauw, HM; Groen, EJN; Horvath, S; Estrada, K; Rivadeneira, F; Hofman, A; Uitterlinden, AG; Robberecht, W; Andersen, PM; Melki, J; Meininger, V; Hardiman, O; Landers, JE; Brown, RH; Shatunov, A; Shaw, CE; Leigh, PN; Al-Chalabi, A; Ophoff, RA; van den Berg, LH; Veldink, JH				Diekstra, Frank P.; Saris, Christiaan G. J.; van Rheenen, Wouter; Franke, Lude; Jansen, Ritsert C.; van Es, Michael A.; van Vught, Paul W. J.; Blauw, Hylke M.; Groen, Ewout J. N.; Horvath, Steve; Estrada, Karol; Rivadeneira, Fernando; Hofman, Albert; Uitterlinden, Andre G.; Robberecht, Wim; Andersen, Peter M.; Melki, Judith; Meininger, Vincent; Hardiman, Orla; Landers, John E.; Brown, Robert H., Jr.; Shatunov, Aleksey; Shaw, Christopher E.; Leigh, P. Nigel; Al-Chalabi, Ammar; Ophoff, Roel A.; van den Berg, Leonard H.; Veldink, Jan H.			Mapping of Gene Expression Reveals CYP27A1 as a Susceptibility Gene for Sporadic ALS	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CEREBROTENDINOUS XANTHOMATOSIS; HEXANUCLEOTIDE REPEAT; LATERAL-SCLEROSIS; VARIANTS; RISK; MUTATIONS; DIAGNOSIS; C9ORF72; LOCI	Amyotrophic lateral sclerosis (ALS) is a progressive, neurodegenerative disease characterized by loss of upper and lower motor neurons. ALS is considered to be a complex trait and genome-wide association studies (GWAS) have implicated a few susceptibility loci. However, many more causal loci remain to be discovered. Since it has been shown that genetic variants associated with complex traits are more likely to be eQTLs than frequency-matched variants from GWAS platforms, we conducted a two-stage genome-wide screening for eQTLs associated with ALS. In addition, we applied an eQTL analysis to finemap association loci. Expression profiles using peripheral blood of 323 sporadic ALS patients and 413 controls were mapped to genome-wide genotyping data. Subsequently, data from a two-stage GWAS (3,568 patients and 10,163 controls) were used to prioritize eQTLs identified in the first stage (162 ALS, 207 controls). These prioritized eQTLs were carried forward to the second sample with both gene-expression and genotyping data (161 ALS, 206 controls). Replicated eQTL SNPs were then tested for association in the second-stage GWAS data to find SNPs associated with disease, that survived correction for multiple testing. We thus identified twelve cis eQTLs with nominally significant associations in the second-stage GWAS data. Eight SNP-transcript pairs of highest significance (lowest p = 1.27 x 10(-51)) withstood multiple-testing correction in the second stage and modulated CYP27A1 gene expression. Additionally, we show that C9orf72 appears to be the only gene in the 9p21.2 locus that is regulated in cis, showing the potential of this approach in identifying causative genes in association loci in ALS. This study has identified candidate genes for sporadic ALS, most notably CYP27A1. Mutations in CYP27A1 are causal to cerebrotendinous xanthomatosis which can present as a clinical mimic of ALS with progressive upper motor neuron loss, making it a plausible susceptibility gene for ALS.	[Diekstra, Frank P.; Saris, Christiaan G. J.; van Rheenen, Wouter; van Es, Michael A.; van Vught, Paul W. J.; Blauw, Hylke M.; Groen, Ewout J. N.; van den Berg, Leonard H.; Veldink, Jan H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [Franke, Lude; Jansen, Ritsert C.] Univ Med Ctr Groningen, Dept Genet, NL-9713 AV Groningen, Netherlands; [Jansen, Ritsert C.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen Bioinformat Ctr, Haren, Netherlands; [Horvath, Steve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Horvath, Steve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biostat, Los Angeles, CA 90095 USA; [Estrada, Karol; Rivadeneira, Fernando; Hofman, Albert; Uitterlinden, Andre G.] Erasmus Univ, Dept Epidemiol & Biostat, Med Ctr Rotterdam, NL-3000 DR Rotterdam, Netherlands; [Robberecht, Wim] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Neurol, Louvain, Belgium; [Robberecht, Wim] Katholieke Univ Leuven VIB, Neurobiol Lab, Vesalius Res Ctr, Louvain, Belgium; [Andersen, Peter M.] Umea Univ, Dept Clin Neurosci, Umea, Sweden; [Melki, Judith] Univ Paris, Bicetre Hosp, Dept Neuropediat, F-75252 Paris, France; [Meininger, Vincent] Univ Paris 06, Hop La Pitie Salpetriere, Dept Neurol, Paris, France; [Hardiman, Orla] Beaumont Hosp, Dept Neurol, Dublin 9, Ireland; [Hardiman, Orla] Trinity Coll Dublin, Dept Neurol, Dublin, Ireland; [Landers, John E.; Brown, Robert H., Jr.] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Landers, John E.; Brown, Robert H., Jr.] Massachusetts Gen Hosp, Dept Neurol, Charlestown, MA USA; [Shatunov, Aleksey; Shaw, Christopher E.; Leigh, P. Nigel; Al-Chalabi, Ammar] Kings Coll London, MRC, Dept Clin Neurosci, Ctr Neurodegenerat Res,Inst Psychiat, London WC2R 2LS, England; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Med Genet, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehav Genet, Los Angeles, CA USA	Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Erasmus University Rotterdam; Erasmus MC; KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Umea University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Trinity College Dublin; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; University of London; King's College London; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles	Diekstra, FP (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands.	j.h.veldink@umcutrecht.nl	Al-Chalabi, Ammar/E-5361-2010; Groen, Ewout JN/L-5081-2016; Hardiman, Orla/Y-3441-2019; Franke, Lude/P-7036-2016; Saris, C.G.J./L-4623-2015; van+Es, Michael/AAC-5772-2021; Jansen, Ritsert C/C-1160-2013; Leigh, Peter/AAD-5638-2019; Rivadeneira, Fernando/O-5385-2015	Al-Chalabi, Ammar/0000-0002-4924-7712; Groen, Ewout JN/0000-0002-2330-9444; Hardiman, Orla/0000-0003-2610-1291; Franke, Lude/0000-0002-5159-8802; Jansen, Ritsert C/0000-0003-2977-9110; Rivadeneira, Fernando/0000-0001-9435-9441; Landers, John/0000-0001-8084-5043; Veldink, Jan/0000-0001-5572-9657; Shaw, Christopher/0000-0003-0251-0146; Shatunov, Aleksey/0000-0002-2671-8040; van Es, Michael/0000-0002-7709-5883	Prinses Beatrix Fonds (Kersten Foundation); VSB fonds; The Netherlands ALS Foundation; J.R. van Dijk; Adessium Foundation; Brain Foundation of The Netherlands; Thierry Latran Foundation; Netherlands Organization of Scientific Research NWO Investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015]; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) [050-060-810]; European Community [259867]; National Institutes of Health [IU19A1063603-01, 5P30CA016042-28, P50CA092131, DK072206]; Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science; Ministry for Health, Welfare and Sports; European Commission (DG XII); Municipality of Rotterdam; The Muscular Dystrophy Association (USA); The Health Research Board of Ireland; The Irish Neurological Association Travel Award; The Irish Motor Neuron Disease Research Foundation; Swedish Brain Research Foundation; Hallstens Research Foundation; Swedish Medical Society; Bjorklund Foundation for ALS Research; Swedish Association; University of Leuven (Methusalem); Belgian Federal Science Policy Office [P6/43]; Association pour la Recherche sur la SLA; Association Reseau SLA Ile de France; ALS Therapy Alliance; Project ALS; Angel Fund; Pierre L. de Bourgknecht ALS Research Foundation; Al-Athel ALS Research Foundation; ALS Family Charitable Foundation; National Institute of Neurological Disorders and Stroke [NS050557]; MRC [G0600974, G0900635, G0500289, G1100695, G0900688, MC_G1000733] Funding Source: UKRI; Medical Research Council [MC_G1000733, G0500289B, G0500289, G1100695, G0900688, G0900635, G0600974] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P50CA092131, P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072206] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058980, R01NS050557] Funding Source: NIH RePORTER	Prinses Beatrix Fonds (Kersten Foundation); VSB fonds; The Netherlands ALS Foundation; J.R. van Dijk; Adessium Foundation; Brain Foundation of The Netherlands; Thierry Latran Foundation; Netherlands Organization of Scientific Research NWO Investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); European Community(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Erasmus Medical Center; Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry for Health, Welfare and Sports; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; The Muscular Dystrophy Association (USA)(Muscular Dystrophy Association); The Health Research Board of Ireland; The Irish Neurological Association Travel Award; The Irish Motor Neuron Disease Research Foundation; Swedish Brain Research Foundation; Hallstens Research Foundation; Swedish Medical Society; Bjorklund Foundation for ALS Research; Swedish Association; University of Leuven (Methusalem)(KU Leuven); Belgian Federal Science Policy Office(Belgian Federal Science Policy Office); Association pour la Recherche sur la SLA; Association Reseau SLA Ile de France; ALS Therapy Alliance; Project ALS; Angel Fund; Pierre L. de Bourgknecht ALS Research Foundation; Al-Athel ALS Research Foundation; ALS Family Charitable Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Prinses Beatrix Fonds (Kersten Foundation); VSB fonds; The Netherlands ALS Foundation and J.R. van Dijk; and the Adessium Foundation to [LHB]. JHV is supported by the Brain Foundation of The Netherlands; and the Thierry Latran Foundation. The GWA study was funded by the Netherlands Organization of Scientific Research NWO Investments [grant numbers 175.010.2005.011, 911-03-012]; the Research Institute for Diseases in the Elderly (014-93-015; RIDE); and the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) [project number 050-060-810]. In addition, the research leading to these results has received funding from the European Community's Health Seventh Framework Programme (FP7/2007-2013) [grant agreement number 259867]. SH is supported by National Institutes of Health [grant numbers IU19A1063603-01, 5P30CA016042-28, P50CA092131, and DK072206]. The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam; Netherlands Organization for the Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. The Irish study was funded by The Muscular Dystrophy Association (USA); The Health Research Board of Ireland; The Irish Neurological Association Travel Award; and The Irish Motor Neuron Disease Research Foundation. In Sweden, this project was supported by the Swedish Brain Research Foundation; the Hallstens Research Foundation; the Swedish Medical Society; the Bjorklund Foundation for ALS Research; and the Swedish Association for the Neurologically Disabled to [PMA]. WR was supported by grants from the University of Leuven (Methusalem); and the Interuniversity Attraction Poles program P6/43 of the Belgian Federal Science Policy Office. In France, this study was funded by the Association pour la Recherche sur la SLA; and the Association Reseau SLA Ile de France. Support was also provided by the ALS Therapy Alliance; Project ALS; the Angel Fund; the Pierre L. de Bourgknecht ALS Research Foundation; the Al-Athel ALS Research Foundation; the ALS Family Charitable Foundation and the National Institute of Neurological Disorders and Stroke [NS050557].'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Byrne S, 2011, J NEUROL NEUROSUR PS, V82, P623, DOI 10.1136/jnnp.2010.224501; CALI JJ, 1991, J BIOL CHEM, V266, P7779; Chio A, 2009, NEUROLOGY, V73, P1681, DOI 10.1212/WNL.0b013e3181c1df1e; Chio A, 2009, HUM MOL GENET, V18, P1524, DOI 10.1093/hmg/ddp059; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Cronin S, 2009, EUR J HUM GENET, V17, P213, DOI 10.1038/ejhg.2008.194; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Dion PA, 2009, NAT REV GENET, V10, P769, DOI 10.1038/nrg2680; Dubois PCA, 2010, NAT GENET, V42, P295, DOI 10.1038/ng.543; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Fernandez-Santiago R, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2009.04.018; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Fu J, 2009, NAT GENET, V41, P166, DOI 10.1038/ng.308; Gallus GN, 2006, NEUROL SCI, V27, P143, DOI 10.1007/s10072-006-0618-7; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Guyant-Marechal L, 2005, AM J MED GENET A, V139A, P114, DOI 10.1002/ajmg.a.30797; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Laaksovirta H, 2010, LANCET NEUROL, V9, P978, DOI 10.1016/S1474-4422(10)70184-8; Leek JT, 2007, PLOS GENET, V3, P1724, DOI 10.1371/journal.pgen.0030161; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Mok K, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.005; Nica AC, 2008, HUM MOL GENET, V17, pR129, DOI 10.1093/hmg/ddn285; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qurashi A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002102; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schymick JC, 2007, HUM MOL GENET, V16, pR233, DOI 10.1093/hmg/ddm215; Shatunov A, 2010, LANCET NEUROL, V9, P986, DOI 10.1016/S1474-4422(10)70197-6; Simpson CL, 2009, HUM MOL GENET, V18, P472, DOI 10.1093/hmg/ddn375; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; van Es MA, 2007, LANCET NEUROL, V6, P869, DOI 10.1016/S1474-4422(07)70222-3; Van Es MA, 2009, AMYOTROPH LATERAL SC, V10, P441, DOI 10.3109/17482960802673042; van Es MA, 2009, NAT GENET, V41, P1083, DOI 10.1038/ng.442; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011	50	42	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35333	10.1371/journal.pone.0035333	http://dx.doi.org/10.1371/journal.pone.0035333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509407	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000305336600101
J	Gong, XH; Jiang, YW; Zhang, X; An, Y; Zhang, J; Wu, Y; Wang, JM; Sun, YF; Liu, YY; Gao, XW; Shen, YP; Wu, XR; Qiu, ZL; Jin, L; Wu, BL; Wang, HY				Gong, Xiaohong; Jiang, Yu-wu; Zhang, Xin; An, Yu; Zhang, Jun; Wu, Ye; Wang, Jingmin; Sun, Yangfei; Liu, Yanyan; Gao, Xuewu; Shen, Yiping; Wu, Xiru; Qiu, Zilong; Jin, Li; Wu, Bai-Lin; Wang, Hongyan			High Proportion of 22q13 Deletions and SHANK3 Mutations in Chinese Patients with Intellectual Disability	PLOS ONE			English	Article							SCAFFOLDING PROTEIN SHANK3; COPY NUMBER VARIATION; MENTAL-RETARDATION; CONGENITAL-ANOMALIES; LEARNING-DISABILITY; GENE-EXPRESSION; ARRAY CGH; DELAY	Intellectual disability (ID) is a heterogeneous disorder caused by chromosomal abnormalities, monogenic factors and environmental factors. 22q13 deletion syndrome is a genetic disorder characterized by severe ID. Although the frequency of 22q13 deletions in ID is unclear, it is believed to be largely underestimated. To address this issue, we used Affymetrix Human SNP 6.0 array to detect the 22q13 deletions in 234 Chinese unexplained ID patients and 103 controls. After the Quality Control (QC) test of raw data, 22q13 deletions were found in four out of 230 cases (1.7%), while absent in parents of the cases and 101 controls. A review of genome-wide microarray studies in ID was performed and the frequency of 22q13 deletions from the literatures was 0.24%, much lower than our report. The overlapping region shared by all 4 cases encompasses the gene SHANK3. A heterozygous de novo nonsense mutation Y1015X of SHANK3 was identified in one ID patient. Cortical neurons were prepared from embryonic mice and were transfected with a control plasmid, shank3 wildtype (WT) or mutant plasmids. Overexpression of the Y1015 mutant in neurons significantly affected neurite outgrowth compared with shank3 WT. These findings suggest that 22q13 deletions may be a more frequent cause for Chinese ID patients than previously thought, and the SHANK3 gene is involved in the neurite development.	[Gong, Xiaohong; Zhang, Xin; Zhang, Jun; Sun, Yangfei; Liu, Yanyan; Gao, Xuewu; Jin, Li; Wang, Hongyan] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Gong, Xiaohong; Zhang, Xin; Zhang, Jun; Sun, Yangfei; Liu, Yanyan; Gao, Xuewu; Jin, Li; Wang, Hongyan] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Jiang, Yu-wu; Wu, Ye; Wang, Jingmin; Wu, Xiru] Peking Univ, Hosp 1, Dept Pediat, Beijing 100871, Peoples R China; [An, Yu; Shen, Yiping; Wu, Bai-Lin; Wang, Hongyan] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [An, Yu; Shen, Yiping; Wu, Bai-Lin] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Zhang, Jun] Fudan Univ, Huashan Hosp, Inst & Dept Digest Dis, Shanghai 200433, Peoples R China; [Qiu, Zilong] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China	Fudan University; Fudan University; Peking University; Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Gong, XH (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	wu_b@fudan.edu.cn; wanghy@fudan.edu.cn	jiang, yu/HGU-0029-2022; Jin, Li/M-5063-2019; liu, yan/HCI-5542-2022; Jin, Li/C-1468-2009	Jin, Li/0000-0002-4546-2415	973 Program [2010CB529601, 2009CB522007]; National Natural Science Foundation of China [30900404]; National Science Fund for Distinguished Young Scholars [81025003]; Program for Innovative Research Team in University [IRT1010]; Ministry of Education of China [2008024610431/4CE20110071110026]; Commission for Science and Technology of Shanghai Municipality [10JC1401300, 11XD1400900]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Program for Innovative Research Team in University; Ministry of Education of China(Ministry of Education, China); Commission for Science and Technology of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from the 973 Program (2010CB529601, 2009CB522007), the National Natural Science Foundation of China (30900404), the National Science Fund for Distinguished Young Scholars (81025003), the Program for Innovative Research Team in University (IRT1010), Doctoral Fund of Ministry of Education of China (2008024610431/4CE20110071110026), and the Commission for Science and Technology of Shanghai Municipality (10JC1401300, 11XD1400900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderlid BM, 2002, HUM GENET, V110, P439, DOI 10.1007/s00439-002-0713-7; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003; Bozdagi O, 2010, MOL AUTISM, V1, DOI 10.1186/2040-2392-1-15; Chelly J, 2006, EUR J HUM GENET, V14, P701, DOI 10.1038/sj.ejhg.5201595; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Cusmano-Ozog K, 2007, AM J MED GENET C, V145C, P393, DOI 10.1002/ajmg.c.30155; Daily DK, 2000, AM FAM PHYSICIAN, V61, P1059; Dhar SU, 2010, AM J MED GENET A, V152A, P573, DOI 10.1002/ajmg.a.33253; Durand CM, 2012, MOL PSYCHIATR, V17, P71, DOI 10.1038/mp.2011.57; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Gauthier J, 2010, P NATL ACAD SCI USA, V107, P7863, DOI 10.1073/pnas.0906232107; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Hamdan FF, 2011, AM J HUM GENET, V88, P306, DOI 10.1016/j.ajhg.2011.02.001; Knight SJL, 2006, CYTOGENET GENOME RES, V115, P215, DOI 10.1159/000095917; Koolen DA, 2009, HUM MUTAT, V30, P283, DOI 10.1002/humu.20883; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Phelan MC, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-14; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Sagoo GS, 2009, GENET MED, V11, P139, DOI 10.1097/GIM.0b013e318194ee8f; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; WATT JL, 1985, J MED GENET, V22, P283, DOI 10.1136/jmg.22.4.283; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Wu Y, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-72	28	32	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34739	10.1371/journal.pone.0034739	http://dx.doi.org/10.1371/journal.pone.0034739			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509352	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600055
J	Heinze, J; Schrempf, A				Heinze, Juergen; Schrempf, Alexandra			Terminal Investment: Individual Reproduction of Ant Queens Increases with Age	PLOS ONE			English	Article							SEX-RATIO; EVOLUTIONARY-THEORIES; LIFE-SPAN; FECUNDITY; LONGEVITY; SENESCENCE; DROSOPHILA; SURVIVAL; EGGS	The pattern of age-specific fecundity is a key component of the life history of organisms and shapes their ecology and evolution. In numerous animals, including humans, reproductive performance decreases with age. Here, we demonstrate that some social insect queens exhibit the opposite pattern. Egg laying rates of Cardiocondyla obscurior ant queens increased with age until death, even when the number of workers caring for them was kept constant. Cardiocondyla, and probably also other ants, therefore resemble the few select organisms with similar age-specific reproductive investment, such as corals, sturgeons, or box turtles (e.g., [1]), but they differ in being more short-lived and lacking individual, though not social, indeterminate growth. Furthermore, in contrast to most other organisms, in which average life span declines with increasing reproductive effort, queens with high egg laying rates survived as long as less fecund queens.	[Heinze, Juergen; Schrempf, Alexandra] Univ Regensburg, Regensburg, Germany	University of Regensburg	Heinze, J (corresponding author), Univ Regensburg, Regensburg, Germany.	Juergen.heinze@biologie.uni-R.de			Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was funded by Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman Gunduz Eylem, 2005, Turkish Journal of Zoology, V29, P291; Al-Lawati H, 2009, ANN ENTOMOL SOC AM, V102, P881, DOI 10.1603/008.102.0514; Chen J, 2001, EXP GERONTOL, V36, P431, DOI 10.1016/S0531-5565(00)00225-4; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; Cotter SC, 2011, FUNCT ECOL, V25, P652, DOI 10.1111/j.1365-2435.2010.01819.x; Cremer S, 2002, P ROY SOC B-BIOL SCI, V269, P417, DOI 10.1098/rspb.2001.1892; DAVID J, 1975, EXP GERONTOL, V10, P17, DOI 10.1016/0531-5565(75)90011-X; Dixon AFG, 2002, ECOL ENTOMOL, V27, P433, DOI 10.1046/j.1365-2311.2002.00429.x; Frohschammer S, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-27; HARD JJ, 1993, OIKOS, V66, P55, DOI 10.2307/3545195; Hartmann A, 2003, EVOLUTION, V57, P2424, DOI 10.1111/j.0014-3820.2003.tb00254.x; Heinze J, 2006, INSECT SOC, V53, P1, DOI 10.1007/s00040-005-0847-4; Heinze J, 2008, GERONTOLOGY, V54, P160, DOI 10.1159/000122472; Holldobler B., 1990, pi; Holldobler B., 2009, SUPERORGANISM; Keller L, 1997, NATURE, V389, P958, DOI 10.1038/40130; KELLER L, 1990, INSECT SOC, V37, P116, DOI 10.1007/BF02224025; Le Bourg E, 1998, GERONTOLOGY, V44, P345, DOI 10.1159/000022040; Lopez-Vaamonde C, 2009, J EVOLUTION BIOL, V22, P983, DOI 10.1111/j.1420-9101.2009.01706.x; Martin JGA, 2011, ECOL LETT, V14, P576, DOI 10.1111/j.1461-0248.2011.01621.x; McNamara JM, 2009, P ROY SOC B-BIOL SCI, V276, P4061, DOI 10.1098/rspb.2009.0959; Medeiros RS, 2000, J APPL ENTOMOL, V124, P319, DOI 10.1046/j.1439-0418.2000.00482.x; Michener C. D., 1964, Insectes Sociaux Paris, V11, P317, DOI 10.1007/BF02227433; Novoseltsev VN, 2005, J GERONTOL A-BIOL, V60, P953, DOI 10.1093/gerona/60.8.953; Schrempf A, 2006, EVOL DEV, V8, P266, DOI 10.1111/j.1525-142X.2006.00097.x; Schrempf A, 2005, CURR BIOL, V15, P267, DOI 10.1016/S0960-9822(05)00071-0; Schrempf A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002592; Schwander T, 2010, TRENDS ECOL EVOL, V25, P275, DOI 10.1016/j.tree.2009.12.001; Tsuji K, 1996, NATURWISSENSCHAFTEN, V83, P577; Tsuji K, 2012, EVOLUTION IN PRESS; Uckan F, 2002, J APPL ENTOMOL, V126, P534, DOI 10.1046/j.1439-0418.2002.00706.x; ULLOACHACON P, 1990, WESTV STUD, P281; Vaupel JW, 2004, THEOR POPUL BIOL, V65, P339, DOI 10.1016/j.tpb.2003.12.003; vom Saal F.S., 1988, P2351; Walter B, 2011, AM NAT, V177, P368, DOI 10.1086/658396; Weladji RB, 2010, OECOLOGIA, V162, P261, DOI 10.1007/s00442-009-1443-5; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Zajitschek F, 2009, AM NAT, V173, P792, DOI 10.1086/598486; Zhou ZS, 2010, ENVIRON ENTOMOL, V39, P1021, DOI 10.1603/EN09176	39	43	43	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35201	10.1371/journal.pone.0035201	http://dx.doi.org/10.1371/journal.pone.0035201			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509399	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336600092
J	Kapur, NK; Shenoy, C; Yunis, AA; Mohammad, NN; Wilson, S; Paruchuri, V; Mackey, EE; Qiao, XY; Shah, A; Esposito, ML; Karas, RH; Jaffe, IZ				Kapur, Navin K.; Shenoy, Chetan; Yunis, Adil A.; Mohammad, Najwa N.; Wilson, Szuhuei; Paruchuri, Vikram; Mackey, Emily E.; Qiao, Xiaoying; Shah, Ameer; Esposito, Michele L.; Karas, Richard H.; Jaffe, Iris Z.			Distinct Effects of Unfractionated Heparin versus Bivalirudin on Circulating Angiogenic Peptides	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ENDOTHELIAL GROWTH-FACTOR; SOLUBLE ENDOGLIN; PREECLAMPSIA; VEGF; CHALLENGES; THERAPY; BINDING; SYSTEM; CANCER	Background: Human studies of therapeutic angiogenesis, stem-cell, and progenitor-cell therapy have failed to demonstrate consistent clinical benefit. Recent studies have shown that heparin increases circulating levels of anti-angiogenic peptides. Given the widely prevalent use of heparin in percutaneous and surgical procedures including those performed as part of studies examining the benefit of therapeutic angiogenesis and cell-based therapy, we compared the effects of unfractionated heparin (UFH) on angiogenic peptides with those of bivalirudin, a relatively newer anticoagulant whose effects on angiogenic peptides have not been studied. Methodology/Principal Findings: We measured soluble fms-like tyrosine kinase-1 (sFLT1), placental growth factor (PlGF), vascular endothelial growth factor (VEGF), and soluble Endoglin (sEng) serum levels by enzyme linked immunosorbent assays (ELISA) in 16 patients undergoing elective percutaneous coronary intervention. Compared to baseline values, sFLT1 and PlGF levels increased by 2629 +/- 313% and 253 +/- 54%, respectively, within 30 minutes of UFH therapy (p<0.01 for both; n = 8). VEGF levels decreased by 93.2 +/- 5% in patients treated with UFH (p, 0.01 versus baseline). No change in sEng levels were observed after UFH therapy. No changes in sFLT1, PlGF, VEGF, or sEng levels were observed in any patients receiving bivalirudin (n = 8). To further explore the direct effect of anticoagulation on circulating angiogenic peptides, adult, male wild-type mice received venous injections of clinically dosed UFH or bivalirudin. Compared to saline controls, sFLT1 and PlGF levels increased by >500% (p<0.01, for both) and VEGF levels increased by 221 +/- 101% (p<0.05) 30 minutes after UFH treatment. Bivalirudin had no effect on peptide levels. To study the cellular origin of peptides after anticoagulant therapy, human coronary endothelial cells were treated with UFH and demonstrated increased sFLT1 and PlGF levels (ANOVA p<0.01 for both) with reduced VEGF levels (ANOVA p<0.05). Bivalirudin had no effect on peptide levels in vitro. Conclusions/Significance: Circulating levels of sFLT1, PlGF, and VEGF are significantly altered by UFH, while bivalirudin therapy has no effect. These findings may have significant implications for clinical studies of therapeutic angiogenesis, stem-cell and progenitor-cell therapy.	[Kapur, Navin K.; Yunis, Adil A.; Mohammad, Najwa N.; Wilson, Szuhuei; Paruchuri, Vikram; Mackey, Emily E.; Qiao, Xiaoying; Shah, Ameer; Esposito, Michele L.; Karas, Richard H.; Jaffe, Iris Z.] Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA; [Kapur, Navin K.; Shenoy, Chetan; Karas, Richard H.; Jaffe, Iris Z.] Tufts Med Ctr, Dept Med, Div Cardiol, Boston, MA USA	Tufts Medical Center; Tufts Medical Center	Kapur, NK (corresponding author), Tufts Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA.	nkapur@tuftsmedicalcenter.org	Shenoy, Chetan/AAF-9363-2020	Shenoy, Chetan/0000-0001-8877-4999	NHLBI NIH HHS [K08 HL094909, R01 HL095590] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095590, K08HL094909] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Carroll TY, 2011, AM J REPROD IMMUNOL, V66, P286, DOI 10.1111/j.1600-0897.2011.01007.x; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; CHEIFETZ S, 1992, J BIOL CHEM, V267, P19027; FOLKMAN J, 1983, SCIENCE, V221, P719, DOI 10.1126/science.6192498; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Kapur NK, 2011, ARTERIOSCL THROM VAS, V31, P443, DOI 10.1161/ATVBAHA.110.215897; Kastrati A, 2008, NEW ENGL J MED, V359, P688, DOI 10.1056/NEJMoa0802944; KENDALL RL, 1994, BIOCHEM BIOPH RES CO, V201, P326, DOI 10.1006/bbrc.1994.1705; Kimmelstiel C, 2011, CIRC-CARDIOVASC INTE, V4, P171, DOI 10.1161/CIRCINTERVENTIONS.110.959098; Kut C, 2007, BRIT J CANCER, V97, P978, DOI 10.1038/sj.bjc.6603923; Levine RJ, 2006, NEW ENGL J MED, V355, P992, DOI 10.1056/NEJMoa055352; Lopez-Novoa JM, 2010, AM J PHYSIOL-HEART C, V299, pH959, DOI 10.1152/ajpheart.01251.2009; MAGLIONE D, 1991, P NATL ACAD SCI USA, V88, P9267, DOI 10.1073/pnas.88.20.9267; MATTHEWS W, 1991, CELL, V65, P1143, DOI 10.1016/0092-8674(91)90010-V; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Rak J, 2003, ARTERIOSCL THROM VAS, V23, P1954, DOI 10.1161/01.ATV.0000100563.16983.19; Rassen JA, 2010, EUR HEART J, V31, P561, DOI 10.1093/eurheartj/ehp437; Searle J, 2011, ARTERIOSCLER THROMB; Sela S, 2011, CIRC RES, V108, P1063, DOI 10.1161/CIRCRESAHA.110.239665; Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Wong NS, 2010, J CLIN ONCOL, V28, P723, DOI 10.1200/JCO.2009.24.0143; Zachary I, 2011, HEART, V97, P181, DOI 10.1136/hrt.2009.180414	24	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34344	10.1371/journal.pone.0034344	http://dx.doi.org/10.1371/journal.pone.0034344			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509290	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600025
J	Mehan, MR; Ayers, D; Thirstrup, D; Xiong, W; Ostroff, RM; Brody, EN; Walker, JJ; Gold, L; Jarvis, TC; Janjic, N; Baird, GS; Wilcox, SK				Mehan, Michael R.; Ayers, Deborah; Thirstrup, Derek; Xiong, Wei; Ostroff, Rachel M.; Brody, Edward N.; Walker, Jeffrey J.; Gold, Larry; Jarvis, Thale C.; Janjic, Nebojsa; Baird, Geoffrey S.; Wilcox, Sheri K.			Protein Signature of Lung Cancer Tissues	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; END-PRODUCTS; E-CADHERIN; PROGNOSTIC-SIGNIFICANCE; SUPEROXIDE-DISMUTASE; MICROARRAY ANALYSIS; PATIENT SURVIVAL; COLLAGEN-XVIII; CELL	Lung cancer remains the most common cause of cancer-related mortality. We applied a highly multiplexed proteomic technology (SOMAscan) to compare protein expression signatures of non small-cell lung cancer (NSCLC) tissues with healthy adjacent and distant tissues from surgical resections. In this first report of SOMAscan applied to tissues, we highlight 36 proteins that exhibit the largest expression differences between matched tumor and non-tumor tissues. The concentrations of twenty proteins increased and sixteen decreased in tumor tissue, thirteen of which are novel for NSCLC. NSCLC tissue biomarkers identified here overlap with a core set identified in a large serum-based NSCLC study with SOMAscan. We show that large-scale comparative analysis of protein expression can be used to develop novel histochemical probes. As expected, relative differences in protein expression are greater in tissues than in serum. The combined results from tissue and serum present the most extensive view to date of the complex changes in NSCLC protein expression and provide important implications for diagnosis and treatment.	[Mehan, Michael R.; Ayers, Deborah; Ostroff, Rachel M.; Brody, Edward N.; Walker, Jeffrey J.; Gold, Larry; Jarvis, Thale C.; Janjic, Nebojsa; Wilcox, Sheri K.] SomaLogic Inc, Boulder, CO USA; [Thirstrup, Derek; Xiong, Wei; Baird, Geoffrey S.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Gold, Larry] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Boulder	Mehan, MR (corresponding author), SomaLogic Inc, Boulder, CO USA.	swilcox@somalogic.com			SomaLogic	SomaLogic	SomaLogic funded the proteomic biomarker research. SomaLogic had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: M Mehan, D Ayers, D Zichi, R Ostroff, E Brody, J Walker, L Gold, T Jarvis, N Janjic, and S Wilcox are full-time employees of SomaLogic. D Thirstrup and G Baird have received research funding from SomaLogic. These interests do not alter the authors' adherence to the PLoS ONE policies on sharing data and materials.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Allavena P, 2004, CRIT REV IMMUNOL, V24, P179, DOI 10.1615/CritRevImmunol.v24.i3.20; Bartling B, 2005, CARCINOGENESIS, V26, P293, DOI 10.1093/carcin/bgh333; Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Bornstein P, 2000, MATRIX BIOL, V19, P557, DOI 10.1016/S0945-053X(00)00104-9; Bossuyt PMM, 2011, JAMA-J AM MED ASSOC, V305, P2229, DOI 10.1001/jama.2011.729; Boyle P, WORLD CANC REPORT; Bremnes RM, 2002, J CLIN ONCOL, V20, P2417, DOI 10.1200/JCO.2002.08.159; Cangara HM, 2010, MICROVASC RES, V80, P133, DOI 10.1016/j.mvr.2010.02.006; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chang H, 2004, CANCER-AM CANCER SOC, V100, P1665, DOI 10.1002/cncr.20156; Chen Y, 2007, J PATHOL, V211, P431, DOI 10.1002/path.2132; Chen Y, 2011, LUNG CANCER, V73, P38, DOI 10.1016/j.lungcan.2010.10.015; Chen ZJ, 2009, J INT MED RES, V37, P551, DOI 10.1177/147323000903700232; Cheng YJ, 2008, INT J CANCER, V123, P1278, DOI 10.1002/ijc.23592; Chijiwa T, 2009, ONCOL REP, V22, P279, DOI 10.3892/or_00000435; Deeb G, 2004, MODERN PATHOL, V17, P430, DOI 10.1038/modpathol.3800041; Diamandis EP, 2010, J NATL CANCER I, V102, P1462, DOI 10.1093/jnci/djq306; Fontanini G, 1999, CLIN CANCER RES, V5, P155; Fontanini G, 1999, BRIT J CANCER, V79, P363, DOI 10.1038/sj.bjc.6690058; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Gupta S, 2011, APPL IMMUNOHISTO M M, V19, P273, DOI 10.1097/PAI.0b013e3182008c29; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Ho JCM, 2001, CANCER RES, V61, P8578; Hofmann HS, 2006, ONCOL REP, V16, P587; Hofmann HS, 2005, CLIN CANCER RES, V11, P1086; Iizasa T, 2004, CLIN CANCER RES, V10, P5361, DOI 10.1158/1078-0432.CCR-04-0443; Imoto H, 1998, J THORAC CARDIOV SUR, V115, P1007, DOI 10.1016/S0022-5223(98)70398-8; Ioannidis JPA, 2011, JAMA-J AM MED ASSOC, V305, P2200, DOI 10.1001/jama.2011.713; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jing R, 2010, NEOPLASMA, V57, P55, DOI 10.4149/neo_2010_01_055; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Carlini MJ, 2010, HUM PATHOL, V41, P697, DOI 10.1016/j.humpath.2009.04.029; Kassis ES, 2009, J THORAC CARDIOV SUR, V138, P412, DOI 10.1016/j.jtcvs.2009.01.033; Kim TM, 2005, CLIN CANCER RES, V11, P8235, DOI 10.1158/1078-0432.CCR-05-1157; Krady MM, 2008, AM J PATHOL, V173, P879, DOI 10.2353/ajpath.2008.080128; Lee YC, 2002, J THORAC CARDIOV SUR, V123, P502, DOI 10.1067/mtc.2002.119334; Liu D, 2007, LUNG CANCER, V58, P384, DOI 10.1016/j.lungcan.2007.07.005; Liu Y, 2007, LUNG CANCER, V56, P307, DOI 10.1016/j.lungcan.2007.01.016; Migita T, 2010, AM J PATHOL, V176, P1756, DOI 10.2353/ajpath.2010.090500; Moran CJ, 2002, CLIN CANCER RES, V8, P3803; Nakamura H, 2003, CANCER-AM CANCER SOC, V97, P2798, DOI 10.1002/cncr.11406; Ohta Y, 2006, ANN THORAC SURG, V82, P1180, DOI 10.1016/j.athoracsur.2006.04.034; Okada M, 2005, J THORAC CARDIOV SUR, V129, P87, DOI 10.1016/j.jtcvs.2004.04.030; Olchovsky D, 2002, ACTA ONCOL, V41, P182, DOI 10.1080/028418602753669571; Oshika Y, 1998, CLIN CANCER RES, V4, P1785; Ostroff Rachel M, 2010, PLoS One, V5, pe15003, DOI 10.1371/journal.pone.0015003; Robert C, 1999, CLIN CANCER RES, V5, P2094; Safranek J, 2009, ANTICANCER RES, V29, P2513; Salden M, 2000, ANN ONCOL, V11, P327, DOI 10.1023/A:1008312801800; Schraml P, 1997, CANCER RES, V57, P3669; Seder CW, 2009, NEOPLASIA, V11, P388, DOI 10.1593/neo.81582; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Sequist LV, 2011, ANN ONCOL, V22, P2616, DOI 10.1093/annonc/mdr489; Shah SA, 2010, J THORAC CARDIOV SUR, V139, P984, DOI 10.1016/j.jtcvs.2009.12.016; Simpson-Haidaris PJ, 2001, ANN NY ACAD SCI, V936, P406; Singhal S, 2008, LUNG CANCER, V60, P313, DOI 10.1016/j.lungcan.2008.03.007; Son JW, 2009, TUBERC RESPIR DIS, V67, P413, DOI 10.4046/trd.2009.67.5.413; Stearman RS, 2005, AM J PATHOL, V167, P1763, DOI 10.1016/S0002-9440(10)61257-6; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Su J, 2004, CHIN J CLIN ONCOL, V1, P126; Taguchi A, 2011, CANCER CELL, V20, P289, DOI 10.1016/j.ccr.2011.08.007; Takada M, 2004, J SURG RES, V122, P61, DOI 10.1016/j.jss.2004.06.002; WEGMANN BR, 1993, EUR J CANCER, V29A, P1578, DOI 10.1016/0959-8049(93)90298-T; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yfanti C, 2008, INT J MOL MED, V22, P421, DOI 10.3892/ijmm_00000038; Yoo DG, 2008, LUNG CANCER, V60, P277, DOI 10.1016/j.lungcan.2007.10.015; Yoo Jin young, 2004, Cancer Res Treat, V36, P303, DOI 10.4143/crt.2004.36.5.303; Yuan A, 2000, AM J RESP CRIT CARE, V162, P1957, DOI 10.1164/ajrccm.162.5.2002108; Zhang ZF, 2006, ANN THORAC SURG, V82, P243, DOI 10.1016/j.athoracsur.2006.01.049	71	63	67	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35157	10.1371/journal.pone.0035157	http://dx.doi.org/10.1371/journal.pone.0035157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509397	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336600090
J	Zuo, BF; Du, XY; Zhao, J; Yang, HX; Wang, C; Wu, YH; Lu, J; Wang, Y; Chen, ZW				Zuo, Baofen; Du, Xiaoyan; Zhao, Jing; Yang, Huixin; Wang, Chao; Wu, Yanhua; Lu, Jing; Wang, Ying; Chen, Zhenwen			Analysis of Microsatellite Polymorphism in Inbred Knockout Mice	PLOS ONE			English	Article							DNA MISMATCH REPAIR; EMBRYONIC STEM-CELLS; COLORECTAL-CANCER; EUKARYOTIC GENOMES; SIMPLE SEQUENCES; GENE; INSTABILITY; PHENOTYPE; MOUSE; COLON	Previously, we found that the genotype of 42 out of 198 mouse microsatellite loci, which are distributed among all chromosomes except the Y chromosome, changed from monomorphism to polymorphism (CMP) in a genetically modified inbred mouse strain. In this study, we further examined whether CMP also relates to the homologous recombination in gene knockout (KO) mouse strains. The same 42 microsatellite loci were analyzed by polymerase chain reaction (PCR) in 29 KO inbred mouse strains via short tandem sequence repeat (STR) scanning and direct sequence cloning to justify microsatellite polymorphisms. The C57BL/6J and 129 mouse strains, from which these 29 KO mice were derived, were chosen as the background controls. The results indicated that 10 out of 42 (23.8%) loci showed CMP in some of these mouse strains. Except for the trinucleotide repeat locus of D3Mit22, which had microsatellite CMP in strain number 9, the core sequences of the remaining 41 loci were dinucleotide repeats, and 9 out of 41 (21.95%) showed CMPs among detected mouse strains. However, 11 out of 29 (37.9%) KO mice strains were recognized as having CMPs. The popular dinucleotide motifs in CMP were (TG)(n) (50%, 2/4), followed by (GT)(n) (27.27%, 3/11) and (CA)(n) (23.08%, 3/13). The microsatellite CMP in (CT)(n) and (AG)(n) repeats were 20% (1/5). According to cloning sequencing results, 6 KO mouse strains showed insertions of nucleotides whereas 1 showed a deletion. Furthermore, 2 loci (D13Mit3 and D14Mit102) revealed CMP in 2 strains, and mouse strain number 9 showed CMPs in two loci (D3Mit22 and D13Mit3) simultaneously. Collectively, these results indicated that microsatellite polymorphisms were present in the examined inbred KO mice.	[Zuo, Baofen; Du, Xiaoyan; Wang, Chao; Wu, Yanhua; Lu, Jing; Wang, Ying; Chen, Zhenwen] Capital Med Univ, Sch Basic Med Sci, Dept Lab Anim Sci, Beijing, Peoples R China; [Zhao, Jing; Yang, Huixin] Nanjing Univ, Model Anim Res Ctr, Nanjing 210008, Jiangsu, Peoples R China	Capital Medical University; Nanjing University	Zuo, BF (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Lab Anim Sci, Beijing, Peoples R China.	wangcam@ccmu.edu.cn; czwen@ccmu.edu	Du, Xiaoyan/ABD-3167-2021; zhao, jing/B-3868-2019	Du, Xiaoyan/0000-0002-4030-7299; 	National Science Foundation of China [30970420, 31071988]; Key Projects in the National Science & Technology Pillar Program [2009BAI83B02]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Projects in the National Science & Technology Pillar Program	This work was funded by National Science Foundation of China (No. 30970420 and No. 31071988;URL:http://www.nsfc.gov.cn) and Key Projects in the National Science & Technology Pillar Program (No. 2009BAI83B02;URL:http://www.most.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALTONEN LA, 1994, CANCER RES, V54, P1645; AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; AQUILINA G, 1994, P NATL ACAD SCI USA, V91, P8905, DOI 10.1073/pnas.91.19.8905; BECKMANN JS, 1992, GENOMICS, V12, P627, DOI 10.1016/0888-7543(92)90285-Z; Boland CR, 1998, CANCER RES, V58, P5248; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; Culligan KM, 2000, NUCLEIC ACIDS RES, V28, P463, DOI 10.1093/nar/28.2.463; Day TK, 2007, INT J RADIAT BIOL, V83, P523, DOI 10.1080/09553000701420582; Doetschman T, 1999, LAB ANIM SCI, V49, P137; Drake TA, 2001, J ORTHOPAED RES, V19, P511, DOI 10.1016/S0736-0266(00)00056-5; Eisener-Dorman AF, 2009, BRAIN BEHAV IMMUN, V23, P318, DOI 10.1016/j.bbi.2008.09.001; FISHEL, 1994, CELL, V77, pU17; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gershaw CJ, 2011, FORENSIC SCI INT-GEN, V5, P16, DOI 10.1016/j.fsigen.2010.07.005; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jascur T, 2006, INT J CANCER, V119, P2030, DOI 10.1002/ijc.22023; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8927, DOI 10.1073/pnas.86.22.8927; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Ledermann B, 2000, EXP PHYSIOL, V85, P603, DOI 10.1017/S0958067000021059; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Ling ZQ, 2010, CANCER LETT, V297, P244, DOI 10.1016/j.canlet.2010.05.017; Mhawech-Fauceglia P, 2009, HISTOPATHOLOGY, V55, P621, DOI 10.1111/j.1365-2559.2009.03410.x; Mitmaker E, 2008, J SURG RES, V150, P40, DOI 10.1016/j.jss.2007.12.760; Muller U, 1999, MECH DEVELOP, V82, P3, DOI 10.1016/S0925-4773(99)00021-0; PALOMBO F, 1995, SCIENCE, V268, P1912, DOI 10.1126/science.7604265; Staebler A, 2000, HUM PATHOL, V31, P354, DOI 10.1016/S0046-8177(00)80250-6; STRAND M, 1995, P NATL ACAD SCI USA, V92, P10418, DOI 10.1073/pnas.92.22.10418; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; TAUTZ D, 1986, NATURE, V322, P652, DOI 10.1038/322652a0; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Weitzmann MN, 1998, J BIOL CHEM, V273, P30742, DOI 10.1074/jbc.273.46.30742; Xue Y, 2010, CLIN CHEM LAB MED, V48, P785, DOI 10.1515/CCLM.2010.154	36	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34555	10.1371/journal.pone.0034555	http://dx.doi.org/10.1371/journal.pone.0034555			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509320	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600035
J	Myles, PR; Nguyen-Van-Tam, JS; Lim, WS; Nicholson, KG; Brett, SJ; Enstone, JE; McMenamin, J; Openshaw, PJM; Read, RC; Taylor, BL; Bannister, B; Semple, MG				Myles, Puja R.; Nguyen-Van-Tam, Jonathan S.; Lim, Wei Shen; Nicholson, Karl G.; Brett, Stephen J.; Enstone, Joanne E.; McMenamin, James; Openshaw, Peter J. M.; Read, Robert C.; Taylor, Bruce L.; Bannister, Barbara; Semple, Malcolm G.			Comparison of CATs, CURB-65 and PMEWS as Triage Tools in Pandemic Influenza Admissions to UK Hospitals: Case Control Analysis Using Retrospective Data	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PREDICTING MORTALITY; SEVERITY; METAANALYSIS	Triage tools have an important role in pandemics to identify those most likely to benefit from higher levels of care. We compared Community Assessment Tools (CATs), the CURB-65 score, and the Pandemic Medical Early Warning Score (PMEWS); to predict higher levels of care (high dependency - Level 2 or intensive care - Level 3) and/or death in patients at or shortly after admission to hospital with A/H1N1 2009 pandemic influenza. This was a case-control analysis using retrospectively collected data from the FLU-CIN cohort (1040 adults, 480 children) with PCR-confirmed A/H1N1 2009 influenza. Area under receiver operator curves (AUROC), sensitivity, specificity, positive predictive values and negative predictive values were calculated. CATs best predicted Level 2/3 admissions in both adults [AUROC (95% CI): CATs 0.77 (0.73, 0.80); CURB-65 0.68 (0.64, 0.72); PMEWS 0.68 (0.64, 0.73), p<0.001] and children [AUROC: CATs 0.74 (0.68, 0.80); CURB-65 0.52 (0.46, 0.59); PMEWS 0.69 (0.62, 0.75), p<0.001]. CURB-65 and CATs were similar in predicting death in adults with both performing better than PMEWS; and CATs best predicted death in children. CATs were the best predictor of Level 2/3 care and/or death for both adults and children. CATs are potentially useful triage tools for predicting need for higher levels of care and/or mortality in patients of all ages.	[Myles, Puja R.; Nguyen-Van-Tam, Jonathan S.; Enstone, Joanne E.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [Lim, Wei Shen] Nottingham Univ Hosp NHS Trust, Dept Resp Med, Nottingham, England; [Nicholson, Karl G.] Leicester Royal Infirm, Infect Dis Unit, Univ Hosp Leicester NHS Trust, Leicester, Leics, England; [Brett, Stephen J.] Imperial Coll Healthcare NHS Trust, Ctr Perioperat Med & Crit Care Res, London, England; [McMenamin, James] NHS Natl Serv Scotland, Hlth Protect Scotland, Glasgow, Lanark, Scotland; [Openshaw, Peter J. M.] Univ London Imperial Coll Sci Technol & Med, Ctr Resp Infect, Natl Heart & Lung Inst, London, England; [Read, Robert C.] Univ Sheffield, Royal Hallamshire Hosp, Dept Infect & Immun, Sheffield S10 2JF, S Yorkshire, England; [Taylor, Bruce L.] Portsmouth Hosp NHS Trust, Dept Crit Care, Portsmouth, Hants, England; [Bannister, Barbara] Royal Free Hampstead NHS Trust, Dept Infect Dis, London, England; [Semple, Malcolm G.] Univ Liverpool, Dept Womens & Childrens Hlth, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	University of Nottingham; Nottingham University Hospital NHS Trust; University Hospitals of Leicester NHS Trust; University of Leicester; Imperial College London; NHS National Services Scotland; Imperial College London; University of Sheffield; Portsmouth Hospitals NHS Trust; University of London; University College London; University of Liverpool	Myles, PR (corresponding author), Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England.	m.g.semple@liverpool.ac.uk	Nguyen-Van-Tam, Jonathan/I-2162-2019; Openshaw, Peter/AAL-9442-2020; Zixuan, Huang/ABI-3557-2020; Semple, Malcolm Gracie/A-8790-2008	Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Openshaw, Peter/0000-0002-7220-2555; Semple, Malcolm Gracie/0000-0001-9700-0418; Read, Robert/0000-0002-4297-6728; Myles, Puja/0000-0002-8976-890X	Department of Health in England; Scottish Government Chief Medical Officer; Public Health Directorate; Roche; GlaxoSmithKline; Astra-Zeneca; F. Hoffmann-La Roche; Pfizer; UK NIHR Biomedical Research Centre; Medical Research Council [G1000758, G1000758B] Funding Source: researchfish; Asthma UK [S06/001] Funding Source: researchfish	Department of Health in England; Scottish Government Chief Medical Officer; Public Health Directorate; Roche(Roche Holding); GlaxoSmithKline(GlaxoSmithKline); Astra-Zeneca(AstraZeneca); F. Hoffmann-La Roche(Hoffmann-La Roche); Pfizer(Pfizer); UK NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK	The Department of Health in England was the main funder for FLU-CIN (United Kingdom Influenza Clinical Information Network). The Scottish Government Chief Medical Officer and Public Health Directorate supported the centre in Scotland. Chairmanship of the FLU-CIN Strategy Group (that includes MGS, BB, JSN-V-T, WSL, PJMO, RCR, BLT, SJB, JMcM, JEE and KGN as members) was provided by the Department of Health, England. The FLU-CIN Strategy Group had final responsibility for the interpretation of findings and decision to submit for publication. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PRM has received an unrestricted educational grant from Roche to conduct research in the area of pandemic influenza. However, the submitted paper is on work that is independent of this grant. JSN-V-T has received funding to attend influenza related meetings, lecture and consultancy fees and research funding from several influenza antiviral drug and vaccine manufacturers. All forms of personal remuneration ceased in September 2010, but research funding from GlaxoSmithKline, Astra-Zeneca and F. Hoffmann-La Roche is ongoing. He is a former employee of SmithKline Beecham plc. (now GlaxoSmithKline), Roche Products Ltd (UK) and Aventis-Pasteur MSD (now Sanofi-Pasteur MSD), all prior to 2005, with no remaining pecuniary interests by way of share holdings, share options and pension rights. WSL has received unrestricted research funding from Pfizer for an unrelated study of pneumococcal pneumonia. KGN, SJB, JEE, JMcM, PJMO, RCR, BLT, BB and MGS have declared that no competing interests exist. None of the research funding for this particular study was from the "several manufacturers" mentioned nor from GlaxoSmithKline, Astra-Zeneca and F. Hoffmann-La Roche. Dr. Malcolm Gracie Semple is a PLoS ONE Editorial Board member. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.; We gratefully acknowledge individuals who helped identify cases and collated clinical data: Alison Booth, Margaret Charlesworth, Sarah Rodenhurst, Angela Ballard and Alison Holmes at Imperial College Healthcare NHS Trust, London, UK; Sally Batham, Phayre Parkinson, Tracy Kumar, and Aiden Dunphy at the University Hospitals of Leicester NHS Trust, Leicester, UK; Anne Tunbridge, Patty Hempsall, Joyce Linskill, Aimee Turner, Sharon Grindle, Dawn Shevlin and Eric Moulds at Sheffield University Hospitals NHS Trust, Sheffield, UK; Elvina White, Elaine Scott, Jennifer Cater, Erica Sergi and Helen Hill at Alder Hey Children's Hospital NHS Foundation Trust, Liverpool, UK; Deborah Fleetwood, Lorna Roche, Sarah Dyas, and Maria Boswell at the Royal Liverpool and Broadgreen University Hospital's Trust, Liverpool, UK; Gillian Vernon, Gillian Houghton, Heather Longworth and Angela Kerrigan at Liverpool Women's Hospital, Liverpool, UK; Sonia Greenwood, Gemma Thompson, Emily Jarvis, Charlotte Minter at the Nottingham University Hospitals NHS Trust, Nottingham, UK; Kristina Lum Kin, Jacqueline Daglish, Sam Hayton, and Gemma Slinn at Birmingham Children's Hospital, Birmingham, UK; Michelle Lacey, Kevin Rooney, Karen Duffy, Anne Gordon, Eleanor Anderson, Hilary Davison, William Carman, Mark Cotton, Arlene Reynolds, Heather Murdoch, Karen Voy, Rosie Hague and Ali McAllister for their contribution to FLU-CIN in Scotland. Brian Smyth and Cathriona Kearns from the National Public Health Agency, Northern Ireland for identifying cases and facilitating data collection; Teresa Cunningham at the Southern Trust and Leslie Boydell at the Belfast Trust for facilitating data collection. Alemayehu Amberbir, Safaa Al-Badri, Baraa Mahgoob and Nachi Arunachalam at the University of Nottingham for data entry; also Graham Watson for database development and support. We also thank Professor Dame Sally Davies and Professor Janet Darbyshire, who Co-Chaired the Influenza Clinical Information Network Strategy Group, and Professor Sir Gordon Duff, Co-Chair of the Scientific Advisory Group for Emergencies, for their support. SJB and PJMO wish to acknowledge the support of the UK NIHR Biomedical Research Centre scheme.	Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; *BRIT THOR SOC, 2004, GUID MAN COMM ACQ PN; Challen K, 2007, CRIT CARE, V11, DOI 10.1186/cc5732; Challen K, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-33; Chalmers JD, 2010, THORAX, V65, P878, DOI 10.1136/thx.2009.133280; Department of Health, 2009, PAND FLU MAN DEM CAP; Department of Health & NHS, 2009, 12368 NHS COI DEP HL; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Goodacre S, 2010, HEALTH TECHNOL ASSES, V14, P173, DOI 10.3310/hta14460-03; Health Protection Agency, 2011, SURV INFL OTH RESP V; Lim WS, 2003, THORAX, V58, P377, DOI 10.1136/thorax.58.5.377; Loke YK, 2010, THORAX, V65, P884, DOI 10.1136/thx.2009.134072; Mulrennan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012849; Myles PR, 2012, THORAX, V67, P709, DOI 10.1136/thoraxjnl-2011-200266; Nguyen-Van-Tam JS, 2010, THORAX, V65, P645, DOI 10.1136/thx.2010.135210; Simon R, 2010, PERS MED, V7, P33, DOI 10.2217/PME.09.49; ZWEIG MH, 1993, CLIN CHEM, V39, P561	17	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34428	10.1371/journal.pone.0034428	http://dx.doi.org/10.1371/journal.pone.0034428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509303	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000304805900031
J	Bobkov, Y; Park, I; Ukhanov, K; Principe, J; Ache, B				Bobkov, Yuriy; Park, Ill; Ukhanov, Kirill; Principe, Jose; Ache, Barry			Cellular Basis for Response Diversity in the Olfactory Periphery	PLOS ONE			English	Article							ODOR REPRESENTATIONS; RECEPTORS; LOBSTER; CHANNEL; MIXTURES; NEURONS	An emerging idea in olfaction is that temporal coding of odor specificity can be intrinsic to the primary olfactory receptor neurons (ORNs). As a first step towards understanding whether lobster ORNs are capable of generating odor-specific temporal activity and what mechanisms underlie any such heterogeneity in discharge pattern, we characterized different patterns of activity in lobster ORNs individually and ensemble using patch-clamp recording and calcium imaging. We demonstrate that lobster ORNs show tonic excitation, tonic inhibition, phaso-tonic excitation, and bursting, and that these patterns are faithfully reflected in the calcium signal. We then demonstrate that the various dynamic patterns of response are inherent in the cells, and that this inherent heterogeneity is largely determined by heterogeneity in the underlying intrinsic conductances.	[Bobkov, Yuriy; Ukhanov, Kirill; Ache, Barry] Univ Florida, Whitney Lab, Ctr Smell & Taste, Gainesville, FL 32611 USA; [Bobkov, Yuriy; Ukhanov, Kirill; Ache, Barry] Univ Florida, McKnight Brain Inst, Gainesville, FL USA; [Park, Ill] Univ Texas Austin, Ctr Perceptual Syst, Austin, TX 78712 USA; [Principe, Jose] Univ Florida, Dept Elect & Comp Engn, Gainesville, FL USA; [Ache, Barry] Univ Florida, Dept Biol, Gainesville, FL USA; [Ache, Barry] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Texas System; University of Texas Austin; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Bobkov, Y (corresponding author), Univ Florida, Whitney Lab, Ctr Smell & Taste, Gainesville, FL 32611 USA.	bobkov@whitney.ufl.edu	principe, jose/N-8099-2014; Park, Memming/N-3092-2016	Park, Memming/0000-0002-4255-7750	National Institute on Deafness and Other Communication Disorders [DC001655, DC011859]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001655, R21DC011859] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institute on Deafness and Other Communication Disorders through awards DC001655 and DC011859 to BWA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bobkov YV, 2007, J NEUROPHYSIOL, V97, P1052, DOI 10.1152/jn.01111.2006; Bobkov YV, 2005, J NEUROPHYSIOL, V93, P1372, DOI 10.1152/jn.00990.2004; BOEKHOFF I, 1994, J NEUROSCI, V14, P3304; Bosier B, 2010, BIOCHEM PHARMACOL, V80, P1, DOI 10.1016/j.bcp.2010.02.013; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Corey EA, 2009, CHEM SENSES, V35, pA65; Dayan P, 2001, COMPUTATIONAL NEUROS; Deng Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018605; Fisher A, 1993, SELECTIVE SIGNALING; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; GRUNERT U, 1988, CELL TISSUE RES, V251, P95, DOI 10.1007/BF00215452; Hollins B, 2003, J COMP NEUROL, V455, P125, DOI 10.1002/cne.10489; Joerges J, 1997, NATURE, V387, P285, DOI 10.1038/387285a0; Kain P, 2008, J NEUROSCI, V28, P4745, DOI 10.1523/JNEUROSCI.5306-07.2008; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Lerma J, 2003, NAT REV NEUROSCI, V4, P481, DOI 10.1038/nrn1118; MCCLINTOCK TS, 1989, P NATL ACAD SCI USA, V86, P8137, DOI 10.1073/pnas.86.20.8137; MICHEL WC, 1994, CHEM SENSES, V19, P11, DOI 10.1093/chemse/19.1.11; Nagel KI, 2011, NAT NEUROSCI, V14, P208, DOI 10.1038/nn.2725; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Raman B, 2010, J NEUROSCI, V30, P1994, DOI 10.1523/JNEUROSCI.5639-09.2010; Rozas JL, 2003, NEURON, V39, P543, DOI 10.1016/S0896-6273(03)00436-7; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Sato K, 2011, P NATL ACAD SCI USA, V108, P11680, DOI 10.1073/pnas.1019622108; Spors H, 2002, NEURON, V34, P301, DOI 10.1016/S0896-6273(02)00644-X; Su CY, 2011, P NATL ACAD SCI USA, V108, P5075, DOI 10.1073/pnas.1100369108; Ukhanov K, 2011, CELL CALCIUM, V49, P100, DOI 10.1016/j.ceca.2010.10.009; Ukhanov K, 2011, J NEUROSCI, V31, P273, DOI 10.1523/JNEUROSCI.3698-10.2011; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Woehler Andrew, 2009, Curr Mol Pharmacol, V2, P237	33	8	8	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34843	10.1371/journal.pone.0034843	http://dx.doi.org/10.1371/journal.pone.0034843			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514675	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600081
J	Eloualid, A; Rhaissi, H; Reguig, A; Bounaceur, S; El Houate, B; Abidi, O; Charif, M; Louanjli, N; Chadli, E; Barakat, A; Bashamboo, A; McElreavey, K; Rouba, H				Eloualid, Abdelmajid; Rhaissi, Houria; Reguig, Ahmed; Bounaceur, Safaa; El Houate, Brahim; Abidi, Omar; Charif, Majida; Louanjli, Noureddine; Chadli, Elbakkay; Barakat, Abdelhamid; Bashamboo, Anu; McElreavey, Ken; Rouba, Hassan			Association of Spermatogenic Failure with the b2/b3 Partial AZFc Deletion	PLOS ONE			English	Article							HUMAN Y-CHROMOSOME; FACTOR-C REGION; MALE-INFERTILITY; OLIGOZOOSPERMIC MEN; GR/GR DELETIONS; AZOOSPERMIC MEN; INCREASED RISK; MICRODELETIONS; HAPLOGROUPS; SUBDELETION	Infertility affects around 1 in 10 men and in most cases the cause is unknown. The Y chromosome plays an important role in spermatogenesis and specific deletions of this chromosome, the AZF deletions, are associated with spermatogenic failure. Recently partial AZF deletions have been described but their association with spermatogenic failure is unclear. Here we screened a total of 339 men with idiopathic spermatogenic failure, and 256 normozoospermic ancestry-matched men for chromosome microdeletions including AZFa, AZFb, AZFc, and the AZFc partial deletions (gr/gr, b1/b3 and b2/b3). AZFa and AZFc deletions were identified in men with severe spermatogenic failure at similar frequencies to those reported elsewhere. Gr/gr deletions were identified in case and control populations at 5.83% and 6.25% respectively suggesting that these deletions are not associated with spermatogenic failure. However, b2/b3 deletions were detected only in men with spermatogenic failure and not in the normospermic individuals. Combined with our previous data this shows an association of the b2/b3 deletion (p=0.0318) with spermatogenic failure in some populations. We recommend screening for this deletion in men with unexplained spermatogenic failure.	[Eloualid, Abdelmajid; Reguig, Ahmed; Bounaceur, Safaa; El Houate, Brahim; Abidi, Omar; Charif, Majida; Barakat, Abdelhamid; Rouba, Hassan] Inst Pasteur, Human Genet Unit, Casablanca, Morocco; [Chadli, Elbakkay] Inst Pasteur, Cytogenet Unit, Casablanca, Morocco; [Louanjli, Noureddine] LABOMAC Lab, Casablanca, Morocco; [Bashamboo, Anu; McElreavey, Ken] Inst Pasteur, Human Dev Genet Unit, Paris, France; [Eloualid, Abdelmajid; Rhaissi, Houria] Fac Sci Ben Msik, Casablanca, Morocco	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Hassan II University of Casablanca	Eloualid, A (corresponding author), Inst Pasteur, Human Genet Unit, Casablanca, Morocco.	abdelmajideloualid@yahoo.fr	Abidi, Omar/AAM-5088-2020	Brahim, EL HOUATE/0000-0002-7781-426X				Aho M, 2001, ACTA OBSTET GYN SCAN, V80, P652, DOI 10.1034/j.1600-0412.2001.800711.x; Ali S, 2002, GENE, V283, P1, DOI 10.1016/S0378-1119(01)00860-5; Alvarez L, 2009, AM J HUM BIOL, V21, P407, DOI 10.1002/ajhb.20888; Arredi B, 2004, AM J HUM GENET, V75, P338, DOI 10.1086/423147; Balkan M, 2008, J ASSIST REPROD GEN, V25, P559, DOI 10.1007/s10815-008-9272-8; Carvalho CMB, 2006, MOL HUM REPROD, V12, P269, DOI 10.1093/molehr/gal029; Ellis N, 2002, GENOME RES, V12, P339; Ferlin A, 2003, J MED GENET, V40, P18, DOI 10.1136/jmg.40.1.18; Fernandes S, 2004, AM J HUM GENET, V74, P180, DOI 10.1086/381132; Fernando L, 2006, ASIAN J ANDROL, V8, P39, DOI 10.1111/j.1745-7262.2006.00100.x; Giachini C, 2008, HUM GENET, V124, P399, DOI 10.1007/s00439-008-0561-1; Imken L, 2007, ASIAN J ANDROL, V9, P674, DOI 10.1111/j.1745-7262.2007.00290.x; Katagiri Y, 2004, REPROD BIOMED ONLINE, V8, P307, DOI 10.1016/S1472-6483(10)60911-X; Krausz C, 2003, INT J ANDROL, V26, P70, DOI 10.1046/j.1365-2605.2003.00402.x; Krausz C, 2009, J MED GENET, V46, P21, DOI 10.1136/jmg.2008.059915; Kucklenbroich K, 2005, HUM REPROD, V20, P191, DOI 10.1098/humrep/deh558; Lynch M, 2005, MOL HUM REPROD, V11, P507, DOI 10.1093/molehr/gah191; Machev N, 2004, J MED GENET, V41, P814, DOI 10.1136/jmg.2004.022111; Mitra A, 2008, INDIAN J MED RES, V127, P124; Okabe M, 1998, AM J HUM GENET, V62, P1274, DOI 10.1086/301895; Osterlund C, 2000, INT J ANDROL, V23, P225, DOI 10.1046/j.1365-2605.2000.00234.x; Pryor JL, 1997, NEW ENGL J MED, V336, P534, DOI 10.1056/NEJM199702203360802; Ravel C, 2009, FERTIL STERIL, V92, P1924, DOI 10.1016/j.fertnstert.2008.08.135; Razvi K., 1999, SMJ, V40, P291; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Repping S, 2004, GENOMICS, V83, P1046, DOI 10.1016/j.ygeno.2003.12.018; SaoPedro SL, 2003, BRAZ J MED BIOL RES, V36, P787, DOI 10.1590/S0100-879X2003000600015; Shahid M, 2011, EUR J HUM GENET, V19, P23, DOI 10.1038/ejhg.2010.151; Shaqalaih Ashraf J, 2009, J Exp Clin Assist Reprod, V6, P7; Simoni M, 2004, INT J ANDROL, V27, P240, DOI 10.1111/j.1365-2605.2004.00495.x; Stouffs K, 2011, HUM REPROD UPDATE, V17, P197, DOI 10.1093/humupd/dmq046; Sun C, 2000, HUM MOL GENET, V9, P2291, DOI 10.1093/oxfordjournals.hmg.a018920; TIEPOLO L, 1976, HUM GENET, V34, P119, DOI 10.1007/BF00278879; van Golde RJT, 2001, HUM REPROD, V16, P289, DOI 10.1093/humrep/16.2.289; Vogt PH, 1996, HUM MOL GENET, V5, P933, DOI 10.1093/hmg/5.7.933; Vogt PH, 2005, HUM REPROD UPDATE, V11, P319, DOI 10.1093/humupd/dmi017; Vutyavanich T, 2007, ASIAN J ANDROL, V9, P68, DOI 10.1111/j.1745-7262.2007.00239.x; Wu B, 2007, HUM REPROD, V22, P1107, DOI 10.1093/humrep/del499; Zhang F, 2006, ANN HUM GENET, V70, P304, DOI 10.1111/j.1469-1809.2005.00231.x; Zhang F, 2007, J MED GENET, V44, P437, DOI 10.1136/jmg.2007.049056	40	30	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34902	10.1371/journal.pone.0034902	http://dx.doi.org/10.1371/journal.pone.0034902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514689	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600095
J	Girbig, D; Grimbs, S; Selbig, J				Girbig, Dorothee; Grimbs, Sergio; Selbig, Joachim			Systematic Analysis of Stability Patterns in Plant Primary Metabolism	PLOS ONE			English	Article							CALVIN CYCLE; NUMERICAL-SIMULATION; PHOTOSYNTHETIC RATE; CARBON; SEDOHEPTULOSE-1,7-BISPHOSPHATASE; ENERGY	Metabolic networks are characterized by complex interactions and regulatory mechanisms between many individual components. These interactions determine whether a steady state is stable to perturbations. Structural kinetic modeling (SKM) is a framework to analyze the stability of metabolic steady states that allows the study of the system Jacobian without requiring detailed knowledge about individual rate equations. Stability criteria can be derived by generating a large number of structural kinetic models (SK-models) with randomly sampled parameter sets and evaluating the resulting Jacobian matrices. Until now, SKM experiments applied univariate tests to detect the network components with the largest influence on stability. In this work, we present an extended SKM approach relying on supervised machine learning to detect patterns of enzyme-metabolite interactions that act together in an orchestrated manner to ensure stability. We demonstrate its application on a detailed SK-model of the Calvin-Benson cycle and connected pathways. The identified stability patterns are highly complex reflecting that changes in dynamic properties depend on concerted interactions between several network components. In total, we find more patterns that reliably ensure stability than patterns ensuring instability. This shows that the design of this system is strongly targeted towards maintaining stability. We also investigate the effect of allosteric regulators revealing that the tendency to stability is significantly increased by including experimentally determined regulatory mechanisms that have not yet been integrated into existing kinetic models.	[Girbig, Dorothee; Selbig, Joachim] Max Planck Inst Mol Plant Physiol, Potsdam, Germany; [Grimbs, Sergio; Selbig, Joachim] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany	Max Planck Society; University of Potsdam	Girbig, D (corresponding author), Max Planck Inst Mol Plant Physiol, Potsdam, Germany.	girbig@mpimp-golm.mpg.de			International Max Planck Research School Primary Metabolism and Plant Growth fellowship; ColoNET project; Federal Ministry of Education and Research [0315417F]	International Max Planck Research School Primary Metabolism and Plant Growth fellowship; ColoNET project; Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	DG is supported by an International Max Planck Research School Primary Metabolism and Plant Growth fellowship. SG and JS are supported by the ColoNET project funded by the Federal Ministry of Education and Research, Grant no. 0315417F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold A, 2011, TRENDS PLANT SCI, V16, P676, DOI 10.1016/j.tplants.2011.09.004; Arrivault S, 2009, PLANT J, V59, P824, DOI 10.1111/j.1365-313X.2009.03902.x; Brautigam A, 2011, PLANT PHYSIOL, V155, P43, DOI 10.1104/pp.110.164970; Bruggeman FJ, 2007, TRENDS MICROBIOL, V15, P45, DOI 10.1016/j.tim.2006.11.003; Bulik S, 2009, FEBS J, V276, P410, DOI 10.1111/j.1742-4658.2008.06784.x; Geigenberger P, 2011, PLANT PHYSIOL, V155, P1566, DOI 10.1104/pp.110.170399; Graciet E, 2004, J EXP BOT, V55, P1245, DOI 10.1093/jxb/erh107; Grimbs S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100186; Grimbs S, 2011, BIOSYSTEMS, V103, P212, DOI 10.1016/j.biosystems.2010.10.015; Heinrich R., 1996, REGULATION CELLULAR; Heldt H-W, 2010, PLANT BIOCH; Jablonsky J, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-185; Kramer DM, 2011, PLANT PHYSIOL, V155, P70, DOI 10.1104/pp.110.166652; Laisk A, 2006, PHOTOSYNTH RES, V90, P45, DOI 10.1007/s11120-006-9109-1; Laisk A, 2009, ADV PHOTOSYNTH RESP, V29, P295; Lefebvre S, 2005, PLANT PHYSIOL, V138, P451, DOI 10.1104/pp.104.055046; Morandini P, 2009, PLANT SCI, V176, P441, DOI 10.1016/j.plantsci.2009.01.005; Nag A, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-94; Nunes-Nesi A, 2011, PLANT PHYSIOL, V155, P101, DOI 10.1104/pp.110.163816; PETTERSSON G, 1988, EUR J BIOCHEM, V175, P661, DOI 10.1111/j.1432-1033.1988.tb14242.x; PORTIS AR, 1983, PLANT PHYSIOL, V71, P936, DOI 10.1104/pp.71.4.936; Quinlan, 2012, DATA MINING TOOLS SE; Quinlan J. R., 1993, C4 5 PROGRAMS MACHIN; Raines CA, 2003, PHOTOSYNTH RES, V75, P1, DOI 10.1023/A:1022421515027; Reznik E, 2010, J THEOR BIOL, V266, P536, DOI 10.1016/j.jtbi.2010.07.023; Rodriguez A, 2009, ELECTRON J BIOTECHN, V12, DOI 10.2225/vol12-issue4-fulltext-2; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Smith AM, 2007, PLANT CELL ENVIRON, V30, P1126, DOI 10.1111/j.1365-3040.2007.01708.x; Steuer R, 2007, PHYTOCHEMISTRY, V68, P2139, DOI 10.1016/j.phytochem.2007.04.041; Steuer R, 2006, P NATL ACAD SCI USA, V103, P11868, DOI 10.1073/pnas.0600013103; Tamoi M, 2006, PLANT CELL PHYSIOL, V47, P380, DOI 10.1093/pcp/pcj004; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zhang L, 2008, PLANT BIOTECHNOL J, V6, P453, DOI 10.1111/j.1467-7652.2008.00332.x; Zhu XG, 2007, PLANT PHYSIOL, V145, P513, DOI 10.1104/pp.107.103713	34	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34686	10.1371/journal.pone.0034686	http://dx.doi.org/10.1371/journal.pone.0034686			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514655	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341600061
J	Guo, JF; Feng, Y; Barnes, P; Huang, FF; Idell, S; Su, DM; Shams, H				Guo, Jianfei; Feng, Yan; Barnes, Peter; Huang, Fang-Fang; Idell, Steven; Su, Dong-Ming; Shams, Homayoun			Deletion of FoxN1 in the Thymic Medullary Epithelium Reduces Peripheral T Cell Responses to Infection and Mimics Changes of Aging	PLOS ONE			English	Article							IMPAIRED IMMUNITY; INFLUENZA-VIRUS; AGED MICE; DIFFERENTIATION; REGENERATION; REPERTOIRE; EXPRESSION; INVOLUTION; DIVERSITY; MEMORY	Aging increases susceptibility to infection, in part because thymic involution culminates in reduced naive T-lymphocyte output. Thymic epithelial cells (TECs) are critical to ensure normal maturation of thymocytes and production of peripheral T cells. The forkhead-class transcription factor, encoded by FoxN1, regulates development, differentiation, and function of TECs, both in the prenatal and postnatal thymus. We recently showed that expression of FoxN1, by keratin 14 (K14)-expressing epithelial cells is essential for maintenance of thymic medullary architecture, and deletion of FoxN1 in K14 promoter-driven TECs inhibited development of mature TECs and reduced the number of total thymocytes. These findings are reminiscent of changes observed during normal thymic aging. In the current report, we compared the effects of K14-driven FoxN1 deletion on peripheral T cell function in response to influenza virus infection with those associated with normal aging in a mouse model. FoxN1-deleted mice had reduced numbers of peripheral CD62L+CD44- naive T-cells. In addition, during influenza infection, these animals had reduced antigen-specific CD8+ T-cell and IgG responses to influenza virus, combined with increased lung injury, weight loss and mortality. These findings paralleled those observed in aged wild type mice, providing the first evidence that K14-mediated FoxN1 deletion causes changes in T-cell function that mimic those in aging during an immune response to challenge with an infectious agent.	[Guo, Jianfei; Feng, Yan; Barnes, Peter; Huang, Fang-Fang; Idell, Steven; Su, Dong-Ming; Shams, Homayoun] Univ Texas Tyler, Hlth Sci Ctr, Tyler, TX 75799 USA	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Guo, JF (corresponding author), Univ Texas Dallas, SW Med Ctr, Dept Radiol, Dallas, TX 75235 USA.	homayoun.shams@uthct.edu			Texas Lung Injury Institute; Cain Foundation for Infectious Disease Research; Center for Pulmonary and Infectious Disease Control (CPIDC) at the University of Texas Health Science Center at Tyler; National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH) [R01AI081995]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081995] Funding Source: NIH RePORTER	Texas Lung Injury Institute; Cain Foundation for Infectious Disease Research; Center for Pulmonary and Infectious Disease Control (CPIDC) at the University of Texas Health Science Center at Tyler; National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the Texas Lung Injury Institute, the Cain Foundation for Infectious Disease Research, the Center for Pulmonary and Infectious Disease Control (CPIDC) at the University of Texas Health Science Center at Tyler and National Institute of Allergy and Infectious Diseases/National Institutes of Health (NIAID/NIH) grant R01AI081995 to Dr. Su. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2009, J IMMUNOL, V182, P784, DOI 10.4049/jimmunol.182.2.784; Chen LZ, 2009, BLOOD, V113, P567, DOI 10.1182/blood-2008-05-156265; Cheng LL, 2010, J BIOL CHEM, V285, P5836, DOI 10.1074/jbc.M109.072124; Chidgey A, 2007, SEMIN IMMUNOL, V19, P331, DOI 10.1016/j.smim.2007.10.006; Frasca D, 2011, J CLIN IMMUNOL, V31, P430, DOI 10.1007/s10875-010-9501-7; Fry TJ, 2002, SPRINGER SEMIN IMMUN, V24, P7, DOI 10.1007/s00281-001-0092-5; Guo JF, 2011, J MOL MED, V89, P263, DOI 10.1007/s00109-010-0700-8; Jiang J, 2011, AGEING RES REV, V10, P422, DOI 10.1016/j.arr.2011.02.001; Jonasson S, 2009, PROSTAG LEUKOTR ESS, V80, P1, DOI 10.1016/j.plefa.2008.10.001; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Liu WM, 2011, HUM VACCINES, V7, P94, DOI 10.4161/hv.7.0.14568; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Ortman CL, 2002, INT IMMUNOL, V14, P813, DOI 10.1093/intimm/dxf042; Shakib S, 2009, J IMMUNOL, V182, P130, DOI 10.4049/jimmunol.182.1.130; Stuart B, 2010, AM J GERIATR PHARMAC, V8, P201, DOI 10.1016/j.amjopharm.2010.05.003; Su DM, 2003, NAT IMMUNOL, V4, P1128, DOI 10.1038/ni983; Sun LG, 2010, AGING CELL, V9, P347, DOI 10.1111/j.1474-9726.2010.00559.x; Swain S, 2005, SEMIN IMMUNOL, V17, P370, DOI 10.1016/j.smim.2005.05.007; Taub DD, 2005, IMMUNOL REV, V205, P72, DOI 10.1111/j.0105-2896.2005.00275.x; Xiao SY, 2007, J IMMUNOL, V179, P8153, DOI 10.4049/jimmunol.179.12.8153; Yager EJ, 2008, J EXP MED, V205, P711, DOI 10.1084/jem.20071140; Zhou X, 2011, VACCINE, V29, P2169, DOI 10.1016/j.vaccine.2010.12.029; Zhu X, 2007, AGING CELL, V6, P663, DOI 10.1111/j.1474-9726.2007.00325.x	23	14	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34681	10.1371/journal.pone.0034681	http://dx.doi.org/10.1371/journal.pone.0034681			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514652	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600058
J	O'Shaughnessy, PJ; Monteiro, A; Abel, M				O'Shaughnessy, Peter J.; Monteiro, Ana; Abel, Margaret			Testicular Development in Mice Lacking Receptors for Follicle Stimulating Hormone and Androgen	PLOS ONE			English	Article							LEYDIG-CELL DEVELOPMENT; SERTOLI-CELLS; POSTNATAL-DEVELOPMENT; IN-VIVO; MOUSE; SPERMATOGENESIS; APOPTOSIS; TESTIS; FSH; PROLIFERATION	Post-natal testicular development is dependent on gonadotrophin and androgen stimulation. Follicle stimulating hormone (FSH) acts through receptors (FSHR) on the Sertoli cell to stimulate spermatogenesis while androgens promote testis growth through receptors (AR) on the Sertoli cells, Leydig cells and peritubular myoid cells. In this study we have examined the effects on testis development of ablating FSHRs (FSHRKO mice) and/or ARs ubiquitously (ARKO mice) or specifically on the Sertoli cells (SCARKO mice). Cell numbers were measured using stereological methods. In ARKO mice Sertoli cell numbers were reduced at all ages from birth until adulthood. FSHR ablation also caused small reductions in Sertoli cell numbers up to day 20 with more marked effects seen in the adult. Germ cell numbers were unaffected by FSHR and/or AR ablation at birth. By day 20 ubiquitous AR or FSHR ablation caused a marked reduction in germ cell numbers with a synergistic effect of losing both receptors (germ cell numbers in FSHRKO. ARKO mice were 3% of control). Germ cell numbers in SCARKO mice were less affected. By adulthood, in contrast, clear synergistic control of germ cell numbers had become established between the actions of FSH and androgen through the Sertoli cells. Leydig cell numbers were normal on day 1 and day 5 in all groups. By day 20 and in adult animals total AR or FSHR ablation significantly reduced Leydig cell numbers but Sertoli cell specific AR ablation had no effect. Results show that, prior to puberty, development of most testicular parameters is more dependent on FSH action than androgen action mediated through the Sertoli cells although androgen action through other cells types is crucial. Post-pubertally, germ cell numbers and spermatogenesis are dependent on FSH and androgen action through the Sertoli cells.	[O'Shaughnessy, Peter J.; Monteiro, Ana] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Abel, Margaret] Univ Oxford, Dept Human Anat & Genet, Oxford, England	University of Glasgow; University of Oxford	O'Shaughnessy, PJ (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	peter.oshaughnessy@glasgow.ac.uk		Monteiro, Ana/0000-0003-2349-9716	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This study was supported by funding from the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel MH, 2008, ENDOCRINOLOGY, V149, P3279, DOI 10.1210/en.2008-0086; Abel MH, 2000, ENDOCRINOLOGY, V141, P1795, DOI 10.1210/en.141.5.1795; Baker PJ, 2003, ENDOCRINOLOGY, V144, P138, DOI 10.1210/en.2002-220637; Baker PJ, 1999, EUR J BIOCHEM, V260, P911, DOI 10.1046/j.1432-1327.1999.00245.x; Baker PJ, 2001, REPRODUCTION, V122, P227, DOI 10.1530/rep.0.1220227; BILLIG H, 1995, ENDOCRINOLOGY, V136, P5, DOI 10.1210/en.136.1.5; Chang CS, 2004, P NATL ACAD SCI USA, V101, P6876, DOI 10.1073/pnas.0307306101; Chausiaux OE, 2008, BIOL REPROD, V78, P77, DOI 10.1095/biolreprod.107.060970; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; De Gendt K, 2005, ENDOCRINOLOGY, V146, P4117, DOI 10.1210/en.2005-0300; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Greep RO, 1936, ANAT REC, V65, P261, DOI 10.1002/ar.1090650303; HARDY MP, 1989, ENDOCRINOLOGY, V124, P762, DOI 10.1210/endo-124-2-762; Haywood M, 2003, ENDOCRINOLOGY, V144, P509, DOI 10.1210/en.2002-220710; Hirst RC, 2004, REPRODUCTION, V128, P43, DOI 10.1530/rep.1.00176; Johnston H, 2004, ENDOCRINOLOGY, V145, P318, DOI 10.1210/en.2003-1055; Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201; Lim P, 2009, ENDOCRINOLOGY; MAYHEW TM, 1992, J NEUROCYTOL, V21, P313, DOI 10.1007/BF01191700; MCLACHLAN RI, 1995, ENDOCRINOLOGY, V136, P4035, DOI 10.1210/en.136.9.4035; Meachem SJ, 2005, J ENDOCRINOL, V186, P429, DOI 10.1677/joe.1.06121; Nef S, 2000, DEV BIOL, V224, P354, DOI 10.1006/dbio.2000.9785; O'Shaughnessy PJ, 2010, ENDOCRINOLOGY, V151, P2343, DOI 10.1210/en.2009-1333; O'Shaughnessy PJ, 2010, REPRODUCTION, V139, P177, DOI 10.1530/REP-09-0377; O'Shaughnessy PJ, 2002, J CELL SCI, V115, P3491; ORTH JM, 1984, ENDOCRINOLOGY, V115, P1248, DOI 10.1210/endo-115-4-1248; Rodriguez I, 1997, EMBO J, V16, P2262, DOI 10.1093/emboj/16.9.2262; Russell LD, 1990, CLEARWATER, P119; Smith PE, 1927, AM J ANAT, V40, P159, DOI 10.1002/aja.1000400202; VERGOUWEN RPFA, 1991, J REPROD FERTIL, V93, P233, DOI 10.1530/jrf.0.0930233; Walczak-Jedrzejowska R, 2011, INT J ANDROL, V34, pE378, DOI 10.1111/j.1365-2605.2011.01146.x; Welsh M, 2012, INT J ANDROL, V35, P25, DOI 10.1111/j.1365-2605.2011.01150.x; Willems A, 2010, INT J ANDROL, V33, P507, DOI 10.1111/j.1365-2605.2009.00964.x; WREFORD NG, 1995, MICROSC RES TECHNIQ, V32, P423, DOI 10.1002/jemt.1070320505; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316	35	59	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35136	10.1371/journal.pone.0035136	http://dx.doi.org/10.1371/journal.pone.0035136			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514715	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305341600121
J	Shen, B; Li, X; Wang, F; Yao, XQ; Yang, D				Shen, Bing; Li, Xiang; Wang, Fei; Yao, Xiaoqiang; Yang, Dan			A Synthetic Chloride Channel Restores Chloride Conductance in Human Cystic Fibrosis Epithelial Cells	PLOS ONE			English	Article							GENE-THERAPY; ION CHANNELS; FLUID TRANSPORT; CFTR; DYSFUNCTION; SECRETION; MEMBRANES; DISEASE	Mutations in the gene-encoding cystic fibrosis transmembrane conductance regulator (CFTR) cause defective transepithelial transport of chloride (Cl-) ions and fluid, thereby becoming responsible for the onset of cystic fibrosis (CF). One strategy to reduce the pathophysiology associated with CF is to increase Cl- transport through alternative pathways. In this paper, we demonstrate that a small synthetic molecule which forms Cl- channels to mediate Cl- transport across lipid bilayer membranes is capable of restoring Cl- permeability in human CF epithelial cells; as a result, it has the potential to become a lead compound for the treatment of human diseases associated with Cl- channel dysfunction.	[Shen, Bing; Yao, Xiaoqiang] Chinese Univ Hong Kong, Dept Physiol, Shatin, Hong Kong, Peoples R China; [Li, Xiang; Yang, Dan] Univ Hong Kong, Dept Chem, Morningside Lab Chem Biol, Hong Kong, Hong Kong, Peoples R China; [Shen, Bing; Wang, Fei] Anhui Med Univ, Dept Physiol, Hefei, Peoples R China	Chinese University of Hong Kong; University of Hong Kong; Anhui Medical University	Shen, B (corresponding author), Chinese Univ Hong Kong, Dept Physiol, Shatin, Hong Kong, Peoples R China.	yao2068@cuhk.edu.hk; yangdan@hku.hk	Li, Xiang/ABG-9385-2020; YANG, Dan/HHD-2733-2022; Yao, Xiaoqiang/I-5413-2016	Li, Xiang/0000-0002-2797-4134; Yao, Xiaoqiang/0000-0002-0687-8186	University of Hong Kong; Hong Kong Research Grants Council [HKU 7367/03M, HKU 2/06C]	University of Hong Kong(University of Hong Kong); Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This study was supported by grants from The University of Hong Kong and the Hong Kong Research Grants Council (HKU 7367/03M and HKU 2/06C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumeister B, 2000, ANGEW CHEM INT EDIT, V39, P1955, DOI 10.1002/1521-3773(20000602)39:11<1955::AID-ANIE1955>3.0.CO;2-M; Broughman JR, 2001, AM J PHYSIOL-CELL PH, V280, pC451, DOI 10.1152/ajpcell.2001.280.3.C451; Cai ZW, 2011, ACTA PHARMACOL SIN, V32, P693, DOI 10.1038/aps.2011.71; Davis AP, 2007, CHEM SOC REV, V36, P348, DOI 10.1039/b512651g; Deng G, 1996, J AM CHEM SOC, V118, P8975, DOI 10.1021/ja961269e; Gorteau V, 2006, J AM CHEM SOC, V128, P14788, DOI 10.1021/ja0665747; Griesenbach U, 2006, GENE THER, V13, P1061, DOI 10.1038/sj.gt.3302809; Jentsch TJ, 2004, NAT CELL BIOL, V6, P1039, DOI 10.1038/ncb1104-1039; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; JIANG CW, 1993, SCIENCE, V262, P424, DOI 10.1126/science.8211164; Jiang CW, 2001, AM J PHYSIOL-LUNG C, V281, pL1164, DOI 10.1152/ajplung.2001.281.5.L1164; Kellerman D, 2008, PULM PHARMACOL THER, V21, P600, DOI 10.1016/j.pupt.2007.12.003; Kunzelmann Karl, 2003, Am J Respir Med, V2, P299; Lee TWR, 2005, BIOCHEM J, V387, P1, DOI 10.1042/BJ20041923; Li X, 2007, J AM CHEM SOC, V129, P7264, DOI 10.1021/ja071961h; Matile S, 2004, TETRAHEDRON, V60, P6405, DOI 10.1016/j.tet.2004.05.052; Mitchell KE, 2000, BBA-BIOMEMBRANES, V1466, P47, DOI 10.1016/S0005-2736(00)00170-X; OBLATTMONTAL M, 1994, P NATL ACAD SCI USA, V91, P1495, DOI 10.1073/pnas.91.4.1495; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Quinton PM, 2007, PHYSIOLOGY, V22, P212, DOI 10.1152/physiol.00041.2006; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; REDDY GL, 1993, J BIOL CHEM, V268, P14608; Rosenecker J, 2006, CURR OPIN MOL THER, V8, P439; Santacroce PV, 2007, J AM CHEM SOC, V129, P1886, DOI 10.1021/ja068067v; Schlesinger PH, 2002, J AM CHEM SOC, V124, P1848, DOI 10.1021/ja016784d; Sermet-Gaudelus I, 2010, AM J RESP CRIT CARE, V182, P1262, DOI 10.1164/rccm.201001-0137OC; Sidorov V, 2002, J AM CHEM SOC, V124, P2267, DOI 10.1021/ja012338e; SMITH JJ, 1994, J CLIN INVEST, V93, P1307, DOI 10.1172/JCI117087; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; Welsh MJ, 1999, J CLIN INVEST, V104, P1165, DOI 10.1172/JCI8634; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170; Zabner J, 2003, AM J PHYSIOL-LUNG C, V284, pL844, DOI 10.1152/ajplung.00355.2002	35	52	52	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34694	10.1371/journal.pone.0034694	http://dx.doi.org/10.1371/journal.pone.0034694			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514656	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341600062
J	Smani, Y; McConnell, MJ; Pachon, J				Smani, Younes; McConnell, Michael J.; Pachon, Jeronimo			Role of Fibronectin in the Adhesion of Acinetobacter baumannii to Host Cells	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; STREPTOCOCCUS-PNEUMONIAE; PSEUDOMONAS-FLUORESCENS; PASTEURELLA-MULTOCIDA; STAPHYLOCOCCUS-AUREUS; BINDING PROTEINS; ADHERENCE; EXPRESSION; STRAINS; GENE	Adhesion to host cells is an initial and important step in Acinetobacter baumannii pathogenesis. However, there is relatively little information on the mechanisms by which A. baumannii binds to and interacts with host cells. Adherence to extracellular matrix proteins, such as fibronectin, affords pathogens with a mechanism to invade epithelial cells. Here, we found that A. baumannii adheres more avidly to immobilized fibronectin than to control protein. Free fibronectin used as a competitor resulted in dose-dependent decreased binding of A. baumannii to fibronectin. Three outer membrane preparations (OMPs) were identified as fibronectin binding proteins (FBPs): OMPA, TonB-dependent copper receptor, and 34 kDa OMP. Moreover, we demonstrated that fibronectin inhibition and neutralization by specific antibody prevented significantly the adhesion of A. baumannii to human lung epithelial cells (A549 cells). Similarly, A. baumannii OMPA neutralization by specific antibody decreased significantly the adhesion of A. baumannii to A549 cells. These data indicate that FBPs are key adhesins that mediate binding of A. baumannii to human lung epithelial cells through interaction with fibronectin on the surface of these host cells.	[Smani, Younes; McConnell, Michael J.; Pachon, Jeronimo] Univ Seville, Clin Unit Infect Dis Microbiol & Prevent Med, Univ Hosp Virgen del Rocio, IBiS,CSIC,Inst Biomed Seville, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Smani, Y (corresponding author), Univ Seville, Clin Unit Infect Dis Microbiol & Prevent Med, Univ Hosp Virgen del Rocio, IBiS,CSIC,Inst Biomed Seville, Seville, Spain.	ysmani-ibis@us.es	Pachon, Jeronimo/M-4337-2014; , Smani/G-5314-2013	, Smani/0000-0001-9302-8384; McConnell, Michael/0000-0003-1028-381X; Pachon, Jeronimo/0000-0002-8166-5308	Spanish Network for Research in Infectious Diseases (Instituto de Salud Carlos III-FEDER, Ministerio de Ciencia e Innovacion) [REIPI RD06/0008]; Consejeria de Salud of the Junta de Andalucia [288/2008]	Spanish Network for Research in Infectious Diseases (Instituto de Salud Carlos III-FEDER, Ministerio de Ciencia e Innovacion); Consejeria de Salud of the Junta de Andalucia(Junta de Andalucia)	Y. Smani is funded by the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008, Instituto de Salud Carlos III-FEDER, Ministerio de Ciencia e Innovacion). This study was supported by a research grant from the Consejeria de Salud of the Junta de Andalucia (288/2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Choi CH, 2005, CELL MICROBIOL, V7, P1127, DOI 10.1111/j.1462-5822.2005.00538.x; Choi CH, 2008, FEMS MICROBIOL LETT, V288, P62, DOI 10.1111/j.1574-6968.2008.01323.x; Choi CH, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-216; Clark RB, 1996, J ANTIMICROB CHEMOTH, V38, P245, DOI 10.1093/jac/38.2.245; Costa SF, 2000, INT J ANTIMICROB AG, V13, P175, DOI 10.1016/S0924-8579(99)00123-5; Cuenca FF, 2003, J BASIC MICROB, V43, P194, DOI 10.1002/jobm.200390022; Dabo SM, 2005, VET MICROBIOL, V110, P265, DOI 10.1016/j.vetmic.2005.08.008; Dabo SM, 2003, MICROB PATHOGENESIS, V35, P147, DOI 10.1016/S0882-4010(03)00098-6; Di Martino P, 2001, CHEMOTHERAPY, V47, P344, DOI 10.1159/000048541; Falagas ME, 2006, CRIT CARE, V10, DOI [10.1186/cc4910, 10.1186/cc4869]; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; Gaddy JA, 2009, INFECT IMMUN, V77, P3150, DOI 10.1128/IAI.00096-09; Gohl O, 2006, APPL ENVIRON MICROB, V72, P1394, DOI 10.1128/AEM.72.2.1394-1401.2006; GREENE C, 1995, MOL MICROBIOL, V17, P1143, DOI 10.1111/j.1365-2958.1995.mmi_17061143.x; Hammerschmidt S, 2006, CURR OPIN MICROBIOL, V9, P12, DOI 10.1016/j.mib.2005.11.001; HANCOCK REW, 1976, J BACTERIOL, V125, P409, DOI 10.1128/JB.125.2.409-415.1976; Henderson B, 2011, FEMS MICROBIOL REV, V35, P147, DOI 10.1111/j.1574-6976.2010.00243.x; Jensch I, 2010, MOL MICROBIOL, V77, P22, DOI 10.1111/j.1365-2958.2010.07189.x; Jin JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017027; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Koljalg S, 1996, APMIS, V104, P659; Kreikemeyer B, 2004, J BIOL CHEM, V279, P15850, DOI 10.1074/jbc.M313613200; Lee JC, 2006, RES MICROBIOL, V157, P360, DOI 10.1016/j.resmic.2005.09.011; Lee JS, 2010, J MICROBIOL, V48, P387, DOI 10.1007/s12275-010-0155-1; McConnell MJ, 2011, INFECT IMMUN, V79, P518, DOI 10.1128/IAI.00741-10; McConnell MJ, 2011, PROTEIN EXPRES PURIF, V77, P98, DOI 10.1016/j.pep.2010.11.019; Mongodin E, 2002, INFECT IMMUN, V70, P620; Mussi MA, 2011, J BACTERIOL, V193, P4736, DOI 10.1128/JB.01533-10; Neeman R, 1998, LANCET, V352, P1974, DOI 10.1016/S0140-6736(97)12452-7; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Osterlund A, 1997, LARYNGOSCOPE, V107, P640; Pauer H, 2009, FEMS IMMUNOL MED MIC, V55, P388, DOI 10.1111/j.1574-695X.2009.00532.x; Rebiere-Huet J, 2002, FEMS MICROBIOL LETT, V215, P121, DOI 10.1016/S0378-1097(02)00920-5; Roger P, 1999, EUR RESPIR J, V13, P1301, DOI 10.1183/09031936.99.13613109; Schwarz-Linek U, 2003, NATURE, V423, P177, DOI 10.1038/nature01589; SKARE JT, 1991, MOL MICROBIOL, V5, P2883, DOI 10.1111/j.1365-2958.1991.tb01848.x; Smani Y, 2011, MICROB PATHOGENESIS, V50, P224, DOI 10.1016/j.micpath.2011.01.008; Tomas MDM, 2005, ANTIMICROB AGENTS CH, V49, P5172, DOI 10.1128/AAC.49.12.5172-5175.2005; Tsang TM, 2010, INFECT IMMUN, V78, P3358, DOI 10.1128/IAI.00238-10; VANDERFLIER M, 1995, INFECT IMMUN, V63, P4317, DOI 10.1128/IAI.63.11.4317-4322.1995; Walia B, 2004, BIOCHEM J, V382, P589, DOI 10.1042/BJ20040021	41	76	81	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e33073	10.1371/journal.pone.0033073	http://dx.doi.org/10.1371/journal.pone.0033073			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514602	gold, Green Published			2022-12-27	WOS:000305341600007
J	Swisher, JD; Sexton, JA; Gatenby, JC; Gore, JC; Tong, F				Swisher, Jascha D.; Sexton, John A.; Gatenby, J. Christopher; Gore, John C.; Tong, Frank			Multishot versus Single-Shot Pulse Sequences in Very High Field fMRI: A Comparison Using Retinotopic Mapping	PLOS ONE			English	Article							HUMAN VISUAL-CORTEX; GRADIENT-RECALLED MRI; ECHO-PLANAR IMAGES; SIGNAL-TO-NOISE; FUNCTIONAL MRI; PHYSIOLOGICAL NOISE; HUMAN-BRAIN; QUANTITATIVE-EVALUATION; COORDINATE SYSTEM; CORTICAL SURFACE	High-resolution functional MRI is a leading application for very high field (7 Tesla) human MR imaging. Though higher field strengths promise improvements in signal-to-noise ratios (SNR) and BOLD contrast relative to fMRI at 3 Tesla, these benefits may be partially offset by accompanying increases in geometric distortion and other off-resonance effects. Such effects may be especially pronounced with the single-shot EPI pulse sequences typically used for fMRI at standard field strengths. As an alternative, one might consider multishot pulse sequences, which may lead to somewhat lower temporal SNR than standard EPI, but which are also often substantially less susceptible to off-resonance effects. Here we consider retinotopic mapping of human visual cortex as a practical test case by which to compare examples of these sequence types for high-resolution fMRI at 7 Tesla. We performed polar angle retinotopic mapping at each of 3 isotropic resolutions (2.0, 1.7, and 1.1 mm) using both accelerated single-shot 2D EPI and accelerated multishot 3D gradient-echo pulse sequences. We found that single-shot EPI indeed led to greater temporal SNR and contrast-to-noise ratios (CNR) than the multishot sequences. However, additional distortion correction in postprocessing was required in order to fully realize these advantages, particularly at higher resolutions. The retinotopic maps produced by both sequence types were qualitatively comparable, and showed equivalent test/retest reliability. Thus, when surface-based analyses are planned, or in other circumstances where geometric distortion is of particular concern, multishot pulse sequences could provide a viable alternative to single-shot EPI.	[Swisher, Jascha D.; Tong, Frank] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Swisher, Jascha D.; Tong, Frank] Vanderbilt Univ, Vis Res Ctr, Nashville, TN USA; [Sexton, John A.; Gore, John C.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Sexton, John A.; Gatenby, J. Christopher; Gore, John C.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN USA; [Gatenby, J. Christopher; Gore, John C.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Swisher, JD (corresponding author), Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA.	j.swisher@vanderbilt.edu			National Institutes of Health [F32 EY019448, 2R01 EB000461, R01 EY017082]; NATIONAL EYE INSTITUTE [F32EY019448, R01EY017082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000461] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by National Institutes of Health grants F32 EY019448 to JDS, 2R01 EB000461 to J. C. Gore, and R01 EY017082 to F. Tong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry RL, 2011, NEUROIMAGE, V55, P1034, DOI 10.1016/j.neuroimage.2010.12.086; Bodurka J, 2007, NEUROIMAGE, V34, P542, DOI 10.1016/j.neuroimage.2006.09.039; Chen NK, 1999, MAGNET RESON MED, V41, P1206, DOI 10.1002/(SICI)1522-2594(199906)41:6<1206::AID-MRM17>3.0.CO;2-L; Cusack R, 2003, NEUROIMAGE, V18, P127, DOI 10.1006/nimg.2002.1281; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Deichmann R, 2002, NEUROIMAGE, V15, P120, DOI 10.1006/nimg.2001.0985; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Duyn JH, 1996, NEUROIMAGE, V4, pS76, DOI 10.1006/nimg.1996.0057; EDELSTEIN WA, 1986, MAGNET RESON MED, V3, P604, DOI 10.1002/mrm.1910030413; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; FRAHM J, 1992, JMRI-J MAGN RESON IM, V2, P501, DOI 10.1002/jmri.1880020505; Goerke U, 2005, NMR BIOMED, V18, P534, DOI 10.1002/nbm.987; Golay X, 2000, MAGNET RESON MED, V43, P779, DOI 10.1002/1522-2594(200006)43:6<779::AID-MRM1>3.0.CO;2-4; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hinds O, 2009, NEUROIMAGE, V46, P915, DOI 10.1016/j.neuroimage.2009.03.036; Hinds OP, 2008, NEUROIMAGE, V39, P1585, DOI 10.1016/j.neuroimage.2007.10.033; Hoffmann MB, 2009, CLIN NEUROPHYSIOL, V120, P108, DOI 10.1016/j.clinph.2008.10.153; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Koopmans PJ, 2010, HUM BRAIN MAPP, V31, P1297, DOI 10.1002/hbm.20936; Kruger G, 2001, MAGNET RESON MED, V46, P631, DOI 10.1002/mrm.1240; Lai S, 1998, MAGNET RESON MED, V39, P68, DOI 10.1002/mrm.1910390112; LIU GY, 1993, MAGNET RESON MED, V30, P68, DOI 10.1002/mrm.1910300111; LIU GY, 1993, MAGNET RESON MED, V30, P764, DOI 10.1002/mrm.1910300617; MOONEN CTW, 1992, MAGNET RESON MED, V26, P184, DOI 10.1002/mrm.1910260118; Neggers SFW, 2008, NMR BIOMED, V21, P663, DOI 10.1002/nbm.1235; Olman CA, 2007, NEUROIMAGE, V34, P1126, DOI 10.1016/j.neuroimage.2006.08.045; Olman CA, 2010, MAGN RESON IMAGING, V28, P1258, DOI 10.1016/j.mri.2010.06.001; Parrish TB, 2000, MAGNET RESON MED, V44, P925, DOI 10.1002/1522-2594(200012)44:6<925::AID-MRM14>3.0.CO;2-M; Polimeni JR, 2010, NEUROIMAGE, V52, P1334, DOI 10.1016/j.neuroimage.2010.05.005; Poser BA, 2010, NEUROIMAGE, V51, P261, DOI 10.1016/j.neuroimage.2010.01.108; Poser BA, 2009, NEUROIMAGE, V45, P1162, DOI 10.1016/j.neuroimage.2009.01.007; Preibisch C, 2003, NEUROIMAGE, V19, P412, DOI 10.1016/S1053-8119(03)00080-6; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; RA JB, 1993, MAGNET RESON MED, V30, P142, DOI 10.1002/mrm.1910300123; Reber PJ, 1998, MAGNET RESON MED, V39, P328, DOI 10.1002/mrm.1910390223; Ress D, 2007, NEUROIMAGE, V34, P74, DOI 10.1016/j.neuroimage.2006.08.020; Schira MM, 2009, J NEUROSCI, V29, P9050, DOI 10.1523/JNEUROSCI.1760-09.2009; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Sodickson DK, 1997, MAGNET RESON MED, V38, P591, DOI 10.1002/mrm.1910380414; Speck O, 2008, MAGN RESON MATER PHY, V21, P73, DOI 10.1007/s10334-007-0087-x; Strothert SC, 2002, NEUROIMAGE, V15, P747, DOI 10.1006/nimg.2001.1034; Triantafyllou C, 2005, NEUROIMAGE, V26, P243, DOI 10.1016/j.neuroimage.2005.01.007; van der Meulen P, 1985, Magn Reson Imaging, V3, P297, DOI 10.1016/0730-725X(85)90362-5; van der Zwaag W, 2011, MAGNETIC RESONANCE M; VANDERMEULEN P, 1988, MAGN RESON IMAGING, V6, P355, DOI 10.1016/0730-725X(88)90472-9; Wandell BA, 2007, NEURON, V56, P366, DOI 10.1016/j.neuron.2007.10.012; Warnking J, 2002, NEUROIMAGE, V17, P1665, DOI 10.1006/nimg.2002.1304; Weisskoff RM, 1992, P ISMRM 11 ANN M; Winawer J, 2010, J VISION, V10, DOI 10.1167/10.5.1; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080	57	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34626	10.1371/journal.pone.0034626	http://dx.doi.org/10.1371/journal.pone.0034626			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514646	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600052
J	Crego-Prieto, V; Martinez, JL; Roca, A; Garcia-Vazquez, E				Crego-Prieto, Victor; Martinez, Jose L.; Roca, Agustin; Garcia-Vazquez, Eva			Interspecific Hybridization Increased in Congeneric Flatfishes after the Prestige Oil Spill	PLOS ONE			English	Article							MEGRIM LEPIDORHOMBUS-BOSCII; 3-SPINED STICKLEBACKS; COLLAPSE; DNA; WHIFFIAGONIS; GASTEROSTEUS; MECHANISMS; BIOMARKERS; EVOLUTION; NORTHEAST	Marine species with relatively low migratory capacity are threatened by habitat alterations derived from human activities. In November 2002 the tanker Prestige sank off the Spanish northwest coast releasing 70,000 tons of fuel and damaging biota in the area. Despite efforts to clean the damaged areas, fuel remnants have affected marine species over the last nine years. This study is focused on two flatfish, Lepidorhombus boscii (four-spotted megrim) and L. whiffiagonis (megrim), whose spawning areas are located at the edge of the continental platform. We have analyzed megrim samples from North Spanish and French waters obtained before and after the oil spill. Genotypes at the nuclear marker 5S rDNA indicate a significant increase in interspecific hybridization after the Prestige accident, likely due to forced spawning overlap. The mitochondrial D-Loop region was employed for determining the direction of hybrid crosses, which were most frequently L. boscii female x L. whiffiagonis male. Reduced ability of L. boscii females to select conspecific mates would explain such asymmetric hybridization. To our knowledge this is the first time that increased hybridization between fish species can be associated to an oil spill. These results illustrate the potential long-term effect of petrol wastes on wild fish species.	[Crego-Prieto, Victor; Martinez, Jose L.; Roca, Agustin; Garcia-Vazquez, Eva] Univ Oviedo, Dept Funct Biol, Oviedo, Spain	University of Oviedo	Crego-Prieto, V (corresponding author), Univ Oviedo, Dept Funct Biol, Oviedo, Spain.	victor.crego.prieto@gmail.com	Fernández, Jose Luis Martínez/M-1802-2018; Martínez Fernández, Jose Luis/AAW-5618-2021; Garcia-Vazquez, Eva/Y-7293-2019	Fernández, Jose Luis Martínez/0000-0001-7716-2428; Martínez Fernández, Jose Luis/0000-0001-7716-2428; Garcia-Vazquez, Eva/0000-0002-8429-838X; Roca-Martinez, Agustin Antonio/0000-0003-2117-0132	Spanish National project MICINN [CGL2009-08279]	Spanish National project MICINN	This study was funded by the Spanish National project MICINN CGL2009-08279. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins-Regan E, 1998, AM ZOOL, V38, P166; Albaiges J, 2006, MAR POLLUT BULL, V53, P205, DOI 10.1016/j.marpolbul.2006.03.012; Andersson Malte, 1994; Arnold ML, 1999, ECOLOGY, V80, P371, DOI 10.1890/0012-9658(1999)080[0371:NHHLCY]2.0.CO;2; AVISE JC, 1984, GENETICS, V108, P237; Behm JE, 2010, AM NAT, V175, P11, DOI 10.1086/648559; Campo D, 2010, J SEA RES, V64, P360, DOI 10.1016/j.seares.2010.05.004; Danancher D, 2009, MAR BIOL, V156, P1869, DOI 10.1007/s00227-009-1219-9; DIGIULIO RT, 1993, AQUAT TOXICOL, V26, P1, DOI 10.1016/0166-445X(93)90002-I; Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058; Estoup A, 1996, MOL MAR BIOL BIOTECH, V5, P295; Garcia-Vazquez E, 2006, J SEA RES, V56, P59, DOI 10.1016/j.seares.2006.04.001; Gilbert TD, PUB AMSA, P1; Gilman RT, 2011, EVOLUTION, V65, P2592, DOI 10.1111/j.1558-5646.2011.01320.x; Gow JL, 2006, MOL ECOL, V15, P739, DOI 10.1111/j.1365-294X.2006.02825.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hochwender CG, 2000, EVOL ECOL, V14, P509, DOI 10.1023/A:1010846514418; ICES, 2008, REP WORK GROUP ASS S; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kraak SBM, 2001, J FISH BIOL, V58, P1458, DOI 10.1111/j.1095-8649.2001.tb02300.x; Landa J, 2000, ICES J MAR SCI, V57, P1077, DOI 10.1006/jmsc.2000.0702; Landa J, 2002, FISH RES, V55, P141, DOI 10.1016/S0165-7836(01)00302-2; Leary CJ, 2006, AM NAT, V168, P431, DOI 10.1086/506975; Leary CJ, 2006, HORM BEHAV, V49, P425, DOI 10.1016/j.yhbeh.2005.09.004; Martinez-Abrain A, 2006, MAR ECOL PROG SER, V318, P271, DOI 10.3354/meps318271; Martinez-Gomez C, 2006, MAR POLLUT BULL, V53, P305, DOI 10.1016/j.marpolbul.2006.03.010; MCPHAIL JD, 1992, CAN J ZOOL, V70, P361, DOI 10.1139/z92-054; Ministerio de Ciencia y Tecnologia y el IEO, 2003, INF 24 VERT PREST SI; Myers MS, 1998, MAR POLLUT BULL, V37, P92, DOI 10.1016/S0025-326X(98)00135-0; Nolte AW, 2005, P ROY SOC B-BIOL SCI, V272, P2379, DOI 10.1098/rspb.2005.3231; PENDAS AM, 1995, MOL ECOL, V4, P275, DOI 10.1111/j.1365-294X.1995.tb00220.x; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Perry RI, 2010, J MARINE SYST, V79, P427, DOI 10.1016/j.jmarsys.2008.12.017; Pietrapiana D, 2002, MAR POLLUT BULL, V44, P238, DOI 10.1016/S0025-326X(01)00249-1; PURVIS IJ, 1983, NUCLEIC ACIDS RES, V11, P5467, DOI 10.1093/nar/11.16.5467; Richardson N, 2010, RESOURCES FUTURE, P1; Rieseberg LH, 2007, GENETICA, V129, P149, DOI 10.1007/s10709-006-9011-y; Rogowska J, 2010, REV ENVIRON CONTAM T, V206, P95, DOI 10.1007/978-1-4419-6260-7_5; Sanchez F, 1998, ICES J MAR SCI, V55, P494, DOI 10.1006/jmsc.1997.0279; Sanchez F, 2006, MAR POLLUT BULL, V53, P332, DOI 10.1016/j.marpolbul.2005.10.018; Scribner KT, 2000, REV FISH BIOL FISHER, V10, P293, DOI 10.1023/A:1016642723238; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Suris-Regueiro JC, 2007, DISASTERS, V31, P201, DOI 10.1111/j.1467-7717.2007.01004.x; Taylor EB, 2006, MOL ECOL, V15, P343, DOI 10.1111/j.1365-294X.2005.02794.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wirtz P, 1999, ANIM BEHAV, V58, P1, DOI 10.1006/anbe.1999.1144; Xia YQ, 2010, DISASTER ADV, V3, P270; Zuberogoitia I, 2006, MAR POLLUT BULL, V52, P1176, DOI 10.1016/j.marpolbul.2006.02.016	48	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34485	10.1371/journal.pone.0034485	http://dx.doi.org/10.1371/journal.pone.0034485			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511945	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338600031
J	Durier, N; Nguyen, C; White, LJ				Durier, Nicolas; Chi Nguyen; White, Lisa J.			Treatment of Hepatitis C as Prevention: A Modeling Case Study in Vietnam	PLOS ONE			English	Article							INJECTION-DRUG USERS; SUSTAINED VIROLOGICAL RESPONSE; VIRUS-INFECTION; VIRAL CLEARANCE; PLUS RIBAVIRIN; HEROIN USERS; THERAPY; REINFECTION; ONSET; HIV	Background: Treatment of hepatitis C (HCV) is very effective, achieving a cure in 50-90% of patients. Besides its own good for individuals, this most likely translates in reduced transmission, but this phenomenon has yet to be fully explored. Methods and Findings: In this mathematical modeling study done in the context of Vietnam, we estimated the public health benefit that HCV therapy for injecting drug users (IDUs) may achieve. Treatment coverage of 25, 50 and 75% of chronically HCV-infected IDUs (4 years into infection) is predicted to reduce the chronic HCV viremia prevalence respectively by 21, 37 and 50%, 11 years after full scale up to the intended coverage. At a constant 50% coverage level, earlier treatment, 3, 2, and 1 year into infection is predicted to reduce the chronic HCV viremia prevalence by 46, 60 and 85%. In these later 3 scenarios, for every 100 treatment courses provided, a total of respectively 50, 61 and 94 new infections could be averted. These benefits were projected in the context of current low coverage of methadone maintenance therapy and needles/ syringes exchange programs, and these services expansion showed complementary preventive benefits to HCV therapy. The program treatment commitment associated with the various scenarios is deemed reasonable. Our model projections are robust under adjustment for uncertainty in the model parameter values. Conclusions: In this case study in Vietnam, we project that treatment of HCV for injecting drug users will have a preventative herd effect in addition to curing patients in need for therapy, achieving a substantial reduction in HCV transmission and prevalence.	[White, Lisa J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford OX3 9DU, England; [White, Lisa J.] Mahidol Univ, Fac Trop Med, Bangkok 10700, Thailand	University of Oxford; Mahidol University	Durier, N (corresponding author), Fdn AIDS Res, Bangkok, Thailand.	nicolasdurier@hotmail.com	Nguyen, Chi/U-6966-2018; White, Lisa/AAC-9396-2020	Nguyen, Chi/0000-0002-9336-1299; White, Lisa/0000-0002-6523-185X	Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant) [089275/Z/09/Z]; Li Ka Shing Foundation-University of Oxford Global Health Programme	Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant); Li Ka Shing Foundation-University of Oxford Global Health Programme	This research was a part of the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme, supported by the Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant 089275/Z/09/Z. www.wellcome.ac.uk) and the Li Ka Shing Foundation-University of Oxford Global Health Programme (www.lksf.org/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, Wkly Epidemiol Rec, V86, P445; [Anonymous], 2011, EV EP IMP HARM RED P; Backmund M, 2004, CLIN INFECT DIS, V39, P1540, DOI 10.1086/425361; Bergenstrom AM, 2010, AIDS, V24, pS20, DOI 10.1097/01.aids.0000390086.14941.91; Clatts MC, 2010, J URBAN HEALTH, V87, P278, DOI 10.1007/s11524-009-9417-9; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Corson S, 2011, INT J DRUG POLICY, V22, P102, DOI 10.1016/j.drugpo.2010.10.007; Dalgard O, 2002, EUR ADDICT RES, V8, P45, DOI 10.1159/000049487; Davis GL, 2003, HEPATOLOGY, V38, P645, DOI 10.1053/jhep.2003.50364; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gerlach JT, 2003, GASTROENTEROLOGY, V125, P80, DOI 10.1016/S0016-5085(03)00668-1; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Grebely J, 2011, J HEPATOL, V55, P76, DOI 10.1016/j.jhep.2010.10.033; Grebely J, 2010, J GASTROEN HEPATOL, V25, P1281, DOI 10.1111/j.1440-1746.2010.06238.x; GRIFFITHS P, 1994, ADDICTION, V89, P301, DOI 10.1111/j.1360-0443.1994.tb00896.x; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hagan H, 2004, EPIDEMIOLOGY, V15, P543, DOI 10.1097/01.ede.0000135170.54913.9d; Hellard M, 2009, CLIN INFECT DIS, V49, P561, DOI 10.1086/600304; Kamal SM, 2006, GASTROENTEROLOGY, V130, P632, DOI 10.1053/j.gastro.2006.01.034; KAPLAN EH, 1989, REV INFECT DIS, V11, P289; Law MG, 2001, ADDICTION, V96, P433, DOI 10.1046/j.1360-0443.2001.9634337.x; Maheshwari A, 2008, LANCET, V372, P321, DOI 10.1016/S0140-6736(08)61116-2; Martin NK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022309; Martin NK, 2011, J HEPATOL, V54, P1137, DOI 10.1016/j.jhep.2010.08.029; Mauss, 2010, HEPATOLOGY CLIN TXB, P22; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Nguyen TL, 2010, J PRACTICAL MED, V742+743, P332; Pollack HA, 2001, MED DECIS MAKING, V21, P357, DOI 10.1177/02729890122062659; Quan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610; Roy E, 2009, DRUG ALCOHOL DEPEN, V102, P158, DOI 10.1016/j.drugalcdep.2009.01.006; Sutton AJ, 2008, J VIRAL HEPATITIS, V15, P809, DOI 10.1111/j.1365-2893.2008.01041.x; United Nations General Assembly, 2010, UNGASS COUNTR PROGR; Wilkinson M, 2009, ALIMENT PHARM THER, V29, P29, DOI 10.1111/j.1365-2036.2008.03834.x; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x; Zeiler I, 2010, DRUG ALCOHOL DEPEN, V110, P228, DOI 10.1016/j.drugalcdep.2010.03.006	36	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34548	10.1371/journal.pone.0034548	http://dx.doi.org/10.1371/journal.pone.0034548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511949	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338600035
J	Marinaro, M; Rezza, G; Del Giudice, G; Colao, V; Tarsitano, E; Camero, M; Losurdo, M; Buonavoglia, C; Tempesta, M				Marinaro, Mariarosaria; Rezza, Giovanni; Del Giudice, Giuseppe; Colao, Valeriana; Tarsitano, Elvira; Camero, Michele; Losurdo, Michele; Buonavoglia, Canio; Tempesta, Maria			A Caprine Herpesvirus 1 Vaccine Adjuvanted with MF59 (TM) Protects against Vaginal Infection and Interferes with the Establishment of Latency in Goats	PLOS ONE			English	Article							SIMPLEX-VIRUS TYPE-2; GENITAL-INFECTION; INFLUENZA VACCINE; IMMUNE-RESPONSES; LANGERHANS CELLS; GAMMA-INTERFERON; PLASMID DNA; LONG-TERM; T-CELLS; MOUSE	The immunogenicity and the efficacy of a beta-propiolactone-inactivated caprine herpesvirus 1 (CpHV-1) vaccine adjuvanted with MF59 (TM) were tested in goats. Following two subcutaneous immunizations, goats developed high titers of CpHV-1-specific serum and vaginal IgG and high serum virus neutralization (VN) titers. Peripheral blood mononuclear cells (PBMC) stimulated in vitro with inactivated CpHV-1 produced high levels of soluble IFN-gamma and exhibited high frequencies of IFN-gamma producing cells while soluble IL-4 was undetectable. On the other hand, control goats receiving the inactivated CpHV-1 vaccine without adjuvant produced only low serum antibody responses. A vaginal challenge with virulent CpHV-1 was performed in all vaccinated goats and in naive goats to assess the efficacy of the two vaccines. Vaginal disease was not detected in goats vaccinated with inactivated CpHV-1 plus MF59 (TM) and these animals had undetectable levels of infectious challenge virus in their vaginal washes. Goats vaccinated with inactivated CpHV-1 in the absence of adjuvant exhibited a less severe disease when compared to naive goats but shed titers of challenge virus that were similar to those of naive goats. Detection and quantitation of latent CpHV-1 DNA in sacral ganglia in challenged goats revealed that the inactivated CpHV-1 plus MF59 (TM) vaccine was able to significantly reduce the latent viral load when compared either to the naive goats or to the goats vaccinated with inactivated CpHV-1 in the absence of adjuvant. Thus, a vaccine composed of inactivated CpHV-1 plus MF59 (TM) as adjuvant was strongly immunogenic and induced effective immunity against vaginal CpHV-1 infection in goats.	[Marinaro, Mariarosaria; Rezza, Giovanni] Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, I-00161 Rome, Italy; [Del Giudice, Giuseppe] Novartis Vaccines & Diagnost, Res Ctr, Siena, Italy; [Colao, Valeriana; Tarsitano, Elvira; Camero, Michele; Losurdo, Michele; Buonavoglia, Canio; Tempesta, Maria] Univ Bari, Dept Vet Publ Hlth, Bari, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Istituto Superiore di Sanita (ISS); Novartis; Universita degli Studi di Bari Aldo Moro	Marinaro, M (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immune Mediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	mary_marinaro@libero.it	rezza, giovanni/D-4393-2016; tempesta, maria/AAE-5332-2021	rezza, giovanni/0000-0003-0268-6790; 	Italian Ministry of Health [5AD/F3]; Ministry of Education, University and Research	Italian Ministry of Health(Ministry of Health, Italy); Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	This work was supported in part by Grant no. 5AD/F3 from the Italian Ministry of Health (recipient MM) and by Grant no. "Fondi Ateneo ex 60%/2008" from the Ministry of Education, University and Research (recipient MT). These funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. GDG is an employee of Novartis Vaccines and Diagnostics, and therefore Novartis Vaccines and Diagnostics played a role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aucouturier J, 2001, VACCINE, V19, P2666, DOI 10.1016/S0264-410X(00)00498-9; Aurelian L, 2004, CLIN DIAGN LAB IMMUN, V11, P437, DOI 10.1128/CDLI.11.3.437-445.2004; Beyer JC, 2001, VACCINE, V19, P1643, DOI 10.1016/S0264-410X(00)00418-7; Black S, 2010, VACCINE, V28, P7331, DOI 10.1016/j.vaccine.2010.08.075; BOS JD, 1993, IMMUNOL TODAY, V14, P75, DOI 10.1016/0167-5699(93)90062-P; Buonavoglia C, 1996, COMP IMMUNOL MICROB, V19, P275, DOI 10.1016/0147-9571(96)00014-8; Camero M, 2010, ANTIVIR THER, V15, P785, DOI 10.3851/IMP1611; Corey L, 1999, JAMA-J AM MED ASSOC, V282, P331, DOI 10.1001/jama.282.4.331; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; DESTASIO PR, 1990, J VIROL, V64, P2588, DOI 10.1128/JVI.64.6.2588-2593.1990; Dobbs ME, 2005, J VIROL, V79, P14546, DOI 10.1128/JVI.79.23.14546-14554.2005; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Dupuis M, 1998, CELL IMMUNOL, V186, P18, DOI 10.1006/cimm.1998.1283; Eis-Hubinger AM, 1986, MED MICROBIOL IMMUN, V175, P281; El Sahly H, 2010, EXPERT REV VACCINES, V9, P1135, DOI [10.1586/ERV.10.111, 10.1586/erv.10.111]; Elia G, 2008, J VIROL METHODS, V148, P155, DOI 10.1016/j.jviromet.2007.10.021; FABIAN RH, 1991, ADV NEUROL, V56, P433; Ferenczy MW, 2007, CURR PHARM DESIGN, V13, P1975, DOI 10.2174/138161207781039779; FLECK M, 1993, ARCH VIROL, V129, P35, DOI 10.1007/BF01316883; Galli G, 2009, P NATL ACAD SCI USA, V106, P3877, DOI 10.1073/pnas.0813390106; Geoffroy F, 1996, VACCINE, V14, P1686, DOI 10.1016/S0264-410X(96)00116-8; GREWAL AS, 1986, AUST VET J, V63, P79, DOI 10.1111/j.1751-0813.1986.tb02935.x; Harandi AM, 2001, J GEN VIROL, V82, P845, DOI 10.1099/0022-1317-82-4-845; HOLLIS DE, 1972, J INVEST DERMATOL, V58, P211, DOI 10.1111/1523-1747.ep12539918; HORNER GW, 1982, NEW ZEAL VET J, V30, P150; Hoshino Y, 2008, VIROLOGY, V372, P56, DOI 10.1016/j.virol.2007.10.031; Johnston C, 2011, J CLIN INVEST, V121, P4600, DOI 10.1172/JCI57148; Jones Cheryl A, 2004, Herpes, V11, P12; KHALIL HM, 1982, J INVEST DERMATOL, V79, P47, DOI 10.1111/1523-1747.ep12510584; Koelle DM, 2006, CURR OPIN INVEST DR, V7, P136; Lekstrom-Himes JA, 1998, J VIROL, V72, P2760, DOI 10.1128/JVI.72.4.2760-2764.1998; Marinaro M, 2011, ANTIGEN SPECIFIC IFN, DOI [10.1016/j.rvsc.2011.09.009, DOI 10.1016/J.RVSC.2011.09.009]; Marinaro M, 2010, J VET DIAGN INVEST, V22, P245, DOI 10.1177/104063871002200213; Marinaro M, 2009, VET MICROBIOL, V138, P266, DOI 10.1016/j.vetmic.2009.04.008; Meeusen ENT, 2007, CLIN MICROBIOL REV, V20, P489, DOI 10.1128/CMR.00005-07; MESTECKY J, 1994, AIDS RES HUM RETROV, V10, pS11; Mikloska Z, 1999, J VIROL, V73, P5934, DOI 10.1128/JVI.73.7.5934-5944.1999; Milligan GN, 1997, VIROLOGY, V229, P259, DOI 10.1006/viro.1997.8441; Morello CS, 2002, J VIROL, V76, P4822, DOI 10.1128/JVI.76.10.4822-4835.2002; Morrison LA, 1998, VIROLOGY, V243, P178, DOI 10.1006/viro.1998.9047; Morrison LA, 2001, J VIROL, V75, P1195, DOI 10.1128/JVI.75.3.1195-1204.2001; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; O'Hagan DT, 2007, CLIN PHARMACOL THER, V82, P740, DOI 10.1038/sj.clpt.6100402; O'Hagan DT, 2011, EXPERT REV VACCINES, V10, P447, DOI [10.1586/erv.11.23, 10.1586/ERV.11.23]; OTT G, 1995, VACCINE, V13, P1557, DOI 10.1016/0264-410X(95)00089-J; Parr EL, 1997, J VIROL, V71, P8109, DOI 10.1128/JVI.71.11.8109-8115.1997; Parr MB, 1999, VIROLOGY, V258, P282, DOI 10.1006/viro.1999.9739; Pellegrini M, 2009, VACCINE, V27, P6959, DOI 10.1016/j.vaccine.2009.08.101; SAITO JK, 1974, AM J VET RES, V35, P847; Stanberry LR, 2004, HERPES S3, V11, p161A; Stoitzner P, 2002, J INVEST DERMATOL, V118, P117, DOI 10.1046/j.0022-202x.2001.01631.x; TARIGAN S, 1987, AUST VET J, V64, P321, DOI 10.1111/j.1751-0813.1987.tb07345.x; Tempesta M, 2007, VACCINE, V25, P7927, DOI 10.1016/j.vaccine.2007.09.004; Tempesta M, 1999, J CLIN MICROBIOL, V37, P1598, DOI 10.1128/JCM.37.5.1598-1599.1999; Tempesta M, 2000, J VET MED B, V47, P197, DOI 10.1046/j.1439-0450.2000.00334.x; Tempesta M, 1999, COMP IMMUNOL MICROB, V22, P137, DOI 10.1016/S0147-9571(98)00029-0; Tempesta M, 2001, VACCINE, V19, P3860, DOI 10.1016/S0264-410X(01)00136-0; THAPAR MA, 1990, IMMUNOLOGY, V70, P121; Thiry J, 2006, VET MICROBIOL, V113, P303, DOI 10.1016/j.vetmic.2005.11.001; TOLPIN MD, 1980, J INFECT DIS, V142, P569, DOI 10.1093/infdis/142.4.569; VANDERLUGT JJ, 1993, J S AFR VET ASSOC, V64, P169; Whitley RJ, 1996, FIELDS VIROLOGY, P2297	62	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34913	10.1371/journal.pone.0034913	http://dx.doi.org/10.1371/journal.pone.0034913			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511971	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338600057
J	Amano, T; Gascuel, J				Amano, Tosikazu; Gascuel, Jean			Expression of Odorant Receptor Family, Type 2 OR in the Aquatic Olfactory Cavity of Amphibian Frog Xenopus tropicalis	PLOS ONE			English	Article							SPERM CHEMOATTRACTANT; BINDING-PROTEIN; GENE SUPERFAMILY; MAMMALIAN SPERM; MOUSE; LAEVIS; REPERTOIRE; EVOLUTION; ALLURIN; CLONING	Recent genome wide in silico analyses discovered a new family (type 2 or family H) of odorant receptors (ORs) in teleost fish and frogs. However, since there is no evidence of the expression of these novel OR genes in olfactory sensory neurons (OSN), it remains unknown if type 2 ORs (OR2) function as odorant receptors. In this study, we examined expression of OR2 genes in the frog Xenopus tropicalis. The overall gene expression pattern is highly complex and differs depending on the gene and developmental stage. RT-PCR analysis in larvae showed that all of the OR2 eta genes we identified were expressed in the peripheral olfactory system and some were detected in the brain and skin. Whole mount in situ hybridization of the larval olfactory cavity confirmed that at least two OR2 eta genes so far tested are expressed in the OSN. Because tadpoles are aquatic animals, OR2 eta genes are probably involved in aquatic olfaction. In adults, OR2 eta genes are expressed in the nose, brain, and testes to different degrees depending on the genes. OR2 eta expression in the olfactory system is restricted to the medium cavity, which participates in the detection of water-soluble odorants, suggesting that OR2 eta s function as receptors for water-soluble odorants. Moreover, the fact that several OR2 eta s are significantly expressed in non-olfactory organs suggests unknown roles in a range of biological processes other than putative odorant receptor functions.	[Amano, Tosikazu; Gascuel, Jean] CNRS, Ctr Sci Gout & Alimentat, UMR6265, Dijon, France; [Amano, Tosikazu; Gascuel, Jean] INRA, Ctr Sci Gout & Alimentat, UMR1324, F-21034 Dijon, France; [Amano, Tosikazu; Gascuel, Jean] Univ Bourgogne, Ctr Sci Gout & Alimentat, UMR, Dijon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut Agro; AgroSup Dijon; Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne	Amano, T (corresponding author), Natl Inst Med Res, Mill Hill, London NW7 1AA, England.	jean.gascuel@u-bourgogne.fr			INRA; Bourgogne Council	INRA; Bourgogne Council	This study received funding from the INRA and the Bourgogne Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alioto TS, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-173; Alioto TS, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-309; ALTNER H, 1962, Z VERGL PHYSIOL, V45, P272, DOI 10.1007/BF00302326; Barnea G, 2004, SCIENCE, V304, P1468, DOI 10.1126/science.1096146; Briand L, 2002, BIOCHEMISTRY-US, V41, P7241, DOI 10.1021/bi015916c; Burnett LA, 2008, DEV BIOL, V316, P408, DOI 10.1016/j.ydbio.2008.01.046; Feinstein P, 2004, CELL, V117, P817, DOI 10.1016/j.cell.2004.05.011; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Freitag J, 1998, J COMP PHYSIOL A, V183, P635, DOI 10.1007/s003590050287; Freitag J, 1995, NEURON, V15, P1383, DOI 10.1016/0896-6273(95)90016-0; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Khaitovich P, 2004, PLOS BIOL, V3, pe42; Kotrschal K., 1991, Reviews in Fish Biology and Fisheries, V1, P3, DOI 10.1007/BF00042659; Kotrschal K, 1996, TRENDS ECOL EVOL, V11, P110, DOI 10.1016/0169-5347(96)81088-3; Mezler M, 1999, J EXP BIOL, V202, P365; Mezler M, 2001, J EXP BIOL, V204, P2987; Millery J, 2005, EUR J NEUROSCI, V22, P1389, DOI 10.1111/j.1460-9568.2005.04337.x; NEF P, 1992, P NATL ACAD SCI USA, V89, P8948, DOI 10.1073/pnas.89.19.8948; Nei M, 2008, NAT REV GENET, V9, P951, DOI 10.1038/nrg2480; Nieuwkoop AA, 1994, NORMAL TIME TABLE XE; Niimura Y, 2005, GENE, V346, P23, DOI 10.1016/j.gene.2004.09.027; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Niimura Y, 2009, GENOME BIOL EVOL, V1, P34, DOI 10.1093/gbe/evp003; Olender Tsviya, 2004, Genet Mol Res, V3, P545; Olson JH, 2001, P NATL ACAD SCI USA, V98, P11205, DOI 10.1073/pnas.211316798; Parmigiani Raphael B, 2004, Genet Mol Res, V3, P521; Pelosi P, 2001, CELL MOL LIFE SCI, V58, P503, DOI 10.1007/PL00000875; Pes D, 1998, GENE, V212, P49, DOI 10.1016/S0378-1119(98)00131-0; Reiss JO, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P43; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; ROGERS KE, 1987, P NATL ACAD SCI USA, V84, P1704, DOI 10.1073/pnas.84.6.1704; Rossler P, 1998, J COMP NEUROL, V395, P273; Rouquier S, 2007, MUTAT RES-FUND MOL M, V616, P95, DOI 10.1016/j.mrfmmm.2006.11.012; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Serizawa S, 2000, NAT NEUROSCI, V3, P687, DOI 10.1038/76641; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; SHI YB, 1994, BBA-GENE STRUCT EXPR, V1217, P227, DOI 10.1016/0167-4781(94)90042-6; Shykind BM, 2005, HUM MOL GENET, V14, pR33, DOI 10.1093/hmg/ddi105; Sosinsky A, 2000, GENOMICS, V70, P49, DOI 10.1006/geno.2000.6363; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Spehr M, 2006, MOL CELL ENDOCRINOL, V250, P128, DOI 10.1016/j.mce.2005.12.035; Strotmann J, 2004, J NEUROSCI, V24, P7754, DOI 10.1523/JNEUROSCI.2588-04.2004; Tcatchoff L, 2006, FEBS LETT, V580, P2102, DOI 10.1016/j.febslet.2006.03.017; Vanderhaeghen P, 1997, GENOMICS, V39, P239, DOI 10.1006/geno.1996.4490; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vosshall LB, 2004, CURR BIOL, V14, pR918, DOI 10.1016/j.cub.2004.10.013; WHITEAR M, 1976, CELL TISSUE RES, V175, P391; Whitear M., 1992, CHEMORECEPTION FISHE, P103; Xiang XY, 2004, DEV BIOL, V275, P343, DOI 10.1016/j.ydbio.2004.08.011; Yanai I, 2004, OMICS, V8, P15, DOI 10.1089/153623104773547462; Young JM, 2002, HUM MOL GENET, V11, P535, DOI 10.1093/hmg/11.5.535; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zhang XM, 2004, P NATL ACAD SCI USA, V101, P14168, DOI 10.1073/pnas.0405350101	57	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e33922	10.1371/journal.pone.0033922	http://dx.doi.org/10.1371/journal.pone.0033922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509266	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600016
J	Kloss-Brandstatter, A; Erhart, G; Lamina, C; Meister, B; Haun, M; Coassin, S; Seifert, M; Klein-Franke, A; Paulweber, B; Kedenko, L; Kollerits, B; Swinkels, DW; Vermeulen, SH; Galesloot, TE; Kronenberg, F; Weiss, G				Kloss-Brandstaetter, Anita; Erhart, Gertraud; Lamina, Claudia; Meister, Bernhard; Haun, Margot; Coassin, Stefan; Seifert, Markus; Klein-Franke, Andreas; Paulweber, Bernhard; Kedenko, Lyudmyla; Kollerits, Barbara; Swinkels, Dorine W.; Vermeulen, Sita H.; Galesloot, Tessel E.; Kronenberg, Florian; Weiss, Guenter			Candidate Gene Sequencing of SLC11A2 and TMPRSS6 in a Family with Severe Anaemia: Common SNPs, Rare Haplotypes, No Causative Mutation	PLOS ONE			English	Article							IRON-DEFICIENCY ANEMIA; GENOME-WIDE ASSOCIATION; MICROCYTIC ANEMIA; MATRIPTASE-2 TMPRSS6; MASS-SPECTROMETRY; SERINE-PROTEASE; HEPCIDIN; METABOLISM; OVERLOAD; DMT1	Background: Iron-refractory iron deficiency anaemia (IRIDA) is a rare disorder which was linked to mutations in two genes (SLC11A2 and TMPRSS6). Common polymorphisms within these genes were associated with serum iron levels. We identified a family of Serbian origin with asymptomatic non-consanguineous parents with three of four children presenting with IRIDA not responding to oral but to intravenous iron supplementation. After excluding all known causes responsible for iron deficiency anaemia we searched for mutations in SLC11A2 and TMPRSS6 that could explain the severe anaemia in these children. Methodology/Results: We sequenced the exons and exon-intron boundaries of SLC11A2 and TMPRSS6 in all six family members. Thereby, we found seven known and fairly common SNPs, but no new mutation. We then genotyped these seven SNPs in the population-based SAPHIR study (n = 1,726) and performed genetic association analysis on iron and ferritin levels. Only two SNPs, which were top-hits from recent GWAS on iron and ferritin, exhibited an effect on iron and ferritin levels in SAPHIR. Six SAPHIR participants carrying the same TMPRSS6 genotypes and haplotype-pairs as one anaemic son showed lower ferritin and iron levels than the average. One individual exhibiting the joint SLC11A2/TMPRSS6 profile of the anaemic son had iron and ferritin levels lying below the 5(th) percentile of the population's iron and ferritin level distribution. We then checked the genotype constellations in the Nijmegen Biomedical Study (n = 1,832), but the profile of the anaemic son did not occur in this population. Conclusions: We cannot exclude a gene-gene interaction between SLC11A2 and TMPRSS6, but we can also not confirm it. As in this case candidate gene sequencing did not reveal causative rare mutations, the samples will be subjected to whole exome sequencing.	[Kloss-Brandstaetter, Anita; Erhart, Gertraud; Lamina, Claudia; Haun, Margot; Coassin, Stefan; Kollerits, Barbara; Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria; [Meister, Bernhard; Klein-Franke, Andreas] Innsbruck Med Univ, Dept Paediat 2, Innsbruck, Austria; [Seifert, Markus; Weiss, Guenter] Innsbruck Med Univ, Dept Internal Med Clin Immunol & Infect Dis 1, Innsbruck, Austria; [Paulweber, Bernhard; Kedenko, Lyudmyla] Paracelsus Med Univ, Dept Internal Med 1, Salzburg, Austria; [Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Genet Endocrine & Metab Dis, NL-6525 ED Nijmegen, Netherlands; [Vermeulen, Sita H.; Galesloot, Tessel E.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Paracelsus Private Medical University; Radboud University Nijmegen; Radboud University Nijmegen	Kloss-Brandstatter, A (corresponding author), Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Div Genet Epidemiol, Innsbruck, Austria.	florian.kronenberg@i-med.ac.at; guenter.weiss@i-med.ac.at	Lamina, Claudia/F-7608-2010; Galesloot, Tessel/P-6667-2015; Kronenberg, Florian/B-1736-2008; Swinkels, Dorine W./H-8098-2014; Coassin, Stefan/J-2611-2018; Vermeulen, Sita H./L-4716-2015	Lamina, Claudia/0000-0002-5398-5806; Galesloot, Tessel/0000-0002-2717-3679; Kronenberg, Florian/0000-0003-2229-1120; Swinkels, Dorine W./0000-0002-1040-9446; Coassin, Stefan/0000-0001-5677-8979; Vermeulen, Sita H./0000-0003-4913-8601; Kloss-Brandstatter, Anita/0000-0002-0873-6704; Weiss, Guenter/0000-0003-0709-2158	Osterreichische Nationalbank [13059]; Fonds zur Forderung der wissenschaftlichen Forschung [19664]; Tiroler Wissenschaftsfonds [UNI-0404/557]; Austrian GEN-AU-Programme (Genome Research in Austria) "GOLD"	Osterreichische Nationalbank; Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Tiroler Wissenschaftsfonds; Austrian GEN-AU-Programme (Genome Research in Austria) "GOLD"	This project was supported by the Osterreichische Nationalbank (grant 13059) to A. Kloss-Brandstatter, by grants from the "Fonds zur Forderung der wissenschaftlichen Forschung" to G. Weiss (grant 19664) and by grants from the Tiroler Wissenschaftsfonds (UNI-0404/557) and from the Austrian GEN-AU-Programme (Genome Research in Austria) "GOLD" to F. Kronenberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abkevich V, 2004, J MED GENET, V41, P492, DOI 10.1136/jmg.2003.015867; Altamura S, 2010, BIOCHEM J, V431, P363, DOI 10.1042/BJ20100668; Anderson GJ, 2009, CURR OPIN GASTROEN, V25, P129, DOI 10.1097/MOG.0b013e32831ef1f7; Beaumont C, 2006, BLOOD, V107, P4168, DOI 10.1182/blood-2005-10-4269; Benyamin B, 2009, NAT GENET, V41, P1173, DOI 10.1038/ng.456; Berglund S, 2010, PEDIATRICS, V126, pE874, DOI 10.1542/peds.2009-3624; Blanco E, 2009, BLOOD CELL MOL DIS, V43, P199, DOI 10.1016/j.bcmd.2009.05.003; Brandstatter A, 2010, ATHEROSCLEROSIS, V210, P474, DOI 10.1016/j.atherosclerosis.2009.12.013; Brasse-Lagnel C, 2011, GASTROENTEROLOGY, V140, P1261, DOI 10.1053/j.gastro.2010.12.037; Camaschella C, 2011, CURR OPIN PEDIATR, V23, P14, DOI 10.1097/MOP.0b013e3283425591; Chambers JC, 2009, NAT GENET, V41, P1170, DOI 10.1038/ng.462; Chew KCM, 2011, J BIOL CHEM, V286, P33380, DOI 10.1074/jbc.M111.268409; Coassin S, 2010, ATHEROSCLEROSIS, V209, P321, DOI 10.1016/j.atherosclerosis.2009.10.026; De Falco L, 2010, HUM MUTAT, V31, pE1390, DOI 10.1002/humu.21243; Delbini P, 2010, BRIT J HAEMATOL, V151, P281, DOI 10.1111/j.1365-2141.2010.08349.x; Finberg KE, 2008, NAT GENET, V40, P569, DOI 10.1038/ng.130; Finberg KE, 2009, SEMIN HEMATOL, V46, P378, DOI 10.1053/j.seminhematol.2009.06.006; Fleming MD, 1997, NAT GENET, V16, P383, DOI 10.1038/ng0897-383; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Ganz T, 2011, ANNU REV MED, V62, P347, DOI 10.1146/annurev-med-050109-142444; Guillem F, 2008, BLOOD, V112, P2089, DOI 10.1182/blood-2008-05-154740; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hoogendoorn EH, 2006, CLIN CHEM, V52, P104, DOI 10.1373/clinchem.2005.055194; Houdayer C, 2008, HUM MUTAT, V29, P975, DOI 10.1002/humu.20765; Iolascon A, 2008, J PEDIATR-US, V152, P136, DOI 10.1016/j.jpeds.2007.08.041; Iolascon A, 2006, BLOOD, V107, P349, DOI 10.1182/blood-2005-06-2477; Knutson MD, 2005, P NATL ACAD SCI USA, V102, P1324, DOI 10.1073/pnas.0409409102; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Ludwiczek S, 2007, NAT MED, V13, P448, DOI 10.1038/nm1542; Melis MA, 2008, HAEMATOL-HEMATOL J, V93, P1473, DOI 10.3324/haematol.13342; Mims MP, 2005, BLOOD, V105, P1337, DOI 10.1182/blood-2004-07-2966; Pichler I, 2011, HUM MOL GENET, V20, P1232, DOI 10.1093/hmg/ddq552; Ramsay AJ, 2009, HUM MOL GENET, V18, P3673, DOI 10.1093/hmg/ddp315; Ramsay AJ, 2009, HAEMATOL-HEMATOL J, V94, P840, DOI 10.3324/haematol.2008.001867; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Song YS, 2010, GENETICS, V186, P1467, DOI 10.1534/genetics.110.119008; Soranzo N, 2010, DIABETES, V59, P3229, DOI 10.2337/db10-0502; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Tanaka T, 2010, BLOOD, V115, P94, DOI 10.1182/blood-2009-07-232496; Theurl I, 2008, BLOOD, V111, P2392, DOI 10.1182/blood-2007-05-090019; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911	47	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35015	10.1371/journal.pone.0035015	http://dx.doi.org/10.1371/journal.pone.0035015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509377	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600073
J	Suh, HS; Choi, N; Tarassishin, L; Lee, SC				Suh, Hyeon-Sook; Choi, Namjong; Tarassishin, Leonid; Lee, Sunhee C.			Regulation of Progranulin Expression in Human Microglia and Proteolysis of Progranulin by Matrix Metalloproteinase-12 (MMP-12)	PLOS ONE			English	Article							LEUKOCYTE PROTEASE INHIBITOR; MACROPHAGE ELASTASE MMP-12; MULTIPLE-SCLEROSIS; GROWTH-FACTOR; INFLAMMATORY RESPONSE; EPITHELIN PRECURSOR; GENE-EXPRESSION; HOST-DEFENSE; CANCER-CELLS; GRANULIN	Background: The essential role of progranulin (PGRN) as a neurotrophic factor has been demonstrated by the discovery that haploinsufficiency due to GRN gene mutations causes frontotemporal lobar dementia. In addition to neurons, microglia in vivo express PGRN, but little is known about the regulation of PGRN expression by microglia. Goal: In the current study, we examined the regulation of expression and function of PGRN, its proteolytic enzyme macrophage elastase (MMP-12), as well as the inhibitor of PGRN proteolysis, secretory leukocyte protease inhibitor (SLPI), in human CNS cells. Methods: Cultures of primary human microglia and astrocytes were stimulated with the TLR ligands (LPS or poly IC), Th1 cytokines (IL-1/IFN gamma), or Th2 cytokines (IL-4, IL-13). Results were analyzed by Q-PCR, immunoblotting or ELISA. The roles of MMP-12 and SLPI in PGRN cleavage were also examined. Results: Unstimulated microglia produced nanogram levels of PGRN, and PGRN release from microglia was suppressed by the TLR ligands or IL-1/IFN gamma, but increased by IL-4 or IL-13. Unexpectedly, while astrocytes stimulated with proinflammatory factors released large amounts of SLPI, none were detected in microglial cultures. We also identified MMP-12 as a PGRN proteolytic enzyme, and SLPI as an inhibitor of MMP-12-induced PGRN proteolysis. Experiments employing PGRN siRNA demonstrated that microglial PGRN was involved in the cytokine and chemokine production following TLR3/4 activation, with its effect on TNF alpha being the most conspicuous. Conclusions: Our study is the first detailed examination of PGRN in human microglia. Our results establish microglia as a significant source of PGRN, and MMP-12 and SLPI as modulators of PGRN proteolysis. Negative and positive regulation of microglial PGRN release by the proinflammatory/Th1 and the Th2 stimuli, respectively, suggests a fundamentally different aspect of PGRN regulation compared to other known microglial activation products. Microglial PGRN appears to function as an endogenous modulator of innate immune responses.	[Suh, Hyeon-Sook; Choi, Namjong; Tarassishin, Leonid; Lee, Sunhee C.] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Suh, HS (corresponding author), Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA.	hyeon-sook.suh@einstein.yu.edu		Tarassishin, Leonid/0000-0002-2649-5465	NIH [KO1 MH084705, RO1 MH55477, T32 NS007098]; Einstein CFAR (Centre for AIDS Research) [P30 AI051519]; CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH055477, K01MH084705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007098] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Einstein CFAR (Centre for AIDS Research); CFAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by NIH KO1 MH084705 (HS), RO1 MH55477 (SCL), T32 NS007098 (HS and LT), the Einstein CFAR (Centre for AIDS Research) grant P30 AI051519 (SCL and NC), and a CFAR pilot grant (HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Al-Ayadhi LY, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-111; Arikan MC, 2005, J CELL PHYSIOL, V204, P139, DOI 10.1002/jcp.20271; Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; Bai XH, 2009, MOL CELL BIOL, V29, P4201, DOI 10.1128/MCB.00056-09; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Bhandari V, 1996, BIOCHEM J, V319, P441, DOI 10.1042/bj3190441; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Butler GS, 2008, MOL CELL BIOL, V28, P4896, DOI 10.1128/MCB.01775-07; Butovsky O, 2006, J CLIN INVEST, V116, P905, DOI 10.1172/JCI26836; Chen-Plotkin AS, 2010, ACTA NEUROPATHOL, V119, P111, DOI 10.1007/s00401-009-0576-2; Coppola G, 2008, ANN NEUROL, V64, P92, DOI 10.1002/ana.21397; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; DaSliva AG, 2008, J NEUROIMMUNOL, V199, P24, DOI 10.1016/j.jneuroim.2008.04.034; De ML, 2011, J MOL NEUROSCI; DENIS M, 1994, J LEUKOCYTE BIOL, V55, P682, DOI 10.1002/jlb.55.5.682; Eriksen JL, 2008, J NEUROCHEM, V104, P287, DOI 10.1111/j.1471-4159.2007.04968.x; Eriksen JL, 2010, ACTA NEUROPATHOL, V119, P107, DOI 10.1007/s00401-009-0623-z; Frampton G, 2011, GUT; Gossas T, 2006, BIOCHEM J, V398, P393, DOI 10.1042/BJ20051933; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Kao AW, 2011, P NATL ACAD SCI USA, V108, P4441, DOI 10.1073/pnas.1100650108; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kojima Y, 2009, ATHEROSCLEROSIS, V206, P102, DOI 10.1016/j.atherosclerosis.2009.02.017; Krause D, 2011, AM J PATHOL, V179, P1360, DOI 10.1016/j.ajpath.2011.05.048; LEE SHC, 1992, LAB INVEST, V67, P465; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Liu J, 1996, J IMMUNOL, V157, P3569; MCNEELY TB, 1995, J CLIN INVEST, V96, P456, DOI 10.1172/JCI118056; Mohan N, 2001, ARTHRITIS RHEUM-US, V44, P2862, DOI 10.1002/1529-0131(200112)44:12<2862::AID-ART474>3.0.CO;2-W; Mueller AM, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-20; Nar H, 2001, J MOL BIOL, V312, P743, DOI 10.1006/jmbi.2001.4953; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Okura H, 2010, J ATHEROSCLER THROMB, V17, P568, DOI 10.5551/jat.3921; Ong CHP, 2006, AM J PHYSIOL-REG I, V291, pR1602, DOI 10.1152/ajpregu.00616.2005; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; Pereson S, 2009, J PATHOL, V219, P173, DOI 10.1002/path.2580; Ramadas RA, 2009, J IMMUNOL, V182, P1560, DOI 10.4049/jimmunol.182.3.1560; Rivieccio MA, 2006, J IMMUNOL, V177, P4735, DOI 10.4049/jimmunol.177.7.4735; Sicotte NL, 2001, NEUROLOGY, V57, P1885, DOI 10.1212/WNL.57.10.1885; Sleegers K, 2010, ANNU REV NEUROSCI, V33, P71, DOI 10.1146/annurev-neuro-060909-153144; Song XY, 1999, J EXP MED, V190, P535, DOI 10.1084/jem.190.4.535; Suh HS, 2007, J VIROL; Sui YJ, 2004, AM J PATHOL, V164, P1557, DOI 10.1016/S0002-9440(10)63714-5; Taggart CC, 2005, J EXP MED, V202, P1659, DOI 10.1084/jem.20050768; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Vercellino M, 2011, MULT SCLER J, V17, P1194, DOI 10.1177/1352458511406164; Wang J, 2010, J NEUROCHEM, V112, P1305, DOI 10.1111/j.1471-4159.2009.06546.x; Xu DM, 2008, MOL CELL PROTEOMICS, V7, P2215, DOI 10.1074/mcp.M800095-MCP200; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	59	79	80	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35115	10.1371/journal.pone.0035115	http://dx.doi.org/10.1371/journal.pone.0035115			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509390	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600084
J	Zhang, KY; Wiktorowicz-Conroy, A; Hutchinson, JR; Doube, M; Klosowski, M; Shefelbine, SJ; Bull, AMJ				Zhang, Kai Yu; Wiktorowicz-Conroy, Alexis; Hutchinson, John R.; Doube, Michael; Klosowski, Michal; Shefelbine, Sandra J.; Bull, Anthony M. J.			3D Morphometric and Posture Study of Felid Scapulae Using Statistical Shape Modelling	PLOS ONE			English	Article							BODY-SIZE; LONG BONES; MAMMALS; BIOMECHANICS; LOCOMOTION; EVOLUTION; FORELIMB; DETERMINANTS; REGISTRATION; ORIENTATION	We present a three dimensional (3D) morphometric modelling study of the scapulae of Felidae, with a focus on the correlations between forelimb postures and extracted scapular shape variations. Our shape modelling results indicate that the scapular infraspinous fossa becomes larger and relatively broader along the craniocaudal axis in larger felids. We infer that this enlargement of the scapular fossa may be a size-related specialization for postural support of the shoulder joint.	[Zhang, Kai Yu; Doube, Michael; Klosowski, Michal; Shefelbine, Sandra J.; Bull, Anthony M. J.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England; [Wiktorowicz-Conroy, Alexis; Hutchinson, John R.] Royal Vet Coll, Struct & Mot Lab, Hatfield, Herts, England; [Doube, Michael] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany	Imperial College London; University of London; University of London Royal Veterinary College; Max Planck Society	Zhang, KY (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England.	a.bull@imperial.ac.uk	Doube, Michael/L-6769-2016; Hutchinson, John/AAH-1593-2020; Bull, Anthony M J/C-2317-2008	Doube, Michael/0000-0002-8021-8127; Bull, Anthony M J/0000-0002-4473-8264; Hutchinson, John/0000-0002-6767-7038	Wellcome Trust [088844]; Engineering and Physical Sciences Research Council (EPSRC); Biotechnology and Biological Sciences Research Council (UK) [BB/F000863/1]; BBSRC [BB/F000863/1, BB/F001169/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F000863/1, BB/F001169/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was done as part of the Medical Engineering Solutions in Osteoarthritis Centre of Excellence, which is funded by the Wellcome Trust (Grant ID: 088844) and the Engineering and Physical Sciences Research Council (EPSRC). This work was also funded by the Biotechnology and Biological Sciences Research Council (UK) (Grant ID: BB/F000863/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANYONGE W, 1993, J ZOOL, V231, P339, DOI 10.1111/j.1469-7998.1993.tb01922.x; Astua D, 2009, EVOLUTION, V63, P2438, DOI 10.1111/j.1558-5646.2009.00720.x; BERTRAM JEA, 1990, J MORPHOL, V204, P157, DOI 10.1002/jmor.1052040205; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Biewener AA, 2004, J APPL PHYSIOL, V97, P2266, DOI 10.1152/japplphysiol.00003.2004; BIEWENER AA, 1990, SCIENCE, V250, P1097, DOI 10.1126/science.2251499; BIEWENER AA, 1983, J EXP BIOL, V105, P147; BIEWENER AA, 1983, J ZOOL, V201, P67, DOI 10.1111/j.1469-7998.1983.tb04261.x; Biewener AA, 2000, SFI S SCI C, P51; Bonnan MF, 2007, ANAT REC, V290, P1089, DOI 10.1002/ar.20578; BRAND RA, 1986, J BIOMECH, V19, P589, DOI 10.1016/0021-9290(86)90164-8; Carrano MT, 2001, J ZOOL, V254, P41, DOI 10.1017/S0952836901000541; Christiansen P, 1999, J ZOOL, V247, P333, DOI 10.1017/S0952836999003052; Christiansen P, 2005, J MORPHOL, V266, P369, DOI 10.1002/jmor.10384; Davies RH, 2002, AOTOMATIC CONSTRUCTI, P77; Day LM, 2007, J EXP BIOL, V210, P642, DOI 10.1242/jeb.02703; Depecker M, 2006, J ANAT, V208, P35, DOI 10.1111/j.1469-7580.2006.00512.x; Doube M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004742; Fischer MS, 2006, J EXP ZOOL PART A, V305A, P935, DOI 10.1002/jez.a.333; Fischer MS, 2002, J EXP BIOL, V205, P1315; FUNG J, 1995, J NEUROSCI, V15, P1121; Iriarte-Diaz J, 2002, J EXP BIOL, V205, P2897; Iwaniuk AN, 1999, CAN J ZOOL, V77, P1064, DOI 10.1139/cjz-77-7-1064; Johnson GR, 1996, J BIOMECH, V29, P1039, DOI 10.1016/0021-9290(95)00176-X; Lee S, 1997, IEEE T VIS COMPUT GR, V3, P228, DOI 10.1109/2945.620490; Lilje KE, 2003, J ZOOL SYST EVOL RES, V41, P118, DOI 10.1046/j.1439-0469.2003.00207.x; Lorenz C, 2000, COMPUT VIS IMAGE UND, V77, P175, DOI 10.1006/cviu.1999.0814; Macpherson JM, 1998, EXP BRAIN RES, V119, P324, DOI 10.1007/s002210050348; MCMAHON TA, 1975, AM NAT, V109, P547, DOI 10.1086/283026; MCMAHON TA, 1975, J APPL PHYSIOL, V39, P619, DOI 10.1152/jappl.1975.39.4.619; Meachen-Samuels J, 2009, J MORPHOL, V270, P729, DOI 10.1002/jmor.10712; Monteiro Leandro R., 2000, Hystrix, V11, P91; Monteiro LR, 1999, J MORPHOL, V241, P251, DOI 10.1002/(SICI)1097-4687(199909)241:3<251::AID-JMOR7>3.0.CO;2-7; Morgan CC, 2009, MAMM BIOL, V74, P499, DOI 10.1016/j.mambio.2008.09.006; Pontzer H, 2009, J HUM EVOL, V56, P43, DOI 10.1016/j.jhevol.2008.09.001; PRICE MV, 1993, BIOL J LINN SOC, V50, P339, DOI 10.1006/bijl.1993.1063; Ren L, 2010, P NATL ACAD SCI USA, V107, P7078, DOI 10.1073/pnas.0911396107; Roberts TJ, 1998, J EXP BIOL, V201, P2753; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; RUFF CB, 1991, J HUM EVOL, V21, P81, DOI 10.1016/0047-2484(91)90001-C; Ruff CB, 2000, J HUM EVOL, V38, P269, DOI 10.1006/jhev.1999.0322; RUFF CB, 1983, AM J PHYS ANTHROPOL, V60, P359, DOI 10.1002/ajpa.1330600308; Schnabel J.A., 2001, LNCS, V2208, P573, DOI [DOI 10.1007/3-540-45468-3_69, DOI 10.1007/3-540-45468-3_]; Scholtz Y, 2010, HOMO, V61, P253, DOI 10.1016/j.jchb.2010.01.048; SELKER F, 1989, J BIOMECH, V22, P1175, DOI 10.1016/0021-9290(89)90219-4; SWIDERSKI DL, 1993, EVOLUTION, V47, P1854, DOI 10.1111/j.1558-5646.1993.tb01274.x; Taylor AB, 1997, J HUM EVOL, V33, P529, DOI 10.1006/jhev.1997.0147; Winter D, 2005, BIOMECHANICS MOTOR C; Yang Y, 2008, THESIS IMPERIAL COLL; Yang YH, 2006, LECT NOTES COMPUT SC, V4057, P306; Young NM, 2008, AM J PHYS ANTHROPOL, V136, P247, DOI 10.1002/ajpa.20799; Young NM, 2006, J ANAT, V209, P623, DOI 10.1111/j.1469-7580.2006.00639.x; ZELDITCH ML, 1995, SYST BIOL, V44, P179, DOI 10.2307/2413705	54	12	14	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34619	10.1371/journal.pone.0034619	http://dx.doi.org/10.1371/journal.pone.0034619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509335	Green Published, gold			2022-12-27	WOS:000305336600041
J	Zhong, J; Baquiran, JB; Bonakdar, N; Lees, J; Ching, YW; Pugacheva, E; Fabry, B; O'Neill, GM				Zhong, Jessie; Baquiran, Jaime B.; Bonakdar, Navid; Lees, Justin; Ching, Yu Wooi; Pugacheva, Elena; Fabry, Ben; O'Neill, Geraldine M.			NEDD9 Stabilizes Focal Adhesions, Increases Binding to the Extra-Cellular Matrix and Differentially Effects 2D versus 3D Cell Migration	PLOS ONE			English	Article							SUBSTRATE LYMPHOCYTE TYPE; TYROSINE PHOSPHORYLATION; ACTIN-FILAMENTS; DOCKING PROTEIN; HUMAN ENHANCER; VINCULIN; HEF1; FAK; SRC; ACTIVATION	The speed of cell migration on 2-dimensional (2D) surfaces is determined by the rate of assembly and disassembly of clustered integrin receptors known as focal adhesions. Different modes of cell migration that have been described in 3D environments are distinguished by their dependence on integrin-mediated interactions with the extra-cellular matrix. In particular, the mesenchymal invasion mode is the most dependent on focal adhesion dynamics. The focal adhesion protein NEDD9 is a key signalling intermediary in mesenchymal cell migration, however whether NEDD9 plays a role in regulating focal adhesion dynamics has not previously been reported. As NEDD9 effects on 2D migration speed appear to depend on the cell type examined, in the present study we have used mouse embryo fibroblasts (MEFs) from mice in which the NEDD9 gene has been depleted (NEDD9 -/- MEFs). This allows comparison with effects of other focal adhesion proteins that have previously been demonstrated using MEFs. We show that focal adhesion disassembly rates are increased in the absence of NEDD9 expression and this is correlated with increased paxillin phosphorylation at focal adhesions. NEDD9-/- MEFs have increased rates of migration on 2D surfaces, but conversely, migration of these cells is significantly reduced in 3D collagen gels. Importantly we show that myosin light chain kinase is activated in 3D in the absence of NEDD9 and is conversely inhibited in 2D cultures. Measurement of adhesion strength reveals that NEDD9-/- MEFs have decreased adhesion to fibronectin, despite upregulated alpha 5 beta 1 fibronectin receptor expression. We find that beta 1 integrin activation is significantly suppressed in the NEDD9-/-, suggesting that in the absence of NEDD9 there is decreased integrin receptor activation. Collectively our data suggest that NEDD9 may promote 3D cell migration by slowing focal adhesion disassembly, promoting integrin receptor activation and increasing adhesion force to the ECM.	[Zhong, Jessie; Baquiran, Jaime B.; Lees, Justin; Ching, Yu Wooi; O'Neill, Geraldine M.] Childrens Hosp Westmead, Kids Res Inst, Childrens Canc Res Unit, Westmead, NSW, Australia; [Zhong, Jessie; O'Neill, Geraldine M.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia; [Bonakdar, Navid; Fabry, Ben] Univ Erlangen Nurnberg, Dept Phys, D-91054 Erlangen, Germany; [Pugacheva, Elena] W Virginia Univ, MBRCC, Morgantown, WV 26506 USA	University of Sydney; University of Sydney; University of Erlangen Nuremberg; West Virginia University	Zhong, J (corresponding author), Childrens Hosp Westmead, Kids Res Inst, Childrens Canc Res Unit, Westmead, NSW, Australia.	geraldine.oneill@health.nsw.gov.au	Fabry, Ben/C-5496-2013; Fabry, Ben/AAT-5717-2020; O'Neill, Geraldine/F-3112-2014	Fabry, Ben/0000-0003-1737-0465; Fabry, Ben/0000-0003-1737-0465; O'Neill, Geraldine/0000-0001-9997-8794; Lees, Justin/0000-0002-0874-2856; Pugacheva, Elena/0000-0001-9814-7446	National Health and Medical Research (NHMRC) Australia [512551, 632515]; New South Wales (NSW) Cancer Council [RG09-16]; University of Sydney; NSW Cancer Institute	National Health and Medical Research (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia); New South Wales (NSW) Cancer Council; University of Sydney(University of Sydney); NSW Cancer Institute	This study was supported by the National Health and Medical Research (NHMRC) Australia grants 512551 and 632515 and New South Wales (NSW) Cancer Council grant RG09-16 to GO. JZ is the recipient of a post-graduate scholarship from the University of Sydney and a NSW Cancer Institute Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach CTT, 2010, CELL ADHES MIGR, V4, P226, DOI 10.4161/cam.4.2.10888; Bach CTT, 2009, MOL CELL BIOL, V29, P1506, DOI 10.1128/MCB.00857-08; Bradbury P, 2012, BBA-MOL CELL RES, V1823, P290, DOI 10.1016/j.bbamcr.2011.10.011; Bradshaw LN, 2011, BBA-MOL CELL RES, V1813, P340, DOI 10.1016/j.bbamcr.2010.11.018; Bui LC, 2009, ONCOGENE, V28, P3642, DOI 10.1038/onc.2009.224; Cowell LN, 2006, ONCOGENE, V25, P7597, DOI 10.1038/sj.onc.1209747; Dadke D, 2006, MOL BIOL CELL, V17, P1204, DOI 10.1091/mbc.E05-03-0237; DIMILLA PA, 1993, J CELL BIOL, V122, P729, DOI 10.1083/jcb.122.3.729; Fincham VJ, 1998, EMBO J, V17, P81, DOI 10.1093/emboj/17.1.81; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Friedl P, 2004, CURR OPIN CELL BIOL, V16, P14, DOI 10.1016/j.ceb.2003.11.001; Hagel M, 2002, MOL CELL BIOL, V22, P901, DOI 10.1128/MCB.22.3.901-915.2002; Harms BD, 2005, BIOPHYS J, V88, P1479, DOI 10.1529/biophysj.104.047365; Honda H, 1999, BIOCHEM BIOPH RES CO, V262, P25, DOI 10.1006/bbrc.1999.1162; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Huttenlocher A, 1996, J CELL BIOL, V134, P1551, DOI 10.1083/jcb.134.6.1551; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Izumchenko E, 2009, CANCER RES, V69, P7198, DOI 10.1158/0008-5472.CAN-09-0795; Kim SH, 2010, CANCER RES, V70, P4054, DOI 10.1158/0008-5472.CAN-09-2110; Kong CF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022666; Law SF, 1996, MOL CELL BIOL, V16, P3327; Lees JG, 2011, ONCOGENE, V30, P1241, DOI 10.1038/onc.2010.516; Lucas JT, 2010, ONCOGENE, V29, P4449, DOI 10.1038/onc.2010.185; Meenderink LM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013412; Mierke CT, 2010, J BIOL CHEM, V285, P13121, DOI 10.1074/jbc.M109.087171; Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472; Nakamoto T, 1997, MOL CELL BIOL, V17, P3884, DOI 10.1128/MCB.17.7.3884; Natarajan M, 2006, ONCOGENE, V25, P1721, DOI 10.1038/sj.onc.1209199; O'Neill GM, 2007, CANCER RES, V67, P8975, DOI 10.1158/0008-5472.CAN-07-1328; O'Neill GM, 2009, CELL ADHES MIGR, V3, P355, DOI 10.4161/cam.3.4.9468; O'Neill GM, 2001, MOL CELL BIOL, V21, P5094, DOI 10.1128/MCB.21.15.5094-5108.2001; Pugacheva EN, 2005, NAT CELL BIOL, V7, P937, DOI 10.1038/ncb1309; Ruest PJ, 2001, MOL CELL BIOL, V21, P7641, DOI 10.1128/MCB.21.22.7641-7652.2001; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Saunders RM, 2006, EUR J CELL BIOL, V85, P487, DOI 10.1016/j.ejcb.2006.01.014; Seo S, 2005, J IMMUNOL, V175, P3492, DOI 10.4049/jimmunol.175.6.3492; Seo S, 2011, CANCER SCI, V102, P2109, DOI 10.1111/j.1349-7006.2011.02066.x; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Singh MK, 2007, CELL BIOCHEM BIOPHYS, V48, P54, DOI 10.1007/s12013-007-0036-3; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zamir E, 1999, J CELL SCI, V112, P1655	45	51	51	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35058	10.1371/journal.pone.0035058	http://dx.doi.org/10.1371/journal.pone.0035058			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509381	Green Published, gold			2022-12-27	WOS:000305336600077
J	Amei, A; Sawyer, S				Amei, Amei; Sawyer, Stanley			Statistical Inference of Selection and Divergence from a Time-Dependent Poisson Random Field Model	PLOS ONE			English	Article							ADAPTIVE PROTEIN EVOLUTION; AMINO-ACID REPLACEMENTS; DROSOPHILA-MELANOGASTER; POPULATION-GENETICS; POSITIVE SELECTION; POLYMORPHISM; DEMOGRAPHY; LIKELIHOOD; MUTATIONS; PATTERNS	We apply a recently developed time-dependent Poisson random field model to aligned DNA sequences from two related biological species to estimate selection coefficients and divergence time. We use Markov chain Monte Carlo methods to estimate species divergence time and selection coefficients for each locus. The model assumes that the selective effects of non-synonymous mutations are normally distributed across genetic loci but constant within loci, and synonymous mutations are selectively neutral. In contrast with previous models, we do not assume that the individual species are at population equilibrium after divergence. Using a data set of 91 genes in two Drosophila species, D. melanogaster and D. simulans, we estimate the species divergence time t(div) = 2.61 N-e (or 1.68 million years, assuming the haploid effective population size N-e = 6.45 x 10(5) years) and a mean selection coefficient per generation mu(gamma) = 1.98/N-e. Although the average selection coefficient is positive, the magnitude of the selection is quite small. Results from numerical simulations are also presented as an accuracy check for the time-dependent model.	[Amei, Amei] Univ Nevada, Dept Math Sci, Las Vegas, NV 89154 USA; [Sawyer, Stanley] Washington Univ, Dept Math, St Louis, MO 63130 USA	Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; Washington University (WUSTL)	Amei, A (corresponding author), Univ Nevada, Dept Math Sci, Las Vegas, NV 89154 USA.	amei.amei@unlv.edu						Abel H. J., 2009, THESIS WASHINGTON U; Amei A, 2010, ANN APPL PROBAB, V20, P1663, DOI 10.1214/09-AAP668; Baines JF, 2008, MOL BIOL EVOL, V25, P1639, DOI 10.1093/molbev/msn111; Begunjh DJ, 2007, PLOS BIOL; Boyko AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000083; Bustamante CD, 2003, THEOR POPUL BIOL, V63, P91, DOI 10.1016/S0040-5809(02)00050-3; Bustamante CD, 2002, NATURE, V416, P531, DOI 10.1038/416531a; Bustamante CD, 2001, GENETICS, V159, P1779; CACCONE A, 1988, GENETICS, V118, P671; Eyre-Walker A, 2002, GENETICS, V162, P2017; Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a; Gelman A., 1996, MARKOV CHAIN MONTE C, P131, DOI DOI 10.1007/978-1-4899-4485-6_8; Glinka S, 2003, GENETICS, V165, P1269; Huerta-Sanchez E, 2008, GENETICS, V178, P325, DOI 10.1534/genetics.107.073361; Keightley PD, 2007, GENETICS, V177, P2251, DOI 10.1534/genetics.107.080663; LEMEUNIER F, 1986, MELANOGASTER SPECIES, P147; Lewontin RC, 1974, GENETIC BASIS EVOLUT; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Meiklejohn CD, 2004, GENETICS, V168, P265, DOI 10.1534/genetics.103.025494; Ometto L, 2005, MOL BIOL EVOL, V22, P2119, DOI 10.1093/molbev/msi207; Proschel M, 2006, GENETICS, V174, P893, DOI 10.1534/genetics.106.058008; SAWYER SA, 1992, GENETICS, V132, P1161; Sawyer SA, 2003, J MOL EVOL, V57, pS154, DOI 10.1007/s00239-003-0022-3; Sawyer SA, 2007, P NATL ACAD SCI USA, V104, P6504, DOI 10.1073/pnas.0701572104; Wakeley J, 2003, GENETICS, V163, P411; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102; Zhu L, 2005, GENETICS, V170, P1411, DOI 10.1534/genetics.104.035097	28	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34413	10.1371/journal.pone.0034413	http://dx.doi.org/10.1371/journal.pone.0034413			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509300	Green Published, gold, Green Submitted			2022-12-27	WOS:000304805900030
J	Gysels, M; Evans, N; Menaca, A; Andrew, E; Toscani, F; Finetti, S; Pasman, HR; Higginson, I; Harding, R; Pool, R				Gysels, Marjolein; Evans, Natalie; Menaca, Arantza; Andrew, Erin; Toscani, Franco; Finetti, Sylvia; Pasman, H. Roeline; Higginson, Irene; Harding, Richard; Pool, Robert		Project PRISMA	Culture and End of Life Care: A Scoping Exercise in Seven European Countries	PLOS ONE			English	Article							TERMINALLY-ILL PATIENTS; QUALITY-OF-LIFE; ADVANCED CANCER-PATIENTS; WRITTEN ETHICS POLICIES; PALLIATIVE-CARE; ADVANCE DIRECTIVES; INTENSIVE-CARE; HEALTH-CARE; DECISION-MAKING; FAMILY-MEMBERS	Aim: Culture is becoming increasingly important in relation to end of life (EoL) care in a context of globalization, migration and European integration. We explore and compare socio-cultural issues that shape EoL care in seven European countries and critically appraise the existing research evidence on cultural issues in EoL care generated in the different countries. Methods: We scoped the literature for Germany, Norway, Belgium, the Netherlands, Spain, Italy and Portugal, carrying out electronic searches in 16 international and country-specific databases and handsearches in 17 journals, bibliographies of relevant papers and webpages. We analysed the literature which was unearthed, in its entirety and by type (reviews, original studies, opinion pieces) and conducted quantitative analyses for each country and across countries. Qualitative techniques generated themes and sub-themes. Results: A total of 868 papers were reviewed. The following themes facilitated cross-country comparison: setting, caregivers, communication, medical EoL decisions, minority ethnic groups, and knowledge, attitudes and values of death and care. The frequencies of themes varied considerably between countries. Sub-themes reflected issues characteristic for specific countries (e.g. culture-specific disclosure in the southern European countries). The work from the seven European countries concentrates on cultural traditions and identities, and there was almost no evidence on ethnic minorities. Conclusion: This scoping review is the first comparative exploration of the cultural differences in the understanding of EoL care in these countries. The diverse body of evidence that was identified on socio-cultural issues in EoL care, reflects clearly distinguishable national cultures of EoL care, with differences in meaning, priorities, and expertise in each country. The diverse ways that EoL care is understood and practised forms a necessary part of what constitutes best evidence for the improvement of EoL care in the future.	[Gysels, Marjolein; Evans, Natalie; Menaca, Arantza; Andrew, Erin; Pool, Robert] Univ Barcelona, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Gysels, Marjolein; Higginson, Irene; Harding, Richard] Kings Coll London, Dept Palliat Care Policy & Rehabil, London WC2R 2LS, England; [Toscani, Franco; Finetti, Sylvia] Fdn Lino Maestroni, Ist Ric Med Palliat, Cremona, Italy; [Gysels, Marjolein; Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands; [Evans, Natalie; Pasman, H. Roeline] Vrije Univ Amsterdam Med Ctr, Expertise Ctr Palliat Care, Emgo Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands	ISGlobal; CRESIB; University of Barcelona; University of London; King's College London; University of Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Gysels, M (corresponding author), Univ Barcelona, Barcelona Ctr Int Hlth Res, Barcelona, Spain.	mhgysels@gmail.com	Evans, Natalie/M-1631-2013; Daveson, Barbara A/G-3122-2012; Murtagh, Fliss/C-3216-2009; Higginson, Irene Julie/C-7309-2012	Evans, Natalie/0000-0001-7124-9282; Murtagh, Fliss/0000-0003-1289-3726; Deliens, Luc/0000-0002-8158-2422; Daveson, Barbara/0000-0001-8039-8749; Koffman, Jonathan/0000-0001-8513-5681; Higginson, Irene Julie/0000-0002-3687-1313; Harding, Richard/0000-0001-9653-8689; Haugen, Dagny Faksvag/0000-0002-8592-4995	European Commission [Health-F2-2008-201655]	European Commission(European CommissionEuropean Commission Joint Research Centre)	PRISMA is funded by the European Commission's Seventh Framework Programme (contract number: Health-F2-2008-201655). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbadie B, 2006, Rev Med Brux, V27, pS287; Abizanda Campos R., 1994, MED INTENSIVA, V18, P100; Abma T A, 2001, Med Health Care Philos, V4, P261, DOI 10.1023/A:1012096917865; Abma TA, 2005, EVAL HEALTH PROF, V28, P90, DOI 10.1177/0163278704273080; Alonso Babarro A, 2002, MED PALIATIVA, V9, P161; Andruccioli J, 2007, J PALLIAT MED, V10, P741, DOI 10.1089/jpm.2006.0200; Andruccioli J, 2009, AM J HOSP PALLIAT ME, V26, P384, DOI 10.1177/1049909109338355; Angel-Lopez-Rey E, 2008, ENFERM CLIN, V18, P115, DOI 10.1016/S1130-8621(08)70712-5; Annunziata MA, 1996, SUPPORT CARE CANCER, V4, P334, DOI 10.1007/BF01788839; [Anonymous], QUALITY DEATH RANKIN; [Anonymous], DAT COMM DIAGN PROGN; Aoun SM, 2005, PALLIATIVE MED, V19, P461, DOI 10.1191/0269216305pm1057oa; Arana M, 1993, ATEN PRIM, V12, P523; Astudillo W, 2005, ALIVIO SITUACIONES D; Aujoulat I, 2002, PATIENT EDUC COUNS, V47, P213, DOI 10.1016/S0738-3991(01)00197-5; Baeke G, 2011, ETHNIC HEALTH, V16, P259, DOI 10.1080/13557858.2011.573538; Bajo Garcia J, 1990, ATEN PRIM, V7, P538; Bayes R, 1999, MED PALIATIVA, V6, P140; Beccaro M, 2006, J EPIDEMIOL COMMUN H, V60, P412, DOI 10.1136/jech.2005.043646; Beccaro M, 2010, J PAIN SYMPTOM MANAG, V39, P1003, DOI 10.1016/j.jpainsymman.2009.11.317; Beck S, 2008, MED HEALTH CARE PHIL, V11, P7, DOI 10.1007/s11019-007-9097-8; Becker G, 2007, J PAIN SYMPTOM MANAG, V33, P711, DOI 10.1016/j.jpainsymman.2006.09.030; Belderrain Belderrain P, 1999, Aten Primaria, V24, P285; Benini F, 2011, ANN I SUPER SANITA, V47, P253, DOI 10.4415/ANN_11_03_03; Bennett MI, 2010, PALLIATIVE MED, V24, P456, DOI 10.1177/0269216310366064; Bernheim JL, 2008, BRIT MED J, V336, P864, DOI 10.1136/bmj.39497.397257.AD; Bickel H, 1998, Z GERONTOL GERIATR, V31, P193, DOI 10.1007/s003910050034; Bilsen J, 2005, PALLIATIVE MED, V19, P151, DOI 10.1191/0269216305pm993oa; Bilsen JJR, 2004, J ADV NURS, V47, P583, DOI 10.1111/j.1365-2648.2004.02982.x; Bilsen J, 2007, SOC SCI MED, V65, P803, DOI 10.1016/j.socscimed.2007.04.016; Bilsen J, 2009, NEW ENGL J MED, V361, P1119, DOI 10.1056/NEJMc0904292; Bock M, 2007, INTENS CARE MED, V33, P1041, DOI 10.1007/s00134-007-0632-0; Borasio GD, 2004, NERVENARZT, V75, P1187, DOI 10.1007/s00115-004-1751-2; Borgsteede SD, 2007, PALLIATIVE MED, V21, P417, DOI 10.1177/0269216307079821; Borgsteede SD, 2006, BRIT J GEN PRACT, V56, P20; Broeckaert B, 2002, ETHICS PALLIATIVE CA, P166; Broeckaert B, 2003, ACTA HOSPITALIA, V43, P9; Buiting HM, 2011, J PAIN SYMPTOM MANAG, V42, P32, DOI 10.1016/j.jpainsymman.2010.10.260; Buiting HM, 2008, EUR J PUBLIC HEALTH, V18, P681, DOI 10.1093/eurpub/ckn084; Bunch Eli Haugen, 2002, Nurs Inq, V9, P187, DOI 10.1046/j.1440-1800.2002.00143.x; Burchardi N, 2005, J NEUROL SCI, V237, P67, DOI 10.1016/j.jns.2005.05.013; Cannaerts N, 2004, QUAL HEALTH RES, V14, P816, DOI 10.1177/1049732304265977; Caro Garcia M P, 2008, Rev Enferm, V31, P54; Cartwright C, 2007, PALLIATIVE MED, V21, P295, DOI 10.1177/0269216307079063; Caruso A, 2000, TUMORI, V86, P199, DOI 10.1177/030089160008600304; Casillas Santana L, 2004, EDUCARE, V21, P6; del Palacio EC, 2007, MED PALIATIVA, V14, P236; CATALANFERNANDEZ JG, 1991, MED CARE, V29, P841, DOI 10.1097/00005650-199109000-00005; Centeno C, 2007, PALLIATIVE MED, V21, P463, DOI 10.1177/0269216307081942; Centeno-Cortes Carlos, 1994, Palliative Medicine, V8, P39, DOI 10.1177/026921639400800107; Chabot BE, 2009, SOC SCI MED, V68, P1745, DOI 10.1016/j.socscimed.2009.03.005; Chambaere Kenneth, 2010, J Pain Symptom Manage, V39, pe5, DOI 10.1016/j.jpainsymman.2009.10.001; Cherny NI, 2010, ANN ONCOL, V21, P615, DOI 10.1093/annonc/mdp581; CIS, 2002, ACT OP MED ANT EUT; CIS, 2008, REL; CIS, 2009, AT PAC CON ENF FAS T; CIS, 1995, PERF ACT SOC ESP; Claessens P, 2007, J HOSPICE PALLIATIVE, V9; Clark D., 2002, ETHICS PALLIATIVE CA; Clark D, 2000, PALLIATIVE MED, V14; Clark D., 1998, MORTALITY, V3, P43, DOI [10.1080/713685885, DOI 10.1080/713685885]; Clark David, 1999, MORTALITY, V4, P225, DOI 10.1080/713685979; Cohen J, 2007, J EPIDEMIOL COMMUN H, V61, P1062, DOI 10.1136/jech.2006.056341; Cohen J, 2006, EUR J PUBLIC HEALTH, V16, P663, DOI 10.1093/eurpub/ckl042; Cohen J, 2006, HEALTH POLICY, V78, P319, DOI 10.1016/j.healthpol.2005.11.003; Cohen J, 2006, SOC SCI MED, V63, P743, DOI 10.1016/j.socscimed.2006.01.026; Cohen J, 2011, J PAIN SYMPTOM MANAG, V42, P839, DOI 10.1016/j.jpainsymman.2011.02.017; Cohen J, 2010, HEALTH PLACE, V16, P784, DOI 10.1016/j.healthplace.2010.04.003; Cohen J, 2010, J CLIN ONCOL, V28, P2267, DOI 10.1200/JCO.2009.23.2850; Corli O, 2009, PALLIATIVE MED, V23, P354, DOI 10.1177/0269216308100772; Cortes CC, 1998, MED CLIN-BARCELONA, V110, P744; Costantini M, 2002, J PAIN SYMPTOM MANAG, V23, P221, DOI 10.1016/S0885-3924(01)00405-5; Costantini M, 2009, ANN ONCOL, V20, P729, DOI 10.1093/annonc/mdn700; Costantini M, 2000, PUBLIC HEALTH, V114, P15, DOI 10.1016/S0033-3506(00)00302-4; Costantini M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-127; Cosyns M, 2008, Rev Med Brux, V29, P77; Dataanalyis, 2003, COMM DIAGN PROGN ONC; De Bal N, 2006, INT J NURS STUD, V43, P589, DOI 10.1016/j.ijnurstu.2005.08.003; de Casterle BD, 2006, J MED ETHICS, V32, P187, DOI 10.1136/jme.2005.011783; De Conno F, 1996, EUROPEAN J PALLIATIV, V3, P38; de Graaff FM, 2003, INT J NURS STUD, V40, P797, DOI 10.1016/S0020-7489(03)00078-6; de Graaff Fuusje M, 2010, BMC Palliat Care, V9, P19, DOI 10.1186/1472-684X-9-19; de Haan Jurriaan, 2002, Med Law Rev, V10, P57, DOI 10.1093/medlaw/10.1.57; de Vogel-Voogt E, 2007, PALLIATIVE MED, V21, P243, DOI 10.1177/0269216307077352; Linares MD, 2007, ENFERM INTENSIV, V18, P3, DOI 10.1016/S1130-2399(07)74384-5; Delfosse Marie-Luce, 2008, Bull Soc Sci Med Grand Duche Luxemb, P299; Deliens L, 2001, KNAW VERHAN, V102, P121; Deliens L, 2000, LANCET, V356, P1806, DOI 10.1016/S0140-6736(00)03233-5; Denier Y, 2009, MED HLTH CARE PHILOS; Denier Y, 2009, J PALLIAT CARE, V25, P264, DOI 10.1177/082585970902500404; Deschepper R, 2006, BRIT J GEN PRACT, V56, P14; Deschepper R, 2008, PATIENT EDUC COUNS, V71, P52, DOI 10.1016/j.pec.2007.11.015; Desmedt MS, 2011, BMC PALLIAT CARE, V10, DOI 10.1186/1472-684X-10-2; Dierickx K, 1998, ACTA NEUROCHIR, V140, P481, DOI 10.1007/s007010050129; DiMola G, 1996, ANN ONCOL, V7, P907, DOI 10.1093/oxfordjournals.annonc.a010792; Dominguez B, 1985, JANO H, p[654, 57]; Esteban A, 2001, INTENS CARE MED, V27, P1744, DOI 10.1007/s00134-001-1111-7; Evans N, 2012, J PAIN SYMPTOM MANAG, V43, P261, DOI 10.1016/j.jpainsymman.2011.04.012; Evans N, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-141; Ewers M, 2007, J PUBLIC HLTH, V15, P475; Fainsinger RL, 2000, PALLIATIVE MED, V14, P257, DOI 10.1191/026921600666097479; Fainsinger RL, 2003, J PALLIATIVE CARE, V19, P43, DOI 10.1177/082585970301900108; FENIGSEN R, 1990, ISSUES LAW MED, V6, P229; Fernandez Diaz R, 1996, ATEN PRIM, V17, P389; Fernandez Suarez A, 2002, Aten Primaria, V30, P449; Ferrario SR, 2004, PALLIATIVE MED, V18, P129, DOI 10.1191/0269216304pm870oa; Ferrario SR, 2003, HEALTH SOC CARE COMM, V11, P103, DOI 10.1046/j.1365-2524.2003.00410.x; Goncalves JAF, 2010, SUPPORT CARE CANCER, V18, P1271, DOI 10.1007/s00520-009-0743-y; Field A, 2002, SOC WORK HEALTH CARE, V35, P523, DOI 10.1300/J010v35n01_10; Fissell RB, 2005, KIDNEY INT, V68, P1282, DOI 10.1111/j.1523-1755.2005.00525.x; Fonseca AM, 2010, INT J PALLIAT NURS, V16, P476, DOI 10.12968/ijpn.2010.16.10.79214; Forde R, 1997, SOC SCI MED, V45, P887, DOI 10.1016/S0277-9536(96)00430-3; Forde R, 2002, RESUSCITATION, V55, P235, DOI 10.1016/S0300-9572(02)00270-8; Formiga F, 2004, QJM-INT J MED, V97, P803, DOI 10.1093/qjmed/hch135; Francke AL, 2000, PALLIATIEVE ZORG VAN; French J, 1973, Am J Nurs, V73, P502, DOI 10.2307/3422716; Garcia Orellan R, 2003, CUIDADOS PALIATIVOS, P305; Gastmans C, 2006, HEALTH POLICY, V76, P169, DOI 10.1016/j.healthpol.2005.09.003; Gastmans C, 2006, J ADV NURS, V54, P53, DOI 10.1111/j.1365-2648.2006.03790.x; Gastmans C, 2004, J MED ETHICS, V30, P212, DOI 10.1136/jme.2003.005082; Gastmans C, 2006, PATIENT EDUC COUNS, V63, P188, DOI 10.1016/j.pec.2005.10.004; Georges JJ, 2002, J CLIN NURS, V11, P785, DOI 10.1046/j.1365-2702.2002.00654.x; Giannini A, 2003, INTENS CARE MED, V29, P1902, DOI 10.1007/s00134-003-1919-4; Garcia EG, 2005, ENFERM CLIN, V15, P220; Goldsteen M, 2006, PATIENT EDUC COUNS, V64, P378, DOI 10.1016/j.pec.2006.04.008; Gomez Pavon FJ, 2002, CARACTERICAS ANCIANO; Gomez-Batiste X., 2001, Medicina Paliativa, V8, P134; Goncalves J Ferraz, 2003, J Palliat Med, V6, P895, DOI 10.1089/109662103322654776; Goncalves JASF, 2001, SUPPORT CARE CANCER, V9, P4; Gordijn B, 2004, HEALTH CARE ANAL, V12, P195, DOI 10.1023/B:HCAN.0000044926.05523.ef; Grassi L, 2000, SUPPORT CARE CANCER, V8, P40; Groot MM, 2005, PALLIATIVE MED, V19, P111, DOI 10.1191/0269216305pm937oa; Gysels M, 2011, CULTURE PRI IN PRESS; Gysels M, 2007, RES METHODS PALLIATI; Harding R, 2010, EUR J CANCER, V46, P1493, DOI 10.1016/j.ejca.2010.01.035; Hedayat KM, 2002, ITALIAN J PEDIAT, V28, P112; Heller A, 2005, Z GERONTOL GERIATR, V36, P360; Hermsen Maaike A, 2003, Med Health Care Philos, V6, P263, DOI 10.1023/A:1025986700278; Herremans J, 2008, REV MED BRUX, V29; Herremans J, 2008, B SOC SCI MED GRAND, V3, P302; Higginson IJ, 2008, EUR J CANCER, V44, P1414, DOI 10.1016/j.ejca.2008.02.024; HOLLAND JC, 1987, CANCER INVEST, V5, P151, DOI 10.3109/07357908709018468; Houtepen R, 2003, NURS ETHICS, V10, P377, DOI 10.1191/0969733003ne620oa; Houttekier D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-228; Houttekier D, 2010, J AM GERIATR SOC, V58, P751, DOI 10.1111/j.1532-5415.2010.02771.x; Houttekier D, 2010, HEALTH PLACE, V16, P132, DOI 10.1016/j.healthplace.2009.09.005; Hov R, 2007, J CLIN NURS, V16, P203, DOI 10.1111/j.1365-2702.2006.01427.x; Huijer M, 2000, J MED ETHICS, V26, P358, DOI 10.1136/jme.26.5.358; Hurst SA, 2007, J MED ETHICS, V33, P51, DOI 10.1136/jme.2005.014266; Husebo Bettina Sandgathe, 2005, Tidsskr Nor Laegeforen, V125, P1352; Hynninen M, 2008, ACTA ANAESTH SCAND, V52, P1081, DOI 10.1111/j.1399-6576.2008.01636.x; Inghelbrecht E, 2009, PALLIATIVE MED, V23, P649, DOI 10.1177/0269216309106810; Inghelbrecht E, 2008, INT J NURS STUD, V45, P1022, DOI 10.1016/j.ijnurstu.2007.06.005; Instituto Nacional de Estatistica de Portugal, 2005, OB DISTR GEOGR RES N; Jans J, 2005, J SOC CHRIST ETHICS, V25, P163, DOI 10.5840/jsce200525210; Janssens R, 1999, REPORT CONCEPTS PALL; Jimeno Aranda A, 1993, ATEN PRIM, V11, P120; Jordhoy MS, 2000, LANCET, V356, P888, DOI 10.1016/S0140-6736(00)02678-7; Jordhoy MS, 2001, BRIT J CANCER, V85, P1478, DOI 10.1054/bjoc.2001.2116; Jordhoy MS, 2001, J CLIN ONCOL, V19, P3884, DOI 10.1200/JCO.2001.19.18.3884; Jox RJ, 2008, PALLIATIVE MED, V22, P675, DOI 10.1177/0269216308089303; Jubb AM, 2002, J MED ETHICS, V28, P342, DOI 10.1136/jme.28.6.342; Justinger C, 2009, CHIRURG, V80, P455, DOI 10.1007/s00104-008-1662-z; Kaarbo E, 2011, J CLIN NURS, V20, P1125, DOI 10.1111/j.1365-2702.2009.03171.x; Kaasa S, 2006, PALLIATIVE MED, V20, P727, DOI 10.1177/0269216306072620; Kirschner R, 1998, Gesundheitswesen, V60, P247; Klastersky J, 2004, Rev Med Brux, V25, P69; Kleinman A., 1980, PATIENTS HEALERS CON; Klinkenberg M, 2004, SOC SCI MED, V59, P2467, DOI 10.1016/j.socscimed.2004.04.006; Kuhnlein P, 2008, AMYOTROPH LATERAL SC, V9, P91, DOI 10.1080/17482960701830495; Lafuerza A, 1998, ONCOLOGIA-BARCELONA, V21, P91; Lemiengre J, 2009, MED HLTH CARE PHILOS; Lemiengre J, 2008, PATIENT EDUC COUNS, V71, P293, DOI 10.1016/j.pec.2007.12.010; Lemiengre J, 2007, HEALTH POLICY, V84, P170, DOI 10.1016/j.healthpol.2007.05.007; Levorato A, 2001, SUPPORT CARE CANCER, V9, P420, DOI 10.1007/s005200100267; LINDSETH A, 1994, J ADV NURS, V20, P245, DOI 10.1046/j.1365-2648.1994.20020245.x; Locatelli C, 2010, J GERIATR ONCOL, V1, P73, DOI 10.1016/j.jgo.2010.07.002; Lopez de Maturana A, 1993, Palliat Med, V7, P39, DOI 10.1177/026921639300700107; Lorensen M, 2003, NURS ETHICS, V10, P175, DOI 10.1191/0969733003ne592oa; Lorente Lopez M., 2004, TRAB SOC SALUD, V49, P83; Lucchiari C, 2010, LIFE SPAN DISABIL, V13, P71; Lynn J, 1997, ANN INTERN MED, V126, P97, DOI 10.7326/0003-4819-126-2-199701150-00001; Maggiore SM, 2005, INTENS CARE MED, V31, P997, DOI 10.1007/s00134-005-2645-x; Mahtani-Chugani V, 2010, PALLIATIVE MED, V24, P787, DOI 10.1177/0269216310380296; Meeussen K, 2011, J PAIN SYMPTOM MANAG, V42, P565, DOI 10.1016/j.jpainsymman.2011.01.011; Meeussen K, 2011, J PAIN SYMPTOM MANAG, V41, P1060, DOI 10.1016/j.jpainsymman.2010.09.020; Menaca A, CRITICAL REV ONCOLOG; Mercadante S, 1996, J PAIN SYMPTOM MANAG, V11, P108, DOI 10.1016/0885-3924(95)00147-6; Miccinesi G, 2005, SOC SCI MED, V60, P1961, DOI 10.1016/j.socscimed.2004.08.061; Miro G, 2006, MED CLIN-BARCELONA, V126, P567, DOI 10.1157/13087707; Molina Linde JM, 2006, MED PALIATIVA, P1311; Molina Linde JM, 2005, MED PAL, V12, P83; Monti M, 2004, SUPPORT CARE CANCER, V12, P752, DOI 10.1007/s00520-004-0617-2; Morasso G, 1997, PSYCHO-ONCOL, V6, P212, DOI 10.1002/(SICI)1099-1611(199709)6:3<212::AID-PON275>3.0.CO;2-X; Morasso G, 2008, PSYCHO-ONCOLOGY, V17, P1073, DOI 10.1002/pon.1332; Morris D, 1999, CULTURE PAIN; Mortier F, 2003, MED DECIS MAKING, V23, P502, DOI 10.1177/0272989X03260137; Muller-Busch HC, 2005, MED HEALTH CARE PHIL, V7, P333; *NIH, 2004, NAT I HLTH STAT OF T; Nordam A, 2003, NURS ETHICS, V10, P388, DOI 10.1191/0969733003ne589oa; Norum Jan, 1993, Tidsskrift for den Norske Laegeforening, V113, P1102; Norum Jan, 1993, Tidsskrift for den Norske Laegeforening, V113, P1107; Norwood F, 2007, MED ANTHROPOL, V26, P139, DOI 10.1080/01459740701283165; Nunez Olarte J M, 2001, Cancer Control, V8, P46; Nyhsen C, 1999, MED KLIN, V94, P536, DOI 10.1007/BF03044950; Nys H, 2000, THEOR MED BIOETH, V21, P425, DOI 10.1023/A:1009921306197; Olano Espinosa E, 1997, Aten Primaria, V19, P483; Oliver C., 2004, MORTALITY, V9, P235, DOI DOI 10.1080/13576270412331272770; Onwuteaka-Philipsen BD, 2006, ARCH INTERN MED, V166, P921, DOI 10.1001/archinte.166.8.921; Onwuteaka-Philipsen BD, 2003, LANCET, V362, P395, DOI 10.1016/S0140-6736(03)14029-9; Osse BHP, 2005, SUPPORT CARE CANCER, V13, P722, DOI 10.1007/s00520-004-0771-6; Osse BHP, 2002, PATIENT EDUC COUNS, V47, P195, DOI 10.1016/S0738-3991(02)00019-8; Osuna E, 1998, J MED ETHICS, V24, P106, DOI 10.1136/jme.24.2.106; Pacheco R, 1989, Med Law, V8, P243; Palomar Gallardo C, 2002, MED PALIATIVA, V9, P3; Palomar Gallardo C, 2001, QUE ENTIENDEN CUIDAD, P37; Pardon K, 2009, PATIENT EDUC COUNS, V77, P421, DOI 10.1016/j.pec.2009.09.011; Payne SA, 2008, PALLIATIVE MED, V22, P336, DOI 10.1177/0269216308090072; Pedersen R, 2008, J MED ETHICS, V34, P230, DOI 10.1136/jme.2006.018531; Pereira SM, 2011, INT J PALLIAT NURS, V17, P373, DOI 10.12968/ijpn.2011.17.8.373; Perez-Carceles M D, 1999, Med Law, V18, P497; Pettila V, 2002, ACTA ANAESTH SCAND, V46, P947, DOI 10.1034/j.1399-6576.2002.460804.x; Pimentel FL, 1999, SUPPORT CARE CANCER, V7, P407, DOI 10.1007/s005200050301; Pinto C, 2009, ONCONEWS, V3, P16; PINZON LCE, 2011, J PAIN SYMPTOM MANAG, V41, P893, DOI DOI 10.1016/J.JPAINSYMMAN.2010.07.016; Pique Prado E, 1999, METAS ENFERMERIA, V2, P47; Porta M, 1997, PALLIATIVE MED, V11, P116, DOI 10.1177/026921639701100205; Poveda de Agustin J, 1992, JANO, V1009, P93; PRONZATO P, 1994, SUPPORT CARE CANCER, V2, P242, DOI 10.1007/BF00365729; Proot IM, 2004, PALLIATIVE MED, V18, P53, DOI 10.1191/0268216304pm818oa; Proot IM, 2003, SCAND J CARING SCI, V17, P113, DOI 10.1046/j.1471-6712.2003.00220.x; Puts M T, 2004, Ned Tijdschr Geneeskd, V148, P277; Ramon I, 2006, REV CLIN ESP, V206, P549, DOI 10.1157/13096302; Richards MA, 1998, PALLIATIVE MED, V12, P399, DOI 10.1191/026921698673432534; Rietjens JAC, 2006, ARCH INTERN MED, V166, P749, DOI 10.1001/archinte.166.7.749; Rietjens JAC, 2005, SOC SCI MED, V61, P1723, DOI 10.1016/j.socscimed.2005.03.024; Riley J, 2005, LANCET, V365, P735; Ringdal GI, 2004, PALLIATIVE MED, V18, P108, DOI 10.1191/0269216304pm878oa; Ringdal GI, 2002, J PAIN SYMPTOM MANAG, V24, P53, DOI 10.1016/S0885-3924(02)00417-7; Ringdal GI, 2001, J PAIN SYMPTOM MANAG, V22, P1016, DOI 10.1016/S0885-3924(01)00363-3; Ripamonti C, 2000, TUMORI J, V86, P412, DOI 10.1177/030089160008600509; Rodriguez G, 2003, NEUROL SCI, V24, P329, DOI 10.1007/s10072-003-0184-1; Rodriguez R, 2005, MED PALIATIVA, V12, P3; Rodriguez Rodriguez C, 2001, CULTURA CUIDADOS, V5, P45; Romoren TI, 2003, AGEING SOC, V23, P471, DOI 10.1017/S0144686X03001247; Rosario Otegui P., 2000, MED Y CULTURA ESTUDI; Rossi PG, 2007, J EPIDEMIOL COMMUN H, V61, P547, DOI 10.1136/jech.2005.045138; Ruiz-Bentez M., 2008, PSICOONCOLOG A, V5, P53, DOI 10.5209/rev_PSIC.2008.v5.n1.16351; Rurup ML, 2012, PALLIATIVE MED, V26, P43, DOI 10.1177/0269216311413836; Rurup ML, 2006, SOC SCI MED, V62, P1552, DOI 10.1016/j.socscimed.2005.08.010; Rurup ML, 2005, J AM GERIATR SOC, V53, P1138, DOI 10.1111/j.1532-5415.2005.53354.x; Saez FDN, 2006, INTENS CARE MED, V32, P1086, DOI 10.1007/s00134-006-0140-7; Safonte-Strumolo N., 2000, FAMILY J COUNSELING, V8, P334, DOI [10.1177/1066480700084002, DOI 10.1177/1066480700084002]; Sahm S, 2005, Med Health Care Philos, V8, P297, DOI 10.1007/s11019-005-2108-8; Sahm S, 2005, SUPPORT CARE CANCER, V13, P206, DOI 10.1007/s00520-004-0725-z; Sahm S, 2005, J MED ETHICS, V31, P437, DOI 10.1136/jme.2004.009605; Sahm SW, 2000, J MED PHILOS, V25, P195, DOI 10.1076/0360-5310(200004)25:2;1-O;FT195; Sanz de la Torre JC, 2000, ENFERMERIA CIENTIFIC, p[220, 17]; Saunders CM, 1997, HOSPICE CARE INT SCI; Schaffer MA, 2007, NURS ETHICS, V14, P242, DOI 10.1177/0969733007073707; Schildmann J, 2006, J MED ETHICS, V32, P567, DOI 10.1136/jme.2005.013904; Rio-Valle JS, 2009, J PALLIAT CARE, V25, P191, DOI 10.1177/082585970902500306; Schou K, 2008, NURS PHILOS, V9, P233, DOI 10.1111/j.1466-769X.2008.00374.x; Sehgal AR, 1996, JAMA-J AM MED ASSOC, V276, P1652, DOI 10.1001/jama.276.20.1652; Servais O, 2001, RECH SOCIOLOGIQUES, V32, P65; Servillo G, 2008, INTENS CARE MED, V34, P1333, DOI 10.1007/s00134-008-1057-0; Seymour J, 2007, SOCIOL HEALTH ILL, V29, P872, DOI 10.1111/j.1467-9566.2007.01045.x; Seymour JE, 2007, SOC SCI MED, V64, P1679, DOI 10.1016/j.socscimed.2006.11.030; Simon-Lorda P, 2008, BIOETHICS, V22, P346, DOI 10.1111/j.1467-8519.2008.00644.x; Smets T, 2011, J PAIN SYMPTOM MANAG, V41, P580, DOI 10.1016/j.jpainsymman.2010.05.015; Solem PE, 1981, TIDSSKRIFT NORSK S1, V1, P7; SOLHEIM K, 1990, Tidsskrift for den Norske Laegeforening, V110, P1957; Solsona JF, 2003, MED CLIN-BARCELONA, V120, P335, DOI 10.1157/13044234; Sorbye L W, 2000, Int J Palliat Nurs, V6, P71; Sorbye LW, 1999, SCAND J CARING SCI, V13, P102, DOI 10.1080/02839319950162642; Sprung CL, 2003, JAMA-J AM MED ASSOC, V290, P790, DOI 10.1001/jama.290.6.790; Sullivan M, 1998, J AM GERIATR SOC, V46, P1251, DOI 10.1111/j.1532-5415.1998.tb04541.x; Surbone A, 2004, CRIT REV ONCOL HEMAT, V52, P165, DOI 10.1016/j.critrevonc.2004.09.002; SURBONE A, 1993, SUPPORT CARE CANCER, V1, P89, DOI 10.1007/BF00366901; Swarte NB, 2003, BMJ-BRIT MED J, V327, P189, DOI 10.1136/bmj.327.7408.189; Tallgren M, 2005, ACTA ANAESTH SCAND, V49, P1092, DOI 10.1111/j.1399-6576.2005.00799.x; TELJE J, 1990, Tidsskrift for den Norske Laegeforening, V110, P1954; The Anne-Mei., 2009, VERLOSSERS NAAST GOD; THOMSEN OO, 1993, LANCET, V341, P473, DOI 10.1016/0140-6736(93)90218-6; Timmermann M, 2009, J PALLIAT CARE, V25, P181, DOI 10.1177/082585970902500305; Tolley DC, 2007, J PAIN SYMPTOM MANAG, V33, P90, DOI 10.1016/j.jpainsymman.2006.10.007; Torjuul Kirsti, 2005, BMC Med Ethics, V6, pE7; Toro LB, 2007, MED PALIATIVA, V14, P164; Toscani F, 2005, J PAIN SYMPTOM MANAG, V30, P33, DOI 10.1016/j.jpainsymman.2005.01.013; Tranoy KE, 1988, MED ETHICS NORWAY MO; Trentin L., 2001, J HEADACHE PAIN, V2, P73, DOI DOI 10.1007/PL00012189; Uceda ME, 2007, MED PALIATIVA, V14, P69; UDEN G, 1992, J ADV NURS, V17, P1028, DOI 10.1111/j.1365-2648.1992.tb02036.x; van Delden JJM, 2004, J MED ETHICS, V30, P447, DOI 10.1136/jme.2002.002857; Van den Block L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-69; Van den Block L, 2008, ARCH INTERN MED, V168, P1747, DOI 10.1001/archinte.168.16.1747; Van den Block L, 2007, JAMA-J AM MED ASSOC, V298, P1638, DOI 10.1001/jama.298.14.1638; Van den Block L, 2006, J CLIN ONCOL, V24, P2842, DOI 10.1200/JCO.2005.03.7531; Van den Eynden B, 2000, SUPPORT CARE CANCER, V8, P59; van der Heide A, 2003, LANCET, V362, P345, DOI 10.1016/S0140-6736(03)14019-6; Van Marwijk H, 2007, PALLIATIVE MED, V21, P609, DOI 10.1177/0269216307082475; van Oorschot B, 2006, J MED ETHICS, V32, P623, DOI 10.1136/jme.2005.015032; van Oorschot B., 2004, ETHIK MED, V16, P112, DOI [10.1007/s00481-004-0299-9, DOI 10.1007/S00481-004-0299-9]; Van Parys T, 2003, PALLIATIVE MED, V17, P111, DOI 10.1191/0269216303pm763op; Van Rensbergen G, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-178; van Staa AL, 2000, PATIENT EDUC COUNS, V41, P93, DOI 10.1016/S0738-3991(00)00119-1; Van Wesemael Y, 2010, EVALUATION HLTH PROF; Van Wesemael Y, 2009, HEALTH SERV RES, V44, P2180, DOI 10.1111/j.1475-6773.2009.01042.x; Van Wesemael Yanna C, 2009, BMC HLTH SERVICES RE, V9; van Wijmen MPS, 2010, BIOETHICS, V24, P118, DOI 10.1111/j.1467-8519.2009.01788.x; VANDERWAL G, 1992, FAM PRACT, V9, P135, DOI 10.1093/fampra/9.2.135; Varrassi G, 2003, J PAIN SYMPTOM MANAG, V26, P590, DOI 10.1016/S0885-3924(03)00224-0; VERONESI A, 1995, EUR J CANCER, V31A, P425, DOI 10.1016/0959-8049(94)00489-R; Verpoort C, 2004, J ADV NURS, V47, P592, DOI 10.1111/j.1365-2648.2004.03148.x; Vincent JL, 1998, INTENS CARE MED, V24, P1251, DOI 10.1007/s001340050758; VINCENT JL, 1990, INTENS CARE MED, V16, P256, DOI 10.1007/BF01705162; Vincent JL, 1999, CRIT CARE MED, V27, P1626, DOI 10.1097/00003246-199908000-00042; Visentin M, 2001, J PAIN SYMPTOM MANAG, V22, P925, DOI 10.1016/S0885-3924(01)00355-4; Voltz R, 1998, J PAIN SYMPTOM MANAG, V16, P153, DOI 10.1016/S0885-3924(98)00067-0; Voorhees J, 2009, J AM GERIATR SOC, V57, pS76; Wanden-Berghe C, 2009, NUTR HOSP, V24, P732, DOI 10.3305/nh.2009.24.6.4558; Welshman AT, 2003, PALLIATIVE MED, V17, P122, DOI 10.1191/0269216303pm724op; Wood WA, 2009, ONCOLOGIST, V14, P77, DOI 10.1634/theoncologist.2008-0158; Zamperetti N, 2006, INTENS CARE MED, V32, P1620, DOI 10.1007/s00134-006-0330-3; Zylicz Z, 1993, AM J HOSP PALLIAT ME, V4, P30	325	86	86	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34188	10.1371/journal.pone.0034188	http://dx.doi.org/10.1371/journal.pone.0034188			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	952PZ	22509278	gold, Green Published, Green Submitted			2022-12-27	WOS:000304805900016
J	Hogue, MCB; Doran, E; Henry, DA				Hogue, Marie-Clare B.; Doran, Evan; Henry, David A.			A Prompt to the Web: The Media and Health Information Seeking Behaviour	PLOS ONE			English	Article							INTERNET; DISEASE	Objective, Design, Setting and Participants: The objective was to investigate media influence on consumers' health related behaviours. A cross-sectional survey of randomly selected adults (18+ years) residing in the Hunter Region of New South Wales Australia was conducted. The sample was selected using a combination of the white pages and random digit dialling. Main Outcome Measures: The proportions of respondents who recalled seeing or hearing about conditions or treatments in the media over the 12 months prior to interview (August 2009-August 2010) and their subsequent health related behaviour. Results: Although most survey participants reported seeking health information from their doctors, around two-thirds of survey participants (551, 68.8%) recalled hearing, seeing or reading about one or more medical conditions (total = 1097 instances) in the mainstream media over the past 12 months. Almost 40% of respondents (307, 38.4%) stated that they had looked for more information about a condition as a result of hearing about it in the media, and most used the internet (269, 87.4%). More than a quarter of respondents (215, 26.9%) indicated that they had asked their doctor about a condition they had heard about in the media. Around half of those who asked their doctor (109, 50.6%) reported that their inquiry resulted in them receiving treatment, of whom almost half (53, 48.3%) reported being prescribed a medicine. Conclusion: The survey results show that consumers become aware of medicines through traditional media and then to learn more often turn to the internet where quality of information may be poor. (252 words)	[Hogue, Marie-Clare B.; Doran, Evan] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia; [Hogue, Marie-Clare B.] Hunter Valley Res Fdn, Maryville, NSW, Australia; [Henry, David A.] Inst Clin Evaluat Sci, Toronto, ON, Canada	University of Newcastle; University of Toronto	Hogue, MCB (corresponding author), Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia.	clare@hvrf.com.au	Henry, David/AAU-4650-2020; Henry, David/AAJ-4332-2020	Henry, David/0000-0001-7169-7704; Henry, David/0000-0003-2934-2242; Doran, Evan/0000-0002-3025-0524	Australia Research Council (ARC) [DP0877633]	Australia Research Council (ARC)(Australian Research Council)	This work was supported by the Australia Research Council (ARC) Grant DP0877633 (http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centre Social Policy Research Unit, 2005, INF MATT CONS FIND O; Clarke JN, 2006, SOC SCI MED, V62, P2591, DOI 10.1016/j.socscimed.2005.11.021; Doran E, 2008, INTERN MED J, V38, P858, DOI 10.1111/j.1445-5994.2008.01814.x; Hall D, 2011, AUST FAM PHYSICIAN, V40, P143; Hall DV, 2008, MED J AUSTRALIA, V189, P326, DOI 10.5694/j.1326-5377.2008.tb02051.x; Korp P, 2006, HEALTH EDUC RES, V21, P78, DOI 10.1093/her/cyh043; Laing A., 2010, PATIENTS PROFESSIONA; Leung L, 2008, CYBERPSYCHOL BEHAV, V11, P565, DOI 10.1089/cpb.2007.0189; Lewis T, 2006, MEDIA CULT SOC, V28, P521, DOI 10.1177/0163443706065027; Lexchin J, 2000, AUSTR PRESCRIBER, V23, P73; Liang BA, 2011, J AM MED ASS, V305; McDaid D, 2005, ONLINE HLTH UNTANGLI; McDaid D, 2011, BUPA HLTH PULSE ONLI; Moses A, 2011, SYDNEY MORNING  0210; Moynihan R, 2002, BRIT MED J, V324, P886, DOI 10.1136/bmj.324.7342.886; Moynihan R, 2006, PLOS MED, V3, P425, DOI 10.1371/journal.pmed.0030191; MPND, 2006, POPULATION HOUSING C; National Medicines Policy Partnerships Forum, 2010, OUTC STAT 2010; National Prescribing Service, 2006, NAT CONS SURV 5 EX S; National Prescribing Service Using Medicines Wisely and Safely, NAT PRESCR SERV US M; Nettleton S, 2005, SOCIOL HEALTH ILL, V27, P972, DOI 10.1111/j.1467-9566.2005.00466.x; Newby D, 2001, AUSTR NZ J PUBLIC HL, V25; Sweet M, 2009, AUST PRESCR, V32, P2; Toop L, 2006, AUST PRESCR, V29, P30, DOI 10.18773/austprescr.2006.018; Wilson A, 2009, PLOS MED, V4; Wiseman R, VIEWS QUALITY USE ME	26	29	29	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34314	10.1371/journal.pone.0034314	http://dx.doi.org/10.1371/journal.pone.0034314			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	952PZ	22509289	Green Published, gold			2022-12-27	WOS:000304805900025
J	Jessop, TS; Smissen, P; Scheelings, F; Dempster, T				Jessop, Tim S.; Smissen, Peter; Scheelings, Franciscus; Dempster, Tim			Demographic and Phenotypic Effects of Human Mediated Trophic Subsidy on a Large Australian Lizard (Varanus varius): Meal Ticket or Last Supper?	PLOS ONE			English	Article							MACRONUTRIENT BALANCE; POPULATION-DYNAMICS; SUPPLEMENTAL FOOD; TRADE-OFFS; SEX-RATIO; REPRODUCTION; ECOLOGY; SIZE; AVAILABILITY; COMPETITION	Humans are increasingly subsidizing and altering natural food webs via changes to nutrient cycling and productivity. Where human trophic subsidies are concentrated and persistent within natural environments, their consumption could have complex consequences for wild animals through altering habitat preferences, phenotypes and fitness attributes that influence population dynamics. Human trophic subsidies conceptually create both costs and benefits for animals that receive increased calorific and altered nutritional inputs. Here, we evaluated the effects of a common terrestrial human trophic subsidies, human food refuse, on population and phenotypic (comprising morphological and physiological health indices) parameters of a large predatory lizard (similar to 2 m length), the lace monitor (Varanus varius), in southern Australia by comparison with individuals not receiving human trophic subsidies. At human trophic subsidies sites, lizards were significantly more abundant and their sex ratio highly male biased compared to control sites in natural forest. Human trophic subsidies recipient lizards were significantly longer, heavier and in much greater body condition. Blood parasites were significantly lower in human trophic subsidies lizards. Collectively, our results imply that human trophic subsidized sites were especially attractive to adult male lace monitors and had large phenotypic effects. However, we cannot rule out that the male-biased aggregations of large monitors at human trophic subsidized sites could lead to reductions in reproductive fitness, through mate competition and offspring survival, and through greater exposure of eggs and juveniles to predation. These possibilities could have negative population consequences. Aggregations of these large predators may also have flow on effects to surrounding food web dynamics through elevated predation levels. Given that flux of energy and nutrients into food webs is central to the regulation of populations and their communities, we advocate further studies of human trophic subsidies be undertaken to evaluate the potentially large ecological implications of this significant human environmental alteration.	[Jessop, Tim S.; Smissen, Peter; Dempster, Tim] Univ Melbourne, Dept Zool, Melbourne, Vic, Australia; [Jessop, Tim S.] Zoos Victoria, Dept Conservat & Res, Parkville, Vic, Australia; [Scheelings, Franciscus] Healesville Sanctuary, Australian Wildlife Hlth Ctr, Healesville, Vic, Australia	University of Melbourne	Jessop, TS (corresponding author), Univ Melbourne, Dept Zool, Melbourne, Vic, Australia.	tjessop@unimelb.edu.au	Jessop, Tim/Q-2473-2019; Jessop, Tim/I-6647-2012; Dempster, Tim/E-9630-2011	Jessop, Tim S./0000-0002-7712-4373; Dempster, Tim/0000-0001-8041-426X	Zoos Victoria	Zoos Victoria	Funding for research was provided by Zoos Victoria as part of the "forest for life" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCESE P, 1988, J ANIM ECOL, V57, P119, DOI 10.2307/4768; Bonier F, 2009, TRENDS ECOL EVOL, V24, P634, DOI 10.1016/j.tree.2009.04.013; Campbell T., 2006, REPTILE MED SURG, P453, DOI 10.1016/B0-72-169327-X/50032-8; Campbell T. W., 2007, AVIAN EXOTIC ANIMAL; CLARK AB, 1978, SCIENCE, V201, P163, DOI 10.1126/science.201.4351.163; Cotter SC, 2011, FUNCT ECOL, V25, P186, DOI 10.1111/j.1365-2435.2010.01766.x; COWIE RJ, 1988, BIRD STUDY, V35, P163, DOI 10.1080/00063658809476985; Dempster T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015646; Doody JS, 2009, ANIM CONSERV, V12, P46, DOI 10.1111/j.1469-1795.2008.00219.x; DOONAN TJ, 1995, ECOLOGY, V76, P814, DOI 10.2307/1939347; Fedriani JM, 2001, ECOGRAPHY, V24, P325, DOI 10.1034/j.1600-0587.2001.240310.x; Guarino F, 2002, J ZOOL, V258, P449, DOI 10.1017/S0952836902001607; Halverson Joy, 2002, P165; Hutchings S, 2003, WILDLIFE RES, V30, P103, DOI 10.1071/WR99067; Jessop T, 2004, P ROY SOC B-BIOL SCI, V271, pS91, DOI 10.1098/rsbl.2003.0102; Jessop Tim, 2010, Biawak, V4, P59; Jessop TS, 2007, BIOL CONSERV, V135, P247, DOI 10.1016/j.biocon.2006.10.025; Jessop TS, 2006, OIKOS, V112, P422, DOI 10.1111/j.0030-1299.2006.14371.x; Kloskowski J, OIKOS IN PRESS, P19942, DOI [10.1111/j.1600-0706.2011, DOI 10.1111/J.1600-0706.2011.19942]; Kvarnemo C, 1996, TRENDS ECOL EVOL, V11, P404, DOI 10.1016/0169-5347(96)10056-2; Madsen T, 2005, OECOLOGIA, V142, P407, DOI 10.1007/s00442-004-1742-9; Martinson TJ, 2003, WILDLIFE SOC B, V31, P510; Meretsky VJ, 1999, J WILDLIFE MANAGE, V63, P107, DOI 10.2307/3802491; Moore IT, 2003, HORM BEHAV, V43, P39, DOI 10.1016/S0018-506X(02)00038-7; Olsson M, 2005, AUSTRAL ECOL, V30, P907; Oro D, 2004, P ROY SOC B-BIOL SCI, V271, P387, DOI 10.1098/rspb.2003.2609; Oro D, 1996, J AVIAN BIOL, V27, P245, DOI 10.2307/3677229; Panek M, 2002, ACTA THERIOL, V47, P433, DOI 10.1007/BF03192468; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Riley SPD, 2003, CONSERV BIOL, V17, P566, DOI 10.1046/j.1523-1739.2003.01458.x; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Robertson BA, 2006, ECOLOGY, V87, P1075, DOI 10.1890/0012-9658(2006)87[1075:AFFUET]2.0.CO;2; Robertson BC, 2006, BIOL LETTERS, V2, P229, DOI 10.1098/rsbl.2005.0430; Sapkota AR, 2007, ENVIRON HEALTH PERSP, V115, P663, DOI 10.1289/ehp.9760; Schlaepfer MA, 2002, TRENDS ECOL EVOL, V17, P474, DOI 10.1016/S0169-5347(02)02580-6; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Simpson SJ, 2009, AGING-US, V1, P875, DOI 10.18632/aging.100098; Sykes John M., 2008, Veterinary Clinics of North America Exotic Animal Practice, V11, P481, DOI 10.1016/j.cvex.2008.03.005; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walpole MJ, 2001, ANIM CONSERV, V4, P67, DOI 10.1017/S136794300100107X; WERREN JH, 1980, SCIENCE, V208, P1157, DOI 10.1126/science.208.4448.1157	44	42	46	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34069	10.1371/journal.pone.0034069	http://dx.doi.org/10.1371/journal.pone.0034069			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509271	Green Submitted, Green Published, gold			2022-12-27	WOS:000304805900012
J	Maiya, R; Kharazia, V; Lasek, AW; Heberlein, U				Maiya, Rajani; Kharazia, Viktor; Lasek, Amy W.; Heberlein, Ulrike			Lmo4 in the Basolateral Complex of the Amygdala Modulates Fear Learning	PLOS ONE			English	Article							LONG-TERM-MEMORY; ELEMENT-BINDING PROTEIN; LIM-DOMAIN; SYNAPTIC PLASTICITY; EXPRESSION; ANXIETY; MOUSE; TRANSCRIPTION; MICE; GENE	Pavlovian fear conditioning is an associative learning paradigm in which mice learn to associate a neutral conditioned stimulus with an aversive unconditioned stimulus. In this study, we demonstrate a novel role for the transcriptional regulator Lmo4 in fear learning. LMO4 is predominantly expressed in pyramidal projection neurons of the basolateral complex of the amygdala (BLC). Mice heterozygous for a genetrap insertion in the Lmo4 locus (Lmo4gt/+), which express 50% less Lmo4 than their wild type (WT) counterparts display enhanced freezing to both the context and the cue in which they received the aversive stimulus. Small-hairpin RNA-mediated knockdown of Lmo4 in the BLC, but not the dentate gyrus region of the hippocampus recapitulated this enhanced conditioning phenotype, suggesting an adult-and brain region-specific role for Lmo4 in fear learning. Immunohistochemical analyses revealed an increase in the number of c-Fos positive puncta in the BLC of Lmo4gt/+ mice in comparison to their WT counterparts after fear conditioning. Lastly, we measured anxiety-like behavior in Lmo4gt/+ mice and in mice with BLC-specific downregulation of Lmo4 using the elevated plus maze, open field, and light/dark box tests. Global or BLC-specific knockdown of Lmo4 did not significantly affect anxiety-like behavior. These results suggest a selective role for LMO4 in the BLC in modulating learned but not unlearned fear.	[Maiya, Rajani; Kharazia, Viktor; Lasek, Amy W.; Heberlein, Ulrike] Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Heberlein, Ulrike] Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94143 USA; [Heberlein, Ulrike] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Maiya, R (corresponding author), Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	rmaiya@gallo.ucsf.edu	Lasek, Amy/AAV-7606-2020	Lasek, Amy/0000-0002-7099-2442; Kharazia, Viktor/0000-0003-0642-6080	State of California for medical research on alcohol and substance abuse through the University of California San Francisco; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016654] Funding Source: NIH RePORTER	State of California for medical research on alcohol and substance abuse through the University of California San Francisco(University of California System); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the State of California for medical research on alcohol and substance abuse through the University of California San Francisco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; Adachi M, 2009, J NEUROSCI, V29, P4218, DOI 10.1523/JNEUROSCI.4225-08.2009; Aizawa H, 2004, SCIENCE, V303, P197, DOI 10.1126/science.1089845; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Bulchand S, 2003, DEV DYNAM, V226, P460, DOI 10.1002/dvdy.10235; Cirelli C, 2000, BRAIN RES, V885, P303, DOI 10.1016/S0006-8993(00)03008-0; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Fanselow MS, 2005, ANNU REV PSYCHOL, V56, P207, DOI 10.1146/annurev.psych.56.091103.070213; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guimarais M, FRONT BEHAV NEUROSCI, V5, P89; Heberlein U, 2009, NEUROPHARMACOLOGY, V56, P97, DOI 10.1016/j.neuropharm.2008.07.023; Hermanson O, 1999, CELL MOL BIOL, V45, P677; Hernandez-Rabaza V, 2008, NEUROBIOL LEARN MEM, V90, P553, DOI 10.1016/j.nlm.2008.06.008; Hong SJ, 2004, P NATL ACAD SCI USA, V101, P2145, DOI 10.1073/pnas.0305170101; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Kashani AH, 2006, J NEUROSCI, V26, P8398, DOI 10.1523/JNEUROSCI.0618-06.2006; Lamprecht R, 2009, GENES BRAIN BEHAV, V8, P735, DOI 10.1111/j.1601-183X.2009.00515.x; Lasek AW, 2007, GENES BRAIN BEHAV, V6, P728, DOI 10.1111/j.1601-183X.2007.00303.x; Lasek AW, J NEUROSCI, V31, P14134; Lasek AW, METHODS MOL BIOL, V602, P283; Lasek AW, GENES BRAIN BEHAV; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee I, 2004, HIPPOCAMPUS, V14, P301, DOI 10.1002/hipo.10177; Maren S, 1996, NEURON, V16, P237, DOI 10.1016/S0896-6273(00)80041-0; McEwen BS, NEUROPHARMACOLOGY, V62, P3; McIlwain KL, 2001, PHYSIOL BEHAV, V73, P705, DOI 10.1016/S0031-9384(01)00528-5; Milan M, 1999, MOL CELL, V4, P267, DOI 10.1016/S1097-2765(00)80374-3; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Paxinos G., 2001, MOUSE BRAIN STEREOTA; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; Rogan MT, 1996, CELL, V85, P469, DOI 10.1016/S0092-8674(00)81247-7; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sajdyk TJ, 1997, BRAIN RES, V764, P262, DOI 10.1016/S0006-8993(97)00594-5; SANDERS SK, 1995, PHARMACOL BIOCHEM BE, V52, P701, DOI 10.1016/0091-3057(95)00153-N; Schafe GE, 1999, LEARN MEMORY, V6, P97; Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038; Singh RR, 2005, CANCER RES, V65, P10594, DOI 10.1158/0008-5472.CAN-05-2268; Thaler JP, 2002, CELL, V110, P237, DOI 10.1016/S0092-8674(02)00823-1; Tsai LTY, 2004, PLOS BIOL, V2, P2122, DOI 10.1371/journal.pbio.0020408; Visvader JE, 1997, P NATL ACAD SCI USA, V94, P13707, DOI 10.1073/pnas.94.25.13707; Wang N, 2007, ONCOGENE, V26, P6431, DOI 10.1038/sj.onc.1210465; Wellman CL, 2007, J NEUROSCI, V27, P684, DOI 10.1523/JNEUROSCI.4595-06.2007	47	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34559	10.1371/journal.pone.0034559	http://dx.doi.org/10.1371/journal.pone.0034559			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	952PZ	22509321	Green Published, Green Submitted, gold			2022-12-27	WOS:000304805900046
J	Adluri, RS; Thirunavukkarasu, M; Zhan, LJ; Dunna, NR; Akita, Y; Selvaraju, V; Otani, H; Sanchez, JA; Ho, YS; Maulik, N				Adluri, Ram Sudheer; Thirunavukkarasu, Mahesh; Zhan, Lijun; Dunna, Nageswara Rao; Akita, Yuzo; Selvaraju, Vaithinathan; Otani, Hajime; Sanchez, Juan A.; Ho, Ye-Shih; Maulik, Nilanjana			Glutaredoxin-1 Overexpression Enhances Neovascularization and Diminishes Ventricular Remodeling in Chronic Myocardial Infarction	PLOS ONE			English	Article							NF-KAPPA-B; S-GLUTATHIONYLATION; GENE-THERAPY; CARDIOMYOCYTE APOPTOSIS; OXIDATIVE STRESS; EXPRESSION; GROWTH; ANGIOPOIETIN-1; MICE; ANGIOGENESIS	Oxidative stress plays a critical role in the pathophysiology of cardiac failure, including the modulation of neovascularization following myocardial infarction (MI). Redox molecules thioredoxin (Trx) and glutaredoxin (Grx) superfamilies actively maintain intracellular thiol-redox homeostasis by scavenging reactive oxygen species. Among these two superfamilies, the pro-angiogenic function of Trx-1 has been reported in chronic MI model whereas similar role of Grx-1 remains uncertain. The present study attempts to establish the role of Grx-1 in neovascularization and ventricular remodeling following MI. Wild-type (WT) and Grx-1 transgenic (Grx-1(Tg/+)) mice were randomized into wild-type sham (WTS), Grx-1(Tg/+) Sham (Grx-1(Tg/+)S), WTMI,Grx-1(Tg/+)MI. MI was induced by permanent occlusion of the LAD coronary artery. Sham groups underwent identical time-matched surgical procedures without LAD ligation. Significant increase in arteriolar density was observed 7 days (d) after surgical intervention in the Grx-1(Tg/+)MI group as compared to the WTMI animals. Further, improvement in myocardial functional parameters 30 d after MI was observed including decreased LVIDs, LVIDd, increased ejection fraction and, fractional shortening was also observed in the Grx-1(Tg/+)MI group as compared to the WTMI animals. Moreover, attenuation of oxidative stress and apoptotic cardiomyocytes was observed in the Grx-1(Tg/+)MI group as compared to the WTMI animals. Increased expression of p-Akt, VEGF, Ang-1, Bcl-2, survivin and DNA binding activity of NF-kappa B were observed in the Grx-1(Tg/+)MI group when compared to WTMI animals as revealed by Western blot analysis and Gel-shift analysis, respectively. These results are the first to demonstrate that Grx-1 induces angiogenesis and diminishes ventricular remodeling apparently through neovascularization mediated by Akt, VEGF, Ang-1 and NF-kB as well as Bcl-2 and survivin-mediated anti-apoptotic pathway in the infarcted myocardium.	[Adluri, Ram Sudheer; Thirunavukkarasu, Mahesh; Zhan, Lijun; Dunna, Nageswara Rao; Akita, Yuzo; Selvaraju, Vaithinathan; Sanchez, Juan A.; Maulik, Nilanjana] Univ Connecticut, Ctr Hlth, Dept Surg, Mol Cardiol & Angiogenesis Lab, Farmington, CT USA; [Otani, Hajime] Kansai Med Univ, Dept Internal Med 2, Moriguchi, Osaka 570, Japan; [Ho, Ye-Shih] Wayne State Univ, Inst Environm Hlth Sci, Detroit, MI USA	University of Connecticut; Kansai Medical University; Wayne State University	Adluri, RS (corresponding author), Univ Connecticut, Ctr Hlth, Dept Surg, Mol Cardiol & Angiogenesis Lab, Farmington, CT USA.	nmaulik@neuron.uchc.edu	Vaithinathan, Selvaraju/D-4277-2013; sanchez, juan/GSD-8167-2022; Sanchez, Juan A./AAQ-1488-2020	Sanchez, Juan A./0000-0002-6789-3208	National Institutes of Health (NIH) [HL-85804, HL-69910]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085804, R01HL069910] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health (NIH) HL-85804 and HL-69910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adluri RS, 2011, J MOL CELL CARDIOL, V50, P239, DOI 10.1016/j.yjmcc.2010.11.002; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Chen JX, 2008, DIABETES, V57, P3335, DOI 10.2337/db08-0503; Condorelli G, 1999, CIRCULATION, V99, P3071, DOI 10.1161/01.CIR.99.23.3071; Currie MJ, 2001, CLIN CANCER RES, V7, P918; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4; Gallogly MM, 2009, ANTIOXID REDOX SIGN, V11, P1059, DOI [10.1089/ars.2008.2291, 10.1089/ARS.2008.2291]; Gallogly MM, 2010, ANTIOXID REDOX SIGN, V12, P1339, DOI 10.1089/ars.2009.2791; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Grunstein J, 2000, MOL CELL BIOL, V20, P7282, DOI 10.1128/MCB.20.19.7282-7291.2000; Hamada Y, 2007, NEPHROL DIAL TRANSPL, V22, P1547, DOI 10.1093/ndt/gfm099; Hirota K, 2000, BIOCHEM BIOPH RES CO, V274, P177, DOI 10.1006/bbrc.2000.3106; Ho YS, 2007, FREE RADICAL BIO MED, V43, P1299, DOI 10.1016/j.freeradbiomed.2007.07.025; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Jones WK, 2005, CARDIOVASC TOXICOL, V5, P183, DOI 10.1385/CT:5:2:183; Katare R, 2010, J MOL CELL CARDIOL; Kupatt C, 2010, J AM COLL CARDIOL, V56, P414, DOI 10.1016/j.jacc.2010.03.050; Lee Y, 2009, APOPTOSIS, V14, P536, DOI 10.1007/s10495-008-0302-x; Leri A, 1998, CIRCULATION, V97, P194, DOI 10.1161/01.CIR.97.2.194; Leri A, 1998, J CLIN INVEST, V101, P1326, DOI 10.1172/JCI316; Lima B, 2009, P NATL ACAD SCI USA, V106, P6297, DOI 10.1073/pnas.0901043106; Mani K, 2008, HEART FAIL REV, V13, P193, DOI 10.1007/s10741-007-9073-7; Maulik N, 2006, ANTIOXID REDOX SIGN, V8, P2161, DOI 10.1089/ars.2006.8.2161; Mieyal JJ, 2008, ANTIOXID REDOX SIGN, V10, P1941, DOI 10.1089/ars.2008.2089; Murata H, 2003, J BIOL CHEM, V278, P50226, DOI 10.1074/jbc.M310171200; Novotny NM, 2009, SHOCK, V31, P335, DOI 10.1097/SHK.0b013e3181862c63; Okuda M, 2001, ARTERIOSCL THROM VAS, V21, P1483, DOI 10.1161/hq0901.095550; Pan S, 2007, CIRC RES, V100, P213, DOI 10.1161/01.RES.0000256089.30318.20; Qanungo S, 2007, J BIOL CHEM, V282, P18427, DOI 10.1074/jbc.M610934200; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; Samuel SM, 2010, CIRCULATION, V121, P1244, DOI 10.1161/CIRCULATIONAHA.109.872481; Samuel SM, 2010, DIABETES, V59, P51, DOI 10.2337/db09-0336; Shelton MD, 2008, MOL CELLS, V25, P332; Singh VP, 2008, DIABETES, V57, P3297, DOI 10.2337/db08-0805; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468; Thirunavukkarasu M, 2008, CIRCULATION, V118; Vincent KA, 2002, TRENDS CARDIOVAS MED, V12, P362, DOI 10.1016/S1050-1738(02)00186-X; Yla-Herttuala S, 2009, BIOCHEM SOC T, V37, P1198, DOI 10.1042/BST0371198; Zhao WY, 2009, INT J EXP PATHOL, V90, P621, DOI 10.1111/j.1365-2613.2009.00682.x; Zidar N, 2007, ADV CLIN CHEM, V44, P1, DOI 10.1016/S0065-2423(07)44001-X	43	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34790	10.1371/journal.pone.0034790	http://dx.doi.org/10.1371/journal.pone.0034790			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523530	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000029
J	Xu, Z; Gao, XX; He, YH; Ju, JY; Zhang, MM; Liu, RH; Wu, YP; Ma, CY; Ma, C; Lin, ZY; Huang, XX; Zhao, Q				Xu, Zhen; Gao, Xinxing; He, Yinghong; Ju, Junyi; Zhang, Miaomiao; Liu, Ronghua; Wu, Yupeng; Ma, Chunyan; Ma, Chi; Lin, Zhaoyu; Huang, Xingxu; Zhao, Quan			Synergistic Effect of SRY and Its Direct Target, WDR5, on Sox9 Expression	PLOS ONE			English	Article							MAMMALIAN SEX DETERMINATION; GLOBIN GENE-EXPRESSION; NF-KAPPA-B; DNA-BINDING; HISTONE H3; LYSINE-4 METHYLATION; DETERMINING REGION; WD-40 PROTEIN; DIFFERENTIATION; ACTIVATION	SRY is a sex-determining gene that encodes a transcription factor, which triggers male development in most mammals. The molecular mechanism of SRY action in testis determination is, however, poorly understood. In this study, we demonstrate that WDR5, which encodes a WD-40 repeat protein, is a direct target of SRY. EMSA experiments and ChIP assays showed that SRY could bind to the WDR5 gene promoter directly. Overexpression of SRY in LNCaP cells significantly increased WDR5 expression concurrent with histone H3K4 methylation on the WDR5 promoter. To specifically address whether SRY contributes to WDR5 regulation, we introduced a 4-hydroxy-tamoxifen-inducible SRY allele into LNCaP cells. Conditional SRY expression triggered enrichment of SRY on the WDR5 promoter resulting in induction of WDR5 transcription. We found that WDR5 was self regulating through a positive feedback loop. WDR5 and SRY interacted and were colocalized in cells. In addition, the interaction of WDR5 with SRY resulted in activation of Sox9 while repressing the expression of beta-catenin. These results suggest that, in conjunction with SRY, WDR5 plays an important role in sex determination.	[Xu, Zhen; He, Yinghong; Ju, Junyi; Zhang, Miaomiao; Liu, Ronghua; Wu, Yupeng; Ma, Chunyan; Ma, Chi; Zhao, Quan] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Mol Immunol & Canc Res Ctr, Nanjing, Jiangsu, Peoples R China; [Gao, Xinxing; Lin, Zhaoyu; Huang, Xingxu] Nanjing Univ, Model Anim Res Ctr, Nanjing, Jiangsu, Peoples R China; [He, Yinghong] Dali Univ, Sch Basic Med, Yunnan, Peoples R China	Nanjing University; Nanjing University; Dali University	Xu, Z (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Mol Immunol & Canc Res Ctr, Nanjing, Jiangsu, Peoples R China.	qzhao@nju.edu.cn	Zhao, Quan/E-9147-2011	Zhao, Quan/0000-0002-8533-1938; huang, xingxu/0000-0001-8934-1247; ju, junyi/0000-0002-9141-2363; Lin, Zhaoyu/0000-0003-2095-7814	National Natural Science Foundation of China (NSFC) [31071118, 31170716, 81121062, SBK201140017, 81060248]; Fundamental Research Funds for the Central Universities; Doctoral Program of Higher Education of China RFDP [20090091110033]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Doctoral Program of Higher Education of China RFDP	This work was supported by National Natural Science Foundation of China (NSFC#31071118, NSFC#31170716, NSFC#81121062, SBK201140017(QZ), NSFC#81060248(YH), the Fundamental Research Funds for the Central Universities, and the Doctoral Program of Higher Education of China RFDP#20090091110033. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; Bhandari RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019935; Bowles J, 1999, NAT GENET, V22, P405, DOI 10.1038/11981; Bradford ST, 2009, BIOL REPROD, V80, P1178, DOI 10.1095/biolreprod.108.071480; Carvin CD, 2004, J BIOL CHEM, V279, P33057, DOI 10.1074/jbc.M405033200; Clement TM, 2011, BIOL REPROD; CONNER F, 1994, NUCLEIC ACIDS RES, V22, P3339, DOI 10.1093/nar/22.16.3339; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; DUBIN RA, 1994, MOL ENDOCRINOL, V8, P1182, DOI 10.1210/me.8.9.1182; FERRARI S, 1992, EMBO J, V11, P4497, DOI 10.1002/j.1460-2075.1992.tb05551.x; Gori F, 2001, J BIOL CHEM, V276, P46515, DOI 10.1074/jbc.M105757200; Gori F, 2006, DEV BIOL, V295, P498, DOI 10.1016/j.ydbio.2006.02.031; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Han ZF, 2006, MOL CELL, V22, P137, DOI 10.1016/j.molcel.2006.03.018; HARLEY VR, 1994, NUCLEIC ACIDS RES, V22, P1500, DOI 10.1093/nar/22.8.1500; Kashimada K, 2010, DEVELOPMENT, V137, P3921, DOI 10.1242/dev.048983; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; PONTIGGIA A, 1994, EMBO J, V13, P6115, DOI 10.1002/j.1460-2075.1994.tb06958.x; Rank G, 2010, BLOOD, V116, P1585, DOI 10.1182/blood-2009-10-251116; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Smale S. T., 2010, COLD SPRING HARB PRO, V2010; Taketo T, 2005, DEV DYNAM, V233, P612, DOI 10.1002/dvdy.20352; Trievel RC, 2009, NAT STRUCT MOL BIOL, V16, P678, DOI 10.1038/nsmb0709-678; Wang YY, 2010, P NATL ACAD SCI USA, V107, P815, DOI 10.1073/pnas.0908967107; Wilhelm D, 2005, DEV BIOL, V287, P111, DOI 10.1016/j.ydbio.2005.08.039; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yao YL, 1998, NUCLEIC ACIDS RES, V26, P3776, DOI 10.1093/nar/26.16.3776; Zelivianski S, 2004, NUCLEIC ACIDS RES, V32, P3566, DOI 10.1093/nar/gkh677; Zhao Q, 2006, BLOOD, V107, P2138, DOI 10.1182/blood-2005-06-2497; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	37	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34327	10.1371/journal.pone.0034327	http://dx.doi.org/10.1371/journal.pone.0034327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523547	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000017
J	Huynh, BT; Fievet, N; Briand, V; Borgella, S; Massougbodji, A; Deloron, P; Cot, M				Bich-Tram Huynh; Fievet, Nadine; Briand, Valerie; Borgella, Sophie; Massougbodji, Achille; Deloron, Philippe; Cot, Michel			Consequences of Gestational Malaria on Birth Weight: Finding the Best Timeframe for Intermittent Preventive Treatment Administration	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE; PREGNANT-WOMEN; PLACENTAL MALARIA; BENIN; EFFICACY; INFECTION; EPIDEMIOLOGY; CHLOROQUINE; RESISTANCE; MEFLOQUINE	To investigate the consequences of intermittent preventive treatment (IPTp) timing on birth weight, we pooled data from two studies conducted in Benin between 2005 and 2010: a prospective cohort of 1037 pregnant women and a randomised trial comparing sulfadoxine-pyrimethamine (SP) to mefloquine in 1601 women. A total of 1439 women (752 in the cohort and 687 in the SP arm of the randomised trial) who delivered live singletons were analysed. We showed that an early intake of the first SP dose (4 months of gestation) was associated with a lower risk of LBW compared to a late intake (6-7 months of gestation) (aOR = 0.5 p = 0.01). We also found a borderline increased risk of placental infection when the first SP dose was administered early in pregnancy (aOR = 1.7 p = 0.1). This study is the first to investigate the timing of SP administration during pregnancy. We clearly demonstrated that women who had an early intake of the first SP dose were less at risk of LBW compared to those who had a late intake. Pregnant women should be encouraged to attend antenatal visits early to get their first SP dose and a third dose of SP could be recommended to cover the whole duration of pregnancy and to avoid late infections of the placenta.	[Bich-Tram Huynh; Fievet, Nadine; Briand, Valerie; Borgella, Sophie; Deloron, Philippe; Cot, Michel] Inst Rech Dev, UMR216, Paris, France; [Bich-Tram Huynh; Fievet, Nadine; Briand, Valerie; Borgella, Sophie; Deloron, Philippe; Cot, Michel] Univ Paris 05, Paris, France; [Massougbodji, Achille] Fac Sci Sante, UER Parasitol, Cotonou, Benin	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Huynh, BT (corresponding author), Inst Rech Dev, UMR216, Paris, France.	bichtrambe@hotmail.com	Deloron, Philippe/G-6305-2010; Cot, Michel/E-7633-2011; Briand, Valerie/S-9398-2019	Deloron, Philippe/0000-0003-4705-2484; Cot, Michel/0000-0003-3014-4294; Briand, Valerie/0000-0001-7927-1855; Fievet, Nadine/0000-0003-2272-9794; Huynh, Bich-Tram/0000-0001-6340-9557	European 7th Framework Programme [200889]; ExxonMobil; GlaxoSmithKline foundation	European 7th Framework Programme(European Commission); ExxonMobil(Exxon Mobil Corporation); GlaxoSmithKline foundation(GlaxoSmithKline)	This paper describes work undertaken in the context of the STOPPAM project, "Strategies To Prevent Pregnancy Associated Malaria'' (www.stoppam.org). STOPPAM is a Small & Medium Scale Collaborative Project supported by the European 7th Framework Programme, contract number: 200889. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by ExxonMobil and the GlaxoSmithKline foundation [research student grant (PhD) to BTH]. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	[Anonymous], 2004, STRATEGIC FRAMEWORK; Aubouy A, 2007, TROP MED INT HEALTH, V12, P886, DOI 10.1111/j.1365-3156.2007.01859.x; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Bertin G, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-196; Huynh BT, 2011, AM J TROP MED HYG, V85, P214, DOI 10.4269/ajtmh.2011.11-0103; Huynh BT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-72; Briand V, 2008, J INFECT DIS, V198, P594, DOI 10.1086/590114; Briand V, 2009, J INFECT DIS, V200, P991, DOI 10.1086/605474; Cottrell G, 2007, AM J TROP MED HYG, V76, P849, DOI 10.4269/ajtmh.2007.76.849; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Falade CO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-88; Filler SJ, 2006, J INFECT DIS, V194, P286, DOI 10.1086/505080; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Harrington WE, 2009, P NATL ACAD SCI USA, V106, P9027, DOI 10.1073/pnas.0901415106; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hommerich L, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-144; Kayentao K, 2005, J INFECT DIS, V191, P109, DOI 10.1086/426400; Le Port A, 2011, AM J TROP MED HYG, V84, P270, DOI 10.4269/ajtmh.2011.10-0319; Maiga OM, CLIN INFECT DIS, V53, P215; Parise ME, 1998, AM J TROP MED HYG, V59, P813, DOI 10.4269/ajtmh.1998.59.813; Rijken MJ, 2011, BJOG-INT J OBSTET GY, V118, P671, DOI 10.1111/j.1471-0528.2010.02880.x; Sirima SB, 2006, AM J TROP MED HYG, V75, P205, DOI 10.4269/ajtmh.2006.75.205; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P351, DOI 10.1111/j.1365-3156.2004.01196.x; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; World Health Organization, 2007, REP TECHN EXP GOUP M	27	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35342	10.1371/journal.pone.0035342	http://dx.doi.org/10.1371/journal.pone.0035342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514730	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600135
J	Broms, JE; Meyer, L; Lavander, M; Larsson, P; Sjostedt, A				Broms, Jeanette E.; Meyer, Lena; Lavander, Moa; Larsson, Par; Sjostedt, Anders			DotU and VgrG, Core Components of Type VI Secretion Systems, Are Essential for Francisella LVS Pathogenicity	PLOS ONE			English	Article							PROTEIN SECRETION; GENE-EXPRESSION; VIRULENCE DETERMINANTS; VIBRIO-CHOLERAE; TULARENSIS LVS; ISLAND; IDENTIFICATION; ICMF; ESCAPE; STRAIN	The Gram-negative bacterium Francisella tularensis causes tularemia, a disease which requires bacterial escape from phagosomes of infected macrophages. Once in the cytosol, the bacterium rapidly multiplies, inhibits activation of the inflammasome and ultimately causes death of the host cell. Of importance for these processes is a 33-kb gene cluster, the Francisella pathogenicity island (FPI), which is believed to encode a type VI secretion system (T6SS). In this study, we analyzed the role of the FPI-encoded proteins VgrG and DotU, which are conserved components of type VI secretion (T6S) clusters. We demonstrate that in F. tularensis LVS, VgrG was shown to form multimers, consistent with its suggested role as a trimeric membrane puncturing device in T6SSs, while the inner membrane protein DotU was shown to stabilize PdpB/IcmF, another T6SS core component. Upon infection of J774 cells, both Delta vgrG and Delta dotU mutants did not escape from phagosomes, and subsequently, did not multiply or cause cytopathogenicity. They also showed impaired activation of the inflammasome and marked attenuation in the mouse model. Moreover, all of the DotU-dependent functions investigated here required the presence of three residues that are essentially conserved among all DotU homologues. Thus, in agreement with a core function in T6S clusters, VgrG and DotU play key roles for modulation of the intracellular host response as well as for the virulence of F. tularensis.	[Broms, Jeanette E.; Meyer, Lena; Lavander, Moa; Sjostedt, Anders] Umea Univ, Dept Clin Microbiol, Umea, Sweden; [Broms, Jeanette E.; Meyer, Lena; Lavander, Moa; Sjostedt, Anders] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden; [Larsson, Par] Swedish Def Res Agcy, Div CBRN Def & Secur, Umea, Sweden	Umea University; Umea University; Saab Group	Broms, JE (corresponding author), Umea Univ, Dept Clin Microbiol, Umea, Sweden.	jeanette.broms@climi.umu.se	Sjöstedt, Anders/AAC-6575-2020	Sjöstedt, Anders/0000-0002-0768-8405	Swedish Research Council [2006-3426, 2006-2877, 2009-5026]; Medical Faculty, Umea University, Umea, Sweden; Swedish Ministry of Foreign Affairs (FOI project) [A4952]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty, Umea University, Umea, Sweden; Swedish Ministry of Foreign Affairs (FOI project)	This work was supported by grants 2006-3426,2006-2877 and 2009-5026 from the Swedish Research Council (www.vr.se) and a grant from the Medical Faculty, Umea University, Umea, Sweden and the Swedish Ministry of Foreign Affairs (FOI project no. A4952) (www.sweden.gov.se/foreign). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Aubert D, 2010, J BIOL CHEM, V285, P35988, DOI 10.1074/jbc.M110.120402; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Bingle LEH, 2008, CURR OPIN MICROBIOL, V11, P3, DOI 10.1016/j.mib.2008.01.006; Blondel CJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-354; Bonemann G, 2010, MOL MICROBIOL, V76, P815, DOI 10.1111/j.1365-2958.2010.07171.x; Bonemann G, 2009, EMBO J, V28, P315, DOI 10.1038/emboj.2008.269; Bonquist L, 2008, INFECT IMMUN, V76, P3502, DOI 10.1128/IAI.00226-08; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Broms JE, 2011, INFECT IMMUN, V79, P3683, DOI 10.1128/IAI.01344-10; Broms JE, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00136; Broms JE, 2009, J BACTERIOL, V191, P2431, DOI 10.1128/JB.01759-08; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Charity JC, 2007, PLOS PATHOG, V3, P770, DOI 10.1371/journal.ppat.0030084; Chase JC, 2009, INFECT IMMUN, V77, P180, DOI 10.1128/IAI.00879-08; Chong A, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00138; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Das Soumita, 2003, In Silico Biology, V3, P287; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; de Bruin OM, 2011, MICROBIOL-SGM, V157, P3483, DOI 10.1099/mic.0.052308-0; DEMOT R, 1994, MOL MICROBIOL, V12, P333; Dove Simon L, 2004, Methods Mol Biol, V261, P231; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Filloux A, 2009, EMBO J, V28, P309, DOI 10.1038/emboj.2008.301; Forslund AL, 2006, MOL MICROBIOL, V59, P1818, DOI 10.1111/j.1365-2958.2006.05061.x; Francis MS, 2000, MOL MICROBIOL, V38, P85, DOI 10.1046/j.1365-2958.2000.02112.x; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; Gil H, 2006, P NATL ACAD SCI USA, V103, P12897, DOI 10.1073/pnas.0602582103; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Horton MR, 1991, DIRECTED MUTAGENESIS, P217; Horzempa J, 2010, INFECT IMMUN, V78, P2607, DOI 10.1128/IAI.00134-10; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lai XH, 2001, INFECT IMMUN, V69, P4691, DOI 10.1128/IAI.69.7.4691-4694.2001; Lindgren H, 2005, MICROBES INFECT, V7, P467, DOI 10.1016/j.micinf.2004.11.020; Lindgren H, 2004, J MED MICROBIOL, V53, P953, DOI 10.1099/jmm.0.45685-0; Liu YC, 2010, BIOINFORMATICS, V26, P1958, DOI 10.1093/bioinformatics/btq338; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Ma LS, 2009, J BACTERIOL, V191, P4316, DOI 10.1128/JB.00029-09; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Mishima M, 2005, BIOCHEMISTRY-US, V44, P10153, DOI 10.1021/bi050624n; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Pukatzki S, 2007, P NATL ACAD SCI USA, V104, P15508, DOI 10.1073/pnas.0706532104; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Saier MH, 2006, J MEMBRANE BIOL, V214, P75, DOI 10.1007/s00232-006-0049-7; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schell MA, 2007, MOL MICROBIOL, V64, P1466, DOI 10.1111/j.1365-2958.2007.05734.x; Sexton JA, 2004, INFECT IMMUN, V72, P5983, DOI 10.1128/IAI.72.10.5983-5992.2004; Shrivastava S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002955; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Suarez G, 2010, J BACTERIOL, V192, P155, DOI 10.1128/JB.01260-09; Suarez G, 2008, MICROB PATHOGENESIS, V44, P344, DOI 10.1016/j.micpath.2007.10.005; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TARNVIK A, 1989, REV INFECT DIS, V11, P440; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Twine S, 2005, INFECT IMMUN, V73, P8345, DOI 10.1128/IAI.73.12.8345-8352.2005; Vallet-Gely I, 2005, P NATL ACAD SCI USA, V102, P11082, DOI 10.1073/pnas.0502663102; VanRheenen SM, 2004, INFECT IMMUN, V72, P5972, DOI 10.1128/IAI.72.10.5972-5982.2004; Vincent CD, 2006, MOL MICROBIOL, V62, P1278, DOI 10.1111/j.1365-2958.2006.05446.x; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zheng J, 2007, MOL MICROBIOL, V66, P1192, DOI 10.1111/j.1365-2958.2007.05993.x; Zusman T, 2004, INFECT IMMUN, V72, P3398, DOI 10.1128/IAI.72.6.3398-3409.2004	83	56	58	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34639	10.1371/journal.pone.0034639	http://dx.doi.org/10.1371/journal.pone.0034639			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514651	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600057
J	Delaney, DG; Johnson, R; Bester, MN; Gennari, E				Delaney, David G.; Johnson, Ryan; Bester, Marthan N.; Gennari, Enrico			Accuracy of Using Visual Identification of White Sharks to Estimate Residency Patterns	PLOS ONE			English	Article							WHALES MEGAPTERA-NOVAEANGLIAE; CARCHARODON-CARCHARIAS; RHINCODON-TYPUS; NATURAL MARKS; SOUTH-AFRICA; POPULATION; COAST; RECOGNITION; RECAPTURE; MIGRATION	Determining the residency of an aquatic species is important but challenging and it remains unclear what is the best sampling methodology. Photo-identification has been used extensively to estimate patterns of animals' residency and is arguably the most common approach, but it may not be the most effective approach in marine environments. To examine this, in 2005, we deployed acoustic transmitters on 22 white sharks (Carcharodon carcharias) in Mossel Bay, South Africa to quantify the probability of detecting these tagged sharks by photo-identification and different deployment strategies of acoustic telemetry equipment. Using the data collected by the different sampling approaches (detections from an acoustic listening station deployed under a chumming vessel versus those from visual sightings and photo-identification), we quantified the methodologies' probability of detection and determined if the sampling approaches, also including an acoustic telemetry array, produce comparable results for patterns of residency. Photo-identification had the lowest probability of detection and underestimated residency. The underestimation is driven by various factors primarily that acoustic telemetry monitors a large area and this reduces the occurrence of false negatives. Therefore, we propose that researchers need to use acoustic telemetry and also continue to develop new sampling approaches as photo-identification techniques are inadequate to determine residency. Using the methods presented in this paper will allow researchers to further refine sampling approaches that enable them to collect more accurate data that will result in better research and more informed management efforts and policy decisions.	[Delaney, David G.; Johnson, Ryan; Gennari, Enrico] Oceans Res, Mossel Bay, South Africa; [Delaney, David G.; Johnson, Ryan; Bester, Marthan N.] Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Gennari, Enrico] S African Inst Aquat Biodivers, Grahamstown, South Africa	University of Pretoria; National Research Foundation - South Africa; South African Institute for Aquatic Biodiversity	Delaney, DG (corresponding author), Oceans Res, Mossel Bay, South Africa.	DGDelaney@gmail.com	Bester, Marthán N/E-5387-2010	Gennari, Enrico/0000-0002-4334-727X	World Wildlife Fund South Africa; South African Department of Environmental Affairs (and Tourism); International Fund for Animal Welfare	World Wildlife Fund South Africa; South African Department of Environmental Affairs (and Tourism); International Fund for Animal Welfare	This study was funded in-part by World Wildlife Fund South Africa, the South African Department of Environmental Affairs (and Tourism), and the International Fund for Animal Welfare. Also a vessel was provided by Andre Hartman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SD, 2011, MAR BIOL, V158, P1233, DOI 10.1007/s00227-011-1643-5; Arzoumanian Z, 2005, J APPL ECOL, V42, P999, DOI 10.1111/j.1365-2664.2005.01117.x; Bansemer CS, 2008, MAR FRESHWATER RES, V59, P1; Barrowman NJ, 1996, BIOMETRICS, V52, P1410, DOI 10.2307/2532854; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bradshaw CJA, 2007, J ANIM ECOL, V76, P480, DOI 10.1111/j.1365-2656.2006.01201.x; Bruce B. D, 2005, SITE FIDELITY RESIDE; Calambokidis J, 2004, FISH B-NOAA, V102, P563; Castro ALF, 2005, ENVIRON BIOL FISH, V72, P213, DOI 10.1007/s10641-004-1479-7; Chapple TK, 2011, BIOL LETTERS, V7, P581, DOI 10.1098/rsbl.2011.0124; Coakes A, 2005, MAR MAMMAL SCI, V21, P323, DOI 10.1111/j.1748-7692.2005.tb01232.x; Cortes E, 2002, CONSERV BIOL, V16, P1048, DOI 10.1046/j.1523-1739.2002.00423.x; Davis TM, 2001, J HERPETOL, V35, P217, DOI 10.2307/1566111; Delaney DG, 2010, ECOL APPL, V20, P1162, DOI 10.1890/09-0309.1; Dicken ML, 2006, ICES J MAR SCI, V63, P1640, DOI 10.1016/j.icesjms.2006.06.009; Domeier ML, 2007, MAR BIOL, V150, P977, DOI 10.1007/s00227-006-0380-7; Feldheim KA, 2002, J FISH BIOL, V61, P1309, DOI 10.1006/jfbi.2002.2139; Fergusson I, 2005, IUCN 2011 VERSION 20; Ferreira CA, 1996, GREAT WHITE SHARKS, P381, DOI 10.1016/B978-012415031-7/50036-7; Forbes VE, 2010, ECOL APPL, V20, P1449, DOI 10.1890/09-1063.1; Gamble L, 2008, J APPL ECOL, V45, P170, DOI 10.1111/j.1365-2664.2007.01368.x; Gilkinson AK, 2007, J WILDLIFE MANAGE, V71, P2045, DOI 10.2193/2006-410; Gubili C, 2009, MAR BIOL, V156, P2199, DOI 10.1007/s00227-009-1233-y; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Hillman G.R., 2003, Aquatic Mammals, V29, P117, DOI 10.1578/016754203101023960; Johnson R, 2009, ENVIRON BIOL FISH, V85, P189, DOI 10.1007/s10641-009-9477-4; Karczmarski Leszek, 1998, Aquatic Mammals, V24, P143; Klimley PA, 1996, GREAT WHITE SHARKS; Kock A., 2006, WWF S AFRICA REPORT, P1; Kohler NE, 2001, ENVIRON BIOL FISH, V60, P191, DOI 10.1023/A:1007679303082; Laroche RK, 2007, MAR ECOL PROG SER, V338, P199, DOI 10.3354/meps338199; Marshall AD, 2011, MAR BIOL, V158, P1111, DOI 10.1007/s00227-011-1634-6; Marshall AD, 2012, J FISH BIOL IN PRESS; MINTA S, 1989, ECOLOGY, V70, P1738, DOI 10.2307/1938108; Mizroch SA, 2004, J MAMMAL, V85, P963, DOI 10.1644/BOS-123; Pierce SJ, 2009, J FISH BIOL, V74, P1291, DOI 10.1111/j.1095-8649.2009.02202.x; Rowat D, 2007, ENVIRON BIOL FISH, V80, P465, DOI 10.1007/s10641-006-9148-7; Strong WR, 1996, GREAT WHITE SHARKS, P401, DOI 10.1016/B978-012415031-7/50038-0; Van Tienhoven AM, 2007, J APPL ECOL, V44, P273, DOI 10.1111/j.1365-2664.2006.01273.x; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Wilson B, 1999, ECOL APPL, V9, P288, DOI 10.1890/1051-0761(1999)009[0288:ESAATI]2.0.CO;2	41	13	13	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34753	10.1371/journal.pone.0034753	http://dx.doi.org/10.1371/journal.pone.0034753			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514662	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600068
J	Evans, PD; McIntyre, NJ; Fluck, RJ; McIntyre, CW; Taal, MW				Evans, Philip D.; McIntyre, Natasha J.; Fluck, Richard J.; McIntyre, Christopher W.; Taal, Maarten W.			Anthropomorphic Measurements That Include Central Fat Distribution Are More Closely Related with Key Risk Factors than BMI in CKD Stage 3	PLOS ONE			English	Article							BODY-MASS INDEX; ALL-CAUSE MORTALITY; ARTERIAL STIFFNESS; KIDNEY-DISEASE; URIC-ACID; CARDIOVASCULAR EVENTS; WAIST CIRCUMFERENCE; WEIGHT-GAIN; OBESITY; ASSOCIATION	Background: Body Mass Index (BMI) as a marker of obesity is an established risk factor for chronic kidney disease (CKD) and cardiovascular disease (CVD). However, BMI can overestimate obesity. Anthropomorphic measurements that include central fat deposition are emerging as a more important risk factor. We studied BMI, waist circumference (WC), waist-to-height ratio (WHtR), waist-to-hip ratio (WHR) and conicity index (CI) in a cohort of patients with CKD stage 3 and compared the associations with other known risk factors for CKD progression and CVD. Methods: 1740 patients with CKD stage 3 were recruited from primary care for the Renal Risk in Derby study. Each participant underwent clinical assessment, including anthropomorphic measurements and pulse wave velocity (PWV), as well as urine and serum biochemistry tests. Results: The mean age of the cohort was 72.9 +/- 9 years with 60% females. The mean eGFR was 52.5 +/- 10.4 ml/min/1.73 m(2) and 16.9% of the cohort had diabetes. With the cohort divided into normal and increased risk of morbidity and mortality using each anthropomorphic measurement, those measurements that included increased central fat distribution were significantly associated with more risk factors for CKD progression and CVD than increased BMI. Univariable analysis demonstrated central fat distribution was correlated with more risk factors than BMI. Subgroup analyses using recognised BMI cut-offs to define obesity and quartiles of WHR and CI demonstrated that increasing central fat distribution was significantly associated with more CKD and CVD risk factors than increasing BMI. Conclusion: Anthropomorphic measurements that include a measure of central fat deposition are related to more key risk factors in CKD stage 3 patients than BMI. Central fat deposition may be of greater importance as a risk factor in CKD than BMI and reliance on BMI alone may therefore underestimate the associated risk.	[Evans, Philip D.; McIntyre, Natasha J.; Fluck, Richard J.; McIntyre, Christopher W.; Taal, Maarten W.] Royal Derby Hosp, Dept Renal Med, Derby, England; [McIntyre, Christopher W.] Univ Nottingham, Dept Vasc Med, Derby, England	University of Nottingham; University of Nottingham	Evans, PD (corresponding author), Royal Derby Hosp, Dept Renal Med, Derby, England.	maarten.taal@derbyhospitals.nhs.uk	McIntyre, Christopher W/O-8927-2014; Stefanadis, Christodoulos/ABH-2232-2020	Taal, Maarten/0000-0002-9065-212X; Stefanadis, Christodoulos/0000-0001-5974-6454	Kidney Research UK; British Renal Society; Roche Products plc.	Kidney Research UK(Kidney Research UK (KRUK)); British Renal Society; Roche Products plc.	This study was supported by a research fellowship grant from Kidney Research UK and the British Renal Society awarded to NJM, as well as an unrestricted educational grant from Roche Products plc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Ashwell M, 1996, BRIT MED J, V313, P559; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chue CD, 2010, HEART, V96, P817, DOI 10.1136/hrt.2009.184879; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Cordeiro AC, 2010, NEPHROL DIAL TRANSPL, V25, P562, DOI 10.1093/ndt/gfp492; de Lusignan S, 2011, NEPHRON CLIN PRACT, V117, pC213, DOI 10.1159/000320341; Ejerblad E, 2006, J AM SOC NEPHROL, V17, P1695, DOI 10.1681/ASN.2005060638; Elsayed EF, 2008, AM J KIDNEY DIS, V52, P29, DOI 10.1053/j.ajkd.2008.02.363; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Gagliardi ACM, 2009, ATHEROSCLEROSIS, V202, P11, DOI 10.1016/j.atherosclerosis.2008.05.022; Gelber RP, 2008, J AM COLL CARDIOL, V52, P605, DOI 10.1016/j.jacc.2008.03.066; Halbesma N, 2006, J AM SOC NEPHROL, V17, P2582, DOI 10.1681/ASN.2005121352; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Kabon B, 2004, ANESTHESIOLOGY, V100, P274, DOI 10.1097/00000542-200402000-00015; Kramer H, 2011, AM J KIDNEY DIS, V58, P177, DOI 10.1053/j.ajkd.2011.02.390; Madero M, 2009, AM J KIDNEY DIS, V53, P796, DOI 10.1053/j.ajkd.2008.12.021; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; McIntyre NJ, 2011, NEPHRON CLIN PRACT, V119, pC269, DOI 10.1159/000329109; McIntyre NJ, 2011, CLIN J AM SOC NEPHRO, V6, P2356, DOI 10.2215/CJN.02420311; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; NHS Information Centre, 2011, STAT OB PHYS ACT DIE; Okura T, 2009, CIRC J, V73, P885, DOI 10.1253/circj.CJ-08-0828; Organization WH, 2011, WAIST CIRCUMFERENCE; Orr JS, 2008, HYPERTENSION, V51, P1519, DOI 10.1161/HYPERTENSIONAHA.108.112946; Pinto-Sietsma SJ, 2003, AM J KIDNEY DIS, V41, P733, DOI 10.1016/S0272-6386(03)00020-9; Postorino M, 2009, J AM COLL CARDIOL, V53, P1265, DOI 10.1016/j.jacc.2008.12.040; Rao MK, 2009, CHRON KIDN DIS EARL, V75, P571; Safar ME, 2002, HYPERTENSION, V39, P735, DOI 10.1161/hy0202.098325; Safar ME, 2004, HYPERTENSION, V43, P163, DOI 10.1161/01.HYP.0000114571.75762.b0; Safar ME, 2006, J AM SOC NEPHROL, V17, pS109, DOI 10.1681/ASN.2005121321; Salahudeen AK, 2003, AM J KIDNEY DIS, V41, P925, DOI 10.1016/S0272-6386(03)00189-6; Short RA, 2005, SEMIN NEPHROL, V25, P25, DOI 10.1016/j.semnephrol.2004.09.005; Srikanthan P, 2009, ANN EPIDEMIOL, V19, P724, DOI 10.1016/j.annepidem.2009.05.003; Toto RD, 2010, AM J KIDNEY DIS, V56, P896, DOI 10.1053/j.ajkd.2010.05.016; Trayhurn Paul, 2008, Archives of Physiology and Biochemistry, V114, P267, DOI [10.1080/13813450802306602, 10.1080/13813450802306602 ]; Upadhyay A, 2009, J AM SOC NEPHROL, V20, P2044, DOI 10.1681/ASN.2009010074; VALDEZ R, 1993, INT J OBESITY, V17, P77; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wahba IM, 2007, CLIN J AM SOC NEPHRO, V2, P550, DOI 10.2215/CJN.04071206; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Wood IS, 2009, P NUTR SOC, V68, P370, DOI 10.1017/S0029665109990206; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Wright M, 2011, NEPHRON CLIN PRACT, V118, pC153, DOI 10.1159/000328067	49	48	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34699	10.1371/journal.pone.0034699	http://dx.doi.org/10.1371/journal.pone.0034699			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511960	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338600046
J	Kluk, MJ; Chapuy, B; Sinha, P; Roy, A; Dal Cin, P; Neuberg, DS; Monti, S; Pinkus, GS; Shipp, MA; Rodig, SJ				Kluk, Michael J.; Chapuy, Bjoern; Sinha, Papiya; Roy, Alyssa; Dal Cin, Paola; Neuberg, Donna S.; Monti, Stefano; Pinkus, Geraldine S.; Shipp, Margaret A.; Rodig, Scott J.			Immunohistochemical Detection of MYC-driven Diffuse Large B-Cell Lymphomas	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; BURKITTS-LYMPHOMA; RITUXIMAB; GENE; TRANSLOCATION; PROGNOSIS; THERAPY; CHOP	Diffuse large B cell lymphoma (DLBCL) is a clinically and genetically heterogeneous disease. A small subset of DLBCLs has translocations involving the MYC locus and an additional group has a molecular signature resembling Burkitt lymphoma (mBL). Presently, identification of such cases by morphology is unreliable and relies on cytogenetic or complex molecular methods such as gene transcriptional profiling. Herein, we describe an immunohistochemical (IHC) method for identifying DLBCLs with increased MYC protein expression. We tested 77 cases of DLBCL and identified 15 cases with high MYC protein expression (nuclear staining in >50% of tumor cells). All MYC translocation positive cases had increased MYC protein expression by this IHC assay. In addition, gene set enrichment analysis (GSEA) of the DLBCL transcriptional profiles revealed that tumors with increased MYC protein expression (regardless of underlying MYC translocation status) had coordinate upregulation of MYC target genes, providing molecular confirmation of the IHC results. We then generated a molecular classifier derived from the MYC IHC results in our cases and employed it to successfully classify mBLs from two previously reported independent case series, providing additional confirmation that the MYC IHC results identify clinically important subsets of DLBCLs. Lastly, we found that DLBCLs with high MYC protein expression had inferior overall survival when treated with R-CHOP. In conclusion, the IHC method described herein can be used to readily identify the biologically and clinically distinct cases of MYC-driven DLBCL, which represent a clinically significant subset of DLBCL cases due to their inferior overall survival.	[Kluk, Michael J.; Sinha, Papiya; Roy, Alyssa; Dal Cin, Paola; Pinkus, Geraldine S.; Rodig, Scott J.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Chapuy, Bjoern; Shipp, Margaret A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Neuberg, Donna S.] Dana Farber Canc Inst, Dept Biostat, Boston, MA 02115 USA; [Monti, Stefano] Boston Univ, Div Computat Biomed, Boston, MA 02215 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Boston University	Kluk, MJ (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	srodig@partners.org	Rodig, Scott/Y-3889-2019; Pillay, Nischalan/F-9536-2012	Monti, Stefano/0000-0002-9376-0660	NIH [PO1CA092625]; Lymphoma Target Testing Center of the Dana-Farber Cancer Institute; Stanley L. Robbins Memorial Research Fund Award; NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Target Testing Center of the Dana-Farber Cancer Institute; Stanley L. Robbins Memorial Research Fund Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by NIH PO1CA092625, the Lymphoma Target Testing Center of the Dana-Farber Cancer Institute and the Stanley L. Robbins Memorial Research Fund Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrans S, 2010, J CLIN ONCOL, V28, P3360, DOI 10.1200/JCO.2009.26.3947; Bonnet M, 2011, BLOOD, V117, P6650, DOI 10.1182/blood-2011-02-336842; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Habermann TM, 2006, J CLIN ONCOL, V24, P3121, DOI 10.1200/JCO.2005.05.1003; Hecht JL, 2000, J CLIN ONCOL, V18, P3707, DOI 10.1200/JCO.2000.18.21.3707; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; MAGRATH IT, 1984, BLOOD, V63, P1102; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mino-Kenudson M, 2010, CLIN CANCER RES, V16, P1561, DOI 10.1158/1078-0432.CCR-09-2845; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Obermann EC, 2009, J CLIN PATHOL, V62, P754, DOI 10.1136/jcp.2009.065227; Ruzinova MB, 2010, AM J SURG PATHOL, V34, P882, DOI 10.1097/PAS.0b013e3181db83af; Salles G, 2011, BLOOD, V117, P7070, DOI 10.1182/blood-2011-04-345256; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Sehn LH, 2005, J CLIN ONCOL, V23, P5027, DOI 10.1200/JCO.2005.09.137; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Swerdlow SH, 2008, WHO CLASSIFICATION T, V22008, P439; Tubbs RR, 2010, USCAP ANN M 2010; Zhang HW, 2011, HEMATOL ONCOL, V29, P185, DOI 10.1002/hon.991	20	118	124	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e33813	10.1371/journal.pone.0033813	http://dx.doi.org/10.1371/journal.pone.0033813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511926	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338600012
J	Liu, ZY; Wang, ZL; Yan, WY; Wu, XB; Zeng, ZJ; Huang, ZY				Liu, Zhi Yong; Wang, Zi Long; Yan, Wei Yu; Wu, Xiao Bo; Zeng, Zhi Jiang; Huang, Zachary Y.			The Sex Determination Gene Shows No Founder Effect in the Giant Honey Bee, Apis dorsata	PLOS ONE			English	Article							SOFTWARE PACKAGE; POPULATION; POLYANDRY; EVOLUTION; SELECTION	Background: All honey bee species (Apis spp) share the same sex determination mechanism using the complementary sex determination (csd) gene. Only individuals heterogeneous at the csd allele develop into females, and the homozygous develop into diploid males, which do not survive. The honeybees are therefore under selection pressure to generate new csd alleles. Previous studies have shown that the csd gene is under balancing selection. We hypothesize that due to the long separation from the mainland of Hainan Island, China, that the giant honey bees (Apis dorsata) should show a founder effect for the csd gene, with many different alleles clustered together, and these would be absent on the mainland. Methodology/Principal Findings: We sampled A. dorsata workers from both Hainan and Guangxi Provinces and then cloned and sequenced region 3 of the csd gene and constructed phylogenetic trees. We failed to find any clustering of the csd alleles according to their geographical origin, i.e. the Hainan and Guangxi samples did not form separate clades. Further analysis by including previously published csd sequences also failed to show any clade-forming in both the Philippines and Malaysia. Conclusions/Significance: Results from this study and those from previous studies did not support the expectations of a founder effect. We conclude that because of the extremely high mating frequency of A. dorsata queens, a founder effect does not apply in this species.	[Liu, Zhi Yong; Wang, Zi Long; Yan, Wei Yu; Wu, Xiao Bo; Zeng, Zhi Jiang] Jiangxi Agr Univ, Honeybee Res Inst, Nanchang, Peoples R China; [Liu, Zhi Yong] Ctr Expt Anim, Inst Occupat Dis Prevent, Nanchang, Peoples R China; [Huang, Zachary Y.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Huang, Zachary Y.] Michigan State Univ, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA	Jiangxi Agricultural University; Michigan State University; Michigan State University	Liu, ZY (corresponding author), Jiangxi Agr Univ, Honeybee Res Inst, Nanchang, Peoples R China.	bees1965@sina.com; bees@msu.edu	Wang, Zhiquan/HHS-6768-2022; Huang, Zachary/D-5485-2011	Huang, Zachary/0000-0001-5354-5547	China Agriculture Research System [CARS-45]; National Natural Science Foundation of China [31060327]; China Postdoctoral Science Foundation [20100481191]; Michigan Agricultural Experiment Station at Michigan State University	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Michigan Agricultural Experiment Station at Michigan State University	This work was supported by China Agriculture Research System (No. CARS-45), the National Natural Science Foundation of China (No. 31060327), the China Postdoctoral Science Foundation (20100481191) and Michigan Agricultural Experiment Station at the Michigan State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beye M, 2003, CELL, V114, P419, DOI 10.1016/S0092-8674(03)00606-8; Burland T G, 2000, Methods Mol Biol, V132, P71; Charlesworth D, 2004, CURR BIOL, V14, pR568, DOI 10.1016/j.cub.2004.07.014; Cho SC, 2006, GENOME RES, V16, P1366, DOI 10.1101/gr.4695306; COOK JM, 1993, HEREDITY, V71, P421, DOI 10.1038/hdy.1993.157; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Hartl Daniel L., 1997; Hasselmann M, 2004, P NATL ACAD SCI USA, V101, P4888, DOI 10.1073/pnas.0307147101; Hasselmann M, 2008, MOL BIOL EVOL, V25, P696, DOI 10.1093/molbev/msn011; Hasselmann M, 2006, GENETICS, V174, P1469, DOI 10.1534/genetics.106.062018; Heimpel GE, 2008, ANNU REV ENTOMOL, V53, P209, DOI 10.1146/annurev.ento.53.103106.093441; Huang F., 2002, FOREST INSECTS HAINA; Jensen AB, 2005, CONSERV GENET, V6, P527, DOI 10.1007/s10592-005-9007-7; KOENIGER N, 1994, APIDOLOGIE, V25, P249, DOI 10.1051/apido:19940211; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MORITZ RFA, 1995, BEHAV ECOL SOCIOBIOL, V37, P357, DOI 10.1007/BF00174141; Oldroyd BP, 1996, ANN ENTOMOL SOC AM, V89, P276, DOI 10.1093/aesa/89.2.276; Provine WB, 2004, GENETICS, V167, P1041; ROSS KG, 1993, GENETICS, V135, P843; Segura JAL, 2000, GENET MOL BIOL, V23, P317; Soulier-Perkins A, 2000, PALAEOGEOGR PALAEOCL, V160, P239, DOI 10.1016/S0031-0182(00)00071-7; South China Sea Institute of Oceanology, 1978, QUAT LITT GEOL S CHI, P15; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wattanachaiyingcharoen W, 2003, APIDOLOGIE, V34, P85, DOI 10.1051/apido:2002044; Woyke J., 1963, Journal of Apicultural Research London, V2, P73; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371	29	4	4	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34436	10.1371/journal.pone.0034436	http://dx.doi.org/10.1371/journal.pone.0034436			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511940	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600026
J	Valle-Leija, P; Blanco-Hernandez, E; Drucker-Colin, R; Gutierrez-Ospina, G; Vidaltamayo, R				Valle-Leija, Pablo; Blanco-Hernandez, Eduardo; Drucker-Colin, Rene; Gutierrez-Ospina, Gabriel; Vidaltamayo, Roman			Supernumerary Formation of Olfactory Glomeruli Induced by Chronic Odorant Exposure: A Constructivist Expression of Neural Plasticity	PLOS ONE			English	Article							OCULAR DOMINANCE; RECEPTOR EXPRESSION; VISUAL DEPRIVATION; SENSORY MAP; IN-VIVO; MOUSE; BULB; EXPERIENCE; REFINEMENT; PROJECTIONS	It is accepted that sensory experience instructs the remodelling of neuronal circuits during postnatal development, after their specification has occurred. The story is less clear with regard to the role of experience during the initial formation of neuronal circuits, whether prenatal or postnatal, since this process is now supposed to be primarily influenced by genetic determinants and spontaneous neuronal firing. Here we evaluated this last issue by examining the effect that postnatal chronic exposure to cognate odorants has on the formation of I7 and M72 glomeruli, iterated olfactory circuits that are formed before and after birth, respectively. We took advantage of double knock-in mice whose I7 and M72 primary afferents express green fluorescent protein and beta-galactosidase, correspondingly. Our results revealed that postnatal odorant chronic exposure led to the formation of permanent supernumerary I7 and M72 glomeruli in a dose and time dependent manner. Glomeruli in exposed mice were formed within the same regions of olfactory bulb and occupy small space volumes compared to the corresponding single circuits in non-exposed mice. We suggest that local reorganization of the primary afferents could participate in the process of formation of supernumerary glomeruli. Overall, our results support that sensory experience indeed instructs the permanent formation of specific glomeruli in the mouse olfactory bulb by means of constructivist processes.	[Valle-Leija, Pablo; Blanco-Hernandez, Eduardo; Drucker-Colin, Rene] Univ Nacl Autonoma Mexico, Dept Neuropatol Mol, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Gutierrez-Ospina, Gabriel] Univ Nacl Autonoma Mexico, Dept Biol Celular & Fisiol, Inst Invest Biomed & Coordinac Psicofisiol, Fac Psicol, Mexico City 04510, DF, Mexico; [Vidaltamayo, Roman] Univ Monterrey, Dept Ciencias Basicas, Ctr Diagnost Mol & Med Personalizada, Garza Garcia, Nuevo Leon, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Valle-Leija, P (corresponding author), Univ Nacl Autonoma Mexico, Dept Neuropatol Mol, Inst Fisiol Celular, Mexico City 04510, DF, Mexico.	gabo@biomedicas.unam.mx; rvidaltamayo@udem.edu.mx	Vidaltamayo, Roman/V-6035-2019; Vidaltamayo, Roman/A-3613-2014	Vidaltamayo, Roman/0000-0002-4747-0830; Vidaltamayo, Roman/0000-0002-4747-0830; Gutierrez Ospina, Gabriel/0000-0002-6286-8281	CONACyT [56295]; UNAM-DGAPA-PAPIIT [IN208311, IN225209]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAM-DGAPA-PAPIIT(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico)	This work was supported by CONACyT grant 56295 to R. Vidaltamayo and UNAM-DGAPA-PAPIIT grants IN208311 to R. Vidaltamayo and IN225209 to R. Drucker-Colin. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alonso M, 2006, J NEUROSCI, V26, P10508, DOI 10.1523/JNEUROSCI.2633-06.2006; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Biju KC, 2008, J COMP NEUROL, V506, P161, DOI 10.1002/cne.21540; Bozza T, 2002, J NEUROSCI, V22, P3033, DOI 10.1523/JNEUROSCI.22-08-03033.2002; Cao L, 2007, J NEUROSCI, V17, P3684; Carrasco MM, 2011, EUR J NEUROSCI, V33, P58, DOI 10.1111/j.1460-9568.2010.07478.x; Case DT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020756; Chesler AT, 2007, P NATL ACAD SCI USA, V104, P1039, DOI 10.1073/pnas.0609215104; Clem RL, 2008, SCIENCE, V319, P101, DOI 10.1126/science.1143808; Cummings DM, 2010, J NEUROSCI, V30, P9172, DOI 10.1523/JNEUROSCI.1717-10.2010; Di Marco S, 2009, J NEUROSCI, V29, P13691, DOI 10.1523/JNEUROSCI.3854-09.2009; Dunfield D, 2009, NEURON, V64, P240, DOI 10.1016/j.neuron.2009.08.034; Feller MB, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-24; Grubb MS, 2004, CURR OPIN NEUROBIOL, V14, P503, DOI 10.1016/j.conb.2004.06.006; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Imai T, 2006, SCIENCE, V314, P657, DOI 10.1126/science.1131794; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kerr MA, 2006, NAT NEUROSCI, V9, P484, DOI 10.1038/nn1673; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Maher BJ, 2009, P NATL ACAD SCI USA, V106, P16865, DOI 10.1073/pnas.0808946106; Merzin M., 2008, THESIS U TARTU; Mobley AS, 2010, J NEUROSCI, V30, P16498, DOI 10.1523/JNEUROSCI.4225-10.2010; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 2006, ANNU REV CELL DEV BI, V22, P713, DOI 10.1146/annurev.cellbio.21.012804.093915; Nakatani H, 2003, EUR J NEUROSCI, V18, P2425, DOI 10.1046/j.1460-9568.2003.02998.x; Nguyen MQ, 2007, CELL, V131, P1009, DOI 10.1016/j.cell.2007.10.050; Nguyen-Ba-Charvet KT, 2008, J NEUROSCI, V28, P4244, DOI 10.1523/JNEUROSCI.5671-07.2008; Oliva AM, 2008, J COMP NEUROL, V510, P475, DOI 10.1002/cne.21800; Oliva AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011359; OROURKE NA, 1994, NEURON, V12, P921, DOI 10.1016/0896-6273(94)90343-3; POMEROY SL, 1990, J NEUROSCI, V10, P1952; Potter SM, 2001, J NEUROSCI, V21, P9713, DOI 10.1523/JNEUROSCI.21-24-09713.2001; Quartz SR, 1997, BEHAV BRAIN SCI, V20, P537; Royal SJ, 1999, J NEUROSCI, V19, P9856; Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545; Schaefer ML, 2001, J COMP NEUROL, V436, P351; Schmidt KE, 2002, CEREB CORTEX, V12, P783, DOI 10.1093/cercor/12.8.783; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Tan J, 2010, NEURON, V65, P912, DOI 10.1016/j.neuron.2010.02.011; Todrank J, 2011, P ROY SOC B-BIOL SCI, V278, P1949, DOI 10.1098/rspb.2010.2314; Xu HP, 2011, NEURON, V70, P1115, DOI 10.1016/j.neuron.2011.04.028; Yu CR, 2004, NEURON, V42, P553, DOI 10.1016/S0896-6273(04)00224-7; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zou DJ, 2004, SCIENCE, V304, P1976, DOI 10.1126/science.1093468	46	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e35358	10.1371/journal.pone.0035358	http://dx.doi.org/10.1371/journal.pone.0035358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511987	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338600073
J	Boumendil, A; Angus, DC; Guitonneau, AL; Menn, AM; Ginsburg, C; Takun, K; Davido, A; Masmoudi, R; Doumenc, B; Pateron, D; Garrouste-Orgeas, M; Somme, D; Simon, T; Aegerter, P; Guidet, B				Boumendil, Ariane; Angus, Derek C.; Guitonneau, Anne-Laure; Menn, Anne-Marie; Ginsburg, Christine; Takun, Khalil; Davido, Alain; Masmoudi, Rafik; Doumenc, Benoit; Pateron, Dominique; Garrouste-Orgeas, Maite; Somme, Dominique; Simon, Tabassome; Aegerter, Philippe; Guidet, Bertrand		ICE-CUB Study Grp	Variability of Intensive Care Admission Decisions for the Very Elderly	PLOS ONE			English	Article							PATIENTS AGED 80; PATIENTS REFUSED ADMISSION; QUALITY-OF-LIFE; MEDICARE BENEFICIARIES; TRIAGE DECISIONS; UNIT ADMISSION; SHORT-TERM; MORTALITY; OUTCOMES; OLDER	Although increasing numbers of very elderly patients are requiring intensive care, few large sample studies have investigated ICU admission of very elderly patients. Data on pre triage by physicians from other specialities is limited. This observational cohort study aims at examining inter-hospital variability of ICU admission rates and its association with patients' outcomes. All patients over 80 years possibly qualifying for ICU admission who presented to the emergency departments (ED) of 15 hospitals in the Paris (France) area during a one-year period were prospectively included in the study. Main outcome measures were ICU eligibility, as assessed by the ED and ICU physicians; in-hospital mortality; and vital and functional status 6 months after the ED visit. 2646 patients (median age 86; interquartile range 83-91) were included in the study. 94% of participants completed follow-up (n = 2495). 12.4% (n = 329) of participants were deemed eligible for ICU admission by ED physicians and intensivists. The overall in-hospital and 6-month mortality rates were respectively 27.2% (n = 717) and 50.7% (n = 1264). At six months, 57.5% (n = 1433) of patients had died or had a functional deterioration. Rates of patients deemed eligible for ICU admission ranged from 5.6% to 38.8% across the participating centers, and this variability persisted after adjustment for patients' characteristics. Despite this variability, we found no association between level of ICU eligibility and either in-hospital death or six-month death or functional deterioration. In France, the likelihood that a very elderly person will be admitted to an ICU varies widely from one hospital to another. Influence of intensive care admission on patients' outcome remains unclear.	[Boumendil, Ariane; Guidet, Bertrand] INSERM, U707, Unite Rech Epidemiol Syst Informat & Modelisat, Paris, France; [Boumendil, Ariane; Guidet, Bertrand] Univ Paris 06, UMRS 707, Paris, France; [Boumendil, Ariane; Aegerter, Philippe] Univ Versailles St Quentin, UPRES EA Sante Environm Vieillissement 2506, Paris, France; [Angus, Derek C.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Guitonneau, Anne-Laure] Hop Bichat Claude Bernard, AP HP, Emergency Dept, F-75877 Paris, France; [Menn, Anne-Marie] Hop Victor Dupouy, Emergency Dept, Argenteuil, France; [Ginsburg, Christine; Takun, Khalil] Hop Cochin, AP HP, Emergency Dept, F-75674 Paris, France; [Davido, Alain; Masmoudi, Rafik] Hop Europe Georges Pompidou, Emergency Dept, Paris, France; [Doumenc, Benoit] Hop Bicetre, AP HP, Emergency Dept, Paris, France; [Pateron, Dominique] Hop St Antoine, AP HP, Emergency Dept, F-75571 Paris, France; [Garrouste-Orgeas, Maite] St Joseph Hosp Network, Med Surg Intens Care Unit, Paris, France; [Somme, Dominique] Hop Europe Georges Pompidou, AP HP, Geriatr Unit, Paris, France; [Simon, Tabassome] Hop St Antoine, AP HP, Unite Rech Clin Est, F-75571 Paris, France; [Simon, Tabassome] Univ Paris 06, Dept Pharmacol, Paris, France; [Aegerter, Philippe] Hop Ambroise Pare, AP HP, Dept Publ Hlth, Boulogne Billancourt, France; [Guidet, Bertrand] Hop St Antoine, AP HP, Med ICU, F-75571 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Hopital Paris Saint-Joseph; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Boumendil, A (corresponding author), INSERM, U707, Unite Rech Epidemiol Syst Informat & Modelisat, Paris, France.	ariane.boumendil@gmail.com	AEGERTER, Philippe/AAY-6003-2021; Angus, Derek C/E-9671-2012; Somme, Dominique/DEH-7131-2022	AEGERTER, Philippe/0000-0002-9156-5028; SIMON, Tabassome/0000-0002-4550-0450; Boumendil, Ariane/0000-0002-2552-0542	French Ministry of Health (PHRC) [AOM 03 035]; French Society of Intensive Care (SRLF - Bourse "Ethique/Evaluation/Qualite")	French Ministry of Health (PHRC); French Society of Intensive Care (SRLF - Bourse "Ethique/Evaluation/Qualite")	This work was supported by grants from the French Ministry of Health (PHRC AOM 03 035) and from the French Society of Intensive Care (SRLF - Bourse "Ethique/Evaluation/Qualite" 2008). The French ministry of Health and the French Society of Intensive Care had no role in the design and conduct of the study, in the collection, management, analysis, or interpretation of the data, or in the preparation, review, or approval of the manuscript.	Aegerter P, 2005, INTENS CARE MED, V31, P416, DOI 10.1007/s00134-005-2557-9; Angus DC, 2004, CRIT CARE MED, V32, P638, DOI 10.1097/01.CCM.0000114816.62331.08; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], REGRESSION MODELLING, DOI DOI 10.1200/JCO.2017.76.1155; Azoulay E, 2001, CRIT CARE MED, V29, P2132, DOI 10.1097/00003246-200111000-00014; Barnato AE, 2004, HEALTH SERV RES, V39, P363, DOI 10.1111/j.1475-6773.2004.00232.x; Boumendil A, 2005, J AM GERIATR SOC, V53, P88, DOI 10.1111/j.1532-5415.2005.53016.x; Boumendil A, 2004, INTENS CARE MED, V30, P647, DOI 10.1007/s00134-003-2150-z; Boumendil A, 2011, ARCH INTERN MED, V171, P1116, DOI 10.1001/archinternmed.2011.102; COOK DJ, 1995, JAMA-J AM MED ASSOC, V273, P703, DOI 10.1001/jama.273.9.703; de Rooij SE, 2006, INTENS CARE MED, V32, P1039, DOI 10.1007/s00134-006-0171-0; de Rooij SEJA, 2008, J AM GERIATR SOC, V56, P816, DOI 10.1111/j.1532-5415.2008.01671.x; Egol A, 1999, CRIT CARE MED, V27, P633; FRISHOLIMA P, 1994, THEOR SURG, V9, P208; Frost DW, 2009, CRIT CARE, V13, DOI 10.1186/cc7791; Garrouste-Orgeas M, 2005, CRIT CARE MED, V33, P750, DOI 10.1097/01.CCM.0000157752.26180.F1; Garrouste-Orgeas M, 2003, INTENS CARE MED, V29, P774, DOI 10.1007/s00134-003-1709-z; Garrouste-Orgeas M, 2006, INTENS CARE MED, V32, P1045, DOI 10.1007/s00134-006-0169-7; Garrouste-Orgeas M, 2009, CRIT CARE MED, V37, P2919, DOI 10.1097/CCM.0b013e3181b019f0; Joynt GM, 2001, INTENS CARE MED, V27, P1459, DOI 10.1007/s001340101041; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; LEMESHOW S, 1993, JAMA-J AM MED ASSOC, V270, P2478, DOI 10.1001/jama.270.20.2478; Luyt CE, 2007, CRIT CARE MED, V35, P3, DOI 10.1097/01.CCM.0000249832.36518.11; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Metcalfe MA, 1997, LANCET, V350, P7, DOI 10.1016/S0140-6736(96)10018-0; MOLLOY DW, 1991, CAN MED ASSOC J, V145, P947; NUCKTON TJ, 1995, ARCH INTERN MED, V155, P1087, DOI 10.1001/archinte.155.10.1087; Rodriguez-Molinero A, 2010, AM J EMERG MED, V28, P757, DOI 10.1016/j.ajem.2009.03.016; Sharma G, 2008, CHEST, V133, P72, DOI 10.1378/chest.07-1007; Shmueli A, 2005, INT J TECHNOL ASSESS, V21, P66, DOI 10.1017/S0266462305050087; Sprung CL, 1997, INTENS CARE MED, V23, P1011, DOI 10.1007/s001340050449; Sprung CL, 1999, CRIT CARE MED, V27, P1073, DOI 10.1097/00003246-199906000-00021; Sprung CL, 2011, CRIT CARE MED; Thiery G, 2005, J CLIN ONCOL, V23, P4406, DOI 10.1200/JCO.2005.01.487; Torres OH, 2006, INTENS CARE MED, V32, P1052, DOI 10.1007/s00134-006-0170-1; Vanhecke TE, 2008, CRIT CARE MED, V36, P812, DOI 10.1097/CCM.0B013E318165FAC7; Wilson DM, 2010, CRIT CARE MED, V38, P303, DOI 10.1097/CCM.0b013e3181b4a263; Wunsch H, 2010, JAMA-J AM MED ASSOC, V303, P849, DOI 10.1001/jama.2010.216; Nguyen YL, 2011, ANN INTENSIVE CARE, V1, DOI 10.1186/2110-5820-1-29	41	103	103	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34387	10.1371/journal.pone.0034387	http://dx.doi.org/10.1371/journal.pone.0034387			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TP	22509296	Green Accepted, Green Published, gold			2022-12-27	WOS:000305336600029
J	Miyazawa, K; Kipkorir, T; Tittman, S; Manuelidis, L				Miyazawa, Kohtaro; Kipkorir, Terry; Tittman, Sarah; Manuelidis, Laura			Continuous Production of Prions after Infectious Particles Are Eliminated: Implications for Alzheimer's Disease	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SCRAPIE AGENTS; PROTEIN; CJD; CELLS; REPLICATION; GENERATION; MICROGLIA; ABSENCE; STRAIN	Rat septal cells, induced to enter a terminal differentiation-like state by temperature shift, produce prion protein (PrP) levels 7x higher than their proliferative counterparts. Host PrP accumulates on the plasma membrane, newly elaborated nanotubes, and cell-to-cell junctions, important conduits for viral spread. To find if elevated PrP increased susceptibility to FU-CJD infection, we determined agent titers under both proliferating and arresting conditions. A short 5 day arrest and a prolonged 140 day arrest increased infectivity by 5x and 122x (> logs) respectively as compared to proliferating cells. Total PrP rapidly increased 7x and was even more elevated in proliferating cells that escaped chronic arrest conditions. Amyloid generating PrP (PrP-res), the "infectious prion'' form, present at similar to 100,000 copies per infectious particle, also increased proportionately by 140 days. However, when these highly infectious cells were switched back to proliferative conditions for 60 days, abundant PrP-res continued to be generated even though 4 logs of titer was lost. An identical 4 log loss was found with maximal PrP and PrP-res production in parallel cells under arresting conditions. While host PrP is essential for TSE agent spread and replication, excessive production of all forms of PrP can be inappropriately perpetuated by living cells, even after the initiating infectious agent is eliminated. Host PrP changes can start as a protective innate immune response that ultimately escapes control. A subset of other neurodegenerative and amyloid diseases, including non-transmissible AD, may be initiated by environmental infectious agents that are no longer present.	[Miyazawa, Kohtaro; Kipkorir, Terry; Tittman, Sarah; Manuelidis, Laura] Yale Univ, Sch Med, Dept Surg, Sect Neuropathol, New Haven, CT 06510 USA	Yale University	Miyazawa, K (corresponding author), Yale Univ, Sch Med, Dept Surg, Sect Neuropathol, New Haven, CT 06510 USA.	laura.manuelidis@yale.edu	Miyazawa, Kohtaro/ABB-1464-2021	Kipkorir, Terry/0000-0001-5466-1726	National Institute of Neurological Diseases and Stroke [RO1 012674-34]	National Institute of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Diseases and Stroke Grant RO1 012674-34. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais S, 2011, CELL MOL LIFE SCI, DOI [10.1007/s00018-00011-00879-z, DOI 10.1007/S00018-00011-00879-Z]; Arjona A, 2004, P NATL ACAD SCI USA, V101, P8768, DOI 10.1073/pnas.0400158101; Baker CA, 2003, P NATL ACAD SCI USA, V100, P675, DOI 10.1073/pnas.0237313100; Baker CA, 2002, J VIROL, V76, P10905, DOI 10.1128/JVI.76.21.10905-10913.2002; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Colby DW, 2011, NAT REV MICROBIOL, V9, P771, DOI 10.1038/nrmicro2650; Cosseddu GM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002370; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; EVES EM, 1994, BRAIN RES, V656, P396, DOI 10.1016/0006-8993(94)91484-2; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Franco D, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-86; Klingeborn M, 2011, P NATL ACAD SCI USA, V108, pE1244, DOI 10.1073/pnas.1111255108; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Liu Y, 2008, J NEUROVIROL, V14, P352, DOI 10.1080/13550280802105283; Lu ZY, 2004, J CELL BIOCHEM, V93, P644, DOI 10.1002/jcb.20220; MANUELIDIS E E, 1989, Alzheimer Disease and Associated Disorders, V3, P100, DOI 10.1097/00002093-198903010-00009; MANUELIDIS EE, 1978, SCIENCE, V200, P1069, DOI 10.1126/science.349691; Manuelidis L, 1997, SCIENCE, V277, P94, DOI 10.1126/science.277.5322.94; MANUELIDIS L, 1994, ANN NY ACAD SCI, V724, P259, DOI 10.1111/j.1749-6632.1994.tb38916.x; Manuelidis L, 1996, VIROLOGY, V216, P46, DOI 10.1006/viro.1996.0033; Manuelidis L, 2009, J CELL BIOCHEM, V106, P220, DOI 10.1002/jcb.21988; Manuelidis L, 2007, J CELL BIOCHEM, V100, P897, DOI 10.1002/jcb.21090; Manuelidis L, 2011, J NEUROVIROL, V17, P131, DOI 10.1007/s13365-010-0007-0; Manuelidis L, 2009, P NATL ACAD SCI USA, V106, P13529, DOI 10.1073/pnas.0905825106; Martin GR, 2011, AM J PATHOL, V179, P2290, DOI 10.1016/j.ajpath.2011.07.025; Miyazawa K, 2011, J CELL BIOCHEM, V112, P3630, DOI 10.1002/jcb.23286; Miyazawa K, 2011, VIRULENCE, V2, P188, DOI 10.4161/viru.2.3.15880; Miyazawa K, 2010, J CELL BIOCHEM, V111, P239, DOI 10.1002/jcb.22723; Nishida N, 2005, SCIENCE, V310, P493, DOI 10.1126/science.1118155; Pasupuleti M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007358; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Shlomchik MJ, 2001, P NATL ACAD SCI USA, V98, P9289, DOI 10.1073/pnas.161055198; Tsutsui S, 2008, AM J PATHOL, V173, P1029, DOI 10.2353/ajpath.2008.071062; Wang F, 2012, J VIROL, V86, P1874, DOI 10.1128/JVI.06216-11	34	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35471	10.1371/journal.pone.0035471	http://dx.doi.org/10.1371/journal.pone.0035471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509412	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600106
J	Richard, J; Morley, SA; Thorne, MAS; Peck, LS				Richard, Joelle; Morley, Simon Anthony; Thorne, Michael A. S.; Peck, Lloyd Samuel			Estimating Long-Term Survival Temperatures at the Assemblage Level in the Marine Environment: Towards Macrophysiology	PLOS ONE			English	Article							SCALLOP ARGOPECTEN-PURPURATUS; GOLDENROD GALL FLY; EUROPEAN MOLLUSKS; CLIMATE-CHANGE; POPULATION-DYNAMICS; POTENTIAL FECUNDITY; OXYGEN LIMITATION; THERMAL TOLERANCE; LIMITS; EVOLUTIONARY	Defining ecologically relevant upper temperature limits of species is important in the context of environmental change. The approach used in the present paper estimates the relationship between rates of temperature change and upper temperature limits for survival in order to evaluate the maximum long-term survival temperature (Ts). This new approach integrates both the exposure time and the exposure temperature in the evaluation of temperature limits. Using data previously published for different temperate and Antarctic marine environments, we calculated Ts in each environment, which allowed us to calculate a new index: the Warming Allowance (WA). This index is defined as the maximum environmental temperature increase which an ectotherm in a given environment can tolerate, possibly with a decrease in performance but without endangering survival over seasonal or lifetime time-scales. It is calculated as the difference between maximum long-term survival temperature (Ts) and mean maximum habitat temperature. It provides a measure of how close a species, assemblage or fauna are living to their temperature limits for long-term survival and hence their vulnerability to environmental warming. In contrast to data for terrestrial environments showing that warming tolerance increases with latitude, results here for marine environments show a less clear pattern as the smallest WA value was for the Peru upwelling system. The method applied here, relating upper temperature limits to rate of experimental warming, has potential for wide application in the identification of faunas with little capacity to survive environmental warming.	[Richard, Joelle; Morley, Simon Anthony; Thorne, Michael A. S.; Peck, Lloyd Samuel] British Antarctic Survey, Cambridge CB3 0ET, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Richard, J (corresponding author), British Antarctic Survey, Cambridge CB3 0ET, England.	Joelle.Richard@univ-brest.fr		Thorne, Michael/0000-0001-7759-612X	Natural Environment Research Council [NE/G000018/1]; NERC [bas0100025, NE/G000018/1] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This study was financed by the Natural Environment Research Council (grant NE/G000018/1 to Dr. Peck). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSELL AD, 1980, MAR BIOL, V58, P33, DOI 10.1007/BF00386877; ANSELL AD, 1981, MAR BIOL, V65, P177, DOI 10.1007/BF00397083; ANSELL AD, 1980, MAR BIOL, V58, P41, DOI 10.1007/BF00386878; Bernardo J, 2007, BIOLOGY LETT, V3, P695, DOI 10.1098/rsbl.2007.0259; BIRKETT DA, 1987, S AFR J MARINE SCI, V5, P191, DOI 10.2989/025776187784522351; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Calosi P, 2008, BIOL LETTERS, V4, P99, DOI 10.1098/rsbl.2007.0408; Chown SL, 2004, FUNCT ECOL, V18, P159, DOI 10.1111/j.0269-8463.2004.00825.x; Chown SL, 2007, ADV INSECT PHYSIOL, V33, P50; Coulson SJ, 2000, ECOGRAPHY, V23, P299, DOI 10.1034/j.1600-0587.2000.d01-1638.x; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; Dobzhansky T., 1950, American Scientist, V38, P209; DOUDOROFF P, 1945, BIOL BULL, V88, P194, DOI 10.2307/1538044; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Irwin JT, 2000, J INSECT PHYSIOL, V46, P655, DOI 10.1016/S0022-1910(99)00153-5; Irwin JT, 2003, OIKOS, V100, P71, DOI 10.1034/j.1600-0706.2003.11738.x; Jiguet F, 2007, GLOBAL CHANGE BIOL, V13, P1672, DOI 10.1111/j.1365-2486.2007.01386.x; KILGOUR DM, 1986, ENVIRON BIOL FISH, V17, P281, DOI 10.1007/BF00001494; Loeschcke V, 2007, AM NAT, V169, P175, DOI 10.1086/510632; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; MacArthur R.H., 1972, pvii; Peck LS, 2008, MAR ECOL PROG SER, V358, P181, DOI 10.3354/meps07336; Peck LS, 2010, MAR BIOL, V157, P2051, DOI 10.1007/s00227-010-1473-x; Peck LS, 2009, FUNCT ECOL, V23, P248, DOI 10.1111/j.1365-2435.2008.01537.x; Peck LS, 2004, FUNCT ECOL, V18, P625, DOI 10.1111/j.0269-8463.2004.00903.x; Peck LS, 2010, MAR BIOL, P157; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2006, DEEP-SEA RES PT II, V53, P1071, DOI 10.1016/j.dsr2.2006.02.015; Portner HO, 2001, NATURWISSENSCHAFTEN, V88, P137; Rezende EL, 2011, FUNCT ECOL, V25, P111, DOI 10.1111/j.1365-2435.2010.01778.x; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; SALT RW, 1961, ANNU REV ENTOMOL, V6, P55, DOI 10.1146/annurev.en.06.010161.000415; Spicer J. I, 1999, PHYSIOL DIVERSITY IT; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stillman JH, 2003, SCIENCE, V301, P65, DOI 10.1126/science.1083073; Stillman JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P200, DOI 10.1086/316738; Stireman JO, 2005, P NATL ACAD SCI USA, V102, P17384, DOI 10.1073/pnas.0508839102; Tomanek L, 1999, J EXP BIOL, V202, P2925; URBAN HJ, 1994, MAR ECOL PROG SER, V107, P139, DOI 10.3354/meps107139; Urban HJ, 1996, MAR BIOL, V125, P725, DOI 10.1007/BF00349255; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WOLFF M, 1987, CAN J FISH AQUAT SCI, V44, P1684, DOI 10.1139/f87-207; Wolff M, 2007, ECOL MODEL, V209, P333, DOI 10.1016/j.ecolmodel.2007.07.013	44	32	32	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34655	10.1371/journal.pone.0034655	http://dx.doi.org/10.1371/journal.pone.0034655			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509340	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000305336600045
J	Nicolaije, C; Diderich, KEM; Botter, SM; Priemel, M; Waarsing, JH; Day, JS; Brandt, RMC; Schilling, AF; Weinans, H; Van der Eerden, BC; van der Horst, GTJ; Hoeijmakers, JHJ; van Leeuwen, JPTM				Nicolaije, Claudia; Diderich, Karin E. M.; Botter, S. M.; Priemel, Matthias; Waarsing, Jan H.; Day, Judd S.; Brandt, Renata M. C.; Schilling, Arndt F.; Weinans, Harrie; Van der Eerden, Bram C.; van der Horst, Gijsbertus T. J.; Hoeijmakers, Jan H. J.; van Leeuwen, Johannes P. T. M.			Age-Related Skeletal Dynamics and Decrease in Bone Strength in DNA Repair Deficient Male Trichothiodystrophy Mice	PLOS ONE			English	Article							STEM-CELLS; OXIDATIVE STRESS; ILIAC CREST; MOUSE MODEL; HOMEOSTASIS; LEPTIN; CANCER; FEMUR	Accumulation of DNA damage caused by oxidative stress is thought to be one of the main contributors of human tissue aging. Trichothiodystrophy (TTD) mice have a mutation in the Ercc2 DNA repair gene, resulting in accumulation of DNA damage and several features of segmental accelerated aging. We used male TTD mice to study the impact of DNA repair on bone metabolism with age. Analysis of bone parameters, measured by micro-computed tomography, displayed an earlier decrease in trabecular and cortical bone as well as a loss of periosteal apposition and a reduction in bone strength in TTD mice with age compared to wild type mice. Ex vivo analysis of bone marrow differentiation potential showed an accelerated reduction in the number of osteogenic and osteoprogenitor cells with unaltered differentiation capacity. Adipocyte differentiation was normal. Early in life, osteoclast number tended to be increased while at 78 weeks it was significantly lower in TTD mice. Our findings reveal the importance of genome stability and proper DNA repair for skeletal homeostasis with age and support the idea that accumulation of damage interferes with normal skeletal maintenance, causing reduction in the number of osteoblast precursors that are required for normal bone remodeling leading to a loss of bone structure and strength.	[Nicolaije, Claudia; Van der Eerden, Bram C.; van Leeuwen, Johannes P. T. M.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Diderich, Karin E. M.; Botter, S. M.; Brandt, Renata M. C.; van der Horst, Gijsbertus T. J.; Hoeijmakers, Jan H. J.] Erasmus MC, Ctr Biomed Genet, MGC Dept Cell Biol & Genet, Rotterdam, Netherlands; [Priemel, Matthias; Schilling, Arndt F.] Univ Hamburg, Sch Med, Dept Trauma Hand & Reconstruct Surg, Hamburg, Germany; [Waarsing, Jan H.; Day, Judd S.; Weinans, Harrie] Erasmus MC, Dept Orthoped, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Hamburg; Erasmus University Rotterdam; Erasmus MC	Nicolaije, C (corresponding author), Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.	j.vanleeuwen@erasmusmc.nl	van der Horst, Gijsbertus TJ/E-3661-2015; Hoeijmakers, Jan/AAX-6972-2021; van der Eerden, Bram CJ/I-7496-2012; van Leeuwen, Johannes/D-5015-2014	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; van der Eerden, Bram CJ/0000-0003-4403-6497; van Leeuwen, Johannes/0000-0002-2282-4006; Diderich, Karin/0000-0003-2637-9998; Weinans, Harrie/0000-0002-2275-6170; Brandt, Renata M. C./0000-0003-0514-5623	National Institute of Health (NIH)/National Institute of Aging (NIA) [1PO1 AG-17242-02]; National Institute of Environment Health Sciences [1UO1 ES011044]; Netherlands Organization for Scientific Research (NWO) through the foundation of the Research Institute Diseases of the Elderly; Dutch Cancer Society; Cancer Genomics Center; EC DNA Repair [LSHG-CT-2005-512113]; LifeSpan [LSHG-CT-2007-036894]; Markage; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017242] Funding Source: NIH RePORTER	National Institute of Health (NIH)/National Institute of Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Environment Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Netherlands Organization for Scientific Research (NWO) through the foundation of the Research Institute Diseases of the Elderly(Netherlands Organization for Scientific Research (NWO)); Dutch Cancer Society(KWF Kankerbestrijding); Cancer Genomics Center; EC DNA Repair; LifeSpan; Markage; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was financially supported by National Institute of Health (NIH)/National Institute of Aging (NIA), grant number 1PO1 AG-17242-02, National Institute of Environment Health Sciences (1UO1 ES011044), Netherlands Organization for Scientific Research (NWO) through the foundation of the Research Institute Diseases of the Elderly, as well as grants from the Dutch Cancer Society, the Cancer Genomics Center, and EC DNA Repair (LSHG-CT-2005-512113), LifeSpan (LSHG-CT-2007-036894) and Markage. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Amling M, 1999, ENDOCRINOLOGY, V140, P4982, DOI 10.1210/en.140.11.4982; Atmani H, 2003, J CELL BIOCHEM, V89, P364, DOI 10.1002/jcb.10507; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bergman RJ, 1996, J BONE MINER RES, V11, P568; BOOTSMA D, 1993, NATURE, V363, P114, DOI 10.1038/363114a0; Botter SM, 2011, AGE, V33, P247, DOI 10.1007/s11357-010-9175-3; Botter SM, 2011, ARTHRITIS RHEUM; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Broderick E, 2005, CALCIFIED TISSUE INT, V76, P379, DOI 10.1007/s00223-004-0150-9; Calabrese V, 2010, METHODS MOL BIOL, V610, P285, DOI 10.1007/978-1-60327-029-8_17; Compe E, 2005, MOL CELL BIOL, V25, P6065, DOI 10.1128/MCB.25.14.6065-6076.2005; de Boer J, 1998, MOL CELL, V1, P981, DOI 10.1016/S1097-2765(00)80098-2; de Boer J, 1999, BIOCHIMIE, V81, P127, DOI 10.1016/S0300-9084(99)80045-5; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Diderich KE, 2011, AGE DORDR; Ducy P, 2000, CELL, V100, P197, DOI 10.1016/S0092-8674(00)81558-5; Giglia-Mari G, 2004, NAT GENET, V36, P714, DOI 10.1038/ng1387; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Halloran BP, 2002, J BONE MINER RES, V17, P1044, DOI 10.1359/jbmr.2002.17.6.1044; Hamrick MW, 2008, OSTEOPOROSIS INT, V19, P905, DOI 10.1007/s00198-007-0487-9; Hanawalt PC, 2002, ONCOGENE, V21, P8949, DOI 10.1038/sj.onc.1206096; Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Horowitz MC, 2001, CYTOKINE GROWTH F R, V12, P9, DOI 10.1016/S1359-6101(00)00030-7; Hoshaw SJ, 1997, J BIOMECH, V30, P323, DOI 10.1016/S0021-9290(96)00159-5; Itin PH, 2001, J AM ACAD DERMATOL, V44, P891, DOI 10.1067/mjd.2001.114294; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; Looker AC, 1998, OSTEOPOROSIS INT, V8, P468, DOI 10.1007/s001980050093; Manolagas SC, 2010, ENDOCR REV, V31, P266, DOI 10.1210/er.2009-0024; Metcalf D, 2007, STEM CELLS, V25, P2390, DOI 10.1634/stemcells.2007-0544; Niedernhofer LJ, 2006, NATURE, V444, P1038, DOI 10.1038/nature05456; Nordin BEC, 1993, METABOLIC BONE STONE; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Park JY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002346; Priemel M, 2010, J BONE MINER RES, V25, P305, DOI 10.1359/jbmr.090728; Rached MT, 2010, CELL METAB, V11, P147, DOI 10.1016/j.cmet.2010.01.001; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Roschger P, 1998, BONE, V23, P319, DOI 10.1016/S8756-3282(98)00112-4; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Russo CR, 2006, BONE, V38, P112, DOI 10.1016/j.bone.2005.07.025; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Satija NK, 2007, STEM CELLS DEV, V16, P7, DOI 10.1089/scd.2006.9998; Seeman E, 2003, J APPL PHYSIOL, V95, P2142, DOI 10.1152/japplphysiol.00564.2003; Turner CH, 2006, ANN NY ACAD SCI, V1068, P429, DOI 10.1196/annals.1346.039; van der Eerden BCJ, 2005, P NATL ACAD SCI USA, V102, P17507, DOI 10.1073/pnas.0505789102; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; van der Pluijm I, 2007, PLOS BIOL, V5, P23, DOI 10.1371/journal.pbio.0050002; Wauquier F, 2009, TRENDS MOL MED, V15, P468, DOI 10.1016/j.molmed.2009.08.004; Wijnhoven SWP, 2005, DNA REPAIR, V4, P1314, DOI 10.1016/j.dnarep.2005.07.002	52	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35246	10.1371/journal.pone.0035246	http://dx.doi.org/10.1371/journal.pone.0035246			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506075	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500083
J	Giorda, C; Picariello, R; Nada, E; Tartaglino, B; Marafetti, L; Costa, G; Gnavi, R				Giorda, Carlo; Picariello, Roberta; Nada, Elisa; Tartaglino, Barbara; Marafetti, Lisa; Costa, Giuseppe; Gnavi, Roberto			The Impact of Adherence to Screening Guidelines and of Diabetes Clinics Referral on Morbidity and Mortality in Diabetes	PLOS ONE			English	Article							QUALITY-OF-CARE; OUTCOMES; CANCER	Despite the heightened awareness of diabetes as a major health problem, evidence on the impact of assistance and organizational factors, as well as of adherence to recommended care guidelines, on morbidity and mortality in diabetes is scanty. We identified diabetic residents in Torino, Italy, as of 1st January 2002, using multiple independent data sources. We collected data on several laboratory tests and specialist medical examinations to compare primary versus specialty care management of diabetes and the fulfillment of a quality-of-care indicator based on existing screening guidelines (GCI). Then, we performed regression analyses to identify associations of these factors with mortality and cardiovascular morbidity over a 4 year-follow-up. Patients with the lowest degree of quality of care (i.e. only cared for by primary care and with no fulfillment of GCI) had worse RRs for all-cause (1.72 [95% CI 1.57-1.89]), cardiovascular (1.74 [95% CI 1.50-2.01]) and cancer (1.35 [95% CI 1.14-1.61]) mortality, compared with those with the highest quality of care. They also showed increased RRs for incidence of major cardiovascular events up to 2.03 (95% CI 1.26-3.28) for lower extremity amputations. Receiving specialist care itself increased survival, but was far more effective when combined with the fulfillment of GCI. Throughout the whole set of analysis, implementation of guidelines emerged as a strong modifier of prognosis. We conclude that management of diabetic patients with a pathway based on both primary and specialist care is associated with a favorable impact on all-cause mortality and CV incidence, provided that guidelines are implemented.	[Giorda, Carlo; Marafetti, Lisa] ASL TO5, Metab & Diabet Unit, Chieri, Regione Piemont, Italy; [Picariello, Roberta; Costa, Giuseppe; Gnavi, Roberto] ASL TO3, Epidemiol Unit, Grugliasco, Regione Piemont, Italy; [Nada, Elisa; Tartaglino, Barbara] Chaira Med Assoc, Chieri, Italy; [Costa, Giuseppe] Univ Turin, Dept Publ Hlth, Turin, Italy	University of Turin	Giorda, C (corresponding author), ASL TO5, Metab & Diabet Unit, Chieri, Regione Piemont, Italy.	giordaca@tin.it	costa, giuseppe/K-2526-2016; Gnavi, Roberto/J-9263-2016; Giorda, Carlo B/D-4485-2018	Gnavi, Roberto/0000-0003-1919-2199; Giorda, Carlo B/0000-0002-4709-8696; COSTA, Giuseppe/0000-0003-3187-4889	Italian National Health System	Italian National Health System	The authors received partial funding from the Italian National Health System. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barchielli A, 2008, EPIDEMIOL PREV, V32, P30; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Bruno G, 2005, DIABETOLOGIA, V48, P427, DOI 10.1007/s00125-004-1667-1; de Belvis AG, 2009, DIABETES RES CLIN PR, V85, P119, DOI 10.1016/j.diabres.2009.05.007; De Berardis G, 2008, NUTR METAB CARDIOVAS, V18, P57, DOI 10.1016/j.numecd.2006.04.009; De Micheli Alberto, 2008, Acta Diabetol; EUCID, 2008, FIN REP EUR COR IND; Giorda C, 2006, DIABETIC MED, V23, P377, DOI 10.1111/j.1464-5491.2006.01851.x; Giorda CB, 2009, EUR J CARDIOV PREV R, V16, P722, DOI 10.1097/HJR.0b013e3283317c3f; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Gnavi R, 2011, DIABETES RES CLIN PR, V92, P205, DOI 10.1016/j.diabres.2011.02.011; Gnavi R, 2008, NUTR METAB CARDIOVAS, V18, P678, DOI 10.1016/j.numecd.2007.11.004; Gnavi R, 2009, DIABETES CARE, V32, P1986, DOI 10.2337/dc09-0647; Govan L, 2011, DIABETOLOGIA, V54, P2000, DOI 10.1007/s00125-011-2176-7; Grant RW, 2005, DIABETES CARE, V28, P337, DOI 10.2337/diacare.28.2.337; Griffin SJ, 2009, COCHRANE DB SYST REV, V21; International Diabetes Federation, 1999, DESKT GUID TYP 2 DIA; Kawachi I, 2010, ANN NY ACAD SCI, V1186, P56, DOI 10.1111/j.1749-6632.2009.05340.x; Khuwaja AK, 2010, DIABETOLOGIA, V53, P389, DOI 10.1007/s00125-009-1581-7; Li S, 2008, AM J MED QUAL, V23, P222, DOI 10.1177/1062860608314940; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; McAlister FA, 2007, QUAL SAF HEALTH CARE, V16, P6, DOI 10.1136/qshc.2006.018648; Renders CM, 2001, DIABETES CARE, V24, P1365, DOI 10.2337/diacare.24.8.1365; Shah BR, 2005, DIABETES CARE, V28, P600, DOI 10.2337/diacare.28.3.600; Simonato L, 2008, EPIDEMIOL PREV, V32, P5; Verlato G, 1996, DIABETES CARE, V19, P211, DOI 10.2337/diacare.19.3.211	26	46	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e33839	10.1371/journal.pone.0033839	http://dx.doi.org/10.1371/journal.pone.0033839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509263	gold, Green Submitted, Green Published			2022-12-27	WOS:000304805900008
J	Liu, JYW; Kasperaviciute, D; Martinian, L; Thom, M; Sisodiya, SM				Liu, Joan Y. W.; Kasperaviciute, Dalia; Martinian, Lillian; Thom, Maria; Sisodiya, Sanjay M.			Neuropathology of 16p13.11 Deletion in Epilepsy	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; CEREBRAL CORTICAL SIZE; HIPPOCAMPAL SCLEROSIS; CYTOPLASMIC DYNEIN; PROTEIN; MIGRATION; NDEL1; LIS1; PREDISPOSE; EXPRESSION	16p13.11 genomic copy number variants are implicated in several neuropsychiatric disorders, such as schizophrenia, autism, mental retardation, ADHD and epilepsy. The mechanisms leading to the diverse clinical manifestations of deletions and duplications at this locus are unknown. Most studies favour NDE1 as the leading disease-causing candidate gene at 16p13.11. In epilepsy at least, the deletion does not appear to unmask recessive-acting mutations in NDE1, with haploinsufficiency and genetic modifiers being prime candidate disease mechanisms. NDE1 encodes a protein critical to cell positioning during cortical development. As a first step, it is important to determine whether 16p13.11 copy number change translates to detectable brain structural alteration. We undertook detailed neuropathology on surgically resected brain tissue of two patients with intractable mesial temporal lobe epilepsy (MTLE), who had the same heterozygous NDE1-containing 800 kb 16p13.11 deletion, using routine histological stains and immunohistochemical markers against a range of layer-specific, white matter, neural precursor and migratory cell proteins, and NDE1 itself. Surgical temporal lobectomy samples from a MTLE case known not to have a deletion in NDE1 and three non-epilepsy cases were included as disease controls. We found that apart from a 3 mm hamartia in the temporal cortex of one MTLE case with NDE1 deletion and known hippocampal sclerosis in the other case, cortical lamination and cytoarchitecture were normal, with no differences between cases with deletion and disease controls. How 16p13.11 copy changes lead to a variety of brain diseases remains unclear, but at least in epilepsy, it would not seem to be through structural abnormality or dyslamination as judged by microscopy or immunohistochemistry. The need to integrate additional data with genetic findings to determine their significance will become more pressing as genetic technologies generate increasingly rich datasets. Detailed examination of brain tissue, where available, will be an important part of this process in neurogenetic disease specifically.	[Liu, Joan Y. W.; Kasperaviciute, Dalia; Martinian, Lillian; Sisodiya, Sanjay M.] UCL Inst Neurol, Dept Clin & Expt Epilepsy, London, England; [Thom, Maria] Natl Hosp Neurol & Neurosurg, Div Neuropathol, London WC1N 3BG, England; [Sisodiya, Sanjay M.] Epilepsy Soc, Gerrards Cross, Bucks, England	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Liu, JYW (corresponding author), UCL Inst Neurol, Dept Clin & Expt Epilepsy, London, England.	s.sisodiya@ucl.ac.uk		Liu, Joan/0000-0002-0777-5189	The Wellcome Trust [084730]; The Medical Research Council, UK [GD400126, G79059]; European Commission within the 7th Framework programme, EURIPIDES; Department of Health Biomedical Centre; Medical Research Council [G0400126, G0600934] Funding Source: researchfish; MRC [G0400126, G0600934] Funding Source: UKRI	The Wellcome Trust(Wellcome TrustEuropean Commission); The Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission within the 7th Framework programme, EURIPIDES; Department of Health Biomedical Centre; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by grants from The Wellcome Trust (084730), The Medical Research Council, UK (GD400126 and G79059), and the European Commission within the 7th Framework programme, EURIPIDES. This work was undertaken at University College London and University College London Hospital, who receive part of their funding from the Department of Health Biomedical Centre scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkuraya FS, 2011, AM J HUM GENET, V88, P536, DOI 10.1016/j.ajhg.2011.04.003; Bakircioglu M, 2011, AM J HUM GENET, V88, P523, DOI 10.1016/j.ajhg.2011.03.019; Bandtlow CE, 2004, EUR J NEUROSCI, V20, P195, DOI 10.1111/j.1460-9568.2004.03470.x; Blumcke I, 2001, HIPPOCAMPUS, V11, P311, DOI 10.1002/hipo.1045; Catarino CB, 2011, EPILEPSIA, V52, P1388, DOI 10.1111/j.1528-1167.2011.03087.x; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; de Kovel CGF, 2010, BRAIN, V133, P23, DOI 10.1093/brain/awp262; Derewenda U, 2007, STRUCTURE, V15, P1467, DOI 10.1016/j.str.2007.09.015; DOBYNS WB, 1992, NEUROLOGY, V42, P1375, DOI 10.1212/WNL.42.7.1375; Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023; Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8; FERRER I, 1992, BRAIN RES, V572, P33, DOI 10.1016/0006-8993(92)90447-H; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Gong C, 2007, J NEUROSCI, V27, P1803, DOI 10.1523/JNEUROSCI.3111-06.2007; Hadjivassiliou G, 2010, ACTA NEUROPATHOL, V120, P517, DOI 10.1007/s00401-010-0686-x; Hannes FD, 2009, J MED GENET, V46, P223, DOI 10.1136/jmg.2007.055202; Heinzen EL, 2010, AM J HUM GENET, V86, P707, DOI 10.1016/j.ajhg.2010.03.018; Helbig I, 2009, NAT GENET, V41, P160, DOI 10.1038/ng.292; Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093; Inoue S, 1998, J CELL SCI, V111, P1555; Karki S, 1999, CURR OPIN CELL BIOL, V11, P45, DOI 10.1016/S0955-0674(99)80006-4; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Liu JYW, 2010, J NEUROSCI METH, V190, P49, DOI 10.1016/j.jneumeth.2010.04.020; LoNigro C, 1997, HUM MOL GENET, V6, P157, DOI 10.1093/hmg/6.2.157; Martinian L, 2009, NEUROPATH APPL NEURO, V35, P394, DOI [10.1111/j.1365-2990.2008.00996.x, 10.1111/j.1365-2990.2009.00996.x]; Mefford HC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000962; Molnar Z, 2006, NEUROSCI RES, V55, P105, DOI 10.1016/j.neures.2006.02.008; Nagamani SCS, 2011, EUR J HUM GENET, V19, P280, DOI 10.1038/ejhg.2010.184; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Ocbina PJ, 2006, MOL CELL NEUROSCI, V33, P126, DOI 10.1016/j.mcn.2006.06.014; Pawlisz AS, 2008, HUM MOL GENET, V17, P2441, DOI 10.1093/hmg/ddn144; Pawlisz AS, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001172; Ramalingam A, 2011, J HUM GENET, V56, P541, DOI 10.1038/jhg.2011.42; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Sasaki S, 2005, MOL CELL BIOL, V25, P7812, DOI 10.1128/MCB.25.17.7812-7827.2005; Sasaki S, 2000, NEURON, V28, P681, DOI 10.1016/S0896-6273(00)00146-X; Scaravilli F, 1998, NEUROPATHOLOGY EPILE; Shaikh TH, 2009, GENOME RES, V19, P1682, DOI 10.1101/gr.083501.108; Shmueli A, 2010, EMBO J, V29, P107, DOI 10.1038/emboj.2009.325; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Sisodiya SM, 2002, BRAIN, V125, P22, DOI 10.1093/brain/awf002; Thom M, 2004, EPILEPSIA, V45, P916, DOI 10.1111/j.0013-9580.2004.46603.x; Thom M, 2002, J NEUROPATH EXP NEUR, V61, P510, DOI 10.1093/jnen/61.6.510; Thom M, 2009, BRAIN PATHOL, V19, P565, DOI 10.1111/j.1750-3639.2008.00201.x; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077; Williams NM, 2010, LANCET, V376, P1401, DOI 10.1016/S0140-6736(10)61109-9; WOLF HK, 1995, J NEUROPATH EXP NEUR, V54, P245, DOI 10.1097/00005072-199503000-00011	49	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34813	10.1371/journal.pone.0034813	http://dx.doi.org/10.1371/journal.pone.0034813			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523559	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000031
J	Wan, J; Csaszar, E; Chen, WQ; Li, KZ; Lubec, G				Wan, Jia; Csaszar, Edina; Chen, Wei-Qiang; Li, Kongzhao; Lubec, Gert			Proteins from Avastin (R) (bevacizumab) Show Tyrosine Nitrations for which the Consequences Are Completely Unclear	PLOS ONE			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; CANCER-PATIENTS; CYTOCHROME P4502B1; OVARIAN-CANCER; INCREASED RISK; PEROXYNITRITE; NEURODEGENERATION; INACTIVATION; METAANALYSIS; 3-NITROTYROSINE	Avastin (R) (bevacizumab) is a protein drug widely used for cancer treatment although its further use is questionable due to serious side effects reported. As no systematic proteomic study on posttranslational modifications (PTMs) was reported so far, it was the aim of the current study to use a gel-based proteomics method for determination of Avastin (R)-protein(s). Avastin (R) was run on two-dimensional gel electrophoresis (2-DE), spots were picked, followed by multi-enzyme in-gel digestion. Subsequently, the resulting peptides and posttranslational modifications were identified by mass spectrometry (nano-LC-ESI-MS/MS; HCT and LTQ Orbitrap MS). Heavy and light chains were observed and the 9 spots that were picked from 2DE-gels were identified as bevacizumab with high sequence coverage. MS/MS results showed multiple tyrosine nitrations on the Avastin (R) light and heavy chains that were either represented as nitrotyrosine or as aminotyrosine, which was shown to be generated from nitrotyrosine under reducing conditions. Protein nitration is known to significantly change protein functions and interactions and it may well be that some of the adverse effects of the protein drug Avastin (R) may be due to this PTM, which may have been generated during production-thus, nitration of Avastin (R) is a challenge for the pharmaceutical industry.	[Wan, Jia; Chen, Wei-Qiang; Li, Kongzhao] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Csaszar, Edina] Max F Perutz Labs, Mass Spectrometry Facil, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Wan, J (corresponding author), Med Univ Vienna, Dept Pediat, Vienna, Austria.	gert.lubec@meduniwien.ac.at		Lubec, Gert/0000-0002-6333-9461; CHEN, Weiqiang/0000-0002-7720-4816				Abello N, 2009, J PROTEOME RES, V8, P3222, DOI 10.1021/pr900039c; Balabanli B, 1999, P NATL ACAD SCI USA, V96, P13136, DOI 10.1073/pnas.96.23.13136; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Bookman MA, 2010, ANN ONCOL, V21, P211, DOI 10.1093/annonc/mdq368; Chen WQ, 2010, PROTEOMICS, V10, P369, DOI 10.1002/pmic.200900624; Chen YH, 2009, J OCUL PHARMACOL TH, V25, P65, DOI 10.1089/jop.2008.0043; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Hapani S, 2010, ONCOLOGY-BASEL, V79, P27, DOI 10.1159/000314980; Heijnen HFG, 2006, FREE RADICAL BIO MED, V40, P1903, DOI 10.1016/j.freeradbiomed.2005.09.006; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Ischiropoulos H, 2009, ARCH BIOCHEM BIOPHYS, V484, P117, DOI 10.1016/j.abb.2008.10.034; Kang SU, 2009, NAT PROTOC, V4, P1093, DOI 10.1038/nprot.2009.92; Lin HL, 2005, CHEM RES TOXICOL, V18, P1203, DOI 10.1021/tx050100o; Lin HL, 2003, CHEM RES TOXICOL, V16, P129, DOI 10.1021/tx020040b; MacMillan-Crow LA, 1999, ARCH BIOCHEM BIOPHYS, V366, P82, DOI 10.1006/abbi.1999.1202; MacMillanCrow LA, 1996, P NATL ACAD SCI USA, V93, P11853, DOI 10.1073/pnas.93.21.11853; Nagpal S, 2011, CHEMOTHER RES PRACT, V602812; Nuijten Mark, 2010, Lung Cancer, V69 Suppl 1, pS4, DOI 10.1016/S0169-5002(10)70132-X; Parastatidis I, 2008, J BIOL CHEM, V283, P33846, DOI 10.1074/jbc.M805522200; Randall LM, 2010, GYNECOL ONCOL, V117, P497, DOI 10.1016/j.ygyno.2010.02.021; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Ranpura V, 2010, AM J HYPERTENS, V23, P460, DOI 10.1038/ajh.2010.25; Reck M, 2010, ANN ONCOL, V21, P1804, DOI 10.1093/annonc/mdq020; Reynolds MR, 2007, BIOCHEMISTRY-US, V46, P7325, DOI 10.1021/bi700430y; Savvides SN, 2002, J BIOL CHEM, V277, P2779, DOI 10.1074/jbc.M108190200; Smith I, 2011, BREAST CANCER RES TR, V130, P133, DOI 10.1007/s10549-011-1695-8; SOKOLOVSKY M, 1967, BIOCHEM BIOPH RES CO, V27, P20, DOI 10.1016/S0006-291X(67)80033-0; Stevens SM, 2008, MOL CELL PROTEOMICS, V7, P2442, DOI 10.1074/mcp.M800065-MCP200; Stone RL, 2010, LANCET ONCOL, V11, P465, DOI 10.1016/S1470-2045(09)70362-6; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P662, DOI 10.1038/nrd2222; Thomson L, 2007, AM J RESP CELL MOL, V36, P152, DOI 10.1165/rcmb.2006-0288SM; Vadseth C, 2004, J BIOL CHEM, V279, P8820, DOI 10.1074/jbc.M306101200; Vaklavas C, 2010, ONCOLOGIST, V15, P130, DOI 10.1634/theoncologist.2009-0252; Van Meter MEM, 2010, CURR OPIN ONCOL, V22, P586, DOI 10.1097/CCO.0b013e32833edc0c; Willett CG, 2010, ONCOLOGIST, V15, P845, DOI 10.1634/theoncologist.2010-0030; Wozel G, 2010, J DTSCH DERMATOL GES, V8, P243, DOI 10.1111/j.1610-0387.2009.07268.x; Wu SH, 2010, J AM SOC NEPHROL, V21, P1381, DOI 10.1681/ASN.2010020167; Xu SQ, 2006, AM J PHYSIOL-HEART C, V290, pH2220, DOI 10.1152/ajpheart.01293.2005	38	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34511	10.1371/journal.pone.0034511	http://dx.doi.org/10.1371/journal.pone.0034511			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523550	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000020
J	Bakouh, N; Cherif-Zahar, B; Hulin, P; Prie, D; Friedlander, G; Edelman, A; Planelles, G				Bakouh, Naziha; Cherif-Zahar, Baya; Hulin, Philippe; Prie, Dominique; Friedlander, Gerard; Edelman, Aleksander; Planelles, Gabrielle			Functional Interaction between CFTR and the Sodium-Phosphate Co-Transport Type 2a in Xenopus laevis Oocytes	PLOS ONE			English	Article							CONDUCTANCE REGULATOR CFTR; DEPENDENT PROTEIN-KINASE; CYSTIC-FIBROSIS; CHANNEL ENAC; R-DOMAIN; CAMP; ACTIVATION; NA+; TRAFFICKING; SITES	Background: A growing number of proteins, including ion transporters, have been shown to interact with Cystic Fibrosis Transmembrane conductance Regulator (CFTR). CFTR is an epithelial chloride channel that is involved in Cystic Fibrosis (CF) when mutated; thus a better knowledge of its functional interactome may help to understand the pathophysiology of this complex disease. In the present study, we investigated if CFTR and the sodium-phosphate co-transporter type 2a (NPT2a) functionally interact after heterologous expression of both proteins in Xenopus laevis oocytes. Methodology/Findings: NPT2a was expressed alone or in combination with CFTR in X. laevis oocytes. Using the two-electrode voltage-clamp technique, the inorganic phosphate-induced current (IPi) was measured and taken as an index of NPT2a activity. The maximal IPi for NPT2a substrates was reduced when CFTR was co-expressed with NPT2a, suggesting a decrease in its expression at the oolemna. This was consistent with Western blot analysis showing reduced NPT2a plasma membrane expression in oocytes co-expressing both proteins, whereas NPT2a protein level in total cell lysate was the same in NPT2a- and NPT2a+CFTR-oocytes. In NPT2a+CFTR- but not in NPT2a-oocytes, IPi and NPT2a surface expression were increased upon PKA stimulation, whereas stimulation of Exchange Protein directly Activated by cAMP (EPAC) had no effect. When NPT2a-oocytes were injected with NEG2, a short amino-acid sequence from the CFTR regulatory domain that regulates PKA-dependent CFTR trafficking to the plasma membrane, IPi values and NPT2a membrane expression were diminished, and could be enhanced by PKA stimulation, thereby mimicking the effects of CFTR co-expression. Conclusion/Perspectives: We conclude that when both CFTR and NPT2a are expressed in X. laevis oocytes, CFTR confers to NPT2a a cAMPi-dependent trafficking to the membrane. This functional interaction raises the hypothesis that CFTR may play a role in phosphate homeostasis.	[Bakouh, Naziha; Cherif-Zahar, Baya; Hulin, Philippe; Prie, Dominique; Friedlander, Gerard; Edelman, Aleksander; Planelles, Gabrielle] INSERM, UMRS 845, Paris, France; [Bakouh, Naziha; Cherif-Zahar, Baya; Hulin, Philippe; Prie, Dominique; Friedlander, Gerard; Edelman, Aleksander; Planelles, Gabrielle] Univ Paris 05, Fac Med Paris Descartes, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bakouh, N (corresponding author), INSERM, UMRS 845, Paris, France.	gabrielle.planelles@inserm.fr	Planelles, Gabrielle/F-9603-2013	Planelles, Gabrielle/0000-0002-7314-8837; Cherif-Zahar, Baya/0000-0002-4965-7252; Friedlander, Gerard/0000-0002-6854-4261	Inserm (Institut National de la Sante et de la Recherche Medicale); Universite Paris-Descartes; Agence Nationale de la Recherche [ANR-07-PHYSIO-017]; Vaincre La Mucoviscidose	Inserm (Institut National de la Sante et de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Universite Paris-Descartes; Agence Nationale de la Recherche(French National Research Agency (ANR)); Vaincre La Mucoviscidose	This research has been supported by grants from Inserm (Institut National de la Sante et de la Recherche Medicale) and Universite Paris-Descartes, and by a grant from Agence Nationale de la Recherche (ANR-07-PHYSIO-017). NB was supported by Vaincre La Mucoviscidose and by Agence Nationale de la Recherche (ANR-07-PHYSIO-017). The funders had no role in study design, results collection and analysis, decision to publish or preparation of the manuscript.	Ahmad A, 2011, CELL PHYSIOL BIOCHEM, V27, P703, DOI 10.1159/000330079; Ali S, 1998, P NATL ACAD SCI USA, V95, P10274, DOI 10.1073/pnas.95.17.10274; Bachhuber T, 2005, J BIOL CHEM, V280, P31587, DOI 10.1074/jbc.M504347200; Bankir L, 2002, AM J PHYSIOL-RENAL, V282, pF376, DOI 10.1152/ajprenal.00202.2001; Bertrand CA, 2003, AM J PHYSIOL-CELL PH, V285, pC1, DOI 10.1152/ajpcell.00554.2002; Bronckers A, 2010, BONE, V46, P1188, DOI 10.1016/j.bone.2009.12.002; Chappe V, 2003, J PHYSIOL-LONDON, V548, P39, DOI 10.1113/jphysiol.2002.035790; Chernova MN, 2003, J PHYSIOL-LONDON, V549, P3, DOI 10.1113/jphysiol.2003.039818; Cunningham R, 2009, AM J PHYSIOL-RENAL, V296, pF355, DOI 10.1152/ajprenal.90426.2008; Deliot N, 2005, AM J PHYSIOL-CELL PH, V289, pC159, DOI 10.1152/ajpcell.00456.2004; Devuyst O, 2002, AM J PHYSIOL-RENAL, V283, pF1176, DOI 10.1152/ajprenal.00184.2002; Foller M, 2011, J AM SOC NEPHROL, V22, P873, DOI 10.1681/ASN.2010070757; Forster IC, 1999, J PHYSIOL-LONDON, V517, P327, DOI 10.1111/j.1469-7793.1999.0327t.x; Gibney EM, 2003, AM J KIDNEY DIS, V42, P1, DOI 10.1016/S0272-6386(03)00403-7; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; HAYES G, 1995, PFLUG ARCH EUR J PHY, V430, P819, DOI 10.1007/BF00386181; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Honegger KJ, 2006, P NATL ACAD SCI USA, V103, P803, DOI 10.1073/pnas.0503562103; HOPPE A, 1988, AM J PHYSIOL, V255, pR557, DOI 10.1152/ajpregu.1988.255.4.R557; Howard M, 1996, KIDNEY INT, V49, P1642, DOI 10.1038/ki.1996.239; Jankowski M, 2001, KIDNEY BLOOD PRESS R, V24, P1, DOI 10.1159/000054198; Ji HJ, 2002, J BIOL CHEM, V277, P8395, DOI 10.1074/jbc.M109465200; Ji HL, 2000, J BIOL CHEM, V275, P27947; Jouret F, 2007, J AM SOC NEPHROL, V18, P707, DOI 10.1681/ASN.2006030269; KATZ SM, 1988, NEW ENGL J MED, V319, P263, DOI 10.1056/NEJM198808043190502; Khundmiri SJ, 2003, J BIOL CHEM, V278, P10134, DOI 10.1074/jbc.M211775200; Kimura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029269; Konig J, 2001, EMBO REP, V2, P1047, DOI 10.1093/embo-reports/kve232; Konstas AA, 2003, PFLUG ARCH EUR J PHY, V445, P513, DOI 10.1007/s00424-002-0957-z; Lewarchik CM, 2008, J BIOL CHEM, V283, P28401, DOI 10.1074/jbc.M800516200; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Ma JJ, 2000, NEWS PHYSIOL SCI, V15, P154; McNicholas CM, 1996, P NATL ACAD SCI USA, V93, P8083, DOI 10.1073/pnas.93.15.8083; Michlig S, 2005, J BIOL CHEM, V280, P38264, DOI 10.1074/jbc.M506308200; Murer H, 2003, ANNU REV PHYSIOL, V65, P531, DOI 10.1146/annurev.physiol.65.042902.092424; Nagel G, 2005, J PHYSIOL-LONDON, V564, P671, DOI 10.1113/jphysiol.2004.079046; Nagel G, 2001, EMBO REP, V2, P249, DOI 10.1093/embo-reports/kve045; Nijholt I, 2000, J NEUROCHEM, V75, P749, DOI 10.1046/j.1471-4159.2000.0750749.x; Poppe H, 2008, NAT METHODS, V5, P277, DOI 10.1038/nmeth0408-277; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Prie D, 2010, NEW ENGL J MED, V362, P2399, DOI 10.1056/NEJMra0904186; Schwake M, 2000, J BIOL CHEM, V275, P13343, DOI 10.1074/jbc.275.18.13343; Shead EF, 2007, THORAX, V62, P650, DOI 10.1136/thx.2006.075887; Shimkets RA, 1997, J BIOL CHEM, V272, P25537, DOI 10.1074/jbc.272.41.25537; Simard CF, 2007, J BIOL CHEM, V282, P18083, DOI 10.1074/jbc.M607811200; Song YL, 2009, AM J PHYSIOL-LUNG C, V297, pL1131, DOI 10.1152/ajplung.00085.2009; Street ME, 2006, HORM RES, V66, P162, DOI 10.1159/000094143; Suaud L, 2002, J BIOL CHEM, V277, P8928, DOI 10.1074/jbc.M111482200; Suaud L, 2007, AM J PHYSIOL-CELL PH, V292, pC1553, DOI 10.1152/ajpcell.00064.2006; Taddei A, 2004, FEBS LETT, V558, P52, DOI 10.1016/S0014-5793(04)00011-0; Wagner CA, 1996, CELL PHYSIOL BIOCHEM, V6, P105, DOI 10.1159/000154799; Wang YX, 2006, EMBO J, V25, P5049, DOI 10.1038/sj.emboj.7601387; Weber WM, 2001, PFLUG ARCH EUR J PHY, V441, P850, DOI 10.1007/s004240000497; Xie JX, 2002, J BIOL CHEM, V277, P23019, DOI 10.1074/jbc.M201661200; Yan WS, 2004, J BIOL CHEM, V279, P23183, DOI 10.1074/jbc.M402373200; Yang LM, 2006, J BIOL CHEM, V281, P9859, DOI 10.1074/jbc.M512046200	56	2	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34879	10.1371/journal.pone.0034879	http://dx.doi.org/10.1371/journal.pone.0034879			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514683	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341600089
J	Fouet, C; Gray, E; Besansky, NJ; Costantini, C				Fouet, Caroline; Gray, Emilie; Besansky, Nora J.; Costantini, Carlo			Adaptation to Aridity in the Malaria Mosquito Anopheles gambiae: Chromosomal Inversion Polymorphism and Body Size Influence Resistance to Desiccation	PLOS ONE			English	Article							MOLECULAR-FORMS; DROSOPHILA-MELANOGASTER; NATURAL-POPULATION; EVOLUTIONARY HISTORY; SENSU-STRICTO; WATER-LOSS; DIPTERA; TRAITS; VECTORS; CLINES	Chromosomal inversions are thought to confer a selective advantage in alternative habitats by protecting co-adapted alleles from recombination. The frequencies of two inversions (2La and 2Rb) of the afro-tropical malaria mosquito Anopheles gambiae change gradually along geographical clines, increasing in frequency with degree of aridity. Such clines can result from gene flow and local selection acting upon alternative karyotypes along the cline, suggesting that these inversions may be associated with tolerance to xeric conditions. Since water loss represents a major challenge in xeric habitats, it can be supposed that genes inside these inversions are involved in water homeostasis. To test this hypothesis, we compared the desiccation resistance of alternative karyotypes from a colonised 2Rb/2La polymorphic population of A. gambiae from Cameroon. The strain included only the molecular form S, one of the genetic units marking incipient speciation in this taxon. Day-old mosquitoes of both sexes were assayed individually for time to death in a dry environment and the karyotype of each was determined post-mortem using molecular diagnostic assays for each inversion. In agreement with expectations based on their eco-geographical distribution, we found that 2La homokaryotypes survived significantly longer (1.3 hours) than the other karyotypes. However, there was weak support for the effect of 2Rb on desiccation resistance. Larger mosquitoes survived longer than smaller ones. Median survival of females was greater than males, but the effect of sex on desiccation resistance was weakly supported, indicating that differential survival was correlated to differences between sexes in average size. We found weak evidence for a heterotic effect of 2La karyotype on size in females. These results support the notion that genes located inside the 2La inversion are involved in water balance, contributing towards local adaptation of A. gambiae to xeric habitats, beyond the adaptive value conferred by a larger body size.	[Fouet, Caroline; Costantini, Carlo] IRD, UMR MIVEGEC, UM1, UM1,UM2,CNRS 5290,IRD 224, Montpellier, France; [Fouet, Caroline; Costantini, Carlo] OCEAC, Yaounde, Cameroon; [Gray, Emilie; Besansky, Nora J.] Univ Notre Dame, Dept Biol Sci, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Notre Dame	Fouet, C (corresponding author), IRD, UMR MIVEGEC, UM1, UM1,UM2,CNRS 5290,IRD 224, Montpellier, France.	carlo.costantini@ird.fr	Costantini, Carlo/F-3470-2012	Costantini, Carlo/0000-0003-1016-129X	French National Academy of Medicine; Volontaire International fellowship; French Ministry of Foreign Affairs; United States National Institutes of Health [R01 AI076584-01A2]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076584] Funding Source: NIH RePORTER	French National Academy of Medicine; Volontaire International fellowship; French Ministry of Foreign Affairs; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CF benefited from a scholarship of the French National Academy of Medicine, and a Volontaire International fellowship sponsored by the French Ministry of Foreign Affairs. This work was funded by United States National Institutes of Health project No. R01 AI076584-01A2 to NJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye-Antwi F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-225; Addo-Bediako A, 2001, J INSECT PHYSIOL, V47, P1377, DOI 10.1016/S0022-1910(01)00128-7; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Betran E, 1998, EVOLUTION, V52, P144, DOI [10.2307/2410929, 10.1111/j.1558-5646.1998.tb05147.x]; BITNERMATHE BC, 1995, HEREDITY, V75, P54, DOI 10.1038/hdy.1995.103; Bradshaw WE, 1997, ECOLOGY, V78, P969, DOI 10.1890/0012-9658(1997)078[0969:HODTAP]2.0.CO;2; BRIEGEL H, 1990, J MED ENTOMOL, V27, P839, DOI 10.1093/jmedent/27.5.839; Brooke BD, 2008, T ROY SOC TROP MED H, V102, P524, DOI 10.1016/j.trstmh.2008.01.001; Caputo B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016415; Cassone BJ, 2011, MOL ECOL, V20, P2567, DOI 10.1111/j.1365-294X.2011.05114.x; Clements AN., 1999, SENSORY RECEPTION BE; Clements AN, 1992, DEVELOPMENT; Coetzee M, 2000, PARASITOL TODAY, V16, P74, DOI 10.1016/S0169-4758(99)01563-X; Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; COLUZZI M, 1992, PARASITOL TODAY, V8, P113, DOI 10.1016/0169-4758(92)90277-9; Coluzzi M, 1984, B WORLD HEALTH ORGAN, V62, P107; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; Coulibaly MB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-133; Crawley M.J., 2007, R BOOK; Crawley M.J., 1993, GLIM ECOLOGISTS; de Souza D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009927; della Torre A, 2002, SCIENCE, V298, P115, DOI 10.1126/science.1078170; della Torre A, 2005, INSECT BIOCHEM MOLEC, V35, P755, DOI 10.1016/j.ibmb.2005.02.006; Djogbenou L, 2010, ACTA TROP, V114, P116, DOI 10.1016/j.actatropica.2010.02.001; Dobzhansky T., 1954, Caryologia Suppl, V6, P435; DOBZHANSKY T, 1947, GENETICS, V32, P142; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; Fanello C, 2002, MED VET ENTOMOL, V16, P461, DOI 10.1046/j.1365-2915.2002.00393.x; Gibbs AG, 2002, COMP BIOCHEM PHYS A, V133, P781, DOI 10.1016/S1095-6433(02)00208-8; Gibbs AG, 2003, J EXP BIOL, V206, P1183, DOI 10.1242/jeb.00233; Gibbs AG, 1997, J EXP BIOL, V200, P1821; Gray EM, 2005, AM J TROP MED HYG, V73, P553, DOI 10.4269/ajtmh.2005.73.553; Gray EM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-215; Hadley N. F, 1994, WATER RELATIONS TERR; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; HASSON E, 1992, HEREDITY, V68, P557, DOI 10.1038/hdy.1992.78; Hoffmann AA, 2004, TRENDS ECOL EVOL, V19, P482, DOI 10.1016/j.tree.2004.06.013; Hoffmann AA, 2007, GENETICA, V129, P133, DOI 10.1007/s10709-006-9010-z; Holzapfel CM, 2002, ECOLOGY, V83, P607, DOI 10.1890/0012-9658(2002)083[0607:PTRBET]2.0.CO;2; HUNT R H, 1973, Parassitologia (Rome), V15, P137; Iriarte PF, 2000, EVOLUTION, V54, P1295, DOI 10.1554/0014-3820(2000)054[1295:TROTUO]2.0.CO;2; Iriarte PJF, 2003, HEREDITY, V91, P51, DOI 10.1038/sj.hdy.6800280; Kennington WJ, 2007, GENETICS, V177, P549, DOI 10.1534/genetics.107.074336; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Koella JC, 1996, J MED ENTOMOL, V33, P261, DOI 10.1093/jmedent/33.2.261; Lawniczak MKN, 2010, SCIENCE, V330, P512, DOI 10.1126/science.1195755; Lee Y, 2009, J MED ENTOMOL, V46, P316, DOI 10.1603/033.046.0216; Lehmann T, 2008, INFECT GENET EVOL, V8, P737, DOI 10.1016/j.meegid.2008.06.003; Lindsay SW, 1998, P ROY SOC B-BIOL SCI, V265, P847, DOI 10.1098/rspb.1998.0369; Lobo NF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-293; LYIMO EO, 1993, MED VET ENTOMOL, V7, P328, DOI 10.1111/j.1365-2915.1993.tb00700.x; Molineaux L, 2020, GARKI PROJECT RES EP, V8; NEI M, 1967, GENETICS, V57, P625; Nevo E, 1997, THEOR POPUL BIOL, V52, P231, DOI 10.1006/tpbi.1997.1330; Norry FM, 1997, HEREDITY, V79, P585, DOI 10.1038/hdy.1997.203; Nuismer SL, 2000, EVOLUTION, V54, P1102; PETRARCA V, 1992, AM J TROP MED HYG, V46, P229, DOI 10.4269/ajtmh.1992.46.229; Petrarca V, 1998, J MED ENTOMOL, V35, P16, DOI 10.1093/jmedent/35.1.16; Pinheiro J., 2019, NLME LINEAR NONLINEA; Polerstock AR, 2002, J MED ENTOMOL, V39, P545, DOI 10.1603/0022-2585-39.3.545; Pombi M, 2008, BMC EVOL BIOL, V8, P309, DOI DOI 10.1186/1471-2148-8-309; Powell JR, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P101; PREVOSTI A, 1985, EVOLUTION, V39, P838, DOI 10.1111/j.1558-5646.1985.tb00425.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rako L, 2006, GENETICA, V128, P373, DOI 10.1007/s10709-006-7375-7; Rako L, 2007, MOL ECOL, V16, P2948, DOI 10.1111/j.1365-294X.2007.03332.x; Rego C, 2009, EVOLUTION, P1; Rocca KAC, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-147; Rodriguez C, 1999, EVOLUTION, V53, P612, DOI [10.1111/j.1558-5646.1999.tb03796.x, 10.2307/2640797]; Rouault JD, 2004, GENETICA, V120, P195, DOI 10.1023/B:GENE.0000017641.75820.49; RUIZ A, 1991, GENETICS, V128, P739; Schmidt-Nielsen K, 1997, ANIMAL PHYSL ADAPTAT; Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17; Therneau TM., SURVIVAL SURVIVAL AN; Tripet F, 2003, AM J TROP MED HYG, V68, P1; Weeks AR, 2000, EXP APPL ACAROL, V24, P775, DOI 10.1023/A:1006486400800; White BJ, 2007, AM J TROP MED HYG, V76, P334; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; Williams AE, 1998, J EXP BIOL, V201, P2953	80	55	55	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34841	10.1371/journal.pone.0034841	http://dx.doi.org/10.1371/journal.pone.0034841			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514674	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600080
J	Kasper, J; Hoffmann, F; Heesen, C; Kopke, S; Geiger, F				Kasper, Juergen; Hoffmann, Frauke; Heesen, Christoph; Koepke, Sascha; Geiger, Friedemann			MAPPIN'SDM - The Multifocal Approach to Sharing in Shared Decision Making	PLOS ONE			English	Article							PATIENTS PERCEIVED INVOLVEMENT; PRIMARY-CARE; PATIENT INVOLVEMENT; OPTION SCALE; VALIDATION; COMMUNICATION; PERCEPTIONS; SUPPORT; QUALITY; VERSION	Background: The wide scale permeation of health care by the shared decision making concept (SDM) reflects its relevance and advanced stage of development. An increasing number of studies evaluating the efficacy of SDM use instruments based on various sub-constructs administered from different viewpoints. However, as the concept has never been captured in operable core definition it is quite difficult to link these parts of evidence. This study aims at investigating interrelations of SDM indicators administered from different perspectives. Method: A comprehensive inventory was developed mapping judgements from different perspectives (observer, doctor, patient) and constructs (behavior, perception) referring to three units (doctor, patient, doctor-patient-dyad) and an identical set of SDM-indicators. The inventory adopted the existing approaches, but added additional observer foci (patient and doctor-patient-dyad) and relevant indicators hitherto neglected by existing instruments. The complete inventory comprising a doctor-patient-questionnaire and an observer-instrument was applied to 40 decision consultations from 10 physicians from different medical fields. Convergent validities were calculated on the basis of Pearson correlation coefficients. Results: Reliabilities for all scales were high to excellent. No correlations were found between observer and patients or physicians neither for means nor for single items. Judgements of doctors and patients were moderately related. Correlations between the observer scales and within the subjective perspectives were high. Inter-perspective agreement was not related to SDM performance or patient activity. Conclusion: The study demonstrates the contribution to involvement made by each of the relevant perspectives and emphasizes the need for an inter-subjective approach regarding SDM measurement.	[Kasper, Juergen; Koepke, Sascha] Univ Hamburg, Fac Math, Unit Hlth Sci & Educ, Hamburg, Germany; [Kasper, Juergen] Univ Med Ctr Hamburg, Dept Primary Med Care, Hamburg, Germany; [Kasper, Juergen; Hoffmann, Frauke] Univ Hamburg, Unit Hlth Sci & Educ, Hamburg, Germany; [Kasper, Juergen; Heesen, Christoph; Koepke, Sascha] Univ Med Ctr Hamburg, Inst Neuroimmunol & Clin MS Res INiMS, Hamburg, Germany; [Koepke, Sascha] Med Univ Lubeck, Nursing Res Grp, Inst Social Med, D-23538 Lubeck, Germany; [Geiger, Friedemann] Univ Med Ctr Schleswig Holstein, Tumor Ctr, Kiel, Germany; [Geiger, Friedemann] Univ Med Ctr Schleswig Holstein, Dept Pediat, Kiel, Germany	University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Lubeck; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Kasper, J (corresponding author), Univ Hamburg, Fac Math, Unit Hlth Sci & Educ, Hamburg, Germany.	k@sper.info			Tumor Center Kiel; Biogen Elan; Bayer-Health Care; Serono; Teva; Merck Serono	Tumor Center Kiel; Biogen Elan; Bayer-Health Care(Bayer AGBayer Healthcare Pharmaceuticals); Serono(Merck & Company); Teva(Teva Pharmaceutical Industries); Merck Serono(Merck & Company)	This work was undertaken as part of the project "Profile of perceived uncertainty as outcome of shared decision making'', which is funded by the Tumor Center Kiel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dr. Heesen has received financial support from Biogen Elan, Bayer-Health Care, Serono and Teva, Dr. Kasper has received travel fees to scientific conferences from Merck Serono. Dr. Kopke, Dr. Hoffmann and Dr. Geiger have nothing to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bekker HL, 2010, PATIENT EDUC COUNS, V78, P357, DOI 10.1016/j.pec.2010.01.002; Bunge M, 2010, PATIENT EDUC COUNS, V78, P316, DOI 10.1016/j.pec.2009.10.029; Charles C, 1997, SOC SCI MED, V44, P681, DOI 10.1016/S0277-9536(96)00221-3; Charles C., 2010, PSICOONCOLOGIA, V7, P243, DOI [10.5209/rev_PSIC.2010.v7.n2.15870, DOI 10.5209/REV_PSIC.2010.V7.N2.15870]; Dolan JG, 2008, PATIENT EDUC COUNS, V73, P418, DOI 10.1016/j.pec.2008.07.032; Elwyn G, 2005, HEALTH EXPECT, V8, P34, DOI 10.1111/j.1369-7625.2004.00311.x; Elwyn G, 2003, QUAL SAF HEALTH CARE, V12, P93, DOI 10.1136/qhc.12.2.93; Elwyn G, 2001, PATIENT EDUC COUNS, V43, P5, DOI 10.1016/S0738-3991(00)00149-X; Entwistle VA, 2004, PATIENT EDUC COUNS, V55, P105, DOI 10.1016/j.pec.2003.08.005; Entwistle VA, 2001, SOC SCI MED, V53, P721, DOI 10.1016/S0277-9536(00)00382-8; Entwistle VA, 2006, PATIENT EDUC COUNS, V63, P268, DOI 10.1016/j.pec.2006.05.002; FREIDIN RB, 1980, ANN INTERN MED, V93, P490, DOI 10.7326/0003-4819-93-3-490; Geiger F, 2011, Z EVID FORT IN PRESS, V4; Goss C, 2007, EPIDEMIOL PSICHIAT S, V16, P339, DOI 10.1017/S1121189X00002529; Guimond P, 2003, PATIENT EDUC COUNS, V50, P235, DOI 10.1016/S0738-3991(03)00043-0; Harter M, 2011, Z EVIDENZ FORTBILD Q, V105, P229, DOI 10.1016/j.zefq.2011.04.018; Heesen C, 2003, ACTA NEUROL SCAND, V107, P363, DOI 10.1034/j.1600-0404.2003.00086.x; JOHNSON CG, 1988, J GEN INTERN MED, V3, P144, DOI 10.1007/BF02596120; Kasper J, 2011, Z EVID FORT IN PRESS, V4; Kasper J, 2011, HLTH EXPECT, DOI 10.111/j.1369-7625.2011.00657.x; Kasper J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026255; Kriston L, 2010, PATIENT EDUC COUNS, V80, P94, DOI 10.1016/j.pec.2009.09.034; Krones T, 2008, ANN FAM MED, V6, P218, DOI 10.1370/afm.854; LeBlanc A, 2009, MED DECIS MAKING, V29, P61, DOI 10.1177/0272989X08327067; Legare F, 2011, J INTERPROF CARE, V25, P18, DOI 10.3109/13561820.2010.490502; LERMAN CE, 1990, J GEN INTERN MED, V5, P29, DOI 10.1007/BF02602306; Loh A, 2006, PATIENT EDUC COUNS, V63, P314, DOI 10.1016/j.pec.2006.04.006; Makoul G, 2006, PATIENT EDUC COUNS, V60, P301, DOI 10.1016/j.pec.2005.06.010; Martin LR, 2003, BEHAV MED, V28, P159, DOI 10.1080/08964280309596054; Melbourne E, 2010, PATIENT EDUC COUNS, V78, P177, DOI 10.1016/j.pec.2009.07.009; O'Connor AM, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001431.pub2, 10.1002/14651858.CD001431.pub3, 10.1002/14651858.CD001431.pub4]; Rothwell PM, 1997, BMJ-BRIT MED J, V314, P1580, DOI 10.1136/bmj.314.7094.1580; Saba GW, 2006, ANN FAM MED, V4, P54, DOI 10.1370/afm.393; Scholl I, 2012, PATIENT ED COU UNPUB; Scholl I, 2011, Z EVIDENZ FORTBILD Q, V105, P313, DOI 10.1016/j.zefq.2011.04.012; Shields CG, 2005, ANN FAM MED, V3, P436, DOI 10.1370/afm.305; Simon D, 2006, PATIENT EDUC COUNS, V63, P319, DOI 10.1016/j.pec.2006.04.012; Singh S, 2010, HEALTH EXPECT, V13, P244, DOI 10.1111/j.1369-7625.2009.00587.x; Smith MY, 2006, J PAIN SYMPTOM MANAG, V32, P71, DOI 10.1016/j.jpainsymman.2006.01.007; Stacey D, 2008, PATIENT EDUC COUNS, V73, P519, DOI 10.1016/j.pec.2008.07.016; STARFIELD B, 1981, AM J PUBLIC HEALTH, V71, P127, DOI 10.2105/AJPH.71.2.127; Towle A, 1999, BRIT MED J, V319, P766, DOI 10.1136/bmj.319.7212.766	42	62	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34849	10.1371/journal.pone.0034849	http://dx.doi.org/10.1371/journal.pone.0034849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UT	22514677	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600083
J	Macia, L; Tsai, VWW; Nguyen, AD; Johnen, H; Kuffner, T; Shi, YC; Lin, S; Herzog, H; Brown, DA; Breit, SN; Sainsbury, A				Macia, Laurence; Tsai, Vicky Wang-Wei; Nguyen, Amy D.; Johnen, Heiko; Kuffner, Tamara; Shi, Yan-Chuan; Lin, Shu; Herzog, Herbert; Brown, David A.; Breit, Samuel N.; Sainsbury, Amanda			Macrophage Inhibitory Cytokine 1 (MIC-1/GDF15) Decreases Food Intake, Body Weight and Improves Glucose Tolerance in Mice on Normal & Obesogenic Diets	PLOS ONE			English	Article							TGF-BETA SUPERFAMILY; NEUROPEPTIDE-Y; MESSENGER-RNA; OBESITY; LEPTIN; MELANOCORTIN; RESISTANCE; OXIDATION; ANOREXIA; INSULIN	Food intake and body weight are controlled by a variety of central and peripheral factors, but the exact mechanisms behind these processes are still not fully understood. Here we show that that macrophage inhibitory cytokine-1 (MIC-1/GDF15), known to have anorexigenic effects particularly in cancer, provides protection against the development of obesity. Both under a normal chow diet and an obesogenic diet, the transgenic overexpression of MIC-1/GDF15 in mice leads to decreased body weight and fat mass. This lean phenotype was associated with decreased spontaneous but not fasting-induced food intake, on a background of unaltered energy expenditure and reduced physical activity. Importantly, the overexpression of MIC-1/GDF15 improved glucose tolerance, both under normal and high fat-fed conditions. Altogether, this work shows that the molecule MIC-1/GDF15 might be beneficial for the treatment of obesity as well as perturbations in glucose homeostasis.	[Macia, Laurence; Nguyen, Amy D.; Shi, Yan-Chuan; Lin, Shu; Herzog, Herbert; Sainsbury, Amanda] Garvan Inst Med Res, Neurosci Program, Sydney, NSW, Australia; [Macia, Laurence] Monash Univ, Dept Immunol, Clayton, Vic, Australia; [Tsai, Vicky Wang-Wei; Johnen, Heiko; Kuffner, Tamara; Brown, David A.; Breit, Samuel N.] St Vincents Hosp, St Vincents Ctr Appl Med Res, Sydney, NSW 2010, Australia; [Herzog, Herbert] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Sainsbury, Amanda] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Sainsbury, Amanda] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	Garvan Institute of Medical Research; Monash University; St Vincents Hospital Sydney; University of New South Wales Sydney; University of New South Wales Sydney; University of Sydney	Macia, L (corresponding author), Garvan Inst Med Res, Neurosci Program, Sydney, NSW, Australia.	amanda.sainsbury-salis@sydney.edu.au	Nguyen, Amy D/K-2588-2019; Macia, laurence/D-5983-2016; /A-4361-2010; Salis, Amanda/A-3187-2011; Shi, Yanchuan/H-5608-2012; Herzog, Herbert/B-8294-2008	Nguyen, Amy D/0000-0003-4603-564X; Macia, laurence/0000-0003-0835-851X; Salis, Amanda/0000-0001-9176-1574; Shi, Yanchuan/0000-0002-8368-6735; , Herbert/0000-0002-1713-1029; lin, shu/0000-0002-4239-2028; Brown, David/0000-0003-1382-9419	National Health and Medical Research Council of Australia [455291]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the National Health and Medical Research Council of Australia (http://www.nhmrc.gov.au/) with research grants (455291), Career Development Awards (SL, DAB and AS) and a Research Fellowship (HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banno R, 2007, FEBS LETT, V581, P1131, DOI 10.1016/j.febslet.2007.02.019; Bergen HT, 1999, BRAIN RES, V851, P198, DOI 10.1016/S0006-8993(99)02186-1; Bootcov MR, 1997, P NATL ACAD SCI USA, V94, P11514, DOI 10.1073/pnas.94.21.11514; Breit SN, 2011, GROWTH FACTORS, V29, P187, DOI 10.3109/08977194.2011.607137; Brown DA, 2002, LANCET, V359, P2159, DOI 10.1016/S0140-6736(02)09093-1; Brown DA, 2011, SERUM MACROPHAGE INH; Ding Q, 2009, ENDOCRINOLOGY, V150, P1688, DOI 10.1210/en.2008-0952; Dostalova I, 2009, EUR J ENDOCRINOL, V161, P397, DOI 10.1530/EJE-09-0417; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; FRAYN KN, 1983, J APPL PHYSIOL, V55, P628, DOI 10.1152/jappl.1983.55.2.628; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Johnen H, 2007, NAT MED, V13, P1333, DOI 10.1038/nm1677; Karczewska-Kupczewska M, 2012, CLIN ENDOCRINOL, V76, P46, DOI 10.1111/j.1365-2265.2011.04139.x; Lin S, 2000, BRAIN RES, V875, P89, DOI 10.1016/S0006-8993(00)02580-4; Marino JS, 2011, TRENDS ENDOCRIN MET, V22, P275, DOI 10.1016/j.tem.2011.03.001; McLean J., 1987, ANIMAL HUMAN CALORIM; Patel HR, 2006, DIABETES, V55, P3091, DOI 10.2337/db05-0624; Sainsbury A, 2010, MOL CELL ENDOCRINOL, V316, P109, DOI 10.1016/j.mce.2009.09.025; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; VanHeek M, 1997, J CLIN INVEST, V99, P385, DOI 10.1172/JCI119171; Wiklund FE, 2010, AGING CELL, V9, P1057, DOI 10.1111/j.1474-9726.2010.00629.x; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; ZARJEVSKI N, 1994, DIABETES, V43, P764, DOI 10.2337/diabetes.43.6.764; Zhang L, 2010, INT J OBESITY, V34, P357, DOI 10.1038/ijo.2009.232	25	118	128	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34868	10.1371/journal.pone.0034868	http://dx.doi.org/10.1371/journal.pone.0034868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514681	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341600087
J	Mass, T; Drake, JL; Haramaty, L; Rosenthal, Y; Schofield, OME; Sherrell, RM; Falkowski, PG				Mass, Tali; Drake, Jeana L.; Haramaty, Liti; Rosenthal, Yair; Schofield, Oscar M. E.; Sherrell, Robert M.; Falkowski, Paul G.			Aragonite Precipitation by "Proto-Polyps" in Coral Cell Cultures	PLOS ONE			English	Article							ORGANIC MATRIX; SCLERACTINIAN CORALS; GALAXEA-FASCICULARIS; REEF; PHOTOSYNTHESIS; CALCIFICATION; BIOMINERALIZATION; RESPONSES	The mechanisms of coral calcification at the molecular, cellular and tissue levels are poorly understood. In this study, we examine calcium carbonate precipitation using novel coral tissue cultures that aggregate to form "proto-polyps". Our goal is to establish an experimental system in which calcification is facilitated at the cellular level, while simultaneously allowing in vitro manipulations of the calcifying fluid. This novel coral culturing technique enables us to study the mechanisms of biomineralization and their implications for geochemical proxies. Viable cell cultures of the hermatypic, zooxanthellate coral, Stylophora pistillata, have been maintained for 6 to 8 weeks. Using an enriched seawater medium with aragonite saturation state similar to open ocean surface waters (Omega(arag) similar to 4), the primary cell cultures assemble into "proto-polyps" which form an extracellular organic matrix (ECM) and precipitate aragonite crystals. These extracellular aragonite crystals, about 10 mm in length, are formed on the external face of the proto-polyps and are identified by their distinctive elongated crystallography and X-ray diffraction pattern. The precipitation of aragonite is independent of photosynthesis by the zooxanthellae, and does not occur in control experiments lacking coral cells or when the coral cells are poisoned with sodium azide. Our results demonstrate that proto-polyps, aggregated from primary coral tissue culture, function (from a biomineralization perspective) similarly to whole corals. This approach provides a novel tool for investigating the biophysical mechanism of calcification in these organisms.	[Mass, Tali; Drake, Jeana L.; Haramaty, Liti; Rosenthal, Yair; Schofield, Oscar M. E.; Sherrell, Robert M.; Falkowski, Paul G.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA; [Rosenthal, Yair; Sherrell, Robert M.; Falkowski, Paul G.] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Mass, T (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08903 USA.	tmass@marine.rutgers.edu	Mass, Tali/AAA-9046-2020; Schofield, Oscar/H-4169-2018	Schofield, Oscar/0000-0003-2359-4131; Mass, Tali/0000-0002-7298-290X	National Science Foundation [EF1041143]; Emerging Frontiers [1041143] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Emerging Frontiers(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by National Science Foundation Grant EF1041143. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Horani FA, 2003, MAR BIOL, V142, P419, DOI 10.1007/s00227-002-0981-8; Allemand D, 1998, J EXP BIOL, V201, P2001; Allemand D, 2004, CR PALEVOL, V3, P453, DOI 10.1016/j.crpv.2004.07.011; Barnes DJ, 1990, ECOSYSTEMS WORLD COR; Clode PL, 2003, BIOL BULL-US, V204, P138, DOI 10.2307/1543549; Clode PL, 2003, PROTOPLASMA, V220, P153, DOI 10.1007/s00709-002-0046-3; Cohen AL, 2003, REV MINERAL GEOCHEM, V54, P151, DOI 10.2113/0540151; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Cuif JP, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000783; Cuif JP, 2003, GEOCHIM COSMOCHIM AC, V67, P75, DOI 10.1016/S0016-7037(02)01041-4; Debreuil J, 2011, MAR BIOL, V158, P2765, DOI 10.1007/s00227-011-1775-7; Domart-Coulon IJ, 2001, P NATL ACAD SCI USA, V98, P11885, DOI 10.1073/pnas.211439698; Fietzke J, 2010, J ANAL ATOM SPECTROM, V25, P1953, DOI 10.1039/c0ja00036a; Gattuso JP, 1999, AM ZOOL, V39, P160; Goffredo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022338; Gorbunov MY, 2000, LIMNOL OCEANOGR, V45, P242, DOI 10.4319/lo.2000.45.1.0242; GRAN G, 1952, ANALYST, V77, P661, DOI 10.1039/an9527700661; Helman Y, 2008, P NATL ACAD SCI USA, V105, P54, DOI 10.1073/pnas.0710604105; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Johnston I.S., 1980, International Review of Cytology, V67, P171; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Krief S, 2010, GEOCHIM COSMOCHIM AC, V74, P4988, DOI 10.1016/j.gca.2010.05.023; Langdon C, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001941; Lewis E., 1998, PROGRAM DEV CO2 SYST; LEWITUS AJ, 1994, LIMNOL OCEANOGR, V39, P182, DOI 10.4319/lo.1994.39.1.0182; Marshall AT, 1998, CORAL REEFS, V17, P37, DOI 10.1007/s003380050092; Mass T, 2011, LIMNOL OCEANOGR, V56, P2176, DOI 10.4319/lo.2011.56.6.2176; MOPPER K, 1982, LIMNOL OCEANOGR, V27, P336, DOI 10.4319/lo.1982.27.2.0336; Muscatine L, 1997, CORAL REEFS, V16, P205, DOI 10.1007/s003380050075; MUSCATINE L, 1969, BIOL BULL-US, V137, P506, DOI 10.2307/1540172; Pochon X, 2010, J PHYCOL, V46, P53, DOI 10.1111/j.1529-8817.2009.00797.x; Puverel S, 2005, COMP BIOCHEM PHYS B, V141, P480, DOI 10.1016/j.cbpc.2005.05.013; Rahman MA, 2006, CALCIFIED TISSUE INT, V78, P178, DOI 10.1007/s00223-005-0253-y; Sinniger Frederic, 2010, Marine Biodiversity, V40, P57, DOI 10.1007/s12526-009-0034-3; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; Venn A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020013; Watanabe T, 2003, COMP BIOCHEM PHYS B, V136, P767, DOI 10.1016/S1096-4959(03)00177-5; Weiner S, 2003, REV MINERAL GEOCHEM, V54, P1, DOI 10.2113/0540001; YOUNG SD, 1971, COMP BIOCHEM PHYSIOL, V40, P113, DOI 10.1016/0305-0491(71)90067-8	39	41	43	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35049	10.1371/journal.pone.0035049	http://dx.doi.org/10.1371/journal.pone.0035049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514707	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600113
J	Silva, MJ; Brodt, MD; Lynch, MA; Stephens, AL; Wood, DJ; Civitelli, R				Silva, Matthew J.; Brodt, Michael D.; Lynch, Michelle A.; Stephens, Abby L.; Wood, Daniel J.; Civitelli, Roberto			Tibial Loading Increases Osteogenic Gene Expression and Cortical Bone Volume in Mature and Middle-Aged Mice	PLOS ONE			English	Article							OSTEOCYTE LACUNAR DENSITY; MECHANICAL-PROPERTIES; INBRED STRAINS; MOUSE TIBIA; ADULT; EXERCISE; YOUNG; RESPONSIVENESS; COMPRESSION; SKELETON	There are conflicting data on whether age reduces the response of the skeleton to mechanical stimuli. We examined this question in female BALB/c mice of different ages, ranging from young to middle-aged (2, 4, 7, 12 months). We first assessed markers of bone turnover in control (non-loaded) mice. Serum osteocalcin and CTX declined significantly from 2 to 4 months (p<0.001). There were similar age-related declines in tibial mRNA expression of osteoblast-and osteoclast-related genes, most notably in late osteoblast/matrix genes. For example, Col1a1 expression declined 90% from 2 to 7 months (p<0.001). We then assessed tibial responses to mechanical loading using age-specific forces to produce similar peak strains (-1300 mu epsilon endocortical; -2350 mu epsilon periosteal). Axial tibial compression was applied to the right leg for 60 cycles/day on alternate days for 1 or 6 weeks. qPCR after 1 week revealed no effect of loading in young (2-month) mice, but significant increases in osteoblast/matrix genes in older mice. For example, in 12-month old mice Col1a1 was increased 6-fold in loaded tibias vs. controls (p = 0.001). In vivo microCT after 6 weeks revealed that loaded tibias in each age group had greater cortical bone volume (BV) than contralateral control tibias (p<0.05), due to relative periosteal expansion. The loading-induced increase in cortical BV was greatest in 4-month old mice (+13%; p<0.05 vs. other ages). In summary, non-loaded female BALB/c mice exhibit an age-related decline in measures related to bone formation. Yet when subjected to tibial compression, mice from 2-12 months have an increase in cortical bone volume. Older mice respond with an upregulation of osteoblast/matrix genes, which increase to levels comparable to young mice. We conclude that mechanical loading of the tibia is anabolic for cortical bone in young and middle-aged female BALB/c mice.	[Silva, Matthew J.; Brodt, Michael D.; Lynch, Michelle A.; Stephens, Abby L.; Wood, Daniel J.] Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA; [Silva, Matthew J.; Stephens, Abby L.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Civitelli, Roberto] Washington Univ, Dept Internal Med, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Silva, MJ (corresponding author), Washington Univ, Dept Orthopaed Surg, St Louis, MO 63130 USA.	silvam@wustl.edu	Civitelli, Roberto/AAA-8260-2019	Civitelli, Roberto/0000-0003-4076-4315; Silva, Matthew/0000-0001-7375-4522; Cheng, Abby/0000-0002-8166-0806	NIH/NIAMS [R01AR047867, P30AR057235]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047867, P30AR057235] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by NIH/NIAMS (www.niams.nih.gov) grants R01AR047867 and P30AR057235 (Washington University Musculoskeletal Research Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beamer WG, 1996, BONE, V18, P397, DOI 10.1016/8756-3282(96)00047-6; Brodt MD, 2010, J BONE MINER RES, V25, P2006, DOI 10.1002/jbmr.96; Buhl KM, 2001, J APPL PHYSIOL, V90, P1359, DOI 10.1152/jappl.2001.90.4.1359; Busse B, 2010, AGING CELL, V9, P1065, DOI 10.1111/j.1474-9726.2010.00633.x; Cao J, 2003, J BONE MINER RES, V18, P270, DOI 10.1359/jbmr.2003.18.2.270; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Dimai HP, 1998, BONE, V22, P211, DOI 10.1016/S8756-3282(97)00268-8; Donahue SW, 2001, AM J PHYSIOL-CELL PH, V281, pC1635, DOI 10.1152/ajpcell.2001.281.5.C1635; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Flurkey KM, 2007, MOUSE BIOMEDICAL RES, V2nd, P637; FORWOOD MR, 1994, BONE, V15, P603, DOI 10.1016/8756-3282(94)90307-7; Frenkel B, 1997, ENDOCRINOLOGY, V138, P2109, DOI 10.1210/en.138.5.2109; Fritton JC, 2008, J BONE MINER RES, V23, P663, DOI [10.1359/jbmr.080104, 10.1359/JBMR.080104]; Fritton JC, 2005, BONE, V36, P1030, DOI 10.1016/j.bone.2005.02.013; Hamrick MW, 2006, BONE, V39, P845, DOI 10.1016/j.bone.2006.04.011; Hoshi A, 1998, TOHOKU J EXP MED, V185, P15, DOI 10.1620/tjem.185.15; Jarvinen TLN, 2003, J BONE MINER RES, V18, P1292, DOI 10.1359/jbmr.2003.18.7.1292; Kesavan C, 2005, J APPL PHYSIOL, V99, P1951, DOI 10.1152/japplphysiol.00401.2005; Klein-Nulend J, 2002, OSTEOPOROSIS INT, V13, P137, DOI 10.1007/s001980200005; Kotiya AA, 2011, BONE, V48, P468, DOI 10.1016/j.bone.2010.10.001; Leppanen OV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002540; Li X, 2002, CALCIFIED TISSUE INT, V71, P416, DOI 10.1007/s00223-001-1106-y; Lynch ME, 2011, BONE, V49, P439, DOI 10.1016/j.bone.2011.05.017; Lynch ME, 2010, J APPL PHYSIOL, V109, P685, DOI 10.1152/japplphysiol.00210.2010; Lynch MA, 2010, J ORTHOP RES, V28, P241, DOI 10.1002/jor.20965; McKenzie JA, 2011, BONE, V48, P250, DOI 10.1016/j.bone.2010.09.005; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; RAAB DM, 1990, J APPL PHYSIOL, V68, P130, DOI 10.1152/jappl.1990.68.1.130; Roosa SMM, 2011, J BONE MINER RES, V26, P100, DOI 10.1002/jbmr.193; RUBIN CT, 1992, CALCIFIED TISSUE INT, V50, P306, DOI 10.1007/BF00301627; SILBERMANN M, 1990, CALCIFIED TISSUE INT, V46, P80, DOI 10.1007/BF02556091; Silva MJ, 2005, ANAT REC PART A, V283A, P380, DOI 10.1002/ar.a.20171; Srinivasan S, 2003, BONE, V33, P946, DOI 10.1016/j.bone.2003.07.009; Sterck JGH, 1998, AM J PHYSIOL-ENDOC M, V274, pE1113, DOI 10.1152/ajpendo.1998.274.6.E1113; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; TURNER CH, 1995, J BONE MINER RES, V10, P1544; UMEMURA Y, 1995, INT J SPORTS MED, V16, P364, DOI 10.1055/s-2007-973021; Vashishth D, 2000, BONE, V26, P375, DOI 10.1016/S8756-3282(00)00236-2; Willinghamm MD, 2010, CALCIFIED TISSUE INT, V86, P470, DOI 10.1007/s00223-010-9359-y; Zaman G, 2010, BONE, V46, P628, DOI 10.1016/j.bone.2009.10.021	40	44	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34980	10.1371/journal.pone.0034980	http://dx.doi.org/10.1371/journal.pone.0034980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514696	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600102
J	Welman, A; Sproul, D; Mullen, P; Muir, M; Kinnaird, AR; Harrison, DJ; Faratian, D; Brunton, VG; Frame, MC				Welman, Arkadiusz; Sproul, Duncan; Mullen, Peter; Muir, Morwenna; Kinnaird, Andrew R.; Harrison, David J.; Faratian, Dana; Brunton, Valerie G.; Frame, Margaret C.			Diversity of Matriptase Expression Level and Function in Breast Cancer	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; TRANSMEMBRANE SERINE-PROTEASE; TISSUE MICROARRAY ANALYSIS; HUMAN PROSTATE-CANCER; CELL-LINES; TUMOR PROGRESSION; ACTIVATION; CARCINOGENESIS; INHIBITOR-1	Overexpression of matriptase has been reported in a variety of human cancers and is sufficient to trigger tumor formation in mice, but the importance of matriptase in breast cancer remains unclear. We analysed matriptase expression in 16 human breast cancer cell lines and in 107 primary breast tumors. The data revealed considerable diversity in the expression level of this protein indicating that the significance of matriptase may vary from case to case. Matriptase protein expression was correlated with HER2 expression and highest expression was seen in HER2-positive cell lines, indicating a potential role in this subgroup. Stable overexpression of matriptase in two breast cancer cell lines had different consequences. In MDA-MB-231 human breast carcinoma cells the only noted consequence of matriptase overexpression was modestly impaired growth in vivo. In contrast, overexpression of matriptase in 4T1 mouse breast carcinoma cells resulted in visible changes in morphology, actin staining and cell to cell contacts. This correlated with downregulation of the cell-cell adhesion molecule E-cadherin. These results suggest that the functions of matriptase in breast cancer are likely to be variable and cell context dependent.	[Welman, Arkadiusz; Sproul, Duncan; Muir, Morwenna; Kinnaird, Andrew R.; Brunton, Valerie G.; Frame, Margaret C.] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland; [Sproul, Duncan; Mullen, Peter; Harrison, David J.; Faratian, Dana] Univ Edinburgh, Inst Genet & Mol Med, Div Pathol, Edinburgh, Midlothian, Scotland; [Sproul, Duncan; Mullen, Peter; Harrison, David J.; Faratian, Dana] Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Breakthrough Res Unit, Edinburgh, Midlothian, Scotland; [Sproul, Duncan] Univ Edinburgh, Inst Genet & Mol Med, Med Res Council Human Genet Unit, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Welman, A (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland.	A.Welman@ed.ac.uk	Muir, Morwenna/N-5448-2019	Muir, Morwenna/0000-0001-5835-3886; Frame, Margaret/0000-0001-5882-1942; harrison, david/0000-0001-9041-9988	Cancer Research UK Program Grant [C157/A9148]	Cancer Research UK Program Grant(Cancer Research UK)	This work was funded by Cancer Research UK Program Grant (C157/A9148). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud CM, 2002, CLIN EXP METASTAS, V19, P639, DOI 10.1023/A:1020985632550; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Brunton VG, 2008, CURR OPIN PHARMACOL, V8, P427, DOI 10.1016/j.coph.2008.06.012; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Cheng HX, 2009, CANCER RES, V69, P1828, DOI 10.1158/0008-5472.CAN-08-3728; Clark EB, 2010, J BIOL CHEM, V285, P27130, DOI 10.1074/jbc.M110.153213; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Darragh MR, 2010, CANCER RES, V70, P1505, DOI 10.1158/0008-5472.CAN-09-1640; Farady CJ, 2007, J MOL BIOL, V369, P1041, DOI 10.1016/j.jmb.2007.03.078; Faratian D, 2009, CANCER RES, V69, P6713, DOI 10.1158/0008-5472.CAN-09-0777; Galkin AV, 2004, PROSTATE, V61, P228, DOI 10.1002/pros.20094; Heuberger J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002915; Jin XL, 2006, CANCER SCI, V97, P1327, DOI 10.1111/j.1349-7006.2006.00328.x; Jin XL, 2005, J CELL BIOCHEM, V95, P632, DOI 10.1002/jcb.20418; Kang JY, 2003, CANCER RES, V63, P1101; Kauppinen JM, 2010, CANCER EPIDEM BIOMAR, V19, P2133, DOI 10.1158/1055-9965.EPI-10-0418; Kim C, 2011, BLOOD, V117, P1415, DOI 10.1182/blood-2010-03-275289; Kiyomiya KI, 2006, AM J PHYSIOL-CELL PH, V291, pC40, DOI 10.1152/ajpcell.00351.2005; Lee HS, 2010, BIOCHEM BIOPH RES CO, V395, P553, DOI 10.1016/j.bbrc.2010.04.065; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Li P, 2007, J MED CHEM, V50, P5976, DOI 10.1021/jm0704898; Lin CY, 2008, FRONT BIOSCI-LANDMRK, V13, P621, DOI 10.2741/2707; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2006, MOL MED, V12, P1, DOI 10.2119/2006-00022.List; List K, 2009, FUTURE ONCOL, V5, P97, DOI 10.2217/14796694.5.1.97; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Milner JM, 2010, ARTHRITIS RHEUM-US, V62, P1955, DOI 10.1002/art.27476; Napp J, 2010, INT J CANCER, V127, P1958, DOI 10.1002/ijc.25405; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Parr C, 2004, CLIN CANCER RES, V10, P202, DOI 10.1158/1078-0432.CCR-0553-3; Serrels B, 2010, CURR BIOL, V20, P1086, DOI 10.1016/j.cub.2010.04.042; SHI YE, 1993, CANCER RES, V53, P1409; SOULE HD, 1990, CANCER RES, V50, P6075; Szabo R, 2011, ONCOGENE, V30, P2003, DOI 10.1038/onc.2010.586; Tsai WC, 2008, DIS MARKERS, V24, P89, DOI 10.1155/2008/945197; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Uhland K, 2006, CELL MOL LIFE SCI, V63, P2968, DOI 10.1007/s00018-006-6298-x; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Voshol H, 2009, FEBS J, V276, P6871, DOI 10.1111/j.1742-4658.2009.07395.x; Wang YF, 2009, J BIOL CHEM, V284, P23094, DOI 10.1074/jbc.M109.012617; Webb SL, 2011, FRONT BIOSCI-LANDMRK, V16, P539, DOI 10.2741/3704; Welm AL, 2007, P NATL ACAD SCI USA, V104, P7570, DOI 10.1073/pnas.0702095104; Welman A, 2006, NAT PROTOC, V1, P803, DOI 10.1038/nprot.2006.117; Welman A, 2010, J BIOL CHEM, V285, P11607, DOI 10.1074/jbc.M110.102392; Wu SR, 2010, AM J PATHOL, V177, P3145, DOI 10.2353/ajpath.2010.100228	50	21	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34182	10.1371/journal.pone.0034182	http://dx.doi.org/10.1371/journal.pone.0034182			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514623	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600028
J	Decker, BK; Perez, F; Hujer, AM; Hujer, KM; Hall, GS; Jacobs, MR; Gebreyes, WA; Zoll, ST; Massire, C; Eshoo, MW; Ecker, DJ; Rather, PN; Bonomo, RA				Decker, Brooke K.; Perez, Federico; Hujer, Andrea M.; Hujer, Kristine M.; Hall, Geraldine S.; Jacobs, Michael R.; Gebreyes, Wondwossen A.; Zoll, Scott T.; Massire, Christian; Eshoo, Mark W.; Ecker, David J.; Rather, Philip N.; Bonomo, Robert A.			Longitudinal Analysis of the Temporal Evolution of Acinetobacter baumannii Strains in Ohio, USA, by Using Rapid Automated Typing Methods	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; MOLECULAR EPIDEMIOLOGY; GENETIC DIVERSITY; OUTBREAK; PCR; REPRODUCIBILITY; DISSEMINATION; EMERGENCE; INFECTION; MILITARY	Genotyping methods are essential to understand the transmission dynamics of Acinetobacter baumannii. We examined the representative genotypes of A. baumannii at different time periods in select locations in Ohio, using two rapid automated typing methods: PCR coupled with electrospray ionization mass spectrometry (PCR/ESI-MS), a form of multi-locus sequence typing (MLST), and repetitive-sequence-based-PCR (rep-PCR). Our analysis included 122 isolates from 4 referral hospital systems, in 2 urban areas of Ohio. These isolates were associated with outbreaks at 3 different time periods (1996, 2000 and 2005-2007). Type assignments of PCR/ESI-MS and rep-PCR were compared to each other and to worldwide (WW) clone types. The discriminatory power of each method was determined using the Simpson's index of diversity (DI). We observed that PCR/ESI-MS sequence type (ST) 14, corresponding to WW clone 3, predominated in 1996, whereas ST 12 and 14 coexisted in the intermediate period (2000) and ST 10 and 12, belonging to WW clone 2, predominated more recently in 2007. The shift from WW clone 3 to WW clone 2 was accompanied by an increase in carbapenem resistance. The DI was approximately 0.74 for PCR/ESI-MS, 0.88 for rep-PCR and 0.90 for the combination of both typing methods. We conclude that combining rapid automated typing methods such as PCR/ESI-MS and rep-PCR serves to optimally characterize the regional molecular epidemiology of A. baumannii. Our data also sheds light on the changing sequence types in an 11 year period in Northeast Ohio.	[Decker, Brooke K.; Perez, Federico; Hujer, Andrea M.; Hujer, Kristine M.; Bonomo, Robert A.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Perez, Federico; Hujer, Andrea M.; Hujer, Kristine M.; Bonomo, Robert A.] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, Res Serv, Cleveland, OH USA; [Hall, Geraldine S.] Cleveland Clin, Pathol & Lab Med Inst, Cleveland, OH 44106 USA; [Jacobs, Michael R.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA; [Gebreyes, Wondwossen A.] Ohio State Univ, Coll Vet Med, Columbus, OH 43210 USA; [Zoll, Scott T.; Massire, Christian; Eshoo, Mark W.; Ecker, David J.] Abbott Mol Inc, Ibis Biosci Inc, Carlsbad, CA USA; [Rather, Philip N.] Vet Affairs Med Ctr, Res Serv, Decatur, GA 30033 USA; [Rather, Philip N.] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cleveland Clinic Foundation; Case Western Reserve University; University System of Ohio; Ohio State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Emory University; Case Western Reserve University; Case Western Reserve University	Decker, BK (corresponding author), NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.	Robert.Bonomo@va.gov		Ecker, David/0000-0003-4350-9037; Decker M.D., Brooke K/0000-0002-3404-9115	Steris Corporation; Veterans Affairs Merit Review Program; National Institute of Allergy and Infectious Diseases at the National Institutes of Health [RO1-AI072219-05]; Geriatric Research, Education and Clinical Care Center VISN [10]; Research Career Scientist Award from the Department of Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072219] Funding Source: NIH RePORTER	Steris Corporation; Veterans Affairs Merit Review Program(US Department of Veterans Affairs); National Institute of Allergy and Infectious Diseases at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Geriatric Research, Education and Clinical Care Center VISN; Research Career Scientist Award from the Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by the Steris Corporation to FP. RAB is supported by the Veterans Affairs Merit Review Program, the National Institute of Allergy and Infectious Diseases at the National Institutes of Health (grants RO1-AI072219-05) and the Geriatric Research, Education and Clinical Care Center VISN 10. PNR is supported by a Research Career Scientist Award from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2010, ANTIMICROB AGENTS CH, V54, P3569, DOI 10.1128/AAC.00057-10; Adams-Haduch JM, 2011, J CLIN MICROBIOL, V49, P3849, DOI 10.1128/JCM.00619-11; Blanc Dominique S., 1998, Clin Microbiol Infect, V4, P61; Diancourt L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010034; Dijkshoorn L, 1996, J CLIN MICROBIOL, V34, P1519, DOI 10.1128/JCM.34.6.1519-1525.1996; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; DIPOPOLO A, 2010, CLIN MICROBIOL INFEC; Ecker JA, 2006, J CLIN MICROBIOL, V44, P2921, DOI 10.1128/JCM.00619-06; Faria NA, 2008, J CLIN MICROBIOL, V46, P136, DOI 10.1128/JCM.01684-07; Fu YQ, 2010, J ANTIMICROB CHEMOTH, V65, P644, DOI 10.1093/jac/dkq027; Gogou V, 2011, J ANTIMICROB CHEMOTH, V66, P2767, DOI 10.1093/jac/dkr390; Grundmann H, 2001, J CLIN MICROBIOL, V39, P4190, DOI 10.1128/JCM.39.11.4190-4192.2001; Grundmann HJ, 1997, J CLIN MICROBIOL, V35, P3071, DOI 10.1128/JCM.35.12.3071-3077.1997; Higgins PG, 2010, J ANTIMICROB CHEMOTH, V65, P233, DOI 10.1093/jac/dkp428; Hujer KM, 2006, ANTIMICROB AGENTS CH, V50, P4114, DOI 10.1128/AAC.00778-06; Hujer KM, 2009, J CLIN MICROBIOL, V47, P1436, DOI 10.1128/JCM.02380-08; HUNTER PR, 1990, J CLIN MICROBIOL, V28, P1903, DOI 10.1128/JCM.28.9.1903-1905.1990; Huys G, 2005, J MED MICROBIOL, V54, P851, DOI 10.1099/jmm.0.45986-0; LIN DM, 1995, J CLIN MICROBIOL, V33, P1596, DOI 10.1128/JCM.33.6.1596-1601.1995; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Minandri F, 2012, J CLIN MICROBIO 0111, P11; Munoz-Price LS, 2008, NEW ENGL J MED, V358, P1271, DOI 10.1056/NEJMra070741; Nemec A, 2004, J MED MICROBIOL, V53, P147, DOI 10.1099/jmm.0.05445-0; Nemec A, 2000, J CLIN MICROBIOL, V38, P3937, DOI 10.1128/JCM.38.11.3937-3941.2000; Nemec A, 2008, J ANTIMICROB CHEMOTH, V62, P484, DOI 10.1093/jac/dkn205; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Perez F, 2007, ANTIMICROB AGENTS CH, V51, P3471, DOI 10.1128/AAC.01464-06; Perez F, 2010, J ANTIMICROB CHEMOTH, V65, P1807, DOI 10.1093/jac/dkq191; Petersen K, 2011, J CLIN MICROBIOL, V49, P159, DOI 10.1128/JCM.00766-10; Runnegar N, 2010, J CLIN MICROBIOL, V48, P4051, DOI 10.1128/JCM.01208-10; Scott P. T., 2004, Morbidity and Mortality Weekly Report, V53, P1063; Scott P, 2007, CLIN INFECT DIS, V44, P1577, DOI 10.1086/518170; Srinivasan VB, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-21; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Towner KJ, 2008, CLIN MICROBIOL INFEC, V14, P161, DOI 10.1111/j.1469-0691.2007.01911.x; Villegas MV, 2003, INFECT CONT HOSP EP, V24, P284, DOI 10.1086/502205; Woodford N, 2011, FEMS MICROBIOL REV, V35, P736, DOI 10.1111/j.1574-6976.2011.00268.x; Wortmann G, 2008, INFECT CONT HOSP EP, V29, P553, DOI 10.1086/588221	39	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e33443	10.1371/journal.pone.0033443	http://dx.doi.org/10.1371/journal.pone.0033443			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511922	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338600008
J	Joanne, P; Hourde, C; Ochala, J; Cauderan, Y; Medja, F; Vignaud, A; Mouisel, E; Hadj-Said, W; Arandel, L; Garcia, L; Goyenvalle, A; Mounier, R; Zibroba, D; Sakamato, K; Butler-Browne, G; Agbulut, O; Ferry, A				Joanne, Pierre; Hourde, Christophe; Ochala, Julien; Cauderan, Yvain; Medja, Fadia; Vignaud, Alban; Mouisel, Etienne; Hadj-Said, Wahiba; Arandel, Ludovic; Garcia, Luis; Goyenvalle, Aurelie; Mounier, Remi; Zibroba, Daria; Sakamato, Kei; Butler-Browne, Gillian; Agbulut, Onnik; Ferry, Arnaud			Impaired Adaptive Response to Mechanical Overloading in Dystrophic Skeletal Muscle	PLOS ONE			English	Article							MDX MICE; SIGNALING PATHWAYS; CELLULAR MECHANISMS; FUNCTIONAL OVERLOAD; MUSCULAR-DYSTROPHY; AKT/MTOR PATHWAY; PLANTARIS MUSCLE; UP-REGULATION; IN-VIVO; HYPERTROPHY	Dystrophin contributes to force transmission and has a protein-scaffolding role for a variety of signaling complexes in skeletal muscle. In the present study, we tested the hypothesis that the muscle adaptive response following mechanical overloading (ML) would be decreased in MDX dystrophic muscle lacking dystrophin. We found that the gains in muscle maximal force production and fatigue resistance in response to ML were both reduced in MDX mice as compared to healthy mice. MDX muscle also exhibited decreased cellular and molecular muscle remodeling (hypertrophy and promotion of slower/oxidative fiber type) in response to ML, and altered intracellular signalings involved in muscle growth and maintenance (mTOR, myostatin, follistatin, AMPK alpha 1, REDD1, atrogin-1, Bnip3). Moreover, dystrophin rescue via exon skipping restored the adaptive response to ML. Therefore our results demonstrate that the adaptive response in response to ML is impaired in dystrophic MDX muscle, most likely because of the dystrophin crucial role.	[Joanne, Pierre; Agbulut, Onnik] Univ Paris Diderot, CNRS EAC4413, Lab Stress & Pathol Cytoskeleton, Unit Funct & Adapt Biol, Paris, France; [Hourde, Christophe; Cauderan, Yvain; Medja, Fadia; Vignaud, Alban; Mouisel, Etienne; Hadj-Said, Wahiba; Arandel, Ludovic; Garcia, Luis; Goyenvalle, Aurelie; Butler-Browne, Gillian; Ferry, Arnaud] Sorbonne Univ, Univ Paris 06, CNRS UMR7215, Inst Myol,UMR S794,INSERM U974, F-75230 Paris 05, France; [Ochala, Julien] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Mounier, Remi] Univ Paris Diderot, Inst Cochin, CNRS UMR8104, INSERM U1016, Paris, France; [Zibroba, Daria; Sakamato, Kei] Univ Dundee, MRC Prot Phosphorylat Unit, Coll Life Sci, Dundee, Scotland	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Uppsala University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Dundee	Joanne, P (corresponding author), Univ Paris Diderot, CNRS EAC4413, Lab Stress & Pathol Cytoskeleton, Unit Funct & Adapt Biol, Paris, France.	arnaud.ferry@upmc.fr	Mouly, Gillian/G-6595-2017; Hourdé, Christophe/H-3844-2011; Goyenvalle, Aurelie/G-3402-2016; García, Luis V/GQA-9712-2022; sakamoto, kei/C-8806-2019; Goyenvalle, Aurélie/GPF-7917-2022; Ochala, Julien/K-4120-2017; ferry, arnaud/D-2816-2019	Hourdé, Christophe/0000-0001-5209-2590; sakamoto, kei/0000-0001-8839-5980; Goyenvalle, Aurélie/0000-0003-3938-1165; Ochala, Julien/0000-0002-6358-2920; ferry, arnaud/0000-0002-6050-4556; butler-browne, gillian/0000-0002-3431-242X; Joanne, Pierre/0000-0002-5873-7000; Agbulut, Onnik/0000-0003-1923-8871; Mouisel, Etienne/0000-0002-4676-5709	Universite Pierre et Marie Curie (UPMC); CNRS; INSERM; Universite Paris Descartes; ANR-Genopath In-A-Fib; ANR-Blanc Androgluco; Association Francaise contre les Myopathies (AFM); MyoAge (EC 7th FP) [223576]; Agence Francaise de Lutte contre le Dopage; Medical Research Council [MC_U127088492] Funding Source: researchfish; MRC [MC_U127088492] Funding Source: UKRI	Universite Pierre et Marie Curie (UPMC); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universite Paris Descartes; ANR-Genopath In-A-Fib(French National Research Agency (ANR)); ANR-Blanc Androgluco(French National Research Agency (ANR)); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); MyoAge (EC 7th FP); Agence Francaise de Lutte contre le Dopage; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Financial support has been provided by Universite Pierre et Marie Curie (UPMC), CNRS, INSERM, Universite Paris Descartes, ANR-Genopath In-A-Fib, ANR-Blanc Androgluco, the Association Francaise contre les Myopathies (AFM), MyoAge (EC 7th FP, contract 223576), and Agence Francaise de Lutte contre le Dopage. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Agbulut O, 2009, AM J PHYSIOL-CELL PH, V296, pC205, DOI 10.1152/ajpcell.00408.2008; Allen DG, 2010, ADV EXP MED BIOL, V682, P297, DOI 10.1007/978-1-4419-6366-6_17; Amirouche A, 2009, ENDOCRINOLOGY, V150, P286, DOI 10.1210/en.2008-0959; BALDWIN KM, 1982, J APPL PHYSIOL, V52, P467, DOI 10.1152/jappl.1982.52.2.467; Barton ER, 2006, AM J PHYSIOL-CELL PH, V290, pC411, DOI 10.1152/ajpcell.00192.2005; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Blaauw B, 2009, FASEB J, V23, P3896, DOI 10.1096/fj.09-131870; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Borst SE, 2004, AGE AGEING, V33, P548, DOI 10.1093/ageing/afh201; BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723, DOI 10.1113/jphysiol.1973.sp010369; Dumonceaux J, 2010, MOL THER, V18, P881, DOI 10.1038/mt.2009.322; Dunn SE, 2000, J CELL BIOL, V151, P663, DOI 10.1083/jcb.151.3.663; Dunn SE, 1999, J BIOL CHEM, V274, P21908, DOI 10.1074/jbc.274.31.21908; Dupont E, 2011, AM J PHYSIOL-REG I, V300, pR408, DOI 10.1152/ajpregu.00793.2009; Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7; Friedrich O, 2010, BIOPHYS J, V98, P606, DOI 10.1016/j.bpj.2009.11.005; Friedrich O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001762; Frontera WR, 1997, MUSCLE NERVE, V20, P948, DOI 10.1002/(SICI)1097-4598(199708)20:8<948::AID-MUS3>3.0.CO;2-6; Gonin P, 2005, J GENE MED, V7, P782, DOI 10.1002/jgm.716; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Gundersen K, 2010, BIOL REV CAMB PHILOS, V86, P564; Hamilton DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011624; Hornberger TA, 2011, INT J BIOCHEM CELL B, V43, P1267, DOI 10.1016/j.biocel.2011.05.007; Hourde C, 2009, ACTA PHYSIOL, V195, P471, DOI 10.1111/j.1748-1716.2008.01902.x; IANUZZO CD, 1976, LIFE SCI, V19, P1517, DOI 10.1016/0024-3205(76)90096-5; Judge LM, 2011, HUM MOL GENET, V20, P4978, DOI 10.1093/hmg/ddr433; Koo T, 2011, HUM GENE THER, V22, P1379, DOI 10.1089/hum.2011.020; Kumar A, 2004, FASEB J, V18, P102, DOI 10.1096/fj.03-0453com; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Lang JM, 2004, EXP BIOL MED, V229, P503, DOI 10.1177/153537020422900608; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Lynch GS, 2001, J PHYSIOL-LONDON, V535, P591, DOI 10.1111/j.1469-7793.2001.00591.x; Marino JS, 2008, AM J PHYSIOL-CELL PH, V295, pC1026, DOI 10.1152/ajpcell.212.2008; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mcgee SL, 2008, J PHYSIOL-LONDON, V586, P1731, DOI 10.1113/jphysiol.2007.143685; Miyazaki M, 2011, J PHYSIOL-LONDON, V589, P1831, DOI 10.1113/jphysiol.2011.205658; Miyazaki M, 2009, J APPL PHYSIOL, V106, P1367, DOI 10.1152/japplphysiol.91355.2008; Miyazaki M, 2009, AM J PHYSIOL-CELL PH, V296, pC583, DOI 10.1152/ajpcell.00464.2008; Mouisel E, 2010, MUSCLE NERVE, V41, P809, DOI 10.1002/mus.21624; Mounier R, 2009, FASEB J, V23, P2264, DOI 10.1096/fj.08-119057; Nakamura A, 2005, BBA-MOL BASIS DIS, V1740, P326, DOI 10.1016/j.bbadis.2004.12.003; Parsons SA, 2004, J BIOL CHEM, V279, P26192, DOI 10.1074/jbc.M313800200; Pietri-Rouxel F, 2010, EMBO J, V29, P643, DOI 10.1038/emboj.2009.366; Ramaswamy KS, 2011, J PHYSL; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Riviere C, 2006, GENE THER, V13, P1300, DOI 10.1038/sj.gt.3302766; Rolland JF, 2006, NEUROBIOL DIS, V24, P466, DOI 10.1016/j.nbd.2006.08.010; ROY RR, 1995, COMP BIOCHEM PHYS A, V111, P569, DOI 10.1016/0300-9629(95)00062-C; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sartori R, 2009, AM J PHYSIOL-CELL PH, V296, pC1248, DOI 10.1152/ajpcell.00104.2009; Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007; Sellman JE, 2006, J APPL PHYSIOL, V100, P258, DOI 10.1152/japplphysiol.00936.2005; Shavlakadze T, 2010, J CELL SCI, V123, P960, DOI 10.1242/jcs.061119; Spangenburg EE, 2006, J APPL PHYSIOL, V100, P129, DOI 10.1152/japplphysiol.00619.2005; Spangenburg EE, 2008, J PHYSIOL-LONDON, V586, P283, DOI 10.1113/jphysiol.2007.141507; Spangenburg EE, 2009, APPL PHYSIOL NUTR ME, V34, P328, DOI 10.1139/H09-010; Stupka N, 2006, NEUROMUSCULAR DISORD, V16, P337, DOI 10.1016/j.nmd.2006.03.003; Sun YT, 2010, J CELL BIOL, V189, P1157, DOI 10.1083/jcb.200912093; Trendelenburg AU, 2009, AM J PHYSIOL-CELL PH, V296, pC1258, DOI 10.1152/ajpcell.00105.2009; Trollet C, 2010, HUM MOL GENET, V19, P2191, DOI 10.1093/hmg/ddq098; Xu Z, 2010, MATRIX BIOL, V29, P461, DOI 10.1016/j.matbio.2010.06.001	64	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e35346	10.1371/journal.pone.0035346	http://dx.doi.org/10.1371/journal.pone.0035346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511986	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338600072
J	Szori-Doroghazi, E; Maroti, G; Szori, M; Nyilasi, A; Rakhely, G; Kovacs, KL				Szori-Doroghazi, Emma; Maroti, Gergely; Szori, Milan; Nyilasi, Andrea; Rakhely, Gabor; Kovacs, Kornel L.			Analyses of the Large Subunit Histidine-Rich Motif Expose an Alternative Proton Transfer Pathway in [NiFe] Hydrogenases	PLOS ONE			English	Article							ACTIVE-SITE; DESULFOVIBRIO-GIGAS; CRYSTAL-STRUCTURE; GAS ACCESS; GENES; CLASSIFICATION; MUTAGENESIS; CONVERSION; CHANNEL; CLUSTER	A highly conserved histidine-rich region with unknown function was recognized in the large subunit of [NiFe] hydrogenases. The HxHxxHxxHxH sequence occurs in most membrane-bound hydrogenases, but only two of these histidines are present in the cytoplasmic ones. Site-directed mutagenesis of the His-rich region of the T. roseopersicina membrane-attached Hyn hydrogenase disclosed that the enzyme activity was significantly affected only by the replacement of the His104 residue. Computational analysis of the hydrogen bond network in the large subunits indicated that the second histidine of this motif might be a component of a proton transfer pathway including Arg487, Asp103, His104 and Glu436. Substitutions of the conserved amino acids of the presumed transfer route impaired the activity of the Hyn hydrogenase. Western hybridization was applied to demonstrate that the cellular level of the mutant hydrogenases was similar to that of the wild type. Mostly based on theoretical modeling, few proton transfer pathways have already been suggested for [NiFe] hydrogenases. Our results propose an alternative route for proton transfer between the [NiFe] active center and the surface of the protein. A novel feature of this model is that this proton pathway is located on the opposite side of the large subunit relative to the position of the small subunit. This is the first study presenting a systematic analysis of an in silico predicted proton translocation pathway in [NiFe] hydrogenases by site-directed mutagenesis.	[Szori-Doroghazi, Emma; Rakhely, Gabor; Kovacs, Kornel L.] Univ Szeged, Dept Biotechnol, Szeged, Hungary; [Maroti, Gergely] Bay Zoltan Fdn Appl Res, BayGen Inst, Szeged, Hungary; [Szori, Milan] Univ Szeged, Juhasz Gyula Fac Educ, Dept Chem Informat, Szeged, Hungary; [Nyilasi, Andrea; Rakhely, Gabor; Kovacs, Kornel L.] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary	Szeged University; Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Szori-Doroghazi, E (corresponding author), Univ Szeged, Dept Biotechnol, Szeged, Hungary.	rakhely@brc.hu	Szőri, Milán/B-7152-2011; Rakhely, Gabor/K-3696-2014	Szőri, Milán/0000-0003-4895-0999; Rakhely, Gabor/0000-0003-2557-3641; Maroti, Gergely/0000-0002-3705-0461	EU [HyVolution FP6-IP-SES6 019825]; FP7 Collaborative Project [SOLAR-H2 FP7-Energy-212508]; domestic funds (NAP-BIO Teller Ede Program) [OMFB-00441/2007, GOP-1.1.2.-07/1-2003+8-0007, Asboth-DAMEC-2007/09, BAROSS-DA07-DA-TECH-07-2008-0012, KoBioCHG TECH_09_04, TAMOP-4.2.1/B-09/1/KONV-2010-0005]	EU(European Commission); FP7 Collaborative Project; domestic funds (NAP-BIO Teller Ede Program)	This work was supported by EU projects HyVolution FP6-IP-SES6 019825 and FP7 Collaborative Project SOLAR-H2 FP7-Energy-212508, and by domestic funds (NAP-BIO Teller Ede Program OMFB-00441/2007, GOP-1.1.2.-07/1-2003+8-0007, Asboth-DAMEC-2007/09, BAROSS-DA07-DA-TECH-07-2008-0012, KoBioCHG TECH_09_04 and TAMOP-4.2.1/B-09/1/KONV-2010-0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRACHT SPJ, 1994, BBA-BIOENERGETICS, V1188, P167, DOI 10.1016/0005-2728(94)90036-1; BOGOROV LV, 1974, MIKROBIOLOGIYA, V43, P326; Brown EC, 2005, J PHYS CHEM B, V109, P7934, DOI 10.1021/jp0450336; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Burgdorf T, 2002, J BACTERIOL, V184, P6280, DOI 10.1128/JB.184.22.6280-6288.2002; CCG, 2007, MOL OP ENV MOE 2007; DeLacey AL, 2003, J BIOL INORG CHEM, V8, P129, DOI 10.1007/s00775-002-0397-4; Dementin S, 2006, J AM CHEM SOC, V128, P5209, DOI 10.1021/ja060233b; Dementin S, 2004, J BIOL CHEM, V279, P10508, DOI 10.1074/jbc.M312716200; Dementin S, 2009, J AM CHEM SOC, V131, P10156, DOI 10.1021/ja9018258; Dischert V, 1999, MOL MICROBIOL, V34, P995, DOI 10.1046/j.1365-2958.1999.01660.x; Dole F, 1997, BIOCHEMISTRY-US, V36, P7847, DOI 10.1021/bi963171i; Duche O, 2005, FEBS J, V272, P3899, DOI 10.1111/j.1742-4658.2005.04806.x; Fodor B, 2001, APPL ENVIRON MICROB, V67, P2476, DOI 10.1128/AEM.67.6.2476-2483.2001; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Frey M, 2001, HDB METALLOPROTEINS; Galvan IF, 2008, PROTEINS, V73, P195, DOI 10.1002/prot.22045; Garcin E, 1999, STRUCT FOLD DES, V7, P557, DOI 10.1016/S0969-2126(99)80072-0; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Henderson LM, 2001, PROTOPLASMA, V217, P37, DOI 10.1007/BF01289411; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; Higuchi Y, 1997, STRUCTURE, V5, P1671, DOI 10.1016/S0969-2126(97)00313-4; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kovacs AT, 2005, FEBS J, V272, P4807, DOI 10.1111/j.1742-4658.2005.04896.x; Kovacs KL, 2005, BIOCHEM SOC T, V33, P61, DOI 10.1042/BST0330061; KOVACS KL, 1990, FEMS MICROBIOL LETT, V87, P407, DOI 10.1016/0378-1097(90)90487-B; Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234; Lenz O, 2002, J MOL MICROB BIOTECH, V4, P255; Leroux F, 2008, P NATL ACAD SCI USA, V105, P11188, DOI 10.1073/pnas.0803689105; Liebgott PP, 2010, NAT CHEM BIOL, V6, P63, DOI [10.1038/NCHEMBIO.276, 10.1038/nchembio.276]; Maroti J, 2010, APPL ENVIRON MICROB, V76, P5113, DOI 10.1128/AEM.00351-10; Marr AC, 2001, COORDIN CHEM REV, V219, P1055, DOI 10.1016/S0010-8545(01)00396-4; Matias PM, 2001, J BIOL INORG CHEM, V6, P63, DOI 10.1007/s007750000167; Montet Y, 1997, NAT STRUCT BIOL, V4, P523, DOI 10.1038/nsb0797-523; MUSVETEAU I, 1994, BIOCHEM BIOPH RES CO, V201, P128, DOI 10.1006/bbrc.1994.1678; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Ogata H, 2009, DALTON T, P7577, DOI 10.1039/b903840j; Rakhely G, 2004, APPL ENVIRON MICROB, V70, P722, DOI 10.1128/AEM.70.2.722-728.2004; Rakhely G, 1996, ANAL BIOCHEM, V243, P181, DOI 10.1006/abio.1996.0499; Rousset M, 1998, P NATL ACAD SCI USA, V95, P11625, DOI 10.1073/pnas.95.20.11625; Szilagyi A, 2002, J MOL MODEL, V8, P58, DOI 10.1007/s00894-001-0071-8; Teixeira VH, 2008, PROTEINS, V70, P1010, DOI 10.1002/prot.21588; Teixeira VH, 2006, BIOPHYS J, V91, P2035, DOI 10.1529/biophysj.106.084376; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Volbeda A, 2002, INT J HYDROGEN ENERG, V27, P1449, DOI 10.1016/S0360-3199(02)00072-1; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; VOORDOUW G, 1989, J BACTERIOL, V171, P2894, DOI 10.1128/jb.171.5.2894-2899.1989; Yeang HY, 1998, ANAL BIOCHEM, V265, P381	51	23	23	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34666	10.1371/journal.pone.0034666	http://dx.doi.org/10.1371/journal.pone.0034666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511957	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600043
J	Balkenius, A; Hansson, B				Balkenius, Anna; Hansson, Bill			Discrimination Training with Multimodal Stimuli Changes Activity in the Mushroom Body of the Hawkmoth Manduca sexta	PLOS ONE			English	Article							COLOR PREFERENCES; FEEDING-BEHAVIOR; ALTERNATIVE USE; ODOR; DROSOPHILA; HONEYBEES; MEMORY; ORGANIZATION; SIMILARITY; INSECTS	Background: The mushroom bodies of the insect brain play an important role in olfactory processing, associative learning and memory. The mushroom bodies show odor-specific spatial patterns of activity and are also influenced by visual stimuli. Methodology/Principal Findings: Functional imaging was used to investigate changes in the in vivo responses of the mushroom body of the hawkmoth Manduca sexta during multimodal discrimination training. A visual and an odour stimulus were presented either together or individually. Initially, mushroom body activation patterns were identical to the odour stimulus and the multimodal stimulus. After training, however, the mushroom body response to the rewarded multimodal stimulus was significantly lower than the response to the unrewarded unimodal odour stimulus, indicating that the coding of the stimuli had changed as a result of training. The opposite pattern was seen when only the unimodal odour stimulus was rewarded. In this case, the mushroom body was more strongly activated by the multimodal stimuli after training. When no stimuli were rewarded, the mushroom body activity decreased for both the multimodal and unimodal odour stimuli. There was no measurable response to the unimodal visual stimulus in any of the experiments. These results can be explained using a connectionist model where the mushroom body is assumed to be excited by olfactory stimulus components, and suppressed by multimodal configurations. Conclusions: Discrimination training with multimodal stimuli consisting of visual and odour cues leads to stimulus specific changes in the in vivo responses of the mushroom body of the hawkmoth.	[Balkenius, Anna] Swedish Agr Univ, Dept Plant Protect Biol, Div Chem Ecol, Alnarp, Sweden; [Hansson, Bill] Max Planck Inst Chem Ecol, Jena, Germany	Swedish University of Agricultural Sciences; Max Planck Society	Balkenius, A (corresponding author), Swedish Agr Univ, Dept Plant Protect Biol, Div Chem Ecol, Alnarp, Sweden.	anna.balkenius@slu.se	Hansson, Bill S/G-2774-2013	Hansson, Bill S/0000-0002-4811-1223	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) [2008-506]; Swedish Research Council; Crafoord Foundation; Max Planck Society	Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Max Planck Society(Max Planck SocietyFoundation CELLEX)	Funded by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas) grant number 2008-506 (www.formas.se), the Linnaeus program ICE3 (the Swedish Research Council), the Crafoord Foundation and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2003, J CHEM ECOL, V29, P2303, DOI 10.1023/A:1026226514968; Balkenius A, 2006, NATURWISSENSCHAFTEN, V93, P255, DOI 10.1007/s00114-006-0099-9; Balkenius A, 2010, J EXP BIOL, V213, P3741, DOI 10.1242/jeb.043760; Balkenius A, 2010, J EXP BIOL, V213, P3257, DOI 10.1242/jeb.045161; Balkenius A, 2009, J EXP BIOL, V212, P535, DOI 10.1242/jeb.021220; BELL RA, 1976, ANN ENTOMOL SOC AM, V69, P365, DOI 10.1093/aesa/69.2.365; Bouton M.E., 1998, OCCAS SETTING ASS LE, P69, DOI [10.1037/10298-003, DOI 10.1037/10298-003]; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; COUVILLON PA, 1988, ANIM LEARN BEHAV, V16, P67, DOI 10.3758/BF03209045; CUTLER DE, 1995, J EXP BIOL, V198, P1909; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Deisig N, 2001, LEARN MEMORY, V8, P70, DOI 10.1101/lm.8.2.70; Dujardin F, 1850, ANN SCI NATURELLES, V3, P195; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; Faber T, 2001, NATURWISSENSCHAFTEN, V88, P472, DOI 10.1007/s001140100263; Frisch K.v, 1914, ZOOLOGISCHE JB, V37, P1, DOI DOI 10.5962/BHL.TITLE.11736; Giurfa M, 1997, J COMP PHYSIOL A, V180, P235, DOI 10.1007/s003590050044; Haehnel M, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00161; HEISENBERG M, 1995, J NEUROSCI, V15, P1951, DOI 10.1523/JNEUROSCI.15-03-01951.1995; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; KEHOE EJ, 1989, J EXP ANAL BEHAV, V52, P427, DOI 10.1901/jeab.1989.52-427; Kelber A, 2005, P ROY SOC B-BIOL SCI, V272, P2143, DOI 10.1098/rspb.2005.3207; Kelber A, 2003, J COMP PHYSIOL A, V189, P661, DOI 10.1007/s00359-003-0440-0; Kelber A, 2002, P ROY SOC B-BIOL SCI, V269, P2573, DOI 10.1098/rspb.2002.2201; Kenyon F., 1896, J COMP NEUROL, V6, P133, DOI DOI 10.1002/CNE.910060302; Li YS, 1999, J COMP NEUROL, V409, P647, DOI 10.1002/(SICI)1096-9861(19990712)409:4<647::AID-CNE9>3.0.CO;2-3; Mackintosh N. J., 1974, PSYCHOL ANIMAL LEARN; Menzel R., 1974, P195; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; MENZEL R, 1968, Z VERGL PHYSIOL, V60, P82, DOI 10.1007/BF00737097; Mustaparta H, 2002, ENTOMOL EXP APPL, V104, P1, DOI 10.1023/A:1021280201479; PEARCE JM, 1994, PSYCHOL REV, V101, P587, DOI 10.1037/0033-295X.101.4.587; Peele P, 2006, J COMP PHYSIOL A, V192, P1083, DOI 10.1007/s00359-006-0152-3; Pelz C, 1997, J EXP BIOL, V200, P837; Peng YQ, 2007, J NEUROSCI, V27, P5139, DOI 10.1523/JNEUROSCI.0472-07.2007; Raguso RA, 2007, J INSECT PHYSIOL, V53, P923, DOI 10.1016/j.jinsphys.2007.03.007; REDHEAD ES, 1995, Q J EXP PSYCHOL-B, V48, P46; Rumelhart D., 1986, PARALLEL DISTRIBUTED; Schmajuk NA, 1997, ANIMAL LEARNING COGN; Schwaerzel M, 2003, J NEUROSCI, V23, P10495, DOI 10.1523/jneurosci.23-33-10495.2003; Skorupski P, 2006, CURR BIOL, V16, pR851, DOI 10.1016/j.cub.2006.08.069; Srinivasan MV, 1998, NATURE, V396, P637, DOI 10.1038/25272; Strausfeld NJ, 2007, DEV NEUROBIOL, V67, P1267, DOI 10.1002/dneu.20396; Strausfeld NJ, 2009, J COMP NEUROL, V513, P265, DOI 10.1002/cne.21948; Strausfeld NJ, 2009, P ROY SOC B-BIOL SCI, V276, P1929, DOI 10.1098/rspb.2008.1471; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Strausfeld NJ, 1995, NERVOUS SYSTEM INVER, P349; Szyszka P, 2008, FRONT SYST NEUROSCI, V2, DOI 10.3389/neuro.06.003.2008; von Frisch Karl, 1919, ZOOL JB, V37, P1; Weiss MR, 1997, ANIM BEHAV, V53, P1043, DOI 10.1006/anbe.1996.0357; [No title captured]	53	9	9	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e32133	10.1371/journal.pone.0032133	http://dx.doi.org/10.1371/journal.pone.0032133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509244	Green Published, gold			2022-12-27	WOS:000305336600003
J	Cui, DR; Wang, L; Qi, AH; Zhou, QH; Zhang, XL; Jiang, W				Cui, Derong; Wang, Li; Qi, Aihua; Zhou, Quanhong; Zhang, Xiaoli; Jiang, Wei			Propofol Prevents Autophagic Cell Death following Oxygen and Glucose Deprivation in PC12 Cells and Cerebral Ischemia-Reperfusion Injury in Rats	PLOS ONE			English	Article							APOPTOTIC MECHANISMS; FOREBRAIN ISCHEMIA; GLUTAMATE RELEASE; HYPOXIA-ISCHEMIA; OXIDATIVE STRESS; NEURONAL INJURY; BECLIN 1; INHIBITION; PROTECTION; CULTURES	Background: Propofol exerts protective effects on neuronal cells, in part through the inhibition of programmed cell death. Autophagic cell death is a type of programmed cell death that plays elusive roles in controlling neuronal damage and metabolic homeostasis. We therefore studied whether propofol could attenuate the formation of autophagosomes, and if so, whether the inhibition of autophagic cell death mediates the neuroprotective effects observed with propofol. Methodology/Principal Findings: The cell model was established by depriving the cells of oxygen and glucose (OGD) for 6 hours, and the rat model of ischemia was introduced by a transient two-vessel occlusion for 10 minutes. Transmission electron microscopy (TEM) revealed that the formation of autophagosomes and autolysosomes in both neuronal PC12 cells and pyramidal rat hippocampal neurons after respective OGD and ischemia/reperfusion (I/R) insults. A western blot analysis revealed that the autophagy-related proteins, such as microtubule-associated protein 1 light chain 3 (LC3-II), Beclin-1 and class III PI3K, were also increased accordingly, but cytoprotective Bcl-2 protein was decreased. The negative effects of OGD and I/R, including the formation of autophagosomes and autolysosomes, the increase in LC3-II, Beclin- 1 and class III PI3K expression and the decline in Bcl-2 production were all inhibited by propofol and specific inhibitors of autophagy, such as 3-methyladenine (3-MA), LY294002 and Bafilomycin A1 (Baf),. Furthermore, in vitro OGD cultures and in vivo I/R rats showed an increase in cell survival following the administration of propofol, as assessed by an MTT assay or histochemical analyses. Conclusions/Significance: Our data suggest that propofol can markedly attenuate autophagic processes via the decreased expression of autophagy-related proteins in vitro and in vivo. This inhibition improves cell survival, which provides a novel explanation for the pleiotropic effects of propofol that benefit the nervous system.	[Cui, Derong; Wang, Li; Zhou, Quanhong; Zhang, Xiaoli; Jiang, Wei] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Anesthesiol, Shanghai 200030, Peoples R China; [Qi, Aihua] Soochow Univ, Dept Postgrad Sch, Suzhou, Peoples R China	Shanghai Jiao Tong University; Soochow University - China	Cui, DR (corresponding author), Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Anesthesiol, Shanghai 200030, Peoples R China.	jiangw@sjtu.edu.cn			Bureau of Health, Shanghai, China [2009Y039]; B. Braun Anesthesia Scientific Research Project; Shanghai Jiaotong University	Bureau of Health, Shanghai, China; B. Braun Anesthesia Scientific Research Project; Shanghai Jiaotong University	This work was supported through grants from the Youth Scientific Research Project, Bureau of Health, Shanghai, China (2009Y039), the B. Braun Anesthesia Scientific Research Project (2009 to Derong Cui) and Shanghai Jiaotong University Medical and Technology Fund (2009 to Li Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adembri C, 2006, ANESTHESIOLOGY, V104, P80, DOI 10.1097/00000542-200601000-00014; Arcadi FA, 1996, LIFE SCI, V58, P961, DOI 10.1016/0024-3205(96)00044-6; Bayona NA, 2004, ANESTHESIOLOGY, V100, P1151, DOI 10.1097/00000542-200405000-00017; Buggy DJ, 2000, ANESTHESIOLOGY, V92, P1067, DOI 10.1097/00000542-200004000-00025; Daskalopoulos R, 2001, ANESTH ANALG, V93, P1199, DOI 10.1097/00000539-200111000-00030; De Riu PL, 2000, EUR J ANAESTH, V17, P18, DOI 10.1097/00003643-200001000-00004; Engelhard K, 2004, EUR J ANAESTH, V21, P530, DOI 10.1017/S0265021504007057; Feiner JR, 2005, ANESTH ANALG, V100, P215, DOI 10.1213/01.ANE.0000142129.17005.73; Furuichi T, 2005, J NEUROSCI RES, V79, P816, DOI 10.1002/jnr.20402; GOLDBERG MP, 1993, J NEUROSCI, V13, P3510; Gottron FJ, 1997, MOL CELL NEUROSCI, V9, P159, DOI 10.1006/mcne.1997.0618; [洪庆涛 Hong Qingtao], 2004, [细胞生物学杂志, Chinese Journal of Cell Biology], V26, P89; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawaguchi M, 2000, ANESTHESIOLOGY, V92, P1335, DOI 10.1097/00000542-200005000-00023; KOCHS E, 1992, ANESTHESIOLOGY, V76, P245, DOI 10.1097/00000542-199202000-00014; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Li HF, 2011, J CEREBR BLOOD F MET, V31, P2106, DOI 10.1038/jcbfm.2011.75; Li J, 2010, BRAIN RES, V1356, P11, DOI 10.1016/j.brainres.2010.08.012; Lingamaneni R, 2001, ANESTHESIOLOGY, V95, P1460, DOI 10.1097/00000542-200112000-00027; Luo CL, 2011, NEUROSCIENCE, V184, P54, DOI 10.1016/j.neuroscience.2011.03.021; Maiuri MC, 2010, EMBO J, V29, P515, DOI 10.1038/emboj.2009.377; MANN SS, 1994, J BIOL CHEM, V269, P11492; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Noh HS, 2010, MOL CELLS, V30, P455, DOI 10.1007/s10059-010-0130-z; ORSER BA, 1995, BRIT J PHARMACOL, V116, P1761, DOI 10.1111/j.1476-5381.1995.tb16660.x; Paris I, 2011, TOXICOL SCI, V121, P376, DOI 10.1093/toxsci/kfr060; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Peters CE, 2001, ANESTHESIOLOGY, V94, P313, DOI 10.1097/00000542-200102000-00022; Qi SH, 2002, ANESTH ANALG, V94, P655, DOI 10.1097/00000539-200203000-00032; Qin AP, 2010, AUTOPHAGY, V6, P738, DOI 10.4161/auto.6.6.12573; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; SHYR MH, 1995, NEUROSCI LETT, V184, P212, DOI 10.1016/0304-3940(94)11209-2; Thoresen SB, 2010, EXP CELL RES, V316, P3368, DOI 10.1016/j.yexcr.2010.07.008; Tsuchiya M, 2001, AM J RESP CRIT CARE, V163, P26, DOI 10.1164/ajrccm.163.1.9911120; Velly LJ, 2003, ANESTHESIOLOGY, V99, P368, DOI 10.1097/00000542-200308000-00018; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Wang JP, 2002, EUR J PHARMACOL, V452, P303, DOI 10.1016/S0014-2999(02)02332-4; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Wen YD, 2008, AUTOPHAGY, V4, P762, DOI 10.4161/auto.6412; Wilson JX, 2002, J NEUROSURG ANESTH, V14, P66, DOI 10.1097/00008506-200201000-00014; Yan CH, 2006, TOXICON, V47, P521, DOI 10.1016/j.toxicon.2006.01.010; Yang YP, 2008, ACTA PHARMACOL SIN, V29, P123, DOI 10.1111/j.1745-7254.2008.00732.x; Zheng Z, 2008, J CEREBR BLOOD F MET, V28, P53, DOI 10.1038/sj.jcbfm.9600502; Zhu CL, 2006, J NEUROCHEM, V96, P1016, DOI 10.1111/j.1471-4159.2005.03639.x	45	59	66	4	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35324	10.1371/journal.pone.0035324	http://dx.doi.org/10.1371/journal.pone.0035324			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509406	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600100
J	Mooney, KA; Pratt, RT; Singer, MS				Mooney, Kailen A.; Pratt, Riley T.; Singer, Michael S.			The Tri-Trophic Interactions Hypothesis: Interactive Effects of Host Plant Quality, Diet Breadth and Natural Enemies on Herbivores	PLOS ONE			English	Article							INSECT HERBIVORES; PHYTOPHAGOUS INSECTS; INTERSPECIFIC INTERACTIONS; GENERALIST CATERPILLARS; FOOD-WEB; COMPETITION; SPECIFICITY; SPECIALIST; GROWTH; EVOLUTION	Several influential hypotheses in plant-herbivore and herbivore-predator interactions consider the interactive effects of plant quality, herbivore diet breadth, and predation on herbivore performance. Yet individually and collectively, these hypotheses fail to address the simultaneous influence of all three factors. Here we review existing hypotheses, and propose the tri-trophic interactions (TTI) hypothesis to consolidate and integrate their predictions. The TTI hypothesis predicts that dietary specialist herbivores (as compared to generalists) should escape predators and be competitively dominant due to faster growth rates, and that such differences should be greater on low quality (as compared to high quality) host plants. To provide a preliminary test of these predictions, we conducted an empirical study comparing the effects of plant (Baccharis salicifolia) quality and predators between a specialist (Uroleucon macolai) and a generalist (Aphis gossypii) aphid herbivore. Consistent with predictions, these three factors interactively determine herbivore performance in ways not addressed by existing hypotheses. Compared to the specialist, the generalist was less fecund, competitively inferior, and more sensitive to low plant quality. Correspondingly, predator effects were contingent upon plant quality only for the generalist. Contrary to predictions, predator effects were weaker for the generalist and on low-quality plants, likely due to density-dependent benefits provided to the generalist by mutualist ants. Because the TTI hypothesis predicts the superior performance of specialists, mutualist ants may be critical to A. gossypii persistence under competition from U. macolai. In summary, the integrative nature of the TTI hypothesis offers novel insight into the determinants of plant-herbivore and herbivore-predator interactions and the coexistence of specialist and generalist herbivores.	[Mooney, Kailen A.; Pratt, Riley T.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Singer, Michael S.] Wesleyan Univ, Dept Biol, Middletown, CT 06459 USA	University of California System; University of California Irvine; Wesleyan University	Mooney, KA (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	mooneyk@uci.edu			National Science Foundation [DEB-0919178, DEB-1120794]; University of California Irvine Academic Senate Council on Research, Computing and Libraries	National Science Foundation(National Science Foundation (NSF)); University of California Irvine Academic Senate Council on Research, Computing and Libraries	This work was funded by National Science Foundation grants DEB-0919178 and DEB-1120794, the University of California Irvine Academic Senate Council on Research, Computing and Libraries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2006, AM NAT, V167, P329, DOI 10.1086/499382; Agrawal AA, 2004, ECOLOGY, V85, P2118, DOI 10.1890/03-4084; BERNAYS E, 1988, ECOLOGY, V69, P886, DOI 10.2307/1941237; Bernays EA, 1997, ECOLOGY, V78, P1157, DOI 10.1890/0012-9658(1997)078[1157:IHDRFB]2.0.CO;2; BERNAYS EA, 1988, ENTOMOL EXP APPL, V49, P131, DOI 10.1007/BF00188246; BERNAYS EA, 1989, OECOLOGIA, V79, P427, DOI 10.1007/BF00384324; Bernays EA, 1998, BIOSCIENCE, V48, P35, DOI 10.2307/1313226; Bernays EA, 1997, ECOL ENTOMOL, V22, P121, DOI 10.1046/j.1365-2311.1997.00042.x; BLACKMAN R.L., 2006, APHIDS WORLDS HERBAC; BRETON LM, 1992, ECOLOGY, V73, P2175, DOI 10.2307/1941465; Brues CT, 1924, AM NAT, V58, P127, DOI 10.1086/279965; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLANCY KM, 1987, ECOLOGY, V68, P733, DOI 10.2307/1938479; Coley PD, 2006, OIKOS, V115, P219, DOI 10.1111/j.2006.0030-1299.14928.x; COLEY PD, 1985, SCIENCE, V230, P895, DOI 10.1126/science.230.4728.895; Cornelissen T, 2005, OIKOS, V111, P488, DOI 10.1111/j.1600-0706.2005.14075.x; Cornell HV, 2003, AM NAT, V161, P507, DOI 10.1086/368346; Cronin JT, 1999, OECOLOGIA, V121, P392, DOI 10.1007/s004420050944; Delph LF, 1999, GENDER SEXUAL DIMORP, P149, DOI DOI 10.1007/978-3-662-03908-3_6; DENNO RF, 1995, ANNU REV ENTOMOL, V40, P297, DOI 10.1146/annurev.en.40.010195.001501; DETHIER VG, 1954, EVOLUTION, V8, P33, DOI 10.2307/2405664; Dicke M, 2000, BIOCHEM SYST ECOL, V28, P601, DOI 10.1016/S0305-1978(99)00106-4; DUSSOURD DE, 1994, ECOLOGY, V75, P69, DOI 10.2307/1939383; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Egas M, 2004, AM NAT, V163, P518, DOI 10.1086/382599; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Eichenseer H, 2010, J CHEM ECOL, V36, P885, DOI 10.1007/s10886-010-9830-2; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; FRAENKEL GS, 1959, SCIENCE, V129, P1466, DOI 10.1126/science.129.3361.1466; FRITZ RS, 1990, ECOLOGY, V71, P1208, DOI 10.2307/1937390; Garcia M, 2005, PEST MANAG SCI, V61, P612, DOI 10.1002/ps.1028; Gassmann AJ, 2005, OECOLOGIA, V144, P62, DOI 10.1007/s00442-005-0038-z; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; Johnson PTJ, 2010, TRENDS ECOL EVOL, V25, P362, DOI 10.1016/j.tree.2010.01.005; Kaplan I, 2002, ENVIRON ENTOMOL, V31, P1175, DOI 10.1603/0046-225X-31.6.1175; Kaplan I, 2007, ECOL LETT, V10, P977, DOI 10.1111/j.1461-0248.2007.01093.x; KARBAN R, 1989, ECOLOGY, V70, P1028, DOI 10.2307/1941371; KRIEGER RI, 1971, SCIENCE, V172, P579, DOI 10.1126/science.172.3983.579; LAWTON JH, 1979, POPULATION DYNAMICS, P223; Linhart YB, 2005, AM NAT, V166, P517, DOI 10.1086/444438; Littell RC., 2006, SAS MIXED MODELS, Vxii; LLOYD DG, 1977, BOT REV, V43, P177, DOI 10.1007/BF02860717; McGuire RJ, 2006, ECOL ENTOMOL, V31, P20, DOI 10.1111/j.0307-6946.2006.00750.x; Mooney KA, INTERACTION IN PRESS; Mooney KA, 2008, AM NAT, V171, pE195, DOI 10.1086/587758; Mooney KA, 2008, OIKOS, V117, P450, DOI 10.1111/j.2007.0030-1299.16284.x; Mooney KA, 2007, ECOLOGY, V88, P2005, DOI 10.1890/06-1095.1; Mooney KA, 2010, SCIENCE, V327, P1642, DOI 10.1126/science.1184814; MORAN N, 1980, J THEOR BIOL, V86, P247, DOI 10.1016/0022-5193(80)90004-1; MORAN N, 1986, ECOLOGY, V67, P108, DOI 10.2307/1938508; MORAN NA, 1990, ECOLOGY, V71, P1050, DOI 10.2307/1937373; Novotny V, 2005, P ROY SOC B-BIOL SCI, V272, P1083, DOI 10.1098/rspb.2004.3023; Novotny V, 2006, SCIENCE, V313, P1115, DOI 10.1126/science.1129237; Olff H, 1999, HERBIVORES PLANTS PR; Oppenheim SJ, 2002, EVOLUTION, V56, P679, DOI 10.1111/j.0014-3820.2002.tb01379.x; POLHEMUS DA, 1988, ANN ENTOMOL SOC AM, V81, P742, DOI 10.1093/aesa/81.5.742; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Rhoades D.F., 1976, RECENT ADV PHYTOCHEM, P168, DOI DOI 10.1007/978-1-4684-2646-5_4; SAS Institute, 2008, SAS VERS 9 2; Schmitz OJ, 2010, RESOLVING ECOSYSTEM; Schmitz OJ, 2008, ANNU REV ECOL EVOL S, V39, P133, DOI 10.1146/annurev.ecolsys.39.110707.173418; Schoonhoven LM, 2005, INSECT PLANT BIOL; SCRIBER JM, 1979, ECOLOGY, V60, P829, DOI 10.2307/1936618; Singer MS, 2008, SPECIALIZATION, SPECIATION, AND RADIATION: THE EVOLUTIONARY BIOLOGY OF HERBIVOROUS INSECTS, P29; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; Singer MS, 2005, ECOL LETT, V8, P1247, DOI 10.1111/j.1461-0248.2005.00835.x; Singer MS, 2004, AM NAT, V164, P423, DOI 10.1086/423152; Smith RA, 2008, ECOLOGY, V89, P2187, DOI 10.1890/07-1441.1; Stadler B, 2002, ECOL LETT, V5, P216, DOI 10.1046/j.1461-0248.2002.00300.x; Stadler B, 2008, MUTUALISM ANTS THEIR; STAMP NE, 1992, ECOL ENTOMOL, V17, P273, DOI 10.1111/j.1365-2311.1992.tb01058.x; Strauss Sharon Y., 2002, P77; Strong DR, 1984, INSECTS PLANTS COMMU; Tilman D., 1982, Monographs in Population Biology, pi; Tscharntke T, 2002, MULTITROPHIC LEVEL I; Vencl FV, 2005, OECOLOGIA, V145, P404, DOI 10.1007/s00442-005-0138-9; Wheeler AG, 2009, P ENTOMOL SOC WASH, V111, P880, DOI 10.4289/0013-8797-111.4.880; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Williams IS, 1999, ECOL ENTOMOL, V24, P490, DOI 10.1046/j.1365-2311.1999.00217.x; WILSON DS, 1994, AM NAT, V144, P692, DOI 10.1086/285702; WYATT IJ, 1965, ANN APPL BIOL, V56, P439, DOI 10.1111/j.1744-7348.1965.tb01262.x; Yao I, 2000, OIKOS, V89, P3, DOI 10.1034/j.1600-0706.2000.890101.x	82	69	71	5	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34403	10.1371/journal.pone.0034403	http://dx.doi.org/10.1371/journal.pone.0034403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509298	Green Published, gold			2022-12-27	WOS:000305336600030
J	Parker, MO; Millington, ME; Combe, FJ; Brennan, CH				Parker, Matthew O.; Millington, Mollie E.; Combe, Fraser J.; Brennan, Caroline H.			Housing Conditions Differentially Affect Physiological and Behavioural Stress Responses of Zebrafish, as well as the Response to Anxiolytics	PLOS ONE			English	Article							ADULT ZEBRAFISH; DANIO-RERIO; MODEL; CORTISOL	Zebrafish are a widely utilised animal model in developmental genetics, and owing to recent advances in our understanding of zebrafish behaviour, their utility as a comparative model in behavioural neuroscience is beginning to be realised. One widely reported behavioural measure is the novel tank-diving assay, which has been often cited as a test of anxiety and stress reactivity. Despite its wide utilisation, and various validations against anxiolytic drugs, reporting of pre-test housing has been sparse in the literature. As zebrafish are a shoaling species, we predicted that housing environment would affect their stress reactivity and, as such, their response in the tank-diving procedure. In our first experiment, we tested various aspects of housing (large groups, large groups with no contact, paired, visual contact only, olfactory contact only) and found that the tank diving response was mediated by visual contact with conspecifics. We also tested the basal cortisol levels of group and individually housed fish, and found that individually housed individuals have lower basal cortisol levels. In our second experiment we found ethanol appeared to have an anxiolytic effect with individually housed fish but not those that were group housed. In our final experiment, we examined the effects of changing the fishes' water prior to tank diving as an additional acclimation procedure. We found that this had no effect on individually housed fish, but appeared to affect the typical tank diving responses of the group housed individuals. In conclusion, we demonstrate that housing represents an important factor in obtaining reliable data from this methodology, and should be considered by researchers interested in comparative models of anxiety in zebrafish in order to refine their approach and to increase the power in their experiments.	[Parker, Matthew O.; Millington, Mollie E.; Combe, Fraser J.; Brennan, Caroline H.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England	University of London; Queen Mary University London	Parker, MO (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	c.h.brennan@qmul.ac.uk	Parker, Matthew/J-6815-2019; Combe, Fraser/AAC-4952-2022; Parker, Matthew/A-2700-2013	Parker, Matthew/0000-0002-7172-5231; Parker, Matthew/0000-0002-7172-5231; Combe, Fraser/0000-0002-9256-4932	National Centre for the Replacement, Refinement, and Reduction of Animals in Research [G1000053]; National Centre for the Replacement [G1000053/1] Funding Source: researchfish	National Centre for the Replacement, Refinement, and Reduction of Animals in Research; National Centre for the Replacement	This work was funded by the National Centre for the Replacement, Refinement, and Reduction of Animals in Research (http://www.nc3rs.org.uk/), grant number G1000053. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bencan Z, 2009, PHARMACOL BIOCHEM BE, V94, P75, DOI 10.1016/j.pbb.2009.07.009; Cachat J, 2010, NAT PROTOC, V5, P1786, DOI 10.1038/nprot.2010.140; Champagne DL, 2010, BEHAV BRAIN RES, V214, P332, DOI 10.1016/j.bbr.2010.06.001; Dahlbom SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023565; Egan RJ, 2009, BEHAV BRAIN RES, V205, P38, DOI 10.1016/j.bbr.2009.06.022; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Gerlai R, 2008, ALCOHOL CLIN EXP RES, V32, P1763, DOI 10.1111/j.1530-0277.2008.00761.x; Levin ED, 2007, PHYSIOL BEHAV, V90, P54, DOI 10.1016/j.physbeh.2006.08.026; Linker A, 2011, NEUROMETHODS, V51, P181, DOI 10.1007/978-1-60761-953-6_15; Love DR, 2004, CURR OPIN BIOTECH, V15, P564, DOI 10.1016/j.copbio.2004.09.004; Mathur P, 2011, BEHAV BRAIN RES, V219, P234, DOI 10.1016/j.bbr.2011.01.019; Maximino C, 2010, BEHAV BRAIN RES, V214, P157, DOI 10.1016/j.bbr.2010.05.031; Miklosi A, 2006, ZEBRAFISH, V3, P227, DOI 10.1089/zeb.2006.3.227; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Norton W, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-90; O'Connor EA, 2010, ANIMAL, V4, P1899, DOI 10.1017/S1751731110001072; Parker MO, 2012, BEHAV BRAIN RES, V227, P73, DOI 10.1016/j.bbr.2011.10.037; Qiu J, 2006, NATURE, V444, P814, DOI 10.1038/444814a; Ramsay JM, 2006, AQUACULTURE, V258, P565, DOI 10.1016/j.aquaculture.2006.04.020; Rosemberg DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019397; Stephens M, 2002, ILAR J, V43, P74	22	97	97	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34992	10.1371/journal.pone.0034992	http://dx.doi.org/10.1371/journal.pone.0034992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509375	Green Published, gold			2022-12-27	WOS:000305336600072
J	Rossoll, D; Bermudez, R; Hauss, H; Schulz, KG; Riebesell, U; Sommer, U; Winder, M				Rossoll, Dennis; Bermudez, Rafael; Hauss, Helena; Schulz, Kai G.; Riebesell, Ulf; Sommer, Ulrich; Winder, Monika			Ocean Acidification-Induced Food Quality Deterioration Constrains Trophic Transfer	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; COPEPOD ACARTIA-TONSA; CO2 CONCENTRATION; CLIMATE-CHANGE; EGG-PRODUCTION; CARBON; IMPACTS; PH; PHYTOPLANKTON; SEAWATER	Our present understanding of ocean acidification (OA) impacts on marine organisms caused by rapidly rising atmospheric carbon dioxide (CO2) concentration is almost entirely limited to single species responses. OA consequences for food web interactions are, however, still unknown. Indirect OA effects can be expected for consumers by changing the nutritional quality of their prey. We used a laboratory experiment to test potential OA effects on algal fatty acid (FA) composition and resulting copepod growth. We show that elevated CO2 significantly changed the FA concentration and composition of the diatom Thalassiosira pseudonana, which constrained growth and reproduction of the copepod Acartia tonsa. A significant decline in both total FAs (28.1 to 17.4 fg cell(-1)) and the ratio of long-chain polyunsaturated to saturated fatty acids (PUFA:SFA) of food algae cultured under elevated (750 mu atm) compared to present day (380 mu atm) pCO(2) was directly translated to copepods. The proportion of total essential FAs declined almost tenfold in copepods and the contribution of saturated fatty acids (SFAs) tripled at high CO2. This rapid and reversible CO2-dependent shift in FA concentration and composition caused a decrease in both copepod somatic growth and egg production from 34 to 5 eggs female(-1) day(-1). Because the diatom-copepod link supports some of the most productive ecosystems in the world, our study demonstrates that OA can have far-reaching consequences for ocean food webs by changing the nutritional quality of essential macromolecules in primary producers that cascade up the food web.	[Rossoll, Dennis; Bermudez, Rafael; Hauss, Helena; Schulz, Kai G.; Riebesell, Ulf; Sommer, Ulrich; Winder, Monika] Helmholtz Ctr Ocean Res Kiel GEOMAR, Kiel, Germany; [Winder, Monika] Stockholm Univ, Dept Syst Ecol, S-10691 Stockholm, Sweden	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; Stockholm University	Rossoll, D (corresponding author), Helmholtz Ctr Ocean Res Kiel GEOMAR, Kiel, Germany.	mwinder@ecology.su.se	Schulz, Kai G./Q-5608-2017; Riebesell, Ulf/AAC-9717-2020; Hauss, Helena M/S-1718-2018; Schulz, Kai/AEZ-9073-2022	Schulz, Kai G./0000-0002-8481-4639; Hauss, Helena M/0000-0002-0754-3388; Schulz, Kai/0000-0002-8481-4639; Riebesell, Ulf/0000-0002-9442-452X; Bermudez, Jorge Rafael/0000-0002-8109-5819	European Community [211384]; German Research Foundation (DFG); Marie Curie IRG [276917]	European Community(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG)); Marie Curie IRG(European Commission)	This work is a contribution to the "European Project on OCean Acidification'' (EPOCA), which received funding from the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement n<SUP>o</SUP> 211384. In addition, financial support from the German Research Foundation (DFG) as part of the priority program 1162 AQUASHIFT and the Marie Curie IRG grant n<SUP>o</SUP> 276917 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Bellerby RGJ, 2008, BIOGEOSCIENCES, V5, P1517, DOI 10.5194/bg-5-1517-2008; Brett MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P115, DOI 10.1007/978-0-387-89366-2_6; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Carvalho AP, 2005, MAR BIOTECHNOL, V7, P381, DOI 10.1007/s10126-004-4047-4; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; Doney SC, 2010, SCIENCE, V328, P1512, DOI 10.1126/science.1185198; Engel A, 2008, BIOGEOSCIENCES, V5, P509, DOI 10.5194/bg-5-509-2008; Fabry VJ, 2008, ICES J MAR SCI, V65, P414, DOI 10.1093/icesjms/fsn048; FAO (Food and Agriculture Organization of the United Nations), 2010, STAT WORLD FISH AQ 2; FRASER AJ, 1989, MAR CHEM, V27, P1, DOI 10.1016/0304-4203(89)90024-8; Glencross BD, 2009, REV AQUACULT, V1, P71, DOI 10.1111/j.1753-5131.2009.01006.x; Gosling SN, 2011, PROG PHYS GEOG, V35, P443, DOI 10.1177/0309133311407650; Hazzard SE, 2003, MAR ECOL PROG SER, V252, P199, DOI 10.3354/meps252199; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Jonasdottir SH, 2009, MAR ECOL PROG SER, V382, P139, DOI 10.3354/meps07985; Kang JX, 2011, BIOTECHNOL ADV, V29, P388, DOI 10.1016/j.biotechadv.2011.02.003; KIORBOE T, 1985, MAR ECOL PROG SER, V26, P85, DOI 10.3354/meps026085; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; LANE AE, 1981, PLANT PHYSIOL, V68, P439, DOI 10.1104/pp.68.2.439; Lischka S, 2011, BIOGEOSCIENCES, V8, P919, DOI 10.5194/bg-8-919-2011; Locke A, 2000, HYDROBIOLOGIA, V437, P187, DOI 10.1023/A:1026563109217; Mayor DJ, 2007, MAR ECOL PROG SER, V350, P91, DOI 10.3354/meps07142; Muller-Navarra DC, 2004, NATURE, V427, P69, DOI 10.1038/nature02210; Muller-Navarra DC, 2000, NATURE, V403, P74, DOI 10.1038/47469; Nielsen LT, 2010, MAR BIOL RES, V6, P542, DOI 10.1080/17451000903476941; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Pohnert G, 2002, PLANT PHYSIOL, V129, P103, DOI 10.1104/pp.010974; R Core Team, 2020, R LANG ENV STAT COMP; Riebesell U, 2000, GEOCHIM COSMOCHIM AC, V64, P4179, DOI 10.1016/S0016-7037(00)00474-9; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Riebesell U., 2011, OCEAN ACIDIFICATION, P99, DOI [10.1093/oso/9780199591091.003.0011, DOI 10.1093/OSO/9780199591091.003.0011]; Riebesell U, 2009, P NATL ACAD SCI USA, V106, P20602, DOI 10.1073/pnas.0813291106; Sato N, 2003, BBA-MOL CELL BIOL L, V1633, P35, DOI 10.1016/S1388-1981(03)00070-2; Solomon S., 2007, PHYS SCI BASIS WORKI; STERNER RW, 2009, PRINCETON GUIDE ECOL, P376; Stoll MHC, 2001, ANAL CHEM, V73, P4111, DOI 10.1021/ac010303r; Suffrian K, 2011, NEW PHYTOL, V190, P595, DOI 10.1111/j.1469-8137.2010.03633.x; Sunday JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022881; TSUZUKI M, 1990, PLANT PHYSIOL, V93, P851, DOI 10.1104/pp.93.3.851; Urabe J, 2003, GLOBAL CHANGE BIOL, V9, P818, DOI 10.1046/j.1365-2486.2003.00634.x; Wichard T, 2007, CHEMBIOCHEM, V8, P1146, DOI 10.1002/cbic.200700053; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026	44	203	211	4	210	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34737	10.1371/journal.pone.0034737	http://dx.doi.org/10.1371/journal.pone.0034737			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509351	gold, Green Accepted, Green Published			2022-12-27	WOS:000305336600054
J	Bodnar, T; Salathe, M				Bodnar, Todd; Salathe, Marcel			Governing the Global Commons with Local Institutions	PLOS ONE			English	Article							PUBLIC-GOODS EXPERIMENTS; ALTRUISTIC PUNISHMENT; GAMES; COOPERATION; DYNAMICS; STRATEGIES; TRAGEDY; HUMANS	Most problems faced by modern human society have two characteristics in common - they are tragedy-of-the-commons type of problems, and they are global problems. Tragedy-of-the-commons type of problems are those where a commonly shared resource is overexploited by free riders at the expense of everyone sharing the resource. The exploitation of global resources such as clean air and water, political stability and peace, etc. underlies many of the most pressing human problems. Punishment of free riding behavior is one of the most frequently used strategies to combat the problem, but the spatial reach of sanctioning institutions is often more limited than the spatial effects of overexploitation. Here, we analyze a general game theoretical model to assess under what circumstances sanctioning institutions with limited reach can maintain the larger commons. We find that the effect of the spatial reach has a strong effect on whether and how the commons can be maintained, and that the transitions between those outcomes are characterized by phase transitions. The latter indicates that a small change in the reach of sanctioning systems can profoundly change the way the global commons can be managed.	[Bodnar, Todd] Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA; [Salathe, Marcel] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Bodnar, T (corresponding author), Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA.	tjb5215@psu.edu		Salathe, Marcel/0000-0002-5079-7797	National Science Foundation [OCI-0821527]; Branco Weiss fellowship	National Science Foundation(National Science Foundation (NSF)); Branco Weiss fellowship	TJB and MS acknowledge computational cluster computing resources funded by the National Science Foundation through grant OCI-0821527. MS acknowledges funding from a Branco Weiss fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREONI J, 1988, J PUBLIC ECON, V37, P291, DOI 10.1016/0047-2727(88)90043-6; Brandt H, 2006, P NATL ACAD SCI USA, V103, P495, DOI 10.1073/pnas.0507229103; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; Ethington Philip J., 2001, PUBLIC CITY POLITICA; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fudenberg D, 2006, J ECON THEORY, V131, P251, DOI 10.1016/j.jet.2005.04.006; Gibson CC, 2000, ECOL ECON, V32, P217, DOI 10.1016/S0921-8009(99)00092-0; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hardin G, 1998, SCIENCE, V280, P682, DOI 10.1126/science.280.5364.682; Hauert C., 2003, Complexity, V8, P31, DOI 10.1002/cplx.10092; Hauert C, 2002, J THEOR BIOL, V218, P187, DOI 10.1006/jtbi.2002.3067; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Helbing D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/8/083005; Helbing D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.057104; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Houghton J.E.T., 2001, IPCC 2001 CLIMATE CH; Milinski M, 2006, P NATL ACAD SCI USA, V103, P3994, DOI 10.1073/pnas.0504902103; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; OLIVER P, 1980, AM J SOCIOL, V85, P1356, DOI 10.1086/227168; Ostrom E., 1990, GOVERNING COMMONS EV; Rendell L, 2010, SCIENCE, V328, P208, DOI 10.1126/science.1184719; Semmann D, 2003, NATURE, V425, P390, DOI 10.1038/nature01986; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sigmund K, 2007, TRENDS ECOL EVOL, V22, P593, DOI 10.1016/j.tree.2007.06.012; Sigmund K, 2011, DYN GAMES APPL, V1, P149, DOI 10.1007/s13235-010-0001-4; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; SUGDEN R, 1984, ECON J, V94, P772, DOI 10.2307/2232294; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Traulsen A, 2009, P NATL ACAD SCI USA, V106, P709, DOI 10.1073/pnas.0808450106; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	36	4	5	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34051	10.1371/journal.pone.0034051	http://dx.doi.org/10.1371/journal.pone.0034051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	952PZ	22509269	Green Submitted, Green Published, gold			2022-12-27	WOS:000304805900011
J	Dirks, U; Gruber-Vodicka, HR; Leisch, N; Bulgheresi, S; Egger, B; Ladurner, P; Ott, JA				Dirks, Ulrich; Gruber-Vodicka, Harald R.; Leisch, Nikolaus; Bulgheresi, Silvia; Egger, Bernhard; Ladurner, Peter; Ott, Joerg A.			Bacterial Symbiosis Maintenance in the Asexually Reproducing and Regenerating Flatworm Paracatenula galateia	PLOS ONE			English	Article							STEM-CELL SYSTEM; CONVOLUTRILOBA-LONGIFISSURA; ENDOSYMBIOTIC BACTERIA; CODAKIA-ORBICULARIS; CHROMATOID BODY; ENCHYTRAEUS-JAPONENSIS; PLANARIAN REGENERATION; APOSYMBIOTIC JUVENILES; ACYRTHOSIPHON-PISUM; ALGAL SYMBIONTS	Bacteriocytes set the stage for some of the most intimate interactions between animal and bacterial cells. In all bacteriocyte possessing systems studied so far, de novo formation of bacteriocytes occurs only once in the host development, at the time of symbiosis establishment. Here, we present the free-living symbiotic flatworm Paracatenula galateia and its intracellular, sulfur-oxidizing bacteria as a system with previously undescribed strategies of bacteriocyte formation and bacterial symbiont transmission. Using thymidine analogue S-phase labeling and immunohistochemistry, we show that all somatic cells in adult worms - including bacteriocytes - originate exclusively from aposymbiotic stem cells (neoblasts). The continued bacteriocyte formation from aposymbiotic stem cells in adult animals represents a previously undescribed strategy of symbiosis maintenance and makes P. galateia a unique system to study bacteriocyte differentiation and development. We also provide morphological and immunohistochemical evidence that P. galateia reproduces by asexual fragmentation and regeneration (paratomy) and, thereby, vertically transmits numerous symbiont-containing bacteriocytes to its asexual progeny. Our data support the earlier reported hypothesis that the symbiont population is subjected to reduced bottleneck effects. This would justify both the codiversification between Paracatenula hosts and their Candidatus Riegeria symbionts, and the slow evolutionary rates observed for several symbiont genes.	[Dirks, Ulrich; Gruber-Vodicka, Harald R.; Leisch, Nikolaus; Ott, Joerg A.] Univ Vienna, Dept Marine Biol, Vienna, Austria; [Bulgheresi, Silvia] Univ Vienna, Dept Genet Ecol, Vienna, Austria; [Egger, Bernhard; Ladurner, Peter] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Egger, Bernhard] UCL, Dept Genet Evolut & Environm, London, England	University of Vienna; University of Vienna; University of Innsbruck; University of London; University College London	Dirks, U (corresponding author), Univ Vienna, Dept Marine Biol, Vienna, Austria.	uli.dirks@gmx.de	Bulgheresi, Silvia/C-3128-2013; Gruber-Vodicka, Harald/AAD-2445-2020	Gruber-Vodicka, Harald/0000-0001-5819-1549; Ott, Joerg/0000-0003-2274-5989; Bulgheresi, Silvia/0000-0002-1441-7152; Egger, Bernhard/0000-0001-6353-9458; Ladurner, Peter/0000-0002-0323-9266; Leisch, Nikolaus/0000-0001-7375-3749	Austrian Science Fund (FWF) [P20394]; Sparkling Science grant [SPA/02 - 81/Plattwurmer]; Leverhulme grant [F/07 134/DA]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Sparkling Science grant; Leverhulme grant	This work was supported by the Austrian Science Fund (FWF) project P20394 (HGV, UD, JO), the Sparkling Science grant SPA/02 - 81/Plattwurmer (BE), the Leverhulme grant F/07 134/DA (BE) and is contribution 921 from the Carrie Bow Cay Laboratory, Caribbean Coral Reef Ecosystem Program, NMNH, Washington, D.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson B, 2001, ACTA ZOOL-STOCKHOLM, V82, P231, DOI 10.1046/j.1463-6395.2001.00084.x; AULADELL C, 1993, J MORPHOL, V216, P319, DOI 10.1002/jmor.1052160307; BAGUNA J, 1989, DEVELOPMENT, V107, P77; Barneah O, 2007, INVERTEBR BIOL, V126, P113, DOI 10.1111/j.1744-7410.2007.00082.x; Braendle C, 2003, PLOS BIOL, V1, P70, DOI 10.1371/journal.pbio.0000021; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; BROOKS MA, 1955, SCIENCE, V122, P242, DOI 10.1126/science.122.3162.242; Buchner P., 1965, ENDOSYMBIOSIS ANIMAL; Bulgheresi S, 2011, MICROBIAL SYMBIONT T, P299; Corley LS, 2006, SEMIN CELL DEV BIOL, V17, P510, DOI 10.1016/j.semcdb.2006.07.002; Darby AC, 2003, APPL ENVIRON MICROB, V69, P4403, DOI 10.1128/AEM.69.8.4403-4407.2003; De Mulder K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-69; DENLINGER DL, 1975, ANN NY ACAD SCI, V266, P162, DOI 10.1111/j.1749-6632.1975.tb35097.x; Dirks U, 2011, MAR BIOL RES, V7, P769, DOI 10.1080/17451000.2011.574880; DOONAN SA, 1982, MAR ECOL PROG SER, V8, P69, DOI 10.3354/meps008069; DOUGLAS AE, 1987, J INSECT PHYSIOL, V33, P109, DOI 10.1016/0022-1910(87)90082-5; DOUGLAS AE, 1985, J MAR BIOL ASSOC UK, V65, P871, DOI 10.1017/S0025315400019378; Egger B, 2007, DEV GENES EVOL, V217, P89, DOI 10.1007/s00427-006-0120-5; Egger B, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-41; Egger B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005502; Ehlers U, 1985, PHYLOGENETISCHE SYST; Fernandez-Taboada E, 2010, DEVELOPMENT, V137, P1055, DOI 10.1242/dev.042564; FUHRMAN JA, 1982, MAR BIOL, V66, P109, DOI 10.1007/BF00397184; Gros O, 2000, SYMBIOSIS, V29, P293; Gros O, 1998, INVERTEBR REPROD DEV, V34, P219, DOI 10.1080/07924259.1998.9652656; Gros O, 2003, MAR BIOL, V142, P57, DOI 10.1007/s00227-002-0921-7; Gros O, 1996, APPL ENVIRON MICROB, V62, P2324, DOI 10.1128/AEM.62.7.2324-2330.1996; Gruber-Vodicka HR, 2011, PNAS; Gschwentner R, 2001, CELL TISSUE RES, V304, P401, DOI 10.1007/s004410100375; HAND SC, 1987, BIOL BULL, V173, P260, DOI 10.2307/1541878; Harmer TL, 2008, APPL ENVIRON MICROB, V74, P3895, DOI 10.1128/AEM.02470-07; Hejnol A, 2008, NATURE, V456, P382, DOI 10.1038/nature07309; Hirose E, 2007, ZOOL SCI, V24, P1241, DOI 10.2108/zsj.24.1241; HORI I, 1982, J ELECTRON MICROSC, V31, P63; Kloiber U, 2009, SYMBIOSIS, V47, P43, DOI 10.1007/BF03179969; Koren O, 2006, APPL ENVIRON MICROB, V72, P5254, DOI 10.1128/AEM.00554-06; Kotaja N, 2007, NAT REV MOL CELL BIO, V8, P85, DOI 10.1038/nrm2081; Ladurner P, 1997, INVERTEBR BIOL, V116, P178, DOI 10.2307/3226895; Ladurner P, 2000, DEV BIOL, V226, P231, DOI 10.1006/dbio.2000.9867; LaJeunesse TC, 2005, CORAL REEFS, V24, P157, DOI 10.1007/s00338-004-0436-4; Lambiase S, 1997, INT J INSECT MORPHOL, V26, P9, DOI 10.1016/S0020-7322(97)88103-2; Maldonado M, 2005, BIOL BULL-US, V209, P94, DOI 10.2307/3593127; Mira A, 2002, MICROBIAL ECOL, V44, P137, DOI 10.1007/s00248-002-0012-9; Miura T, 2003, J EXP ZOOL PART B, V295B, P59, DOI 10.1002/jez.b.00003; MORACZEWSKI J, 1977, ZOOMORPHOLOGIE, V88, P65, DOI 10.1007/BF00993304; Moran NA, 1996, P NATL ACAD SCI USA, V93, P2873, DOI 10.1073/pnas.93.7.2873; Morris DJ, 2006, INT J PARASITOL, V36, P371, DOI 10.1016/j.ijpara.2005.10.009; Myohara M, 1999, DEV GROWTH DIFFER, V41, P549; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Nussbaumer AD, 2006, NATURE, V441, P345, DOI 10.1038/nature04793; Ott JA, 1982, PSZNI MAR ECOL, V3, P313, DOI DOI 10.1111/J.1439-0485.1982.TB00282.X; PALMBERG I, 1990, PROTOPLASMA, V158, P109, DOI 10.1007/BF01323123; Peek AS, 1998, MOL BIOL EVOL, V15, P1514, DOI 10.1093/oxfordjournals.molbev.a025879; Peter R., 2004, J APPL BIOMED, V2, P21; Pflugfelder B, 2009, CELL TISSUE RES, V337, P149, DOI 10.1007/s00441-009-0811-0; Philippe H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000717; Philippe H, 2011, NATURE, V470, P255, DOI 10.1038/nature09676; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; RIEGER RM, 1981, HYDROBIOLOGIA, V84, P213, DOI 10.1007/BF00026183; Rispe C, 2000, AM NAT, V156, P425, DOI 10.1086/303396; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Sachs JL, 2006, P ROY SOC B-BIOL SCI, V273, P425, DOI 10.1098/rspb.2005.3346; Sachs JL, 2011, TRENDS ECOL EVOL, V26, P202, DOI 10.1016/j.tree.2011.01.010; Sterrer W., 1974, P63; THORINGTON G, 1979, T AM MICROSC SOC, V98, P401, DOI 10.2307/3225725; van der Land J., 1975, Z ZOOL SYST EVOL, V1, P86, DOI DOI 10.1126/SCIENCE.1064574; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Yoshida-Noro C, 2010, DEV GROWTH DIFFER, V52, P43, DOI 10.1111/j.1440-169X.2009.01149.x	68	13	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34709	10.1371/journal.pone.0034709	http://dx.doi.org/10.1371/journal.pone.0034709			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509347	Green Published, gold			2022-12-27	WOS:000304805900057
J	Damiano, S; Fusco, R; Morano, A; De Mizio, M; Paterno, R; De Rosa, A; Spinelli, R; Amente, S; Frunzio, R; Mondola, P; Miot, F; Laccetti, P; Santillo, M; Avvedimento, EV				Damiano, Simona; Fusco, Roberta; Morano, Annalisa; De Mizio, Mariarosaria; Paterno, Roberto; De Rosa, Antonella; Spinelli, Rosa; Amente, Stefano; Frunzio, Rodolfo; Mondola, Paolo; Miot, Francoise; Laccetti, Paolo; Santillo, Mariarosaria; Avvedimento, Enrico Vittorio			Reactive Oxygen Species Regulate the Levels of Dual Oxidase (Duox1-2) in Human Neuroblastoma Cells	PLOS ONE			English	Article							GENERATING NADPH OXIDASES; LONG-TERM POTENTIATION; GROWTH-FACTOR; NOX ENZYMES; HYDROGEN-PEROXIDE; ROS; RECEPTOR; ACTIVATION; RAT; INHIBITION	Dual Oxidases (DUOX) 1 and 2 are efficiently expressed in thyroid, gut, lung and immune system. The function and the regulation of these enzymes in mammals are still largely unknown. We report here that DUOX 1 and 2 are expressed in human neuroblastoma SK-N-BE cells as well as in a human oligodendrocyte cell line (MO3-13) and in rat brain and they are induced by platelet derived growth factor (PDGF). The levels of DUOX 1 and 2 proteins and mRNAs are induced by reactive oxygen species (ROS) produced by the membrane NADPH oxidase. As to the mechanism, we find that PDGF stimulates membrane NADPH oxidase to produce ROS, which stabilize DUOX1 and 2 mRNAs and increases the levels of the proteins. Silencing of gp91(phox) (NOX2), or of the other membrane subunit of NADPH oxidase, p22(phox), blocks PDGF induction of DUOX1 and 2. These data unravel a novel mechanism of regulation of DUOX enzymes by ROS and identify a circuitry linking NADPH oxidase activity to DUOX1 and 2 levels in neuroblastoma cells.	[Damiano, Simona; De Mizio, Mariarosaria; Mondola, Paolo; Santillo, Mariarosaria] Univ Naples Federico II, Sez Fisiol, Dipartimento Neurosci, Naples, Italy; [Fusco, Roberta; De Rosa, Antonella; Spinelli, Rosa; Amente, Stefano; Frunzio, Rodolfo; Laccetti, Paolo] Univ Naples Federico II, Dipartimento Biol Strutturale & Funzionale, Naples, Italy; [Morano, Annalisa; Avvedimento, Enrico Vittorio] Univ Naples Federico II, CNR, Ist Endocrinol & Oncol Sperimentale, Dipartimento Biol & Patol Mol & Cellulare, Naples, Italy; [Morano, Annalisa] Ctr Riferimento Oncol Basilicata, IRCCS, Lab Ric Preclin & Traslazionale, Potenza, Italy; [Paterno, Roberto] Univ Naples Federico II, Dipartimento Med Clin & Sperimentale, Naples, Italy; [Miot, Francoise] Univ Libre Bruxelles, Inst Rech Interdisciplinaire Biol Humaine & Mol, Brussels, Belgium	University of Naples Federico II; University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; IRCCS CROB; University of Naples Federico II; Universite Libre de Bruxelles	Damiano, S (corresponding author), Univ Naples Federico II, Sez Fisiol, Dipartimento Neurosci, Naples, Italy.	paolo.laccetti@unina.it; marsanti@unina.it; avvedim@unina.it	Amente, Stefano/AAU-7605-2020; Morano, Annalisa/K-6955-2012	Amente, Stefano/0000-0003-0612-6096; Morano, Annalisa/0000-0002-5609-4742; Spinelli, Rosa/0000-0001-7308-4119	Academic Spin Off Prius s.r.l. Sistema Integrato Diagnosi Terapia; MIUR (Ministero dell'Universita e della Ricerca); AIRC [IG 11364]; Universita di Napoli Federico II, Naples, Italy	Academic Spin Off Prius s.r.l. Sistema Integrato Diagnosi Terapia; MIUR (Ministero dell'Universita e della Ricerca)(Ministry of Education, Universities and Research (MIUR)); AIRC(Fondazione AIRC per la ricerca sul cancro); Universita di Napoli Federico II, Naples, Italy	This work was partly supported by grants from the Academic Spin Off Prius s.r.l. Sistema Integrato Diagnosi & Terapia (Dr. Avvedimento, Dr. Santillo, Dr. Paterno, Dr. Damiano); MIUR (Ministero dell'Universita e della Ricerca) Dr. Laccetti, Dr. Mondola, Dr. Avvedimento; AIRC (IG 11364), Dr. Laccetti, Dr. Avvedimento. Dr. Fusco is recipient of a fellowship in the PhD program in Molecular Genetics, Universita di Napoli Federico II, Naples, Italy. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Baumer AT, 2008, J BIOL CHEM, V283, P7864, DOI 10.1074/jbc.M704997200; BALLAGI AE, 1994, CELL TRANSPLANT, V3, P453, DOI 10.1177/096368979400300602; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bedard K, 2012, FREE RADICAL BIO MED, V52, P725, DOI 10.1016/j.freeradbiomed.2011.11.023; BJORKMAN U, 1992, ENDOCRINOLOGY, V130, P393, DOI 10.1210/en.130.1.393; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; CORVILAIN B, 1991, ENDOCRINOLOGY, V128, P779, DOI 10.1210/endo-128-2-779; De Deken X, 2002, EXP CELL RES, V273, P187, DOI 10.1006/excr.2001.5444; Diatchuk V, 1997, J BIOL CHEM, V272, P13292, DOI 10.1074/jbc.272.20.13292; Donko A, 2005, PHILOS T R SOC B, V360, P2301, DOI 10.1098/rstb.2005.1767; Gahtan E, 1998, EUR J NEUROSCI, V10, P538, DOI 10.1046/j.1460-9568.1998.00058.x; Guijarro MV, 2007, CARCINOGENESIS, V28, P2096, DOI 10.1093/carcin/bgm124; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Harper RW, 2005, FEBS LETT, V579, P4911, DOI 10.1016/j.febslet.2005.08.002; Hidalgo C, 2007, ANTIOXID REDOX SIGN, V9, P245, DOI 10.1089/ars.2007.9.245; Jaquet V, 2009, ANTIOXID REDOX SIGN, V11, P2535, DOI [10.1089/ars.2009.2585, 10.1089/ARS.2009.2585]; Kishida KT, 2006, MOL CELL BIOL, V26, P5908, DOI 10.1128/MCB.00269-06; Knapp LT, 2002, J NEUROSCI RES, V70, P1, DOI 10.1002/jnr.10371; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P332, DOI 10.1016/j.freeradbiomed.2007.03.027; Lambeth JD, 2007, FREE RADICAL BIO MED, V43, P319, DOI 10.1016/j.freeradbiomed.2007.03.028; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Leulier F, 2009, NAT IMMUNOL, V10, P936, DOI 10.1038/ni0909-936; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Mohapel P, 2005, NEUROSCIENCE, V132, P767, DOI 10.1016/j.neuroscience.2004.11.056; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; NIKKHAH G, 1993, EXP BRAIN RES, V92, P516; Pachucki J, 2004, MOL CELL ENDOCRINOL, V214, P53, DOI 10.1016/j.mce.2003.11.026; Rigutto S, 2007, EXP CELL RES, V313, P3892, DOI 10.1016/j.yexcr.2007.06.011; Seru R, 2004, J NEUROCHEM, V91, P613, DOI 10.1111/j.1471-4159.2004.02754.x; Singh DK, 2005, CELL, V121, P281, DOI 10.1016/j.cell.2005.02.036; Sorce S, 2009, ANTIOXID REDOX SIGN, V11, P2481, DOI [10.1089/ars.2009.2578, 10.1089/ARS.2009.2578]; STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341; Svegliati S, 2005, J BIOL CHEM, V280, P36474, DOI 10.1074/jbc.M502851200; Tsatmali M, 2006, MOL CELL NEUROSCI, V33, P345, DOI 10.1016/j.mcn.2006.08.005; Zhao J, 2008, CANCER RES, V68, P4133, DOI 10.1158/0008-5472.CAN-08-0432	38	30	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34405	10.1371/journal.pone.0034405	http://dx.doi.org/10.1371/journal.pone.0034405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523549	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000019
J	Kelsey, L; Katoch, P; Johnson, KE; Batra, SK; Mehta, PP				Kelsey, Linda; Katoch, Parul; Johnson, Kristen E.; Batra, Surinder K.; Mehta, Parmender P.			Retinoids Regulate the Formation and Degradation of Gap Junctions in Androgen-Responsive Human Prostate Cancer Cells	PLOS ONE			English	Article							VITAMIN-A; INTERCELLULAR COMMUNICATION; TIGHT JUNCTIONS; E-CADHERIN; INTRAEPITHELIAL NEOPLASIA; 9-CIS-RETINOIC ACID; PROTEIN CONNEXIN32; MICE DEFICIENT; TUMOR-CELLS; GROWTH	The retinoids, the natural or synthetic derivatives of Vitamin A (retinol), are essential for the normal development of prostate and have been shown to modulate prostate cancer progression in vivo as well as to modulate growth of several prostate cancer cell lines. 9-cis-retinoic acid and all-trans-retinoic acid are the two most important metabolites of retinol. Gap junctions, formed of proteins called connexins, are ensembles of intercellular channels that permit the exchange of small growth regulatory molecules between adjoining cells. Gap junctional communication is instrumental in the control of cell growth. We examined the effect of 9-cis-retinoic acid and all-trans retinoic acid on the formation and degradation of gap junctions as well as on junctional communication in an androgen-responsive prostate cancer cell line, LNCaP, which expressed retrovirally introduced connexin32, a connexin expressed by the luminal cells and well-differentiated cells of prostate tumors. Our results showed that 9-cis-retinoic acid and all-trans retinoic acid enhanced the assembly of connexin32 into gap junctions. Our results further showed that 9-cis-retinoic acid and all-trans-retinoic acid prevented androgen-regulated degradation of gap junctions, post-translationally, independent of androgen receptor mediated signaling. Finally, our findings showed that formation of gap junctions sensitized connexin32-expressing LNCaP cells to the growth modifying effects of 9-cis-retinoic acid, all-trans-retinoic acid and androgens. Thus, the effects of retinoids and androgens on growth and the formation and degradation of gap junctions and their function might be related to their ability to modulate prostate growth and cancer.	[Kelsey, Linda; Katoch, Parul; Johnson, Kristen E.; Batra, Surinder K.; Mehta, Parmender P.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Kelsey, L (corresponding author), Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA.	pmehta@unmc.edu			NIH [CA113903]; DOD PCRP (Department of Defense Prostate Cancer Research Program) [081198]; Nebraska State Grant [LB506]; Nebraska Center for Cellular Signaling; NCI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD PCRP (Department of Defense Prostate Cancer Research Program); Nebraska State Grant; Nebraska Center for Cellular Signaling; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by NIH CA113903, DOD PCRP (Department of Defense Prostate Cancer Research Program) 081198, and Nebraska State Grant LB506 (PPM). We gratefully acknowledge support from the Nebraska Center for Cellular Signaling and NCI training fellowship to Kristen Johnson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albini A, 2007, NAT REV CANC, V7; Altucci L, 2001, NAT REV CANCER, V1, P181, DOI 10.1038/35106036; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Bavamian Sabine, 2009, P511, DOI 10.1007/978-1-59745-489-6_26; Bertram JS, 1999, NUTR REV, V57, P182, DOI 10.1111/j.1753-4887.1999.tb06941.x; Beyer Eric C., 2009, P3, DOI 10.1007/978-1-59745-489-6_1; Blutt SE, 1997, ENDOCRINOLOGY, V138, P1491, DOI 10.1210/en.138.4.1491; Chakraborty S, 2010, J BIOL CHEM, V285, P10761, DOI 10.1074/jbc.M109.053348; Christov KT, 2002, CANCER RES, V62, P5178; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; CUNHA GR, 1987, ENDOCR REV, V8, P338, DOI 10.1210/edrv-8-3-338; Dehm SM, 2005, EXPERT REV ANTICANC, V5, P63, DOI 10.1586/14737140.5.1.63; DERMIETZEL R, 1987, J CELL BIOL, V105, P1925, DOI 10.1083/jcb.105.4.1925; Duester G, 2008, CELL, V134, P921, DOI 10.1016/j.cell.2008.09.002; Esquenet M, 1996, PROSTATE, V28, P182, DOI 10.1002/(SICI)1097-0045(199603)28:3<182::AID-PROS5>3.0.CO;2-H; Farla P, 2005, J CELL SCI, V118, P4187, DOI 10.1242/jcs.02546; Feldman D, 2000, ENDOCRINOLOGY, V141, P5, DOI 10.1210/en.141.1.5; FONG CJ, 1993, J UROLOGY, V149, P1190, DOI 10.1016/S0022-5347(17)36345-0; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Goodenough DA, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002576; Govindarajan R, 2002, J BIOL CHEM, V277, P50087, DOI 10.1074/jbc.M202652200; Govindarajan R, 2010, MOL BIOL CELL, V21, P4089, DOI 10.1091/mbc.E10-05-0403; Habermann H, 2002, J UROLOGY, V167, P655, DOI 10.1016/S0022-5347(01)69118-3; Habermann H, 2001, ENDOCRINOLOGY, V142, P359, DOI 10.1210/en.142.1.359; Habermann H, 2001, J UROLOGY, V166, P2267, DOI 10.1016/S0022-5347(05)65548-6; Hernandez-Blazquez FJ, 2001, EXP CELL RES, V270, P235, DOI 10.1006/excr.2001.5342; Huang JP, 2002, CANCER RES, V62, P4812; Igawa T, 2002, PROSTATE, V50, P222, DOI 10.1002/pros.10054; Iversen P, 2002, UROLOGY, V60, P64, DOI 10.1016/S0090-4295(02)01576-5; JONGEN WMF, 1991, J CELL BIOL, V114, P545, DOI 10.1083/jcb.114.3.545; Kardami E, 2007, PROG BIOPHYS MOL BIO, V94, P245, DOI 10.1016/j.pbiomolbio.2007.03.009; Kemppainen JA, 1996, UROLOGY, V48, P157, DOI 10.1016/S0090-4295(96)00117-3; King TJ, 2005, BBA-BIOMEMBRANES, V1719, P146, DOI 10.1016/j.bbamem.2005.08.012; King TJ, 2004, CARCINOGENESIS, V25, P669, DOI 10.1093/carcin/bgh071; King TJ, 2004, CANCER RES, V64, P7191, DOI 10.1158/0008-5472.CAN-04-0624; Kojima T, 2001, EXP CELL RES, V263, P193, DOI 10.1006/excr.2000.5103; Kojima T, 2002, EXP CELL RES, V276, P40, DOI 10.1006/excr.2002.5511; KOJIMA T, 1994, J CELL SCI, V107, P3579; KOJIMA T, 1995, J CELL SCI, V108, P1347; Kojima T, 2007, J MEMBRANE BIOL, V217, P13, DOI 10.1007/s00232-007-9021-4; Kokai Y, 2011, J MEMBRANE BIOL, V217, P13; Kokontis JM, 1998, MOL ENDOCRINOL, V12, P941, DOI 10.1210/me.12.7.941; KOLONEL LN, 1987, CANCER RES, V47, P2982; Laird DW, 2010, TRENDS CELL BIOL, V20, P92, DOI 10.1016/j.tcb.2009.11.001; Laird DW, 2006, BIOCHEM J, V394, P527, DOI 10.1042/BJ20051922; LASNITZKI I, 1974, CANCER RES, V34, P1564; LASNITZKI I, 1976, BRIT J CANCER, V34, P239, DOI 10.1038/bjc.1976.158; LASNITZKI I, 1975, BRIT J CANCER, V32, P168, DOI 10.1038/bjc.1975.146; Liby KT, 2007, NAT REV CANCER, V7, P357, DOI 10.1038/nrc2129; LOHNES D, 1993, CELL, V73, P643, DOI 10.1016/0092-8674(93)90246-M; Manual M, 2006, ANNU REV PHARMACOL, V46, P451; Marker PC, 2003, DEV BIOL, V253, P165, DOI 10.1016/S0012-1606(02)00031-3; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; Mehta P, 1999, DEV GENET, V24, P91, DOI 10.1002/(SICI)1520-6408(1999)24:1/2<91::AID-DVG10>3.0.CO;2-#; MEHTA PP, 1989, J CELL BIOL, V108, P1053, DOI 10.1083/jcb.108.3.1053; MEHTA PP, 1986, CELL, V44, P187, DOI 10.1016/0092-8674(86)90497-6; MEHTA PP, 1991, J CELL BIOL, V113, P371, DOI 10.1083/jcb.113.2.371; MEYER RA, 1992, J CELL BIOL, V119, P179, DOI 10.1083/jcb.119.1.179; Mitra S, 2006, MOL BIOL CELL, V17, P5400, DOI 10.1091/mbc.E06-04-0280; Murthy S, 2003, PROSTATE, V56, P293, DOI 10.1002/pros.10261; Naus CC, 2010, NAT REV CANCER, V10, P435, DOI 10.1038/nrc2841; Peehl DM, 2003, ENDOCR-RELAT CANCER, V10, P131, DOI 10.1677/erc.0.0100131; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Pfahl M, 1996, ANNU REV NUTR, V16, P257, DOI 10.1146/annurev.nu.16.070196.001353; REICHMAN ME, 1990, CANCER RES, V50, P2311; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; SCHUURMANS ALG, 1991, J STEROID BIOCHEM, V40, P193, DOI 10.1016/0960-0760(91)90182-5; Shen MM, 2010, GENE DEV, V24, P1967, DOI 10.1101/gad.1965810; Sporn MB, 2002, NAT REV CANCER, V2, P537, DOI 10.1038/nrc844; Temme A, 1997, CURR BIOL, V7, P713, DOI 10.1016/S0960-9822(06)00302-2; Trosko JE, 2006, ANN NY ACAD SCI, V1089, P36, DOI 10.1196/annals.1386.018; Trosko JE, 2007, J MEMBRANE BIOL, V218, P93, DOI 10.1007/s00232-007-9072-6; Trosko JE, 2006, NUTR CANCER, V54, P102, DOI 10.1207/s15327914nc5401_12; Trosko JE, 2001, MUTAT RES-FUND MOL M, V480, P219, DOI 10.1016/S0027-5107(01)00181-6; Umekita Y, 1996, P NATL ACAD SCI USA, V93, P11802, DOI 10.1073/pnas.93.21.11802; VanSlyke JK, 2000, METHODS, V20, P156, DOI 10.1006/meth.1999.0933; Vezina CM, 2008, DEV DYNAM, V237, P1321, DOI 10.1002/dvdy.21526; Wang M, 2007, J CELL SCI, V120, P320, DOI 10.1242/jcs.03343; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; Zhang XK, 2002, ENDOCR-RELAT CANCER, V9, DOI 10.1677/erc.0.0090087; Zhao XY, 1999, ENDOCRINOLOGY, V140, P1205, DOI 10.1210/en.140.3.1205	82	18	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e32846	10.1371/journal.pone.0032846	http://dx.doi.org/10.1371/journal.pone.0032846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514600	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600005
J	Kinch, DC; Peters, JH; Simasko, SM				Kinch, Dallas C.; Peters, James H.; Simasko, Steven M.			Comparative Pharmacology of Cholecystokinin Induced Activation of Cultured Vagal Afferent Neurons from Rats and Mice	PLOS ONE			English	Article							RECEPTOR POTENTIAL CHANNELS; PHOSPHOLIPASE A(2) PATHWAYS; PANCREATIC ACINAR-CELLS; C-TERMINAL HEPTAPEPTIDE; AFFINITY CCK RECEPTORS; A RECEPTORS; NODOSE GANGLIA; SIGNAL-TRANSDUCTION; CA2+ OSCILLATIONS; GLUTAMATE RELEASE	Cholecystokinin (CCK) facilitates the process of satiation via activation of vagal afferent neurons innervating the upper gastrointestinal tract. Recent findings indicate CCK acts on these neurons via a ruthenium red (RuR) sensitive pathway that involves members of the vanilloid (V) subfamily of transient receptor potential (TRP) channels. To further test this mechanism, the mouse provides an ideal model in which genetic tools could be applied. However, whether CCK acts by similar mechanism(s) in mice has not been determined. In the present study we explored the actions of CCK on nodose neurons isolated from Sprague Dawley (SD) rat and two strains of mice; C57BL/6 and BalbC using fluorescence-based calcium imaging. With minor exceptions nodose neurons isolated from all species/strains behaved similarly. They all respond to brief depolarization with a large calcium transient. A significant subset of neurons responded to capsaicin (CAP), a TRPV1 agonist, although neurons from C57BL/6 were 10-fold more sensitive to CAP than SD rats or BalbC mice, and a significantly smaller fraction of neurons from BalbC mice responded to CAP. CCK-8 dose-dependently activated a subpopulation of neurons with similar dose dependency, percent responders, and overlap between CCK and CAP responsiveness. In all species/strains CCK-8 induced activation was significantly attenuated (but not completely blocked) by pretreatment with the TRPV channel blocker RuR. Surprisingly, the CCK analogue JMV-180, which is reported to have pure antagonistic properties in rat but mixed agonist/antagonist properties in mice, behaved as a pure antagonist to CCK in both rat and mouse neurons. The pure antagonistic action of JMV-180 in this in vitro preparation suggests that prior reported differential effects of JMV-180 on satiation in rats versus mouse must be mediated by a site other than vagal afferent activation.	[Kinch, Dallas C.; Peters, James H.; Simasko, Steven M.] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Program Neurosci, Pullman, WA 99164 USA	Washington State University	Kinch, DC (corresponding author), Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Program Neurosci, Pullman, WA 99164 USA.	simasko@vetmed.wsu.edu		Simasko, Steven/0000-0002-4129-1698	National Institutes of Health [DK067146]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067146, R01DK092651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health grant: DK067146 (SMS). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Archer-Lahlou E, 2005, J BIOL CHEM, V280, P10664, DOI 10.1074/jbc.M409451200; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; BIANCHI BR, 1994, J PHARMACOL EXP THER, V268, P996; Cawston EE, 2010, BRIT J PHARMACOL, V159, P1009, DOI 10.1111/j.1476-5381.2009.00489.x; Chung E, 2002, AUTON NEUROSCI-BASIC, V97, P83, DOI 10.1016/S1566-0702(02)00045-0; Correll CC, 2004, NEUROSCI LETT, V370, P55, DOI 10.1016/j.neulet.2004.07.058; Crawley JN, 1997, PSYCHOPHARMACOLOGY, V132, P107, DOI 10.1007/s002130050327; CRAWLEY JN, 1994, PEPTIDES, V15, P731, DOI 10.1016/0196-9781(94)90104-X; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; Dockray GJ, 2009, REGUL PEPTIDES, V155, P6, DOI 10.1016/j.regpep.2009.03.015; DUCLAUX R, 1976, J PHYSIOL-LONDON, V260, P487, DOI 10.1113/jphysiol.1976.sp011527; DUN NJ, 1991, BRAIN RES, V556, P161, DOI 10.1016/0006-8993(91)90562-A; FULCRAND P, 1988, INT J PEPT PROT RES, V32, P384; Gaisano GG, 2010, NEUROGASTROENT MOTIL, V22, P470, DOI 10.1111/j.1365-2982.2009.01430.x; GALAS MC, 1988, AM J PHYSIOL, V254, pG176, DOI 10.1152/ajpgi.1988.254.2.G176; Ghanekar D, 1997, J PHARMACOL EXP THER, V282, P1206; Grundy D, 2006, AUTON NEUROSCI-BASIC, V125, P76, DOI 10.1016/j.autneu.2006.01.009; Heldsinger A, 2011, J BIOL CHEM, V286, P11707, DOI 10.1074/jbc.M110.198945; HOLZER P, 1991, PHARMACOL REV, V43, P143; Ji BA, 2000, J BIOL CHEM, V275, P19115, DOI 10.1074/jbc.M001685200; Lankisch TO, 1999, EUR J CELL BIOL, V78, P632, DOI 10.1016/S0171-9335(99)80048-X; Lankisch TO, 2002, AM J PHYSIOL-GASTR L, V282, pG1002, DOI 10.1152/ajpgi.00313.2001; Li Y, 2011, AM J PHYSIOL-GASTR L, V300, pG217, DOI 10.1152/ajpgi.00356.2010; MATOZAKI T, 1989, AM J PHYSIOL, V257, pG594, DOI 10.1152/ajpgi.1989.257.4.G594; Peters JH, 2010, NEURON, V65, P657, DOI 10.1016/j.neuron.2010.02.017; Peters JH, 2006, AM J PHYSIOL-REG I, V290, pR1544, DOI 10.1152/ajpregu.00811.2005; Peters JH, 2004, ENDOCRINOLOGY, V145, P3652, DOI 10.1210/en.2004-0221; Peters JH, 2005, AM J PHYSL CELL PHYS; Poosti R, 2000, MOL PHARMACOL, V58, P1381, DOI 10.1124/mol.58.6.1381; Powley TL, 2002, AM J PHYSIOL-GASTR L, V283, pG1217, DOI 10.1152/ajpgi.00249.2002; Ralevic V, 2003, BIOCHEM PHARMACOL, V65, P143, DOI 10.1016/S0006-2952(02)01451-X; Ritter RC, 2004, PHYSIOL BEHAV, V81, P249, DOI 10.1016/j.physbeh.2004.02.012; RITTER RC, 1985, AM J PHYSIOL, V248, pR501, DOI 10.1152/ajpregu.1985.248.4.R501; RODRIGUEZ M, 1987, J MED CHEM, V30, P1366, DOI 10.1021/jm00391a017; SALUJA AK, 1992, J BIOL CHEM, V267, P11202; Sarri E, 2001, BRIT J PHARMACOL, V133, P1227, DOI 10.1038/sj.bjp.0704190; SATO S, 1989, AM J PHYSIOL, V257, pG202, DOI 10.1152/ajpgi.1989.257.2.G202; SCHWARTZ GJ, 1994, AM J PHYSIOL, V267, pR303, DOI 10.1152/ajpregu.1994.267.1.R303; Shoudai K, 2010, J NEUROSCI, V30, P14470, DOI 10.1523/JNEUROSCI.2557-10.2010; Simasko SM, 2002, AM J PHYSIOL-REG I, V283, pR1303, DOI 10.1152/ajpregu.00050.2002; Simasko SM, 2003, AM J PHYSL GASTROINT; Smart D, 2001, EUR J PHARMACOL, V417, P51, DOI 10.1016/S0014-2999(01)00901-3; STARK HA, 1989, BIOCHIM BIOPHYS ACTA, V1010, P145, DOI 10.1016/0167-4889(89)90154-7; TSUNODA Y, 1995, AM J PHYSIOL-GASTR L, V269, pG435, DOI 10.1152/ajpgi.1995.269.3.G435; Wank SA, 1998, AM J PHYSIOL-GASTR L, V274, pG607, DOI 10.1152/ajpgi.1998.274.4.G607; WANK SA, 1995, AM J PHYSIOL-GASTR L, V269, pG628, DOI 10.1152/ajpgi.1995.269.5.G628; WEATHERFORD SC, 1993, AM J PHYSIOL, V264, pR244, DOI 10.1152/ajpregu.1993.264.2.R244; WEATHERFORD SC, 1992, AM J PHYSIOL, V262, pR574, DOI 10.1152/ajpregu.1992.262.4.R574; WIDDOP RE, 1994, J AUTONOM NERV SYST, V46, P65, DOI 10.1016/0165-1838(94)90145-7; Williams JA, 2002, PHARMACOL TOXICOL, V91, P297, DOI 10.1034/j.1600-0773.2002.910606.x; YULE DI, 1993, AM J PHYSIOL, V265, pG999, DOI 10.1152/ajpgi.1993.265.5.G999; YULE DI, 1992, J BIOL CHEM, V267, P13830; Zhang L, 2004, AM J PHYSIOL-GASTR L, V286, pG983, DOI 10.1152/ajpgi.00441.2003; Zhao H, 2011, AUTON NEUROSCI-BASIC, V164, P20, DOI 10.1016/j.autneu.2011.05.004; Zhao HA, 2010, ENDOCRINOLOGY, V151, P5237, DOI 10.1210/en.2010-0504; Zhao H, 2010, AM J PHYSIOL-GASTR L, V298, pG212, DOI 10.1152/ajpgi.00396.2009	56	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34755	10.1371/journal.pone.0034755	http://dx.doi.org/10.1371/journal.pone.0034755			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514663	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600069
J	Sehgal, N; Kumawat, KL; Basu, A; Ravindranath, V				Sehgal, Neha; Kumawat, Kanhaiya Lal; Basu, Anirban; Ravindranath, Vijayalakshmi			Fenofibrate Reduces Mortality and Precludes Neurological Deficits in Survivors in Murine Model of Japanese Encephalitis Viral Infection	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; CYTOCHROME P4504F; VIRUS INFECTION; KAPPA-B; BRAIN; INFLAMMATION; PPAR; NEUROPROTECTION; HYPERLIPIDEMIA; REPLICATION	Background: Japanese encephalitis (JE), the most common form of viral encephalitis occurs periodically in endemic areas leading to high mortality and neurological deficits in survivors. It is caused by a flavivirus, Japanese encephalitis virus (JEV), which is transmitted to humans through mosquitoes. No effective cure exists for reducing mortality and morbidity caused by JEV infection, which is primarily due to excessive inflammatory response. Fenofibrate, a peroxisome proliferator-activated receptor-alpha (PPAR alpha) agonist is known to resolve inflammation by repressing nuclear factor-kappa B (NF-kappa B) and enhancing transcription of anti-oxidant and anti-inflammatory genes. In addition, fenofibrate also up-regulates a class of proteins, cytochrome P4504Fs (Cyp4fs), which are involved in detoxification of the potent pro-inflammatory eicosanoid, leukotriene B-4 (LTB4) to 20-hydroxy LTB4. Methodology/Principal Findings: The neuroprotective effect of fenofibrate was examined using in vitro (BV-2 microglial cell line) and in vivo (BALB/cmice) models of JEV infection. Mice were treated with fenofibrate for 2 or 4 days prior to JEV exposure. Pretreatment with fenofibrate for 4 but not 2 days reduced mortality by 80% and brain LTB4 levels decreased concomitantly with the induction of Cyp4f15 and 4f18, which catalyze detoxification of LTB4 through hydroxylation. Expression of cytokines and chemokine decreased significantly as did microglial activation and replication of the JEV virus. Conclusions/Significance: Fenofibrate confers neuroprotection against Japanese encephalitis, in vivo, in mouse model of JEV infection. Thus, fenofibrate, a PPAR alpha agonist that is commonly used as a hypolipidemic drug could potentially be used for prophylaxis during JE epidemics to reduce mortality and morbidity.	[Sehgal, Neha; Kumawat, Kanhaiya Lal; Basu, Anirban; Ravindranath, Vijayalakshmi] Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Manesar, Haryana, India	Department of Biotechnology (DBT) India; National Brain Research Centre (NBRC)	Sehgal, N (corresponding author), Natl Brain Res Ctr, Div Mol & Cellular Neurosci, Manesar, Haryana, India.	viji@cns.iisc.ernet.in		Basu, Anirban/0000-0002-5200-2054	National Institutes of Health [MH 70054]; J.C. Bose National Fellowship; CORE grant from National Brain Research Centre	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); J.C. Bose National Fellowship; CORE grant from National Brain Research Centre	This work was supported by National Institutes of Health grant MH 70054, J.C. Bose National Fellowship and CORE grant from National Brain Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archambeaud-Mouveroux F, 2006, REV MED INTERNE, V27, P573, DOI 10.1016/j.revmed.2006.02.013; Arnaiz SL, 1995, BBA-MOL BASIS DIS, V1272, P175; Azab AN, 2004, PROSTAG LEUKOTR ESS, V70, P67, DOI 10.1016/j.plefa.2003.08.005; Barker BJ, 2003, DIABETES CARE, V26, P2482, DOI 10.2337/diacare.26.8.2482; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bharati Kaushik, 2006, Expert Rev Anti Infect Ther, V4, P313, DOI 10.1586/14787210.4.2.313; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bordet R, 2006, BIOCHEM SOC T, V34, P1341, DOI 10.1042/BST0341341; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen CJ, 2002, J GEN VIROL, V83, P1897, DOI 10.1099/0022-1317-83-8-1897; Chen XR, 2007, J NEUROTRAUM, V24, P1119, DOI 10.1089/neu.2006.0216; Choi JH, 2006, EUR J PEDIATR, V165, P138, DOI 10.1007/s00431-005-0009-8; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Corton JC, 2000, ANNU REV PHARMACOL, V40, P491, DOI 10.1146/annurev.pharmtox.40.1.491; Cree MG, 2007, ANN SURG, V245, P214, DOI 10.1097/01.sla.0000250409.51289.ca; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200; Deplanque D, 2003, J NEUROSCI, V23, P6264; DESAI A, 1995, ACTA NEUROPATHOL, V89, P368, DOI 10.1007/BF00309631; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; Elsayed EF, 2010, PEDIATR NEPHROL, V25, P7, DOI 10.1007/s00467-009-1223-9; Fruchart JC, 2001, PHARMACOL RES, V44, P345, DOI 10.1006/phrs.2001.0871; Fruchart JC, 2009, ATHEROSCLEROSIS, V205, P1, DOI 10.1016/j.atherosclerosis.2009.03.008; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Gray E, 2011, EUR J NEUROSCI, V33, P1421, DOI 10.1111/j.1460-9568.2011.07637.x; Halstead Scott B, 2010, Curr Infect Dis Rep, V12, P174, DOI 10.1007/s11908-010-0098-z; Kalsotra A, 2007, ARCH BIOCHEM BIOPHYS, V461, P104, DOI 10.1016/j.abb.2007.02.027; Kalsotra A, 2006, PHARMACOL THERAPEUT, V112, P589, DOI 10.1016/j.pharmthera.2006.03.008; Kaur R, 2003, J NEUROVIROL, V9, P421, DOI 10.1080/13550280390218454; Koh KK, 2008, INT J CARDIOL, V124, P149, DOI 10.1016/j.ijcard.2007.04.080; KUMAR R, 1991, Indian Pediatrics, V28, P1525; KUMAR R, 1993, INDIAN J MED RES-A, V97, P9; MEHL JK, 1980, ANTIMICROB AGENTS CH, V18, P269, DOI 10.1128/AAC.18.2.269; Mishra MK, 2008, J NEUROCHEM, V105, P1582, DOI 10.1111/j.1471-4159.2008.05238.x; Peyrl A, 2011, PEDIAT BLOOD CANC; Ramazan D, 2010, CASE REPORTS MED; Sehgal N, 2011, BIOCHEM PHARMACOL, V82, P53, DOI 10.1016/j.bcp.2011.03.025; Skolnik PR, 2002, JAIDS-J ACQ IMM DEF, V31, P1, DOI 10.1097/00126334-200209010-00001; Soldan SS, 2004, J NEUROIMMUNOL, V146, P209, DOI 10.1016/j.jneuroim.2003.10.033; Stahel PF, 2008, PPAR RES, V2008, DOI 10.1155/2008/538141; Tahmaz M, 2007, RENAL FAILURE, V29, P927, DOI 10.1080/08860220701573640; Thongtan T, 2010, MICROBES INFECT, V12, P37, DOI 10.1016/j.micinf.2009.09.013; Tsimihodimos V, 2009, CURR PHARM DESIGN, V15, P517, DOI 10.2174/138161209787315675; Vanden Berghe W, 2003, ADV EXP MED BIOL, V544, P181; Vrati S, 1999, J GEN VIROL, V80, P1665, DOI 10.1099/0022-1317-80-7-1665; Wang GM, 2010, BRAIN RES, V1359, P247, DOI 10.1016/j.brainres.2010.08.075; Wang Y, 2008, J NEUROTRAUM, V25, P1187, DOI 10.1089/neu.2008.0542; Wei JC, 2010, BIOCHEM BIOPH RES CO, V396, P787, DOI 10.1016/j.bbrc.2010.04.133; Wilder-Smith A, 2010, CURR OPIN INFECT DIS, V23, P426, DOI 10.1097/QCO.0b013e32833c1d01; Wilson Mary E, 2009, Curr Infect Dis Rep, V11, P37; Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328; Wu JY, 2009, EUR J CLIN PHARMACOL, V65, P1169, DOI 10.1007/s00228-009-0723-7; Youssef J, 2004, J BIOMED BIOTECHNOL, P156, DOI 10.1155/S1110724304308065	55	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35427	10.1371/journal.pone.0035427	http://dx.doi.org/10.1371/journal.pone.0035427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514742	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600147
J	Xu, TJ; Sun, YN; Shi, G; Wang, RX				Xu, Tianjun; Sun, Yuena; Shi, Ge; Wang, Rixin			Miiuy Croaker Hepcidin Gene and Comparative Analyses Reveal Evidence for Positive Selection	PLOS ONE			English	Article							FLOUNDER PARALICHTHYS-OLIVACEUS; ANIMAL ANTIMICROBIAL PEPTIDES; AMINO-ACID SITES; EXPRESSION ANALYSIS; PHYLOGENETIC ANALYSIS; MOLECULAR EVOLUTION; MAXIMUM-LIKELIHOOD; BASS HEPCIDIN; IDENTIFICATION; CLONING	Hepcidin antimicrobial peptide (HAMP) is a small cysteine-rich peptide and a key molecule of the innate immune system against bacterial infections. Molecular cloning and genomic characterization of HAMP gene in the miiuy croaker (Miichthys miiuy) were reported in this study. The miiuy croaker HAMP was predicted to encode a prepropeptide of 99 amino acids, a tentative RX(K/R) R cleavage motif and eight characteristic cysteine residues were also identified. The gene organization is also similar to corresponding genes in mammals and fish consisting of three exons and two introns. Sequence polymorphism analysis showed that only two different sequences were identified and encoded two proteins in six individuals. As reported for most other species, the expression level was highest in liver and an up-regulation of transcription was seen in spleen, intestine and kidney examined at 24 h after injection of pathogenic bacteria, Vibrio anguillarum, the expression pattern implied that miiuy croaker HAMP is an important component of the first line defense against invading pathogens. In addition, we report on the underlying mechanism that maintains sequences diversity among fish and mammalian species, respectively. A series of site-model tests implemented in the CODEML program revealed that moderate positive Darwinian selection is likely to cause the molecular evolution in the fish HAMP2 genes and it also showed that the fish HAMP1 genes and HAMP2 genes under different selection pressures.	[Xu, Tianjun; Sun, Yuena; Shi, Ge; Wang, Rixin] Zhejiang Ocean Univ, Lab Marine Living Resources & Mol Engn, Coll Marine Sci, Zhoushan, Peoples R China	Zhejiang Ocean University	Xu, TJ (corresponding author), Zhejiang Ocean Univ, Lab Marine Living Resources & Mol Engn, Coll Marine Sci, Zhoushan, Peoples R China.	wangrixin1123@126.com	Xu, Tianjun/G-2545-2013		Nation Nature Science Foundation of China [31001120]; Zhejiang Provincial Natural Science Foundation of China [Y3100013]	Nation Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	This study was supported by Nation Nature Science Foundation of China (31001120) and Zhejiang Provincial Natural Science Foundation of China (Y3100013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreu D, 1998, BIOPOLYMERS, V47, P415, DOI 10.1002/(SICI)1097-0282(1998)47:6<415::AID-BIP2>3.0.CO;2-D; Bao BL, 2005, DEV COMP IMMUNOL, V29, P939, DOI 10.1016/j.dci.2005.03.006; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Chen SL, 2005, ANTIMICROB AGENTS CH, V49, P1608, DOI 10.1128/AAC.49.4.1608-1612.2005; Chen SL, 2007, FISH SHELLFISH IMMUN, V22, P172, DOI 10.1016/j.fsi.2006.04.004; Douglas SE, 2003, DEV COMP IMMUNOL, V27, P589, DOI 10.1016/S0145-305X(03)00036-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fernandes JMO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009501; Ford MJ, 2002, MOL ECOL, V11, P1245, DOI 10.1046/j.1365-294X.2002.01536.x; Fu YM, 2007, MOL CELL BIOCHEM, V305, P191, DOI 10.1007/s11010-007-9543-1; Glover KA, 2007, DIS AQUAT ORGAN, V76, P57, DOI 10.3354/dao076057; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hedengren M, 2000, BIOCHEM BIOPH RES CO, V279, P574, DOI 10.1006/bbrc.2000.3988; HILL RE, 1987, NATURE, V326, P96, DOI 10.1038/326096a0; Hilton KB, 2008, GENE, V415, P40, DOI 10.1016/j.gene.2008.02.016; Hirono I, 2005, FEBS J, V272, P5257, DOI 10.1111/j.1742-4658.2005.04922.x; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Huang PH, 2007, MOL IMMUNOL, V44, P1922, DOI 10.1016/j.molimm.2006.09.031; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Hunter HN, 2002, J BIOL CHEM, V277, P37597, DOI 10.1074/jbc.M205305200; Hwang PM, 1998, BIOCHEM CELL BIOL, V76, P235, DOI 10.1139/bcb-76-2-3-235; Kim YO, 2008, MOL CELL BIOCHEM, V315, P131, DOI 10.1007/s11010-008-9796-3; Kimura M., 1983, NEUTRAL THEORY MOL E; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Lauth X, 2005, J BIOL CHEM, V280, P9272, DOI 10.1074/jbc.M411154200; Lehrer RI, 1999, CURR OPIN IMMUNOL, V11, P23, DOI 10.1016/S0952-7915(99)80005-3; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Lynch M, 2001, GENETICS, V159, P1789; Martin-Antonio B, 2009, FISH SHELLFISH IMMUN, V26, P483, DOI 10.1016/j.fsi.2009.01.012; Mukherjee S, 2009, P NATL ACAD SCI USA, V106, P7073, DOI 10.1073/pnas.0811357106; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; Nicolas P, 2003, PEPTIDES, V24, P1669, DOI 10.1016/j.peptides.2003.08.017; Padhi A, 2007, MOL DIVERS, V11, P119, DOI 10.1007/s11030-007-9066-4; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rastogi S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-28; Sambrook J., 2001, MOL CLONING LAB MANU; Segat L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-120; Sheikh N, 2007, LAB INVEST, V87, P713, DOI 10.1038/labinvest.3700553; Shi JS, 2006, DEV COMP IMMUNOL, V30, P746, DOI 10.1016/j.dci.2005.10.009; Shike H, 2002, EUR J BIOCHEM, V269, P2232, DOI 10.1046/j.1432-1033.2002.02881.x; Solstad T, 2008, FISH SHELLFISH IMMUN, V25, P298, DOI 10.1016/j.fsi.2008.05.013; Tennessen JA, 2005, J EVOLUTION BIOL, V18, P1387, DOI 10.1111/j.1420-9101.2005.00925.x; Valore EV, 2008, BLOOD CELL MOL DIS, V40, P132, DOI 10.1016/j.bcmd.2007.07.009; Xu TJ, 2008, FISH SHELLFISH IMMUN, V25, P213, DOI 10.1016/j.fsi.2008.05.007; Xu TJ, 2011, DEV COMP IMMUNOL, V35, P483, DOI 10.1016/j.dci.2010.12.003; Xu TJ, 2010, FISH SHELLFISH IMMUN, V29, P1099, DOI 10.1016/j.fsi.2010.08.013; Yang M, 2007, FISH SHELLFISH IMMUN, V23, P1060, DOI 10.1016/j.fsi.2007.04.011; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Zhang YA, 2004, VET IMMUNOL IMMUNOP, V101, P259, DOI 10.1016/j.vetimm.2004.05.005	55	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e35449	10.1371/journal.pone.0035449	http://dx.doi.org/10.1371/journal.pone.0035449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511989	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338600075
J	Abou Tayoun, AN; Pikielny, C; Dolph, PJ				Abou Tayoun, Ahmad N.; Pikielny, Claudio; Dolph, Patrick J.			Roles of the Drosophila SK Channel (dSK) in Courtship Memory	PLOS ONE			English	Article							LONG-TERM-MEMORY; CA2+-ACTIVATED K+ CHANNELS; SMALL-CONDUCTANCE; POTASSIUM CHANNELS; APAMIN; PLASTICITY; CIRCUIT; LOCALIZATION; CONTRIBUTES; PERFORMANCE	A role for SK channels in synaptic plasticity has been very well-characterized. However, in the absence of simple genetic animal models, their role in behavioral memory remains elusive. Here, we take advantage of Drosophila melanogaster with its single SK gene (dSK) and well-established courtship memory assay to investigate the contribution of this channel to memory. Using two independent dSK alleles, a null mutation and a dominant negative subunit, we show that while dSK negatively regulates the acquisition of short-term memory 30 min after a short training session, it is required for normal long-term memory 24 h after extended training. These findings highlight important functions for dSK in courtship memory and suggest that SK channels can mediate multiple forms of behavioral plasticity.	[Abou Tayoun, Ahmad N.; Dolph, Patrick J.] Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA; [Pikielny, Claudio] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Genet, Hanover, NH 03756 USA	Dartmouth College; Dartmouth College	Abou Tayoun, AN (corresponding author), Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA.	Patrick.Dolph@dartmouth.edu			National Institute of Health; Div Of Biological Infrastructure [1039423] Funding Source: National Science Foundation	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by a grant from the National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Baker KD, 2011, BEHAV BRAIN RES, V216, P458, DOI 10.1016/j.bbr.2010.07.032; BRAND AH, 1993, DEVELOPMENT, V118, P401; Deschaux O, 2005, NEUROSCI LETT, V386, P5, DOI 10.1016/j.neulet.2005.05.050; Deschaux O, 1997, NEUROSCI LETT, V227, P57, DOI 10.1016/S0304-3940(97)00301-7; Deschaux O, 1997, NEUROSCI LETT, V222, P159, DOI 10.1016/S0304-3940(97)13367-5; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Fournier C, 2001, BEHAV BRAIN RES, V121, P81, DOI 10.1016/S0166-4328(00)00387-9; GAILEY DA, 1985, GENETICS, V111, P795; GARCIA ML, 1991, J BIOENERG BIOMEMBR, V23, P615, DOI 10.1007/BF00785814; Griffith LC, 2009, LEARN MEMORY, V16, P743, DOI 10.1101/lm.956309; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Joiner MA, 2000, LEARN MEMORY, V7, P32, DOI 10.1101/lm.7.1.32; Joiner MLA, 1999, LEARN MEMORY, V6, P177; Kamyshev NG, 1999, LEARN MEMORY, V6, P1; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kane NS, 1997, NEURON, V18, P307, DOI 10.1016/S0896-6273(00)80270-6; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709; Lancaster B, 2001, J PHYSIOL-LONDON, V536, P809, DOI 10.1111/j.1469-7793.2001.00809.x; Liu X, 2009, NAT NEUROSCI, V12, P53, DOI 10.1038/nn.2235; McBride SMJ, 1999, NEURON, V24, P967, DOI 10.1016/S0896-6273(00)81043-0; MESSIER C, 1991, BRAIN RES, V551, P322, DOI 10.1016/0006-8993(91)90950-Z; Millership JE, 2011, AM J PHYSIOL-CELL PH, V300, pC792, DOI 10.1152/ajpcell.00274.2010; Mpari Bedel, 2005, Journal of Integrative Neuroscience, V4, P381, DOI 10.1142/S0219635205000884; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Pitman J, 2011, CURR BIOL; Preisig-Muller R, 2002, P NATL ACAD SCI USA, V99, P7774, DOI 10.1073/pnas.102609499; SIEGEL RW, 1979, P NATL ACAD SCI USA, V76, P3430, DOI 10.1073/pnas.76.7.3430; Stackman RW, 2002, J NEUROSCI, V22, P10163; Thum AS, 2007, J NEUROSCI, V27, P11132, DOI 10.1523/JNEUROSCI.2712-07.2007; van der Staay FJ, 1999, NEUROSCI BIOBEHAV R, V23, P1087, DOI 10.1016/S0149-7634(99)00043-3; Xue T, 2002, CIRC RES, V90, P1267, DOI 10.1161/01.RES.0000024390.97889.C6; YANG MY, 1995, NEURON, V15, P45; Yu DH, 2004, NEURON, V42, P437, DOI 10.1016/S0896-6273(04)00217-X; Yu DH, 2006, NEURON, V52, P845, DOI 10.1016/j.neuron.2006.10.030; Zars T., 2000, Science (Washington D C), V288, P672, DOI 10.1126/science.288.5466.672	39	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34665	10.1371/journal.pone.0034665	http://dx.doi.org/10.1371/journal.pone.0034665			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509342	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336600047
J	Geng, Y; Wang, YH; Yang, K; Wang, SP; Zeng, H; Baumann, F; Kuehn, P; Scholten, T; He, JS				Geng, Yan; Wang, Yonghui; Yang, Kuo; Wang, Shaopeng; Zeng, Hui; Baumann, Frank; Kuehn, Peter; Scholten, Thomas; He, Jin-Sheng			Soil Respiration in Tibetan Alpine Grasslands: Belowground Biomass and Soil Moisture, but Not Soil Temperature, Best Explain the Large-Scale Patterns	PLOS ONE			English	Article							CARBON-DIOXIDE; NITROGEN MINERALIZATION; INTERANNUAL VARIABILITY; ORGANIC-CARBON; ARCTIC TUNDRA; CO2 EFFLUX; TRADE-OFFS; ECOSYSTEM; PERMAFROST; CLIMATE	The Tibetan Plateau is an essential area to study the potential feedback effects of soils to climate change due to the rapid rise in its air temperature in the past several decades and the large amounts of soil organic carbon (SOC) stocks, particularly in the permafrost. Yet it is one of the most under-investigated regions in soil respiration (Rs) studies. Here, Rs rates were measured at 42 sites in alpine grasslands (including alpine steppes and meadows) along a transect across the Tibetan Plateau during the peak growing season of 2006 and 2007 in order to test whether: (1) belowground biomass (BGB) is most closely related to spatial variation in Rs due to high root biomass density, and (2) soil temperature significantly influences spatial pattern of Rs owing to metabolic limitation from the low temperature in cold, high-altitude ecosystems. The average daily mean Rs of the alpine grasslands at peak growing season was 3.92 mu mol CO2 m(-2) s(-1), ranging from 0.39 to 12.88 mu mol CO2 m(-2) s(-1), with average daily mean Rs of 2.01 and 5.49 mu mol CO2 m(-2) s(-1) for steppes and meadows, respectively. By regression tree analysis, BGB, aboveground biomass (AGB), SOC, soil moisture (SM), and vegetation type were selected out of 15 variables examined, as the factors influencing large-scale variation in Rs. With a structural equation modelling approach, we found only BGB and SM had direct effects on Rs, while other factors indirectly affecting Rs through BGB or SM. Most (80%) of the variation in Rs could be attributed to the difference in BGB among sites. BGB and SM together accounted for the majority (82%) of spatial patterns of Rs. Our results only support the first hypothesis, suggesting that models incorporating BGB and SM can improve Rs estimation at regional scale.	[Geng, Yan; Wang, Yonghui; Yang, Kuo; Wang, Shaopeng; Zeng, Hui; He, Jin-Sheng] Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China; [Geng, Yan; Wang, Yonghui; Yang, Kuo; Wang, Shaopeng; Zeng, Hui; He, Jin-Sheng] Peking Univ, Key Lab Earth Surface Proc, Minist Educ, Beijing 100871, Peoples R China; [Geng, Yan; He, Jin-Sheng] Chinese Acad Sci, NW Inst Plateau Biol, Key Lab Adaptat & Evolut Plateau Biota, Xining, Peoples R China; [Zeng, Hui] Peking Univ, Shenzhen Grad Sch, Shenzhen Key Lab Circular Econ, Shenzhen, Peoples R China; [Baumann, Frank; Kuehn, Peter; Scholten, Thomas] Univ Tubingen, Dept Geosci Phys Geog & Soil Sci, Tubingen, Germany	Peking University; Peking University; Chinese Academy of Sciences; Peking University; University Town of Shenzhen; Eberhard Karls University of Tubingen	Geng, Y (corresponding author), Peking Univ, Coll Urban & Environm Sci, Dept Ecol, Beijing 100871, Peoples R China.	jshe@nwipb.cas.cn	Scholten, Thomas/E-4024-2012; Wang, Shaopeng/J-7091-2012; Kühn, Peter/A-9146-2009; He, Jin-Sheng/A-4053-2009	Scholten, Thomas/0000-0002-4875-2602; Kühn, Peter/0000-0002-4417-5633; He, Jin-Sheng/0000-0001-5081-3569; Wang, Shaopeng/0000-0002-9430-8879	Chinese Academy of Sciences [KSCX2-YW-Z-0806, XDA05050304]; National Natural Science Foundation of China [31025005, 31021001]; National Program on Key Basic Research Project [2010CB950602]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project(National Basic Research Program of China)	This study was supported by the "Program of One Hundred Talented People" of the Chinese Academy of Sciences (Grant No. KSCX2-YW-Z-0806), the National Natural Science Foundation of China (Grant No. 31025005 and 31021001), National Program on Key Basic Research Project (Grant No. 2010CB950602), and the "Strategic Priority Research Program" of the Chinese Academy of Sciences (Grant No. XDA05050304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P1156, DOI 10.1111/j.1365-2486.2008.01549.x; Amundson R, 2001, ANNU REV EARTH PL SC, V29, P535, DOI 10.1146/annurev.earth.29.1.535; [Anonymous], 2002, CAUSE CORRELATION BI; Baumann F, 2009, GLOBAL CHANGE BIOL, V15, P3001, DOI 10.1111/j.1365-2486.2009.01953.x; Bentler P. M., 2006, EQS 6 STRUCTURAL EQU, DOI 10.1080/1612197X.2016.1153130; BILLINGS WD, 1982, OECOLOGIA, V53, P7, DOI 10.1007/BF00377129; Bohner J, 2005, BOREAS, V34, P220, DOI 10.1080/03009480510012917; Bond-Lamberty B, 2010, BIOGEOSCIENCES, V7, P1915, DOI 10.5194/bg-7-1915-2010; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Breiman L., 1984, CLASSIFICATION REGRE; Burke IC, 1997, ECOLOGY, V78, P1330, DOI 10.1890/0012-9658(1997)078[1330:RATVIN]2.0.CO;2; Cao GM, 2004, SOIL BIOL BIOCHEM, V36, P237, DOI 10.1016/j.soilbio.2003.09.010; Chapin F.S., 2002, PRINCIPLES TERRESTRI, DOI 10.1007/978-1-4419-9504-9; Chen QS, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003538; Cheng GD, 2005, J COLD REG ENG, V19, P19, DOI 10.1061/(ASCE)0887-381X(2005)19:1(19); Cheng GD, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000631; Craine JM, 2002, FUNCT ECOL, V16, P563, DOI 10.1046/j.1365-2435.2002.00660.x; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2002, AGR FOREST METEOROL, V113, P21, DOI 10.1016/S0168-1923(02)00100-4; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; DENNIS JG, 1977, ARCTIC ALPINE RES, V9, P113, DOI 10.2307/1550574; Dong YS, 2005, CHINESE SCI BULL, V50, P583, DOI 10.1360/04wd0356; Dornbush ME, 2006, ECOSYSTEMS, V9, P909, DOI 10.1007/s10021-005-0093-7; ESWARAN H, 1993, SOIL SCI SOC AM J, V57, P192, DOI 10.2136/sssaj1993.03615995005700010034x; Fang JY, 2001, SCIENCE, V293, P1723, DOI 10.1126/science.293.5536.1723a; Fierer N, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002644; Gower ST, 1997, J GEOPHYS RES-ATMOS, V102, P29029, DOI [10.1029/97JD02317, 10.1029/97JD01440]; Grace JB, 2006, ECOL APPL, V16, P503, DOI 10.1890/1051-0761(2006)016[0503:ASEMAO]2.0.CO;2; Grace JB, 1997, AM NAT, V149, P436, DOI 10.1086/285999; Grace JB., 2015, STRUCTURAL EQUATION; He JS, 2009, ECOLOGY, V90, P2779, DOI 10.1890/08-1126.1; He JS, 2006, NEW PHYTOL, V170, P835, DOI 10.1111/j.1469-8137.2006.01704.x; Hibbard KA, 2005, BIOGEOCHEMISTRY, V73, P29, DOI 10.1007/s10533-004-2946-0; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Hou, 1982, VEGETATION MAP PEOPL; Jenny H., 1941, FACTORS SOIL FORMATI; Kutsch WL, 2010, BIOGEOCHEMISTRY, V100, P167, DOI 10.1007/s10533-010-9414-9; Lamb EG, 2008, ECOLOGY, V89, P216, DOI 10.1890/07-0393.1; Li GY, 2011, ECOL RES, V26, P497, DOI 10.1007/s11284-011-0806-7; Li L-H, 2000, ACTA PHYTOECOL SIN, V24, P680; Lin XW, 2011, AGR FOREST METEOROL, V151, P792, DOI 10.1016/j.agrformet.2011.01.009; Luo Y., 2006, SOIL RESP ENV, P35, DOI [10.1016/B978-012088782-8/50003-6, DOI 10.1016/B978-012088782-8/50003-6]; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; McCulley RL, 2005, ECOSYSTEMS, V8, P106, DOI 10.1007/s10021-004-0117-8; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Misson L, 2006, TREE PHYSIOL, V26, P833, DOI 10.1093/treephys/26.7.833; Nan ZT, 2005, SCI CHINA SER D, V48, P797, DOI 10.1360/03yd0258; Nobrega S, 2008, ECOSYSTEMS, V11, P377, DOI 10.1007/s10021-008-9128-1; Qi YC, 2006, ADV ATMOS SCI, V23, P726, DOI 10.1007/s00376-006-0726-6; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Ripley EA, 1992, NATURAL GRASSLANDS I, P151; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Ryan MG, 2005, BIOGEOCHEMISTRY, V73, P3, DOI 10.1007/s10533-004-5167-7; SAS Institute, 1999, SAS STAT US GUID VER; Savage K, 2008, FUNCT ECOL, V22, P1000, DOI 10.1111/j.1365-2435.2008.01414.x; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Schlesinger WH., 1997, BIOGEOCHEMISTRY; Shi PL, 2006, AGR FOREST METEOROL, V137, P220, DOI 10.1016/j.agrformet.2006.02.008; Shipley B, 2006, ECOLOGY, V87, P535, DOI 10.1890/05-1051; Subke JA, 2006, GLOBAL CHANGE BIOL, V12, P921, DOI 10.1111/j.1365-2486.2006.01117.x; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; Wan SQ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001971; Wang GC, 2004, CHINESE SCI BULL, V49, P642, DOI 10.1360/03wd0241; WANG JT, 1988, VEGETATIO, V75, P135; Wang JF, 2010, ENVIRON EARTH SCI, V60, P537, DOI 10.1007/s12665-009-0193-3; Wu, 1980, VEGETATION CHINA; [吴绍洪 Wu Shaohong], 2005, [地理学报, Acta Geographica Sinica], V60, P3; Xu M, 2001, GLOBAL BIOGEOCHEM CY, V15, P687, DOI 10.1029/2000GB001365; Yan LM, 2010, GLOBAL CHANGE BIOL, V16, P2345, DOI 10.1111/j.1365-2486.2009.02091.x; Yang YH, 2008, GLOBAL CHANGE BIOL, V14, P1592, DOI 10.1111/j.1365-2486.2008.01591.x; Yang YH, 2009, J VEG SCI, V20, P177, DOI 10.1111/j.1654-1103.2009.05566.x; Zhang J., 1988, VEGETATION XIZANG TI; Zhang XZ, 2005, SCI CHINA SER D, V48, P218, DOI 10.1360/05zd0022; Zhao L, 2004, GLOBAL PLANET CHANGE, V43, P19, DOI 10.1016/j.gloplacha.2004.02.003; Zhou X, 2007, GLOBAL CHANGE BIOL, V13, P761, DOI 10.1111/j.1365-2486.2007.01333.x; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908	79	97	109	13	189	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34968	10.1371/journal.pone.0034968	http://dx.doi.org/10.1371/journal.pone.0034968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509373	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336600071
J	Honnemann, J; Sanz-Moreno, A; Wolf, E; Eilers, M; Elsasser, HP				Hoennemann, Jan; Sanz-Moreno, Adrian; Wolf, Elmar; Eilers, Martin; Elsaesser, Hans-Peter			Miz1 Is a Critical Repressor of cdkn1a during Skin Tumorigenesis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR MIZ-1; CELL-CYCLE ARREST; C-MYC; TUMOR-SUPPRESSOR; CANCER-CELLS; POZ DOMAIN; P21; DIFFERENTIATION; P15(INK4B); SENESCENCE	The transcription factor Miz1 forms repressive DNA-binding complexes with the Myc, Gfi-1 and Bcl-6 oncoproteins. Known target genes of these complexes encode the cyclin-dependent kinase inhibitors (CKIs) cdkn2b (p15(Ink4)), cdkn1a (p21(Cip1)), and cdkn1c (p57(Kip2)). Whether Miz1-mediated repression is important for control of cell proliferation in vivo and for tumor formation is unknown. Here we show that deletion of the Miz1 POZ domain, which is critical for Miz1 function, restrains the development of skin tumors in a model of chemically-induced, Ras-dependent tumorigenesis. While the stem cell compartment appears unaffected, interfollicular keratinocytes lacking functional Miz1 exhibit a reduced proliferation and an accelerated differentiation of the epidermis in response to the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA). Tumorigenesis, proliferation and normal differentiation are restored in animals lacking cdkn1a, but not in those lacking cdkn2b. Our data demonstrate that Miz1-mediated attenuation of cell cycle arrest pathways via repression of cdkn1a has a critical role during tumorigenesis in the skin.	[Hoennemann, Jan; Sanz-Moreno, Adrian; Elsaesser, Hans-Peter] Univ Marburg, Dept Cytobiol, D-35032 Marburg, Germany; [Wolf, Elmar; Eilers, Martin] Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97070 Wurzburg, Germany	Philipps University Marburg; University of Wurzburg	Honnemann, J (corresponding author), Univ Marburg, Dept Cytobiol, D-35032 Marburg, Germany.	elsaesse@mailer.uni-marburg.de	Wolf, Elmar/AAY-8493-2021	Wolf, Elmar/0000-0002-5299-6335; Eilers, Martin/0000-0002-0376-6533; Sanz-Moreno, Adrian/0000-0001-9478-5432; Wolf, Eckhard/0000-0002-0430-9510	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich Transregio 17, B5, International GRK 767]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich Transregio 17, Project B5, and International GRK 767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2003, MOL CELL BIOL, V23, P7648, DOI 10.1128/MCB.23.21.7648-7657.2003; Atanasoski S, 2006, GLIA, V53, P147, DOI 10.1002/glia.20263; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Basu S, 2009, P NATL ACAD SCI USA, V106, P1433, DOI 10.1073/pnas.0804863106; BICKENBACH JR, 1981, J DENT RES, V60, P1611, DOI 10.1177/002203458106000311011; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Borgdorff V, 2010, ONCOGENE, V29, P2262, DOI 10.1038/onc.2009.497; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; CAMPISI J, 2010, CURR OPIN GENET DEV; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; de Keizer PLJ, 2010, CANC RES; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Gebhardt A, 2006, J CELL BIOL, V172, P139, DOI 10.1083/jcb.200506057; Gebhardt A, 2007, J CELL SCI, V120, P2586, DOI 10.1242/jcs.007104; Herkert B, 2010, J CELL BIOL, V188, P905, DOI 10.1083/jcb.200908103; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Kemp CJ, 2005, SEMIN CANCER BIOL, V15, P460, DOI 10.1016/j.semcancer.2005.06.003; Kime L, 2003, BIOCHEM J, V370, P291, DOI 10.1042/BJ20021679; Kosan C, 2010, IMMUNITY, V33, P917, DOI 10.1016/j.immuni.2010.11.028; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Liu J, 2009, P NATL ACAD SCI USA, V106, P18279, DOI 10.1073/pnas.0906328106; Miao L, 2010, ONCOGENE, V29, P711, DOI 10.1038/onc.2009.372; Moroy T, 2011, SEMIN IMMUNOL; Moroy T, 2011, SEMIN IMMUNOL, V23, P379, DOI 10.1016/j.smim.2011.09.001; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nagase H, 2003, CANCER RES, V63, P4849; Patel JH, 2007, J BIOL CHEM, V282, P5, DOI 10.1074/jbc.M609138200; Peukert K, 1997, EMBO J, V16, P5672, DOI 10.1093/emboj/16.18.5672; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Ridd K, 2010, TOXICOL IN VITRO, V24, P910, DOI 10.1016/j.tiv.2009.11.017; Sayama K, 1999, J CELL PHYSIOL, V179, P40, DOI 10.1002/(SICI)1097-4652(199904)179:1<40::AID-JCP5>3.0.CO;2-Z; Seoane J, 2001, NAT CELL BIOL, V3, P400, DOI 10.1038/35070086; Oskarsson T, 2006, GENE DEV, V20, P2024, DOI 10.1101/gad.381206; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Stead MA, 2007, J MOL BIOL, V373, P820, DOI 10.1016/j.jmb.2007.08.026; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Riggelen J, 2010, GENE DEV, V24, P1281, DOI 10.1101/gad.585710; Wanzel M, 2003, TRENDS CELL BIOL, V13, P146, DOI 10.1016/S0962-8924(03)00003-5; Wanzel M, 2008, NAT CELL BIOL, V10, P1051, DOI 10.1038/ncb1764; Weinberg WC, 2002, CRIT REV ORAL BIOL M, V13, P453, DOI 10.1177/154411130201300603; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; YUSPA SH, 1981, J SUPRAMOL STR CELL, V17, P245, DOI 10.1002/jsscb.380170306; YUSPA SH, 1980, CANCER RES, V40, P4694; Zanet J, 2005, J CELL SCI, V118, P1693, DOI 10.1242/jcs.02298	49	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34885	10.1371/journal.pone.0034885	http://dx.doi.org/10.1371/journal.pone.0034885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509363	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600063
J	Komatsuzaki, Y; Hatanaka, Y; Murakami, G; Mukai, H; Hojo, Y; Saito, M; Kimoto, T; Kawato, S				Komatsuzaki, Yoshimasa; Hatanaka, Yusuke; Murakami, Gen; Mukai, Hideo; Hojo, Yasushi; Saito, Minoru; Kimoto, Tetsuya; Kawato, Suguru			Corticosterone Induces Rapid Spinogenesis via Synaptic Glucocorticoid Receptors and Kinase Networks in Hippocampus	PLOS ONE			English	Article							MALE-RAT HIPPOCAMPUS; CA3 PYRAMIDAL NEURONS; PROTEIN-KINASE; DENDRITIC MORPHOLOGY; INHIBITOR; BRAIN; CORTACTIN; STRESS; PHOSPHORYLATION; POTENTIATION	Background: Modulation of dendritic spines under acute stress is attracting much attention. Exposure to acute stress induces corticosterone (CORT) secretion from the adrenal cortex, resulting in rapid increase of CORT levels in plasma and the hippocampus. Methodology/Principal Findings: Here we demonstrated the mechanisms of rapid effect (similar to 1 h) of CORT on the density and morphology of spines by imaging neurons in adult male rat hippocampal slices. The application of CORT at 100-1000 nM induced a rapid increase in the density of spines of CA1 pyramidal neurons. The density of small-head spines (0.20.-0.4 mu m) was increased even at low CORT levels (100-200 nM). The density of middle-head spines (0.4-0.5 mu m) was increased at high CORT levels between 400-1000 nM. The density of large-head spines (0.5-1.0 mu m) was increased only at 1000 nM CORT. Co-administration of RU486, an antagonist of glucocorticoid receptor (GR), abolished the effect of CORT. Blocking a single kinase, such as MAPK, PKA, PKC or PI3K, suppressed CORT-induced enhancement of spinogenesis. Blocking NMDA receptors suppressed the CORT effect. Conclusions/Significance: These results imply that stress levels of CORT (100-1000 nM) drive the spinogenesis via synaptic GR and multiple kinase pathways.	[Komatsuzaki, Yoshimasa; Hatanaka, Yusuke; Murakami, Gen; Mukai, Hideo; Hojo, Yasushi; Kimoto, Tetsuya; Kawato, Suguru] Univ Tokyo, Grad Sch Arts & Sci, Dept Biophys & Life Sci, Tokyo, Japan; [Komatsuzaki, Yoshimasa] Nihon Univ, Coll Sci & Technol, Dept Phys, Tokyo 101, Japan; [Murakami, Gen; Mukai, Hideo; Hojo, Yasushi; Kawato, Suguru] Univ Tokyo, Japan Sci & Technol Agcy, Bioinformat Project, Tokyo, Japan; [Saito, Minoru] Nihon Univ, Grad Sch Integrated Basic, Dept Correlat Study Phys & Chem, Tokyo, Japan	University of Tokyo; Nihon University; Japan Science & Technology Agency (JST); University of Tokyo; Nihon University	Komatsuzaki, Y (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Biophys & Life Sci, Tokyo, Japan.	kawato@bio.c.u-tokyo.ac.jp	Hojo, Yasushi/D-2964-2011		Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [23700496] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Core Research for Evolutional Science and Technology Project of Japan Science and Technology Agency, Bioinformatics Project of Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfarez DN, 2009, HIPPOCAMPUS, V19, P828, DOI 10.1002/hipo.20566; Breuner CW, 2002, J ENDOCRINOL, V175, P99, DOI 10.1677/joe.0.1750099; Campbell DH, 1999, CANCER RES, V59, P5376; Chen YC, 2008, J NEUROSCI, V28, P2903, DOI 10.1523/JNEUROSCI.0225-08.2008; Chen YZ, 2001, NEWS PHYSIOL SCI, V16, P292; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Croxtall JD, 2000, BRIT J PHARMACOL, V130, P289, DOI 10.1038/sj.bjp.0703272; Daly RJ, 2004, BIOCHEM J, V382, P13, DOI 10.1042/BJ20040737; DIAMOND DM, 1992, HIPPOCAMPUS, V2, P421, DOI 10.1002/hipo.450020409; Duan H, 2002, NEUROSCIENCE, V114, P349, DOI 10.1016/S0306-4522(02)00305-6; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Ebner MJ, 2006, ENDOCRINOLOGY, V147, P179, DOI 10.1210/en.2005-1065; GSCHWENDT M, 1994, BIOCHEM BIOPH RES CO, V199, P93, DOI 10.1006/bbrc.1994.1199; Hatanaka Y, 2009, BIOCHEM BIOPH RES CO, V381, P728, DOI 10.1016/j.bbrc.2009.02.130; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; Hering H, 2003, J NEUROSCI, V23, P11759; Higashi E, 2007, DRUG METAB DISPOS, V35, P508, DOI 10.1124/dmd.106.014084; Higo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021631; Karst H, 2000, NAT NEUROSCI, V3, P977, DOI 10.1038/79910; Komatsuzaki Y, 2005, BIOCHEM BIOPH RES CO, V335, P1002, DOI 10.1016/j.bbrc.2005.07.173; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Limbourg FP, 2002, J CLIN INVEST, V110, P1729, DOI 10.1172/JCI200215481; Lupien SJ, 1997, BRAIN RES REV, V24, P1, DOI 10.1016/S0165-0173(97)00004-0; MacQueen GM, 2003, P NATL ACAD SCI USA, V100, P1387, DOI 10.1073/pnas.0337481100; MORALESMEDINA JC, 2009, J CHEM NEUROANAT; Morimoto M, 1996, NEUROSCI RES, V26, P235, DOI 10.1016/S0168-0102(96)01105-4; Mukai H, 2011, CEREBRAL CO IN PRESS; Mukai H, 2006, NEUROENDOCRINOLOGY, V84, P255, DOI 10.1159/000097747; Mukai H, 2007, J NEUROCHEM, V100, P950, DOI 10.1111/j.1471-4159.2006.04264.x; Ooishi Y, 2011, CEREBRAL CORTEX; PARDRIDGE WM, 1979, J CLIN INVEST, V64, P145, DOI 10.1172/JCI109433; Reagan LP, 1997, J CHEM NEUROANAT, V13, P149, DOI 10.1016/S0891-0618(97)00031-8; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Roozendaal B, 2002, EUR J NEUROSCI, V15, P553, DOI 10.1046/j.0953-816x.2001.01876.x; Sato S, 2004, BIOCHEM BIOPH RES CO, V321, P510, DOI 10.1016/j.bbrc.2004.06.168; Shibuya K, 2003, BBA-GEN SUBJECTS, V1619, P301, DOI 10.1016/S0304-4165(02)00489-0; Shinohara Y, 2008, P NATL ACAD SCI USA, V105, P19498, DOI 10.1073/pnas.0807461105; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Sorrells SF, 2009, NEURON, V64, P33, DOI 10.1016/j.neuron.2009.09.032; Tsurugizawa T, 2005, BIOCHEM BIOPH RES CO, V337, P1345, DOI 10.1016/j.bbrc.2005.09.188; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; WATANABE Y, 1992, BRAIN RES, V588, P341, DOI 10.1016/0006-8993(92)91597-8; Weed SA, 1998, J CELL SCI, V111, P2433; WIEDERRECHT G, 1993, ANN NY ACAD SCI, V696, P9, DOI 10.1111/j.1749-6632.1993.tb17137.x; WOOLLEY CS, 1990, BRAIN RES, V531, P225, DOI 10.1016/0006-8993(90)90778-A	45	48	54	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34124	10.1371/journal.pone.0034124	http://dx.doi.org/10.1371/journal.pone.0034124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509272	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336600020
J	Marteau, TM; Aveyard, P; Munafo, MR; Prevost, AT; Hollands, GJ; Armstrong, D; Sutton, S; Hill, C; Johnstone, E; Kinmonth, AL				Marteau, Theresa M.; Aveyard, Paul; Munafo, Marcus R.; Prevost, A. Toby; Hollands, Gareth J.; Armstrong, David; Sutton, Stephen; Hill, Chloe; Johnstone, Elaine; Kinmonth, Ann Louise			Effect on Adherence to Nicotine Replacement Therapy of Informing Smokers Their Dose Is Determined by Their Genotype: A Randomised Controlled Trial	PLOS ONE			English	Article							SMOKING-CESSATION; PRIMARY-CARE; IMPACT; METAANALYSIS; DEPENDENCE; GENETICS; LOZENGES; FUTURE	Background: The behavioural impact of pharmacogenomics is untested. We tested two hypotheses concerning the behavioural impact of informing smokers their oral dose of NRT is tailored to analysis of DNA. Methods and Findings: We conducted an RCT with smokers in smoking cessation clinics (N = 633). In combination with NRT patch, participants were informed that their doses of oral NRT were based either on their mu-opioid receptor (OPRM1) genotype, or their nicotine dependence questionnaire score ( phenotype). The proportion of prescribed NRT consumed in the first 28 days following quitting was not significantly different between groups: (68.5% of prescribed NRT consumed in genotype vs 63.6%, phenotype group, difference = 5.0%, 95% CI -0.9,10.8, p = 0.098). Motivation to make another quit attempt among those (n = 331) not abstinent at six months was not significantly different between groups (p = 0.23). Abstinence at 28 days was not different between groups (p = 0.67); at six months was greater in genotype than phenotype group (13.7% vs 7.9%, difference = 5.8%, 95% CI 1.0,10.7, p = 0.018). Conclusions: Informing smokers their oral dose of NRT was tailored to genotype not phenotype had a small, statistically non-significant effect on 28-day adherence to NRT. Among those still smoking at six months, there was no evidence that saying NRT was tailored to genotype adversely affected motivation to make another quit attempt. Higher abstinence rate at six months in the genotype arm requires investigation.	[Marteau, Theresa M.; Hollands, Gareth J.; Hill, Chloe] Kings Coll London, Psychol Dept Guys, Hlth Psychol Sect, London WC2R 2LS, England; [Aveyard, Paul] Univ Birmingham, Birmingham, W Midlands, England; [Munafo, Marcus R.] Univ Bristol, Dept Expt Psychol, Bristol, Avon, England; [Prevost, A. Toby; Armstrong, David] Kings Coll London, Dept Primary Care & Publ Hlth Sci, London WC2R 2LS, England; [Sutton, Stephen; Kinmonth, Ann Louise] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Johnstone, Elaine] Univ Oxford, Dept Clin Pharmacol, Oxford, England	University of London; King's College London; University of Birmingham; University of Bristol; University of London; King's College London; University of Cambridge; University of Oxford	Marteau, TM (corresponding author), Kings Coll London, Psychol Dept Guys, Hlth Psychol Sect, London WC2R 2LS, England.	theresa.marteau@kcl.ac.uk	Munafo, Marcus/AAE-2306-2020; Armstrong, David/AAI-4476-2021	Munafo, Marcus/0000-0002-4049-993X; Armstrong, David/0000-0003-3652-9662; Hollands, Gareth/0000-0002-0492-3924; Prevost, A. Toby/0000-0003-1723-0796; Marteau, Theresa/0000-0003-3025-1129; Sutton, Stephen/0000-0003-1610-0404; Aveyard, Paul/0000-0002-1802-4217	Medical Research Council, UK [G0500274]; National Institute of Health Research (NIHR); UK Centre for Tobacco Control Studies (UKCTCS); British Heart Foundation; Cancer Research UK; Economic and Social Research Council; Medical Research Council; National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration; Primary Care Research Network; Medical Research Council [G0500274, G0500267] Funding Source: researchfish; MRC [G0500274, G0500267] Funding Source: UKRI	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); UK Centre for Tobacco Control Studies (UKCTCS); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration(National Institute for Health Research (NIHR)); Primary Care Research Network; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded as part of a grant from the Medical Research Council, UK (Risk communication in preventive medicine: Optimising the impact of DNA risk information; G0500274 PI: TMM). The trial protocol was peer reviewed by the Council. PA is funded by a personal award from the National Institute of Health Research (NIHR) and by the UK Centre for Tobacco Control Studies (UKCTCS). PA and MRM are members of UKCTCS, a UKCRC Public Health Research: Centre of Excellence. Funding from British Heart Foundation, Cancer Research UK, Economic and Social Research Council, Medical Research Council, and the National Institute for Health Research, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The sponsors and funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Trial nurses, Jennie Inglis, Jackie Ingram, Robert Shortman, Dafydd Snelling recruited and treated the trial participants. The Primary Care Research Network supported access to the general practices in Bristol and Birmingham that hosted and supported the research nurses. We are grateful to them all and to the participants who gave of their time freely.	Alterman AI, 1999, DRUG ALCOHOL DEPEN, V53, P159, DOI 10.1016/S0376-8716(98)00124-0; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Collins F, 2010, NATURE, V464, P674, DOI 10.1038/464674a; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Collins RE, 2011, GENET MED, V13, P273, DOI 10.1097/GIM.0b013e3181f710ca; Gramling R, 2003, GENET MED, V5, P172, DOI 10.1097/01.GIM.0000068986.03217.BB; HAJEK P, 1989, BRIT J ADDICT, V84, P591; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Iselin MG, 2003, COGNITIVE THER RES, V27, P205, DOI 10.1023/A:1023513310243; Lancaster GA, 2010, STAT METHODS MED RES, V19, P349, DOI 10.1177/0962280209359883; Lerman C, 2004, PHARMACOGENOMICS J, V4, P184, DOI 10.1038/sj.tpj.6500238; Lerman CE, 2007, AM J PREV MED, V33, pS398, DOI 10.1016/j.amepre.2007.09.006; Li MD, 2003, ADDICTION, V98, P23, DOI 10.1046/j.1360-0443.2003.00295.x; Li Ming D, 2006, Curr Psychiatry Rep, V8, P158, DOI 10.1007/s11920-006-0016-0; Marteau T, 2004, AM J MED GENET A, V128A, P285, DOI 10.1002/ajmg.a.30102; Marteau TM, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007275.pub2; Marteau TM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-680; Marteau TM, 2006, SOC SCI MED, V62, P1360, DOI 10.1016/j.socscimed.2005.08.005; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Munafo MR, 2007, PHARMACOGENOMICS J, V7, P353, DOI 10.1038/sj.tpj.6500432; Munafo MR, 2005, CURR OPIN MOL THER, V7, P202; Munafo MR, 2005, PHARMACOGENOMICS, V6, P211, DOI 10.1517/14622416.6.3.211; Phelan JC, 2006, PSYCHIAT SERV, V57, P382, DOI 10.1176/appi.ps.57.3.382; Schnoll Robert A, 2007, Curr Psychiatry Rep, V9, P349, DOI 10.1007/s11920-007-0045-3; Shiffman S, 2008, CLIN THER, V30, P1461, DOI 10.1016/j.clinthera.2008.07.019; Shiffman S, 2007, ADDICTION, V102, P809, DOI 10.1111/j.1360-0443.2007.01791.x; Shiloh S, 2002, J BEHAV MED, V25, P373, DOI 10.1023/A:1015818532390; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000146.pub3; The NHS Centre for Smoking Cessation and Training (NCSCT), 2010, LEARN OUTC TRAIN STO; Webb TL, 2006, PSYCHOL BULL, V132, P249, DOI 10.1037/0033-2909.132.2.249; West R, 2005, ADDICTION, V100, P299, DOI 10.1111/j.1360-0443.2004.00995.x; Wright AJ, 2003, TOB CONTROL, V12, P227, DOI 10.1136/tc.12.2.227; Wu JR, 2008, NURS CLIN N AM, V43, P133, DOI 10.1016/j.cnur.2007.10.006	33	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35249	10.1371/journal.pone.0035249	http://dx.doi.org/10.1371/journal.pone.0035249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TP	22509402	Green Published, gold			2022-12-27	WOS:000305336600096
J	Kang, S; Jang, JH; Price, MP; Gautam, M; Benson, CJ; Gong, HY; Welsh, MJ; Brennan, TJ				Kang, Sinyoung; Jang, Jun Ho; Price, Margaret P.; Gautam, Mamta; Benson, Christopher J.; Gong, Huiyu; Welsh, Michael J.; Brennan, Timothy J.			Simultaneous Disruption of Mouse ASIC1a, ASIC2 and ASIC3 Genes Enhances Cutaneous Mechanosensitivity	PLOS ONE			English	Article							SENSING ION CHANNELS; ROOT GANGLION NEURONS; RAT HAIRY SKIN; SENSORY NEURONS; CAENORHABDITIS-ELEGANS; RECEPTIVE PROPERTIES; ACTIVATED CURRENTS; ACID; PAIN; NOCICEPTORS	Three observations have suggested that acid-sensing ion channels (ASICs) might be mammalian cutaneous mechanoreceptors; they are structurally related to Caenorhabditis elegans mechanoreceptors, they are localized in specialized cutaneous mechanosensory structures, and mechanical displacement generates an ASIC-dependent depolarization in some neurons. However, previous studies of mice bearing a single disrupted ASIC gene showed only subtle or no alterations in cutaneous mechanosensitivity. Because functional redundancy of ASIC subunits might explain limited phenotypic alterations, we hypothesized that disrupting multiple ASIC genes would markedly impair cutaneous mechanosensation. We found the opposite. In behavioral studies, mice with simultaneous disruptions of ASIC1a, -2 and -3 genes (triple-knockouts, TKOs) showed increased paw withdrawal frequencies when mechanically stimulated with von Frey filaments. Moreover, in single-fiber nerve recordings of cutaneous afferents, mechanical stimulation generated enhanced activity in A-mechanonociceptors of ASIC TKOs compared to wild-type mice. Responses of all other fiber types did not differ between the two genotypes. These data indicate that ASIC subunits influence cutaneous mechanosensitivity. However, it is unlikely that ASICs directly transduce mechanical stimuli. We speculate that physical and/or functional association of ASICs with other components of the mechanosensory transduction apparatus contributes to normal cutaneous mechanosensation.	[Kang, Sinyoung; Jang, Jun Ho; Brennan, Timothy J.] Univ Iowa, Dept Anesthesia, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Price, Margaret P.; Gautam, Mamta; Benson, Christopher J.; Gong, Huiyu; Welsh, Michael J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Benson, Christopher J.; Welsh, Michael J.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Brennan, Timothy J.] Univ Iowa, Dept Pharmacol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Welsh, Michael J.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; Howard Hughes Medical Institute	Kang, S (corresponding author), Univ Iowa, Dept Anesthesia, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	tim-brennan@uiowa.edu		Brennan, Timothy/0000-0002-0150-5145; Kang, Sinyoung/0000-0002-9632-2420; Benson, Christopher/0000-0001-6600-8193; Welsh, Michael/0000-0002-1646-6206	NIH [GM067762]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067762] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MJW is an Investigator of the HHMI (Howard Hughes Medical Institute). TJB was supported by NIH GM067762. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anzai N, 2002, J BIOL CHEM, V277, P16655, DOI 10.1074/jbc.M201087200; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; BENNETT GJ, 1993, MUSCLE NERVE, V16, P1040, DOI 10.1002/mus.880161007; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Birdsong WT, 2010, NEURON, V68, P739, DOI 10.1016/j.neuron.2010.09.029; Calavia MG, 2010, CELL MOL NEUROBIOL, V30, P841, DOI 10.1007/s10571-010-9511-2; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; de la Rosa DA, 2002, P NATL ACAD SCI USA, V99, P2326, DOI 10.1073/pnas.042688199; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Deval E, 2006, J BIOL CHEM, V281, P1796, DOI 10.1074/jbc.M509669200; Djouhri L, 1998, J PHYSIOL-LONDON, V513, P857, DOI 10.1111/j.1469-7793.1998.857ba.x; Drew LJ, 2004, J PHYSIOL-LONDON, V556, P691, DOI 10.1113/jphysiol.2003.058693; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Gao ZH, 2006, J APPL PHYSIOL, V100, P421, DOI 10.1152/japplphysiol.00659.2005; Gao ZH, 2007, J APPL PHYSIOL, V102, P2288, DOI 10.1152/japplphysiol.00161.2007; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Ge WQ, 2002, J NEUROPHYSIOL, V87, P1686, DOI 10.1152/jn.00414.2001; Geffeney SL, 2011, NEURON, V71, P845, DOI 10.1016/j.neuron.2011.06.038; Hitomi Y, 2009, BIOMED RES-TOKYO, V30, P113, DOI 10.2220/biomedres.30.113; Hruska-Hageman AM, 2004, J BIOL CHEM, V279, P46962, DOI 10.1074/jbc.M405874200; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Khalsa PS, 1997, J NEUROPHYSIOL, V78, P492, DOI 10.1152/jn.1997.78.1.492; Khalsa PS, 2000, J NEUROPHYSIOL, V83, P3049, DOI 10.1152/jn.2000.83.5.3049; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; Leonard AS, 2003, P NATL ACAD SCI USA, V100, P2029, DOI 10.1073/pnas.252782799; Light AR, 2008, J NEUROPHYSIOL, V100, P1184, DOI 10.1152/jn.01344.2007; Lilley S, 2004, J NEUROSCI, V24, P1013, DOI 10.1523/JNEUROSCI.3191-03.2004; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Magerl W, 2001, BRAIN, V124, P1754, DOI 10.1093/brain/124.9.1754; Mogil JS, 2005, J NEUROSCI, V25, P9893, DOI 10.1523/JNEUROSCI.2019-05.2005; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; NAGY JI, 1981, NEUROSCIENCE, V6, P1923, DOI 10.1016/0306-4522(81)90032-4; NAGY JI, 1983, J NEUROSCI, V3, P399; Naves LA, 2005, BRAZ J MED BIOL RES, V38, P1561, DOI 10.1590/S0100-879X2005001100001; O'Hagan R, 2005, NAT NEUROSCI, V8, P43, DOI 10.1038/nn1362; Page AJ, 2004, GASTROENTEROLOGY, V127, P1739, DOI 10.1053/j.gastro.2004.08.061; Petroff EY, 2008, P NATL ACAD SCI USA, V105, P3140, DOI 10.1073/pnas.0712280105; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2004, J BIOL CHEM, V279, P53886, DOI 10.1074/jbc.M407708200; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; RITTER AM, 1992, J NEUROPHYSIOL, V68, P2033, DOI 10.1152/jn.1992.68.6.2033; Roza C, 2004, J PHYSIOL-LONDON, V558, P659, DOI 10.1113/jphysiol.2004.066001; Schnizler MK, 2009, J BIOL CHEM, V284, P2697, DOI 10.1074/jbc.M805110200; SHIR Y, 1990, NEUROSCI LETT, V115, P62, DOI 10.1016/0304-3940(90)90518-E; Staniland AA, 2009, EUR J PAIN, V13, P554, DOI 10.1016/j.ejpain.2008.07.001; STEEN KH, 1992, J NEUROSCI, V12, P86; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Welsh MJ, 2002, J BIOL CHEM, V277, P2369, DOI 10.1074/jbc.R100060200; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zha XM, 2009, J NEUROSCI, V29, P8438, DOI 10.1523/JNEUROSCI.1284-09.2009; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	57	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35225	10.1371/journal.pone.0035225	http://dx.doi.org/10.1371/journal.pone.0035225			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506072	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500080
J	Sigurdsson, G; Fleming, RMT; Heinken, A; Thiele, I				Sigurdsson, Gunnar; Fleming, Ronan M. T.; Heinken, Almut; Thiele, Ines			A Systems Biology Approach to Drug Targets in Pseudomonas aeruginosa Biofilm	PLOS ONE			English	Article							METABOLIC NETWORK ANALYSIS; CONSTRAINT-BASED MODELS; FLUX BALANCE ANALYSIS; QUANTITATIVE PREDICTION; CELLULAR-METABOLISM; MUTANT LIBRARY; RECONSTRUCTION; PAO1; INFECTIONS; GENE	Antibiotic resistance is an increasing problem in the health care system and we are in a constant race with evolving bacteria. Biofilm-associated growth is thought to play a key role in bacterial adaptability and antibiotic resistance. We employed a systems biology approach to identify candidate drug targets for biofilm-associated bacteria by imitating specific microenvironments found in microbial communities associated with biofilm formation. A previously reconstructed metabolic model of Pseudomonas aeruginosa (PA) was used to study the effect of gene deletion on bacterial growth in planktonic and biofilm-like environmental conditions. A set of 26 genes essential in both conditions was identified. Moreover, these genes have no homology with any human gene. While none of these genes were essential in only one of the conditions, we found condition-dependent genes, which could be used to slow growth specifically in biofilm-associated PA. Furthermore, we performed a double gene deletion study and obtained 17 combinations consisting of 21 different genes, which were conditionally essential. While most of the difference in double essential gene sets could be explained by different medium composition found in biofilm-like and planktonic conditions, we observed a clear effect of changes in oxygen availability on the growth performance. Eight gene pairs were found to be synthetic lethal in oxygen-limited conditions. These gene sets may serve as novel metabolic drug targets to combat particularly biofilm-associated PA. Taken together, this study demonstrates that metabolic modeling of human pathogens can be used to identify oxygen-sensitive drug targets and thus, that this systems biology approach represents a powerful tool to identify novel candidate antibiotic targets.	[Sigurdsson, Gunnar; Fleming, Ronan M. T.; Heinken, Almut; Thiele, Ines] Univ Iceland, Ctr Syst Biol, Reykajavik, Iceland; [Thiele, Ines] Univ Iceland, Fac Ind Engn Mech Engn & Comp Sci, Reykajavik, Iceland	University of Iceland; University of Iceland	Sigurdsson, G (corresponding author), Univ Iceland, Ctr Syst Biol, Reykajavik, Iceland.	ines.thiele@gmail.com	Thiele, Ines/A-7629-2014; Fleming, Ronan MT/ABC-4093-2021	Thiele, Ines/0000-0002-8071-7110; Fleming, Ronan MT/0000-0001-5346-9812; Heinken, Almut/0000-0001-6938-8072	Marie Curie International Reintegration Grant within the 7th European Community Framework Program [249261]; student innovation grant by the Icelandic Research Fund (Rannis)	Marie Curie International Reintegration Grant within the 7th European Community Framework Program; student innovation grant by the Icelandic Research Fund (Rannis)	This research was supported by a Marie Curie International Reintegration Grant awarded to IT (No 249261) within the 7th European Community Framework Program. GS was funded, in part, by a student innovation grant by the Icelandic Research Fund (Rannis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bielecki P, 2008, BIOTECHNOL LETT, V30, P777, DOI 10.1007/s10529-007-9620-2; BODEY GP, 1983, REV INFECT DIS, V5, P279; Borriello G, 2004, ANTIMICROB AGENTS CH, V48, P2659, DOI 10.1128/AAC.48.7.2659-2664.2004; Carmeli Y, 1999, ANTIMICROB AGENTS CH, V43, P1379, DOI 10.1128/AAC.43.6.1379; del Pozo JL, 2007, CLIN PHARMACOL THER, V82, P204, DOI 10.1038/sj.clpt.6100247; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fang KC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-83; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fleming RMT, 2009, BIOPHYS CHEM, V145, P47, DOI 10.1016/j.bpc.2009.08.007; Fleming RMT, 2011, BIOINFORMATICS, V27, P142, DOI 10.1093/bioinformatics/btq607; Gonzalez O, 2008, MOL BIOSYST, V4, P148, DOI 10.1039/b715203e; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26; Kell DB, 2006, DRUG DISCOV TODAY, V11, P1085, DOI 10.1016/j.drudis.2006.10.004; Lee DS, 2009, J BACTERIOL, V191, P4015, DOI 10.1128/JB.01743-08; Lewenza S, 2005, GENOME RES, V15, P583, DOI 10.1101/gr.3513905; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; Musken M, 2010, MICROBIOL-SGM, V156, P431, DOI 10.1099/mic.0.033290-0; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; Oberhardt MA, 2010, J BACTERIOL, V192, P5534, DOI 10.1128/JB.00900-10; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Obrzut S, 2010, J CARDIOVASC TRANSL, V3, P643, DOI 10.1007/s12265-010-9223-5; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Palsson B, 2009, FEBS LETT, V583, P3900, DOI 10.1016/j.febslet.2009.09.031; Palsson BO., 2006, SYSTEMS BIOL PROPERT; Perumal Deepak, 2007, In Silico Biology, V7, P453; Perumal D, 2011, J DRUG TARGET, V19, P1, DOI 10.3109/10611861003649753; Pommerenke C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001074; Price ND, 2006, BIOPHYS J, V90, P3919, DOI 10.1529/biophysj.105.072645; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Selvarasu S, 2010, MOL BIOSYST, V6, P152, DOI 10.1039/b912865d; Sigurdsson MI, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-140; Silver LL, 2007, NAT REV DRUG DISCOV, V6, P41, DOI 10.1038/nrd2202; Sriramulu DD, 2005, J MED MICROBIOL, V54, P667, DOI 10.1099/jmm.0.45969-0; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Thiele I, 2005, J BACTERIOL, V187, P5818, DOI 10.1128/JB.187.16.5818-5830.2005; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Wang Y, 2007, SCI CHINA SER C, V50, P385, DOI 10.1007/s11427-007-0044-y; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	46	30	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34337	10.1371/journal.pone.0034337	http://dx.doi.org/10.1371/journal.pone.0034337			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523548	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000018
J	Evans, K; Patterson, TA; Reid, H; Harley, SJ				Evans, Karen; Patterson, Toby A.; Reid, Howard; Harley, Shelton J.			Reproductive Schedules in Southern Bluefin Tuna: Are Current Assumptions Appropriate?	PLOS ONE			English	Article							THUNNUS-THYNNUS; POPULATION-STRUCTURE; SPAWNING MIGRATION; THERMAL BIOLOGY; GROWTH-RATES; MOVEMENTS; SATELLITE; MACCOYII; TRACKING; GULF	Southern bluefin tuna (SBT) appear to comprise a single stock that is assumed to be both mixed across its distribution and having reproductive adults that are obligate, annual spawners. The putative annual migration cycle of mature SBT consists of dispersed foraging at temperate latitudes with migration to a single spawning ground in the tropical eastern Indian Ocean. Spawning migrations have been assumed to target two peaks in spawning activity; one in September-October and a second in February-March. SBT of sizes comparable to that of individuals observed on the spawning ground were satellite tagged in the Tasman Sea region (2003-2008) and demonstrated both migrations to the spawning grounds and residency in the Tasman Sea region throughout the whole year. All individuals undertaking apparent spawning migrations timed their movements to coincide with the second recognised spawning peak or even later. These observations suggest that SBT may demonstrate substantial flexibility in the scheduling of reproductive events and may even not spawn annually as currently assumed. Further, the population on the spawning grounds may be temporally structured in association with foraging regions. These findings provide new perspectives on bluefin population and spatial dynamics and warrant further investigation and consideration of reproductive schedules in this species.	[Evans, Karen; Patterson, Toby A.] CSIRO, Div Marine & Atmospher Res, Wealth Oceans Natl Res Flagship, Hobart, Tas, Australia; [Reid, Howard; Harley, Shelton J.] New Zealand Minist Fisheries, Wellington, New Zealand	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Evans, K (corresponding author), CSIRO, Div Marine & Atmospher Res, Wealth Oceans Natl Res Flagship, Hobart, Tas, Australia.	karen.evans@csiro.au	Patterson, Toby/B-3836-2011; evans, karen/D-7110-2012	Patterson, Toby/0000-0002-7150-9205; Evans, Karen/0000-0003-2205-4264	Australian Fisheries Management Authority; Australian Government Department of Agriculture, Forestry and Fisheries; New Zealand Ministry of Fisheries [STN2003-01, STN2003-01B, STN2004-01]	Australian Fisheries Management Authority; Australian Government Department of Agriculture, Forestry and Fisheries(Australian Government); New Zealand Ministry of Fisheries	Funding was provided by the Australian Fisheries Management Authority, the Australian Government Department of Agriculture, Forestry and Fisheries and commercial fishing industry levies administered by the New Zealand Ministry of Fisheries under projects STN2003-01, STN2003-01B, and STN2004-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal FJ, 2010, ICES J MAR SCI, V67, P466, DOI 10.1093/icesjms/fsp252; BAYLIFF W H, 1991, Inter-American Tropical Tuna Commission Bulletin, V20, P3; Bayliff WM, 1994, FAO FISHERIES TECHNI, V336, P244; BELL JD, 1992, J FISH BIOL, V40, P107, DOI 10.1111/j.1095-8649.1992.tb02558.x; Blank JM, 2004, J EXP BIOL, V207, P881, DOI 10.1242/jeb.00820; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; CAREY FG, 1973, COMP BIOCHEM PHYSIOL, V44, P375, DOI 10.1016/0300-9629(73)90490-8; Caton A.E., 1991, WORLD M STOCK ASSESS, V7, P181; Chapman EW, 2011, CAN J FISH AQUAT SCI, V68, P1934, DOI 10.1139/F2011-109; Dahl J, 2004, CAN J ZOOL, V82, P1864, DOI 10.1139/Z04-184; Davis TLO, 1995, CCSBT SCI M 10 19 JU; DICKSON KA, 1995, ENVIRON BIOL FISH, V42, P65, DOI 10.1007/BF00002352; Engelhard GH, 2005, BIOL LETT-UK, V1, P172, DOI 10.1098/rsbl.2004.0290; Evans K, 2011, J EXP MAR BIOL ECOL, V398, P9, DOI 10.1016/j.jembe.2010.11.006; Farley J, 2009, 14 M SCI COMM CCSBT; Farley J, 2011, CCSBT EXT SCI COMM 1; Farley JH, 2007, J FISH BIOL, V71, P852, DOI 10.1111/j.1095-8649.2007.01556.x; Farley JH, 2007, FISH RES, V83, P151, DOI 10.1016/j.fishres.2006.09.006; Farley JH, 1998, FISH B-NOAA, V96, P223; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Graham Jeffrey B., 2001, Fish Physiology, V19, P121; Grewe PM, 1997, MAR BIOL, V127, P555, DOI 10.1007/s002270050045; Hoolihan JP, 2005, MAR BIOL, V146, P1015, DOI 10.1007/s00227-004-1488-2; Itoh T, 2006, FISHERIES SCI, V72, P53, DOI 10.1111/j.1444-2906.2006.01116.x; JENKINS GP, 1991, CAN J FISH AQUAT SCI, V48, P1358, DOI 10.1139/f91-162; Karakulak S., 2004, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V56, P1158; Korsmeyer K.E., 2001, TUNA PHYSL ECOLOGY E, P35, DOI DOI 10.1016/S1546-5098(01)19003-5; Landeira-Fernandez AM, 2004, AM J PHYSIOL-REG I, V286, pR398, DOI 10.1152/ajpregu.00392.2003; Livingston ME, 1997, FISH B-NOAA, V95, P99; Lutcavage ME, 1999, CAN J FISH AQUAT SCI, V56, P173, DOI 10.1139/cjfas-56-2-173; MCGOWAN MF, 1989, FISH B-NOAA, V87, P615; McMahon CR, 2011, ANIM WELFARE, V20, P515; Metcalfe JD, 1997, NATURE, V387, P665, DOI 10.1038/42622; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Nishikawa Y., 1985, FAR SEAS FISH RES LA, V12, P1; Patterson TA, 2008, FISH OCEANOGR, V17, P352, DOI 10.1111/j.1365-2419.2008.00483.x; Polacheck T, 2004, CAN J FISH AQUAT SCI, V61, P307, DOI 10.1139/F04-005; Rideout RM, 2000, J FISH BIOL, V57, P1429, DOI 10.1111/j.1095-8649.2000.tb02222.x; Rideout RM, 2005, FISH FISH, V6, P50, DOI 10.1111/j.1467-2679.2005.00174.x; Righton D, 2008, MAR BIOL, V153, P507, DOI 10.1007/s00227-007-0818-6; Roff Derek, 2002, pi; Sawada Y, 2005, AQUAC RES, V36, P413, DOI 10.1111/j.1365-2109.2005.01222.x; Schaefer Kurt M., 2001, Fish Physiology, V19, P225; Secor DH, 2008, T AM FISH SOC, V137, P782, DOI 10.1577/T07-105.1; Secor DH, 2007, FISH B-NOAA, V105, P62; Shingu C, 1977, INT COMM CONSERV ATL, V6, P366; Sims DW, 2004, J ANIM ECOL, V73, P333, DOI 10.1111/j.0021-8790.2004.00810.x; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Yukinawa M., 1984, REP RES DIV FISH AGE, P1	53	15	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34550	10.1371/journal.pone.0034550	http://dx.doi.org/10.1371/journal.pone.0034550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514636	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600041
J	Horm, VS; Gutierrez, RA; Nicholls, JM; Buchy, P				Horm, Viseth Srey; Gutierrez, Ramona A.; Nicholls, John M.; Buchy, Philippe			Highly Pathogenic Influenza A(H5N1) Virus Survival in Complex Artificial Aquatic Biotopes	PLOS ONE			English	Article							A H5N1 VIRUS; AVIAN INFLUENZA; RISK-FACTORS; DIFFERENT TEMPERATURES; HUMAN INFECTION; RT-PCR; WATER; PERSISTENCE; CAMBODIA; TENACITY	Background: Very little is known regarding the persistence of Highly Pathogenic Avian Influenza (HPAI) H5N1 viruses in aquatic environments in tropical countries, although environmental materials have been suggested to play a role as reservoirs and sources of transmission for H5N1 viruses. Methodology/Principal Findings: The survival of HPAI H5N1 viruses in experimental aquatic biotopes (water, mud, aquatic flora and fauna) relevant to field conditions in Cambodia was investigated. Artificial aquatic biotopes, including simple ones containing only mud and water, and complex biotopes involving the presence of aquatic flora and fauna, were set up. They were experimentally contaminated with H5N1 virus. The persistence of HPAI H5N1 virus (local avian and human isolates) was determined by virus isolation in embryonated chicken eggs and by real-time reverse-polymerase chain reaction. Persistence of infectious virus did not exceed 4 days, and was only identified in rain water. No infectious virus particles were detected in pond and lake water or mud even when high inoculum doses were used. However, viral RNA persisted up to 20 days in rain water and 7 days in pond or lake water. Viral RNA was also detected in mud samples, up to 14 days post-contamination in several cases. Infectious virus and viral RNA was detected in few cases in the aquatic fauna and flora, especially in bivalves and labyrinth fish, although these organisms seemed to be mostly passive carriers of the virus rather than host allowing virus replication. Conclusions/Significance: Although several factors for the survival and persistence of HPAI viruses in the environment are still to be elucidated, and are particularly hard to control in laboratory conditions, our results, along with previous data, support the idea that environmental surveillance is of major relevance for avian influenza control programs.	[Horm, Viseth Srey; Gutierrez, Ramona A.; Buchy, Philippe] Reseau Int Inst Pasteur, Inst Pasteur Cambodge, Virol Unit, Phnom Penh, Cambodia; [Nicholls, John M.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; University of Hong Kong	Horm, VS (corresponding author), Reseau Int Inst Pasteur, Inst Pasteur Cambodge, Virol Unit, Phnom Penh, Cambodia.	pbuchy@pasteur-kh.org	; Nicholls, John Malcolm/C-4375-2009	BUCHY, Philippe/0000-0003-1372-3008; Nicholls, John Malcolm/0000-0001-7217-7444	6th Framework Program grant (Resistance of Influenza Viruses in Environmental Reservoirs and Systems, RIVERS) from the European Union [FP6-2005-SSP-5-B-INFLUENZA]	6th Framework Program grant (Resistance of Influenza Viruses in Environmental Reservoirs and Systems, RIVERS) from the European Union	This work was supported by 6th Framework Program grant FP6-2005-SSP-5-B-INFLUENZA (Resistance of Influenza Viruses in Environmental Reservoirs and Systems, RIVERS) from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Areechokchai Darin, 2006, MMWR Suppl, V55, P3; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Cavailler P, 2010, J CLIN VIROL, V48, P123, DOI 10.1016/j.jcv.2010.02.021; Deboosere N, 2012, J VIROL METHODS, V179, P148, DOI 10.1016/j.jviromet.2011.10.013; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Domanska-Blicharz K, 2010, AVIAN DIS, V54, P734, DOI 10.1637/8786-040109-ResNote.1; Dovas CI, 2010, APPL ENVIRON MICROB, V76, P2165, DOI 10.1128/AEM.01929-09; Faust C, 2009, P ROY SOC B-BIOL SCI, V276, P3727, DOI 10.1098/rspb.2009.0572; Guan J, 2009, AVIAN DIS, V53, P26, DOI 10.1637/8381-062008-Reg.1; Gutierrez RA, 2009, VIRUSES-BASEL, V1, P335, DOI 10.3390/v1030335; Horm SV, 2011, J VIROL METHODS, V176, P69, DOI 10.1016/j.jviromet.2011.06.002; Horm SV, 2012, INFLUENZA O IN PRESS; Iglesias I, 2010, AVIAN DIS, V54, P814, DOI 10.1637/8970-062609-Reg.1; Indriani R, 2010, EMERG INFECT DIS, V16, P1889, DOI 10.3201/eid1612.100402; Khalenkov A, 2008, J VIROL METHODS, V149, P180, DOI 10.1016/j.jviromet.2008.01.001; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; Lebarbenchon C, 2010, EMERG INFECT DIS, V16, P1057, DOI 10.3201/eid1607.090389; Lewis GD, 2000, J APPL MICROBIOL, V88, P633, DOI 10.1046/j.1365-2672.2000.01008.x; Lu H, 2003, AVIAN DIS, V47, P1015, DOI 10.1637/0005-2086-47.s3.1015; Nazir J, 2011, APPL ENVIRON MICROB, V77, P4981, DOI 10.1128/AEM.00415-11; Nazir J, 2010, AVIAN DIS, V54, P720, DOI 10.1637/8754-033109-ResNote.1; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; OIE, 2011, WORLD ORG AN HLTH OU; Paek MR, 2010, POULTRY SCI, V89, P1647, DOI 10.3382/ps.2010-00800; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Shahid MA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-38; Stallknecht DE, 2009, REV SCI TECH OIE, V28, P59; Stumpf P, 2010, AVIAN DIS, V54, P1183, DOI 10.1637/9162-111709-Reg.1; Sturm-Ramirez KM, 2005, J VIROL, V79, P11269, DOI 10.1128/JVI.79.17.11269-11279.2005; Swayne D.E., 2003, DIS POULTRY, Vtwelfth, P135; Tiwari A, 2006, AVIAN DIS, V50, P284, DOI 10.1637/7453-101205R.1; Van Kerkhove MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014582; Vong S, 2008, EMERG INFECT DIS, V14, P1303, DOI 10.3201/eid1408.070912; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; World Health Organization (WHO), 2011, CUM NUMB CONF HUM CA; Zarkov IS, 2006, REV MED VET-TOULOUSE, V157, P471	38	21	21	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34160	10.1371/journal.pone.0034160	http://dx.doi.org/10.1371/journal.pone.0034160			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514622	Green Published, gold			2022-12-27	WOS:000305341600027
J	Kongpetch, S; Kukongviriyapan, V; Prawan, A; Senggunprai, L; Kukongviriyapan, U; Buranrat, B				Kongpetch, Sarinya; Kukongviriyapan, Veerapol; Prawan, Auemduan; Senggunprai, Laddawan; Kukongviriyapan, Upa; Buranrat, Benjaporn			Crucial Role of Heme Oxygenase-1 on the Sensitivity of Cholangiocarcinoma Cells to Chemotherapeutic Agents	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; PROTOPORPHYRIN-IX; BENZODIAZEPINE-RECEPTOR; ZINC PROTOPORPHYRIN; CARBON-MONOXIDE; TUMOR-GROWTH; IN-VIVO; EXPRESSION; CANCER; INHIBITION	Cancer cells acquire drug resistance via various mechanisms including enhanced cellular cytoprotective and antioxidant activities. Heme oxygenase-1 (HO-1) is a key enzyme exerting potent cytoprotection, cell proliferation and drug resistance. We aimed to investigate roles of HO-1 in human cholangiocarcinoma (CCA) cells for cytoprotection against chemotherapeutic agents. KKU-100 and KKU-M214 CCA cell lines with high and low HO-1 expression levels, respectively, were used to evaluate the sensitivity to chemotherapeutic agents, gemcitabine (Gem) and doxorubicin. Inhibition of HO-1 by zinc protoporphyrin IX (ZnPP) sensitized both cell types to the cytotoxicity of chemotherapeutic agents. HO-1 gene silencing by siRNA validated the cytoprotective effect of HO-1 on CCA cells against Gem. Induction of HO-1 protein expression by stannous chloride enhanced the cytoprotection and suppression of apoptosis caused by anticancer agents. The sensitizing effect of ZnPP was associated with increased ROS formation and loss of mitochondrial transmembrane potential, while Gem alone did not show any effects. A ROS scavenger, Tempol, abolished the sensitizing effect of ZnPP on Gem. Combination of ZnPP and Gem enhanced the release of cytochrome c and increased p21 levels. The results show that HO-1 played a critical role in cytoprotection in CCA cells against chemotherapeutic agents. Targeted inhibition of HO-1 may be a strategy to overcome drug resistance in chemotherapy of bile duct cancer.	[Kongpetch, Sarinya; Kukongviriyapan, Veerapol; Prawan, Auemduan; Senggunprai, Laddawan] Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen, Thailand; [Kukongviriyapan, Upa] Khon Kaen Univ, Fac Med, Dept Physiol, Khon Kaen, Thailand; [Kukongviriyapan, Veerapol; Prawan, Auemduan; Senggunprai, Laddawan] Khon Kaen Univ, Liver Fluke & Cholangiocarcinoma Res Ctr, Khon Kaen, Thailand; [Buranrat, Benjaporn] Univ Phayao, Fac Pharmaceut Sci, Phayao, Thailand	Khon Kaen University; Khon Kaen University; Khon Kaen University; University of Phayao	Kongpetch, S (corresponding author), Khon Kaen Univ, Fac Med, Dept Pharmacol, Khon Kaen, Thailand.	veerapol@kku.ac.th	PRAWAN, AUEMDUAN/B-1639-2015	prawan, auemduan/0000-0001-6713-567X	Thailand Research Fund, Office of the Higher Education Commission through SHeP-GMS of Khon Kaen University; Faculty of Medicine, Khon Kaen University; Royal Golden Jubilee Ph.D. Programme	Thailand Research Fund, Office of the Higher Education Commission through SHeP-GMS of Khon Kaen University; Faculty of Medicine, Khon Kaen University; Royal Golden Jubilee Ph.D. Programme	This study was supported by Thailand Research Fund, Office of the Higher Education Commission through SHeP-GMS of Khon Kaen University, a grant-in-aid from Faculty of Medicine, Khon Kaen University and a scholarship from the Royal Golden Jubilee Ph.D. Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004; Berberat PO, 2005, CLIN CANCER RES, V11, P3790, DOI 10.1158/1078-0432.CCR-04-2159; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Boutros C, 2007, J SURG RES, V143, P437, DOI 10.1016/j.jss.2007.02.013; Buranrat B, 2007, WORLD J GASTROENTERO, V13, P6219, DOI 10.3748/wjg.13.6219; Buranrat B, 2010, WORLD J GASTROENTERO, V16, P2362, DOI 10.3748/wjg.v16.i19.2362; Correa-Costa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014298; Doi K, 1999, BRIT J CANCER, V80, P1945, DOI 10.1038/sj.bjc.6690624; Fang J, 2003, CANCER RES, V63, P3567; Giris M, 2010, J SURG RES, V164, P266, DOI 10.1016/j.jss.2009.04.013; Goodman AI, 1997, P SOC EXP BIOL MED, V214, P54; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Hezel AF, 2008, ONCOLOGIST, V13, P415, DOI 10.1634/theoncologist.2007-0252; Jinawath N, 2006, HEPATOLOGY, V44, P1025, DOI 10.1002/hep.21330; Jozkowicz A, 2007, ANTIOXID REDOX SIGN, V9, P2099, DOI 10.1089/ars.2007.1659; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; Kuroda H, 2010, LUNG CANCER, V67, P31, DOI 10.1016/j.lungcan.2009.03.015; Li CH, 2005, J BIOL CHEM, V280, P26193, DOI 10.1074/jbc.M501371200; Maines MD, 1996, UROLOGY, V47, P727, DOI 10.1016/S0090-4295(96)00010-6; Malhi H, 2006, J HEPATOL, V45, P856, DOI 10.1016/j.jhep.2006.09.001; Marahatta SB, 2006, CANCER LETT, V236, P276, DOI 10.1016/j.canlet.2005.05.020; Miyake M, 2010, UROL INT, V85, P355, DOI 10.1159/000317785; Miyazaki T, 2010, CANCER SCI, V101, P1409, DOI 10.1111/j.1349-7006.2010.01550.x; Nowis D, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-197; Nuhn P, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-37; Ohgari Y, 2011, J BIOCHEM, V149, P153, DOI 10.1093/jb/mvq126; PASTORINO JG, 1994, J BIOL CHEM, V269, P31041; Patel T, 2011, NAT REV GASTRO HEPAT, V8, P189, DOI 10.1038/nrgastro.2011.20; Prawan A, 2005, EUR J CANCER PREV, V14, P245, DOI 10.1097/00008469-200506000-00008; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P2157, DOI 10.1089/ars.2007.1811; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Shin HR, 2010, CANCER SCI, V101, P579, DOI 10.1111/j.1349-7006.2009.01458.x; Sripa B, 2008, CURR OPIN GASTROEN, V24, P349, DOI 10.1097/MOG.0b013e3282fbf9b3; Suphim B, 2010, FOOD CHEM TOXICOL, V48, P2265, DOI 10.1016/j.fct.2010.05.059; Tolis C, 1999, EUR J CANCER, V35, P796, DOI 10.1016/S0959-8049(98)00425-0; Was H, 2006, AM J PATHOL, V169, P2181, DOI 10.2353/ajpath.2006.051365	36	70	72	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34994	10.1371/journal.pone.0034994	http://dx.doi.org/10.1371/journal.pone.0034994			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514698	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600104
J	Liu, W; Shi, LJ; Wu, L; Feng, JQ; Yang, X; Li, J; Zhou, ZT; Zhang, CP				Liu, Wei; Shi, Lin-Jun; Wu, Lan; Feng, Jin-Qiu; Yang, Xi; Li, Jiang; Zhou, Zeng-Tong; Zhang, Chen-Ping			Oral Cancer Development in Patients with Leukoplakia - Clinicopathological Factors Affecting Outcome	PLOS ONE			English	Article							POTENTIALLY MALIGNANT DISORDERS; FOLLOW-UP; RETROSPECTIVE COHORT; PRECANCEROUS LESIONS; PREMALIGNANT LESIONS; TRANSFORMATION; DYSPLASIA; CLASSIFICATION; EPIDEMIOLOGY; PREVENTION	Background: Oral leukoplakia (OL) is the best-known potentially malignant disorder. The objective of the current study was to evaluate the clinicopathological factors predictive of outcome in a large cohort of patients with OL, and report our experience in the early detection of malignant events. Methods: A total of 320 patients with biopsy-proven OL were retrospectively reviewed from the study institution who had a mean follow-up of 5.1 years. Data on patient and lesion at initial diagnosis and patient underwent sequential biopsies were reviewed. Multiple biopsies indicates >=3 times sequential biopsies. Oral cancer-free survival rate (OCFS) was determined by the Kaplan-Meier method and significant factors were identified by Cox regression analysis. Results: The 3-year and 5-year OCFS was 86.6% and 82.0%, respectively. A new binary system of grading oral dysplasia was performed and Kaplan-Meier analysis indicated that high-grade dysplasia had significantly higher malignant incidence than low-grade dysplasia (5-year OCFS, 90.5% vs 59.0%; P<0.001), especially during the first 2-3 years of follow-up. Multivariate analysis revealed that the 4 factors including patient aged >60 years, lesion located at lateral/ventral tongue, non-homogenous lesion, high-grade dysplasia were independent significant indicators for OL malignant transformation. In addition, significant positive correlation between the multiple biopsies and these 4 factors and malignant outcome was established. Conclusions: Elderly patients with OL located at lateral/ventral tongue and who had non-homogenous lesion with high-grade dysplasia correlated much higher risk of transformation. This high-risk subpopulation was suggested to undergo sequential biopsies and histologic examination contributing to early detection of malignant event.	[Liu, Wei; Yang, Xi; Zhang, Chen-Ping] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral Maxillofacial Head & Neck Oncol, Shanghai Key Lab Stomatol,Sch Med, Shanghai 200030, Peoples R China; [Shi, Lin-Jun; Wu, Lan; Zhou, Zeng-Tong] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral Mucosal Dis, Sch Med, Shanghai 200030, Peoples R China; [Feng, Jin-Qiu] Shanghai Municipal Hosp Oral Hlth, Dept Prevent Dent, Shanghai, Peoples R China; [Li, Jiang] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral Pathol, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Liu, W (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Oral Maxillofacial Head & Neck Oncol, Shanghai Key Lab Stomatol,Sch Med, Shanghai 200030, Peoples R China.	liuweb@hotmail.com; zhang.chenping@hotmail.com			Science and Technology Commission of Shanghai [10DZ1951300, 10DZ1974200, 11DZ1972600, 08DZ2271100]; Shanghai Health Bureau [ZYSNXD-CC-ZDYJ004]; Shanghai Leading Academic Discipline Project [S30206]	Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Health Bureau; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by Science and Technology Commission of Shanghai (10DZ1951300, 10DZ1974200, 11DZ1972600, and 08DZ2271100), Shanghai Health Bureau (ZYSNXD-CC-ZDYJ004), and Shanghai Leading Academic Discipline Project (S30206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arduino PG, 2009, J ORAL PATHOL MED, V38, P540, DOI 10.1111/j.1600-0714.2009.00782.x; Ganly I, 2012, CANCER-AM CANCER SOC, V118, P101, DOI 10.1002/cncr.26229; GUPTA PC, 1989, CANCER-AM CANCER SOC, V63, P2247, DOI 10.1002/1097-0142(19890601)63:11<2247::AID-CNCR2820631132>3.0.CO;2-D; Ho PS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-260; Holmstrup P, 2007, J ORAL PATHOL MED, V36, P262, DOI 10.1111/j.1600-0714.2007.00513.x; Holmstrup P, 2006, ORAL ONCOL, V42, P461, DOI 10.1016/j.oraloncology.2005.08.011; Jeong WJ, 2012, J ORAL PATHOL MED, V41, P384, DOI 10.1111/j.1600-0714.2011.01106.x; Kujan O, 2006, ORAL ONCOL, V42, P987, DOI 10.1016/j.oraloncology.2005.12.014; Lee JJ, 2000, CLIN CANCER RES, V6, P1702; LIND PO, 1987, SCAND J DENT RES, V95, P449; Liu W, 2011, HISTOPATHOLOGY, V59, P733, DOI 10.1111/j.1365-2559.2011.03938.x; Liu W, 2011, HISTOPATHOLOGY, V59, P292, DOI 10.1111/j.1365-2559.2011.03934.x; Lodi G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001829.pub3; Mehanna HM, 2009, HEAD NECK-J SCI SPEC, V31, P1600, DOI 10.1002/hed.21131; Napier SS, 2008, J ORAL PATHOL MED, V37, P1, DOI 10.1111/j.1600-0714.2007.00579.x; Neville BW, 2002, CA-CANCER J CLIN, V52, P195, DOI 10.3322/canjclin.52.4.195; Petersen PE, 2009, ORAL ONCOL, V45, P454, DOI 10.1016/j.oraloncology.2008.05.023; Pindborg JJ, 1997, HISTOLOGICAL TYPING, P21; Ribeiro AS, 2010, INT J DENT, V2010, DOI 10.1155/2010/186018; Schepman KP, 1998, ORAL ONCOL, V34, P270, DOI 10.1016/S1368-8375(98)80007-9; Shin MN, 2000, BRIT J CANCER, V82, P1871, DOI 10.1054/bjoc.2000.1208; SILVERMAN S, 1984, CANCER, V53, P563; Tilakaratne WM, 2011, J ORAL PATHOL MED, V40, P533, DOI 10.1111/j.1600-0714.2011.01033.x; van der Waal I, 2010, ORAL ONCOL, V46, P423, DOI 10.1016/j.oraloncology.2010.02.016; van der Waal I, 2009, ORAL ONCOL, V45, P317, DOI 10.1016/j.oraloncology.2008.05.016; vanderWaal I, 1997, ORAL ONCOL, V33, P291, DOI 10.1016/S1368-8375(97)00002-X; Warnakulasuriya S, 2008, J ORAL PATHOL MED, V37, P127, DOI 10.1111/j.1600-0714.2007.00584.x; Warnakulasuriya S, 2007, J ORAL PATHOL MED, V36, P575, DOI 10.1111/j.1600-0714.2007.00582.x; Warnakulasuriya S, 2011, J ORAL PATHOL MED, V40, P677, DOI 10.1111/j.1600-0714.2011.01054.x; Warnakulasuriya S, 2011, PERIODONTOL 2000, V57, P38, DOI 10.1111/j.1600-0757.2011.00395.x; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Zini A, 2010, J ORAL PATHOL MED, V39, P299, DOI 10.1111/j.1600-0714.2009.00845.x	32	62	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34773	10.1371/journal.pone.0034773	http://dx.doi.org/10.1371/journal.pone.0034773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514665	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341600071
J	Jellbauer, S; Panthel, K; Hetrodt, JH; Russmann, H				Jellbauer, Stefan; Panthel, Klaus; Hetrodt, Justin H.; Ruessmann, Holger			CD8 T-Cell Induction against Vascular Endothelial Growth Factor Receptor 2 by Salmonella for Vaccination Purposes against a Murine Melanoma	PLOS ONE			English	Article							III SECRETION SYSTEM; STEM-LIKE CELLS; ANTIGEN DELIVERY; TUMOR-GROWTH; SELECTIVE EXPRESSION; BACTERIAL-INFECTION; MEMORY CELLS; HOST-CELLS; ANGIOGENESIS; IMMUNOTHERAPY	The Salmonella type III secretion system (T3SS) efficiently translocates heterologous proteins into the cytosol of eukaryotic cells. This leads to an antigen-specific CD8 T-cell induction in mice orally immunized with recombinant Salmonella. Recently, we have used Salmonella's T3SS as a prophylactic and therapeutic intervention against a murine fibrosarcoma. In this study, we constructed a recombinant Salmonella strain translocating the immunogenic H-2D(b)-specific CD8 T-cell epitope VILTNPISM (KDR2) from the murine vascular endothelial growth factor receptor 2 (VEGFR2). VEGFR2 is a member of the tyrosine protein kinase family and is upregulated on proliferating endothelial cells of the tumor vasculature. After single orogastric vaccination, we detected significant numbers of KDR2-tetramer-positive CD8 T cells in the spleens of immunized mice. The efficacy of these cytotoxic T cells was evaluated in a prophylactic setting to protect mice from challenges with B16F10 melanoma cells in a flank tumor model, and to reduce dissemination of spontaneous pulmonary melanoma metastases. Vaccinated mice revealed a reduction of angiogenesis by 62% in the solid tumor and consequently a significant decrease of tumor growth as compared to non-immunized mice. Moreover, in the lung metastasis model, immunization with recombinant Salmonella resulted in a reduction of the metastatic melanoma burden by approximately 60%.	[Jellbauer, Stefan; Panthel, Klaus; Hetrodt, Justin H.] Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany; [Jellbauer, Stefan] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92717 USA; [Ruessmann, Holger] HELIOS Clin Emil von Behring, Inst Microbiol Immunol & Lab Med, Berlin, Germany	University of Munich; University of California System; University of California Irvine	Jellbauer, S (corresponding author), Univ Munich, Max von Pettenkofer Inst Hyg & Med Microbiol, Munich, Germany.	holger.ruessmann@helios-kliniken.de			Deutsche Forschungsgemeinschaft [RU 838/2-1, RU 838/3-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	SJ and HR were supported by the Deutsche Forschungsgemeinschaft (grants RU 838/2-1 and RU 838/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berchtold C, 2009, INFECT IMMUN, V77, P5501, DOI 10.1128/IAI.00700-09; Busch DH, 1998, IMMUNITY, V8, P353, DOI 10.1016/S1074-7613(00)80540-3; Busch DH, 1998, J EXP MED, V188, P61, DOI 10.1084/jem.188.1.61; DeLisser HM, 1997, AM J PATHOL, V151, P671; Domenech VES, 2005, MICROBES INFECT, V7, P860, DOI 10.1016/j.micinf.2005.02.007; Dong YJ, 2006, J IMMUNOTHER, V29, P32, DOI 10.1097/01.cji.0000175494.13476.56; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 1992, Semin Cancer Biol, V3, P65; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galan JE, 1998, P NATL ACAD SCI USA, V95, P14006, DOI 10.1073/pnas.95.24.14006; Garrido F, 1997, IMMUNOL TODAY, V18, P89, DOI 10.1016/S0167-5699(96)10075-X; Guttinger M, 2000, CANCER RES, V60, P4211; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Huster KM, 2006, CURR OPIN IMMUNOL, V18, P458, DOI 10.1016/j.coi.2006.05.008; Huster KM, 2006, EUR J IMMUNOL, V36, P1453, DOI 10.1002/eji.200635874; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaniga K, 1996, MOL MICROBIOL, V21, P633, DOI 10.1111/j.1365-2958.1996.tb02571.x; Kotton CN, 2004, INFECT IMMUN, V72, P5535, DOI 10.1128/IAI.72.10.5535-5547.2004; Lauvau G, 2001, SCIENCE, V294, P1735, DOI 10.1126/science.1064571; Li YW, 2002, J EXP MED, V195, P1575, DOI 10.1084/jem.20020072; Liu JY, 2003, BLOOD, V102, P1815, DOI 10.1182/blood-2002-12-3772; Lyons JA, 2007, GENE THER, V14, P503, DOI 10.1038/sj.gt.3302889; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Medina E, 2001, VACCINE, V19, P1573, DOI 10.1016/S0264-410X(00)00354-6; Nair S, 2003, BLOOD, V102, P964, DOI 10.1182/blood-2002-12-3738; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Niethammer AG, 2002, NAT MED, V8, P1369, DOI 10.1038/nm794; Nishikawa H, 2006, J CLIN INVEST, V116, P1946, DOI 10.1172/JCI28045; Okaji Y, 2006, EJSO, V32, P363, DOI 10.1016/j.ejso.2006.01.016; Panthel K, 2006, MICROBES INFECT, V8, P2539, DOI 10.1016/j.micinf.2006.07.004; Plum SM, 2000, VACCINE, V19, P1294, DOI 10.1016/S0264-410X(00)00210-3; POSTE G, 1980, CANCER RES, V40, P1636; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Roider E, 2011, CANCER IMMUNOL IMMUN, V60, P371, DOI 10.1007/s00262-010-0950-x; Russmann H, 1998, SCIENCE, V281, P565, DOI 10.1126/science.281.5376.565; Russmann H, 2001, J IMMUNOL, V167, P357, DOI 10.4049/jimmunol.167.1.357; Salgaller ML, 2003, CURR OPIN MOL THER, V5, P657; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996; Seliger B, 1997, IMMUNOL TODAY, V18, P292, DOI 10.1016/S0167-5699(97)01052-9; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998; Suzuki H, 2010, EUR J IMMUNOL, V40, P197, DOI 10.1002/eji.200939887; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wei YQ, 2000, NAT MED, V6, P1160, DOI 10.1038/80506	48	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34214	10.1371/journal.pone.0034214	http://dx.doi.org/10.1371/journal.pone.0034214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511934	Green Published, gold			2022-12-27	WOS:000305338600020
J	Li, YC; Liu, YW; Fu, LL; Mei, CL; Dai, B				Li, Yongchuan; Liu, Yawei; Fu, Lili; Mei, Changlin; Dai, Bing			Efficacy of Short-Term High-Dose Statin in Preventing Contrast-Induced Nephropathy: A Meta-Analysis of Seven Randomized Controlled Trials	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ACUTE CORONARY SYNDROMES; ACUTE-RENAL-FAILURE; REDUCTASE INHIBITORS; CLINICAL-TRIALS; RISK-FACTORS; ATORVASTATIN; ANGIOGRAPHY; THERAPY; PRETREATMENT	Background: A few studies focused on statin therapy as specific prophylactic measures of contrast-induced nephropathy have been published with conflicting results. In this meta-analysis of randomized controlled trials, we aimed to assess the effectiveness of shor-term high-dose statin treatment for the prevention of CIN and clinical outcomes and re-evaluate of the potential benefits of statin therapy. Methods: We searched PubMed, OVID, EMBASE, Web of science and the Cochrane Central Register of Controlled Trials databases for randomized controlled trials comparing short-term high-dose statin treatment versus low-dose statin treatment or placebo for preventing CIN. Our outcome measures were the risk of CIN within 2-5 days after contrast administration and need for dialysis. Results: Seven randomized controlled trials with a total of 1,399 patients were identified and analyzed. The overall results based on fixed-effect model showed that the use of short-term high-dose statin treatment was associated with a significant reduction in risk of CIN (RR = 0.51, 95% CI 0.34-0.76, p = 0.001; I-2 = 0%). The incidence of acute renal failure requiring dialysis was not significant different after the use of statin (RR = 0.33, 95% CI 0.05-2.10, p = 0.24; I-2 = 0%). The use of statin was not associated with a significant decrease in the plasma C-reactive protein level (SMD 20.64, 95% CI: 21.57 to 0.29, P = 0.18, I-2 = 97%). Conclusions: Although this meta-analysis supports the use of statin to reduce the incidence of CIN, it must be considered in the context of variable patient demographics. Only a limited recommendation can be made in favour of the use of statin based on current data. Considering the limitations of included studies, a large, well designed trial that incorporates the evaluation of clinically relevant outcomes in participants with different underlying risks of CIN is required to more adequately assess the role for statin in CIN prevention.	[Li, Yongchuan; Liu, Yawei; Fu, Lili; Mei, Changlin; Dai, Bing] Second Mil Med Univ, Div Nephrol, Nephrol Inst PLA, Shanghai Changzheng Hosp, Shanghai, Peoples R China	Naval Medical University	Li, YC (corresponding author), Second Mil Med Univ, Div Nephrol, Nephrol Inst PLA, Shanghai Changzheng Hosp, Shanghai, Peoples R China.	chlmei1954@yahoo.com.cn; daibin105@yahoo.com.cn		Li, Yongchuan/0000-0002-6075-9276	National Natural Science Foundation of China [30900692, 81000283, 30971368]; Shanghai Leading Academic Discipline Project [B902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was supported by grants from the National Natural Science Foundation of China (30900692, 81000283, 30971368) and Shanghai Leading Academic Discipline Project (B902). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acikel S, 2010, BLOOD COAGUL FIBRIN, V21, P750, DOI 10.1097/MBC.0b013e32834014a4; Attallah N, 2004, CLIN NEPHROL, V62, P273; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bonetti PO, 2003, EUR HEART J, V24, P225, DOI 10.1016/S0195-668X(02)00419-0; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Davignon J, 2004, CIRCULATION, V109, P39, DOI 10.1161/01.CIR.0000131517.20177.5a; Goldenberg I, 2005, CAN MED ASSOC J, V172, P1461, DOI 10.1503/cmaj.1040847; Gruberg L, 2001, CATHETER CARDIO INTE, V52, P409, DOI 10.1002/ccd.1093; Hernandez-Perera O, 1998, J CLIN INVEST, V101, P2711, DOI 10.1172/JCI1500; Ichiki T, 2001, ARTERIOSCL THROM VAS, V21, P1896, DOI 10.1161/hq1201.099430; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jia XW, 2009, AM J CARDIOL, V104, P519, DOI 10.1016/j.amjcard.2009.04.014; Jo SH, 2008, AM HEART J, V155, DOI 10.1016/j.ahj.2007.11.042; Jo SH, 2005, AM J CARDIOL, V96, p115H; John S, 2005, AM HEART J, V149, DOI 10.1016/j.ahj.2004.06.027; Kaesemeyer WH, 1999, J AM COLL CARDIOL, V33, P234, DOI 10.1016/S0735-1097(98)00514-2; Katholi RE, 1998, AM J KIDNEY DIS, V32, P64, DOI 10.1053/ajkd.1998.v32.pm9669426; Khanal S, 2005, AM J MED, V118, P843, DOI 10.1016/j.amjmed.2005.03.031; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; McCullough PA, 1997, AM J MED, V103, P368, DOI 10.1016/S0002-9343(97)00150-2; McCullough PA, 2008, AM J KIDNEY DIS, V51, P169, DOI 10.1053/j.ajkd.2007.12.004; Morikawa Shigeru, 2002, J Atheroscler Thromb, V9, P178; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Ozhan H, 2010, ANGIOLOGY, V61, P711, DOI 10.1177/0003319710364216; Pappy R, 2011, INT J CARDIOL, V151, P348, DOI 10.1016/j.ijcard.2011.05.045; Patti G, 2011, AM J CARDIOL, V108, P1, DOI 10.1016/j.amjcard.2011.03.001; Piorkowski M, 2007, J AM COLL CARDIOL, V49, P1035, DOI 10.1016/j.jacc.2006.10.064; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Tepel M, 2006, CIRCULATION, V113, P1799, DOI 10.1161/CIRCULATIONAHA.105.595090; Tepel M, 2002, CURR OPIN NEPHROL HY, V11, P503, DOI 10.1097/00041552-200209000-00005; Toso A, 2010, AM J CARDIOL, V105, P288, DOI 10.1016/j.amjcard.2009.09.026; Tumlin J, 2006, AM J CARDIOL, V98, p14K, DOI 10.1016/j.amjcard.2006.01.020; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0; Wagner AH, 2000, ARTERIOSCL THROM VAS, V20, P61, DOI 10.1161/01.ATV.20.1.61; Zhang BC, 2011, CAN J CARDIOL, V27, P851, DOI 10.1016/j.cjca.2011.05.005; Zhang L, 2011, INT J CLIN PRACT, V65, P624, DOI 10.1111/j.1742-1241.2010.02588.x; Zhang T, 2011, AM J NEPHROL, V33, P344, DOI 10.1159/000326269; Zhou Xia, 2009, Zhonghua Xinxueguanbing Zazhi, V37, P394, DOI 10.3760/cma.j.issn.0253-3758.2009.05.003; Zhou Y, 2011, CLIN NEPHROL, V76, P475, DOI 10.5414/CN106950	40	68	72	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34450	10.1371/journal.pone.0034450	http://dx.doi.org/10.1371/journal.pone.0034450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511942	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338600028
J	Thomas, D; Naughton, J; Cote, C; Welkos, S; Manchester, M; Young, JAT				Thomas, Diane; Naughton, John; Cote, Christopher; Welkos, Susan; Manchester, Marianne; Young, John A. T.			Delayed Toxicity Associated with Soluble Anthrax Toxin Receptor Decoy-Ig Fusion Protein Treatment	PLOS ONE			English	Article							PROTECTIVE ANTIGEN; IN-VITRO; STOICHIOMETRY; MACROPHAGES; KINETICS; TRIGGERS; BINDING	Soluble receptor decoy inhibitors, including receptor-immunogloubulin (Ig) fusion proteins, have shown promise as candidate anthrax toxin therapeutics. These agents act by binding to the receptor-interaction site on the protective antigen (PA) toxin subunit, thereby blocking toxin binding to cell surface receptors. Here we have made the surprising observation that co-administration of receptor decoy-Ig fusion proteins significantly delayed, but did not protect, rats challenged with anthrax lethal toxin. The delayed toxicity was associated with the in vivo assembly of a long-lived complex comprised of anthrax lethal toxin and the receptor decoy-Ig inhibitor. Intoxication in this system presumably results from the slow dissociation of the toxin complex from the inhibitor following their prolonged circulation. We conclude that while receptor decoy-Ig proteins represent promising candidates for the early treatment of B. anthracis infection, they may not be suitable for therapeutic use at later stages when fatal levels of toxin have already accumulated in the bloodstream.	[Thomas, Diane; Manchester, Marianne] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Naughton, John; Young, John A. T.] Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, La Jolla, CA 92037 USA; [Cote, Christopher; Welkos, Susan] USA, Med Res Inst Infect Dis, Bacteriol Div, Frederick, MD USA	University of California System; University of California San Diego; Salk Institute	Thomas, D (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	mmanchester@ucsd.edu; jyoung@salk.edu		Young, John/0000-0003-1824-2561; Welkos, Susan/0000-0002-7254-3480; Manchester, Marianne/0000-0002-7143-5744	National Institutes of Health [AI 076852]; Nomis Foundation; James B. Pendleton Charitable Trust; Defense Threat Reduction Agency JSTO-CBD [CBM.VAXBT.03.10.RD.004]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI076852] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nomis Foundation; James B. Pendleton Charitable Trust; Defense Threat Reduction Agency JSTO-CBD(United States Department of DefenseDefense Threat Reduction Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant AI 076852 (JATY and MM) and by the Nomis Foundation and the James B. Pendleton Charitable Trust (JATY). Work performed at USAMRIID was sponsored by the Defense Threat Reduction Agency JSTO-CBD as plan #CBM.VAXBT.03.10.RD.004/Medical Research/Material Command Research Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Abrami L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000792; Abrami L, 2010, P NATL ACAD SCI USA, V107, P1420, DOI 10.1073/pnas.0910782107; Bradley K, 2001, NATURE, V414; Cote CK, 2006, INFECT IMMUN, V74, P469, DOI 10.1128/IAI.74.1.469-480.2006; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; EZZELL JW, 1984, INFECT IMMUN, V45, P761, DOI 10.1128/IAI.45.3.761-767.1984; EZZELL JW, 1992, J GEN MICROBIOL, V138, P543, DOI 10.1099/00221287-138-3-543; Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200; Kintzer AF, 2009, J MOL BIOL, V392, P614, DOI 10.1016/j.jmb.2009.07.037; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; MILNE JC, 1993, MOL MICROBIOL, V10, P647, DOI 10.1111/j.1365-2958.1993.tb00936.x; MILNE JC, 1994, J BIOL CHEM, V269, P20607; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Mogridge J, 2002, BIOCHEMISTRY-US, V41, P1079, DOI 10.1021/bi015860m; Panchal RG, 2005, J BIOL CHEM, V280, P10834, DOI 10.1074/jbc.M412210200; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; Pilpa RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002354; Rainey GJA, 2004, NAT REV MICROBIOL, V2, P721, DOI 10.1038/nrmicro977; Scobie HM, 2006, PLOS PATHOG, V2, P949, DOI 10.1371/journal.ppat.0020111; Scobie HM, 2005, J INFECT DIS, V192, P1047, DOI 10.1086/432731; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Sharma S, 2009, ANTIMICROB AGENTS CH, V53, P1210, DOI 10.1128/AAC.01294-08; Vuyisich M, 2008, PROTEIN J, V27, P292, DOI 10.1007/s10930-008-9137-0; Wigelsworth DJ, 2004, J BIOL CHEM, V279, P23349, DOI 10.1074/jbc.M401292200; Wycoff KL, 2011, ANTIMICROB AGENTS CH, V55, P132, DOI 10.1128/AAC.00592-10; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	29	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34611	10.1371/journal.pone.0034611	http://dx.doi.org/10.1371/journal.pone.0034611			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511955	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338600041
J	Kaniewska, P; Campbell, PR; Kline, DI; Rodriguez-Lanetty, M; Miller, DJ; Dove, S; Hoegh-Guldberg, O				Kaniewska, Paulina; Campbell, Paul R.; Kline, David I.; Rodriguez-Lanetty, Mauricio; Miller, David J.; Dove, Sophie; Hoegh-Guldberg, Ove			Major Cellular and Physiological Impacts of Ocean Acidification on a Reef Building Coral	PLOS ONE			English	Article							OXIDATIVE STRESS; CLIMATE-CHANGE; CARBONIC-ACID; RELEASE; TRANSPORT; APOPTOSIS; SEAWATER; BINDING; PH; ZOOXANTHELLAE	As atmospheric levels of CO2 increase, reef-building corals are under greater stress from both increased sea surface temperatures and declining sea water pH. To date, most studies have focused on either coral bleaching due to warming oceans or declining calcification due to decreasing oceanic carbonate ion concentrations. Here, through the use of physiology measurements and cDNA microarrays, we show that changes in pH and ocean chemistry consistent with two scenarios put forward by the Intergovernmental Panel on Climate Change (IPCC) drive major changes in gene expression, respiration, photosynthesis and symbiosis of the coral, Acropora millepora, before affects on biomineralisation are apparent at the phenotype level. Under high CO2 conditions corals at the phenotype level lost over half their Symbiodinium populations, and had a decrease in both photosynthesis and respiration. Changes in gene expression were consistent with metabolic suppression, an increase in oxidative stress, apoptosis and symbiont loss. Other expression patterns demonstrate upregulation of membrane transporters, as well as the regulation of genes involved in membrane cytoskeletal interactions and cytoskeletal remodeling. These widespread changes in gene expression emphasize the need to expand future studies of ocean acidification to include a wider spectrum of cellular processes, many of which may occur before impacts on calcification.	[Kaniewska, Paulina; Kline, David I.; Dove, Sophie] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Campbell, Paul R.] Agri Sci Queensland, Dept Employment Econ Dev & Innovat, Dutton Pk, Qld, Australia; [Rodriguez-Lanetty, Mauricio] Univ Louisiana Lafayette, Dept Biol, Lafayette, LA 70504 USA; [Miller, David J.; Dove, Sophie; Hoegh-Guldberg, Ove] James Cook Univ, Sch Pharm & Mol Sci, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Miller, David J.; Dove, Sophie; Hoegh-Guldberg, Ove] James Cook Univ, Sch Pharm & Mol Sci, Coral Genom Grp, Townsville, Qld 4811, Australia; [Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia	University of Queensland; Queensland Department of Agriculture & Fisheries; University of Louisiana Lafayette; James Cook University; James Cook University; University of Queensland	Kaniewska, P (corresponding author), Australian Inst Marine Sci, Townsville, Qld, Australia.	p.kaniewska@aims.gov.au	Hoegh-Guldberg, Ove/ABA-5420-2020; Dove, Sophie/I-7873-2013; Hoegh-Guldberg, Ove/H-6169-2011	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Dove, Sophie/0000-0003-1823-8634; Hoegh-Guldberg, Ove/0000-0001-7510-6713; Kline, David/0000-0001-5128-9439	Australian Research Council Centre for Excellence for Coral Reef Studies	Australian Research Council Centre for Excellence for Coral Reef Studies(Australian Research Council)	This work was supported by the Australian Research Council Centre for Excellence for Coral Reef Studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Barnes D.J., 1990, P109; Bay LK, 2009, MOL ECOL, V18, P3062, DOI 10.1111/j.1365-294X.2009.04257.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Crawley A, 2010, GLOBAL CHANGE BIOL, V16, P851, DOI 10.1111/j.1365-2486.2009.01943.x; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Cully M, 2008, CELL, V133, P1292, DOI 10.1016/j.cell.2008.06.020; Davidson JF, 2001, MOL CELL BIOL, V21, P8483, DOI 10.1128/MCB.21.24.8483-8489.2001; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DeSalvo MK, 2010, MAR ECOL PROG SER, V402, P97, DOI 10.3354/meps08372; Dickson AG, 2003, MAR CHEM, V80, P185, DOI 10.1016/S0304-4203(02)00133-0; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Doherty GJ, 2008, ANNU REV BIOPHYS, V37, P65, DOI 10.1146/annurev.biophys.37.032807.125912; Dollar GL, 2005, NATURE, V437, P1376, DOI 10.1038/nature04116; Doney SC, 2009, ANNU REV MAR SCI, V1, P169, DOI 10.1146/annurev.marine.010908.163834; Dunn SR, 2009, ISJ-INVERT SURVIV J, V6, P7; Dunn SR, 2006, J MOL EVOL, V63, P95, DOI 10.1007/s00239-005-0236-7; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Foret S, 2007, CORAL REEFS, V26, P475, DOI 10.1007/s00338-007-0206-1; Furla P, 2000, AM J PHYSIOL-REG I, V278, pR870, DOI 10.1152/ajpregu.2000.278.4.R870; Grasso LC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-540; GROSSER J, 1981, J LIPID RES, V22, P437; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Guppy M, 1999, BIOL REV, V74, P1, DOI 10.1017/S0006323198005258; Hauer J, 2005, P NATL ACAD SCI USA, V102, P2874, DOI 10.1073/pnas.0500187102; HEISLER N, 1989, CAN J ZOOL, V67, P2923, DOI 10.1139/z89-415; Hidalgo C, 2005, PHILOS T R SOC B, V360, P2237, DOI 10.1098/rstb.2005.1759; Hinton A, 2009, J BIOL CHEM, V284, P16400, DOI 10.1074/jbc.M901201200; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Hoeflich KP, 2004, INT J BIOCHEM CELL B, V36, P2131, DOI 10.1016/j.biocel.2003.11.018; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Huertas IE, 2002, PLANT PHYSIOL, V130, P284, DOI 10.1104/pp.004598; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9; Kasri NN, 2004, BIOL RES, V37, P577; Kleypas JA, 1999, SCIENCE, V284, P118, DOI 10.1126/science.284.5411.118; Kraus ZJ, 2008, J IMMUNOL, V181, P7800, DOI 10.4049/jimmunol.181.11.7800; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; Lankat-Buttgereit B, 2009, BIOL CELL, V101, P309, DOI 10.1042/BC20080191; LEESMILLER JP, 1992, NATURE, V359, P244, DOI 10.1038/359244a0; Lesser MP, 2004, CORAL REEFS, V23, P367, DOI 10.1007/s00338-004-0392-z; Lewis E., 1998, PROGRAM DEV CO2 SYST; Li Y, 1996, P NATL ACAD SCI USA, V93, P9606, DOI 10.1073/pnas.93.18.9606; Lough JM, 2008, J ENVIRON MONITOR, V10, P21, DOI [10.1039/b714627m, 10.1039/B714627M]; Matsuyama S, 2000, CELL DEATH DIFFER, V7, P1155, DOI 10.1038/sj.cdd.4400779; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Miller DJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r59; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Muller J, 2007, PROTOPLASMA, V230, P231, DOI 10.1007/s00709-006-0239-2; Munday PL, 2009, P NATL ACAD SCI USA, V106, P1848, DOI 10.1073/pnas.0809996106; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Muscatine L., 1990, P75; Obara M, 2008, NEUROCHEM INT, V52, P905, DOI 10.1016/j.neuint.2007.10.015; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pelejero C, 2010, TRENDS ECOL EVOL, V25, P332, DOI 10.1016/j.tree.2010.02.002; Pernice M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016095; Petrackova D, 2010, J MEMBRANE BIOL, V233, P73, DOI 10.1007/s00232-010-9226-9; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Portner HO, 2000, J EXP BIOL, V203, P2417; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Rodolfo-Metalpa R, 2011, NAT CLIM CHANGE, V1, P308, DOI 10.1038/NCLIMATE1200; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schallreuter KU, 2007, BIOCHEM BIOPH RES CO, V360, P70, DOI 10.1016/j.bbrc.2007.05.218; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Shima DT, 1999, CURR BIOL, V9, P821, DOI 10.1016/S0960-9822(99)80365-0; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spencer-Davies P, 1989, MAR BIOL, V101, P389, DOI DOI 10.1007/BF00428135; Stenmark H, 2001, GENOME BIOL, V2; STIMSON J, 1991, J EXP MAR BIOL ECOL, V153, P63, DOI 10.1016/S0022-0981(05)80006-1; THORPE C, 1995, FASEB J, V9, P718, DOI 10.1096/fasebj.9.9.7601336; Todgham AE, 2009, J EXP BIOL, V212, P2579, DOI 10.1242/jeb.032540; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veron JEN, 2008, CORAL REEFS, V27, P459, DOI 10.1007/s00338-008-0381-8; von Heijne G, 2007, J INTERN MED, V261, P543, DOI 10.1111/j.1365-2796.2007.01792.x; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Whiteley NM, 2001, J EXP BIOL, V204, P1003; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	89	178	180	6	210	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34659	10.1371/journal.pone.0034659	http://dx.doi.org/10.1371/journal.pone.0034659			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509341	gold, Green Accepted, Green Published			2022-12-27	WOS:000305336600046
J	Stephenson, RS; Boyett, MR; Hart, G; Nikolaidou, T; Cai, X; Corno, AF; Alphonso, N; Jeffery, N; Jarvis, JC				Stephenson, Robert S.; Boyett, Mark R.; Hart, George; Nikolaidou, Theodora; Cai, Xue; Corno, Antonio F.; Alphonso, Nelson; Jeffery, Nathan; Jarvis, Jonathan C.			Contrast Enhanced Micro-Computed Tomography Resolves the 3-Dimensional Morphology of the Cardiac Conduction System in Mammalian Hearts	PLOS ONE			English	Article							ATRIOVENTRICULAR NODE; RECONSTRUCTION; CT; FIBERS; MODEL	The general anatomy of the cardiac conduction system (CCS) has been known for 100 years, but its complex and irregular three-dimensional (3D) geometry is not so well understood. This is largely because the conducting tissue is not distinct from the surrounding tissue by dissection. The best descriptions of its anatomy come from studies based on serial sectioning of samples taken from the appropriate areas of the heart. Low X-ray attenuation has formerly ruled out micro-computed tomography (micro-CT) as a modality to resolve internal structures of soft tissue, but incorporation of iodine, which has a high molecular weight, into those tissues enhances the differential attenuation of X-rays and allows visualisation of fine detail in embryos and skeletal muscle. Here, with the use of a iodine based contrast agent (I2KI), we present contrast enhanced micro-CT images of cardiac tissue from rat and rabbit in which the three major subdivisions of the CCS can be differentiated from the surrounding contractile myocardium and visualised in 3D. Structures identified include the sinoatrial node (SAN) and the atrioventricular conduction axis: the penetrating bundle, His bundle, the bundle branches and the Purkinje network. Although the current findings are consistent with existing anatomical representations, the representations shown here offer superior resolution and are the first 3D representations of the CCS within a single intact mammalian heart.	[Stephenson, Robert S.; Hart, George; Jeffery, Nathan; Jarvis, Jonathan C.] Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England; [Boyett, Mark R.; Nikolaidou, Theodora; Cai, Xue] Univ Manchester, Sch Med, Cardiovasc Res Grp, Manchester, Greater Manches, England; [Corno, Antonio F.] Prince Salman Heart Ctr, Riyadh, Saudi Arabia; [Alphonso, Nelson] Alder Hey Childrens NHS Fdn Trust, Liverpool, Merseyside, England	University of Liverpool; University of Manchester; Alder Hey Children's NHS Foundation Trust	Stephenson, RS (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Dept Musculoskeletal Biol, Liverpool L69 3BX, Merseyside, England.	jcj@liverpool.ac.uk	Stephenson, Robert/AAO-4019-2021; Alphonso, Nelson/A-7647-2014	Stephenson, Robert/0000-0002-4153-6026; Alphonso, Nelson/0000-0002-3735-8298; Nikolaidou, Theodora/0000-0002-8810-0414; Boyett, Mark/0000-0003-3931-2020; Jeffery, Nathan/0000-0001-5166-2029	Alder Hey Childrens' NHS Hospital Trust; EPSRC [EP/F007906/1] Funding Source: UKRI; NERC [NE/G001952/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F007906/1] Funding Source: researchfish; National Institute for Health Research [ACF-2007-06-003] Funding Source: researchfish; Natural Environment Research Council [NE/G001952/1] Funding Source: researchfish	Alder Hey Childrens' NHS Hospital Trust; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Work was funded by the Cardiac Surgical Research Fund of the Alder Hey Childrens' NHS Hospital Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airey JA, 2004, CIRCULATION, V109, P1401, DOI 10.1161/01.CIR.0000124222.16321.26; Almajdub M, 2008, CONTRAST MEDIA MOL I, V3, P120, DOI 10.1002/cmmi.238; Atkinson A, 2011, J MOL CELL CARDIOL, V51, P689, DOI 10.1016/j.yjmcc.2011.05.020; Badea C. T., 2005, MOL IMAGING, V4, P110; Badea CT, 2008, COMPUT MED IMAG GRAP, V32, P239, DOI 10.1016/j.compmedimag.2007.12.004; Badea CT, 2008, MED PHYS, V35, P1170, DOI 10.1118/1.2868778; Bordas R, 2011, PROG BIOPHYS MOL BIO, V107, P90, DOI 10.1016/j.pbiomolbio.2011.05.002; Boyett MR, 2009, EXP PHYSIOL, V94, P1035, DOI 10.1113/expphysiol.2009.046920; Boyett MR, 2005, J ELECTROCARDIOL, V38, P113, DOI 10.1016/j.jelectrocard.2005.06.102; Chandler N, 2011, ANAT REC, V294, P970, DOI 10.1002/ar.21379; Cox PG, 2011, ANAT REC HOBOKEN, V294, pspc1; Degenhardt K, 2010, CIRCULATION CARDIOVA; Dobrzynski H, 2005, CIRCULATION, V111, P846, DOI 10.1161/01.CIR.0000152100.04087.DB; Jeffery NS, 2011, J BIOMECH, V44, P189, DOI 10.1016/j.jbiomech.2010.08.027; Ko YS, 2004, CIRCULATION, V109, P1172, DOI 10.1161/01.CIR.0000117233.57190.BD; Lecker DN, 1997, J POLYM SCI POL CHEM, V35, P1409, DOI 10.1002/(SICI)1099-0518(199706)35:8<1409::AID-POLA9>3.0.CO;2-U; Li J, 2005, DETAILED 3D MODEL RA, P603; Li J, 2008, CIRC RES, V102, P975, DOI 10.1161/CIRCRESAHA.108.172403; Metscher Brian D., 2009, BMC Physiology, V9, P11, DOI 10.1186/1472-6793-9-11; Metscher BD, 2009, DEV DYNAM, V238, P632, DOI 10.1002/dvdy.21857; Myers DC, 2003, TRENDS CARDIOVAS MED, V13, P289, DOI 10.1016/S1050-1738(03)00119-1; NIELSEN PMF, 1991, AM J PHYSIOL, V260, pH1365, DOI 10.1152/ajpheart.1991.260.4.H1365; SAENGER W, 1984, NATURWISSENSCHAFTEN, V71, P31, DOI 10.1007/BF00365977; Tawara S, 2000, CONDUCTION SYSTEM MA; Weninger WJ, 2006, ANAT EMBRYOL, V211, P213, DOI 10.1007/s00429-005-0073-x; Yoo S, 2006, CIRCULATION, V114, P1360, DOI 10.1161/CIRCULATIONAHA.106.613182	26	92	94	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35299	10.1371/journal.pone.0035299	http://dx.doi.org/10.1371/journal.pone.0035299			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509404	Green Published, Green Accepted, gold			2022-12-27	WOS:000305336600098
J	Vinegoni, C; Fumene Feruglio, P; Razansky, D; Gorbatov, R; Ntziachristos, V; Sbarbati, A; Nahrendorf, M; Weissleder, R				Vinegoni, Claudio; Fumene Feruglio, Paolo; Razansky, Daniel; Gorbatov, Rostic; Ntziachristos, Vasilis; Sbarbati, Andrea; Nahrendorf, Matthias; Weissleder, Ralph			Mapping Molecular Agents Distributions in Whole Mice Hearts Using Born-Normalized Optical Projection Tomography	PLOS ONE			English	Article							FIBER ORIENTATION; MICROSCOPY; STRAIN; DEEP	To date there is a lack of tools to map the spatio-temporal dynamics of diverse cells in experimental heart models. Conventional histology is labor intensive with limited coverage, whereas many imaging techniques do not have sufficiently high enough spatial resolution to map cell distributions. We have designed and built a high resolution, dual channel Born-normalized near-infrared fluorescence optical projection tomography system to quantitatively and spatially resolve molecular agents distribution within whole murine heart. We validated the use of the system in a mouse model of monocytes/macrophages recruitment during myocardial infarction. While acquired, data were processed and reconstructed in real time. Tomographic analysis and visualization of the key inflammatory components were obtained via a mathematical formalism based on left ventricular modeling. We observed extensive monocyte recruitment within and around the infarcted areas and discovered that monocytes were also extensively recruited into non-ischemic myocardium, beyond that of injured tissue, such as the septum.	[Vinegoni, Claudio; Fumene Feruglio, Paolo; Gorbatov, Rostic; Nahrendorf, Matthias; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Vinegoni, Claudio; Fumene Feruglio, Paolo; Gorbatov, Rostic; Nahrendorf, Matthias; Weissleder, Ralph] Harvard Univ, Sch Med, Richard B Simches Res Ctr, Boston, MA USA; [Vinegoni, Claudio] Massachusetts Gen Hosp, Ctr Mol Imaging Res, Charlestown, MA USA; [Vinegoni, Claudio] Harvard Univ, Sch Med, Charlestown, MA USA; [Fumene Feruglio, Paolo; Sbarbati, Andrea] Univ Verona, Dept Neurol Neuropsychol Morphol & Movement Sci, I-37100 Verona, Italy; [Razansky, Daniel; Ntziachristos, Vasilis] Tech Univ Munich, Inst Biol & Med Imaging, Neuherberg, Germany; [Razansky, Daniel; Ntziachristos, Vasilis] Helmholtz Ctr Munich, Neuherberg, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; University of Verona; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Vinegoni, C (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	cvinegoni@mgh.harvard.edu	Vinegoni, Claudio/A-9490-2012; vinegoni, claudio/AGU-2461-2022; Razansky, Daniel/B-8590-2015	Vinegoni, Claudio/0000-0002-9818-3639; /0000-0003-0828-4143; Razansky, Daniel/0000-0001-8676-0964	NIH [RO1EB006432]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006432] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by NIH grant no. RO1EB006432. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Janabi S, 2011, HISTOPATHOLOGY, DOI [DOI 10.1111/J.1365-2559.2011.03814.X, 10.1111/j.1365-2559.2011.03814.x]; Alanentalo T, 2007, NAT METHODS, V4, P31, DOI 10.1038/NMETH985; American Heart Association, CARD DIS STAT; Bankman I. N., 2000, HDB MED IMAGING PROC; BOVENDEERD PHM, 1992, J BIOMECH, V25, P1129, DOI 10.1016/0021-9290(92)90069-D; Choi HF, 2009, IFMBE PROC, V22, P307; Conchello JA, 2005, NAT METHODS, V2, P920, DOI 10.1038/NMETH815; Condeelis J., 2010, COLD SPRING HARB PER, V2, P122; DODGE HT, 1960, AM HEART J, V60, P762, DOI 10.1016/0002-8703(60)90359-8; Ewald AJ, 2002, DEV DYNAM, V225, P369, DOI 10.1002/dvdy.10169; Fang QQ, 2009, I S BIOMED IMAGING, P1142, DOI 10.1109/ISBI.2009.5193259; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Geerts L, 2002, AM J PHYSIOL-HEART C, V283, pH139, DOI 10.1152/ajpheart.00968.2001; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Nahrendorf M, 2010, PNAS, V107, P7010; Nahrendorf M, 2008, CIRCULATION, V117, P379, DOI 10.1161/CIRCULATIONAHA.107.741181; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2007, CIRC RES, V100, P1218, DOI 10.1161/01.RES.0000265064.46075.31; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Nahrendorf M, 2009, ARTERIOSCL THROM VAS, V29, P1444, DOI 10.1161/ATVBAHA.109.193086; Ntziachristos V, 2004, P NATL ACAD SCI USA, V101, P12294, DOI 10.1073/pnas.0401137101; Ntziachristos V, 2002, NAT MED, V8, P757, DOI 10.1038/nm729; Panizzi P, 2010, J AM COLL CARDIOL, V55, P1629, DOI 10.1016/j.jacc.2009.08.089; Rijcken J, 1997, J BIOMECH, V30, P1041, DOI 10.1016/S0021-9290(97)00064-X; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Sosnovik DE, 2007, CIRCULATION, V115, P1384, DOI 10.1161/CIRCULATIONAHA.106.663351; Vallet B, 2006, SPIE C MED IMAGING, V6144, P1370; vanSteensel B, 1996, J CELL SCI, V109, P787; Vendelin M, 2002, AM J PHYSIOL-HEART C, V283, pH1072, DOI 10.1152/ajpheart.00874.2001; Vinegoni C, 2008, NAT METHODS, V5, P45, DOI 10.1038/NMETH1149; Vinegoni C, 2009, OPT LETT, V34, P319, DOI 10.1364/OL.34.000319; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015	33	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34427	10.1371/journal.pone.0034427	http://dx.doi.org/10.1371/journal.pone.0034427			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509302	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600032
J	Lisi, A; Briganti, E; Ledda, M; Losi, P; Grimaldi, S; Marchese, R; Soldani, G				Lisi, Antonella; Briganti, Enrica; Ledda, Mario; Losi, Paola; Grimaldi, Settimio; Marchese, Rodolfo; Soldani, Giorgio			A Combined Synthetic-Fibrin Scaffold Supports Growth and Cardiomyogenic Commitment of Human Placental Derived Stem Cells	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; NITRIC-OXIDE SYNTHASE; BONE-MARROW-CELLS; AMNIOTIC MEMBRANE; OSTEOGENIC DIFFERENTIATION; PROGENITOR CELLS; CARDIAC-FUNCTION; ADIPOSE-TISSUE; LIVING CELLS; REPAIR	Aims: A potential therapy for myocardial infarction is to deliver isolated stem cells to the infarcted site. A key issue with this therapy is to have at one's disposal a suitable cell delivery system which, besides being able to support cell proliferation and differentiation, may also provide handling and elastic properties which do not affect cardiac contractile function. In this study an elastic scaffold, obtained combining a poly(ether) urethane-polydimethylsiloxane (PEtU-PDMS) semi-interpenetrating polymeric network (s-IPN) with fibrin, was used as a substrate for in vitro studies of human amniotic mesenchymal stromal cells (hAMSC) growth and differentiation. Methodology/Principal Findings: After hAMSC seeding on the fibrin side of the scaffold, cell metabolic activity and proliferation were evaluated by WST-1 and bromodeoxyuridine assays. Morphological changes and mRNAs expression for cardiac differentiation markers in the hAMSCs were examined using immunofluorescence and RT-PCR analysis. The beginning of cardiomyogenic commitment of hAMSCs grown on the scaffold was induced, for the first time in this cell population, by a nitric oxide (NO) treatment. Following NO treatment hAMSCs show morphological changes, an increase of the messenger cardiac differentiation markers [troponin I (TnI) and NK2 transcription factor related locus 5 (Nkx2.5)] and a modulation of the endothelial markers [vascular endothelial growth factor (VEGF) and kinase insert domain receptor (KDR)]. Conclusions/Significance: The results of this study suggest that the s-IPN PEtU-PDMS/fibrin combined scaffold allows a better proliferation and metabolic activity of hAMSCs cultured up to 14 days, compared to the ones grown on plastic dishes. In addition, the combined scaffold sustains the beginning of hAMSCs differentiation process towards a cardiomyogenic lineage.	[Lisi, Antonella; Ledda, Mario; Grimaldi, Settimio] CNR, Inst Translat Pharmacol, Rome, Italy; [Briganti, Enrica; Losi, Paola; Soldani, Giorgio] CNR, Inst Clin Physiol, Massa, Italy; [Marchese, Rodolfo] S Peter Hosp FBF, Res Ctr, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Lisi, A (corresponding author), CNR, Inst Translat Pharmacol, Rome, Italy.	giorgio.soldani@ifc.cnr.it	Lisi, Antonella/C-7024-2015; Ledda, Mario/ABA-8685-2021; Ledda, Mario/AAP-2356-2021; Ledda, Mario/B-5656-2015	Lisi, Antonella/0000-0002-5465-9500; Ledda, Mario/0000-0002-0349-8938; Ledda, Mario/0000-0002-0349-8938				Armani DL, 2001, ANN NY ACAD SCI, V936, P566; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X; Berglund JD, 2003, BIOMATERIALS, V24, P1241, DOI 10.1016/S0142-9612(02)00506-9; Bloch W, 1999, CARDIOVASC RES, V43, P675, DOI 10.1016/S0008-6363(99)00160-1; Briganti E, 2006, J MATER SCI-MATER M, V17, P259, DOI 10.1007/s10856-006-7312-4; Briganti E, 2010, J CONTROL RELEASE, V142, P14, DOI 10.1016/j.jconrel.2009.09.029; Burattini S, 2004, EUR J HISTOCHEM, V48, P223; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Casey ML, 1996, BIOL REPROD, V55, P1253, DOI 10.1095/biolreprod55.6.1253; Cebotari S, 2002, CIRCULATION, V106, pI63, DOI 10.1161/01.cir.0000032900.55215.85; Chang CJ, 2006, STEM CELLS, V24, P2466, DOI 10.1634/stemcells.2006-0071; Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762; Fan CL, 2006, CLIN EXP PHARMACOL P, V33, P617, DOI 10.1111/j.1440-1681.2006.04416.x; Feng QP, 2002, CIRCULATION, V106, P873, DOI 10.1161/01.CIR.0000024114.82981.EA; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Gu R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031279; Gupta MK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028935; Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Itoh H, 2001, ARTIF ORGANS, V25, P213, DOI 10.1046/j.1525-1594.2001.025003213.x; Jockenhoevel S, 2001, EUR J CARDIO-THORAC, V19, P424, DOI 10.1016/S1010-7940(01)00624-8; Kanno S, 2004, P NATL ACAD SCI USA, V101, P12277, DOI 10.1073/pnas.0401557101; Katare RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009275; Kellar RS, 2005, TISSUE ENG, V11, P1678, DOI 10.1089/ten.2005.11.1678; Kinnaird T, 2004, CIRC RES, V95, P354, DOI 10.1161/01.RES.0000137878.26174.66; Kofidis T, 2005, J HEART LUNG TRANSPL, V24, P737, DOI 10.1016/j.healun.2004.03.023; Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021; Kraehenbuehl TP, 2011, BIOMATERIALS, V32, P1102, DOI 10.1016/j.biomaterials.2010.10.005; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Leor J, 2000, CIRCULATION, V102, P56; Lian N, 2009, J BIOL CHEM, V284, P30518, DOI 10.1074/jbc.M109.052373; Lim CT, 2006, J BIOMECH, V39, P195, DOI 10.1016/j.jbiomech.2004.12.008; Liu JB, 2004, AM J PHYSIOL-HEART C, V287, pH501, DOI 10.1152/ajpheart.00019.2004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Losi P, 2010, BIOMATERIALS, V31, P5336, DOI 10.1016/j.biomaterials.2010.03.033; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Mangano C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018721; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Manuelpillai U, 2011, PLACENTA, V32, pS320, DOI 10.1016/j.placenta.2011.04.010; Miyagawa S, 2005, TRANSPLANTATION, V80, P1586, DOI 10.1097/01.tp.0000181163.69108.dd; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Murry CE, 2006, J AM COLL CARDIOL, V47, P1777, DOI 10.1016/j.jacc.2006.02.002; Nakamuta JS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006005; Niklason LE, 1997, TRANSPL IMMUNOL, V5, P303; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Parolini O, 2009, REGEN MED, V4, P275, DOI 10.2217/17460751.4.2.275; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026211; Psaltis PJ, 2008, STEM CELLS, V26, P2201, DOI 10.1634/stemcells.2008-0428; Rodriguez JP, 2004, J CELL BIOCHEM, V93, P721, DOI 10.1002/jcb.20234; Sanger JW, 2002, CLIN ORTHOP RELAT R, pS153, DOI 10.1097/01.blo.0000031973.69509.21; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Schaner PJ, 2004, J VASC SURG, V40, P146, DOI 10.1016/j.jvs.2004.03.033; Schmidt CE, 2000, BIOMATERIALS, V21, P2215, DOI 10.1016/S0142-9612(00)00148-4; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Semenov OV, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.869; Simpson D, 2007, STEM CELLS, V25, P2350, DOI 10.1634/stemcells.2007-0132; Soldani G, 2010, PCTIB2010052343; Soldani Giorgio, 2004, Cardiol Young, V14 Suppl 3, P20, DOI 10.1017/S104795110400650X; Stock UA, 2001, ANNU REV MED, V52, P443, DOI 10.1146/annurev.med.52.1.443; Suuronen EJ, 2008, SEMIN THORAC CARDIOV, V20, P110, DOI 10.1053/j.semtcvs.2008.03.005; Tang YL, 2004, REGUL PEPTIDES, V117, P3, DOI 10.1016/j.regpep.2003.09.005; Titushkin I, 2007, BIOPHYS J, V93, P3693, DOI 10.1529/biophysj.107.107797; van Amerongen Machteld J., 2002, Angiogenesis, V5, P173, DOI 10.1023/A:1023822504224; van Hinsbergh VWM, 2001, ANN NY ACAD SCI, V936, P426; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Wolbank S, 2007, TISSUE ENG, V13, P1173, DOI 10.1089/ten.2006.0313; Xing YJ, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-6; Xiong QA, 2011, STEM CELLS, V29, P367, DOI 10.1002/stem.580; Ye Q, 2000, EUR J CARDIO-THORAC, V17, P587, DOI 10.1016/S1010-7940(00)00373-0; Yourek G, 2007, ASAIO J, V53, P219, DOI 10.1097/MAT.0b013e31802deb2d; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	75	33	35	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34284	10.1371/journal.pone.0034284	http://dx.doi.org/10.1371/journal.pone.0034284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509287	Green Published, Green Submitted, gold			2022-12-27	WOS:000304805900023
J	Verma, VK; Taneja, V; Jaiswal, A; Sharma, S; Behera, D; Sreenivas, V; Chauhan, SS; Prasad, HK				Verma, Vikas Kumar; Taneja, Vibha; Jaiswal, Anand; Sharma, Sangeeta; Behera, Digamber; Sreenivas, Vishnubhatla; Chauhan, Shyam Singh; Prasad, Hanumanthappa Krishna			Prevalence, Distribution and Functional Significance of the-237C to T Polymorphism in the IL-12R beta 2 Promoter in Indian Tuberculosis Patients	PLOS ONE			English	Article							TIME RT-PCR; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVITY; PULMONARY TUBERCULOSIS; CELL-DIFFERENTIATION; RECEPTOR EXPRESSION; IFN-GAMMA; IL-12; CYTOKINE; DISEASE	Cytokine/cytokine receptor gene polymorphisms related to structure/expression could impact immune response. Hence, the -237 polymorphic site in the 5' promoter region of the IL-12R beta 2 (SNP ID: rs11810249) gene associated with the AP-4 transcription motif GAGCTG, was examined. Amplicons encompassing the polymorphism were generated from 46 pulmonary tuberculosis patients, 35 family contacts and 28 miscellaneous volunteers and sequenced. The C allele predominated among patients, (93.4%, 43/46), and in all volunteers and contacts screened, but the T allele was exclusively limited to patients, (6.5%, 3/46). The functional impact of this polymorphism on transcriptional activity was assessed by Luciferase-reporter and electrophoretic mobility shift assays (EMSA). Luciferase-reporter assays showed a significant reduction in transcriptional efficiency with T compared to C allele. The reduction in transcriptional efficiency with the T allele construct (pGIL-12Rb2-T), in U-87MG, THP-1 and Jurkat cell lines, were 53, 37.6, and 49.8% respectively, compared to the C allele construct (pGIL-12Rb2-C). Similarly, densitometric analysis of the EMSA assay showed reduced binding of the AP-4 transcription factor, to T compared to the C nucleotide probe. Reduced mRNA expression in all patients (3/3) harboring the T allele was seen, whereas individuals with the C allele exhibited high mRNA expression (17/25; 68%, p = 0.05). These observations were in agreement with the in vitro assessment of the promoter activity by Luciferase-reporter and EMSA assays. The reduced expression of IL-12R beta 2 transcripts in 8 patients despite having the C allele was attributed to the predominant over expression of the suppressors (IL-4 and GATA-3) and reduced expression of enhancers (IFN-alpha) of IL-12R beta 2 transcripts. The 17 high IL-12R beta 2 mRNA expressers had significantly elevated IFN-alpha mRNA levels compared to low expressers and volunteers. Notwithstanding the presence of high levels of IL-12R beta 2 mRNA in these patients elevated IFN-alpha expression could modulate their immune responses to Mycobacterium tuberculosis.	[Verma, Vikas Kumar; Taneja, Vibha; Prasad, Hanumanthappa Krishna] All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India; [Jaiswal, Anand; Sharma, Sangeeta; Behera, Digamber] LRS Inst TB & Resp Dis, New Delhi, India; [Sreenivas, Vishnubhatla] All India Inst Med Sci, Dept Biostat, New Delhi, India; [Chauhan, Shyam Singh] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Verma, VK (corresponding author), All India Inst Med Sci, Dept Biotechnol, New Delhi 110029, India.	hk_prasad@hotmail.com	Verma, Vikas/I-6593-2018	Verma, Vikas/0000-0003-2890-9200	Department of Biotechnology; Department of Atomic Energy [2011/37B/38/BRNS]; Indian Council of Medical Research, Government of India	Department of Biotechnology; Department of Atomic Energy(Department of Atomic Energy (DAE)); Indian Council of Medical Research, Government of India(Indian Council of Medical Research (ICMR))	The study has been supported with financial support from the Departments of Biotechnology and Atomic Energy (No. 2011/37B/38/BRNS) and the Indian Council of Medical Research, Government of India. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bhattacharyya S, 1999, INFECT IMMUN, V67, P5597, DOI 10.1128/IAI.67.11.5597-5603.1999; Bidwell J, 1999, GENES IMMUN, V1, P3, DOI 10.1038/sj.gene.6363645; Boeuf P, 2005, BMC IMMUNOL, V6, DOI 10.1186/1471-2172-6-5; Burl S, 2007, CLIN EXP IMMUNOL, V149, P117, DOI 10.1111/j.1365-2249.2007.03399.x; Cheng CK, 2003, MOL ENDOCRINOL, V17, P1175, DOI 10.1210/me.2002-0418; CHUA AO, 1995, J IMMUNOL, V155, P4286; Gupta V, 2010, HUM IMMUNOL; Guyot-Revol V, 2006, AM J RESP CRIT CARE, V173, P803, DOI 10.1164/rccm.200508-1294OC; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; HU YF, 1990, GENE DEV, V4, P1741, DOI 10.1101/gad.4.10.1741; Huber JP, J IMMUNOL, V185, P813; Imai K, 2006, J BIOL CHEM, V281, P12495, DOI 10.1074/jbc.M511773200; Jaberipour M, 2011, MIDDLE EAST J CANCER, V2, P19; Keen LJ, 2002, TRANSPL IMMUNOL, V10, P143, DOI 10.1016/S0966-3274(02)00061-8; Keerthivasan S, 2007, GENE, V399, P129, DOI 10.1016/j.gene.2007.05.002; Kim JW, 2007, BIOCHEM BIOPH RES CO, V354, P517, DOI 10.1016/j.bbrc.2007.01.008; Knight JC, 2004, TRENDS GENET, V20, P113, DOI 10.1016/j.tig.2004.01.001; Letimier FA, 2007, EMBO J, V26, P1292, DOI 10.1038/sj.emboj.7601586; Liang L, 2011, FEMS IMMUNOL MED MIC, V62, P84, DOI 10.1111/j.1574-695X.2011.00791.x; Liu BS, 2011, BLOOD, V117, P2385, DOI 10.1182/blood-2010-07-298976; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma SL, 2010, NEUROBIOL AGING; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Matsui E, 1999, BIOCHEM BIOPH RES CO, V266, P551, DOI 10.1006/bbrc.1999.1859; MERMOD N, 1988, NATURE, V332, P557, DOI 10.1038/332557a0; Ohyama H, 2005, J CLIN PATHOL, V58, P740, DOI 10.1136/jcp.2004.023903; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rayamajhi M, 2010, J EXP MED, V207, P327, DOI 10.1084/jem.20091746; Rodriguez-Antona C, 2003, MOL PHARMACOL, V63, P1180, DOI 10.1124/mol.63.5.1180; Rogge L, 1997, J EXP MED, V185, P825, DOI 10.1084/jem.185.5.825; Rosenzweig SD, 2004, CLIN IMMUNOL, V112, P113, DOI 10.1016/j.clim.2004.03.018; SARMA GR, 1990, TUBERCLE, V71, P277; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200; Singhal A, 2007, INFECT IMMUN, V75, P2500, DOI 10.1128/IAI.01743-06; Smith AJP, 2009, CYTOKINE GROWTH F R, V20, P43, DOI 10.1016/j.cytogfr.2008.11.006; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Taha RA, 1999, AM J RESP CRIT CARE, V160, P1119, DOI 10.1164/ajrccm.160.4.9807120; Taha RA, 1997, AM J RESP CRIT CARE, V155, P1135, DOI 10.1164/ajrccm.155.3.9116999; Toh ML, 2009, CYTOKINE, V48, P226, DOI 10.1016/j.cyto.2009.07.013; van Deventer SJH, 2000, INTENS CARE MED, V26, pS98, DOI 10.1007/s001340051125; van Rietschoten JGI, 2004, TISSUE ANTIGENS, V63, P538, DOI 10.1111/j.0001-2815.2004.00223.x; van Rietschoten JGI, 2001, J BIOL CHEM, V276, P34509, DOI 10.1074/jbc.M102536200; Watford WT, 2003, CYTOKINE GROWTH F R, V14, P361, DOI 10.1016/S1359-6101(03)00043-1; Wu CY, 1998, J IMMUNOL, V161, P2723; Yagi R, 2011, INT IMMUNOL, V23, P415, DOI 10.1093/intimm/dxr029; Yim JJ, 2010, RESPIROLOGY, V15, P241, DOI 10.1111/j.1440-1843.2009.01690.x; Zaki MH, 2001, J INVEST DERMATOL, V117, P119, DOI 10.1046/j.0022-202x.2001.01354.x; Zhang M, 1999, J IMMUNOL, V162, P2441; Zhao Z, 2008, J IMMUNOL, V181, P3870, DOI 10.4049/jimmunol.181.6.3870	50	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34355	10.1371/journal.pone.0034355	http://dx.doi.org/10.1371/journal.pone.0034355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509293	gold, Green Published, Green Submitted			2022-12-27	WOS:000304805900026
J	Takala, H; Ylanne, J				Takala, Heikki; Ylanne, Jari			Binding Properties and Stability of the Ras-Association Domain of Rap1-GTP Interacting Adapter Molecule (RIAM)	PLOS ONE			English	Article							ACTIVATION; INTEGRINS; ENANASP; GTPASE; LIGAND; SIGNAL; SWITCH	The Rap1-GTP interacting adapter protein (RIAM) is an important protein in Rap1-mediated integrin activation. By binding to both Rap1 GTPase and talin, RIAM recruits talin to the cell membrane, thus facilitating talin-dependent integrin activation. In this article, we studied the role of the RIAM Ras-association (RA) and pleckstrin-homology (PH) domains in the interaction with Rap1. We found that the RA domain was sufficient for GTP-dependent interaction with Rap1B, and the addition of the PH domain did not change the binding affinity. We also detected GTP-independent interaction of Rap1B with the N-terminus of RIAM. In addition, we found that the PH domain stabilized the RA domain both in vitro and in cells.	[Takala, Heikki] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; Univ Jyvaskyla, Nanosci Ctr, Jyvaskyla, Finland	University of Jyvaskyla; University of Jyvaskyla	Takala, H (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	jylanne@jyu.fi	Takala, Heikki/GVT-1834-2022; Takala, Heikki/ABC-9139-2020	Takala, Heikki/0000-0003-2518-8583; Takala, Heikki/0000-0003-2518-8583; Ylanne, Jari/0000-0003-4627-021X	Academy of Finland [1147613, 138327]; Ellen and Artturi Nyyssonen Foundation	Academy of Finland(Academy of Finland); Ellen and Artturi Nyyssonen Foundation	This work was supported by Academy of Finland grant 1147613, 138327 to JY and by a fellowship from the Ellen and Artturi Nyyssonen Foundation to HT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boettner B, 2009, CURR OPIN CELL BIOL, V21, P684, DOI 10.1016/j.ceb.2009.06.004; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Brinkmann T, 2002, J BIOL CHEM, V277, P12525, DOI 10.1074/jbc.M109176200; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Chrzanowska-Wodnicka M, 2005, J CLIN INVEST, V115, P680, DOI 10.1172/JCI200522973; Depetris RS, 2009, NAT STRUCT MOL BIOL, V16, P833, DOI 10.1038/nsmb.1642; Filchtinski D, 2010, J MOL BIOL, V399, P422, DOI 10.1016/j.jmb.2010.03.046; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; HERRMANN C, 1995, J BIOL CHEM, V270, P2901, DOI 10.1074/jbc.270.7.2901; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jenzora A, 2005, FEBS LETT, V579, P455, DOI 10.1016/j.febslet.2004.10.110; Katagiri K, 2000, MOL CELL BIOL, V20, P1956, DOI 10.1128/MCB.20.6.1956-1969.2000; Kinbara K, 2003, NAT REV MOL CELL BIO, V4, P767, DOI 10.1038/nrm1229; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Lad Y, 2008, J BIOL CHEM, V283, P35154, DOI 10.1074/jbc.M802592200; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Menasche G, 2007, MOL CELL BIOL, V27, P4070, DOI 10.1128/MCB.02011-06; Miinalainen IJ, 2003, J BIOL CHEM, V278, P20154, DOI 10.1074/jbc.M302851200; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pentikainen U, 2011, J BIOL CHEM, V286, P26921, DOI 10.1074/jbc.M110.195958; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Sebzda E, 2002, NAT IMMUNOL, V3, P251, DOI 10.1038/ni765; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048	30	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e31955	10.1371/journal.pone.0031955	http://dx.doi.org/10.1371/journal.pone.0031955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523535	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000004
J	Wang, HJ; Tan, G; Dong, L; Cheng, L; Li, KJ; Wang, ZY; Luo, HF				Wang, Hongjiang; Tan, Guang; Dong, Lei; Cheng, Lei; Li, Kejun; Wang, Zhongyu; Luo, Haifeng			Circulating MiR-125b as a Marker Predicting Chemoresistance in Breast Cancer	PLOS ONE			English	Article							CHEMOTHERAPY RESPONSE; BAK1 EXPRESSION; TUMOR-CELLS; MICRORNA; RESISTANCE; BIOMARKERS; METASTASIS; GROWTH; RNA; SUPPRESSION	Background: Chemotherapy is an important component in the treatment paradigm for breast cancers. However, the resistance of cancer cells to chemotherapeutic agents frequently results in the subsequent recurrence and metastasis. Identification of molecular markers to predict treatment outcome is therefore warranted. The aim of the present study was to evaluate whether expression of circulating microRNAs (miRNAs) can predict clinical outcome in breast cancer patients treated with adjuvant chemotherapy. Methodology/Principal Findings: Circulating miRNAs in blood serum prior to treatment were determined by quantitative Real-Time PCR in 56 breast cancer patients with invasive ductal carcinoma and pre-operative neoadjuvant chemotherapy. Proliferating cell nuclear antigen (PCNA) immunostaining and TUNEL were performed in surgical samples to determine the effects of chemotherapy on cancer cell proliferation and apoptosis, respectively. Among the miRNAs tested, only miR-125b was significantly associated with therapeutic response, exhibiting higher expression level in non-responsive patients (n = 26, 46%; p = 0.008). In addition, breast cancers with high miR-125b expression had higher percentage of proliferating cells and lower percentage of apoptotic cells in the corresponding surgical specimens obtained after neoadjuvant chemotherapy. Increased resistance to anticancer drug was observed in vitro in breast cancer cells with ectopic miR-125b expression; conversely, reducing miR-125b level sensitized breast cancer cells to chemotherapy. Moreover, we demonstrated that the E2F3 was a direct target of miR-125b in breast cancer cells. Conclusions/Significance: These data suggest that circulating miR-125b expression is associated with chemotherapeutic resistance of breast cancer. This finding has important implications in the development of targeted therapeutics for overcoming chemotherapeutic resistance in novel anti-cancer strategies.	[Wang, Hongjiang; Tan, Guang; Dong, Lei; Cheng, Lei; Li, Kejun; Wang, Zhongyu; Luo, Haifeng] Dalian Med Univ, Affiliated Hosp 1, Dept Gen Surg, Dalian, Peoples R China	Dalian Medical University	Wang, HJ (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Dept Gen Surg, Dalian, Peoples R China.	hjwang@dlmedu.edu.cn			National Natural Science Foundation of China [81141098]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	These studies were supported, in part, by grants from the National Natural Science Foundation of China (No.81141098). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbato C, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/803069; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Bockmeyer CL, 2011, BREAST CANC RES TREA; Burger H, 2003, CLIN CANCER RES, V9, P827; CHEN LP, 1995, GYNECOL ONCOL, V56, P231; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Cho William C. S., 2011, Frontiers in Genetics, V2, P7, DOI 10.3389/fgene.2011.00007; Corcoran C, 2011, CLIN CHEM, V57, P18, DOI 10.1373/clinchem.2010.150730; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Faneyte IF, 2003, BRIT J CANCER, V88, P406, DOI 10.1038/sj.bjc.6600749; Feng N, 2011, MOL BIOL REP; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujita Y, 2008, BIOCHEM BIOPH RES CO, V377, P114, DOI 10.1016/j.bbrc.2008.09.086; Gebeshuber CA, 2009, EMBO REP, V10, P400, DOI 10.1038/embor.2009.9; Geisler S, 2003, CLIN CANCER RES, V9, P5582; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; Hartkopf AD, 2011, ANTICANCER RES, V31, P979; He M, 2011, BREAST CANCER RES TR, V126, P231, DOI 10.1007/s10549-010-1276-2; Heneghan HM, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2798; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kong W, 2010, J BIOL CHEM, V285, P17869, DOI 10.1074/jbc.M110.101055; Kovalchuk O, 2008, MOL CANCER THER, V7, P2152, DOI 10.1158/1535-7163.MCT-08-0021; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lange CA, 2011, ENDOCR-RELAT CANCER, V18, pC19, DOI 10.1530/ERC-11-0112; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Ma L, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2720; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Martinez LA, 2010, MOL CELL BIOL, V30, P524, DOI 10.1128/MCB.00938-09; Mudduluru G, 2011, ONCOGENE, V30, P2888, DOI 10.1038/onc.2011.13; Noonan EJ, 2011, MICRORNAS IN CANCER TRANSLATIONAL RESEARCH, P415, DOI 10.1007/978-94-007-0298-1_18; Ozek NS, 2010, ANALYST, V135, P3094, DOI 10.1039/c0an00543f; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Rajabi Hasan, 2010, Genes Cancer, V1, P62; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Scott GK, 2007, J BIOL CHEM, V282, P1479, DOI 10.1074/jbc.M609383200; Senderowicz AM, 2003, CANCER CHEMOTH PHARM, V52, pS61, DOI 10.1007/s00280-003-0624-x; Shi XB, 2007, P NATL ACAD SCI USA, V104, P19983, DOI 10.1073/pnas.0706641104; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Sieuwerts AM, 2011, CLIN CANCER RES, V17, P3600, DOI 10.1158/1078-0432.CCR-11-0255; Tan M, 2002, MOL CELL, V9, P993, DOI 10.1016/S1097-2765(02)00510-5; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tian S, 2010, BIOCHEM BIOPH RES CO, V396, P435, DOI 10.1016/j.bbrc.2010.04.112; Tordai A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2088; Veerla S, 2009, INT J CANCER, V124, P2236, DOI 10.1002/ijc.24183; Visone R, 2007, ONCOGENE, V26, P7590, DOI 10.1038/sj.onc.1210564; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Xia HF, 2009, CELL PHYSIOL BIOCHEM, V23, P347, DOI 10.1159/000218181; Yu DC, 2011, INT J MOL SCI, V12, P2055, DOI 10.3390/ijms12032055; Zhang Y, 2011, CANCER RES, V71, P3552, DOI 10.1158/0008-5472.CAN-10-2435; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200; Zhou M, 2010, J BIOL CHEM, V285, P21496, DOI 10.1074/jbc.M109.083337	57	49	62	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34210	10.1371/journal.pone.0034210	http://dx.doi.org/10.1371/journal.pone.0034210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523546	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345000015
J	Abere, B; Wikan, N; Ubol, S; Auewarakul, P; Paemanee, A; Kittisenachai, S; Roytrakul, S; Smith, DR				Abere, Bizunesh; Wikan, Nitwara; Ubol, Sukathida; Auewarakul, Prasert; Paemanee, Atchara; Kittisenachai, Suthathip; Roytrakul, Sittiruk; Smith, Duncan R.			Proteomic Analysis of Chikungunya Virus Infected Microgial Cells	PLOS ONE			English	Article							MICROGLIAL CELLS; IDENTIFICATION; TRANSLATION; PROTEINS; QUANTITATION; MACHINERY; SEQUENCE; BIOLOGY; HSP70; GENE	Chikungunya virus (CHIKV) is a recently re-emerged public health problem in many countries bordering the Indian Ocean and elsewhere. Chikungunya fever is a relatively self limiting febrile disease, but the consequences of chikungunya fever can include a long lasting, debilitating arthralgia, and occasional neurological involvement has been reported. Macrophages have been implicated as an important cell target of CHIKV with regards to both their role as an immune mediator, as well evidence pointing to long term viral persistence in these cells. Microglial cells are the resident brain macrophages, and so this study sought to define the proteomic changes in a human microglial cell line (CHME-5) in response to CHIKV infection. GeLC-MS/MS analysis of CHIKV infected and mock infected cells identified some 1455 individual proteins, of which 90 proteins, belonging to diverse cellular pathways, were significantly down regulated at a significance level of p<0.01. Analysis of the protein profile in response to infection did not support a global inhibition of either normal or IRES-mediated translation, but was consistent with the targeting of specific cellular pathways including those regulating innate antiviral mechanisms.	[Abere, Bizunesh; Wikan, Nitwara; Smith, Duncan R.] Mahidol Univ, Mol Pathol Lab, Inst Mol Biosci, Bangkok 10700, Thailand; [Ubol, Sukathida] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand; [Ubol, Sukathida; Auewarakul, Prasert; Smith, Duncan R.] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Bangkok 10700, Thailand; [Auewarakul, Prasert] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand; [Paemanee, Atchara; Kittisenachai, Suthathip; Roytrakul, Sittiruk] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol, Genome Inst, Pathum Thani, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC)	Abere, B (corresponding author), Mahidol Univ, Mol Pathol Lab, Inst Mol Biosci, Bangkok 10700, Thailand.	sittiruk@biotec.or.th; duncan_r_smith@hotmail.com	Wikan, Nitwara/V-9296-2017; Abere, Bizunesh/ABF-9220-2021; Smith, Duncan R/C-6891-2011; Wikan, Nitwara/GSN-6014-2022	Wikan, Nitwara/0000-0002-0708-0328; Abere, Bizunesh/0000-0002-1857-4374; Smith, Duncan R/0000-0002-6592-9852; Wikan, Nitwara/0000-0002-0708-0328; Auewarakul, Prasert/0000-0002-4745-4291; Paemanee, Atchara/0000-0001-9206-3153	Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Mahidol University; Ethiopian Ministry of Agriculture and Rural Development through the Rural Capacity Building Project; TRF; Mahidol University (Thai Royal Golden Jubilee) Scholarship	Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Mahidol University; Ethiopian Ministry of Agriculture and Rural Development through the Rural Capacity Building Project; TRF(Thailand Research Fund (TRF)); Mahidol University (Thai Royal Golden Jubilee) Scholarship	This work was supported by grants from the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative and Mahidol University. BA is supported by the Ethiopian Ministry of Agriculture and Rural Development through the Rural Capacity Building Project. NW is supported by a TRF and Mahidol University (Thai Royal Golden Jubilee) Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIKAT BK, 1964, INDIAN J MED RES, V52, P660; Bernard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011479; Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005; Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Bordi L, 2008, CLIN INFECT DIS, V47, P428, DOI 10.1086/589925; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Cherian SS, 2009, INFECT GENET EVOL, V9, P16, DOI 10.1016/j.meegid.2008.09.004; Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003; Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029; Das T, 2010, PROG NEUROBIOL, V91, P121, DOI 10.1016/j.pneurobio.2009.12.006; Dhanwani R, 2011, PROTEOMICS, V11, P1936, DOI 10.1002/pmic.201000500; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Fros JJ, 2010, J VIROL, V84, P10877, DOI 10.1128/JVI.00949-10; Ganesan K, 2008, AM J NEURORADIOL, V29, P1636, DOI 10.3174/ajnr.A1133; Garmashova N, 2007, J VIROL, V81, P2472, DOI 10.1128/JVI.02073-06; Garmashova N, 2006, J VIROL, V80, P5686, DOI 10.1128/JVI.02739-05; Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060; Gorchakov R, 2004, J VIROL, V78, P8455, DOI 10.1128/JVI.78.16.8455-8467.2004; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; HAGA S, 1989, ACTA NEUROPATHOL, V77, P569, DOI 10.1007/BF00687883; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Her ZS, 2010, J IMMUNOL, V184, P5903, DOI 10.4049/jimmunol.0904181; Jaffar-Bandjee MC, 2010, EXPERT REV ANTI-INFE, V8, P987, DOI [10.1586/eri.10.92, 10.1586/ERI.10.92]; JANABI N, 1995, NEUROSCI LETT, V195, P105, DOI 10.1016/0304-3940(94)11792-H; Johansson C, 2006, PROTEOMICS, V6, P4475, DOI 10.1002/pmic.200500921; Khan AH, 2002, J GEN VIROL, V83, P3075, DOI 10.1099/0022-1317-83-12-3075; Kmiec Z, 2001, ADV ANAT EMBRYOL CEL, V161, P1; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Krejbich-Trotot P, 2011, FASEB J, V25, P314, DOI 10.1096/fj.10-164178; Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104; Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646; Lenglet Y, 2006, J Gynecol Obstet Biol Reprod (Paris), V35, P578; Li G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016546; Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003; Negro F, 2010, GUT, V59, P1279, DOI 10.1136/gut.2009.192732; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X; Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471; Pratt WB, 2003, EXP BIOL MED, V228, P111, DOI 10.1177/153537020322800201; Pulmanausahakul R, 2011, INT J INFECT DIS, V15, pE671, DOI 10.1016/j.ijid.2011.06.002; Ray PS, 2006, EMBO REP, V7, P404, DOI 10.1038/sj.embor.7400623; ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(57)90022-6, 10.1016/0035-9203(55)90080-8]; ROSS R. W., 1956, JOUR HYG, V54, P177; Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025; Rubtsova MP, 2003, J BIOL CHEM, V278, P22350, DOI 10.1074/jbc.M303213200; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; SARKAR JK, 1964, INDIAN J MED RES, V52, P684; Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368; Shin-Ya M, 2005, BIOCHEM BIOPH RES CO, V329, P1139, DOI 10.1016/j.bbrc.2005.02.088; Simmons JD, 2010, J VIROL, V84, P11429, DOI 10.1128/JVI.00577-10; Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024; Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089; Soussi T, 2000, ANN NY ACAD SCI, V910, P121; Sudeep AB, 2008, J BIOSCIENCES, V33, P443, DOI 10.1007/s12038-008-0063-2; Swaminathan S, 1996, VIROLOGY, V219, P321, DOI 10.1006/viro.1996.0255; Thepparit C, 2010, MICROBIOL-SGM, V156, P2855, DOI 10.1099/mic.0.041400-0; Thongtan T, 2010, MICROBES INFECT, V12, P37, DOI 10.1016/j.micinf.2009.09.013; Thorsell A, 2007, RAPID COMMUN MASS SP, V21, P771, DOI 10.1002/rcm.2898; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; White LK, 2011, J VIROL, V85, P606, DOI 10.1128/JVI.00767-10; Wikan N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031102; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	64	50	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34800	10.1371/journal.pone.0034800	http://dx.doi.org/10.1371/journal.pone.0034800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514668	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600074
J	Byers, SL; Wiles, MV; Dunn, SL; Taft, RA				Byers, Shannon L.; Wiles, Michael V.; Dunn, Sadie L.; Taft, Robert A.			Mouse Estrous Cycle Identification Tool and Images	PLOS ONE			English	Article							MICE; CYCLICITY; VAGINA	The efficiency of producing timed pregnant or pseudopregnant mice can be increased by identifying those in proestrus or estrus. Visual observation of the vagina is the quickest method, requires no special equipment, and is best used when only proestrus or estrus stages need to be identified. Strain to strain differences, especially in coat color can make it difficult to determine the stage of the estrous cycle accurately by visual observation. Presented here are a series of images of the vaginal opening at each stage of the estrous cycle for 3 mouse strains of different coat colors: black (C57BL/6J), agouti (CByB6F1/J) and albino (BALB/cByJ). When all 4 stages (proestrus, estrus, metestrus, and diestrus) need to be identified, vaginal cytology is regarded as the most accurate method. An identification tool is presented to aid the user in determining the stage of estrous when using vaginal cytology. These images and descriptions are an excellent resource for learning how to determine the stage of the estrous cycle by visual observation or vaginal cytology.	[Byers, Shannon L.; Dunn, Sadie L.; Taft, Robert A.] Jackson Lab, Reprod Sci R&D, Bar Harbor, ME 04609 USA	Jackson Laboratory	Byers, SL (corresponding author), Jackson Lab, Reprod Sci R&D, 600 Main St, Bar Harbor, ME 04609 USA.	rob.taft@jax.org		Taft, Robert/0000-0002-3634-3342; wiles, michael/0000-0002-3620-8386				Achiraman S, 2011, ZOOL SCI, V28, P600, DOI 10.2108/zsj.28.600; Allen E, 1922, AM J ANAT, V30, P297, DOI 10.1002/aja.1000300303; BRONSON FH, 1966, BIOL LABORATORY MOUS, P187; Caligioni CS., 2009, ASSESSING REPROD STA; CHAMPLIN AK, 1973, BIOL REPROD, V8, P491, DOI 10.1093/biolreprod/8.4.491; FELICIO LS, 1984, BIOL REPROD, V31, P446, DOI 10.1095/biolreprod31.3.446; Green E. L., 1968, BIOL LAB MOUSE; NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327; Ramos SD, 2001, J APPL PHYSIOL, V91, P667, DOI 10.1152/jappl.2001.91.2.667; SNELL GD, 1966, BIOL LAB MOUSE	10	574	590	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35538	10.1371/journal.pone.0035538	http://dx.doi.org/10.1371/journal.pone.0035538			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514749	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600154
J	Duarte, JMN; Agostinho, PM; Carvalho, RA; Cunha, RA				Duarte, Joao M. N.; Agostinho, Paula M.; Carvalho, Rui A.; Cunha, Rodrigo A.			Caffeine Consumption Prevents Diabetes-Induced Memory Impairment and Synaptotoxicity in the Hippocampus of NONcZNO10/LTJ Mice	PLOS ONE			English	Article							ADENOSINE A(2A) RECEPTORS; VESICULAR GLUTAMATE TRANSPORTERS; RECOGNITION MEMORY; ALZHEIMER-DISEASE; ANIMAL-MODELS; ANTAGONISTS; PATHOLOGY; RATS; DEFICITS; NEUROINFLAMMATION	Diabetic conditions are associated with modified brain function, namely with cognitive deficits, through largely undetermined processes. More than understanding the underlying mechanism, it is important to devise novel strategies to alleviate diabetes-induced cognitive deficits. Caffeine (a mixed antagonist of adenosine A(1) and A(2A) receptors) emerges as a promising candidate since caffeine consumption reduces the risk of diabetes and effectively prevents memory deficits caused by different noxious stimuli. Thus, we took advantage of a novel animal model of type 2 diabetes to investigate the behavioural, neurochemical and morphological modifications present in the hippocampus and tested if caffeine consumption might prevent these changes. We used a model closely mimicking the human type 2 diabetes condition, NONcNZO10/LtJ mice, which become diabetic at 7-11 months when kept under an 11% fat diet. Caffeine (1 g/l) was applied in the drinking water from 7 months onwards. Diabetic mice displayed a decreased spontaneous alternation in the Y-maze accompanied by a decreased density of nerve terminal markers (synaptophysin, SNAP25), mainly glutamatergic (vesicular glutamate transporters), and increased astrogliosis (GFAP immunoreactivity) compared to their wild type littermates kept under the same diet. Furthermore, diabetic mice displayed up-regulated A(2A) receptors and down-regulated A1 receptors in the hippocampus. Caffeine consumption restored memory performance and abrogated the diabetes-induced loss of nerve terminals and astrogliosis. These results provide the first evidence that type 2 diabetic mice display a loss of nerve terminal markers and astrogliosis, which is associated with memory impairment; furthermore, caffeine consumption prevents synaptic dysfunction and astrogliosis as well as memory impairment in type 2 diabetes.	[Duarte, Joao M. N.; Agostinho, Paula M.; Carvalho, Rui A.; Cunha, Rodrigo A.] Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal; [Duarte, Joao M. N.; Carvalho, Rui A.] Univ Coimbra, Fac Sci & Technol, Dept Life Sci, Coimbra, Portugal; [Agostinho, Paula M.; Cunha, Rodrigo A.] Univ Coimbra, Fac Med, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra; Universidade de Coimbra	Duarte, JMN (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal.	cunharod@gmail.com	Carvalho, Rui A/A-6661-2010; Agostinho, Paula/F-3748-2010; Cunha, Rodrigo A/E-7475-2015; Duarte, João M.N./H-4887-2012	Carvalho, Rui A/0000-0003-1820-0353; Agostinho, Paula/0000-0001-5523-4945; Cunha, Rodrigo A/0000-0003-2550-6422; Duarte, João M.N./0000-0001-5984-1574	Fundacao para a Ciencia e a Tecnologia [POCTI/SAU-NEU/56098/2004, POCI/SAU-FCF/59601/2004]; Fundacao Oriente	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundacao Oriente	This work is supported by Fundacao para a Ciencia e a Tecnologia (POCTI/SAU-NEU/56098/2004, POCI/SAU-FCF/59601/2004) and Fundacao Oriente. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendash GW, 2006, NEUROSCIENCE, V142, P941, DOI 10.1016/j.neuroscience.2006.07.021; Bell KFS, 2006, NEUROBIOL AGING, V27, P1644, DOI 10.1016/j.neurobiolaging.2005.09.034; Biessels GJ, 2010, J ALZHEIMERS DIS, V20, pS143, DOI 10.3233/JAD-2010-091228; Biessels GJ, 2005, NEUROBIOL AGING, V26, pS36, DOI 10.1016/j.neurobiolaging.2005.08.015; Boison D, 2010, CELL DEATH DIFFER, V17, P1071, DOI 10.1038/cdd.2009.131; Boison D, 2008, PROG NEUROBIOL, V84, P249, DOI 10.1016/j.pneurobio.2007.12.002; Brothers HM, 2010, NEUROSCI LETT, V480, P97, DOI 10.1016/j.neulet.2010.06.013; Canas PM, 2009, J NEUROSCI, V29, P14741, DOI 10.1523/JNEUROSCI.3728-09.2009; Cerqueira V, 2006, NEUROPHYSIOL CLIN, V36, P219, DOI 10.1016/j.neucli.2006.08.005; Chen JF, 2007, PROG NEUROBIOL, V83, P310, DOI 10.1016/j.pneurobio.2007.09.002; Chen XS, 2010, J ALZHEIMERS DIS, V20, pS127, DOI 10.3233/JAD-2010-1376; Cho YR, 2007, AM J PHYSIOL-ENDOC M, V293, pE327, DOI 10.1152/ajpendo.00376.2006; Cognato GP, 2010, J NEUROCHEM, V112, P453, DOI 10.1111/j.1471-4159.2009.06465.x; Coleman P, 2004, NEUROLOGY, V63, P1155, DOI 10.1212/01.WNL.0000140626.48118.0A; Convit A, 2003, P NATL ACAD SCI USA, V100, P2019, DOI 10.1073/pnas.0336073100; Costa MS, 2008, NEUROSCIENCE, V153, P1071, DOI 10.1016/j.neuroscience.2008.03.038; Costenla AR, 2010, J ALZHEIMERS DIS, V20, pS25, DOI 10.3233/JAD-2010-091384; Cunha GMA, 2006, NEUROSCIENCE, V141, P1775, DOI 10.1016/j.neuroscience.2006.05.024; Cunha Rodrigo A, 2005, Purinergic Signal, V1, P111, DOI 10.1007/s11302-005-0649-1; Cunha RA, 2010, J ALZHEIMERS DIS, V20, pS95, DOI 10.3233/JAD-2010-1408; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Dall'Igna OP, 2007, EXP NEUROL, V203, P241, DOI 10.1016/j.expneurol.2006.08.008; Dare E, 2007, PHYSIOL BEHAV, V92, P15, DOI 10.1016/j.physbeh.2007.05.031; Duarte JMN, 2006, NEUROCHEM INT, V48, P144, DOI 10.1016/j.neuint.2005.08.008; Duarte JMN, 2009, J NEUROCHEM, V111, P368, DOI 10.1111/j.1471-4159.2009.06349.x; Eid T, 2008, EPILEPSIA, V49, P42, DOI 10.1111/j.1528-1167.2008.01492.x; Fredholm BB, 2005, INT REV NEUROBIOL, V63, P191, DOI 10.1016/S0074-7742(05)63007-3; Fuhrmann M, 2007, J NEUROSCI, V27, P6224, DOI 10.1523/JNEUROSCI.5062-06.2007; Garden GA, 2002, J NEUROSCI, V22, P4015, DOI 10.1523/JNEUROSCI.22-10-04015.2002; Gaspar JM, 2010, NEUROSCIENCE, V169, P1589, DOI 10.1016/j.neuroscience.2010.06.021; Gevaerd MS, 2001, BRAIN RES BULL, V55, P101, DOI 10.1016/S0361-9230(01)00501-9; Glantz LA, 2006, SCHIZOPHR RES, V81, P47, DOI 10.1016/j.schres.2005.08.014; Gold SM, 2007, DIABETOLOGIA, V50, P711, DOI 10.1007/s00125-007-0602-7; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Kirvell SL, 2006, J NEUROCHEM, V98, P939, DOI 10.1111/j.1471-4159.2006.03935.x; Lebed YV, 2008, NEUROSCI LETT, V444, P181, DOI 10.1016/j.neulet.2008.07.094; Leiter EH, 2004, DIABETES, V53, pS4, DOI 10.2337/diabetes.53.2007.S4; Li H, 2001, J NEUROSCI, V21, P8473, DOI 10.1523/JNEUROSCI.21-21-08473.2001; Maia L, 2002, EUR J NEUROL, V9, P377, DOI 10.1046/j.1468-1331.2002.00421.x; Matos M, 2012, GLIA, V60, P702, DOI 10.1002/glia.22290; Minkeviciene R, 2008, J NEUROCHEM, V105, P584, DOI 10.1111/j.1471-4159.2007.05147.x; Ortinski PI, 2010, NAT NEUROSCI, V13, P584, DOI 10.1038/nn.2535; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pires VA, 2009, BEHAV PHARMACOL, V20, P134, DOI 10.1097/FBP.0b013e32832a80bf; Prediger RDS, 2005, NEUROBIOL AGING, V26, P957, DOI 10.1016/j.neurobiolaging.2004.08.012; Rebola N, 2005, NEUROSCIENCE, V132, P893, DOI 10.1016/j.neuroscience.2005.01.014; Rebola N, 2008, NEURON, V57, P121, DOI 10.1016/j.neuron.2007.11.023; Rebola N, 2011, J NEUROCHEM, V117, P100, DOI 10.1111/j.1471-4159.2011.07178.x; Rodrigues RJ, 2008, NEUROBIOL AGING, V29, P1597, DOI 10.1016/j.neurobiolaging.2007.03.025; Rodrigues RJ, 2005, J NEUROSCI, V25, P6286, DOI 10.1523/JNEUROSCI.0628-05.2005; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; Silva CG, 2007, NEUROBIOL DIS, V27, P182, DOI 10.1016/j.nbd.2007.04.018; Spinetta MJ, 2008, PSYCHOPHARMACOLOGY, V201, P361, DOI 10.1007/s00213-008-1294-5; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Takahashi RN, 2008, FRONT BIOSCI-LANDMRK, V13, P2614, DOI 10.2741/2870; van Dam RM, 2005, JAMA-J AM MED ASSOC, V294, P97, DOI 10.1001/jama.294.1.97; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4; Yu LQ, 2008, ANN NEUROL, V63, P338, DOI 10.1002/ana.21313	58	96	99	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e21899	10.1371/journal.pone.0021899	http://dx.doi.org/10.1371/journal.pone.0021899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514596	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600001
J	Jedynak, JP; Cameron, CM; Robinson, TE				Jedynak, Jakub P.; Cameron, Courtney M.; Robinson, Terry E.			Repeated Methamphetamine Administration Differentially Alters Fos Expression in Caudate-Putamen Patch and Matrix Compartments and Nucleus Accumbens	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; DOPAMINE-DEFICIENT MICE; BEHAVIORAL SENSITIZATION; ENVIRONMENTAL CONTEXT; DORSAL STRIATUM; BASAL GANGLIA; RAT STRIATUM; AUTORADIOGRAPHIC LOCALIZATION; OPIATE RECEPTOR; AMPHETAMINE	Background: The repeated administration of psychostimulant drugs produces a persistent and long-lasting increase ("sensitization") in their psychomotor effects, which is thought to be due to changes in the neural circuitry that mediate these behaviors. One index of neuronal activation used to identify brain regions altered by repeated exposure to drugs involves their ability to induce immediate early genes, such as c-fos. Numerous reports have demonstrated that past drug experience alters the ability of drugs to induce c-fos in the striatum, but very few have examined Fos protein expression in the two major compartments in the striatum-the so-called patch/striosome and matrix. Methodology/Principal Findings: In the present study, we used immunohistochemistry to investigate the effects of pretreatment with methamphetamine on the ability of a subsequent methamphetamine challenge to induce Fos protein expression in the patch and matrix compartments of the dorsolateral and dorsomedial caudate-putamen and in the ventral striatum (nucleus accumbens). Animals pretreated with methamphetamine developed robust psychomotor sensitization. A methamphetamine challenge increased the number of Fos-positive cells in all areas of the dorsal and ventral striatum. However, methamphetamine challenge induced Fos expression in more cells in the patch than in the matrix compartment in the dorsolateral and dorsomedial caudate-putamen. Furthermore, past experience with methamphetamine increased the number of methamphetamine-induced Fos positive cells in the patch compartment of the dorsal caudate putamen, but not in the matrix or in the core or shell of the nucleus accumbens. Conclusions/Significance: These data suggest that drug-induced alterations in the patch compartment of the dorsal caudate-putamen may preferentially contribute to some of the enduring changes in brain activity and behavior produced by repeated treatment with methamphetamine.	[Jedynak, Jakub P.; Robinson, Terry E.] Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA; [Cameron, Courtney M.; Robinson, Terry E.] Univ Michigan, Dept Psychol, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jedynak, JP (corresponding author), Univ Michigan, Neurosci Program, Ann Arbor, MI 48109 USA.	jjedynak@umn.edu		Jedynak, Jakub/0000-0001-7291-3632	National Institute on Drug Abuse [R37 DA04294, F31 DA01920]; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA004294, T32DA007281] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Grants from the National Institute on Drug Abuse (R37 DA04294 and F31 DA01920) to TER and JPJ supported this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiani A, 1999, BEHAV BRAIN RES, V103, P203, DOI 10.1016/S0166-4328(99)00041-8; Badiani A, 2004, BEHAV PHARMACOL, V15, P327, DOI 10.1097/00008877-200409000-00004; BADIANI A, 1995, BRAIN RES, V674, P291, DOI 10.1016/0006-8993(95)00028-O; BADIANI A, 1995, PSYCHOPHARMACOLOGY, V117, P443, DOI 10.1007/BF02246217; Badiani A, 1998, J NEUROSCI, V18, P10579; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Canales JJ, 2000, NAT NEUROSCI, V3, P377, DOI 10.1038/73949; Castner SA, 1996, BRAIN RES, V712, P245, DOI 10.1016/0006-8993(95)01429-2; Corbit LH, 2007, J NEUROSCI, V27, P13977, DOI 10.1523/JNEUROSCI.4097-07.2007; Crittenden JR, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00059; Crombag HS, 2002, BEHAV BRAIN RES, V136, P455, DOI 10.1016/S0166-4328(02)00196-1; D'Souza DN, 2002, J APPL PHYSIOL, V92, P493, DOI 10.1152/japplphysiol.00565.2001; DRAGUNOW M, 1991, EUR J PHARM-MOLEC PH, V206, P255, DOI 10.1016/S0922-4106(05)80027-6; Flagel SB, 2007, BEHAV PHARMACOL, V18, P297, DOI 10.1097/FBP.0b013e3281f522a4; Fujiyama F, 2011, EUR J NEUROSCI, V33, P668, DOI 10.1111/j.1460-9568.2010.07564.x; GERFEN CR, 1985, J COMP NEUROL, V236, P454, DOI 10.1002/cne.902360404; GERFEN CR, 1987, J NEUROSCI, V7, P3915; GERFEN CR, 1985, P NATL ACAD SCI USA, V82, P8780, DOI 10.1073/pnas.82.24.8780; GERFEN CR, 1984, NATURE, V311, P461, DOI 10.1038/311461a0; GERFEN CR, 1989, SCIENCE, V246, P385, DOI 10.1126/science.2799392; Goodwin JS, 2008, J BIOL CHEM; GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723, DOI 10.1073/pnas.75.11.5723; GRAYBIEL AM, 1990, P NATL ACAD SCI USA, V87, P6912, DOI 10.1073/pnas.87.17.6912; GROENEWEGEN HJ, 1987, NEUROSCIENCE, V23, P103, DOI 10.1016/0306-4522(87)90275-2; Iadarola M J, 1993, NIDA Res Monogr, V125, P181; KANENO S, 1981, EUR J PHARMACOL, V72, P101, DOI 10.1016/0014-2999(81)90304-6; Kincaid AE, 1996, J COMP NEUROL, V374, P578; Kolb B, 2003, P NATL ACAD SCI USA, V100, P10523, DOI 10.1073/pnas.1834271100; Koshimizu Y, 2008, EUR J NEUROSCI, V28, P2053, DOI 10.1111/j.1460-9568.2008.06502.x; KREBS MO, 1991, J NEUROSCI, V11, P1256; Levesque M, 2005, P NATL ACAD SCI USA, V102, P11888, DOI 10.1073/pnas.0502710102; Mattson BJ, 2007, BEHAV BRAIN RES, V185, P88, DOI 10.1016/j.bbr.2007.07.024; Miura M, 2007, J NEUROSCI, V27, P9721, DOI 10.1523/JNEUROSCI.2993-07.2007; NISHIKAWA T, 1983, EUR J PHARMACOL, V88, P195, DOI 10.1016/0014-2999(83)90006-7; NORMAN AB, 1993, BRAIN RES, V603, P125, DOI 10.1016/0006-8993(93)91308-F; Ostrander MM, 2003, NEUROSCIENCE, V120, P551, DOI 10.1016/S0306-4522(03)00247-1; PAULSON PE, 1991, PSYCHOPHARMACOLOGY, V103, P480, DOI 10.1007/BF02244248; PERT CB, 1975, LIFE SCI, V16, P1849, DOI 10.1016/0024-3205(75)90289-1; PERT CB, 1976, P NATL ACAD SCI USA, V73, P3729, DOI 10.1073/pnas.73.10.3729; RAGSDALE CW, 1988, J COMP NEUROL, V269, P506, DOI 10.1002/cne.902690404; Robinson S, 2007, PSYCHOPHARMACOLOGY, V191, P567, DOI 10.1007/s00213-006-0579-9; ROBINSON TE, 1986, BRAIN RES REV, V11, P157, DOI 10.1016/0165-0173(86)90002-0; Segal DS, 1997, J PHARMACOL EXP THER, V282, P561; SNYDERKELLER AM, 1991, EXP NEUROL, V113, P155, DOI 10.1016/0014-4886(91)90171-8; Szczypka MS, 2001, NEURON, V30, P819, DOI 10.1016/S0896-6273(01)00319-1; Uslaner J, 2001, EUR J NEUROSCI, V13, P1977, DOI 10.1046/j.0953-816x.2001.01574.x; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; Vanderschuren LJMJ, 2002, EUR J NEUROSCI, V16, P2462, DOI 10.1046/j.1460-9568.2002.02308.x; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; White NM, 1998, P NATL ACAD SCI USA, V95, P6486, DOI 10.1073/pnas.95.11.6486; Wright CI, 1996, J NEUROSCI, V16, P1877; YOUNG ST, 1991, P NATL ACAD SCI USA, V88, P1291, DOI 10.1073/pnas.88.4.1291; Zhang JH, 2006, J NEUROSCI, V26, P13287, DOI 10.1523/JNEUROSCI.3795-06.2006	53	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34227	10.1371/journal.pone.0034227	http://dx.doi.org/10.1371/journal.pone.0034227			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514626	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600031
J	Ji, PF; Liu, GM; Xu, J; Wang, XM; Li, JT; Zhao, ZX; Zhang, XF; Zhang, Y; Xu, P; Sun, XW				Ji, Peifeng; Liu, Guiming; Xu, Jian; Wang, Xumin; Li, Jiongtang; Zhao, Zixia; Zhang, Xiaofeng; Zhang, Yan; Xu, Peng; Sun, Xiaowen			Characterization of Common Carp Transcriptome: Sequencing, De Novo Assembly, Annotation and Comparative Genomics	PLOS ONE			English	Article							CYPRINUS-CARPIO; EXPRESSION ANALYSIS; CHANNEL CATFISH; GENE-EXPRESSION; EST SEQUENCES; GENERATION; MARKERS; FAMILY; LOCI; TAGS	Background: Common carp (Cyprinus carpio) is one of the most important aquaculture species of Cyprinidae with an annual global production of 3.4 million tons, accounting for nearly 14% of the freshwater aquaculture production in the world. Due to the economical and ecological importance of common carp, genomic data are eagerly needed for genetic improvement purpose. However, there is still no sufficient transcriptome data available. The objective of the project is to sequence transcriptome deeply and provide well-assembled transcriptome sequences to common carp research community. Result: Transcriptome sequencing of common carp was performed using Roche 454 platform. A total of 1,418,591 clean ESTs were collected and assembled into 36,811 cDNA contigs, with average length of 888 bp and N50 length of 1,002 bp. Annotation was performed and a total of 19,165 unique proteins were identified from assembled contigs. Gene ontology and KEGG analysis were performed and classified all contigs into functional categories for understanding gene functions and regulation pathways. Open Reading Frames (ORFs) were detected from 29,869 (81.1%) contigs with an average ORF length of 763 bp. From these contigs, 9,625 full-length cDNAs were identified with sequence length from 201 bp to 9,956 bp. Comparative analysis revealed that 27,693(75.2%) contigs have significant similarity to zebrafish Refseq proteins, and 24,371(66.2%), 24,501(66.5%) and 25,025(70.0%) to teraodon, medaka and three-spined stickleback refseq proteins. A total of 2,064 microsatellites were initially identified from 1,730 contigs, and 1,639 unique sequences had sufficient flanking sequences on both sides for primer design. Conclusion: The transcriptome of common carp had been deep sequenced, de novo assembled and characterized, providing the valuable resource for better understanding of common carp genome. The transcriptome data will facilitate future functional studies on common carp genome, and gradually apply in breeding programs of common carp, as well as closely related other Cyprinids.	[Ji, Peifeng; Xu, Jian; Li, Jiongtang; Zhao, Zixia; Zhang, Yan; Xu, Peng; Sun, Xiaowen] Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Liu, Guiming; Wang, Xumin] Chinese Acad Sci, Beijing Inst Genom, CAS Key Lab Genome Sci & Informat, Beijing, Peoples R China; [Zhang, Xiaofeng; Sun, Xiaowen] Chinese Acad Fishery Sci, Heilongjiang Fisheries Res Inst, Harbin, Peoples R China	Chinese Academy of Fishery Sciences; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS	Ji, PF (corresponding author), Chinese Acad Fishery Sci, Ctr Appl Aquat Genom, Beijing, Peoples R China.	xupeng@cafs.ac.cn; sunxw2002@163.com	Zhao, Zi-Xia/AAM-8065-2021; wang, xumin/HII-8627-2022; Sun, Xiaowen/F-1516-2014; Xu, Jian/H-5349-2019; Xu, Peng/J-4018-2012	Zhao, Zi-Xia/0000-0003-1099-3387; Xu, Jian/0000-0003-0274-4268; Xu, Peng/0000-0002-1531-5078	National Department Public Benefit Research Foundation [200903045]; National High-tech R&D Program of China [2011AA100401]; National Natural Science Foundation of China [31101893]	National Department Public Benefit Research Foundation; National High-tech R&D Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from National Department Public Benefit Research Foundation (No. 200903045), National High-tech R&D Program of China (2011AA100401), and National Natural Science Foundation of China (No. 31101893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernathy JW, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-176; Cheng L, 2010, ANIM GENET, V41, P191, DOI 10.1111/j.1365-2052.2009.01985.x; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; FAO, 2007, STAT WORLD FISH AQ 2; Hale MC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-404; Hampton M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027021; He SP, 2008, MOL PHYLOGENET EVOL, V46, P818, DOI 10.1016/j.ympev.2007.06.001; Hou R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021560; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jung H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027938; Kongchum P, 2010, FISH SHELLFISH IMMUN, V29, P356, DOI 10.1016/j.fsi.2010.04.013; Kroupova H, 2010, ENVIRON TOXICOL CHEM, V29, P535, DOI 10.1002/etc.84; Kulhanek SA, 2011, ECOL APPL, V21, P203, DOI 10.1890/09-1639.1; Kumar S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-571; Li Y, 2011, MAR BIOTECHNOL, V13, P706, DOI 10.1007/s10126-010-9332-9; Liu D, 2010, MAR BIOTECHNOL, V12, P186, DOI 10.1007/s10126-009-9212-3; Mao Rui-Xin, 2009, Yichuan, V31, P407, DOI 10.3724/SP.J.1005.2009.00407; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW669, DOI 10.1093/nar/gki436; Moens LN, 2007, J BIOCHEM MOL TOXIC, V21, P299, DOI 10.1002/jbt.20190; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Nandi S, 2007, GENETICA, V131, P81, DOI 10.1007/s10709-006-9115-4; Sha Z, 2008, MOL IMMUNOLOGY; Sun X, 2004, AQUACULTURE, V238, P8; THURSTON MI, 2005, MSATFINDER DETECTION; Van Campenhout K, 2009, ENVIRON TOXICOL CHEM, V28, P209, DOI 10.1897/08-136.1; Wan Y, 2011, MOL BIOL REP, P1; Wang CH, 2004, AQUACULTURE, V231, P83, DOI 10.1016/j.aquaculture.2003.10.040; Wang D, 2007, AQUACULTURE, V271, P558, DOI 10.1016/j.aquaculture.2007.06.001; Wang Q, 2006, MOL IMMUNOL, V43, P1676, DOI 10.1016/j.molimm.2005.09.023; Wang SL, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r8; Williams DR, 2008, J FISH BIOL, V72, P2095, DOI 10.1111/j.1095-8649.2008.01875.x; Xu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021057; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-537; Xu P, 2011, MAR BIOTECHNOL, V13, P215, DOI 10.1007/s10126-010-9283-1; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Yan XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030925; Zhang Ya-Qin, 2011, Medical Mycology, V49, P435, DOI 10.3109/13693786.2010.540723; Zhang Y, 2008, J GENET GENOMICS, V35, P97, DOI 10.1016/S1673-8527(08)60015-6; Zhou Jianfeng, 2004, Genetika, V40, P1389	40	109	119	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35152	10.1371/journal.pone.0035152	http://dx.doi.org/10.1371/journal.pone.0035152			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514716	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600122
J	Liapis, A; Chen, FW; Davies, JP; Wang, R; Ioannou, YA				Liapis, Anastasia; Chen, Fannie W.; Davies, Joanna P.; Wang, Rong; Ioannou, Yiannis A.			MLN64 Transport to the Late Endosome Is Regulated by Binding to 14-3-3 via a Non-canonical Binding Site	PLOS ONE			English	Article							MEMBRANE-PROTEINS; ENDOPLASMIC-RETICULUM; NUCLEAR-LOCALIZATION; START DOMAIN; EXOENZYME-S; CHOLESTEROL; CELLS; PHOSPHORYLATION; MITOCHONDRIA; ORGANELLES	MLN64 is an integral membrane protein localized to the late endosome and plasma membrane that is thought to function as a mediator of cholesterol transport from endosomal membranes to the plasma membrane and/or mitochondria. The protein consists of two distinct domains: an N-terminal membrane-spanning domain that shares homology with the MENTHO protein and a C-terminal steroidogenic acute regulatory protein (StAR)-related lipid transfer (START) domain that binds cholesterol. To further characterize the MLN64 protein, full-length and truncated proteins were overexpressed in cells and the effects on MLN64 trafficking and endosomal morphology were observed. To gain insight into MLN64 function, affinity chromatography and mass spectrometric techniques were used to identify potential MLN64 interacting partners. Of the 15 candidate proteins identified, 14-3-3 was chosen for further characterization. We show that MLN64 interacts with 14-3-3 in vitro as well as in vivo and that the strength of the interaction is dependent on the 14-3-3 isoform. Furthermore, blocking the interaction through the use of a 14-3-3 antagonist or MLN64 mutagenesis delays the trafficking of MLN64 to the late endosome and also results in the dispersal of endocytic vesicles to the cell periphery. Taken together, these studies have determined that MLN64 is a novel 14-3-3 binding protein and indicate that 14-3-3 plays a role in the endosomal trafficking of MLN64. Furthermore, these studies suggest that 14-3-3 may be the link by which MLN64 exerts its effects on the actin-mediated endosome dynamics.	[Liapis, Anastasia; Chen, Fannie W.; Davies, Joanna P.; Wang, Rong; Ioannou, Yiannis A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai	Liapis, A (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA.	Yiannis.Ioannou@mssm.edu	Wang, Rong/A-8721-2009		National Institutes of Health [DK082712, NS066199, NS058335, NS061777, RR022415, RR17802]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health grants DK082712, NS066199, NS058335 to YAI and grants NS061777, RR022415 and RR17802 to RW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpy F, 2002, J BIOL CHEM, V277, P50780, DOI 10.1074/jbc.M208290200; Alpy F, 2001, J BIOL CHEM, V276, P4261, DOI 10.1074/jbc.M006279200; Alpy F, 2005, J BIOL CHEM; Balla S, 2006, NAT METHODS, V3, P175, DOI 10.1038/nmeth856; Borthwick F, 2010, CLIN SCI, V119, P265, DOI 10.1042/CS20100266; Charman M, 2010, J LIPID RES, V51, P1023, DOI 10.1194/jlr.M002345; Chen FW, 2005, BIOCHEM J, V390, P549, DOI 10.1042/BJ20050236; del Campo JJ, 2005, CURR BIOL, V15, P413, DOI 10.1016/j.cub.2005.01.054; Faul C, 2005, J CELL BIOL, V169, P415, DOI 10.1083/jcb.200411169; Fu HA, 2000, ANNU REV PHARMACOL, V40, P617, DOI 10.1146/annurev.pharmtox.40.1.617; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; GOLDSTEIN JL, 1983, METHOD ENZYMOL, V98, P241; GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; Holtta-Vuori M, 2005, MOL BIOL CELL, V16, P3873, DOI 10.1091/mbc.E04-12-1105; King SR, 2006, NEUROSCIENCE, V139, P1031, DOI 10.1016/j.neuroscience.2006.01.063; Kishida T, 2004, J BIOL CHEM, V279, P19276, DOI 10.1074/jbc.M400717200; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Masters SC, 2001, J BIOL CHEM, V276, P45193, DOI 10.1074/jbc.M105971200; MoogLutz C, 1997, INT J CANCER, V71, P183, DOI 10.1002/(SICI)1097-0215(19970410)71:2<183::AID-IJC10>3.0.CO;2-J; Nishimura Y, 2004, EUR J CELL BIOL, V83, P369, DOI 10.1078/0171-9335-00382; Nufer O, 2003, CURR BIOL, V13, pR391, DOI 10.1016/S0960-9822(03)00318-X; O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1; Obsilova V, 2005, BIOCHEMISTRY-US, V44, P11608, DOI 10.1021/bi050618r; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Petosa C, 1998, J BIOL CHEM, V273, P16305, DOI 10.1074/jbc.273.26.16305; Ramser EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013462; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Seimiya H, 2000, EMBO J, V19, P2652, DOI 10.1093/emboj/19.11.2652; Shikano S, 2006, TRENDS CELL BIOL, V16, P370, DOI 10.1016/j.tcb.2006.05.006; Sorokina EM, 2011, AM J PHYSIOL-CELL PH, V300, pC1430, DOI 10.1152/ajpcell.00285.2010; Sumioka A, 2005, J BIOL CHEM, V280, P42364, DOI 10.1074/jbc.M504278200; Tsujishita Y, 2000, NAT STRUCT BIOL, V7, P408; Tzivion G, 2002, J BIOL CHEM, V277, P3061, DOI 10.1074/jbc.R100059200; Walter M, 2009, BIOL CELL, V101, P141, DOI 10.1042/BC20070171; Watari H, 1997, P NATL ACAD SCI USA, V94, P8462, DOI 10.1073/pnas.94.16.8462; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zeidner KM, 1999, ANAL BIOCHEM, V267, P104, DOI 10.1006/abio.1998.2966; Zhang LX, 1997, J BIOL CHEM, V272, P13717, DOI 10.1074/jbc.272.21.13717; Zhang M, 2002, J BIOL CHEM, V277, P33300, DOI 10.1074/jbc.M200003200	42	23	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34424	10.1371/journal.pone.0034424	http://dx.doi.org/10.1371/journal.pone.0034424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514632	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600037
J	Nin, DS; Kok, WK; Li, F; Takahashi, S; Chng, WJ; Khan, M				Nin, Dawn Sijin; Kok, Wai Kay; Li, Feng; Takahashi, Shinichiro; Chng, Wee Joo; Khan, Matiullah			Role of Misfolded N-CoR Mediated Transcriptional Deregulation of Flt3 in Acute Monocytic Leukemia (AML)-M5 Subtype	PLOS ONE			English	Article							NUCLEAR RECEPTOR COREPRESSOR; PML-RAR-ALPHA; THERAPEUTIC TARGET; UNFOLDED PROTEIN; STEM-CELL; EXPRESSION; REPRESSION; GENE; COMPLEX; MSIN3	The nuclear receptor co-repressor (N-CoR) is a key component of the generic multi-protein complex involved in transcriptional control. Flt3, a key regulator of hematopoietic cell growth, is frequently deregulated in AML (acute myeloid leukemia). Here, we report that loss of N-CoR-mediated transcriptional control of Flt3 due to misfolding, contributes to malignant growth in AML of the M5 subtype (AML-M5). An analysis of hematopoietic genes in AML cells led to the identification of Flt3 as a transcriptional target of N-CoR. Flt3 level was inversely related to N-CoR status in various leukemia cells. N-CoR was associated with the Flt3 promoter in-vivo, and a reporter driven by the Flt3 promoter was effectively repressed by N-CoR. Blocking N-CoR loss with Genistein; an inhibitor of N-CoR misfolding, significantly down-regulated Flt3 levels regardless of the Flt3 receptor mutational status and promoted the differentiation of AML-M5 cells. While stimulation of the Flt3 receptor with the Flt3 ligand triggered N-CoR loss, Flt3 antibody mediated blockade of Flt3 ligand-receptor binding led to N-CoR stabilization. Genetic ablation of N-CoR potentiated Flt3 ligand induced proliferation of BA/F3 cells. These findings suggest that N-CoR-induced repression of Flt3 might be crucial for limiting the contribution of the Flt3 signaling pathway on the growth potential of leukemic cells and its deregulation due to N-CoR loss in AML-M5, could contribute to malignant growth by conferring a proliferative advantage to the leukemic blasts. Therapeutic restoration of NCoR function could thus be a useful approach in restricting the contribution of the Flt3 signaling pathway in AML-M5 pathogenesis.	[Nin, Dawn Sijin; Kok, Wai Kay; Li, Feng; Chng, Wee Joo; Khan, Matiullah] Natl Univ Singapore, Yong Loo Lin Sch Med, Canc Sci Inst, Singapore 117595, Singapore; [Nin, Dawn Sijin; Chng, Wee Joo; Khan, Matiullah] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Chng, Wee Joo] Natl Univ Hlth Syst, Dept Hematol Oncol, Natl Canc Inst Singapore, Singapore, Singapore; [Takahashi, Shinichiro] Kitasato Univ, Sch Allied Hlth Sci, Div Hematol, Kanagawa, Japan	National University of Singapore; National University of Singapore; National University of Singapore; Kitasato University	Nin, DS (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Canc Sci Inst, Singapore 117595, Singapore.	khanmmd@gmail.com	Takahashi, Shinichiro/AAX-7125-2020	Takahashi, Shinichiro/0000-0003-0011-6065	Singapore Stem Cell Consortium [SSCC-04-06]; Biomedical Research Council of Singapore [BMRC-06/1/21/19/478]	Singapore Stem Cell Consortium; Biomedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	Grant Support: Singapore Stem Cell Consortium grant SSCC-04-06 (M Khan) and Biomedical Research Council of Singapore grant BMRC-06/1/21/19/478 (M. Khan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNES F, 1994, GENE, V145, P283, DOI 10.1016/0378-1119(94)90021-3; Aleskog A, 2005, LEUKEMIA RES, V29, P1079, DOI 10.1016/j.leukres.2005.02.017; Armstrong SA, 2003, CANCER CELL, V3, P173, DOI 10.1016/S1535-6108(03)00003-5; Balgobind BV, 2009, BLOOD, V114, P2489, DOI 10.1182/blood-2009-04-215152; BIRG F, 1994, LEUKEMIA LYMPHOMA, V13, P223, DOI 10.3109/10428199409056285; BIRG F, 1992, BLOOD, V80, P2584; CAROW CE, 1995, CYTOGENET CELL GENET, V70, P255, DOI 10.1159/000134046; Gilliland DG, 2003, BEST PRACT RES CL HA, V16, P409, DOI 10.1016/S1521-6926(03)00063-X; Haferlach T, 2002, BRIT J HAEMATOL, V118, P426, DOI 10.1046/j.1365-2141.2002.03599.x; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HORLEIN AJ, 1995, NATURE, V377, P397, DOI 10.1038/377397a0; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Karauzum SB, 2005, EXP ONCOL, V27, P229; Khan MM, 2004, J BIOL CHEM, V279, P11814, DOI 10.1074/jbc.M312121200; Khan MM, 2001, J BIOL CHEM, V276, P43491, DOI 10.1074/jbc.C100532200; Khan MM, 2001, MOL CELL, V7, P1233, DOI 10.1016/S1097-2765(01)00257-X; Kikushige Y, 2008, J IMMUNOL, V180, P7358, DOI 10.4049/jimmunol.180.11.7358; Kindler T, 2010, BLOOD, V116, P5089, DOI 10.1182/blood-2010-04-261867; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Le Beau MM, 2003, BLOOD, V102, P1072, DOI 10.1182/blood-2003-01-0155; Lilakos K, 2006, ANTICANCER RES, V26, P1201; Moore MAS, 2007, EXP HEMATOL, V35, P105, DOI 10.1016/j.exphem.2007.01.018; MUENCH MO, 1995, BLOOD, V85, P963, DOI 10.1182/blood.V85.4.963.bloodjournal854963; Ng APP, 2007, MOL CANCER THER, V6, P2240, DOI 10.1158/1535-7163.MCT-06-0705; Ng APP, 2006, CANCER RES, V66, P9903, DOI 10.1158/0008-5472.CAN-06-0002; Ng APP, 2011, MOL CANCER RES, V9, P878, DOI 10.1158/1541-7786.MCR-10-0545; Nomura T, 1999, GENE DEV, V13, P412, DOI 10.1101/gad.13.4.412; Parcells BW, 2006, STEM CELLS, V24, P1174, DOI 10.1634/stemcells.2005-0519; Stubbs MC, 2008, LEUKEMIA, V22, P66, DOI 10.1038/sj.leu.2404951; Stubbs MC, 2007, CURR DRUG TARGETS, V8, P703, DOI 10.2174/138945007780830782; Swansbury GJ, 1998, LEUKEMIA, V12, P792, DOI 10.1038/sj.leu.2401014; Villeneuve P, 2008, LEUKEMIA RES, V32, P269, DOI 10.1016/j.leukres.2007.06.019; Zhang DZ, 2007, CELL RES, V17, P804, DOI 10.1038/cr.2007.72	35	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34501	10.1371/journal.pone.0034501	http://dx.doi.org/10.1371/journal.pone.0034501			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514634	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600039
J	Payne, NL; Sun, GZ; Herszfeld, D; Tat-Goh, PA; Verma, PJ; Parkington, HC; Coleman, HA; Tonta, MA; Siatskas, C; Bernard, CCA				Payne, Natalie L.; Sun, Guizhi; Herszfeld, Daniella; Tat-Goh, Pollyanna A.; Verma, Paul J.; Parkington, Helena C.; Coleman, Harold A.; Tonta, Mary A.; Siatskas, Christopher; Bernard, Claude C. A.			Comparative Study on the Therapeutic Potential of Neurally Differentiated Stem Cells in a Mouse Model of Multiple Sclerosis	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; AUTOIMMUNE ENCEPHALOMYELITIS; STEM/PRECURSOR CELLS; PRECURSOR CELLS; BONE-MARROW; BRAIN; EXPRESSION; RECOVERY; NEURONS; NEUROPROTECTION	Background: Transplantation of neural stem cells (NSCs) is a promising novel approach to the treatment of neuroinflammatory diseases such as multiple sclerosis (MS). NSCs can be derived from primary central nervous system (CNS) tissue or obtained by neural differentiation of embryonic stem (ES) cells, the latter having the advantage of readily providing an unlimited number of cells for therapeutic purposes. Using a mouse model of MS, we evaluated the therapeutic potential of NSCs derived from ES cells by two different neural differentiation protocols that utilized adherent culture conditions and compared their effect to primary NSCs derived from the subventricular zone (SVZ). Methodology/Principal Findings: The proliferation and secretion of pro-inflammatory cytokines by antigen-stimulated splenocytes was reduced in the presence of SVZ-NSCs, while ES cell-derived NSCs exerted differential immunosuppressive effects. Surprisingly, intravenously injected NSCs displayed no significant therapeutic impact on clinical and pathological disease outcomes in mice with experimental autoimmune encephalomyelitis (EAE) induced by recombinant myelin oligodendrocyte glycoprotein, independent of the cell source. Studies tracking the biodistribution of transplanted ES cell-derived NSCs revealed that these cells were unable to traffic to the CNS or peripheral lymphoid tissues, consistent with the lack of cell surface homing molecules. Attenuation of peripheral immune responses could only be achieved through multiple high doses of NSCs administered intraperitoneally, which led to some neuroprotective effects within the CNS. Conclusion/Significance: Systemic transplantation of these NSCs does not have a major influence on the clinical course of rMOG-induced EAE. Improving the efficiency at which NSCs home to inflammatory sites may enhance their therapeutic potential in this model of CNS autoimmunity.	[Payne, Natalie L.; Sun, Guizhi; Herszfeld, Daniella; Siatskas, Christopher; Bernard, Claude C. A.] Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia; [Tat-Goh, Pollyanna A.; Verma, Paul J.] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [Parkington, Helena C.; Coleman, Harold A.; Tonta, Mary A.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia	Monash University; Monash University; Monash University	Payne, NL (corresponding author), Monash Univ, Monash Immunol & Stem Cell Labs, Clayton, Vic, Australia.	Claude.Bernard@monash.edu.au	Verma, Paul/AAQ-4657-2021	Bernard, Claude Charles Andre/0000-0003-2816-5328	Baker Foundation; National Health and Medical Research Council of Australia; Diana Asmar Fund; Eva and Les Erdi AUSiMED Fellowship in Neurological Diseases; Cure Multiple Sclerosis Fellowship-Neurological Diseases; Trish MS Research Foundation; Monash University	Baker Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diana Asmar Fund; Eva and Les Erdi AUSiMED Fellowship in Neurological Diseases; Cure Multiple Sclerosis Fellowship-Neurological Diseases; Trish MS Research Foundation; Monash University(Monash University)	This work was supported by grants from the Baker Foundation, the National Health and Medical Research Council of Australia, the Diana Asmar Fund, The Eva and Les Erdi AUSiMED Fellowship in Neurological Diseases and Cure Multiple Sclerosis Fellowship-Neurological Diseases. N.P. was supported by a Trish MS Research Foundation Postgraduate Research Scholarship and a Monash University Postgraduate Publication Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharonowiz M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003145; Akesson E, 2009, STEM CELL RES, V2, P56, DOI 10.1016/j.scr.2008.06.002; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Bakshi A, 2005, BRAIN RES, V1065, P8, DOI 10.1016/j.brainres.2005.09.059; Bettadapura J, 1998, J NEUROCHEM, V70, P1593, DOI 10.1046/j.1471-4159.1998.70041593.x; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Brocke S, 1999, P NATL ACAD SCI USA, V96, P6896, DOI 10.1073/pnas.96.12.6896; Brustle O, 1997, P NATL ACAD SCI USA, V94, P14809, DOI 10.1073/pnas.94.26.14809; Campos LS, 2004, J NEUROSCI RES, V78, P761, DOI 10.1002/jnr.20333; Codarri L, 2010, CURR OPIN NEUROL, V23, P205, DOI 10.1097/WCO.0b013e3283391feb; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Conti L, 2010, NAT REV NEUROSCI, V11, P176, DOI 10.1038/nrn2761; Crocker SJ, 2011, NEUROPATH APPL NEURO, V37, P643, DOI 10.1111/j.1365-2990.2011.01165.x; Einstein O, 2003, MOL CELL NEUROSCI, V24, P1074, DOI 10.1016/j.mcn.2003.08.009; Einstein O, 2006, EXP NEUROL, V198, P275, DOI 10.1016/j.expneurol.2005.11.007; Einstein O, 2007, ANN NEUROL, V61, P209, DOI 10.1002/ana.21033; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Gordon D, 2008, NEUROSCI LETT, V448, P71, DOI 10.1016/j.neulet.2008.10.040; Gu XQ, 2004, AM J PHYSIOL-CELL PH, V287, pC691, DOI 10.1152/ajpcell.00066.2004; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Imitola J, 2005, PHARMACOL THERAPEUT, V106, P163, DOI 10.1016/j.pharmthera.2004.11.007; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Johnson MA, 2007, J NEUROSCI, V27, P3069, DOI 10.1523/JNEUROSCI.4562-06.2007; Kim SY, 2009, J NEUROSCI RES, V87, P2264, DOI 10.1002/jnr.22050; Krumbholz M, 2006, BRAIN, V129, P200, DOI 10.1093/brain/awh680; Lee ST, 2005, NEUROSCI RES, V52, P243, DOI 10.1016/j.neures.2005.03.016; LINNINGTON C, 1984, J NEUROIMMUNOL, V6, P387, DOI 10.1016/0165-5728(84)90064-X; Liu KKY, 2009, J NEUROIMMUNOL, V215, P49, DOI 10.1016/j.jneuroim.2009.08.003; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; McDonald JW, 1999, NAT MED, V5, P1410, DOI 10.1038/70986; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Parsons XH, 2009, CYTOTHERAPY, V11, P815, DOI 10.3109/14653240903180092; Payne Natalie, 2011, Curr Stem Cell Res Ther, V6, P50, DOI 10.2174/157488811794480735; Payne N, 2008, J AUTOIMMUN, V31, P288, DOI 10.1016/j.jaut.2008.04.002; Pendharkar AV, 2010, STROKE, V41, P2064, DOI 10.1161/STROKEAHA.109.575993; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Perez-Alvarez MJ, 2008, J NEUROSCI RES, V86, P1871, DOI 10.1002/jnr.21623; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pluchino S, 2008, J NEUROL SCI, V265, P105, DOI 10.1016/j.jns.2007.07.020; Pluchino S, 2009, ANN NEUROL, V66, P343, DOI 10.1002/ana.21745; Pluchino S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005959; Politi LS, 2007, STEM CELLS, V25, P2583, DOI 10.1634/stemcells.2007-0037; Prowse ABJ, 2011, STEM CELL RES, V6, P1, DOI 10.1016/j.scr.2010.09.005; Rafei M, 2009, MOL THER, V17, P1799, DOI 10.1038/mt.2009.157; Rafei M, 2008, BLOOD, V112, P4991, DOI 10.1182/blood-2008-07-166892; Rampon C, 2008, STEM CELLS, V26, P1673, DOI 10.1634/stemcells.2008-0122; Reekmans KP, 2011, CELL TRANSPLANT, V20, P851, DOI 10.3727/096368910X543411; Reid CA, 2006, NEUROPHARMACOLOGY, V51, P587, DOI 10.1016/j.neuropharm.2006.05.001; Reubinoff BE, 2001, NAT BIOTECHNOL, V19, P1134, DOI 10.1038/nbt1201-1134; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Robey TE, 2008, J MOL CELL CARDIOL, V45, P567, DOI 10.1016/j.yjmcc.2008.03.009; Rossi B, 2011, J LEUKOCYTE BIOL, V89, P539, DOI 10.1189/jlb.0710432; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Schwarz SC, 2010, TRANSL RES, V156, P155, DOI 10.1016/j.trsl.2010.07.002; Shin S, 2007, STEM CELLS, V25, P1298, DOI 10.1634/stemcells.2006-0660; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; SZABO P, 1994, DEVELOPMENT, V120, P1651; Tat PA, 2010, CELL TRANSPLANT, V19, P525, DOI 10.3727/096368910X491374; Tran PB, 2003, NAT REV NEUROSCI, V4, P444, DOI 10.1038/nrn1116; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; Yang JX, 2010, AM J PATHOL, V177, P1989, DOI 10.2353/ajpath.2010.091203; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	69	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35093	10.1371/journal.pone.0035093	http://dx.doi.org/10.1371/journal.pone.0035093			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514711	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600117
J	Porcheron, G; Chanteloup, NK; Trotereau, A; Bree, A; Schouler, C				Porcheron, Gaelle; Chanteloup, Nathalie Katy; Trotereau, Angelina; Bree, Annie; Schouler, Catherine			Effect of Fructooligosaccharide Metabolism on Chicken Colonization by an Extra-Intestinal Pathogenic Escherichia coli Strain	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; INTESTINAL COLONIZATION; COLONIC MICROBIOTA; INDUCER EXCLUSION; BROILER-CHICKENS; GENOMIC ISLAND; VIRULENCE; BACTERIA; CECUM; ENTEROBACTERIACEAE	Extra-intestinal pathogenic Escherichia coli (ExPEC) strains cause many diseases in humans and animals. While remaining asymptomatic, they can colonize the intestine for subsequent extra-intestinal infection and dissemination in the environment. We have previously identified the fos locus, a gene cluster within a pathogenicity island of the avian ExPEC strain BEN2908, involved in the metabolism of short-chain fructooligosaccharides (scFOS). It is assumed that these sugars are metabolized by the probiotic bacteria of the microbiota present in the intestine, leading to a decrease in the pathogenic bacterial population. However, we have previously shown that scFOS metabolism helps BEN2908 to colonize the intestine, its reservoir. As the fos locus is located on a pathogenicity island, one aim of this study was to investigate a possible role of this locus in the virulence of the strain for chicken. We thus analysed fos gene expression in extracts of target organs of avian colibacillosis and performed a virulence assay in chickens. Moreover, in order to understand the involvement of the fos locus in intestinal colonization, we monitored the expression of fos genes and their implication in the growth ability of the strain in intestinal extracts of chicken. We also performed intestinal colonization assays in axenic and Specific Pathogen-Free (SPF) chickens. We demonstrated that the fos locus is not involved in the virulence of BEN2908 for chickens and is strongly involved in axenic chicken cecal colonization both in vitro and in vivo. However, even if the presence of a microbiota does not inhibit the growth advantage of BEN2908 in ceca in vitro, overall, growth of the strain is not favoured in the ceca of SPF chickens. These findings indicate that scFOS metabolism by an ExPEC strain can contribute to its fitness in ceca but this benefit is fully dependent on the bacteria present in the microbiota.	[Porcheron, Gaelle; Chanteloup, Nathalie Katy; Trotereau, Angelina; Bree, Annie; Schouler, Catherine] INRA, Infectiol & Sante Publ UMR1282, F-37380 Nouzilly, France; [Porcheron, Gaelle; Chanteloup, Nathalie Katy; Trotereau, Angelina; Bree, Annie; Schouler, Catherine] Univ Tours, Infectiol & Sante Publ UMR1282, Tours, France	INRAE; Universite de Tours	Porcheron, G (corresponding author), INRA, Infectiol & Sante Publ UMR1282, F-37380 Nouzilly, France.	Catherine.Schouler@tours.inra.fr	Schouler, Catherine/AAE-2207-2022	Schouler, Catherine/0000-0002-3480-6278; Porcheron, Gaelle/0000-0002-0406-7662	Era-NET PathoGenoMics European [ANR-06-PATHO-002-01]; Institut National de la Recherche Agronomique; Institut Federatif de Recherche [136]	Era-NET PathoGenoMics European; Institut National de la Recherche Agronomique; Institut Federatif de Recherche	This work was funded by the Era-NET PathoGenoMics European program (grant ANR-06-PATHO-002-01), the Institut National de la Recherche Agronomique and the Institut Federatif de Recherche 136 (Agents Transmissibles et Infectiologie). GP is a pre-doctoral fellow of INRA (MICA)/Region Centre (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES EM, 1972, AM J CLIN NUTR, V25, P1475; Barnes HJ, 2003, DIS POULTRY, V11th, P56; Barrangou R, 2003, P NATL ACAD SCI USA, V100, P8957, DOI 10.1073/pnas.1332765100; Belanger L, 2011, FEMS IMMUNOL MED MIC, V62, P1, DOI 10.1111/j.1574-695X.2011.00797.x; Bjerrum L, 2006, POULTRY SCI, V85, P1151, DOI 10.1093/ps/85.7.1151; Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141; CAIN JR, 1976, AM J CLIN NUTR, V29, P1397, DOI 10.1093/ajcn/29.12.1397; Chanteloup NK, 2011, VET MICROBIOL, V147, P435, DOI 10.1016/j.vetmic.2010.07.013; Chouikha I, 2006, J BACTERIOL, V188, P977, DOI 10.1128/JB.188.3.977-987.2006; CLENCH MH, 1995, WILSON BULL, V107, P93; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; DHO M, 1982, AVIAN DIS, V26, P787, DOI 10.2307/1589865; Dho-Moulin M, 1999, VET RES, V30, P299; Diard M, 2010, J BACTERIOL, V192, P4885, DOI 10.1128/JB.00804-10; Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]; Edelman S, 2003, VET MICROBIOL, V91, P41, DOI 10.1016/S0378-1135(02)00153-0; Ewers C, 2009, APPL ENVIRON MICROB, V75, P184, DOI 10.1128/AEM.01324-08; Falony G, 2009, APPL ENVIRON MICROB, V75, P454, DOI 10.1128/AEM.01488-08; FRETER R, 1983, INFECT IMMUN, V39, P686, DOI 10.1128/IAI.39.2.686-703.1983; FRETER R, 1981, INFECT IMMUN, V34, P241, DOI 10.1128/IAI.34.1.241-249.1981; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Gong JH, 2002, FEMS MICROBIOL LETT, V208, P1, DOI 10.1111/j.1574-6968.2002.tb11051.x; Gusils C, 2003, CAN J MICROBIOL, V49, P472, DOI [10.1139/w03-055, 10.1139/W03-055]; HARRY EG, 1965, VET REC, V77, P35; Hennequin C, 2009, INFECT IMMUN, V77, P5449, DOI 10.1128/IAI.00837-09; Herias MV, 1997, INFECT IMMUN, V65, P531; HERIAS MV, 1995, INFECT IMMUN, V63, P4781; Hermans D, 2010, POULTRY SCI, V89, P1144, DOI 10.3382/ps.2010-00717; Hogema BM, 1998, MOL MICROBIOL, V30, P487, DOI 10.1046/j.1365-2958.1998.01053.x; Jantunen ME, 2001, J MED MICROBIOL, V50, P650, DOI 10.1099/0022-1317-50-7-650; Johnson JR, 2002, J LAB CLIN MED, V139, P155, DOI 10.1067/mlc.2002.121550; Johnson JR, 2001, INFECT IMMUN, V69, P1306, DOI 10.1128/IAI.69.3.1306-1314.2001; Kaplan H, 2003, APPL ENVIRON MICROB, V69, P2217, DOI 10.1128/AEM.69.4.2217-2222.2003; Le Bars J, 1976, Ann Rech Vet, V7, P383; Leatham-Jensen MP, 2012, INFECT IMMUN; Miller JH, 1972, EXPT MOL GENETICS, Vxvi, P466; Moreno E, 2009, MICROBES INFECT, V11, P274, DOI 10.1016/j.micinf.2008.12.002; Nowrouzian FL, 2005, J INFECT DIS, V191, P1078, DOI 10.1086/427996; Nowrouzian FL, 2006, MICROBES INFECT, V8, P834, DOI 10.1016/j.micinf.2005.10.011; Olsen KN, 2008, ANTON LEEUW INT J G, V94, P423, DOI 10.1007/s10482-008-9260-0; Picard B, 1999, INFECT IMMUN, V67, P546, DOI 10.1128/IAI.67.2.546-553.1999; PLUSCHKE G, 1983, INFECT IMMUN, V39, P599, DOI 10.1128/IAI.39.2.599-608.1983; Porcheron G, 2011, MOL MICROBIOL, V81, P717, DOI 10.1111/j.1365-2958.2011.07725.x; Ritsema T, 2003, CURR OPIN PLANT BIOL, V6, P223, DOI 10.1016/S1369-5266(03)00034-7; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Roberfroid MB, 2001, AM J CLIN NUTR, V73, p406S, DOI 10.1093/ajcn/73.2.406s; Ron EZ, 2006, CURR OPIN MICROBIOL, V9, P28, DOI 10.1016/j.mib.2005.12.001; Rouquet G, 2009, J BACTERIOL, V191, P4427, DOI 10.1128/JB.00103-09; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Russo TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2; Ryan SM, 2005, APPL ENVIRON MICROB, V71, P3475, DOI 10.1128/AEM.71.7.3475-3482.2005; SAIER MH, 1989, MICROBIOL REV, V53, P109, DOI 10.1128/MMBR.53.1.109-120.1989; Schierack P, 2008, ENVIRON MICROBIOL, V10, P1742, DOI 10.1111/j.1462-2920.2008.01595.x; Schierack P, 2007, MICROBIOL-SGM, V153, P3830, DOI 10.1099/mic.0.2007/010173-0; Schouler C, 2009, J BACTERIOL, V191, P388, DOI 10.1128/JB.01052-08; SELDEN R, 1971, ANN INTERN MED, V74, P657, DOI 10.7326/0003-4819-74-5-657; Shpigel NY, 2008, CURR OPIN MICROBIOL, V11, P60, DOI 10.1016/j.mib.2008.01.004; Smith JL, 2007, FOODBORNE PATHOG DIS, V4, P134, DOI 10.1089/fpd.2007.0087; Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005; TURK DE, 1982, POULTRY SCI, V61, P1225, DOI 10.3382/ps.0611225; Whittow G.C., 1986, P221; Wiles TJ, 2008, EXP MOL PATHOL, V85, P11, DOI 10.1016/j.yexmp.2008.03.007; Yamamoto Shingo, 2007, Journal of Infection and Chemotherapy, V13, P68, DOI 10.1007/s10156-007-0506-y; Zhang LX, 2002, J CLIN MICROBIOL, V40, P3951, DOI 10.1128/JCM.40.11.3951-3955.2002; Zhu XY, 2002, APPL ENVIRON MICROB, V68, P124, DOI 10.1128/AEM.68.1.124-137.2002	66	10	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35475	10.1371/journal.pone.0035475	http://dx.doi.org/10.1371/journal.pone.0035475			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514747	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600152
J	Xu, F; Wu, DC; Toriyama, R; Ma, FL; Itakura, S; Lee, K				Xu, Fen; Wu, Dingcheng; Toriyama, Rie; Ma, Fengling; Itakura, Shoji; Lee, Kang			Similarities and Differences in Chinese and Caucasian Adults' Use of Facial Cues for Trustworthiness Judgments	PLOS ONE			English	Article							AGGRESSIVE-BEHAVIOR; 1ST IMPRESSIONS; HUMAN AMYGDALA; HOMO-SAPIENS; FACES; ATTRACTIVENESS; TRUST; MODEL; RECOGNITION; AVERAGENESS	Background: All cultural groups in the world place paramount value on interpersonal trust. Existing research suggests that although accurate judgments of another's trustworthiness require extensive interactions with the person, we often make trustworthiness judgments based on facial cues on the first encounter. However, little is known about what facial cues are used for such judgments and what the bases are on which individuals make their trustworthiness judgments. Methodology/Principal Findings: In the present study, we tested the hypothesis that individuals may use facial attractiveness cues as a "shortcut'' for judging another's trustworthiness due to the lack of other more informative and in-depth information about trustworthiness. Using data-driven statistical models of 3D Caucasian faces, we compared facial cues used for judging the trustworthiness of Caucasian faces by Caucasian participants who were highly experienced with Caucasian faces, and the facial cues used by Chinese participants who were unfamiliar with Caucasian faces. We found that Chinese and Caucasian participants used similar facial cues to judge trustworthiness. Also, both Chinese and Caucasian participants used almost identical facial cues for judging trustworthiness and attractiveness. Conclusions/Significance: The results suggest that without opportunities to interact with another person extensively, we use the less racially specific and more universal attractiveness cues as a "shortcut'' for trustworthiness judgments.	[Xu, Fen; Ma, Fengling] Zhejiang Sci Tech Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China; [Wu, Dingcheng] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Toriyama, Rie; Lee, Kang] Univ Toronto, Dr Eric Jackman Inst Child Study, Toronto, ON, Canada; [Itakura, Shoji] Kyoto Univ, Dept Psychol, Kyoto, Japan; [Lee, Kang] Univ Calif San Diego, Dept Psychol, San Diego, CA 92103 USA	Zhejiang Sci-Tech University; Beijing Normal University; University of Toronto; Kyoto University; University of California System; University of California San Diego	Xu, F (corresponding author), Zhejiang Sci Tech Univ, Dept Psychol, Hangzhou, Zhejiang, Peoples R China.	fenxu@zstu.edu.cn; wudingcheng@ion.ac.cn; kang.lee@utoronto.ca	Wu, Dingcheng/C-3778-2008	Wu, Dingcheng/0000-0002-4108-9625	National Natural Science Foundation of China [31170996, 30528027, 31028010]; Zhejiang Provincial Natural Science Foundation of China [Y2110369]; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health (NIH) [R01HD046526]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046526] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [21118001] Funding Source: KAKEN	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The present study was supported by grants from the National Natural Science Foundation of China (31170996 & 30528027 & 31028010), the Zhejiang Provincial Natural Science Foundation of China (Y2110369), the Natural Sciences and Engineering Research Council of Canada, and the National Institutes of Health (NIH) (R01HD046526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS GR, 1977, J PSYCHOL, V96, P287, DOI 10.1080/00223980.1977.9915911; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Blanz V, 1999, COMP GRAPH, P187, DOI 10.1145/311535.311556; Brewer Gayle., 2007, J EVOLUTIONARY PSYCH, V5, P39, DOI [DOI 10.1556/JEP.2007.1002, 10.1556/JEP.2007.1002]; Buckingham G, 2006, EVOL HUM BEHAV, V27, P381, DOI 10.1016/j.evolhumbehav.2006.03.001; Carre JM, 2010, PERCEPTION, V39, P356, DOI 10.1068/p6543; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; Carre JM, 2008, P ROY SOC B-BIOL SCI, V275, P2651, DOI 10.1098/rspb.2008.0873; Cooper PA, 2006, DEVELOPMENTAL SCI, V9, P530, DOI 10.1111/j.1467-7687.2006.00520.x; Das S., 2011, MULTICOLLINEARITY PR, DOI 10.2139/ssrn.1830043; DION K, 1972, J PERS SOC PSYCHOL, V24, P285, DOI 10.1037/h0033731; Engell AD, 2007, J COGNITIVE NEUROSCI, V19, P1508, DOI 10.1162/jocn.2007.19.9.1508; Fisak B, 2007, BODY IMAGE, V4, P213, DOI 10.1016/j.bodyim.2007.03.004; Ge LZ, 2009, PERCEPTION, V38, P1199, DOI 10.1068/p6136; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; Haselhuhn MP, 2011, P BIOL SCI; Kalick SM, 1998, PSYCHOL SCI, V9, P8, DOI 10.1111/1467-9280.00002; LODGE M, 1989, AM POLIT SCI REV, V83, P399, DOI 10.2307/1962397; MAYER RC, 1995, ACAD MANAGE REV, V20, P709, DOI 10.2307/258792; McCormick CM, 2010, J VIS, V10, P599, DOI [10.1167/10.7.599, DOI 10.1167/10.7.599]; Mcknight DH, 1998, ACAD MANAGE REV, V23, P473, DOI 10.5465/AMR.1998.926622; Mueller U, 1997, BEHAV ECOL, V8, P569; Oosterhof NN, 2008, P NATL ACAD SCI USA, V105, P11087, DOI 10.1073/pnas.0805664105; Porter S, 2008, CAN J BEHAV SCI, V40, P171, DOI 10.1037/0008-400X.40.3.171; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2007, PERCEPTION, V36, P1244, DOI 10.1068/p5712; Rhodes G, 2009, PERCEPTION, V38, P232, DOI 10.1068/p6110; Rule NO, 2008, PSYCHOL SCI, V19, P109, DOI 10.1111/j.1467-9280.2008.02054.x; Said CP, 2009, J COGNITIVE NEUROSCI, V21, P519, DOI 10.1162/jocn.2009.21041; Short LA, EVOLUTION H IN PRESS; Stanley DA, 2011, P NATL ACAD SCI USA, V108, P7710, DOI 10.1073/pnas.1014345108; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Todorov A, 2005, SCIENCE, V308, P1623, DOI 10.1126/science.1110589; Todorov A, 2008, SOC COGN AFFECT NEUR, V3, P119, DOI 10.1093/scan/nsn009; Tsukiura T, 2010, SOC COGN AFFECT NEUR; Willis J, 2006, PSYCHOL SCI, V17, P592, DOI 10.1111/j.1467-9280.2006.01750.x; Winston JS, 2002, NAT NEUROSCI, V5, P277, DOI 10.1038/nn816; ZAND DE, 1972, ADMIN SCI QUART, V17, P229, DOI 10.2307/2393957; ZEBROWITZ LA, 1993, J PERS SOC PSYCHOL, V65, P85, DOI 10.1037/0022-3514.65.1.85; Zebrowitz LA, 2012, J CROSS CULT PSYCHOL, V43, P119, DOI 10.1177/0022022111411386	40	26	27	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34859	10.1371/journal.pone.0034859	http://dx.doi.org/10.1371/journal.pone.0034859			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UT	22514680	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600086
J	Zhu, CS; Xiong, ZJ; Chen, XH; Peng, FH; Hu, XQ; Chen, YM; Wang, Q				Zhu, Cansheng; Xiong, Zhaojun; Chen, Xiaohong; Peng, Fuhua; Hu, Xueqiang; Chen, Yanming; Wang, Qing			Artemisinin Attenuates Lipopolysaccharide-Stimulated Proinflammatory Responses by Inhibiting NF-kappa B Pathway in Microglia Cells	PLOS ONE			English	Article							PARKINSONS-DISEASE; NITRIC-OXIDE; ALZHEIMERS-DISEASE; ACTIVATION; MECHANISMS; INFLAMMATION; DERIVATIVES; INDUCTION; CYTOKINES; PROTEINS	Microglial activation plays an important role in neuroinflammation, which contributes to neuronal damage, and inhibition of microglial activation may have therapeutic benefits that could alleviate the progression of neurodegeneration. Recent studies have indicated that the antimalarial agent artemisinin has the ability to inhibit NF-kappa B activation. In this study, the inhibitory effects of artemisinin on the production of proinflammatory mediators were investigated in lipopolysaccharide (LPS)-stimulated primary microglia. Our results show that artemisinin significantly inhibited LPS-induced production of tumor necrosis factor-alpha (TNF-alpha), interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1) and nitric oxide (NO). Artemisinin significantly decreased both the mRNA and the protein levels of these pro-inflammatory cytokines and inducible nitric oxide synthase (iNOS) and increased the protein levels of I kappa B-alpha, which forms a cytoplasmic inactive complex with the p65-p50 heterodimeric complex. Artemisinin treatment significantly inhibited basal and LPS-induced migration of BV-2 microglia. Electrophoretic mobility shift assays revealed increased NF-kappa B binding activity in LPS-stimulated primary microglia, and this increase could be prevented by artemisinin. The inhibitory effects of artemisinin on LPS-stimulated microglia were blocked after I kappa B-alpha was silenced with I kappa B-alpha siRNA. Our results suggest that artemisinin is able to inhibit neuroinflammation by interfering with NF-kappa B signaling. The data provide direct evidence of the potential application of artemisinin for the treatment of neuroinflammatory diseases.	[Zhu, Cansheng; Chen, Xiaohong; Peng, Fuhua; Hu, Xueqiang; Wang, Qing] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China; [Xiong, Zhaojun] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Cardiovasc Dis, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Yanming] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Endocrinol & Metab, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhu, CS (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Neurol, Guangzhou 510275, Guangdong, Peoples R China.	yanmingch@qq.com; qingwangzssy@yahoo.com.cn		Wang, Qing/0000-0002-3882-6540				Akundi RS, 2005, GLIA, V51, P199, DOI 10.1002/glia.20198; Aldieri E, 2003, FEBS LETT, V552, P141, DOI 10.1016/S0014-5793(03)00905-0; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barron KD, 1995, J NEUROL SCI, V134, P57, DOI 10.1016/0022-510X(95)00209-K; Carmody RJ, 2007, CELL MOL IMMUNOL, V4, P31; Choi DK, 2005, J NEUROSCI, V25, P6594, DOI 10.1523/JNEUROSCI.0970-05.2005; Dignam DJ, 1983, NUCLEIC ACIDS RES, V11, P1475; Dirscherl K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-3; Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412; Eikelenboom P, 2004, J NEURAL TRANSM, V111, P281, DOI 10.1007/s00702-003-0055-1; Fiebich BL, 2002, J NEUROIMMUNOL, V132, P18, DOI 10.1016/S0165-5728(02)00279-5; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; Hashioka S, 2007, EXP NEUROL, V206, P33, DOI 10.1016/j.expneurol.2007.03.022; Haynes RK, 2001, CURR OPIN INFECT DIS, V14, P719, DOI 10.1097/00001432-200112000-00010; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kaur G, 2010, NEUROSURG CLIN N AM, V21, P43, DOI 10.1016/j.nec.2009.08.009; Koning N, 2007, ANN NEUROL, V62, P504, DOI 10.1002/ana.21220; Krause DL, 2010, INT J ALZHEIMERS DIS, V14; Le WD, 2001, J NEUROSCI, V21, P8447, DOI 10.1523/JNEUROSCI.21-21-08447.2001; Lee SM, 2004, J NEUROCHEM, V91, P568, DOI 10.1111/j.1471-4159.2004.02780.x; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Minghetti L, 1998, PROG NEUROBIOL, V54, P99, DOI 10.1016/S0301-0082(97)00052-X; Nomura Y, 2001, LIFE SCI, V68, P1695, DOI 10.1016/S0024-3205(01)00967-5; Park JS, 2007, J PHARMACOL EXP THER, V320, P1237, DOI 10.1124/jpet.106.114322; Qian L, 2010, J NEURAL TRANSM, V117, P971, DOI 10.1007/s00702-010-0428-1; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; Ullrich O, 2001, FASEB J, V15, P1460, DOI 10.1096/fj.00-0540fje; Wang JX, 2009, ACTA PHARMACOL SIN, V30, P1428, DOI 10.1038/aps.2009.138; Wang MJ, 2002, EUR J NEUROSCI, V16, P2103, DOI 10.1046/j.1460-9568.2002.02290.x; Wang Y, 2011, INT J MOL MED, V27, P233, DOI 10.3892/ijmm.2010.580; Wang ZJ, 2007, J IMMUNOL, V179, P5958, DOI 10.4049/jimmunol.179.9.5958; Wartenberg M, 2003, LAB INVEST, V83, P1647, DOI 10.1097/01.LAB.0000098424.38003.FF; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; Xu H, 2007, RHEUMATOLOGY, V46, P920, DOI 10.1093/rheumatology/kem014; Zielasek J, 1996, ADV NEUROIMMUNOL, V6, P191, DOI 10.1016/0960-5428(96)00017-4	37	50	51	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35125	10.1371/journal.pone.0035125	http://dx.doi.org/10.1371/journal.pone.0035125			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514713	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600119
J	Schwab, C; Swoboda, R; Kotrschal, K; Bugnyar, T				Schwab, Christine; Swoboda, Ruth; Kotrschal, Kurt; Bugnyar, Thomas			Recipients Affect Prosocial and Altruistic Choices in Jackdaws, Corvus monedula	PLOS ONE			English	Article							COMMON RAVENS; CHIMPANZEES HELP; FOOD; COOPERATION; EVOLUTION; BEHAVIOR; KIN	Other-regarding preferences are a critical feature of human cooperation but to what extent non-human animals exhibit these preferences is a matter of intense discussion. We tested whether jackdaws show prosocial behaviour (providing benefits to others at no cost to themselves) and altruism (providing benefits to others while incurring costs) with both sibling and non-sibling recipients. In the prosocial condition, a box was baited on both the actor's and the recipient's side (1/1 option), whereas another box provided food only for the actor (1/0 option). In the altruistic condition, the boxes contained food for either the actor (1/0 option) or the recipient (0/1 option). The proportion of selfish (1/0 option) and cooperative (1/1 and 0/1 option, respectively) actors' choices was significantly affected by the recipients' behaviour. If recipients approached the boxes first and positioned themselves next to the box baited on their side, trying to access the food reward (recipient-first trials), actors were significantly more cooperative than when the actors approached the boxes first and made their choice prior to the recipients' arrival (actor-first trials). Further, in recipient-first trials actors were more cooperative towards recipients of the opposite sex, an effect that was even more pronounced in the altruistic condition. Hence, at no cost to the actors, all recipients could significantly influence the actors' behaviour, whereas at high costs this could be achieved even more so by recipients of different sex. Local/stimulus enhancement is discussed as the most likely cognitive mechanism to account for these effects.	[Schwab, Christine] KLI Evolut & Cognit Res, Altenberg, Austria; [Schwab, Christine; Swoboda, Ruth; Kotrschal, Kurt; Bugnyar, Thomas] Konrad Lorenz Res Stn Ethol, Gruenau, Austria; [Swoboda, Ruth; Kotrschal, Kurt] Univ Vienna, Dept Behav Biol, Vienna, Austria; [Bugnyar, Thomas] Univ Vienna, Dept Cognit Biol, Vienna, Austria	University of Vienna; University of Vienna	Schwab, C (corresponding author), KLI Evolut & Cognit Res, Altenberg, Austria.	christine.schwab@kli.ac.at			Austrian Science Fund (FWF) [P 18920-B17, I105-G11, Y 366-B17]; KLI for Evolution and Cognition Research, Altenberg, Austria; Austrian Science Fund (FWF) [Y 366] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); KLI for Evolution and Cognition Research, Altenberg, Austria; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The study was funded by the Austrian Science Fund (FWF): [P 18920-B17; I105-G11 and Y 366-B17]. Dr. Schwab was supported by a fellowship from the KLI for Evolution and Cognition Research, Altenberg, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baglione V, 2003, SCIENCE, V300, P1947, DOI 10.1126/science.1082429; Boesch C, 2000, CHIMPANZEES TAI FORE; Bradbury Jack W., 1998, pi; Brosnan SF, 2010, PHILOS T R SOC B, V365, P2699, DOI 10.1098/rstb.2010.0154; Bugnyar T, 2001, ANIM BEHAV, V61, P949, DOI 10.1006/anbe.2000.1668; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Cronin KA, 2010, P ROY SOC B-BIOL SCI, V277, P3845, DOI 10.1098/rspb.2010.0879; Cronin KA, 2009, J COMP PSYCHOL, V123, P231, DOI 10.1037/a0015094; De Kort SR, 2006, ANIM BEHAV, V72, P297, DOI 10.1016/j.anbehav.2005.10.016; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; Dugatkin L.A., 1997, COOPERATION ANIMALS; Emery N. J., 2004, COMP ANAL MINDS, P181, DOI DOI 10.1098/RSTB.2006.1991; Emery NJ, 2007, PHILOS T R SOC B, V362, P489, DOI 10.1098/rstb.2006.1991; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fritz J, 1999, ANIM BEHAV, V57, P785, DOI 10.1006/anbe.1998.1035; Hauser, 1996, EVOL COMMUN; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P2363, DOI 10.1098/rspb.2003.2509; HEINRICH B, 1991, BEHAV ECOL SOCIOBIOL, V28, P13; HENDERSON IG, 1993, ORNIS SCAND, V24, P142, DOI 10.2307/3676364; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Horner V, 2011, P NATL ACAD SCI USA, V108, P13847, DOI 10.1073/pnas.1111088108; Hrdy S.B., 2005, ATTACHMENT BONDING N, P9, DOI DOI 10.1016/J.GLOENVCHA.2013.12.001; Iwaniuk AN, 2005, BRAIN BEHAV EVOLUT, V65, P215, DOI 10.1159/000084313; Jensen K, 2006, P ROY SOC B-BIOL SCI, V273, P1013, DOI 10.1098/rspb.2005.3417; Massen JJM, 2011, BENEFITING FRIENDS D; Massen JJM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009734; Melis AP, 2011, P ROY SOC B-BIOL SCI, V278, P1405, DOI 10.1098/rspb.2010.1735; Mitani JC, 2000, ANIM BEHAV, V59, P885, DOI 10.1006/anbe.1999.1389; Nishida Toshisada, 1996, P114, DOI 10.1017/CBO9780511752414.011; Noe R, 2006, ANIM BEHAV, V71, P1, DOI 10.1016/j.anbehav.2005.03.037; PARKER PG, 1994, ANIM BEHAV, V48, P1085, DOI 10.1006/anbe.1994.1342; Rendell L, 2011, TRENDS COGN SCI, V15, P68, DOI 10.1016/j.tics.2010.12.002; ROELL A, 1978, BEHAVIOUR, V64, P1; Scheid C, 2008, ANIM BEHAV, V76, P1701, DOI 10.1016/j.anbehav.2008.07.023; Schwab C, 2008, BEHAV PROCESS, V79, P148, DOI 10.1016/j.beproc.2008.07.002; Schwab C, 2008, ANIM BEHAV, V75, P501, DOI 10.1016/j.anbehav.2007.06.006; Shettleworth SJ, 2010, TRENDS COGN SCI, V14, P477, DOI 10.1016/j.tics.2010.07.002; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; von Bayern AMP, 2007, BEHAVIOUR, V144, P711, DOI 10.1163/156853907781347826; von Bayern AMP, 2009, CURR BIOL, V19, P602, DOI 10.1016/j.cub.2009.02.062; Vonk J, 2008, ANIM BEHAV, V75, P1757, DOI 10.1016/j.anbehav.2007.09.036; WAITE RK, 1981, Z TIERPSYCHOL, V57, P15; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Watts DP, 1998, BEHAV ECOL SOCIOBIOL, V44, P43, DOI 10.1007/s002650050513; WECHSLER B, 1988, BEHAVIOUR, V107, P267, DOI 10.1163/156853988X00377; WHITEN A, 1992, ADV STUD BEHAV, V21, P239, DOI 10.1016/S0065-3454(08)60146-1; Yamamoto S, 2010, ANIM BEHAV, V79, P595, DOI 10.1016/j.anbehav.2009.11.034; Yamamoto S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007416; Zentall Thomas R., 1996, P221, DOI 10.1016/B978-012273965-1/50012-1; [No title captured]	53	39	40	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34922	10.1371/journal.pone.0034922	http://dx.doi.org/10.1371/journal.pone.0034922			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511972	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338600058
J	Aithal, A; Sharma, A; Joshi, S; Raghava, GPS; Varshney, GC				Aithal, Abhijit; Sharma, Arun; Joshi, Shilpy; Raghava, Gajendra P. S.; Varshney, Grish C.			PolysacDB: A Database of Microbial Polysaccharide Antigens and Their Antibodies	PLOS ONE			English	Article							COMPREHENSIVE DATABASE; VACCINES; LIGANDS; TOOLS	Vaccines based on microbial cell surface polysaccharides have long been considered as attractive means to control infectious diseases. To realize this goal, detailed systematic information about the antigenic polysaccharide is necessary. However, only a few databases that provide limited knowledge in this area are available. This paper describes PolysacDB, a manually curated database of antigenic polysaccharides. We collected and compiled comprehensive information from literature and web resources about antigenic polysaccharides of microbial origin. The current version of the database has 1,554 entries of 149 different antigenic polysaccharides from 347 different microbes. Each entry provides comprehensive information about an antigenic polysaccharide, i.e., its origin, function, protocols for its conjugation to carriers, antibodies produced, details of assay systems, specificities of antibodies, proposed epitopes involved and antibody utilities. For convenience to the user, we have integrated web interface for searching, advanced searching and browsing data in database. This database will be useful for researchers working on polysaccharide-based vaccines. It is freely available from the URL: http://crdd.osdd.net/raghava/polysacdb/.	[Aithal, Abhijit; Joshi, Shilpy; Varshney, Grish C.] Inst Microbial Technol, Cell Biol & Immunol Div, Chandigarh, India; [Sharma, Arun; Raghava, Gajendra P. S.] Inst Microbial Technol, Bioinformat Ctr, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Aithal, A (corresponding author), Inst Microbial Technol, Cell Biol & Immunol Div, Chandigarh, India.	raghava@imtech.res.in; grish@imtech.res.in	Raghava, Gajendra/B-1717-2009; Raghava, Gajendra P.S./AAA-2413-2022; Aithal, Abhijit/AAR-9856-2021	Raghava, Gajendra P.S./0000-0002-8902-2876; Sharma, Arun/0000-0003-3854-7944; Aithal, Abhijit/0000-0001-9035-7529	Council of Scientific and Industrial Research (CSIR); Department of Biotechnology, Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	The work was supported by Council of Scientific and Industrial Research (CSIR) and Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012; Bhasin M, 2003, BIOINFORMATICS, V19, P665, DOI 10.1093/bioinformatics/btg055; Chailyan A, 2012, NUCLEIC ACIDS RES, V40, pD1230, DOI 10.1093/nar/gkr806; Comstock LE, 2006, CELL, V126, P847, DOI 10.1016/j.cell.2006.08.021; Giudicelli V, 1997, NUCLEIC ACIDS RES, V25, P206, DOI 10.1093/nar/25.1.206; Jones C, 2005, AN ACAD BRAS CIENC, V77, P293, DOI 10.1590/S0001-37652005000200009; Lata S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-180; Pirofski LA, 2001, TRENDS MICROBIOL, V9, P445, DOI 10.1016/S0966-842X(01)02134-5; PLUSCHKE G, 1986, INFECT IMMUN, V51, P286, DOI 10.1128/IAI.51.1.286-293.1986; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Saha S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-79; Singh MK, 2006, BIOINFORMATICS, V22, P253, DOI 10.1093/bioinformatics/bti692; Toseland Christopher P, 2005, Immunome Res, V1, P4, DOI 10.1186/1745-7580-1-4; Varki A, 2009, ESSENTIALS GLYCOBIOL; Vita R, 2010, NUCLEIC ACIDS RES, V38, pD854, DOI 10.1093/nar/gkp1004	15	7	7	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34613	10.1371/journal.pone.0034613	http://dx.doi.org/10.1371/journal.pone.0034613			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509333	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600039
J	Pang, JJ; Deng, WT; Dai, XF; Lei, B; Everhart, D; Umino, Y; Li, J; Zhang, KQ; Mao, S; Boye, SL; Liu, L; Chiodo, VA; Liu, X; Shi, W; Tao, Y; Chang, B; Hauswirth, WW				Pang, Ji-Jing; Deng, Wen-Tao; Dai, Xufeng; Lei, Bo; Everhart, Drew; Umino, Yumiko; Li, Jie; Zhang, Keqing; Mao, Song; Boye, Sanford L.; Liu, Li; Chiodo, Vince A.; Liu, Xuan; Shi, Wei; Tao, Ye; Chang, Bo; Hauswirth, William W.			AAV-Mediated Cone Rescue in a Naturally Occurring Mouse Model of CNGA3-Achromatopsia	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNEL; GENE-THERAPY; ADENOASSOCIATED VIRUS; ALPHA-SUBUNIT; CNGA3 MUTATIONS; MICE LACKING; RD10 MOUSE; PHOTORECEPTOR; VISION; ACHROMATOPSIA	Achromatopsia is a rare autosomal recessive disorder which shows color blindness, severely impaired visual acuity, and extreme sensitivity to bright light. Mutations in the alpha subunits of the cone cyclic nucleotide-gated channels (CNGA3) are responsible for about 1/4 of achromatopsia in the U.S. and Europe. Here, we test whether gene replacement therapy using an AAV5 vector could restore cone-mediated function and arrest cone degeneration in the cpfl5 mouse, a naturally occurring mouse model of achromatopsia with a CNGA3 mutation. We show that gene therapy leads to significant rescue of cone-mediated ERGs, normal visual acuities and contrast sensitivities. Normal expression and outer segment localization of both M- and S-opsins were maintained in treated retinas. The therapeutic effect of treatment lasted for at least 5 months post-injection. This study is the first demonstration of substantial, relatively long-term restoration of cone-mediated light responsiveness and visual behavior in a naturally occurring mouse model of CNGA3 achromatopsia. The results provide the foundation for development of an AAV5-based gene therapy trial for human CNGA3 achromatopsia.	[Pang, Ji-Jing; Deng, Wen-Tao; Dai, Xufeng; Li, Jie; Mao, Song; Boye, Sanford L.; Liu, Li; Chiodo, Vince A.; Liu, Xuan; Shi, Wei; Tao, Ye; Hauswirth, William W.] Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA; [Pang, Ji-Jing; Dai, Xufeng] Wenzhou Med Coll, Sch Optometry & Ophthalmol, Hosp Eye, Wenzhou, Peoples R China; [Lei, Bo; Zhang, Keqing] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Everhart, Drew; Umino, Yumiko] SUNY Upstate Med Univ, Syracuse, NY USA; [Chang, Bo] Jackson Lab, Bar Harbor, ME 04609 USA	State University System of Florida; University of Florida; Wenzhou Medical University; Chongqing Medical University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Jackson Laboratory	Pang, JJ (corresponding author), Univ Florida, Coll Med, Dept Ophthalmol, Gainesville, FL 32610 USA.	jpang@ufl.edu	Deng, Wen-Tao/AAC-4754-2021	Lei, Bo/0000-0002-5497-0905; hauswirth, william/0000-0002-3244-4947; Chang, Bo/0000-0001-8259-7290; Deng, Wen-Tao/0000-0002-9357-0656	National Institutes of Health [EY018331, EY021721, EY017246]; Macular Vision Research Foundation; Foundation Fighting Blindness, Fight for Sight; Lions of Central NY; Research to Prevent Blindness, Inc.; Juvenile Diabetes Research Foundation; NATIONAL EYE INSTITUTE [P30EY021721, R21EY018331, F32EY017246, R01EY019943] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Macular Vision Research Foundation; Foundation Fighting Blindness, Fight for Sight; Lions of Central NY; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Institutes of Health grants EY018331 (JP), EY021721 (WWH), EY017246 (DE), and by grants from the Macular Vision Research Foundation, Foundation Fighting Blindness, Fight for Sight (DE), Lions of Central NY, Research to Prevent Blindness, Inc., and Juvenile Diabetes Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja Y, 2008, MOL VIS, V14, P1293; Alexander JJ, 2007, NAT MED, V13, P685, DOI 10.1038/nm1596; Aligianis IA, 2002, J MED GENET, V39, P656, DOI 10.1136/jmg.39.9.656; Allocca M, 2011, INVEST OPHTH VIS SCI, V52, P5713, DOI 10.1167/iovs.10-6269; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Boye SE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011306; Burns ME, 2005, NEURON, V48, P387, DOI 10.1016/j.neuron.2005.10.014; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Cideciyan AV, 2009, NEW ENGL J MED, V361, P725, DOI 10.1056/NEJMc0903652; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Deng WT, 2009, P NATL ACAD SCI USA, V106, P17681, DOI 10.1073/pnas.0901382106; Genead MA, 2011, INVEST OPHTH VIS SCI, V52, P7298, DOI 10.1167/iovs.11-7762; Glushakova LG, 2006, INVEST OPHTH VIS SCI, V47, P3505, DOI 10.1167/iovs.05-1670; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Jacobson SG, 2006, MOL THER, V13, P1074, DOI 10.1016/j.ymthe.2006.03.005; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Johnson S, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011437; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kohl S, 2005, EUR J HUM GENET, V13, P302, DOI 10.1038/sj.ejhg.5201269; Kohl S, 2002, AM J HUM GENET, V71, P422, DOI 10.1086/341835; Kohl S, 1998, NAT GENET, V19, P257, DOI 10.1038/935; Kohl S, 2000, HUM MOL GENET, V9, P2107, DOI 10.1093/hmg/9.14.2107; Komaromy AM, 2010, HUM MOL GENET, V19, P2581, DOI 10.1093/hmg/ddq136; Kong FS, 2010, EXP EYE RES, V90, P546, DOI 10.1016/j.exer.2010.01.011; Li X, 2011, INVEST OPHTH VIS SCI, V52, P7, DOI 10.1167/iovs.10-6138; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Matveev AV, 2008, J NEUROCHEM, V106, P2042, DOI 10.1111/j.1471-4159.2008.05548.x; Michaelides M, 2004, BRIT J OPHTHALMOL, V88, P291, DOI 10.1136/bjo.2003.027102; Michaelides M, 2006, SURV OPHTHALMOL, V51, P232, DOI 10.1016/j.survophthal.2006.02.007; Michalakis S, 2005, INVEST OPHTH VIS SCI, V46, P1516, DOI 10.1167/iovs.04-1503; Michalakis S, 2010, MOL THER, V18, P2057, DOI 10.1038/mt.2010.149; Milunsky A, 1999, CLIN GENET, V56, P82, DOI 10.1034/j.1399-0004.1999.560112.x; Pang J, 2010, GENE THER, V17, P815, DOI 10.1038/gt.2010.29; Pang JJ, 2012, CURR MOL MED, V12, P316, DOI 10.2174/156652412799218877; Pang JJ, 2008, INVEST OPHTH VIS SCI, V49, P4278, DOI 10.1167/iovs.07-1622; Pang JJ, 2011, MOL THER, V19, P234, DOI 10.1038/mt.2010.273; Pang JJ, 2010, ADV EXP MED BIOL, V664, P639, DOI 10.1007/978-1-4419-1399-9_73; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; Peng CH, 2004, NEURON, V42, P401, DOI 10.1016/S0896-6273(04)00225-9; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Thiadens AAHJ, 2009, AM J HUM GENET, V85, P240, DOI 10.1016/j.ajhg.2009.06.016; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613; Yang GS, 2002, J VIROL, V76, P7651, DOI 10.1128/JVI.76.15.7651-7660.2002; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	46	91	96	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35250	10.1371/journal.pone.0035250	http://dx.doi.org/10.1371/journal.pone.0035250			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509403	Green Published, gold			2022-12-27	WOS:000305336600097
J	Zheng, XW; Wang, L; Zhu, YW; Guan, Q; Li, HJ; Xiong, ZG; Deng, LY; Lu, J; Miao, XP; Cheng, LM				Zheng, Xiawen; Wang, Li; Zhu, Yaowu; Guan, Qing; Li, Huijun; Xiong, Zhigang; Deng, Lingyan; Lu, Jie; Miao, Xiaoping; Cheng, Liming			The SNP rs961253 in 20p12.3 Is Associated with Colorectal Cancer Risk: A Case-Control Study and a Meta-Analysis of the Published Literature	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENETIC-VARIANTS; SCAN; POLYMORPHISMS; SUPPRESSION; BIAS	Background: Colorectal cancer (CRC) is the third common cancer and the fourth leading cause of cancer death worldwide. A single nucleotide polymorphism (SNP), rs961253 located in 20p12, was firstly described to be associated with the increased risk of CRC in a genome-wide association study; however, more recent replication studies yielded controversial results. Methodology/Principal Findings: A hospital-based case-control study in a Chinese population was firstly performed, and then a meta-analysis combining the current and previously published studies were conducted to explore the real effect of rs961253 in CRC susceptibility. In the Chinese population including 641 cases and 1037 controls, per-A-allele conferred an OR of 1.60 (95% CI = 1.26-2.02) under additive model. In the meta-analysis including 29859 cases and 29696 controls, per-A-allele have an OR of 1.13 (95% CI = 1.09-1.18) under a random-effects model due to heterogeneity (P = 0.019). Nevertheless, the heterogeneity can be totally explained by ethnicity, with the tau(2)reduced to 0 after including ethnicity in meta-regression model. In stratified analysis by ethnicity, per-A-allele had ORs of 1.34 (95% CI = 1.20-1.50) and 1.11 (95% CI = 1.08-1.14) for Asian and European, respectively, without heterogeneity. Modest influence of each study was observed on overall estimate in sensitive analysis, and evident tendency to significant association was seen in cumulative analysis over time, together indicating the robust stability of the current results. Conclusions/Significance: The results from our study and the meta-analysis provided firm evidence that rs961253 significantly contributed to CRC risk in both Asian and European population.	[Zheng, Xiawen; Zhu, Yaowu; Guan, Qing; Li, Huijun; Xiong, Zhigang; Deng, Lingyan; Lu, Jie; Cheng, Liming] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Lab Med, Wuhan 430074, Peoples R China; [Zheng, Xiawen; Miao, Xiaoping] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth,Dept Epidemiol & Biostat, MOE Key Lab Environm & Hlth, Wuhan 430074, Peoples R China; [Wang, Li] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Epidemiol & Biostat, Beijing, Peoples R China; [Wang, Li] Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Cheng, LM (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Lab Med, Wuhan 430074, Peoples R China.	chengliming@tjh.tjmu.edu.cn	miao, xiaoping/C-4336-2011; Xiao, Hu/GMX-0258-2022	miao, xiaoping/0000-0002-6818-9722; 	Natural Science Foundation of China [NSFC-81001275, 81171878]; Fok Ying Tung Foundation for Young Teachers in the Higher Education Institutions of China [131038]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying Tung Foundation for Young Teachers in the Higher Education Institutions of China	This work was supported by the National Natural Science Foundation of China [NSFC-81001275 and 81171878 to X.M.] and the Fok Ying Tung Foundation for Young Teachers in the Higher Education Institutions of China (131038) to X.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck SE, 2006, AM J PHYSIOL-GASTR L, V291, pG135, DOI 10.1152/ajpgi.00482.2005; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; He J, 2011, CANCER EPIDEM BIOMAR, V20, P70, DOI 10.1158/1055-9965.EPI-10-0892; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ho JW, 2011, BRIT J CANCER, V104, P369, DOI 10.1038/sj.bjc.6605977; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mullen B, 2001, PERS SOC PSYCHOL B, V27, P1450, DOI 10.1177/01461672012711006; Niittymaki I, 2010, CANCER EPIDEM BIOMAR, V19, P1478, DOI 10.1158/1055-9965.EPI-09-1320; Pabalan NA, 2010, ASIAN PAC J CANCER P, V11, P33; Park JH, 2011, P NATL ACAD SCI USA, V108, P18026, DOI 10.1073/pnas.1114759108; Qiu L, 2008, EUR J CANCER, V44, P2241, DOI 10.1016/j.ejca.2008.06.024; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tenesa A, 2009, NAT REV GENET, V10, P353, DOI 10.1038/nrg2574; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; von Holst S, 2010, BRIT J CANCER, V103, P575, DOI 10.1038/sj.bjc.6605774; Xiong F, 2010, CANCER EPIDEM BIOMAR, V19, P1855, DOI 10.1158/1055-9965.EPI-10-0210; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhong H, 2010, GENET EPIDEMIOL, V34, P78, DOI 10.1002/gepi.20437	38	8	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34625	10.1371/journal.pone.0034625	http://dx.doi.org/10.1371/journal.pone.0034625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509336	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336600042
J	Blanc, F; Noblet, V; Jung, B; Rousseau, F; Renard, F; Bourre, B; Longato, N; Cremel, N; Di Bitonto, L; Kleitz, C; Collongues, N; Foucher, J; Kremer, S; Armspach, JP; de Seze, J				Blanc, Frederic; Noblet, Vincent; Jung, Barbara; Rousseau, Francois; Renard, Felix; Bourre, Bertrand; Longato, Nadine; Cremel, Nadjette; Di Bitonto, Laure; Kleitz, Catherine; Collongues, Nicolas; Foucher, Jack; Kremer, Stephane; Armspach, Jean-Paul; de Seze, Jerome			White Matter Atrophy and Cognitive Dysfunctions in Neuromyelitis Optica	PLOS ONE			English	Article							DIFFUSION-TENSOR MRI; MULTIPLE-SCLEROSIS; FUNCTIONAL-ORGANIZATION; SPECTRUM DISORDERS; EPISODIC MEMORY; CEREBRAL LESION; BRAIN; DAMAGE; AQUAPORIN-4; DISABILITY	Neuromyelitis optica (NMO) is an inflammatory disease of central nervous system characterized by optic neuritis and longitudinally extensive acute transverse myelitis. NMO patients have cognitive dysfunctions but other clinical symptoms of brain origin are rare. In the present study, we aimed to investigate cognitive functions and brain volume in NMO. The study population consisted of 28 patients with NMO and 28 healthy control subjects matched for age, sex and educational level. We applied a French translation of the Brief Repeatable Battery (BRB-N) to the NMO patients. Using SIENAx for global brain volume (Grey Matter, GM; White Matter, WM; and whole brain) and VBM for focal brain volume (GM and WM), NMO patients and controls were compared. Voxel-level correlations between diminished brain concentration and cognitive performance for each tests were performed. Focal and global brain volume of NMO patients with and without cognitive impairment were also compared. Fifteen NMO patients (54%) had cognitive impairment with memory, executive function, attention and speed of information processing deficits. Global and focal brain atrophy of WM but not Grey Matter (GM) was found in the NMO patients group. The focal WM atrophy included the optic chiasm, pons, cerebellum, the corpus callosum and parts of the frontal, temporal and parietal lobes, including superior longitudinal fascicle. Visual memory, verbal memory, speed of information processing, short-term memory and executive functions were correlated to focal WM volumes. The comparison of patients with, to patients without cognitive impairment showed a clear decrease of global and focal WM, including brainstem, corticospinal tracts, corpus callosum but also superior and inferior longitudinal fascicles. Cognitive impairment in NMO patients is correlated to the decreased of global and focal WM volume of the brain. Further studies are needed to better understand the precise origin of cognitive impairment in NMO patients, particularly in the WM.	[Blanc, Frederic; Jung, Barbara; Bourre, Bertrand; Longato, Nadine; Cremel, Nadjette; Di Bitonto, Laure; Kleitz, Catherine; Collongues, Nicolas; de Seze, Jerome] Univ Hosp Strasbourg, Dept Neurol, Neuropsychol Serv, Strasbourg, France; [Blanc, Frederic; Renard, Felix; Bourre, Bertrand; Collongues, Nicolas; Kremer, Stephane; Armspach, Jean-Paul; de Seze, Jerome] Univ Strasbourg, UMR 7237, LINC, Strasbourg, France; [Blanc, Frederic; Noblet, Vincent; Rousseau, Francois; Renard, Felix; Bourre, Bertrand; Collongues, Nicolas; Kremer, Stephane; Armspach, Jean-Paul; de Seze, Jerome] CNRS, Strasbourg, France; [Blanc, Frederic; Jung, Barbara; Longato, Nadine; Cremel, Nadjette; Di Bitonto, Laure; Kleitz, Catherine] Univ Hosp Strasbourg, Dept Neurol, CMRR, Strasbourg, France; [Noblet, Vincent; Rousseau, Francois; Renard, Felix] Univ Strasbourg, UMR 7005, LSIIT Image Sci Comp Sci & Remote Sensing Lab, Strasbourg, France; [Foucher, Jack] Univ Hosp Strasbourg, INSERM, U666, Strasbourg, France; [Kremer, Stephane] Univ Hosp Strasbourg, Serv Neuroradiol, Strasbourg, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU Strasbourg	Blanc, F (corresponding author), Univ Hosp Strasbourg, Dept Neurol, Neuropsychol Serv, Strasbourg, France.	Frederic.Blanc@chru-Strasbourg.fr	De Seze, Jerome/M-8316-2016; collongues, nicolas/J-9830-2016; Noblet, Vincent/B-3992-2009; Blanc, Frederic/AAE-7975-2019; rousseau, francois/B-3338-2008; Noblet, Vincent/ABE-4264-2020	De Seze, Jerome/0000-0002-7197-7578; collongues, nicolas/0000-0002-3683-5582; Blanc, Frederic/0000-0002-6714-3247; rousseau, francois/0000-0001-9837-7487; 				Aboul-Enein F, 2010, AM J NEURORADIOL, V31, P76, DOI 10.3174/ajnr.A1791; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Benarroch EE, 2009, NEUROLOGY, V73, P1699, DOI 10.1212/WNL.0b013e3181c2937c; Bichuetti DB, 2008, J NEUROL, V255, P1895, DOI 10.1007/s00415-009-0940-0; Blanc F, 2008, ARCH NEUROL-CHICAGO, V65, P84, DOI 10.1001/archneurol.2007.16; Bledowski C, 2010, BEHAV BRAIN RES, V214, P172, DOI 10.1016/j.bbr.2010.05.041; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Chalumeau-Lemoine L, 2006, ARCH NEUROL-CHICAGO, V63, P591, DOI 10.1001/archneur.63.4.591; Collongues N, 2010, NEUROLOGY, V74, P736, DOI 10.1212/WNL.0b013e3181d31e35; de Seze J, 2010, J NEUROL NEUROSUR PS, V81, P409, DOI 10.1136/jnnp.2008.168070; De Stefano N, 2002, ARCH NEUROL-CHICAGO, V59, P1565, DOI 10.1001/archneur.59.10.1565; Dujardin K, 2004, REV NEUROL-FRANCE, V160, P51, DOI 10.1016/S0035-3787(04)70847-4; Eichenbaum H, 2008, HIPPOCAMPUS, V18, P1314, DOI 10.1002/hipo.20500; Gault F, 1894, THESIS FACULTE MED P; He DA, 2011, BRAIN COGNITION, V77, P80, DOI 10.1016/j.bandc.2011.05.007; Hengstman GJD, 2007, MULT SCLER, V13, P679, DOI 10.1177/1352458506070145; Kim JE, 2011, J NEUROL SCI, V302, P43, DOI 10.1016/j.jns.2010.12.001; Kim JH, 2007, J CLIN NEUROL, V3, P62, DOI 10.3988/jcn.2007.3.1.62; Koenigs M, 2011, NEUROPSYCHOLOGIA, V49, P3612, DOI 10.1016/j.neuropsychologia.2011.09.013; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Marignier R, 2008, MULT SCLER, V14, P440, DOI 10.1177/1352458507084595; McKeon A, 2009, ARCH NEUROL-CHICAGO, V66, P1134, DOI 10.1001/archneurol.2009.178; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Nakamura M, 2005, MULT SCLER J, V11, P735, DOI 10.1191/1352458505ms1236cr; Ozturk A, 2010, MULT SCLER J, V16, P166, DOI 10.1177/1352458509353649; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P964, DOI 10.1001/archneur.63.7.964; Pittock SJ, 2006, ARCH NEUROL-CHICAGO, V63, P390, DOI 10.1001/archneur.63.3.390; Popescu BFG, 2010, NEUROLOGY, V75, P2103, DOI 10.1212/WNL.0b013e318200d80c; Rocca MA, 2004, NEUROLOGY, V62, P476, DOI 10.1212/01.WNL.0000106946.08741.41; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Saji E, 2010, NEUROLOGY, V74, pA169; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Sharma S, 2010, MED IMAGE ANAL, V14, P373, DOI 10.1016/j.media.2010.02.002; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; Vestergaard M, 2011, J COGNITIVE NEUROSCI, V23, P2135, DOI 10.1162/jocn.2010.21592; Wechsler D, 2008, WAIS 3 WECHSLER ADUL, VFourth; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Yu CS, 2006, AM J NEURORADIOL, V27, P1009; Yu CS, 2008, RADIOLOGY, V246, P222, DOI 10.1148/radiol.2461062075; Zaidel Dahlia W., 1995, Biological Research, V28, P51	43	63	69	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e33878	10.1371/journal.pone.0033878	http://dx.doi.org/10.1371/journal.pone.0033878			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509264	Green Submitted, gold, Green Published			2022-12-27	WOS:000304805900009
J	Kelsall, CJ; Hoile, SP; Irvine, NA; Masoodi, M; Torrens, C; Lillycrop, KA; Calder, PC; Clough, GF; Hanson, MA; Burdge, GC				Kelsall, Christopher J.; Hoile, Samuel P.; Irvine, Nicola A.; Masoodi, Mojgan; Torrens, Christopher; Lillycrop, Karen A.; Calder, Philip C.; Clough, Geraldine F.; Hanson, Mark A.; Burdge, Graham C.			Vascular Dysfunction Induced in Offspring by Maternal Dietary Fat Involves Altered Arterial Polyunsaturated Fatty Acid Biosynthesis	PLOS ONE			English	Article							PROTEIN-RESTRICTED DIET; LINOLEIC-ACID; ENDOTHELIAL DYSFUNCTION; ARACHIDONIC-ACID; NITRIC-OXIDE; DELTA-5 DESATURASE; GENE-EXPRESSION; PREGNANT RATS; METABOLISM; TRANS	Nutrition during development affects risk of future cardiovascular disease. Relatively little is known about whether the amount and type of fat in the maternal diet affect vascular function in the offspring. To investigate this, pregnant and lactating rats were fed either 7%(w/w) or 21%(w/w) fat enriched in either18:2n-6, trans fatty acids, saturated fatty acids, or fish oil. Their offspring were fed 4%(w/w) soybean oil from weaning until day 77. Type and amount of maternal dietary fat altered acetylcholine (ACh)-mediated vaso-relaxation in offspring aortae and mesenteric arteries, contingent on sex. Amount, but not type, of maternal dietary fat altered phenylephrine (Pe)-induced vasoconstriction in these arteries. Maternal 21% fat diet decreased 20:4n-6 concentration in offspring aortae. We investigated the role of Delta 6 and Delta 5 desaturases, showing that their inhibition in aortae and mesenteric arteries reduced vasoconstriction, but not vaso-relaxation, and the synthesis of specific pro-constriction eicosanoids. Removal of the aortic endothelium did not alter the effect of inhibition of Delta 6 and Delta 5 desaturases on Pe-mediated vasoconstriction. Thus arterial smooth muscle 20:4n-6 biosynthesis de novo appears to be important for Pe-mediated vasoconstriction. Next we studied genes encoding these desaturases, finding that maternal 21% fat reduced Fads2 mRNA expression and increased Fads1 in offspring aortae, indicating dysregulation of 20:4n-6 biosynthesis. Methylation at CpG -394 bp 5' to the Fads2 transcription start site predicted its expression. This locus was hypermethylated in offspring of dams fed 21% fat. Pe treatment of aortae for 10 minutes increased Fads2, but not Fads1, mRNA expression (76%; P<0.05). This suggests that Fads2 may be an immediate early gene in the response of aortae to Pe. Thus both amount and type of maternal dietary fat induce altered regulation of vascular tone in offspring though differential effects on vaso-relaxation, and persistent changes in vasoconstriction via epigenetic processes controlling arterial polyunsaturated fatty acid biosynthesis.	[Kelsall, Christopher J.; Hoile, Samuel P.; Irvine, Nicola A.; Torrens, Christopher; Calder, Philip C.; Clough, Geraldine F.; Hanson, Mark A.; Burdge, Graham C.] Univ Southampton, Acad Unit Human Dev & Hlth, Fac Med, Southampton SO9 5NH, Hants, England; [Masoodi, Mojgan] Elsie Widdowson Lab, MRC Human Nutr Res, Cambridge, England; [Lillycrop, Karen A.] Univ Southampton, Fac Nat & Environm Sci, Southampton SO9 5NH, Hants, England	University of Southampton; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Southampton	Kelsall, CJ (corresponding author), Univ Southampton, Acad Unit Human Dev & Hlth, Fac Med, Southampton SO9 5NH, Hants, England.	g.c.burdge@southampton.ac.uk	Torrens, Christopher/A-8117-2013; Burdge, Graham/A-2370-2014; MASOODI, MOJGAN/P-1499-2019; Calder, Philip C/E-9739-2013; Hanson, Mark/AAE-8236-2019	Torrens, Christopher/0000-0003-4377-0112; Burdge, Graham/0000-0002-7665-2967; MASOODI, MOJGAN/0000-0001-9840-1731; Calder, Philip C/0000-0002-6038-710X; Hanson, Mark/0000-0002-6907-613X; Lillycrop, Karen/0000-0001-7350-5489	British Heart Foundation [PG/08/126/26417, CH/02/01]; Medical Research Council; MRC [MC_EX_G0800783, MC_UP_A090_1006] Funding Source: UKRI; Medical Research Council [MC_EX_G0800783, MC_UP_A090_1006] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a grant (PG/08/126/26417) from the British Heart Foundation (http://www.bhf.org.uk) which also provided salary support for MAH (CH/02/01). MM acknowledges research support from the Medical Research Council (http://www.mrc.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANEL A, 1990, BIOCHIM BIOPHYS ACTA, V1044, P323, DOI 10.1016/0005-2760(90)90076-A; Antoniades C, 2009, AM J CARDIOL, V103, P216, DOI 10.1016/j.amjcard.2008.08.056; Armitage JA, 2005, J PHYSIOL-LONDON, V565, P171, DOI 10.1113/jphysiol.2005.084947; Armitage JA, 2007, EXP PHYSIOL, V92, P583, DOI 10.1113/expphysiol.2006.036202; Babu GJ, 2000, J MOL CELL CARDIOL, V32, P1447, DOI 10.1006/jmcc.2000.1185; Burdge GC, 2000, BRIT J NUTR, V84, P781; Burdge GC, 2006, NUTR RES REV, V19, P26, DOI 10.1079/NRR2005113; Burdge GC, 2009, J NUTR, V139, P1054, DOI 10.3945/jn.109.104653; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Chadha PS, 2010, J PHARMACOL EXP THER, V335, P284, DOI 10.1124/jpet.110.167593; CHAPKIN RS, 1988, J IMMUNOL, V140, P2350; Chiu HC, 2001, J CLIN INVEST, V107, P813, DOI 10.1172/JCI10947; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Couloubaly S, 2007, EUR J CLIN INVEST, V37, P692, DOI 10.1111/j.1365-2362.2007.01843.x; Czernichow S, 2010, BRIT J NUTR, V104, P788, DOI 10.1017/S0007114510002096; Das UN, 2007, PROSTAG LEUKOTR ESS, V76, P251, DOI 10.1016/j.plefa.2007.03.001; DECSI T, 1995, ANN NUTR METAB, V39, P36, DOI 10.1159/000177840; DeltonVandenbroucke I, 1997, J LIPID RES, V38, P147; DESCHRIJVER R, 1982, LIPIDS, V17, P27, DOI 10.1007/BF02535118; Devlin AM, 2007, J BIOL CHEM, V282, P37082, DOI 10.1074/jbc.M704256200; Feletou M, 2010, PFLUG ARCH EUR J PHY, V459, P941, DOI 10.1007/s00424-010-0812-6; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ghosh P, 2001, J PHYSIOL-LONDON, V533, P815, DOI 10.1111/j.1469-7793.2001.00815.x; Giannotti G, 2007, HERZ, V32, P568, DOI 10.1007/s00059-007-3073-1; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gluckman PD, 2007, P NATL ACAD SCI USA, V104, P12796, DOI 10.1073/pnas.0705667104; Goligorsky MS, 2002, AM J PHYSIOL-RENAL, V283, pF1, DOI 10.1152/ajprenal.00377.2001; Hansen-Petrik MB, 2002, CANCER LETT, V175, P157, DOI 10.1016/S0304-3835(01)00715-7; Harmon SD, 2003, LIPIDS, V38, P469, DOI 10.1007/s11745-003-1086-9; Harris RG, 2002, J BIOL CHEM, V277, P34815, DOI 10.1074/jbc.M109609200; Hilgers RHP, 2009, BRIT J PHARMACOL, V156, P1239, DOI 10.1111/j.1476-5381.2009.00128.x; Hunter JE, 2010, AM J CLIN NUTR, V91, P46, DOI 10.3945/ajcn.2009.27661; Innis SM, 1999, AM J CLIN NUTR, V70, P383; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; KOLETZKO B, 1992, ACTA PAEDIATR, V81, P302, DOI 10.1111/j.1651-2227.1992.tb12230.x; Kwak JH, 2011, ATHEROSCLEROSIS, V214, P94, DOI 10.1016/j.atherosclerosis.2010.10.004; Lattka E, 2010, J LIPID RES, V51, P182, DOI 10.1194/jlr.M900289-JLR200; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lillycrop KA, 2007, BRIT J NUTR, V97, P1064, DOI 10.1017/S000711450769196X; Martinelli N, 2008, AM J CLIN NUTR, V88, P941, DOI 10.1093/ajcn/88.4.941; Masoodi M, 2008, RAPID COMMUN MASS SP, V22, P75, DOI 10.1002/rcm.3331; Masoodi M, 2010, ANAL CHEM, V82, P8176, DOI 10.1021/ac1015563; Mozaffarian D, 2006, ATHEROSCLEROSIS SUPP, V7, P29, DOI 10.1016/j.atherosclerosissup.2006.04.007; PETTERSEN J, 1992, LIPIDS, V27, P761, DOI 10.1007/BF02535846; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Psota TL, 2006, AM J CARDIOL, V98, p3I, DOI 10.1016/j.amjcard.2005.12.022; Reeves PG, 1997, J NUTR, V127, pS838; Ringseis R, 2010, PROSTAG LEUKOTR ESS, V82, P189, DOI 10.1016/j.plefa.2010.02.022; ROSENTHAL MD, 1983, BIOCHIM BIOPHYS ACTA, V750, P490, DOI 10.1016/0005-2760(83)90189-3; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; SCHWARTZ SM, 1980, ARTERY, V8, P305; SHIMIZU S, 1991, LIPIDS, V26, P512, DOI 10.1007/BF02536595; Simopoulos AP, 2010, EXP BIOL MED, V235, P785, DOI 10.1258/ebm.2010.009298; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Taylor PD, 2004, J PHYSIOL-LONDON, V558, P943, DOI 10.1113/jphysiol.2002.018879; Torrens C, 2006, HYPERTENSION, V47, P982, DOI 10.1161/01.HYP.0000215580.43711.d1; Torrens C, 2009, BRIT J NUTR, V101, P27, DOI 10.1017/S0007114508988760; Virdis A, 2010, MATURITAS, V67, P20, DOI 10.1016/j.maturitas.2010.04.006; VOSS AC, 1988, LIPIDS, V23, P660, DOI 10.1007/BF02535664; Weisinger HS, 2001, NAT MED, V7, P258, DOI 10.1038/85354; Wise H, 2002, NEUROSIGNALS, V11, P20, DOI 10.1159/000057318; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949	64	43	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34492	10.1371/journal.pone.0034492	http://dx.doi.org/10.1371/journal.pone.0034492			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509311	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000304805900039
J	Herrera-Valdez, MA				Herrera-Valdez, Marco Arieli			Membranes with the Same Ion Channel Populations but Different Excitabilities	PLOS ONE			English	Article							EXCITATORY SYNAPTIC-TRANSMISSION; MATHEMATICAL-MODEL; NICOTINIC ACETYLCHOLINE; DELAYED-RECTIFIER; SODIUM-CHANNELS; VOLTAGE-CLAMP; ELECTRICAL-ACTIVITY; DROSOPHILA NEURONS; BIOPHYSICAL MODEL; HUXLEY EQUATIONS	Electrical signaling allows communication within and between different tissues and is necessary for the survival of multicellular organisms. The ionic transport that underlies transmembrane currents in cells is mediated by transporters and channels. Fast ionic transport through channels is typically modeled with a conductance-based formulation that describes current in terms of electrical drift without diffusion. In contrast, currents written in terms of drift and diffusion are not as widely used in the literature in spite of being more realistic and capable of displaying experimentally observable phenomena that conductance-based models cannot reproduce (e. g. rectification). The two formulations are mathematically related: conductance-based currents are linear approximations of drift-diffusion currents. However, conductance-based models of membrane potential are not first-order approximations of drift-diffusion models. Bifurcation analysis and numerical simulations show that the two approaches predict qualitatively and quantitatively different behaviors in the dynamics of membrane potential. For instance, two neuronal membrane models with identical populations of ion channels, one written with conductance-based currents, the other with drift-diffusion currents, undergo transitions into and out of repetitive oscillations through different mechanisms and for different levels of stimulation. These differences in excitability are observed in response to excitatory synaptic input, and across different levels of ion channel expression. In general, the electrophysiological profiles of membranes modeled with drift-diffusion and conductance-based models having identical ion channel populations are different, potentially causing the input-output and computational properties of networks constructed with these models to be different as well. The drift-diffusion formulation is thus proposed as a theoretical improvement over conductance-based models that may lead to more accurate predictions and interpretations of experimental data at the single cell and network levels.	[Herrera-Valdez, Marco Arieli] Univ Arizona, Dept Math, Tucson, AZ 85721 USA; [Herrera-Valdez, Marco Arieli] Univ Arizona, Evelyn F McKnight Brain Inst, Tucson, AZ USA; [Herrera-Valdez, Marco Arieli] Univ Puerto Rico Cayey, Dept Math & Phys, Cayey, PR USA; [Herrera-Valdez, Marco Arieli] Univ Puerto Rico Cayey, Inst Interdisciplinary Res, Cayey, PR USA	University of Arizona; University of Arizona; University of Puerto Rico; University of Puerto Rico at Cayey; University of Puerto Rico; University of Puerto Rico at Cayey	Herrera-Valdez, MA (corresponding author), Univ Arizona, Dept Math, Tucson, AZ 85721 USA.	marco.herrera@upr.edu	Herrera-Valdez, Marco Arieli/J-5782-2019	Herrera-Valdez, Marco Arieli/0000-0001-8224-9077	University of Puerto Rico through its BRIC program from the National; Center for Minority Health and Health Disparities (NCMHD) [1P20MD006144-01]; BRIC team from the Institute of Interdisciplinary Research at the University of Puerto Rico in Cayey; National Institute on Minority Health and Health Disparities [P20MD006144] Funding Source: NIH RePORTER	University of Puerto Rico through its BRIC program from the National; Center for Minority Health and Health Disparities (NCMHD); BRIC team from the Institute of Interdisciplinary Research at the University of Puerto Rico in Cayey; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Partial funding for this publication was provided by the University of Puerto Rico through its BRIC program from the National. No additional external funding was received for this study Center for Minority Health and Health Disparities (NCMHD), grant #1P20MD006144-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The author thanks Joceline Lega for her guidance, criticism, and encouragement. Thanks also to Sandra Berger, Greg Buzzard, and Errol Montes-Pizarro for their comments and all the discussions we had related to this manuscript. Special thanks to Erin McKiernan and the two unknown reviewers for their encouragement and suggestions which helped to improve this manuscript. The author extends special thanks to Isar Godreau and other members of the BRIC team from the Institute of Interdisciplinary Research at the University of Puerto Rico in Cayey for their financial and logistic support, which made this publication possible.	ADRAIN RH, 1970, J PHYSIOL-LONDON, V208, P607; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; AVRON E, 1991, BIOL CYBERN, V65, P487, DOI 10.1007/BF00204662; BAER SM, 1989, SIAM J APPL MATH, V49, P55, DOI 10.1137/0149003; Baranauskas G, 2006, J NEUROSCI, V26, P671, DOI 10.1523/JNEUROSCI.2283-05.2006; BUCHHOLTZ F, 1992, J NEUROPHYSIOL, V67, P332, DOI 10.1152/jn.1992.67.2.332; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; Chu ZG, 2000, BRAIN RES, V887, P399, DOI 10.1016/S0006-8993(00)03076-6; Clay JR, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.020.2009; Clay JR, 2008, J R SOC INTERFACE, V5, P1421, DOI 10.1098/rsif.2008.0166; CLAY JR, 1984, BIOPHYS J, V45, P481, DOI 10.1016/S0006-3495(84)84172-7; CLAY JR, 1991, J PHYSIOL-LONDON, V444, P499, DOI 10.1113/jphysiol.1991.sp018890; DEMIR SS, 1994, AM J PHYSIOL, V266, pC832, DOI 10.1152/ajpcell.1994.266.3.C832; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; DESTEXHE A, 1994, NEURAL COMPUT, V6, P14, DOI 10.1162/neco.1994.6.1.14; DIFRANCESCO D, 1985, PHILOS T ROY SOC B, V307, P353, DOI 10.1098/rstb.1985.0001; Duch C, 2008, J NEUROPHYSIOL, V100, P2525, DOI 10.1152/jn.90758.2008; Eisenberg B, 1998, ACCOUNTS CHEM RES, V31, P117, DOI 10.1021/ar950051e; Endresen LP, 2000, EUR BIOPHYS J BIOPHY, V29, P90, DOI 10.1007/s002490050254; Ermentrout G. B., 2010, INTERDISCIPLINARY AP, V35; FOHLMEISTER JF, 1990, BRAIN RES, V510, P343, DOI 10.1016/0006-8993(90)91388-W; Fohlmeister JF, 1997, J NEUROPHYSIOL, V78, P1935, DOI 10.1152/jn.1997.78.4.1935; Galligan JJ, 2000, J AUTONOM NERV SYST, V81, P97, DOI 10.1016/S0165-1838(00)00130-2; Gerstner W, 2002, SPIKING NEURON MODEL; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; HARDIE RC, 1994, J GEN PHYSIOL, V103, P389, DOI 10.1085/jgp.103.3.389; Herrera-Valdez MA, 2009, THESIS U ARIZONA; Herrera-Valdez MA, 2011, THESIS MATH U ARIZON; Herrera-Valdez MA, 2011, J THEOR BIOL, V270, P164, DOI 10.1016/j.jtbi.2010.09.042; Hille B., 1992, IONIC CHANNELS EXCIT; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOUNSGAARD J, 1984, EXP BRAIN RES, V55, P391; Ikeno H, 1999, NEUROCOMPUTING, V26-7, P177, DOI 10.1016/S0925-2312(99)00079-X; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Izhikevich E., 2007, DYNAMICAL SYSTEMS NE; JACK JJB, 1981, J PHYSIOL-LONDON, V321, P65, DOI 10.1113/jphysiol.1981.sp013972; Johnston D., 1995, FDN CELLULAR NEUROPH; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; KEPLER TB, 1992, BIOL CYBERN, V66, P381, DOI 10.1007/BF00197717; King GF, 2008, CHANNELS, V2, P100, DOI 10.4161/chan.2.2.6022; Koch C., 1998, METHODS NEURONAL MOD, DOI 10.1016/s0898-1221(98)91179-8; KRINSKII VI, 1973, BIOFIZIKA+, V18, P506; Kuhn A, 2004, J NEUROSCI, V24, P2345, DOI 10.1523/JNEUROSCI.3349-03.2004; Lee D, 1999, J NEUROSCI, V19, P5311; Lee RH, 1998, J NEUROPHYSIOL, V80, P583, DOI 10.1152/jn.1998.80.2.583; Lin WH, 2009, J NEUROPHYSIOL, V102, P1994, DOI 10.1152/jn.00613.2009; Mitchell CC, 2003, B MATH BIOL, V65, P767, DOI 10.1016/S0092-8240(03)00041-7; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; NEHER E, 1971, J GEN PHYSIOL, V58, P36, DOI 10.1085/jgp.58.1.36; Nonner W, 1998, BIOPHYS J, V75, P1287, DOI 10.1016/S0006-3495(98)74048-2; Nowotny T, 2007, NEURAL COMPUT, V19, P1985, DOI 10.1162/neco.2007.19.8.1985; ODOWD DK, 1988, J NEUROSCI, V8, P3633; PAK MD, 1991, J NEUROSCI, V11, P869; Pedersen MG, 2010, BIOPHYS J, V99, P3200, DOI 10.1016/j.bpj.2010.09.004; Peng IF, 2007, J NEUROPHYSIOL, V97, P780, DOI 10.1152/jn.01012.2006; Prinz AA, 2003, J NEUROPHYSIOL, V90, P3998, DOI 10.1152/jn.00641.2003; RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; RALL W, 1959, EXP NEUROL, V1, P491, DOI 10.1016/0014-4886(59)90046-9; RASMUSSON RL, 1990, AM J PHYSIOL, V259, pH352, DOI 10.1152/ajpheart.1990.259.2.H352; RASMUSSON RL, 1990, AM J PHYSIOL, V259, pH370, DOI 10.1152/ajpheart.1990.259.2.H370; RIBALET B, 1982, AM J PHYSIOL, V242, pC296, DOI 10.1152/ajpcell.1982.242.5.C296; RINZEL J, 1985, FED PROC, V44, P2944; RINZEL J, 1988, BIOPHYS J, V54, P551, DOI 10.1016/S0006-3495(88)82988-6; Rinzel J., 1989, ANAL NEURAL EXCITABI; Roerig B, 1997, J NEUROSCI, V17, P8353; SALKOFF L, 1992, TRENDS NEUROSCI, V15, P161, DOI 10.1016/0166-2236(92)90165-5; Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104; Smith LA, 1996, J NEUROSCI, V16, P7868; Stevens CF, 1979, ION PERMEATION MEMBR, V3; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Tang X, 2010, NEUROSCIENCE, V166, P397, DOI 10.1016/j.neuroscience.2010.01.005; TRAUB RD, 1991, J NEUROPHYSIOL, V66, P635, DOI 10.1152/jn.1991.66.2.635; TSUNODA S, 1995, J NEUROSCI, V15, P1741, DOI 10.1523/JNEUROSCI.15-03-01741.1995; TSUNODA S, 1995, J NEUROSCI, V15, P5209; VANDENBERG CA, 1991, BIOPHYS J, V60, P1499, DOI 10.1016/S0006-3495(91)82185-3; WALMSLEY B, 1987, J NEUROSCI, V7, P1037; Warmke JW, 1997, J GEN PHYSIOL, V110, P119, DOI 10.1085/jgp.110.2.119; WEI A, 1990, SCIENCE, V248, P599, DOI 10.1126/science.2333511; WEISS T, 1996, CELLULAR BIOPHYSICS, V1; Weiss T., 1996, CELLULAR BIOPHYSICS, VII; Wilders R, 2007, MED BIOL ENG COMPUT, V45, P189, DOI 10.1007/s11517-006-0127-0; Willms AR, 1999, J COMPUT NEUROSCI, V6, P145, DOI 10.1023/A:1008880518515; Yang J, 2009, NEUROSCIENCE, V163, P799, DOI 10.1016/j.neuroscience.2009.07.007	84	2	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34636	10.1371/journal.pone.0034636	http://dx.doi.org/10.1371/journal.pone.0034636			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523552	gold, Green Submitted, Green Published			2022-12-27	WOS:000305345000022
J	Malchiodi-Albedi, F; Paradisi, S; Di Nottia, M; Simone, D; Travaglione, S; Falzano, L; Guidotti, M; Frank, C; Cutarelli, A; Fabbri, A; Fiorentini, C				Malchiodi-Albedi, Fiorella; Paradisi, Silvia; Di Nottia, Michela; Simone, Daiana; Travaglione, Sara; Falzano, Loredana; Guidotti, Marco; Frank, Claudio; Cutarelli, Alessandro; Fabbri, Alessia; Fiorentini, Carla			CNF1 Improves Astrocytic Ability to Support Neuronal Growth and Differentiation In vitro	PLOS ONE			English	Article							LONG-TERM POTENTIATION; RHO-GTPASES; ACTIVATION; PLASTICITY; ROLES; MORPHOGENESIS; NEUROGENESIS; INFLAMMATION; INDUCTION; SURVIVAL	Modulation of cerebral Rho GTPases activity in mice brain by intracerebral administration of Cytotoxic Necrotizing Factor 1 (CNF1) leads to enhanced neurotransmission and synaptic plasticity and improves learning and memory. To gain more insight into the interactions between CNF1 and neuronal cells, we used primary neuronal and astrocytic cultures from rat embryonic brain to study CNF1 effects on neuronal differentiation, focusing on dendritic tree growth and synapse formation, which are strictly modulated by Rho GTPases. CNF1 profoundly remodeled the cytoskeleton of hippocampal and cortical neurons, which showed philopodia-like, actin-positive projections, thickened and poorly branched dendrites, and a decrease in synapse number. CNF1 removal, however, restored dendritic tree development and synapse formation, suggesting that the toxin can reversibly block neuronal differentiation. On differentiated neurons, CNF1 had a similar effacing effect on synapses. Therefore, a direct interaction with CNF1 is apparently deleterious for neurons. Since astrocytes play a pivotal role in neuronal differentiation and synaptic regulation, we wondered if the beneficial in vivo effect could be mediated by astrocytes. Primary astrocytes from embryonic cortex were treated with CNF1 for 48 hours and used as a substrate for growing hippocampal neurons. Such neurons showed an increased development of neurites, in respect to age-matched controls, with a wider dendritic tree and a richer content in synapses. In CNF1-exposed astrocytes, the production of interleukin 1 beta, known to reduce dendrite development and complexity in neuronal cultures, was decreased. These results demonstrate that astrocytes, under the influence of CNF1, increase their supporting activity on neuronal growth and differentiation, possibly related to the diminished levels of interleukin 1 beta. These observations suggest that the enhanced synaptic plasticity and improved learning and memory described in CNF1-injected mice are probably mediated by astrocytes.	[Malchiodi-Albedi, Fiorella; Paradisi, Silvia; Simone, Daiana] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Di Nottia, Michela; Travaglione, Sara; Falzano, Loredana; Fabbri, Alessia; Fiorentini, Carla] Ist Super Sanita, Dept Therapeut Res & Med Evaluat, I-00161 Rome, Italy; [Guidotti, Marco] Ist Super Sanita, Dept Vet Publ Hlth & Food Safety, I-00161 Rome, Italy; [Frank, Claudio; Cutarelli, Alessandro] Ist Super Sanita, Natl Ctr Rare Dis, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS)	Malchiodi-Albedi, F (corresponding author), Ist Super Sanita, Dept Cell Biol & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	fiorella.malchiodi@iss.it; carla.fiorentini@iss.it	Travaglione, Sara/AAJ-2516-2021; Di Nottia, Michela/J-5207-2018; FIORENTINI, CARLA/AAG-8005-2019; Fabbri, Alessia/AAA-4594-2019; Guidotti, Marco/D-2069-2015; Fiorentini, Carla/Q-2088-2015; Malchiodi-Albedi, Fiorella/A-5944-2015; FRANK, CLAUDIO/A-6642-2015	Di Nottia, Michela/0000-0001-8970-0617; FIORENTINI, CARLA/0000-0003-1707-6282; Fabbri, Alessia/0000-0002-3075-3367; Fiorentini, Carla/0000-0003-1707-6282; Malchiodi-Albedi, Fiorella/0000-0001-7202-0391; FRANK, CLAUDIO/0000-0002-6016-5750; Travaglione, Sara/0000-0002-2816-0490; falzano, loredana/0000-0003-4074-180X	Italia-USA Collaboration Program [Fascicolo 11US/1]; Cure_FXS project under the E-Rare program	Italia-USA Collaboration Program; Cure_FXS project under the E-Rare program	This work was partially supported by "Italia-USA Collaboration Program", Fascicolo 11US/1 (to Dr. Fiorentini) and by the Cure_FXS project (www.cure-fxs.eu) under the E-Rare program (to Dr. Fiorentini and Dr. Malchiodi-Albedi). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asrar S, 2009, NEUROPHARMACOLOGY, V56, P73, DOI 10.1016/j.neuropharm.2008.06.055; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Cerri C, 2011, J NEUROSCI, V31, P15163, DOI 10.1523/JNEUROSCI.2617-11.2011; Chen CJ, 2000, J NEUROCHEM, V75, P1557, DOI 10.1046/j.1471-4159.2000.0751557.x; Cordero-Llana O, 2011, CELL DEATH DIFFER, V18, P907, DOI 10.1038/cdd.2010.169; De Filippis B, 2012, NEUROPSYCHOPHARMACOL, V37, P1152, DOI 10.1038/npp.2011.301; De Viti S, 2010, BEHAV BRAIN RES, V212, P78, DOI 10.1016/j.bbr.2010.03.049; Diana G, 2007, P NATL ACAD SCI USA, V104, P636, DOI 10.1073/pnas.0610059104; Emirandetti A, 2006, BRAIN RES, V1095, P35, DOI 10.1016/j.brainres.2006.04.021; FALZANO L, 1993, MOL MICROBIOL, V9, P1247, DOI 10.1111/j.1365-2958.1993.tb01254.x; Flatau G, 1997, NATURE, V387, P729, DOI 10.1038/42743; Fortin DA, 2010, J NEUROSCI, V30, P11565, DOI 10.1523/JNEUROSCI.1746-10.2010; Fu WY, 2007, NAT NEUROSCI, V10, P67, DOI 10.1038/nn1811; Garay Paula A, 2010, Front Synaptic Neurosci, V2, P136, DOI 10.3389/fnsyn.2010.00136; Gilmore JH, 2004, NEUROPSYCHOPHARMACOL, V29, P1221, DOI 10.1038/sj.npp.1300446; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Hotulainen P, 2010, J CELL BIOL, V189, P619, DOI 10.1083/jcb.201003008; KANAI Y, 1993, TRENDS NEUROSCI, V16, P365, DOI 10.1016/0166-2236(93)90094-3; Kasri NN, 2008, PFLUG ARCH EUR J PHY, V455, P787, DOI 10.1007/s00424-007-0385-1; Kuzumaki N, 2010, SYNAPSE, V64, P721, DOI 10.1002/syn.20800; Linseman DA, 2008, FRONT BIOSCI-LANDMRK, V13, P657, DOI 10.2741/2710; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Malchiodi-Albedi F, 2001, GLIA, V34, P68, DOI 10.1002/glia.1041; Menet V, 2001, J NEUROSCI, V21, P6147; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Murakoshi H, 2011, NATURE, V472, P100, DOI 10.1038/nature09823; O'Kane EM, 2003, J NEUROCHEM, V87, P1309, DOI 10.1046/j.1471-4159.2003.02102.x; Pavone F, 2009, PAIN, V145, P219, DOI 10.1016/j.pain.2009.06.026; Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6; Rex CS, 2009, J CELL BIOL, V186, P85, DOI 10.1083/jcb.200901084; Rossi D, 2009, BRAIN RES BULL, V80, P224, DOI 10.1016/j.brainresbull.2009.07.012; Rozovsky I, 2005, NEUROBIOL AGING, V26, P705, DOI 10.1016/j.neurobiolaging.2004.06.009; Saneyoshi T, 2010, CURR OPIN NEUROBIOL, V20, P108, DOI 10.1016/j.conb.2009.09.013; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Stipursky J, 2011, LIFE SCI, V89, P524, DOI 10.1016/j.lfs.2011.04.005; Tashiro A, 2008, METHOD ENZYMOL, V439, P285, DOI 10.1016/S0076-6879(07)00421-1; Tolias KF, 2005, NEURON, V45, P525, DOI 10.1016/j.neuron.2005.01.024; Tolias KF, 2011, PROG NEUROBIOL, V94, P133, DOI 10.1016/j.pneurobio.2011.04.011; Tong LQ, 2008, NEUROBIOL AGING, V29, P1380, DOI 10.1016/j.neurobiolaging.2007.02.027; VERNADAKIS A, 1988, INT REV NEUROBIOL, V30, P149; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x	42	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34115	10.1371/journal.pone.0034115	http://dx.doi.org/10.1371/journal.pone.0034115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523545	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345000014
J	Chen, QQ; Wang, H; Hetmanski, JB; Zhang, TX; Ruczinski, I; Schwender, H; Liang, KY; Fallin, MD; Redett, RJ; Raymond, GV; Chou, YHW; Chen, PKT; Yeow, V; Chong, SS; Cheah, FSH; Jabs, EW; Scott, AF; Beaty, TH				Chen, Qianqian; Wang, Hong; Hetmanski, Jacqueline B.; Zhang, Tianxiao; Ruczinski, Ingo; Schwender, Holger; Liang, Kung Yee; Fallin, M. Daniele; Redett, Richard J.; Raymond, Gerald V.; Chou, Yah-Huei Wu; Chen, Philip Kuo-Ting; Yeow, Vincent; Chong, Samuel S.; Cheah, Felicia S. H.; Jabs, Ethylin Wang; Scott, Alan F.; Beaty, Terri H.			BMP4 Was Associated with NSCL/P in an Asian Population	PLOS ONE			English	Article							NONSYNDROMIC CLEFT-LIP; 4 GENE POLYMORPHISMS; PALATE; LINKAGE; SUSCEPTIBILITY; LIP/PALATE; VARIANTS; FUSION	Background: The Bone Morphogenetic Protein 4 gene (BMP4) is located in chromosome 14q22-q23 which has shown evidence of linkage for isolated nonsyndromic cleft lip with or without cleft palate (NSCL/P) in a genome wide linkage analysis of human multiplex families. BMP4 has been shown to play crucial roles in lip and palatal development in animal models. Several candidate gene association analyses also supported its potential risk for NSCL/P, however, results across these association studies have been inconsistent. The aim of the current study was to test for possible association between markers in and around the BMP4 gene and NSCL/P in Asian and Maryland trios. Methodology/Principal Findings: Family Based Association Test was used to test for deviation from Mendelian assortment for 12 SNPs in and around BMP4. Nominal significant evidence of linkage and association was seen for three SNPs (rs10130587, rs2738265 and rs2761887) in 221 Asian trios and for one SNP (rs762642) in 76 Maryland trios. Statistical significance still held for rs10130587 after Bonferroni correction (corrected p = 0.019) among the Asian group. Estimated odds ratio for carrying the apparent high risk allele at this SNP was 1.61 (95% CI = 1.20, 2.18). Conclusions: Our results provided further evidence of association between BMP4 and NSCL/P.	[Chen, Qianqian; Wang, Hong] Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China; [Hetmanski, Jacqueline B.; Ruczinski, Ingo; Fallin, M. Daniele; Beaty, Terri H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Zhang, Tianxiao] Washington Univ, Div Biol & Biomed Sci, St Louis, MO USA; [Schwender, Holger] TU Dortmund Univ, Dept Fac Stat, Dortmund, Germany; [Liang, Kung Yee] Natl Yang Ming Univ, Dept Life Sci, Taipei 112, Taiwan; [Liang, Kung Yee] Natl Yang Ming Univ, Inst Genome Sci, Taipei 112, Taiwan; [Redett, Richard J.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Raymond, Gerald V.] Johns Hopkins Univ, Sch Med, Kennedy Krieger Inst, Baltimore, MD USA; [Chou, Yah-Huei Wu] Chang Gung Mem Hosp, Dept Med Res, Taipei 10591, Taiwan; [Chen, Philip Kuo-Ting] Chang Gung Mem Hosp, Craniofacial Ctr, Taipei 10591, Taiwan; [Yeow, Vincent] KK Womens & Childrens Hosp, Dept Plast Surg, Singapore, Singapore; [Chong, Samuel S.; Cheah, Felicia S. H.] Natl Univ Singapore, Dept Pediat, Singapore 117548, Singapore; [Jabs, Ethylin Wang] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Jabs, Ethylin Wang] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Scott, Alan F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Peking University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Washington University (WUSTL); Dortmund University of Technology; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Johns Hopkins University; Johns Hopkins University; Kennedy Krieger Institute; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; KK Women's & Children's Hospital; National University of Singapore; Johns Hopkins University; Icahn School of Medicine at Mount Sinai; Johns Hopkins University	Wang, H (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing 100871, Peoples R China.	hwang2010@yahoo.cn	Chong, Samuel S./D-8098-2015	Chong, Samuel S./0000-0002-1872-5937; Jabs, Ethylin/0000-0001-8983-5466	National Institute of Dental & Craniofacial Research [R21-DE-013707, R01-DE-014581]; Fogarty Institution [D43-TW006176]; FOGARTY INTERNATIONAL CENTER [D43TW006176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014581] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R21DE013707] Funding Source: NIH RePORTER	National Institute of Dental & Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Fogarty Institution; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by grants from the National Institute of Dental & Craniofacial Research (No. R21-DE-013707 and R01-DE-014581) and Fogarty Institution (No. D43-TW006176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ashique AM, 2002, DEVELOPMENT, V129, P4647; Barlow AJ, 1997, DEVELOPMENT, V124, P391; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beaty TH, 2010, NAT GENET, V42, P525, DOI 10.1038/ng.580; Birnbaum S, 2009, NAT GENET, V41, P473, DOI 10.1038/ng.333; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Grant SFA, 2009, J PEDIATR-US, V155, P909, DOI 10.1016/j.jpeds.2009.06.020; Hashmi SS, 2005, AM J MED GENET A, V134A, P368, DOI 10.1002/ajmg.a.30618; Jianyan L, 2010, INT J ORAL MAX SURG, V39, P50, DOI 10.1016/j.ijom.2009.10.010; Jugessur A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005385; Laird NM, 2006, NAT REV GENET, V7, P385, DOI 10.1038/nrg1839; Lidral AC, 2004, BIRTH DEFECTS RES A, V70, P893, DOI 10.1002/bdra.20096; Lin JY, 2008, DNA CELL BIOL, V27, P601, DOI 10.1089/dna.2008.0777; Liu W, 2005, DEVELOPMENT, V132, P1453, DOI 10.1242/dev.01676; Mangold E, 2010, NAT GENET, V42, P24, DOI 10.1038/ng.506; Marazita ML, 2009, HUM HERED, V68, P151, DOI 10.1159/000224636; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; MITCHELL LE, 2002, CLEFT LIP PALATE, P214; Mossey P., 2002, CLEFT LIP PALATE, P127; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Murray JC, 2002, CLIN GENET, V61, P248, DOI 10.1034/j.1399-0004.2002.610402.x; Oliphant A., 2002, BIOTECHNIQUES, V32, pS56, DOI DOI 10.2144/JUN0207; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Paiva KBS, 2010, ACTA HISTOCHEM, V112, P508, DOI 10.1016/j.acthis.2009.05.007; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Suazo J, 2010, DNA CELL BIOL, V29, P59, DOI 10.1089/dna.2009.0944; Suzuki S, 2009, AM J HUM GENET, V84, P406, DOI 10.1016/j.ajhg.2009.02.002; Trainor PA, 2005, SEMIN CELL DEV BIOL, V16, P683, DOI 10.1016/j.semcdb.2005.06.007; Wang H, 2011, CLEFT PALAT IN PRESS; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241	31	20	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35347	10.1371/journal.pone.0035347	http://dx.doi.org/10.1371/journal.pone.0035347			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514733	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600138
J	Zerlanko, BJ; Bartholin, L; Melhuish, TA; Wotton, D				Zerlanko, Brad J.; Bartholin, Laurent; Melhuish, Tiffany A.; Wotton, David			Premature Senescence and Increased TGF beta Signaling in the Absence of Tgif1	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SMAD TRANSCRIPTIONAL COREPRESSOR; LARGE GENE LISTS; TETRAPLOIDY CHECKPOINT; TARGETED DISRUPTION; FUNCTIONAL-ANALYSIS; CELLS; PROTEIN; SPECIFICITY; PROGRESSION	Transforming growth factor beta (TGF beta) signaling regulates cell cycle progression in several cell types, primarily by inducing a G1 cell cycle arrest. Tgif1 is a transcriptional corepressor that limits TGFb responsive gene expression. Here we demonstrate that primary mouse embryo fibroblasts (MEFs) lacking Tgif1 proliferate slowly, accumulate increased levels of DNA damage, and senesce prematurely. We also provide evidence that the effects of loss of Tgif1 on proliferation and senescence are not limited to primary cells. The increased DNA damage in Tgif1 null MEFs can be partially reversed by culturing cells at physiological oxygen levels, and growth in normoxic conditions also partially rescues the proliferation defect, suggesting that in the absence of Tgif1 primary MEFs are less able to cope with elevated levels of oxidative stress. Additionally, we show that Tgif1 null MEFs are more sensitive to TGF beta-mediated growth inhibition, and that treatment with a TGFb receptor kinase inhibitor increases proliferation of Tgif1 null MEFs. Conversely, persistent treatment of wild type cells with low levels of TGFb slows proliferation and induces senescence, suggesting that TGF beta signaling also contributes to cellular senescence. We suggest that in the absence of Tgif1, a persistent increase in TGFb responsive transcription and a reduced ability to deal with hyperoxic stress result in premature senescence in primary MEFs.	[Zerlanko, Brad J.] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA; Univ Virginia, Ctr Cell Signaling, Charlottesville, VA USA	University of Virginia; University of Virginia	Zerlanko, BJ (corresponding author), Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA 22903 USA.	dw2p@virginia.edu	Bartholin, Laurent/Q-6655-2017	Bartholin, Laurent/0000-0002-5637-3223; Wotton, David/0000-0002-4652-5350	National Institutes of Health [HD39926, HD52707]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039926, R01HD052707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008136] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants, HD39926 and HD52707, to DW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED SA, 1994, J IMMUNOL METHODS, V170, P211, DOI 10.1016/0022-1759(94)90396-4; ALEXANDROW MG, 1995, CANCER RES, V55, P1452; Bartholin L, 2002, ONCOGENE, V21, P2227, DOI 10.1038/sj.onc.1205294; Bartholin L, 2006, MOL CELL BIOL, V26, P990, DOI 10.1128/MCB.26.3.990-1001.2006; Bartholin L, 2008, DEV BIOL, V319, P285, DOI 10.1016/j.ydbio.2008.04.027; Bertolino E, 1995, J BIOL CHEM, V270, P31178, DOI 10.1074/jbc.270.52.31178; Borel F, 2002, P NATL ACAD SCI USA, V99, P9819, DOI 10.1073/pnas.152205299; Burglin TR, 1997, NUCLEIC ACIDS RES, V25, P4173, DOI 10.1093/nar/25.21.4173; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Gripp KW, 2000, NAT GENET, V25, P205, DOI 10.1038/76074; Hamid R, 2009, MOL ONCOL, V3, P451, DOI 10.1016/j.molonc.2009.07.004; HANNON GJ, 1994, NATURE, V371, P257, DOI 10.1038/371257a0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HM, 2008, CANCER RES, V68, P3724, DOI 10.1158/0008-5472.CAN-08-0479; Hyman CA, 2003, MOL CELL BIOL, V23, P9262, DOI 10.1128/MCB.23.24.9262-9274.2003; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jin JZ, 2006, DEV DYNAM, V235, P547, DOI 10.1002/dvdy.20642; Lanni JS, 1997, P NATL ACAD SCI USA, V94, P9679, DOI 10.1073/pnas.94.18.9679; Lo RS, 2001, EMBO J, V20, P128, DOI 10.1093/emboj/20.1.128; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; MacLaren A, 2004, MOL CELL BIOL, V24, P9006, DOI 10.1128/MCB.24.20.9006-9018.2004; Mar L, 2006, MOL CELL BIOL, V26, P4302, DOI 10.1128/MCB.02156-05; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Melhuish TA, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-2; Melhuish TA, 2001, J BIOL CHEM, V276, P32109, DOI 10.1074/jbc.M103377200; Melhuish TA, 2000, J BIOL CHEM, V275, P39762, DOI 10.1074/jbc.C000416200; Melhuish TA, 2010, J CELL BIOCHEM, V111, P380, DOI 10.1002/jcb.22713; Merrill JC, 2010, J MOL BIOL, V398, P657, DOI 10.1016/j.jmb.2010.03.048; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Muenke M, 2000, CURR OPIN GENET DEV, V10, P262, DOI 10.1016/S0959-437X(00)00084-8; Powers SE, 2010, DEVELOPMENT, V137, P249, DOI 10.1242/dev.040782; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Seo SR, 2004, EMBO J, V23, P3780, DOI 10.1038/sj.emboj.7600398; Seo SR, 2006, MOL CELL, V23, P547, DOI 10.1016/j.molcel.2006.06.018; Shen J, 2005, MOL CELL BIOL, V25, P3639, DOI 10.1128/MCB.25.9.3639-3647.2005; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Suzuki M, 2006, RADIAT RES, V165, P269, DOI 10.1667/RR3508.1; Taniguchi K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002524; Uetake Y, 2004, J CELL BIOL, V165, P609, DOI 10.1083/jcb.200403014; Warner BJ, 1999, MOL CELL BIOL, V19, P5913; Wotton D, 1999, CELL, V97, P29, DOI 10.1016/S0092-8674(00)80712-6; Wotton D, 2001, CELL GROWTH DIFFER, V12, P457; Wotton D, 2001, CURR TOP MICROBIOL, V254, P145	49	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35460	10.1371/journal.pone.0035460	http://dx.doi.org/10.1371/journal.pone.0035460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514746	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600151
J	Rand, PS; Goslin, M; Gross, MR; Irvine, JR; Augerot, X; McHugh, PA; Bugaev, VF				Rand, Peter S.; Goslin, Matthew; Gross, Mart R.; Irvine, James R.; Augerot, Xanthippe; McHugh, Peter A.; Bugaev, Victor F.			Global Assessment of Extinction Risk to Populations of Sockeye Salmon Oncorhynchus nerka	PLOS ONE			English	Article							PACIFIC SALMON; FRASER-RIVER; BRITISH-COLUMBIA; CLIMATE-CHANGE; VIABILITY ANALYSIS; BRISTOL BAY; TRENDS; CANADA; CONSERVATION; DIVERSITY	Background: Concern about the decline of wild salmon has attracted the attention of the International Union for the Conservation of Nature (IUCN). The IUCN applies quantitative criteria to assess risk of extinction and publishes its results on the Red List of Threatened Species. However, the focus is on the species level and thus may fail to show the risk to populations. The IUCN has adapted their criteria to apply to populations but there exist few examples of this type of assessment. We assessed the status of sockeye salmon Oncorhynchus nerka as a model for application of the IUCN population-level assessments and to provide the first global assessment of the status of an anadromous Pacific salmon. Methods/Principal Findings: We found from demographic data that the sockeye salmon species is not presently at risk of extinction. We identified 98 independent populations with varying levels of risk within the species' range. Of these, 5 (5%) are already extinct. We analyzed the risk for 62 out of 93 extant populations (67%) and found that 17 of these (27%) are at risk of extinction. The greatest number and concentration of extinct and threatened populations is in the southern part of the North American range, primarily due to overfishing, freshwater habitat loss, dams, hatcheries, and changing ocean conditions. Conclusions/Significance: Although sockeye salmon are not at risk at the species-level, about one-third of the populations that we analyzed are at risk or already extinct. Without an understanding of risk to biodiversity at the level of populations, the biodiversity loss in salmon would be greatly underrepresented on the Red List. We urge government, conservation organizations, scientists and the public to recognize this limitation of the Red List. We also urge recognition that about one-third of sockeye salmon global population diversity is at risk of extinction or already extinct.	[Rand, Peter S.] Wild Salmon Ctr, Portland, OR USA; [Goslin, Matthew] Ecotrust, Portland, OR USA; [Gross, Mart R.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Irvine, James R.] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9R 5K6, Canada; [Augerot, Xanthippe] Pangaea Environm LLC, Corvallis, OR USA; [McHugh, Peter A.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand; [Bugaev, Victor F.] KamchatNIRO, Pacific Res Inst Fisheries & Oceanog, Petropavlovsk Kamchatski, Russia	University of Toronto; Fisheries & Oceans Canada; University of Canterbury; Research lnstitute of Fisheries & Oceanography	Rand, PS (corresponding author), Wild Salmon Ctr, Portland, OR USA.	prand@wildsalmoncenter.org		Irvine, Jim/0000-0002-5314-0109	Gordon and Betty Moore Foundation through the State of the Salmon Program; joint program of the Wild Salmon Center and Ecotrust based in Portland, Oregon, United States of America; NSERC of Canada grants	Gordon and Betty Moore Foundation through the State of the Salmon Program; joint program of the Wild Salmon Center and Ecotrust based in Portland, Oregon, United States of America; NSERC of Canada grants	This study was supported by the Gordon and Betty Moore Foundation through the State of the Salmon Program, a joint program of the Wild Salmon Center and Ecotrust based in Portland, Oregon, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We greatly appreciate the advice and input from staff from a number of resource agencies and treaty organizations that made this assessment possible, including especially the Department of Fisheries and Oceans Canada (K. Benner, S. Grant), the Pacific Salmon Commission (M. Lapointe), and the Alaska Department of Fish and Game (P. Nelson, S. Kelley, J. Regnart, J. McCullough, and D. Molyneaux). We thank R. Waples, P. Mundy, M. Kaeriyama, G. Ruggerone, and K. English for advice, analytical support and suggestions. We thank the editors and anonymous journal reviewers for helpful comments. A. Gladieux produced the final versions of Figures 1, 2, 3. Periscopic (periscopic.com) based in Portland, Oregon, USA created the web visualization. M. Gross was supported by NSERC of Canada grants.	Alaska Department of Fish and Game, 2003, AN WAT CAT ATL; Allendorf FW, 1997, CONSERV BIOL, V11, P140, DOI 10.1046/j.1523-1739.1997.95248.x; [Anonymous], 1996, FED REG, V61, P4722; Augerot X, 2005, ATLAS PACIFIC SALMON; Battin J, 2007, P NATL ACAD SCI USA, V104, P6720, DOI 10.1073/pnas.0701685104; Beacham TD, 2006, T AM FISH SOC, V135, P174, DOI 10.1577/T05-149.1; Beacham TD, 2006, T AM FISH SOC, V135, P97, DOI 10.1577/T05-118.1; Beamish RJ, 1999, CAN J FISH AQUAT SCI, V56, P516, DOI 10.1139/cjfas-56-3-516; BEAMISH RJ, 1993, CAN J FISH AQUAT SCI, V50, P1002, DOI 10.1139/f93-116; Bocharov LN, 2005, PLANNING CONDUCTING; Bugaev V.F., 2007, FISHES KAMCHATKA RIV; Bugaev VF, 1995, SOCKEYE SALMON ONCOR; Bugaev VF, 2010, SOCKEYE SALMON KAMCH; Bugaev VF, 2002, IZV TIKHOOKEAN NII R, V130, P679; Burgner RobertL, 1991, PACIFIC SALMON LIFE, P2; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Cooke SJ, 2004, FISHERIES, V29, P22, DOI 10.1577/1548-8446(2004)29[22:AMTAHE]2.0.CO;2; COSEWIC, 2003, COSEWIC ASS STAT REP; Crozier LG, 2008, EVOL APPL, V1, P252, DOI 10.1111/j.1752-4571.2008.00033.x; Department of Fisheries and Oceans Canada, 2005, CAN POL CONS WILD PA; Department of Fisheries and Oceans Canada, 2001, FISH IN SUMM SYST SA; Dronova NA., 2008, ILLEGAL UNREPORTED U; Dulvy NK, 2005, J APPL ECOL, V42, P883, DOI 10.1111/j.1365-2664.2005.01063.x; Eggers DM, 2008, ALASKA DEP FISH GAME; Eggers DM, 2009, FISHERY DATA SERIES; Eggers Douglas M., 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P53; English KK, 2004, 13 PAC SALM COMM; European Commission, 2006, 216 COM EUR COMM; Geiger Harold J., 2002, Alaska Fishery Research Bulletin, V9, P128; Geiger HJ, 2005, ALASKA DEP FISH GAME; Gotelli NJ, 2013, ECOSIMR 1 00; Gottesfeld A., 2008, SKEENA RIVER FISH TH; Grant SCH, 2011, 2011087 DFO CAN SCI; Gritsenko O.F., 2006, Rybnoe Khozyaistvo, V2, P44; Gustafson RG, 2007, CONSERV BIOL, V21, P1009, DOI 10.1111/j.1523-1739.2007.00693.x; Habicht C, 2007, T AM FISH SOC, V136, P82, DOI 10.1577/T06-001.1; Harvey B, 2002, GHOST RUNS FUTURE WI; Healey M, 2011, CAN J FISH AQUAT SCI, V68, P718, DOI [10.1139/F11-010, 10.1139/f2011-010]; Hendry A. P., 2004, EVOLUTION ILLUMINATE; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Holmes EE, 2001, P NATL ACAD SCI USA, V98, P5072, DOI 10.1073/pnas.081055898; Holmes EE, 2002, ECOLOGY, V83, P2379; Holtby LB, 2007, 2007070 CAN STOCK AS; Hyatt K.D., 1999, 99191 CAN STOCK ASS; HYDRO1k, 1998, HYDRO1K EL DER DAT; Iliashenko VY, 2000, RED DATA BOOK RUSSIA; Irvine J. R., 2009, North Pacific Anadromous Fish Commission Bulletin, V5, P39; Irvine JR, 2008, AM FISH S S, V49, P391; Irvine JR, 2011, ICES J MAR SCI, V68, P1122, DOI 10.1093/icesjms/fsq199; Irvine JR, 2009, ENVIRON SCI POLICY, V12, P140, DOI 10.1016/j.envsci.2008.09.007; Irvine JR, 2005, FISHERIES, V30, P11, DOI 10.1577/1548-8446(2005)30[11:CSARA]2.0.CO;2; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; IUCN, 1994, IUCN RED LIST CAT; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Manni F, 2004, HUM BIOL, V76, P173, DOI 10.1353/hub.2004.0034; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; McClure MM, 2003, ECOL APPL, V13, P964, DOI 10.1890/1051-0761(2003)13[964:ALMSAA]2.0.CO;2; McElhany P, 2000, MEMNMFSNWFSC42 NOAA; McFarlane GA, 2000, PROG OCEANOGR, V47, P147, DOI 10.1016/S0079-6611(00)00034-3; McKinnell SM, 2001, N AM J FISH MANAGE, V21, P774, DOI 10.1577/1548-8675(2001)021<0774:TDOOLS>2.0.CO;2; Meacham Charles P., 1994, Alaska Fishery Research Bulletin, V1, P76; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING BI; Milner AM, 2008, AQUAC RES, V20, P179; Naish KA, 2008, ADV MAR BIOL, V53, P61, DOI 10.1016/S0065-2881(07)53002-6; National Research Council, 2004, ATL SALM MAIN; Patterson DA, 2008, EVALUATION POTENTIAL; Paulsen CM, 2007, T AM FISH SOC, V136, P346, DOI 10.1577/T05-300.1; Pavlov DS, 1999, DOKL AKAD NAUK+, V367, P709; Pimm SL, 1997, NATURE HUMAN SOC QUE, P46; Piston AW, 2010, FISHERY DATA SERIES; Porszt EJ, 2009, THESIS SIMON FRASER; PRIMACK RB, 2008, PRIMER CONSERVATION; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Rand Peter S., 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P271; Rand PS, 2006, T AM FISH SOC, V135, P655, DOI 10.1577/T05-023.1; Rand PS, 2008, IUCN 2008 IUCN RED L; Rice JC, 2007, ICES J MAR SCI, V64, P1; Riddell B, 2004, PACIFIC SALMON RESOU; Ruggerone GT, 2010, MAR COAST FISH, V2, P306, DOI 10.1577/C09-054.1; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; Schubert ND, 2002, 2002064 CAN SCI ADV; Sinyakov SA, 2006, FISHERY IND HARVEST; Slaney TL, 1996, FISHERIES, V21, P20, DOI 10.1577/1548-8446(1996)021<0020:SOASAT>2.0.CO;2; Standards and Petitions Working Group, 2010, GUID US IUCN RED LIS; Streamnet, 2003, AN FISH DISTR; Van Alen BW, 2000, SUSTAINABLE FISHERIES MANAGEMENT: PACIFIC SALMON, P161; Wallace BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024510; Walters C.J., 2008, REPORT SKEENA INDEPE; Walters CJ., 2020, FISHERIES ECOLOGY MA, DOI [10.2307/j.ctv10vm1f6, DOI 10.2307/J.CTV10VM1F6]; Waples R, 1995, AM FISH SOC S, P17; Waples R.S., 1991, MAR FISH REV, V53, P11; Wood CC, 1995, AM FISH S S, V17, P195; Wood CC, 2001, MANAGING BIODIVERSIT; Wood CC, 2008, CONSERV BIOL, V22, P36, DOI 10.1111/j.1523-1739.2007.00856.x	94	24	24	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34065	10.1371/journal.pone.0034065	http://dx.doi.org/10.1371/journal.pone.0034065			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511930	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600016
J	Wolen, AR; Phillips, CA; Langston, MA; Putman, AH; Vorster, PJ; Bruce, NA; York, TP; Williams, RW; Miles, MF				Wolen, Aaron R.; Phillips, Charles A.; Langston, Michael A.; Putman, Alex H.; Vorster, Paul J.; Bruce, Nathan A.; York, Timothy P.; Williams, Robert W.; Miles, Michael F.			Genetic Dissection of Acute Ethanol Responsive Gene Networks in Prefrontal Cortex: Functional and Mechanistic Implications	PLOS ONE			English	Article							QUANTITATIVE-TRAIT LOCI; RECOMBINANT INBRED STRAINS; GENOME-WIDE SEARCH; ALCOHOL DEPENDENCE; RECEPTOR AGONIST; CAENORHABDITIS-ELEGANS; BEHAVIORAL-RESPONSES; CONGENIC STRAINS; MOUSE STRAINS; EXPRESSION	Background: Individual differences in initial sensitivity to ethanol are strongly related to the heritable risk of alcoholism in humans. To elucidate key molecular networks that modulate ethanol sensitivity we performed the first systems genetics analysis of ethanol-responsive gene expression in brain regions of the mesocorticolimbic reward circuit (prefrontal cortex, nucleus accumbens, and ventral midbrain) across a highly diverse family of 27 isogenic mouse strains (BXD panel) before and after treatment with ethanol. Results: Acute ethanol altered the expression of similar to 2,750 genes in one or more regions and 400 transcripts were jointly modulated in all three. Ethanol-responsive gene networks were extracted with a powerful graph theoretical method that efficiently summarized ethanol's effects. These networks correlated with acute behavioral responses to ethanol and other drugs of abuse. As predicted, networks were heavily populated by genes controlling synaptic transmission and neuroplasticity. Several of the most densely interconnected network hubs, including Kcnma1 and Gsk3 beta, are known to influence behavioral or physiological responses to ethanol, validating our overall approach. Other major hub genes like Grm3, Pten and Nrg3 represent novel targets of ethanol effects. Networks were under strong genetic control by variants that we mapped to a small number of chromosomal loci. Using a novel combination of genetic, bioinformatic and network-based approaches, we identified high priority cis-regulatory candidate genes, including Scn1b, Gria1, Sncb and Nell2. Conclusions: The ethanol-responsive gene networks identified here represent a previously uncharacterized intermediate phenotype between DNA variation and ethanol sensitivity in mice. Networks involved in synaptic transmission were strongly regulated by ethanol and could contribute to behavioral plasticity seen with chronic ethanol. Our novel finding that hub genes and a small number of loci exert major influence over the ethanol response of gene networks could have important implications for future studies regarding the mechanisms and treatment of alcohol use disorders.	[Wolen, Aaron R.; York, Timothy P.; Miles, Michael F.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA; [Putman, Alex H.; Vorster, Paul J.; Bruce, Nathan A.; Miles, Michael F.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA USA; [Miles, Michael F.] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA; [Phillips, Charles A.; Langston, Michael A.] Univ Tennessee, Dept Elect Engn & Comp Sci, Knoxville, TN USA; [Williams, Robert W.] Univ Tennessee Hlth Sci, Dept Anat & Neurobiol, Memphis, TN USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Health Science Center	Wolen, AR (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, Richmond, VA 23284 USA.	mfmiles@vcu.edu	Wolen, Aaron/H-9545-2014; Williams, Robert W./H-8789-2016	Wolen, Aaron/0000-0003-2542-2202; Williams, Robert W./0000-0001-8924-4447; Love, Zelda/0000-0002-2478-7720	National Institute on Alcohol Abuse and Alcoholism grants [P20AA017828, U01AA0116667, U01AA016662, U01AA13499]; National Institute of Mental Health grant [T32MH20030]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH020030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA016662, U01AA013499, U01AA016667, U01AA017590, R01AA013678, P20AA017828] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism grants; National Institute of Mental Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was funded by National Institute on Alcohol Abuse and Alcoholism grants P20AA017828 (MFM), U01AA0116667 (MFM), U01AA016662 (MFM), U01AA13499 (RWW), and National Institute of Mental Health grant T32MH20030 (ARW; PI: Michael Neale). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Abu-Khzam F, 2006, ALGORITHMICA, V45; Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Backstrom P, 2005, EUR J PHARMACOL, V528, P110, DOI 10.1016/j.ejphar.2005.10.051; BELKNAP JK, 1995, LIFE SCI, V57, pPL117, DOI 10.1016/0024-3205(95)02040-P; Bennett B, 2002, ALCOHOL CLIN EXP RES, V26, P1615, DOI 10.1097/01.ALC.0000037136.49550.B3; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Chandler LJ, 2006, ALCOHOL CLIN EXP RES, V30, P368, DOI 10.1111/j.1530-0277.2006.00041.x; Chandra S, 2004, P NATL ACAD SCI USA, V101, P14966, DOI 10.1073/pnas.0406283101; Chen G, 2009, NEUROTOX RES, V15, P321, DOI 10.1007/s12640-009-9036-y; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chesler E, 2005, P RECOMB SAT WORKSH; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cooper TF, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-237; CRABBE JC, 1983, NEUROBEH TOXICOL TER, V5, P181; CSARDI G., 2006, INTERJOURNAL COMPLEX, V1695; CUNNINGHAM CL, 1995, PSYCHOPHARMACOLOGY, V120, P28, DOI 10.1007/BF02246142; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Dopico AM, 1996, MOL PHARMACOL, V49, P40; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Edenberg HJ, 2010, ALCOHOL CLIN EXP RES, V34, P840, DOI 10.1111/j.1530-0277.2010.01156.x; Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Foroud T, 2000, ALCOHOL CLIN EXP RES, V24, P933, DOI 10.1097/00000374-200007000-00001; French RL, 2009, P NATL ACAD SCI USA, V106, P20924, DOI 10.1073/pnas.0910813106; Garlow SJ, 2005, ENDOCRINOLOGY, V146, P2362, DOI 10.1210/en.2004-1450; Gass JT, 2008, BIOCHEM PHARMACOL, V75, P218, DOI 10.1016/j.bcp.2007.06.039; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gill KJ, 2003, PHARMACOGENETICS, V13, P329, DOI 10.1097/00008571-200306000-00004; Grisel JE, 2002, ALCOHOL CLIN EXP RES, V26, P610, DOI 10.1097/00000374-200205000-00004; Heath AC, 1997, PSYCHOL MED, V27, P1381, DOI 10.1017/S0033291797005643; Hill SY, 2004, AM J MED GENET B, V128B, P102, DOI 10.1002/ajmg.b.30013; Horishita T, 2008, J PHARMACOL EXP THER, V326, P270, DOI 10.1124/jpet.108.138370; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jones BC, 1999, PHARMACOGENETICS, V9, P607, DOI 10.1097/01213011-199910000-00007; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kao WT, 2010, P NATL ACAD SCI USA, V107, P15619, DOI 10.1073/pnas.1005410107; Kapfhamer D, 2008, GENES BRAIN BEHAV, V7, P669, DOI 10.1111/j.1601-183X.2008.00404.x; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Kendler KS, 2011, ALCOHOL CLIN EXP RES, V35, P963, DOI 10.1111/j.1530-0277.2010.01427.x; KENDLER KS, 1994, AM J PSYCHIAT, V151, P707; Kennedy RE, 2006, BIOINFORMATICS, V22, P1272, DOI 10.1093/bioinformatics/btl108; Kennedy RE, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-154; Kerns RT, 2005, J NEUROSCI, V25, P2255, DOI 10.1523/JNEUROSCI.4372-04.2005; Kugler KG, 2010, SOURCE CODE BIOL MED, V5, DOI 10.1186/1751-0473-5-3; Langston M, 2006, SAC 06 P 2006 ACM S; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Lovinger DM, 2005, NAT NEUROSCI, V8, P1471, DOI 10.1038/nn1581; Manichaikul A, 2006, GENETICS, V174, P481, DOI 10.1534/genetics.106.061549; Markel PD, 1996, BEHAV GENET, V26, P447, DOI 10.1007/BF02359489; Martin MV, 2006, GENES BRAIN BEHAV, V5, P614, DOI 10.1111/j.1601-183X.2006.00215.x; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; METTEN P, 1994, BEHAV PHARMACOL, V5, P533, DOI 10.1097/00008877-199408000-00014; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Morar B, 2010, MOL PSYCHIAT; Mulligan MK, 2006, P NATL ACAD SCI USA, V103, P6368, DOI 10.1073/pnas.0510188103; PHILLIPS TJ, 1994, BEHAV NEUROSCI, V108, P789, DOI 10.1037/0735-7044.108.4.789; Quigley DA, 2009, NATURE, V458, P505, DOI 10.1038/nature07683; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reich T, 1998, AM J MED GENET, V81, P207, DOI 10.1002/(SICI)1096-8628(19980508)81:3<207::AID-AJMG1>3.3.CO;2-X; Risinger FO, 2003, ALCOHOL CLIN EXP RES, V27, P756, DOI 10.1097/01.ALC.0000065697.73554.DF; Robinson TE, 1997, J NEUROSCI, V17, P8491; Rodd ZA, 2006, BEHAV BRAIN RES, V171, P207, DOI 10.1016/j.bbr.2006.03.032; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; SCHUCKIT MA, 1984, ARCH GEN PSYCHIAT, V41, P879; SCHUCKIT MA, 1987, J CONSULT CLIN PSYCH, V55, P301, DOI 10.1037/0022-006X.55.3.301; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Scott RE, 2005, J CELL PHYSIOL, V204, P99, DOI 10.1002/jcp.20263; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shifman S, 2006, PLOS BIOL, V4, P2227, DOI 10.1371/journal.pbio.0040395; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tabakoff B, 2008, MAMM GENOME, V19, P352, DOI 10.1007/s00335-008-9115-z; TOLLIVER BK, 1994, J PHARMACOL EXP THER, V270, P1230; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vadasz C, 2000, ALCOHOL, V20, P161, DOI 10.1016/S0741-8329(99)00068-3; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Wahlstrom A, 1986, NIDA Res Monogr, V75, P603; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams RW, 2001, GENOME BIOL, V2; Yang RJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2595, DOI 10.1038/sj.npp.1301665; Zhang L, 2002, J MOL BIOL, V317, P225, DOI 10.1006/jmbi.2001.5350	86	55	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e33575	10.1371/journal.pone.0033575	http://dx.doi.org/10.1371/journal.pone.0033575			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511924	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338600010
J	Chatterjee, N; Bohmann, D				Chatterjee, Nirmalya; Bohmann, Dirk			A Versatile Phi C31 Based Reporter System for Measuring AP-1 and Nrf2 Signaling in Drosophila and in Tissue Culture	PLOS ONE			English	Article							OXIDATIVE STRESS; TERMINAL KINASE; JUN; MORPHOGENESIS; TRANSDUCTION; MAF; PHOSPHORYLATION; TRANSFORMATION; CONSTRUCTION; EXPRESSION	This paper describes the construction and characterization of a system of transcriptional reporter genes for monitoring the activity of signaling pathways and gene regulation mechanisms in intact Drosophila, dissected tissues or cultured cells. Transgenic integration of the reporters into the Drosophila germline was performed in a site-directed manner, using Phi C31 integrase. This strategy avoids variable position effects and assures low base level activity and high signal responsiveness. Defined integration sites furthermore enable the experimenter to compare the activity of different reporters in one organism. The reporter constructs have a modular design to facilitate the combination of promoter elements (synthetic transcription factor binding sites or natural regulatory sequences), reporter genes (eGFP, or DsRed.T4), and genomic integration sites. The system was used to analyze and compare the activity and signal response profiles of two stress inducible transcription factors, AP-1 and Nrf2. To complement the transgenic reporter fly lines, tissue culture assays were developed in which the same synthetic ARE and TRE elements control the expression of firefly luciferase.	[Chatterjee, Nirmalya; Bohmann, Dirk] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA	University of Rochester	Chatterjee, N (corresponding author), Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA.	dirk_bohmann@urmc.rochester.edu	Chatterjee, Nirmalya/AAS-8484-2021	Chatterjee, Nirmalya/0000-0003-0613-7916	NYSTEM (New York State Stem Cell Science) [C024319]; NIH (National Institute of Health) [R01AG039753]; NATIONAL INSTITUTE ON AGING [R01AG039753] Funding Source: NIH RePORTER	NYSTEM (New York State Stem Cell Science); NIH (National Institute of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the NYSTEM (New York State Stem Cell Science) Grant C024319 and the NIH (National Institute of Health) Grant R01AG039753 to Dirk Bohmann. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armknecht S, 2005, METHOD ENZYMOL, V392, P55, DOI 10.1016/S0076-6879(04)92004-6; Arziman Z, 2005, NUCLEIC ACIDS RES, V33, pW582, DOI 10.1093/nar/gki468; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074; Boy AL, 2010, GENESIS, V48, P452, DOI 10.1002/dvg.20637; Ciapponi L, 2001, GENE DEV, V15, P1540, DOI 10.1101/gad.886301; DANIELS SB, 1986, GENETICS, V113, P265; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Glise B, 1997, GENE DEV, V11, P1738, DOI 10.1101/gad.11.13.1738; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006; Homsy JG, 2006, DEV DYNAM, V235, P427, DOI 10.1002/dvdy.20649; Huang CS, 1997, P NATL ACAD SCI USA, V94, P5826, DOI 10.1073/pnas.94.11.5826; Hur W, 2011, CURR OPIN CHEM BIOL, V15, P162, DOI 10.1016/j.cbpa.2010.12.009; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Jasper H, 2001, DEV CELL, V1, P579, DOI 10.1016/S1534-5807(01)00045-4; Jiang TT, 2008, BIOTECHNOL GENET ENG, V25, P41, DOI 10.5661/bger-25-41; Katoh Y, 2005, ARCH BIOCHEM BIOPHYS, V433, P342, DOI 10.1016/j.abb.2004.10.012; Kensler TW, 1999, CHEM RES TOXICOL, V12, P113, DOI 10.1021/tx980185b; KERPPOLA TK, 1994, ONCOGENE, V9, P675; Kockel L, 1997, GENE DEV, V11, P1748, DOI 10.1101/gad.11.13.1748; Kockel L, 2001, ONCOGENE, V20, P2347, DOI 10.1038/sj.onc.1204300; Lopez-Bergami P, 2010, NAT REV CANCER, V10, P65, DOI 10.1038/nrc2681; Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.0.CO;2-L; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Noselli S, 1998, TRENDS GENET, V14, P33, DOI 10.1016/S0168-9525(97)01320-6; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Peverali FA, 1996, EMBO J, V15, P3943, DOI 10.1002/j.1460-2075.1996.tb00768.x; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Rogers WA, 2011, JOVE-J VIS EXP, DOI 10.3791/3395; Steinbrink Sandra, 2008, V420, P139, DOI 10.1007/978-1-59745-583-1_8; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3; Sykiotis Gerasimos P., 2008, V20, P225, DOI 10.1007/4735_2007_0251; Tsai CW, 2011, J NUTR, V141, P2119, DOI 10.3945/jn.111.146779; Veraksa A, 2000, DEVELOPMENT, V127, P4023; Weber U, 2000, DEVELOPMENT, V127, P3619; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001	47	127	127	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34063	10.1371/journal.pone.0034063	http://dx.doi.org/10.1371/journal.pone.0034063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509270	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600019
J	Kang, TH; Mao, CP; He, LM; Tsai, YC; Liu, K; La, V; Wu, TC; Hung, CF				Kang, Tae Heung; Mao, Chih-Ping; He, Liangmei; Tsai, Ya-Chea; Liu, Katherine; La, Victor; Wu, T. -C.; Hung, Chien-Fu			Tumor-Targeted Delivery of IL-2 by NKG2D Leads to Accumulation of Antigen-Specific CD8+T Cells in the Tumor Loci and Enhanced Anti-Tumor Effects	PLOS ONE			English	Article							HIGH-DOSE INTERLEUKIN-2; T-CELLS; IN-VIVO; CANCER-THERAPY; OVARIAN-CANCER; DNA VACCINES; RECEPTOR; IMMUNITY; IMMUNOTHERAPY; GENE	Interleukin-2 (IL-2) has been shown to promote tumor-specific T-cell proliferation and differentiation but systemic administration of IL-2 results in significant toxicity. Therefore, a strategy that can specifically deliver IL-2 to the tumor location may alleviate concerns of toxicity. Because NKG2D ligands have been shown to be highly expressed in many cancer cells but not in healthy cells, we reason that a chimeric protein consisting of NKG2D linked to IL-2 will lead to the specific targeting of IL-2 to the tumor location. Therefore, we created chimeric proteins consisting of NKG2D linked to Gaussia luciferase (GLuc; a marker protein) or IL-2 to form NKG2D-Fc-GLuc and NKG2D-Fc-IL2, respectively. We demonstrated that NKG2D linked to GLuc was able to deliver GLuc to the tumor location in vivo. Furthermore, we showed that TC-1 tumor-bearing mice intramuscularly injected with DNA encoding NKG2D-Fc-IL2, followed by electroporation, exhibited an increased number of luciferase-expressing E7-specific CD8+ T cells at the tumor location. More importantly, treatment with the DNA construct encoding NKG2D-Fc-IL2 significantly enhanced the therapeutic anti-tumor effects generated by intradermal vaccination with therapeutic HPV DNA in tumor-bearing mice. Therefore, by linking NKG2D to IL2, we are able to specifically deliver IL-2 to the tumor location, enhancing antigen-specific T-cell immune response and controlling tumor growth. Our approach represents a platform technology to specifically deliver proteins of interest to tumor loci.	[Kang, Tae Heung; Mao, Chih-Ping; He, Liangmei; Tsai, Ya-Chea; Liu, Katherine; La, Victor; Wu, T. -C.; Hung, Chien-Fu] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA; [Wu, T. -C.; Hung, Chien-Fu] Johns Hopkins Univ, Dept Oncol, Baltimore, MD USA; [Wu, T. -C.] Johns Hopkins Univ, Dept Obstet & Gynecol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kang, TH (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA.	chung2@jhmi.edu	Liu, Katherine/GQA-3751-2022		National Cancer Institute [P50 CA098252, 1 RO1 CA114425-01]; American Cancer Society; NATIONAL CANCER INSTITUTE [P50CA098252, R01CA114425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007247] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Cancer Institute Specialized Programs of Research Excellence (http://trp.cancer.gov/) in Cervical Cancer P50 CA098252 and 1 RO1 CA114425-01, and the American Cancer Society (http://www.cancer.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar NH, 2012, ADV UROL, V2012, DOI 10.1155/2012/973820; Bakkum-Gamez JN, 2008, GYNECOL ONCOL, V108, P141, DOI 10.1016/j.ygyno.2007.09.010; Best SR, 2009, VACCINE, V27, P5450, DOI 10.1016/j.vaccine.2009.07.005; Chen CH, 2000, CANCER RES, V60, P1035; Cheng WF, 2001, J CLIN INVEST, V108, P669, DOI 10.1172/JCI200112346; Choi JH, 2004, J CLIN ENDOCR METAB, V89, P5508, DOI 10.1210/jc.2004-0044; Durrant LG, 2011, EXPERT REV VACCINES, V10, P1093, DOI [10.1586/erv.11.33, 10.1586/ERV.11.33]; Ertl HCJ, 2011, CANCER RES, V71, P3175, DOI 10.1158/0008-5472.CAN-10-4035; Hassan R, 2004, CLIN CANCER RES, V10, P3937, DOI 10.1158/1078-0432.CCR-03-0801; Kim D, 2007, HUM GENE THER, V18, P575, DOI 10.1089/hum.2007.038; Lee CF, 2004, CANCER GENE THER, V11, P194, DOI 10.1038/sj.cgt.7700658; Lin CT, 2007, IMMUNOL LETT, V114, P86, DOI 10.1016/j.imlet.2007.09.008; Lin KY, 1996, CANCER RES, V56, P21; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Malek TR, 2004, NAT REV IMMUNOL, V4, P665, DOI 10.1038/nri1435; Nausch N, 2008, ONCOGENE, V27, P5944, DOI 10.1038/onc.2008.272; Pule MA, 2005, MOL THER, V12, P933, DOI 10.1016/j.ymthe.2005.04.016; Ramakrishna V, 1997, INT J CANCER, V73, P143, DOI 10.1002/(SICI)1097-0215(19970926)73:1<143::AID-IJC22>3.0.CO;2-G; Ramos CA, 2011, EXPERT OPIN BIOL TH, V11, P855, DOI 10.1517/14712598.2011.573476; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; ROSENBERG SA, 1987, NEW ENGL J MED, V316, P889, DOI 10.1056/NEJM198704093161501; ROSENBERG SA, 1989, ANN SURG, V210, P474, DOI 10.1097/00000658-198910000-00008; Scholler N, 1999, P NATL ACAD SCI USA, V96, P11531, DOI 10.1073/pnas.96.20.11531; Tannous BA, 2005, MOL THER, V11, P435, DOI 10.1016/j.ymthe.2004.10.016; Utreja Puneet, 2010, Current Drug Delivery, V7, P152; Vella AT, 1998, P NATL ACAD SCI USA, V95, P3810, DOI 10.1073/pnas.95.7.3810; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Zhang T, 2005, BLOOD, V106, P1544, DOI 10.1182/blood-2004-11-4365	29	31	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35141	10.1371/journal.pone.0035141	http://dx.doi.org/10.1371/journal.pone.0035141			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509395	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336600088
J	Bromann, K; Toivari, M; Viljanen, K; Vuoristo, A; Ruohonen, L; Nakari-Setala, T				Bromann, Kirsi; Toivari, Mervi; Viljanen, Kaarina; Vuoristo, Anu; Ruohonen, Laura; Nakari-Setala, Tiina			Identification and Characterization of a Novel Diterpene Gene Cluster in Aspergillus nidulans	PLOS ONE			English	Article							ENT-KAURENE SYNTHASE; SECONDARY METABOLISM; CHEMICAL-COMPOSITION; GIBBERELLA-FUJIKUROI; ASEXUAL DEVELOPMENT; FUNCTIONAL-ANALYSIS; SEXUAL DEVELOPMENT; NATURAL-PRODUCTS; ESSENTIAL OILS; PROTEIN	Fungal secondary metabolites are a rich source of medically useful compounds due to their pharmaceutical and toxic properties. Sequencing of fungal genomes has revealed numerous secondary metabolite gene clusters, yet products of many of these biosynthetic pathways are unknown since the expression of the clustered genes usually remains silent in normal laboratory conditions. Therefore, to discover new metabolites, it is important to find ways to induce the expression of genes in these otherwise silent biosynthetic clusters. We discovered a novel secondary metabolite in Aspergillus nidulans by predicting a biosynthetic gene cluster with genomic mining. A Zn(II)(2)Cys(6)-type transcription factor, PbcR, was identified, and its role as a pathway-specific activator for the predicted gene cluster was demonstrated. Overexpression of pbcR upregulated the transcription of seven genes in the identified cluster and led to the production of a diterpene compound, which was characterized with GC/MS as ent-pimara-8(14),15-diene. A change in morphology was also observed in the strains overexpressing pbcR. The activation of a cryptic gene cluster by overexpression of its putative Zn(II)(2)Cys(6)-type transcription factor led to discovery of a novel secondary metabolite in Aspergillus nidulans. Quantitative real-time PCR and DNA array analysis allowed us to predict the borders of the biosynthetic gene cluster. Furthermore, we identified a novel fungal pimaradiene cyclase gene as well as genes encoding 3-hydroxy-3-methyl-glutaryl-coenzyme A (HMG-CoA) reductase and a geranylgeranyl pyrophosphate (GGPP) synthase. None of these genes have been previously implicated in the biosynthesis of terpenes in Aspergillus nidulans. These results identify the first Aspergillus nidulans diterpene gene cluster and suggest a biosynthetic pathway for ent-pimara-8(14),15-diene.	[Bromann, Kirsi; Toivari, Mervi; Viljanen, Kaarina; Vuoristo, Anu; Ruohonen, Laura; Nakari-Setala, Tiina] VTT Tech Res Ctr Finland, Espoo, Finland	VTT Technical Research Center Finland	Bromann, K (corresponding author), VTT Tech Res Ctr Finland, Espoo, Finland.	kirsi.bromann@vtt.fi	Toivari, Mervi/T-6804-2017	Toivari, Mervi/0000-0002-5477-6416	ForestCluster Ltd.; Academy of Finland [21084]	ForestCluster Ltd.; Academy of Finland(Academy of Finland)	This work was supported by ForestCluster Ltd. Future Biorefinery Research Program (http://www.forestcluster.fi/d/content/future-biorefinery) and by the Academy of Finland grant no. 21084 (http://www.aka.fi/en-GB/A/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alasbahi RH, 2010, PLANTA MED, V76, P753, DOI 10.1055/s-0029-1240919; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aponte JC, 2011, PLANTA MED, V77, P1597, DOI 10.1055/s-0030-1270960; BARRATT RW, 1965, GENETICS, V52, P233; Bayram O, 2011, FEMS MICROBIOL REV; Bergmann S, 2007, NAT CHEM BIOL, V3, P213, DOI 10.1038/nchembio869; Bishayee A, 2011, FRONT BIOSCI-LANDMRK, V16, P980, DOI 10.2741/3730; Bok JW, 2006, CHEM BIOL, V13, P31, DOI 10.1016/j.chembiol.2005.10.008; Bouhired S, 2007, FUNGAL GENET BIOL, V44, P1134, DOI 10.1016/j.fgb.2006.12.010; Brakhage AA, 2011, FUNGAL GENET BIOL, V48, P15, DOI 10.1016/j.fgb.2010.04.004; Brown DW, 2007, EUKARYOT CELL, V6, P1210, DOI 10.1128/EC.00400-06; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Calvo AM, 2008, FUNGAL GENET BIOL, V45, P1053, DOI 10.1016/j.fgb.2008.03.014; Chiang YM, 2009, J AM CHEM SOC, V131, P2965, DOI 10.1021/ja8088185; Conforti F, 2009, FOOD CHEM, V116, P898, DOI 10.1016/j.foodchem.2009.03.044; DOCKERILL B, 1977, J CHEM SOC PERK T 1, P324, DOI 10.1039/p19770000324; Ebel R, 2010, MAR DRUGS, V8, P2340, DOI 10.3390/md8082340; Eisendle M, 2006, EUKARYOT CELL, V5, P1596, DOI 10.1128/EC.00057-06; Etxebeste O, 2008, EUKARYOT CELL, V7, P38, DOI 10.1128/EC.00207-07; Fernandes M, 1998, MOL MICROBIOL, V28, P1355, DOI 10.1046/j.1365-2958.1998.00907.x; Fox EM, 2008, CURR OPIN MICROBIOL, V11, P481, DOI 10.1016/j.mib.2008.10.007; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Goto T, 2010, PPAR RES, V2010, DOI 10.1155/2010/483958; Haas H, 2003, BIOCHEM J, V371, P505, DOI 10.1042/BJ20021685; Hamm S, 2005, PHYTOCHEMISTRY, V66, P1499, DOI 10.1016/j.phytochem.2005.04.025; Harris SD, 2009, FUNGAL GENET BIOL, V46, pS82, DOI 10.1016/j.fgb.2008.07.023; Hoffmeister D, 2007, NAT PROD REP, V24, P393, DOI 10.1039/b603084j; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Jones CA, 2007, MOL BIOL CELL, V18, P2123, DOI 10.1091/mbc.E06-03-0226; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kanno Y, 2006, BIOSCI BIOTECH BIOCH, V70, P1702, DOI 10.1271/bbb.60044; Karioti A, 2004, J AGR FOOD CHEM, V52, P8094, DOI 10.1021/jf040150j; Kawaide H, 1997, J BIOL CHEM, V272, P21706, DOI 10.1074/jbc.272.35.21706; Keller NP, 2005, NAT REV MICROBIOL, V3, P937, DOI 10.1038/nrmicro1286; Keller NP, 1997, FUNGAL GENET BIOL, V21, P17, DOI 10.1006/fgbi.1997.0970; Kenmoku H, 2004, BIOSCI BIOTECH BIOCH, V68, P1574, DOI 10.1271/bbb.68.1574; Kuiate JR, 2006, J ETHNOPHARMACOL, V103, P160, DOI 10.1016/j.jep.2005.07.022; Kuorelahti S, 2006, MOL MICROBIOL, V61, P1060, DOI 10.1111/j.1365-2958.2006.05294.x; Kwon NJ, 2010, MOL MICROBIOL, V77, P1203, DOI 10.1111/j.1365-2958.2010.07282.x; Mabey JE, 2004, NUCLEIC ACIDS RES, V32, pD401, DOI 10.1093/nar/gkh009; MacPherson S, 2006, MICROBIOL MOL BIOL R, V70, P583, DOI 10.1128/MMBR.00015-06; Min BS, 2001, PLANTA MED, V67, P811, DOI 10.1055/s-2001-18854; Moore D, 2002, CURRENT PROTOCOLS MO, P211; Mylonakis E, 2007, PLOS PATHOG, V3, P859, DOI 10.1371/journal.ppat.0030101; Oide S, 2007, EUKARYOT CELL, V6, P1339, DOI 10.1128/EC.00111-07; Osbourn A, 2010, TRENDS GENET, V26, P449, DOI 10.1016/j.tig.2010.07.001; Palmer JM, 2010, CURR OPIN MICROBIOL, V13, P431, DOI 10.1016/j.mib.2010.04.008; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Peters RJ, 2010, NAT PROD REP, V27, P1521, DOI 10.1039/c0np00019a; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Porto TS, 2009, FITOTERAPIA, V80, P432, DOI 10.1016/j.fitote.2009.06.003; Rohlfs M, 2007, BIOL LETTERS, V3, P523, DOI 10.1098/rsbl.2007.0338; Schrettl M, 2008, MOL MICROBIOL, V70, P27, DOI 10.1111/j.1365-2958.2008.06376.x; Senatore F, 2007, CROAT CHEM ACTA, V80, P135; Tan W, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-27; Toyomasu T, 2000, BIOSCI BIOTECH BIOCH, V64, P660, DOI 10.1271/bbb.64.660; Toyomasu T, 2008, BIOSCI BIOTECH BIOCH, V72, P1038, DOI 10.1271/bbb.70790; Toyomasu T, 2007, P NATL ACAD SCI USA, V104, P3084, DOI 10.1073/pnas.0608426104; Toyomasu T, 2009, J ORG CHEM, V74, P1541, DOI 10.1021/jo802319e; Tudzynski B, 1999, APPL MICROBIOL BIOT, V52, P298, DOI 10.1007/s002530051524; von Dohren H, 2009, FUNGAL GENET BIOL, V46, pS45, DOI 10.1016/j.fgb.2008.08.008; Yin WB, 2011, J MICROBIOL, V49, P329, DOI 10.1007/s12275-011-1009-1; Yu JH, 2005, ANNU REV PHYTOPATHOL, V43, P437, DOI 10.1146/annurev.phyto.43.040204.140214	66	43	61	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35450	10.1371/journal.pone.0035450	http://dx.doi.org/10.1371/journal.pone.0035450			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506079	gold, Green Published			2022-12-27	WOS:000305297500087
J	Avaria-Llautureo, J; Hernandez, CE; Boric-Bargetto, D; Canales-Aguirre, CB; Morales-Pallero, B; Rodriguez-Serrano, E				Avaria-Llautureo, Jorge; Hernandez, Cristian E.; Boric-Bargetto, Dusan; Canales-Aguirre, Cristian B.; Morales-Pallero, Bryan; Rodriguez-Serrano, Enrique			Body Size Evolution in Extant Oryzomyini Rodents: Cope's Rule or Miniaturization?	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; CRICETIDAE SIGMODONTINAE; BAYESIAN-INFERENCE; ANCESTRAL STATES; MUROID RODENTS; FOSSIL MAMMALS; RICE RATS; TRENDS; DIVERSIFICATION; GENUS	At the macroevolutionary level, one of the first and most important hypotheses that proposes an evolutionary tendency in the evolution of body sizes is "Cope's rule". This rule has considerable empirical support in the fossil record and predicts that the size of species within a lineage increases over evolutionary time. Nevertheless, there is also a large amount of evidence indicating the opposite pattern of miniaturization over evolutionary time. A recent analysis using a single phylogenetic tree approach and a Bayesian based model of evolution found no evidence for Cope's rule in extant mammal species. Here we utilize a likelihood-based phylogenetic method, to test the evolutionary trend in body size, which considers phylogenetic uncertainty, to discern between Cope's rule and miniaturization, using extant Oryzomyini rodents as a study model. We evaluated body size trends using two principal predictions: (a) phylogenetically related species are more similar in their body size, than expected by chance; (b) body size increased (Cope's rule)/decreased (miniaturization) over time. Consequently the distribution of forces and/or constraints that affect the tendency are homogenous and generate this directional process from a small/large sized ancestor. Results showed that body size in the Oryzomyini tribe evolved according to phylogenetic relationships, with a positive trend, from a small sized ancestor. Our results support that the high diversity and specialization currently observed in the Oryzomyini tribe is a consequence of the evolutionary trend of increased body size, following and supporting Cope's rule.	[Avaria-Llautureo, Jorge; Hernandez, Cristian E.; Boric-Bargetto, Dusan; Canales-Aguirre, Cristian B.; Morales-Pallero, Bryan; Rodriguez-Serrano, Enrique] Univ Concepcion, Lab Ecol Mol & Filoinformat, Dept Zool, Fac Ciencias Nat & Oceanog, Concepcion, Chile	Universidad de Concepcion	Avaria-Llautureo, J (corresponding author), Univ Concepcion, Lab Ecol Mol & Filoinformat, Dept Zool, Fac Ciencias Nat & Oceanog, Concepcion, Chile.	cristianhernand@udec.cl	Hernández, Cristián E./GLS-1111-2022; Canales-Aguirre, Cristian B./K-4034-2019; Hernández, Cristián E./AAS-1286-2020; Hernández, Cristián E./C-4414-2012; Canales-Aguirre, Cristian B./G-8688-2013	Hernández, Cristián E./0000-0002-9811-2881; Canales-Aguirre, Cristian B./0000-0002-8468-6139; Hernández, Cristián E./0000-0002-9811-2881; Canales-Aguirre, Cristian B./0000-0002-8468-6139; Avaria-Llautureo, Jorge/0000-0002-8610-7428; Boric-Bargetto, Dusan/0000-0002-4568-8828; Rodriguez-Serrano, Enrique/0000-0002-5049-8500	Fondo de Desarrollo en Ciencia y Tecnologia [11080110]; CONICYT; Escuela de Graduados of the Universidad de Concepcion	Fondo de Desarrollo en Ciencia y Tecnologia; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Escuela de Graduados of the Universidad de Concepcion	This study was funded by Fondo de Desarrollo en Ciencia y Tecnologia Grant # 11080110 to CEH (http://www.fondecyt.cl/578/channel.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are very grateful to Paula E. Neill, Michel Laurin, Nicolas Salamin, Melanie Monroe, and two anonymous reviewers for comments and suggestions that greatly improved the final version of the manuscript. We also thank Eduardo Palma for facilitating bibliographic data and literature about oryzomines. Previous versions of this paper were improved by comments from Guillermo D'Elia. Jorge Avaria-Llautureo and Bryan Morales-Pallero were supported by a CONICYT Master's Fellowship. Dusan Boric-Bargetto was supported by a CONICYT Doctoral Fellowship, and Cristian B. Canales-Aguirre was supported by a Doctoral Fellowship from the Escuela de Graduados of the Universidad de Concepcion.	Alroy J, 1998, SCIENCE, V280, P731, DOI 10.1126/science.280.5364.731; Alroy J, 2000, PALEOBIOLOGY, V26, P319, DOI 10.1666/0094-8373(2000)026<0319:UTDOTW>2.0.CO;2; Alroy J, 2000, PALEOBIOLOGY, V26, P707, DOI 10.1666/0094-8373(2000)026<0707:NMFQMP>2.0.CO;2; Brown J. H., 1995, MACROECOLOGY; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; Clauset A, 2008, SCIENCE, V321, P399, DOI 10.1126/science.1157534; COATES AG, 1992, GEOL SOC AM BULL, V104, P814, DOI 10.1130/0016-7606(1992)104<0814:COTIOP>2.3.CO;2; Cope CD, 1887, ORIGIN FITTEST; D'Elia G, 2006, MOL PHYLOGENET EVOL, V38, P558, DOI 10.1016/j.ympev.2005.08.011; D'Elia G, 2003, CLADISTICS, V19, P307, DOI 10.1016/S0748-3007(03)00071-9; D'Elia Guillermo, 2000, Mastozoologia Neotropical, V7, P47; DAMUTH J, 1993, NATURE, V365, P748, DOI 10.1038/365748a0; Demetrius L, 2000, P ROY SOC B-BIOL SCI, V267, P2385, DOI 10.1098/rspb.2000.1295; DIAL KP, 1988, ECOLOGY, V69, P1620, DOI 10.2307/1941660; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Palma RE, 2010, ZOOL J LINN SOC-LOND, V160, P551, DOI 10.1111/j.1096-3642.2009.00621.x; Engel SR, 1998, MOL BIOL EVOL, V15, P35, DOI 10.1093/oxfordjournals.molbev.a025845; Felsenstein J., 2004, INFERRING PHYLOGENIE; FitzJohn RG, 2010, SYST BIOL, V59, P619, DOI 10.1093/sysbio/syq053; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Frobisch NB, 2009, SYST BIOL, V58, P312, DOI 10.1093/sysbio/syp029; Gaston KJ, 2001, P NATL ACAD SCI USA, V98, P14493, DOI 10.1073/pnas.251332098; Gaston KJ, 2002, P ROY SOC B-BIOL SCI, V269, P1079, DOI 10.1098/rspb.2002.1969; Gelman Andrew, 1995, BAYESIAN DATA ANAL; GOULD SJ, 1988, J PALEONTOL, V62, P319, DOI 10.1017/S0022336000059126; HANKEN J, 1993, ANNU REV ECOL SYST, V24, P501, DOI 10.1146/annurev.es.24.110193.002441; HANKEN J, 1992, J EVOLUTION BIOL, V5, P549, DOI 10.1046/j.1420-9101.1992.5040549.x; Holder M, 2003, NAT REV GENET, V4, P275, DOI 10.1038/nrg1044; Hone DWE, 2007, J EVOLUTION BIOL, V20, P1164, DOI 10.1111/j.1420-9101.2006.01284.x; Hone DWE, 2005, J EVOLUTION BIOL, V18, P587, DOI 10.1111/j.1420-9101.2004.00870.x; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Huelsenbeck JP, 2000, SCIENCE, V288, P2349, DOI 10.1126/science.288.5475.2349; Ibaraki M, 1997, TECTONOPHYSICS, V281, P99, DOI 10.1016/S0040-1951(97)00161-3; Jansa SA, 2004, MOL PHYLOGENET EVOL, V31, P256, DOI 10.1016/j.ympev.2003.07.002; Kingsolver JG, 2004, EVOLUTION, V58, P1608; Knouft JH, 2003, AM NAT, V161, P413, DOI 10.1086/346133; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Lutzoni F, 2001, NATURE, V411, P937, DOI 10.1038/35082053; Martins EP, 1997, AM NAT, V149, P646, DOI 10.1086/286013; Maurer BA, 1998, EVOL ECOL, V12, P925, DOI 10.1023/A:1006512121434; MCFADDEN BJ, 1992, FOSSIL HORSES SYSTEM; McFarlane DA, 2001, CARIBB J SCI, V37, P182; McShea DW, 2000, PALEOBIOLOGY, V26, P330, DOI 10.1666/0094-8373(2000)026<0330:TTAT>2.0.CO;2; MCSHEA DW, 1994, EVOLUTION, V48, P1747, DOI 10.1111/j.1558-5646.1994.tb02211.x; Moen DS, 2006, J EVOLUTION BIOL, V19, P1210, DOI 10.1111/j.1420-9101.2006.01082.x; Monroe MJ, 2010, J EVOLUTION BIOL, V23, P2017, DOI 10.1111/j.1420-9101.2010.02051.x; Novack-Gottshall PM, 2008, P NATL ACAD SCI USA, V105, P5430, DOI 10.1073/pnas.0709645105; Oakley TH, 2000, EVOLUTION, V54, P397; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P121; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PAGEL M, 2002, BIOL EVOLUTION STAT, P148; Pagel M, 2005, EVOLUTION CULTURAL D, P235; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Pagel Mark, 2002, VVolume 64, P269; Pardinas U. F. J., 1996, Estudios Geologicos (Madrid), V52, P367; Pardinas UFJ, 2008, J MAMMAL, V89, P1270, DOI 10.1644/07-MAMM-A-099.1; Pardinas Ulyses F. J., 2002, Mastozoologia Neotropical, V9, P209; Pardinas Ulyses F. J., 2003, Mastozoologia Neotropical, V10, P69; Percequillo AR, 2011, ZOOL J LINN SOC-LOND, V161, P357, DOI 10.1111/j.1096-3642.2010.00643.x; PIANKA ER, 1995, AM NAT, V146, P398, DOI 10.1086/285806; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; R Core Team, 2018, R LANG ENV STAT COMP; Rabosky DL, 2010, EVOLUTION, V64, P1816, DOI 10.1111/j.1558-5646.2009.00926.x; Raia P, 2012, AM NAT, V179, P328, DOI 10.1086/664081; Rambaut A., 2007, FIGTREE V1; REZENDE EL, 2003, FISIOLOGIA ECOLOGICA, P79; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Ruber L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-38; SCHLUTER D, 1995, NATURE, V377, P108, DOI 10.1038/377108a0; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Sibly RM, 2007, P NATL ACAD SCI USA, V104, P17707, DOI 10.1073/pnas.0707725104; Silvestro D, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-311; Smith FA, 2010, SCIENCE, V330, P1216, DOI 10.1126/science.1194830; Smith Margaret F., 1999, Journal of Mammalian Evolution, V6, P89, DOI 10.1023/A:1020668004578; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x; Steppan SJ, 1996, J VERTEBR PALEONTOL, V16, P522, DOI 10.1080/02724634.1996.10011337; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Teta Pablo, 2004, Mastozool. neotrop., V11, P69; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Trites AW, 1998, CAN J ZOOL, V76, P886, DOI 10.1139/cjz-76-5-886; Turvey ST, 2010, ZOOL J LINN SOC-LOND, V160, P748, DOI 10.1111/j.1096-3642.2009.00628.x; Venditti C, 2006, SYST BIOL, V55, P637, DOI 10.1080/10635150600865567; Venditti C, 2011, NATURE, V479, P393, DOI 10.1038/nature10516; Voss RS, 2009, CARIBB J SCI, V45, P73; Wade MJ, 2001, TRENDS ECOL EVOL, V16, P498, DOI 10.1016/S0169-5347(01)02213-3; Wang SC, 2001, EVOLUTION, V55, P849, DOI 10.1554/0014-3820(2001)055[0849:QPADLS]2.0.CO;2; Webster AJ, 2002, P ROY SOC B-BIOL SCI, V269, P143, DOI 10.1098/rspb.2001.1873; Weksler M, 2003, MOL PHYLOGENET EVOL, V29, P331, DOI 10.1016/S1055-7903(03)00132-5; Weksler M, 2006, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2006)296; Weksler M, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3537[1:TNGOOR]2.0.CO;2; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; XIA X, 2000, DATA ANAL MOL BIOL E; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Yeh J, 2002, EVOLUTION, V56, P628; Zijlstra JS, 2010, J MAMMAL, V91, P860, DOI 10.1644/09-MAMM-A-208.1	101	15	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34654	10.1371/journal.pone.0034654	http://dx.doi.org/10.1371/journal.pone.0034654			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509339	gold, Green Published, Green Submitted			2022-12-27	WOS:000304805900055
J	Koster, F; Gouveia, K; Zhou, Y; Lowery, K; Russell, R; MacInnes, H; Pollock, Z; Layton, RC; Cromwell, J; Toleno, D; Pyle, J; Zubelewicz, M; Harrod, K; Sampath, R; Hofstadler, S; Gao, P; Liu, YS; Cheng, YS				Koster, Frederick; Gouveia, Kristine; Zhou, Yue; Lowery, Kristin; Russell, Robert; MacInnes, Heather; Pollock, Zemmie; Layton, R. Colby; Cromwell, Jennifer; Toleno, Denise; Pyle, John; Zubelewicz, Michael; Harrod, Kevin; Sampath, Rangarajan; Hofstadler, Steven; Gao, Peng; Liu, Yushi; Cheng, Yung-Sung			Exhaled Aerosol Transmission of Pandemic and Seasonal H1N1 Influenza Viruses in the Ferret	PLOS ONE			English	Article							A VIRUS; AIRBORNE TRANSMISSION; H5N1 VIRUS; INFECTION; MODEL; ORIGIN; INHALATION; PARTICLES; MECHANICS; VIRULENCE	Person-to-person transmission of influenza viruses occurs by contact (direct and fomites) and non-contact (droplet and small particle aerosol) routes, but the quantitative dynamics and relative contributions of these routes are incompletely understood. The transmissibility of influenza strains estimated from secondary attack rates in closed human populations is confounded by large variations in population susceptibilities. An experimental method to phenotype strains for transmissibility in an animal model could provide relative efficiencies of transmission. We developed an experimental method to detect exhaled viral aerosol transmission between unanesthetized infected and susceptible ferrets, measured aerosol particle size and number, and quantified the viral genomic RNA in the exhaled aerosol. During brief 3-hour exposures to exhaled viral aerosols in airflow-controlled chambers, three strains of pandemic 2009 H1N1 strains were frequently transmitted to susceptible ferrets. In contrast one seasonal H1N1 strain was not transmitted in spite of higher levels of viral RNA in the exhaled aerosol. Among three pandemic strains, the two strains causing weight loss and illness in the intranasally infected 'donor' ferrets were transmitted less efficiently from the donor than the strain causing no detectable illness, suggesting that the mucosal inflammatory response may attenuate viable exhaled virus. Although exhaled viral RNA remained constant, transmission efficiency diminished from day 1 to day 5 after donor infection. Thus, aerosol transmission between ferrets may be dependent on at least four characteristics of virus-host relationships including the level of exhaled virus, infectious particle size, mucosal inflammation, and viral replication efficiency in susceptible mucosa.	[Koster, Frederick; Russell, Robert; Pollock, Zemmie; Zubelewicz, Michael] Lovelace Resp Res Inst, Program Appl Sci, Albuquerque, NM USA; [Koster, Frederick; Gouveia, Kristine; MacInnes, Heather; Layton, R. Colby; Pyle, John; Harrod, Kevin; Gao, Peng] Lovelace Resp Res Inst, Program Infect Dis, Albuquerque, NM USA; [Zhou, Yue; Cheng, Yung-Sung] Lovelace Resp Res Inst, Program Aerosol Sci, Albuquerque, NM USA; [Lowery, Kristin; Cromwell, Jennifer; Toleno, Denise; Sampath, Rangarajan; Hofstadler, Steven] Ibis Biosci, Analyt Serv Lab, Carlsbad, CA USA; [Liu, Yushi] Lovelace Resp Res Inst, Program Lung Canc, Albuquerque, NM USA	Lovelace Respiratory Research Institute; Lovelace Respiratory Research Institute; Lovelace Respiratory Research Institute; Lovelace Respiratory Research Institute	Koster, F (corresponding author), Lovelace Resp Res Inst, Program Appl Sci, Albuquerque, NM USA.	fkoster@lrri.org	Liu, Yushi/A-1533-2014	Liu, Yushi/0000-0003-4185-4187; Harrod, Kevin/0000-0003-0780-9470	NIAID [1U01 AI074561, HHSN2662004000951]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074561] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was funded by the NIAID grant 1U01 AI074561 and NIAID contract HHSN2662004000951. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALFORD RH, 1966, P SOC EXP BIOL MED, V122, P800, DOI 10.3181/00379727-122-31255; [Anonymous], PREPARING INFLUENZA; Balcan D, 2009, BMC MED, V10, P7; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Belser JA, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001705; BOYD RL, 1981, J APPL PHYSIOL, V50, P799, DOI 10.1152/jappl.1981.50.4.799; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; COUCH RB, 1966, BACTERIOL REV, V30, P517, DOI 10.1128/MMBR.30.3.517-529.1966; Cox CS., 1987, AEROBIOLOGICAL PATHW; Deyde VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013293; Edwards DA, 2004, P NATL ACAD SCI USA, V101, P17383, DOI 10.1073/pnas.0408159101; Fabian P, 2009, INDOOR AIR, V19, P433, DOI 10.1111/j.1600-0668.2009.00609.x; Fabian P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002691; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Gubareva LV, 1998, J INFECT DIS, V178, P1592, DOI 10.1086/314515; Gustin KM, 2011, P NATL ACAD SCI USA, V108, P8432, DOI 10.1073/pnas.1100768108; Herfst S, 2010, J VIROL, V84, P3752, DOI 10.1128/JVI.02634-09; Herlocher ML, 2001, J INFECT DIS, V184, P542, DOI 10.1086/322801; Lednicky JA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-231; Lemieux C, 2007, EMERG INFECT DIS, V13, P173, DOI 10.3201/eid1301.061202; Lindsley WG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015100; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; MacInnes H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024448; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Marcus PI, 2009, J VIROL, V83, P8122, DOI 10.1128/JVI.02680-08; Mitchell H, 2011, J VIROL, V85, P1125, DOI 10.1128/JVI.01722-10; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Ngunjiri JM, 2008, J VIROL, V82, P2673, DOI 10.1128/JVI.02221-07; Rowe T, 2010, VIROLOGY, V401, P257, DOI 10.1016/j.virol.2010.02.020; Roy CJ, 2004, NEW ENGL J MED, V350, P1710, DOI 10.1056/NEJMp048051; Sampath R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000489; Sorrell EM, 2009, P NATL ACAD SCI USA, V106, P7565, DOI 10.1073/pnas.0900877106; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; Steel J, 2010, J VIROL, V84, P21, DOI 10.1128/JVI.01732-09; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Taubenberger JK, 2006, P AM PHILOS SOC, V150, P86; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Thompson M. G., 2010, Morbidity and Mortality Weekly Report, V59, P1057; Truscott J, 2009, PLOS CURRENTS, V2; Tuttle RS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-135; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; VINEGAR A, 1982, J APPL PHYSIOL, V52, P832, DOI 10.1152/jappl.1982.52.4.832; Vukotich Charles J Jr, 2010, Emerg Infect Dis, V16, pe2; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; White LF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001498; Whitley RJ, 2010, J INFECT DIS, V201, P976, DOI 10.1086/651133; Wie Z, 2007, J VIROL METHODS, V144, P122; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Yen HL, 2005, ANTIMICROB AGENTS CH, V49, P4075, DOI 10.1128/AAC.49.10.4075-4084.2005	54	59	59	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e33118	10.1371/journal.pone.0033118	http://dx.doi.org/10.1371/journal.pone.0033118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509254	Green Published, gold, Green Submitted			2022-12-27	WOS:000304805900006
J	Liu, XJ; Swenson, NG; Wright, SJ; Zhang, LW; Song, K; Du, YJ; Zhang, JL; Mi, XC; Ren, HB; Ma, KP				Liu, Xiaojuan; Swenson, Nathan G.; Joseph Wright, S.; Zhang, Liwen; Song, Kai; Du, Yanjun; Zhang, Jinlong; Mi, Xiangcheng; Ren, Haibao; Ma, Keping			Covariation in Plant Functional Traits and Soil Fertility within Two Species-Rich Forests	PLOS ONE			English	Article							WOOD SPECIFIC-GRAVITY; HABITAT ASSOCIATIONS; GLOBAL PATTERNS; LEAF TRAITS; TRADE-OFF; SEED MASS; CLIMATE; SIZE; TEMPERATURE; DIVERSITY	The distribution of plant species along environmental gradients is expected to be predictable based on organismal function. Plant functional trait research has shown that trait values generally vary predictably along broad-scale climatic and soil gradients. This work has also demonstrated that at any one point along these gradients there is a large amount of interspecific trait variation. The present research proposes that this variation may be explained by the local-scale sorting of traits along soil fertility and acidity axes. Specifically, we predicted that trait values associated with high resource acquisition and growth rates would be found on soils that are more fertile and less acidic. We tested the expected relationships at the species-level and quadrat-level (20 x 20 m) using two large forest plots in Panama and China that contain over 450 species combined. Predicted relationships between leaf area and wood density and soil fertility were supported in some instances, but the majority of the predicted relationships were rejected. Alternative resource axes, such as light gradients, therefore likely play a larger role in determining the interspecific variability in plant functional traits in the two forests studied.	[Liu, Xiaojuan; Song, Kai; Du, Yanjun; Zhang, Jinlong; Mi, Xiangcheng; Ren, Haibao; Ma, Keping] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Swenson, Nathan G.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Joseph Wright, S.] Smithsonian Trop Res Inst, Balboa, Panama; [Zhang, Liwen] Chinese Acad Sci, Yantai Inst Coastal Zone Res, Yantai, Shandong, Peoples R China; [Liu, Xiaojuan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Michigan State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Chinese Academy of Sciences; Yantai Institute of Coastal Zone Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, XJ (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	kpma@ibcas.ac.cn	Liu, Xiaojuan/B-4947-2017; Zhang, Jinlong/AFL-0257-2022; Swenson, Nathan/A-3514-2012; Wright, Stuart Joseph/M-3311-2013	Zhang, Jinlong/0000-0002-1161-5460; Swenson, Nathan/0000-0003-3819-9767; Wright, Stuart Joseph/0000-0003-4260-5676	Chinese Academy of Sciences [KZCX2-YW-430]; Center for Tropical Forest Science (CTFS); F. H. Levinson Fund; Biodiversity Committee of the Chinese Academy of Sciences; National Science Foundation; MacArthur Foundation; Smithsonian Tropical Research Institute	Chinese Academy of Sciences(Chinese Academy of Sciences); Center for Tropical Forest Science (CTFS); F. H. Levinson Fund; Biodiversity Committee of the Chinese Academy of Sciences; National Science Foundation(National Science Foundation (NSF)); MacArthur Foundation; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute)	This work was supported by a key innovation project of the Chinese Academy of Sciences (KZCX2-YW-430) and a research grant from the Center for Tropical Forest Science (CTFS). The F. H. Levinson Fund supported functional traits measurements at Barro Colorado Island (BCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Fang Teng, Chen Shengwen, Lai Zhenxi and Jiang Zhiyong for species identification and data collection at Gutianshan. The Administration Bureau of the Gutianshan National Nature Reserve and the Smithsonian Tropical Research Institute provided local support. The Biodiversity Committee of the Chinese Academy of Sciences supported the GTS plot. The National Science Foundation, the MacArthur Foundation and the Smithsonian Tropical Research Institute supported the BCI plot.	Azcarate FM, 2002, J VEG SCI, V13, P159, DOI 10.1111/j.1654-1103.2002.tb02035.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolmgren K, 2008, OIKOS, V117, P424, DOI 10.1111/j.2007.0030-1299.16142.x; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; DOLPH GE, 1980, BIOTROPICA, V12, P91, DOI 10.2307/2387724; Editorial Committee for Flora Reipublicae Popularis Sinicae, 1961, FLOR REIP POP SIN; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Garcia LV, 2004, OIKOS, V105, P657, DOI 10.1111/j.0030-1299.2004.13046.x; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GIVNISH T J, 1978, P351; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hubbell S.P., 1983, TROPICAL RAIN FOREST, P25; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Wright SJ, 2010, ECOLOGY, V91, P3664, DOI 10.1890/09-2335.1; King DA, 2006, J ECOL, V94, P670, DOI 10.1111/j.1365-2745.2006.01112.x; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lai JS, 2009, J VEG SCI, V20, P415, DOI 10.1111/j.1654-1103.2009.01065.x; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; Leishman MR, 2000, FUNCT ECOL, V14, P293, DOI 10.1046/j.1365-2435.2000.00425.x; Moles AT, 2009, J ECOL, V97, P923, DOI 10.1111/j.1365-2745.2009.01526.x; Moles AT, 2005, P NATL ACAD SCI USA, V102, P10540, DOI 10.1073/pnas.0501473102; Muller-Landau HC, 2004, BIOTROPICA, V36, P20, DOI 10.1111/j.1744-7429.2004.tb00292.x; Muller-Landau HC, 2010, P NATL ACAD SCI USA, V107, P4242, DOI 10.1073/pnas.0911637107; Nascimento HEM, 2005, J VEG SCI, V16, P625, DOI 10.1111/j.1654-1103.2005.tb02405.x; Ordonez JC, 2009, GLOBAL ECOL BIOGEOGR, V18, P137, DOI 10.1111/j.1466-8238.2008.00441.x; Poorter L, 2006, ECOLOGY, V87, P1289, DOI 10.1890/0012-9658(2006)87[1289:AOMTST]2.0.CO;2; Quesada C.A., 2009, BIOGEOSCI DISCUSS, V6, P3993, DOI DOI 10.5194/BGD-6-3993-2009; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Schimper AFW, 1989, PLANZENGEOGRAPHIE PH; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sterck FJ, 2006, AM NAT, V167, P758, DOI 10.1086/503056; Swenson NG, 2007, AM J BOT, V94, P451, DOI 10.3732/ajb.94.3.451; Swenson NG, 2010, ECOLOGY, V91, P2234, DOI 10.1890/09-1743.1; van Gelder HA, 2006, NEW PHYTOL, V171, P367, DOI 10.1111/j.1469-8137.2006.01757.x; Westoby M, 1996, PHILOS T R SOC B, V351, P1309, DOI 10.1098/rstb.1996.0114; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; Wiemann MC, 2002, WOOD FIBER SCI, V34, P96; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Wright IJ, 2002, NEW PHYTOL, V155, P403, DOI 10.1046/j.1469-8137.2002.00479.x; Wu Z.Y., 1994, FLORA CHINA; Zhang LW, 2011, PLANT SOILI IN PRESS	45	34	41	8	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34767	10.1371/journal.pone.0034767	http://dx.doi.org/10.1371/journal.pone.0034767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509355	Green Published, gold			2022-12-27	WOS:000304805900058
J	Brasen, JC; Jacobsen, JCB; Holstein-Rathlou, NH				Brasen, Jens Christian; Jacobsen, Jens Christian Brings; Holstein-Rathlou, Niels-Henrik			The Nanostructure of Myoendothelial Junctions Contributes to Signal Rectification between Endothelial and Vascular Smooth Muscle Cells	PLOS ONE			English	Article							MATHEMATICAL-MODEL; GAP-JUNCTIONS; CALCIUM DYNAMICS; CA2+; RAT; POTASSIUM; CHANNELS; MICRODOMAINS; ARTERIOLES; DIFFUSION	Micro-anatomical structures in tissues have potential physiological effects. In arteries and arterioles smooth muscle cells and endothelial cells are separated by the internal elastic lamina, but the two cell layers often make contact through micro protrusions called myoendothelial junctions. Cross talk between the two cell layers is important in regulating blood pressure and flow. We have used a spatiotemporal mathematical model to investigate how the myoendothelial junctions affect the information flow between the two cell layers. The geometry of the model mimics the structure of the two cell types and the myoendothelial junction. The model is implemented as a 2D axi-symmetrical model and solved using the finite element method. We have simulated diffusion of Ca2+ and IP3 between the two cell types and we show that the micro-anatomical structure of the myoendothelial junction in itself may rectify a signal between the two cell layers. The rectification is caused by the asymmetrical structure of the myoendothelial junction. Because the head of the myoendothelial junction is separated from the cell it is attached to by a narrow neck region, a signal generated in the neighboring cell can easily drive a concentration change in the head of the myoendothelial protrusion. Subsequently the signal can be amplified in the head, and activate the entire cell. In contrast, a signal in the cell from which the myoendothelial junction originates will be attenuated and delayed in the neck region as it travels into the head of the myoendothelial junction and the neighboring cell.	[Brasen, Jens Christian; Jacobsen, Jens Christian Brings; Holstein-Rathlou, Niels-Henrik] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	University of Copenhagen	Brasen, JC (corresponding author), Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark.	jcbrasen@sund.ku.dk	Jacobsen, Jens Christian/B-7304-2008; Holstein-Rathlou, Niels-Henrik/B-2781-2008; Brasen, Jens Christian/C-4301-2015	Brasen, Jens Christian/0000-0003-4446-6331; Holstein-Rathlou, Niels-Henrik/0000-0003-1683-3464	Danish Council for Independent Research - Medical Sciences [10-082148]	Danish Council for Independent Research - Medical Sciences(Det Frie Forskningsrad (DFF))	The study was supported by The Danish Council for Independent Research - Medical Sciences (grant no. 10-082148). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Beny JL, 1999, NEWS PHYSIOL SCI, V14, P68; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Brasen JC, 2010, CELL CALCIUM, V47, P339, DOI 10.1016/j.ceca.2010.01.005; Brenner R, 2000, NATURE, V407, P870, DOI 10.1038/35038011; Burns WR, 2004, MICROCIRCULATION, V11, P279, DOI 10.1080/10739680490425985; CHAD JE, 1984, BIOPHYS J, V45, P993, DOI 10.1016/S0006-3495(84)84244-7; Chadha PS, 2011, J PHARMACOL EXP THER, V336, P701, DOI 10.1124/jpet.110.165795; Chilton L, 2011, CARDIOVASC RES, V92, P169, DOI 10.1093/cvr/cvr179; Davies EV, 1996, BIOCHEM SOC T, V24, pS92, DOI 10.1042/bst024092s; de Wit C, 2006, BIOL CHEM, V387, P3, DOI 10.1515/BC.2006.002; DEYOUNG GW, 1992, P NATL ACAD SCI USA, V89, P9895, DOI 10.1073/pnas.89.20.9895; Dora KA, 2003, J VASC RES, V40, P480, DOI 10.1159/000074549; Dora KA, 1997, P NATL ACAD SCI USA, V94, P6529, DOI 10.1073/pnas.94.12.6529; Dora KA, 2008, CIRC RES, V102, P1247, DOI 10.1161/CIRCRESAHA.108.172379; Evans WH, 2002, MOL MEMBR BIOL, V19, P121, DOI 10.1080/09687680210139839; Haddy FJ, 2006, AM J PHYSIOL-REG I, V290, pR546, DOI 10.1152/ajpregu.00491.2005; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Isakson BE, 2008, J CELL SCI, V121, P3664, DOI 10.1242/jcs.037481; Isakson BE, 2007, CIRC RES, V100, P246, DOI 10.1161/01.RES.0000257744.23795.93; Jaggar JH, 2000, AM J PHYSIOL-CELL PH, V278, pC235, DOI 10.1152/ajpcell.2000.278.2.C235; Kapela A, 2008, J THEOR BIOL, V253, P238, DOI 10.1016/j.jtbi.2008.03.004; Kapela A, 2009, MICROCIRCULATION, V16, P694, DOI 10.3109/10739680903177539; Kotaleski JH, 2010, NAT REV NEUROSCI, V11, P239, DOI 10.1038/nrn2807; LEDERER WJ, 1990, SCIENCE, V248, P283, DOI 10.1126/science.2326638; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; Mather S, 2005, CIRC RES, V97, P399, DOI 10.1161/01.RES.0000178008.46759.d0; MCCARRON JG, 1990, AM J PHYSIOL, V259, pH902, DOI 10.1152/ajpheart.1990.259.3.H902; Means S, 2006, BIOPHYS J, V91, P537, DOI 10.1529/biophysj.105.075036; Naraghi M, 1997, J NEUROSCI, V17, P6961; Nausch LWM, 2012, AM J PHYSIOL-HEART C, V302, pH594, DOI 10.1152/ajpheart.00773.2011; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Sandow SL, 2009, CLIN EXP PHARMACOL P, V36, P67, DOI 10.1111/j.1440-1681.2008.05076.x; Sandow SL, 2000, CIRC RES, V86, P341, DOI 10.1161/01.RES.86.3.341; Sandow SL, 2011, MICROCIRCUL IN PRESS; Silva HS, 2007, AM J PHYSIOL-CELL PH, V293, pC277, DOI 10.1152/ajpcell.00542.2006; Smith PD, 2008, J PHYSIOL-LONDON, V586, P1147, DOI 10.1113/jphysiol.2007.145474; Tran CH, 2012, AM J PHYSL IN PRESS; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176	40	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e33632	10.1371/journal.pone.0033632	http://dx.doi.org/10.1371/journal.pone.0033632			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523541	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000010
J	Frenette, P; Haines, E; Loloyan, M; Kinal, M; Pakarian, P; Piekny, A				Frenette, Paul; Haines, Eric; Loloyan, Michael; Kinal, Mena; Pakarian, Paknoosh; Piekny, Alisa			An Anillin-Ect2 Complex Stabilizes Central Spindle Microtubules at the Cortex during Cytokinesis	PLOS ONE			English	Article							CLEAVAGE FURROW FORMATION; CONTRACTILE RING; EXCHANGE FACTOR; RHOGEF ECT2; MYOSIN-II; PROTEIN; RECRUITMENT; INITIATION; PATHWAYS; MYOGEF	Cytokinesis occurs due to the RhoA-dependent ingression of an actomyosin ring. During anaphase, the Rho GEF (guanine nucleotide exchange factor) Ect2 is recruited to the central spindle via its interaction with MgcRacGAP/Cyk-4, and activates RhoA in the central plane of the cell. Ect2 also localizes to the cortex, where it has access to RhoA. The N-terminus of Ect2 binds to Cyk-4, and the C-terminus contains conserved DH (Dbl homologous) and PH (Pleckstrin Homology) domains with GEF activity. The PH domain is required for Ect2's cortical localization, but its molecular function is not known. In cultured human cells, we found that the PH domain interacts with anillin, a contractile ring protein that scaffolds actin and myosin and interacts with RhoA. The anillin-Ect2 interaction may require Ect2's association with lipids, since a novel mutation in the PH domain, which disrupts phospholipid association, weakens their interaction. An anillin-RacGAP50C (homologue of Cyk-4) complex was previously described in Drosophila, which may crosslink the central spindle to the cortex to stabilize the position of the contractile ring. Our data supports an analogous function for the anillin-Ect2 complex in human cells and one hypothesis is that this complex has functionally replaced the Drosophila anillin-RacGAP50C complex. Complexes between central spindle proteins and cortical proteins could regulate the position of the contractile ring by stabilizing microtubule-cortical interactions at the division plane to ensure the generation of active RhoA in a discrete zone.	[Frenette, Paul; Haines, Eric; Loloyan, Michael; Kinal, Mena; Pakarian, Paknoosh; Piekny, Alisa] Concordia Univ, Dept Biol, Montreal, PQ H3G 1M8, Canada	Concordia University - Canada	Frenette, P (corresponding author), Univ Montreal, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.	apiekny@alcor.concordia.ca	Frenette, Paul S/J-8272-2012	Frenette, Paul S/0000-0003-0862-9922	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (CIHR-http://www.cihr-irsc.gc.ca/e/193.html) to AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASSEN PR, 1991, J CELL SCI, V99, P523; Asiedu M, 2009, MOL BIOL CELL, V20, P1428, DOI 10.1091/mbc.E08-01-0001; Bement WM, 2005, J CELL BIOL, V170, P91, DOI 10.1083/jcb.200501131; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Bringmann H, 2005, NATURE, V436, P731, DOI 10.1038/nature03823; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Cabernard C, 2010, NATURE, V467, P91, DOI 10.1038/nature09334; Canman JC, 2008, SCIENCE, V322, P1543, DOI 10.1126/science.1163086; Chalamalasetty RB, 2006, J CELL SCI, V119, P3008, DOI 10.1242/jcs.03032; D'Avino PP, 2008, J CELL SCI, V121, P1151, DOI 10.1242/jcs.026716; Dechant R, 2003, DEV CELL, V4, P333, DOI 10.1016/S1534-5807(03)00057-1; Wu D, 2006, CELL CYCLE, V5, P1234, DOI 10.4161/cc.5.11.2815; Field SJ, 2005, CURR BIOL, V15, P1407, DOI 10.1016/j.cub.2005.06.059; Goldbach P, 2010, MOL BIOL CELL, V21, P1482, DOI 10.1091/mbc.E09-08-0714; Gregory SL, 2008, CURR BIOL, V18, P25, DOI 10.1016/j.cub.2007.11.050; Hara T, 2006, ONCOGENE, V25, P566, DOI 10.1038/sj.onc.1209078; Hickson GRX, 2008, J CELL BIOL, V180, P285, DOI 10.1083/jcb.200709005; Janetopoulos C, 2005, DEV CELL, V8, P467, DOI 10.1016/j.devcel.2005.02.010; Kechad A, 2012, CURR BIOL, V22, P197, DOI 10.1016/j.cub.2011.11.062; Lewellyn L, 2010, MOL BIOL CELL, V21, P50, DOI 10.1091/mbc.E09-01-0089; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Piekny A, 2005, TRENDS CELL BIOL, V15, P651, DOI 10.1016/j.tcb.2005.10.006; Piekny AJ, 2008, CURR BIOL, V18, P30, DOI 10.1016/j.cub.2007.11.068; Piekny AJ, 2010, SEMIN CELL DEV BIOL, V21, P881, DOI 10.1016/j.semcdb.2010.08.002; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Saito S, 2004, J BIOL CHEM, V279, P7169, DOI 10.1074/jbc.M306725200; Sedzinski J, 2011, NATURE, V476, P462, DOI 10.1038/nature10286; Solski PA, 2004, J BIOL CHEM, V279, P25226, DOI 10.1074/jbc.M313792200; Somers WG, 2003, DEV CELL, V4, P29, DOI 10.1016/S1534-5807(02)00402-1; Straight AF, 2005, MOL BIOL CELL, V16, P193, DOI 10.1091/mbc.E04-08-0758; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Su KC, 2011, DEV CELL, V21, P1104, DOI 10.1016/j.devcel.2011.11.003; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; van Impel A, 2009, DEVELOPMENT, V136, P813, DOI 10.1242/dev.026203; von Dassow G, 2009, J CELL BIOL, V187, P831, DOI 10.1083/jcb.200907090; Wheatley SP, 1996, J CELL BIOL, V135, P981, DOI 10.1083/jcb.135.4.981; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Wong R, 2005, CURR BIOL, V15, P1401, DOI 10.1016/j.cub.2005.06.060; Yoshida S, 2009, GENE DEV, V23, P810, DOI 10.1101/gad.1785209; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Zhao WM, 2005, J BIOL CHEM, V280, P33516, DOI 10.1074/jbc.M504657200; Zhao WM, 2005, P NATL ACAD SCI USA, V102, P13158, DOI 10.1073/pnas.0504145102	45	57	57	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34888	10.1371/journal.pone.0034888	http://dx.doi.org/10.1371/journal.pone.0034888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514687	Green Accepted, gold, Green Published			2022-12-27	WOS:000305341600093
J	Hagag, S; Kubitschek-Barreira, P; Neves, GWP; Amar, D; Nierman, W; Shalit, I; Shamir, R; Lopes-Bezerra, L; Osherov, N				Hagag, Shelly; Kubitschek-Barreira, Paula; Neves, Gabriela W. P.; Amar, David; Nierman, William; Shalit, Itamar; Shamir, Ron; Lopes-Bezerra, Leila; Osherov, Nir			Transcriptional and Proteomic Analysis of the Aspergillus fumigatus Delta prtT Protease-Deficient Mutant	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; SECRETED PROTEASES; KINASE MPKA; VIRULENCE; IDENTIFICATION; EXPRESSION; BIOSYNTHESIS; REPRESENTS; PSEUROTIN; REGULATOR	Aspergillus fumigatus is the most common opportunistic mold pathogen of humans, infecting immunocompromised patients. The fungus invades the lungs and other organs, causing severe damage. Penetration of the pulmonary epithelium is a key step in the infectious process. A. fumigatus produces extracellular proteases to degrade the host structural barriers. The A. fumigatus transcription factor PrtT controls the expression of multiple secreted proteases. PrtT shows similarity to the fungal Gal4-type Zn(2)-Cys(6) DNA-binding domain of several transcription factors. In this work, we further investigate the function of this transcription factor by performing a transcriptional and a proteomic analysis of the Delta prtT mutant. Unexpectedly, microarray analysis revealed that in addition to the expected decrease in protease expression, expression of genes involved in iron uptake and ergosterol synthesis was dramatically decreased in the Delta prtT mutant. A second finding of interest is that deletion of prtT resulted in the upregulation of four secondary metabolite clusters, including genes for the biosynthesis of toxic pseurotin A. Proteomic analysis identified reduced levels of three secreted proteases (ALP1 protease, TppA, AFUA_2G01250) and increased levels of three secreted polysaccharide-degrading enzymes in the Delta prtT mutant possibly in response to its inability to derive sufficient nourishment from protein breakdown. This report highlights the complexity of gene regulation by PrtT, and suggests a potential novel link between the regulation of protease secretion and the control of iron uptake, ergosterol biosynthesis and secondary metabolite production in A. fumigatus.	[Hagag, Shelly; Osherov, Nir] Sackler Sch Med Ramat Aviv, Dept Clin Microbiol & Immunol, Tel Aviv, Israel; [Kubitschek-Barreira, Paula; Neves, Gabriela W. P.; Lopes-Bezerra, Leila] Univ Estado Rio de Janeiro, Roberto Alcantara Gomes Inst Biol, Dept Cellular Biol, Rio De Janeiro, Brazil; [Amar, David; Shamir, Ron] Tel Aviv Univ, Dept Comp Sci, IL-69978 Tel Aviv, Israel; [Nierman, William] J CraigVenter Inst, Rockville, MD USA; [Shalit, Itamar] Sackler Sch Med, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Universidade do Estado do Rio de Janeiro; Tel Aviv University; J. Craig Venter Institute; Tel Aviv University; Sackler Faculty of Medicine	Hagag, S (corresponding author), Sackler Sch Med Ramat Aviv, Dept Clin Microbiol & Immunol, Tel Aviv, Israel.	nosherov@post.tau.ac.il	Shamir, Ron/E-6514-2011; Kubitschek-Barreira, Paula/C-1200-2015; Lopes Bezerra, Leila/K-8405-2015	Shamir, Ron/0000-0003-1889-9870; Kubitschek-Barreira, Paula/0000-0001-9083-2908; Lopes Bezerra, Leila/0000-0003-2397-7597	Israel Academy of Sciences [186/09]; Israel Ministry of Health [3-5201]	Israel Academy of Sciences; Israel Ministry of Health	This work was funded by an Israel Academy of Sciences grant (186/09) and an Israel Ministry of Health grant (3-5201) to NO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAINBRIDGE BW, 1971, J GEN MICROBIOL, V66, P319, DOI 10.1099/00221287-66-3-319; Behnsen J, 2010, INFECT IMMUN, V78, P3585, DOI 10.1128/IAI.01353-09; Bergmann A, 2009, INFECT IMMUN, V77, P4041, DOI 10.1128/IAI.00425-09; Blatzer M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002374; Borger P, 1999, J INFECT DIS, V180, P1267, DOI 10.1086/315027; Brakhage AA, 2005, CURR DRUG TARGETS, V6, P875, DOI 10.2174/138945005774912717; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Jain R, 2011, MOL MICROBIOL, V82, P39, DOI 10.1111/j.1365-2958.2011.07778.x; Kogan TV, 2004, J INFECT DIS, V189, P1965, DOI 10.1086/420850; Komagata D, 1996, J ANTIBIOT, V49, P958, DOI 10.7164/antibiotics.49.958; Kornitzer D, 2009, CURR OPIN MICROBIOL, V12, P377, DOI 10.1016/j.mib.2009.05.005; Lamarre C, 2007, FUNGAL GENET BIOL, V44, P682, DOI 10.1016/j.fgb.2007.01.009; Lambou K, 2010, MOL MICROBIOL, V75, P910, DOI 10.1111/j.1365-2958.2009.07024.x; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Lee CY, 2002, FEMS MICROBIOL LETT, V209, P31, DOI 10.1111/j.1574-6968.2002.tb11105.x; Lessing F, 2007, EUKARYOT CELL, V6, P2290, DOI 10.1128/EC.00267-07; Liu H, 2010, MOL MICROBIOL, V78, P1038, DOI 10.1111/j.1365-2958.2010.07389.x; Maiya S, 2007, CHEMBIOCHEM, V8, P1736, DOI 10.1002/cbic.200700202; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Montano SP, 2002, P NATL ACAD SCI USA, V99, P14041, DOI 10.1073/pnas.222312199; Neustadt M, 2009, ELECTROPHORESIS, V30, P2142, DOI 10.1002/elps.200800700; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Osherov N, 2007, NEW INSIGHTS MED MYC; Pardo M, 2000, ELECTROPHORESIS, V21, P3396, DOI 10.1002/1522-2683(20001001)21:16<3396::AID-ELPS3396>3.0.CO;2-J; Perrin RM, 2007, PLOS PATHOG, V3, P508, DOI 10.1371/journal.ppat.0030050; Pitarch A, 2002, MOL CELL PROTEOMICS, V1, P967, DOI 10.1074/mcp.M200062-MCP200; Power T, 2006, INT MICROBIOL, V9, P281; Rambach G, 2010, MOL IMMUNOL, V47, P1438, DOI 10.1016/j.molimm.2010.02.010; Schrettl M, 2004, J EXP MED, V200, P1213, DOI 10.1084/jem.20041242; Schrettl M, 2010, PLOS PATHOG, V6, DOI DOI E1001124; Schrettl M, 2008, MOL MICROBIOL, V70, P27, DOI 10.1111/j.1365-2958.2008.06376.x; Schwienbacher M, 2005, MED MYCOL, V43, P623, DOI 10.1080/13693780500089216; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sharon H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017509; Sharon H, 2009, INFECT IMMUN, V77, P4051, DOI 10.1128/IAI.00426-09; Soriani FM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-12; Sriranganadane D, 2010, J PROTEOME RES, V9, P3511, DOI 10.1021/pr901202z; Twumasi-Boateng K, 2009, EUKARYOT CELL, V8, P104, DOI 10.1128/EC.00265-08; Ulitsky I, 2010, NAT PROTOC, V5, P303, DOI 10.1038/nprot.2009.230; Valiante V, 2008, FUNGAL GENET BIOL, V45, P618, DOI 10.1016/j.fgb.2007.09.006; Vodisch M, 2011, J PROTEOME RES, V10, P2508, DOI 10.1021/pr1012812; Wartenberg D, 2011, INT J MED MICROBIOL, DOI 101016/jijmm201104016; Willger SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000200	46	18	30	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e33604	10.1371/journal.pone.0033604	http://dx.doi.org/10.1371/journal.pone.0033604			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514608	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600013
J	Hellier, JL; Arevalo, NL; Smith, L; Xiong, KN; Restrepo, D				Hellier, Jennifer L.; Arevalo, Nicole L.; Smith, Lynelle; Xiong, Ka-Na; Restrepo, Diego			alpha 7-Nicotinic Acetylcholine Receptor: Role in Early Odor Learning Preference in Mice	PLOS ONE			English	Article							DEFICIENT SENSORY INHIBITION; MAIN OLFACTORY-BULB; NICOTINIC RECEPTORS; NEWBORN MICE; DBA/2 MICE; HIPPOCAMPAL INTERNEURONS; LAMINAR DISTRIBUTION; CHOLINERGIC MARKERS; INDUCED PLASTICITY; KNOCKOUT MICE	Recently, we have shown that mice with decreased expression of alpha 7-nicotinic acetylcholine receptors (alpha 7) in the olfactory bulb were associated with a deficit in odor discrimination compared to wild-type mice. However, it is unknown if mice with decreased alpha 7-receptor expression also show a deficit in early odor learning preference (ELP), an enhanced behavioral response to odors with attractive value observed in rats. In this study, we modified ELP methods performed in rats and implemented similar conditions in mice. From post-natal days 5-18, wild-type mice were stroked simultaneously with an odor presentation (conditioned odor) for 90 s daily. Control mice were only stroked, exposed to odor, or neither. On the day of testing (P21), mice that were stroked in concert with a conditioned odor significantly investigated the conditioned odor compared to a novel odor, as observed similarly in rats. However, mice with a decrease in alpha 7-receptor expression that were stroked during a conditioned odor did not show a behavioral response to that odorant. These results suggest that decreased alpha 7-receptor expression has a role in associative learning, olfactory preference, and/or sensory processing deficits.	[Hellier, Jennifer L.; Arevalo, Nicole L.; Smith, Lynelle; Xiong, Ka-Na; Restrepo, Diego] Univ Colorado Anschutz Med Campus, Dept Cell & Dev Biol, Aurora, CO USA; [Restrepo, Diego] Univ Colorado Anschutz Med Campus, Program Neurosci, Aurora, CO USA; [Hellier, Jennifer L.; Arevalo, Nicole L.; Smith, Lynelle; Xiong, Ka-Na; Restrepo, Diego] Univ Colorado Anschutz Med Campus, Rocky Mt Taste & Smell Ctr, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Hellier, JL (corresponding author), Univ Colorado Anschutz Med Campus, Dept Cell & Dev Biol, Aurora, CO USA.	Jennifer.Hellier@ucdenver.edu			NIH [MH06858, DC 04657, DC00566, DC008855]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004657, R01DC000566, R01DC008855] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by NIH grants MH06858, DC 04657, DC00566, and DC008855 (DR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CE, 2008, BRAIN RES, V1194, P138, DOI 10.1016/j.brainres.2007.12.007; Akil H, 2010, SCIENCE, V327, P1580, DOI 10.1126/science.1188654; Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396; Arnaiz-Cot JJ, 2008, EUR J NEUROSCI, V27, P1097, DOI 10.1111/j.1460-9568.2008.06077.x; Bouslama M, 2007, NEUROSCIENCE, V150, P712, DOI 10.1016/j.neuroscience.2007.09.030; Bouslama M, 2006, NEUROSCIENCE, V141, P795, DOI 10.1016/j.neuroscience.2006.04.002; Bouslama M, 2005, BEHAV BRAIN RES, V161, P102, DOI 10.1016/j.bbr.2005.01.010; Doucette W, 2007, LEARN MEMORY, V14, P539, DOI 10.1101/lm.606407; Doucette W, 2011, NEURON, V69, P1176, DOI 10.1016/j.neuron.2011.02.024; Durand E, 2003, J APPL PHYSIOL, V94, P812, DOI 10.1152/japplphysiol.00488.2002; El-Etri MM, 1999, NEUROSCIENCE, V93, P611, DOI 10.1016/S0306-4522(99)00169-4; Fletcher ML, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-02-j0005.2002; Frazier CJ, 2003, J NEUROPHYSIOL, V89, P3018, DOI 10.1152/jn.01036.2002; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Freedman R, 2000, J CHEM NEUROANAT, V20, P299, DOI 10.1016/S0891-0618(00)00109-5; Guan ZZ, 1999, NEUROREPORT, V10, P1779, DOI 10.1097/00001756-199906030-00028; Hashimoto K, 2005, PSYCHOPHARMACOLOGY, V183, P13, DOI 10.1007/s00213-005-0142-0; Hellier JL, 2010, BRAIN RES, V1358, P140, DOI 10.1016/j.brainres.2010.08.027; Hogg RC, 2007, BIOCHEM PHARMACOL, V73, P459, DOI 10.1016/j.bcp.2006.08.010; Jiang MR, 1996, J NEUROSCI, V16, P6319; JOHANSON IB, 1980, BEHAV NEURAL BIOL, V29, P132, DOI 10.1016/S0163-1047(80)92596-0; Kelso ML, 2006, BRAIN RES, V1083, P204, DOI 10.1016/j.brainres.2006.01.127; Kulak JM, 1997, J NEUROSCI, V17, P5263; LARGE TH, 1986, J NEUROCHEM, V46, P671, DOI 10.1111/j.1471-4159.1986.tb13024.x; LEJEUNE H, 1995, J CHEM NEUROANAT, V9, P99, DOI 10.1016/0891-0618(95)00070-N; LeJeune H, 1996, J COMP NEUROL, V373, P433, DOI 10.1002/(SICI)1096-9861(19960923)373:3<433::AID-CNE8>3.0.CO;2-3; LEJEUNE H, 1993, J COMP NEUROL, V336, P279; Leonard S, 2000, EUR J PHARMACOL, V393, P237, DOI 10.1016/S0014-2999(00)00035-2; Marutle A, 2001, J CHEM NEUROANAT, V22, P115, DOI 10.1016/S0891-0618(01)00117-X; MCLEAN JH, 1993, BEHAV NEURAL BIOL, V60, P152, DOI 10.1016/0163-1047(93)90257-I; Metherate R, 2004, LEARN MEMORY, V11, P50, DOI 10.1101/lm.69904; Moberg PJ, 2006, J CLIN EXP NEUROPSYC, V28, P1444, DOI 10.1080/13803390500434409; O'Leary KT, 2003, J NEUROCHEM, V84, P952, DOI 10.1046/j.1471-4159.2003.01575.x; Oliva AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011359; Paylor R, 1998, LEARN MEMORY, V5, P302; Roalf DR, 2006, J NEUROPSYCH CLIN N, V18, P389, DOI 10.1176/appi.neuropsych.18.3.389; Ross RG, 2010, J CHILD PSYCHOL PSYC, V51, P535, DOI 10.1111/j.1469-7610.2009.02187.x; Rupp CI, 2005, SCHIZOPHRENIA BULL, V31, P155, DOI 10.1093/schbul/sbi018; Rupp CI, 2005, SCHIZOPHR RES, V74, P149, DOI 10.1016/j.schres.2004.07.010; Salcedo E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025441; Samama B, 1999, NEUROBIOL LEARN MEM, V71, P219, DOI 10.1006/nlme.1998.3869; SAYKIN AJ, 1991, ARCH GEN PSYCHIAT, V48, P618; Simosky JK, 2003, PSYCHOPHARMACOLOGY, V165, P386, DOI 10.1007/s00213-002-1285-x; Simosky JK, 2001, BIOL PSYCHIAT, V50, P493, DOI 10.1016/S0006-3223(01)01093-9; Simosky JK, 2008, BRAIN RES, V1233, P129, DOI 10.1016/j.brainres.2008.07.057; Slotnick B, 2005, CURR PROTOC NEUROSCI; Stevens KE, 1998, PSYCHOPHARMACOLOGY, V136, P320, DOI 10.1007/s002130050573; Stevens KE, 1996, NEUROPSYCHOPHARMACOL, V15, P152, DOI 10.1016/0893-133X(95)00178-G; Stoker AK, 2011, STUDIES KNOCKOUT MIC; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Sullivan RM, 2000, BEHAV NEUROSCI, V114, P957, DOI 10.1037/0735-7044.114.5.957; SULLIVAN RM, 1986, DEV BRAIN RES, V27, P278, DOI 10.1016/0165-3806(86)90256-7; SULLIVAN RM, 1995, DEV PSYCHOBIOL, V28, P213, DOI 10.1002/dev.420280403; SULLIVAN RM, 1994, BRAIN RES, V643, P306, DOI 10.1016/0006-8993(94)90038-8; SULLIVAN RM, 1992, DEV BRAIN RES, V70, P279, DOI 10.1016/0165-3806(92)90207-D; Sullivan RM, 2003, LEARN MEMORY, V10, P1, DOI 10.1101/lm.58203; SULLIVAN RM, 1993, BEHAV NEUROSCI, V107, P254, DOI 10.1037/0735-7044.107.2.254; SULLIVAN RM, 1991, DEV BRAIN RES, V60, P219, DOI 10.1016/0165-3806(91)90050-S; SULLIVAN RM, 1989, PSYCHOBIOLOGY, V17, P29; SULLIVAN RM, 1988, DEV PSYCHOBIOL, V21, P215, DOI 10.1002/dev.420210303; SULLIVAN RM, 1989, J NEUROSCI, V9, P3998; SULLIVAN RM, 1988, PHYSIOL BEHAV, V44, P85, DOI 10.1016/0031-9384(88)90349-6; Turetsky BI, 2009, SCHIZOPHRENIA BULL, V35, P1117, DOI 10.1093/schbul/sbp111; Turetsky BI, 2009, NEUROPSYCHOPHARMACOL, V34, P767, DOI 10.1038/npp.2008.139; WILSON DA, 1994, BEHAV NEURAL BIOL, V61, P1, DOI 10.1016/S0163-1047(05)80039-1; WILSON DA, 1987, J NEUROSCI, V7, P3154; Wilson DA, 2004, LEARN MEMORY, V11, P28, DOI 10.1101/lm.66404; WILSON DA, 1991, BEHAV NEUROSCI, V105, P843, DOI 10.1037/0735-7044.105.6.843; Woodruff-Pak Diana S, 2002, Behav Cogn Neurosci Rev, V1, P5, DOI 10.1177/1534582302001001002; Young JW, 2011, GENES BRAIN BEHAV, V10, P720, DOI 10.1111/j.1601-183X.2011.00711.x; Yu WF, 2007, NEUROSCIENCE, V146, P1618, DOI 10.1016/j.neuroscience.2007.03.002; Yuan Q, 2003, J NEUROSCI, V23, P4760	72	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35251	10.1371/journal.pone.0035251	http://dx.doi.org/10.1371/journal.pone.0035251			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514723	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341600128
J	Hu, HB; Deng, HY; Fang, Y				Hu, Haibei; Deng, Huayun; Fang, Ye			Label-Free Phenotypic Profiling Identified D-Luciferin as a GPR35 Agonist	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; CELLS; ACID; PHARMACOLOGY; DERIVATIVES; SELECTIVITY; EXPRESSION; TARGET; LIGAND; ASSAYS	Fluorescent and luminescent probes are essential to both in vitro molecular assays and in vivo imaging techniques, and have been extensively used to measure biological function. However, little is known about the biological activity, thus potential interferences with the assay results, of these probe molecules. Here we show that D-luciferin, one of the most widely used bioluminescence substrates, is a partial agonist for G protein-coupled receptor-35 (GPR35). Label-free phenotypic profiling using dynamic mass redistribution (DMR) assays showed that D-luciferin led to a DMR signal in native HT-29 cells, whose characteristics are similar to those induced by known GPR35 agonists including zaprinast and pamoic acid. DMR assays further showed that D-luciferin is a partial agonist competitive to several known GPR35 agonists and antagonists. D-luciferin was found to cause the phosphorylation of ERK that was suppressed by known GPR35 antagonists, and also result in beta-arrestin translocation signal but with low efficacy. These results not only suggest that D-luciferin is a partial agonist of GPR35, but also will evoke careful interpretation of biological data obtained using molecular and in vivo imaging assays when these probe molecules are used.	[Hu, Haibei; Deng, Huayun; Fang, Ye] Corning Inc, Biochem Technol, Div Sci & Technol, Corning, NY 14831 USA	Corning Inc; State University of New York (SUNY) System; SUNY Community College	Hu, HB (corresponding author), Corning Inc, Biochem Technol, Div Sci & Technol, Corning, NY 14831 USA.	fangy2@corning.com						Ando Y, 2008, NAT PHOTONICS, V2, P44, DOI 10.1038/nphoton.2007.251; [Anonymous], 2010, MOL PROBES HDB A GUI, P664; Cosi C, 2011, NEUROPHARMACOLOGY, V60, P1227, DOI 10.1016/j.neuropharm.2010.11.014; Deng HY, 2011, J MED CHEM, V54, P7385, DOI 10.1021/jm200999f; Deng HY, 2011, FEBS LETT, V585, P1957, DOI 10.1016/j.febslet.2011.05.026; Fang Y, 2006, ASSAY DRUG DEV TECHN, V4, P583, DOI 10.1089/adt.2006.4.583; Fang Y, 2006, BIOPHYS J, V91, P1925, DOI [10.1529/biophysj.105.077818, 10.1529/biophysj.105.007818]; [Anonymous], 2010, Drug Discov Today Technol, V7, pe1, DOI 10.1016/j.ddtec.2010.05.001; Ferrie AM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00033; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; Henstridge CM, 2010, BRIT J PHARMACOL, V160, P604, DOI 10.1111/j.1476-5381.2009.00625.x; Heynen-Genel S, 2010, ANTAGONISTS ORPHAN R; Imielinski M, 2009, NAT GENET, V41, P1335, DOI 10.1038/ng.489; Jenkins L, 2010, BIOCHEM J, V432, P451, DOI 10.1042/BJ20101287; Kenakin TP, 2009, NAT REV DRUG DISCOV, V8, P617, DOI 10.1038/nrd2838; Luker GD, 2008, J NUCL MED, V49, P1, DOI 10.2967/jnumed.107.045799; McGuinness R, 2007, CURR OPIN PHARMACOL, V7, P535, DOI 10.1016/j.coph.2007.08.004; Milligan G, 2011, TRENDS PHARMACOL SCI, V32, P317, DOI 10.1016/j.tips.2011.02.002; Min KD, 2010, BIOCHEM BIOPH RES CO, V393, P55, DOI 10.1016/j.bbrc.2010.01.076; Nakatsu T, 2006, NATURE, V440, P372, DOI 10.1038/nature04542; Oka S, 2010, BIOCHEM BIOPH RES CO, V395, P232, DOI 10.1016/j.bbrc.2010.03.169; Okumura S, 2004, CANCER SCI, V95, P131, DOI 10.1111/j.1349-7006.2004.tb03193.x; Schroder R, 2010, NAT BIOTECHNOL, V28, P943, DOI 10.1038/nbt.1671; Scott CW, 2010, DRUG DISCOV TODAY, V15, P704, DOI 10.1016/j.drudis.2010.06.008; Shinde R, 2006, BIOCHEMISTRY-US, V45, P11103, DOI 10.1021/bi060475o; Sun YV, 2008, GENET EPIDEMIOL, V32, P350, DOI 10.1002/gepi.20309; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Taniguchi Y, 2008, PHARMACOLOGY, V82, P245, DOI 10.1159/000157625; Taniguchi Y, 2006, FEBS LETT, V580, P5003, DOI 10.1016/j.febslet.2006.08.015; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Walter T, 2010, NAT METHODS, V7, pS26, DOI [10.1038/nmeth.1431, 10.1038/NMETH.1431]; Wang JH, 2006, J BIOL CHEM, V281, P22021, DOI 10.1074/jbc.M603503200; Yang YH, 2010, PHARMACOLOGY, V86, P1, DOI 10.1159/000314164; Zhao PW, 2010, MOL PHARMACOL, V78, P560, DOI 10.1124/mol.110.066746	35	21	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34934	10.1371/journal.pone.0034934	http://dx.doi.org/10.1371/journal.pone.0034934			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511974	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338600060
J	Liu, YF; Zhang, N; Liu, X; Wang, XQ; Wang, ZX; Chen, YY; Yao, HW; Ge, M; Pan, XM				Liu, Yan-Feng; Zhang, Nan; Liu, Xi; Wang, Xinquan; Wang, Zhi-Xin; Chen, Yuanyuan; Yao, Hong-Wei; Ge, Meng; Pan, Xian-Ming			Molecular Mechanism Underlying the Interaction of Typical Sac10b Family Proteins with DNA	PLOS ONE			English	Article							ARCHAEAL CHROMATIN PROTEIN; ARCHAEBACTERIUM SULFOLOBUS-ACIDOCALDARIUS; NUCLEIC-ACID BINDING; CRYSTAL-STRUCTURE; ALBA; SSH10B; SIR2; ACETYLATION; STABILITY; SOFTWARE	The Sac10b protein family is regarded as a family of DNA-binding proteins that is highly conserved and widely distributed within the archaea. Sac10b family members are typically small basic dimeric proteins that bind to DNA with cooperativity and no sequence specificity and are capable of constraining DNA negative supercoils, protecting DNA from Dnase I digestion, and do not compact DNA obviously. However, a detailed understanding of the structural basis of the interaction of Sac10b family proteins with DNA is still lacking. Here, we determined the crystal structure of Mth10b, an atypical member of the Sac10b family from Methanobacterium thermoautotrophicum Delta H, at 2.2 angstrom. Unlike typical Sac10b family proteins, Mth10b is an acidic protein and binds to neither DNA nor RNA. The overall structure of Mth10b displays high similarity to its homologs, but three pairs of conserved positively charged residues located at the presumed DNA-binding surface are substituted by non-charged residues in Mth10b. Through amino acids interchanges, the DNA-binding ability of Mth10b was restored successfully, whereas the DNA-binding ability of Sso10b, a typical Sac10b family member, was weakened greatly. Based on these results, we propose a model describing the molecular mechanism underlying the interactions of typical Sac10b family proteins with DNA that explains all the characteristics of the interactions between typical Sac10b family members and DNA.	[Liu, Yan-Feng; Zhang, Nan; Liu, Xi; Wang, Xinquan; Wang, Zhi-Xin; Yao, Hong-Wei; Pan, Xian-Ming] Tsinghua Univ, Sch Life Sci, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China; [Wang, Zhi-Xin; Chen, Yuanyuan; Ge, Meng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China	Tsinghua University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Liu, YF (corresponding author), Tsinghua Univ, Sch Life Sci, Minist Educ, Key Lab Bioinformat, Beijing 100084, Peoples R China.	gem@moon.ibp.ac.cn; pan-xm@mail.tsinghua.edu.cn	Chen, Yuanyuan/GXG-2130-2022; , 0000-0003-2383-1942/B-1483-2015; wang, zhixin/GZH-2500-2022; Yao, Hongwei/B-1483-2015	, 0000-0003-2383-1942/0000-0003-2383-1942; Yao, Hongwei/0000-0001-8518-7019	Natural Science Foundation of China [30870475]; Ministry of Science and Technology of China [2009CB918801]; China Postdoctoral Science Foundation [201104166, 20100470567]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by grants 30870475 from the Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default124.htm), 2009CB918801 from the Ministry of Science and Technology of China (http://www.most.gov.cn/), 201104166 and 20100470567 from China Postdoctoral Science Foundation (http://www.chinapostdoctor.org.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bell SD, 2002, SCIENCE, V296, P148, DOI 10.1126/science.1070506; Biyani K, 2005, BIOCHEMISTRY-US, V44, P14217, DOI 10.1021/bi051266r; BOHRMANN B, 1994, J STRUCT BIOL, V112, P70, DOI 10.1006/jsbi.1994.1008; Chou CC, 2003, J BACTERIOL, V185, P4066, DOI 10.1128/JB.185.14.4066-4073.2003; Cui Q, 2003, J BIOL CHEM, V278, P51015, DOI 10.1074/jbc.M308510200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forterre P, 1999, MOL MICROBIOL, V32, P669, DOI 10.1046/j.1365-2958.1999.01366.x; Ge M, 2008, J BIOL CHEM, V283, P31690, DOI 10.1074/jbc.M805750200; Ge M, 2009, EXTREMOPHILES, V13, P131, DOI 10.1007/s00792-008-0204-4; GROTE M, 1986, BIOCHIM BIOPHYS ACTA, V873, P405, DOI 10.1016/0167-4838(86)90090-7; Guo R, 2003, MOL MICROBIOL, V50, P1605, DOI 10.1046/j.1365-2958.2003.03793.x; Hada K, 2008, BIOSCI BIOTECH BIOCH, V72, P749, DOI 10.1271/bbb.70639; Jelinska C, 2010, BIOCHEM J, V427, P49, DOI 10.1042/BJ20091841; Kumarevel T, 2008, PROTEINS, V71, P1156, DOI 10.1002/prot.21807; Liu YF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019977; LURZ R, 1986, EMBO J, V5, P3715, DOI 10.1002/j.1460-2075.1986.tb04705.x; Marsh VL, 2005, J BIOL CHEM, V280, P21122, DOI 10.1074/jbc.M501280200; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Reeve JN, 2003, MOL MICROBIOL, V48, P587, DOI 10.1046/j.1365-2958.2003.03439.x; Sandman K, 2005, CURR OPIN MICROBIOL, V8, P656, DOI 10.1016/j.mib.2005.10.007; Szilagyi A, 2000, STRUCTURE, V8, P493, DOI 10.1016/S0969-2126(00)00133-7; Wang GG, 2003, PROTEIN SCI, V12, P2815, DOI 10.1110/ps.03325103; WANG JC, 1979, P NATL ACAD SCI USA, V76, P200, DOI 10.1073/pnas.76.1.200; Wardleworth BN, 2002, EMBO J, V21, P4654, DOI 10.1093/emboj/cdf465; White MF, 2002, TRENDS GENET, V18, P621, DOI 10.1016/S0168-9525(02)02808-1; Xu S, 2004, BIOCHEM J, V382, P433, DOI 10.1042/BJ20040191; Xue H, 2000, J BACTERIOL, V182, P3929, DOI 10.1128/JB.182.14.3929-3933.2000; Zhao KH, 2003, J BIOL CHEM, V278, P26071, DOI 10.1074/jbc.M303666200	30	4	4	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34986	10.1371/journal.pone.0034986	http://dx.doi.org/10.1371/journal.pone.0034986			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511977	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600063
J	Su, RW; Jia, B; Ni, H; Lei, W; Yue, SL; Feng, XH; Deng, WB; Liu, JL; Zhao, ZA; Wang, TS; Yang, ZM				Su, Ren-Wei; Jia, Bo; Ni, Hua; Lei, Wei; Yue, Shun-Li; Feng, Xu-Hui; Deng, Weng-Bo; Liu, Ji-Long; Zhao, Zhen-Ao; Wang, Tong-Song; Yang, Zeng-Ming			Junctional Adhesion Molecule 2 Mediates the Interaction between Hatched Blastocyst and Luminal Epithelium: Induction by Progesterone and LIF	PLOS ONE			English	Article							LEUKEMIA INHIBITORY FACTOR; HEMATOPOIETIC STEM-CELLS; MOUSE UTERUS; EMBRYO IMPLANTATION; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; JAM-B; STAT3; PERIIMPLANTATION; ALPHA-4-BETA-1	Background: Junctional adhesion molecule 2 (Jam2) is a member of the JAM superfamily. JAMs are localized at intercellular contacts and participated in the assembly and maintenance of junctions, and control of cell permeability. Because Jam2 is highly expressed in the luminal epithelium on day 4 of pregnancy, this study was to determine whether Jam2 plays a role in uterine receptivity and blastocyst attachment in mouse uterus. Methodology/Principal Findings: Jam2 is highly expressed in the uterine luminal epithelium on days 3 and 4 of pregnancy. Progesterone induces Jam2 expression in ovariectomized mice, which is blocked by progesterone antagonist RU486. Jam2 expression on day 4 of pregnancy is also inhibited by RU486 treatment. Leukemia inhibitory factor (LIF) up-regulates Jam2 protein in isolated luminal epithelium from day 4 uterus, which is blocked by S3I-201, a cell-permeable inhibitor for Stat3 phosphorylation. Under adhesion assay, recombinant Jam2 protein increases the rate of blastocyst adhesion. Both soluble recombinant Jam2 and Jam3 can reverse this process. Conclusion: Jam2 is highly expressed in the luminal epithelium of receptive uterus and up-regulated by progesterone and LIF via tyrosine phosphorylation of Stat3. Jam2 may play a role in the interaction between hatched blastocyst and receptive uterus.	[Su, Ren-Wei; Liu, Ji-Long; Wang, Tong-Song; Yang, Zeng-Ming] Shantou Univ, Dept Biol, Shantou, Peoples R China; [Su, Ren-Wei; Ni, Hua; Lei, Wei; Yue, Shun-Li; Zhao, Zhen-Ao] NE Agr Univ, Coll Life Sci, Harbin, Heilongjiang, Peoples R China; [Su, Ren-Wei; Jia, Bo; Feng, Xu-Hui; Deng, Weng-Bo] Xiamen Univ, Coll Life Sci, Xiamen, Fujian, Peoples R China	Shantou University; Northeast Agricultural University - China; Xiamen University	Su, RW (corresponding author), Shantou Univ, Dept Biol, Shantou, Peoples R China.	zmyang@stu.edu.cn	feng, xuhui/D-9450-2017; Yang, ZM/G-4627-2010; Lei, Wei/N-7611-2013; Lei, Wei/I-3640-2014; feng, xuhui/AAD-9832-2019	feng, xuhui/0000-0003-4649-183X; Lei, Wei/0000-0002-8342-8859; 	National Basic Research Program of China [2011CB944402]; National Natural Science Foundation of China [30930013, 31071276]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by National Basic Research Program of China (2011CB944402) and National Natural Science Foundation of China (30930013 and 31071276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beguelin W, 2010, MOL CELL BIOL, V30, P5456, DOI 10.1128/MCB.00012-10; BHATT H, 1991, P NATL ACAD SCI USA, V88, P11408, DOI 10.1073/pnas.88.24.11408; BIGSBY RM, 1986, AM J PHYSIOL, V251, pE630, DOI 10.1152/ajpendo.1986.251.5.E630; Cartwright JE, 2005, EXP CELL RES, V304, P328, DOI 10.1016/j.yexcr.2004.11.013; Chen JR, 2000, ENDOCRINOLOGY, V141, P4365, DOI 10.1210/en.141.12.4365; Cheng JG, 2001, P NATL ACAD SCI USA, V98, P8680, DOI 10.1073/pnas.151180898; Cunningham SA, 2000, J BIOL CHEM, V275, P34750, DOI 10.1074/jbc.M002718200; Cunningham SA, 2002, J BIOL CHEM, V277, P27589, DOI 10.1074/jbc.C200331200; Danielsson KG, 2003, STEROIDS, V68, P1069, DOI 10.1016/S0039-128X(03)00131-4; Ernst M, 2001, J EXP MED, V194, P189, DOI 10.1084/jem.194.2.189; ESCARY JL, 1993, NATURE, V363, P361, DOI 10.1038/363361a0; Franco HL, 2008, SEMIN CELL DEV BIOL, V19, P178, DOI 10.1016/j.semcdb.2007.12.001; HUETHUDSON YM, 1989, ENDOCRINOLOGY, V125, P1683, DOI 10.1210/endo-125-3-1683; Lamagna C, 2005, MOL BIOL CELL, V16, P4992, DOI 10.1091/mbc.E05-04-0310; Liang TW, 2002, J IMMUNOL, V168, P1618, DOI 10.4049/jimmunol.168.4.1618; Lim HJ, 2009, EXP CELL RES, V315, P619, DOI 10.1016/j.yexcr.2008.07.025; Lu DP, 2002, CELL RES, V12, P373, DOI 10.1038/sj.cr.7290139; Ludwig RJ, 2009, IMMUNOLOGY, V128, P196, DOI 10.1111/j.1365-2567.2009.03100.x; Ludwig RJ, 2005, J INVEST DERMATOL, V125, P969, DOI 10.1111/j.0022-202X.2005.23912.x; Ma XH, 2006, J BIOL CHEM, V281, P9351, DOI 10.1074/jbc.M511512200; Mandell KJ, 2005, ADV DRUG DELIVER REV, V57, P857, DOI 10.1016/j.addr.2005.01.005; Marwood M, 2009, ENDOCRINOLOGY, V150, P2915, DOI 10.1210/en.2008-1538; Ni H, 2002, BIOL REPROD, V67, P351, DOI 10.1095/biolreprod67.1.351; Pan HY, 2006, ENDOCRINOLOGY, V147, P4904, DOI 10.1210/en.2006-0140; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Psychoyos A, 1973, Vitam Horm, V31, P201; Sakaguchi T, 2006, MOL CELL BIOL, V26, P6557, DOI 10.1128/MCB.00729-06; SHEN MM, 1992, P NATL ACAD SCI USA, V89, P8240, DOI 10.1073/pnas.89.17.8240; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Teng CB, 2004, MOL REPROD DEV, V69, P1, DOI 10.1002/mrd.20149; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096; Wilcox AJ, 1999, NEW ENGL J MED, V340, P1796, DOI 10.1056/NEJM199906103402304; Yang ZM, 1996, MOL REPROD DEV, V43, P470	35	10	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34325	10.1371/journal.pone.0034325	http://dx.doi.org/10.1371/journal.pone.0034325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511936	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338600022
J	Barz, B; Urbanc, B				Barz, Bogdan; Urbanc, Brigita			Dimer Formation Enhances Structural Differences between Amyloid beta-Protein (1-40) and (1-42): An Explicit-Solvent Molecular Dynamics Study	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; FORCE-FIELD; CONFORMATIONAL TRANSITION; EXPERIMENTAL CONSTRAINTS; OLIGOMER FORMATION; C-TERMINUS; A-BETA-42; PEPTIDE; A-BETA(1-40); WATER	Amyloid beta-protein (A beta) is central to the pathology of Alzheimer's disease. A 5% difference in the primary structure of the two predominant alloforms, A beta(1-40) and A beta(1-42), results in distinct assembly pathways and toxicity properties. Discrete molecular dynamics (DMD) studies of A beta(1-40) and A beta(1-42) assembly resulted in alloform-specific oligomer size distributions consistent with experimental findings. Here, a large ensemble of DMD-derived A beta(1-40) and A beta(1-42) monomers and dimers was subjected to fully atomistic molecular dynamics (MD) simulations using the OPLS-AA force field combined with two water models, SPCE and TIP3P. The resulting all-atom conformations were slightly larger, less compact, had similar turn and lower beta-strand propensities than those predicted by DMD. Fully atomistic A beta(1-40) and A beta(1-42) monomers populated qualitatively similar free energy landscapes. In contrast, the free energy landscape of A beta(1-42) dimers indicated a larger conformational variability in comparison to that of A beta(1-40) dimers. A beta(1-42) dimers were characterized by an increased flexibility in the N-terminal region D1-R5 and a larger solvent exposure of charged amino acids relative to A beta(1-40) dimers. Of the three positively charged amino acids, R5 was the most and K16 the least involved in salt bridge formation. This result was independent of the water model, alloform, and assembly state. Overall, salt bridge propensities increased upon dimer formation. An exception was the salt bridge propensity of K28, which decreased upon formation of A beta(1-42) dimers and was significantly lower than in A beta(1-40) dimers. The potential relevance of the three positively charged amino acids in mediating the Ab oligomer toxicity is discussed in the light of available experimental data.	[Barz, Bogdan; Urbanc, Brigita] Drexel Univ, Dept Phys, Philadelphia, PA 19104 USA	Drexel University	Barz, B (corresponding author), Drexel Univ, Dept Phys, Philadelphia, PA 19104 USA.	brigita@drexel.edu	Urbanc, Brigita/AAG-1530-2020; Urbanc, Brigita/G-5839-2011	Urbanc, Brigita/0000-0001-9159-7698; Urbanc, Brigita/0000-0001-9159-7698	National Institutes of Health [AG027818]; National Science Foundation [PHYS100030]; NATIONAL INSTITUTE ON AGING [P01AG027818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was partially supported by the National Institutes of Health grant AG027818. This work used the Extreme Science and Engineering Discovery Environment, supported by National Science Foundation PHYS100030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ball KA, 2011, BIOCHEMISTRY-US, V50, P7612, DOI 10.1021/bi200732x; Baumketner A, 2006, PROTEIN SCI, V15, P420, DOI 10.1110/ps.051762406; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bernstein SL, 2009, NAT CHEM, V1, P326, DOI [10.1038/NCHEM.247, 10.1038/nchem.247]; Bitan G, 2003, J BIOL CHEM, V278, P34882, DOI 10.1074/jbc.M300825200; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bora RP, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3249609; Brovchenko I, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3012562; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Cote S, 2011, J CHEM THEORY COMPUT, V7, P2584, DOI 10.1021/ct1006967; Crescenzi O, 2002, EUR J BIOCHEM, V269, P5642, DOI 10.1046/j.1432-1033.2002.03271.x; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Davis CH, 2009, BIOPHYS J, V96, P785, DOI 10.1016/j.bpj.2008.09.053; Ding F, 2003, PROTEINS, V53, P220, DOI 10.1002/prot.10468; Fawzi NL, 2008, J AM CHEM SOC, V130, P6145, DOI 10.1021/ja710366c; Finkelstein A. V., 2002, PROTEIN PHYS COURSE; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Glabe CC, 2005, SUB CELL BIOCHEM, V38, P167; Gnanakaran S, 2003, J PHYS CHEM B, V107, P12555, DOI 10.1021/jp0359079; Gursky O, 2000, BBA-PROTEIN STRUCT M, V1476, P93, DOI 10.1016/S0167-4838(99)00228-9; Hagarman A, 2010, J AM CHEM SOC, V132, P540, DOI 10.1021/ja9058052; Hardy J, 2003, ANN NEUROL, V54, P143, DOI 10.1002/ana.10624; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2006, J PHYS CHEM B, V110, P17616, DOI 10.1021/jp0641029; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iijima K, 2004, P NATL ACAD SCI USA, V101, P6623, DOI 10.1073/pnas.0400895101; JARRETT JT, 1993, ANN NY ACAD SCI, V695, P144, DOI 10.1111/j.1749-6632.1993.tb23043.x; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kim S, 2010, BIOPHYS J, V99, P1949, DOI 10.1016/j.bpj.2010.07.008; Kirkitadze MD, 2001, J MOL BIOL, V312, P1103, DOI 10.1006/jmbi.2001.4970; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2002, NEUROBIOL AGING, V23, P231, DOI 10.1016/S0197-4580(01)00312-8; Lam AR, 2008, J AM CHEM SOC, V130, P17413, DOI 10.1021/ja804984h; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lee C, 2011, J COMPUT CHEM, V32, P349, DOI 10.1002/jcc.21628; Lin YS, 2012, BIOPHYS J, V102, P315, DOI 10.1016/j.bpj.2011.12.002; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lockhart C, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3610427; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; Luttmann E, 2006, CHEM PHYS, V323, P138, DOI 10.1016/j.chemphys.2005.08.071; Maiti P, 2010, J NEUROCHEM, V113, P1252, DOI 10.1111/j.1471-4159.2010.06692.x; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Melquiond A, 2008, CURR ALZHEIMER RES, V5, P244, DOI 10.2174/156720508784533330; Mitternacht S, 2011, J MOL BIOL, V410, P357, DOI 10.1016/j.jmb.2011.05.014; Mitternacht S, 2010, PROTEINS, V78, P2600, DOI 10.1002/prot.22775; Nerenberg PS, 2011, J CHEM THEORY COMPUT, V7, P1220, DOI 10.1021/ct2000183; Oda A, 2011, J CHROMATOGR B, V879, P3337, DOI 10.1016/j.jchromb.2011.08.011; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Raffa DF, 2007, J PHYS CHEM B, V111, P3789, DOI 10.1021/jp0689621; Riek R, 2001, EUR J BIOCHEM, V268, P5930, DOI 10.1046/j.0014-2956.2001.02537.x; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Rubinstein A, 2009, PRION, V3, P31, DOI 10.4161/pri.3.1.8388; Samiotakis A, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3404401; Sawamura N, 2000, J BIOL CHEM, V275, P27901; Sciarretta KL, 2005, BIOCHEMISTRY-US, V44, P6003, DOI 10.1021/bi0474867; Sgourakis N., 2011, J MOL BIOL, V368, P1448; Sgourakis NG, 2007, J MOL BIOL, V368, P1448, DOI 10.1016/j.jmb.2007.02.093; Sinha S, 2011, J AM CHEM SOC, V133, P16958, DOI 10.1021/ja206279b; Streltsov VA, 2011, J NEUROSCI, V31, P1419, DOI 10.1523/JNEUROSCI.4259-10.2011; Takeda T, 2009, J PHYS CHEM B, V113, P6692, DOI 10.1021/jp9016773; Takeda T, 2009, PROTEINS, V77, P1, DOI 10.1002/prot.22406; Teplow DB, 2006, ACCOUNTS CHEM RES, V39, P635, DOI 10.1021/ar050063s; Tomaselli S, 2006, CHEMBIOCHEM, V7, P257, DOI 10.1002/cbic.200500223; Triguero L, 2008, J PHYS CHEM B, V112, P7123, DOI 10.1021/jp801168v; Urbanc B, 2011, J MOL BIOL, V410, P316, DOI 10.1016/j.jmb.2011.05.021; Urbanc B, 2010, J AM CHEM SOC, V132, P4266, DOI 10.1021/ja9096303; Urbanc B, 2004, P NATL ACAD SCI USA, V101, P17345, DOI 10.1073/pnas.0408153101; Urbanc Brigita, 2006, Current Alzheimer Research, V3, P493, DOI 10.2174/156720506779025170; Urbanc B, 2006, METHOD ENZYMOL, V412, P314, DOI 10.1016/S0076-6879(06)12019-4; Usui K, 2009, P NATL ACAD SCI USA, V106, P18563, DOI 10.1073/pnas.0804758106; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Velez-Vega C, 2011, J PHYS CHEM B, V115, P4900, DOI 10.1021/jp1086575; Vitalis A, 2009, J COMPUT CHEM, V30, P673, DOI 10.1002/jcc.21005; Williams TL, 2011, FEBS J, V278, P3905, DOI 10.1111/j.1742-4658.2011.08228.x; Williams TL, 2010, LANGMUIR, V26, P17260, DOI 10.1021/la101581g; Wise Scira O., 2011, J CHEM PHYS, V135; Wu C, 2011, CURR OPIN STRUC BIOL, V21, P209, DOI 10.1016/j.sbi.2011.02.002; Xu YC, 2005, P NATL ACAD SCI USA, V102, P5403, DOI 10.1073/pnas.0501218102; Yan YL, 2006, J MOL BIOL, V364, P853, DOI 10.1016/j.jmb.2006.09.046; Yang C, 2009, J MOL STRUC-THEOCHEM, V907, P51, DOI 10.1016/j.theochem.2009.04.014; Yang MF, 2008, J MOL BIOL, V384, P450, DOI 10.1016/j.jmb.2008.09.039; Yun SJ, 2007, BIOPHYS J, V92, P4064, DOI 10.1529/biophysj.106.097766	93	85	86	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34345	10.1371/journal.pone.0034345	http://dx.doi.org/10.1371/journal.pone.0034345			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509291	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600026
J	Chaperon, F; Fendt, M; Kelly, PH; Lingenhoehl, K; Mosbacher, J; Olpe, HR; Schmid, P; Sturchler, C; McAllister, KH; van der Putten, PH; Gee, CE				Chaperon, Frederique; Fendt, Markus; Kelly, Peter H.; Lingenhoehl, Kurt; Mosbacher, Johannes; Olpe, Hans-Rudolf; Schmid, Peter; Sturchler, Christine; McAllister, Kevin H.; van der Putten, P. Herman; Gee, Christine E.			Gastrin-Releasing Peptide Signaling Plays a Limited and Subtle Role in Amygdala Physiology and Aversive Memory	PLOS ONE			English	Article							CONDITIONED TASTE-AVERSION; LONG-TERM POTENTIATION; INHIBITORY CIRCUITS; ANXIETY DISORDERS; FEAR EXTINCTION; SOCIAL ANXIETY; DEFICIENT MICE; LEARNED FEAR; RAT; BOMBESIN	Links between synaptic plasticity in the lateral amygdala (LA) and Pavlovian fear learning are well established. Neuropeptides including gastrin-releasing peptide (GRP) can modulate LA function. GRP increases inhibition in the LA and mice lacking the GRP receptor (GRPR KO) show more pronounced and persistent fear after single-trial associative learning. Here, we confirmed these initial findings and examined whether they extrapolate to more aspects of amygdala physiology and to other forms of aversive associative learning. GRP application in brain slices from wildtype but not GRPR KO mice increased spontaneous inhibitory activity in LA pyramidal neurons. In amygdala slices from GRPR KO mice, GRP did not increase inhibitory activity. In comparison to wildtype, short-but not long-term plasticity was increased in the cortico-lateral amygdala (LA) pathway of GRPR KO amygdala slices, whereas no changes were detected in the thalamo-LA pathway. In addition, GRPR KO mice showed enhanced fear evoked by single-trial conditioning and reduced spontaneous firing of neurons in the central nucleus of the amygdala (CeA). Altogether, these results are consistent with a potentially important modulatory role of GRP/GRPR signaling in the amygdala. However, administration of GRP or the GRPR antagonist (D-Phe(6), Leu-NHEt13, des-Met(14))-Bombesin (6-14) did not affect amygdala LTP in brain slices, nor did they affect the expression of conditioned fear following intra-amygdala administration. GRPR KO mice also failed to show differences in fear expression and extinction after multiple-trial fear conditioning, and there were no differences in conditioned taste aversion or gustatory neophobia. Collectively, our data indicate that GRP/GRPR signaling modulates amygdala physiology in a paradigm-specific fashion that likely is insufficient to generate therapeutic effects across amygdala-dependent disorders.	[Chaperon, Frederique; Fendt, Markus; Kelly, Peter H.; Lingenhoehl, Kurt; Mosbacher, Johannes; Olpe, Hans-Rudolf; Schmid, Peter; Sturchler, Christine; McAllister, Kevin H.; van der Putten, P. Herman; Gee, Christine E.] Novartis AG, Novartis Inst Biomed Res, Basel, Switzerland	Novartis	Chaperon, F (corresponding author), Novartis AG, Novartis Inst Biomed Res, Basel, Switzerland.	christine.gee@zmnh.uni-hamburg.de	Fendt, Markus/G-1888-2013; Gee, Christine E/E-9241-2013	Fendt, Markus/0000-0002-3451-1226; Gee, Christine E/0000-0003-0345-3665				Bedard T, 2007, BEHAV BRAIN RES, V179, P133, DOI 10.1016/j.bbr.2007.01.021; Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7; Cao XY, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-52; Ciocchi S, 2010, NATURE, V468, P277, DOI 10.1038/nature09559; Davis Michael, 2006, NeuroRx, V3, P82, DOI 10.1016/j.nurx.2005.12.008; De la Fuente M, 2000, LIFE SCI, V67, P2125, DOI 10.1016/S0024-3205(00)00799-2; Delgado MR, 2006, BIOL PSYCHOL, V73, P39, DOI 10.1016/j.biopsycho.2006.01.006; Dityatev AE, 2005, NEUROSCIENTIST, V11, P75, DOI 10.1177/1073858404270857; Ehrlich I, 2009, NEURON, V62, P757, DOI 10.1016/j.neuron.2009.05.026; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; FLOOD JF, 1988, BRAIN RES, V460, P314, DOI 10.1016/0006-8993(88)90375-7; Hampton LL, 1998, P NATL ACAD SCI USA, V95, P3188, DOI 10.1073/pnas.95.6.3188; Huber D, 2005, SCIENCE, V308, P245, DOI 10.1126/science.1105636; Humeau Y, 2003, NATURE, V426, P841, DOI 10.1038/nature02194; Isoardi NA, 2007, EUR J NEUROSCI, V26, P1036, DOI 10.1111/j.1460-9568.2007.05714.x; Jeffry J, 2011, PHYSIOLOGY, V26, P286, DOI 10.1152/physiol.00007.2011; Jungling K, 2008, NEURON, V59, P298, DOI 10.1016/j.neuron.2008.07.002; Kim JJ, 2006, NEUROSCI BIOBEHAV R, V30, P188, DOI 10.1016/j.neubiorev.2005.06.005; Likhtik E, 2008, NATURE, V454, P642, DOI 10.1038/nature07167; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; Martel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030942; Merali Z, 2008, EUR J NEUROSCI, V28, P165, DOI 10.1111/j.1460-9568.2008.06281.x; Merali Z, 2011, BEHAV BRAIN RES, V216, P519, DOI 10.1016/j.bbr.2010.08.027; Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008; Mineka S, 2008, ACTA PSYCHOL, V127, P567, DOI 10.1016/j.actpsy.2007.11.007; Mountney C, 2006, SOC NEUR ABSTR, V2006, P6938; Mountney C, 2008, PSYCHOPHARMACOLOGY, V200, P51, DOI 10.1007/s00213-008-1118-7; Mountney C, 2006, PSYCHOPHARMACOLOGY, V189, P287, DOI 10.1007/s00213-006-0585-y; Patel O, 2006, BBA-REV CANCER, V1766, P23, DOI 10.1016/j.bbcan.2006.01.003; Paxinos G. F, MOUSE BRAIN STEREOTA; Phan KL, 2006, BIOL PSYCHIAT, V59, P424, DOI 10.1016/j.biopsych.2005.08.012; Quirk GJ, 2003, ANN NY ACAD SCI, V985, P263; Rashidy-Pour A, 1998, BRAIN RES, V814, P127, DOI 10.1016/S0006-8993(98)01066-X; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Reilly S, 2005, NEUROSCI BIOBEHAV R, V29, P1067, DOI 10.1016/j.neubiorev.2005.03.025; Roesler R, 2004, EUR J NEUROSCI, V19, P1041, DOI 10.1111/j.0953-816X.2004.03175.x; Rogan MT, 1996, CELL, V85, P469, DOI 10.1016/S0092-8674(00)81247-7; ROGAN MT, 1995, NEURON, V15, P127, DOI 10.1016/0896-6273(95)90070-5; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Shumyatsky GP, 2002, CELL, V111, P905, DOI 10.1016/S0092-8674(02)01116-9; Sigurdsson T, 2007, NEUROPHARMACOLOGY, V52, P215, DOI 10.1016/j.neuropharm.2006.06.022; Wahlsten D, 2003, J NEUROBIOL, V54, P283, DOI 10.1002/neu.10173; Welzl H, 2001, BEHAV BRAIN RES, V125, P205, DOI 10.1016/S0166-4328(01)00302-3; Yamada K, 2000, PHYSIOL BEHAV, V68, P555, DOI 10.1016/S0031-9384(99)00214-0; Yamamoto T, 2007, CHEM SENSES, V32, P105, DOI 10.1093/chemse/bjj045	48	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34963	10.1371/journal.pone.0034963	http://dx.doi.org/10.1371/journal.pone.0034963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509372	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600070
J	Wang, YJ; Solt, LA; Kojetin, DJ; Burris, TP				Wang, Yongjun; Solt, Laura A.; Kojetin, Douglas J.; Burris, Thomas P.			Regulation of p53 Stability and Apoptosis by a ROR Agonist	PLOS ONE			English	Article							CIRCADIAN GENE-EXPRESSION; BREAST-CANCER RISK; DNA-DAMAGE; SHIFT-WORK; REV-ERB; RECEPTOR; ALPHA; CLOCK; LIVER; STABILIZATION	Activation of p53 function leading to cell-cycle arrest and/or apoptosis is a promising strategy for development of anticancer therapeutic agents. Here, we describe a novel mechanism for stabilization of p53 protein expression via activation of the orphan nuclear receptor, ROR alpha. We demonstrate that treatment of cancer cells with a newly described synthetic ROR agonist, SR1078, leads to p53 stabilization and induction of apoptosis. These data suggest that synthetic ROR agonists may hold utility in the treatment of cancer.	[Wang, Yongjun; Solt, Laura A.; Kojetin, Douglas J.; Burris, Thomas P.] Scripps Res Inst, Jupiter, FL USA	Scripps Research Institute	Wang, YJ (corresponding author), Scripps Res Inst, Jupiter, FL USA.	tburris@scripps.edu	Burris, Thomas P/B-3886-2016	Burris, Thomas P/0000-0003-2922-4449	National Institutes of Health (NIH) [DK089984, MH092769]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK089984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092769] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (NIH) DK089984, MH092769. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Chauvet C, 2002, BIOCHEM J, V364, P449, DOI 10.1042/BJ20011558; Chen ST, 2005, CARCINOGENESIS, V26, P1241, DOI 10.1093/carcin/bgi075; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Filipski E, 2002, J NATL CANCER I, V94, P690; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hansen J, 2001, EPIDEMIOLOGY, V12, P74, DOI 10.1097/00001648-200101000-00013; Kim H, 2011, MOL CELL, V44, P797, DOI 10.1016/j.molcel.2011.09.023; Kumar N, 2011, ACS CHEM BIOL, V6, P218, DOI 10.1021/cb1002762; Kuo SJ, 2009, VIRCHOWS ARCH, V454, P467, DOI 10.1007/s00428-009-0761-7; Lin YM, 2008, MOL CARCINOGEN, V47, P925, DOI 10.1002/mc.20446; Megdal SP, 2005, EUR J CANCER, V41, P2023, DOI 10.1016/j.ejca.2005.05.010; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Pan X, 2009, P NATL ACAD SCI USA, V106, P3788, DOI 10.1073/pnas.0810147106; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563, DOI 10.1093/jnci/93.20.1563; Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825; SHAH PN, 1984, CANCER RES, V44, P3403; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Stayrook KR, 2008, MOL PHARMACOL, V73, P607, DOI 10.1124/mol.107.039099; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; van den Heiligenberg S, 1999, LIFE SCI, V64, P2523, DOI 10.1016/S0024-3205(99)00210-6; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang Y, 2010, IDENTIFICATION SR107, P1029; Wang YJ, 2008, MOL PHARMACOL, V74, P1716, DOI 10.1124/mol.108.048538; Wang Y, 2008, J BIOL CHEM, V283, P26332, DOI 10.1074/jbc.M804808200; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Wang YJ, 2010, J BIOL CHEM, V285, P5013, DOI 10.1074/jbc.M109.080614; Yang XM, 2009, BREAST CANCER RES TR, V117, P423, DOI 10.1007/s10549-008-0133-z; Zhu Y, 2006, ONCOGENE, V25, P2901, DOI 10.1038/sj.onc.1209314	33	45	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34921	10.1371/journal.pone.0034921	http://dx.doi.org/10.1371/journal.pone.0034921			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509368	Green Published, gold			2022-12-27	WOS:000305336600066
J	Ai, Q; Ma, X; Huang, QB; Liu, SW; Shi, TP; Zhang, C; Zhu, MY; Zhang, Y; Wang, BJ; Ni, D; Li, HZ; Zheng, T; Zhang, X				Ai, Qing; Ma, Xin; Huang, Qingbo; Liu, Shangwen; Shi, Taoping; Zhang, Chao; Zhu, Mingyang; Zhang, Yu; Wang, Baojun; Ni, Dong; Li, Hongzhao; Zheng, Tao; Zhang, Xu			High-Level Expression of Notch1 Increased the Risk of Metastasis in T1 Stage Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							CANCER METASTASIS; IN-VITRO; GROWTH; FEATURES; SUPPRESSION; INHIBITION; LINES	Background: Although metastasis of clear cell renal cell carcinoma (ccRCC) is basically observed in late stage tumors, T1 stage metastasis of ccRCC can also be found with no definite molecular cause resulting inappropriate selection of surgery method and poor prognosis. Notch signaling is a conserved, widely expressed signal pathway that mediates various cellular processes in normal development and tumorigenesis. This study aims to explore the potential role and mechanism of Notch signaling in the metastasis of T1 stage ccRCC. Methodology/Principal Findings: The expression of Notch1 and Jagged1 were analyzed in tumor tissues and matched normal adjacent tissues obtained from 51 ccRCC patients. Compared to non-tumor tissues, Notch1 and Jagged1 expression was significantly elevated both in mRNA and protein levels in tumors. Tissue samples of localized and metastatic tumors were divided into three groups based on their tumor stages and the relative mRNA expression of Notch1 and Jagged1 were analyzed. Compared to localized tumors, Notch1 expression was significantly elevated in metastatic tumors in T1 stage while Jagged1 expression was not statistically different between localized and metastatic tumors of all stages. The average size of metastatic tumors was significantly larger than localized tumors in T1 stage ccRCC and the elevated expression of Notch1 was significantly positive correlated with the tumor diameter. The functional significance of Notch signaling was studied by transfection of 786-O, Caki-1 and HKC cell lines with full-length expression plasmids of Notch1 and Jagged1. Compared to the corresponding controls, all cell lines demonstrated significant promotion in cell proliferation and migration while cell cycle remained unaffected. Conclusions/Significance: High-level expression of Notch signaling increased the risk of metastasis in T1 stage ccRCC by stimulating the proliferation and migration of tumor cells, which may be helpful for the selection of suitable operation method and prognosis of ccRCC.	[Ai, Qing; Zhang, Chao; Ni, Dong] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Ai, Qing; Ma, Xin; Huang, Qingbo; Liu, Shangwen; Shi, Taoping; Zhang, Chao; Zhu, Mingyang; Zhang, Yu; Wang, Baojun; Ni, Dong; Li, Hongzhao; Zheng, Tao; Zhang, Xu] Chinese Peoples Liberat Army Gen Hosp, Mil Postgrad Med Coll, Dept Urol, State Key Lab Kidney Dis, Beijing, Peoples R China	Nankai University; Chinese People's Liberation Army General Hospital	Ai, Q (corresponding author), Nankai Univ, Sch Med, Tianjin 300071, Peoples R China.	xzhang@foxmail.com	zhang, xu/GYE-3558-2022		National Natural Science Foundation of China [30972982]; Chinese Scientific Research Project for Health Industry [201002010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Scientific Research Project for Health Industry	This work was financially supported by National Natural Science Foundation of China (No. 30972982) and Chinese Scientific Research Project for Health Industry (No. 201002010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Campbell SC, 2009, J UROLOGY, V182, P1271, DOI 10.1016/j.juro.2009.07.004; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Cheville JC, 2001, J UROLOGY, V166, P453, DOI 10.1016/S0022-5347(05)65962-9; Chu D, 2010, ANN SURG ONCOL, V17, P1337, DOI 10.1245/s10434-009-0893-7; D'Souza B, 2008, ONCOGENE, V27, P5148, DOI 10.1038/onc.2008.229; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Hu Z, 2011, UROL ONCOL-SEMIN ORI, V29, P430, DOI 10.1016/j.urolonc.2009.06.004; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jung M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-47; Lau WK, 2002, UROLOGY, V59, P532, DOI 10.1016/S0090-4295(01)01589-8; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Lughezzani G, 2009, J UROLOGY, V182, P1287, DOI 10.1016/j.juro.2009.06.018; Miller J, 1999, UROLOGY, V54, P988, DOI 10.1016/S0090-4295(99)00347-7; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Racusen LC, 1997, J LAB CLIN MED, V129, P318, DOI 10.1016/S0022-2143(97)90180-3; Remzi M, 2006, J UROLOGY, V176, P896, DOI 10.1016/j.juro.2006.04.047; Sjolund J, 2008, J CLIN INVEST, V118, P217, DOI 10.1172/JCI32086; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Sun S, 2009, PATHOLOGY, V41, P335, DOI 10.1080/00313020902885003; Wang MY, 2010, MED ONCOL, V27, P1329, DOI 10.1007/s12032-009-9384-8; WILLIAMS RD, 1976, IN VITRO CELL DEV B, V12, P623; Wu K, 2010, JPN J CLIN ONCOL; Yeh TS, 2009, CANCER RES, V69, P5039, DOI 10.1158/0008-5472.CAN-08-4021; Zhang TH, 2011, J ORAL PATHOL MED, V40, P37, DOI 10.1111/j.1600-0714.2010.00931.x	29	43	50	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35022	10.1371/journal.pone.0035022	http://dx.doi.org/10.1371/journal.pone.0035022			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506064	Green Submitted, Green Published, gold			2022-12-27	WOS:000305297500071
J	Kilgour, AHM; Subedi, D; Gray, CD; Deary, IJ; Lawrie, SM; Wardlaw, JM; Starr, JM				Kilgour, Alixe H. M.; Subedi, Deepak; Gray, Calum D.; Deary, Ian J.; Lawrie, Stephen M.; Wardlaw, Joanna M.; Starr, John M.			Design and Validation of a Novel Method to Measure Cross-Sectional Area of Neck Muscles Included during Routine MR Brain Volume Imaging	PLOS ONE			English	Article							NUTRITIONAL ASSESSMENT; OLDER PERSONS; SARCOPENIA; STRENGTH; MASS; MEN; DISEASE; SIZE; MORTALITY; GENDER	Introduction: Low muscle mass secondary to disease and ageing is an important cause of excess mortality and morbidity. Many studies include a MR brain scan but no peripheral measure of muscle mass. We developed a technique to measure posterior neck muscle cross-sectional area (CSA) on volumetric MR brain scans enabling brain and muscle size to be measured simultaneously. Methods: We performed four studies to develop and test: feasibility, inter-rater reliability, repeatability and external validity. We used T1-weighted MR brain imaging from young and older subjects, obtained on different scanners, and collected mid-thigh MR data. Results: After developing the technique and demonstrating feasibility, we tested it for inter-rater reliability in 40 subjects. Intraclass correlation coefficients (ICC) between raters were 0.99 (95% confidence intervals (CI) 0.98-1.00) for the combined group (trapezius, splenius and semispinalis), 0.92 (CI 0.85-0.96) for obliquus and 0.92 (CI 0.85-0.96) for sternocleidomastoid. The first unrotated principal component explained 72.2% of total neck muscle CSA variance and correlated positively with both right (r = 0.52, p = .001) and left (r = 0.50, p = .002) grip strength. The 14 subjects in the repeatability study had had two MR brain scans on three different scanners. The ICC for between scanner variation for total neck muscle CSA was high at 0.94 (CI 0.86-0.98). The ICCs for within scanner variations were also high, with values of 0.95 (CI 0.86-0.98), 0.97 (CI 0.92-0.99) and 0.96 (CI 0.86-0.99) for the three scanners. The external validity study found a correlation coefficient for total thigh CSA and total neck CSA of 0.88. Discussion: We present a feasible, valid and reliable method for measuring neck muscle CSA on T1-weighted MR brain scans. Larger studies are needed to validate and apply our technique with subjects differing in age, ethnicity and geographical location.	[Kilgour, Alixe H. M.; Deary, Ian J.; Wardlaw, Joanna M.; Starr, John M.] Univ Edinburgh, Geriatr Med Unit, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Subedi, Deepak; Wardlaw, Joanna M.] Univ Edinburgh, Brain Res Imaging Ctr, Edinburgh, Midlothian, Scotland; [Gray, Calum D.] Univ Edinburgh, Clin Res Imaging Ctr, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Gray, Calum D.; Lawrie, Stephen M.; Wardlaw, Joanna M.] Scottish Imaging Network, Edinburgh, Midlothian, Scotland; [Lawrie, Stephen M.] Univ Edinburgh, Div Psychiat, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Kilgour, AHM (corresponding author), Univ Edinburgh, Geriatr Med Unit, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	ahmkilgour@doctors.org.uk	Hernandez, María/GYU-3543-2022; Wardlaw, Joanna M/Y-3456-2019; Lawrie, Stephen MacGregor/AAD-1607-2021; Deary, Ian J/C-6297-2009	Wardlaw, Joanna M/0000-0002-9812-6642; Lawrie, Stephen MacGregor/0000-0002-2444-5675; Deary, Ian J/0000-0002-1733-263X; Kilgour, Alixe/0000-0003-1270-821X; Gray, Calum/0000-0002-2816-4707	Research Into Ageing programme grant; Age UK; Biotechnology and Biological Sciences Research Council (BBSRC); Engineering and Physical Sciences Research Council (EPSRC); Economic and Social Research Council (ESRC); Medical Research Council (MRC); Chief Scientist Office (Scotland) [CZB/4/427]; MRC [G1001245, G0700704, G0701120] Funding Source: UKRI; Medical Research Council [1578687, G0701120, G1001245, G0700704B, G0700704] Funding Source: researchfish	Research Into Ageing programme grant; Age UK; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office (Scotland); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The LBC1936 data were collected by a Research Into Ageing programme grant; this research continues as part of the Age UK-funded (formerly Help the Aged) Disconnected Mind project. The work was undertaken by The University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology, part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698). Funding from the Biotechnology and Biological Sciences Research Council (BBSRC), Engineering and Physical Sciences Research Council (EPSRC), Economic and Social Research Council (ESRC) and Medical Research Council (MRC) is gratefully acknowledged. This funding fully supported A. Kilgour during this research. The CaliBrain study was funded by a Chief Scientist Office (Scotland) Project Grant (CZB/4/427). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JL, 2003, SCAND J MED SCI SPOR, V13, P40, DOI 10.1034/j.1600-0838.2003.00299.x; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Bannerman E, 1997, BRIT MED J, V315, P338, DOI 10.1136/bmj.315.7104.338; BLUMENTHAL HT, 1985, J GERONTOL, V40, P767; Boyle PA, 2009, ARCH NEUROL-CHICAGO, V66, P1339, DOI 10.1001/archneurol.2009.240; Cagnie B, 2010, J MANIP PHYSIOL THER, V33, P286, DOI 10.1016/j.jmpt.2010.03.010; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Dai TH, 2001, EXP BRAIN RES, V140, P290, DOI 10.1007/s002210100815; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Deary IJ, 2011, J GERONTOL B; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Elliott JM, 2007, CLIN ANAT, V20, P35, DOI 10.1002/ca.20252; Ellis KA, 2009, INT PSYCHOGERIATR, V21, P672, DOI 10.1017/S1041610209009405; Gallagher D, 1997, J APPL PHYSIOL, V83, P229, DOI 10.1152/jappl.1997.83.1.229; Gallagher D, 1998, APPL RADIAT ISOTOPES, V49, P733, DOI 10.1016/S0969-8043(97)00096-1; Godard MP, 2002, MED SCI SPORT EXER, V34, P1126, DOI 10.1097/00005768-200207000-00012; Gountouna VE, 2010, NEUROIMAGE, V49, P552, DOI 10.1016/j.neuroimage.2009.07.026; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Janssen I, 2000, J APPL PHYSIOL, V89, P81; Kongsgaard M, 2004, RESP MED, V98, P1000, DOI 10.1016/j.rmed.2004.03.003; Larsson L, 1978, Acta Physiol Scand Suppl, V457, P1; LERNER A, 1986, PEDIATRICS, V77, P732; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; McIntyre CW, 2006, NEPHROL DIAL TRANSPL, V21, P2210, DOI 10.1093/ndt/gfl064; Moorhead T William J, 2009, BMC Med Imaging, V9, P8, DOI 10.1186/1471-2342-9-8; Ohkawa S, 2000, AM J CLIN NUTR, V71, P485; Roubenoff R, 2003, AM J MED, V115, P429, DOI 10.1016/j.amjmed.2003.05.001; Tisdale MJ, 2002, NAT REV CANCER, V2, P862, DOI 10.1038/nrc927; Tsuyama K, 2001, EUR J APPL PHYSIOL, V84, P487, DOI 10.1007/s004210100405; Ulbrich EJ, 2011, J MAGN RESON IMAGING, V33, P668, DOI 10.1002/jmri.22446; Wardlaw J, 2011, INT J STROKE	31	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34444	10.1371/journal.pone.0034444	http://dx.doi.org/10.1371/journal.pone.0034444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509305	Green Published, Green Submitted, gold			2022-12-27	WOS:000304805900033
J	Moore, RG; Lange, TS; Robinson, K; Kim, KK; Uzun, A; Horan, TC; Kawar, N; Yano, N; Chu, SR; Mao, QF; Brard, L; DePaepe, ME; Padbury, JF; Arnold, LA; Brodsky, A; Shen, TL; Singh, RK				Moore, Richard G.; Lange, Thilo S.; Robinson, Katina; Kim, Kyu K.; Uzun, Alper; Horan, Timothy C.; Kawar, Nada; Yano, Naohiro; Chu, Sharon R.; Mao, Quanfu; Brard, Laurent; DePaepe, Monique E.; Padbury, James F.; Arnold, Leggy A.; Brodsky, Alexander; Shen, Tun-Li; Singh, Rakesh K.			Efficacy of a Non-Hypercalcemic Vitamin-D2 Derived Anti-Cancer Agent (MT19c) and Inhibition of Fatty Acid Synthesis in an Ovarian Cancer Xenograft Model	PLOS ONE			English	Article							SYNTHASE INHIBITION; GENE-EXPRESSION; PATHWAY; RECEPTOR; ONCOGENE; AKT; OVEREXPRESSION; PROGRESSION; CISPLATIN; MARKERS	Background: Numerous vitamin-D analogs exhibited poor response rates, high systemic toxicities and hypercalcemia in human trials to treat cancer. We identified the first non-hypercalcemic anti-cancer vitamin D analog MT19c by altering the A-ring of ergocalciferol. This study describes the therapeutic efficacy and mechanism of action of MT19c in both in vitro and in vivo models. Methodology/Principal Finding: Antitumor efficacy of MT19c was evaluated in ovarian cancer cell (SKOV-3) xenografts in nude mice and a syngenic rat ovarian cancer model. Serum calcium levels of MT19c or calcitriol treated animals were measured. In-silico molecular docking simulation and a cell based VDR reporter assay revealed MT19c-VDR interaction. Genomewide mRNA analysis of MT19c treated tumors identified drug targets which were verified by immunoblotting and microscopy. Quantification of cellular malonyl CoA was carried out by HPLC-MS. A binding study with PPAR-Y receptor was performed. MT19c reduced ovarian cancer growth in xenograft and syngeneic animal models without causing hypercalcemia or acute toxicity. MT19c is a weak vitamin-D receptor (VDR) antagonist that disrupted the interaction between VDR and coactivator SRC2-3. Genome-wide mRNA analysis and western blot and microscopy of MT19c treated xenograft tumors showed inhibition of fatty acid synthase (FASN) activity. MT19c reduced cellular levels of malonyl CoA in SKOV-3 cells and inhibited EGFR/phosphoinositol-3kinase (PI-3K) activity independently of PPAR-gamma protein. Significance: Antitumor effects of non-hypercalcemic agent MT19c provide a new approach to the design of vitamin-D based anticancer molecules and a rationale for developing MT19c as a therapeutic agent for malignant ovarian tumors by targeting oncogenic de novo lipogenesis.	[Moore, Richard G.; Lange, Thilo S.; Robinson, Katina; Kim, Kyu K.; Horan, Timothy C.; Kawar, Nada; Singh, Rakesh K.] Brown Univ, Women & Infants Hosp Rhode Isl, Dept Obstet & Gynecol, Mol Therapeut Lab,Program Womens Oncol,Alpert Med, Providence, RI 02912 USA; [Uzun, Alper] Brown Univ, Dept Pediat, Ctr Computat Mol Biol, Women & Infants Hosp Rhode Isl,Alpert Med Sch, Providence, RI 02912 USA; [Brard, Laurent] So Illinois Med Sch, Springfield, IL USA; [Arnold, Leggy A.] Univ Wisconsin, Milwaukee, WI 53201 USA; [Brodsky, Alexander] Brown Univ, Dept Biol & Med, Providence, RI 02912 USA; [Shen, Tun-Li] Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University; Women & Infants Hospital Rhode Island; Brown University; Women & Infants Hospital Rhode Island; Southern Illinois University System; Southern Illinois University; University of Wisconsin System; University of Wisconsin Milwaukee; Brown University; Brown University	Moore, RG (corresponding author), Brown Univ, Women & Infants Hosp Rhode Isl, Dept Obstet & Gynecol, Mol Therapeut Lab,Program Womens Oncol,Alpert Med, Providence, RI 02912 USA.	rsingh@wihri.org		Uzun, Alper/0000-0001-6489-8591; Arnold, Leggy/0000-0003-1411-1572; Brard, Laurent/0000-0003-0065-1826				Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brard L, 2011, GYNECOL ONCOL, V123, P370, DOI 10.1016/j.ygyno.2011.07.002; Bury Y, 2000, MOL PHARMACOL, V58, P1067, DOI 10.1124/mol.58.5.1067; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cerne D, 2010, ARCH MED RES, V41, P405, DOI 10.1016/j.arcmed.2010.08.007; Deeb KK, 2007, NAT REV CANCER, V7, P684, DOI 10.1038/nrc2196; Dorward A, 1997, J BIOENERG BIOMEMBR, V29, P385, DOI 10.1023/A:1022454932269; Feau C, 2009, ACS CHEM BIOL, V4, P834, DOI 10.1021/cb900143a; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Grunt TW, 2009, BIOCHEM BIOPH RES CO, V385, P454, DOI 10.1016/j.bbrc.2009.05.085; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Kuhajda FP, 2000, NUTRITION, V16, P202, DOI 10.1016/S0899-9007(99)00266-X; Kumar-Sinha C, 2003, CANCER RES, V63, P132; Lange TS, 2008, DRUG DES DEV THER, V3, P1; Leitao MM, 2003, GYNECOL ONCOL, V91, P123, DOI 10.1016/S0090-8258(03)00464-5; Lempiainen H, 2005, MOL ENDOCRINOL, V19, P2258, DOI 10.1210/me.2004-0534; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Menendez JA, 2005, J CELL BIOCHEM, V94, P1, DOI 10.1002/jcb.20310; Menendez JA, 2004, P NATL ACAD SCI USA, V101, P10715, DOI 10.1073/pnas.0403390101; Menendez JA, 2010, BBA-MOL CELL BIOL L, V1801, P381, DOI 10.1016/j.bbalip.2009.09.005; Merida Isabel, 2006, Clin Transl Oncol, V8, P711, DOI 10.1007/s12094-006-0117-6; Miao BC, 2010, P NATL ACAD SCI USA, V107, P20126, DOI 10.1073/pnas.1004522107; Migita T, 2009, JNCI-J NATL CANCER I, V101, P519, DOI 10.1093/jnci/djp030; Milgraum LZ, 1997, CLIN CANCER RES, V3, P2115; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Phelps SLB, 2008, GYNECOL ONCOL, V109, P411, DOI 10.1016/j.ygyno.2008.02.030; Pizer ES, 1996, CANCER RES, V56, P1189; Pizer ES, 2000, CANCER RES, V60, P213; Pizer ES, 2001, PROSTATE, V47, P102, DOI 10.1002/pros.1052; Rashid A, 1997, AM J PATHOL, V150, P201; Rose GS, 1996, AM J OBSTET GYNECOL, V175, P593; Schilder R, 2005, P AM ASSOC CANC RES, V46, P5744; Sehdev AS, 2010, MODERN PATHOL, V23, P844, DOI 10.1038/modpathol.2010.60; Sewell JM, 2002, BRIT J CANCER, V86, P456, DOI 10.1038/sj.bjc.6600058; Stuckey A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-308; Uddin S, 2008, J CLIN ENDOCR METAB, V93, P4088, DOI 10.1210/jc.2008-0503; Uddin S, 2011, MOL MED, V17, P635, DOI 10.2119/molmed.2011.00046; Ueda SM, 2010, J ONCOL, V2010, DOI 10.1155/2010/285191; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Welsh JB, 2001, P NATL ACAD SCI USA, V98, P1176, DOI 10.1073/pnas.98.3.1176; Yano N, 2007, AM J PHYSIOL-HEART C, V293, pH385, DOI 10.1152/ajpheart.01318.2006; Zhou WB, 2007, CANCER RES, V67, P2964, DOI 10.1158/0008-5472.CAN-06-3439	45	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34443	10.1371/journal.pone.0034443	http://dx.doi.org/10.1371/journal.pone.0034443			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509304	Green Submitted, gold, Green Published			2022-12-27	WOS:000304805900032
J	Raghavendran, HRB; Sathyanath, R; Shin, J; Kim, HK; Han, JM; Cho, J; Son, CG				Raghavendran, Hanumantha Rao Balaji; Sathyanath, Rekha; Shin, JangWoo; Kim, Hyeong Keug; Han, Jong Min; Cho, JungHyo; Son, Chang Gue			Panax ginseng Modulates Cytokines in Bone Marrow Toxicity and Myelopoiesis: Ginsenoside Rg1 Partially Supports Myelopoiesis	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; TUMOR-NECROSIS-FACTOR; ENDOTHELIAL-CELLS SUPPORT; FACTOR-ALPHA; PROLIFERATION; INTERLEUKIN-3; DIFFERENTIATION; 5-FLUOROURACIL; ENHANCEMENT; LIGAND	In this study, we have demonstrated that Korean Panax ginseng (KG) significantly enhances myelopoiesis in vitro and reconstitutes bone marrow after 5-flurouracil-induced (5FU) myelosuppression in mice. KG promoted total white blood cell, lymphocyte, neutrophil and platelet counts and improved body weight, spleen weight, and thymus weight. The number of CFU-GM in bone marrow cells of mice and serum levels of IL-3 and GM-CSF were significantly improved after KG treatment. KG induced significant c-Kit, SCF and IL-1 mRNA expression in spleen. Moreover, treatment with KG led to marked improvements in 5FU-induced histopathological changes in bone marrow and spleen, and partial suppression of thymus damage. The levels of IL-3 and GM-CSF in cultured bone marrow cells after 24 h stimulation with KG were considerably increased. The mechanism underlying promotion of myelopoiesis by KG was assessed by monitoring gene expression at two time-points of 4 and 8 h. Treatment with Rg1 (0.5, 1 and 1.5 mu mol) specifically enhanced c-Kit, IL-6 and TNF-alpha mRNA expression in cultured bone marrow cells. Our results collectively suggest that the anti-myelotoxicity activity and promotion of myelopoiesis by KG are mediated through cytokines. Moreover, the ginsenoside, Rg1, supports the role of KG in myelopoiesis to some extent.	[Raghavendran, Hanumantha Rao Balaji; Sathyanath, Rekha; Shin, JangWoo; Kim, Hyeong Keug; Han, Jong Min; Cho, JungHyo; Son, Chang Gue] Univ Daejeon, Daejeon Oriental Hosp Daejeon, Liver & Immunol Res Ctr, Taejon, South Korea		Raghavendran, HRB (corresponding author), Univ Daejeon, Daejeon Oriental Hosp Daejeon, Liver & Immunol Res Ctr, Taejon, South Korea.	hbr_bala@yahoo.com; ckson@dju.ac.kr	raghavendran, hanumantha rao balaji/B-8507-2012; son, chang gue/ABC-2215-2021		National Research Foundation from the Republic of Korea's Ministry of Education, Science and Technology [R01-2007-000-11248-0, 20110003150]	National Research Foundation from the Republic of Korea's Ministry of Education, Science and Technology	This study was supported by a grant from the National Research Foundation (R01-2007-000-11248-0 and 20110003150) from the Republic of Korea's Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alenzi Faris Q., 2005, Yale Journal of Biology and Medicine, V78, P25; AlmeidaPorada G, 1996, J LAB CLIN MED, V128, P399, DOI 10.1016/S0022-2143(96)80012-6; Artym Jolanta, 2007, Postepy Hig Med Dosw (Online), V61, P129; Attele AS, 1999, BIOCHEM PHARMACOL, V58, P1685, DOI 10.1016/S0006-2952(99)00212-9; BARTOLD PM, 1991, J PERIODONTAL RES, V26, P339, DOI 10.1111/j.1600-0765.1991.tb02072.x; Batard P, 2000, J CELL SCI, V113, P383; Cashman JD, 1998, BLOOD, V92, P2338, DOI 10.1182/blood.V92.7.2338.2338_2338_2344; Chang Yuan S, 2003, Integr Cancer Ther, V2, P13, DOI 10.1177/1534735403251167; Chen Di, 2003, Zhongguo Zhong Xi Yi Jie He Za Zhi, V23, P845; Chen M.-W., 2005, MIL MED J S CHINA, V19, P4; Chen Xiao-Hong, 2006, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V14, P343; Dalmau SR, 1997, LEUKEMIA RES, V21, P93, DOI 10.1016/S0145-2126(96)00052-5; DAVIS TA, 1995, BLOOD, V85, P1751, DOI 10.1182/blood.V85.7.1751.bloodjournal8571751; De Maria R, 1999, NATURE, V401, P489, DOI 10.1038/46809; deHaan G, 1996, BLOOD, V87, P4581, DOI 10.1182/blood.V87.11.4581.bloodjournal87114581; Deonarain R, 2003, P NATL ACAD SCI USA, V100, P13453, DOI 10.1073/pnas.2230460100; DINARELLO CA, 1989, ADV IMMUNOL, V44, P153, DOI 10.1016/S0065-2776(08)60642-2; FACKLER MJ, 1995, BLOOD, V85, P3040, DOI 10.1182/blood.V85.11.3040.bloodjournal85113040; Gao RL, 2007, ACTA PHARMACOL SIN, V28, P703, DOI 10.1111/j.1745-7254.2007.00551.x; GILMORE GL, 1995, EXP HEMATOL, V23, P1319; Grem JL, 2000, INVEST NEW DRUG, V18, P299, DOI 10.1023/A:1006416410198; IKEBUCHI K, 1987, P NATL ACAD SCI USA, V84, P9035, DOI 10.1073/pnas.84.24.9035; Jodrell DI, 2001, BRIT J CANCER, V84, P600, DOI 10.1054/bjoc.2000.1664; JONES AT, 1993, BLOOD, V82, P1133; Joo SS, 2004, FITOTERAPIA, V75, P337, DOI 10.1016/j.fitote.2004.02.008; Kang Xin-Mei, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P730; Kim HJ, 2007, J VET SCI, V8, P39, DOI 10.4142/jvs.2007.8.1.39; KOIKE K, 1987, J CELL PHYSIOL, V131, P458, DOI 10.1002/jcp.1041310319; LEARY AG, 1987, BLOOD, V70, P1343; Lee DCW, 2011, MOLECULES, V16, P2802, DOI 10.3390/molecules16042802; Lee YJ, 1997, MOL CELL ENDOCRINOL, V133, P135, DOI 10.1016/S0303-7207(97)00160-3; LEONARD JP, 1994, BLOOD, V83, P1499; Leung KW, 2006, J BIOL CHEM, V281, P36280, DOI 10.1074/jbc.M606698200; Li HB, 2006, J PRACT ONCOL, V20, P18; Li WM, 2000, CYTOKINE, V12, P1017, DOI 10.1006/cyto.1999.0678; Lu XZ, 2008, ACTA PHARMACOL SIN, V29, P1209, DOI 10.1111/j.1745-7254.2008.00874.x; Lund JE., 2000, SCHALMS VET HEMATOLO, V5th ed, P44; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; NAND S, 1994, BLOOD, V83, P357; PAQUETTE RL, 1988, BLOOD, V71, P1596; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Reya T, 1998, BLOOD, V91, P2935, DOI 10.1182/blood.V91.8.2935.2935_2935_2947; ROODMAN GD, 1987, EXP HEMATOL, V15, P928; Ryan D. H., 2001, WILLIAMS HEMATOLOGY, V6, P9; Saif M Wasif, 2005, Clin Colorectal Cancer, V5, P89, DOI 10.3816/CCC.2005.n.020; Shi AW, 2009, ACTA PHARMACOL SIN, V30, P299, DOI 10.1038/aps.2009.6; SMITH JW, 1992, J CLIN ONCOL, V10, P1141, DOI 10.1200/JCO.1992.10.7.1141; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Tomiak A, 2000, AM J CLIN ONCOL-CANC, V23, P94, DOI 10.1097/00000421-200002000-00025; Vento S, 2008, LANCET ONCOL, V9, P982, DOI 10.1016/S1470-2045(08)70255-9; Voog E, 2000, J CLIN ONCOL, V18, P325, DOI 10.1200/JCO.2000.18.2.325; WINTON EF, 1994, BLOOD, V84, P65; Yance DR, 2006, INTEGR CANCER THER, V5, P9, DOI 10.1177/1534735405285562; Yun TK, 2003, MUTAT RES-FUND MOL M, V523, P63, DOI 10.1016/S0027-5107(02)00322-6; Zeuner A, 2007, CANCER RES, V67, P2007; Zhang QH, 2008, FOOD CHEM TOXICOL, V46, P293, DOI 10.1016/j.fct.2007.08.025	56	27	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e33733	10.1371/journal.pone.0033733	http://dx.doi.org/10.1371/journal.pone.0033733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523542	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000011
J	Gao, R; Yang, LL; Chen, HJ; Liu, Y; Liang, L; Yuan, W				Gao, Rui; Yang, Lili; Chen, Huajiang; Liu, Yang; Liang, Lei; Yuan, Wen			Long Term Results of Anterior Corpectomy and Fusion for Cervical Spondylotic Myelopathy	PLOS ONE			English	Article							FOLLOW-UP; OUTCOMES; SURGERY; DISC; DISKECTOMY; DIAGNOSIS; REMOVAL	Background: Results showed good clinical outcomes of anterior corpectomy and fusion (ACCF) for patients with cervical spondylotic myelopathy (CSM) during a short term follow-up; however, studies assessing long term results are relatively scarce. In this study we intended to assess the long term clinical and radiographic outcomes, find out the factors that may affect the long term clinical outcome and evaluate the incidence of adjacent segment disease (ASD). Methods: This is a retrospective study of 145 consecutive CSM patients on ACCF treatment with a minimum follow-up of 5 years. Clinical data were collected from medical and operative records. Patients were evaluated by using the Japanese Orthopedic Association (JOA) scoring system preoperatively and during the follow-up. X-rays results of cervical spine were obtained from all patients. Correlations between the long term clinical outcome and various factors were also analyzed. Findings: Ninety-three males and fifty-two females completed the follow-up. The mean age at operation was 51.0 years, and the mean follow-up period was 102.1 months. Both postoperative sagittal segmental alignment (SSA) and the sagittal alignment of the whole cervical spine (SACS) increased significantly in terms of cervical lordosis. The mean increase of JOA was 3.8 +/- 1.3 postoperatively, and the overall recovery rate was 62.5%. Logistic regression analysis showed that preoperative duration of symptoms >12 months, high-intensity signal in spinal cord and preoperative JOA score <= 9 were important predictors of the fair recovery rate (<= 50%). Repeated surgery due to ASD was performed in 7 (4.8%) cases. Conclusions: ACCF with anterior plate fixation is a reliable and effective method for treating CSM in terms of JOA score and the recovery rate. The correction of cervical alignment and the repeated surgery rate for ASD are also considered to be satisfactory.	[Gao, Rui; Yang, Lili; Chen, Huajiang; Liu, Yang; Liang, Lei; Yuan, Wen] Second Mil Med Univ, Changzheng Orthoped Hosp, Dept Spine Surg, Shanghai, Peoples R China	Naval Medical University	Gao, R (corresponding author), Second Mil Med Univ, Changzheng Orthoped Hosp, Dept Spine Surg, Shanghai, Peoples R China.	wenyuanspine@gmail.com						Andaluz N, 2012, J NEUROSURG-SPINE, V16, P2, DOI 10.3171/2011.9.SPINE10430; Baron EM, 2007, NEUROSURGERY, V60, P35, DOI 10.1227/01.NEU.0000215383.64386.82; Chen Y, 2008, J SPINAL DISORD TECH, V21, P489, DOI 10.1097/BSD.0b013e318158de22; Chibbaro S, 2006, J CLIN NEUROSCI, V13, P233, DOI 10.1016/j.jocn.2005.04.011; Chibbaro S, 2009, J NEUROSURG-SPINE, V10, P458, DOI 10.3171/2009.1.SPINE08186; CLOWARD RB, 1958, J NEUROSURG, V15, P602, DOI 10.3171/jns.1958.15.6.0602; Faldini C, 2010, J ORTHOP TRAUMATOL, V11, P99, DOI 10.1007/s10195-010-0093-z; Fessler RG, 1998, NEUROSURGERY, V43, P257, DOI 10.1097/00006123-199808000-00044; Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519, DOI 10.2106/00004623-199904000-00009; HIRABAYASHI K, 1981, SPINE, V6, P354, DOI 10.1097/00007632-198107000-00005; Ikenaga M, 2006, SPINE, V31, P1568, DOI 10.1097/01.brs.0000221985.37468.0f; Kadanka Z, 2005, EUR J NEUROL, V12, P16, DOI 10.1111/j.1468-1331.2004.00947.x; Klineberg E, 2010, ORTHOP CLIN N AM, V41, P193, DOI 10.1016/j.ocl.2009.12.010; Lin QS, 2011, J ORTHOP TRAUMA, V25, P670, DOI 10.1097/BOT.0b013e318214b59e; Matsuda Y, 1999, SPINE, V24, P529, DOI 10.1097/00007632-199903150-00005; Matsumoto M, 2001, SPINE, V26, P1592, DOI 10.1097/00007632-200107150-00021; Mccormick WE, 2003, CLEV CLIN J MED, V70, P899, DOI 10.3949/ccjm.70.10.899; MEHALIC TF, 1990, NEUROSURGERY, V26, P217, DOI 10.1227/00006123-199002000-00006; Naderi S, 1998, NEUROSURGERY, V43, P43, DOI 10.1097/00006123-199807000-00028; Riew KD, 1999, SPINE, V24, P2404, DOI 10.1097/00007632-199911150-00019; SMITH GW, 1958, J BONE JOINT SURG AM, V40, P607, DOI 10.2106/00004623-195840030-00009; Suri Ashish, 2003, Spine J, V3, P33, DOI 10.1016/S1529-9430(02)00448-5; Uchida K, 2005, J ORTHOP SCI, V10, P564, DOI 10.1007/s00776-005-0953-1; Uribe JS, 2009, EUR SPINE J, V18, P654, DOI 10.1007/s00586-009-0897-9; Walraevens J, 2010, NEUROSURGERY, V67, P679, DOI 10.1227/01.NEU.0000377039.89725.F3; Wang JC, 2003, SPINE, V28, P1016, DOI 10.1097/00007632-200305150-00011; Xu BS, 2009, J SPINAL DISORD TECH, V22, P105, DOI 10.1097/BSD.0b013e31816d6579; Yan DL, 2011, ARCH ORTHOP TRAUM SU, V131, P1369, DOI 10.1007/s00402-011-1317-2; Young WF, 2000, AM FAM PHYSICIAN, V62, P1064; Yue WM, 2005, SPINE, V30, P2138, DOI 10.1097/01.brs.0000180479.63092.17; Yukawa Y, 2007, SPINE, V32, P1675, DOI 10.1097/BRS.0b013e318074d62e	31	33	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34811	10.1371/journal.pone.0034811	http://dx.doi.org/10.1371/journal.pone.0034811			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514669	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600075
J	Glaros, T; Fu, Y; Xing, JH; Li, LW				Glaros, Trevor; Fu, Yan; Xing, Jianhua; Li, Liwu			Molecular Mechanism Underlying Persistent Induction of LCN2 by Lipopolysaccharide in Kidney Fibroblasts	PLOS ONE			English	Article							RECEPTOR-ASSOCIATED KINASE; NEUTROPHIL GELATINASE; METABOLIC ENDOTOXEMIA; LIPOCALIN; CELLS; NGAL; INFLAMMATION; SIGNALS; HUMANS; MICE	The neutrophil gelatinase-associated lipocalin 2 (LCN2) is a critical inflammatory mediator persistently induced during endotoxemia, contributing to tubular damage and kidney failure. The intracellular process responsible for persistent induction of LCN2 by bacterial endotoxin Lipopolysaccharide (LPS) is not well understood. Using primary kidney fibroblasts, we observed that LPS-induced LCN2 expression requires a coupled circuit involving an early transient phase of AP-1 path and a late persistent phase of C/EBP delta path, both of which are dependent upon the interleukin 1 receptor associated kinase 1 (IRAK-1). Using immunoprecipitation analysis we observed transient binding of AP-1 to the promoters of both TNF alpha and C/ebp delta. On the other hand, we only observed persistent binding of C/EBP delta to its own promoter but not on TNF alpha. Blockage of new protein synthesis using cyclohexamide significantly reduced the expression of C/EBP delta as well as LCN2. By chromatin immunoprecipitation analyses, we demonstrated that LPS recruited C/EBP delta to the Lcn2 promoter in WT, but not IRAK-1 deficient fibroblasts. A differential equation-based computational model captured the dynamic circuit leading to the persistent induction of LCN2. In vivo, we observed elevated levels of LCN2 in kidneys harvested from LPS-injected WT mice as compared to IRAK-1 deficient mice. Taken together, this study has identified an integrated intracellular network involved in the persistent induction of LCN2 by LPS.	[Glaros, Trevor; Li, Liwu] Virginia Polytech Inst & State Univ, Lab Innate Immun & Inflammat, Blacksburg, VA 24061 USA; [Glaros, Trevor; Fu, Yan; Xing, Jianhua; Li, Liwu] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Fu, Yan] Virginia Polytech Inst & State Univ, Interdisciplinary Program Genet Bioinformat & Com, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Glaros, T (corresponding author), Virginia Polytech Inst & State Univ, Lab Innate Immun & Inflammat, Blacksburg, VA 24061 USA.	lwli@vt.edu	Xing, Jianhua/A-8101-2012	Xing, Jianhua/0000-0002-3700-8765; Li, Liwu/0000-0001-8870-5299	Institute of Critical Technology and Applied Sciences from Virginia Tech; Division Of Mathematical Sciences [0969417] Funding Source: National Science Foundation	Institute of Critical Technology and Applied Sciences from Virginia Tech; Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work is supported by an internal institutional fund from the Institute of Critical Technology and Applied Sciences from Virginia Tech. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolignano D, 2010, EUR J CLIN INVEST, V40, P273, DOI 10.1111/j.1365-2362.2010.02258.x; Bonomini Francesca, 2010, Front Biosci (Schol Ed), V2, P591; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Ding LM, 2010, CIRC J, V74, P523, DOI 10.1253/circj.CJ-09-0485; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; KJELDSEN L, 1993, J BIOL CHEM, V268, P10425; Kravchenko VV, 2003, J BIOL CHEM, V278, P26612, DOI 10.1074/jbc.M303001200; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; Li XX, 2005, J MOL MED, V83, P258, DOI 10.1007/s00109-004-0622-4; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Lu YC, 2009, J IMMUNOL, V182, P7212, DOI 10.4049/jimmunol.0802971; Maitra U, 2011, J IMMUNOL, V186, P4467, DOI 10.4049/jimmunol.1003300; Maitra U, 2009, MOL CELL BIOL, V29, P5989, DOI 10.1128/MCB.00541-09; Mehta NN, 2010, DIABETES, V59, P172, DOI 10.2337/db09-0367; Moreno-Navarrete JM, 2010, INT J OBESITY, V34, P240, DOI 10.1038/ijo.2009.242; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Peairs A, 2010, CELL MOL IMMUNOL, V7, P123, DOI 10.1038/cmi.2010.1; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; SMOLENS P, 1981, AM J MED, V70, P479, DOI 10.1016/0002-9343(81)90568-4; Su JM, 2009, J INNATE IMMUN, V1, P164, DOI 10.1159/000158541; Sunil VR, 2007, EXP MOL PATHOL, V83, P177, DOI 10.1016/j.yexmp.2007.03.004; Tyson JJ, 2010, ANNU REV PHYS CHEM, V61, P219, DOI 10.1146/annurev.physchem.012809.103457; Viau A, 2010, J CLIN INVEST, V120, P4065, DOI 10.1172/JCI42004; Yamamoto M, 2009, ADV EXP MED BIOL, V667, P59, DOI 10.1007/978-1-4419-1603-7_6	27	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34633	10.1371/journal.pone.0034633	http://dx.doi.org/10.1371/journal.pone.0034633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514649	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600055
J	Hwang, YY; Barakat, AI				Hwang, Yongyun; Barakat, Abdul I.			Dynamics of Mechanical Signal Transmission through Prestressed Stress Fibers	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; SHEAR-STRESS; LIVING CELLS; EXTRACELLULAR-MATRIX; ACTIN-FILAMENTS; ION CHANNELS; MECHANOTRANSDUCTION; INTEGRINS; MICROTUBULES; PROPAGATION	Transmission of mechanical stimuli through the actin cytoskeleton has been proposed as a mechanism for rapid long-distance mechanotransduction in cells; however, a quantitative understanding of the dynamics of this transmission and the physical factors governing it remains lacking. Two key features of the actin cytoskeleton are its viscoelastic nature and the presence of prestress due to actomyosin motor activity. We develop a model of mechanical signal transmission through prestressed viscoelastic actin stress fibers that directly connect the cell surface to the nucleus. The analysis considers both temporally stationary and oscillatory mechanical signals and accounts for cytosolic drag on the stress fibers. To elucidate the physical parameters that govern mechanical signal transmission, we initially focus on the highly simplified case of a single stress fiber. The results demonstrate that the dynamics of mechanical signal transmission depend on whether the applied force leads to transverse or axial motion of the stress fiber. For transverse motion, mechanical signal transmission is dominated by prestress while fiber elasticity has a negligible effect. Conversely, signal transmission for axial motion is mediated uniquely by elasticity due to the absence of a prestress restoring force. Mechanical signal transmission is significantly delayed by stress fiber material viscosity, while cytosolic damping becomes important only for longer stress fibers. Only transverse motion yields the rapid and long-distance mechanical signal transmission dynamics observed experimentally. For simple networks of stress fibers, mechanical signals are transmitted rapidly to the nucleus when the fibers are oriented largely orthogonal to the applied force, whereas the presence of fibers parallel to the applied force slows down mechanical signal transmission significantly. The present results suggest that cytoskeletal prestress mediates rapid mechanical signal transmission and allows temporally oscillatory signals in the physiological frequency range to travel a long distance without significant decay due to material viscosity and/or cytosolic drag.	[Hwang, Yongyun; Barakat, Abdul I.] Ecole Polytech, CNRS, Hydrodynam Lab LadHyX, Dept Mech,UMR7646, F-91128 Palaiseau, France; [Barakat, Abdul I.] Univ Calif Davis, Davis, CA 95616 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut Polytechnique de Paris; University of California System; University of California Davis	Hwang, YY (corresponding author), Ecole Polytech, CNRS, Hydrodynam Lab LadHyX, Dept Mech,UMR7646, F-91128 Palaiseau, France.	barakat@ladhyx.polytechnique.fr	Barakat, Abdul I/AAI-3117-2020	Barakat, Abdul I/0000-0002-7551-3631	Ecole Polytechnique through a Gaspard Monge International Scholarship; AXA Research Fund	Ecole Polytechnique through a Gaspard Monge International Scholarship; AXA Research Fund(AXA Research Fund)	YH is supported by Ecole Polytechnique through a Gaspard Monge International Scholarship. This work was funded in part by an endowment in Cardiovascular Cellular Engineering from the AXA Research Fund (http://www.axa-research.org/en/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barakat AI, 1999, CIRC RES, V85, P820, DOI 10.1161/01.RES.85.9.820; Barakat AI, 2006, BIOMATERIALS, V27, P671, DOI 10.1016/j.biomaterials.2005.07.036; Bewley TR, 2008, NUMERICAL RENAISSANC; Boal D. H., 2002, MECH CELL; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Chappell DC, 1998, CIRC RES, V82, P532, DOI 10.1161/01.RES.82.5.532; Chien S, 2007, AM J PHYSIOL-HEART C, V292, pH1209, DOI 10.1152/ajpheart.01047.2006; Deguchi S, 2006, J BIOMECH, V39, P2603, DOI 10.1016/j.jbiomech.2005.08.026; Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3; Gautam M, 2006, J BIOL CHEM, V281, P36492, DOI 10.1074/jbc.M605866200; Giannone G, 2006, TRENDS CELL BIOL, V16, P213, DOI 10.1016/j.tcb.2006.02.005; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Hahn C, 2009, NAT REV MOL CELL BIO, V10, P53, DOI 10.1038/nrm2596; Helmke BP, 2002, ANN BIOMED ENG, V30, P284, DOI 10.1114/1.1467926; Howard J., 2001, MECH MOTOR PROTEINS; Howard J, 2009, ANNU REV BIOPHYS, V38, P217, DOI 10.1146/annurcv.biophys.050708.133732; Hu SH, 2005, BIOCHEM BIOPH RES CO, V329, P423, DOI 10.1016/j.bbrc.2005.02.026; Hu SH, 2004, AM J PHYSIOL-CELL PH, V287, pC1184, DOI 10.1152/ajpcell.00224.2004; Hu SH, 2003, AM J PHYSIOL-CELL PH, V285, pC1082, DOI 10.1152/ajpcell.00159.2003; Hu Shaohua, 2006, Molecular & Cellular Biomechanics, V3, P49; Inman DJ, 2001, ENG VIBRATION; Itano N, 2003, P NATL ACAD SCI USA, V100, P5181, DOI 10.1073/pnas.0531397100; Jaalouk DE, 2009, NAT REV MOL CELL BIO, V10, P63, DOI 10.1038/nrm2597; Katoh K, 1998, MOL BIOL CELL, V9, P1919, DOI 10.1091/mbc.9.7.1919; Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506; Lieu DK, 2004, AM J PHYSIOL-CELL PH, V286, pC1367, DOI 10.1152/ajpcell.00243.2003; Lu L, 2008, BIOPHYS J, V95, P6060, DOI 10.1529/biophysj.108.133462; Ma L, 1997, NAT CELL BIOL, V3, P503; Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849; Matthews BD, 2006, J CELL SCI, V119, P508, DOI 10.1242/jcs.02760; Meyer CJ, 2000, NAT CELL BIOL, V2, P666, DOI 10.1038/35023621; Na S, 2008, P NATL ACAD SCI USA, V105, P6626, DOI 10.1073/pnas.0711704105; Prat AG, 1996, AM J PHYSIOL-CELL PH, V270, pC1532, DOI 10.1152/ajpcell.1996.270.5.C1532; Shyy JY, 2002, CIRC RES, V91, P769, DOI 10.1161/01.RES.0000038487.19924.18; Stamenovic D, 2002, AM J PHYSIOL-CELL PH, V282, pC617, DOI 10.1152/ajpcell.00271.2001; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Wang N, 2005, BIOCHEM BIOPH RES CO, V328, P1133, DOI 10.1016/j.bbrc.2005.01.070; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; WONG AJ, 1983, SCIENCE, V219, P867, DOI 10.1126/science.6681677	43	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35343	10.1371/journal.pone.0035343	http://dx.doi.org/10.1371/journal.pone.0035343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514731	gold, Green Published			2022-12-27	WOS:000305341600136
J	Madsen, R; Banday, VS; Moritz, T; Trygg, J; Lejon, K				Madsen, Rasmus; Banday, Viqar Showkat; Moritz, Thomas; Trygg, Johan; Lejon, Kristina			Altered Metabolic Signature in Pre-Diabetic NOD Mice	PLOS ONE			English	Article							NONOBESE DIABETIC MICE; ISLET AUTOIMMUNITY; GENE-EXPRESSION; AMINO-ACID; TYPE-1; POLYMORPHISMS; CHILDREN; REGION; MOUSE; CELLS	Altered metabolism proceeding seroconversion in children progressing to Type 1 diabetes has previously been demonstrated. We tested the hypothesis that non-obese diabetic (NOD) mice show a similarly altered metabolic profile compared to C57BL/6 mice. Blood samples from NOD and C57BL/6 female mice was collected at 0, 1, 2, 3, 4, 5, 6, 7, 9, 11, 13 and 15 weeks and the metabolite content was analyzed using GC-MS. Based on the data of 89 identified metabolites OPLS-DA analysis was employed to determine the most discriminative metabolites. In silico analysis of potential involved metabolic enzymes was performed using the dbSNP data base. Already at 0 weeks NOD mice displayed a unique metabolic signature compared to C57BL/6. A shift in the metabolism was observed for both strains the first weeks of life, a pattern that stabilized after 5 weeks of age. Multivariate analysis revealed the most discriminative metabolites, which included inosine and glutamic acid. In silico analysis of the genes in the involved metabolic pathways revealed several SNPs in either regulatory or coding regions, some in previously defined insulin dependent diabetes (Idd) regions. Our result shows that NOD mice display an altered metabolic profile that is partly resembling the previously observation made in children progressing to Type 1 diabetes. The level of glutamic acid was one of the most discriminative metabolites in addition to several metabolites in the TCA cycle and nucleic acid components. The in silico analysis indicated that the genes responsible for this reside within previously defined Idd regions.	[Madsen, Rasmus; Trygg, Johan] Umea Univ, Dept Chem, Computat Life Sci Cluster CLiC, Umea, Sweden; [Banday, Viqar Showkat; Lejon, Kristina] Umea Univ, Div Immunol, Dept Clin Microbiol, Umea, Sweden; [Moritz, Thomas] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden	Umea University; Umea University; Swedish University of Agricultural Sciences; Umea University	Madsen, R (corresponding author), Umea Univ, Dept Chem, Computat Life Sci Cluster CLiC, Umea, Sweden.	kristina.lejon@climi.umu.se		Madsen, Rasmus Bodker/0000-0001-8538-7491; Moritz, Thomas/0000-0002-4258-3190; Banday, Viqar/0000-0002-5081-2272	Kempe Foundation; Medical Faculty at Umea University; Insamlingsstiftelsen at Umea University; Magnus Bergvalls stiftelse; JDRF [1-2008-1011]; Children Diabetes Foundation in Sweden	Kempe Foundation; Medical Faculty at Umea University; Insamlingsstiftelsen at Umea University; Magnus Bergvalls stiftelse; JDRF(Juvenile Diabetes Research Foundation); Children Diabetes Foundation in Sweden	This work was supported by the Kempe Foundation, the Medical Faculty at Umea University, Insamlingsstiftelsen at Umea University, Magnus Bergvalls stiftelse, JDRF (1-2008-1011), and the Children Diabetes Foundation in Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akesson L, 2011, METABOLOMICS, P1; Andersen CM, 2010, J CHEMOMETR, V24, P728, DOI 10.1002/cem.1360; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Chen YG, 2011, J IMMUNOL, V186, P4278, DOI 10.4049/jimmunol.1003733; Driver JP, 2011, SEMIN IMMUNOPATHOL, V33, P67, DOI 10.1007/s00281-010-0204-1; Duan J, 2003, MOL PSYCHIATR, V8, P901, DOI 10.1038/sj.mp.4001403; Field LL, 2005, DIABETES, V54, P1588, DOI 10.2337/diabetes.54.5.1588; FLOYD JC, 1963, J CLIN INVEST, V42, P1714, DOI 10.1172/JCI104857; Fonseca SG, 2010, ISLETS, V2, P1, DOI 10.4161/isl.2.1.10456; FORSGREN S, 1991, SCAND J IMMUNOL, V34, P445, DOI 10.1111/j.1365-3083.1991.tb01567.x; Guyton AC, 2011, MEDICAL PHYSL; Jollife I. T., 2002, PRINCIPAL COMPONENT; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Makino S, 1980, Jikken Dobutsu, V29, P1; Miller GM, 2002, MOL PSYCHIATR, V7, P44, DOI 10.1038/sj/mp/4000921; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; Oskouie FG, 2011, J IMMUNOL, V186, P6798, DOI 10.4049/jimmunol.1004222; Pflueger M, 2011, DIABETES, V60, P2740, DOI 10.2337/db10-1652; Redestig H, 2009, ANAL CHEM, V81, P7974, DOI 10.1021/ac901143w; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shoda LKM, 2005, IMMUNITY, V23, P115, DOI 10.1016/j.immuni.2005.08.002; Sysi-Aho M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002257; TISCH R, 1993, NATURE, V366, P72, DOI 10.1038/366072a0; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Trygg J., 2005, ANAL CHEM, V77, P8086; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Vehik K, 2011, DIABETES-METAB RES, V27, P3, DOI 10.1002/dmrr.1141; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639	30	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35445	10.1371/journal.pone.0035445	http://dx.doi.org/10.1371/journal.pone.0035445			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514744	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600149
J	Miramontes, O; Boyer, D; Bartumeus, F				Miramontes, Octavio; Boyer, Denis; Bartumeus, Frederic			The Effects of Spatially Heterogeneous Prey Distributions on Detection Patterns in Foraging Seabirds	PLOS ONE			English	Article							FLIGHT SEARCH PATTERNS; WANDERING ALBATROSSES; MARINE PREDATOR; LEVY WALK; SATELLITE TRACKING; MOVEMENT PATTERNS; ACTIVITY BUDGETS; PATCH STRUCTURE; SOUTH-ATLANTIC; PELAGIC FISH	Many attempts to relate animal foraging patterns to landscape heterogeneity are focused on the analysis of foragers movements. Resource detection patterns in space and time are not commonly studied, yet they are tightly coupled to landscape properties and add relevant information on foraging behavior. By exploring simple foraging models in unpredictable environments we show that the distribution of intervals between detected prey (detection statistics) is mostly determined by the spatial structure of the prey field and essentially distinct from predator displacement statistics. Detections are expected to be Poissonian in uniform random environments for markedly different foraging movements (e. g. Levy and ballistic). This prediction is supported by data on the time intervals between diving events on short-range foraging seabirds such as the thick-billed murre (Uria lomvia). However, Poissonian detection statistics is not observed in long-range seabirds such as the wandering albatross (Diomedea exulans) due to the fractal nature of the prey field, covering a wide range of spatial scales. For this scenario, models of fractal prey fields induce non-Poissonian patterns of detection in good agreement with two albatross data sets. We find that the specific shape of the distribution of time intervals between prey detection is mainly driven by meso and submeso-scale landscape structures and depends little on the forager strategy or behavioral responses.	[Miramontes, Octavio; Boyer, Denis] Univ Nacl Autonoma Mexico, Inst Fis, Dept Sistemas Complejos, Mexico City, DF, Mexico; [Miramontes, Octavio; Boyer, Denis] Univ Nacl Autonoma Mexico, C3, Mexico City 04510, DF, Mexico; [Miramontes, Octavio] Univ Fed Parana, Dept Fis, BR-80060000 Curitiba, Parana, Brazil; [Bartumeus, Frederic] Ctr Estudis Avancats Blanes, Blanes, Girona, Spain	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidade Federal do Parana; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB)	Miramontes, O (corresponding author), Univ Nacl Autonoma Mexico, Inst Fis, Dept Sistemas Complejos, Mexico City, DF, Mexico.	octavio@fisica.unam.mx	miramontes, octavio/ABG-8963-2020; Miramontes, Octavio/A-1870-2012; Bartumeus, Frederic/D-1911-2010	miramontes, octavio/0000-0001-8306-0014; Bartumeus, Frederic/0000-0001-6908-3797	PAPIIT-Universidad Nacional Autonoma de Mexico [IN-118306, IN-107309, IN-101712]; Ramon y Cajal Program from the Spanish Ministry of Science and Innovation	PAPIIT-Universidad Nacional Autonoma de Mexico(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); Ramon y Cajal Program from the Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	OM and DB were supported by PAPIIT-Universidad Nacional Autonoma de Mexico Grants IN-118306, IN-107309 and IN-101712. FB is supported by the Ramon y Cajal Program from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALERSTAM T, 1993, PHILOS T ROY SOC B, V340, P55, DOI 10.1098/rstb.1993.0048; Atkinson RPD, 2002, OIKOS, V98, P134, DOI 10.1034/j.1600-0706.2002.980114.x; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; Bartumeus F, 2009, OIKOS, V118, P488, DOI 10.1111/j.1600-0706.2009.17313.x; Bartumeus F, 2008, P NATL ACAD SCI USA, V105, P19072, DOI 10.1073/pnas.0801926105; BENHAMOU S, 1989, ANIM BEHAV, V38, P375, DOI 10.1016/S0003-3472(89)80030-2; Benhamou S, 2007, ECOLOGY, V88, P1962, DOI 10.1890/06-1769.1; Berrow SD, 2000, J AVIAN BIOL, V31, P303, DOI 10.1034/j.1600-048X.2000.310305.x; Bertrand S, 2005, ICES J MAR SCI, V62, P477, DOI 10.1016/j.icesjms.2004.12.002; Boyer D, 2012, UNPUB; CAIRNS DK, 1992, CONDOR, V94, P811, DOI 10.2307/1369279; CAIRNS DK, 1987, AUK, V104, P218, DOI 10.1093/auk/104.2.218; Crawford RJM, 2008, AFR J MAR SCI, V30, P177, DOI 10.2989/AJMS.2008.30.1.18.468; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Einoder LD, 2009, FISH RES, V95, P6, DOI 10.1016/j.fishres.2008.09.024; Elliott KH, 2009, BEHAV ECOL SOCIOBIOL, V63, P1773, DOI 10.1007/s00265-009-0801-y; Fauchald P, 2000, ECOLOGY, V81, P773, DOI 10.1890/0012-9658(2000)081[0773:SDPPIT]2.0.CO;2; Frederiksen M, 2007, MAR ECOL PROG SER, V352, P205, DOI 10.3354/meps07071; Freon P, 2005, B MAR SCI, V76, P385; Fritz H, 2003, P ROY SOC B-BIOL SCI, V270, P1143, DOI 10.1098/rspb.2003.2350; Garrison LP, 2002, FISH OCEANOGR, V11, P267, DOI 10.1046/j.1365-2419.2002.00205.x; Gonzalez-Solis J, 2000, MAR ECOL PROG SER, V204, P279, DOI 10.3354/meps204279; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; HASSELL MP, 1974, J ANIM ECOL, V43, P567, DOI 10.2307/3384; Irons DB, 1998, ECOLOGY, V79, P647, DOI 10.2307/176960; Isliker H, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026413; JOUVENTIN P, 1990, NATURE, V343, P746, DOI 10.1038/343746a0; Kai ET, 2009, P NATL ACAD SCI USA, V106, P8245, DOI 10.1073/pnas.0811034106; KOTLIAR NB, 1990, OIKOS, V59, P253, DOI 10.2307/3545542; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; Louzao M, 2011, MAR ECOL PROG SER, V429, P291, DOI 10.3354/meps09126; Makris NC, 2006, SCIENCE, V311, P660, DOI 10.1126/science.1121756; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; Medvinsky A, 2000, NONLINEAR DYNAMICS P, V4, P135; Monaghan P, 1996, OIKOS, V77, P227, DOI 10.2307/3546061; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; MYSAK LA, 1986, CAN J FISH AQUAT SCI, V43, P464, DOI 10.1139/f86-057; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Osborne A. R., 1989, Tellus, Series A (Dynamic Meteorology and Oceanography), V41A, P416, DOI 10.1111/j.1600-0870.1989.tb00392.x; Pauly D, 2003, SCIENCE, V302, P1359, DOI 10.1126/science.1088667; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Piatt JF, 2007, MAR ECOL PROG SER, V352, P199, DOI 10.3354/meps07070; Plank MJ, 2008, J R SOC INTERFACE, V5, P1077, DOI 10.1098/rsif.2008.0006; PRINCE PA, 1992, ANTARCT SCI, V4, P31, DOI 10.1017/S0954102092000075; PRINCE PA, 1984, CONDOR, V86, P297, DOI 10.2307/1366998; Ramos-Fernandez G, 2004, BEHAV ECOL SOCIOBIOL, V55, P223, DOI 10.1007/s00265-003-0700-6; Reynolds AM, 2009, ECOLOGY, V90, P877, DOI 10.1890/08-0153.1; Reynolds A, 2008, ECOLOGY, V89, P2347, DOI 10.1890/07-1688.1; Rodhouse PG, 1996, MAR ECOL PROG SER, V136, P37, DOI 10.3354/meps136037; Shlesinger MF, 2000, GROWTH FORM FRACTAL, P279; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Sims DW, 2007, J ANIM ECOL, V76, P222, DOI 10.1111/j.1365-2656.2006.01208.x; Sydeman WJ, 2001, PROG OCEANOGR, V49, P309, DOI 10.1016/S0079-6611(01)00028-3; Tsuda Atsushi, 1995, Journal of Oceanography, V51, P261, DOI 10.1007/BF02285164; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Weimerskirch H, 2005, ECOLOGY, V86, P2611, DOI 10.1890/04-1866; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Weimerskirch H, 1997, MAR ECOL PROG SER, V151, P245, DOI 10.3354/meps151245; Weimerskirch H, 2000, NATURE, V406, P955, DOI 10.1038/35023068; Weimerskirch H, 2005, MAR ECOL PROG SER, V288, P251, DOI 10.3354/meps288251; WEIMERSKIRCH H, 1993, AUK, V110, P325; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Weimerskirch H, 2007, DEEP-SEA RES PT II, V54, P211, DOI 10.1016/j.dsr2.2006.11.013; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; With KA, 1999, ECOLOGY, V80, P1340, DOI 10.1890/0012-9658(1999)080[1340:MRTPSI]2.0.CO;2; Wood AG, 2000, J AVIAN BIOL, V31, P278, DOI 10.1034/j.1600-048X.2000.310302.x	68	34	34	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34317	10.1371/journal.pone.0034317	http://dx.doi.org/10.1371/journal.pone.0034317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514629	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600034
J	Phan-Ba, R; Calay, P; Grodent, P; Delrue, G; Lommers, E; Delvaux, V; Moonen, G; Belachew, S				Phan-Ba, Remy; Calay, Philippe; Grodent, Patrick; Delrue, Gael; Lommers, Emilie; Delvaux, Valerie; Moonen, Gustave; Belachew, Shibeshih			Motor Fatigue Measurement by Distance-Induced Slow Down of Walking Speed in Multiple Sclerosis	PLOS ONE			English	Article							STATUS SCALE EDSS; FUNCTIONAL COMPOSITE; DISABILITY; GAIT; MS; MULTICENTER; IMPAIRMENT; CAPACITY; TRIAL	Background and rationale: Motor fatigue and ambulation impairment are prominent clinical features of people with multiple sclerosis (pMS). We hypothesized that a multimodal and comparative assessment of walking speed on short and long distance would allow a better delineation and quantification of gait fatigability in pMS. Our objectives were to compare 4 walking paradigms: the timed 25-foot walk (T25FW), a corrected version of the T25FW with dynamic start (T25FW(+)), the timed 100-meter walk (T100MW) and the timed 500-meter walk (T500MW). Methods: Thirty controls and 81 pMS performed the 4 walking tests in a single study visit. Results: The 4 walking tests were performed with a slower WS in pMS compared to controls even in subgroups with minimal disability. The finishing speed of the last 100-meter of the T500MW was the slowest measurable WS whereas the T25FW+ provided the fastest measurable WS. The ratio between such slowest and fastest WS (Deceleration Index, DI) was significantly lower only in pMS with EDSS 4.0-6.0, a pyramidal or cerebellar functional system score reaching 3 or a maximum reported walking distance <= 4000 m. Conclusion: The motor fatigue which triggers gait deceleration over a sustained effort in pMS can be measured by the WS ratio between performances on a very short distance and the finishing pace on a longer more demanding task. The absolute walking speed is abnormal early in MS whatever the distance of effort when patients are unaware of ambulation impairment. In contrast, the DI-measured ambulation fatigability appears to take place later in the disease course.	[Phan-Ba, Remy; Calay, Philippe; Grodent, Patrick; Delrue, Gael; Lommers, Emilie; Delvaux, Valerie; Moonen, Gustave; Belachew, Shibeshih] MYelin Disorders Res teaM MYDREAM, Liege, Belgium; [Phan-Ba, Remy; Calay, Philippe; Delrue, Gael; Lommers, Emilie; Delvaux, Valerie; Moonen, Gustave; Belachew, Shibeshih] Univ Liege, Dept Neurol, Liege, Belgium; [Phan-Ba, Remy; Calay, Philippe; Grodent, Patrick; Delrue, Gael; Lommers, Emilie; Delvaux, Valerie; Moonen, Gustave; Belachew, Shibeshih] CHU Liege, Liege, Belgium; [Grodent, Patrick] Univ Liege, Dept Phys Med & Rehabil, Liege, Belgium	University of Liege; University of Liege; University of Liege	Phan-Ba, R (corresponding author), MYelin Disorders Res teaM MYDREAM, Liege, Belgium.	remy.phanba@chu.ulg.ac.be	Belachew, Shibeshih/V-9185-2019	Belachew, Shibeshih/0000-0003-3976-1950	Biogen Idec; Merck Serono; Sanofi-Aventis; TEVA; Novartis Pharma	Biogen Idec(Biogen); Merck Serono(Merck & Company); Sanofi-Aventis(Sanofi-Aventis); TEVA(Teva Pharmaceutical Industries); Novartis Pharma	SB received compensation for serving as an advisor or consultant for Bayer Schering Pharma, Biogen Idec, Merck-Serono and received educational grants from Biogen Idec, Merck Serono, Sanofi-Aventis, TEVA, and Novartis Pharma. PC received an educational grant from Biogen Idec. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Albrecht H, 2001, MULT SCLER J, V7, P105, DOI 10.1191/135245801678227621; Benedetti MG, 1999, MULT SCLER J, V5, P363, DOI 10.1191/135245899678846393; Corradini ML, 1997, IEEE T BIO-MED ENG, V44, P1029, DOI 10.1109/10.641330; Creange A, 2007, MULT SCLER, V13, P220, DOI 10.1177/1352458506070667; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Feys P, 2012, MULT SCLER J, V18, P351, DOI 10.1177/1352458511419881; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; Gijbels D, 2011, MULT SCLER; Gijbels D, 2012, MULT SCLER J, V18, P364, DOI 10.1177/1352458511420598; Goldman MD, 2008, MULT SCLER J, V14, P383, DOI 10.1177/1352458507082607; Heesen C, 2008, MULT SCLER, V14, P988, DOI 10.1177/1352458508088916; Kalron A, 2010, GAIT POSTURE, V32, P332, DOI 10.1016/j.gaitpost.2010.06.002; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Martin CL, 2006, MULT SCLER J, V12, P620, DOI 10.1177/1352458506070658; Miller D, 2011, 5 JOINT TRIENN C EUR; Nieuwenhuis MM, 2006, MULT SCLER J, V12, P495, DOI 10.1191/1352458506ms1293oa; Phan-Ba R, 2011, NEUROREHABIL NEURAL; Phan-Ba R, 2011, NEUROREHABI IN PRESS; Phan-Ba R, 2011, NEUROREHAB NEURAL RE, V25, P672, DOI 10.1177/1545968310397204; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Schimpl M, 2011, 5 JOINT TRIENN C EUR; Schimpl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023299; Schwid SR, 1999, NEUROLOGY, V53, P743, DOI 10.1212/WNL.53.4.743; Steens A, 2011, NEUROIMAGE	24	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34744	10.1371/journal.pone.0034744	http://dx.doi.org/10.1371/journal.pone.0034744			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514661	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600067
J	Seber, LE; Barnett, BW; McConnell, EJ; Hume, SD; Cai, J; Boles, K; Davis, KR				Seber, Lauren E.; Barnett, Brian W.; McConnell, Elizabeth J.; Hume, Steven D.; Cai, Jian; Boles, Kati; Davis, Keith R.			Scalable Purification and Characterization of the Anticancer Lunasin Peptide from Soybean	PLOS ONE			English	Article							CORE HISTONE ACETYLATION; AMINO-ACID-SEQUENCE; SEED PEPTIDE; GLYCINE-MAX; CANCER; CELLS; PROTEIN; EXPRESSION; ACTIVATION; INHIBITOR	Lunasin is a peptide derived from the soybean 2S albumin seed protein that has both anticancer and anti-inflammatory activities. Large-scale animal studies and human clinical trials to determine the efficacy of lunasin in vivo have been hampered by the cost of synthetic lunasin and the lack of a method for obtaining gram quantities of highly purified lunasin from plant sources. The goal of this study was to develop a large-scale method to generate highly purified lunasin from defatted soy flour. A scalable method was developed that utilizes the sequential application of anion-exchange chromatography, ultrafiltration, and reversed-phase chromatography. This method generates lunasin preparations of >99% purity with a yield of 442 mg/kg defatted soy flour. Mass spectrometry of the purified lunasin revealed that the peptide is 44 amino acids in length and represents the original published sequence of lunasin with an additional C-terminal asparagine residue. Histone-binding assays demonstrated that the biological activity of the purified lunasin was similar to that of synthetic lunasin. This study provides a robust method for purifying commercial-scale quantities of biologically-active lunasin and clearly identifies the predominant form of lunasin in soy flour. This method will greatly facilitate the development of lunasin as a potential nutraceutical or therapeutic anticancer agent.	[Seber, Lauren E.; Davis, Keith R.] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA; [Seber, Lauren E.; Barnett, Brian W.; McConnell, Elizabeth J.; Boles, Kati; Davis, Keith R.] Owensboro Canc Res Program, Owensboro, KY USA; [Hume, Steven D.] Kentucky BioProc LLC, Owensboro, KY USA; [Cai, Jian; Davis, Keith R.] Univ Louisville, Dept Pharmacol & Toxicol, Louisville, KY 40292 USA	University of Louisville; University of Louisville	Seber, LE (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40292 USA.	keith.davis@louisville.edu	Davis, Keith R/C-5623-2009; Davis, Keith/H-3242-2019	Davis, Keith R/0000-0002-7432-8610; Davis, Keith/0000-0002-7432-8610	Kentucky Soybean Promotion Board; Owensboro Grain Company, LLC; United States Army Medical Research & Materiel Command; Telemedicine & Advanced Technology Research Center [W81XWH-09-2-0022]	Kentucky Soybean Promotion Board; Owensboro Grain Company, LLC; United States Army Medical Research & Materiel Command; Telemedicine & Advanced Technology Research Center	This research and development project was made possible by funds provided by the Kentucky Soybean Promotion Board (www.kysoy.org), Owensboro Grain Company, LLC (www.owensborograin.com), and a contract that was awarded and administered by the United States Army Medical Research & Materiel Command and the Telemedicine & Advanced Technology Research Center (www.tatrc.org/), under Contract Number: W81XWH-09-2-0022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views, opinions and/or findings contained in this research are those of the authors and do not necessarily reflect the views of the Department of Defense and should not be construed as an official Department of Defense/Army position, policy or decision unless so designated by other documentation. No official endorsement should be made.	AMPE C, 1986, EUR J BIOCHEM, V159, P597, DOI 10.1111/j.1432-1033.1986.tb09926.x; de Lumen BO, 2005, NUTR REV, V63, P16, DOI [10.1301/nr.2004.janr.16-21, 10.1111/j.1753-4887.2005.tb00106.x]; De Mejia EG, 2004, J AGR FOOD CHEM, V52, P5882, DOI 10.1021/jf0496752; de Mejia EG, 2009, PEPTIDES, V30, P2388, DOI 10.1016/j.peptides.2009.08.005; de Mejia EG, 2010, MOL NUTR FOOD RES, V54, P406, DOI 10.1002/mnfr.200900073; DEMEJIA E, 2006, SEXUALITY REPROD MEN, V4, P91; Dia VP, 2009, FOOD CHEM, V114, P108, DOI 10.1016/j.foodchem.2008.09.023; Dia VP, 2011, CANCER LETT, V313, P167, DOI 10.1016/j.canlet.2011.09.002; Dia VP, 2011, PEPTIDES, V32, P1979, DOI 10.1016/j.peptides.2011.09.009; Dia VP, 2011, MOL NUTR FOOD RES, V55, P623, DOI 10.1002/mnfr.201000419; Dia VP, 2010, CANCER LETT, V295, P44, DOI 10.1016/j.canlet.2010.02.010; Dia VP, 2008, J AGR FOOD CHEM, V56, P11707, DOI 10.1021/jf802475z; ERICSON ML, 1986, J BIOL CHEM, V261, P4576; Galvez AF, 2001, CANCER RES, V61, P7473; Galvez AF, 1999, NAT BIOTECHNOL, V17, P495, DOI 10.1038/8676; Galvez AF, 2011, NUTR CANCER, V63, P623, DOI 10.1080/01635581.2011.539312; Hernandez-Ledesma B, 2011, MOL NUTR FOOD RES, V55, P989, DOI 10.1002/mnfr.201000632; Hernandez-Ledesma B, 2009, BIOCHEM BIOPH RES CO, V390, P803, DOI 10.1016/j.bbrc.2009.10.053; Hernandez-Ledesma B, 2009, PEPTIDES, V30, P426, DOI 10.1016/j.peptides.2008.11.002; Hsieh CC, 2010, CHEM-BIOL INTERACT, V186, P127, DOI 10.1016/j.cbi.2010.04.027; Hsieh CC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008890; Jeong HJ, 2003, J AGR FOOD CHEM, V51, P7901, DOI 10.1021/jf034460y; Jeong HJ, 2002, J AGR FOOD CHEM, V50, P5903, DOI 10.1021/jf0256945; Jeong HJ, 2007, CANCER LETT, V255, P42, DOI 10.1016/j.canlet.2007.03.022; Jeong HJ, 2007, J AGR FOOD CHEM, V55, P632, DOI 10.1021/jf062405u; Jeong JB, 2007, J AGR FOOD CHEM, V55, P10707, DOI 10.1021/jf072363p; Jeong JB, 2010, CANCER LETT, V293, P58, DOI 10.1016/j.canlet.2009.12.019; KREBBERS E, 1988, PLANT PHYSIOL, V87, P859, DOI 10.1104/pp.87.4.859; Lam Y, 2003, NUTR CANCER, V47, P88, DOI 10.1207/s15327914nc4701_11; Lin J, 2004, BBA-PROTEINS PROTEOM, V1698, P203, DOI 10.1016/j.bbapap.2003.12.001; Maldonado-Cervantes E, 2010, PEPTIDES, V31, P1635, DOI 10.1016/j.peptides.2010.06.014; ODANI S, 1987, J BIOL CHEM, V262, P10502; Omoni AO, 2005, NUTR REV, V63, P272, DOI 10.1111/j.1753-4887.2005.tb00141.x; Silva-Sanchez C, 2008, J AGR FOOD CHEM, V56, P1233, DOI 10.1021/jf072911z; Wang WY, 2008, J AOAC INT, V91, P936	35	40	43	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35409	10.1371/journal.pone.0035409	http://dx.doi.org/10.1371/journal.pone.0035409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514740	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600145
J	Soberg, K; Larsen, ACV; Diskar, M; Backe, PH; Bjoras, M; Jahnsen, T; Laerdahl, JK; Rognes, T; Herberg, FW; Skalhegg, BS				Soberg, Kristoffer; Larsen, Anja C. V.; Diskar, Mandy; Backe, Paul H.; Bjoras, Magnar; Jahnsen, Tore; Laerdahl, Jon K.; Rognes, Torbjorn; Herberg, Friedrich W.; Skalhegg, Bjorn S.			Identification and Characterization of Novel Mutations in the Human Gene Encoding the Catalytic Subunit Calpha of Protein Kinase A (PKA)	PLOS ONE			English	Article							REGULATORY SUBUNIT; SPLICE VARIANTS; C-BETA; HUMAN TESTIS; METAL-IONS; ISOFORM; ALPHA; SPECIFICITY; HOLOENZYMES; INHIBITORS	The genes PRKACA and PRKACB encode the principal catalytic (C) subunits of protein kinase A (PKA) C alpha and C beta, respectively. C alpha is expressed in all eukaryotic tissues examined and studies of C alpha knockout mice demonstrate a crucial role for C alpha in normal physiology. We have sequenced exon 2 through 10 of PRKACA from the genome of 498 Norwegian donors and extracted information about PRKACA mutations from public databases. We identified four interesting nonsynonymous point mutations, Arg45Gln, Ser109Pro, Gly186Val, and Ser263Cys, in the C alpha 1 splice variant of the kinase. C alpha variants harboring the different amino acid mutations were analyzed for kinase activity and regulatory (R) subunit binding. Whereas mutation of residues 45 and 263 did not alter catalytic activity or R subunit binding, mutation of Ser(109) significantly reduced kinase activity while R subunit binding was unaltered. Mutation of C alpha Gly(186) completely abrogated kinase activity and PKA type I but not type II holoenzyme formation. Gly(186) is located in the highly conserved DFG motif of C alpha and mutation of this residue to Val was predicted to result in loss of binding of ATP and Mg2+, which may explain the kinetic inactivity. We hypothesize that individuals born with mutations of Ser(109) or Gly(186) may be faced with abnormal development and possibly severe disease.	[Soberg, Kristoffer; Larsen, Anja C. V.; Skalhegg, Bjorn S.] Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway; [Soberg, Kristoffer; Jahnsen, Tore] Univ Oslo, Dept Biochem, Inst Basic Med Sci, Oslo 3, Norway; [Diskar, Mandy; Herberg, Friedrich W.] Univ Kassel, Dept Biochem, Kassel, Germany; [Backe, Paul H.; Bjoras, Magnar; Laerdahl, Jon K.; Rognes, Torbjorn] Oslo Univ Hosp, Rikshosp, Dept Microbiol, CMBN, Oslo, Norway; [Backe, Paul H.; Bjoras, Magnar] Univ Oslo, Dept Med Biochem, Oslo, Norway; [Laerdahl, Jon K.] Univ Oslo, Dept Informat, Bioinformat Core Facil, N-0316 Oslo, Norway	University of Oslo; University of Oslo; Universitat Kassel; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo	Soberg, K (corresponding author), Univ Oslo, Inst Basic Med Sci, Dept Nutr, Oslo, Norway.	b.s.skalhegg@medisin.uio.no	Skålhegg, Bjørn Steen/AAZ-2976-2021; Bjørås, Magnar/N-9286-2017; Herberg, Friedrich W/B-5572-2015; Rognes, Torbjørn/A-9692-2008	Skålhegg, Bjørn Steen/0000-0002-3481-8084; Herberg, Friedrich W/0000-0001-7117-7653; Rognes, Torbjørn/0000-0002-9329-9974; Laerdahl, Jon Kristen/0000-0002-0826-9464	University of Oslo; Research Council of Norway; Otto Braun Fund (B. Braun Melsungen AG); European Union Affinity Proteome [HEALTH-2007-1.1-4-222635]; Deutsche Forschungsgemeinschaft (DFG) [He1818/6]	University of Oslo; Research Council of Norway(Research Council of Norway); Otto Braun Fund (B. Braun Melsungen AG); European Union Affinity Proteome; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the University of Oslo (K. S., A. C. V. L., T.J., and B. S. S.) and the Research Council of Norway (T. R. and J.K.L.). The Oslo University Hospital, Helse Sor-Ost (M. B. and P. H. B.). M. D. was funded by the Otto Braun Fund (B. Braun Melsungen AG), and F.W.H. was supported by grants from the European Union Affinity Proteome (HEALTH-2007-1.1-4-222635) and the Deutsche Forschungsgemeinschaft (DFG, He1818/6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JA, 1993, PROTEIN SCI, V2, P2177, DOI 10.1002/pro.5560021217; Apweiler R, 2011, NUCLEIC ACIDS RES, V39, pD214, DOI 10.1093/nar/gkq1020; BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; Boikos SA, 2007, HUM MOL GENET, V16, pR80, DOI 10.1093/hmg/ddm019; Colledge M, 1999, TRENDS CELL BIOL, V9, P216, DOI 10.1016/S0962-8924(99)01558-5; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Desseyn JL, 2000, P NATL ACAD SCI USA, V97, P6433, DOI 10.1073/pnas.97.12.6433; Diskar M, 2007, CELL SIGNAL, V19, P2024, DOI 10.1016/j.cellsig.2007.05.012; Dodge K, 2000, FEBS LETT, V476, P58, DOI 10.1016/S0014-5793(00)01671-9; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Funderud A, 2009, CELL SIGNAL, V21, P274, DOI 10.1016/j.cellsig.2008.10.013; Guthrie CR, 1997, J BIOL CHEM, V272, P29560, DOI 10.1074/jbc.272.47.29560; HEIMDAL K, 1995, CANCER EPIDEM BIOMAR, V4, P123; Hemmer W, 1997, ANAL BIOCHEM, V245, P115, DOI 10.1006/abio.1996.9952; Herberg FW, 1997, PROTEIN SCI, V6, P569; HERBERG FW, 1993, BIOCHEMISTRY-US, V32, P14015, DOI 10.1021/bi00213a035; Herberg FW, 1999, BIOCHEMISTRY-US, V38, P6352, DOI 10.1021/bi982672w; Huang YZ, 2002, J BIOL CHEM, V277, P19889, DOI 10.1074/jbc.M111412200; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Khavrutskii IV, 2009, BIOCHEMISTRY-US, V48, P11532, DOI 10.1021/bi901475g; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Kvissel AK, 2004, CELL SIGNAL, V16, P577, DOI 10.1016/j.cellsig.2003.08.014; Larsen ACV, 2008, FEBS J, V275, P250, DOI 10.1111/j.1742-4658.2007.06195.x; Moretti S, 2009, BBA-MOL CELL RES, V1793, P1634, DOI 10.1016/j.bbamcr.2009.09.001; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; OLSEN AO, 1995, INT J CANCER, V61, P312, DOI 10.1002/ijc.2910610306; Orstavik S, 2005, FEBS J, V272, P1559, DOI 10.1111/j.1742-4658.2005.04568.x; Orstavik S, 2001, EUR J BIOCHEM, V268, P5066, DOI 10.1046/j.0014-2956.2001.02429.x; OYEN O, 1989, FEBS LETT, V246, P57, DOI 10.1016/0014-5793(89)80253-4; Prinz A, 2006, CELL SIGNAL, V18, P1616, DOI 10.1016/j.cellsig.2006.01.013; Reinton N, 2000, BIOL REPROD, V63, P607, DOI 10.1095/biolreprod63.2.607; Reinton N, 1998, GENOMICS, V49, P290, DOI 10.1006/geno.1998.5240; Riva A, 2002, BIOINFORMATICS, V18, P1681, DOI 10.1093/bioinformatics/18.12.1681; San Agustin JT, 1998, J BIOL CHEM, V273, P24874, DOI 10.1074/jbc.273.38.24874; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schiebel K, 1997, HUM MOL GENET, V6, P1985, DOI 10.1093/hmg/6.11.1985; Schirrmann T, 2010, ANTIBODY ENGINEERING, VOL 2, SECOND EDITION, P387, DOI 10.1007/978-3-642-01147-4_30; Schrodinger L., 2020, PYMOL; Shaffer J, 1999, BIOCHEMISTRY-US, V38, P5572, DOI 10.1021/bi982768q; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Skalhegg BS, 2000, FRONT BIOSCI-LANDMRK, V5, pD678, DOI 10.2741/Skalhegg; Skalhegg BS, 2002, MOL ENDOCRINOL, V16, P630, DOI 10.1210/me.16.3.630; Solberg R, 1997, ENDOCRINOLOGY, V138, P169, DOI 10.1210/en.138.1.169; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Ten Eyck LF, 2008, BBA-PROTEINS PROTEOM, V1784, P238, DOI 10.1016/j.bbapap.2007.11.002; Thompson EE, 2009, PROTEIN SCI, V18, P2016, DOI 10.1002/pro.209; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; UHLER MD, 1986, J BIOL CHEM, V261, P5360; Vetter MM, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-40; WIEMANN S, 1991, J BIOL CHEM, V266, P5140; WITT JJ, 1975, ANAL BIOCHEM, V66, P253, DOI 10.1016/0003-2697(75)90743-5; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Zimmermann B, 1999, J BIOL CHEM, V274, P5370, DOI 10.1074/jbc.274.9.5370; Zimmermann B, 2008, BIOCHEM J, V413, P93, DOI 10.1042/BJ20071665	59	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34838	10.1371/journal.pone.0034838	http://dx.doi.org/10.1371/journal.pone.0034838			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514673	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600079
J	Wang, CL; Ulloa, M; Mullens, TR; Yu, JZ; Roberts, PA				Wang, Congli; Ulloa, Mauricio; Mullens, Teresa R.; Yu, John Z.; Roberts, Philip A.			QTL Analysis for Transgressive Resistance to Root-Knot Nematode in Interspecific Cotton (Gossypium spp.) Progeny Derived from Susceptible Parents	PLOS ONE			English	Article							HELIANTHUS-PARADOXUS ASTERACEAE; ADULT-PLANT RESISTANCE; F-SP TRITICI; STRIPE RUST; RENIFORM NEMATODE; HIRSUTUM L.; GENE RKN1; SEGREGATION; INHERITANCE; MARKERS	The southern root-knot nematode (RKN, Meloidogyne incognita) is a major soil-inhabiting plant parasite that causes significant yield losses in cotton (Gossypium spp.). Progeny from crosses between cotton genotypes susceptible to RKN produced segregants in subsequent populations which were highly resistant to this parasite. A recombinant inbred line (RIL) population of 138 lines developed from a cross between Upland cotton TM-1 (G. hirsutum L.) and Pima 3-79 (G. barbadense L.), both susceptible to RKN, was used to identify quantitative trait loci (QTLs) determining responses to RKN in greenhouse infection assays with simple sequence repeat (SSR) markers. Compared to both parents, 53.6% and 52.1% of RILs showed less (P<0.05) root-galling index (GI) and had lower (P<0.05) nematode egg production (eggs per gram root, EGR). Highly resistant lines (transgressive segregants) were identified in this RIL population for GI and/or EGR in two greenhouse experiments. QTLs were identified using the single-marker analysis nonparametric mapping Kruskal-Wallis test. Four major QTLs located on chromosomes 3, 4, 11, and 17 were identified to account for 8.0 to 12.3% of the phenotypic variance (R-2) in root-galling. Two major QTLs accounting for 9.7% and 10.6% of EGR variance were identified on chromosomes 14 and 23 (P<0.005), respectively. In addition, 19 putative QTLs (P<0.05) accounted for 4.5-7.7% of phenotypic variance (R-2) in GI, and 15 QTLs accounted for 4.2-7.3% of phenotypic variance in EGR. In lines with alleles positive for resistance contributed by both parents in combinations of two to four QTLs, dramatic reductions of >50% in both GI and EGR were observed. The transgressive segregants with epistatic effects derived from susceptible parents indicate that high levels of nematode resistance in cotton may be attained by pyramiding positive alleles using a QTL mapping approach.	[Wang, Congli; Mullens, Teresa R.; Roberts, Philip A.] Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA; [Ulloa, Mauricio] USDA ARS, Western Integrated Cropping Syst Res Unit, Shafter, CA USA; [Yu, John Z.] USDA ARS, So Plains Agr Res Ctr, College Stn, TX USA	University of California System; University of California Riverside; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Wang, CL (corresponding author), Univ Calif Riverside, Dept Nematol, Riverside, CA 92521 USA.	philip.roberts@ucr.edu			Cotton Incorporated University of California Discovery Grant [08-321, 06-10632]; Cotton Incorporated	Cotton Incorporated University of California Discovery Grant; Cotton Incorporated(Cotton R&D Corp)	Funding provided by Cotton Incorporated (grant # 08-321) University of California Discovery Grant (Grant#06-10632). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Cotton Incorporated through their research grants program designed to address cotton field production problems, funded a portion of the research in this study conducted in the Roberts lab, in a manner typical of other funding agency programs. No other form of support from this funder was provided. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aghnoum R, 2011, J PLANT PHYSIOL, V168, P45, DOI 10.1016/j.jplph.2010.09.005; Bayles MB, 2005, CROP SCI, V45, P2087, DOI 10.2135/cropsci2004.0631; Bell MA, 2005, TRENDS ECOL EVOL, V20, P358, DOI 10.1016/j.tree.2005.04.021; Bezawada C., 2003, Journal of Cotton Science, V7, P179; Bolek Y, 2005, PLANT SCI, V168, P1581, DOI 10.1016/j.plantsci.2005.02.008; BRIDGE J, 1980, TROP PEST MANAGE, V26, P296, DOI 10.1080/09670878009414416; CHERIF M, 1993, PLANT PATHOL, V42, P617, DOI 10.1111/j.1365-3059.1993.tb01542.x; DEVICENTE MC, 1993, GENETICS, V134, P585; Dighe ND, 2009, CROP SCI, V49, P1151, DOI 10.2135/cropsci2008.03.0129; Frelichowski JE, 2006, MOL GENET GENOMICS, V275, P479, DOI 10.1007/s00438-006-0106-z; Goodell P. B., 1994, 1994 Proceedings Beltwide Cotton Conferences, January 5-8, San Diego, CA, USA., P265; Gutierrez OA, 2011, THEOR APPL GENET, V122, P271, DOI 10.1007/s00122-010-1442-2; Gutierrrez OA, 2010, THEOR APPL GENET, V121, P1323, DOI 10.1007/s00122-010-1391-9; HUSSEY RS, 1973, PLANT DIS REP, V57, P1025; Hyer A. H., 1984, P BELTW COTT PROD RE, P377; HYER AH, 1979, CROP SCI, V19, P898, DOI 10.2135/cropsci1979.0011183X001900060036x; Imtiaz M, 2003, NEW ZEAL J CROP HORT, V31, P23, DOI 10.1080/01140671.2003.9514232; Kohel RJ, 2001, EUPHYTICA, V121, P163, DOI 10.1023/A:1012263413418; Lexer C, 2003, EVOLUTION, V57, P1989, DOI 10.1111/j.0014-3820.2003.tb00379.x; Lexer C, 2003, MOL ECOL, V12, P1225, DOI 10.1046/j.1365-294X.2003.01803.x; Navabi A, 2004, CROP SCI, V44, P1156, DOI 10.2135/cropsci2004.1156; Niu C, 2008, THEOR APPL GENET, V117, P1313, DOI 10.1007/s00122-008-0865-5; Park YH, 2005, MOL GENET GENOMICS, V274, P428, DOI 10.1007/s00438-005-0037-0; Rieseberg LH, 2003, PHILOS T R SOC B, V358, P1141, DOI 10.1098/rstb.2003.1283; Rieseberg LH, 1999, HEREDITY, V83, P363, DOI 10.1038/sj.hdy.6886170; Robinson AF, 2007, CROP SCI, V47, P1865, DOI 10.2135/cropsci2006.12.0776; Romano GB, 2009, THEOR APPL GENET, V120, P139, DOI 10.1007/s00122-009-1165-4; Shen XL, 2006, THEOR APPL GENET, V113, P1539, DOI 10.1007/s00122-006-0401-4; Shen XL, 2010, THEOR APPL GENET, V121, P1623, DOI 10.1007/s00122-010-1415-5; SHEPHERD RL, 1974, CROP SCI, V14, P872, DOI 10.2135/cropsci1974.0011183X001400060029x; Staal J, 2006, PLANT J, V46, P218, DOI 10.1111/j.1365-313X.2006.02688.x; TURCOTTE EL, 1963, COTTON IMPROVE C P, V15, P36; Ulloa M., 2007, Technical crops, P1; Ulloa M, 2005, J HERED, V96, P132, DOI 10.1093/jhered/esi020; Ulloa M, 2010, PLANT BREEDING, V129, P541, DOI 10.1111/j.1439-0523.2009.01717.x; Ulloa M, 2008, P WORLD COTT RES C 1; Ulloa M, 2011, MOL GENET GENOMICS, V286, P21, DOI 10.1007/s00438-011-0616-1; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Van Ooijen J. W., 2004, MAPQTL 5 SOFTWARE CA; WALLWORK H, 1984, EUPHYTICA, V33, P123, DOI 10.1007/BF00022758; Wang C, 2006, THEOR APPL GENET, V112, P770, DOI 10.1007/s00122-005-0183-0; Wang C, 2006, J NEMATOL, V38, P250; Wang C, 2006, PHYTOPATHOLOGY, V96, P727, DOI 10.1094/PHYTO-96-0727; Wang CL, 2008, MOL GENET GENOMICS, V279, P41, DOI 10.1007/s00438-007-0292-3; Wang CL, 2006, EUPHYTICA, V152, P185, DOI 10.1007/s10681-006-9197-1; Wang HM, 2008, J INTEGR PLANT BIOL, V50, P174, DOI 10.1111/j.1744-7909.2007.00612.x; Welch ME, 2002, AM J BOT, V89, P472, DOI 10.3732/ajb.89.3.472; Winter SMJ, 2007, THEOR APPL GENET, V114, P461, DOI 10.1007/s00122-006-0446-4; Ynturi P, 2006, CROP SCI, V46, P2670, DOI 10.2135/cropsci2006.05.0319; Zhang ZJ, 2001, PHYTOPATHOLOGY, V91, P680, DOI 10.1094/PHYTO.2001.91.7.680; Zhao G, 2005, CROP SCI, V45, P1441, DOI 10.2135/cropsci2004.0560	51	40	41	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34874	10.1371/journal.pone.0034874	http://dx.doi.org/10.1371/journal.pone.0034874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514682	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600088
J	Falcone, B; Coffman, BA; Clark, VP; Parasuraman, R				Falcone, Brian; Coffman, Brian A.; Clark, Vincent P.; Parasuraman, Raja			Transcranial Direct Current Stimulation Augments Perceptual Sensitivity and 24-Hour Retention in a Complex Threat Detection Task	PLOS ONE			English	Article							ATTENTION; BRAIN; TDCS; MOTION; CORTEX	We have previously shown that transcranial direct current stimulation (tDCS) improved performance of a complex visual perceptual learning task (Clark et al. 2012). However, it is not known whether tDCS can enhance perceptual sensitivity independently of non-specific, arousal-linked changes in response bias, nor whether any such sensitivity benefit can be retained over time. We examined the influence of stimulation of the right inferior frontal cortex using tDCS on perceptual learning and retention in 37 healthy participants, using signal detection theory to distinguish effects on perceptual sensitivity (d') from response bias (beta). Anodal stimulation with 2 mA increased d', compared to a 0.1 mA sham stimulation control, with no effect on beta. On completion of training, participants in the active stimulation group had more than double the perceptual sensitivity of the control group. Furthermore, the performance enhancement was maintained for 24 hours. The results show that tDCS augments both skill acquisition and retention in a complex detection task and that the benefits are rooted in an improvement in sensitivity (d'), rather than changes in response bias (beta). Stimulation-driven acceleration of learning and its retention over 24 hours may result from increased activation of prefrontal cortical regions that provide top-down attentional control signals to object recognition areas.	[Falcone, Brian; Parasuraman, Raja] George Mason Univ, Ctr Excellence Neuroergon Technol & Cognit CENT, Fairfax, VA 22030 USA; [Coffman, Brian A.; Clark, Vincent P.] Univ New Mexico, Mind Res Network & Lovelace Biomed & Environm Res, Albuquerque, NM 87131 USA	George Mason University; Lovelace Respiratory Research Institute; University of New Mexico	Falcone, B (corresponding author), George Mason Univ, Ctr Excellence Neuroergon Technol & Cognit CENT, Fairfax, VA 22030 USA.	rparasur@gmu.edu	Clark, Vincent P/B-3343-2010	Clark, Vincent P/0000-0002-9151-2102	Air Force Office of Sponsored Research [FA9550-10-1-0385]	Air Force Office of Sponsored Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This research was supported by Air Force Office of Sponsored Research grant FA9550-10-1-0385 to Raja Parasuraman. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, NAT NEUROSCI, V5, P1019, DOI 10.1038/nn928; Antal A, 2004, J COGNITIVE NEUROSCI, V16, P521, DOI 10.1162/089892904323057263; Bikson M, 2004, J PHYSIOL-LONDON, V557, P175, DOI 10.1113/jphysiol.2003.055772; Bikson Marom, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1616; Bikson M, 2009, CLIN NEUROPHYSIOL, V120, P1033, DOI 10.1016/j.clinph.2009.03.018; Bolognini N, 2010, BRAIN RES, V1349, P76, DOI 10.1016/j.brainres.2010.06.053; Broadbent D. E., 1971, DECISION STRESS; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Clark VP, 2012, NEUROIMAGE, V59, P117, DOI 10.1016/j.neuroimage.2010.11.036; Clark VP, 2011, NEUROSCI LETT, V500, P67, DOI 10.1016/j.neulet.2011.05.244; Coren S., 1994, SENSATION PERCEPTION; Cotton Incorporated, 2021, COTMAN; Cowan NB, 1988, ATTENTION MEMORY INT; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Dockery CA, 2009, J NEUROSCI, V29, P7271, DOI 10.1523/JNEUROSCI.0065-09.2009; Druckman D, 1998, ENHANCING HUMAN PERF; Farah MJ, 2004, NAT REV NEUROSCI, V5, P421, DOI 10.1038/nrn1390; Goldstone RL, 1998, ANNU REV PSYCHOL, V49, P585, DOI 10.1146/annurev.psych.49.1.585; Green DM, 1966, SIGNAL DETECTION THE; Luber B, 2008, CEREB CORTEX, V18, P2077, DOI 10.1093/cercor/bhm231; MACKWORTH JF, 1965, CAN J PSYCHOLOGY, V19, P104, DOI 10.1037/h0082897; MACMILLAN J, 2005, DARWARS ARCHITECTURE; Macmillan NA, 2005, DETECTION THEORY USE; Merzenich MM, 1996, SCIENCE, V271, P77, DOI 10.1126/science.271.5245.77; NUECHTERLEIN KH, 1983, J ABNORM PSYCHOL, V92, P4, DOI 10.1037/0021-843X.92.1.4; PARASURAMAN R, 1991, J CLIN EXP NEUROPSYC, V13, P789, DOI 10.1080/01688639108401090; Parasuraman R., 1993, NEUROPSYCHOLOGY, V7, P242, DOI DOI 10.1037/0894-4105.7.3.242; Parasuraman R, 2008, NEUROERGONOMICS BRAI, P430; Parasuraman R, 2012, NEUROIMAGE, V59, P1, DOI 10.1016/j.neuroimage.2011.08.011; Parasuraman R, 2009, J EXP PSYCHOL-APPL, V15, P275, DOI 10.1037/a0017132; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Stone DB, 2009, NEUROREPORT, V20, P1115, DOI 10.1097/WNR.0b013e32832e9aa2; Swets J., 1982, EVALUATION DIAGNOSTI; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Thompson J, 2012, NEUROIMAGE, V59, P4, DOI 10.1016/j.neuroimage.2011.05.044; Utz KS, 2010, NEUROPSYCHOLOGIA, V48, P2789, DOI 10.1016/j.neuropsychologia.2010.06.002; Walther D, 2005, COMPUT VIS IMAGE UND, V100, P41, DOI 10.1016/j.cviu.2004.09.004; WARBURTON DM, 1972, PSYCHOPHARMACOLOGIA, V27, P275, DOI 10.1007/BF00422808	38	67	73	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34993	10.1371/journal.pone.0034993	http://dx.doi.org/10.1371/journal.pone.0034993			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511978	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338600064
J	Lamrabet, O; Merhej, V; Pontarotti, P; Raoult, D; Drancourt, M				Lamrabet, Otmane; Merhej, Vicky; Pontarotti, Pierre; Raoult, Didier; Drancourt, Michel			The Genealogic Tree of Mycobacteria Reveals a Long-Standing Sympatric Life into Free-Living Protozoa	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; AMEBAS-RESISTING BACTERIA; ACANTHAMOEBA-CASTELLANII; COCULTURE PROCEDURE; REACTIVE NITROGEN; GIANT VIRUSES; MELTING-POT; TUBERCULOSIS; MICROORGANISMS; EVOLUTION	Free-living protozoa allow horizontal gene transfer with and between the microorganisms that they host. They host mycobacteria for which the sources of transferred genes remain unknown. Using BLASTp, we searched within the genomes of 15 mycobacteria for homologous genes with 34 amoeba-resistant bacteria and the free-living protozoa Dictyostelium discoideum. Subsequent phylogenetic analysis of these sequences revealed that eight mycobacterial open-reading frames (ORFs) were probably acquired via horizontal transfer from beta-and gamma-Proteobacteria and from Firmicutes, but the transfer histories could not be reliably established in details. One further ORF encoding a pyridine nucleotide disulfide oxidoreductase (pyr-redox) placed non-tuberculous mycobacteria in a clade with Legionella spp., Francisella spp., Coxiella burnetii, the ciliate Tetrahymena thermophila and D. discoideum with a high reliability. Co-culturing Mycobacterium avium and Legionella pneumophila with the amoeba Acanthamoeba polyphaga demonstrated that these two bacteria could live together in amoebae for five days, indicating the biological relevance of intra-amoebal transfer of the pyr-redox gene. In conclusion, the results of this study support the hypothesis that protists can serve as a source and a place for gene transfer in mycobacteria.	[Lamrabet, Otmane; Merhej, Vicky; Raoult, Didier; Drancourt, Michel] Aix Marseille Univ, URMITE CNRS IRD UMR 6236, IFR48, Marseille, France; [Pontarotti, Pierre] Aix Marseille Univ, CNRS, Equipe Evolut Biol & Modelisat UMR 6632, IRF48, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Lamrabet, O (corresponding author), Aix Marseille Univ, URMITE CNRS IRD UMR 6236, IFR48, Marseille, France.	Michel.Drancourt@univmed.fr	, pontarotti/ABB-1753-2021; RAOULT, Didier/A-8434-2008; Merhej, Vicky/J-4733-2015	RAOULT, Didier/0000-0002-0633-5974; Pierre, Pontarotti/0000-0001-7202-3648; merhej, vicky/0000-0002-8688-6943; Lamrabet, Otmane/0000-0002-7015-1942				Adekambi T, 2006, APPL ENVIRON MICROB, V72, P5974, DOI 10.1128/AEM.03075-05; Ahmed N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000968; Audic S, 2007, PLOS GENET, V3, P1454, DOI 10.1371/journal.pgen.0030138; BARKER J, 1994, MICROBIOL-UK, V140, P1253, DOI 10.1099/00221287-140-6-1253; Becq J, 2007, MOL BIOL EVOL, V24, P1861, DOI 10.1093/molbev/msm111; Ben Salah I, 2009, CLIN MICROBIOL INFEC, V15, P894; Ben Salah I, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-99; Boyer M, 2011, P NATL ACAD SCI USA, V108, P10296, DOI 10.1073/pnas.1101118108; Boyer M, 2009, P NATL ACAD SCI USA, V106, P21848, DOI 10.1073/pnas.0911354106; Brandl MT, 2005, APPL ENVIRON MICROB, V71, P1562, DOI 10.1128/AEM.71.3.1562-1569.2005; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Chrisman CJ, 2010, APPL ENVIRON MICROB, V76, P6056, DOI 10.1128/AEM.00812-10; Coros A, 2008, J BACTERIOL, V190, P3408, DOI 10.1128/JB.00009-08; Da Lage JL, 2004, CELL MOL LIFE SCI, V61, P97, DOI 10.1007/s00018-003-3334-y; Devillard E, 1999, FEMS MICROBIOL LETT, V181, P145, DOI 10.1111/j.1574-6968.1999.tb08837.x; Fabrino DL, 2009, MICROBES INFECT, V11, P868, DOI 10.1016/j.micinf.2009.05.007; Faguy DM, 2000, TRENDS GENET, V16, P196, DOI 10.1016/S0168-9525(00)02007-2; Gamieldien J, 2002, TRENDS GENET, V18, P5, DOI 10.1016/S0168-9525(01)02529-X; Garcia-Vallve S, 2000, MOL BIOL EVOL, V17, P352, DOI 10.1093/oxfordjournals.molbev.a026315; Ghigo E, 2009, ANN NY ACAD SCI, V1166, P55, DOI 10.1111/j.1749-6632.2009.04515.x; Greub G, 2004, CLIN MICROBIOL REV, V17, P413, DOI 10.1128/CMR.17.2.413-433.2004; Greub G, 2004, EMERG INFECT DIS, V10, P470, DOI 10.3201/eid1003.020792; Greub G, 2002, APPL ENVIRON MICROB, V68, P3076, DOI 10.1128/AEM.68.6.3076-3084.2002; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Hotopp JCD, 2011, TRENDS GENET, V27, P157, DOI 10.1016/j.tig.2011.01.005; Kinsella RJ, 2003, P NATL ACAD SCI USA, V100, P10320, DOI 10.1073/pnas.1737230100; La Scola B, 2001, J CLIN MICROBIOL, V39, P365, DOI 10.1128/JCM.39.1.365-366.2001; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lurie-Weinberger MN, 2010, INT J MED MICROBIOL, V300, P470, DOI 10.1016/j.ijmm.2010.04.016; Marri PR, 2006, CAN J MICROBIOL, V52, P560, DOI 10.1139/W06-001; Medie FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020499; Miltner EC, 2000, ANTIMICROB AGENTS CH, V44, P1990, DOI 10.1128/AAC.44.7.1990-1994.2000; Moliner C, 2010, FEMS MICROBIOL REV, V34, P281, DOI [10.1111/j.1574-6976.2009.00209.x, 10.1111/j.1574-6976.2010.00209.x]; Moliner Claire, 2009, BMC Res Notes, V2, P51, DOI 10.1186/1756-0500-2-51; MORAN NA, 1993, P ROY SOC B-BIOL SCI, V253, P167, DOI 10.1098/rspb.1993.0098; Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12; Ogata H, 2006, PLOS GENET, V2, P733, DOI 10.1371/journal.pgen.0020076; Pagnier I, 2008, ENVIRON MICROBIOL, V10, P1135, DOI 10.1111/j.1462-2920.2007.01530.x; Pagnier I, 2009, FUTURE MICROBIOL, V4, P615, DOI 10.2217/FMB.09.25; Raoult D, 2010, INTERVIROLOGY, V53, P321, DOI 10.1159/000312917; Raoult D, 2010, LANCET, V375, P104, DOI 10.1016/S0140-6736(09)61958-9; Ricard G, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-22; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROWBOTHAM TJ, 1983, J CLIN PATHOL, V36, P978, DOI 10.1136/jcp.36.9.978; Saisongkorh W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012666; Schmitz-Esser S, 2010, J BACTERIOL, V192, P1045, DOI 10.1128/JB.01379-09; Snelling WJ, 2006, ARCH MICROBIOL, V186, P31, DOI 10.1007/s00203-006-0119-3; Stahl C, 2001, MOL MICROBIOL, V40, P451, DOI 10.1046/j.1365-2958.2001.02394.x; Steinert M, 2005, CELL MICROBIOL, V7, P307, DOI 10.1111/j.1462-5822.2005.00493.x; Taylor SJ, 2003, APPL ENVIRON MICROB, V69, P4316, DOI 10.1128/AEM.69.7.4316-4319.2003; Thomas V, 2008, ENVIRON MICROBIOL, V10, P2728, DOI 10.1111/j.1462-2920.2008.01693.x; Thomas V, 2010, INTERVIROLOGY, V53, P254, DOI 10.1159/000312910; Thomas V, 2010, FEMS MICROBIOL REV, V34, P231, DOI 10.1111/j.1574-6976.2009.00190.x; Ung KSE, 2006, FEBS LETT, V580, P2712, DOI 10.1016/j.febslet.2006.04.026; Vaerewijck MJM, 2010, J APPL MICROBIOL, V109, P1566, DOI 10.1111/j.1365-2672.2010.04783.x; Venketaraman V, 2005, INFECT IMMUN, V73, P1886, DOI 10.1128/IAI.73.3.1886-1889.2005; Veyrier F, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-196; Zahrt TC, 2002, ANTIOXID REDOX SIGN, V4, P141, DOI 10.1089/152308602753625924; ZHANG Y, 1991, MOL MICROBIOL, V5, P381, DOI 10.1111/j.1365-2958.1991.tb02120.x	63	23	23	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34754	10.1371/journal.pone.0034754	http://dx.doi.org/10.1371/journal.pone.0034754			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511965	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600051
J	Appaix, F; Girod, S; Boisseau, S; Romer, J; Vial, JC; Albrieux, M; Maurin, M; Depaulis, A; Guillemain, I; van der Sanden, B				Appaix, Florence; Girod, Sabine; Boisseau, Sylvie; Roemer, Johannes; Vial, Jean-Claude; Albrieux, Mireille; Maurin, Mathieu; Depaulis, Antoine; Guillemain, Isabelle; van der Sanden, Boudewijn			Specific In Vivo Staining of Astrocytes in the Whole Brain after Intravenous Injection of Sulforhodamine Dyes	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; MOUSE NEOCORTEX; NETWORKS; MECHANISMS; DISEASE; GLIA	Fluorescent staining of astrocytes without damaging or interfering with normal brain functions is essential for intravital microscopy studies. Current methods involved either transgenic mice or local intracerebral injection of sulforhodamine 101. Transgenic rat models rarely exist, and in mice, a backcross with GFAP transgenic mice may be difficult. Local injections of fluorescent dyes are invasive. Here, we propose a non-invasive, specific and ubiquitous method to stain astrocytes in vivo. This method is based on iv injection of sulforhodamine dyes and is applicable on rats and mice from postnatal age to adulthood. The astrocytes staining obtained after iv injection was maintained for nearly half a day and showed no adverse reaction on astrocytic calcium signals or electroencephalographic recordings in vivo. The high contrast of the staining facilitates the image processing and allows to quantify 3D morphological parameters of the astrocytes and to characterize their network. Our method may become a reference for in vivo staining of the whole astrocytes population in animal models of neurological disorders.	[Appaix, Florence; Girod, Sabine; Boisseau, Sylvie; Roemer, Johannes; Albrieux, Mireille; Maurin, Mathieu; Depaulis, Antoine; Guillemain, Isabelle; van der Sanden, Boudewijn] INSERM, U836, Grenoble Inst Neurosci, Grenoble, France; [Appaix, Florence; Girod, Sabine; Boisseau, Sylvie; Roemer, Johannes; Vial, Jean-Claude; Albrieux, Mireille; Maurin, Mathieu; Depaulis, Antoine; Guillemain, Isabelle; van der Sanden, Boudewijn] Univ Grenoble 1, Grenoble, France; [Vial, Jean-Claude] CNRS, UMR 5588, Lab Interdisciplinaire Phys, St Martin Dheres, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Appaix, F (corresponding author), INSERM, U836, Grenoble Inst Neurosci, Grenoble, France.	florence.appaix@ujf-grenoble.fr	Albrieux, Mireille/H-3824-2017; Girod, Sabine/H-7835-2019; Depaulis, Antoine/B-6098-2012	Albrieux, Mireille/0000-0002-2817-2563; Girod, Sabine/0000-0002-6974-6076; Depaulis, Antoine/0000-0001-6543-6700; Vial, Jean-Claude/0000-0003-2658-4270; van der Sanden, Boudewijn/0000-0001-9444-2499	Inserm; Fondation Francaise pour la Recherche en Epilepsie (FFRE); Agence Nationale pour la Recherche (ANR) [P008407]; Contrat de projets Etat-region (CPER); Ministere de la Recherche et de l'Enseignement superieur	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Fondation Francaise pour la Recherche en Epilepsie (FFRE); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Contrat de projets Etat-region (CPER); Ministere de la Recherche et de l'Enseignement superieur	This work was supported by Inserm and grants from Fondation Francaise pour la Recherche en Epilepsie (FFRE), Agence Nationale pour la Recherche (ANR : programme "Maladie Neurologique, Maladie Psychiatrique" grant # P008407 - GliEpi) and Contrat de projets Etat-region (CPER). Sabine Girod received a PhD fellowship from the Ministere de la Recherche et de l'Enseignement superieur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Albota MA, 1998, APPL OPTICS, V37, P7352, DOI 10.1364/AO.37.007352; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Chia TH, 2009, J NEUROPHYSIOL, V102, P1310, DOI 10.1152/jn.91208.2008; Danober L, 1998, PROG NEUROBIOL, V55, P27, DOI 10.1016/S0301-0082(97)00091-9; Doube M, 2010, BONE; Emsley JG, 2006, NEURON GLIA BIOL, V2, P175, DOI 10.1017/S1740925X06000202; European Commission SCCP, 2008, OP AC RED 52; Giaume C, 2010, NAT REV NEUROSCI, V11, P87, DOI 10.1038/nrn2757; Girouard H, 2010, P NATL ACAD SCI USA, V107, P3811, DOI 10.1073/pnas.0914722107; Haydon PG, 2006, PHYSIOL REV, V86, P1009, DOI 10.1152/physrev.00049.2005; Heinrich C, 2006, J NEUROSCI, V26, P4701, DOI 10.1523/JNEUROSCI.5516-05.2006; Helmchen F, 2008, METHOD ENZYMOL, V444, P231, DOI 10.1016/S0076-6879(08)02810-3; Hirase H, 2004, PLOS BIOL, V2, P494, DOI 10.1371/journal.pbio.0020096; Hirrlinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004286; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Kang J, 2010, NEUROSCIENCE; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Komitova M, 2011, GLIA, V59, P800, DOI 10.1002/glia.21152; Konishi N, 1992, J TOXICOL PATHOL, V5, P157; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Mank M, 2008, NAT METHODS, V5, P805, DOI 10.1038/NMETH.1243; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; McCaslin AFH, 2011, J CEREBR BLOOD F MET, V31, P795, DOI 10.1038/jcbfm.2010.204; Mishima T, 2010, J NEUROSCI, V30, P3093, DOI 10.1523/JNEUROSCI.5065-09.2010; Mulligan SJ, 2004, NATURE, V431, P195, DOI 10.1038/nature02827; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Ogata K, 2002, NEUROSCIENCE, V113, P221, DOI 10.1016/S0306-4522(02)00041-6; Peng HC, 2010, NAT BIOTECHNOL, V28, P348, DOI 10.1038/nbt.1612; Platel JC, 2007, EUR J NEUROSCI, V25, P920, DOI 10.1111/j.1460-9568.2007.05367.x; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rasband W., 2006, IMAGEJ; Riban V, 2002, NEUROSCIENCE, V112, P101, DOI 10.1016/S0306-4522(02)00064-7; Risher WC, 2009, GLIA, V57, P207, DOI 10.1002/glia.20747; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Seifert G, 2006, NAT REV NEUROSCI, V7, P194, DOI 10.1038/nrn1870; Simard M, 2003, J NEUROSCI, V23, P9254; Sloan HL, 2010, NEUROIMAGE, V53, P399, DOI 10.1016/j.neuroimage.2010.07.014; Takata N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002525; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tian GF, 2005, NAT MED, V11, P973, DOI 10.1038/nm1277; Verant P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3041163; Verkhratsky A, 2006, J CELL MOL MED, V10, P826, DOI 10.1111/j.1582-4934.2006.tb00527.x; Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015; Wolburg H, 2005, NEUROGLIA, V2, P19, DOI [10.1093/acprof:oso/9780195152227.001.0001/acprof-9780195152227-chapter-2, DOI 10.1093/ACPROF:OSO/9780195152227.003]; Woodruff-Pak DS, 2008, J ALZHEIMERS DIS, V15, P507; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Zipfel WR, 2003, NAT BIOTECHNOL, V21, P1368, DOI 10.1038/nbt899	51	49	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35169	10.1371/journal.pone.0035169	http://dx.doi.org/10.1371/journal.pone.0035169			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509398	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336600091
J	Henn, BM; Hon, L; Macpherson, JM; Eriksson, N; Saxonov, S; Pe'er, I; Mountain, JL				Henn, Brenna M.; Hon, Lawrence; Macpherson, J. Michael; Eriksson, Nick; Saxonov, Serge; Pe'er, Itsik; Mountain, Joanna L.			Cryptic Distant Relatives Are Common in Both Isolated and Cosmopolitan Genetic Samples	PLOS ONE			English	Article							HISTORY; ASSOCIATION; INFERENCE; ANCESTRY; PAIRS	Although a few hundred single nucleotide polymorphisms (SNPs) suffice to infer close familial relationships, high density genome-wide SNP data make possible the inference of more distant relationships such as 2nd to 9th cousinships. In order to characterize the relationship between genetic similarity and degree of kinship given a timeframe of 100-300 years, we analyzed the sharing of DNA inferred to be identical by descent (IBD) in a subset of individuals from the 23andMe customer database (n = 22,757) and from the Human Genome Diversity Panel (HGDP-CEPH, n = 952). With data from 121 populations, we show that the average amount of DNA shared IBD in most ethnolinguistically-defined populations, for example Native American groups, Finns and Ashkenazi Jews, differs from continentally-defined populations by several orders of magnitude. Via extensive pedigree-based simulations, we determined bounds for predicted degrees of relationship given the amount of genomic IBD sharing in both endogamous and 'unrelated' population samples. Using these bounds as a guide, we detected tens of thousands of 2nd to 9th degree cousin pairs within a heterogenous set of 5,000 Europeans. The ubiquity of distant relatives, detected via IBD segments, in both ethnolinguistic populations and in large 'unrelated' populations samples has important implications for genetic genealogy, forensics and genotype/phenotype mapping studies.	[Henn, Brenna M.; Hon, Lawrence; Macpherson, J. Michael; Eriksson, Nick; Saxonov, Serge; Mountain, Joanna L.] 23andMe Inc, Mountain View, CA USA; [Henn, Brenna M.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Pe'er, Itsik] Columbia Univ, Dept Comp Sci, New York, NY 10027 USA	Stanford University; Columbia University	Henn, BM (corresponding author), 23andMe Inc, Mountain View, CA USA.	bmhenn@stanford.edu; joanna@23andme.com		Henn, Brenna/0000-0003-4998-287X	23andMe, Inc.	23andMe, Inc.	BMH, LH, JMM, NE, SS, and JLM are or were previously employed by 23andMe and own stock options in the company. The research described in this paper is related to a web site feature developed by 23andMe. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. However, the authors' obligations to protect their customers' privacy (as outlined in our Terms of Service and Privacy Statement) prevent them from making their customers' individual-level data publicly available. Aggregate-level data (for example, in the form of tables that were used for the authors' statistics) can be made available upon request. This research was designed by the 23andMe, Inc. research team and funded by 23andMe, Inc. (www.23andme.com/research). There are no current external funding sources for this study. 23andMe, Inc. non-research staff had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen A, 2009, GENET EPIDEMIOL, V33, P266, DOI 10.1002/gepi.20378; Alkuraya FS, 2010, GENET MED, V12, P236, DOI 10.1097/GIM.0b013e3181ceb95d; Atzmon G, 2010, AM J HUM GENET, V86, P850, DOI 10.1016/j.ajhg.2010.04.015; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Behar DM, 2006, AM J HUM GENET, V78, P487, DOI 10.1086/500307; Bodmer W, 1971, GENETICS HUMAN POPUL; Browning BL, 2011, AM J HUM GENET, V88, P173, DOI 10.1016/j.ajhg.2011.01.010; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Browning SR, 2010, AM J HUM GENET, V86, P526, DOI 10.1016/j.ajhg.2010.02.021; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Derrida B, 2000, PHYSICA A, V281, P1, DOI 10.1016/S0378-4371(00)00031-5; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gignoux CR, 2011, P NATL ACAD SCI USA, V108, P6044, DOI 10.1073/pnas.0914274108; Gusev A, 2009, GENOME RES, V19, P318, DOI 10.1101/gr.081398.108; Henn BM, 2010, HUM MOL GENET, V19, pR221, DOI 10.1093/hmg/ddq403; Hudson R.R., 1990, OXF SURV EVOL BIOL, V7, P44; Huff CD, 2011, GENOME RES, V21, P768, DOI 10.1101/gr.115972.110; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; Kitchen A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001596; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Leibon G, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1340; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Macpherson J. Michael, 2004, Human Genomics, V1, P345; Malecot G., 1948, MATH HEREDITE; McEvoy BP, 2009, GENOME RES, V19, P804, DOI 10.1101/gr.083394.108; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Moltke I, 2011, GENOME RES, V21, P1168, DOI 10.1101/gr.115360.110; Mountain Joanna L., 2005, Human Genomics, V2, P4; Nalls MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000415; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; O'Dushlaine C, 2010, EUR J HUM GENET, V18, P1269, DOI 10.1038/ejhg.2010.92; Price AL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000505; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Rohde DLT, 2004, NATURE, V431, P562, DOI 10.1038/nature02842; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2002, NAT REV GENET, V3, P380, DOI 10.1038/nrg795; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Slatkin M, 2004, AM J HUM GENET, V75, P282, DOI 10.1086/423146; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; U.S. Census Bureau, 2007, 3 US CENS BUR, P3; Wang S, 2007, PLOS GENET, V3, P2049, DOI 10.1371/journal.pgen.0030185; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Zlojutro M, 2009, AM J PHYS ANTHROPOL, V139, P474, DOI 10.1002/ajpa.21003	45	101	104	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34267	10.1371/journal.pone.0034267	http://dx.doi.org/10.1371/journal.pone.0034267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509285	gold, Green Submitted, Green Published			2022-12-27	WOS:000304805900022
J	Tundo, G; Ciaccio, C; Sbardella, D; Boraso, M; Viviani, B; Coletta, M; Marini, S				Tundo, Grazia; Ciaccio, Chiara; Sbardella, Diego; Boraso, Mariaserena; Viviani, Barbara; Coletta, Massimiliano; Marini, Stefano			Somatostatin Modulates Insulin-Degrading-Enzyme Metabolism: Implications for the Regulation of Microglia Activity in AD	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; HAPLOTYPE BLOCK; BETA; PROTEIN; BRAIN; LOCALIZATION; ASSOCIATION; DEGRADATION; ACTIVATION; THERAPY	The deposition of beta-amyloid (A beta) into senile plaques and the impairment of somatostatin-mediated neurotransmission are key pathological events in the onset of Alzheimer's disease (AD). Insulin-degrading-enzyme (IDE) is one of the main extracellular protease targeting A beta, and thus it represents an interesting pharmacological target for AD therapy. We show that the active form of somatostatin-14 regulates IDE activity by affecting its expression and secretion in microglia cells. A similar effect can also be observed when adding octreotide. Following a previous observation where somatostatin directly interacts with IDE, here we demonstrate that somatostatin regulates A beta catabolism by modulating IDE proteolytic activity in IDE gene-silencing experiments. As a whole, these data indicate the relevant role played by somatostatin and, potentially, by analogue octreotide, in preventing Ab accumulation by partially restoring IDE activity.	[Tundo, Grazia; Ciaccio, Chiara; Sbardella, Diego; Coletta, Massimiliano; Marini, Stefano] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Rome, Italy; [Sbardella, Diego; Coletta, Massimiliano] Interuniv Consortium Res Chem Met Biol Syst, Bari, Italy; [Boraso, Mariaserena; Viviani, Barbara] Univ Milan, Dept Pharmacol Sci, Milan, Italy	University of Rome Tor Vergata; University of Milan	Tundo, G (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, Rome, Italy.	Stefano.marini@uniroma2.it	Sbardella, Diego/K-7519-2016; Sbardella, Diego/N-9187-2015; Coletta, Massimo/N-9049-2015; Coletta, Massimiliano/GSN-5927-2022; Marini, Stefano/B-1161-2012	Sbardella, Diego/0000-0002-9924-7761; Marini, Stefano/0000-0003-1299-6696; COLETTA, Massimiliano/0000-0002-5489-9467; Viviani, Barbara/0000-0002-0935-0459; TUNDO, Grazia Raffaella/0000-0002-3866-3171	Italian MIUR [FIRB RBNE03PX83]	Italian MIUR(Ministry of Education, Universities and Research (MIUR))	The study received financial support from the Italian MIUR (FIRB RBNE03PX83 to M.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFHOLTER JA, 1990, MOL ENDOCRINOL, V4, P1125, DOI 10.1210/mend-4-8-1125; Backstrom JR, 1996, J NEUROSCI, V16, P7910; BAUER W, 1982, LIFE SCI, V31, P1133, DOI 10.1016/0024-3205(82)90087-X; Bernstein HG, 1999, NEUROSCI LETT, V263, P161, DOI 10.1016/S0304-3940(99)00135-4; BETHGE N, 1981, HORM METAB RES, V13, P709, DOI 10.1055/s-2007-1019383; Bitting L, 1996, J BIOL CHEM, V271, P16084, DOI 10.1074/jbc.271.27.16084; Bjork BF, 2007, NEUROBIOL AGING, V28, P1374, DOI 10.1016/j.neurobiolaging.2006.06.017; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cervia D, 2007, PHARMACOL THERAPEUT, V116, P322, DOI 10.1016/j.pharmthera.2007.06.010; Ciaccio C, 2009, J MOL BIOL, V385, P1556, DOI 10.1016/j.jmb.2008.11.025; Cook DG, 2003, AM J PATHOL, V162, P313, DOI 10.1016/S0002-9440(10)63822-9; Craft S, 1999, ARCH GEN PSYCHIAT, V56, P1135, DOI 10.1001/archpsyc.56.12.1135; Crouch PJ, 2008, INT J BIOCHEM CELL B, V40, P181, DOI 10.1016/j.biocel.2007.07.013; Davis KL, 1999, ARCH GEN PSYCHIAT, V56, P981, DOI 10.1001/archpsyc.56.11.981; Doggrell SA, 2004, EXPERT OPIN INV DRUG, V13, P69, DOI 10.1517/13543784.13.1.69; Doraiswamy PM, 2006, EXPERT OPIN PHARMACO, V7, P1, DOI 10.1517/14656566.7.1.1; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Ertekin-Taner N, 2004, HUM MUTAT, V23, P334, DOI 10.1002/humu.20016; ESPINOSA R, 1991, CYTOGENET CELL GENET, V57, P184, DOI 10.1159/000133142; Evin G, 2002, PEPTIDES, V23, P1285, DOI 10.1016/S0196-9781(02)00063-3; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; FEINDT J, 1995, J NEUROCHEM, V65, P1997; Feindt J, 1998, MOL BRAIN RES, V60, P228, DOI 10.1016/S0169-328X(98)00184-3; Feuk L, 2005, AM J MED GENET B, V136B, P69, DOI 10.1002/ajmg.b.30172; Fleisher-Berkovich S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-61; Hickman SE, 2008, J NEUROSCI, V28, P8354, DOI 10.1523/JNEUROSCI.0616-08.2008; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Lamberts SWJ, 1996, NEW ENGL J MED, V334, P246, DOI 10.1056/NEJM199601253340408; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; MOURADIAN MM, 1991, ANN NEUROL, V30, P610, DOI 10.1002/ana.410300415; Nilsson CL, 2001, PEPTIDES, V22, P2105, DOI 10.1016/S0196-9781(01)00571-X; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Shie FS, 2007, CURR MED CHEM, V14, P2865, DOI 10.2174/092986707782359981; Tokita K, 2005, EUR J PHARMACOL, V527, P111, DOI 10.1016/j.ejphar.2005.10.022; Van Uden E, 1999, NEUROSCIENCE, V88, P687, DOI 10.1016/S0306-4522(98)00272-3; Walker DG, 2006, J LEUKOCYTE BIOL, V79, P596, DOI 10.1189/jlb.0705377; Wang DS, 2006, J BIOMED BIOTECHNOL, V3, P1; Watson GS, 2009, J ALZHEIMERS DIS, V18, P595, DOI 10.3233/JAD-2009-1165; Yan P, 2006, J BIOL CHEM, V281, P24566, DOI 10.1074/jbc.M602440200; Zhao LX, 2004, J NEUROSCI, V24, P11120, DOI 10.1523/JNEUROSCI.2860-04.2004	43	32	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34376	10.1371/journal.pone.0034376	http://dx.doi.org/10.1371/journal.pone.0034376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509294	gold, Green Published, Green Submitted			2022-12-27	WOS:000304805900027
J	Benton, M; Macartney-Coxson, D; Eccles, D; Griffiths, L; Chambers, G; Lea, R				Benton, Miles; Macartney-Coxson, Donia; Eccles, David; Griffiths, Lyn; Chambers, Geoff; Lea, Rod			Complete Mitochondrial Genome Sequencing Reveals Novel Haplotypes in a Polynesian Population	PLOS ONE			English	Article							DNA VARIANT; HUMAN MTDNA; EVOLUTIONARY HISTORY; DIABETES-MELLITUS; POLYMORPHISMS; SELECTION; SUSCEPTIBILITY; MICRONESIANS; ASSOCIATION; PREVALENCE	The high risk of metabolic disease traits in Polynesians may be partly explained by elevated prevalence of genetic variants involved in energy metabolism. The genetics of Polynesian populations has been shaped by island hoping migration events which have possibly favoured thrifty genes. The aim of this study was to sequence the mitochondrial genome in a group of Maoris in an effort to characterise genome variation in this Polynesian population for use in future disease association studies. We sequenced the complete mitochondrial genomes of 20 non-admixed Maori subjects using Affymetrix technology. DNA diversity analyses showed the Maori group exhibited reduced mitochondrial genome diversity compared to other worldwide populations, which is consistent with historical bottleneck and founder effects. Global phylogenetic analysis positioned these Maori subjects specifically within mitochondrial haplogroup - B4a1a1. Interestingly, we identified several novel variants that collectively form new and unique Maori motifs - B4a1a1c, B4a1a1a3 and B4a1a1a5. Compared to ancestral populations we observed an increased frequency of non-synonymous coding variants of several mitochondrial genes in the Maori group, which may be a result of positive selection and/or genetic drift effects. In conclusion, this study reports the first complete mitochondrial genome sequence data for a Maori population. Overall, these new data reveal novel mitochondrial genome signatures in this Polynesian population and enhance the phylogenetic picture of maternal ancestry in Oceania. The increased frequency of several mitochondrial coding variants makes them good candidates for future studies aimed at assessment of metabolic disease risk in Polynesian populations.	[Benton, Miles; Eccles, David; Chambers, Geoff] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Macartney-Coxson, Donia; Eccles, David; Lea, Rod] Kenepuru Sci Ctr, Inst Environm Sci & Res, Sandringham, New Zealand; [Benton, Miles; Griffiths, Lyn; Lea, Rod] Griffith Univ, Griffith Hlth Inst, Genom Res Ctr, Nathan, Qld 4111, Australia	Victoria University Wellington; Griffith University; Menzies Health Institute Queensland	Benton, M (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.	r.lea@griffith.edu.au		Chambers, Geoffrey/0000-0003-1019-6855; Benton, Miles/0000-0003-3442-965X; Lea, Rodney/0000-0002-1148-5862; Griffiths, Lyn/0000-0002-6774-5475; Macartney-Coxson, Donia/0000-0002-1051-537X	Wellington Health Research Council [1387]	Wellington Health Research Council	This research was funded by the Wellington Health Research Council Grant #1387. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bellwood P, 2011, INVESTIGATING ARCHAEOLOGICAL CULTURES: MATERIAL CULTURE, VARIABILITY, AND TRANSMISSION, P321, DOI 10.1007/978-1-4419-6970-5_16; Bhat A, 2007, HUM GENET, V120, P821, DOI 10.1007/s00439-006-0272-4; Chinnery PF, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.048876; DOWSE GK, 1991, AM J EPIDEMIOL, V133, P1093, DOI 10.1093/oxfordjournals.aje.a115822; Eltsov N, 2009, MTPHYL SOFTWARE TOOL; Guo LJ, 2005, MITOCHONDRION, V5, P15, DOI 10.1016/j.mito.2004.09.001; HAGELBERG E, 1993, P ROY SOC B-BIOL SCI, V252, P163, DOI 10.1098/rspb.1993.0061; HERTZBERG M, 1989, AM J HUM GENET, V44, P504; Ingman M, 2001, J HERED, V92, P454, DOI 10.1093/jhered/92.6.454; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Kim JH, 2002, DIABETIC MED, V19, P681, DOI 10.1046/j.1464-5491.2002.00747.x; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lea RA, 2007, PHARMACOGENETICS ADM; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liou CW, 2007, J CLIN ENDOCR METAB, V92, P235, DOI 10.1210/jc.2006-0653; Lum JK, 2000, AM J PHYS ANTHROPOL, V113, P151; Lum JK, 1998, AM J PHYS ANTHROPOL, V105, P109, DOI 10.1002/(SICI)1096-8644(199802)105:2<109::AID-AJPA1>3.0.CO;2-Q; LUM JK, 1994, HUM BIOL, V66, P567; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Maechler P, 2006, BIOCHEM SOC T, V34, P824, DOI 10.1042/BST0340824; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; MELTON T, 1995, AM J HUM GENET, V57, P403; Merriwether DA, 2005, P NATL ACAD SCI USA, V102, P13034, DOI 10.1073/pnas.0506195102; Ministry of Health, 2008, PORTR HLTH KEY RES 2; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4; Moilanen JS, 2003, MOL BIOL EVOL, V20, P2132, DOI 10.1093/molbev/msg230; Murray-McIntosh RP, 1998, P NATL ACAD SCI USA, V95, P9047, DOI 10.1073/pnas.95.15.9047; NEEL JV, 1962, AM J HUM GENET, V14, P353; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Pierson MJ, 2006, DECIPHERING HUMAN PO; Poulton J, 1998, DIABETOLOGIA, V41, P54, DOI 10.1007/s001250050866; Poulton J, 2002, DIABETIC MED, V19, P969, DOI 10.1046/j.0742-3071.2002.00836.x; REDD AJ, 1995, MOL BIOL EVOL, V12, P604; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Soares Pedro, 2011, Am J Hum Genet, V88, P239, DOI 10.1016/j.ajhg.2011.01.009; SYKES B, 1995, AM J HUM GENET, V57, P1463; Tabbada KA, 2010, MOL BIOL EVOL, V27, P21, DOI 10.1093/molbev/msp215; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Trejaut JA, 2005, PLOS BIOL, V3, P1; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Whyte ALH, 2005, HUM BIOL, V77, P157, DOI 10.1353/hub.2005.0045; Yang TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021595; ZIMMET P, 1990, DIABETES METAB REV, V6, P91, DOI 10.1002/dmr.5610060203; ZIMMET P, 1977, DIABETOLOGIA, V13, P111, DOI 10.1007/BF00745137	52	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35026	10.1371/journal.pone.0035026	http://dx.doi.org/10.1371/journal.pone.0035026			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514703	Green Published, gold			2022-12-27	WOS:000305341600109
J	Faix, DJ; Hawksworth, AW; Myers, CA; Hansen, CJ; Ortiguerra, RG; Halpin, R; Wentworth, D; Pacha, LA; Schwartz, EG; Garcia, SMS; Eick-Cost, AA; Clagett, CD; Khurana, S; Golding, H; Blair, PJ				Faix, Dennis J.; Hawksworth, Anthony W.; Myers, Christopher A.; Hansen, Christian J.; Ortiguerra, Ryan G.; Halpin, Rebecca; Wentworth, David; Pacha, Laura A.; Schwartz, Erica G.; Garcia, Shawn M. S.; Eick-Cost, Angelia A.; Clagett, Christopher D.; Khurana, Surender; Golding, Hana; Blair, Patrick J.			Decreased Serologic Response in Vaccinated Military Recruits during 2011 Correspond to Genetic Drift in Concurrent Circulating Pandemic A/H1N1 Viruses	PLOS ONE			English	Article							INACTIVATED INFLUENZA VACCINES; US NAVY SHIP; H1N1 VIRUS; RELATIVE EFFICACY; BASIC TRAINEES; YOUNG-CHILDREN; H5N1 VIRUS; LIVE; ADULTS; TRIVALENT	Background: Population-based febrile respiratory illness surveillance conducted by the Department of Defense contributes to an estimate of vaccine effectiveness. Between January and March 2011, 64 cases of 2009 A/H1N1 (pH1N1), including one fatality, were confirmed in immunized recruits at Fort Jackson, South Carolina, suggesting insufficient efficacy for the pH1N1 component of the live attenuated influenza vaccine (LAIV). Methodology/Principal Findings: To test serologic protection, serum samples were collected at least 30 days post-vaccination from recruits at Fort Jackson (LAIV), Parris Island (LAIV and trivalent inactivated vaccine [TIV]) at Cape May, New Jersey (TIV) and responses measured against pre-vaccination sera. A subset of 78 LAIV and 64 TIV sera pairs from recruits who reported neither influenza vaccination in the prior year nor fever during training were tested by microneutralization (MN) and hemagglutination inhibition (HI) assays. MN results demonstrated that seroconversion in paired sera was greater in those who received TIV versus LAIV (74% and 37%). Additionally, the fold change associated with TIV vaccination was significantly different between circulating (2011) versus the vaccine strain (2009) of pH1N1 viruses (ANOVA p value = 0.0006). HI analyses revealed similar trends. Surface plasmon resonance (SPR) analysis revealed that the quantity, IgG/IgM ratios, and affinity of anti-HA antibodies were significantly greater in TIV vaccinees. Finally, sequence analysis of the HA1 gene in concurrent circulating 2011 pH1N1 isolates from Fort Jackson exhibited modest amino acid divergence from the vaccine strain. Conclusions/Significance: Among military recruits in 2011, serum antibody response differed by vaccine type (LAIV vs. TIV) and pH1N1 virus year (2009 vs. 2011). We hypothesize that antigen drift in circulating pH1N1 viruses contributed to reduce vaccine effectiveness at Fort Jackson. Our findings have wider implications regarding vaccine protection from circulating pH1N1 viruses in 2011-2012.	[Faix, Dennis J.; Hawksworth, Anthony W.; Myers, Christopher A.; Hansen, Christian J.; Ortiguerra, Ryan G.; Blair, Patrick J.] USN, Hlth Res Ctr, Dept Operat Infect Dis, San Diego, CA 92152 USA; [Halpin, Rebecca; Wentworth, David] J Craig Venter Inst, Viral Programs, Rockville, MD USA; [Pacha, Laura A.] Army Publ Hlth Command, Dis Epidemiol Program, Aberdeen Proving Ground, MD USA; [Schwartz, Erica G.] US Coast Guard Headquarters, Washington, DC USA; [Garcia, Shawn M. S.] USN, Hosp Beaufort, Beaufort, SC USA; [Eick-Cost, Angelia A.] Armed Forces Hlth Surveillance Ctr, Div Epidemiol & Anal, Silver Spring, MD USA; [Clagett, Christopher D.] Navy & Marine Corps Publ Hlth Ctr, Portsmouth, VA USA; [Khurana, Surender; Golding, Hana] US FDA, Ctr Biol Evaluat & Res, Div Viral Prod, Bethesda, MD USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC); J. Craig Venter Institute; United States Department of Defense; United States Navy; US Food & Drug Administration (FDA)	Faix, DJ (corresponding author), USN, Hlth Res Ctr, Dept Operat Infect Dis, San Diego, CA 92152 USA.	patrick.blair@med.navy.mil		Wentworth, David/0000-0002-5190-980X	U.S. Department of Defense Armed Forces Health Surveillance Center division of the Global Emerging Infections Surveillance and Response System; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900007C]	U.S. Department of Defense Armed Forces Health Surveillance Center division of the Global Emerging Infections Surveillance and Response System; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was sponsored in part by a grant from the U.S. Department of Defense Armed Forces Health Surveillance Center division of the Global Emerging Infections Surveillance and Response System, and in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract number HHSN272200900007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose CS, 2011, INFLUENZA OTHER RESP, V5, P67, DOI 10.1111/j.1750-2659.2010.00183.x; Ashkenazi S, 2006, PEDIATR INFECT DIS J, V25, P870, DOI 10.1097/01.inf.0000237829.66310.85; Belshe RB, 2010, INFLUENZA OTHER RESP, V4, P141, DOI 10.1111/j.1750-2659.2009.00124.x; Belshe RB, 2010, VACCINE, V28, P2149, DOI 10.1016/j.vaccine.2009.11.068; Boehmer LM, 2010, ONCOLOGY-NY, V24, P1167; Burke RL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S2-S6; Byerly CR, 2010, PUBLIC HEALTH REP, V125, P82; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Crum-Cianflone NF, 2011, CLIN INFECT DIS, V52, P138, DOI 10.1093/cid/ciq019; Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5; Earhart KC, 2001, EMERG INFECT DIS, V7, P463, DOI 10.3201/eid0703.017320; Eick AA, 2009, VACCINE, V27, P3568, DOI 10.1016/j.vaccine.2009.03.088; Fleming DM, 2006, PEDIATR INFECT DIS J, V25, P860, DOI 10.1097/01.inf.0000237797.14283.cf; Forrest BD, 2011, VACCINE, V29, P3633, DOI 10.1016/j.vaccine.2011.03.029; Galiano M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023779; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Gaydos JC, 2006, EMERG INFECT DIS, V12, P23, DOI 10.3201/eid1201.050965; Ghedin E, 2005, NATURE, V437, P1162, DOI 10.1038/nature04239; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Grabenstein JD, 2006, EPIDEMIOL REV, V28, P3, DOI 10.1093/epirev/mxj003; Gray GC, 2000, CLIN INFECT DIS, V31, P663, DOI 10.1086/313999; Gray GC, 1999, EMERG INFECT DIS, V5, P379, DOI 10.3201/eid0503.990308; Griffin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023085; Grotto I, 1998, CLIN INFECT DIS, V26, P913, DOI 10.1086/513934; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; He XS, 2008, J INFECT DIS, V197, P803, DOI 10.1086/528804; Hoft DF, 2011, J INFECT DIS, V204, P845, DOI 10.1093/infdis/jir436; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Khurana S, PLOS ONE, V5; Khurana S, 2011, J VIROL, V85, P10945, DOI 10.1128/JVI.05406-11; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Khurana S, 2011, J VIROL, V85, P1246, DOI 10.1128/JVI.02107-10; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011548; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; KSIAZEK TG, 1980, AM J EPIDEMIOL, V112, P487, DOI 10.1093/oxfordjournals.aje.a113018; Mallory RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013755; McNeill M, 2005, MIL MED, V170, P94, DOI 10.7205/MILMED.170.1.94; Metzgar D, 2010, J CLIN MICROBIOL, V48, P4228, DOI 10.1128/JCM.01336-10; MILLER LF, 1963, MIL MED, V128, P858, DOI 10.1093/milmed/128.9.858; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; Myers CA, 2011, AM J TROP MED HYG, V85, P961, DOI 10.4269/ajtmh.2011.11-0098; Myers CA, 2011, CLIN INFECT DIS, V53, P207, DOI 10.1093/cid/cir282; Nelson M., 2009, PLOS CURR, V1, DOI [DOI 10.1371/CURRENTS.RRN1126, 10.1371/currents.RRN1126]; Nelson MI, 2011, J VIROL, V85, P828, DOI 10.1128/JVI.01762-10; Nguyen JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009332; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; Rimmelzwaan GF, 2008, VACCINE, V26, pD41, DOI 10.1016/j.vaccine.2008.07.043; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Rubertone MV, 2002, AM J PUBLIC HEALTH, V92, P1900, DOI 10.2105/AJPH.92.12.1900; Russell KL, 2006, VACCINE, V24, P2835, DOI 10.1016/j.vaccine.2005.12.062; Russell KL, 2005, VACCINE, V23, P1981, DOI 10.1016/j.vaccine.2004.10.023; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Sharma S, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-280; Strickler JK, 2007, EMERG INFECT DIS, V13, P617, DOI 10.3201/eid1304.061308; Tasker SA, 1999, ANN INTERN MED, V131, P430, DOI 10.7326/0003-4819-131-6-199909210-00006; Veguilla V, 2011, J CLIN MICROBIOL, V49, P2210, DOI 10.1128/JCM.00229-11; Wang Z, 2009, JAMA-J AM MED ASSOC, V301, P945, DOI 10.1001/jama.2009.265; Ye JQ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001145	59	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34581	10.1371/journal.pone.0034581	http://dx.doi.org/10.1371/journal.pone.0034581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514639	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341600045
J	Liang, QH; Jiang, Y; Zhu, X; Cui, RR; Liu, GY; Liu, Y; Wu, SS; Liao, XB; Xie, H; Zhou, HD; Wu, XP; Yuan, LQ; Liao, EY				Liang, Qiu-Hua; Jiang, Yi; Zhu, Xiao; Cui, Rong-Rong; Liu, Guan-Ying; Liu, Yuan; Wu, Shan-Shan; Liao, Xiao-Bo; Xie, Hui; Zhou, Hou-De; Wu, Xian-Ping; Yuan, Ling-Qing; Liao, Er-Yuan			Ghrelin Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells through the ERK Pathway	PLOS ONE			English	Article							IN-VITRO; ARTERIAL CALCIFICATION; ACYLATED PEPTIDE; HORMONE; MECHANISMS; VIVO; IDENTIFICATION; PROLIFERATION; EXPRESSION; PITUITARY	Vascular calcification results from osteoblastic differentiation of vascular smooth muscle cells (VSMCs) and is a major risk factor for cardiovascular events. Ghrelin is a newly discovered bioactive peptide that acts as a natural endogenous ligand of the growth hormone secretagog receptor (GHSR). Several studies have identified the protective effects of ghrelin on the cardiovascular system, however research on the effects and mechanisms of ghrelin on vascular calcification is still quite rare. In this study, we determined the effect of ghrelin on osteoblastic differentiation of VSMCs and investigated the mechanism involved using the two universally accepted calcifying models of calcifying vascular smooth muscle cells (CVSMCs) and beta-glycerophosphate (beta-GP)-induced VSMCs. Our data demonstrated that ghrelin inhibits osteoblastic differentiation and mineralization of VSMCs due to decreased alkaline phosphatase (ALP) activity, Runx2 expression, bone morphogenetic protein-2 (BMP-2) expression and calcium content. Further study demonstrated that ghrelin exerted this suppression effect via an extracellular signal-related kinase (ERK)-dependent pathway and that the suppression effect of ghrelin was time dependent and dose dependent. Furthermore, inhibition of the growth hormone secretagog receptor (GHSR), the ghrelin receptor, by siRNA significantly reversed the activation of ERK by ghrelin. In conclusion, our study suggests that ghrelin may inhibit osteoblastic differentiation of VSMCs through the GHSR/ERK pathway.	[Liang, Qiu-Hua; Zhu, Xiao; Cui, Rong-Rong; Liu, Guan-Ying; Liu, Yuan; Wu, Shan-Shan; Xie, Hui; Zhou, Hou-De; Wu, Xian-Ping; Yuan, Ling-Qing; Liao, Er-Yuan] Cent S Univ, Xiang Ya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China; [Jiang, Yi] Cent S Univ, Xiang Ya Hosp 2, Dept Pathol, Changsha, Hunan, Peoples R China; [Cui, Rong-Rong] Cent S Univ, Xiang Ya Hosp 2, Dept Pediat, Changsha, Hunan, Peoples R China; [Liao, Xiao-Bo] Cent S Univ, Xiang Ya Hosp 2, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Yuan, LQ (corresponding author), Cent S Univ, Xiang Ya Hosp 2, Inst Metab & Endocrinol, Changsha, Hunan, Peoples R China.	allenylq@hotmail.com; eyliao007@yahoo.com.cn	Xie, Hui/AAF-8152-2020; Yuan, Ling-Qing/D-2102-2019	Yi, Jiang/0000-0002-7877-0561; Yuan, Ling-Qing/0000-0001-8602-7113; Zhou, Hou-De/0000-0001-9131-4141	National Natural Science Foundation of China [30801174, 30900622, 81070246, 81000313]; Ministry of Education of the People's Republic of China [078202042]; Central South University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of the People's Republic of China(Ministry of Education, China); Central South University	This work was supported by funding from The National Natural Science Foundation of China (No. 30801174, 30900622, 81070246 and 81000313). Scholarship Award for Excellent Doctoral Student granted by Ministry of Education of the People's Republic of China (078202042); Excellent Doctoral Dissertation of training support program of Central South University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2004, ARTERIOSCL THROM VAS, V24, P1161, DOI 10.1161/01.ATV.0000133194.94939.42; Alexander MY, 2005, ARTERIOSCL THROM VAS, V25, P1851, DOI 10.1161/01.ATV.0000175750.94742.46; Bing HT, 2006, J CELL BIOCHEM, V99, P1343, DOI 10.1002/jcb.20999; Bostrom K, 2001, AM J CARDIOL, V88, p20E; Byon CH, 2011, ARTERIOSCL THROM VAS, V31, P1387, DOI 10.1161/ATVBAHA.110.222547; Date Y, 2000, ENDOCRINOLOGY, V141, P4255, DOI 10.1210/en.141.11.4255; Doherty TM, 2002, FASEB J, V16, DOI 10.1096/fj.01-0898hyp; Fukushima N, 2005, J BONE MINER RES, V20, P790, DOI 10.1359/JBMR.041237; Granata R, 2010, J MOL ENDOCRINOL, V45, P107, DOI 10.1677/JME-10-0019; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kim SW, 2009, J CELL BIOCHEM, V106, P626, DOI 10.1002/jcb.22042; Kim SW, 2005, BONE, V37, P359, DOI 10.1016/j.bone.2005.04.020; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Li GZ, 2005, REGUL PEPTIDES, V129, P167, DOI 10.1016/j.regpep.2005.02.015; Liao XB, 2008, AMINO ACIDS, V34, P525, DOI 10.1007/s00726-007-0003-8; Liao XB, 2010, AMINO ACIDS, V39, P375, DOI 10.1007/s00726-009-0448-z; Liu HM, 2010, J CELL BIOCHEM, V111, P1556, DOI 10.1002/jcb.22887; Luo XH, 2009, J BONE MINER RES, V24, P1461, DOI [10.1359/JBMR.090227, 10.1359/jbmr.090227]; McKee KK, 1997, MOL ENDOCRINOL, V11, P415, DOI 10.1210/me.11.4.415; Nakahara T, 2010, BIOCHEM BIOPH RES CO, V394, P243, DOI 10.1016/j.bbrc.2009.11.038; Oikawa Y, 2011, CELL RES, V21, P1578, DOI 10.1038/cr.2011.90; Papotti M, 2000, J CLIN ENDOCR METAB, V85, P3803, DOI 10.1210/jc.85.10.3803; Radcliff K, 2005, CIRC RES, V96, P398, DOI 10.1161/01.RES.0000157671.47477.71; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shan PF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017938; Shao JS, 2006, ARTERIOSCL THROM VAS, V26, P1423, DOI 10.1161/01.ATV.0000220441.42041.20; Shi YL, 2009, J CELL BIOCHEM, V108, P1184, DOI 10.1002/jcb.22348; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Tanaka T, 2008, MOL CELL BIOL, V28, P1147, DOI 10.1128/MCB.01771-07; Xie H, 2011, CARDIOVASC RES; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Zhang GG, 2010, CURR CARDIOL REV, V6, P62, DOI 10.2174/157340310790231662	36	50	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e33126	10.1371/journal.pone.0033126	http://dx.doi.org/10.1371/journal.pone.0033126			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514603	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600008
J	Sachsenroder, J; Twardziok, S; Hammerl, JA; Janczyk, P; Wrede, P; Hertwig, S; Johne, R				Sachsenroeder, Jana; Twardziok, Sven; Hammerl, Jens A.; Janczyk, Pawel; Wrede, Paul; Hertwig, Stefan; Johne, Reimar			Simultaneous Identification of DNA and RNA Viruses Present in Pig Faeces Using Process-Controlled Deep Sequencing	PLOS ONE			English	Article							HEPATITIS-E VIRUS; METAGENOMIC ANALYSES; GENOMIC ANALYSIS; STOOL SAMPLES; AMPLIFICATION; CALICIVIRUS; GENERATION; DIVERSITY; DIARRHEA; VIROME	Background: Animal faeces comprise a community of many different microorganisms including bacteria and viruses. Only scarce information is available about the diversity of viruses present in the faeces of pigs. Here we describe a protocol, which was optimized for the purification of the total fraction of viral particles from pig faeces. The genomes of the purified DNA and RNA viruses were simultaneously amplified by PCR and subjected to deep sequencing followed by bioinformatic analyses. The efficiency of the method was monitored using a process control consisting of three bacteriophages (T4, M13 and MS2) with different morphology and genome types. Defined amounts of the bacteriophages were added to the sample and their abundance was assessed by quantitative PCR during the preparation procedure. Results: The procedure was applied to a pooled faecal sample of five pigs. From this sample, 69,613 sequence reads were generated. All of the added bacteriophages were identified by sequence analysis of the reads. In total, 7.7% of the reads showed significant sequence identities with published viral sequences. They mainly originated from bacteriophages (73.9%) and mammalian viruses (23.9%); 0.8% of the sequences showed identities to plant viruses. The most abundant detected porcine viruses were kobuvirus, rotavirus C, astrovirus, enterovirus B, sapovirus and picobirnavirus. In addition, sequences with identities to the chimpanzee stool-associated circular ssDNA virus were identified. Whole genome analysis indicates that this virus, tentatively designated as pig stool-associated circular ssDNA virus (PigSCV), represents a novel pig virus. Conclusion: The established protocol enables the simultaneous detection of DNA and RNA viruses in pig faeces including the identification of so far unknown viruses. It may be applied in studies investigating aetiology, epidemiology and ecology of diseases. The implemented process control serves as quality control, ensures comparability of the method and may be used for further method optimization.	[Sachsenroeder, Jana; Hammerl, Jens A.; Janczyk, Pawel; Hertwig, Stefan; Johne, Reimar] Fed Inst Risk Assessment, Berlin, Germany; [Twardziok, Sven; Wrede, Paul] Inst Mol Biol & Bioinformat, Charite, Berlin, Germany	Federal Institute for Risk Assessment; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sachsenroder, J (corresponding author), Fed Inst Risk Assessment, Berlin, Germany.	Reimar.Johne@bfr.bund.de	Hammerl, Jens Andre/Y-6406-2018	Hammerl, Jens Andre/0000-0002-6930-4358; Twardziok, Sven/0000-0002-0326-5704	German Research Foundation (DFG) [SFB 852/1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was supported by the German Research Foundation (DFG) through grant SFB 852/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Blinkova O, 2010, J GEN VIROL, V91, P74, DOI 10.1099/vir.0.015446-0; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Cann AJ, 2005, VIRUS GENES, V30, P151, DOI 10.1007/s11262-004-5624-3; Costafreda MI, 2006, APPL ENVIRON MICROB, V72, P3846, DOI 10.1128/AEM.02660-05; Day JM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-313; Djikeng A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007264; Dreier J, 2005, J CLIN MICROBIOL, V43, P4551, DOI 10.1128/JCM.43.9.4551-4557.2005; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Ge XY, 2011, J GEN VIROL, V92, P2646, DOI 10.1099/vir.0.034108-0; Halaihel N, 2010, EPIDEMIOL INFECT, V138, P542, DOI 10.1017/S0950268809990872; Jere KC, 2011, J MED VIROL, V83, P2018, DOI 10.1002/jmv.22207; Johne R, 2009, TRENDS MICROBIOL, V17, P205, DOI 10.1016/j.tim.2009.02.004; Kim HK, 2011, J GEN VIROL; Kim YJ, 1999, J CLIN MICROBIOL, V37, P1484, DOI 10.1128/JCM.37.5.1484-1488.1999; Lamendella R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-103; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Li LL, 2010, J VIROL, V84, P1674, DOI 10.1128/JVI.02109-09; Lin Y, 2011, BIOINFORMATICS, V27, P2031, DOI 10.1093/bioinformatics/btr319; Maidana-Giret MT, 2009, AIDS, V23, P2277, DOI 10.1097/QAD.0b013e32832d7a11; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Midgley SE, 2011, VET MICROBIOL; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Palmenberg AC, 2005, VIRUS TAXONOMY, P12; Phan TG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002218; Pignatelli M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019984; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216; Roossinck MJ, 2010, MOL ECOL, V19, P81, DOI 10.1111/j.1365-294X.2009.04470.x; Sambrook J., 2001, MOL CLONING LAB MANU; Sencer DJ, 2011, CLIN INFECT DIS   S1, V52, P4; Shan TL, 2011, J VIROL, V85, P11697, DOI 10.1128/JVI.05217-11; Shannon CE, 1997, M D COMPUT, V14, P306; SMITH HW, 1983, J GEN MICROBIOL, V129, P2659; Tang P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/fmb.09.120, 10.2217/FMB.09.120]; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; van der Poel WHM, 2001, EMERG INFECT DIS, V7, P970, DOI 10.3201/eid0706.010608; Victoria JG, 2009, J VIROL, V83, P4642, DOI 10.1128/JVI.02301-08; Ward P, 2009, J APPL MICROBIOL, V106, P1360, DOI 10.1111/j.1365-2672.2008.04104.x; Zhang Tao, 2006, Journal of Fungal Research, V4, P1	46	62	66	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34631	10.1371/journal.pone.0034631	http://dx.doi.org/10.1371/journal.pone.0034631			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514648	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341600054
J	Xiang, S; Dong, HH; Liang, HF; He, SQ; Zhang, W; Li, CH; Zhang, BX; Zhang, BH; Jing, K; Tomlinson, S; van Rooijen, N; Jiang, L; Cianflone, K; Chen, XP				Xiang, Shuai; Dong, Han-Hua; Liang, Hui-Fang; He, Song-Qing; Zhang, Wei; Li, Chang-Hai; Zhang, Bi-Xiang; Zhang, Bin-Hao; Jing, Kai; Tomlinson, Stephen; van Rooijen, Nico; Jiang, Li; Cianflone, Katherine; Chen, Xiao-Ping			Oval Cell Response Is Attenuated by Depletion of Liver Resident Macrophages in the 2-AAF/Partial Hepatectomy Rat	PLOS ONE			English	Article							HEPATIC PROGENITOR CELLS; PRECURSOR-PRODUCT RELATIONSHIP; KUPFFER CELLS; GADOLINIUM CHLORIDE; HEPATOCELLULAR-CARCINOMA; STEM-CELLS; IN-VIVO; REGENERATION; HEPATOCYTES; EXPRESSION	Background/Aims: Macrophages are known to play an important role in hepatocyte mediated liver regeneration by secreting inflammatory mediators. However, there is little information available on the role of resident macrophages in oval cell mediated liver regeneration. In the present study we aimed to investigate the role of macrophages in oval cell expansion induced by 2-acetylaminofluorene/partial hepatectomy (2-AAF/PH) in rats. Methodology/Principal Findings: We depleted macrophages in the liver of 2-AAF/PH treated rats by injecting liposome encapsulated clodronate 48 hours before PH. Regeneration of remnant liver mass, as well as proliferation and differentiation of oval cells were measured. We found that macrophage-depleted rats suffered higher mortality and liver transaminase levels. We also showed that depletion of macrophages yielded a significant decrease of EPCAM and PCK positive oval cells in immunohistochemical stained liver sections 9 days after PH. Meanwhile, oval cell differentiation was also attenuated as a result of macrophage depletion, as large foci of small basophilic hepatocytes were observed by day 9 following hepatectomy in control rats whereas they were almost absent in macrophage depleted rats. Accordingly, real-time polymerase chain reaction analysis showed lower expression of albumin mRNA in macrophage depleted livers. Then we assessed whether macrophage depletion may affect hepatic production of stimulating cytokines for liver regeneration. We showed that macrophage-depletion significantly inhibited hepatic expression of tumor necrosis factor-a and interleukin-6, along with a lack of signal transducer and activator of transcription 3 phosphorylation during the early period following hepatectomy. Conclusions: These data indicate that macrophages play an important role in oval cell mediated liver regeneration in the 2-AAF/PH model.	[Xiang, Shuai; Dong, Han-Hua; Liang, Hui-Fang; Li, Chang-Hai; Jiang, Li; Chen, Xiao-Ping] Huazhong Univ Sci & Technol, Tongji Hosp, Hepat Surg Ctr, Wuhan 430074, Peoples R China; [He, Song-Qing; Zhang, Wei; Zhang, Bi-Xiang; Zhang, Bin-Hao; Jing, Kai] Guilin Med Univ, Affiliated Hosp, Dept Hepatobiliary Surg, Guilin, Peoples R China; [Tomlinson, Stephen] Med Univ S Carolina, Dept Microbiol & Immunol, Darby Childrens Res Inst, Charleston, SC 29425 USA; [van Rooijen, Nico] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol, Amsterdam, Netherlands; [Cianflone, Katherine] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	Huazhong University of Science & Technology; Guilin Medical University; Medical University of South Carolina; Vrije Universiteit Amsterdam; Laval University	Xiang, S (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Hepat Surg Ctr, Wuhan 430074, Peoples R China.	chenxp@medmail.com.cn	Van Rooijen, Nico/Z-1578-2019		National Natural Science Foundation of China [30872499, 30972797, 30973498]; Natural Science Foundation of Hubei Province of China [2008CDB146]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province)	This work was supported by the grants from The National Natural Science Foundation of China (Grant No. 30872499, 30972797 and 30973498) (website:http://www.nsfc.gov.cn/Portal0/default152.htm) and The Natural Science Foundation of Hubei Province of China (Grant No. 2008CDB146)(http://www.hbstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abshagen K, 2007, AM J PHYSIOL-GASTR L, V292, pG1570, DOI 10.1152/ajpgi.00399.2006; Bilzer M, 2006, LIVER INT, V26, P1175, DOI 10.1111/j.1478-3231.2006.01342.x; Boulton RA, 1998, J HEPATOL, V29, P271, DOI 10.1016/S0168-8278(98)80013-5; BRAUN L, 1989, CANCER RES, V49, P1554; DECKER K, 1990, EUR J BIOCHEM, V192, P245, DOI 10.1111/j.1432-1033.1990.tb19222.x; Devey L, 2009, MOL THER, V17, P65, DOI 10.1038/mt.2008.237; Dong XS, 2010, J HUAZHONG U SCI-MED, V30, P55, DOI 10.1007/s11596-010-0110-8; Dong ZJ, 2007, CELL MOL IMMUNOL, V4, P241; Evarts RP, 1996, CARCINOGENESIS, V17, P2143, DOI 10.1093/carcin/17.10.2143; EVARTS RP, 1989, CANCER RES, V49, P1541; EVARTS RP, 1987, CARCINOGENESIS, V8, P1737, DOI 10.1093/carcin/8.11.1737; Faa G, 1998, J HEPATOL, V29, P628, DOI 10.1016/S0168-8278(98)80158-X; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Gao B, 2005, CELL MOL IMMUNOL, V2, P92; Gregory SH, 1998, J IMMUNOL, V160, P6056; HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296, DOI 10.1002/jlb.52.3.296; Jensen CH, 2004, AM J PATHOL, V164, P1347, DOI 10.1016/S0002-9440(10)63221-X; Jin CX, 2011, BIOCHEM BIOPH RES CO, V409, P803, DOI 10.1016/j.bbrc.2011.05.094; Ju C, 2002, CHEM RES TOXICOL, V15, P1504, DOI 10.1021/tx0255976; Kinoshita M, 2010, J HEPATOL, V53, P903, DOI 10.1016/j.jhep.2010.04.037; Knight B, 2000, J EXP MED, V192, P1809, DOI 10.1084/jem.192.12.1809; Knight B, 2007, J HEPATOL, V46, P134, DOI 10.1016/j.jhep.2006.08.015; Kuhlmann WD, 2006, INT J EXP PATHOL, V87, P343, DOI 10.1111/j.1365-2613.2006.00485.x; Laszlo V, 2008, HISTOCHEM CELL BIOL, V130, P1005, DOI 10.1007/s00418-008-0482-z; Lee CM, 2004, INT J BIOCHEM CELL B, V36, P481, DOI 10.1016/j.biocel.2003.08.004; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Libbrecht L, 2002, SEMIN CELL DEV BIOL, V13, P389, DOI 10.1016/S1084952102001258; Libbrecht L, 2000, J HEPATOL, V33, P76, DOI 10.1016/S0168-8278(00)80162-2; Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6; Lowes KN, 2003, J GASTROEN HEPATOL, V18, P4, DOI 10.1046/j.1440-1746.2003.02906.x; Meijer C, 2000, LIVER, V20, P66, DOI 10.1034/j.1600-0676.2000.020001066.x; Nagy P, 1998, HEPATOLOGY, V28, P423, DOI 10.1002/hep.510280220; NAGY P, 1994, J CELL BIOL, V126, P223, DOI 10.1083/jcb.126.1.223; Olynyk JK, 1998, AM J PATHOL, V152, P347; Paku S, 2001, AM J PATHOL, V158, P1313, DOI 10.1016/S0002-9440(10)64082-5; Rai RM, 1996, AM J PHYSIOL-GASTR L, V270, pG909, DOI 10.1152/ajpgi.1996.270.6.G909; Roskams TA, 2003, SEMIN LIVER DIS, V23, P385; Santoni-Rugiu E, 2005, APMIS, V113, P876, DOI 10.1111/j.1600-0463.2005.apm_386.x; Shupe T, 2005, STEM CELL REV, V1, P261, DOI 10.1385/SCR:1:3:261; Strick-Marchand H, 2008, J IMMUNOL, V181, P2764, DOI 10.4049/jimmunol.181.4.2764; Theise ND, 2006, AM J PHYSIOL-GASTR L, V290, pG189, DOI 10.1152/ajpgi.00041.2005; VANROOIJEN N, 1990, CELL TISSUE RES, V260, P215, DOI 10.1007/BF00318625; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; VanRooijen N, 1996, HEPATOLOGY, V23, P1239; Viebahn CS, 2010, J HEPATOL, V53, P500, DOI 10.1016/j.jhep.2010.04.010; Yin L, 2002, HISTOL HISTOPATHOL, V17, P65, DOI 10.14670/HH-17.65; Zhang W, 2009, WORLD J GASTROENTERO, V15, P552, DOI 10.3748/wjg.15.552	48	28	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35180	10.1371/journal.pone.0035180	http://dx.doi.org/10.1371/journal.pone.0035180			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514719	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600125
J	Zhang, XR; Wang, YX; Zhang, ZJ; Li, L; Reynolds, GP				Zhang, Xiang Rong; Wang, Ying Xin; Zhang, Zhi Jun; Li, Lei; Reynolds, Gavin P.			The Effect of Chronic Antipsychotic Drug on Hypothalamic Expression of Neural Nitric Oxide Synthase and Dopamine D2 Receptor in the Male Rat	PLOS ONE			English	Article							MEDIAL PREOPTIC NUCLEUS; PARAVENTRICULAR NUCLEUS; SEXUAL-BEHAVIOR; PENILE ERECTION; HALOPERIDOL; RISPERIDONE; DYSFUNCTION; QUETIAPINE; IMPACT; AREA	Antipsychotic-induced sexual dysfunction is a common and serious clinical side effect. It has been demonstrated that both neuronal nitric oxide (nNOS) and dopamine D2 receptor (DRD2) in the medial preoptic area (MPOA) and the paraventricular nucleus (PVN) of the hypothalamus have important roles in the regulation of sexual behaviour. We investigated the influences of 21 days' antipsychotic drug administration on expression of nNOS and DRD2 in the rat hypothalamus. Haloperidol (0.5 mg/kg/day i.p.) significantly decreased nNOS integrated optical density in a sub-nucleus of the MPOA, medial preoptic nucleus (MPN), and decreased the nNOS integrated optical density and cell density in another sub-nucleus of the MPOA, anterodorsal preoptic nucleus (ADP). Risperidone (0.25 mg/kg) inhibited the nNOS integrated optical density in the ADP. nNOS mRNA and protein in the MPOA but not the PVN was also significantly decreased by haloperidol. Haloperidol and risperidone increased DRD2 mRNA and protein expression in both the MPOA and the PVN. Quetiapine (20 mg/kg/day i.p.) did not influence the expression of nNOS and DRD2 in either the MPOA or the PVN. These findings indicate that hypothalamic nNOS and DRD2 are affected to different extents by chronic administration of risperidone and haloperidol, but are unaffected by quetiapine. These central effects might play a role in sexual dysfunction induced by certain antipsychotic drugs.	[Zhang, Xiang Rong; Wang, Ying Xin; Zhang, Zhi Jun; Li, Lei] Southeast Univ, Affiliated Zhongda Hosp, Dept Neuropsychiat, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiang Rong; Wang, Ying Xin; Zhang, Zhi Jun; Li, Lei] Southeast Univ, Sch Med, Neuropsychiat Res Inst, Nanjing, Jiangsu, Peoples R China; [Zhang, Xiang Rong; Reynolds, Gavin P.] Queens Univ Belfast, Sch Med & Dent, Dept Psychiat, Belfast BT7 1NN, Antrim, North Ireland; [Reynolds, Gavin P.] Sheffield Hallam Univ, Biomed Res Ctr, Sheffield S1 1WB, S Yorkshire, England	Southeast University - China; Southeast University - China; Queens University Belfast; Sheffield Hallam University	Zhang, XR (corresponding author), Southeast Univ, Affiliated Zhongda Hosp, Dept Neuropsychiat, Nanjing, Jiangsu, Peoples R China.	zhijunzhang838@yahoo.com.cn	Reynolds, Gavin/AAM-9985-2020	Reynolds, Gavin/0000-0001-9026-7726	National Basic Research Program of China (973 Program) [2010CB529602]; National Natural Science Foundation of China [30900482, F040805]; JiangSu Province Natural Science Foundation of China [BK2009280]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); JiangSu Province Natural Science Foundation of China(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Basic Research Program of China (973 Program, 2010CB529602), National Natural Science Foundation of China (No. 30900482 and F040805), and JiangSu Province Natural Science Foundation of China (BK2009280). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARENDASH GW, 1983, BRAIN RES BULL, V10, P147, DOI 10.1016/0361-9230(83)90086-2; Argiolas A, 2005, PROG NEUROBIOL, V76, P1, DOI 10.1016/j.pneurobio.2005.06.002; Argiolas A, 2003, J Endocrinol Invest, V26, P20; Balthazart J, 2007, FRONT NEUROENDOCRIN, V28, P161, DOI 10.1016/j.yfrne.2007.05.003; CHEN JF, 1993, NEUROSCIENCE, V54, P669, DOI 10.1016/0306-4522(93)90238-B; Cutler AJ, 2003, PSYCHONEUROENDOCRINO, V28, P69, DOI 10.1016/S0306-4530(02)00113-0; D'Souza U, 1997, NEUROPHARMACOLOGY, V36, P1689, DOI 10.1016/S0028-3908(97)00163-9; Dossenbach M, 2004, J CLIN PSYCHIAT, V65, P312; FLETCHER EJ, 1994, EUR J PHARM-MOLEC PH, V267, P249, DOI 10.1016/0922-4106(94)90178-3; FOX CA, 1994, EXP NEUROL, V130, P288, DOI 10.1006/exnr.1994.1207; Gurevich EV, 1999, NEUROPSYCHOPHARMACOL, V20, P60, DOI 10.1016/S0893-133X(98)00066-9; Hull EM, 2006, BRAIN RES, V1126, P66, DOI 10.1016/j.brainres.2006.08.031; Iwahashi K, 1996, NEUROPSYCHOBIOLOGY, V33, P76, DOI 10.1159/000119253; JENNER P, 1983, J NEURAL TRANSM, P205; Jensen D, 2008, NEUROSCIENCE, V155, P308, DOI 10.1016/j.neuroscience.2008.05.024; Joyce JN, 2001, SYNAPSE, V40, P137, DOI 10.1002/syn.1035; Knegtering R, 2004, J CLIN PSYCHOPHARM, V24, P56, DOI 10.1097/01.jcp.0000106220.36344.04; Lambert M, 2004, EUR PSYCHIAT, V19, P415, DOI 10.1016/j.eurpsy.2004.06.031; Mallis D, 2006, J SEX MED, V3, P442, DOI 10.1111/j.1743-6109.2005.00173.x; MEADORWOODRUFF JH, 1991, NEUROPSYCHOPHARMACOL, V5, P231; Melis MR, 2007, EUR J NEUROSCI, V26, P1026, DOI 10.1111/j.1460-9568.2007.05721.x; Melis MR, 1996, EUR J NEUROSCI, V8, P2056, DOI 10.1111/j.1460-9568.1996.tb00725.x; Olfson M, 2005, J CLIN PSYCHIAT, V66, P331, DOI 10.4088/JCP.v66n0309; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Peeters M, 2008, NEUROSCI BIOBEHAV R, V32, P438, DOI 10.1016/j.neubiorev.2007.07.013; Perkins DO, 2002, J CLIN PSYCHIAT, V63, P1121, DOI 10.4088/JCP.v63n1206; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PFAUS JG, 1991, BEHAV NEUROSCI, V105, P727, DOI 10.1037/0735-7044.105.5.727; Pu S, 1998, J NEUROENDOCRINOL, V10, P617, DOI 10.1046/j.1365-2826.1998.00245.x; Rosenberg KP, 2003, J SEX MARITAL THER, V29, P289, DOI 10.1080/00926230390195524; RUPNIAK NMJ, 1983, LIFE SCI, V32, P2289, DOI 10.1016/0024-3205(83)90759-2; Sasaki M, 2000, P NATL ACAD SCI USA, V97, P8617, DOI 10.1073/pnas.97.15.8617; Sato S, 2005, BRAIN RES, V1043, P205, DOI 10.1016/j.brainres.2005.02.074; SIMERLY RB, 1986, J COMP NEUROL, V246, P312, DOI 10.1002/cne.902460304; SIMERLY RB, 1988, J COMP NEUROL, V270, P209, DOI 10.1002/cne.902700205; Wang-Tilz Y, 2006, EPILEPSIA, V47, P233, DOI 10.1111/j.1528-1167.2006.00414.x; Wood RI, 1999, J NEUROBIOL, V39, P359, DOI 10.1002/(SICI)1097-4695(19990605)39:3<359::AID-NEU3>3.0.CO;2-W; Wu SN, 2000, NEUROPSYCHOPHARMACOL, V23, P676, DOI 10.1016/S0893-133X(00)00151-2; Xavier LL, 2005, BRAIN RES PROTOC, V16, P58, DOI 10.1016/j.brainresprot.2005.10.002; Xi ZQ, 2007, EUR J NEUROL, V14, P865, DOI 10.1111/j.1468-1331.2007.01777.x; Zhang XR, 2011, J SEX MED, V8, P3345, DOI 10.1111/j.1743-6109.2010.01740.x; Zhang XR, 2011, PHARMACOGENOMICS, V12, P1127, DOI [10.2217/pgs.11.46, 10.2217/PGS.11.46]; Zhang XR, 2010, EUR NEUROPSYCHOPHARM, V20, P211, DOI 10.1016/j.euroneuro.2009.10.002; Zhang XG, 2007, J PSYCHOPHARMACOL, V21, P428, DOI 10.1177/0269881106068702	44	2	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e33247	10.1371/journal.pone.0033247	http://dx.doi.org/10.1371/journal.pone.0033247			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514604	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341600009
J	Maruyama, Y; Yasuda, R; Kuroda, M; Eto, Y				Maruyama, Yutaka; Yasuda, Reiko; Kuroda, Motonaka; Eto, Yuzuru			Kokumi Substances, Enhancers of Basic Tastes, Induce Responses in Calcium-Sensing Receptor Expressing Taste Cells	PLOS ONE			English	Article							EXTRACELLULAR CA2+-SENSING RECEPTOR; GLUTAMYL PEPTIDES; ACID TASTE; III CELLS; BUDS; MOUSE; SWEET; COMMUNICATION; HEMICHANNELS; BITTER	Recently, we reported that calcium-sensing receptor (CaSR) is a receptor for kokumi substances, which enhance the intensities of salty, sweet and umami tastes. Furthermore, we found that several gamma-glutamyl peptides, which are CaSR agonists, are kokumi substances. In this study, we elucidated the receptor cells for kokumi substances, and their physiological properties. For this purpose, we used Calcium Green-1 loaded mouse taste cells in lingual tissue slices and confocal microscopy. Kokumi substances, applied focally around taste pores, induced an increase in the intracellular Ca2+ concentration ([Ca2+](i)) in a subset of taste cells. These responses were inhibited by pretreatment with the CaSR inhibitor, NPS2143. However, the kokumi substance-induced responses did not require extracellular Ca2+. CaSR-expressing taste cells are a different subset of cells from the T1R3-expressing umami or sweet taste receptor cells. These observations indicate that CaSR-expressing taste cells are the primary detectors of kokumi substances, and that they are an independent population from the influenced basic taste receptor cells, at least in the case of sweet and umami.	[Maruyama, Yutaka; Yasuda, Reiko; Kuroda, Motonaka; Eto, Yuzuru] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan	Ajinomoto Co Inc	Maruyama, Y (corresponding author), Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan.	yutaka_maruyama@ajinomoto.com			Ajinomoto Co., Inc.	Ajinomoto Co., Inc.	This study was funded by Ajinomoto Co., Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; Brown EM, 2001, PHYSIOL REV, V81, P239, DOI 10.1152/physrev.2001.81.1.239; Bystrova MF, 2010, J CELL SCI, V123, P972, DOI 10.1242/jcs.061879; Caicedo A, 2002, J PHYSIOL-LONDON, V544, P501, DOI 10.1113/jphysiol.2002.027862; Caicedo A, 2000, J NEUROSCI, V20, P7978; Chattopadhyay N, 1997, BIOL CHEM, V378, P759; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Conigrave AD, 2000, P NATL ACAD SCI USA, V97, P4814, DOI 10.1073/pnas.97.9.4814; Dando R, 2009, J PHYSIOL-LONDON, V587, P5899, DOI 10.1113/jphysiol.2009.180083; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Dunkel A, 2007, J AGR FOOD CHEM, V55, P6712, DOI 10.1021/jf071276u; Dvoryanchikov G, 2007, J COMP NEUROL, V505, P302, DOI 10.1002/cne.21494; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Gabriel AS, 2009, BIOCHEM BIOPH RES CO, V378, P414, DOI 10.1016/j.bbrc.2008.11.060; Gowen M, 2000, J CLIN INVEST, V105, P1595, DOI 10.1172/JCI9038; Helmchen G, 2000, CALIBRATION FLUORESC; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang LQ, 1999, NAT NEUROSCI, V2, P1055, DOI 10.1038/15981; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; Iwatsuki K, 2009, BIOCHEM BIOPH RES CO, V388, P1, DOI 10.1016/j.bbrc.2009.07.069; KINNAMON JC, 1985, J COMP NEUROL, V235, P48, DOI 10.1002/cne.902350105; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Maruyama Y, 2006, J NEUROSCI, V26, P2227, DOI 10.1523/JNEUROSCI.4329-05.2006; McCaughey SA, 2005, PHYSIOL BEHAV, V84, P335, DOI 10.1016/j.physbeh.2004.12.010; Medler KF, 2003, J NEUROSCI, V23, P2608; Michlig S, 2007, J COMP NEUROL, V502, P1003, DOI 10.1002/cne.21354; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; MURRAY RG, 1993, MICROSC RES TECHNIQ, V26, P209, DOI 10.1002/jemt.1070260304; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; NINOMIYA Y, 1982, BRAIN RES, V244, P370, DOI 10.1016/0006-8993(82)90100-7; Nofre G, 1987, US patent, Patent No. 4921939; Ogura T, 1999, J NEUROPHYSIOL, V82, P2657, DOI 10.1152/jn.1999.82.5.2657; Ohsu T, 2010, J BIOL CHEM, V285, P1016, DOI 10.1074/jbc.M109.029165; Richter TA, 2004, J NEUROPHYSIOL, V92, P1928, DOI 10.1152/jn.00273.2004; Roberts CD, 2009, J PHYSIOL-LONDON, V587, P1657, DOI 10.1113/jphysiol.2009.170555; Rodriguez M, 2005, AM J PHYSIOL-RENAL, V288, pF253, DOI 10.1152/ajprenal.00302.2004; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Rossler P, 1998, EUR J CELL BIOL, V77, P253; Rybczynska A, 2006, J ENDOCRINOL, V191, P189, DOI 10.1677/joe.1.06924; SALARI H, 1993, AM J RESP CELL MOL, V9, P405, DOI 10.1165/ajrcmb/9.4.405; THOMPSON AK, 1991, J BIOL CHEM, V266, P23856; Toelstede S, 2009, J AGR FOOD CHEM, V57, P3738, DOI 10.1021/jf900280j; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Tordoff MG, 2008, PHYSIOL GENOMICS, V34, P338, DOI 10.1152/physiolgenomics.90200.2008; UEDA Y, 1990, AGR BIOL CHEM TOKYO, V54, P163, DOI 10.1080/00021369.1990.10869909; Ueda Y, 1997, BIOSCI BIOTECH BIOCH, V61, P1977, DOI 10.1271/bbb.61.1977; Wang MH, 2006, J BIOL CHEM, V281, P8864, DOI 10.1074/jbc.M512865200; Yee CL, 2001, J COMP NEUROL, V440, P97, DOI 10.1002/cne.1372; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	53	85	92	7	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34489	10.1371/journal.pone.0034489	http://dx.doi.org/10.1371/journal.pone.0034489			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511946	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338600032
J	Peng, WW; Hu, L; Zhang, ZG; Hu, Y				Peng, Weiwei; Hu, Li; Zhang, Zhiguo; Hu, Yong			Causality in the Association between P300 and Alpha Event-Related Desynchronization	PLOS ONE			English	Article							AUDITORY ODDBALL; EEG-DYNAMICS; BRAIN; OSCILLATIONS; POTENTIALS; STIMULI; PHASE; RHYTHMS; CORTEX; SYNCHRONIZATION	Recent findings indicated that both P300 and alpha event-related desynchronization (alpha-ERD) were associated, and similarly involved in cognitive brain functioning, e. g., attention allocation and memory updating. However, an explicit causal influence between the neural generators of P300 and alpha-ERD has not yet been investigated. In the present study, using an oddball task paradigm, we assessed the task effect (target vs. non-target) on P300 and alpha-ERD elicited by stimuli of four sensory modalities, i.e., audition, vision, somatosensory, and pain, estimated their respective neural generators, and investigated the information flow among their neural generators using time-varying effective connectivity in the target condition. Across sensory modalities, the scalp topographies of P300 and alpha-ERD were similar and respectively maximal at parietal and occipital regions in the target condition. Source analysis revealed that P300 and alpha-ERD were mainly generated from posterior cingulate cortex and occipital lobe respectively. As revealed by time-varying effective connectivity, the cortical information was consistently flowed from alpha-ERD sources to P300 sources in the target condition for all four sensory modalities. All these findings showed that P300 in the target condition is modulated by the changes of alpha-ERD, which would be useful to explore neural mechanism of cognitive information processing in the human brain.	[Peng, Weiwei; Hu, Yong] Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Hu, Li] Southwest Univ, Key Lab Cognit & Personal, Minist Educ, Chongqing, Peoples R China; [Hu, Li] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Zhang, Zhiguo] Univ Hong Kong, Dept Elect & Elect Engn, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; Southwest University - China; Southwest University - China; University of Hong Kong	Peng, WW (corresponding author), Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.	huli@swu.edu.cn; yhud@hku.hk	Hu, Yong/C-4276-2009	Hu, Yong/0000-0003-0305-5616	University of Hong Kong CRCG Seed Fund; Fundamental Research Funds for the Central Universities [SWU1109010]; Hong Kong SAR Research Grants Council [HKU762111M]	University of Hong Kong CRCG Seed Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hong Kong SAR Research Grants Council	WP and YH were partially supported by The University of Hong Kong CRCG Seed Fund (http://www3.hku.hk/rss/index.php/fund/seed-basic). LH was supported by the Fundamental Research Funds for the Central Universities (SWU1109010, http://www.dost.moe.edu.cn/). ZZ was supported by the Hong Kong SAR Research Grants Council (HKU762111M, http://www.ugc.edu.hk/eng/rgc/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian ED, 1934, BRAIN, V57, P355, DOI 10.1093/brain/57.4.355; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; Barry RJ, 2004, CLIN NEUROPHYSIOL, V115, P2593, DOI 10.1016/j.clinph.2004.06.004; Barry RJ, 2000, INT J PSYCHOPHYSIOL, V39, P39, DOI 10.1016/S0167-8760(00)00114-8; BASAR E, 1984, INT J NEUROSCI, V24, P1, DOI 10.3109/00207458409079530; Basar E, 1999, IEEE ENG MED BIOL, V18, P56, DOI 10.1109/51.765190; BASAR E, 1985, INT J NEUROSCI, V26, P161; Basar E, 1997, INT J PSYCHOPHYSIOL, V26, P5, DOI 10.1016/S0167-8760(97)00753-8; Basar E, 2000, INT J PSYCHOPHYSIOL, V35, P95, DOI 10.1016/S0167-8760(99)00047-1; Basar E, 2001, INT J PSYCHOPHYSIOL, V39, P241, DOI 10.1016/S0167-8760(00)00145-8; BASAR E, 1991, ACTA OTO-LARYNGOL, P25; Basar E, 1997, BIOL CYBERN, V76, P471, DOI 10.1007/s004220050360; Bastiaansen MCM, 2002, CLIN NEUROPHYSIOL, V113, P1882, DOI 10.1016/S1388-2457(02)00303-6; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; BRANDT ME, 1991, INT J NEUROSCI, V61, P261, DOI 10.3109/00207459108990744; Brandt ME, 1997, INT J PSYCHOPHYSIOL, V26, P285, DOI 10.1016/S0167-8760(97)00771-X; BRANDT ME, 1991, ELECTROEN CLIN NEURO, V80, P16, DOI 10.1016/0168-5597(91)90037-X; Brookes MJ, 2005, NEUROIMAGE, V26, P302, DOI 10.1016/j.neuroimage.2005.01.050; Comerchero MD, 1999, CLIN NEUROPHYSIOL, V110, P24, DOI 10.1016/S0168-5597(98)00033-1; daSilva FHL, 1997, INT J PSYCHOPHYSIOL, V26, P237; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Durka PJ, 2004, IEEE T BIO-MED ENG, V51, P1167, DOI 10.1109/TBME.2004.827341; Gaetz W, 2006, NEUROIMAGE, V30, P899, DOI 10.1016/j.neuroimage.2005.10.009; Girden E.R., 1992, ANOVA REPEATED MEASU, V84; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hamalainen JA, 2011, NEUROIMAGE, V54, P1910, DOI 10.1016/j.neuroimage.2010.10.016; He B, 2011, J NEUROSCI METH, V195, P261, DOI 10.1016/j.jneumeth.2010.11.015; Hegerl U, 1997, PSYCHIAT RES-NEUROIM, V74, P109, DOI 10.1016/S0925-4927(97)03129-6; Hillyard SA, 2009, NEW ENCY NEUROSCIENC, V30, P13, DOI DOI 10.1016/B978-008045046-9.00311-9; Hoechstetter K, BESA RES TUTORIAL 4; Hua KG, 2009, CEREB CORTEX, V19, P1889, DOI 10.1093/cercor/bhn215; Huster RJ, 2010, HUM BRAIN MAPP, V31, P1260, DOI 10.1002/hbm.20933; Iannetti GD, 2008, J NEUROPHYSIOL, V100, P815, DOI 10.1152/jn.00097.2008; Inui K, 2006, CEREB CORTEX, V16, P355, DOI 10.1093/cercor.bhi114; Inui K, 2002, PAIN, V96, P247, DOI 10.1016/S0304-3959(01)00453-5; JANSEN BH, 1991, ELECTROEN CLIN NEURO, V80, P241, DOI 10.1016/0168-5597(91)90107-9; JASIUKAITIS P, 1988, PSYCHOPHYSIOLOGY, V25, P157, DOI 10.1111/j.1469-8986.1988.tb00979.x; John SB, 1959, ELECTROEN CLIN NEURO, V12, P317; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; Kandel R. E., 2000, PRINCIPLES NEURAL SC; Klimesch W, 1997, INT J PSYCHOPHYSIOL, V26, P319, DOI 10.1016/S0167-8760(97)00773-3; Klimesch W, 1998, NEUROSCI LETT, V244, P73, DOI 10.1016/S0304-3940(98)00122-0; Kolev V, 1999, CLIN NEUROPHYSIOL, V110, P1784, DOI 10.1016/S1388-2457(99)00105-4; Ku YX, 2010, NEUROSCI LETT, V472, P5, DOI 10.1016/j.neulet.2010.01.040; Li YZ, 2008, CHINESE SCI BULL, V53, P76, DOI 10.1007/s11434-008-0060-8; Linden DEJ, 2005, NEUROSCIENTIST, V11, P563, DOI 10.1177/1073858405280524; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; MILTNER W, 1989, PAIN, V38, P303, DOI 10.1016/0304-3959(89)90217-0; Mouraux A, 2008, MAGN RESON IMAGING, V26, P1041, DOI 10.1016/j.mri.2008.01.011; Mouraux A, 2010, PAIN, V150, P199, DOI 10.1016/j.pain.2010.04.026; Mu Y, 2008, BRAIN RES, V1234, P128, DOI 10.1016/j.brainres.2008.07.113; Mullen T., 2010, BIOL CYBERN; Muller BW, 2003, NEUROREPORT, V14, P1597, DOI 10.1097/00001756-200308260-00011; Palva S, 2007, TRENDS NEUROSCI, V30, P150, DOI 10.1016/j.tins.2007.02.001; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; PFURTSCHELLER G, 1994, INT J PSYCHOPHYSIOL, V16, P147, DOI 10.1016/0167-8760(89)90041-X; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Polich J, 1997, INT J PSYCHOPHYSIOL, V26, P299, DOI 10.1016/S0167-8760(97)00772-1; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; RAHN E, 1993, INT J NEUROSCI, V72, P123, DOI 10.3109/00207459308991629; Rahn E, 1993, Int J Neurosci, V69, P207; Remond A, 1967, ELECTROENCEPH CL S26, V26, P42; ROGAN JC, 1979, BRIT J MATH STAT PSY, V32, P269, DOI 10.1111/j.2044-8317.1979.tb00598.x; Sauseng P, 2008, NEUROSCI BIOBEHAV R, V32, P1001, DOI 10.1016/j.neubiorev.2008.03.014; Schurmann M, 2001, INT J PSYCHOPHYSIOL, V39, P151, DOI 10.1016/S0167-8760(00)00138-0; Schurmann M, 1997, INT J PSYCHOPHYSIOL, V26, P149, DOI 10.1016/S0167-8760(97)00762-9; Stancak A, 2006, PROG BRAIN RES, V159, P237, DOI 10.1016/S0079-6123(06)59016-8; Tarkka IM, 1996, NEUROSCIENCE, V75, P275, DOI 10.1016/0306-4522(96)00287-4; Treede RD, 2003, NEUROPHYSIOL CLIN, V33, P303, DOI 10.1016/j.neucli.2003.10.009; Valentini E, 2012, NEUROIMAGE, V59, P1571, DOI 10.1016/j.neuroimage.2011.08.069; Yang L, 2009, IFMBE PROC, V25, P493, DOI 10.1007/978-3-642-03879-2_138; Yordanova J, 1998, NEUROREPORT, V9, P3159, DOI 10.1097/00001756-199810050-00007; Yordanova J, 2001, PSYCHOPHYSIOLOGY, V38, P143, DOI 10.1017/S0048577201990079; Zaslansky R, 1996, PAIN, V66, P39, DOI 10.1016/0304-3959(96)03020-5; Zhang ZG, 2010, EEG SIM APPL 7 INT C	76	52	54	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34163	10.1371/journal.pone.0034163	http://dx.doi.org/10.1371/journal.pone.0034163			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511933	gold, Green Published			2022-12-27	WOS:000305338600019
J	Pinho, R; Borenstein, E; Feldman, MW				Pinho, Ricardo; Borenstein, Elhanan; Feldman, Marcus W.			Most Networks in Wagner's Model Are Cycling	PLOS ONE			English	Article							GENE NETWORKS; KAUFFMAN NETWORKS; TRANSCRIPTIONAL REGULATION; THRESHOLD NETWORKS; BOOLEAN NETWORK; ROBUSTNESS; EVOLUTION; DYNAMICS; STABILITY; TOPOLOGY	In this paper we study a model of gene networks introduced by Andreas Wagner in the 1990s that has been used extensively to study the evolution of mutational robustness. We investigate a range of model features and parameters and evaluate the extent to which they influence the probability that a random gene network will produce a fixed point steady state expression pattern. There are many different types of models used in the literature, (discrete/continuous, sparse/dense, small/large network) and we attempt to put some order into this diversity, motivated by the fact that many properties are qualitatively the same in all the models. Our main result is that random networks in all models give rise to cyclic behavior more often than fixed points. And although periodic orbits seem to dominate network dynamics, they are usually considered unstable and not allowed to survive in previous evolutionary studies. Defining stability as the probability of fixed points, we show that the stability distribution of these networks is highly robust to changes in its parameters. We also find sparser networks to be more stable, which may help to explain why they seem to be favored by evolution. We have unified several disconnected previous studies of this class of models under the framework of stability, in a way that had not been systematically explored before.	[Pinho, Ricardo; Feldman, Marcus W.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Pinho, Ricardo] Inst Gulbenkian Ciencias, PhD Program Computat Biol, Oeiras, Portugal; [Borenstein, Elhanan] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Stanford University; Instituto Gulbenkian de Ciencia; University of Washington; University of Washington Seattle	Pinho, R (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	rpinho@stanford.edu	Pinho, Ricardo/G-2643-2012; Pinho, Ricardo/GQH-3657-2022	Pinho, Ricardo/0000-0003-3116-4553; Pinho, Ricardo/0000-0003-3116-4553	Fundacao Calouste Gulbenkian; Siemens SA; Fundacao para a Ciencia e Tecnologia [SFRH/BD/33531/2008]; National Institutes of Health grant [GM28016]; National Science Foundation award [CNS-0619926]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028016] Funding Source: NIH RePORTER	Fundacao Calouste Gulbenkian(European Commission); Siemens SA; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation award(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Ph.D. Program in Computational Biology is sponsored by Fundacao Calouste Gulbenkian, Siemens SA, and Fundacao para a Ciencia e Tecnologia (fellowship SFRH/BD/33531/2008). The research was also supported in part by National Institutes of Health grant GM28016 and National Science Foundation award CNS-0619926. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2003, J THEOR BIOL, V223, P1, DOI 10.1016/S0022-5193(03)00035-3; Aldana M, 2003, PERSPECTIVES AND PROBLEMS IN NONLINEAR SCIENCE, P23; Anafi RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014413; Azevedo RBR, 2006, NATURE, V440, P87, DOI 10.1038/nature04488; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Borenstein E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000202; Bornholdt S, 2001, BIOL CHEM, V382, P1289, DOI 10.1515/BC.2001.161; Bornholdt S, 2005, SCIENCE, V310, P449, DOI 10.1126/science.1119959; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Burda Z, 2009, ARXIV09104077V1QBIOM; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Ciliberti S, 2007, P NATL ACAD SCI USA, V104, P13591, DOI 10.1073/pnas.0705396104; Ciliberti S, 2007, PLOS COMPUT BIOL, V3, P164, DOI 10.1371/journal.pcbi.0030015; Draghi J, 2009, J EVOLUTION BIOL, V22, P599, DOI 10.1111/j.1420-9101.2008.01663.x; Drossel B, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.088701; Drossel B, 2008, ARXIV07063351V2CONDM; Espinosa-soto C, 2004, PLANT CELL, V16, P2923, DOI 10.1105/tpc.104.021725; Espinosa-Soto C, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000719; Gama-Castro S, 2011, NUCLEIC ACIDS RES, V39, pD98, DOI 10.1093/nar/gkq1110; Greil F, 2007, EUR PHYS J B, V57, P109, DOI 10.1140/epjb/e2007-00161-0; Greil F, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.048701; Greil F, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/10/373; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huerta-Sanchez E, 2007, THEOR POPUL BIOL, V71, P121, DOI 10.1016/j.tpb.2006.10.006; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kaneko K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000434; Kauffman S, 2003, P NATL ACAD SCI USA, V100, P14796, DOI 10.1073/pnas.2036429100; Kauffman S, 2004, P NATL ACAD SCI USA, V101, P17102, DOI 10.1073/pnas.0407783101; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; Klemm K, 2005, PHYS REV E, V72, P1; KURTEN KE, 1988, PHYS LETT A, V129, P157, DOI 10.1016/0375-9601(88)90135-1; KURTEN KE, 1988, J PHYS A-MATH GEN, V21, pL615, DOI 10.1088/0305-4470/21/11/009; Li FT, 2004, P NATL ACAD SCI USA, V101, P4781, DOI 10.1073/pnas.0305937101; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Martin OC, 2009, GENETICS, V183, P673, DOI 10.1534/genetics.109.104174; Masel J, 2004, J EVOLUTION BIOL, V17, P1106, DOI 10.1111/j.1420-9101.2004.00739.x; McDonald D, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-49; Palmer ME, 2009, EVOLUTION, V63, P418, DOI 10.1111/j.1558-5646.2008.00577.x; Paul U, 2006, PHYS REV E, V73, P1; Rodriguez-Caso C, 2009, MOL BIOSYST, V5, P1617, DOI [10.1039/b904960f, 10.1039/B904960f]; Rohlf T, 2002, PHYSICA A, V310, P245, DOI 10.1016/S0378-4371(02)00798-7; Rohlf T, 2009, ARXIV09083610V1QBIOM; Rohlf T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.248701; Samuelsson B, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.098701; Sevim V, 2008, J THEOR BIOL, V253, P323, DOI 10.1016/j.jtbi.2008.03.003; Siegal ML, 2007, GENETICA, V129, P83, DOI 10.1007/s10709-006-0035-0; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; WAGNER A, 1994, P NATL ACAD SCI USA, V91, P4387, DOI 10.1073/pnas.91.10.4387; Wagner A, 1996, EVOLUTION, V50, P1008, DOI 10.1111/j.1558-5646.1996.tb02342.x	53	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34285	10.1371/journal.pone.0034285	http://dx.doi.org/10.1371/journal.pone.0034285			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511935	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600021
J	Butler, RJ; Porro, LB; Galton, PM; Chiappe, LM				Butler, Richard J.; Porro, Laura B.; Galton, Peter M.; Chiappe, Luis M.			Anatomy and Cranial Functional Morphology of the Small-Bodied Dinosaur Fruitadens haagarorum from the Upper Jurassic of the USA	PLOS ONE			English	Article							PRIMITIVE ORNITHISCHIAN DINOSAUR; EARLY EVOLUTION; SOUTH-AFRICA; HETERODONTOSAURID DINOSAUR; CHANGCHUNSAURUS-PARVUS; CERATOPSIAN DINOSAUR; MANDIBULAR CORPUS; COMPLETE SKELETON; JILIN PROVINCE; ORIGIN	Background: Heterodontosaurids are an important but enigmatic and poorly understood early radiation of ornithischian dinosaurs. The late-surviving heterodontosaurid Fruitadens haagarorum from the Late Jurassic (early Tithonian) Morrison Formation of the western USA is represented by remains of several small (<1 metre total body length, <1 kg body mass) individuals that include well-preserved but incomplete cranial and postcranial material. Fruitadens is hypothesized to represent one of the smallest known ornithischian dinosaurs. Methodology/Principal Findings: We describe the cranial and postcranial anatomy of Fruitadens in detail, providing comparisons to all other known heterodontosaurid taxa. High resolution micro-CT data provides new insights into tooth replacement and the internal anatomy of the tooth-bearing bones. Moreover, we provide a preliminary functional analysis of the skull of late-surviving heterodontosaurids, discuss the implications of Fruitadens for current understanding of heterodontosaurid monophyly, and briefly review the evolution and biogeography of heterodontosaurids. Conclusions/Significance: The validity of Fruitadens is supported by multiple unique characters of the dentition and hindlimb as well as a distinct character combination. Fruitadens shares highly distinctive appendicular characters with other heterodontosaurids, strengthening monophyly of the clade on the basis of the postcranium. Mandibular morphology and muscle moment arms suggest that the jaws of late-surviving heterodontosaurids, including Fruitadens, were adapted for rapid biting at large gape angles, contrasting with the jaws of the stratigraphically older Heterodontosaurus, which were better suited for strong jaw adduction at small gapes. The lack of wear facets and plesiomorphic dentition suggest that Fruitadens used orthal jaw movements and employed simple puncture-crushing to process food. In combination with its small body size, these results suggest that Fruitadens was an ecological generalist, consuming select plant material and possibly insects or other invertebrates.	[Butler, Richard J.] Bayer Staatssammlung Palaontol & Geol, Munich, Germany; [Butler, Richard J.] Univ Munich, GeoBio Ctr, Munich, Germany; [Porro, Laura B.] Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA; [Galton, Peter M.] Univ Bridgeport, Bridgeport, CT USA; [Chiappe, Luis M.] Los Angeles Cty Museum Nat Hist, Dinosaur Inst, Los Angeles, CA USA	University of Munich; University of Chicago; University of Bridgeport	Butler, RJ (corresponding author), Bayer Staatssammlung Palaontol & Geol, Munich, Germany.	butler.richard.j@gmail.com	Butler, Richard J./A-5239-2011	Butler, Richard J./0000-0003-2136-7541; Chiappe, Luis/0000-0001-9661-0601; Porro, Laura/0000-0002-0546-2381	Alexander von Humboldt Postdoctoral Research Fellowship; German Research Foundation [BU 2587/3-1]	Alexander von Humboldt Postdoctoral Research Fellowship(Alexander von Humboldt Foundation); German Research Foundation(German Research Foundation (DFG))	RJB was supported during the completion of this research by an Alexander von Humboldt Postdoctoral Research Fellowship and the German Research Foundation Emmy Noether Programme (BU 2587/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attridge J., 1985, Journal of Vertebrate Paleontology, V5, P128; Averianov AO, 2006, J SYST PALAEONTOL, V4, P359, DOI 10.1017/S1477201906001933; Baez AM, 2001, AMEGHINIANA, V38, P271; Bakker R. T., 1990, HUNTERIA, V2, P8; BAKKER RT, 1974, NATURE, V248, P168, DOI 10.1038/248168a0; Barrett Paul M., 2000, P42, DOI 10.1017/CBO9780511549717.004; Barrett PM, 2009, ZOOTAXA, P31, DOI 10.11646/zootaxa.2072.1.2; Barrett Paul M., 1999, Journal of Vertebrate Paleontology, V19, p31A; Barrett PM, 2006, TRENDS ECOL EVOL, V21, P217, DOI 10.1016/j.tree.2006.01.002; Barrett PM, 2005, J PALEONTOL, V79, P981, DOI 10.1666/0022-3360(2005)079[0981:ARODLY]2.0.CO;2; Barrett PM, 1998, THESIS U CAMBRIDGE; Bell PR, 2009, ANAT REC, V292, P1338, DOI 10.1002/ar.20978; BIKNEVICIUS AR, 1992, J ZOOL, V228, P479, DOI 10.1111/j.1469-7998.1992.tb04450.x; BOCK W J, 1968, Journal of Biomechanics, V1, P89, DOI 10.1016/0021-9290(68)90011-0; BOCK WJ, 1965, EVOLUTION, V19, P269, DOI 10.2307/2406439; BOCK WJ, 1966, AUK, V83, P10, DOI 10.2307/4082976; BONAPARTE JF, 1976, J PALEONTOL, V50, P808; Broom R, 1911, ANN S AFR MUS, V7, P291; Brown B, 1908, B AM MUS NAT HIST, V24, P187; Brusatte SL, 2010, EARTH-SCI REV, V101, P68, DOI 10.1016/j.earscirev.2010.04.001; Butler RJ, 2008, J VERTEBR PALEONTOL, V28, P702, DOI 10.1671/0272-4634(2008)28[702:AJSOTP]2.0.CO;2; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2007, P ROY SOC B-BIOL SCI, V274, P2041, DOI 10.1098/rspb.2007.0367; Butler RJ, 2006, NEUES JAHRB GEOL P-M, P613; Butler RJ, 2011, PALAEONTOLOGY, V54, P667, DOI 10.1111/j.1475-4983.2011.01046.x; Butler RJ, 2010, ZOOL J LINN SOC-LOND, V160, P648, DOI 10.1111/j.1096-3642.2009.00631.x; Butler RJ, 2010, P ROY SOC B-BIOL SCI, V277, P375, DOI 10.1098/rspb.2009.1494; Butler RJ, 2009, CRETACEOUS RES, V30, P63, DOI 10.1016/j.cretres.2008.03.002; Butler RJ, 2005, ZOOL J LINN SOC-LOND, V145, P175, DOI 10.1111/j.1096-3642.2005.00182.x; Callison G., 1984, Journal of Vertebrate Paleontology, V3, P200; Callison G, 1980, EVALUATION FOSSIL VE, P142; Callison G., 1987, PALEONTOLOGY GEOLOGY, P91; CASAMIQUELA RM, 1967, AMEGHINIANA, V4, P47; CHARIG A J, 1974, Annals of the South African Museum, V64, P167; CLARK JM, 1985, THESIS U CALIFORNIA; Colbert E.H., 1981, Museum of Northern Arizona Bulletin, P1; COOPER M R, 1985, Annals of the South African Museum, V95, P281; Cooper WE, 2002, J ZOOL, V257, P487, DOI 10.1017/S0952836902001085; Crompton A.W., 1986, P223; CROMPTON AW, 1962, NATURE, V196, P1074, DOI 10.1038/1961074a0; Dullemeijer P., 1974, CONCEPTS APPROACHES; Dzik J, 2003, J VERTEBR PALEONTOL, V23, P556, DOI 10.1671/A1097; Engelmann George F., 1998, Modern Geology, V23, P343; Engelmann GF, 1999, UTAH GEOLOGICAL SURV, P161; EVANS SE, 1994, IN THE SHADOW OF THE DINOSAURS, P303; Evans Susan E., 1996, Museum of Northern Arizona Bulletin, V60, P243; Foster J., 2007, JURASSIC W DINOSAURS; Foster John R., 2003, Brigham Young University Geology Studies, V47, P17; Galton P.M., 1973, Brigham Young Univ Stud Geol, V20, P137; GALTON P M, 1978, Palaeontologische Zeitschrift, V52, P138; Galton P.M, 2006, HORNS BEAKS CERATOPS, P17; Galton Peter M., 2002, Journal of Vertebrate Paleontology, V22, p55A; Galton Peter M., 2009, Revue de Paleobiologie, V28, P211; GALTON PM, 1973, LETHAIA, V6, P67, DOI 10.1111/j.1502-3931.1973.tb00873.x; Galton PM, BERNISSART IN PRESS; Galton PM., 1974, B BRIT MUS NAT HIS A, V25, P1; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; GILMORE CHARLES W., 1931, PROC U S NATION MUS, V79, P1; Gohlich UB, 2005, CAN J EARTH SCI, V42, P307, DOI 10.1139/E05-005; GOW C E, 1990, Annals of the South African Museum, V99, P367; GOW CE, 1975, ZOOL J LINN SOC-LOND, V57, P335, DOI 10.1111/j.1096-3642.1975.tb01895.x; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; GREAVES W S, 1974, Forma et Functio, V7, P363; GREAVES WS, 1991, ZOOL J LINN SOC-LOND, V102, P367, DOI 10.1111/j.1096-3642.1991.tb00006.x; Haas G., 1963, Annals of the Carnegie Museum, V36, P139; HAAS GEORG, 1955, AMER MUS NOVITATES, V1729, P1; Haubold H., 1990, Revue de Paleobiologie, V9, P149; Haughton S. H., 1924, Annals of the South African Museum, V12, P323; He X., 1984, MIDDLE JURASSIC DINO; Holliday CM, 2007, J MORPHOL, V268, P457, DOI 10.1002/jmor.10524; HOPSON JA, 1980, LETHAIA, V13, P93, DOI 10.1111/j.1502-3931.1980.tb01035.x; HOPSON JA, 1975, S AFR J SCI, V71, P302; Hylander WL, 1998, AM J PHYS ANTHROPOL, V107, P257, DOI 10.1002/(SICI)1096-8644(199811)107:3<257::AID-AJPA3>3.3.CO;2-Y; Irmis Randall B., 2007, Historical Biology, V19, P3, DOI 10.1080/08912960600719988; Jin LY, 2010, J VERTEBR PALEONTOL, V30, P196, DOI 10.1080/02724630903412372; Kirkland J. I., 2006, NEW MEXICO MUSEUM NA, V36, P67; Kirkland James I., 1994, P124; Kirkland James I., 1998, Modern Geology, V22, P503; Kirkland JI, 1997, ENCY DINOSAURS, P254; Kowallis B.J., 1998, MODERN GEOLOGIST, V22, P235; Kuhn O., 1966, REPTILIEN SYSTEM STA; Langer MC, 2010, BIOL REV, V85, P55, DOI 10.1111/j.1469-185X.2009.00094.x; Langer Max Cardoso, 2003, Paleobios, V23, P1; LAUDER GV, 1982, J THEOR BIOL, V97, P57, DOI 10.1016/0022-5193(82)90276-4; Liu ZJ, 2000, ARCH ORAL BIOL, V45, P95, DOI 10.1016/S0003-9969(99)00127-2; Lu JC, 2011, SCIENCE, V331, P321, DOI 10.1126/science.1197323; Luo ZX, 2005, SCIENCE, V308, P103, DOI 10.1126/science.1108875; Lydekker R., 1888, CATALOGUE FOSSIL R 1; Madsen JH., 2000, UTAH GEOLOGICAL SURV, V2, P1; Marsh O.C., 1889, AM J SCI, V38, P173, DOI [10.2475/ajs.s3-38.224.173, DOI 10.2475/AJS.S3-38.224.173]; Martinez RN, 2011, SCIENCE, V331, P206, DOI 10.1126/science.1198467; MARYANSKA T, 1985, Acta Palaeontologica Polonica, V30, P137; Maryanska T, 1974, Palaeontologia Polonica, VNo. 30, P45; Maryanska T, 1984, 27 INT GEOL C, P286; Mazetta GV, 2004, AMEGHINIANA, V41, P605; Mazzatta Gerardo V., 2000, Gaia (Lisboa), V15, P185; Molnar Ralph E., 2000, Gaia (Lisboa), V15, P193; Nesbitt SJ, 2009, SCIENCE, V326, P1530, DOI 10.1126/science.1180350; Norman D.B., 1984, 3 S MESOZOIC TERREST, P157; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P393; Norman DB, 2011, ZOOL J LINN SOC-LOND, V163, P182, DOI 10.1111/j.1096-3642.2011.00697.x; Norman DB, 2002, SPEC PAP PALAEONTOL, P161; Olshevsky G, 1994, KYORYUGAKU SAIZENSEN, V8, P74; OSTROM JOHN H., 1964, POSTILLA [YALE PEABODY MUS], V88, P1; Owen R., 1861, PALAEONTOGRAPHICAL S, VXII, P31; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Owen R., 1874, PALAEONTOGRAPHICAL S, VXXVII, P1; PARKS WA, 1922, U TORONTO STUDIES GE, V13, P1; Peng Guangzhao, 1992, Vertebrata Palasiatica, V30, P39; PERLE A, 1982, Acta Palaeontologica Polonica, V27, P115; Pierce SE, 2008, J MORPHOL, V269, P840, DOI 10.1002/jmor.10627; Plotnick RE, 2000, PALEOBIOLOGY, V26, P305, DOI 10.1666/0094-8373(2000)26[305:IBEFAI]2.0.CO;2; Pol D, 2011, NATURWISSENSCHAFTEN, V98, P369, DOI 10.1007/s00114-011-0780-5; Porro L, 2007, J VERTEBR PALEONTOL, V27, p131A; Porro LB, 2010, EARTH ENV SCI T R SO, V101, P351, DOI 10.1017/S175569101102010X; Porro LB, 2011, J MORPHOL, V272, P910, DOI 10.1002/jmor.10957; Porro LB, 2009, THESIS U CAMBRIDGE; RASMUSSEN TE, 1981, J PALEONTOL, V55, P1109; RASMUSSEN TE, 1981, J PALEONTOL, V55, P628; Rayfield EJ, 2001, THESIS U CAMBRIDGE; Rougier Guillermo W., 1996, American Museum Novitates, V3183, P1; Sanchez-Hernandez B, 2007, PALAEOGEOGR PALAEOCL, V249, P180, DOI 10.1016/j.palaeo.2007.01.009; Santa Luca A. P., 1980, ANN S AFR MUS, V79, P159, DOI DOI 10.1038/264324A0; SANTALUCA AP, 1976, NATURE, V264, P324, DOI 10.1038/264324a0; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P168; Sereno P.C., 1984, 3 S MESOZOIC TERREST, P219; Sereno Paul C., 1993, Journal of Vertebrate Paleontology, V13, P451; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Sereno PC, 1997, ANNU REV EARTH PL SC, V25, P435, DOI 10.1146/annurev.earth.25.1.435; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; Sereno PC, 2005, STEM ARCHOSAURIA; Smith J. M., 1959, School Science Review, V40, P289; Smith Kathleen K., 1993, P150; SUES H-D, 1987, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V198, P1; Tatarinov LP, 1985, PALEONTOL J, V19, P138; Therrien F, 2005, LIFE O PAST, P179; THULBORN R A, 1970, Zoological Journal of the Linnean Society, V49, P235, DOI 10.1111/j.1096-3642.1970.tb00739.x; THULBORN R A, 1972, Palaeontology (Oxford), V15, P29; THULBORN RA, 1978, LETHAIA, V11, P185, DOI 10.1111/j.1502-3931.1978.tb01226.x; THULBORN RA, 1974, ZOOL J LINN SOC-LOND, V55, P151, DOI 10.1111/j.1096-3642.1974.tb01591.x; Thulborn RA, 1973, MEMORIAS SERVICOS GE, V22, P89; Turner CE, 1999, UTAH GEOLOGICAL SURV, P75; Tykoski R. S., 2005, MESA SOUTHWEST MUS B, V11, P72; Tykoski RS, 1998, THESIS U TEXAS TX; VANDRONGELEN W, 1982, ANAT ANZEIGER, V151, P337; Walker J. D., 2009, GSA TODAY, V19, P60, DOI DOI 10.1130/2009.CTS004R2C; Weishampel D.B., 1990, P486; WEISHAMPEL DB, 1984, ADV ANAT EMBRYOL CEL, V87, P1; Weishampel DB., 2004, DINOSAURIA; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; Westneat MW, 2004, INTEGR COMP BIOL, V44, P378, DOI 10.1093/icb/44.5.378; Witmer LM, 2009, NATURE, V458, P293, DOI 10.1038/458293a; Xu X, 2002, NATURE, V416, P314, DOI 10.1038/416314a; Xu X, 2006, P ROY SOC B-BIOL SCI, V273, P2135, DOI 10.1098/rspb.2006.3566; Yang Z. J, 1982, COLLECTED WORKS YANG, P38; You HL, 2003, ACTA PALAEONTOL POL, V48, P261; You HL, 2003, ACTA GEOL SIN-ENGL, V77, P15; Zhao XJ, 2006, ACTA GEOL SIN-ENGL, V80, P467; Zheng XT, 2009, NATURE, V458, P333, DOI 10.1038/nature07856	161	60	61	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e31556	10.1371/journal.pone.0031556	http://dx.doi.org/10.1371/journal.pone.0031556			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509242	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600002
J	Frogne, T; Sylvestersen, KB; Kubicek, S; Nielsen, ML; Hecksher-Sorensen, J				Frogne, Thomas; Sylvestersen, Kathrine Beck; Kubicek, Stefan; Nielsen, Michael Lund; Hecksher-Sorensen, Jacob			Pdx1 Is Post-Translationally Modified In vivo and Serine 61 Is the Principal Site of Phosphorylation	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; HOMEODOMAIN TRANSCRIPTION FACTOR; DUODENAL HOMEOBOX-1 PROTEIN; INSULIN PROMOTER ACTIVITY; DNA-BINDING ACTIVITY; DIABETES-MELLITUS; GENE; EXPRESSION; ACTIVATION; GLUCOSE	Maintaining sufficient levels of Pdx1 activity is a prerequisite for proper regulation of blood glucose homeostasis and beta cell function. Mice that are haploinsufficient for Pdx1 display impaired glucose tolerance and lack the ability to increase beta cell mass in response to decreased insulin signaling. Several studies have shown that post-translational modifications are regulating Pdx1 activity through intracellular localization and binding to co-factors. Understanding the signaling cues converging on Pdx1 and modulating its activity is therefore an attractive approach in diabetes treatment. We employed a novel technique called Nanofluidic Proteomic Immunoassay to characterize the post-translational profile of Pdx1. Following isoelectric focusing in nano-capillaries, this technology relies on a pan specific antibody for detection and it therefore allows the relative abundance of differently charged protein species to be examined simultaneously. In all eukaryotic cells tested we find that the Pdx1 protein separates into four distinct peaks whereas Pdx1 protein from bacteria only produces one peak. Of the four peaks in eukaryotic cells we correlate one of them to a phosphorylation Using alanine scanning and mass spectrometry we map this phosphorylation to serine 61 in both Min6 cells and in exogenous Pdx1 over-expressed in HEK293 cells. A single phosphorylation is also present in cultured islets but it remains unaffected by changes in glucose levels. It is present during embryogenesis but is not required for pancreas development.	[Frogne, Thomas; Hecksher-Sorensen, Jacob] Hagedorn Res Inst, Dept Beta Cell Regenerat, Gentofte, Denmark; [Sylvestersen, Kathrine Beck; Nielsen, Michael Lund] Univ Copenhagen, Ctr Prot Res, Copenhagen, Denmark; [Kubicek, Stefan] Austrian Acad Sci, Res Ctr Mol Med, A-1010 Vienna, Austria	Novo Nordisk; Hagedorn Research Institute; University of Copenhagen; Austrian Academy of Sciences	Frogne, T (corresponding author), Hagedorn Res Inst, Dept Beta Cell Regenerat, Gentofte, Denmark.	jhes@hagedorn.dk	Hecksher-Sørensen, Jacob/AAB-3424-2021; Kubicek, Stefan/C-2089-2017	Kubicek, Stefan/0000-0003-0855-8343; Nielsen, Michael/0000-0002-0067-9039; Beck Sylvestersen, Kathrine/0000-0002-8201-4769	JDRF [26-2008-639]; EU [PIOF-GA-2008-21135]	JDRF(Juvenile Diabetes Research Foundation); EU(European Commission)	This work was made possible by funding from the JDRF www.jdrf.org; grant #26-2008-639 (to JH-S) and EU FP7 Marie Curie Fellowship www.mariecurie.org PIOF-GA-2008-21135 (SK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Hagedorn Research Institute is affiliated to Novo Nordisk. JH-S owns equity shares in Novo Nordisk A/S. JH-S is 100% employed by Novo Nordisk. TF is 100% funded by a grant from JDRF. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Ahnfelt-Ronne J, 2007, J HISTOCHEM CYTOCHEM, V55, P925, DOI 10.1369/jhc.7A7226.2007; An R, 2006, BIOCHEM SOC T, V34, P791, DOI 10.1042/BST0340791; An R, 2010, BIOCH BIOPHYS RES CO; Boucher MJ, 2006, J BIOL CHEM, V281, P6395, DOI 10.1074/jbc.M511597200; Carlotti F, 2008, BIOCHEM BIOPH RES CO, V370, P225, DOI 10.1016/j.bbrc.2008.03.071; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Cox J, 2009, NAT PROTOC, V4, P698, DOI 10.1038/nprot.2009.36; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Elrick LJ, 2001, DIABETES, V50, P2244, DOI 10.2337/diabetes.50.10.2244; Fan AC, 2009, NAT MED, V15, P566, DOI 10.1038/nm.1903; Fernandez-Alvarez J, 2004, DIABETOLOGIA, V47, P470, DOI 10.1007/s00125-004-1332-8; Fujimoto K, 2010, P NATL ACAD SCI US; Galbo T, EUR J HISTOCHEM, V54, pe19; Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Grapin-Botton A, 2001, GENE DEV, V15, P444, DOI 10.1101/gad.846001; Hani EH, 1999, J CLIN INVEST, V104, pR41, DOI 10.1172/JCI7469; Holland AM, 2005, DIABETES, V54, P2586, DOI 10.2337/diabetes.54.9.2586; Horb ME, 2003, CURR BIOL, V13, P105, DOI 10.1016/S0960-9822(02)01434-3; Huang HG, 2001, GENESIS, V30, P134, DOI 10.1002/gene.1048; Humphrey RK, 2010, J BIOL CHEM, V285, P3406, DOI 10.1074/jbc.M109.006734; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Jorgensen MC, 2007, ENDOCR REV, V28, P685, DOI 10.1210/er.2007-0016; Khoo S, 2003, J BIOL CHEM, V278, P32969, DOI 10.1074/jbc.M301198200; Kim YC, 2011, EMBO J; Kishi A, 2003, AM J PHYSIOL-ENDOC M, V284, pE830, DOI 10.1152/ajpendo.00390.2002; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Lebrun P, 2005, J BIOL CHEM, V280, P38203, DOI 10.1074/jbc.M504842200; Leibowitz G, 2001, DIABETES, V50, P1799, DOI 10.2337/diabetes.50.8.1799; Macfarlane WM, 1999, J BIOL CHEM, V274, P1011, DOI 10.1074/jbc.274.2.1011; Meng R, 2010, CELL MOL LIFE SCI; Milewski WM, 1998, ENDOCRINOLOGY, V139, P1440, DOI 10.1210/en.139.3.1440; Mosley AL, 2004, J BIOL CHEM, V279, P54241, DOI 10.1074/jbc.M410379200; Mosley AL, 2004, MOL ENDOCRINOL, V18, P2279, DOI 10.1210/me.2003-0463; O'Neill RA, 2006, P NATL ACAD SCI USA, V103, P16153, DOI 10.1073/pnas.0607973103; Offield MF, 1996, DEVELOPMENT, V122, P983; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pedersen JK, 2005, DEV BIOL, V288, P487, DOI 10.1016/j.ydbio.2005.10.001; Petersen HV, 1998, FEBS LETT, V431, P362, DOI 10.1016/S0014-5793(98)00776-5; Rosenberg LC, 2010, DEV DYNAM, V239, P1950, DOI 10.1002/dvdy.22329; Seufert J, 1998, J CLIN INVEST, V101, P2528, DOI 10.1172/JCI2401; Stanojevic V, 2004, ENDOCRINOLOGY, V145, P2918, DOI 10.1210/en.2003-1188; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Waeber G, 1996, MOL ENDOCRINOL, V10, P1327, DOI 10.1210/me.10.11.1327; Watada H, 1996, DIABETES, V45, P1478, DOI 10.2337/diabetes.45.11.1478; WRIGHT CVE, 1989, DEVELOPMENT, V105, P787; Wu H, 1999, BIOCHEM J, V344, P813, DOI 10.1042/0264-6021:3440813; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; Yee NS, 2001, GENESIS, V30, P137, DOI 10.1002/gene.1049	53	14	14	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35233	10.1371/journal.pone.0035233	http://dx.doi.org/10.1371/journal.pone.0035233			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509401	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336600095
J	Hilborn, RC; Brookshire, B; Mattingly, J; Purushotham, A; Sharma, A				Hilborn, Robert C.; Brookshire, Benjamin; Mattingly, Jenna; Purushotham, Anusha; Sharma, Anuraag			The Transition between Stochastic and Deterministic Behavior in an Excitable Gene Circuit	PLOS ONE			English	Article							COPY NUMBER VARIATION; CIRCADIAN CLOCK; NOISE; COMPENSATION; ANEUPLOIDY; EXPRESSION; DOSAGE	We explore the connection between a stochastic simulation model and an ordinary differential equations (ODEs) model of the dynamics of an excitable gene circuit that exhibits noise-induced oscillations. Near a bifurcation point in the ODE model, the stochastic simulation model yields behavior dramatically different from that predicted by the ODE model. We analyze how that behavior depends on the gene copy number and find very slow convergence to the large number limit near the bifurcation point. The implications for understanding the dynamics of gene circuits and other birth-death dynamical systems with small numbers of constituents are discussed.	[Hilborn, Robert C.; Brookshire, Benjamin; Mattingly, Jenna; Purushotham, Anusha; Sharma, Anuraag] Univ Texas Dallas, Richardson, TX 75083 USA	University of Texas System; University of Texas Dallas	Hilborn, RC (corresponding author), Univ Texas Dallas, Richardson, TX 75083 USA.	rhilborn@aapt.org		Purushotham, Arnie/0000-0001-8577-9655				Acar M, 2010, SCIENCE, V329, P1656, DOI 10.1126/science.1190544; Arnold L., 2003, RANDOM DYNAMICAL SYS; Boland RP, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051131; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cagatay T, 2009, CELL, V139, P512, DOI 10.1016/j.cell.2009.07.046; Galla T, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021909; GILLESPIE DT, 1976, J COMPUT PHYS, V22, P403, DOI 10.1016/0021-9991(76)90041-3; Gillespie DT, 2000, J CHEM PHYS, V113, P297, DOI 10.1063/1.481811; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hilborn RC, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031112; Hou ZH, 2003, J CHEM PHYS, V119, P11508, DOI 10.1063/1.1624053; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Koseska A, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.020901; Lande R., 2003, OXFORD SERIES ECOLOG; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lu TK, 2009, NAT BIOTECHNOL, V27, P1139, DOI 10.1038/nbt.1591; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Mazzio EA, 2012, EPIGENETICS-US, V7, P119, DOI 10.4161/epi.7.2.18764; Mills RE, 2011, NATURE, V470, P59, DOI 10.1038/nature09708; Murphy KF, 2007, P NATL ACAD SCI USA, V104, P12726, DOI 10.1073/pnas.0608451104; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Sethna JP, 2006, STAT MECH ENTROPY OR; Springer M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.19; Steuer R, 2003, BIOSYSTEMS, V72, P241, DOI 10.1016/j.biosystems.2003.07.001; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Torres EM, 2008, GENETICS, V179, P737, DOI 10.1534/genetics.108.090878; Turcotte M, 2008, P NATL ACAD SCI USA, V105, P15732, DOI 10.1073/pnas.0806349105; Ullner E, 2009, BIOPHYS J, V96, P3573, DOI 10.1016/j.bpj.2009.02.031; Van Kampen NG, 1992, STOCHASTIC PROCESSES; Vilar JMG, 2002, P NATL ACAD SCI USA, V99, P5988, DOI 10.1073/pnas.092133899; Yeomans J.M., 1992, STAT MECH PHASE TRAN, VVolume 19; Zakharova A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019696	35	4	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34536	10.1371/journal.pone.0034536	http://dx.doi.org/10.1371/journal.pone.0034536			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509317	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336600034
J	Lu, PY; Hontecillas, R; Horne, WT; Carbo, A; Viladomiu, M; Pedragosa, M; Bevan, DR; Lewis, SN; Bassaganya-Riera, J				Lu, Pinyi; Hontecillas, Raquel; Horne, William T.; Carbo, Adria; Viladomiu, Monica; Pedragosa, Mireia; Bevan, David R.; Lewis, Stephanie N.; Bassaganya-Riera, Josep			Computational Modeling-Based Discovery of Novel Classes of Anti-Inflammatory Drugs That Target Lanthionine Synthetase C-Like Protein 2	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; TISSUE-SPECIFIC EXPRESSION; REGULATORY T-CELLS; ABSCISIC-ACID; CELLULAR-SENSITIVITY; COUPLED RECEPTOR; HOMOLOGY MODELS; HUMAN LANCL2; PPAR-GAMMA; DOCKING	Background: Lanthionine synthetase component C-like protein 2 (LANCL2) is a member of the eukaryotic lanthionine synthetase component C-Like protein family involved in signal transduction and insulin sensitization. Recently, LANCL2 is a target for the binding and signaling of abscisic acid (ABA), a plant hormone with anti-diabetic and anti-inflammatory effects. Methodology/Principal Findings: The goal of this study was to determine the role of LANCL2 as a potential therapeutic target for developing novel drugs and nutraceuticals against inflammatory diseases. Previously, we performed homology modeling to construct a three-dimensional structure of LANCL2 using the crystal structure of lanthionine synthetase component C-like protein 1 (LANCL1) as a template. Using this model, structure-based virtual screening was performed using compounds from NCI (National Cancer Institute) Diversity Set II, ChemBridge, ZINC natural products, and FDA-approved drugs databases. Several potential ligands were identified using molecular docking. In order to validate the anti-inflammatory efficacy of the top ranked compound (NSC61610) in the NCI Diversity Set II, a series of in vitro and pre-clinical efficacy studies were performed using a mouse model of dextran sodium sulfate (DSS)-induced colitis. Our findings showed that the lead compound, NSC61610, activated peroxisome proliferator-activated receptor gamma in a LANCL2- and adenylate cyclase/ cAMP dependent manner in vitro and ameliorated experimental colitis by down-modulating colonic inflammatory gene expression and favoring regulatory T cell responses. Conclusions/Significance: LANCL2 is a novel therapeutic target for inflammatory diseases. High-throughput, structure-based virtual screening is an effective computational-based drug design method for discovering anti-inflammatory LANCL2-based drug candidates.	[Lu, Pinyi; Hontecillas, Raquel; Horne, William T.; Carbo, Adria; Viladomiu, Monica; Pedragosa, Mireia; Bevan, David R.; Lewis, Stephanie N.; Bassaganya-Riera, Josep] Virginia Tech, Ctr Modeling Immun Enter Pathogens, Blacksburg, VA 24061 USA; [Lu, Pinyi; Hontecillas, Raquel; Horne, William T.; Carbo, Adria; Viladomiu, Monica; Pedragosa, Mireia; Lewis, Stephanie N.; Bassaganya-Riera, Josep] Virginia Tech, Virginia Bioinformat Inst, Nutr Immunol & Mol Med Lab, Blacksburg, VA USA; [Bevan, David R.; Lewis, Stephanie N.] Virginia Tech, Dept Biochem, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Lu, PY (corresponding author), Virginia Tech, Ctr Modeling Immun Enter Pathogens, Blacksburg, VA 24061 USA.	lpy0526@vbi.vt.edu; jbassaga@vbi.vt.edu	Lu, Pinyi/U-4513-2017; Viladomiu, Monica/GNM-6447-2022	Bevan, David/0000-0001-9974-1105; Lewis, Stephanie/0000-0001-8724-2069; Lu, Pinyi/0000-0003-1962-5783	National Center for Complementary and Alternative Medicine at the National Institutes of Health [5R01AT004308]; NIAID [HHSN272201000056C]; Nutritional Immunology and Molecular Medicine Laboratory; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004308] Funding Source: NIH RePORTER	National Center for Complementary and Alternative Medicine at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Nutritional Immunology and Molecular Medicine Laboratory; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	Supported by award number 5R01AT004308 of the National Center for Complementary and Alternative Medicine at the National Institutes of Health awarded to J.B.-R. and NIAID Contract No. HHSN272201000056C to JBR and funds from the Nutritional Immunology and Molecular Medicine Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049; Bassaganya-Riera J, 2010, CURR MED CHEM, V17, P467, DOI 10.2174/092986710790226110; Bassaganya-Riera J, 2011, J BIOL CHEM, V286, P2504, DOI 10.1074/jbc.M110.160077; Bissantz C, 2003, PROTEINS, V50, P5, DOI 10.1002/prot.10237; Boden EK, 2008, CURR OPIN GASTROEN, V24, P733, DOI 10.1097/MOG.0b013e328311f26e; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Canduri F, 2008, CURR DRUG TARGETS, V9, P1048, DOI 10.2174/138945008786949423; Chatterjee C, 2005, CHEM REV, V105, P633, DOI 10.1021/cr030105v; Costanzi S, 2008, J MED CHEM, V51, P2907, DOI 10.1021/jm800044k; Evers A, 2004, ANGEW CHEM INT EDIT, V43, P248, DOI 10.1002/anie.200352776; Ewing TJA, 2001, J COMPUT AID MOL DES, V15, P411, DOI 10.1023/A:1011115820450; Ferrara P, 2004, J MED CHEM, V47, P3032, DOI 10.1021/jm030489h; Gao ZT, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-104; Groux H, 1999, IMMUNOL TODAY, V20, P442, DOI 10.1016/S0167-5699(99)01510-8; GURI AJ, 2010, J NUTR BIOC IN PRESS; Guri AJ, 2008, J NUTR BIOCHEM, V19, P216, DOI 10.1016/j.jnutbio.2007.02.010; Guri AJ, 2007, CLIN NUTR, V26, P107, DOI 10.1016/j.clnu.2006.07.008; Guri AJ, 2010, J NUTR BIOCHEM, V21, P1178, DOI 10.1016/j.jnutbio.2009.10.003; Guri AJ, 2010, CLIN NUTR, V29, P824, DOI 10.1016/j.clnu.2010.02.009; Guri AJ, 2010, CLIN NUTR, V29, P646, DOI 10.1016/j.clnu.2010.02.003; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Khan WI, 2006, AM J PHYSIOL-GASTR L, V291, pG803, DOI 10.1152/ajpgi.00069.2006; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Landlinger C, 2006, BBA-BIOMEMBRANES, V1758, P1759, DOI 10.1016/j.bbamem.2006.07.018; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leach MW, 1999, TOXICOL PATHOL, V27, P123, DOI 10.1177/019262339902700124; Li HL, 2006, NUCLEIC ACIDS RES, V34, pW219, DOI 10.1093/nar/gkl114; Li MC, 2004, WORLD J GASTROENTERO, V10, P620, DOI 10.3748/wjg.v10.i5.620; Lu PY, 2011, J MOL MODEL, V17, P543, DOI 10.1007/s00894-010-0748-y; Mayer H, 1998, BBA-GENE STRUCT EXPR, V1395, P301, DOI 10.1016/S0167-4781(97)00178-4; Mayer H, 2001, DNA SEQUENCE, V12, P161, DOI 10.3109/10425170109080770; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mudter J, 2007, INFLAMM BOWEL DIS, V13, P1016, DOI 10.1002/ibd.20148; Park S, 2003, CANCER RES, V63, P723; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schapira M, 2003, P NATL ACAD SCI USA, V100, P7354, DOI 10.1073/pnas.1131854100; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Sturla L, 2011, BIOCHEM BIOPH RES CO, V415, P390, DOI 10.1016/j.bbrc.2011.10.079; Sturla L, 2009, J BIOL CHEM, V284, P28045, DOI 10.1074/jbc.M109.035329; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Zhang WC, 2009, GENE DEV, V23, P1387, DOI 10.1101/gad.1789209	44	29	33	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34643	10.1371/journal.pone.0034643	http://dx.doi.org/10.1371/journal.pone.0034643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509338	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600044
J	Streitner, I; Goldhofer, M; Cho, SB; Kinscherf, R; Thielecke, H; Borggrefe, M; Suselbeck, T; Streitner, F				Streitner, Ines; Goldhofer, Markus; Cho, Sungbo; Kinscherf, Ralf; Thielecke, Hagen; Borggrefe, Martin; Sueselbeck, Tim; Streitner, Florian			Cellular Imaging of Human Atherosclerotic Lesions by Intravascular Electric Impedance Spectroscopy	PLOS ONE			English	Article							PLAQUE; CATHETER; INFLAMMATION; ARTERIES; AORTA	Background: Newer techniques are required to identify atherosclerotic lesions that are prone to rupture. Electric impedance spectroscopy (EIS) is able to provide information about the cellular composition of biological tissue. The present study was performed to determine the influence of inflammatory processes in type Va (lipid core, thick fibrous cap) and Vc (abundant fibrous connective tissue while lipid is minimal or even absent) human atherosclerotic lesions on the electrical impedance of these lesions measured by EIS. Methods and Results: EIS was performed on 1 aortic and 3 femoral human arteries at 25 spots with visually heavy plaque burden. Severely calcified lesions were excluded from analysis. A highly flexible micro-electrode mounted onto a balloon catheter was placed on marked regions to measure impedance values at 100 kHz. After paraffin embedding, visible marked cross sections (n = 21) were processed. Assessment of lesion types was performed by Movats staining. Immunostaining for CD31 (marker of neovascularisation), CD36 (scavenger cells) and MMP-3 (matrix metalloproteinase-3) was performed. The amount of positive cells was assessed semi-quantitatively. 15 type Va lesions and 6 type Vc lesions were identified. Lesions containing abundant CD36-, CD31- and MMP-3-positive staining revealed significantly higher impedance values compared to lesions with marginal or without positive staining (CD36+455 +/- 50 Omega vs. CD36-346 +/- 53 Omega, p = 0.001; CD31+ 436 +/- 43 Omega vs. CD31-340 +/- 55 Omega, p = 0.001; MMP-3+ 400 +/- 68 Omega vs. MMP-3-323 +/- 33 Omega, p = 0.03). Conclusions: Atherosclerotic lesions with abundant neovascularisation (CD31), many scavenger receptor class B expressing cells (CD36) or high amount of MMP-3 immunoreactivity reveal significantly higher impedance values compared to lesions with marginal or no detection of immunoreactivity. Findings suggest that inflammatory processes in vulnerable plaques affect the impedance of atherosclerotic lesions and might therefore be detected by EIS.	[Streitner, Ines; Goldhofer, Markus; Borggrefe, Martin; Sueselbeck, Tim; Streitner, Florian] Univ Med Ctr Mannheim, Dept Med Cardiol 1, Mannheim, Germany; [Cho, Sungbo; Thielecke, Hagen] Fraunhofer Inst Biomed Engn, Dept Biohybride Syst, St Ingbert, Germany; [Kinscherf, Ralf] Univ Marburg, Dept Med Cell Biol, Marburg, Germany	Ruprecht Karls University Heidelberg; Fraunhofer Gesellschaft; Philipps University Marburg	Streitner, I (corresponding author), Univ Med Ctr Mannheim, Dept Med Cardiol 1, Mannheim, Germany.	I.Streitner@t-online.de	Kinscherf, Ralf/AAV-7164-2021		Faculty of Medicine, University of Heidelberg	Faculty of Medicine, University of Heidelberg	This work was supported by a grant of the Faculty of Medicine, University of Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho SB, 2005, PHYSIOL MEAS, V26, pS19, DOI 10.1088/0967-3334/26/2/002; Cho SB, 2006, IEEE T BIO-MED ENG, V53, P2401, DOI 10.1109/TBME.2006.883616; Fuster V, 2005, J AM COLL CARDIOL, V46, P937, DOI 10.1016/j.jacc.2005.03.074; Harb D, 2009, CARDIOVASC RES, V83, P42, DOI 10.1093/cvr/cvp081; Moreno PR, 2006, CURR MOL MED, V6, P457, DOI 10.2174/156652406778018635; Moreno PR, 2002, CIRCULATION, V105, P2504, DOI 10.1161/01.CIR.0000017265.52501.37; Newby AC, 2009, THROMB HAEMOSTASIS, V101, P1006, DOI 10.1160/TH08-07-0469; SLAGER CJ, 1992, IEEE T BIO-MED ENG, V39, P411, DOI 10.1109/10.126614; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Stieglitz T, 2000, BIOMED MICRODEVICES, V2, P283, DOI 10.1023/A:1009955222114; Stiles DK, 2005, BIOELECTROMAGNETICS, V26, P54, DOI 10.1002/bem.20074; Stiles DK, 2003, IEEE T BIO-MED ENG, V50, P916, DOI 10.1109/TBME.2003.813545; Streitner I, 2009, ATHEROSCLEROSIS, V206, P464, DOI 10.1016/j.atherosclerosis.2009.03.015; Suselbeck T, 2005, BASIC RES CARDIOL, V100, P28, DOI 10.1007/s00395-004-0501-8; Suselbeck T, 2005, BASIC RES CARDIOL, V100, P446, DOI 10.1007/s00395-005-0527-6; ten Kate GL, 2010, CURR PROB CARDIOLOGY, V35, P556, DOI 10.1016/j.cpcardiol.2010.09.002	16	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35405	10.1371/journal.pone.0035405	http://dx.doi.org/10.1371/journal.pone.0035405			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509411	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600105
J	Tabish, AM; Poels, K; Hoet, P; Godderis, L				Tabish, Ali M.; Poels, Katrien; Hoet, Peter; Godderis, Lode			Epigenetic Factors in Cancer Risk: Effect of Chemical Carcinogens on Global DNA Methylation Pattern in Human TK6 Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; GENE-EXPRESSION; LIVER; LUNG; HEPATOCARCINOGENESIS; TRICHLOROETHYLENE; MECHANISMS; MUTATIONS; TOXICITY; PATHWAYS	In the current study, we assessed the global DNA methylation changes in human lymphoblastoid (TK6) cells in vitro in response to 5 direct and 10 indirect-acting genotoxic agents. TK6 cells were exposed to the selected agents for 24 h in the presence and/or absence of S9 metabolic mix. Liquid chromatography-mass spectrometry was used for quantitative profiling of 5-methyl-2'-deoxycytidine. The effect of exposure on 5-methyl-2'-deoxycytidine between control and exposed cultures was assessed by applying the marginal model with correlated residuals on % global DNA methylation data. We reported the induction of global DNA hypomethylation in TK6 cells in response to S9 metabolic mix, under the current experimental settings. Benzene, hydroquinone, styrene, carbon tetrachloride and trichloroethylene induced global DNA hypomethylation in TK6 cells. Furthermore, we showed that dose did not have an effect on global DNA methylation in TK6 cells. In conclusion we report changes in global DNA methylation as an early event in response to agents traditionally considered as genotoxic.	[Tabish, Ali M.; Poels, Katrien; Hoet, Peter; Godderis, Lode] Katholieke Univ Leuven, Dept Occupat Environm & Insurance Med, Louvain, Belgium; [Godderis, Lode] IDEWE, External Serv Prevent Protect Work, Heverlee, Belgium	KU Leuven	Tabish, AM (corresponding author), Katholieke Univ Leuven, Dept Occupat Environm & Insurance Med, Louvain, Belgium.	Tabish.Ali@med.kuleuven.be	Hoet, Peter/H-9987-2013; Godderis, Lode/AAE-5880-2019	Hoet, Peter/0000-0002-0292-6603; Godderis, Lode/0000-0003-4764-8835	Katholieke Universiteit Leuven	Katholieke Universiteit Leuven(KU Leuven)	This work was supported by Katholieke Universiteit Leuven Research Fund. The funders played no part in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badham HJ, 2010, CHEM-BIOL INTERACT, V184, P218, DOI 10.1016/j.cbi.2009.11.005; Bagnyukovay TV, 2008, CARCINOGENESIS, V29, P638, DOI 10.1093/carcin/bgm303; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Bombail V, 2004, TOXICOL LETT, V149, P51, DOI 10.1016/j.toxlet.2004.01.003; Borroto JIG, 2001, MUTAT RES-GEN TOX EN, V497, P177, DOI 10.1016/S1383-5718(01)00262-5; Carbone Michele, 2004, Cancer Res, V64, P5518, DOI 10.1158/0008-5472.CAN-04-0255; Harvilchuck JA, 2009, TOXICOLOGY, V264, P171, DOI 10.1016/j.tox.2009.08.001; Hitchler MJ, 2007, FREE RADICAL BIO MED, V43, P1023, DOI 10.1016/j.freeradbiomed.2007.06.027; Hussain SP, 2007, ONCOGENE, V26, P2166, DOI 10.1038/sj.onc.1210279; Karpinets TV, 2005, CARCINOGENESIS, V26, P1323, DOI 10.1093/carcin/bgi079; Lertratanangkoon K, 1997, CANCER LETT, V120, P149, DOI 10.1016/S0304-3835(97)00300-5; Loeb LA, 2008, CANCER RES, V68, P6863, DOI 10.1158/0008-5472.CAN-08-2852; Marin-Kuan M, 2008, TOXICON, V52, P195, DOI 10.1016/j.toxicon.2008.04.166; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nakayama K, 2006, TOXICOL APPL PHARM, V217, P299, DOI 10.1016/j.taap.2006.09.008; Panayiotidis MI, 2009, MUTAT RES-GEN TOX EN, V674, P23, DOI 10.1016/j.mrgentox.2008.10.006; Paolini M, 2004, CARCINOGENESIS, V25, P61, DOI 10.1093/carcin/bgg174; PARODI S, 1992, TOXICOL LETT, V64-5, P621, DOI 10.1016/0378-4274(92)90240-K; Pavanello S, 2009, INT J CANCER, V125, P1692, DOI 10.1002/ijc.24492; Pitot HC, 2007, ANNU REV PATHOL-MECH, V2, P1, DOI 10.1146/annurev.pathol.2.010506.092027; Pogribny IP, 2010, MUTATION RE IN PRESS; Poirier MC, 2004, NAT REV CANCER, V4, P630, DOI 10.1038/nrc1410; Quinlivan EP, 2008, ANAL BIOCHEM, V373, P383, DOI 10.1016/j.ab.2007.09.031; Rahman I, 2003, J BIOCHEM MOL BIOL, V36, P95; Rundle A, 2006, MUTAT RES-FUND MOL M, V600, P23, DOI 10.1016/j.mrfmmm.2006.05.031; Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Shiao YH, 2009, ENVIRON MOL MUTAGEN, V50, P68, DOI 10.1002/em.20432; Song LG, 2005, ANAL CHEM, V77, P504, DOI 10.1021/ac0489420; Tao LH, 1999, J BIOCHEM MOL TOXIC, V13, P231; Tryndyak VP, 2006, CARCINOGENESIS, V27, P1713, DOI 10.1093/carcin/bgl050; Tsuda S, 2000, MUTAT RES-GEN TOX EN, V467, P83, DOI 10.1016/S1383-5718(00)00014-0; van Leeuwen DM, 2005, TOXICOL SCI, V86, P200, DOI 10.1093/toxsci/kfi168; VARELAMOREIRAS G, 1995, HEPATOLOGY, V22, P1310, DOI 10.1016/0270-9139(95)90644-4; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; YAMASAKI H, 1992, TOXICOL LETT, V64-5, P597, DOI 10.1016/0378-4274(92)90237-E; Yauk CL, 2008, ENVIRON MOL MUTAGEN, V49, P26, DOI 10.1002/em.20359; Ziech D, 2011, MUTAT RES-FUND MOL M, V711, P167, DOI 10.1016/j.mrfmmm.2011.02.015; Ziech D, 2010, CHEM-BIOL INTERACT, V188, P340, DOI 10.1016/j.cbi.2010.06.012	38	49	51	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34674	10.1371/journal.pone.0034674	http://dx.doi.org/10.1371/journal.pone.0034674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509344	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336600048
J	Tong, Z; Yang, XXO; Yan, HC; Liu, WH; Niu, XY; Shi, Y; Fang, WF; Xiong, B; Wan, Y; Dong, C				Tong, Zan; Yang, Xuexian O.; Yan, Huichao; Liu, Weihuang; Niu, Xiaoyin; Shi, Yun; Fang, Wenfeng; Xiong, Bing; Wan, Yu; Dong, Chen			A Protective Role by Interleukin-17F in Colon Tumorigenesis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; COLITIS-ASSOCIATED CANCER; CELL-GROWTH; CYTOKINE; IL-17F; ANGIOGENESIS; RESPONSES; MICE; IDENTIFICATION; EXPRESSION	Interleukin-17F (IL-17F), produced by Th17 cells and other immune cells, is a member of IL-17 cytokine family with highest homology to IL-17A. IL-17F has been shown to have multiple functions in inflammatory responses. While IL-17A plays important roles in cancer development, the function of IL-17F in tumorigenesis has not yet been elucidated. In the current study, we found that IL-17F is expressed in normal human colonic epithelial cells, but this expression is greatly decreased in colon cancer tissues. To examine the roles of IL-17F in colon cancer, we have used IL-17F over-expressing colon cancer cell lines and IL-17F-deficient mice. Our data showed decreased tumor growth of IL-17F-transfected HCT116 cells comparing to mock transfectants when transplanted in nude mice. Conversely, there were increased colonic tumor numbers and tumor areas in II-17f(-)/(-) mice than those from wild-type controls after colon cancer induction. These results indicate that IL-17F plays an inhibitory role in colon tumorigenesis in vivo. In IL-17F over-expressing tumors, there was no significant change in leukocyte infiltration; instead, we found decreased VEGF levels and CD31(+) cells. While the VEGF levels were increased in the colon tissues of Il-17f(-)/(-) mice with colon cancer. Together, our findings demonstrate a protective role for IL-17F in colon cancer development, possibly via inhibiting tumor angiogenesis.	[Tong, Zan; Yan, Huichao; Liu, Weihuang; Wan, Yu] Wuhan Univ, Sch Basic Med Sci, Wuhan 430072, Peoples R China; [Yang, Xuexian O.; Niu, Xiaoyin; Shi, Yun; Dong, Chen] Univ Texas MD Anderson Canc Ctr, Ctr Inflammat & Canc, Dept Immunol, Houston, TX 77030 USA; [Yang, Xuexian O.] Univ New Mexico, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Fang, Wenfeng; Xiong, Bing] Wuhan Univ, Dept Oncol, Zhongnan Hosp, Wuhan 430072, Peoples R China	Wuhan University; University of Texas System; UTMD Anderson Cancer Center; University of New Mexico; University of New Mexico's Health Sciences Center; Wuhan University	Tong, Z (corresponding author), Wuhan Univ, Sch Basic Med Sci, Wuhan 430072, Peoples R China.	ztong@whu.edu.cn; cdong@mdanderson.org	Tong, Zan/AAL-3648-2020; Yang, Xuexian/Y-2472-2019; dong, chen/B-3181-2009	Yang, Xuexian/0000-0001-6816-7024; dong, chen/0000-0002-0084-9130	Wuhan University; MD Anderson Cancer Center; American Heart Association	Wuhan University; MD Anderson Cancer Center; American Heart Association(American Heart Association)	This research was supported by the Chang Jiang Lecture Scholarship Program of Wuhan University and MD Anderson Cancer Center to Dr. Dong. Dr. Yang received a grant from American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Benchetrit F, 2002, BLOOD, V99, P2114, DOI 10.1182/blood.V99.6.2114; Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107; Chang SH, 2007, CELL RES, V17, P435, DOI 10.1038/cr.2007.35; Chang SH, 2009, CYTOKINE, V46, P7, DOI 10.1016/j.cyto.2008.12.024; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; FAJARDO LF, 1992, AM J PATHOL, V140, P539; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hirahara N, 2001, ONCOLOGY-BASEL, V61, P79, DOI 10.1159/000055357; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Kawaguchi M, 2001, J IMMUNOL, V167, P4430, DOI 10.4049/jimmunol.167.8.4430; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Le Gouvello S, 2008, GUT, V57, P772, DOI 10.1136/gut.2007.123794; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Moseley TA, 2003, CYTOKINE GROWTH F R, V14, P155, DOI 10.1016/S1359-6101(03)00002-9; Murugaiyan G, 2009, J IMMUNOL, V183, P4169, DOI 10.4049/jimmunol.0901017; Numasaki M, 2003, BLOOD, V101, P2620, DOI 10.1182/blood-2002-05-1461; Numasaki M, 2005, J IMMUNOL, V175, P6177, DOI 10.4049/jimmunol.175.9.6177; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Seiderer J, 2008, INFLAMM BOWEL DIS, V14, P437, DOI 10.1002/ibd.20339; Starnes T, 2001, J IMMUNOL, V167, P4137, DOI 10.4049/jimmunol.167.8.4137; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Tartour E, 1999, CANCER RES, V59, P3698; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Xie YF, 2010, CANCER INVEST, V28, P598, DOI 10.3109/07357900903287030; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978	33	90	97	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34959	10.1371/journal.pone.0034959	http://dx.doi.org/10.1371/journal.pone.0034959			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509371	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600069
J	Bradshaw, CS; Pirotta, M; De Guingand, D; Hocking, JS; Morton, AN; Garland, SM; Fehler, G; Morrow, A; Walker, S; Vodstrcil, LA; Fairley, CK				Bradshaw, Catriona S.; Pirotta, Marie; De Guingand, Deborah; Hocking, Jane S.; Morton, Anna N.; Garland, Suzanne M.; Fehler, Glenda; Morrow, Andrea; Walker, Sandra; Vodstrcil, Lenka A.; Fairley, Christopher K.			Efficacy of Oral Metronidazole with Vaginal Clindamycin or Vaginal Probiotic for Bacterial Vaginosis: Randomised Placebo-Controlled Double-Blind Trial	PLOS ONE			English	Article							THERAPY; LACTOBACILLI; WOMEN; RECURRENCE; ESTRIOL; FLORA; RISK	Background: To determine if oral metronidazole (MTZ-400mg bid) with 2% vaginal clindamycin-cream (Clind) or a Lactobacillus acidophilus vaginal-probiotic containing oestriol (Prob) reduces 6-month bacterial vaginosis (BV) recurrence. Methods: Double-blind placebo-controlled parallel-group single-site study with balanced randomization (1:1:1) conducted at Melbourne Sexual Health Centre, Australia. Participants with symptomatic BV [Nugent Score (NS) = 7-10 or >= 3 Amsel's criteria and NS = 4-10], were randomly allocated to MTZ-Clind, MTZ-Prob or MTZ-Placebo and assessed at 1,2,3 and 6 months. MTZ and Clind were administered for 7 days and Prob and Placebo for 12 days. Primary outcome was BV recurrence (NS of 7-10) on self-collected vaginal-swabs over 6-months. Cumulative BV recurrence rates were compared between groups by Chi-squared statistics. Kaplan-Meier, log rank and Cox regression analyses were used to compare time until and risk of BV recurrence between groups. Results: 450 18-50 year old females were randomized and 408 (91%), equally distributed between groups, provided >= 1 NS post-randomization and were included in analyses; 42 (9%) participants with no post-randomization data were excluded. Six-month retention rates were 78% (n = 351). One-month BV recurrence (NS 7-10) rates were 3.6% (5/140), 6.8% (9/133) and 9.6% (13/135) in the MTZ-Clind, MTZ-Prob and MTZ-Placebo groups respectively, p = 0.13. Hazard ratios (HR) for BV recurrence at one-month, adjusted for adherence to vaginal therapy, were 0.43 (95% CI 0.15-1.22) and 0.75 (95% CI 0.32-1.76) in the MTZ-Clind and MTZ-Prob groups compared to MTZ-Plac respectively. Cumulative 6-month BV recurrence was 28.2%; (95% CI 24.0-32.7%) with no difference between groups, p = 0.82; HRs for 6-month BV recurrence for MTZ-Clind and MTZ-Prob compared to MTZ-Plac, adjusted for adherence to vaginal therapy were 1.09(95% CI = 0.70-1.70) and 1.03(95% CI = 0.65-1.63), respectively. No serious adverse events occurred. Conclusion: Combining the recommended first line therapies of oral metronidazole and vaginal clindamycin, or oral metronidazole with an extended-course of a commercially available vaginal-L. acidophilus probiotic, does not reduce BV recurrence.	[Bradshaw, Catriona S.; De Guingand, Deborah; Hocking, Jane S.; Morrow, Andrea; Walker, Sandra; Vodstrcil, Lenka A.; Fairley, Christopher K.] Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic, Australia; [Bradshaw, Catriona S.; Morton, Anna N.; Fehler, Glenda; Fairley, Christopher K.] Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Bradshaw, Catriona S.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Pirotta, Marie] Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia; [Hocking, Jane S.] Univ Melbourne, Ctr Womens Hlth Gender & Soc, Melbourne, Vic, Australia; [Garland, Suzanne M.] Royal Womens Hosp, Dept Microbiol & Infect Dis, Melbourne, Vic, Australia; [Garland, Suzanne M.] Univ Melbourne, Dept Obstet & Gynaecol, Melbourne, Vic, Australia; [Garland, Suzanne M.] Royal Childrens Hosp, Dept Microbiol, Melbourne, Vic, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; Monash University; University of Melbourne; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne	Bradshaw, CS (corresponding author), Univ Melbourne, Melbourne Sch Populat Hlth, Melbourne, Vic, Australia.	cbradshaw@mshc.org.au	Vodstrcil, Lenka/AAC-1896-2019; Vodstrcil, Lenka/AAF-8722-2020; Hocking, Jane/AAD-5203-2021	Vodstrcil, Lenka/0000-0003-3679-9195; Hocking, Jane/0000-0001-9329-8501; Christopher, Fairley/0000-0001-9081-1664; bradshaw, catriona/0000-0002-6643-5678	Australian National Health and Medical Research Council (NHMRC) [APP454644, APP 456164, 566576]; Department of Health and Aging	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Department of Health and Aging	This work was supported by the Australian National Health and Medical Research Council (NHMRC) Project Grant (APP454644). CSB and JSH were supported by research fellowships issued by the Australian National Health and Medical Research Council (APP 456164 and 566576 respectively). MP was supported by a Primary Health Care Research Evaluation and Development Mid-Career Fellowship, Department of Health and Aging. The NHMRC and Department of Health and Aging had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Medinova (Switzerland) provided the probiotic and placebo free of charge and had no commercial interest in the study. They did not provide funds or research support for the study. Specifically Medinova made recommendations for the duration of use the probiotic therapy in the study, but had no other role in study design, data collection and analysis or decision to publish. Medinova were given a draft of the manuscript to review but had no other role in preparation of the manuscript. CSB, MP, JSH, SMG, ANM, DG, GF, AM, SW, LAV, CKF do not have a commercial or other association that might pose a conflict of interest.	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; Aroutcheva A, 2001, AM J OBSTET GYNECOL, V185, P375, DOI 10.1067/mob.2001.115867; Austin MN, 2005, J CLIN MICROBIOL, V43, P4492, DOI 10.1128/JCM.43.9.4492-4497.2005; Barrons R, 2008, CLIN THER, V30, P453, DOI 10.1016/j.clinthera.2008.03.013; Beigi RH, 2004, AM J OBSTET GYNECOL, V191, P1124, DOI 10.1016/j.ajog.2004.05.033; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Bradshaw CS, 2005, OBSTET GYNECOL, V106, P105, DOI 10.1097/01.AOG.0000163247.78533.7b; Calzolari E, 2000, INT J GYNECOL OBSTET, V70, P341, DOI 10.1016/S0020-7292(00)00217-4; Hemmerling A, 2010, SEX TRANSM DIS, V37, P745, DOI 10.1097/OLQ.0b013e3181e50026; Hemmerling A, 2009, SEX TRANSM DIS, V36, P564, DOI 10.1097/OLQ.0b013e3181a74924; Koumans EH, 2002, CLIN INFECT DIS, V35, pS152, DOI 10.1086/342103; Larsson PG, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-223; Mastromarino P, 2002, J APPL MICROBIOL, V93, P884, DOI 10.1046/j.1365-2672.2002.01759.x; Meltzer MC, 2008, SEX TRANSM DIS, V35, P611, DOI 10.1097/OLQ.0b013e318167b105; Nelson DB, 2003, J CLIN EPIDEMIOL, V56, P862, DOI 10.1016/S0895-4356(03)00073-8; Nyirjesy P, 2007, SEX TRANSM DIS, V34, P197, DOI 10.1097/01.olq.0000235152.98601.d7; Oduyebo OO, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006055.pub2; Ozkinay E, 2005, BJOG-INT J OBSTET GY, V112, P234, DOI 10.1111/j.1471-0528.2004.00329.x; Parent D, 1996, ARZNEIMITTELFORSCH, V46, P68; Senok AC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006289.pub2; Shoubnikova M, 1997, CONTRACEPTION, V55, P355, DOI 10.1016/S0010-7824(97)00044-9; Strauss Robert A, 2005, Infect Dis Obstet Gynecol, V13, P31; Vasquez A, 2002, J CLIN MICROBIOL, V40, P2746, DOI 10.1128/JCM.40.8.2746-2749.2002; Velraeds MMC, 1998, J MED MICROBIOL, V47, P1081, DOI 10.1099/00222615-47-12-1081; Veres S, 2004, OBSTET GYNECOL, V104, P555, DOI 10.1097/01.AOG.0000136082.59644.13; Ya W, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.05.023	26	70	75	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34540	10.1371/journal.pone.0034540	http://dx.doi.org/10.1371/journal.pone.0034540			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509319	Green Published, gold			2022-12-27	WOS:000304805900045
J	Govindan, BN; Swihart, RK				Govindan, Byju N.; Swihart, Robert K.			Experimental Beetle Metapopulations Respond Positively to Dynamic Landscapes and Reduced Connectivity	PLOS ONE			English	Article							EXTINCTION THRESHOLDS; HABITAT FRAGMENTATION; INTERSPECIFIC COMPETITION; POPULATION REGULATION; SPATIAL DYNAMICS; FLOUR; DISPERSAL; PERMEABILITY; PERSISTENCE; STABILITY	Interactive effects of multiple environmental factors on metapopulation dynamics have received scant attention. We designed a laboratory study to test hypotheses regarding interactive effects of factors affecting the metapopulation dynamics of red flour beetle, Tribolium castaneum. Within a four-patch landscape we modified resource level (constant and diminishing), patch connectivity (high and low) and patch configuration (static and dynamic) to conduct a 2(3) factorial experiment, consisting of 8 metapopulations, each with 3 replicates. For comparison, two control populations consisting of isolated and static subpopulations were provided with resources at constant or diminishing levels. Longitudinal data from 22 tri-weekly counts of beetle abundance were analyzed using Bayesian Poisson generalized linear mixed models to estimate additive and interactive effects of factors affecting abundance. Constant resource levels, low connectivity and dynamic patches yielded greater levels of adult beetle abundance. For a given resource level, frequency of colonization exceeded extinction in landscapes with dynamic patches when connectivity was low, thereby promoting greater patch occupancy. Negative density dependence of pupae on adults occurred and was stronger in landscapes with low connectivity and constant resources; these metapopulations also demonstrated greatest stability. Metapopulations in control landscapes went extinct quickly, denoting lower persistence than comparable landscapes with low connectivity. When landscape carrying capacity was constant, habitat destruction coupled with low connectivity created asynchronous local dynamics and refugia within which cannibalism of pupae was reduced. Increasing connectivity may be counterproductive and habitat destruction/recreation may be beneficial to species in some contexts.	[Govindan, Byju N.; Swihart, Robert K.] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Govindan, BN (corresponding author), Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA.	rswihart@purdue.edu	Govindan, Byju N./J-7665-2015; Swihart, Robert K/D-2787-2016	Govindan, Byju N./0000-0001-8126-1445; 	James S. McDonnell Foundation; Department of Forestry and Natural Resources, Purdue University	James S. McDonnell Foundation; Department of Forestry and Natural Resources, Purdue University	Financial support for this project was provided by the James S. McDonnell Foundation and the Department of Forestry and Natural Resources, Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bancroft JS, 2003, ECOLOGY, V84, P1756, DOI 10.1890/0012-9658(2003)084[1756:AETOFA]2.0.CO;2; Bancroft JS, 2001, ENVIRON ENTOMOL, V30, P1061, DOI 10.1603/0046-225X-30.6.1061; Bascompte J, 1996, J ANIM ECOL, V65, P465, DOI 10.2307/5781; BENGTSSON J, 1995, OECOLOGIA, V101, P397, DOI 10.1007/BF00329418; BENGTSSON J, 1989, NATURE, V340, P713, DOI 10.1038/340713a0; Benoit HP, 1998, ECOLOGY, V79, P2839, DOI 10.1890/0012-9658(1998)079[2839:TTDCOC]2.0.CO;2; Biedermann R, 2004, OIKOS, V107, P645, DOI 10.1111/j.0030-1299.2004.13358.x; Boudjemadi K, 1999, J ANIM ECOL, V68, P1207, DOI 10.1046/j.1365-2656.1999.00363.x; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Bull JC, 2006, J ANIM ECOL, V75, P899, DOI 10.1111/j.1365-2656.2006.01107.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Campbell JF, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.20; DESHARNAIS RA, 1987, J ANIM ECOL, V56, P885, DOI 10.2307/4955; DeWoody YD, 2005, AM NAT, V166, P42, DOI 10.1086/430639; Dey S, 2006, SCIENCE, V312, P434, DOI 10.1126/science.1125317; FORNEY KA, 1989, CONSERV BIOL, V3, P45, DOI 10.1111/j.1523-1739.1989.tb00223.x; Frank K, 1998, LANDSCAPE ECOL, V13, P363, DOI 10.1023/A:1008054906030; Freckleton RP, 2002, J ECOL, V90, P419, DOI 10.1046/j.1365-2745.2002.00692.x; Godoy W. A. C., 2005, Braz. J. Biol., V65, P271, DOI 10.1590/S1519-69842005000200010; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Hanski I, 1999, METAPOPULATION ECOLO; Harding K, 2003, AM NAT, V161, P168, DOI 10.1086/367727; Harrison S, 1999, ECOGRAPHY, V22, P225, DOI 10.1111/j.1600-0587.1999.tb00496.x; Hess GR, 1996, AM NAT, V148, P226, DOI 10.1086/285922; Hill MF, 1999, ECOL LETT, V2, P121, DOI 10.1046/j.1461-0248.1999.22061.x; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Keymer JE, 2000, AM NAT, V156, P478, DOI 10.1086/303407; Kindvall O, 1999, J ANIM ECOL, V68, P172, DOI 10.1046/j.1365-2656.1999.00273.x; LAVIE B, 1978, CAN J GENET CYTOL, V20, P589, DOI 10.1139/g78-068; Leelaja BC, 2007, J STORED PROD RES, V43, P206, DOI 10.1016/j.jspr.2006.05.003; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Levins R., 1970, SOME MATH PROBLEMS B, P77; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; MCARDLE BH, 1990, J ANIM ECOL, V59, P439, DOI 10.2307/4873; Moilanen A, 1998, ECOLOGY, V79, P2503, DOI 10.1890/0012-9658(1998)079[2503:MDEOHQ]2.0.CO;2; Molofsky J, 2005, P NATL ACAD SCI USA, V102, P3726, DOI 10.1073/pnas.0404576102; PARK T, 1948, ECOLOGY, V29, P368, DOI 10.2307/1930996; PARK T, 1948, ECOL MONOGR, V18, P265, DOI 10.2307/1948641; R Core Development Team, 2009, R LANG ENV STAT COMP; Sonleitner F. J., 1961, Physiological Zoology Chicago, V34, P233; SONLEITNER FJ, 1991, RES POPUL ECOL, V33, P1, DOI 10.1007/BF02514569; STAMPS JA, 1987, AM NAT, V129, P533, DOI 10.1086/284656; Stevens VM, 2006, OECOLOGIA, V150, P161, DOI 10.1007/s00442-006-0500-6; Stier AC, 2010, ECOLOGY, V91, P2826, DOI 10.1890/09-1993.1; TAYLOR LR, 1980, J ANIM ECOL, V49, P209, DOI 10.2307/4285; Vuilleumier S, 2007, THEOR POPUL BIOL, V72, P77, DOI 10.1016/j.tpb.2006.11.001; With KA, 1999, CONSERV BIOL, V13, P314, DOI 10.1046/j.1523-1739.1999.013002314.x	49	6	6	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34518	10.1371/journal.pone.0034518	http://dx.doi.org/10.1371/journal.pone.0034518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509314	Green Submitted, Green Published, gold			2022-12-27	WOS:000304805900042
J	Lind, A; Siersema, PD; Kusters, JG; Van der Linden, JAM; Knol, EF; Koenderman, L				Lind, Alexandra; Siersema, Peter D.; Kusters, Johannes G.; Van der Linden, Jan A. M.; Knol, Edward F.; Koenderman, Leo			The Immune Cell Composition in Barrett's Metaplastic Tissue Resembles That in Normal Duodenal Tissue	PLOS ONE			English	Article							T-CELLS; CELIAC-DISEASE; ESOPHAGEAL ADENOCARCINOMA; FOOD ALLERGY; MUCOSA; EOSINOPHILIA; LYMPHOCYTES; DIAGNOSIS; CHILDREN; INTEGRIN	Background and Objective: Barrett's esophagus (BE) is characterized by the transition of squamous epithelium into columnar epithelium with intestinal metaplasia. The increased number and types of immune cells in BE have been indicated to be due to a Th2-type inflammatory process. We tested the alternative hypothesis that the abundance of T-cells in BE is caused by a homing mechanism that is found in the duodenum. Patients and Methods: Biopsies from BE and duodenal tissue from 30 BE patients and duodenal tissue from 18 controls were characterized by immmunohistochemistry for the presence of T-cells and eosinophils(eos). Ex vivo expanded T-cells were further phenotyped by multicolor analysis using flowcytometry. Results: The high percentage of CD4(+)-T cells (69 +/- 3% (mean +/- SEM/n = 17, by flowcytometry)), measured by flowcytometry and immunohistochemistry, and the presence of non-activated eosinophils found in BE by immunohistochemical staining, were not different from that found in duodenal tissue. Expanded lymphocytes from these tissues had a similar phenotype, characterized by a comparable but low percentage of alpha E(CD103) positive CD4(+)cells (44 +/- 5% in BE, 43 +/- 4% in duodenum of BE and 34 +/- 7% in duodenum of controls) and a similar percentage of granzyme-B(+)CD8(+) cells(44 +/- 5% in BE, 33 +/- 6% in duodenum of BE and 36 +/- 7% in duodenum of controls). In addition, a similar percentage of alpha 4 beta 7(+) T-lymphocytes (63 +/- 5% in BE, 58 +/- 5% in duodenum of BE and 62 +/- 8% in duodenum of controls) was found. Finally, mRNA expression of the ligand for alpha 4 beta 7, MAdCAM-1, was also similar in BE and duodenal tissue. No evidence for a Th2-response was found as almost no IL-4(+)-T-cells were seen. Conclusion: The immune cell composition (lymphocytes and eosinophils) and expression of intestinal adhesion molecule MAdCAM-1 is similar in BE and duodenum. This supports the hypothesis that homing of lymphocytes to BE tissue is mainly caused by intestinal homing signals rather than to an active inflammatory response.	[Lind, Alexandra; Van der Linden, Jan A. M.; Koenderman, Leo] Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands; [Lind, Alexandra; Siersema, Peter D.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands; [Kusters, Johannes G.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Knol, Edward F.] Univ Med Ctr Utrecht, Dept Dermatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Lind, A (corresponding author), Univ Med Ctr Utrecht, Dept Resp Med, Utrecht, Netherlands.	L.Koenderman@umcutrecht.nl	Koenderman, Leo/AAE-7870-2020; Siersema, Peter/V-1636-2019	Koenderman, Leo/0000-0002-5636-6453; Knol, Edward/0000-0001-7368-9820	Dutch Digestive Foundation	Dutch Digestive Foundation	This study was funded by Dutch Digestive Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Agace W, 2010, IMMUNOL LETT, V128, P21, DOI 10.1016/j.imlet.2009.09.012; Anz D, 2011, INT J CANCER, V129, P2417, DOI 10.1002/ijc.25902; Armstrong D, 2004, ALIMENT PHARM THER, V20, P40, DOI 10.1111/j.1365-2036.2004.02132.x; Armstrong D, 1996, GASTROENTEROLOGY, V111, P85, DOI 10.1053/gast.1996.v111.pm8698230; Augustin MT, 2005, SCAND J GASTROENTERO, V40, P1398, DOI 10.1080/00365520510023765; Becker V, 2008, ENDOSCOPY, V40, P888, DOI 10.1055/s-2008-1077718; Bobryshev YV, 2009, J GASTROINTEST SURG, V13, P44, DOI 10.1007/s11605-008-0613-9; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; Chehade M, 2010, CURR OPIN ALLERGY CL, V10, P231, DOI 10.1097/ACI.0b013e328338cbab; Clark RA, 2006, J INVEST DERMATOL, V126, P1059, DOI 10.1038/sj.jid.5700199; Conus S, 2010, J ALLERGY CLIN IMMUN, V126, P175, DOI 10.1016/j.jaci.2010.04.029; CORNES JS, 1965, GUT, V6, P225, DOI 10.1136/gut.6.3.225; DeNucci CC, 2009, CRIT REV IMMUNOL, V29, P87, DOI 10.1615/CritRevImmunol.v29.i2.10; El-Khayat HR, 2010, J GASTROINTEST LIVER, V19, P175; Farstad IN, 1996, IMMUNOLOGY, V89, P227, DOI 10.1046/j.1365-2567.1996.d01-727.x; Fernandez S, 2011, AM J GASTROENTEROL, V106, P528, DOI 10.1038/ajg.2010.465; Fitzgerald RC, 2002, GUT, V51, P316, DOI 10.1136/gut.51.3.316; Fitzgerald RC, 2002, GUT, V50, P451, DOI 10.1136/gut.50.4.451; Grose RH, 2007, GUT, V56, P790, DOI 10.1136/gut.2006.095307; Ho J, 2008, J IMMUNOL, V180, P2573, DOI 10.4049/jimmunol.180.4.2573; Koch SD, 2008, HUM IMMUNOL, V69, P737, DOI 10.1016/j.humimm.2008.08.281; Kulaylat MN, 2010, J SURG ONCOL, V101, P706, DOI 10.1002/jso.21505; Campos LEM, 2009, J BRAS PNEUMOL, V35, P561, DOI 10.1590/S1806-37132009000600010; Moons LMG, 2005, J PATHOL, V207, P269, DOI 10.1002/path.1847; Onwuegbusi BA, 2006, GUT, V55, P764, DOI 10.1136/gut.2005.076430; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Perez-Machado MA, 2003, EUR J IMMUNOL, V33, P2307, DOI 10.1002/eji.200323308; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Prasad KK, 2010, WORLD J PEDIATR, V6, P60, DOI 10.1007/s12519-010-0008-3; Rastogi A, 2008, GASTROINTEST ENDOSC, V67, P394, DOI 10.1016/j.gie.2007.07.019; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Smyth LJC, 2010, CHEST, V138, P905, DOI 10.1378/chest.09-3079; Spechler SJ, 1999, CURR OPIN GASTROEN, V15, P352, DOI 10.1097/00001574-199907000-00014; Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058; Vogelsang H, 2001, ENDOSCOPY, V33, P336, DOI 10.1055/s-2001-13702; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; Whittles CE, 1999, J PATHOL, V187, P535, DOI 10.1002/(SICI)1096-9896(199904)187:5<535::AID-PATH302>3.0.CO;2-G; Zingg U, 2010, EJSO-EUR J SURG ONC, V36, P670, DOI 10.1016/j.ejso.2010.05.012; Zuo L, 2007, IMMUNOL ALLERGY CLIN, V27, P443, DOI 10.1016/j.iac.2007.06.002	40	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e33899	10.1371/journal.pone.0033899	http://dx.doi.org/10.1371/journal.pone.0033899			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509265	gold, Green Submitted, Green Published			2022-12-27	WOS:000304805900010
J	Yang, H; Zhai, GJ; Ji, XX; Xiong, FX; Su, J; McNutt, MA				Yang, Hua; Zhai, Guojun; Ji, Xiaoxu; Xiong, Fuxia; Su, Jing; McNutt, Michael A.			LAPTM4B Allele*2 Is a Marker of Poor Prognosis Following Hepatic Tumor Resection for Hepatocellular Carcinoma	PLOS ONE			English	Article							GALLBLADDER CARCINOMA; OVARIAN-CARCINOMA; GENE POLYMORPHISM; OVEREXPRESSION; CANCER; CELLS; SUSCEPTIBILITY; METASTASIS; RESISTANCE; EXPRESSION	Background: Lysosomal protein transmembrane 4 beta (LAPTM4B) is a gene related to hepatocellular carcinoma that has two alleles designated LAPTM4B*1 and LAPTM4B*2. This study aimed to investigate the correlation of LAPTM4B genotype with prognosis and clinicopathologic features in patients who have undergone resection for hepatocellular carcinoma (HCC). Methodology/Principal Findings: The LAPTM4B genotype was analyzed by PCR in 68 patients who had undergone curative hepatic resection for hepatocellular carcinoma. The correlation of LAPTM4B genotype with clinicopathologic parameters was assessed with the Chi-squared test. Differences in patient survival were determined by the Kaplan-Meier method. Multivariate analysis of prognostic factors was carried out with Cox regression analysis. Patients with LAPTM4B *2 had both significantly shorter overall survival (OS) and shorter disease-free survival (DFS) (both P<0.001). Multivariate analysis showed that LAPTM4B genotype is an independent prognostic factor for OS and DFS (both P<0.001). Conclusions/Significance: Allele *2 of LAPTM4B is a risk factor associated with poor prognosis in patients with resected HCC. LAPTM4B status may be useful preoperatively as an adjunct in evaluation of the operability of HCC.	[Yang, Hua] Peking Univ, Dept Cell Biol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Zhai, Guojun] Peking Univ, Hosp 3, Dept Intervent Radiol & Vasc Surg, Beijing 100871, Peoples R China; [Ji, Xiaoxu] Peking Univ, Hosp 3, Dept Gen Surg, Beijing 100871, Peoples R China; [Xiong, Fuxia] Loma Linda Univ, Dept Pharmacol, Loma Linda, CA 92350 USA; [Su, Jing; McNutt, Michael A.] Peking Univ, Dept Pathol, Sch Basic Med Sci, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Loma Linda University; Peking University	Yang, H (corresponding author), Peking Univ, Dept Cell Biol, Sch Basic Med Sci, Beijing 100871, Peoples R China.	yanghua@bjmu.edu.cn			National Nature Science Fund [31000622]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100001120043]	National Nature Science Fund(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by grants from the National Nature Science Fund (No. 31000622) and Specialized Research Fund for the Doctoral Program of Higher Education of China (20100001120043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng XJ, 2008, ANN ONCOL, V19, P527, DOI 10.1093/annonc/mdm469; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Howe HL, 2001, J NATL CANCER I, V93, P824, DOI 10.1093/jnci/93.11.824; Landis SH, 1998, CA-CANCER J CLIN, V48, P6, DOI 10.3322/canjclin.48.1.6; Li L, 2010, ONCOGENE, V29, P5785, DOI 10.1038/onc.2010.303; Li Y, 2010, NAT MED, V16, P214, DOI 10.1038/nm.2090; Liu XR, 2009, CANCER SCI, V100, P2335, DOI 10.1111/j.1349-7006.2009.01346.x; Liu Y, 2007, ANN ONCOL, V18, P311, DOI 10.1093/annonc/mdl394; Llovet JM, 2003, LANCET, V362, P1907, DOI 10.1016/S0140-6736(03)14964-1; Meng FL, 2011, CANCER-AM CANCER SOC, V117, P2652, DOI 10.1002/cncr.25833; Shao GZ, 2003, ONCOGENE, V22, P5060, DOI 10.1038/sj.onc.1206832; Suriawinata A, 2004, SEMIN LIVER DIS, V24, P77; Wang S, 2012, ANN ONCOL, V23, P1864, DOI 10.1093/annonc/mdr538; Yang H, 2012, MED ONCOL, V29, P2809, DOI 10.1007/s12032-012-0173-4; Yang H, 2010, CANCER LETT, V294, P236, DOI 10.1016/j.canlet.2010.02.006; Yang H, 2010, J SURG ONCOL, V101, P363, DOI 10.1002/jso.21489; Yang H, 2010, J CANCER RES CLIN, V136, P275, DOI 10.1007/s00432-009-0659-4; Yang Y, 2008, ONCOL REP, V20, P1077, DOI 10.3892/or_00000112; Yin MZ, 2011, INT J CANCER, V129, P629, DOI 10.1002/ijc.25689; Zhai GJ, 2012, MED ONCOL, V29, P2744, DOI 10.1007/s12032-011-0139-y; Zhou L, 2008, CANCER LETT, V264, P209, DOI 10.1016/j.canlet.2008.01.025; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025; Zhou L, 2011, SURGERY, V150, P25, DOI 10.1016/j.surg.2010.12.010; Zhou L, 2010, HEPATO-GASTROENTEROL, V57, P207; Zhou L, 2010, AM J SURG, V199, P515, DOI 10.1016/j.amjsurg.2009.03.031	26	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34984	10.1371/journal.pone.0034984	http://dx.doi.org/10.1371/journal.pone.0034984			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509374	gold, Green Published, Green Submitted			2022-12-27	WOS:000304805900063
J	Bankapur, A; Krishnamurthy, RS; Zachariah, E; Santhosh, C; Chougule, B; Praveen, B; Valiathan, M; Mathur, D				Bankapur, Aseefhali; Krishnamurthy, R. Sagar; Zachariah, Elsa; Santhosh, Chidangil; Chougule, Basavaraj; Praveen, Bhavishna; Valiathan, Manna; Mathur, Deepak			Micro-Raman Spectroscopy of Silver Nanoparticle Induced Stress on Optically-Trapped Stem Cells	PLOS ONE			English	Article							RED-BLOOD-CELLS; UV RESONANCE RAMAN; OXIDATIVE STRESS; IRON-OXIDE; CARBON NANOTUBES; LIVING CELLS; DNA-DAMAGE; TOXICITY; CYTOTOXICITY; TWEEZERS	We report here results of a single-cell Raman spectroscopy study of stress effects induced by silver nanoparticles in human mesenchymal stem cells (hMSCs). A high-sensitivity, high-resolution Raman Tweezers set-up has been used to monitor nanoparticle-induced biochemical changes in optically-trapped single cells. Our micro-Raman spectroscopic study reveals that hMSCs treated with silver nanoparticles undergo oxidative stress at doping levels in excess of 2 mu g/ml, with results of a statistical analysis of Raman spectra suggesting that the induced stress becomes more dominant at nanoparticle concentration levels above 3 mu g/ml.	[Bankapur, Aseefhali; Zachariah, Elsa; Santhosh, Chidangil; Praveen, Bhavishna; Mathur, Deepak] Manipal Univ, Ctr Atom & Mol Phys, Manipal, Karnataka, India; [Krishnamurthy, R. Sagar; Chougule, Basavaraj] Stempeut Res Pvt Ltd, Manipal, Karnataka, India; [Valiathan, Manna] Kasturba Med Coll & Hosp, Dept Pathol, Manipal, Karnataka, India; [Mathur, Deepak] Tata Inst Fundamental Res, Mumbai 400005, Maharashtra, India	Manipal Academy of Higher Education (MAHE); Manipal Academy of Higher Education (MAHE); Kasturba Medical College, Manipal; Tata Institute of Fundamental Research (TIFR)	Bankapur, A (corresponding author), Manipal Univ, Ctr Atom & Mol Phys, Manipal, Karnataka, India.	atmol1@tifr.res.in	Bankapur, Aseefhali/G-8637-2015; Bankapur, Aseefhali/AAN-1484-2020; Mathur, Deepak/K-5000-2019	Bankapur, Aseefhali/0000-0001-9237-8980; Bankapur, Aseefhali/0000-0001-9237-8980; Mathur, Deepak/0000-0002-2322-6331; CHIDANGIL, SANTHOSH/0000-0002-2973-6834	Manipal University; Tata Institute of Fundamental Research	Manipal University; Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR))	The work is funded by research grants given by Manipal University and Tata Institute of Fundamental Research. No funding has been obtained from Stempeutics Research Private Limited. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RSK and BC are employees of Stempeutics Research Pvt. Ltd. These authors contributed to all aspects of the study reported in this submission.	ABELLO L, 1989, SURF SCI, V215, P158, DOI 10.1016/0039-6028(89)90707-3; Ahamed M, 2008, TOXICOL APPL PHARM, V233, P404, DOI 10.1016/j.taap.2008.09.015; Ami D, 2008, BBA-MOL CELL RES, V1783, P98, DOI 10.1016/j.bbamcr.2007.08.003; AshaRani PV, 2009, ACS NANO, V3, P279, DOI 10.1021/nn800596w; ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; ASHKIN A, 1970, PHYS REV LETT, V24, P156, DOI 10.1103/PhysRevLett.24.156; Bankapur A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010427; Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Chan JW, 2006, BIOPHYS J, V90, P648, DOI 10.1529/biophysj.105.066761; Chang WT, 2009, J RAMAN SPECTROSC, V40, P1194, DOI 10.1002/jrs.2261; Chen K, 2006, OPT LETT, V31, P2015, DOI 10.1364/OL.31.002015; Creely CM, 2005, OPT EXPRESS, V13, P6105, DOI 10.1364/OPEX.13.006105; Creely CM, 2005, OPT COMMUN, V245, P465, DOI 10.1016/j.optcom.2004.10.011; De Luca AC, 2008, OPT EXPRESS, V16, P7943, DOI 10.1364/OE.16.007943; Delcroix GJR, 2009, BRAIN RES, V1255, P18, DOI 10.1016/j.brainres.2008.12.013; Deng JL, 2005, J RAMAN SPECTROSC, V36, P257, DOI 10.1002/jrs.1301; Donaldson Ken, 2003, Ann Ist Super Sanita, V39, P405; Duran N, 2010, J BRAZIL CHEM SOC, V21, P949, DOI 10.1590/S0103-50532010000600002; Erdmann K, 2005, AAPS J, V7, pE195, DOI 10.1208/aapsj070118; Foldbjerg R, 2011, ARCH TOXICOL, V85, P743, DOI 10.1007/s00204-010-0545-5; Gessner R, 2004, CHEMPHYSCHEM, V5, P1159, DOI 10.1002/cphc.200400026; Grabinski C, 2007, CARBON, V45, P2828, DOI 10.1016/j.carbon.2007.08.039; Greulich C, 2009, LANGENBECK ARCH SURG, V394, P495, DOI 10.1007/s00423-009-0472-1; Harvey TJ, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2999609; Hawi SR, 1996, CANCER LETT, V110, P35, DOI 10.1016/S0304-3835(96)04455-2; Heymer A, 2008, BIOMATERIALS, V29, P1473, DOI 10.1016/j.biomaterials.2007.12.003; Hsin YH, 2008, TOXICOL LETT, V179, P130, DOI 10.1016/j.toxlet.2008.04.015; Huang DM, 2005, FASEB J, V19, P2014, DOI 10.1096/fj.05-4288fje; Huang DM, 2008, TOXICOL APPL PHARM, V231, P208, DOI 10.1016/j.taap.2008.04.009; Huang DM, 2009, BIOMATERIALS, V30, P3645, DOI 10.1016/j.biomaterials.2009.03.032; Jess PRT, 2007, J RAMAN SPECTROSC, V38, P1082, DOI 10.1002/jrs.1712; Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Knief P, 2009, ANALYST, V134, P1182, DOI 10.1039/b821393c; Lara Humberto H., 2010, Journal of Nanobiotechnology, V8, P1, DOI [10.1186/1477-3155-8-1, 10.1186/1477-3155-8-15]; Li N, 2008, FREE RADICAL BIO MED, V44, P1689, DOI 10.1016/j.freeradbiomed.2008.01.028; Li P, 2005, OPT LETT, V30, P156, DOI 10.1364/OL.30.000156; Lin Weisheng, 2008, Toxicological and Environmental Chemistry, V90, P983, DOI 10.1080/02772240701802559; Liu HL, 2010, INT J NANOMED, V5, P1017, DOI 10.2147/IJN.S14572; Liu W, 2010, NANOTOXICOLOGY, V4, P319, DOI 10.3109/17435390.2010.483745; MANOHARAN R, 1990, J MICROBIOL METH, V11, P1, DOI 10.1016/0167-7012(90)90042-5; Moritz TJ, 2010, J RAMAN SPECTROSC, V41, P33, DOI 10.1002/jrs.2436; Musarrat Javed, 2009, International Journal of Nanoparticles, V2, P402, DOI 10.1504/IJNP.2009.028775; Nallathamby PD, 2010, NANOSCALE, V2, P942, DOI 10.1039/c0nr00080a; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; NELSON WH, 1992, APPL SPECTROSC REV, V27, P67, DOI 10.1080/05704929208018270; Neuman KC, 1999, BIOPHYS J, V77, P2856, DOI 10.1016/S0006-3495(99)77117-1; Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021; Ojeda JF, 2006, OPT EXPRESS, V14, P5385, DOI 10.1364/OE.14.005385; Panacek A, 2006, J PHYS CHEM B, V110, P16248, DOI 10.1021/jp063826h; Park EJ, 2008, TOXICOLOGY, V245, P90, DOI 10.1016/j.tox.2007.12.022; Park TH, 2007, J BIOTECHNOL, V131, pS65, DOI 10.1016/j.jbiotec.2007.07.112; Parker F, APPL INFRARED RAMAN; Perna G, 2007, J MOL STRUCT, V834, P182, DOI 10.1016/j.molstruc.2006.12.014; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Podstawka E, 2004, APPL SPECTROSC, V58, P581, DOI 10.1366/000370204774103417; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Prucek R, 2011, BIOMATERIALS, V32, P4704, DOI 10.1016/j.biomaterials.2011.03.039; PUPPELS GJ, 1991, BIOPHYS J, V60, P1046, DOI 10.1016/S0006-3495(91)82142-7; PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Raja SN, 2008, J BIOMED OPT, V13; Ramser K, 2004, J BIOMED OPT, V9, P593, DOI 10.1117/1.1689336; Rao S, 2009, BIOPHYS J, V96, P209, DOI 10.1529/biophysj.108.139097; Reeves JF, 2008, MUTAT RES-FUND MOL M, V640, P113, DOI 10.1016/j.mrfmmm.2007.12.010; Samberg ME, 2010, ENVIRON HEALTH PERSP, V118, P407, DOI 10.1289/ehp.0901398; Sayes CM, 2005, BIOMATERIALS, V26, P7587, DOI 10.1016/j.biomaterials.2005.05.027; Schrand AM, 2007, J PHYS CHEM B, V111, P2, DOI 10.1021/jp066387v; Singh GP, 2005, ANAL CHEM, V77, P2564, DOI 10.1021/ac048359j; Snook RD, 2009, INTEGR BIOL-UK, V1, P43, DOI 10.1039/b815253e; Sriram MI, 2010, INT J NANOMED, V5, P753, DOI 10.2147/IJN.S11727; Stewart S, 1999, SPECTROCHIM ACTA A, V55, P1615, DOI 10.1016/S1386-1425(98)00293-5; SVOBODA K, 1994, ANNU REV BIOPH BIOM, V23, P247, DOI 10.1146/annurev.bb.23.060194.001335; Sze K, 1970, INORG CHEM, V14, P1975; Tang H, 2007, OPT EXPRESS, V15, P12708, DOI 10.1364/OE.15.012708; TU AT, 1976, INT J PEPT PROT RES, V8, P337; Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228; Wise JP, 2010, AQUAT TOXICOL, V97, P34, DOI 10.1016/j.aquatox.2009.11.016; WOLD S, 1987, CHEMOMETR INTELL LAB, V2, P37, DOI 10.1016/0169-7439(87)80084-9; Xia T, 2006, NANO LETT, V6, P1794, DOI 10.1021/nl061025k; Xie CG, 2004, OPT EXPRESS, V12, P6208, DOI 10.1364/OPEX.12.006208; Xie CG, 2002, OPT LETT, V27, P249, DOI 10.1364/OL.27.000249; Yen HJ, 2009, SMALL, V5, P1553, DOI 10.1002/smll.200900126; Zachariah E, 2010, J PHOTOCH PHOTOBIO B, V100, P113, DOI 10.1016/j.jphotobiol.2010.05.009	85	26	26	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35075	10.1371/journal.pone.0035075	http://dx.doi.org/10.1371/journal.pone.0035075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514708	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341600114
J	Cafueri, G; Parodi, F; Pistorio, A; Bertolotto, M; Ventura, F; Gambini, C; Bianco, P; Dallegri, F; Pistoia, V; Pezzolo, A; Palombo, D				Cafueri, Giuseppe; Parodi, Federica; Pistorio, Angela; Bertolotto, Maria; Ventura, Francesco; Gambini, Claudio; Bianco, Paolo; Dallegri, Franco; Pistoia, Vito; Pezzolo, Annalisa; Palombo, Domenico			Endothelial and Smooth Muscle Cells from Abdominal Aortic Aneurysm Have Increased Oxidative Stress and Telomere Attrition	PLOS ONE			English	Article							SEQUENCE VARIANT; HUMAN-DISEASE; T-CELLS; LENGTH; DNA; PATHOGENESIS; INFLAMMATION; MUTATIONS; MEDIATORS; LINKAGE	Background: Abdominal aortic aneurysm (AAA) is a complex multi-factorial disease with life-threatening complications. AAA is typically asymptomatic and its rupture is associated with high mortality rate. Both environmental and genetic risk factors are involved in AAA pathogenesis. Aim of this study was to investigate telomere length (TL) and oxidative DNA damage in paired blood lymphocytes, aortic endothelial cells (EC), vascular smooth muscle cells (VSMC), and epidermal cells from patients with AAA in comparison with matched controls. Methods: TL was assessed using a modification of quantitative (Q)-FISH in combination with immunofluorescence for CD31 or alpha-smooth muscle actin to detect EC and VSMC, respectively. Oxidative DNA damage was investigated by immunofluorescence staining for 7, 8-dihydro-8-oxo-2'-deoxyguanosine (8-oxo-dG). Results and Conclusions: Telomeres were found to be significantly shortened in EC, VSMC, keratinocytes and blood lymphocytes from AAA patients compared to matched controls. 8-oxo-dG immunoreactivity, indicative of oxidative DNA damage, was detected at higher levels in all of the above cell types from AAA patients compared to matched controls. Increased DNA double strand breaks were detected in AAA patients vs controls by nuclear staining for gamma-H2AX histone. There was statistically significant inverse correlation between TL and accumulation of oxidative DNA damage in blood lymphocytes from AAA patients. This study shows for the first time that EC and VSMC from AAA have shortened telomeres and oxidative DNA damage. Similar findings were obtained with circulating lymphocytes and keratinocytes, indicating the systemic nature of the disease. Potential translational implications of these findings are discussed.	[Cafueri, Giuseppe; Palombo, Domenico] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Parodi, Federica; Pistoia, Vito; Pezzolo, Annalisa] IRCCS Gaslini Hosp, Lab Oncol, Genoa, Italy; [Pistorio, Angela] IRCCS Gaslini Hosp, Epidemiol & Biostat Unit, Genoa, Italy; [Bertolotto, Maria; Dallegri, Franco] Univ Genoa, Dept Internal Med, I-16126 Genoa, Italy; [Ventura, Francesco] Univ Genoa, Dept Legal Med, Genoa, Italy; [Gambini, Claudio] IRCCS Gaslini Hosp, Pathol Lab, Genoa, Italy; [Bianco, Paolo] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy	University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; Sapienza University Rome	Cafueri, G (corresponding author), Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy.	annalisapezzolo@ospedale-gaslini.ge.it	Pezzolo, Annalisa/AAA-7424-2020; Pistorio, Angela/D-1375-2009; Ventura, Francesco/GPX-6074-2022	Pistorio, Angela/0000-0002-6895-8720; Bertolotto, Maria Bianca/0000-0002-4889-8046; DALLEGRI, FRANCO/0000-0001-9537-4547	Progetti di Ricerca Corrente Ministero della Salute, Italy	Progetti di Ricerca Corrente Ministero della Salute, Italy	This study was supported by Progetti di Ricerca Corrente Ministero della Salute, Italy to G. Gaslini Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida J, 2008, EXP GERONTOL, V43, P833, DOI 10.1016/j.exger.2008.06.001; ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; [Anonymous], 1997, SWINSCOW TVD STAT SQ; Atturu G, 2010, EUR J VASC ENDOVASC, V39, P559, DOI 10.1016/j.ejvs.2010.01.013; Blackburn EH, 2000, NATURE, V408, P53, DOI 10.1038/35040500; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Canela A, 2007, P NATL ACAD SCI USA, V104, P5300, DOI 10.1073/pnas.0609367104; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Demissie S, 2006, AGING CELL, V5, P325, DOI 10.1111/j.1474-9726.2006.00224.x; Ejiri J, 2003, CARDIOVASC RES, V59, P988, DOI 10.1016/S0008-6363(03)00523-6; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Forester ND, 2005, IMMUNOLOGY, V115, P262, DOI 10.1111/j.1365-2567.2005.02157.x; Gretarsdottir S, 2010, NAT GENET, V42, P692, DOI 10.1038/ng.622; Guo DC, 2007, NAT GENET, V39, P1488, DOI 10.1038/ng.2007.6; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hashimoto T, 2001, NEUROSURGERY, V49, P124, DOI 10.1097/00006123-200107000-00019; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Henderson EL, 1999, CIRCULATION, V99, P96, DOI 10.1161/01.CIR.99.1.96; Houard X, 2009, CARDIOVASC RES, V82, P532, DOI 10.1093/cvr/cvp048; Ishibashi M, 2004, ARTERIOSCL THROM VAS, V24, pE174, DOI 10.1161/01.ATV.0000143384.69170.2d; Kawanishi S, 2004, ANN NY ACAD SCI, V1019, P278, DOI 10.1196/annals.1297.047; Kuivaniemi H, 2008, CIRCULATION, V117, P242, DOI 10.1161/CIRCULATIONAHA.107.690982; Lindholt JS, 2006, EUR J VASC ENDOVASC, V31, P453, DOI 10.1016/j.ejvs.2005.10.030; Martens UM, 1998, NAT GENET, V18, P76, DOI 10.1038/ng0198-018; Martinez-Pinna R, 2010, ATHEROSCLEROSIS, V212, P333, DOI 10.1016/j.atherosclerosis.2010.05.031; Mason PJ, 2005, CURR MOL MED, V5, P159, DOI 10.2174/1566524053586581; Matthews C, 2006, CIRC RES, V99, P156, DOI 10.1161/01.RES.0000233315.38086.bc; McCormick ML, 2007, ARTERIOSCL THROM VAS, V27, P461, DOI 10.1161/01.ATV.0000257552.94483.14; Miller FJ, 2002, ARTERIOSCL THROM VAS, V22, P560, DOI 10.1161/01.ATV.0000013778.72404.30; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Nahrendorf M, 2011, ARTERIOSCL THROM VAS, V31, P750, DOI 10.1161/ATVBAHA.110.221499; Narath R, 2005, CYTOM PART A, V68A, P113, DOI 10.1002/cyto.a.20190; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Okuda K, 2000, ATHEROSCLEROSIS, V152, P391, DOI 10.1016/S0021-9150(99)00482-7; Passos JF, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.5; Pellier I, 2011, PEDIATRICS, V127, pE498, DOI 10.1542/peds.2009-2987; Pezzolo A, 2007, J CLIN ONCOL, V25, P376, DOI 10.1200/JCO.2006.09.0696; Ramos-Mozo P, 2011, ARTERIOSCL THROM VAS, V31, P3011, DOI 10.1161/ATVBAHA.111.237537; Rhee DB, 2011, DNA REPAIR, V10, P34, DOI 10.1016/j.dnarep.2010.09.008; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Satoh K, 2010, ANTIOXID REDOX SIGN, V12, P675, DOI 10.1089/ars.2009.2875; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shibamura H, 2004, CIRCULATION, V109, P2103, DOI 10.1161/01.CIR.0000127857.77161.A1; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Sova H, 2010, BRIT J CANCER, V102, P1018, DOI 10.1038/sj.bjc.6605565; Thompson RW, 2002, CARDIOVASC SURG, V10, P389, DOI 10.1016/S0967-2109(02)00042-X; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Touat Z, 2006, AM J PATHOL, V168, P1022, DOI 10.2353/ajpath.2006.050868; Trouba KJ, 2002, ANTIOXID REDOX SIGN, V4, P665, DOI 10.1089/15230860260220175; VAZIRI H, 1993, AM J HUM GENET, V52, P661; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; Westin ER, 2011, ANTIOXID REDOX SIGN, V14, P985, DOI 10.1089/ars.2010.3444; Wilson WRW, 2008, EUR HEART J, V29, P2689, DOI 10.1093/eurheartj/ehn386; Wu K, 2000, J IMMUNOL, V165, P4742, DOI 10.4049/jimmunol.165.8.4742; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	60	69	70	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35312	10.1371/journal.pone.0035312	http://dx.doi.org/10.1371/journal.pone.0035312			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514726	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600131
J	Chen, Y; Lee, SF; Blanc, E; Reuter, C; Wertheim, B; Martinez-Diaz, P; Hoffmann, AA; Partridge, L				Chen, Ying; Lee, Siu F.; Blanc, Eric; Reuter, Caroline; Wertheim, Bregje; Martinez-Diaz, Pedro; Hoffmann, Ary A.; Partridge, Linda			Genome-Wide Transcription Analysis of Clinal Genetic Variation in Drosophila	PLOS ONE			English	Article							BODY-SIZE; INVERSION IN(3R)PAYNE; NATURAL VARIATION; FAT-BODY; SERPENT; MELANOGASTER; EXPRESSION; PROMOTER; ADH; IDENTIFICATION	Clinal variation in quantitative traits is widespread, but its genetic basis awaits identification. Drosophila melanogaster shows adaptive, clinal variation in traits such as body size along latitudinal gradients on multiple continents. To investigate genome wide transcription differentiation between North and South that might contribute to the clinal phenotypic variation, we compared RNA expression patterns during development of D. melanogaster from tropical northern and temperate southern populations using whole genome tiling arrays. We found that genes that were differentially expressed between the cline ends were generally associated with metabolism and growth, and experimental alteration of expression of a sample of them generally resulted in altered body size in the predicted direction, sometimes significantly so. We further identified the serpent (srp) transcription factor binding sites to be enriched near genes up-regulated in expression in the south. Analysis of clinal populations revealed a significant cline in the expression level of srp. Experimental over-expression of srp increased body size, as predicted from its clinal expression pattern, suggesting that it may be involved in regulating adaptive clinal variation in Drosophila. This study identified a handful of genes that contributed to clinal phenotypic variation through altered gene expression level, yet misexpression of individual gene led to modest body size change.	[Chen, Ying; Reuter, Caroline; Wertheim, Bregje; Martinez-Diaz, Pedro; Partridge, Linda] UCL, Dept Genet Evolut & Environm, London, England; [Lee, Siu F.; Hoffmann, Ary A.] Univ Melbourne, Dept Genet, Inst Bio21, Parkville, Vic 3052, Australia; [Blanc, Eric] Kings Coll London, MRC Ctr Dev Neurobiol, London WC2R 2LS, England	University of London; University College London; University of Melbourne; University of London; King's College London	Chen, Y (corresponding author), UCL, Dept Genet Evolut & Environm, London, England.	mojiao@gmail.com; l.partridge@ucl.ac.uk	Lee, Siu Fai/L-4690-2018; Hoffmann, Ary/R-2972-2019; Hoffmann, Ary/C-2961-2011; Partridge, Linda/E-7342-2015; Wertheim, Bregje/B-6436-2009	Hoffmann, Ary/0000-0001-9497-7645; Wertheim, Bregje/0000-0001-8555-1925; Lee, Siu Fai/0000-0001-6234-4819; Partridge, Linda/0000-0001-9615-0094	National Environmental Research Council [NE/E006574]; Australian Research Council; Natural Environment Research Council [NE/E006574/1] Funding Source: researchfish; NERC [NE/E006574/1] Funding Source: UKRI	National Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Australian Research Council(Australian Research Council); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work is funded by National Environmental Research Council grant NE/E006574 to LP, and Australian Research Council Discovery and Australian Laureate Fellowship grants to AAH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL T, 1993, DEVELOPMENT, V119, P623; Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; ANDERSON SM, 1983, P NATL ACAD SCI-BIOL, V80, P4798, DOI 10.1073/pnas.80.15.4798; Bass TM, 2007, J GERONTOL A-BIOL, V62, P1071, DOI 10.1093/gerona/62.10.1071; Berrigan D, 1997, COMP BIOCHEM PHYS A, V118, P1301, DOI 10.1016/S0300-9629(97)00030-3; Bray NJ, 2003, AM J HUM GENET, V73, P152, DOI 10.1086/376578; Breslin T, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-193; Calboli FCF, 2003, EVOLUTION, V57, P566, DOI 10.1111/j.0014-3820.2003.tb01548.x; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Gilad Y, 2006, CURR OPIN GENET DEV, V16, P553, DOI 10.1016/j.gde.2006.09.005; Gockel J, 2002, HEREDITY, V89, P145, DOI 10.1038/sj.hdy.6800121; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Grady WM, 2000, NAT GENET, V26, P16, DOI 10.1038/79120; Hayes SA, 2001, DEVELOPMENT, V128, P1193; Hoffmann AA, 2001, EVOLUTION, V55, P1621, DOI 10.1111/j.0014-3820.2001.tb00681.x; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; JAMES AC, 1995, GENETICS, V140, P659; James AC, 1997, GENETICS, V146, P881; Kennington WJ, 2007, GENETICS, V177, P549, DOI 10.1534/genetics.107.074336; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; LAURIE CC, 1988, P NATL ACAD SCI USA, V85, P5161, DOI 10.1073/pnas.85.14.5161; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; LIN WH, 1995, J BIOL CHEM, V270, P25150, DOI 10.1074/jbc.270.42.25150; Lipardi C, 2009, P NATL ACAD SCI USA, V106, P15645, DOI 10.1073/pnas.0904984106; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; McKechnie SW, 2010, MOL ECOL, V19, P775, DOI 10.1111/j.1365-294X.2009.04509.x; Mitrovski P, 2001, P ROY SOC B-BIOL SCI, V268, P2163, DOI 10.1098/rspb.2001.1787; Petersen UM, 1999, EMBO J, V18, P4013, DOI 10.1093/emboj/18.14.4013; Rako L, 2006, GENETICA, V128, P373, DOI 10.1007/s10709-006-7375-7; Sam S, 1996, MECH DEVELOP, V60, P197, DOI 10.1016/S0925-4773(96)00615-6; Sambandan D, 2008, GENETICS, V179, P1079, DOI 10.1534/genetics.108.086769; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Shiraiwa T, 2000, J NEUROGENET, V14, P145, DOI 10.3109/01677060009083480; Skelly DA, 2009, ANNU REV GENOM HUM G, V10, P313, DOI 10.1146/annurev-genom-082908-150121; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tingvall TO, 2001, P NATL ACAD SCI USA, V98, P3884, DOI 10.1073/pnas.061230198; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Weeks AR, 2002, ECOL LETT, V5, P756, DOI 10.1046/j.1461-0248.2002.00380.x; Wertheim B, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r94; WINBERG JO, 1985, BIOCHEM GENET, V23, P205, DOI 10.1007/BF00504319; WINICK J, 1993, DEVELOPMENT, V119, P1055	42	12	12	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34620	10.1371/journal.pone.0034620	http://dx.doi.org/10.1371/journal.pone.0034620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514645	Green Published, gold			2022-12-27	WOS:000305341600051
J	Edwardson, CL; Gorely, T; Davies, MJ; Gray, LJ; Khunti, K; Wilmot, EG; Yates, T; Biddle, SJH				Edwardson, Charlotte L.; Gorely, Trish; Davies, Melanie J.; Gray, Laura J.; Khunti, Kamlesh; Wilmot, Emma G.; Yates, Thomas; Biddle, Stuart J. H.			Association of Sedentary Behaviour with Metabolic Syndrome: A Meta-Analysis	PLOS ONE			English	Article							TELEVISION VIEWING TIME; CARDIOVASCULAR-DISEASE; PHYSICAL INACTIVITY; SKELETAL-MUSCLE; UNITED-STATES; RISK; MORTALITY; OBESITY; ADULTS; DEFINITION	Background: In recent years there has been a growing interest in the relationship between sedentary behaviour (sitting) and health outcomes. Only recently have there been studies assessing the association between time spent in sedentary behaviour and the metabolic syndrome. The aim of this study is to quantify the association between sedentary behaviour and the metabolic syndrome in adults using meta-analysis. Methodology/Principal Findings: Medline, Embase and the Cochrane Library were searched using medical subject headings and key words related to sedentary behaviours and the metabolic syndrome. Reference lists of relevant articles and personal databases were hand searched. Inclusion criteria were: (1) cross sectional or prospective design; (2) include adults >= 18 years of age; (3) self-reported or objectively measured sedentary time; and (4) an outcome measure of metabolic syndrome. Odds Ratio (OR) and 95% confidence intervals for metabolic syndrome comparing the highest level of sedentary behaviour to the lowest were extracted for each study. Data were pooled using random effects models to take into account heterogeneity between studies. Ten cross-sectional studies (n = 21393 participants), one high, four moderate and five poor quality, were identified. Greater time spent sedentary increased the odds of metabolic syndrome by 73% (OR 1.73, 95% CI 1.55-1.94, p<0.0001). There were no differences for subgroups of sex, sedentary behaviour measure, metabolic syndrome definition, study quality or country income. There was no evidence of statistical heterogeneity (I-2 = 0.0%, p = 0.61) or publication bias (Eggers test t = 1.05, p = 0.32). Conclusions: People who spend higher amounts of time in sedentary behaviours have greater odds of having metabolic syndrome. Reducing sedentary behaviours is potentially important for the prevention of metabolic syndrome.	[Edwardson, Charlotte L.; Davies, Melanie J.; Wilmot, Emma G.] Univ Hosp Leicester, Diabet Res Dept, Leicester, Leics, England; [Edwardson, Charlotte L.; Gorely, Trish; Biddle, Stuart J. H.] Univ Loughborough, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Davies, Melanie J.; Wilmot, Emma G.; Yates, Thomas] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Gray, Laura J.; Khunti, Kamlesh] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England	University Hospitals of Leicester NHS Trust; University of Leicester; Loughborough University; University of Leicester; University of Leicester	Edwardson, CL (corresponding author), Univ Hosp Leicester, Diabet Res Dept, Leicester, Leics, England.	C.L.Edwardson2@lboro.ac.uk	Biddle, Stuart/AAE-9395-2019; /ABC-9527-2021	Biddle, Stuart/0000-0002-7663-6895; Wilmot, Emma G/0000-0002-8698-6207; Khunti, Kamlesh/0000-0003-2343-7099; Edwardson, Charlotte/0000-0001-6485-9330; Davies, Melanie/0000-0002-9987-9371; Gray, Laura/0000-0002-9284-9321	Leicester-Loughborough NIHR Biomedical Research Unit; National Institute for Health Research [RP-PG-0606-1272, RP-DG-1210-10183] Funding Source: researchfish	Leicester-Loughborough NIHR Biomedical Research Unit; National Institute for Health Research(National Institute for Health Research (NIHR))	This study is part of the research portfolio supported by the Leicester-Loughborough NIHR Biomedical Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or prearation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alibegovic AC, 2009, DIABETES, V58, P2749, DOI 10.2337/db09-0369; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Brown SA, 2003, WESTERN J NURS RES, V25, P205, DOI 10.1177/0193945902250038; Clark BK, 2009, OBES REV, V10, P7, DOI 10.1111/j.1467-789X.2008.00508.x; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Ford ES, 2005, DIABETES CARE, V28, P1769, DOI 10.2337/diacare.28.7.1769; Galassi A, 2006, AM J MED, V119, P812, DOI 10.1016/j.amjmed.2006.02.031; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Healy GN, 2007, DIABETES CARE, V30, P1384, DOI 10.2337/dc07-0114; Helmerhorst HJF, 2009, DIABETES, V58, P1776, DOI 10.2337/db08-1773; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hojbjerre L, 2010, DIABETES, V59, P2790, DOI 10.2337/db10-0320; Lewis S, 2001, BMJ-BRIT MED J, V322, P1479, DOI 10.1136/bmj.322.7300.1479; Lipsey MW, 2001, PRACTICAL META ANAL, DOI DOI 10.1016/J.AUTNEU.2007.06.087; Lynch BM, 2010, CANCER EPIDEM BIOMAR, V19, P2691, DOI 10.1158/1055-9965.EPI-10-0815; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; MRC Biostatistics Unit, COCHR HDB SYST REV I; Parsons TJ, 2008, EUR J CLIN NUTR, V62, P1355, DOI 10.1038/sj.ejcn.1602884; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; Pearson N, 2011, AM J PREV MED, V41, P178, DOI 10.1016/j.amepre.2011.05.002; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; REYMER PWA, 1995, NAT GENET, V10, P28, DOI 10.1038/ng0595-28; SHIMADA M, 1995, ARTERIOSCL THROM VAS, V15, P1688, DOI 10.1161/01.ATV.15.10.1688; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sugiyama T, 2008, ANN BEHAV MED, V35, P245, DOI 10.1007/s12160-008-9017-z; van Uffelen JGZ, 2010, AM J PREV MED, V39, P379, DOI 10.1016/j.amepre.2010.05.024; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wijndaele K, 2009, EUR J CLIN NUTR, V63, P421, DOI 10.1038/sj.ejcn.1602944; Wong WCW, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-23; Zderic TW, 2006, J APPL PHYSIOL, V100, P249, DOI 10.1152/japplphysiol.00925.2005	36	330	340	6	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34916	10.1371/journal.pone.0034916	http://dx.doi.org/10.1371/journal.pone.0034916			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514690	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000305341600096
J	Karman, J; Gumlaw, NK; Zhang, JH; Jiang, JL; Cheng, SH; Zhu, YX				Karman, Jozsef; Gumlaw, Nathan K.; Zhang, Jinhua; Jiang, Ji-Lei; Cheng, Seng H.; Zhu, Yunxiang			Proteasome Inhibition Is Partially Effective in Attenuating Pre-Existing Immunity against Recombinant Adeno-Associated Viral Vectors	PLOS ONE			English	Article							ALPHA-GALACTOSIDASE-A; B-CELL DEVELOPMENT; PHASE-I TRIAL; GENE-THERAPY; MULTIPLE-MYELOMA; HEMOPHILIA-B; GAUCHER-DISEASE; PLASMA-CELLS; AAV VECTORS; MOUSE MODEL	Pre-existing immunity against adeno-associated virus (AAV) remains a major challenge facing the clinical use of systemic administration of recombinant AAV vectors for the treatment of genetic and acquired diseases using gene therapy. In this study, we evaluated the potential of bortezomib (marketed under trade name Velcade) to abrogate a pre-existing immunity to AAV in mice, thereby allowing subsequent transduction by a recombinant AAV vector of the same serotype. We demonstrate that bortezomib efficiently reduces AAV-specific IgG titres and moderates the cytotoxic T cell response in mice that have a pre-existing immunity to AAV2/8. Significant depletion of AAV2/8-specific IgG-producing plasma cells in secondary lymphoid organs and bone marrow was observed. However, this inhibition of the immune response by bortezomib was insufficient to allow subsequent re-infection with a recombinant AAV vector of a similar serotype. We show that this shortcoming is probably due to the combination of residual antibody levels and the inability of bortezomib to completely deplete the memory B cells that are re-activated in response to a repeated infection with a recombinant AAV vector. Taken together, the results of this study argue for the use of immunosuppressive therapies that target both plasma and memory B cells for the efficient elimination of pre-existing immunity against AAV2/8 vectors.	[Karman, Jozsef; Gumlaw, Nathan K.; Zhang, Jinhua; Jiang, Ji-Lei; Cheng, Seng H.; Zhu, Yunxiang] Genzyme Corp, Genet Dis Sci, Framingham, MA 01701 USA	Sanofi-Aventis; Genzyme Corporation	Karman, J (corresponding author), Genzyme Corp, Genet Dis Sci, Framingham, MA 01701 USA.	jozsef.karman@genzyme.com	Cheng, Seng H/AAC-6564-2022					Amanna IJ, 2010, IMMUNOL REV, V236, P125, DOI 10.1111/j.1600-065X.2010.00912.x; Attar EC, 2008, CLIN CANCER RES, V14, P1446, DOI 10.1158/1078-0432.CCR-07-4626; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Brantly ML, 2006, HUM GENE THER, V17, P1177, DOI 10.1089/hum.2006.17.1177; Calame KL, 2001, NAT IMMUNOL, V2, P1103, DOI 10.1038/ni1201-1103; Chao HJ, 2002, MOL THER, V5, P716, DOI 10.1006/mthe.2002.0607; Chirmule N, 1999, GENE THER, V6, P1574, DOI 10.1038/sj.gt.3300994; Curran MP, 2009, DRUGS, V69, P859, DOI 10.2165/00003495-200969070-00006; Finn JD, 2010, MOL THER, V18, P135, DOI 10.1038/mt.2009.257; Grieger JC, 2005, ADV BIOCHEM ENG BIOT, V99, P119, DOI 10.1007/10_005; Gu HT, 2008, MOL CANCER THER, V7, P2298, DOI 10.1158/1535-7163.MCT-08-0186; Hemeryck A, 2007, CANCER CHEMOTH PHARM, V60, P777, DOI 10.1007/s00280-007-0424-9; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Kloetzel PM, 2004, BBA-MOL CELL RES, V1695, P225, DOI 10.1016/j.bbamcr.2004.10.004; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; MacLachlan TK, 2011, MOL THER, V19, P326, DOI 10.1038/mt.2010.258; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; Manning WC, 1998, HUM GENE THER, V9, P477, DOI 10.1089/hum.1998.9.4-477; Manno CS, 2003, BLOOD, V101, P2963, DOI 10.1182/blood-2002-10-3296; Marshall J, 2002, MOL THER, V6, P179, DOI 10.1006/mthe.2002.0650; McEachern KA, 2006, J GENE MED, V8, P719, DOI 10.1002/jgm.901; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; McIntosh JH, 2012, GENE THER, V19, P78, DOI 10.1038/gt.2011.64; Meister S, 2007, CANCER RES, V67, P1783, DOI 10.1158/0008-5472.CAN-06-2258; Monahan PE, 2010, MOL THER, V18, P1907, DOI 10.1038/mt.2010.170; Montenegro-Miranda PS, 2011, HUM GENE THER, V22, P605, DOI 10.1089/hum.2010.222; Murphy SL, 2008, MOL THER, V16, P138, DOI 10.1038/sj.mt.6300334; Nathwani AC, 2009, GENE THER, V16, P60, DOI 10.1038/gt.2008.137; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Neubert K, 2008, NAT MED, V14, P748, DOI 10.1038/nm1763; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Rajkumar SV, 2011, AM J HEMATOL, V86, P57, DOI 10.1002/ajh.21913; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Scallan CD, 2006, BLOOD, V107, P1810, DOI 10.1182/blood-2005-08-3229; Xie YM, 2010, J MOL CELL BIOL, V2, P308, DOI 10.1093/jmcb/mjq030; Ziegler RJ, 2004, MOL THER, V9, P231, DOI 10.1016/j.ymthe.2003.11.015; Ziegler RJ, 2007, MOL THER, V15, P492, DOI 10.1038/sj.mt.6300066	39	15	16	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34684	10.1371/journal.pone.0034684	http://dx.doi.org/10.1371/journal.pone.0034684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514654	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600060
J	Phillips, S; Wilson, WH				Phillips, Steven; Wilson, William H.			Categorial Compositionality III: F-(co)algebras and the Systematicity of Recursive Capacities in Human Cognition	PLOS ONE			English	Article							LANGUAGE; CONNECTIONISM; NUMBER	Human cognitive capacity includes recursively definable concepts, which are prevalent in domains involving lists, numbers, and languages. Cognitive science currently lacks a satisfactory explanation for the systematic nature of such capacities (i.e., why the capacity for some recursive cognitive abilities-e. g., finding the smallest number in a list-implies the capacity for certain others-finding the largest number, given knowledge of number order). The category-theoretic constructs of initial F-algebra, catamorphism, and their duals, final coalgebra and anamorphism provide a formal, systematic treatment of recursion in computer science. Here, we use this formalism to explain the systematicity of recursive cognitive capacities without ad hoc assumptions (i.e., to the same explanatory standard used in our account of systematicity for non-recursive capacities). The presence of an initial algebra/final coalgebra explains systematicity because all recursive cognitive capacities, in the domain of interest, factor through (are composed of) the same component process. Moreover, this factorization is unique, hence no further (ad hoc) assumptions are required to establish the intrinsic connection between members of a group of systematically-related capacities. This formulation also provides a new perspective on the relationship between recursive cognitive capacities. In particular, the link between number and language does not depend on recursion, as such, but on the underlying functor on which the group of recursive capacities is based. Thus, many species (and infants) can employ recursive processes without having a full-blown capacity for number and language.	[Phillips, Steven] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Math Neuroinformat Grp, Tsukuba, Ibaraki, Japan; [Wilson, William H.] Univ New S Wales, Sch Comp Sci & Engn, Sydney, NSW, Australia	National Institute of Advanced Industrial Science & Technology (AIST); University of New South Wales Sydney	Phillips, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Math Neuroinformat Grp, Tsukuba, Ibaraki, Japan.	steve@ni.aist.go.jp	Phillips, Steven/N-3425-2016; Wilson, William/B-2575-2008	Phillips, Steven/0000-0002-5694-0670; Wilson, William/0000-0002-4307-2368	Japanese Society for the Promotion of Science (JSPS) [22300092]	Japanese Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Japanese Society for the Promotion of Science (JSPS) Grant-in-Aid (Grant No.: 22300092) to the first author. (http://www.jsps.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa K, 2003, STUDIES MIND BRAIN; AWODEY S, 2006, OXFORD LOGIC GUIDES; Bird R, 1987, LOGIC PROGRAMMING CA, P3; Bird R., 1998, PRENTICE HALL SERIES; Carey Susan, 2009, OXFORD SERIES COGNIT; Clark S., 2008, PROC 2 QUANTUM INTER, V1998, P133; Corballis MC, 2007, COGNITIVE SCI, V31, P697, DOI 10.1080/15326900701399947; FODOR J, 1990, COGNITION, V35, P183, DOI 10.1016/0010-0277(90)90014-B; Fodor J. A., 1975, LANGUAGE THOUGHT; FODOR JA, 1988, COGNITION, V28, P3, DOI 10.1016/0010-0277(88)90031-5; Gelman R, 2005, TRENDS COGN SCI, V9, P6, DOI 10.1016/j.tics.2004.11.004; Gentner TQ, 2006, NATURE, V440, P1204, DOI 10.1038/nature04675; Gibbons J., 1998, INT C FUNCTIONAL PRO, P273, DOI [10.1145/289423.289455, DOI 10.1145/289423.289455]; Halford GS, 2007, TRENDS COGN SCI, V11, P236, DOI 10.1016/j.tics.2007.04.001; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hutton G, 1999, J FUNCTIONAL PROGRAM, V9, P355, DOI DOI 10.1017/S0956796899003500; Hutton G, 1998, P 3 ACM SIGPLAN INT; Jones SP, HASKELL 98 LANGUAGE; LAWVERE FW, 1997, FDN COMPUTING; Mac Lane S, 2000, GRADUATE TEXTS MATH; MALCOLM G, 1990, SCI COMPUT PROGRAM, V14, P255, DOI 10.1016/0167-6423(90)90023-7; Manes E. G., 1986, ALGEBRAIC APPROACHES; McLaughlin BP, 2009, SYNTHESE, V170, P251, DOI 10.1007/s11229-009-9582-0; Meijer E, 1991, LECT NOTES COMPUTER, V523, P125; Phillips S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002102; Phillips S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000858; Phillips S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000599; Pierce Benjamin C., 1991, FDN COMPUTING; Rips LJ, 2008, BEHAV BRAIN SCI, V31, P623, DOI 10.1017/S0140525X08005566; SPIVEY M, 1989, LECT NOTES COMPUT SC, V375, P399	31	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35028	10.1371/journal.pone.0035028	http://dx.doi.org/10.1371/journal.pone.0035028			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514704	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600110
J	Santos, G; Hormiga, JA; Arense, P; Canovas, M; Torres, NV				Santos, Guido; Hormiga, Jose A.; Arense, Paula; Canovas, Manuel; Torres, Nester V.			Modelling and Analysis of Central Metabolism Operating Regulatory Interactions in Salt Stress Conditions in a L-Carnitine Overproducing E. coli Strain	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; SIGNAL-TRANSDUCTION; STRINGENT RESPONSE; SYSTEMS; PHYSIOLOGY; TRANSPORT; SIGMA(S); PATHWAY	Based on experimental data from E. coli cultures, we have devised a mathematical model in the GMA-power law formalism that describes the central and L-carnitine metabolism in and between two steady states, non-osmotic and hyperosmotic (0.3 M NaCl). A key feature of this model is the introduction of type of kinetic order, the osmotic stress kinetic orders (g(OSn)), derived from the power law general formalism, which represent the effect of osmotic stress in each metabolic process of the model. By considering the values of the g(OSn) linked to each metabolic process we found that osmotic stress has a positive and determinant influence on the increase in flux in energetic metabolism (glycolysis); L-carnitine biosynthesis production; the transformation/excretion of Acetyl-CoA into acetate and ethanol; the input flux of peptone into the cell; the anabolic use of pyruvate and biomass decomposition. In contrast, we found that although the osmotic stress has an inhibitory effect on the transformation flux from the glycolytic end products (pyruvate) to Acetyl-CoA, this inhibition is counteracted by other effects (the increase in pyruvate concentration) to the extent that the whole flux increases. In the same vein, the down regulation exerted by osmotic stress on fumarate uptake and its oxidation and the production and export of lactate and pyruvate are reversed by other factors up to the point that the first increased and the second remained unchanged. The model analysis shows that in osmotic conditions the energy and fermentation pathways undergo substantial rearrangement. This is illustrated by the observation that the increase in the fermentation fluxes is not connected with fluxes towards the tricaboxylic acid intermediates and the synthesis of biomass. The osmotic stress associated with these fluxes reflects these changes. All these observations support that the responses to salt stress observed in E. coli might be conserved in halophiles. Flux evolution during osmotic adaptations showed a hyperbolic (increasing or decreasing) pattern except in the case of peptone and fumarate uptake by the cell, which initially decreased. Finally, the model also throws light on the role of L-carnitine as osmoprotectant.	[Santos, Guido; Hormiga, Jose A.; Torres, Nester V.] Univ La Laguna, Dept Bioquim & Biol Mol, San Cristobal La Laguna, Santa Cruz De T, Spain; [Arense, Paula; Canovas, Manuel] Univ Murcia, Dept Bioquim & Biol Mol B, Murcia, Spain	Universidad de la Laguna; University of Murcia	Santos, G (corresponding author), Univ La Laguna, Dept Bioquim & Biol Mol, San Cristobal La Laguna, Santa Cruz De T, Spain.	ntorres@ull.edu.es	Canovas, Manuel/K-3860-2014; Santos, Guido/AAB-4695-2019; Torres, Nestor/K-2529-2014	Canovas, Manuel/0000-0003-3254-1736; Santos, Guido/0000-0002-4231-5946; Torres, Nestor/0000-0002-7594-9515	Spanish Ministerio de Ciencia e Innovacion (MICINN) [BIO2008-04500-C02-01, BIO2008-04500-C02-02, BIO2011-29233-C02-01, BIO2011-29233-C02-02]; Agencia Canaria de Ciencia, Innovacion y Sociedad de la Informacion (ACIISI) [PIL2070901, 08660/PI/08]	Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia Canaria de Ciencia, Innovacion y Sociedad de la Informacion (ACIISI)	This work was funded by research Grants from Spanish Ministerio de Ciencia e Innovacion (MICINN), Ref. No. BIO2008-04500-C02-01; BIO2008-04500-C02-02; BIO2011-29233-C02-01; BIO2011-29233-C02-02. Also from Agencia Canaria de Ciencia, Innovacion y Sociedad de la Informacion (ACIISI) Ref. PIL2070901 and Seneca Ref. 08660/PI/08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arense P, 2010, PROCESS BIOCHEM, V45, P1459, DOI 10.1016/j.procbio.2010.05.022; Bailey JE, 1986, BIOCH ENG FUNDAMENTA, P497; Bernal V, 2007, MICROB CELL FACT, V6, P1, DOI 10.1186/1475-2859-6-31; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; Canovas M, 2007, BIOTECHNOL BIOENG, V96, P722, DOI 10.1002/bit.21128; Canovas M, 2006, METAB ENG, V8, P603, DOI 10.1016/j.ymben.2006.06.002; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Fonseca LL, 2011, MOL BIOSYST, V7, P731, DOI 10.1039/c0mb00102c; Gadgil M, 2005, BIOTECHNOL PROGR, V21, P689, DOI 10.1021/bp049630l; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; Hengge-Aronis R, 1999, CURR OPIN MICROBIOL, V2, P148, DOI 10.1016/S1369-5274(99)80026-5; HenggeAronis R, 1996, MOL MICROBIOL, V21, P887, DOI 10.1046/j.1365-2958.1996.511405.x; Hormiga J, 2010, MOL BIOSYST, V6, P699, DOI 10.1039/b913063b; Kappes RM, 1998, MICROBIOL-UK, V144, P83, DOI 10.1099/00221287-144-1-83; KLEMAN GL, 1994, APPL ENVIRON MICROB, V60, P3952, DOI 10.1128/AEM.60.11.3952-3958.1994; Macdonald N., 1978, LECT NOTES BIOMATHEM; Marin-Sanguino A, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-38; Salles IM, 2007, METAB ENG, V9, P152, DOI 10.1016/j.ymben.2006.09.002; Mocek WT, 2005, MATH BIOSCI, V198, P190, DOI 10.1016/j.mbs.2005.08.001; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Varela CA, 2004, APPL ENVIRON MICROB, V70, P4222, DOI 10.1128/AEM.70.7.4222-4229.2004; Vera J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-38; Vera J, 2007, CELL SIGNAL, V19, P1531, DOI 10.1016/j.cellsig.2007.01.029; Verheul A, 1998, J APPL MICROBIOL, V85, P1036, DOI 10.1111/j.1365-2672.1998.tb05269.x; Voit E. O., 2000, COMPUTATIONAL ANAL B; Zientz E, 1996, J BACTERIOL, V178, P7241, DOI 10.1128/jb.178.24.7241-7247.1996	28	2	2	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34533	10.1371/journal.pone.0034533	http://dx.doi.org/10.1371/journal.pone.0034533			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514635	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600040
J	Shorey, LE; Hagman, AM; Williams, DE; Ho, E; Dashwood, RH; Benninghoff, AD				Shorey, Lyndsey E.; Hagman, Amanda M.; Williams, David E.; Ho, Emily; Dashwood, Roderick H.; Benninghoff, Abby D.			3,3 '-Diindolylmethane Induces G(1) Arrest and Apoptosis in Human Acute T-Cell Lymphoblastic Leukemia Cells	PLOS ONE			English	Article							BREAST-CANCER CELLS; NF-KAPPA-B; SIGNALING PATHWAYS; MOLECULAR PATHOGENESIS; PROSTATE-CANCER; INDOLE-3-CARBINOL; GROWTH; MICE; NOTCH; INHIBITION	Certain bioactive food components, including indole-3-carbinol (I3C) and 3,3'-diindolylmethane (DIM) from cruciferous vegetables, have been shown to target cellular pathways regulating carcinogenesis. Previously, our laboratory showed that dietary I3C is an effective transplacental chemopreventive agent in a dibenzo[def,p]chrysene (DBC)-dependent model of murine T-cell lymphoblastic lymphoma. The primary objective of the present study was to extend our chemoprevention studies in mice to an analogous human neoplasm in cell culture. Therefore, we tested the hypothesis that I3C or DIM may be chemotherapeutic in human T-cell acute lymphoblastic leukemia (T-ALL) cells. Treatment of the T-ALL cell lines CCRF-CEM, CCRF-HSB2, SUP-T1 and Jurkat with DIM in vitro significantly reduced cell proliferation and viability at concentrations 8- to 25-fold lower than the parent compound I3C. DIM (7.5 mu M) arrested CEM and HSB2 cells at the G(1) phase of the cell cycle and 15 mu M DIM significantly increased the percentage of apoptotic cells in all T-ALL lines. In CEM cells, DIM reduced protein expression of cyclin dependent kinases 4 and 6 (CDK4, CDK6) and D-type cyclin 3 (CCND3); DIM also significantly altered expression of eight transcripts related to human apoptosis (BCL2L10, CD40LG, HRK, TNF, TNFRSF1A, TNFRSF25, TNFSF8, TRAF4). Similar anticancer effects of DIM were observed in vivo. Dietary exposure to 100 ppm DIM significantly decreased the rate of growth of human CEM xenografts in immunodeficient SCID mice, reduced final tumor size by 44% and increased the apoptotic index compared to control-fed mice. Taken together, our results demonstrate a potential for therapeutic application of DIM in T-ALL.	[Shorey, Lyndsey E.; Williams, David E.; Dashwood, Roderick H.] Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA; [Shorey, Lyndsey E.; Williams, David E.; Ho, Emily; Dashwood, Roderick H.] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Hagman, Amanda M.; Benninghoff, Abby D.] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Ho, Emily] Oregon State Univ, Dept Nutr & Exercise Sci, Corvallis, OR 97331 USA; [Benninghoff, Abby D.] Utah State Univ, Utah Sci Technol & Res Appl Nutr Res, Logan, UT 84322 USA; [Benninghoff, Abby D.] Utah State Univ, Sch Vet Med, Logan, UT 84322 USA	Oregon State University; Oregon State University; Utah System of Higher Education; Utah State University; Oregon State University; Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Shorey, LE (corresponding author), Oregon State Univ, Dept Environm & Mol Toxicol, Corvallis, OR 97331 USA.	abby.benninghoff@usu.edu	Benninghoff, Abby/AAK-6775-2020; Dashwood, Roderick/AAF-2025-2020; Benninghoff, Abby/F-7694-2011	Benninghoff, Abby/0000-0002-7993-0117; Shorey-Kendrick, Lyndsey/0000-0001-8060-0097	National Cancer Institute [R21CA135523, P01CA90890]; National Institute of Environmental Health Sciences [T32ES07060]; Linus Pauling Institute at Oregon State University; USANA Health Sciences; Utah Agricultural Experiment Station, Utah State University; USANA Health Sciences via Linus Pauling Institute; NATIONAL CANCER INSTITUTE [R21CA135523, P01CA090890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007060] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Linus Pauling Institute at Oregon State University; USANA Health Sciences; Utah Agricultural Experiment Station, Utah State University; USANA Health Sciences via Linus Pauling Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Cancer Institute (grant numbers R21CA135523 and P01CA90890), the National Institute of Environmental Health Sciences (grant number T32ES07060), the Linus Pauling Institute at Oregon State University, and USANA Health Sciences. This research was supported by the Utah Agricultural Experiment Station, Utah State University, and approved as journal paper number 8406. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BioResponse Nutrients, LLC donated the DIM formulation used in this study, BioResponse-DIM. The monetary value of this donation is less than $500. BioResponse Nutrients, LLC did not have any involvement in the experiment design, execution, analysis or composition of this manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. USANA Health Sciences provided financial support for this research, via its support of the Linus Pauling Institute and associated laboratories. USANA did not have any involvement in the experiment design, execution, analysis or composition of this manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Aggarwal BB, 2005, CELL CYCLE, V4, P1201, DOI 10.4161/cc.4.9.1993; Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; American Cancer Society, 2012, CANC FACTS FIG 2012; Anderton MJ, 2004, DRUG METAB DISPOS, V32, P632, DOI 10.1124/dmd.32.6.632; Anderton MJ, 2003, J CHROMATOGR B, V787, P281, DOI 10.1016/S1570-0232(02)00923-6; Ausserlechner MJ, 2001, J BIOL CHEM, V276, P10984, DOI 10.1074/jbc.M008188200; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bradlow HL, 2010, IN VIVO, V24, P387; Bradlow HL, 2008, IN VIVO, V22, P441; Burger R, 1999, LEUKEMIA RES, V23, P19, DOI 10.1016/S0145-2126(98)00133-7; Cardoso BA, 2008, BRAZ J MED BIOL RES, V41, P344, DOI 10.1590/S0100-879X2008005000016; Chang XF, 2005, CARCINOGENESIS, V26, P771, DOI 10.1093/carcin/bgi018; Chilosi M, 1998, AM J PATHOL, V152, P209; Choi HY, 2009, J POLYM ENG, V29, P1, DOI 10.1515/POLYENG.2009.29.1-3.1; Donaldson MS, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-19; Ferrando Adolfo A, 2009, Hematology Am Soc Hematol Educ Program, P353, DOI 10.1182/asheducation-2009.1.353; Firestone GL, 2003, J NUTR, V133, p2448S, DOI 10.1093/jn/133.7.2448S; Garikapaty VPS, 2006, BIOCHEM BIOPH RES CO, V340, P718, DOI 10.1016/j.bbrc.2005.12.059; Goldberg JM, 2003, J CLIN ONCOL, V21, P3616, DOI 10.1200/JCO.2003.10.116; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; GROSE KR, 1992, CHEM RES TOXICOL, V5, P188, DOI 10.1021/tx00026a007; Guo DM, 2011, LEUKEMIA LYMPHOMA, V52, P1200, DOI 10.3109/10428194.2011.564696; Hayes JD, 2008, EUR J NUTR, V47, P73, DOI 10.1007/s00394-008-2009-8; Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009; Hong C, 2002, BIOCHEM PHARMACOL, V63, P1085, DOI 10.1016/S0006-2952(02)00856-0; HOUGHTON PJ, 1989, CANCER RES, V49, P7124; Howlader N, 2011, SEER CANC STAT REV 1; Jensen CD, 2004, CANCER CAUSE CONTROL, V15, P559, DOI 10.1023/B:CACO.0000036161.98734.17; Liu SY, 2009, ANN HEMATOL, V88, P613, DOI 10.1007/s00277-008-0646-x; Machijima Y, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-7; Nagel S, LEUK RES, V34, P521; Neave AS, 2005, TOXICOL SCI, V83, P126, DOI 10.1093/toxsci/kfi008; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rahman KMW, 2007, MOL CANCER THER, V6, P2757, DOI 10.1158/1535-7163.MCT-07-0336; Rahman KMW, 2005, CANCER RES, V65, P364; Rao SS, 2009, CANCER RES, V69, P3060, DOI 10.1158/0008-5472.CAN-08-4295; Reed GA, 2008, CANCER EPIDEM BIOMAR, V17, P2619, DOI 10.1158/1055-9965.EPI-08-0520; Sanz C, 2000, BLOOD, V95, P2742, DOI 10.1182/blood.V95.9.2742.009k24_2742_2747; Sarkar FH, 2004, MUTAT RES-FUND MOL M, V555, P53, DOI 10.1016/j.mrfmmm.2004.04.015; Screpanti I, 2003, TRENDS MOL MED, V9, P30, DOI 10.1016/S1471-4914(02)00003-5; Sepkovic DW, 2001, NUTR CANCER, V41, P57, DOI 10.1080/01635581.2001.9680612; Shapiro GI, 2000, CELL BIOCHEM BIOPHYS, V33, P189, DOI 10.1385/CBB:33:2:189; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; STRESSER DM, 1995, DRUG METAB DISPOS, V23, P965; Takada Y, 2005, BLOOD, V106, P641, DOI 10.1182/blood-2004-12-4589; Tammam J, 2009, BRIT J PHARMACOL, V158, P1183, DOI 10.1111/j.1476-5381.2009.00389.x; Teitell MA, 2009, ANNU REV PATHOL-MECH, V4, P175, DOI 10.1146/annurev.pathol.4.110807.092227; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yan Y, 1996, BLOOD, V88, P3137, DOI 10.1182/blood.V88.8.3137.bloodjournal8883137; Yan Y, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-51; Yu Z, 2006, CANCER RES, V66, P755, DOI 10.1158/0008-5472.CAN-05-3390; Zhao WL, 2010, LEUKEMIA, V24, P13, DOI 10.1038/leu.2009.223	53	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34975	10.1371/journal.pone.0034975	http://dx.doi.org/10.1371/journal.pone.0034975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514694	gold, Green Published			2022-12-27	WOS:000305341600100
J	Steffensen, MA; Jensen, BAH; Holst, PJ; Bassi, MR; Christensen, JP; Thomsen, AR				Steffensen, Maria Abildgaard; Jensen, Benjamin Anderschou Holbech; Holst, Peter Johannes; Bassi, Maria Rosaria; Christensen, Jan Pravsgaard; Thomsen, Allan Randrup			Pre-Existing Vector Immunity Does Not Prevent Replication Deficient Adenovirus from Inducing Efficient CD8 T-Cell Memory and Recall Responses	PLOS ONE			English	Article							RECOMBINANT ADENOVIRUS; NEUTRALIZING ANTIBODIES; DENDRITIC CELLS; VACCINE VECTORS; IN-VIVO; VIRUS; HEXON; SEROTYPE; CONSTRUCTION; DNA	Adenoviral vectors have shown a great potential for vaccine development due to their inherent ability to induce potent and protective CD8 T-cell responses. However, a critical issue regarding the use of these vectors is the existence of inhibitory immunity against the most commonly used Ad5 vector in a large part of the human population. We have recently developed an improved adenoviral vaccine vector system in which the vector expresses the transgene tethered to the MHC class II associated invariant chain (Ii). To further evaluate the potential of this system, the concept of pre-existing inhibitory immunity to adenoviral vectors was revisited to investigate whether the inhibition previously seen with the Ad5 vector also applied to the optimized vector system. We found this to be the case, and antibodies dominated as the mechanism underlying inhibitory vector immunity. However, presence of CD8 T cells directed against epitopes in the adenoviral vector seemed to correlate with repression of the induced response in re-vaccinated B-cell deficient mice. More importantly, despite a repressed primary effector CD8 T-cell response in Ad5-immune animals subjected to vaccination, memory T cells were generated that provided the foundation for an efficient recall response and protection upon subsequent viral challenge. Furthermore, the transgene specific response could be efficiently boosted by homologous re-immunization. Taken together, these studies indicate that adenoviral vectors can be used to induce efficient CD8 T-cell memory even in individuals with pre-existing vector immunity.	[Steffensen, Maria Abildgaard; Jensen, Benjamin Anderschou Holbech; Holst, Peter Johannes; Bassi, Maria Rosaria; Christensen, Jan Pravsgaard; Thomsen, Allan Randrup] Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark	University of Copenhagen	Steffensen, MA (corresponding author), Univ Copenhagen, Inst Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	athomsen@sund.ku.dk	Jensen, Benjamin A. H./M-4661-2014; Christensen, Jan Pravsgaard/I-4782-2017	Jensen, Benjamin A. H./0000-0001-6991-0828; Christensen, Jan Pravsgaard/0000-0002-4299-9479; Thomsen, Allan Randrup/0000-0002-2392-9803; Holst, Peter Johannes/0000-0002-1279-304X; Bassi, Maria Rosaria/0000-0001-6736-6152	Aase og Ejnar Danielsen's Foundation; Augustinus Foundation; Else and Mogens Wedell-Wedellsborg's Foundation; Beckett Foundation; Familien Erichsen's Foundation; Agnes and Poul Friis' Foundation; Fonden til Laegevidenskabens fremme	Aase og Ejnar Danielsen's Foundation; Augustinus Foundation; Else and Mogens Wedell-Wedellsborg's Foundation; Beckett Foundation; Familien Erichsen's Foundation; Agnes and Poul Friis' Foundation; Fonden til Laegevidenskabens fremme	Aase og Ejnar Danielsen's Foundation, the Augustinus Foundation, Else and Mogens Wedell-Wedellsborg's Foundation, the Beckett Foundation, Familien Erichsen's Foundation, Agnes and Poul Friis' Foundation and 'Fonden til Laegevidenskabens fremme' financially supported these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann MF, 2005, J IMMUNOL, V175, P4686, DOI 10.4049/jimmunol.175.7.4686; Barouch DH, 2011, VACCINE, V29, P5203, DOI 10.1016/j.vaccine.2011.05.025; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Barouch DH, 2003, J VIROL, V77, P8729, DOI 10.1128/JVI.77.16.8729-8735.2003; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; BECKER TC, 1994, METHOD CELL BIOL, V43, P161; Casimiro DR, 2003, J VIROL, V77, P7663, DOI 10.1128/JVI.77.13.7663-7668.2003; Cui WG, 2010, IMMUNOL REV, V236, P151, DOI 10.1111/j.1600-065X.2010.00926.x; Finn OJ, 2008, NEW ENGL J MED, V358, P2704, DOI 10.1056/NEJMra072739; Gall J, 1996, J VIROL, V70, P2116, DOI 10.1128/JVI.70.4.2116-2123.1996; Gall JGD, 1998, J VIROL, V72, P10260, DOI 10.1128/JVI.72.12.10260-10264.1998; Holst PJ, 2008, J IMMUNOL, V180, P3339, DOI 10.4049/jimmunol.180.5.3339; Holst PJ, 2011, J IMMUNOL, V186, P3997, DOI 10.4049/jimmunol.1001251; Holst PJ, 2010, J IMMUNOL, V184, P4431, DOI 10.4049/jimmunol.0900537; Lindsay RWB, 2010, J IMMUNOL, V185, P1513, DOI 10.4049/jimmunol.1000338; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; Mizuguchi H, 1999, HUM GENE THER, V10, P2013, DOI 10.1089/10430349950017374; Mizuguchi H, 1998, HUM GENE THER, V9, P2577, DOI 10.1089/hum.1998.9.17-2577; Osada T, 2009, CANCER GENE THER, V16, P673, DOI 10.1038/cgt.2009.17; Pellegrini M, 2010, EUR J IMMUNOL, V40, P1852, DOI 10.1002/eji.201040603; Pichla-Gollon SL, 2009, J VIROL, V83, P5567, DOI 10.1128/JVI.00405-09; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Roy S, 1998, J VIROL, V72, P6875, DOI 10.1128/JVI.72.8.6875-6879.1998; Sumida SM, 2005, J IMMUNOL, V174, P7179, DOI 10.4049/jimmunol.174.11.7179; Sumida SM, 2004, J VIROL, V78, P2666, DOI 10.1128/JVI.78.6.2666-2673.2004; Tatsis N, 2007, BLOOD, V110, P1916, DOI 10.1182/blood-2007-02-062117; THOMSEN AR, 1988, IMMUNOLOGY, V65, P9; Wu HJ, 2002, J VIROL, V76, P12775, DOI 10.1128/JVI.76.24.12775-12782.2002; Yang TC, 2006, J IMMUNOL, V176, P200, DOI 10.4049/jimmunol.176.1.200; Yang ZY, 2003, J VIROL, V77, P799, DOI 10.1128/JVI.77.1.799-803.2003	31	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34884	10.1371/journal.pone.0034884	http://dx.doi.org/10.1371/journal.pone.0034884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514686	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600092
J	Wright, CM; Francis, SMS; Tan, ME; Martins, MU; Winterford, C; Davidson, MR; Duhig, EE; Clarke, BE; Hayward, NK; Yang, IA; Bowman, RV; Fong, KM				Wright, Casey M.; Francis, Santiyagu M. Savarimuthu; Tan, Maxine E.; Martins, Maria U.; Winterford, Clay; Davidson, Morgan R.; Duhig, Edwina E.; Clarke, Belinda E.; Hayward, Nicholas K.; Yang, Ian A.; Bowman, Rayleen V.; Fong, Kwun M.			MS4A1 Dysregulation in Asbestos-Related Lung Squamous Cell Carcinoma Is Due to CD20 Stromal Lymphocyte Expression	PLOS ONE			English	Article							GENE-EXPRESSION; LASER CAPTURE; RT-PCR; CANCER; MICROARRAY; TISSUE; MICRODISSECTION; CROCIDOLITE; VALIDATION; PROFILES	Asbestos-related lung cancer accounts for 4-12% of lung cancers worldwide. We have previously identified ADAM28 as a putative oncogene involved in asbestos-related lung adenocarcinoma (ARLC-AC). We hypothesised that similarly gene expression profiling of asbestos-related lung squamous cell carcinomas (ARLC-SCC) may identify candidate oncogenes for ARLC-SCC. We undertook a microarray gene expression study in 56 subjects; 26 ARLC-SCC (defined as lung asbestos body (AB) counts >20AB/gram wet weight (gww) and 30 non-asbestos related lung squamous cell carcinoma (NARLC-SCC; no detectable lung asbestos bodies; 0AB/gww). Microarray and bioinformatics analysis identified six candidate genes differentially expressed between ARLC-SCC and NARLC-SCC based on statistical significance (p<0.001) and fold change (FC) of >2-fold. Two genes MS4A1 and CARD18, were technically replicated by qRT-PCR and showed consistent directional changes. As we also found MS4A1 to be overexpressed in ARLC-ACs, we selected this gene for biological validation in independent test sets (one internal, and one external dataset (2 primary tumor sets)). MS4A1 RNA expression dysregulation was validated in the external dataset but not in our internal dataset, likely due to the small sample size in the test set as immunohistochemical (IHC) staining for MS4A1 (CD20) showed that protein expression localized predominantly to stromal lymphocytes rather than tumor cells in ARLC-SCC. We conclude that differential expression of MS4A1 in this comparative gene expression study of ARLC-SCC versus NARLC-SCC is a stromal signal of uncertain significance, and an example of the rationale for tumor cell enrichment in preparation for gene expression studies where the aim is to identify markers of particular tumor phenotypes. Finally, our study failed to identify any strong gene candidates whose expression serves as a marker of asbestos etiology. Future research is required to determine the role of stromal lymphocyte MS4A1 dysregulation in pulmonary SCCs caused by asbestos.	[Wright, Casey M.; Francis, Santiyagu M. Savarimuthu; Davidson, Morgan R.; Yang, Ian A.; Bowman, Rayleen V.; Fong, Kwun M.] Univ Queensland, Thorac Res Ctr, Sch Med, Brisbane, Qld 4072, Australia; [Wright, Casey M.; Francis, Santiyagu M. Savarimuthu; Tan, Maxine E.; Martins, Maria U.; Davidson, Morgan R.; Yang, Ian A.; Bowman, Rayleen V.; Fong, Kwun M.] Prince Charles Hosp, Dept Thorac Med, Brisbane, Qld, Australia; [Hayward, Nicholas K.] Queensland Inst Med Res, Oncogen Lab, Brisbane, Qld 4006, Australia; [Duhig, Edwina E.; Clarke, Belinda E.] Prince Charles Hosp, Dept Anat Pathol, Brisbane, Qld, Australia; [Winterford, Clay] Queensland Inst Med Res, Histotechnol Facil, Brisbane, Qld 4006, Australia	University of Queensland; Prince Charles Hospital; QIMR Berghofer Medical Research Institute; Prince Charles Hospital; QIMR Berghofer Medical Research Institute	Wright, CM (corresponding author), Univ Queensland, Thorac Res Ctr, Sch Med, Brisbane, Qld 4072, Australia.	casey.wright@uqconnect.edu.au	Wright, Casey/G-1078-2011; Dodds, Casey/HGC-6866-2022; Wright, Casey M/J-9693-2014; hayward, nicholas k/C-1367-2015; Martins, Maria/K-1525-2014; hayward, nick/AAV-8802-2020; Bowman, Rayleen V/G-4144-2013; Fong, Kwun M/G-6369-2010; Yang, Ian A/B-9609-2008	Wright, Casey M/0000-0001-9214-5749; hayward, nicholas k/0000-0003-4760-1033; Yang, Ian A/0000-0001-8338-1993; Davidson, Morgan/0000-0003-0881-1409; Fong, Kwun/0000-0002-6507-1403	National Health and Medical Research Council (NHMRC); Queensland Smart State project grants; NH&MRC Practitioner Fellowship; NH&MRC Senior Principal Research Fellowship; NH&MRC Career Development Award; NH&MRC Biomedical Scholarship; Cancer Council Queensland Senior Research Fellowship; Queensland Clinical Research Fellowship; Prince Charles Hospital Foundation [FRC0207-21]; Dust Diseases Board (New South Wales, Australia)	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Queensland Smart State project grants; NH&MRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NH&MRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NH&MRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia); NH&MRC Biomedical Scholarship(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Queensland Senior Research Fellowship(Cancer Council Queensland); Queensland Clinical Research Fellowship; Prince Charles Hospital Foundation; Dust Diseases Board (New South Wales, Australia)	This work supported by: National Health and Medical Research Council (NH&MRC) and Queensland Smart State project grants; NH&MRC Practitioner Fellowship (to KF), NH&MRC Senior Principal Research Fellowship (to NH), NH&MRC Career Development Award (to IY), NH&MRC Biomedical Scholarship (to SS, CW), Cancer Council Queensland Senior Research Fellowship (to KF), Queensland Clinical Research Fellowship (to KF, IY), The Prince Charles Hospital Foundation (FRC0207-21) and the Dust Diseases Board (New South Wales, Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; de Bruin EC, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-142; deKlerk NH, 1996, OCCUP ENVIRON MED, V53, P157, DOI 10.1136/oem.53.3.157; Druilhe A, 2001, CELL DEATH DIFFER, V8, P649, DOI 10.1038/sj.cdd.4400881; El-Serag HB, 2009, SCAND J GASTROENTERO, V44, P787, DOI 10.1080/00365520902898127; Etienne W, 2004, BIOTECHNIQUES, V36, P618, DOI 10.2144/04364ST02; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Henderson DW, 2004, INT J OCCUP ENV HEAL, V10, P40, DOI 10.1179/oeh.2004.10.1.40; Hiscox S, 2011, EXPERT OPIN THER TAR, V15, P609, DOI 10.1517/14728222.2011.561201; Klee EW, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-13; Lee BW, 1998, AM J RESP CRIT CARE, V157, P748, DOI 10.1164/ajrccm.157.3.9707025; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Rajeevan MS, 2001, J MOL DIAGN, V3, P26, DOI 10.1016/S1525-1578(10)60646-0; Roggli VL, 2000, ANN OCCUP HYG, V44, P109, DOI 10.1093/annhyg/44.2.109; Roggli VL, 1992, APPENDIX TISSUE DIGE, P402; Sacchi S, 2001, CRIT REV ONCOL HEMAT, V37, P13, DOI 10.1016/S1040-8428(00)00069-X; Schneider F, 2008, ULTRASTRUCT PATHOL, V32, P171, DOI 10.1080/01913120802343848; *SEER PROGR, 2004, SEER STAT DAT INC SE; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Tam CS, 2008, BRIT J HAEMATOL, V141, P36, DOI 10.1111/j.1365-2141.2008.07012.x; Wikman H, 2007, ONCOGENE, V26, P4730, DOI 10.1038/sj.onc.1210270; Wright CM, 2008, J THORAC ONCOL, V3, P569, DOI 10.1097/JTO.0b013e318174e046; Wright CM, 2010, GENE CHROMOSOME CANC, V49, P688, DOI 10.1002/gcc.20779; Wurmbach E, 2003, METHODS, V31, P306, DOI 10.1016/S1046-2023(03)00161-0	26	15	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34943	10.1371/journal.pone.0034943	http://dx.doi.org/10.1371/journal.pone.0034943			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514692	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600098
J	Engelberth, J; Contreras, CF; Viswanathan, S				Engelberth, Jurgen; Contreras, Claudia Fabiola; Viswanathan, Sriram			Transcriptional Analysis of Distant Signaling Induced by Insect Elicitors and Mechanical Wounding in Zea mays	PLOS ONE			English	Article							RIBOSOME-INACTIVATING PROTEIN; JASMONIC ACID; NICOTIANA-ATTENUATA; 12-OXO-PHYTODIENOIC ACID; PLANT-RESPONSES; MANDUCA-SEXTA; INDUCED RESISTANCE; ORAL SECRETIONS; ARABIDOPSIS; HERBIVORY	When plants are under insect herbivore attack defensive measures are activated not only locally, but also in distant and systemic tissues. While insect elicitors (IE) abundant in the oral secretions of the attacking herbivore are essential in the regulation of induced defenses, little is known about their effects on systemic defense signaling in maize (Zea mays). The goal of this study was therefore to identify genetic markers that can be used to further characterize local and systemic signaling events induced by IE or mechanical wounding (MW). We selected genes for this study based on their putative involvement in signaling (allene oxide synthase), regulation of gene expression (transcription factor MYC7), and in direct defenses (ribosome inactivating protein) and analyzed their expression in different sections of the treated leaf as well as in systemic parts of the same plant. We found the most significant transcript accumulation of the selected genes after treatment with insect elicitors in those parts with increased JA levels. Additionally, treatment with IE did also induce the accumulation of MYC7 transcripts in basal parts of the treated leaf and systemically. MW, in contrast, did induce RIP and AOS only locally, but not MYC7. This local suppression of MYC7 was further studied by adding glutathione (GSH) as an electron donor to MW plants to quench putative alpha, beta-unsaturated carbonyls, which build up to significant levels around the damage site. Indeed, GSH-treated MW plants accumulated MYC7 at the damage site and also produced more volatiles, suggesting a putative redox-regulatory element being involved in the suppression of MYC7. The results presented herein provide evidence for the specific induction of distant signaling events triggered by IE, most likely through electric signaling. Additionally, a putative role for MW-induced alpha, beta-unsaturated carbonyls in the transcriptional regulation of defense genes was discovered.	[Engelberth, Jurgen; Contreras, Claudia Fabiola; Viswanathan, Sriram] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA	University of Texas System; University of Texas at San Antonio (UTSA)	Engelberth, J (corresponding author), Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA.	jurgen.engelberth@utsa.edu	Engelberth, Jurgen/D-3131-2011	Engelberth, Jurgen/0000-0002-6853-1954	National Science Foundation Award [IOS-0925613]; USDA, NIFA award [03836]; USFS [05-04-1207-JV-11132650-118]; College of Science at The University of Texas at San Antonio; Direct For Biological Sciences [0925615] Funding Source: National Science Foundation	National Science Foundation Award(National Science Foundation (NSF)); USDA, NIFA award; USFS; College of Science at The University of Texas at San Antonio; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Award IOS-0925613 and USDA, NIFA award 03836 to JE. CFC was supported in part by USFS 05-04-1207-JV-11132650-118. Furthermore, support by the The College of Science at The University of Texas at San Antonio was greatly appreciated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alborn HT, 2007, P NATL ACAD SCI USA, V104, P12976, DOI 10.1073/pnas.0705947104; Alborn HT, 1997, SCIENCE, V276, P945, DOI 10.1126/science.276.5314.945; Almeras E, 2003, PLANT J, V34, P202, DOI 10.1046/j.1365-313X.2003.01718.x; BALDWIN IT, 1990, TRENDS ECOL EVOL, V5, P91, DOI 10.1016/0169-5347(90)90237-8; BASS HW, 1992, PLANT CELL, V4, P225, DOI 10.1105/tpc.4.2.225; Bass HW, 2004, J EXP BOT, V55, P2219, DOI 10.1093/jxb/erh243; Bottcher C, 2009, FEBS J, V276, P4693, DOI 10.1111/j.1742-4658.2009.07195.x; Boter M, 2011, GENE DEV, V18, P1577; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Chung HS, 2008, PLANT PHYSIOL, V146, P952, DOI 10.1104/pp.107.115691; Dave A, 2011, PLANT CELL, V23, P583, DOI 10.1105/tpc.110.081489; Davoine C, 2006, PLANT PHYSIOL, V140, P1484, DOI 10.1104/pp.105.074690; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Degenhardt DC, 2010, PHYTOCHEMISTRY, V71, P2024, DOI 10.1016/j.phytochem.2010.09.010; Dueckershoff K, 2008, BBA-PROTEINS PROTEOM, V1784, P1975, DOI 10.1016/j.bbapap.2008.09.003; Engelberth J, 2004, P NATL ACAD SCI USA, V101, P1781, DOI 10.1073/pnas.0308037100; Engelberth J, 2012, BIOCOMMUNICATION PLA; Engelberth J, 2007, MOL PLANT MICROBE IN, V20, P707, DOI 10.1094/MPMI-20-6-0707; Engelberth M. J., 2009, JOVE-J VIS EXP, V1127, DOI [10.3791/1127, DOI 10.3791/1127]; Gatehouse JA, 2002, NEW PHYTOL, V156, P145, DOI 10.1046/j.1469-8137.2002.00519.x; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Havill NP, 1999, OECOLOGIA, V120, P295, DOI 10.1007/s004420050861; Heil M, 2002, TRENDS PLANT SCI, V7, P61, DOI 10.1016/S1360-1385(01)02186-0; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Kang JH, 2006, PLANT CELL, V18, P3303, DOI 10.1105/tpc.106.041103; Koo AJK, 2009, PLANT J, V59, P974, DOI 10.1111/j.1365-313X.2009.03924.x; Maischak H, 2010, PLANT SIGNAL BEHAV, V5, P988, DOI [10.4161/psb.5.8.12223, 10.1104/pp.108.133884]; Ohkama-Ohtsu N, 2009, PLANT CELL PHYSL, V52, P205; Park YS, 2010, PLANTA, V231, P1425, DOI 10.1007/s00425-010-1143-8; Pauwels L, 2009, TRENDS PLANT SCI, V14, P87, DOI 10.1016/j.tplants.2008.11.005; Pohnert G, 1999, TETRAHEDRON, V55, P11275, DOI 10.1016/S0040-4020(99)00639-0; Ryan CA, 2000, BBA-PROTEIN STRUCT M, V1477, P112, DOI 10.1016/S0167-4838(99)00269-1; Schaller F, 2001, J EXP BOT, V52, P11, DOI 10.1093/jexbot/52.354.11; Schittko U, 2000, PLANTA, V210, P343, DOI 10.1007/PL00008143; Schmelz EA, 2006, P NATL ACAD SCI USA, V103, P8894, DOI 10.1073/pnas.0602328103; Schmelz EA, 2009, P NATL ACAD SCI USA, V106, P653, DOI 10.1073/pnas.0811861106; Shen BZ, 2000, P NATL ACAD SCI USA, V97, P14807, DOI 10.1073/pnas.240284097; Shiojiri K, 2006, PLOS BIOL, V4, P1044, DOI 10.1371/journal.pbio.0040164; Spiteller D, 2003, TETRAHEDRON, V59, P135, DOI 10.1016/S0040-4020(02)01489-8; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; STIRPE F, 1986, BIOCHEM J, V240, P659, DOI 10.1042/bj2400659; Stratmann JW, 2003, TRENDS PLANT SCI, V8, P247, DOI 10.1016/S1360-1385(03)00106-7; Takabayashi J, 1996, TRENDS PLANT SCI, V1, P109, DOI 10.1016/S1360-1385(96)90004-7; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Tumlinson J.H., 1999, P95; Tumlinson JH, 1999, NOVART FDN SYMP, V223, P105; Tumlinson JH, 1999, NOVART FDN SYMP, V223, P160; TURLINGS TCJ, 1992, P NATL ACAD SCI USA, V89, P8399, DOI 10.1073/pnas.89.17.8399; TURLINGS TCJ, 1991, J CHEM ECOL, V17, P2235, DOI 10.1007/BF00988004; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Wu JQ, 2007, PLANT CELL, V19, P1096, DOI 10.1105/tpc.106.049353; Wu JQ, 2010, ANNU REV GENET, V44, P1, DOI 10.1146/annurev-genet-102209-163500; Zimmermann MR, 2009, PLANT PHYSIOL, V149, P1593, DOI 10.1104/pp.108.133884	56	28	30	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34855	10.1371/journal.pone.0034855	http://dx.doi.org/10.1371/journal.pone.0034855			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511969	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338600055
J	Ray, J; Dondrup, M; Modha, S; Steen, IH; Sandaa, RA; Clokie, M				Ray, Jessica; Dondrup, Michael; Modha, Sejal; Steen, Ida Helene; Sandaa, Ruth-Anne; Clokie, Martha			Finding a Needle in the Virus Metagenome Haystack - Micro-Metagenome Analysis Captures a Snapshot of the Diversity of a Bacteriophage Armoire	PLOS ONE			English	Article							HYDROTHERMAL-VENT; ENDEAVOR RIDGE; POPULATION-DYNAMICS; PHAGE INTEGRASES; MARINE-BACTERIA; GROWTH-RATE; DEEP; COMMUNITY; ABUNDANCE; SEQUENCE	Viruses are ubiquitous in the oceans and critical components of marine microbial communities, regulating nutrient transfer to higher trophic levels or to the dissolved organic pool through lysis of host cells. Hydrothermal vent systems are oases of biological activity in the deep oceans, for which knowledge of biodiversity and its impact on global ocean biogeochemical cycling is still in its infancy. In order to gain biological insight into viral communities present in hydrothermal vent systems, we developed a method based on deep-sequencing of pulsed field gel electrophoretic bands representing key viral fractions present in seawater within and surrounding a hydrothermal plume derived from Loki's Castle vent field at the Arctic Mid-Ocean Ridge. The reduction in virus community complexity afforded by this novel approach enabled the near complete reconstruction of a lambda-like phage genome from the virus fraction of the plume. Phylogenetic examination of distinct gene regions in this lambdoid phage genome unveiled diversity at loci encoding superinfection exclusion- and integrase-like proteins. This suggests the importance of fine-tuning lyosgenic conversion as a viral survival strategy, and provides insights into the nature of host-virus and virus-virus interactions, within hydrothermal plumes. By reducing the complexity of the viral community through targeted sequencing of prominent dsDNA viral fractions, this method has selectively mimicked virus dominance approaching that hitherto achieved only through culturing, thus enabling bioinformatic analysis to locate a lambdoid viral "needle" within the greater viral community "haystack". Such targeted analyses have great potential for accelerating the extraction of biological knowledge from diverse and poorly understood environmental viral communities.	[Ray, Jessica; Steen, Ida Helene; Sandaa, Ruth-Anne] Univ Bergen, Dept Biol, Bergen, Norway; [Dondrup, Michael] Uni Comp CBU, Uni Res AS, Bergen, Norway; [Modha, Sejal; Clokie, Martha] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England	University of Bergen; University of Bergen; University of Leicester	Ray, J (corresponding author), Univ Bergen, Dept Biol, Bergen, Norway.	ruth.sandaa@bio.uib.no	Ray, Jessica Louise/D-2210-2018; Steen, Ida Helene/HGD-1549-2022	Ray, Jessica Louise/0000-0002-7305-5737; Modha, Sejal/0000-0002-8440-885X; Dondrup, Michael/0000-0002-2371-5928; Clokie, Martha/0000-0002-6069-8936	Centre for Geobiology, University of Bergen; Norwegian Research Council [186142/V40]; ERC	Centre for Geobiology, University of Bergen; Norwegian Research Council(Research Council of NorwayEuropean Commission); ERC(European Research Council (ERC)European Commission)	The research cruise was funded by the Centre for Geobiology, University of Bergen. This study was supported by the Norwegian Research Council for research programme 'Viral lysis and programmed cell death in marine phytoplankton' (VIPMAP, 186142/V40) and the project ERC Advanced Grant: MIcrobial Network OrganiSation (MINOS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 2003, RES MICROBIOL, V154, P245, DOI 10.1016/S0923-2508(03)00067-6; Allen EE, 2007, P NATL ACAD SCI USA, V104, P1883, DOI 10.1073/pnas.0604851104; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Balding C, 2005, ENVIRON MICROBIOL, V7, P1558, DOI 10.1111/j.1462-2920.2005.00845.x; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; BERGH O, 1989, NATURE, V340, P467, DOI 10.1038/340467a0; Bohannan BJM, 2000, ECOL LETT, V3, P362, DOI 10.1046/j.1461-0248.2000.00161.x; BRATBAK G, 1992, MAR ECOL PROG SER, V83, P273, DOI 10.3354/meps083273; BRATBAK G, 1994, MICROBIAL ECOL, V28, P209, DOI 10.1007/BF00166811; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Breitbart M, 2004, P ROY SOC B-BIOL SCI, V271, P565, DOI 10.1098/rspb.2003.2628; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Breitbart M, 2005, BACTERIOPHAGE PATHOE, P66; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; BURD BJ, 1995, J PLANKTON RES, V17, P965, DOI 10.1093/plankt/17.5.965; BURD BJ, 1994, DEEP-SEA RES PT I, V41, P1407, DOI 10.1016/0967-0637(94)90105-8; Carter J, 2009, VIROLOGY PRINCIPLES; CHENG SC, 1995, GENETICS, V140, P875; Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439; De Paepe M, 2006, PLOS BIOL, V4, P1248, DOI 10.1371/journal.pbio.0040193; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Desplats C, 2003, RES MICROBIOL, V154, P259, DOI 10.1016/S0923-2508(03)00069-X; Dick GJ, 2010, ENVIRON MICROBIOL, V12, P1334, DOI 10.1111/j.1462-2920.2010.02177.x; Durinck S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-2; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; FUHRMAN JA, 1993, OCEANOGRAPHY, V6, P51; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haible D, 2006, J VIROL METHODS, V135, P9, DOI 10.1016/j.jviromet.2006.01.017; HELDAL M, 1991, MAR ECOL PROG SER, V72, P205, DOI 10.3354/meps072205; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; JANNASCH HW, 1985, SCIENCE, V229, P717, DOI 10.1126/science.229.4715.717; Jiang SC, 1998, MICROBIAL ECOL, V35, P235, DOI 10.1007/s002489900079; Karl DM, 1995, MICR EXTREM UNUSUAL, P35; Kaye JZ, 2000, FEMS MICROBIOL ECOL, V32, P249; Kim KH, 2008, APPL ENVIRON MICROB, V74, P5975, DOI 10.1128/AEM.01275-08; Lam P, 2004, FEMS MICROBIOL ECOL, V47, P191, DOI 10.1016/S0168-6496(03)00256-3; Larsen A, 2001, MAR ECOL PROG SER, V221, P47, DOI 10.3354/meps221047; Lennon JT, 2007, ISME J, V1, P300, DOI 10.1038/ismej.2007.37; LENSKI RE, 1984, J THEOR BIOL, V108, P319, DOI 10.1016/S0022-5193(84)80035-1; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LIN L, 1977, J VIROL, V21, P554, DOI 10.1128/JVI.21.2.554-559.1977; Lindell D, 2007, NATURE, V449, P83, DOI 10.1038/nature06130; Manini E, 2008, MICROB ECOL, V55, P626, DOI 10.1007/s00248-007-9306-2; Mann NH, 2003, FEMS MICROBIOL REV, V27, P17, DOI 10.1016/S0168-6445(03)00016-0; Marie D, 1999, APPL ENVIRON MICROB, V65, P45; MATZ K, 1982, GENETICS, V102, P319; McCollom TM, 2000, DEEP-SEA RES PT I, V47, P85, DOI 10.1016/S0967-0637(99)00048-5; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Middelboe M, 2009, ENVIRON MICROBIOL, V11, P1971, DOI 10.1111/j.1462-2920.2009.01920.x; MITCHELL R, 1969, ENVIRON SCI TECHNOL, V3, P941, DOI 10.1021/es60033a007; NAGANUMA T, 1989, DEEP-SEA RES, V36, P1379, DOI 10.1016/0198-0149(89)90089-7; Nakagawa S, 2005, ENVIRON MICROBIOL, V7, P1619, DOI 10.1111/j.1462-2920.2005.00856.x; Napolitano MG, 2011, INFECT GENET EVOL, V11, P423, DOI 10.1016/j.meegid.2010.12.003; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Ortmann AC, 2005, DEEP-SEA RES PT I, V52, P1515, DOI 10.1016/j.dsr.2005.04.002; Panelli S, 2006, GENE, V372, P1, DOI 10.1016/j.gene.2006.01.032; Parada V, 2007, APPL ENVIRON MICROB, V73, P4429, DOI 10.1128/AEM.00029-07; PARMA DH, 1992, GENE DEV, V6, P497, DOI 10.1101/gad.6.3.497; Parnell LD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002216; Parsley LC, 2011, SOIL MICROBIAL DNA P, P109; Paul JH, 2005, CURR OPIN BIOTECH, V16, P299, DOI 10.1016/j.copbio.2005.03.007; Paul JH, 2002, COMP BIOCHEM PHYS B, V133, P463, DOI 10.1016/S1096-4959(02)00168-9; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Pedersen RB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1124; Polson SW, 2011, ISME J, V5, P366, DOI 10.1038/ismej.2010.122; PROCTOR LM, 1990, NATURE, V343, P60, DOI 10.1038/343060a0; PROCTOR LM, 1992, MAR ECOL PROG SER, V87, P283, DOI 10.3354/meps087283; RANADE K, 1993, J BACTERIOL, V175, P4712, DOI 10.1128/JB.175.15.4712-4718.1993; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; RODIN SN, 1983, J THEOR BIOL, V100, P185, DOI 10.1016/0022-5193(83)90346-6; Rohwer F, 2000, LIMNOL OCEANOGR, V45, P408, DOI 10.4319/lo.2000.45.2.0408; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Rohwer F, 2009, ENVIRON MICROBIOL, V11, P2771, DOI 10.1111/j.1462-2920.2009.02101.x; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Sandaa R-A, 2010, FINGERPRINTING AQUAT, P9; Sandaa RA, 2006, APPL ENVIRON MICROB, V72, P4610, DOI 10.1128/AEM.00168-06; Sandaa RA, 2009, ENVIRON MICROBIOL, V11, P2585, DOI 10.1111/j.1462-2920.2009.01983.x; Santos F, 2007, ENVIRON MICROBIOL, V9, P1711, DOI 10.1111/j.1462-2920.2007.01289.x; Santos F, 2010, ENVIRON MICROBIOL, V12, P2965, DOI 10.1111/j.1462-2920.2010.02273.x; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; Schwalbach MS, 2004, AQUAT MICROB ECOL, V34, P117, DOI 10.3354/ame034117; Scott KM, 2006, PLOS BIOL, V4, P2196, DOI 10.1371/journal.pbio.0040383; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; Slavcev RA, 2003, MOL GENET GENOMICS, V269, P40, DOI 10.1007/s00438-002-0787-x; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; Sullivan MB, 2006, PLOS BIOL, V4, P1344, DOI 10.1371/journal.pbio.0040234; Sunamura M, 2004, APPL ENVIRON MICROB, V70, P1190, DOI 10.1128/AEM.70.2.1190-1198.2004; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Takai K, 2004, APPL ENVIRON MICROB, V70, P2404, DOI 10.1128/AEM.70.4.2404-2413.2004; Thingstad TF, 1997, AQUAT MICROB ECOL, V13, P19, DOI 10.3354/ame013019; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMSON RE, 1992, DEEP-SEA RES, V39, P55, DOI 10.1016/0198-0149(92)90020-T; Tucker KP, 2011, ISME J, V5, P822, DOI 10.1038/ismej.2010.188; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Weinbauer MG, 2003, LIMNOL OCEANOGR, V48, P1457, DOI 10.4319/lo.2003.48.4.1457; Weinbauer MG, 1999, AQUAT MICROB ECOL, V17, P111, DOI 10.3354/ame017111; Weitz JS, 2005, P NATL ACAD SCI USA, V102, P9535, DOI 10.1073/pnas.0504062102; Williamson SJ, 2008, ISME J, V2, P1112, DOI 10.1038/ismej.2008.73; Williamson SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001456; Williamson SJ, 2002, APPL ENVIRON MICROB, V68, P4307, DOI 10.1128/AEM.68.9.4307-4314.2002; Williamson SJ, 2001, APPL ENVIRON MICROB, V67, P1682, DOI 10.1128/AEM.67.4.1682-1688.2001; Winter C, 2004, APPL ENVIRON MICROB, V70, P804, DOI 10.1128/AEM.70.2.804-813.2004; Wommack KE, 1999, APPL ENVIRON MICROB, V65, P231; Wommack KE, 2010, FILTRATION BASED MET, P110	111	18	18	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34238	10.1371/journal.pone.0034238	http://dx.doi.org/10.1371/journal.pone.0034238			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509283	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600023
J	Zhu, L; Wu, XC; Li, O; Qian, CD; Gao, HC				Zhu, Liang; Wu, Xuechang; Li, Ou; Qian, Chaodong; Gao, Haichun			Cloning and Characterization of Genes Involved in Nostoxanthin Biosynthesis of Sphingomonas elodea ATCC 31461	PLOS ONE			English	Article							AEROBIC PHOTOSYNTHETIC BACTERIUM; GRAM-NEGATIVE BACTERIA; CAROTENOID BIOSYNTHESIS; FUNCTIONAL-ANALYSIS; ESCHERICHIA-COLI; BETA-CAROTENE; CLUSTER; GELLAN; SYSTEM; BREVUNDIMONAS	Most Sphingomonas species synthesize the yellow carotenoid nostoxanthin. However, the carotenoid biosynthetic pathway of these species remains unclear. In this study, we cloned and characterized a carotenoid biosynthesis gene cluster containing four carotenogenic genes (crtG, crtY, crtI and crtB) and a beta-carotene hydroxylase gene (crtZ) located outside the cluster, from the gellan-gum producing bacterium Sphingomonas elodea ATCC 31461. Each of these genes was inactivated, and the biochemical function of each gene was confirmed based on chromatographic and spectroscopic analysis of the intermediates accumulated in the knockout mutants. Moreover, the crtG gene encoding the 2,2'-beta-hydroxylase and the crtZ gene encoding the beta-carotene hydroxylase, both responsible for hydroxylation of beta-carotene, were confirmed by complementation studies using Escherichia coli producing different carotenoids. Expression of crtG in zeaxanthin and beta-carotene accumulating E. coli cells resulted in the formation of nostoxanthin and 2,2'-dihydroxy-beta-carotene, respectively. Based on these results, a biochemical pathway for synthesis of nostoxanthin in S. elodea ATCC 31461 is proposed.	[Zhu, Liang; Wu, Xuechang; Li, Ou; Qian, Chaodong; Gao, Haichun] Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhu, L (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Microbiol, Hangzhou 310003, Zhejiang, Peoples R China.	mblab@163.com	Gao, Haichun/A-2160-2014; Gao, Haichun/AFU-4588-2022	Gao, Haichun/0000-0002-2647-6563; Gao, Haichun/0000-0002-2647-6563				ARMSTRONG GA, 1990, P NATL ACAD SCI USA, V87, P9975, DOI 10.1073/pnas.87.24.9975; FIALHO AM, 1991, LETT APPL MICROBIOL, V12, P85, DOI 10.1111/j.1472-765X.1991.tb00511.x; Fialho AM, 2008, APPL MICROBIOL BIOT, V79, P889, DOI 10.1007/s00253-008-1496-0; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Frank HA, 1996, PHOTOCHEM PHOTOBIOL, V63, P257, DOI 10.1111/j.1751-1097.1996.tb03022.x; GAY P, 1985, J BACTERIOL, V164, P918, DOI 10.1128/JB.164.2.918-921.1985; Gich F, 2006, INT J SYST EVOL MICR, V56, P847, DOI 10.1099/ijs.0.63970-0; Hanada S, 1997, INT J SYST BACTERIOL, V47, P408, DOI 10.1099/00207713-47-2-408; Harding N, 2006, US Patent, Patent No. 0199201; Iwai M, 2008, PLANT CELL PHYSIOL, V49, P1678, DOI 10.1093/pcp/pcn142; JENKINS CL, 1979, CURR MICROBIOL, V3, P1, DOI 10.1007/BF02603124; Johnson E A, 1996, Adv Biochem Eng Biotechnol, V53, P119; KANG KS, 1982, APPL ENVIRON MICROB, V43, P1086, DOI 10.1128/AEM.43.5.1086-1091.1982; Landrum JT, 2001, ARCH BIOCHEM BIOPHYS, V385, P28, DOI 10.1006/abbi.2000.2171; Lenz O, 1998, P NATL ACAD SCI USA, V95, P12474, DOI 10.1073/pnas.95.21.12474; Leys NMEJ, 2004, APPL ENVIRON MICROB, V70, P1944, DOI 10.1128/AEM.70.4.1944-1955.2004; Liang CW, 2006, INT J BIOL SCI, V2, P197; MISAWA N, 1995, BIOCHEM BIOPH RES CO, V209, P867, DOI 10.1006/bbrc.1995.1579; MISAWA N, 1990, J BACTERIOL, V172, P6704, DOI 10.1128/jb.172.12.6704-6712.1990; MISAWA N, 1995, J BACTERIOL, V177, P6575, DOI 10.1128/jb.177.22.6575-6584.1995; Nishida Y, 2005, APPL ENVIRON MICROB, V71, P4286, DOI 10.1128/AEM.71.8.4286-4296.2005; Olson JA, 1995, FASEB J, V9, P1547, DOI 10.1096/fasebj.9.15.8529833; Osawa A, 2011, PHYTOCHEMISTRY, V72, P711, DOI 10.1016/j.phytochem.2011.02.017; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; Sambrook J., 2001, MOL CLONING LAB MANU; Sandmann G, 2001, ARCH BIOCHEM BIOPHYS, V385, P4, DOI 10.1006/abbi.2000.2170; Sestak Z., 2004, CAROTENOIDS, V42, DOI 10.1023/b:phot.0000040641.40049.19,2; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; TAKAICHI S, 1992, METHOD ENZYMOL, V213, P374; Takaichi S, 2000, PHOTOSYNTH RES, V65, P93, DOI 10.1023/A:1006445503030; TAKAICHI S, 1990, ARCH MICROBIOL, V153, P118, DOI 10.1007/BF00247807; Tan GH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni124; Tao L, 2006, GENE, V379, P101, DOI 10.1016/j.gene.2006.04.017; Videira PA, 2000, APPL ENVIRON MICROB, V66, P2252, DOI 10.1128/AEM.66.5.2252-2258.2000; Walter MH, 2011, NAT PROD REP, V28, P663, DOI 10.1039/c0np00036a; Wu XC, 2011, CARBOHYD POLYM, V84, P1201, DOI 10.1016/j.carbpol.2011.01.018; Zhu L, 2011, J IND MICROBIOL BIOT, V38, P1507, DOI 10.1007/s10295-010-0937-9	37	14	14	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35099	10.1371/journal.pone.0035099	http://dx.doi.org/10.1371/journal.pone.0035099			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509387	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336600082
J	Chandra, SHV; Wacker, I; Appelt, UK; Behrens, J; Schneikert, J				Chandra, Shree Harsha Vijaya; Wacker, Ingrid; Appelt, Uwe Kurt; Behrens, Juergen; Schneikert, Jean			A Common Role for Various Human Truncated Adenomatous Polyposis Coli Isoforms in the Control of Beta-Catenin Activity and Cell Proliferation	PLOS ONE			English	Article							APC GENE; INTESTINAL POLYPS; SIGNALING PATHWAY; COLORECTAL TUMORS; STEM-CELLS; TRANSCRIPTION; PHOSPHORYLATION; EXPRESSION; MUTATIONS; CANCER	The tumour suppressor gene adenomatous polyposis coli (APC) is mutated in most colorectal cancer cases, leading to the synthesis of truncated APC products and the stabilization of beta-catenin. Truncated APC is almost always retained in tumour cells, suggesting that it serves an essential function. Here, RNA interference has been used to down-regulate truncated APC in several colorectal cancer cell lines expressing truncated APCs of different lengths, thereby performing an analysis covering most of the mutation cluster region (MCR). The consequences on proliferation in vitro, tumour formation in vivo and the level and transcriptional activity of beta-catenin have been investigated. Down-regulation of truncated APC results in an inhibition of tumour cell population expansion in vitro in 6 cell lines out of 6 and inhibition of tumour outgrowth in vivo as analysed in one of these cell lines, HT29. This provides a general rule explaining the retention of truncated APC in colorectal tumours and defines it as a suitable target for therapeutic intervention. Actually, we also show that it is possible to design a shRNA that targets a specific truncated isoform of APC without altering the expression of wild-type APC. Downregulation of truncated APC is accompanied by an up-regulation of the transcriptional activity of beta-catenin in 5 out of 6 cell lines. Surprisingly, the increased signalling is associated in most cases (4 out of 5) with an up-regulation of beta-catenin levels, indicating that truncated APC can still modulate wnt signalling through controlling the level of beta-catenin. This control can happen even when truncated APC lacks the beta-catenin inhibiting domain (CiD) involved in targeting beta-catenin for proteasomal degradation. Thus, truncated APC is an essential component of colorectal cancer cells, required for cell proliferation, possibly by adjusting beta-catenin signalling to the "just right" level.	[Chandra, Shree Harsha Vijaya; Wacker, Ingrid; Appelt, Uwe Kurt; Behrens, Juergen; Schneikert, Jean] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Chandra, SHV (corresponding author), Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Gluckstr, D-91054 Erlangen, Germany.	jschneik@molmed.uni-erlangen.de	Vijaya Chandra, Shree Harsha/GYA-5830-2022		Interdisziplinares Zentrum fur Klinische Forschung; Sander Stiftung; Deutsche Forschungsgemeinschaft [SCHN 1189/1-1]	Interdisziplinares Zentrum fur Klinische Forschung; Sander Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Interdisziplinares Zentrum fur Klinische Forschung (www.izkf.med.uni-erlangen.de/) and the Sander Stiftung (www.sanst.de) to JB and the Deutsche Forschungsgemeinschaft (www.dfg.de)to JS (grant noSCHN 1189/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque C, 2002, HUM MOL GENET, V11, P1549, DOI 10.1093/hmg/11.13.1549; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Behlke MA, 2006, MOL THER, V13, P644, DOI 10.1016/j.ymthe.2006.01.001; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Cheung AF, 2010, ONCOGENE, V29, P1857, DOI 10.1038/onc.2009.457; Dikovskaya D, 2007, J CELL BIOL, V176, P183, DOI 10.1083/jcb.200610099; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; FODDE R, 1994, P NATL ACAD SCI USA, V91, P8969, DOI 10.1073/pnas.91.19.8969; Gaspar C, 2008, AM J PATHOL, V172, P1363, DOI 10.2353/ajpath.2008.070851; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Gupta PK, 1997, CANCER RES, V57, P1188; Haigis KM, 2003, NAT GENET, V33, P33, DOI 10.1038/ng1055; Hong Y, 2007, MUTAT RES-FUND MOL M, V614, P48, DOI 10.1016/j.mrfmmm.2006.06.006; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kohler EM, 2008, HUM MOL GENET, V17, P1978, DOI 10.1093/hmg/ddn095; Kohler EM, 2009, HUM MOL GENET, V18, P213, DOI 10.1093/hmg/ddn338; Krieghoff E, 2006, J CELL SCI, V119, P1453, DOI 10.1242/jcs.02864; Lewis A, 2010, GUT, V59, P1680, DOI 10.1136/gut.2009.193680; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Manjunath N, 2010, DISCOV MED, V9, P418; McCart AE, 2008, PATHOL RES PRACT, V204, P479, DOI 10.1016/j.prp.2008.03.004; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Nielsen M, 2007, EUR J HUM GENET, V15, P1034, DOI 10.1038/sj.ejhg.5201871; Nieuwenhuis MH, 2007, CRIT REV ONCOL HEMAT, V61, P153, DOI 10.1016/j.critrevonc.2006.07.004; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Pollard P, 2009, GASTROENTEROLOGY, V136, P2204, DOI 10.1053/j.gastro.2009.02.058; Roberts DM, 2011, MOL BIOL CELL; Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Sangrar W, 2007, MOL CELL BIOL, V27, P6140, DOI 10.1128/MCB.01744-06; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Schneikert J, 2006, INT J CANCER, V119, P74, DOI 10.1002/ijc.21826; Schneikert J, 2007, GUT, V56, P417, DOI 10.1136/gut.2006.093310; Schneikert J, 2007, HUM MOL GENET, V16, P199, DOI 10.1093/hmg/ddl464; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Sieber OM, 2002, P NATL ACAD SCI USA, V99, P16910, DOI 10.1073/pnas.012679099; Sirven A, 2001, MOL THER, V3, P438, DOI 10.1006/mthe.2001.0282; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wang HM, 2008, CANCER LETT, V272, P253, DOI 10.1016/j.canlet.2008.07.010; Yang J, 2006, J BIOL CHEM, V281, P17751, DOI 10.1074/jbc.M600831200; Zhu G., 2011, ONCOGENE	49	27	31	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34479	10.1371/journal.pone.0034479	http://dx.doi.org/10.1371/journal.pone.0034479			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509309	Green Submitted, Green Published, gold			2022-12-27	WOS:000304805900037
J	Cho, IS; Jung, M; Kwon, KS; Moon, E; Cho, JH; Yoon, KH; Kim, JW; Lee, YD; Kim, SS; Suh-Kim, H				Cho, In-Su; Jung, Miyoung; Kwon, Ki-Sun; Moon, Eunpyo; Cho, Jang-Hyeon; Yoon, Kun-Ho; Kim, Ji-Won; Lee, Young-Don; Kim, Sung-Soo; Suh-Kim, Haeyoung			Deregulation of CREB Signaling Pathway Induced by Chronic Hyperglycemia Downregulates NeuroD Transcription	PLOS ONE			English	Article							INSULIN GENE-TRANSCRIPTION; PROTEIN PHOSPHATASE 2A; PANCREATIC BETA-CELLS; CYCLIC-AMP; DIABETES-MELLITUS; CATALYTIC-SUBUNIT; GLUCOSE; EXPRESSION; SECRETION; PHOSPHORYLATION	CREB mediates the transcriptional effects of glucose and incretin hormones in insulin-target cells and insulin-producing beta-cells. Although the inhibition of CREB activity is known to decrease the beta-cell mass, it is still unknown what factors inversely alter the CREB signaling pathway in beta-cells. Here, we show that beta-cell dysfunctions occurring in chronic hyperglycemia are not caused by simple inhibition of CREB activity but rather by the persistent activation of CREB due to decreases in protein phophatase PP2A. When freshly isolated rat pancreatic islets were chronically exposed to 25 mM (high) glucose, the PP2A activity was reduced with a concomitant increase in active pCREB. Brief challenges with 15 mM glucose or 30 mM forskolin after 2 hour fasting further increased the level of pCREB and consequently induced the persistent expression of ICER. The excessively produced ICER was sufficient to repress the transcription of NeuroD, insulin, and SUR1 genes. In contrast, when islets were grown in 5 mM (low) glucose, CREB was transiently activated in response to glucose or forskolin stimuli. Thus, ICER expression was transient and insufficient to repress those target genes. Importantly, overexpression of PP2A reversed the adverse effects of chronic hyperglycemia and successfully restored the transient activation of CREB and ICER. Conversely, depletion of PP2A with siRNA was sufficient to disrupt the negative feedback regulation of CREB and induce hyperglycemic phenotypes even under low glucose conditions. Our findings suggest that the failure of the negative feedback regulation of CREB is the primary cause for beta-cell dysfunctions under conditions of pathogenic hyperglycemia, and PP2A can be a novel target for future therapies aiming to protect beta-cells mass in the late transitional phase of non-insulin dependent type 2 diabetes (NIDDM).	[Cho, In-Su; Lee, Young-Don; Kim, Sung-Soo; Suh-Kim, Haeyoung] Ajou Univ, Dept Anat, Suwon 441749, South Korea; [Jung, Miyoung; Moon, Eunpyo] Ajou Univ, Dept Biol Sci, Suwon 441749, South Korea; [Cho, In-Su; Suh-Kim, Haeyoung] Ajou Univ, Grad Neurosci Program, Suwon, South Korea; [Cho, In-Su; Suh-Kim, Haeyoung] Ajou Univ, Div Cell Transformat & Restorat, Suwon 441749, South Korea; [Kwon, Ki-Sun] KRIBB, Aging Res Ctr, Taejon, South Korea; [Cho, Jang-Hyeon] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Yoon, Kun-Ho; Kim, Ji-Won] Catholic Univ, Sch Med, Dept Endocrinol, Seoul, South Korea	Ajou University; Ajou University; Ajou University; Ajou University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Baylor College of Medicine; Catholic University of Korea	Cho, IS (corresponding author), Ajou Univ, Dept Anat, Suwon 441749, South Korea.	kimdmg@ajou.ac.kr; hysuh@ajou.ac.kr		Suh-Kim, Haeyoung/0000-0001-8175-1209; Kim, Sung-Soo/0000-0003-3591-5932	Brain Research Center [2011K000262]; National Research Foundation (NRF) [2011-0019435]; Ministry of Education, Science and Technology, the Republic of Korea	Brain Research Center; National Research Foundation (NRF); Ministry of Education, Science and Technology, the Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by a grant (2011K000262) to HSK from Brain Research Center of the 21st Century Frontier Research Program and a grant (2011-0019435) from National Research Foundation (NRF) funded by the Ministry of Education, Science and Technology, the Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahmani A, 2006, EMBO J, V25, P977, DOI 10.1038/sj.emboj.7601008; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; AMMON HPT, 1984, N-S ARCH PHARMACOL, V326, P364, DOI 10.1007/BF00501444; Bernal-Mizrachi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011969; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Chae JH, 2004, MOL CELLS, V18, P271; Chakrabarti SK, 2003, TRENDS ENDOCRIN MET, V14, P78, DOI 10.1016/S1043-2760(02)00039-5; Cho JH, 2004, MOL NEUROBIOL, V30, P35, DOI 10.1385/MN:30:1:035; Chu K, 2001, RECENT PROG HORM RES, V56, P23, DOI 10.1210/rp.56.1.23; CLARK JL, 1969, P NATL ACAD SCI USA, V62, P278, DOI 10.1073/pnas.62.1.278; EFRAT S, 1994, TRENDS BIOCHEM SCI, V19, P535, DOI 10.1016/0968-0004(94)90056-6; Elrick LJ, 2001, DIABETES, V50, P2244, DOI 10.2337/diabetes.50.10.2244; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Ghil SH, 2000, J NEUROCHEM, V74, P151, DOI 10.1046/j.1471-4159.2000.0740151.x; Gotz J, 2009, CELL MOL LIFE SCI, V66, P1321, DOI 10.1007/s00018-009-9070-1; GOODISON S, 1992, BIOCHEM J, V285, P563, DOI 10.1042/bj2850563; Gotz J, 2003, METHOD ENZYMOL, V366, P390; Gu CY, 2010, CELL METAB, V11, P298, DOI 10.1016/j.cmet.2010.03.006; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; Huang HP, 2000, MOL CELL BIOL, V20, P3292, DOI 10.1128/MCB.20.9.3292-3307.2000; Huang Y, 2007, ACTA PHARMACOL SIN, V28, P1181, DOI 10.1111/j.1745-7254.2007.00626.x; Inada A, 1998, BIOCHEM BIOPH RES CO, V253, P712, DOI 10.1006/bbrc.1998.9833; Inada A, 1999, J BIOL CHEM, V274, P21095, DOI 10.1074/jbc.274.30.21095; Inada A, 2004, MOL CELL BIOL, V24, P2831, DOI 10.1128/MCB.24.7.2831-2841.2004; Ishizuka N, 2007, BIOCHEM BIOPH RES CO, V354, P271, DOI 10.1016/j.bbrc.2006.12.197; Jangati GR, 2007, ENDOCRINE, V31, P248, DOI 10.1007/s12020-007-0046-3; Jhala US, 2003, GENE DEV, V17, P1575, DOI 10.1101/gad.1097103; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Jonas JC, 2009, DIABETES OBES METAB, V11, P65, DOI 10.1111/j.1463-1326.2009.01112.x; Jones A, 2009, J ALZHEIMERS DIS, V16, P787, DOI 10.3233/JAD-2009-0973; Jones PM, 1998, ENDOCR REV, V19, P429, DOI 10.1210/er.19.4.429; KIDA Y, 1990, J CLIN INVEST, V85, P476, DOI 10.1172/JCI114462; KIDA Y, 1992, J CLIN INVEST, V89, P610, DOI 10.1172/JCI115627; Kim JW, 2002, MOL ENDOCRINOL, V16, P1097, DOI 10.1210/me.16.5.1097; Kins S, 2001, J BIOL CHEM, V276, P38193; Kowluru A, 2005, BIOCHEM PHARMACOL, V69, P1681, DOI 10.1016/j.bcp.2005.03.018; Lamas M, 1997, MOL ENDOCRINOL, V11, P1415, DOI 10.1210/me.11.10.1415; LAOIDE BM, 1993, EMBO J, V12, P1179, DOI 10.1002/j.1460-2075.1993.tb05759.x; Lee JK, 2000, DEV DYNAM, V217, P361, DOI 10.1002/(SICI)1097-0177(200004)217:4<361::AID-DVDY3>3.0.CO;2-8; Li JS, 2004, AM J PHYSIOL-ENDOC M, V286, pE818, DOI 10.1152/ajpendo.00307.2003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald PE, 2002, DIABETES, V51, pS434, DOI 10.2337/diabetes.51.2007.S434; Malecki MT, 1999, NAT GENET, V23, P323, DOI 10.1038/15500; Maronde E, 1999, J NEUROSCI, V19, P3326; Marsich E, 2003, BIOCHEM J, V376, P707, DOI 10.1042/BJ20031021; Martin CC, 2003, BIOCHEM J, V371, P675, DOI 10.1042/BJ20021585; Mioduszewska B, 2003, J NEUROCHEM, V87, P1313, DOI 10.1046/j.1471-4159.2003.02116.x; Moates JM, 2003, DIABETES, V52, P403, DOI 10.2337/diabetes.52.2.403; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Mutoh H, 1997, P NATL ACAD SCI USA, V94, P3560, DOI 10.1073/pnas.94.8.3560; NAYA FJ, 1995, GENE DEV, V9, P1009, DOI 10.1101/gad.9.8.1009; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; NICHOLS M, 1992, EMBO J, V11, P3337, DOI 10.1002/j.1460-2075.1992.tb05412.x; Oetjen E, 2003, MOL PHARMACOL, V63, P1289, DOI 10.1124/mol.63.6.1289; Oliveria SF, 2003, J CELL BIOL, V160, P101, DOI 10.1083/jcb.200209127; Palsgaard J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006575; Permana PA, 1997, GENOMICS, V41, P110, DOI 10.1006/geno.1997.4649; Rafiq I, 1998, J BIOL CHEM, V273, P23241, DOI 10.1074/jbc.273.36.23241; Redmon JB, 1996, J CLIN INVEST, V98, P2786, DOI 10.1172/JCI119105; Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9; Sato Y, 1998, BRIT J PHARMACOL, V123, P97, DOI 10.1038/sj.bjp.0701578; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; SUTTON R, 1986, TRANSPLANTATION, V42, P689, DOI 10.1097/00007890-198612000-00022; Ullrich S, 1996, PFLUG ARCH EUR J PHY, V432, P630, DOI 10.1007/s004240050179; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wang YG, 2010, P NATL ACAD SCI USA, V107, P3087, DOI 10.1073/pnas.0914897107; WENTWORTH BM, 1986, J MOL EVOL, V23, P305, DOI 10.1007/BF02100639; Xiao CQ, 2007, CHINESE MED J-PEKING, V120, P1020, DOI 10.1097/00029330-200706010-00016; Xu WZ, 1998, BIOCHEM BIOPH RES CO, V247, P814, DOI 10.1006/bbrc.1998.8897; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zhou YP, 2003, J BIOL CHEM, V278, P51316, DOI 10.1074/jbc.M307972200	72	17	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34860	10.1371/journal.pone.0034860	http://dx.doi.org/10.1371/journal.pone.0034860			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509362	gold, Green Published, Green Submitted			2022-12-27	WOS:000304805900060
J	Bhardwaj, G; Ko, KD; Hong, YJ; Zhang, ZH; Ho, NL; Chintapalli, SV; Kline, LA; Gotlin, M; Hartranft, DN; Patterson, ME; Dave, F; Smith, EJ; Holmes, EC; Patterson, RL; van Rossum, DB				Bhardwaj, Gaurav; Ko, Kyung Dae; Hong, Yoojin; Zhang, Zhenhai; Ho, Ngai Lam; Chintapalli, Sree V.; Kline, Lindsay A.; Gotlin, Matthew; Hartranft, David Nicholas; Patterson, Morgen E.; Dave, Foram; Smith, Evan J.; Holmes, Edward C.; Patterson, Randen L.; van Rossum, Damian B.			PHYRN: A Robust Method for Phylogenetic Analysis of Highly Divergent Sequences	PLOS ONE			English	Article							MULTIPLE ALIGNMENT; TWILIGHT ZONE; PROTEIN; INFORMATION; SIMULATION; COMPLEXITY; EXPRESSION; ALGORITHM; EVOLUTION; INFERENCE	Both multiple sequence alignment and phylogenetic analysis are problematic in the "twilight zone" of sequence similarity (<= 25% amino acid identity). Herein we explore the accuracy of phylogenetic inference at extreme sequence divergence using a variety of simulated data sets. We evaluate four leading multiple sequence alignment (MSA) methods (MAFFT, T-COFFEE, CLUSTAL, and MUSCLE) and six commonly used programs of tree estimation (Distance-based: Neighbor-Joining; Character-based: PhyML, RAxML, GARLI, Maximum Parsimony, and Bayesian) against a novel MSA-independent method (PHYRN) described here. Strikingly, at "midnight zone" genetic distances (similar to 7% pairwise identity and 4.0 gaps per position), PHYRN returns high-resolution phylogenies that outperform traditional approaches. We reason this is due to PHRYN's capability to amplify informative positions, even at the most extreme levels of sequence divergence. We also assess the applicability of the PHYRN algorithm for inferring deep evolutionary relationships in the divergent DANGER protein superfamily, for which PHYRN infers a more robust tree compared to MSA-based approaches. Taken together, these results demonstrate that PHYRN represents a powerful mechanism for mapping uncharted frontiers in highly divergent protein sequence data sets.	[Bhardwaj, Gaurav; Ko, Kyung Dae; Hong, Yoojin; Zhang, Zhenhai; Ho, Ngai Lam; Kline, Lindsay A.; Gotlin, Matthew; Hartranft, David Nicholas; Patterson, Morgen E.; Dave, Foram; Smith, Evan J.; Patterson, Randen L.; van Rossum, Damian B.] Penn State Univ, Ctr Computat Prote, University Pk, PA 16802 USA; [Bhardwaj, Gaurav; Ko, Kyung Dae; Hong, Yoojin; Kline, Lindsay A.; Gotlin, Matthew; Hartranft, David Nicholas; Smith, Evan J.; Holmes, Edward C.; van Rossum, Damian B.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Hong, Yoojin; Ho, Ngai Lam] Penn State Univ, Dept Comp Sci & Engn, University Pk, PA 16802 USA; [Zhang, Zhenhai] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Holmes, Edward C.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Bhardwaj, Gaurav; Patterson, Randen L.] Univ Calif Davis, Dept Biochem & Mol Med, Sch Med, Davis, CA 95616 USA; [Chintapalli, Sree V.; Patterson, Randen L.] Univ Calif Davis, Dept Physiol & Membrane Biol, Sch Med, Davis, CA 95616 USA; [Bhardwaj, Gaurav; Chintapalli, Sree V.; Patterson, Randen L.; van Rossum, Damian B.] Univ Calif Davis, Ctr Translat Biosci & Comp, Davis, CA 95616 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Bhardwaj, G (corresponding author), Penn State Univ, Ctr Computat Prote, University Pk, PA 16802 USA.	randen100@gmail.com; dbv10@psu.edu	Holmes, Edward/GVR-9499-2022; Holmes, Edward/Y-2789-2019; Zhang, Zhenhai/GRX-5887-2022	Holmes, Edward/0000-0001-9596-3552; Zhang, Zhenhai/0000-0002-4310-0525; Bhardwaj, Gaurav/0000-0001-6554-2335; /0000-0003-4660-2755; van Rossum, Damian/0000-0003-1011-2586	Searle Young Investigators Award; PSU; NCSA [TG-MCB070027N]; National Science Foundation [428-15 691M]; National Institutes of Health [R01 GM087410-01]; Fellowship from the Eberly College of Sciences; Huck Institutes of the Life Sciences; Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087410] Funding Source: NIH RePORTER	Searle Young Investigators Award; PSU; NCSA; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fellowship from the Eberly College of Sciences; Huck Institutes of the Life Sciences; Pennsylvania Department of Health using Tobacco Settlement Funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Searle Young Investigators Award and start-up money from PSU (RLP), NCSA grant TG-MCB070027N (RLP, DVR), The National Science Foundation 428-15 691M (RLP, DVR), and The National Institutes of Health R01 GM087410-01 (RLP, DVR). This project was also funded by a Fellowship from the Eberly College of Sciences and the Huck Institutes of the Life Sciences (DVR) and a grant with the Pennsylvania Department of Health using Tobacco Settlement Funds (DVR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beiko RG, 2007, BIOINFORMATICS, V23, P825, DOI 10.1093/bioinformatics/btm024; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bhardwaj G, 2010, ARXIV Q BIO PE Q BIO, P1; Blake JD, 2001, J MOL BIOL, V307, P721, DOI 10.1006/jmbi.2001.4495; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; Chang GS, 2008, P NATL ACAD SCI USA, V105, P13474, DOI 10.1073/pnas.0803860105; CHOW KL, 1995, DEVELOPMENT, V121, P3615; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Essoussi N, 2008, BIOINFORMATION, V2, P452; Grassly NC, 1997, COMPUT APPL BIOSCI, V13, P559; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Han QX, 2011, J VIROL, V85, P6464, DOI 10.1128/JVI.02298-10; Hohl M, 2007, SYST BIOL, V56, P206, DOI 10.1080/10635150701294741; Hong Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020557; Hong Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013596; Hongchun Yao, 2009, Proceedings of the 2009 9th International Conference on Electronic Measurement & Instruments (ICEMI 2009), P1, DOI 10.1109/ICEMI.2009.5274132; Kang BN, 2010, J NEUROSCI, V30, P93, DOI 10.1523/JNEUROSCI.3974-09.2010; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Ko KD, 2009, PHYS ARCH, P1; Ko KD, 2008, ARXIV0806; Lassmann T, 2009, NUCLEIC ACIDS RES, V37, P858, DOI 10.1093/nar/gkn1006; Lau GTC, 2001, BIOCHEM BIOPH RES CO, V280, P1378, DOI 10.1006/bbrc.2001.4290; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LEMPEL A, 1976, IEEE T INFORM THEORY, V22, P75, DOI 10.1109/TIT.1976.1055501; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu K, 2012, SYST BIOL, V61, P90, DOI 10.1093/sysbio/syr095; Liu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013057; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Nikolaidis N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000204; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Roch S, 2010, SCIENCE, V327, P1376, DOI 10.1126/science.1182300; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roshan U, 2006, BIOINFORMATICS, V22, P2715, DOI 10.1093/bioinformatics/btl472; Sonnhammer ELL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-108; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stoye J, 1998, BIOINFORMATICS, V14, P157, DOI 10.1093/bioinformatics/14.2.157; Subramanian AR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-66; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ulitsky I, 2006, J COMPUT BIOL, V13, P336, DOI 10.1089/cmb.2006.13.336; van Rossum DB, 2006, J BIOL CHEM, V281, P37111, DOI 10.1074/jbc.M608760200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2009, DEV GROWTH DIFFER, V51, P167, DOI 10.1111/j.1440-169X.2009.01103.x; Wheeler TJ, 2009, LECT N BIOINFORMAT, V5724, P375, DOI 10.1007/978-3-642-04241-6_31; Wilgenbusch James C, 2003, Curr Protoc Bioinformatics, VChapter 6, DOI 10.1002/0471250953.bi0604s00; Wong YM, 2002, MECH DEVELOP, V113, P149, DOI 10.1016/S0925-4773(02)00012-6; Yona G, 2002, J MOL BIOL, V315, P1257, DOI 10.1006/jmbi.2001.5293; Zwickl D. J, 2006, GENETIC ALGORITHM AP	55	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34261	10.1371/journal.pone.0034261	http://dx.doi.org/10.1371/journal.pone.0034261			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514627	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341600032
J	Brouwer, RM; Mandl, RCW; Schnack, HG; van Soelen, ILC; van Baal, GC; Peper, JS; Kahn, RS; Boomsma, DI; Pol, HEH				Brouwer, Rachel M.; Mandl, Rene C. W.; Schnack, Hugo G.; van Soelen, Inge L. C.; van Baal, G. Caroline; Peper, Jiska S.; Kahn, Rene S.; Boomsma, Dorret I.; Pol, H. E. Hulshoff			White Matter Development in Early Puberty: A Longitudinal Volumetric and Diffusion Tensor Imaging Twin Study	PLOS ONE			English	Article							AGE-RELATED-CHANGES; HUMAN BRAIN; CORTICAL THICKNESS; CORPUS-CALLOSUM; GROWTH-PATTERNS; NORMAL-CHILDREN; CHILDHOOD; MRI; ADOLESCENCE; ADULTHOOD	White matter microstructure and volume show synchronous developmental patterns in children. White matter volume increases considerably during development. Fractional anisotropy, a measure for white matter microstructural directionality, also increases with age. Development of white matter volume and development of white matter microstructure seem to go hand in hand. The extent to which the same or different genetic and/or environmental factors drive these two aspects of white matter maturation is currently unknown. We mapped changes in white matter volume, surface area and diffusion parameters in mono- and dizygotic twins who were scanned at age 9 (203 individuals) and again at age 12 (126 individuals). Over the three-year interval, white matter volume (+6.0%) and surface area (+1.7%) increased, fiber bundles expanded (most pronounced in the left arcuate fasciculus and splenium), and fractional anisotropy increased (+3.0%). Genes influenced white matter volume (heritability similar to 85%),surface area (similar to 85%), and fractional anisotropy (locally 7% to 50%) at both ages. Finally, volumetric white matter growth was negatively correlated with fractional anisotropy increase (r=-0.62) and this relationship was driven by environmental factors. In children who showed the most pronounced white matter growth, fractional anisotropy increased the least and vice-versa. Thus, white matter development in childhood may reflect a process of both expansion and fiber optimization.	[Brouwer, Rachel M.; Mandl, Rene C. W.; Schnack, Hugo G.; van Soelen, Inge L. C.; van Baal, G. Caroline; Peper, Jiska S.; Kahn, Rene S.; Pol, H. E. Hulshoff] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [van Soelen, Inge L. C.; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Amsterdam, Netherlands; [Peper, Jiska S.] Leiden Univ, Brain & Dev Lab, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Leiden University; Leiden University - Excl LUMC	Brouwer, RM (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands.	r.m.brouwer-4@umcutrecht.nl	Hulshoff Pol, Hilleke Evertje/B-4795-2014; Mandl, René C.W./AAU-7037-2020; Boomsma, Dorret I/AAX-4470-2020	Hulshoff Pol, Hilleke Evertje/0000-0002-2038-5281; 	Netherlands Organisation for Scientific Research [NWO 51.02.060, NWO 480-04-004]; High Potential Grant University Utrecht, Hersenstichting Nederland [2010(1)-79]; European Research Council [ERC-230374]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); High Potential Grant University Utrecht, Hersenstichting Nederland; European Research Council(European Research Council (ERC)European Commission)	This research has been supported by grants from the Netherlands Organisation for Scientific Research (NWO 51.02.060, NWO 480-04-004), the High Potential Grant University Utrecht, Hersenstichting Nederland (2010(1)-79) and European Research Council (ERC-230374). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Andersson JLR, 2002, NEUROIMAGE, V16, P177, DOI 10.1006/nimg.2001.1039; Asato MR, 2010, CEREB CORTEX, V20, P2122, DOI 10.1093/cercor/bhp282; Bartzokis G, 2001, ARCH GEN PSYCHIAT, V58, P461, DOI 10.1001/archpsyc.58.5.461; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Bava S, 2010, BRAIN RES, V1327, P38, DOI 10.1016/j.brainres.2010.02.066; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; BENES FM, 1994, ARCH GEN PSYCHIAT, V51, P477; Boomsma D, 2002, NAT REV GENET, V3, P872, DOI 10.1038/nrg932; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Brans RGH, 2010, J NEUROSCI, V30, P5519, DOI 10.1523/JNEUROSCI.5841-09.2010; Brouwer RM, 2010, NEUROIMAGE, V53, P1085, DOI 10.1016/j.neuroimage.2010.03.017; Brouwer RM, 2010, NEUROIMAGE, V49, P467, DOI 10.1016/j.neuroimage.2009.07.041; Cascio CJ, 2007, J AM ACAD CHILD PSY, V46, P213, DOI 10.1097/01.chi.0000246064.93200.e8; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chiang MC, 2011, NEUROIMAGE, V54, P2308, DOI 10.1016/j.neuroimage.2010.10.015; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Falconer D. S., 1996, INTRO QUANTITATIVE G; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gerig G, 2004, P ANN INT IEEE EMBS, V26, P4421; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Gogtay N, 2008, P NATL ACAD SCI USA, V105, P15979, DOI 10.1073/pnas.0806485105; Gulani V, 2001, MAGNET RESON MED, V45, P191, DOI 10.1002/1522-2594(200102)45:2<191::AID-MRM1025>3.0.CO;2-9; Hua X, 2009, HUM BRAIN MAPP, V30, P209, DOI 10.1002/hbm.20498; Imperati D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023437; Jito J, 2008, J MAGN RESON IMAGING, V28, P847, DOI 10.1002/jmri.21496; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Ladouceur CD, 2012, DEV COGN NEUROS-NETH, V2, P36, DOI 10.1016/j.dcn.2011.06.002; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Lebel C, 2010, NEUROIMAGE, V52, P20, DOI 10.1016/j.neuroimage.2010.03.072; Lerch JP, 2008, NEUROBIOL AGING, V29, P23, DOI 10.1016/j.neurobiolaging.2006.09.013; Madler B, 2008, MAGN RESON IMAGING, V26, P874, DOI 10.1016/j.mri.2008.01.047; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Mandl RCW, 2010, SCHIZOPHRENIA BULL, V36, P778, DOI 10.1093/schbul/sbn161; McGraw P, 2002, AM J ROENTGENOL, V179, P1515, DOI 10.2214/ajr.179.6.1791515; Mori S, 2002, MAGN RESON MED, V47, P215, DOI 10.1002/mrm.10074; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Muetzel RL, 2008, NEUROIMAGE, V39, P1918, DOI 10.1016/j.neuroimage.2007.10.018; Neale M. C., 2006, MX STAT MODELING, V7th; Neale MC, 1992, METHODOLOGY GENETIC; Peper JS, 2008, PSYCHONEUROENDOCRINO, V33, P909, DOI 10.1016/j.psyneuen.2008.03.017; Peper JS, 2009, HUM BRAIN MAPP, V30, P2184, DOI 10.1002/hbm.20660; Perrin JS, 2008, J NEUROSCI, V28, P9519, DOI 10.1523/JNEUROSCI.1212-08.2008; Raznahan A, 2011, J NEUROSCI, V31, P7174, DOI 10.1523/JNEUROSCI.0054-11.2011; Schmithorst VJ, 2010, BRAIN COGNITION, V72, P16, DOI 10.1016/j.bandc.2009.06.005; Sowell ER, 2004, J NEUROSCI, V24, P8223, DOI 10.1523/JNEUROSCI.1798-04.2004; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Thompson PM, 2000, NATURE, V404, P190, DOI 10.1038/35004593; Tyszka JM, 2006, NEUROIMAGE, V29, P1058, DOI 10.1016/j.neuroimage.2005.08.037; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Soelen ILC, 2011, NEUROIMAGE; van Soelen ILC, 2013, HUM BRAIN MAPP, V34, P713, DOI 10.1002/hbm.21468; Yakovlev P.I., 1967, REGIONAL DEV BRAIN E; Yoon U, 2010, NEUROIMAGE, V53, P1117, DOI 10.1016/j.neuroimage.2010.01.007	59	77	78	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e32316	10.1371/journal.pone.0032316	http://dx.doi.org/10.1371/journal.pone.0032316			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514599	Green Published, gold			2022-12-27	WOS:000305341600004
J	Chacko, AM; Nayak, M; Greineder, CF; DeLisser, HM; Muzykantov, VR				Chacko, Ann-Marie; Nayak, Madhura; Greineder, Colin F.; DeLisser, Horace M.; Muzykantov, Vladimir R.			Collaborative Enhancement of Antibody Binding to Distinct PECAM-1 Epitopes Modulates Endothelial Targeting	PLOS ONE			English	Article							CELL ADHESION MOLECULE-1; HUMAN GROWTH-HORMONE; ACTIVATED PROTEIN-C; MONOCLONAL-ANTIBODIES; CONVERTING-ENZYME; IN-VIVO; PROPHYLACTIC THROMBOLYSIS; NEUTROPHIL RECRUITMENT; PULMONARY VASCULATURE; HEMOPHILIC BINDING	Antibodies to platelet endothelial cell adhesion molecule-1 (PECAM-1) facilitate targeted drug delivery to endothelial cells by "vascular immunotargeting.'' To define the targeting quantitatively, we investigated the endothelial binding of monoclonal antibodies (mAbs) to extracellular epitopes of PECAM-1. Surprisingly, we have found in human and mouse cell culture models that the endothelial binding of PECAM-directed mAbs and scFv therapeutic fusion protein is increased by co-administration of a paired mAb directed to an adjacent, yet distinct PECAM-1 epitope. This results in significant enhancement of functional activity of a PECAM-1-targeted scFv-thrombomodulin fusion protein generating therapeutic activated Protein C. The "collaborative enhancement'' of mAb binding is affirmed in vivo, as manifested by enhanced pulmonary accumulation of intravenously administered radiolabeled PECAM-1 mAb when co-injected with an unlabeled paired mAb in mice. This is the first demonstration of a positive modulatory effect of endothelial binding and vascular immunotargeting provided by the simultaneous binding a paired mAb to adjacent distinct epitopes. The "collaborative enhancement'' phenomenon provides a novel paradigm for optimizing the endothelial-targeted delivery of therapeutic agents.	[Chacko, Ann-Marie; Nayak, Madhura] Univ Penn, Dept Radiol, Div Nucl Med & Clin Mol Imaging, Perelman Sch Med, Philadelphia, PA 19104 USA; [Greineder, Colin F.] Univ Penn, Dept Emergency Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [DeLisser, Horace M.] Univ Penn, Pulm Allergy & Crit Care Div, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chacko, Ann-Marie; Greineder, Colin F.; Muzykantov, Vladimir R.] Univ Penn, Inst Translat Med & Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Chacko, AM (corresponding author), Univ Penn, Dept Radiol, Div Nucl Med & Clin Mol Imaging, Perelman Sch Med, Philadelphia, PA 19104 USA.	muzykant@mail.med.upenn.edu	DeLisser, Horace/AFM-1942-2022	Greineder, Colin/0000-0001-9740-7672; Chacko, Ann-Marie/0000-0001-5140-2622	National Institutes of Health [R01-HL091950, R01-HL087036]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091950, R01HL087036] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant R01-HL091950 and R01-HL087036 (VRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; AGUILAR RC, 1994, MOL CELL BIOCHEM, V136, P35, DOI 10.1007/BF00931602; Aguilar RC, 2000, LIFE SCI, V66, P1021, DOI 10.1016/S0024-3205(99)00667-0; Aird WC, 2007, CURR DRUG TARGETS, V8, P501, DOI 10.2174/138945007780362782; Atochina EN, 1998, AM J PHYSIOL-LUNG C, V275, pL806, DOI 10.1152/ajplung.1998.275.4.L806; ChristofidouSolomidou M, 1997, J IMMUNOL, V158, P4872; Coombe DR, 2008, BIOCHEMISTRY-US, V47, P4863, DOI 10.1021/bi7024595; Danilov SM, 2001, AM J PHYSIOL-LUNG C, V280, pL1335, DOI 10.1152/ajplung.2001.280.6.L1335; DELISSER HM, 1994, IMMUNOL TODAY, V15, P490, DOI 10.1016/0167-5699(94)90195-3; DeLisser HM, 1997, AM J PATHOL, V151, P671; DIAMOND AG, 1984, J IMMUNOL, V132, P1169; Ding BS, 2008, BLOOD, V111, P1999, DOI 10.1182/blood-2007-07-103002; Ding BS, 2009, AM J RESP CRIT CARE, V180, P247, DOI 10.1164/rccm.200809-1433OC; Ding BS, 2005, BLOOD, V106, P4191, DOI 10.1182/blood-2005-05-2002; Feistritzer C, 2006, J BIOL CHEM, V281, P20077, DOI 10.1074/jbc.M600506200; Fujiwara K, 2006, J INTERN MED, V259, P373, DOI 10.1111/j.1365-2796.2006.01623.x; Gandhi NS, 2008, BIOCHEMISTRY-US, V47, P4851, DOI 10.1021/bi702455e; Garnacho C, 2008, J CONTROL RELEASE, V130, P226, DOI 10.1016/j.jconrel.2008.06.007; Garnacho C, 2008, BLOOD, V111, P3024, DOI 10.1182/blood-2007-06-098657; Gordon K, 2010, TISSUE ANTIGENS, V75, P136, DOI 10.1111/j.1399-0039.2009.01416.x; Gurubhagavatula I, 1998, J CLIN INVEST, V101, P212, DOI 10.1172/JCI269; Hajitou A, 2006, CELL, V125, P385, DOI 10.1016/j.cell.2006.02.042; Kaufman DA, 2004, BIOCHEM BIOPH RES CO, V320, P1076, DOI 10.1016/j.bbrc.2004.06.055; Kobayashi M, 2005, J ATHEROSCLER THROMB, V12, P138, DOI 10.5551/jat.12.138; Kohlstedt K, 2006, MOL PHARMACOL, V69, P1725, DOI 10.1124/mol.105.020636; Kowalska MA, 2007, BLOOD, V110, P1903, DOI 10.1182/blood-2007-03-081901; Kozower BD, 2003, NAT BIOTECHNOL, V21, P392, DOI 10.1038/nbt806; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; MULLER WA, 1989, J EXP MED, V170, P399, DOI 10.1084/jem.170.2.399; Muro S, 2005, CURR PHARM DESIGN, V11, P2383, DOI 10.2174/1381612054367274; Muzykantov Vladimir R, 2005, Expert Opin Drug Deliv, V2, P909, DOI 10.1517/17425247.2.5.909; Nakada MT, 2000, J IMMUNOL, V164, P452, DOI 10.4049/jimmunol.164.1.452; Naperova IA, 2008, J PROTEOME RES, V7, P3396, DOI 10.1021/pr800142w; NEWMAN PJ, 1994, ANN NY ACAD SCI, V714, P165, DOI 10.1111/j.1749-6632.1994.tb12041.x; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Newman PJ, 2003, ARTERIOSCL THROM VAS, V23, P953, DOI 10.1161/01.ATV.0000071347.69358.D9; Newton JP, 1997, J BIOL CHEM, V272, P20555, DOI 10.1074/jbc.272.33.20555; Ogawara KI, 2004, HUM GENE THER, V15, P433, DOI 10.1089/10430340460745766; Oh P, 2004, NATURE, V429, P629, DOI 10.1038/nature02580; Peracchi A, 2011, BBA-PROTEINS PROTEOM, V1814, P922, DOI 10.1016/j.bbapap.2010.10.008; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Shuvaev VV, 2011, FASEB J, V25, P348, DOI 10.1096/fj.10-169789; STAN RV, 2009, PULMONARY ENDOTHELIU, P25; Stuttfeld E, 2009, IUBMB LIFE, V61, P915, DOI 10.1002/iub.234; Sun J, 1996, J BIOL CHEM, V271, P18561, DOI 10.1074/jbc.271.31.18561; Sun QH, 1996, J BIOL CHEM, V271, P11090, DOI 10.1074/jbc.271.19.11090; Sweitzer TD, 2003, FREE RADICAL BIO MED, V34, P1035, DOI 10.1016/S0891-5849(03)00029-7; Tsai CJ, 2008, J MOL BIOL, V378, P1, DOI 10.1016/j.jmb.2008.02.034; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; VECCHI A, 1994, EUR J CELL BIOL, V63, P247; Weiler H, 2003, J THROMB HAEMOST, V1, P1515, DOI 10.1046/j.1538-7836.2003.00306.x; Yan HC, 1996, CELL ADHES COMMUN, V3, P475, DOI 10.3109/15419069609081024; YAN HC, 1995, J BIOL CHEM, V270, P23672, DOI 10.1074/jbc.270.40.23672; YAN HC, 1995, CELL ADHES COMMUN, V3, P45, DOI 10.3109/15419069509081277	54	28	32	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34958	10.1371/journal.pone.0034958	http://dx.doi.org/10.1371/journal.pone.0034958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514693	Green Published, Green Submitted			2022-12-27	WOS:000305341600099
J	Guo, CY; Liu, HB; Zhang, BH; Cadaneanu, RM; Mayle, AM; Garraway, IP				Guo, Changyong; Liu, Haibo; Zhang, Bao-Hui; Cadaneanu, Radu M.; Mayle, Aqila M.; Garraway, Isla P.			Epcam, CD44, and CD49f Distinguish Sphere-Forming Human Prostate Basal Cells from a Subpopulation with Predominant Tubule Initiation Capability	PLOS ONE			English	Article							EPITHELIAL STEM-CELLS; MURINE PROSTATE; PROGENITOR CELLS; CANCER CELLS; NEURAL STEM; IN-VITRO; EXPRESSION; MARKER; DIFFERENTIATION; IDENTIFICATION	Background: Human prostate basal cells expressing alpha-6 integrin (CD49f(Hi)) and/or CD44 form prostaspheres in vitro. This functional trait is often correlated with stem/progenitor (S/P) activity, including the ability to self-renew and induce differentiated tubules in vivo. Antigenic profiles that distinguish tubule-initiating prostate stem cells (SCs) from progenitor cells (PCs) and mature luminal cells (LCs) with less regenerative potential are unknown. Methodology/Principle Findings: Prostasphere assays and RT-PCR analysis was performed following FACS separation of total benign prostate cells based upon combinations of Epcam, CD44, and/or CD49f expression. Epithelial cell fractions were isolated, including Epcam(+)CD44(+) and Epcam+CD44+CD49f(Hi) basal cells that formed abundant spheres. When non-sphere-forming Epcam(+)CD44(-) cells were fractionated based upon CD49f expression, a distinct subpopulation (Epcam(+)CD44(-)CD49f(Hi)) was identified that possessed a basal profile similar to Epcam(+)CD44(+)CD49f(Hi) sphere-forming cells (p63(+)AR(Lo)PSA(-)). Evaluation of tubule induction capability of fractionated cells was performed, in vivo, via a fully humanized prostate tissue regeneration assay. Non-sphere-forming Epcam(+)CD44(-) cells induced significantly more prostate tubular structures than Epcam(+)CD44(+) sphere-forming cells. Further fractionation based upon CD49f co-expression identified Epcam(+)CD44(-)CD49f(Hi) (non-sphere-forming) basal cells with significantly increased tubule induction activity compared to Epcam(+)CD440(-)CD49f(Lo) (true) luminal cells. Conclusions/Significance: Our data delineates antigenic profiles that functionally distinguish human prostate epithelial subpopulations, including putative SCs that display superior tubule initiation capability and induce differentiated ductal/acini structures, sphere-forming PCs with relatively decreased tubule initiation activity, and terminally differentiated LCs that lack both sphere-forming and tubule-initiation activity. The results clearly demonstrate that sphere-forming ability is not predictive of tubule-initiation activity. The subpopulations identified are of interest because they may play distinct roles as cells of origin in the development of prostatic diseases, including cancer.	[Guo, Changyong; Liu, Haibo; Zhang, Bao-Hui; Cadaneanu, Radu M.; Mayle, Aqila M.; Garraway, Isla P.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA; [Guo, Changyong; Liu, Haibo; Zhang, Bao-Hui; Cadaneanu, Radu M.; Mayle, Aqila M.; Garraway, Isla P.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Mayle, Aqila M.; Garraway, Isla P.] Greater Los Angeles Vet Affairs Med Ctr, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Guo, CY (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Urol, Los Angeles, CA 90095 USA.	igarraway@mednet.ucla.edu			Prostate Cancer Foundation (Challenge Award); Jean Perkins Foundation; Department of Defense [PC061068, PC07373]; National Institutes of Health [CA-16042, AI-28697]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER	Prostate Cancer Foundation (Challenge Award); Jean Perkins Foundation; Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support for these studies was provided by the Prostate Cancer Foundation (Challenge Award, PI: Dr. Owen Witte), the Jean Perkins Foundation, the Department of Defense (PC061068 and PC07373), and the National Institutes of Health CA-16042 and AI-28697. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buzhor E, 2011, TISSUE ENG A; Collins AT, 2001, J CELL SCI, V114, P3865; CUNHA GR, 1978, J EXP ZOOL, V205, P181, DOI 10.1002/jez.1402050203; Deleyrolle LP, 2009, PROG BRAIN RES, V175, P43, DOI 10.1016/S0079-6123(09)17504-0; Deleyrolle Loic P., 2009, V549, P91, DOI 10.1007/978-1-60327-931-4_7; Epstein JI, 2010, J UROLOGY, V183, P433, DOI 10.1016/j.juro.2009.10.046; Farnie G, 2006, Ernst Schering Found Symp Proc, P141; Garraway IP, 2004, PROSTATE, V61, P209, DOI 10.1002/pros.20096; Garraway IP, 2010, PROSTATE, V70, P491, DOI 10.1002/pros.21083; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Griend DJV, 2008, CANCER RES, V68, P9703, DOI 10.1158/0008-5472.CAN-08-3084; Kurtz JE, 2010, EXPERT OPIN BIOL TH, V10, P951, DOI 10.1517/14712598.2010.482098; Lang SH, 2010, STEM CELLS DEV, V19, P537, DOI 10.1089/scd.2009.0291; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Litvinov IV, 2006, CANCER RES, V66, P8598, DOI 10.1158/0008-5472.CAN-06-1228; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Palapattu GS, 2009, PROSTATE, V69, P787, DOI 10.1002/pros.20928; Pastrana E, 2011, CELL STEM CELL, V8, P486, DOI 10.1016/j.stem.2011.04.007; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Patriarca C, 2011, CANC TREAT REV; Peehl DM, 2005, ENDOCR-RELAT CANCER, V12, P19, DOI 10.1677/erc.1.00795; Peehl DM, 2004, J CELL BIOCHEM, V91, P185, DOI 10.1002/jcb.10691; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; SIGNORETTI S, 2006, SEMIN CANC BIOL; Tran CP, 2002, MOL CANCER RES, V1, P113; van Leenders G, 2002, PROSTATE, V51, P98, DOI 10.1002/pros.10073; van Leenders GJLH, 2001, J PATHOL, V195, P563, DOI 10.1002/path.993; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	33	40	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34219	10.1371/journal.pone.0034219	http://dx.doi.org/10.1371/journal.pone.0034219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514625	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600030
J	Lee, CM; Jung, ID; Noh, KT; Lee, JS; Park, JW; Heo, DR; Park, JH; Chang, JH; Choi, IW; Kim, JS; Shin, YK; Park, SJ; Han, MK; Lee, CG; Cho, WK; Park, YM				Lee, Chang-Min; Jung, In Duk; Noh, Kyung Tae; Lee, Jun Sik; Park, Jin Wook; Heo, Deok Rim; Park, Jun Ho; Chang, Jeong Hyun; Choi, Il-Whan; Kim, Jong-Suk; Shin, Yong Kyoo; Park, Sung-Joo; Han, Myung-Kwan; Lee, Chun Geun; Cho, Won-Kyung; Park, Yeong-Min			An Essential Regulatory Role of Downstream of Kinase-1 in the Ovalbumin-Induced Murine Model of Asthma	PLOS ONE			English	Article							ALLERGIC AIRWAY INFLAMMATION; ADAPTER PROTEIN DOK-1; NF-KAPPA-B; LUNG INFLAMMATION; CELLS; RESPONSES; DIFFERENTIATION; ACTIVATION; EXPRESSION; GATA-3	The downstream of kinase (DOK)-1 is involved in the protein tyrosine kinase (PTK) pathway in mast cells, but the role of DOK-1 in the pathogenesis of asthma has not been defined. In this study, we have demonstrated a novel regulatory role of DOK-1 in airway inflammation and physiologic responses in a murine model of asthma using lentiviral vector containing DOK-1 cDNA or DOK-1-specific ShRNA. The OVA-induced inflammatory cells, airway hyperresponsiveness, Th2 cytokine expression, and mucus response were significantly reduced in DOK-1 overexpressing mice compared to OVA-challenged control mice. The transgenic introduction of DOK-1 significantly stimulated the activation and expression of STAT-4 and T-bet, while impressively inhibiting the activation and expression of STAT-6 and GATA-3 in airway epithelial cells. On the other hand, DOK-1 knockdown mice enhanced STAT-6 expression and its nuclear translocation compared to OVA-challenged control mice. When viewed in combination, our studies demonstrate DOK-1 regulates allergen-induced Th2 immune responses by selective stimulation and inhibition of STAT-4 and STAT-6 signaling pathways, respectively. These studies provide a novel insight on the regulatory role of DOK-1 in allergen-induced Th2 inflammation and airway responses, which has therapeutic potential for asthma and other allergic diseases.	[Lee, Chang-Min; Jung, In Duk; Noh, Kyung Tae; Park, Jin Wook; Heo, Deok Rim; Park, Yeong-Min] Pusan Natl Univ, Dept Microbiol & Immunol, Med Res Inst, Sch Med, Yangsan, South Korea; [Lee, Jun Sik] Chosun Univ, Dept Biol, Coll Nat Sci, Kwangju, South Korea; [Park, Jun Ho] Busan Med Ctr, Dept Thorac & Cardiovasc Surg, Pusan, South Korea; [Chang, Jeong Hyun] Daegu Haany Univ, Coll Hlth & Therapy, Dept Clin Labratory Sci, Gyeong San, South Korea; [Choi, Il-Whan] Inje Univ, Coll Med, Dept Microbiol, Pusan, South Korea; [Kim, Jong-Suk] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju, South Korea; [Shin, Yong Kyoo] Chung Ang Univ, Coll Med, Dept Pharmacol, Seoul, South Korea; [Park, Sung-Joo] Wonkwang Univ, Coll Oriental Med, Dept Herbol, Iksan, Jeonbuk, South Korea; [Han, Myung-Kwan] Chonbuk Natl Univ, Sch Med, Dept Microbiol & Immunol, Jeonju, South Korea; [Lee, Chun Geun; Cho, Won-Kyung] Yale Univ, Sch Med, Dept Internal Med, Sect Pulm & Crit Care Med, New Haven, CT 06510 USA	Pusan National University; Pusan National University Hospital; Chosun University; Pusan National University; Pusan National University Hospital; Daegu Haany University; Inje University; Jeonbuk National University; Chung Ang University; Chung Ang University Hospital; Wonkwang University; Jeonbuk National University; Yale University	Lee, CM (corresponding author), Pusan Natl Univ, Dept Microbiol & Immunol, Med Res Inst, Sch Med, Yangsan, South Korea.	immunpym@pusan.ac.kr	Lee, Chun Geun/AAC-2838-2021	Han, Myung-Kwan/0000-0003-1931-8898; Cho, Won-Kyung/0000-0003-1540-545X	Korea Research Foundation Grant; Korean Government (MOEHRD, Basic Research Promotion Fund) [KRF-2007-E00006]; Pusan National University in program Post-Doc.; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111025-1101-0000100]	Korea Research Foundation Grant(National Research Foundation of Korea); Korean Government (MOEHRD, Basic Research Promotion Fund)(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); Pusan National University in program Post-Doc.; Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD, Basic Research Promotion Fund) (KRF-2007-E00006) and financially supported by Pusan National University in program Post-Doc., 2009. This study was also financially supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A111025-1101-0000100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2004, NATURE, V432, P7, DOI 10.1038/432007a; Barnes PJ, 2008, J CLIN INVEST, V118, P3546, DOI 10.1172/JCI36130; Bhandari V, 2006, P NATL ACAD SCI USA, V103, P11021, DOI 10.1073/pnas.0601057103; Choi JR, 2009, INT IMMUNOPHARMACOL, V9, P918, DOI 10.1016/j.intimp.2009.03.018; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Darcan-Nicolaisen Y, 2009, J IMMUNOL, V182, P7501, DOI 10.4049/jimmunol.0713433; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Dong S, 2006, J EXP MED, V203, P2509, DOI 10.1084/jem.20060650; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Held HD, 2000, J APPL PHYSIOL, V88, P2192, DOI 10.1152/jappl.2000.88.6.2192; Hiragun T, 2005, MOL PHARMACOL, V67, P598, DOI 10.1124/mol.104.008607; Hirahara K, 2008, J ALLERGY CLIN IMMUN, V122, P512, DOI 10.1016/j.jaci.2008.06.004; Hirota JA, 2009, CLIN EXP ALLERGY, V39, P147, DOI 10.1111/j.1365-2222.2008.03109.x; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Inoue A, 2007, J BIOCHEM, V142, P257, DOI 10.1093/jb/mvm127; Itoh S, 2005, J BIOL CHEM, V280, P26383, DOI 10.1074/jbc.M410262200; Jeon SG, 2007, J ALLERGY CLIN IMMUN, V120, P803, DOI 10.1016/j.jaci.2007.05.030; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Kim D, 2009, CLIN EXP ALLERGY, V39, P280, DOI 10.1111/j.1365-2222.2008.03124.x; Kim SH, 2006, FEBS LETT, V580, P1883, DOI 10.1016/j.febslet.2006.02.052; Koch M, 2006, AM J RESP CELL MOL, V35, P211, DOI 10.1165/rcmb.2005-0293OC; Kurowska-Stolarska M, 2008, J IMMUNOL, V181, P4780, DOI 10.4049/jimmunol.181.7.4780; Lee CG, 2004, NAT MED, V10, P1095, DOI 10.1038/nm1105; Lee CC, 2008, MOL THER, V16, P60, DOI 10.1038/sj.mt.6300309; Lee JS, 2007, FEBS LETT, V581, P57, DOI 10.1016/j.febslet.2006.11.077; Lee PJ, 2006, J CLIN INVEST, V116, P163, DOI 10.1172/JCI25711; Mancardi DA, 2008, J CLIN INVEST, V118, P3738, DOI 10.1172/JCI36452; Marshall E, 2001, SCIENCE, V293, P405; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; Mullings RE, 2001, J ALLERGY CLIN IMMUN, V108, P832, DOI 10.1067/mai.2001.119554; Niki M, 2004, J EXP MED, V200, P1689, DOI 10.1084/jem.20041306; Nikolaidis NM, 2006, EXP LUNG RES, V32, P483, DOI 10.1080/01902140601059547; Pernis AB, 2002, J CLIN INVEST, V109, P1279, DOI 10.1172/JCI200215786; Richardson PJ, 1997, NATURE, V385, P684, DOI 10.1038/385684b0; Shinohara H, 2005, J EXP MED, V201, P333, DOI 10.1084/jem.20041817; Shinohara H, 2004, GENES CELLS, V9, P601, DOI 10.1111/j.1356-9597.2004.00748.x; Simeone-Penney MC, 2007, J IMMUNOL, V178, P6191, DOI 10.4049/jimmunol.178.10.6191; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Tamachi T, 2009, BIOCHEM BIOPH RES CO, V382, P751, DOI 10.1016/j.bbrc.2009.03.101; Vogel G, 2002, SCIENCE, V295, P253; Wu LT, 2009, MOL IMMUNOL, V46, P2167, DOI 10.1016/j.molimm.2009.04.032; Zhou M, 2003, IMMUNOL RES, V28, P25, DOI 10.1385/IR:28:1:25	44	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34554	10.1371/journal.pone.0034554	http://dx.doi.org/10.1371/journal.pone.0034554			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514638	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600043
J	Li, F; Zhou, ML				Li, Feng; Zhou, Mingliang			Local Microenvironment Provides Important Cues for Cell Differentiation in Lingual Epithelia	PLOS ONE			English	Article							EPIDERMAL STEM-CELLS; TGF-BETA; STRATIFIED EPITHELIA; TRANSGENIC MICE; MOUSE TONGUE; CYCLE ARREST; HOMEOSTASIS; CANCER; SKIN; PROLIFERATION	Transgenic Keratin14-rtTA-PTR mice specifically express Keratin14 (K14) in the tongue epithelia, as well as co-express EGFP and the dominant negative Delta Tgfbr2 genes upon treatment with Doxycycline (Dox). As TGF-beta signaling negatively regulates the stem cell cycle and proliferation, its disruption by Dox induction in these transgenic mice shortens the cell cycle and allows observation of the final fate of those mutated cell lineages within a short period of time. Here, we used inducible transgenic mice to track the K14+ cells through the cell migration stream by immunohistochemical an immunofluorescent imaging. We showed that these cells have different development patterns from the tip to posterior of the tongue, achieved presumably by integrating positional information from the microenvironment. The expression of the K14 gene was variable, depending on the location of the tongue and papillae. Disruption of TGF-beta signaling in K14+ progenitor cells resulted in proliferation of stem cell pools.	[Li, Feng] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dev Biol Lab, Shanghai 200030, Peoples R China; [Zhou, Mingliang] Monell Chem Senses Ctr, Philadelphia, PA 19104 USA; [Li, Feng] Shanghai Jiao Tong Univ, Sch Med, Dept Lab Anim Sci, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Monell Chemical Senses Center; Shanghai Jiao Tong University	Li, F (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dev Biol Lab, Shanghai 200030, Peoples R China.	lifengwest@gmail.com		Li, Feng/0000-0003-1291-5315	National Institutes of Health [R01 DC007487]; National Science Foundation [DBJ-0216310]; Shanghai Municipal Education Commission [08YZ42]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC))	This work was supported by National Institutes of Health (R01 DC007487) and National Science Foundation (DBJ-0216310) and Shanghai Municipal Education Commission (Technological innovation projects 08YZ42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Buck A, 2006, SIGNAL TRANSDUCTION, V6, P345; CAMERON IL, 1966, J EXP ZOOL, V163, P271, DOI 10.1002/jez.1401630306; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; Foster KW, 2005, ONCOGENE, V24, P1491, DOI 10.1038/sj.onc.1208307; Frugier T, 2005, GENESIS, V42, P1, DOI 10.1002/gene.20115; Frye M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000763; GIEHL K, 2006, SIGNAL TRANSDUCTION, V6, P355; Gu BN, 2010, J CELL BIOCHEM, V110, P1279, DOI 10.1002/jcb.22650; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Iavarone A, 1997, NATURE, V387, P417; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Niemann C, 2002, DEVELOPMENT, V129, P95; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; REYNISDOTTIR I, 1995, GENE DEV, V9, P1831, DOI 10.1101/gad.9.15.1831; Ross M. H., 1989, HISTOLOGY TEXT ATLAS; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Sjolund J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023057; Slack JMW, 2000, SCIENCE, V287, P1431, DOI 10.1126/science.287.5457.1431; Stover DG, 2007, J CELL BIOCHEM, V101, P851, DOI 10.1002/jcb.21149; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tu WH, 2003, NEOPLASIA, V5, P267, DOI 10.1016/S1476-5586(03)80058-1; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Watt FM, 2006, CURR OPIN GENET DEV, V16, P518, DOI 10.1016/j.gde.2006.08.006; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Xie W, 1999, ONCOGENE, V18, P3593, DOI 10.1038/sj.onc.1202673; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5	42	4	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35362	10.1371/journal.pone.0035362	http://dx.doi.org/10.1371/journal.pone.0035362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514735	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600140
J	Moes, M; Le Bechec, A; Crespo, I; Laurini, C; Halavatyi, A; Vetter, G; del Sol, A; Friederich, E				Moes, Michele; Le Bechec, Antony; Crespo, Isaac; Laurini, Christina; Halavatyi, Aliaksandr; Vetter, Guillaume; del Sol, Antonio; Friederich, Evelyne			A Novel Network Integrating a miRNA-203/SNAI1 Feedback Loop which Regulates Epithelial to Mesenchymal Transition	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; GENE-EXPRESSION; ZEB1; CELLS; SNAIL; REPRESSION; INDUCTION; TARGETS; EMT	Background: The majority of human cancer deaths are caused by metastasis. The metastatic dissemination is initiated by the breakdown of epithelial cell homeostasis. During this phenomenon, referred to as epithelial to mesenchymal transition (EMT), cells change their genetic and trancriptomic program leading to phenotypic and functional alterations. The challenge of understanding this dynamic process resides in unraveling regulatory networks involving master transcription factors (e. g. SNAI1/2, ZEB1/2 and TWIST1) and microRNAs. Here we investigated microRNAs regulated by SNAI1 and their potential role in the regulatory networks underlying epithelial plasticity. Results: By a large-scale analysis on epithelial plasticity, we highlighted miR-203 and its molecular link with SNAI1 and the miR-200 family, key regulators of epithelial homeostasis. During SNAI1-induced EMT in MCF7 breast cancer cells, miR-203 and miR-200 family members were repressed in a timely correlated manner. Importantly, miR-203 repressed endogenous SNAI1, forming a double negative miR203/SNAI1 feedback loop. We integrated this novel miR203/SNAI1 with the known miR200/ZEB feedback loops to construct an a priori EMT core network. Dynamic simulations revealed stable epithelial and mesenchymal states, and underscored the crucial role of the miR203/SNAI1 feedback loop in state transitions underlying epithelial plasticity. Conclusion: By combining computational biology and experimental approaches, we propose a novel EMT core network integrating two fundamental negative feedback loops, miR203/SNAI1 and miR200/ZEB. Altogether our analysis implies that this novel EMT core network could function as a switch controlling epithelial cell plasticity during differentiation and cancer progression.	[Moes, Michele; Le Bechec, Antony; Laurini, Christina; Halavatyi, Aliaksandr; Vetter, Guillaume; Friederich, Evelyne] Univ Luxembourg, Cytoskeleton & Cell Plast Lab, Life Sci Res Unit FSCT, Luxembourg, Luxembourg; [Crespo, Isaac; del Sol, Antonio] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Esch Sur Alzette, Luxembourg	University of Luxembourg; University of Luxembourg	Moes, M (corresponding author), Univ Luxembourg, Cytoskeleton & Cell Plast Lab, Life Sci Res Unit FSCT, Luxembourg, Luxembourg.	moesmichele@gmail.com; evelyne.friederich@uni.lu	del Sol, Antonio/M-7431-2017	del Sol, Antonio/0000-0002-9926-617X; Le Bechec, Antony/0000-0002-9629-0916; Crespo, Isaac/0000-0003-1603-9535; Crespo, Isaac/0000-0003-3151-3901	National Research Fund, Luxembourg [FNR/BIOSAN/07/12, TR-PDR BFR08-084, TR-PHD BFR08-112]; Fondation Cancer; University of Luxembourg	National Research Fund, Luxembourg(Luxembourg National Research Fund); Fondation Cancer; University of Luxembourg	This work has been supported by the National Research Fund, Luxembourg (FNR/BIOSAN/07/12, ALB: AFR fellowship TR-PDR BFR08-084; AH: AFR PhD Fellowship TR-PHD BFR08-112), the "Fondation Cancer'' and the University of Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castilla MA, 2011, J PATHOL, V223, P72, DOI 10.1002/path.2802; Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Brabletz S, 2010, EMBO REP, V11, P670, DOI 10.1038/embor.2010.117; Bracken CP, 2009, CELL MOL LIFE SCI, V66, P1682, DOI 10.1007/s00018-009-8750-1; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Dave N, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.168625; Gill JG, 2011, STEM CELLS, V29, P764, DOI 10.1002/stem.628; Gordon AJE, 2009, PLOS BIOL, V7, P364, DOI 10.1371/journal.pbio.1000044; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Guaita S, 2002, J BIOL CHEM, V277, P39209, DOI 10.1074/jbc.M206400200; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Le B'echec Antony, 2008, In Silico Biology, V8, P63; Le Bechec A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-67; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Nissan X, 2011, DEV BIOL, V356, P506, DOI 10.1016/j.ydbio.2011.06.004; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Saini S, 2011, CLIN CANCER RES, V17, P5287, DOI 10.1158/1078-0432.CCR-10-2619; Saumet A, 2009, BLOOD, V113, P412, DOI 10.1182/blood-2008-05-158139; Shiraishi T, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000851; Sokilde R, 2011, MOL CANCER THER, V10, P375, DOI 10.1158/1535-7163.MCT-10-0605; Tasseff R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008864; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Tran DD, 2011, MOL CANCER RES, V9, P1644, DOI 10.1158/1541-7786.MCR-11-0371; Vetter G, 2009, BIOCHEM BIOPH RES CO, V385, P485, DOI 10.1016/j.bbrc.2009.05.025; Viticchie G, 2011, CELL CYCLE, V10, P1121, DOI 10.4161/cc.10.7.15180; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yatskou Mikalai, 2008, BMC Res Notes, V1, P80, DOI 10.1186/1756-0500-1-80; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	38	135	139	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35440	10.1371/journal.pone.0035440	http://dx.doi.org/10.1371/journal.pone.0035440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514743	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600148
J	Niu, YD; Stanford, K; Kropinski, AM; Ackermann, HW; Johnson, RP; She, YM; Ahmed, R; Villegas, A; McAllister, TA				Niu, Yan D.; Stanford, Kim; Kropinski, Andrew M.; Ackermann, Hans-Wolfgang; Johnson, Roger P.; She, Yi-Min; Ahmed, Rafiq; Villegas, Andre; McAllister, Tim A.			Genomic, Proteomic and Physiological Characterization of a T5-like Bacteriophage for Control of Shiga Toxin-Producing Escherichia coli O157:H7	PLOS ONE			English	Article							TRANSFER-RNA GENES; RECEPTOR-BINDING; FEEDLOT CATTLE; PHAGE; SEQUENCE; O157H7; PROTEINS; DATABASE; THERAPY; PROGRAM	Despite multiple control measures, Escherichia coli O157:H7 (STEC O157:H7) continues to be responsible for many food borne outbreaks in North America and elsewhere. Bacteriophage therapy may prove useful for controlling this pathogen in the host, their environment and food. Bacteriophage vB_EcoS_AKFV33 (AKFV33), a T5-like phage of Siphoviridae lysed common phage types of STEC O157:H7 and not non-O157 E. coli. Moreover, STEC O157:H7 isolated from the same feedlot pen from which the phage was obtained, were highly susceptible to AKFV33. Adsorption rate constant and burst size were estimated to be 9.31x10(-9) ml/min and 350 PFU/infected cell, respectively. The genome of AKVF33 was 108,853 bp (38.95% G+C), containing 160 open reading frames (ORFs), 22 tRNA genes and 32 strong promoters recognized by host RNA polymerase. Of 12 ORFs without homologues to T5-like phages, 7 predicted novel proteins while others exhibited low identity (<60%) to proteins in the National Centre for Biotechnology Information database. AKVF33 also lacked the L-shaped tail fiber protein typical of T5, but was predicted to have tail fibers comprised of 2 novel proteins with low identity (37-41%) to tail fibers of E. coli phage phiEco32 of Podoviridae, a putative side tail fiber protein of a prophage from E. coli IAI39 and a conserved domain protein of E. coli MS196-1. The receptor-binding tail protein (pb5) shared an overall identify of 29-72% to that of other T5-like phages, with no region coding for more than 6 amino acids in common. Proteomic analysis identified 4 structural proteins corresponding to the capsid, major tail, tail fiber and pore-forming tail tip (pb2). The genome of AKFV33 lacked regions coding for known virulence factors, integration-related proteins or antibiotic resistance determinants. Phage AKFV33 is a unique, highly lytic STEC O157:H7-specific T5-like phage that may have considerable potential as a pre- and post-harvest biocontrol agent.	[Niu, Yan D.; McAllister, Tim A.] Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada; [Stanford, Kim] Ctr Agr, Lethbridge, AB, Canada; [Kropinski, Andrew M.; Johnson, Roger P.; Villegas, Andre] Publ Hlth Agcy Canada, Lab Foodborne Zoonoses, Guelph, ON, Canada; [Kropinski, Andrew M.] Univ Guelph, Dept Cellular & Mol Biol, Guelph, ON N1G 2W1, Canada; [Ackermann, Hans-Wolfgang] Univ Laval, Fac Med, Dept Microbiol, Quebec City, PQ G1K 7P4, Canada; [She, Yi-Min] Hlth Canada, Biol & Genet Therapies Directorate, Ctr Vaccine Evaluat, Ottawa, ON K1A 0L2, Canada; [Ahmed, Rafiq] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	Agriculture & Agri Food Canada; Public Health Agency of Canada; University of Guelph; Laval University; Health Canada; Public Health Agency of Canada	Niu, YD (corresponding author), Agr & Agri Food Canada, Lethbridge Res Ctr, Lethbridge, AB, Canada.	tim.mcallister@agr.gc.ca	Kropinski, Andrew M/H-7130-2016; McAllister, Tim A./R-9201-2017	Kropinski, Andrew M/0000-0002-6871-6799; McAllister, Tim A./0000-0002-8266-6513; She, Yi-Min/0000-0002-0571-4630	Alberta Livestock and Meat Agency, Agriculture and Agri-Food Canada Peer-Reviewed Project Program	Alberta Livestock and Meat Agency, Agriculture and Agri-Food Canada Peer-Reviewed Project Program	This work was supported by the Alberta Livestock and Meat Agency, Agriculture and Agri-Food Canada Peer-Reviewed Project Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuladze T, 2008, APPL ENVIRON MICROB, V74, P6230, DOI 10.1128/AEM.01465-08; Adams MH, 1959, BACTERIOPHAGES; Akulenko N V, 2004, Mol Biol (Mosk), V38, P632; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anany H, 2011, APPL ENVIRON MICROB, V77, P6379, DOI 10.1128/AEM.05493-11; [Anonymous], ANN SUMM 2009; Atterbury RJ, 2009, MICROB BIOTECHNOL, V2, P601, DOI 10.1111/j.1751-7915.2009.00089.x; Bailly-Bechet M, 2007, GENOME RES, V17, P1486, DOI 10.1101/gr.6649807; Balogh B, 2010, CURR PHARM BIOTECHNO, V11, P48, DOI 10.2174/138920110790725302; Boulanger P, 2008, J BIOL CHEM, V283, P13556, DOI 10.1074/jbc.M800052200; Calistri E, 2011, MOL PHYLOGENET EVOL, V60, P228, DOI 10.1016/j.ympev.2011.04.015; Callaway TR, 2008, FOODBORNE PATHOG DIS, V5, P183, DOI 10.1089/fpd.2007.0057; Callaway TR, 2009, CURR ISSUES MOL BIOL, V11, P67; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Edgell DR, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-290; Friedrich NC, 2007, P NATL ACAD SCI USA, V104, P6176, DOI 10.1073/pnas.0609915104; HELLER K, 1982, J VIROL, V41, P222, DOI 10.1128/JVI.41.1.222-227.1982; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hong J, 2008, FEMS MICROBIOL LETT, V289, P202, DOI 10.1111/j.1574-6968.2008.01397.x; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Jacobs GH, 2000, NUCLEIC ACIDS RES, V28, P293, DOI 10.1093/nar/28.1.293; Jamalludeen N, 2009, VET MICROBIOL, V136, P135, DOI 10.1016/j.vetmic.2008.10.021; Johnson R. P., 2008, Animal Health Research Reviews, V9, P201, DOI 10.1017/S1466252308001576; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Kim M, 2011, APPL ENVIRON MICROB, V77, P2042, DOI 10.1128/AEM.02504-10; Koo J, 2001, APPL ENVIRON MICROB, V67, P2895, DOI 10.1128/AEM.67.7.2895-2902.2001; Koski LB, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-151; Kropinski Andrew M., 2009, V501, P151, DOI 10.1007/978-1-60327-164-6_15; Kutter EM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-430; LABAW LW, 1953, J BACTERIOL, V66, P429, DOI 10.1128/JB.66.4.429-436.1953; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Letellier L, 2004, FRONT BIOSCI-LANDMRK, V9, P1228, DOI 10.2741/1333; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; Liao WC, 2011, J VIROL, V85, P6567, DOI 10.1128/JVI.02378-10; Lingohr Erika, 2009, V502, P19, DOI 10.1007/978-1-60327-565-1_3; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Ma YS, 2008, APPL ENVIRON MICROB, V74, P4799, DOI 10.1128/AEM.00246-08; Maura D, 2011, APPL MICROBIOL BIOT, V90, P851, DOI 10.1007/s00253-011-3227-1; MCCORQUODALE D J, 1975, Critical Reviews in Microbiology, V4, P101, DOI 10.3109/10408417509111574; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Mohawk KL, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/258185; Niu YD, 2009, J APPL MICROBIOL, V107, P646, DOI 10.1111/j.1365-2672.2009.04231.x; Niu YD, 2009, APPL ENVIRON MICROB, V75, P1271, DOI 10.1128/AEM.02100-08; Nyachuba DG, 2010, NUTR REV, V68, P257, DOI 10.1111/j.1753-4887.2010.00286.x; OCHMAN H, 1984, J BACTERIOL, V157, P690, DOI 10.1128/JB.157.2.690-693.1984; Rabsch W, 2007, J BACTERIOL, V189, P5658, DOI 10.1128/JB.00437-07; Raghavan R, 2009, J BACTERIOL, V191, P6193, DOI 10.1128/JB.00675-09; Raya Raul R, 2011, Bacteriophage, V1, P15; Rivas L, 2010, APPL ENVIRON MICROB, V76, P7210, DOI 10.1128/AEM.01530-10; Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2; Sambrook J., 2001, MOL CLONING LAB MANU; Sayer JR, 2006, BACTERIOPHAGES, P268; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Stanford K, 2010, J FOOD PROTECT, V73, P1304, DOI 10.4315/0362-028X-73.7.1304; Stephens TP, 2009, J ANIM SCI, V87, P4151, DOI 10.2527/jas.2009-1967; Tang GQ, 2005, J BIOL CHEM, V280, P40707, DOI 10.1074/jbc.M508013200; Tran NQ, 2010, MOL MICROBIOL, V77, P492, DOI 10.1111/j.1365-2958.2010.07221.x; Villegas A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-41; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Wang JB, 2005, VIROLOGY, V332, P45, DOI 10.1016/j.virol.2004.10.049; WARNER HR, 1969, J VIROL, V3, P331, DOI 10.1128/JVI.3.3.331-336.1969; Weinbauer MG, 2004, FEMS MICROBIOL REV, V28, P127, DOI 10.1016/j.femsre.2003.08.001; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; ZWEIG M, 1973, J MOL BIOL, V80, P505, DOI 10.1016/0022-2836(73)90418-X; ZWEIG M, 1973, VIROLOGY, V51, P443, DOI 10.1016/0042-6822(73)90443-1	72	40	42	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34585	10.1371/journal.pone.0034585	http://dx.doi.org/10.1371/journal.pone.0034585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514640	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600046
J	Rijken, MJ; Gilder, ME; Thwin, MM; Kajeechewa, HML; Wiladphaingern, J; Lwin, KM; Jones, C; Nosten, F; McGready, R				Rijken, Marcus J.; Gilder, Mary Ellen; May Myo Thwin; Kajeechewa, Honey Moon Ladda; Wiladphaingern, Jacher; Khin Maung Lwin; Jones, Caroline; Nosten, Francois; McGready, Rose			Refugee and Migrant Women's Views of Antenatal Ultrasound on the Thai Burmese Border: A Mixed Methods Study	PLOS ONE			English	Article							LOW-RESOURCE SETTINGS; FETAL ULTRASOUND; HEALTH-CARE; PREGNANCY; SEX; ULTRASONOGRAPHY; CHALLENGES; FEAR	Background: Antenatal ultrasound suits developing countries by virtue of its versatility, relatively low cost and safety, but little is known about women's or local provider's perspectives of this upcoming technology in such settings. This study was undertaken to better understand how routine obstetric ultrasound is experienced in a displaced Burmese population and identify barriers to its acceptance by local patients and providers. Methodology/Principal Findings: Qualitative (30 observations, 19 interviews, seven focus group discussions) and quantitative methods (questionnaire survey with 644 pregnant women) were used to provide a comprehensive understanding along four major themes: safety, emotions, information and communication, and unintended consequences of antenatal ultrasound in refugee and migrant clinics on the Thai Burmese border. One of the main concerns expressed by women was the danger of childbirth which they mainly attributed to fetal malposition. Both providers and patients recognized ultrasound as a technology improving the safety of pregnancy and delivery. A minority of patients experienced transitory shyness or anxiety before the ultrasound, but reported that these feelings could be ameliorated with improved patient information and staff communication. Unintended consequences of overuse and gender selective abortions in this population were not common. Conclusions/Significance: The results of this study are being used to improve local practice and allow development of explanatory materials for this population with low literacy. We strongly encourage facilities introducing new technology in resource poor settings to assess acceptability through similar inquiry.	[Rijken, Marcus J.; Gilder, Mary Ellen; May Myo Thwin; Kajeechewa, Honey Moon Ladda; Wiladphaingern, Jacher; Khin Maung Lwin; Nosten, Francois; McGready, Rose] Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand; [Jones, Caroline] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Kilifi, Kenya; [Jones, Caroline] Univ Oxford, Dept Publ Hlth & Primary Care, Oxford OX3 7LF, England; [Jones, Caroline; Nosten, Francois; McGready, Rose] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 9DU, England; [Nosten, Francois; McGready, Rose] Mahidol Univ, Fac Trop Med, Bangkok, Thailand	Mahidol University; Kenya Medical Research Institute; University of Oxford; University of Oxford; Mahidol University	Rijken, MJ (corresponding author), Shoklo Malaria Res Unit, Mae Sot, Tak, Thailand.	marcus@shoklo-unit.com	McGready, Rose/A-3290-2014; Nosten, Francois/AAC-5509-2019	McGready, Rose/0000-0003-1621-3257; Nosten, Francois/0000-0002-7951-0745; Rijken, Marcus/0000-0003-0914-5508; Gilder, Mary Ellen T/0000-0001-8811-8123	Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant); Christophe and Rodolphe Merieux Foundation; National Institutes of Health Office of the Director; Fogarty International Center; Office of AIDS Research; National Cancer Center; National Eye Institute; National Heart, Blood, and Lung Institute; National Institute of Dental and Craniofacial Research; National Institute On Drug Abuse; National Institute of Mental Health; National Institute of Allergy and Infectious Diseases; National Institutes of Health Office of Women's Health and Research [R24 TW007988]; American Relief and Recovery Act; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER	Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant)(Wellcome Trust); Christophe and Rodolphe Merieux Foundation; National Institutes of Health Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Center; National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Institute On Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health Office of Women's Health and Research; American Relief and Recovery Act; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was a part of the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme, supported by the Wellcome Trust of Great Britain (Major Overseas Programme-Thailand Unit Core Grant). The Christophe and Rodolphe Merieux Foundation supported the study through a prize (2008) to FN. MEG was supported by the National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Institute, National Institute of Dental and Craniofacial Research, National Institute On Drug Abuse, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases, and National Institutes of Health Office of Women's Health and Research through the Fogarty International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988) and the American Relief and Recovery Act. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bashour H, 2005, REPROD HEALTH MATTER, V13, P147, DOI 10.1016/S0968-8080(05)25164-9; Carrara VI, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-45; Chigbu CO, 2008, INT J GYNECOL OBSTET, V100, P287, DOI 10.1016/j.ijgo.2007.09.021; Ding QJ, 2006, BMJ-BRIT MED J, V333, P371, DOI 10.1136/bmj.38775.672662.80; Ekelin M, 2009, PRENATAL DIAG, V29, P952, DOI 10.1002/pd.2324; Gammeltoft T, 2007, REPROD HEALTH MATTER, V15, P163, DOI 10.1016/S0968-8080(06)29280-2; Garcia J, 2002, BIRTH-ISS PERINAT C, V29, P225, DOI 10.1046/j.1523-536X.2002.00198.x; Harpel TS, 2008, HEALTH-LONDON, V12, P295, DOI 10.1177/1363459308090050; Harris RD, 2009, J ULTRAS MED, V28, P1067, DOI 10.7863/jum.2009.28.8.1067; Hesketh T, 2006, P NATL ACAD SCI USA, V103, P13271, DOI 10.1073/pnas.0602203103; Hofmeyr GJ, 2009, ULTRASOUND OBST GYN, V34, P367, DOI 10.1002/uog.7352; Hofmeyr GJ, 2009, INT J GYNECOL OBSTET, V107, pS21, DOI 10.1016/j.ijgo.2009.07.017; Kongnyuy EJ, 2007, TROP DOCT, V37, P70, DOI 10.1258/004947507780609310; Larsson AK, 2009, J ULTRAS MED, V28, P1663, DOI 10.7863/jum.2009.28.12.1663; Luxemburger C, 1998, T ROY SOC TROP MED H, V92, P129, DOI 10.1016/S0035-9203(98)90717-9; Maru DSR, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-18; Molander E, 2010, MIDWIFERY, V26, P18, DOI 10.1016/j.midw.2008.04.008; Papp Z, 2003, INT J GYNECOL OBSTET, V82, P339, DOI 10.1016/S0020-7292(03)00224-8; Rijken MJ, 2009, ULTRASOUND OBST GYN, V34, P395, DOI 10.1002/uog.7350; Sedgmen B, 2006, ULTRASOUND OBST GYN, V27, P245, DOI 10.1002/uog.2703; Seffah JD, 2009, CLIN OBSTET GYNECOL, V52, P250, DOI 10.1097/GRF.0b013e3181a4c2d5; Tautz S, 2000, SOC SCI MED, V50, P689, DOI 10.1016/S0277-9536(99)00321-4; Ugwu Anthony C, 2007, Radiol Technol, V79, P113; Yeboah MY, 2010, INT J GYNECOL OBSTET, V111, P271, DOI 10.1016/j.ijgo.2010.07.019	24	14	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34018	10.1371/journal.pone.0034018	http://dx.doi.org/10.1371/journal.pone.0034018			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514615	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341600020
J	Wang, Y; Yi, L; Wu, ZF; Shao, J; Liu, GJ; Fan, HJ; Zhang, W; Lu, CP				Wang, Yang; Yi, Li; Wu, Zongfu; Shao, Jing; Liu, Guangjin; Fan, Hongjie; Zhang, Wei; Lu, Chengping			Comparative Proteomic Analysis of Streptococcus suis Biofilms and Planktonic Cells That Identified Biofilm Infection-Related Immunogenic Proteins	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; ORNITHINE CARBAMOYLTRANSFERASE; NEISSERIA-GONORRHOEAE; BACTERIAL BIOFILMS; MOLECULAR-CLONING; EPITHELIAL-CELLS; BACILLUS-CEREUS	Streptococcus suis (SS) is a zoonotic pathogen that causes severe disease symptoms in pigs and humans. Biofilms of SS bind to extracellular matrix proteins in both endothelial and epithelial cells and cause persistent infections. In this study, the differences in the protein expression profiles of SS grown either as planktonic cells or biofilms were identified using comparative proteomic analysis. The results revealed the existence of 13 proteins of varying amounts, among which six were upregulated and seven were downregulated in the Streptococcus biofilm compared with the planktonic controls. The convalescent serum from mini-pig, challenged with SS, was applied in a Western blot assay to visualize all proteins from the biofilm that were grown in vitro and separated by two-dimensional gel electrophoresis. A total of 10 immunoreactive protein spots corresponding to nine unique proteins were identified by MALDI-TOF/TOF-MS. Of these nine proteins, five (Manganese-dependent superoxide dismutase, UDP-N-acetylglucosamine 1-carboxyvinyltransferase, ornithine carbamoyltransferase, phosphoglycerate kinase, Hypothetical protein SSU05_0403) had no previously reported immunogenic properties in SS to our knowledge. The remaining four immunogenic proteins (glyceraldehyde-3-phosphate dehydrogenase, hemolysin, pyruvate dehydrogenase and DnaK) were identified under both planktonic and biofilm growth conditions. In conclusion, the protein expression pattern of SS, grown as biofilm, was different from the SS grown as planktonic cells. These five immunogenic proteins that were specific to SS biofilm cells may potentially be targeted as vaccine candidates to protect against SS biofilm infections. The four proteins common to both biofilm and planktonic cells can be targeted as vaccine candidates to protect against both biofilm and acute infections.	[Wang, Yang; Yi, Li; Wu, Zongfu; Shao, Jing; Liu, Guangjin; Fan, Hongjie; Zhang, Wei; Lu, Chengping] Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Peoples R China; [Wang, Yang] Henan Univ Sci & Technol, Coll Anim Sci & Technol, Luoyang, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Henan University of Science & Technology	Wang, Y (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Anim Bacteriol, Nanjing, Peoples R China.	vszw@njau.edu.cn; lucp@njau.edu.cn	Wu, Zongfu/J-7296-2019	Wu, Zongfu/0000-0002-6048-6829	National Natural Science Foundation of China [U0931002]; Youth Foundation of National Natural Science Foundation of China [30800815]; Program for New Century Excellent Talents in University of Ministry of Education of Chine [NCET-110671]; Special Fund for Public Welfare Industry of Chinese Ministry of Agriculture [200903055, 200803016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Foundation of National Natural Science Foundation of China; Program for New Century Excellent Talents in University of Ministry of Education of Chine(Program for New Century Excellent Talents in University (NCET)); Special Fund for Public Welfare Industry of Chinese Ministry of Agriculture	This work was supported by the National Natural Science Foundation of China (U0931002), Youth Foundation of National Natural Science Foundation of China (No. 30800815); Program for New Century Excellent Talents in University of Ministry of Education of Chine (No. NCET-110671); Special Fund for Public Welfare Industry of Chinese Ministry of Agriculture (200903055, 200803016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SI, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-162; Benga L, 2004, CELL MICROBIOL, V6, P867, DOI 10.1111/j.1462-5822.2004.00409.x; Blom NS, 1996, NAT STRUCT BIOL, V3, P856, DOI 10.1038/nsb1096-856; Brady RA, 2008, FEMS IMMUNOL MED MIC, V52, P13, DOI 10.1111/j.1574-695X.2007.00357.x; Brady RA, 2006, INFECT IMMUN, V74, P3415, DOI 10.1128/IAI.00392-06; Brassard J, 2004, VET MICROBIOL, V102, P87, DOI 10.1016/j.vetmic.2004.05.008; BROWN MRW, 1988, J ANTIMICROB CHEMOTH, V22, P777, DOI 10.1093/jac/22.6.777; Charland N, 2000, INFECT IMMUN, V68, P637, DOI 10.1128/IAI.68.2.637-643.2000; DelVecchio VG, 2006, APPL ENVIRON MICROB, V72, P6355, DOI 10.1128/AEM.00455-06; Domingo GJ, 1999, EUR J BIOCHEM, V266, P1136, DOI 10.1046/j.1432-1327.1999.00966.x; Esgleas M, 2005, FEMS MICROBIOL LETT, V244, P33, DOI 10.1016/j.femsle.2005.01.017; Francolini I, 2010, FEMS IMMUNOL MED MIC, V59, P227, DOI 10.1111/j.1574-695X.2010.00665.x; Gavrilin MA, 2000, BIOCHEM BIOPH RES CO, V277, P37, DOI 10.1006/bbrc.2000.3619; Geng HR, 2008, J PROTEOME RES, V7, P4132, DOI 10.1021/pr800196v; Gottschalk M, 2010, FUTURE MICROBIOL, V5, P371, DOI [10.2217/fmb.10.2, 10.2217/FMB.10.2]; Hess J, 1997, INFECT IMMUN, V65, P1286, DOI 10.1128/IAI.65.4.1286-1292.1997; Hussain M, 1999, INFECT IMMUN, V67, P6688; Jomaa M, 2005, FEMS IMMUNOL MED MIC, V44, P59, DOI 10.1016/j.femsim.2004.12.001; Kalmokoff M, 2006, J BACTERIOL, V188, P4312, DOI 10.1128/JB.01975-05; Kawai K, 2004, VACCINE, V22, P3411, DOI 10.1016/j.vaccine.2004.02.026; Kim SW, 1998, FEMS MICROBIOL LETT, V161, P217, DOI 10.1111/j.1574-6968.1998.tb12951.x; Korithoski B, 2008, FEMS MICROBIOL LETT, V289, P13, DOI 10.1111/j.1574-6968.2008.01351.x; Kumar S, 2009, ARCH MICROBIOL, V191, P425, DOI 10.1007/s00203-009-0468-9; Lemos JAC, 2000, FEMS IMMUNOL MED MIC, V28, P121, DOI 10.1111/j.1574-695X.2000.tb01465.x; Lim KHL, 2008, INFECT IMMUN, V76, P3569, DOI 10.1128/IAI.01725-07; Liu Y, 2005, MICROBIOL IMMUNOL, V49, P605, DOI 10.1111/j.1348-0421.2005.tb03652.x; March JB, 2006, INFECT IMMUN, V74, P167, DOI 10.1128/IAI.74.1.167-174.2006; Matic JN, 2003, GENE, V319, P99, DOI 10.1016/S0378-1119(03)00798-4; McMillan DJ, 2004, FEMS IMMUNOL MED MIC, V40, P249, DOI 10.1016/S0928-8244(04)00003-3; Onate AA, 1999, INFECT IMMUN, V67, P986; Oosthuizen MC, 2002, APPL ENVIRON MICROB, V68, P2770, DOI 10.1128/AEM.68.6.2770-2780.2002; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Peng L, 2003, APPL MICROBIOL BIOT, V61, P163, DOI 10.1007/s00253-002-1202-6; Pernot L, 2004, J BIOL CHEM, V279, P16463, DOI 10.1074/jbc.M313492200; Planchon S, 2009, J PROTEOME RES, V8, P1797, DOI 10.1021/pr8004056; Puttamreddy S, 2010, INFECT IMMUN, V78, P2377, DOI 10.1128/IAI.00156-10; Rathsam C, 2005, J PROTEOME RES, V4, P2161, DOI 10.1021/pr0502471; Resch A, 2005, APPL ENVIRON MICROB, V71, P2663, DOI 10.1128/AEM.71.5.2663-2676.2005; Rozen R, 2001, FEMS MICROBIOL LETT, V195, P205, DOI 10.1016/S0378-1097(01)00009-X; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Savini Vincenzo, 2010, Recent Pat Antiinfect Drug Discov, V5, P168; Sen A, 2001, J BIOCHEM MOL TOXIC, V15, P243; Shin JH, 2009, J MICROBIOL, V47, P728, DOI 10.1007/s12275-009-0158-y; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Svensater G, 2001, FEMS MICROBIOL LETT, V205, P139, DOI 10.1111/j.1574-6968.2001.tb10937.x; Tseng HJ, 2001, MOL MICROBIOL, V40, P1175, DOI 10.1046/j.1365-2958.2001.02460.x; Uppuluri P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000828; van Alen T, 2010, PROTEOMICS, V10, P4512, DOI 10.1002/pmic.201000267; Vemullpalli R, 2000, INFECT IMMUN, V68, P3290, DOI 10.1128/IAI.68.6.3290-3296.2000; Wang KC, 2007, BERL MUNCH TIERARZTL, V120, P207, DOI 10.2376/0005-9366-120-207; Wang Y, 2011, FEMS MICROBIOL LETT, V316, P36, DOI 10.1111/j.1574-6968.2010.02189.x; Welin J, 2003, FEMS MICROBIOL LETT, V227, P287, DOI 10.1016/S0378-1097(03)00693-1; Wijeratne AJ, 2007, PLANT J, V52, P14, DOI 10.1111/j.1365-313X.2007.03217.x; Wu H, 2009, INFECT IMMUN, V77, P1091, DOI 10.1128/IAI.00825-08; Yu Hong-jie, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P636; Yu W, 2009, J BIOL CHEM, V284, P13669, DOI 10.1074/jbc.M901921200; Zhang AD, 2008, PROTEOMICS, V8, P3506, DOI 10.1002/pmic.200800007; Zhang W, 2007, ZOONOSES PUBLIC HLTH, V54, P253, DOI 10.1111/j.1863-2378.2007.01056.x; Zhang W, 2007, PROTEOMICS, V7, P4468, DOI 10.1002/pmic.200700294; Zhu PP, 1996, PROTEIN SCI, V5, P1719, DOI 10.1002/pro.5560050825	61	34	36	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e33371	10.1371/journal.pone.0033371	http://dx.doi.org/10.1371/journal.pone.0033371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514606	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600011
J	Billing, O; Natarajan, B; Mohammed, A; Naredi, P; Kao, G				Billing, Ola; Natarajan, Balasubramanian; Mohammed, Ateequrrahman; Naredi, Peter; Kao, Gautam			A Directed RNAi Screen Based on Larval Growth Arrest Reveals New Modifiers of C. elegans Insulin Signaling	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE; DAUER FORMATION; INTERACTOME; LONGEVITY; TRANSCRIPTION; BIOGENESIS; SECRETION; PROTEINS; BEHAVIOR	Genes regulating Caenorhabditis elegans insulin/IGF signaling (IIS) have largely been identified on the basis of their involvement in dauer development or longevity. A third IIS phenotype is the first larval stage (L1) diapause, which is also influenced by asna-1, a regulator of DAF-28/insulin secretion. We reasoned that new regulators of IIS strength might be identified in screens based on the L1 diapause and the asna-1 phenotype. Eighty-six genes were selected for analysis by virtue of their predicted interaction with ASNA-1 and screened for asna-1-like larval arrest. ykt-6, mrps-2, mrps-10 and mrpl-43 were identified as genes which, when inactivated, caused larval arrest without any associated feeding defects. Several tests indicated that IIS strength was weaker and that insulin secretion was defective in these animals. This study highlights the role of the Golgi network and the mitochondria in insulin secretion and provides a new list of genes that modulate IIS in C. elegans.	[Billing, Ola; Natarajan, Balasubramanian; Mohammed, Ateequrrahman; Naredi, Peter; Kao, Gautam] Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University	Billing, O (corresponding author), Umea Univ, Dept Surg & Perioperat Sci, Umea, Sweden.	peter.naredi@surgery.umu.se; gautam.kao@surgery.umu.se	Naredi, Peter/AAG-1504-2019	Billing, Ola/0000-0001-5824-6263; Naredi, Peter/0000-0002-5652-0422; Natarajan, Balasubramanian/0000-0003-2371-0550	Swedish Cancer Society [CAN2007'901]; Swedish Research Council [K2008-68X-20803-01-3]; Cancer Research Foundation in Northern Sweden; Vasterbottens County Council (ALF)	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Research Foundation in Northern Sweden; Vasterbottens County Council (ALF)	This work was supported by the Swedish Cancer Society (CAN2007'901), the Swedish Research Council (K2008-68X-20803-01-3), the Cancer Research Foundation in Northern Sweden and Vasterbottens County Council (ALF-means). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auld KL, 2006, GENETICS, V174, P215, DOI 10.1534/genetics.106.058362; Baugh LR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018086; Baugh LR, 2006, CURR BIOL, V16, P780, DOI 10.1016/j.cub.2006.03.021; Billing O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014507; BRENNER S, 1974, GENETICS, V77, P71; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Fukuyama M, 2006, CURR BIOL, V16, P773, DOI 10.1016/j.cub.2006.02.073; Gallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017827; Gems D, 1998, GENETICS, V150, P129; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Hemmingsson O, 2010, CANCER RES, V70, P10321, DOI 10.1158/0008-5472.CAN-10-1548; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Kim T, 2006, PHYSIOLOGY, V21, P124, DOI 10.1152/physiol.00043.2005; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lee BH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000213; Lee MJ, 2008, CURR BIOL, V18, P211, DOI 10.1016/j.cub.2008.01.007; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Maekawa M, 2009, GENES CELLS, V14, P1003, DOI 10.1111/j.1365-2443.2009.01325.x; Metz J, 2006, J BIOL CHEM, V281, P410, DOI 10.1074/jbc.M507481200; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rabu C, 2009, J CELL SCI, V122, P3605, DOI 10.1242/jcs.041210; Riddle DL, GENETIC ENV REGULATI; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; THOMAS JH, 1993, GENETICS, V134, P1105; Tsang WY, 2001, J BIOL CHEM, V276, P32240, DOI 10.1074/jbc.M103999200; Tseng YY, 2007, FEBS J, V274, P2566, DOI 10.1111/j.1742-4658.2007.05791.x; Wiederkehr A, 2006, ENDOCRINOLOGY, V147, P2643, DOI 10.1210/en.2006-0057; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287	44	8	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34507	10.1371/journal.pone.0034507	http://dx.doi.org/10.1371/journal.pone.0034507			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511947	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338600033
J	Debowski, AW; Carnoy, C; Verbrugghe, P; Nilsson, HO; Gauntlett, JC; Fulurija, A; Camilleri, T; Berg, DE; Marshall, BJ; Benghezal, M				Debowski, Aleksandra W.; Carnoy, Christophe; Verbrugghe, Phebe; Nilsson, Hans-Olof; Gauntlett, Jonathan C.; Fulurija, Alma; Camilleri, Tania; Berg, Douglas E.; Marshall, Barry J.; Benghezal, Mohammed			Xer Recombinase and Genome Integrity in Helicobacter pylori, a Pathogen without Topoisomerase IV	PLOS ONE			English	Article							CHROMOSOME DIMER RESOLUTION; SITE-SPECIFIC RECOMBINATION; ESCHERICHIA-COLI; DNA GYRASE; FUNCTIONAL-CHARACTERIZATION; TERMINUS REGION; IN-VIVO; FTSK; PROTEIN; REPLICATION	In the model organism E. coli, recombination mediated by the related XerC and XerD recombinases complexed with the FtsK translocase at specialized dif sites, resolves dimeric chromosomes into free monomers to allow efficient chromosome segregation at cell division. Computational genome analysis of Helicobacter pylori, a slow growing gastric pathogen, identified just one chromosomal xer gene (xerH) and its cognate dif site (difH). Here we show that recombination between directly repeated difH sites requires XerH, FtsK but not XerT, the TnPZ transposon associated recombinase. xerH inactivation was not lethal, but resulted in increased DNA per cell, suggesting defective chromosome segregation. The xerH mutant also failed to colonize mice, and was more susceptible to UV and ciprofloxacin, which induce DNA breakage, and thereby recombination and chromosome dimer formation. xerH inactivation and overexpression each led to a DNA segregation defect, suggesting a role for Xer recombination in regulation of replication. In addition to chromosome dimer resolution and based on the absence of genes for topoisomerase IV (parC, parE) in H. pylori, we speculate that XerH may contribute to chromosome decatenation, although possible involvement of H. pylori's DNA gyrase and topoisomerase III homologue are also considered. Further analyses of this system should contribute to general understanding of and possibly therapy development for H. pylori, which causes peptic ulcers and gastric cancer; for the closely related, diarrheagenic Campylobacter species; and for unrelated slow growing pathogens that lack topoisomerase IV, such as Mycobacterium tuberculosis.	[Debowski, Aleksandra W.; Verbrugghe, Phebe; Nilsson, Hans-Olof; Gauntlett, Jonathan C.; Fulurija, Alma; Camilleri, Tania; Marshall, Barry J.; Benghezal, Mohammed] Univ Western Australia, Ondek Pty Ltd, Sch Pathol & Lab Med, Marshall Ctr Infect Dis Res & Training, Nedlands, WA, Australia; [Debowski, Aleksandra W.; Verbrugghe, Phebe; Nilsson, Hans-Olof; Gauntlett, Jonathan C.; Fulurija, Alma; Camilleri, Tania; Marshall, Barry J.; Benghezal, Mohammed] Univ Western Australia, Helicobacter Pylori Res Lab, Sch Pathol & Lab Med, Marshall Ctr Infect Dis Res & Training, Nedlands, WA, Australia; [Carnoy, Christophe] Univ Lille Nord France, Inst Pasteur Lille, Ctr Infect & Immun Lille, CNRS,INSERM,U1019,UMR 8204, Lille, France; [Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	University of Western Australia; University of Western Australia; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Washington University (WUSTL)	Debowski, AW (corresponding author), Univ Western Australia, Ondek Pty Ltd, Sch Pathol & Lab Med, Marshall Ctr Infect Dis Res & Training, M504, Nedlands, WA, Australia.	mbenghezal@ondek.com	Flow, CMCA/C-4191-2013	Verbrugghe, Phebe/0000-0002-9773-1015; CARNOY, Christophe/0000-0003-2047-5153; Marshall, Barry/0000-0003-4853-5015; Fulurija, Alma/0000-0003-1776-785X; Benghezal, Mohammed/0000-0002-4207-0192	Ondek Pty Ltd; US National Institutes of Health [R21 AI078237, R21 AI088337]; PhD scholarship from NSERC (Natural Sciences and Engineering Research Council of Canada); Australian Government; University of Western Australia Research Grants Scheme [RA/1/485/802]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078237, R21AI088337] Funding Source: NIH RePORTER	Ondek Pty Ltd; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhD scholarship from NSERC (Natural Sciences and Engineering Research Council of Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Australian Government(Australian GovernmentCGIAR); University of Western Australia Research Grants Scheme; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was supported by Ondek Pty Ltd, by research grants to DEB from the US National Institutes of Health R21 AI078237, R21 AI088337 and by a PhD scholarship from NSERC (Natural Sciences and Engineering Research Council of Canada) and the Australian Government to AWD and by a grant to MB from the University of Western Australia Research Grants Scheme RA/1/485/802. HN, JCG, AF, TC, BJM and MB are Employees of Ondek Pty Ltd and participated in the study design, data collection and analysis, and preparation of the manuscript. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Ambur OH, 2009, FEMS MICROBIOL REV, V33, P453, DOI 10.1111/j.1574-6976.2009.00173.x; Aubry A, 2006, BIOCHEM BIOPH RES CO, V348, P158, DOI 10.1016/j.bbrc.2006.07.017; Aussel L, 2002, CELL, V108, P195, DOI 10.1016/S0092-8674(02)00624-4; Benghezal M, 2009, Australian Patent Application No, Patent No. 2009902990; Bigot S, 2005, EMBO J, V24, P3770, DOI 10.1038/sj.emboj.7600835; BLAKELY G, 1993, CELL, V75, P351, DOI 10.1016/0092-8674(93)80076-Q; Blakely GW, 1997, J MOL BIOL, V265, P30, DOI 10.1006/jmbi.1996.0709; Bloor AE, 2006, APPL ENVIRON MICROB, V72, P2520, DOI 10.1128/AEM.72.4.2520-2525.2006; Carnoy C, 2002, J BACTERIOL, V184, P4489, DOI 10.1128/JB.184.16.4489-4499.2002; Carnoy C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006531; Chen CR, 1996, J MOL BIOL, V258, P627, DOI 10.1006/jmbi.1996.0274; Cortez D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001166; Crozat E, 2010, CHEMBIOCHEM, V11, P2232, DOI 10.1002/cbic.201000347; Dailidiene D, 2006, APPL ENVIRON MICROB, V72, P5908, DOI 10.1128/AEM.01135-06; Duggin IG, 2011, EMBO J, V30, P145, DOI 10.1038/emboj.2010.301; Dumrese C, 2009, FEBS LETT, V583, P1637, DOI 10.1016/j.febslet.2009.04.027; Espeli O, 2003, J BIOL CHEM, V278, P44639, DOI 10.1074/jbc.M308926200; FISCHER W, 2010, NUCL ACIDS RES; Grainge I, 2007, EMBO J, V26, P4228, DOI 10.1038/sj.emboj.7601849; Hendrickson H, 2006, J MOL EVOL, V62, P615, DOI 10.1007/s00239-005-0192-2; HUISMAN O, 1984, P NATL ACAD SCI-BIOL, V81, P4490, DOI 10.1073/pnas.81.14.4490; Ip SCY, 2003, EMBO J, V22, P6399, DOI 10.1093/emboj/cdg589; Kang J, 2008, J BACTERIOL, V190, P4218, DOI 10.1128/JB.01848-07; KATO J, 1990, CELL, V63, P393, DOI 10.1016/0092-8674(90)90172-B; Kersulyte D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006859; Kono N, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-19; KUEMPEL PL, 1991, NEW BIOL, V3, P799; Langford ML, 2006, HELICOBACTER, V11, P477, DOI 10.1111/j.1523-5378.2006.00441.x; Le Bourgeois P, 2007, PLOS GENET, V3, P1190, DOI 10.1371/journal.pgen.0030117; LESLIE NR, 1995, EMBO J, V14, P1561, DOI 10.1002/j.1460-2075.1995.tb07142.x; Michel B, 2000, MOL MICROBIOL, V37, P180, DOI 10.1046/j.1365-2958.2000.01989.x; Nolivos S, 2010, NUCLEIC ACIDS RES, V38, P6477, DOI 10.1093/nar/gkq507; Nurse P, 2003, J BIOL CHEM, V278, P8653, DOI 10.1074/jbc.M211211200; Olczak AA, 2002, J BACTERIOL, V184, P3186, DOI 10.1128/JB.184.12.3186-3193.2002; Recchia GD, 1999, EMBO J, V18, P5724, DOI 10.1093/emboj/18.20.5724; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schoep TD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015042; Sciochetti SA, 2001, J BACTERIOL, V183, P1058, DOI 10.1128/JB.183.3.1058-1068.2001; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Styer CM, 2010, INFECT IMMUN, V78, P1593, DOI 10.1128/IAI.01297-09; TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Val ME, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000201; Wang LL, 1998, MOL MICROBIOL, V29, P731, DOI 10.1046/j.1365-2958.1998.00958.x; Yates J, 2003, MOL MICROBIOL, V49, P241, DOI 10.1046/j.1365-2958.2003.03574.x; Zakrzewska-Czerwinska J, 2007, FEMS MICROBIOL REV, V31, P378, DOI 10.1111/j.1574-6976.2007.00070.x; Zawilak-Pawlik A, 2007, MOL MICROBIOL, V65, P979, DOI 10.1111/j.1365-2958.2007.05853.x; ZECHIEDRICH EL, 1995, GENE DEV, V9, P2859, DOI 10.1101/gad.9.22.2859	49	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e33310	10.1371/journal.pone.0033310	http://dx.doi.org/10.1371/journal.pone.0033310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511919	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338600005
J	Sunter, J; Wickstead, B; Gull, K; Carrington, M				Sunter, Jack; Wickstead, Bill; Gull, Keith; Carrington, Mark			A New Generation of T7 RNA Polymerase-Independent Inducible Expression Plasmids for Trypanosoma brucei	PLOS ONE			English	Article							GENE-EXPRESSION; SYSTEM; INTERFERENCE; VECTORS	Expression of transgenes is central to forward and reverse genetic analysis in Trypanosoma brucei. The inducible expression of transgenes in trypanosomes is based on the tetracycline repressor binding to a tetracycline operator to prevent transcription in the absence of tetracycline. The same inducible system is used to produce double-stranded RNA for RNAi knockdown of target genes. This study describes a new plasmid pSPR2.1 that drives consistent high-level expression of tetracycline repressor in procyclic form trypanosomes. A complementary expression plasmid, p3227, was constructed. The major difference between this and current plasmids is the separation of the inducible transgene and selectable marker promoters by the plasmid backbone. The plasmid p3227 was able to support inducible expression in cell lines containing pSPR2.1 as well as the established Lister 427 29-13 cell line. p3666, a derivative of p3227, was made for inducible expression of stem loop RNAi constructs and was effective for knockdown of DRBD3, which had proved problematic using existing RNAi plasmids with head-to-head promoters. The plasmid system was also able to support inducible transgene expression and DRBD3 RNAi knockdown in bloodstream form cells expressing tetracycline repressor from an integrated copy of the plasmid pHD1313.	[Sunter, Jack; Carrington, Mark] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Wickstead, Bill] Univ Nottingham, Ctr Genet & Genom, Nottingham NG7 2RD, England; [Wickstead, Bill; Gull, Keith] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Cambridge; University of Nottingham; University of Oxford	Sunter, J (corresponding author), Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1QW, England.	mc115@cam.ac.uk	Carrington, Mark/N-3653-2019; Carrington, Mark/N-4892-2018	Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Sunter, Jack/0000-0002-2836-9622; Wickstead, Bill/0000-0002-4620-9091	Wellcome Trust [085956/Z/08/Z]; BBSRC (Biotechnology and Biological Sciences Research Council) studentship	Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC (Biotechnology and Biological Sciences Research Council) studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	MC was funded by the Wellcome Trust, Grant Number 085956/Z/08/Z. JS was supported by a BBSRC (Biotechnology and Biological Sciences Research Council) studentship. BW and KG were funded by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibu VP, 2005, MOL BIOCHEM PARASIT, V139, P75, DOI 10.1016/j.molbiopara.2004.10.002; Alsford S, 2005, MOL BIOCHEM PARASIT, V144, P142, DOI 10.1016/j.molbiopara.2005.08.009; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Biebinger S, 1997, MOL BIOCHEM PARASIT, V85, P99, DOI 10.1016/S0166-6851(96)02815-0; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Estevez AM, 2008, NUCLEIC ACIDS RES, V36, P4573, DOI 10.1093/nar/gkn406; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; LaCount DJ, 2000, MOL BIOCHEM PARASIT, V111, P67, DOI 10.1016/S0166-6851(00)00300-5; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1998, NUCLEIC ACIDS RES, V26, P4626, DOI 10.1093/nar/26.20.4626; WIRTZ E, 1994, NUCLEIC ACIDS RES, V22, P3887, DOI 10.1093/nar/22.19.3887; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WIRTZ E, 1995, SCIENCE, V268, P1179, DOI 10.1126/science.7761835; WOODWARD R, 1990, J CELL SCI, V95, P49	14	21	21	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e35167	10.1371/journal.pone.0035167	http://dx.doi.org/10.1371/journal.pone.0035167			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511983	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338600069
J	Brezinski, EA; Armstrong, AW				Brezinski, Elizabeth A.; Armstrong, April W.			Off-Label Biologic Regimens in Psoriasis: A Systematic Review of Efficacy and Safety of Dose Escalation, Reduction, and Interrupted Biologic Therapy	PLOS ONE			English	Review							CHRONIC PLAQUE PSORIASIS; INTERLEUKIN-12/23 MONOCLONAL-ANTIBODY; PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; CONTROLLED PHASE-III; TO-SEVERE PSORIASIS; DOUBLE-BLIND; CLINICAL-RESPONSE; INFLIXIMAB MONOTHERAPY; ETANERCEPT THERAPY	Objectives: While off-label dosing of biologic treatments may be necessary in selected psoriasis patients, no systematic review exists to date that synthesizes the efficacy and safety of these off-label dosing regimens. The aim of this systematic review is to evaluate efficacy and safety of off-label dosing regimens (dose escalation, dose reduction, and interrupted treatment) with etanercept, adalimumab, infliximab, ustekinumab, and alefacept for psoriasis treatment. Data Sources and Study Selection: We searched OVID Medline from January 1, 1990 through August 1, 2011 for prospective clinical trials that studied biologic therapy for psoriasis treatment in adults. Individual articles were screened for studies that examined escalated, reduced, or interrupted therapy with etanercept, adalimumab, infliximab, ustekinumab, or alefacept. Data Synthesis: A total of 23 articles with 12,617 patients matched the inclusion and exclusion criteria for the systematic review. Data were examined for primary and secondary efficacy outcomes and adverse events including infections, malignancies, cardiovascular events, and anti-drug antibodies. The preponderance of data suggests that continuous treatment with anti-TNF agents and anti-IL12/23 agent was necessary for maintenance of disease control. Among non-responders, dose escalation with etanercept, adalimumab, ustekinumab, and alefacept typically resulted in greater efficacy than standard dosing. Dose reduction with etanercept and alefacept resulted in reduced efficacy. Withdrawal of the examined biologics led to an increase in disease activity; efficacy from retreatment did not result in equivalent initial response rates for most biologics. Safety data on off-label dosing regimens are limited. Conclusion: Dose escalation in non-responders generally resulted in increased efficacy in the examined biologics used to treat moderate-to-severe psoriasis. Continuous treatment with anti-TNF agents and anti-IL12/23 agent results in superior efficacy over interrupted therapy. The decision to use off-label dosing needs to account for both benefits and risks and be individualized to patients' disease severity, quality of life, and existence of comorbidities.	[Brezinski, Elizabeth A.] Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA; [Armstrong, April W.] Univ Calif Davis, Dept Dermatol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Brezinski, EA (corresponding author), Univ Calif Davis, Sch Med, Sacramento, CA 95817 USA.	aprilarmstrong@post.harvard.edu						[Anonymous], STEL UST PACK INS; [Anonymous], HUM AD PRESCR INF PA; [Anonymous], AM AL PACK INS; Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Cafardi Jennifer A, 2008, Skinmed, V7, P67, DOI 10.1111/j.1751-7125.2008.07346.x; Cassano N, 2010, INT J IMMUNOPATH PH, V23, P797, DOI 10.1177/039463201002300314; *CENT INC, REM INFL PACK INS; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; Dommasch ED, 2011, J AM ACAD DERMATOL, V64, P1035, DOI 10.1016/j.jaad.2010.09.734; Ferrandiz C, 2010, CLIN DERMATOL, V28, P81, DOI 10.1016/j.clindermatol.2009.03.002; Gordon KB, 2006, J DERMATOL TREAT, V17, P9, DOI 10.1080/09546630500472838; Gordon KB, 2006, J AM ACAD DERMATOL, V55, P598, DOI 10.1016/j.jaad.2006.05.027; Gordon Kenneth B, 2003, J Drugs Dermatol, V2, P624; Gottlieb AB, 2004, J AM ACAD DERMATOL, V51, P534, DOI 10.1016/j.jaad.2004.02.021; Gottlieb AB, 2003, J AM ACAD DERMATOL, V48, P829, DOI 10.1067/mjd.2003.307; Gribetz CH, 2005, J AM ACAD DERMATOL, V53, P73, DOI 10.1016/j.jaad.2005.03.053; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; Ho VCY, 2001, J AM ACAD DERMATOL, V44, P643, DOI 10.1067/mjd.2001.112400; *IMM CORP, ENBR ET PACK INS; Koo J, 1996, DERMATOL CLIN, V14, P485, DOI 10.1016/S0733-8635(05)70376-4; Krueger G, 2001, ARCH DERMATOL, V137, P280; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Krueger GG, 2002, J AM ACAD DERMATOL, V47, P821, DOI 10.1067/mjd.2002.127247; Kupper TS, 2003, NEW ENGL J MED, V349, P1987, DOI 10.1056/NEJMp038164; Lebwohl M, 2003, ARCH DERMATOL, V139, P719, DOI 10.1001/archderm.139.6.719; Lecluse LLA, 2010, ARCH DERMATOL, V146, P127, DOI 10.1001/archdermatol.2009.347; Leonardi CL, 2003, NEW ENGL J MED, V349, P2014, DOI 10.1056/NEJMoa030409; Leonardi C, 2010, J DRUGS DERMATOL, V9, P928; Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4; Lowe NJ, 2003, INT J DERMATOL, V42, P224, DOI 10.1046/j.1365-4362.2003.01793.x; Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010; Menter A, 2007, J AM ACAD DERMATOL, V56, P31, DOI 10.1016/j.jaad.2006.07.017; Menter A, 2010, J AM ACAD DERMATOL, V63, P448, DOI 10.1016/j.jaad.2009.09.040; MIHATSCH MJ, 1992, BRIT J DERMATOL, V126, P621; Moore A, 2007, J AM ACAD DERMATOL, V56, P598, DOI 10.1016/j.jaad.2006.09.002; Nickoloff BJ, 2006, J AM ACAD DERMATOL, V54, pS143, DOI 10.1016/j.jaad.2005.10.059; Ortonne JP, 2009, BRIT J DERMATOL, V161, P1190, DOI 10.1111/j.1365-2133.2009.09238.x; Ortonne JP, 2003, J EUR ACAD DERMATOL, V17, P12, DOI 10.1046/j.1468-3083.17.s2.3.x; Ortonne JP, 1999, BRIT J DERMATOL, V140, P1; Papp K, 2011, BRIT J DERMATOL, V164, P434, DOI 10.1111/j.1365-2133.2010.10139.x; Papp KA, 2005, BRIT J DERMATOL, V152, P1304, DOI 10.1111/j.1365-2133.2005.06688.x; Papp KA, 2008, LANCET, V371, P1675, DOI 10.1016/S0140-6736(08)60726-6; Prinz JC, 2003, J EUR ACAD DERMATOL, V17, P257, DOI 10.1046/j.1468-3083.2003.00720.x; Rapp SR, 1999, J AM ACAD DERMATOL, V41, P401, DOI 10.1016/S0190-9622(99)70112-X; Reich K, 2005, LANCET, V366, P1367, DOI 10.1016/S0140-6736(05)67566-6; Roberts JL, 2010, J AM ACAD DERMATOL, V62, P968, DOI 10.1016/j.jaad.2009.07.032; Ryan C, 2011, JAMA-J AM MED ASSOC, V306, P864, DOI 10.1001/jama.2011.1211; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Stern RS, 2004, J INVEST DERM SYMP P, V9, P136, DOI 10.1046/j.1087-0024.2003.09102.x; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001	50	83	85	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e33486	10.1371/journal.pone.0033486	http://dx.doi.org/10.1371/journal.pone.0033486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509259	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600012
J	Lai, RPJ; Seaman, MS; Tonks, P; Wegmann, F; Seilly, DJ; Frost, SDW; LaBranche, CC; Montefiori, DC; Dey, AK; Srivastava, IK; Sattentau, Q; Barnett, SW; Heeney, JL				Lai, Rachel P. J.; Seaman, Michael S.; Tonks, Paul; Wegmann, Frank; Seilly, David J.; Frost, Simon D. W.; LaBranche, Celia C.; Montefiori, David C.; Dey, Antu K.; Srivastava, Indresh K.; Sattentau, Quentin; Barnett, Susan W.; Heeney, Jonathan L.			Mixed Adjuvant Formulations Reveal a New Combination That Elicit Antibody Response Comparable to Freund's Adjuvants	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INFECTED HUMAN VOLUNTEERS; HEPATITIS-B-VACCINE; NEUTRALIZING ANTIBODIES; MF59 ADJUVANT; ENVELOPE GLYCOPROTEIN; MONOCLONAL-ANTIBODIES; DENDRITIC CELLS; HIV-1; IMMUNOGENICITY	Adjuvant formulations capable of inducing high titer and high affinity antibody responses would provide a major advance in the development of vaccines to viral infections such as HIV-1. Although oil-in-water emulsions, such as Freund's adjuvant (FCA/FIA), are known to be potent, their toxicity and reactogenicity make them unacceptable for human use. Here, we explored different adjuvants and compared their ability to elicit antibody responses to FCA/FIA. Recombinant soluble trimeric HIV-1 gp140 antigen was formulated in different adjuvants, including FCA/FIA, Carbopol-971P, Carbopol-974P and the licensed adjuvant MF59, or combinations of MF59 and Carbopol. The antigen-adjuvant formulation was administered in a prime-boost regimen into rabbits, and elicitation of antigen binding and neutralizing antibodies (nAbs) was evaluated. When used individually, only FCA/FIA elicited significantly higher titer of nAbs than the control group (gp140 in PBS (p<0.05)). Sequential prime-boost immunizations with different adjuvants did not offer improvements over the use of FCA/FIA or MF59. Remarkably however, the concurrent use of the combination of Carbopol-971P and MF59 induced potent adjuvant activity with significantly higher titer nAbs than FCA/FIA (p<0.05). This combination was not associated with any obvious local or systemic adverse effects. Antibody competition indicated that the majority of the neutralizing activities were directed to the CD4 binding site (CD4bs). Increased antibody titers to the gp41 membrane proximal external region (MPER) and gp120 V3 were detected when the more potent adjuvants were used. These data reveal that the combination of Carbopol-971P and MF59 is unusually potent for eliciting nAbs to a variety of HIV-1 nAb epitopes.	[Lai, Rachel P. J.; Tonks, Paul; Seilly, David J.; Frost, Simon D. W.; Heeney, Jonathan L.] Univ Cambridge, Dept Vet Med, Cambridge, England; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Div Viral Pathogenesis, Boston, MA 02215 USA; [Wegmann, Frank; Sattentau, Quentin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [LaBranche, Celia C.; Montefiori, David C.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA	University of Cambridge; Harvard University; Beth Israel Deaconess Medical Center; University of Oxford; Duke University	Lai, RPJ (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	jlh66@cam.ac.uk	Frost, Simon/F-3648-2010; Dey, Antu/A-1305-2013	Frost, Simon/0000-0002-5207-9879; Dey, Antu/0000-0001-7438-9379; Lai, Rachel/0000-0003-3418-850X; Heeney, Jonathan/0000-0003-2702-1621; Wegmann, Frank/0000-0002-9821-1492	National Institutes of Health HIVRAD consortium [1P01AI06628]; Bill and Melinda Gates Foundation [38637]; Comprehensive Antibody-Vaccine Immune Monitoring Consortium [38619]; Royal Society; MRC [G0000635] Funding Source: UKRI; Medical Research Council [G0000635] Funding Source: researchfish	National Institutes of Health HIVRAD consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Comprehensive Antibody-Vaccine Immune Monitoring Consortium; Royal Society(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Institutes of Health HIVRAD consortium (grant #1P01AI06628) and partially by the Bill and Melinda Gates Foundation funded Consortium of AIDS Vaccine Discovery (grant #38637) and the Comprehensive Antibody-Vaccine Immune Monitoring Consortium (grant #38619). SDWF is supported in part by a Royal Society Wolfson Research Merit Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, SUVAXYN MHYO SUSPENS; Aucouturier Jerome, 2002, Expert Rev Vaccines, V1, P111, DOI 10.1586/14760584.1.1.111; Banzhoff A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004384; Binley JM, 1997, AIDS RES HUM RETROV, V13, P1007, DOI 10.1089/aid.1997.13.1007; BlancoFuente H, 1996, INT J PHARM, V142, P169, DOI 10.1016/0378-5173(96)04665-0; Bonacucina G, 2004, INT J PHARM, V282, P115, DOI 10.1016/j.ijpharm.2004.06.012; Boyle J, 2007, VACCINE, V25, P2541, DOI 10.1016/j.vaccine.2006.12.018; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cole KS, 1997, J VIROL, V71, P5069, DOI 10.1128/JVI.71.7.5069-5079.1997; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Cranage MP, 2011, VACCINE, V29, P1421, DOI 10.1016/j.vaccine.2010.12.034; Cunningham CK, 2001, CLIN INFECT DIS, V32, P801, DOI 10.1086/319215; DEVASH Y, 1990, P NATL ACAD SCI USA, V87, P3445, DOI 10.1073/pnas.87.9.3445; Dey AK, 2012, VACCINE; Dey AK, 2011, EXPERT REV VACCINES, V10, P227, DOI 10.1586/ERV.10.142; Dupuis M, 1998, CELL IMMUNOL, V186, P18, DOI 10.1006/cimm.1998.1283; Elicker S, 2009, BERL MUNCH TIERARZTL, V122, P348, DOI 10.2376/0005-9366-122-348; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Genton B, 2000, VACCINE, V18, P2504, DOI 10.1016/S0264-410X(00)00036-0; Glenny AT, 1930, BMJ-BRIT MED J, V1930, P244, DOI 10.1136/bmj.2.3632.244; Graham BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011995; Gregoriadis G, 1989, IMMUNOLOGICAL ADJUVA, pviii; GUALANDI GL, 1988, MICROBIOLOGICA, V11, P363; GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O; Halperin SA, 2006, VACCINE, V24, P20, DOI 10.1016/j.vaccine.2005.08.095; Heeney Jonathan Luke, 2004, Expert Rev Vaccines, V3, pS53, DOI 10.1586/14760584.3.4.S53; Heineman TC, 1999, VACCINE, V17, P2769, DOI 10.1016/S0264-410X(99)00088-2; Huber M, 2010, J VIROL, V84, P10700, DOI 10.1128/JVI.01111-10; Huleatt JW, 2007, VACCINE, V25, P763, DOI 10.1016/j.vaccine.2006.08.013; KAHN JO, 1994, J INFECT DIS, V170, P1288, DOI 10.1093/infdis/170.5.1288; Karsa DRE, CHEM ASPECTS DRUG DE; Krashias G, 2010, VACCINE, V28, P2482, DOI 10.1016/j.vaccine.2010.01.046; LANGENBERG AGM, 1995, ANN INTERN MED, V122, P889, DOI 10.7326/0003-4819-122-12-199506150-00001; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Manmohan Singh N, 2007, VACCINE ADJUVANTS DE, px; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mbow ML, 2010, CURR OPIN IMMUNOL, V22, P411, DOI 10.1016/j.coi.2010.04.004; Miller LH, 2005, TRENDS PARASITOL, V21, P412, DOI 10.1016/j.pt.2005.07.005; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MUMFORD JA, 1994, EPIDEMIOL INFECT, V112, P421, DOI 10.1017/S0950268800057848; Nitayaphan S, 2000, VACCINE, V18, P1448, DOI 10.1016/S0264-410X(99)00421-1; O'Hagan DT, 2007, EXPERT REV VACCINES, V6, P699, DOI 10.1586/14760584.6.5.699; O'Hagan DT, 2000, VACCINE ADJUVANTS PR, px; Opriessnig T, 2006, VET PATHOL, V43, P281, DOI 10.1354/vp.43-3-281; Ott G, 1995, Pharm Biotechnol, V6, P277; Pass RF, 1999, J INFECT DIS, V180, P970, DOI 10.1086/315022; Podda Audino, 2003, Expert Rev Vaccines, V2, P197, DOI 10.1586/14760584.2.2.197; Schwarz TF, 2009, VACCINE, V27, P6284, DOI 10.1016/j.vaccine.2009.01.040; Seubert A, 2008, J IMMUNOL, V180, P5402, DOI 10.4049/jimmunol.180.8.5402; Srivastava IK, 2002, J VIROL, V76, P2835, DOI 10.1128/JVI.76.6.2835-2847.2002; Toledo H, 2001, VACCINE, V19, P4328, DOI 10.1016/S0264-410X(01)00111-6; Traquina P, 1996, J INFECT DIS, V174, P1168, DOI 10.1093/infdis/174.6.1168; Wade A, 1994, HDB PHARM EXCIPIENTS, pxv; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zhao J, 2009, J VIROL, V83, P4102, DOI 10.1128/JVI.02173-08	60	35	35	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35083	10.1371/journal.pone.0035083	http://dx.doi.org/10.1371/journal.pone.0035083			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509385	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336600081
J	Levula, M; Oksala, N; Airla, N; Zeitlin, R; Salenius, JP; Jarvinen, O; Venermo, M; Partio, T; Saarinen, J; Somppi, T; Suominen, V; Virkkunen, J; Hautalahti, J; Laaksonen, R; Kahonen, M; Mennander, A; Kytomaki, L; Soini, JT; Parkkinen, J; Pelto-Huikko, M; Lehtimaki, T				Levula, Mari; Oksala, Niku; Airla, Nina; Zeitlin, Rainer; Salenius, Juha-Pekka; Jarvinen, Otso; Venermo, Maarit; Partio, Teemu; Saarinen, Jukka; Somppi, Taija; Suominen, VeliPekka; Virkkunen, Jyrki; Hautalahti, Juha; Laaksonen, Reijo; Kahonen, Mika; Mennander, Ari; Kytomaki, Leena; Soini, Juhani T.; Parkkinen, Jyrki; Pelto-Huikko, Markku; Lehtimaki, Terho			Genes Involved in Systemic and Arterial Bed Dependent Atherosclerosis - Tampere Vascular Study	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; LASER MICRODISSECTION; APOLIPOPROTEIN-E; EXPRESSION; RECEPTOR; CELLS; INTERLEUKIN-12; INTEGRIN; DIFFERENTIATION; CHONDROADHERIN	Background: Atherosclerosis is a complex disease with hundreds of genes influencing its progression. In addition, the phenotype of the disease varies significantly depending on the arterial bed. Methodology/Principal Findings: We characterized the genes generally involved in human advanced atherosclerotic (AHA type V-VI) plaques in carotid and femoral arteries as well as aortas from 24 subjects of Tampere Vascular study and compared the results to non-atherosclerotic internal thoracic arteries (n = 6) using genome-wide expression array and QRT-PCR. In addition we determined genes that were typical for each arterial plaque studied. To gain a comprehensive insight into the pathologic processes in the plaques we also analyzed pathways and gene sets dysregulated in this disease using gene set enrichment analysis (GSEA). According to the selection criteria used (>3.0 fold change and p-value <0.05), 235 genes were up-regulated and 68 genes down-regulated in the carotid plaques, 242 genes up-regulated and 116 down-regulated in the femoral plaques and 256 genes up-regulated and 49 genes down-regulated in the aortic plaques. Nine genes were found to be specifically induced predominantly in aortic plaques, e. g., lactoferrin, and three genes in femoral plaques, e.g., chondroadherin, whereas no gene was found to be specific for carotid plaques. In pathway analysis, a total of 28 pathways or gene sets were found to be significantly dysregulated in atherosclerotic plaques (false discovery rate [FDR] <0.25). Conclusions: This study describes comprehensively the gene expression changes that generally prevail in human atherosclerotic plaques. In addition, site specific genes induced only in femoral or aortic plaques were found, reflecting that atherosclerotic process has unique features in different vascular beds.	[Levula, Mari; Oksala, Niku; Airla, Nina; Laaksonen, Reijo; Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, Tampere Univ Hosp,Ctr Lab Med, FIN-33101 Tampere, Finland; [Levula, Mari; Oksala, Niku; Airla, Nina; Laaksonen, Reijo; Lehtimaki, Terho] Univ Tampere, Sch Med, Dept Clin Chem, FIN-33101 Tampere, Finland; [Oksala, Niku; Zeitlin, Rainer; Salenius, Juha-Pekka; Venermo, Maarit; Partio, Teemu; Saarinen, Jukka; Somppi, Taija; Suominen, VeliPekka; Virkkunen, Jyrki; Hautalahti, Juha] Tampere Univ Hosp, Dept Surg, Div Vasc Surg, Tampere, Finland; [Jarvinen, Otso; Mennander, Ari] Tampere Univ Hosp, Ctr Heart, Dept Cardiac Surg, Tampere, Finland; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Kytomaki, Leena; Soini, Juhani T.] Turku Ctr Biotechnol, Turku, Finland; [Parkkinen, Jyrki] Ctr Lab Med, Dept Pathol, Tampere, Finland; [Pelto-Huikko, Markku] Tampere Univ Hosp, Dept Pathol, Tampere, Finland; [Pelto-Huikko, Markku] Univ Tampere, Sch Med, Dept Dev Biol, FIN-33101 Tampere, Finland	Tampere University; Tampere University Hospital; Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Tampere University; University of Turku; Tampere University; Tampere University Hospital; Tampere University	Levula, M (corresponding author), Univ Tampere, Sch Med, Dept Clin Chem, Tampere Univ Hosp,Ctr Lab Med, FIN-33101 Tampere, Finland.	mari@levula.fi	Pillay, Nischalan/F-9536-2012; Laaksonen, Reijo/D-6323-2014; Lehtimäki, Terho/AAD-1094-2022	Lehtimäki, Terho/0000-0002-2555-4427; Soini, Juhani/0000-0002-5574-0650; Kahonen, Mika/0000-0002-4510-7341; Venermo, Maarit/0000-0001-8814-0988	Tampere University Hospital; Emil Aaltonen Foundation; Finnish Cultural Foundation; Research Foundation of Orion Corporation; Jenny and Antti Wihuri Foundation; Academy of Finland [104821]; Finnish Foundation for Cardiovascular Research; Yrjo Jahnsson Foundation; European Union [201668]	Tampere University Hospital; Emil Aaltonen Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Research Foundation of Orion Corporation; Jenny and Antti Wihuri Foundation; Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Yrjo Jahnsson Foundation; European Union(European Commission)	This study was supported with grants from the Medical Research Fund of Tampere University Hospital (TL), the Emil Aaltonen Foundation (TL), the Pirkanmaa Regional Fund of the Finnish Cultural Foundation, the Research Foundation of Orion Corporation, the Jenny and Antti Wihuri Foundation, and the Academy of Finland (grant no. 104821), the Finnish Foundation for Cardiovascular Research, the Yrjo Jahnsson Foundation and European Union 7th Framework Program, grant number 201668, Athroremo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker EN, 2005, CELL MOL LIFE SCI, V62, P2531, DOI 10.1007/s00018-005-5368-9; Barjaktarevic I, 2006, J IMMUNOL, V177, P4369, DOI 10.4049/jimmunol.177.7.4369; BOGDAN C, 1994, J LEUKOCYTE BIOL, V55, P227, DOI 10.1002/jlb.55.2.227; Brandtzaeg P, 2005, IMMUNOL REV, V206, P32, DOI 10.1111/j.0105-2896.2005.00283.x; Bursi CA, 2004, CURR OPIN LIPIDOL, V15, P145, DOI [10.1097/00041433-200404000-00007, 10.1097/01.mol.0000124526.75650.13]; Cagnin S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-13; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; Carbonnelle-Puscian A, 2009, LEUKEMIA, V23, P952, DOI 10.1038/leu.2008.380; Carlsson LE, 1999, BLOOD, V93, P3583, DOI 10.1182/blood.V93.11.3583.410k34_3583_3586; Chu CC, 1997, P NATL ACAD SCI USA, V94, P2507, DOI 10.1073/pnas.94.6.2507; Corti A, CELLULAR MOL NEUROBI, V30, P1163; Czuczman MS, 2010, LEUKEMIA LYMPHOMA, V51, P983, DOI 10.3109/10428191003717746; Davenport P, 2003, AM J PATHOL, V163, P1117, DOI 10.1016/S0002-9440(10)63471-2; Elkind MS, 2005, ATHEROSCLEROSIS, V180, P181, DOI 10.1016/j.atherosclerosis.2004.11.015; Estensen ME, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.05.008; Ferrero E, 2002, ANN NY ACAD SCI, V971, P355, DOI 10.1111/j.1749-6632.2002.tb04495.x; Fong KY, 2002, ANN ACAD MED SINGAP, V31, P702; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gjerstorff MF, 2008, TISSUE ANTIGENS, V71, P187, DOI 10.1111/j.1399-0039.2007.00997.x; Gjerstorff MF, PROTEIN EXPRESSION P, V73, P217; Greenow K, 2005, J MOL MED, V83, P329, DOI 10.1007/s00109-004-0631-3; Grenache DG, 2003, ARTERIOSCL THROM VAS, V23, P2104, DOI 10.1161/01.ATV.0000097282.22923.EF; Hagg DA, 2008, ATHEROSCLEROSIS; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; Haskard DO, 2008, CURR OPIN LIPIDOL, V19, P478, DOI 10.1097/MOL.0b013e32830f4a06; HELLE KB, 1990, NEUROCHEM INT, V17, P165, DOI 10.1016/0197-0186(90)90139-K; Jansson AM, 2009, EUR HEART J, V30, P25, DOI 10.1093/eurheartj/ehn513; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; Kingsbury GA, 2001, J IMMUNOL, V166, P5675, DOI 10.4049/jimmunol.166.9.5675; Kular RK, 2009, J INTERF CYTOK RES, V29, P645, DOI 10.1089/jir.2008.0099; Legrand D, 2008, ADV EXP MED BIOL, V606, P163, DOI 10.1007/978-0-387-74087-4_6; Lewis MJ, 2009, CIRCULATION, V120, P417, DOI 10.1161/CIRCULATIONAHA.109.868158; Li F, FASEB J, V24, P810; Lim WCT, 2006, BIOCHIMIE, V88, P367, DOI 10.1016/j.biochi.2005.11.001; Maldonado RA, 2004, NATURE, V431, P527, DOI 10.1038/nature02916; Maldonado RA, 2009, J EXP MED, V206, P877, DOI 10.1084/jem.20082900; Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415; Mansson B, 2001, J BIOL CHEM, V276, P32883, DOI 10.1074/jbc.M101680200; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; Marquet J, 2010, EUR J IMMUNOL, V40, P2557, DOI 10.1002/eji.201040428; Marshall AJ, 2002, J IMMUNOL, V169, P2381, DOI 10.4049/jimmunol.169.5.2381; Mikelis C, 2007, RECENT PAT ANTI-CANC, V2, P175, DOI 10.2174/157489207780832405; Mizuno M, 1996, CALCIFIED TISSUE INT, V59, P163, DOI 10.1007/s002239900103; Moratz C, 2004, METHOD ENZYMOL, V389, P15; NASSAR GM, 1994, J BIOL CHEM, V269, P27631; Nguyen Y K, 1994, J Fla Med Assoc, V81, P467; Niedzielska I, 2010, THROMB RES, V126, P324, DOI 10.1016/j.thromres.2010.06.018; Oksala N, 2009, ANN MED, V41, P279, DOI 10.1080/07853890802649738; Pellieux C, 2003, J BIOL CHEM, V278, P29136, DOI 10.1074/jbc.M300598200; Pistoia V, 2009, J CLIN ONCOL, V27, P4809, DOI 10.1200/JCO.2008.21.3579; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Puddu P, 2009, BIOCHIMIE, V91, P11, DOI 10.1016/j.biochi.2008.05.005; Raffetto JD, 2008, BIOCHEM PHARMACOL, V75, P346, DOI 10.1016/j.bcp.2007.07.004; Randi AM, 2003, J THROMB HAEMOST, V1, P829, DOI 10.1046/j.1538-7836.2003.00113.x; Reape TJ, 1999, AM J PATHOL, V154, P365, DOI 10.1016/S0002-9440(10)65283-2; Sahu BS, 2010, CELL MOL LIFE SCI, V67, P861, DOI 10.1007/s00018-009-0208-y; SALONEN JT, 1992, LANCET, V339, P883, DOI 10.1016/0140-6736(92)90926-T; Schaffler A, 2005, BBA-GENE STRUCT EXPR, V1732, P96, DOI 10.1016/j.bbaexp.2005.11.005; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Seo D, 2004, ARTERIOSCL THROM VAS, V24, P1922, DOI 10.1161/01.ATV.0000141358.65242.1f; Sharifi BG, 2006, ARTERIOSCL THROM VAS, V26, P1273, DOI 10.1161/01.ATV.0000222017.05085.8e; SHI SR, 1991, J HISTOCHEM CYTOCHEM, V39, P741, DOI 10.1177/39.6.1709656; Singh M, 2007, FRONT BIOSCI-LANDMRK, V12, P214, DOI 10.2741/2059; Sjoberg AP, 2009, MOL IMMUNOL, V46, P830, DOI 10.1016/j.molimm.2008.09.018; Smyth G, 2005, LIMMA LINEAR MODELS; STARY HC, 1995, ARTERIOSCL THROM VAS, V15, P1512, DOI 10.1161/01.ATV.15.9.1512; Stolle K, 2004, J HISTOCHEM CYTOCHEM, V52, P1511, DOI 10.1369/jhc.4A6289.2004; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugiyama Y, STROKE J CEREBRAL CI, V42, P770; TEDDER TF, 1989, J IMMUNOL, V142, P2560; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; Tuomisto TT, 2003, ARTERIOSCL THROM VAS, V23, P2235, DOI 10.1161/01.ATV.0000102551.91154.96; Tyson KL, 2002, PHYSIOL GENOMICS, V9, P121, DOI 10.1152/physiolgenomics.00116.2001; Vengen IT, ATHEROSCLEROSIS; Weigert J, 2005, FEBS LETT, V579, P5565, DOI 10.1016/j.febslet.2005.09.022; Xiao SX, 2006, BBA-MOL BASIS DIS, V1762, P1001, DOI 10.1016/j.bbadis.2006.09.003; Zhang XY, 2006, CIRC RES, V98, P524, DOI 10.1161/01.RES.0000204452.46568.57; Zhou XH, 2003, BIOMED PHARMACOTHER, V57, P287, DOI 10.1016/S0753-3322(03)00082-9	81	32	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e33787	10.1371/journal.pone.0033787	http://dx.doi.org/10.1371/journal.pone.0033787			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509262	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336600015
J	de Jong, PR; Schadenberg, AWL; van den Broek, T; Beekman, JM; van Wijk, F; Coffer, PJ; Prakken, BJ; Jansen, NJG				de Jong, Petrus R.; Schadenberg, Alvin W. L.; van den Broek, Theo; Beekman, Jeffrey M.; van Wijk, Femke; Coffer, Paul J.; Prakken, Berent J.; Jansen, Nicolaas J. G.			STAT3 Regulates Monocyte TNF-Alpha Production in Systemic Inflammation Caused by Cardiac Surgery with Cardiopulmonary Bypass	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; NECROSIS-FACTOR-ALPHA; ANTIINFLAMMATORY RESPONSE; CYTOKINE SIGNALING-3; ENDOTOXEMIA MODEL; HUMAN MACROPHAGES; IMMUNE-RESPONSE; SEPTIC PATIENTS; INTENSIVE-CARE; LPS BINDING	Background: Cardiopulmonary bypass (CPB) surgery initiates a controlled systemic inflammatory response characterized by a cytokine storm, monocytosis and transient monocyte activation. However, the responsiveness of monocytes to Toll-like receptor (TLR)-mediated activation decreases throughout the postoperative course. The purpose of this study was to identify the major signaling pathway involved in plasma-mediated inhibition of LPS-induced tumor necrosis factor (TNF)-alpha production by monocytes. Methodology/Principal Findings: Pediatric patients that underwent CPB-assisted surgical correction of simple congenital heart defects were enrolled (n = 38). Peripheral blood mononuclear cells (PBMC) and plasma samples were isolated at consecutive time points. Patient plasma samples were added back to monocytes obtained pre-operatively for ex vivo LPS stimulations and TNF-alpha and IL-6 production was measured by flow cytometry. LPS-induced p38 mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-kappa B activation by patient plasma was assessed by Western blotting. A cell-permeable peptide inhibitor was used to block STAT3 signaling. We found that plasma samples obtained 4 h after surgery, regardless of pre-operative dexamethasone treatment, potently inhibited LPS-induced TNF-alpha but not IL-6 synthesis by monocytes. This was not associated with attenuation of p38 MAPK activation or I kappa B-alpha degradation. However, abrogation of the IL-10/STAT3 pathway restored LPS-induced TNF-alpha production in the presence of suppressive patient plasma. Conclusions/Significance: Our findings suggest that STAT3 signaling plays a crucial role in the downregulation of TNF-alpha synthesis by human monocytes in the course of systemic inflammation in vivo. Thus, STAT3 might be a potential molecular target for pharmacological intervention in clinical syndromes characterized by systemic inflammation.	[de Jong, Petrus R.; Schadenberg, Alvin W. L.; van den Broek, Theo; Jansen, Nicolaas J. G.] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Pediat Intens Care, Utrecht, Netherlands; [de Jong, Petrus R.; Schadenberg, Alvin W. L.; van den Broek, Theo; van Wijk, Femke; Coffer, Paul J.; Prakken, Berent J.] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Deptartment Pediat Immunol, Ctr Mol & Cellular Intervent, Utrecht, Netherlands; [Beekman, Jeffrey M.; Coffer, Paul J.] Univ Med Ctr Utrecht, Dept Immunol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center	de Jong, PR (corresponding author), Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Pediat Intens Care, Utrecht, Netherlands.	n.j.g.jansen@umcutrecht.nl	Beekman, Jeffrey M/I-7781-2014; , van den Broek T/I-9651-2019; Coffer, Paul/AAF-7970-2020	Beekman, Jeffrey M/0000-0003-4886-3756; , van den Broek T/0000-0002-2781-5731; de Jong, Petrus/0000-0003-2321-1153	Wilhelmina Children's Hospital Research Fund; Alexandre Suerman MD/PhD Program of the University Medical Center Utrecht; Dutch Organization for Scientific Research (NWO VIDI); Dutch Arthritis Foundation	Wilhelmina Children's Hospital Research Fund; Alexandre Suerman MD/PhD Program of the University Medical Center Utrecht; Dutch Organization for Scientific Research (NWO VIDI)(Netherlands Organization for Scientific Research (NWO)); Dutch Arthritis Foundation	This study was supported in part by a grant from the Wilhelmina Children's Hospital Research Fund. P.R.d.J. is supported by the Alexandre Suerman MD/PhD Program of the University Medical Center Utrecht. B.J.P. is supported by Grants from the Dutch Organization for Scientific Research (NWO VIDI innovation grant) and the Dutch Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2006, CRIT CARE MED, V34, P2377, DOI 10.1097/01.CCM.0000233875.93866.88; Allen ML, 2006, CRIT CARE MED, V34, P2658, DOI 10.1097/01.CCM.0000240243.28129.36; Allen ML, 2002, CRIT CARE MED, V30, P1140, DOI 10.1097/00003246-200205000-00031; Argyris M, 2006, EUR J CARDIO-THORAC, V29, P456, DOI 10.1016/j.ejcts.2005.12.035; Bazzoni F, 2010, EUR J IMMUNOL, V40, P2360, DOI 10.1002/eji.200940294; Berlato C, 2002, J IMMUNOL, V168, P6404, DOI 10.4049/jimmunol.168.12.6404; Boengler K, 2008, PHARMACOL THERAPEUT, V120, P172, DOI 10.1016/j.pharmthera.2008.08.002; Bolli R, 2011, J MOL CELL CARDIOL, V50, P589, DOI 10.1016/j.yjmcc.2011.01.002; Borgermann J, 2002, J THORAC CARDIOV SUR, V124, P608, DOI 10.1067/mtc.2002.122300; Checchia Paul A, 2005, Pediatr Crit Care Med, V6, P441, DOI 10.1097/01.PCC.0000163678.20704.C5; Chew MS, 2001, ANESTHESIOLOGY, V94, P745, DOI 10.1097/00000542-200105000-00010; de Jager W, 2005, J IMMUNOL METHODS, V300, P124, DOI 10.1016/j.jim.2005.03.009; de Jong H, 2009, ARTHRITIS RHEUM-US, V60, P1966, DOI 10.1002/art.24656; Dehoux MS, 2000, CRIT CARE MED, V28, P1721, DOI 10.1097/00003246-200006000-00004; Diegeler A, 2000, CIRCULATION, V102, P95; Dybdahl B, 2002, CIRCULATION, V105, P685, DOI 10.1161/hc0602.103617; Evans BJ, 2008, J THORAC CARDIOV SUR, V135, P999, DOI 10.1016/j.jtcvs.2007.08.071; Franke A, 2002, ANN THORAC SURG, V74, P363, DOI 10.1016/S0003-4975(02)03658-5; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hadley JS, 2007, SHOCK, V27, P466, DOI 10.1097/01.shk.0000245033.69977.c5; HAZIOT A, 1993, J IMMUNOL, V150, P5556; Heusch G, 2011, CIRC RES, V109, P1302, DOI 10.1161/CIRCRESAHA.111.255604; Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064; Kitchens RL, 2000, J ENDOTOXIN RES, V6, P477, DOI 10.1177/09680519000060061101; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Lequier LL, 2000, CHEST, V117, P1706, DOI 10.1378/chest.117.6.1706; Matsukawa A, 2003, J IMMUNOL, V171, P6198, DOI 10.4049/jimmunol.171.11.6198; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; Murray PJ, 2005, P NATL ACAD SCI USA, V102, P8686, DOI 10.1073/pnas.0500419102; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Ogata M, 2000, CRIT CARE MED, V28, P3166, DOI 10.1097/00003246-200009000-00007; Oiva J, 2010, CRIT CARE MED, V38, P1702, DOI 10.1097/CCM.0b013e3181e7161c; Pachot A, 2008, J IMMUNOL, V180, P6421, DOI 10.4049/jimmunol.180.9.6421; Peters M, 1999, BRIT MED J, V319, P609, DOI 10.1136/bmj.319.7210.609; Piao W, 2009, J LEUKOCYTE BIOL, V86, P863, DOI 10.1189/jlb.0309189; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Pils MC, 2010, EUR J IMMUNOL, V40, P443, DOI 10.1002/eji.200939592; Riley JK, 1999, J BIOL CHEM, V274, P16513, DOI 10.1074/jbc.274.23.16513; Sablotzki A, 1997, EUR J CARDIO-THORAC, V11, P763, DOI 10.1016/S1010-7940(97)01154-8; Sarvikivi E, 2008, AM J INFECT CONTROL, V36, P564, DOI 10.1016/j.ajic.2007.11.006; Schadenberg AWL, 2011, EUR J IMMUNOL, V41, P1132, DOI 10.1002/eji.201040363; Seghaye MC, 1996, J THORAC CARDIOV SUR, V111, P545, DOI 10.1016/S0022-5223(96)70306-9; Shames BD, 1998, SHOCK, V10, P389, DOI 10.1097/00024382-199812000-00002; Takeda K, 1999, IMMUNITY, V10, P39, DOI 10.1016/S1074-7613(00)80005-9; Takezako N, 2006, BIOCHEM BIOPH RES CO, V341, P425, DOI 10.1016/j.bbrc.2005.12.206; Tamassia N, 2008, INT IMMUNOL, V20, P535, DOI 10.1093/intimm/dxn015; Tarnok A, 2001, SHOCK, V16, P24, DOI 10.1097/00024382-200116001-00006; Tomic V, 2005, CIRCULATION, V112, P2912, DOI 10.1161/CIRCULATIONAHA.104.531152; Turkson J, 2001, J BIOL CHEM, V276, P45443, DOI 10.1074/jbc.M107527200; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Wilhelm W, 2002, SHOCK, V17, P354, DOI 10.1097/00024382-200205000-00002; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567; Williams LM, 2007, J BIOL CHEM, V282, P6965, DOI 10.1074/jbc.M609101200; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Xing LY, 2003, SHOCK, V20, P10, DOI 10.1097/01.shk.0000065704.84144.a4; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938	56	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35070	10.1371/journal.pone.0035070	http://dx.doi.org/10.1371/journal.pone.0035070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506067	Green Published, gold, Green Submitted			2022-12-27	WOS:000305297500074
J	Voigt, A; Schofl, G; Saluz, HP				Voigt, Anja; Schoefl, Gerhard; Saluz, Hans Peter			The Chlamydia psittaci Genome: A Comparative Analysis of Intracellular Pathogens	PLOS ONE			English	Article							CLOSELY-RELATED BACTERIAL; III SECRETION; INCLUSION MEMBRANE; FAMILY PROTEIN; TRACHOMATIS; SEQUENCE; PNEUMONIAE; GENE; IDENTIFICATION; EVOLUTION	Background: Chlamydiaceae are a family of obligate intracellular pathogens causing a wide range of diseases in animals and humans, and facing unique evolutionary constraints not encountered by free-living prokaryotes. To investigate genomic aspects of infection, virulence and host preference we have sequenced Chlamydia psittaci, the pathogenic agent of ornithosis. Results: A comparison of the genome of the avian Chlamydia psittaci isolate 6BC with the genomes of other chlamydial species, C. trachomatis, C. muridarum, C. pneumoniae, C. abortus, C. felis and C. caviae, revealed a high level of sequence conservation and synteny across taxa, with the major exception of the human pathogen C. trachomatis. Important differences manifest in the polymorphic membrane protein family specific for the Chlamydiae and in the highly variable chlamydial plasticity zone. We identified a number of psittaci-specific polymorphic membrane proteins of the G family that may be related to differences in host-range and/or virulence as compared to closely related Chlamydiaceae. We calculated non-synonymous to synonymous substitution rate ratios for pairs of orthologous genes to identify putative targets of adaptive evolution and predicted type III secreted effector proteins. Conclusions: This study is the first detailed analysis of the Chlamydia psittaci genome sequence. It provides insights in the genome architecture of C. psittaci and proposes a number of novel candidate genes mostly of yet unknown function that may be important for pathogen-host interactions.	[Voigt, Anja; Schoefl, Gerhard; Saluz, Hans Peter] Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany; [Saluz, Hans Peter] Univ Jena, Jena, Germany	Hans Knoll Institute (HKI); Friedrich Schiller University of Jena	Voigt, A (corresponding author), Leibniz Inst Nat Prod Res & Infect Biol, Jena, Germany.	hanspeter.saluz@hki-jena.de		Schofl, Gerhard/0000-0003-3000-3205	Jena School of Microbial Communication (JSCM); Bundesministerium fur Bildung und Forschung (BMBF); Thuringer Aufbaubank (TAB)	Jena School of Microbial Communication (JSCM); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Thuringer Aufbaubank (TAB)	This work was supported by the Jena School of Microbial Communication (JSCM), the Bundesministerium fur Bildung und Forschung (BMBF), and the Thuringer Aufbaubank (TAB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdelRahman YM, 2005, FEMS MICROBIOL REV, V29, P949, DOI 10.1016/j.femsre.2005.03.002; Alves JMP, 2007, CHEM BIODIVERS, V4, P2593, DOI 10.1002/cbdv.200790212; Amici A, 1997, FEBS LETT, V419, P263, DOI 10.1016/S0014-5793(97)01464-6; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Azuma Y, 2006, DNA RES, V13, P15, DOI 10.1093/dnares/dsi027; Bannantine JP, 2000, CELL MICROBIOL, V2, P35; Beeckman DSA, 2010, CURR ISSUES MOL BIOL, V12, P17; Beeckman DSA, 2008, VET RES, V39, DOI 10.1051/vetres:2008002; Bertelli C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010890; Case ED, 2011, J BACTERIOL, V193, P4396, DOI 10.1128/JB.00294-11; CEBALLOS MM, 1979, INFECT IMMUN, V25, P98, DOI 10.1128/IAI.25.1.98-102.1979; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Collingro A, 2011, MOL BIOL EVOL, V28, P3253, DOI 10.1093/molbev/msr161; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Fehlner-Gardiner C, 2002, J BIOL CHEM, V277, P26893, DOI 10.1074/jbc.M203937200; Gomes JP, 2006, J BACTERIOL, V188, P275, DOI 10.1128/JB.188.1.275-286.2006; Grimwood J, 1999, Microb Comp Genomics, V4, P187, DOI 10.1089/omi.1.1999.4.187; Grinblat-Huse V, 2011, J BACTERIOL, V193, P4039, DOI 10.1128/JB.05277-11; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gupta R, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-38; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Harkinezhad T, 2009, VET MICROBIOL, V135, P68, DOI 10.1016/j.vetmic.2008.09.046; HATCH TP, 1982, J BACTERIOL, V150, P662, DOI 10.1128/JB.150.2.662-670.1982; HATCH TP, 1975, J BACTERIOL, V122, P393, DOI 10.1128/JB.122.2.393-400.1975; Henderson IR, 2001, TRENDS MICROBIOL, V9, P573, DOI 10.1016/S0966-842X(01)02234-X; Henning K, 2000, DEUT TIERARZTL WOCH, V107, P49; Horn M, 2008, ANNU REV MICROBIOL, V62, P113, DOI 10.1146/annurev.micro.62.081307.162818; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Kalman S, 1999, NAT GENET, V21, P385, DOI 10.1038/7716; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kimura M, 1985, NEUTRAL THEORY MOL E; Koonin EV, 2010, NAT REV GENET, V11, P487, DOI 10.1038/nrg2810; Kuo CC, 2011, 22 EDITORS BERGEYS M, VFour, P846; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; Mamirova L, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-17; MCCLARTY G, 1991, J BACTERIOL, V173, P4922, DOI 10.1128/jb.173.16.4922-4931.1991; MCCLARTY G, 1993, J BACTERIOL, V175, P4662, DOI 10.1128/JB.175.15.4662-4669.1993; McClarty G, 2007, CURR OPIN MICROBIOL, V10, P47, DOI 10.1016/j.mib.2006.12.003; Mitchell CM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-442; Molleken K, 2010, MOL MICROBIOL, V78, P1004, DOI 10.1111/j.1365-2958.2010.07386.x; Mojica S, 2011, J BACTERIOL, V193, P3690, DOI 10.1128/JB.00454-11; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Moroney JF, 1998, CLIN INFECT DIS, V26, P1425, DOI 10.1086/516368; Nelson DE, 2006, INFECT IMMUN, V74, P73, DOI 10.1128/IAI.74.1.73-80.2006; Novichkov PS, 2009, J BACTERIOL, V191, P65, DOI 10.1128/JB.01237-08; Ohya K, 2008, CLIN VACCINE IMMUNOL, V15, P1606, DOI 10.1128/CVI.00134-08; Pannekoek Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014179; Peeling RW, 1996, EMERG INFECT DIS, V2, P307, DOI 10.3201/eid0204.960406; PEITSCH M C, 1991, Current Opinion in Cell Biology, V3, P710, DOI 10.1016/0955-0674(91)90045-Z; Pesi R, 2010, FEBS J, V277, P4863, DOI 10.1111/j.1742-4658.2010.07891.x; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Petrovay F, 2008, J MED MICROBIOL, V57, P1296, DOI 10.1099/jmm.0.2008/001578-0; Ponting CP, 1999, CURR BIOL, V9, pR911, DOI 10.1016/S0960-9822(00)80102-5; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Read TD, 2003, NUCLEIC ACIDS RES, V31, P2134, DOI 10.1093/nar/gkg321; Read TD, 2000, NUCLEIC ACIDS RES, V28, P1397, DOI 10.1093/nar/28.6.1397; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Rockey DD, 2000, INFECT IMMUN, V68, P5473, DOI 10.1128/IAI.68.10.5473-5479.2000; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; ROCKEY DD, 1995, MOL MICROBIOL, V15, P617, DOI 10.1111/j.1365-2958.1995.tb02371.x; Rockey DD, 2000, PROKARYOTIC DEVELOPMENT, P403; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; SAIKKU P, 1992, J INFECTION, V25, P27, DOI 10.1016/0163-4453(92)91913-V; Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100; Seth-Smith HMB, 2011, J BACTERIOL, V193, P1282, DOI 10.1128/JB.01435-10; Seth-Smith HMB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-239; Shao JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004920; Shirai M, 2000, NUCLEIC ACIDS RES, V28, P2311, DOI 10.1093/nar/28.12.2311; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Stephens RS, 2009, FEMS IMMUNOL MED MIC, V55, P115, DOI 10.1111/j.1574-695X.2008.00516.x; Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754; Stephens RS, 2001, CURR OPIN MICROBIOL, V4, P16, DOI 10.1016/S1369-5274(00)00158-2; Streit WR, 2003, APPL MICROBIOL BIOT, V61, P21, DOI 10.1007/s00253-002-1186-2; Subtil A, 2001, MOL MICROBIOL, V39, P792, DOI 10.1046/j.1365-2958.2001.02272.x; Taylor LD, 2010, INFECT IMMUN, V78, P2691, DOI 10.1128/IAI.01455-09; Thomson NR, 2008, GENOME RES, V18, P161, DOI 10.1101/gr.7020108; Thomson NR, 2005, GENOME RES, V15, P629, DOI 10.1101/gr.3684805; TIPPLES G, 1993, MOL MICROBIOL, V8, P1105, DOI 10.1111/j.1365-2958.1993.tb01655.x; TIPPLES G, 1991, J BACTERIOL, V173, P4932, DOI 10.1128/jb.173.16.4932-4940.1991; Tjaden J, 1999, J BACTERIOL, V181, P1196, DOI 10.1128/JB.181.4.1196-1202.1999; Toft C, 2010, NAT REV GENET, V11, P465, DOI 10.1038/nrg2798; TRIBBY IIE, 1966, J BACTERIOL, V91, P2362, DOI 10.1128/JB.91.6.2362-2367.1966; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Van Droogenbroeck C, 2009, VET MICROBIOL, V135, P78, DOI 10.1016/j.vetmic.2008.09.047; Vandahl BBS, 2004, PROTEOMICS, V4, P2831, DOI 10.1002/pmic.200400940; Voigt A, 2011, J BACTERIOL, V193, P2662, DOI 10.1128/JB.00236-11; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wang J, 2009, VACCINE, V27, P2967, DOI 10.1016/j.vaccine.2009.02.095; Wang YJ, 2011, BIOINFORMATICS, V27, P777, DOI 10.1093/bioinformatics/btr021; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wolf YI, 1999, TRENDS GENET, V15, P173, DOI 10.1016/S0168-9525(99)01704-7; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1297, DOI 10.1107/S1744309110023055	96	73	74	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35097	10.1371/journal.pone.0035097	http://dx.doi.org/10.1371/journal.pone.0035097			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506068	gold, Green Published, Green Submitted			2022-12-27	WOS:000305297500075
J	Itzhaki, Z; Margalit, H				Itzhaki, Zohar; Margalit, Hanah			Reduced Polymorphism in Domains Involved in Protein-Protein Interactions	PLOS ONE			English	Article							CONSERVATION; RESIDUES; DATABASE; SITES; PFAM	Genome sequencing of various individuals or isolates of the same species allows studying the polymorphism level of specific proteins and protein domains. Here we ask whether domains that are known to be involved in mediating protein-protein interactions show lower polymorphism than other domains. To this end we take advantage of a recent genome sequence dataset of 39 Saccahromyces cerevisiae strains and the experimentally determined protein interaction network of the laboratory strain. We analyze the polymorphism in domain residues involved in interactions at various levels of resolution, depending on their likelihood to be interaction mediators. We find that domains involved in interactions are less polymorphic than other domains. Furthermore, as the likelihood of a residue to be involved in interaction increases, its polymorphism decreases. Our results suggest that purifying selection operates on domains capable of mediating protein interactions to maintain their function.	[Itzhaki, Zohar; Margalit, Hanah] Hebrew Univ Jerusalem, Dept Microbiol & Mol Genet, IMRIC, Fac Med, Jerusalem, Israel	Hebrew University of Jerusalem	Itzhaki, Z (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	hanahm@ekmd.huji.ac.il	Margalit, Hanah/H-1651-2013; Barnett-Itzhaki, Zohar/AAA-4029-2021	Barnett-Itzhaki, Zohar/0000-0001-9891-9397	Israel Science Foundation	Israel Science Foundation(Israel Science Foundation)	This study was funded by the Israel Science Foundation administered by the Israel Academy of Sciences and Humanities (HM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7; Deng MH, 2002, GENOME RES, V12, P1540, DOI 10.1101/gr.153002; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hu ZJ, 2000, PROTEINS, V39, P331, DOI 10.1002/(SICI)1097-0134(20000601)39:4<331::AID-PROT60>3.0.CO;2-A; Itzhaki Z, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-12-r125; Itzhaki Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021724; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Ng SK, 2003, BIOINFORMATICS, V19, P923, DOI 10.1093/bioinformatics/btg118; Nye TMW, 2005, BIOINFORMATICS, V21, P993, DOI 10.1093/bioinformatics/bti086; Ouzounis C, 1998, Pac Symp Biocomput, P401; Riley R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r89; Schuster-Bockler B, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-259; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; She MP, 2004, NAT STRUCT MOL BIOL, V11, P249, DOI 10.1038/nsmb730; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Sprinzak E, 2001, J MOL BIOL, V311, P681, DOI 10.1006/jmbi.2001.4920; Stein A, 2011, CURR OPIN STRUC BIOL, V21, P200, DOI 10.1016/j.sbi.2011.01.005; Stein A, 2011, NUCLEIC ACIDS RES, V39, pD718, DOI 10.1093/nar/gkq962; Steward A, 2002, J MOL BIOL, V318, P935, DOI 10.1016/S0022-2836(02)00184-5; Vishnoi A, 2011, MOL BIOL EVOL; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107	27	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34503	10.1371/journal.pone.0034503	http://dx.doi.org/10.1371/journal.pone.0034503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509312	Green Published, Green Submitted, gold			2022-12-27	WOS:000304805900040
J	Mazumder, ED; Jardin, C; Vogel, B; Heck, E; Scholz, B; Lengenfelder, D; Sticht, H; Ensser, A				Mazumder, Eman Dey; Jardin, Christophe; Vogel, Benjamin; Heck, Elke; Scholz, Brigitte; Lengenfelder, Doris; Sticht, Heinrich; Ensser, Armin			A Molecular Model for the Differential Activation of STAT3 and STAT6 by the Herpesviral Oncoprotein Tip	PLOS ONE			English	Article							LCK-BINDING ELEMENTS; HUMAN T-CELLS; GROWTH TRANSFORMATION; SIGNAL TRANSDUCER; SAIMIRI; PROTEIN; PHOSPHORYLATION; IDENTIFICATION; GENOME; REGION	Constitutive STAT signaling provides growth promoting signals in many forms of malignancy. We performed molecular modeling and molecular dynamics studies of the interaction between the regulatory Src homology 2 (SH2) domains of STAT3 and 6 with phosphorylated peptides of the herpesviral oncoprotein Tip, which facilitates Src kinase mediated STAT-activation and T cell proliferation. The studies give insight into the ligand binding specificity of the STAT SH2 domains and provide the first model for the differential activation of STAT3 or STAT6 by two distinct regions of the viral Tip protein. The biological relevance of the modeled interactions was then confirmed by activation studies using corresponding recombinant oncoproteins, and finally by respective recombinant viruses. The functional data give experimental validation of the molecular dynamics study, and provide evidence for the involvement of STAT6 in the herpesvirus induced T cell proliferation.	[Mazumder, Eman Dey; Vogel, Benjamin; Scholz, Brigitte; Lengenfelder, Doris; Ensser, Armin] Univ Erlangen Nurnberg, Univ Klinikum, Inst Clin & Mol Virol, D-91054 Erlangen, Germany; [Jardin, Christophe; Sticht, Heinrich] Univ Erlangen Nurnberg, Div Bioinformat, Inst Biochem, Emil Fischer Zentrum, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Mazumder, ED (corresponding author), Univ Erlangen Nurnberg, Univ Klinikum, Inst Clin & Mol Virol, D-91054 Erlangen, Germany.	ensser@viro.med.uni-erlangen.de	Jardin, Christophe/GYD-3751-2022	Jardin, Christophe/0000-0003-1627-6960; Sticht, Heinrich/0000-0001-5644-045X	Deutsche Forschungsgemeinschaf [Sonderforschungsbereich 796, Graduiertenkolleg 1071]; Wilhelm Sander-Stiftung [2009.002.1]	Deutsche Forschungsgemeinschaf(German Research Foundation (DFG)); Wilhelm Sander-Stiftung	This work was supported by the Deutsche Forschungsgemeinschaft (Sonderforschungsbereich 796 and Graduiertenkolleg 1071) and the Wilhelm Sander-Stiftung 2009.002.1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberter B, 2007, J VIROL, V81, P2524, DOI 10.1128/JVI.01931-06; Alberter B, 2011, J VIROL, V85, P5456, DOI 10.1128/JVI.00164-11; Albrecht JC, 2005, J VIROL, V79, P10507, DOI 10.1128/JVI.79.16.10507-10513.2005; Albrecht JC, 2004, J VIROL, V78, P9814, DOI 10.1128/JVI.78.18.9814-9819.2004; Antunes F, 2011, MOL CELL BIOL, V31, P3029, DOI 10.1128/MCB.05300-11; Bauer F, 2004, BIOCHEMISTRY-US, V43, P14932, DOI 10.1021/bi0485068; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Bernado P, 2009, PROTEIN SCI, V18, P716, DOI 10.1002/pro.83; BIESINGER B, 1995, J BIOL CHEM, V270, P4729, DOI 10.1074/jbc.270.9.4729; BIESINGER B, 1992, P NATL ACAD SCI USA, V89, P3116, DOI 10.1073/pnas.89.7.3116; Bruns HA, 2006, CRIT REV ONCOL HEMAT, V57, P245, DOI 10.1016/j.critrevonc.2005.08.005; Case DA, 2006, AMBER9 VERSION; Cho NH, 2004, J EXP MED, V200, P681, DOI 10.1084/jem.20040924; Chung YH, 2004, J VIROL, V78, P6489, DOI 10.1128/JVI.78.12.6489-6497.2004; Ensser A, 1999, J VIROL, V73, P10551, DOI 10.1128/JVI.73.12.10551-10555.1999; Ensser A, 2003, VIROLOGY, V314, P471, DOI 10.1016/S0042-6822(03)00449-5; Fickenscher H, 1997, J VIROL, V71, P2252, DOI 10.1128/JVI.71.3.2252-2263.1997; Fickenscher H, 1996, J VIROL, V70, P6012, DOI 10.1128/JVI.70.9.6012-6019.1996; Fleckenstein B., 1982, HERPESVIRUSES, V1, P253; Goenka S, 2011, IMMUNOL RES, V50, P87, DOI 10.1007/s12026-011-8205-2; Heck E, 2005, J VIROL, V79, P5713, DOI 10.1128/JVI.79.9.5713-5720.2005; Heck E, 2006, J VIROL, V80, P9934, DOI 10.1128/JVI.01112-06; Homeyer N, 2006, J MOL MODEL, V12, P281, DOI 10.1007/s00894-005-0028-4; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Huang HM, 2008, MOL CELL PROTEOMICS, V7, P768, DOI 10.1074/mcp.M700312-MCP200; Humphrey RW, 1996, BLOOD, V88, P297, DOI 10.1182/blood.V88.1.297.bloodjournal881297; Jardin C, 2008, J PHYS CHEM B, V112, P13391, DOI 10.1021/jp801319k; JUNG JU, 1991, J VIROL, V65, P6953, DOI 10.1128/JVI.65.12.6953-6960.1991; JUNG JU, 1995, J BIOL CHEM, V270, P20660, DOI 10.1074/jbc.270.35.20660; Kim Y, 2012, J GEN VIROL, V93, P330, DOI 10.1099/vir.0.036087-0; Kjellen P, 2002, VIROLOGY, V297, P281, DOI 10.1006/viro.2002.1419; Lund TC, 1999, J VIROL, V73, P1689, DOI 10.1128/JVI.73.2.1689-1694.1999; Lund TC, 1999, CELL SIGNAL, V11, P789, DOI 10.1016/S0898-6568(99)00045-5; Lund TC, 1997, J VIROL, V71, P6677, DOI 10.1128/JVI.71.9.6677-6682.1997; Mandal PK, 2007, BIOORG MED CHEM LETT, V17, P654, DOI 10.1016/j.bmcl.2006.10.099; MEDVECZKY P, 1984, J VIROL, V52, P938, DOI 10.1128/JVI.52.3.938-944.1984; MELENDEZ LV, 1968, LAB ANIM CARE, V18, P374; Meyer T, 2007, EXPERT OPIN THER TAR, V11, P1355, DOI 10.1517/14728222.11.10.1355; Moriggl R, 2005, CANCER CELL, V7, P87, DOI 10.1016/j.ccr.2004.12.010; Neculai D, 2005, J BIOL CHEM, V280, P40782, DOI 10.1074/jbc.M507682200; Reiss C, 2002, VIROLOGY, V294, P31, DOI 10.1006/viro.2001.1304; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Wiederkehr-Adam M, 2003, J BIOL CHEM, V278, P16117, DOI 10.1074/jbc.M300261200; Zielke K, 2012, J VIROL, V86, P1862, DOI 10.1128/JVI.06295-11	47	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34306	10.1371/journal.pone.0034306	http://dx.doi.org/10.1371/journal.pone.0034306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509288	Green Published, Green Submitted, gold			2022-12-27	WOS:000304805900024
J	Singh, BK; Tripathi, M; Chaudhari, BP; Pandey, PK; Kakkar, P				Singh, Brijesh Kumar; Tripathi, Madhulika; Chaudhari, Bhushan P.; Pandey, Pramod K.; Kakkar, Poonam			Natural Terpenes Prevent Mitochondrial Dysfunction, Oxidative Stress and Release of Apoptotic Proteins during Nimesulide-Hepatotoxicity in Rats	PLOS ONE			English	Article							IN-VITRO; PERMEABILITY TRANSITION; EXPRESSION; DAMAGE; LIVER; DRUG; PROTECTS; MICE	Nimesulide, an anti-inflammatory and analgesic drug, is reported to cause severe hepatotoxicity. In this study, molecular mechanisms involved in deranged oxidant-antioxidant homeostasis and mitochondrial dysfunction during nimesulide-induced hepatotoxicity and its attenuation by plant derived terpenes, camphene and geraniol has been explored in male Sprague-Dawley rats. Hepatotoxicity due to nimesulide (80 mg/kg BW) was evident from elevated SGPT, SGOT, bilirubin and histo-pathological changes. Antioxidants and key redox enzymes (iNOS, mtNOS, Cu/Zn-SOD, Mn-SOD, GPx and GR) were altered significantly as assessed by their mRNA expression, Immunoblot analysis and enzyme activities. Redox imbalance along with oxidative stress was evident from decreased NAD(P) H and GSH (56% and 74% respectively; P<0.001), increased superoxide and secondary ROS/RNS generation along with oxidative damage to cellular macromolecules. Nimesulide reduced mitochondrial activity, depolarized mitochondria and caused membrane permeability transition (MPT) followed by release of apoptotic proteins (AIF; apoptosis inducing factor, EndoG; endonuclease G, and Cyto c; cytochrome c). It also significantly activated caspase-9 and caspase-3 and increased oxidative DNA damage (level of 8-Oxoguanine glycosylase; P<0.05). A combination of camphene and geraniol (CG; 1:1), when pre-administered in rats (10 mg/kg BW), accorded protection against nimesulide hepatotoxicity in vivo, as evident from normalized serum biomarkers and histopathology. mRNA expression and activity of key antioxidant and redox enzymes along with oxidative stress were also normalized due to CG pre-treatment. Downstream effects like decreased mitochondrial swelling, inhibition in release of apoptotic proteins, prevention of mitochondrial depolarization along with reduction in oxidized NAD(P) H and increased mitochondrial electron flow further supported protective action of selected terpenes against nimesulide toxicity. Therefore CG, a combination of natural terpenes prevented nimesulide induced cellular damage and ensuing hepatotoxicity.	[Singh, Brijesh Kumar; Tripathi, Madhulika; Kakkar, Poonam] CSIR Indian Inst Toxicol Res, Herbal Res Sect, Lucknow, Uttar Pradesh, India; [Chaudhari, Bhushan P.] CSIR Indian Inst Toxicol Res, Pathol Lab, Lucknow, Uttar Pradesh, India; [Singh, Brijesh Kumar; Pandey, Pramod K.] Bundelkhand Univ, Dept Biotechnol, Jhansi, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Toxicology Research (IITR); Bundelkhand University	Singh, BK (corresponding author), CSIR Indian Inst Toxicol Res, Herbal Res Sect, Lucknow, Uttar Pradesh, India.	poonam_kakkar@yahoo.com	Singh, Brijesh K/C-1093-2009	Singh, Brijesh K/0000-0003-4615-3988	Council of Scientific and Industrial Research [SIP-08]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	The funding received under the Council of Scientific and Industrial Research funded supra-institutional project (SIP-08) was utilized for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aithal GP, 2011, CLIN PHARMACOL THER, V89, P806, DOI 10.1038/clpt.2011.58; Boelsterli UA, 2007, TOXICOL APPL PHARM, V220, P92, DOI 10.1016/j.taap.2006.12.013; Borras C, 2003, FREE RADICAL BIO MED, V34, P546, DOI 10.1016/S0891-5849(02)01356-4; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Circu ML, 2010, FREE RADICAL BIO MED, V48, P749, DOI 10.1016/j.freeradbiomed.2009.12.022; Cohen G, 1999, J NEUROCHEM, V73, P2310, DOI 10.1046/j.1471-4159.1999.0732310.x; Costantini P, 2002, CELL DEATH DIFFER, V9, P82, DOI 10.1038/sj.cdd.4400932; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Druzhyna NM, 2003, GLIA, V42, P370, DOI 10.1002/glia.10230; Dykens James A., 2008, DRUG INDUCED MITOCHO; FDA, 2005, EST MAX SAF START DO; Gagliano N, 2006, TOXICOLOGY, V225, P214, DOI 10.1016/j.tox.2006.06.004; Girish C, 2009, INDIAN J MED RES, V129, P569; Goncalves MB, 2010, BRIT J PHARMACOL, V159, P1118, DOI 10.1111/j.1476-5381.2009.00618.x; Gupta AK, 2007, REV INDIAN MED PLANT; Jaeschke H, 2011, LIFE SCI, V88, P737, DOI 10.1016/j.lfs.2011.01.025; KAKKAR P, 1984, INDIAN J BIOCHEM BIO, V21, P130; Kakkar P, 2007, MOL CELL BIOCHEM, V305, P235, DOI 10.1007/s11010-007-9520-8; Kruglov AG, 2007, BIOCHEM PHARMACOL, V74, P545, DOI 10.1016/j.bcp.2007.05.012; LEVINE RL, 1990, METHOD ENZYMOL, V186, P464; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEHROTRA S, 1991, FREE RADICAL BIO MED, V10, P277, DOI 10.1016/0891-5849(91)90034-Z; Nieminen AL, 2008, DRUG INDUCED MITOCHO, P414; Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002; Pradhan SC, 2006, INDIAN J MED RES, V124, P491; Sharma S, 2012, NUTRITION, V28, P173, DOI 10.1016/j.nut.2011.02.012; Siendones E, 2004, HEPATOLOGY, V40, P1295, DOI 10.1002/hep.20448; Singh BK, 2011, MOL CELL BIOCHEM, V357, P373, DOI 10.1007/s11010-011-0908-0; Singh BK, 2010, TOXICOLOGY, V275, P1, DOI 10.1016/j.tox.2010.05.001; Tay VKS, 2005, FREE RADICAL BIO MED, V39, P949, DOI 10.1016/j.freeradbiomed.2005.05.013; Tiwari M, 2009, TOXICOL IN VITRO, V23, P295, DOI 10.1016/j.tiv.2008.12.014; Tripathi M, 2009, FOOD CHEM TOXICOL, V47, P339, DOI 10.1016/j.fct.2008.11.028; Tripathi M, 2011, J ETHNOPHARMACOL, V136, P94, DOI 10.1016/j.jep.2011.04.014; Tripathi M, 2010, TOXICOL IN VITRO, V24, P495, DOI 10.1016/j.tiv.2009.09.011; Venardos K, 2005, MOL CELL BIOCHEM, V270, P131, DOI 10.1007/s11010-005-5279-y; Warrington S J, 1993, Drugs, V46 Suppl 1, P263; World Health Organization (WHO), 2008, WHO DRUG INF; Yuan LY, 2009, MOL ASPECTS MED, V30, P29, DOI 10.1016/j.mam.2008.08.003; Zhang HH, 2011, AM J PATHOL, V178, P1715, DOI 10.1016/j.ajpath.2010.12.038; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	40	45	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34200	10.1371/journal.pone.0034200	http://dx.doi.org/10.1371/journal.pone.0034200			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509279	gold, Green Submitted, Green Published			2022-12-27	WOS:000304805900017
J	Cha, MY; Han, SH; Son, SM; Hong, HS; Choi, YJ; Byun, J; Mook-Jung, I				Cha, Moon-Yong; Han, Sun-Ho; Son, Sung Min; Hong, Hyun-Seok; Choi, Young-Ju; Byun, Jayoung; Mook-Jung, Inhee			Mitochondria-Specific Accumulation of Amyloid beta Induces Mitochondrial Dysfunction Leading to Apoptotic Cell Death	PLOS ONE			English	Article							ALZHEIMERS-DISEASE NEURONS; A-BETA; PRECURSOR PROTEIN; OXIDATIVE DAMAGE; BRAIN; RAGE; ACTIVATION; ABNORMALITIES; PATHOGENESIS; CONTRIBUTES	Mitochondria are best known as the essential intracellular organelles that host the homeostasis required for cellular survival, but they also have relevance in diverse disease-related conditions, including Alzheimer's disease (AD). Amyloid beta (A beta) peptide is the key molecule in AD pathogenesis, and has been highlighted in the implication of mitochondrial abnormality during the disease progress. Neuronal exposure to A beta impairs mitochondrial dynamics and function. Furthermore, mitochondrial A beta accumulation has been detected in the AD brain. However, the underlying mechanism of how A beta affects mitochondrial function remains uncertain, and it is questionable whether mitochondrial A beta accumulation followed by mitochondrial dysfunction leads directly to neuronal toxicity. This study demonstrated that an exogenous A beta(1-42) treatment, when applied to the hippocampal cell line of mice (specifically HT22 cells), caused a deleterious alteration in mitochondria in both morphology and function. A clathrin-mediated endocytosis blocker rescued the exogenous A beta(1-42)-mediated mitochondrial dysfunction. Furthermore, the mitochondria-targeted accumulation of A beta(1-42) in HT22 cells using A beta(1-42) with a mitochondria-targeting sequence induced the identical morphological alteration of mitochondria as that observed in the APP/PS AD mouse model and exogenous A beta(1-42)-treated HT22 cells. In addition, subsequent mitochondrial dysfunctions were demonstrated in the mitochondria-specific A beta(1-42) accumulation model, which proved indistinguishable from the mitochondrial impairment induced by exogenous A beta(1-42)-treated HT22 cells. Finally, cellular toxicity was directly induced by mitochondria-targeted A beta(1-42) accumulation, which mimics the apoptosis process in exogenous A beta(1-42)-treated HT22 cells. Taken together, these results indicate that mitochondria-targeted A beta(1-42) accumulation is the necessary and sufficient condition for A beta-mediated mitochondria impairments, and leads directly to cellular death rather than along with other A beta-mediated signaling alterations.	[Cha, Moon-Yong; Han, Sun-Ho; Son, Sung Min; Choi, Young-Ju; Byun, Jayoung; Mook-Jung, Inhee] Seoul Natl Univ, Coll Med, Dept Biochem & Biomed Sci, Seoul, South Korea; [Hong, Hyun-Seok] Medifron DBT Inc, Ansan, Kyunggi Do, South Korea	Seoul National University (SNU)	Cha, MY (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Biomed Sci, Seoul, South Korea.	inhee@snu.ac.kr	Mook, Inhee/J-2754-2012	Son, Sung Min/0000-0002-3536-1952	21C Frontier Functional Proteomics Project [FPR08K1301-02210]; National Research Foundation [20090081673]; World Class University-Neurocytomics; KNIH ROAD R&D Program Project [2009-0443]; Basic Research Program [200805943]	21C Frontier Functional Proteomics Project(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Research Foundation; World Class University-Neurocytomics; KNIH ROAD R&D Program Project; Basic Research Program	This work was supported by grants from the 21C Frontier Functional Proteomics Project (FPR08K1301-02210); National Research Foundation (20090081673); World Class University-Neurocytomics; KNIH ROAD R&D Program Project (2009-0443); and supported in part by the Basic Research Program (200805943). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anandatheerthavarada HK, 2003, J CELL BIOL, V161, P41, DOI 10.1083/jcb.200207030; Askanas V, 1996, P NATL ACAD SCI USA, V93, P1314, DOI 10.1073/pnas.93.3.1314; Baloyannis SJ, 2006, J ALZHEIMERS DIS, V9, P119; Baloyannis Stavros J, 2004, Am J Alzheimers Dis Other Demen, V19, P89, DOI 10.1177/153331750401900205; Bezprozvanny I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.263pe16; Calkins MJ, 2011, BBA-MOL BASIS DIS, V1812, P507, DOI 10.1016/j.bbadis.2011.01.007; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Chacinska A, 2009, CELL, V138, P628, DOI 10.1016/j.cell.2009.08.005; Cho HJ, 2009, FASEB J, V23, P2639, DOI 10.1096/fj.08-126383; Corona C, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.57; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Grazette LP, 2004, J AM COLL CARDIOL, V44, P2231, DOI 10.1016/j.jacc.2004.08.066; Han SH, 2011, MOL CELLS, V31, P91, DOI 10.1007/s10059-011-0030-x; Haruna Y, 2007, P NATL ACAD SCI USA, V104, P2331, DOI 10.1073/pnas.0611079104; Hatanpaa K, 1998, MOL BRAIN RES, V59, P13, DOI 10.1016/S0169-328X(98)00117-X; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Kadowaki H, 2005, CELL DEATH DIFFER, V12, P19, DOI 10.1038/sj.cdd.4401528; Kupcsik L, 2011, METHODS MOL BIOL, V740, P13, DOI 10.1007/978-1-61779-108-6_3; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Li N, 2010, ACTA PHARMACOL SIN, V31, P265, DOI 10.1038/aps.2010.3; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Manczak M, 2010, J ALZHEIMERS DIS, V20, pS609, DOI 10.3233/JAD-2010-100564; Maurer I, 2000, NEUROBIOL AGING, V21, P455, DOI 10.1016/S0197-4580(00)00112-3; MIZUNO Y, 1995, BBA-MOL BASIS DIS, V1271, P265, DOI 10.1016/0925-4439(95)00038-6; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Origlia N, 2008, J NEUROSCI, V28, P3521, DOI 10.1523/JNEUROSCI.0204-08.2008; Raisova M, 2001, J INVEST DERMATOL, V117, P333, DOI 10.1046/j.0022-202x.2001.01409.x; Reddy PH, 2010, J ALZHEIMERS DIS, V20, pS499, DOI 10.3233/JAD-2010-100504; Seelert H, 2009, BBA-BIOENERGETICS, V1787, P657, DOI 10.1016/j.bbabio.2009.02.028; SHIGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771, DOI 10.1073/pnas.91.23.10771; Small DH, 2009, J ALZHEIMERS DIS, V16, P225, DOI 10.3233/JAD-2009-0951; Takuma K, 2009, P NATL ACAD SCI USA, V106, P20021, DOI 10.1073/pnas.0905686106; Trimmer PA, 2000, EXP NEUROL, V162, P37, DOI 10.1006/exnr.2000.7333; Wu FB, 2009, AGEING RES REV, V8, P147, DOI 10.1016/j.arr.2009.03.002; XIAO, 2008, INT J MED SCI, V5, P295; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SD, 1998, RESTOR NEUROL NEUROS, V12, P167	40	167	170	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34929	10.1371/journal.pone.0034929	http://dx.doi.org/10.1371/journal.pone.0034929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514691	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341600097
J	Tanaka, M; Shigihara, Y; Funakura, M; Kanai, E; Watanabe, Y				Tanaka, Masaaki; Shigihara, Yoshihito; Funakura, Masami; Kanai, Etsuko; Watanabe, Yasuyoshi			Fatigue-Associated Alterations of Cognitive Function and Electroencephalographic Power Densities	PLOS ONE			English	Article							PHYSICAL FATIGUE; MENTAL FATIGUE; PERFORMANCE; SLEEPINESS; ATTENTION; BRAIN	Fatigue is a common problem in modern society. We attempted to identify moderate-to long-term fatigue-related alterations in the central nervous system using cognitive tasks and electroencephalography (EEG) measures. The study group consisted of 17 healthy male participants. After saliva samples were collected to measure copy number of human herpesvirus (HHV)-6 DNA to assess the level of moderate-to long-term fatigue, subjects were evaluated using EEG, with their eyes open for 2 min, then closed for 1 min sitting quietly. Thereafter, they completed cognitive task trials to evaluate simple selective attention for 3 min (Task 1) and conflict-controlling selective attention for 6 min (Task 2, which included Stroop trials). The percent error of Task 2 for Stroop trials was positively associated with the copy number of saliva HHV-6 DNA, although the simple selective attention measures in Task 1 did not differ significantly. EEG power densities (especially the alpha power density) during the eye-closed condition were negatively associated with the saliva HHV-6 DNA level. Impaired high-level information processing such as that required for conflict-controlling selective attention in the central nervous system may be a characteristic feature of moderate-to long-term fatigue.	[Tanaka, Masaaki; Shigihara, Yoshihito; Watanabe, Yasuyoshi] Osaka City Univ, Dept Physiol, Grad Sch Med, Abeno Ku, Osaka 558, Japan; [Funakura, Masami; Kanai, Etsuko] Panasonic Corp, Digital & Network Technol Dev Ctr, Kadoma, Osaka, Japan; [Watanabe, Yasuyoshi] RIKEN, Ctr Mol Imaging Sci, Chuo Ku, Kobe, Hyogo, Japan	Osaka Metropolitan University; Panasonic; RIKEN	Tanaka, M (corresponding author), Osaka City Univ, Dept Physiol, Grad Sch Med, Abeno Ku, Osaka 558, Japan.	masa-t@msic.med.osaka-cu.ac.jp	Shigihara, Yoshihito/AFL-8377-2022; Shigihara, Yoshihito/AAG-8442-2022	Shigihara, Yoshihito/0000-0003-0996-110X; Shigihara, Yoshihito/0000-0003-0996-110X	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [KAKENHI: 23300241]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by the Grant-in-Aid for Scientific Research B (KAKENHI: 23300241) from Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ataka S, 2008, NUTRITION, V24, P233, DOI 10.1016/j.nut.2007.12.002; Ataka S, 2007, NUTRITION, V23, P419, DOI 10.1016/j.nut.2007.03.002; Boksem MAS, 2008, BRAIN RES REV, V59, P125, DOI 10.1016/j.brainresrev.2008.07.001; Boksem MAS, 2005, COGNITIVE BRAIN RES, V25, P107, DOI 10.1016/j.cogbrainres.2005.04.011; Brand N, 1997, PERCEPT MOTOR SKILL, V84, P455, DOI 10.2466/pms.1997.84.2.455; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Caseras X, 2008, PSYCHOL MED, V38, P941, DOI 10.1017/S0033291708003450; Caseras X, 2006, PSYCHOSOM MED, V68, P947, DOI 10.1097/01.psy.0000242770.50979.5f; de Lange FP, 2008, BRAIN, V131, P2172, DOI 10.1093/brain/awn140; de Lange FP, 2004, BRAIN, V127, P1948, DOI 10.1093/brain/awh225; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; GASSER T, 1982, ELECTROEN CLIN NEURO, V53, P119, DOI 10.1016/0013-4694(82)90112-2; Kaida K, 2006, CLIN NEUROPHYSIOL, V117, P1574, DOI 10.1016/j.clinph.2006.03.011; Killgore WDS, 2009, AVIAT SPACE ENVIR MD, V80, P81, DOI 10.3357/ASEM.2396.2009; Kondo Kazuhiro, 2005, Uirusu, V55, P9, DOI 10.2222/jsv.55.9; Lal SKL, 2001, BIOL PSYCHOL, V55, P173, DOI 10.1016/S0301-0511(00)00085-5; LaManca J.J., 1998, AM J MED, V105, P59; Leonard C, 1998, IRISH J MED SCI, V167, P22, DOI 10.1007/BF02937548; Lorist MM, 2005, COGNITIVE BRAIN RES, V24, P199, DOI 10.1016/j.cogbrainres.2005.01.018; Lutz J, 2008, ARTHRITIS RHEUM-US, V58, P3960, DOI 10.1002/art.24070; Mizuma H, 2009, NUTR RES, V29, P145, DOI 10.1016/j.nutres.2009.02.003; Mizuno K, 2007, FATIGUE SCI HUMAN HL, P47; Mizuno K, 2008, NUTRITION, V24, P293, DOI 10.1016/j.nut.2007.12.007; Moss-Morris R, 2003, BRIT J HEALTH PSYCH, V8, P195, DOI 10.1348/135910703321649169; Nozaki S, 2009, NUTRITION, V25, P51, DOI 10.1016/j.nut.2008.07.010; Okada T, 2004, BMC NEUROL, V4, DOI 10.1186/1471-2377-4-14; RAY C, 1993, BRIT J CLIN PSYCHOL, V32, P357, DOI 10.1111/j.2044-8260.1993.tb01068.x; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Stampi C, 1995, WORK STRESS, V9, P368, DOI 10.1080/02678379508256574; Suda M, 2009, BRAIN RES, V1252, P152, DOI 10.1016/j.brainres.2008.11.077; Tanaka M, 2010, MED HYPOTHESES, V75, P244, DOI 10.1016/j.mehy.2010.02.032; Thomas RJ, 2005, SLEEP MED, V6, P399, DOI 10.1016/j.sleep.2005.04.005; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Wallman KE, 2004, MED J AUSTRALIA, V180, P444, DOI 10.5694/j.1326-5377.2004.tb06019.x; Watanabe Y., 2007, FATIGUE SCI HUMAN HL, P5; Wijesuriya N, 2008, IEEE ENG MED BIO, P5716, DOI 10.1109/IEMBS.2008.4650512; Yamamoto S, 2004, NEUROREPORT, V15, P2571, DOI 10.1097/00001756-200412030-00002	37	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34774	10.1371/journal.pone.0034774	http://dx.doi.org/10.1371/journal.pone.0034774			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514666	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600072
J	Yang, DY; Fu, Y; Wu, XH; Xie, Y; Nie, HM; Chen, L; Nong, X; Gu, XB; Wang, SX; Peng, XR; Yan, N; Zhang, RH; Zheng, WP; Yang, GY				Yang, Deying; Fu, Yan; Wu, Xuhang; Xie, Yue; Nie, Huaming; Chen, Lin; Nong, Xiang; Gu, Xiaobin; Wang, Shuxian; Peng, Xuerong; Yan, Ning; Zhang, Runhui; Zheng, Wanpeng; Yang, Guangyou			Annotation of the Transcriptome from Taenia pisiformis and Its Comparative Analysis with Three Taeniidae Species	PLOS ONE			English	Article							RABBIT ORYCTOLAGUS-CUNICULUS; ECHINOCOCCUS-MULTILOCULARIS; HELMINTH-PARASITES; SOLIUM; CYSTICERCOSIS; GENES; EXPRESSION; PROTECTION; RELEVANCE; DIAGNOSIS	Background: Taenia pisiformis is one of the most common intestinal tapeworms and can cause infections in canines. Adult T. pisiformis (canines as definitive hosts) and Cysticercus pisiformis (rabbits as intermediate hosts) cause significant health problems to the host and considerable socio-economic losses as a consequence. No complete genomic data regarding T. pisiformis are currently available in public databases. RNA-seq provides an effective approach to analyze the eukaryotic transcriptome to generate large functional gene datasets that can be used for further studies. Methodology/Principal Findings: In this study, 2.67 million sequencing clean reads and 72,957 unigenes were generated using the RNA-seq technique. Based on a sequence similarity search with known proteins, a total of 26,012 unigenes (no redundancy) were identified after quality control procedures via the alignment of four databases. Overall, 15,920 unigenes were mapped to 203 Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways. Through analyzing the glycolysis/gluconeogenesis and axonal guidance pathways, we achieved an in-depth understanding of the biochemistry of T. pisiformis. Here, we selected four unigenes at random and obtained their full-length cDNA clones using RACE PCR. Functional distribution characteristics were gained through comparing four cestode species (72,957 unigenes of T. pisiformis, 30,700 ESTs of T. solium, 1,058 ESTs of Eg+Em [conserved ESTs between Echinococcus granulosus and Echinococcus multilocularis]), with the cluster of orthologous groups (COG) and gene ontology (GO) functional classification systems. Furthermore, the conserved common genes in these four cestode species were obtained and aligned by the KEGG database. Conclusion: This study provides an extensive transcriptome dataset obtained from the deep sequencing of T. pisiformis in a non-model whole genome. The identification of conserved genes may provide novel approaches for potential drug targets and vaccinations against cestode infections. Research can now accelerate into the functional genomics, immunity and gene expression profiles of cestode species.	[Yang, Deying; Fu, Yan; Wu, Xuhang; Xie, Yue; Nie, Huaming; Chen, Lin; Nong, Xiang; Gu, Xiaobin; Wang, Shuxian; Yan, Ning; Zhang, Runhui; Zheng, Wanpeng; Yang, Guangyou] Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Yaan, Peoples R China; [Peng, Xuerong] Sichuan Agr Univ, Coll Life & Basic Sci, Dept Chem, Yaan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Yang, DY (corresponding author), Sichuan Agr Univ, Coll Vet Med, Dept Parasitol, Yaan, Peoples R China.	guangyou1963@yahoo.com.cn			Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) [IRT0848]	Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This study was supported by grant from the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) (grant no. IRT0848). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Diaz H, 2006, PARASITOL INT, V55, pS127, DOI 10.1016/j.parint.2005.11.020; Allan JC, 1999, J HELMINTHOL, V73, P289, DOI 10.1017/S0022149X99000487; Almeida CR, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-35; Atluri VSR, 2011, ACTA TROP, V118, P165, DOI 10.1016/j.actatropica.2011.02.009; Bagrade G, 2009, J HELMINTHOL, V83, P63, DOI 10.1017/S0022149X08123860; Borroto-Escuela DO, 2011, IUBMB LIFE, V63, P463, DOI 10.1002/iub.473; Brehm K, 2010, PARASITOLOGY, V137, P537, DOI 10.1017/S0031182009991727; Bueno EC, 2005, AM J TROP MED HYG, V72, P278, DOI 10.4269/ajtmh.2005.72.278; Cheadle JP, 2002, CANCER RES, V62, P363; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Du WY, 2011, PARASITOL RES, V109, P567, DOI 10.1007/s00436-011-2285-8; Ferrer E, 2005, EXP PARASITOL, V110, P1, DOI 10.1016/j.exppara.2004.11.014; Foronda P, 2003, J PARASITOL, V89, P952, DOI 10.1645/GE-3048; Guan KL, 2003, NAT REV NEUROSCI, V4, P941, DOI 10.1038/nrn1254; Guo YJ, 2004, VACCINE, V22, P3841, DOI 10.1016/j.vaccine.2004.07.012; Hoberg EP, 2006, PARASITOL INT, V55, pS23, DOI 10.1016/j.parint.2005.11.049; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jia WZ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-447; Lahmar Samia, 2008, Tunis Med, V86, P657; Lee KD, 2010, J PARASITOL, V96, P58, DOI 10.1645/GE-2195.1; Li GQ, 2007, SENIOR PARASITOLOGY; Li J, 2004, GENE, V326, P157, DOI 10.1016/j.gene.2003.10.027; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lidell ME, 2006, P NATL ACAD SCI USA, V103, P9298, DOI 10.1073/pnas.0600623103; Liu B, 2001, THESIS JILIN U; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Lundstrom J, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000919; Martin NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027191; Martinez-Moreno FJ, 2007, VET PARASITOL, V143, P7, DOI 10.1016/j.vetpar.2006.08.004; McManus DP, 2003, LANCET, V362, P1295, DOI 10.1016/S0140-6736(03)14573-4; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Owiny JR, 2001, CONTEMP TOP LAB ANIM, V40, P45; Peng DJ, 2010, CELL CYCLE, V9, P4650, DOI 10.4161/cc.9.23.13957; Pour AA, 2011, PARASITOL RES, V108, P1229, DOI 10.1007/s00436-010-2170-x; Ragunathan L, 2010, J MICROBIOL IMMUNOL, V43, P228, DOI 10.1016/S1684-1182(10)60036-9; RAJASEKARIAH GR, 1985, EXP PARASITOL, V59, P321, DOI 10.1016/0014-4894(85)90087-6; Saarma U, 2009, PARASITOLOGY, V136, P317, DOI 10.1017/S0031182008005453; Saeed I, 2006, VET PARASITOL, V139, P168, DOI 10.1016/j.vetpar.2006.02.015; Saenz B, 2011, MED MICROBI IN PRESS; Sako Y, 2007, MOL BIOCHEM PARASIT, V154, P181, DOI 10.1016/j.molbiopara.2007.04.016; Scholl EH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-r39; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Solis CF, 2005, INFECT IMMUN, V73, P1895, DOI 10.1128/IAI.73.3.1895-1897.2005; [孙晓林 SUN Xiaolin], 2008, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V39, P1100; Thompson RCA, 2008, EXP PARASITOL, V119, P439, DOI 10.1016/j.exppara.2008.04.016; Torgerson PR, 2009, TRENDS PARASITOL, V25, P164, DOI 10.1016/j.pt.2008.12.008; Wang M, 2004, VET PARASITOLOGY; White AC, 1997, CHEM IMMUNOL, V66, P209; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Ymlahi-Ouazzani Q, 2010, NEUROGENETICS, V11, P27, DOI 10.1007/s10048-009-0200-6; Zhou YX, 2008, J ZHEJIANG AGR SCI, V3, P372	52	30	32	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e32283	10.1371/journal.pone.0032283	http://dx.doi.org/10.1371/journal.pone.0032283			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514598	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341600003
J	Chechi, K; Gelinas, Y; Mathieu, P; Deshaies, Y; Richard, D				Chechi, Kanta; Gelinas, Yves; Mathieu, Patrick; Deshaies, Yves; Richard, Denis			Validation of Reference Genes for the Relative Quantification of Gene Expression in Human Epicardial Adipose Tissue	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; SURGERY POSSIBLE ROLE; REAL-TIME; HOUSEKEEPING GENES; DECREASED ADIPONECTIN; RIBOSOMAL-RNA; RT-PCR; FAT; NORMALIZATION; LEPTIN	Background: Relative quantification is a commonly used method for assessing gene expression, however its accuracy and reliability is dependent upon the choice of an optimal endogenous control gene, and such choice cannot be made a priori. There is limited information available on suitable reference genes to be used for studies involving human epicardial adipose tissue. The objective of the current study was to evaluate and identify optimal reference genes for use in the relative quantification of gene expression in human epicardial fat depots of lean, overweight and obese subjects. Methodology/Principal Findings: Some of the commonly used reference genes including 18S, ACTB, RPL27, HPRT, CYCA, GAPDH, RPLPO, POLR2A and B2M were quantified using real-time PCR analysis. The expression stability of these genes was evaluated using Genorm, Normfinder and Bestkeeper algorithms. In addition, the effect of sample size on the validation process was studied by randomly categorizing subjects in two cohorts of n = 2 and n = 33. Conclusions/Significance: CYCA, GAPDH and RPL27 were identified as the most stable genes common to all three algorithms and both sample sizes. Their use as reference gene pairs might contribute to the enhanced robustness of relative quantification in the studies involving the human epicardial adipose tissue.	[Chechi, Kanta; Gelinas, Yves; Mathieu, Patrick; Deshaies, Yves; Richard, Denis] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	Laval University	Chechi, K (corresponding author), Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada.	Denis.Richard@criucpq.ulaval.ca	Deshaies, Yves/E-9858-2013	Deshaies, Yves/0000-0002-6242-4592; Chechi, Kanta/0000-0003-1929-4128	postdoctoral fellowships from the Canadian Institute of Health Research (CIHR)'s Training Program in Obesity Research; Fonds de Recherche du Quebec en Sante (FRSQ)	postdoctoral fellowships from the Canadian Institute of Health Research (CIHR)'s Training Program in Obesity Research(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec en Sante (FRSQ)	This work was supported by postdoctoral fellowships from the Canadian Institute of Health Research (CIHR)'s Training Program in Obesity Research and the Fonds de Recherche du Quebec en Sante (FRSQ) to KC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Baker AR, 2009, J CLIN ENDOCR METAB, V94, P261, DOI 10.1210/jc.2007-2579; Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1; Bambace Clara, 2011, Cardiovasc Pathol, V20, pe153, DOI 10.1016/j.carpath.2010.07.005; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; Bettencourt N, 2011, INT J CARDIOL   0119; Brattelid T, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-22; Bustin SA, 2005, CLIN SCI, V109, P365, DOI 10.1042/CS20050086; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Catalan V, 2007, HORM METAB RES, V39, P495, DOI 10.1055/s-2007-982502; Company JM, 2010, J APPL PHYSIOL, V109, P1904, DOI 10.1152/japplphysiol.00621.2010; Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106; Derks NM, 2008, NEUROSCIENCE, V156, P305, DOI 10.1016/j.neuroscience.2008.07.047; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Eiras S, 2008, CYTOKINE, V43, P174, DOI 10.1016/j.cyto.2008.05.006; Eiras S, 2010, CYTOKINE, V51, P207, DOI 10.1016/j.cyto.2010.05.009; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Gormez S, 2011, INTERNAL MED, V50, P805, DOI 10.2169/internalmedicine.50.4753; Graham TL, 2005, ATHEROSCLEROSIS, V181, P29, DOI 10.1016/j.atherosclerosis.2004.12.028; Guauque-Olarte S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019908; Haugen F, 2006, AM J PHYSIOL-ENDOC M, V290, pE326, DOI 10.1152/ajpendo.00020.2005; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Huang ZH, 2011, METABOLISM, V60, P1692, DOI 10.1016/j.metabol.2011.04.012; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Iacobellis G, 2003, CLIN CARDIOL, V26, P237, DOI 10.1002/clc.4960260508; Iacobellis G, 2003, OBES RES, V11, P304, DOI 10.1038/oby.2003.45; Iacobellis G, 2009, HORM METAB RES, V41, P855, DOI 10.1055/s-0029-1231081; Iglesias MJ, 2006, REV ESP CARDIOL, V59, P1252, DOI 10.1016/S1885-5857(07)60081-4; Kotulak T, 2011, PHYSIOL RES, V60, P757, DOI 10.33549/physiolres.932134; Kremen J, 2006, J CLIN ENDOCR METAB, V91, P4620, DOI 10.1210/jc.2006-1044; Ling DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017762; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Qiu J, 2007, BIOCHEM BIOPH RES CO, V352, P469, DOI 10.1016/j.bbrc.2006.11.049; Rabkin SW, 2007, OBES REV, V8, P253, DOI 10.1111/j.1467-789X.2006.00293.x; Rondelet B, 2012, EUR HEART J, V33, P1017, DOI 10.1093/eurheartj/ehr111; Roubicek T, 2008, PHYSIOL RES, V57, P911, DOI 10.33549/physiolres.931315; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Silaghi A, 2007, AM J PHYSIOL-ENDOC M, V293, pE1443, DOI 10.1152/ajpendo.00273.2007; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Mustelier JV, 2011, ARQ BRAS CARDIOL, V97, P122, DOI 10.1590/S0066-782X2011005000068; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vandesompele Jo, 2009, P47; Vural B, 2008, CARDIOVASC PATHOL, V17, P392, DOI 10.1016/j.carpath.2008.02.006; Wang B, 2008, J ENDOCRINOL, V198, P127, DOI 10.1677/JOE-08-0156; Yerramasu A, 2011, ATHEROSCLEROSIS, DOI [10.1016/j.athero-sclerosis, DOI 10.1016/J.ATHEROSCLEROSIS.2011.09.04]; Zhou YA, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-2	47	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e32265	10.1371/journal.pone.0032265	http://dx.doi.org/10.1371/journal.pone.0032265			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511915	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338600001
J	Akirav, EM; Preston-Hurlburt, P; Garyu, J; Henegariu, O; Clynes, R; Schmidt, M; Herold, KC				Akirav, Eitan M.; Preston-Hurlburt, Paula; Garyu, Justin; Henegariu, Octavian; Clynes, Raphael; Schmidt, Marie; Herold, Kevan C.			RAGE Expression in Human T Cells: A Link between Environmental Factors and Adaptive Immune Responses	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; MOBILITY GROUP BOX-1; DIABETIC VASCULOPATHY; ALZHEIMERS-DISEASE; SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; SOLUBLE RECEPTOR; DENDRITIC CELLS; ACTIVATION; ATHEROSCLEROSIS	The Receptor for Advanced Glycation Endproducts (RAGE) is a scavenger ligand that binds glycated endproducts as well as molecules released during cell death such as S100b and HMGB1. RAGE is expressed on antigen presenting cells where it may participate in activation of innate immune responses but its role in adaptive human immune responses has not been described. We have found that RAGE is expressed intracellularly in human T cells following TCR activation but constitutively on T cells from patients with diabetes. The levels of RAGE on T cells from patients with diabetes are not related to the level of glucose control. It co-localizes to the endosomes. Its expression increases in activated T cells from healthy control subjects but bystander cells also express RAGE after stimulation of the antigen specific T cells. RAGE ligands enhance RAGE expression. In patients with T1D, the level of RAGE expression decreases with T cell activation. RAGE+ T cells express higher levels of IL-17A, CD107a, and IL-5 than RAGE- cells from the same individual with T1D. Our studies have identified the expression of RAGE on adaptive immune cells and a role for this receptor and its ligands in modulating human immune responses.	[Akirav, Eitan M.; Preston-Hurlburt, Paula; Garyu, Justin; Henegariu, Octavian; Herold, Kevan C.] Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA; [Akirav, Eitan M.; Preston-Hurlburt, Paula; Garyu, Justin; Henegariu, Octavian; Herold, Kevan C.] Yale Univ, Dept Internal Med, New Haven, CT USA; [Clynes, Raphael] Columbia Univ, Dept Med, New York, NY USA; [Schmidt, Marie] NYU, Dept Med, New York, NY 10016 USA	Yale University; Yale University; Columbia University; New York University	Akirav, EM (corresponding author), Yale Univ, Dept Immunobiol, New Haven, CT 06520 USA.	kevan.herold@yale.edu			Juvenile Diabetes Research Foundation [2004-808]	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	This work was supported by a Juvenile Diabetes Research Foundation grant: 2004-808. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumugam T, 2004, J BIOL CHEM, V279, P5059, DOI 10.1074/jbc.M310124200; Basta G, 2005, ARTERIOSCL THROM VAS, V25, P1401, DOI 10.1161/01.ATV.0000167522.48370.5e; BEVERLY B, 1992, INT IMMUNOL, V4, P661, DOI 10.1093/intimm/4.6.661; Caldwell CC, 2001, J IMMUNOL, V167, P6140, DOI 10.4049/jimmunol.167.11.6140; Chen YL, 2008, J IMMUNOL, V181, P4272, DOI 10.4049/jimmunol.181.6.4272; Chen YL, 2004, J IMMUNOL, V173, P1399, DOI 10.4049/jimmunol.173.2.1399; Dettoraki A, 2009, J PEDIATR ENDOCR MET, V22, P895, DOI 10.1515/JPEM.2009.22.10.895; Diabet Control Complications Trial Res Grp, 1998, ANN INTERN MED, V128, P517, DOI 10.7326/0003-4819-128-7-199804010-00001; Dumitriu IE, 2005, J IMMUNOL, V174, P7506, DOI 10.4049/jimmunol.174.12.7506; Fang F, 2010, FASEB J, V24, P1043, DOI 10.1096/fj.09-139634; Feng L, 2005, DIABETES CARE, V28, P379, DOI 10.2337/diacare.28.2.379; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Frauwirth KA, 2004, J IMMUNOL, V172, P4661, DOI 10.4049/jimmunol.172.8.4661; Fuentes MK, 2007, DIS COLON RECTUM, V50, P1230, DOI 10.1007/s10350-006-0850-5; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Ge JB, 2005, ARTERIOSCL THROM VAS, V25, P2157, DOI 10.1161/01.ATV.0000181744.58265.63; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Greten J, 1996, NEPHROL DIAL TRANSPL, V11, P786, DOI 10.1093/oxfordjournals.ndt.a027399; Harja E, 2008, J CLIN INVEST, V118, P183, DOI 10.1172/JCI32703; Hofmann MA, 2005, ATHEROSCLEROSIS, V182, P301, DOI 10.1016/j.atherosclerosis.2005.02.006; Hofmann MA, 2002, GENES IMMUN, V3, P123, DOI 10.1038/sj.gene.6363861; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hou FF, 2004, J AM SOC NEPHROL, V15, P1889, DOI 10.1097/01.asn.0000131526.99506.f7; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Kalea AZ, 2010, CANCER RES, V70, P5628, DOI 10.1158/0008-5472.CAN-10-0595; Kalea AZ, 2009, FASEB J, V23, P1766, DOI 10.1096/fj.08-117739; Kim W, 2005, ANN NY ACAD SCI, V1043, P553, DOI 10.1196/annals.1338.063; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Li W, 2006, CURR OPIN PHARMACOL, V6, P130, DOI 10.1016/j.coph.2005.10.010; Liliensiek B, 2004, J CLIN INVEST, V113, P1641, DOI 10.1172/JCI200418704; Lin L, 2006, CELL MOL IMMUNOL, V3, P351; Matsuoka N, 2010, J CLIN INVEST, V120, P735, DOI 10.1172/JCI41360; Moser B, 2005, ARTHRITIS RES THER, V7, P142, DOI 10.1186/ar1764; Moser B, 2007, J IMMUNOL, V179, P8051, DOI 10.4049/jimmunol.179.12.8051; Nakamura K, 2008, DIABETES-METAB RES, V24, P109, DOI 10.1002/dmrr.766; Nakayama T, 2010, SEMIN IMMUNOL, V22, P303, DOI 10.1016/j.smim.2010.04.010; Obermaier Bianca, 2003, Biol Proced Online, V5, P197, DOI 10.1251/bpo62; Ohashi K, 2010, CLIN IMMUNOL, V134, P345, DOI 10.1016/j.clim.2009.10.008; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Pollreisz A, 2010, ATHEROSCLEROSIS; Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390; Reddy MA, 2006, J BIOL CHEM, V281, P13685, DOI 10.1074/jbc.M511425200; Rong LL, 2005, RESTOR NEUROL NEUROS, V23, P355; Schmidt A M, 2000, Curr Atheroscler Rep, V2, P430, DOI 10.1007/s11883-000-0082-4; Schmidt AM, 2000, TRENDS ENDOCRIN MET, V11, P368, DOI 10.1016/S1043-2760(00)00311-8; SCHMIDT AM, 1995, J CLIN INVEST, V96, P1395, DOI 10.1172/JCI118175; Schmidt AM, 2000, BBA-MOL CELL RES, V1498, P99, DOI 10.1016/S0167-4889(00)00087-2; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI14002; Schmidt AM, 1999, CIRC RES, V84, P489, DOI 10.1161/01.RES.84.5.489; Schmidt AM, 1996, DIABETES, V45, pS77, DOI 10.2337/diab.45.3.S77; Schneider R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3118jc3; Shang LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010092; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sosenko JM, 2008, DIABETES CARE, V31, P2188, DOI 10.2337/dc08-0935; Taguchi A, 2000, NATURE, V405, P354, DOI 10.1038/35012626; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Wang YJ, 2010, J IMMUNOL, V185, P1822, DOI 10.4049/jimmunol.0903398; Wautier JL, 1996, J CLIN INVEST, V97, P238, DOI 10.1172/JCI118397; Xanthis A, 2009, ANGIOLOGY, V60, P772, DOI 10.1177/0003319708328569; Yan SD, 2000, NAT MED, V6, P643, DOI 10.1038/76216; Yan SD, 1997, P NATL ACAD SCI USA, V94, P5296, DOI 10.1073/pnas.94.10.5296; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D; Yan SF, 2010, CIRC RES, V106, P842, DOI 10.1161/CIRCRESAHA.109.212217; Yan Shi-Fang, 2004, Diab Vasc Dis Res, V1, P10, DOI 10.3132/dvdr.2004.001; Yeh CH, 2001, DIABETES, V50, P1495, DOI 10.2337/diabetes.50.6.1495; Zoukourian C, 1996, INT ANGIOL, V15, P195	70	69	73	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34698	10.1371/journal.pone.0034698	http://dx.doi.org/10.1371/journal.pone.0034698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509345	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336600049
J	Tiemann, L; Schulz, E; Winkelmann, A; Ronel, J; Henningsen, P; Ploner, M				Tiemann, Laura; Schulz, Enrico; Winkelmann, Andreas; Ronel, Joram; Henningsen, Peter; Ploner, Markus			Behavioral and Neuronal Investigations of Hypervigilance in Patients with Fibromyalgia Syndrome	PLOS ONE			English	Article							GAMMA-BAND ACTIVITY; GENERALIZED HYPERVIGILANCE; CHRONIC PAIN; CENTRAL SENSITIZATION; HEALTHY CONTROLS; WIDESPREAD PAIN; REACTION-TIMES; ATTENTION; INTENSITY; BRAIN	Painful stimuli are of utmost behavioral relevance and thereby affect attentional resources. In health, variable effects of pain on attention have been observed, indicating alerting as well as distracting effects of pain. In the human brain, these effects are closely related to modulations of neuronal gamma oscillations. As hypervigilance as an abnormal increase of attention to external stimuli has been implicated in chronic pain states, we assumed both attentional performance and pain-induced gamma oscillations to be altered in patients with fibromyalgia syndrome (FMS). We recorded electroencephalography from healthy subjects (n = 22) and patients with FMS (n = 19) during an attention demanding visual reaction time task. In 50% of the trials we applied painful laser stimuli. The results of self-assessment questionnaires confirm that patients with FMS consider themselves hypervigilant towards pain as compared to healthy controls. However, the experimental findings indicate that the effects of painful stimuli on attentional performance and neuronal gamma oscillations do not differ between patients and healthy subjects. We further found a significant correlation between the pain-induced modulation of visual gamma oscillations and the pain-induced modulation of reaction times. This relationship did not differ between groups either. These findings confirm a close relationship between gamma oscillations and the variable attentional effects of pain, which appear to be comparable in health and disease. Thus, our results do not provide evidence for a behavioral or neuronal manifestation of hypervigilance in patients with FMS.	[Tiemann, Laura; Schulz, Enrico; Ploner, Markus] Tech Univ Munich, Dept Neurol, Munich, Germany; [Winkelmann, Andreas] Klinikum Univ Munchen, Dept Phys Med & Rehabil, Munich, Germany; [Ronel, Joram; Henningsen, Peter] Tech Univ Munich, Dept Psychosomat Med & Psychotherapy, Munich, Germany	Technical University of Munich; University of Munich; Technical University of Munich	Tiemann, L (corresponding author), Tech Univ Munich, Dept Neurol, Munich, Germany.	tiemann@lrz.tu-muenchen.de	Schulz, Enrico/AAM-3590-2020; Ploner, Markus/C-3281-2013	Schulz, Enrico/0000-0001-8188-380X; Ploner, Markus/0000-0002-7767-7170; Tiemann, Laura/0000-0002-5261-5459	Studienstiftung des deutschen Volkes; EFIC [European Federation of IASP(R) (International Association for the Study of Pain) Chapters]; Deutsche ForschungsgemeinschaftResearch (Research Training Group) [1373/PL 321/6-1]	Studienstiftung des deutschen Volkes; EFIC [European Federation of IASP(R) (International Association for the Study of Pain) Chapters]; Deutsche ForschungsgemeinschaftResearch (Research Training Group)	This study was supported by the Studienstiftung des deutschen Volkes (www.studienstiftung.de), by an EFIC [European Federation of IASP (R) (International Association for the Study of Pain) Chapters]-Grunenthal Grant (www.grunenthal.com) and by the Deutsche Forschungsgemeinschaft (www.dfg.de; Research Training Group 1373/PL 321/6-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andino SLG, 2005, HUM BRAIN MAPP, V24, P50, DOI 10.1002/hbm.20056; Asmundson GJG, 2005, J PAIN, V6, P497, DOI 10.1016/j.jpain.2005.02.012; Babiloni C, 2004, BEHAV BRAIN RES, V152, P137, DOI 10.1016/j.bbr.2003.10.004; Bauer M, 2009, VISION RES, V49, P931, DOI 10.1016/j.visres.2009.03.014; Bingel U, 2007, NEURON, V55, P157, DOI 10.1016/j.neuron.2007.05.032; Buhle J, 2010, PAIN, V149, P19, DOI 10.1016/j.pain.2009.10.027; CAMPBELL JN, 1983, BRAIN RES, V266, P203, DOI 10.1016/0006-8993(83)90650-9; Carrillo-de-la-Pena MT, 2006, J PAIN, V7, P480, DOI 10.1016/j.jpain.2006.01.452; Crombez G, 2005, PAIN, V116, P4, DOI 10.1016/j.pain.2005.03.035; Crombez G, 1998, BEHAV RES THER, V36, P195, DOI 10.1016/S0005-7967(97)10008-0; Crombez G, 2004, CLIN J PAIN, V20, P98, DOI 10.1097/00002508-200403000-00006; Crombez G, 1997, PAIN, V70, P149, DOI 10.1016/S0304-3959(96)03304-0; Crombez G, 1996, BEHAV RES THER, V34, P911, DOI 10.1016/S0005-7967(96)00058-7; Desmeules JA, 2003, ARTHRITIS RHEUM-US, V48, P1420, DOI 10.1002/art.10893; Dohrenbusch R, 2001, SCHMERZ, V15, P38, DOI 10.1007/s004820170047; Dohrenbusch R, 1997, Z RHEUMATOL, V56, P334, DOI 10.1007/s003930050047; Eccleston C, 1999, PSYCHOL BULL, V125, P356, DOI 10.1037/0033-2909.125.3.356; ECCLESTON C, 1994, BRIT J CLIN PSYCHOL, V33, P535, DOI 10.1111/j.2044-8260.1994.tb01150.x; Eccleston C, 1997, PAIN, V72, P209, DOI 10.1016/S0304-3959(97)00030-4; Fisher R. A., 1921, METRON             4, V1, P3, DOI DOI 10.1093/BIOMET/9.1-2.22; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Frund I, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-27; Geisser ME, 2008, J PAIN, V9, P417, DOI 10.1016/j.jpain.2007.12.006; GIBSON SJ, 1994, PAIN, V58, P185, DOI 10.1016/0304-3959(94)90198-8; GRANGES G, 1993, ARTHRITIS RHEUM, V36, P642, DOI 10.1002/art.1780360510; Hauck M, 2007, J NEUROSCI, V27, P9270, DOI 10.1523/JNEUROSCI.2283-07.2007; Hollins M, 2009, PAIN, V141, P215, DOI 10.1016/j.pain.2008.10.003; Hoogenboom N, 2006, NEUROIMAGE, V29, P764, DOI 10.1016/j.neuroimage.2005.08.043; Hurtig IM, 2001, CLIN J PAIN, V17, P316, DOI 10.1097/00002508-200112000-00005; Iacoboni M, 2000, NEUROPSYCHOLOGIA, V38, P535, DOI 10.1016/S0028-3932(99)00121-9; Jensen O, 2007, TRENDS NEUROSCI, V30, P317, DOI 10.1016/j.tins.2007.05.001; Julien N, 2005, PAIN, V114, P295, DOI 10.1016/j.pain.2004.12.032; Kakigi R, 2005, CLIN NEUROPHYSIOL, V116, P743, DOI 10.1016/j.clinph.2004.11.016; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Klauenberg S, 2008, PAIN, V140, P332, DOI 10.1016/j.pain.2008.09.003; Kosek E, 1996, PAIN, V68, P375, DOI 10.1016/S0304-3959(96)03188-0; Lautenbacher S, 1997, CLIN J PAIN, V13, P189, DOI 10.1097/00002508-199709000-00003; LAUTENBACHER S, 1994, PAIN, V59, P45, DOI 10.1016/0304-3959(94)90046-9; Legrain V, 2009, PAIN, V144, P230, DOI 10.1016/j.pain.2009.03.020; McCracken LM, 1997, BEHAV THER, V28, P271, DOI 10.1016/S0005-7894(97)80047-0; McDermid AJ, 1996, PAIN, V66, P133, DOI 10.1016/0304-3959(96)03059-X; Peiris MTR, 2005, P ANN INT IEEE EMBS, P5735, DOI 10.1109/IEMBS.2005.1615790; Peters ML, 2000, PAIN, V86, P283, DOI 10.1016/S0304-3959(00)00259-1; Petrovic P, 2000, PAIN, V85, P19, DOI 10.1016/S0304-3959(99)00232-8; Petzke F, 2003, PAIN, V105, P403, DOI 10.1016/S0304-3959(03)00204-5; Ploner M, 2006, CEREB CORTEX, V16, P537, DOI 10.1093/cercor/bhj001; Ploner M, 2004, J NEUROPHYSIOL, V92, P1825, DOI 10.1152/jn.00260.2004; Seminowicz DA, 2004, PAIN, V112, P48, DOI 10.1016/j.pain.2004.07.027; Seminowicz DA, 2007, PAIN, V130, P8, DOI 10.1016/j.pain.2007.03.036; Seminowicz DA, 2007, CEREB CORTEX, V17, P1412, DOI 10.1093/cercor/bhl052; Smith BW, 2008, PAIN, V140, P420, DOI 10.1016/j.pain.2008.09.018; SMYTHE H, 1986, AM J MED, V81, P90, DOI 10.1016/0002-9343(86)90884-3; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Sullivan MJL, 2001, PAIN, V91, P147, DOI 10.1016/S0304-3959(00)00430-9; Tiemann L, 2010, PAIN, V150, P302, DOI 10.1016/j.pain.2010.05.014; Van Damme S, 2010, NEUROSCI BIOBEHAV R, V34, P204, DOI 10.1016/j.neubiorev.2009.01.005; Veldhuijzen DS, 2006, J PAIN, V7, P11, DOI 10.1016/j.jpain.2005.06.003; WOLFE F, 1990, ARTHRITIS RHEUM-US, V33, P160, DOI 10.1002/art.1780330203; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258; Woolf CJ, 2011, PAIN, V152, pS2, DOI 10.1016/j.pain.2010.09.030	60	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35068	10.1371/journal.pone.0035068	http://dx.doi.org/10.1371/journal.pone.0035068			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509383	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336600079
J	Chan, AHY; Tan, HC; Chow, AY; Lim, APC; Lok, SM; Moreland, NJ; Vasudevan, SG; MacAry, PA; Ooi, EE; Hanson, BJ				Chan, Annie Hoi Yi; Tan, Hwee Cheng; Chow, Angelia Yee; Lim, Angeline Pei Chiew; Lok, Shee Mei; Moreland, Nicole J.; Vasudevan, Subhash G.; MacAry, Paul A.; Ooi, Eng Eong; Hanson, Brendon J.			A Human PrM Antibody That Recognizes a Novel Cryptic Epitope on Dengue E Glycoprotein	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; MONOCLONAL-ANTIBODY; IMMUNE-RESPONSE; PROTEIN; INFECTION; IDENTIFICATION; VACCINE; ENHANCEMENT; PEPTIDES	Dengue virus (DENV) is a major mosquito-borne pathogen infecting up to 100 million people each year; so far no effective treatment or vaccines are available. Recently, highly cross-reactive and infection-enhancing pre-membrane (prM)-specific antibodies were found to dominate the anti-DENV immune response in humans, raising concern over vaccine candidates that contain native dengue prM sequences. In this study, we have isolated a broadly cross-reactive prM-specific antibody, D29, during a screen with a non-immunized human Fab-phage library against the four serotypes of DENV. The antibody is capable of restoring the infectivity of virtually non-infectious immature DENV (imDENV) in FccR-bearing K562 cells. Remarkably, D29 also cross-reacted with a cryptic epitope on the envelope (E) protein located to the DI/DII junction as evidenced by site-directed mutagenesis. This cryptic epitope, while inaccessible to antibody binding in a native virus particle, may become exposed if E is not properly folded. These findings suggest that generation of anti-prM antibodies that enhance DENV infection may not be completely avoided even with immunization strategies employing E protein alone or subunits of E proteins.	[Chan, Annie Hoi Yi; Lim, Angeline Pei Chiew; Ooi, Eng Eong; Hanson, Brendon J.] DSO Natl Labs, DMERI, Biodef Programme, Singapore, Singapore; [Chan, Annie Hoi Yi; MacAry, Paul A.; Ooi, Eng Eong; Hanson, Brendon J.] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore; [Tan, Hwee Cheng; Chow, Angelia Yee; Lok, Shee Mei; Moreland, Nicole J.; Vasudevan, Subhash G.; Ooi, Eng Eong] Duke NUS Grad Med Sch, Emerging Infect Dis Programme, Singapore, Singapore; [Lok, Shee Mei] Natl Univ Singapore, Ctr BioImaging Sci, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Chan, AHY (corresponding author), DSO Natl Labs, DMERI, Biodef Programme, Singapore, Singapore.	engeong.ooi@duke-nus.edu.sg; hbrendon@dso.org.sg	Lok, Shee-mei/I-7050-2012	Lok, Shee-Mei/0000-0003-4631-8041; Moreland, Nicole/0000-0001-6548-637X; MacAry, Paul/0000-0002-1139-8996; Vasudevan, Subhash/0000-0002-5083-3831; Ooi, Eng Eong/0000-0002-0520-1544	Defense Research and Technology Office, Ministry of Defense, Singapore; National Medical Research Council of Singapore	Defense Research and Technology Office, Ministry of Defense, Singapore; National Medical Research Council of Singapore(National Medical Research Council, Singapore)	Defense Research and Technology Office, Ministry of Defense, Singapore and National Medical Research Council of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balakrishnan T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029430; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Chambers TJ, 1997, VACCINE, V15, P1494, DOI 10.1016/S0264-410X(97)00195-3; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Durbin AP, 2010, CURR TOP MICROBIOL, V338, P129, DOI 10.1007/978-3-642-02215-9_10; Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0; Falconar AKI, 1999, ARCH VIROL, V144, P2313, DOI 10.1007/s007050050646; Freund Natalia Tarnovitski, 2009, Curr Protoc Immunol, VChapter 9, DOI 10.1002/0471142735.im0908s86; Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104; Gromowski GD, 2007, VIROLOGY, V366, P349, DOI 10.1016/j.virol.2007.05.042; Guy B, 2011, LANCET, V377, P381, DOI 10.1016/S0140-6736(11)60128-1; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Hanson BJ, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-126; Hiramatsu K, 1996, VIROLOGY, V224, P437, DOI 10.1006/viro.1996.0550; KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444; Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08; Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06; Lin M, 2010, J GEN VIROL, V91, P2928, DOI 10.1099/vir.0.023259-0; Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002; Menendez A, 2005, ANAL BIOCHEM, V336, P145, DOI 10.1016/j.ab.2004.09.048; Moreland NJ, PLOS NEGL TROP DIS, V4, pe881; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161; Putnak JR, 2008, AM J TROP MED HYG, V79, P115, DOI 10.4269/ajtmh.2008.79.115; Puttikhunt C, 2008, J MED VIROL, V80, P125, DOI 10.1002/jmv.21047; Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718; SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30; Thullier P, 2001, J GEN VIROL, V82, P1885, DOI 10.1099/0022-1317-82-8-1885; Tripp RA, 2005, J VIROL METHODS, V128, P21, DOI 10.1016/j.jviromet.2005.03.021; Vazquez S, 2002, VACCINE, V20, P1823, DOI 10.1016/S0264-410X(01)00515-1; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; World Health Organization, 2009, VECT BORN VIR INF DE; Wu HC, 2001, J CLIN MICROBIOL, V39, P977, DOI 10.1128/JCM.39.3.977-982.2001; Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09; Zheng A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001157; Zheng L, 2008, BIOCHEM BIOPH RES CO, V375, P619, DOI 10.1016/j.bbrc.2008.08.055	37	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e33451	10.1371/journal.pone.0033451	http://dx.doi.org/10.1371/journal.pone.0033451			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509258	Green Published, gold, Green Submitted			2022-12-27	WOS:000304805900007
J	Ginter, CC; DeWitt, TJ; Fish, FE; Marshall, CD				Ginter, Carly C.; DeWitt, Thomas J.; Fish, Frank E.; Marshall, Christopher D.			Fused Traditional and Geometric Morphometrics Demonstrate Pinniped Whisker Diversity	PLOS ONE			English	Article							SEALS PHOCA-VITULINA; TRICHECHUS MANATUS LATIROSTRIS; LIGHT-MICROSCOPIC ANALYSIS; FOLLICLE-SINUS COMPLEX; MYSTACIAL PAD; PRINCIPAL COMPONENTS; SENSORY INNERVATION; HYDRODYNAMIC TRAILS; HALICHOERUS-GRYPUS; MARINE MAMMALS	Vibrissae (whiskers) are important components of the mammalian tactile sensory system, and primarily function as detectors of vibrotactile information from the environment. Pinnipeds possess the largest vibrissae among mammals and their vibrissal hair shafts demonstrate a diversity of shapes. The vibrissae of most phocid seals exhibit a beaded morphology with repeating sequences of crests and troughs along their length. However, there are few detailed analyses of pinniped vibrissal morphology, and these are limited to a few species. Therefore, we comparatively characterized differences in vibrissal hair shaft morphologies among phocid species with a beaded profile, phocid species with a smooth profile, and otariids with a smooth profile using traditional and geometric morphometric methods. Traditional morphometric measurements (peak-to-peak distance, crest width, trough width and total length) were collected using digital photographs. Elliptic Fourier analysis (geometric morphometrics) was used to quantify the outlines of whole vibrissae. The traditional and geometric morphometric datasets were subsequently combined by mathematically scaling each to true rank, followed by a single eigendecomposition. Quadratic discriminant function analysis demonstrated that 79.3, 97.8 and 100% of individuals could be correctly classified to their species based on vibrissal shape variables in the traditional, geometric and combined morphometric analyses, respectively. Phocids with beaded vibrissae, phocids with smooth vibrissae, and otariids each occupied distinct morphospace in the geometric morphometric and combined data analyses. Otariids split into two groups in the geometric morphometric analysis and gray seals appeared intermediate between beaded-and smooth-whiskered species in the traditional and combined analyses. Vibrissal hair shafts modulate the transduction of environmental stimuli to the mechanoreceptors in the follicle-sinus complex (F-SC), which results in vibrotactile reception, but it is currently unclear how the diversity of shapes affects environmental signal modulation.	[Ginter, Carly C.; DeWitt, Thomas J.; Marshall, Christopher D.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Fish, Frank E.] W Chester Univ, Dept Biol, W Chester, PA 19380 USA; [Marshall, Christopher D.] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA	Texas A&M University System; Texas A&M University College Station; Pennsylvania State System of Higher Education (PASSHE); West Chester University of Pennsylvania; Texas A&M University System	Ginter, CC (corresponding author), Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA.	ccginter@tamu.edu	Marshall, Christopher/AAF-9097-2019	DeWitt, Thomas/0000-0001-7405-3904	Department of Marine Biology, Texas AM University	Department of Marine Biology, Texas AM University	Funding was provided by the Department of Marine Biology, Texas A&M University (http://www.tamug.edu/marb/) to CCG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHL AS, 1986, VET RES COMMUN, V10, P245, DOI 10.1007/BF02213989; Bonner W. N., 1968, BRIT ANTARCTIC SURVE, V56, P1; Burgess PR, 1973, HDB SENSORY PHYSIOLO, VII, P29; Burns J.J., 1981, P145; CAMERON AW, 1967, CAN J ZOOLOG, V45, P161, DOI 10.1139/z67-023; DARROCH JN, 1985, BIOMETRIKA, V72, P241, DOI 10.2307/2336077; Dehnhardt G, 1998, NATURE, V394, P235, DOI 10.1038/28303; Dehnhardt G, 2001, SCIENCE, V293, P102, DOI 10.1126/science.1060514; DEHNHARDT G, 1995, J EXP BIOL, V198, P2317; Dehnhardt G, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P287; DYKES RW, 1975, J NEUROPHYSIOL, V38, P650, DOI 10.1152/jn.1975.38.3.650; Fay FH, 1982, N AM FAUNA, DOI DOI 10.3996/NAFA.74.0001; Ginter CC, 2010, MAR MAMMAL SCI, V26, P733, DOI 10.1111/j.1748-7692.2009.00365.x; Glaser N, 2011, J COMP PHYSIOL A, V197, P141, DOI 10.1007/s00359-010-0594-5; GOTTSCHALDT KM, 1973, J PHYSIOL-LONDON, V235, P287, DOI 10.1113/jphysiol.1973.sp010388; Greaves DK, 2004, MAR MAMMAL SCI, V20, P296, DOI 10.1111/j.1748-7692.2004.tb01158.x; Halata Z, 1975, Adv Anat Embryol Cell Biol, V50, P3; Hanke FD, 2011, J COMP PHYSIOL A, V197, P203, DOI 10.1007/s00359-010-0600-y; Hanke W, 2010, J EXP BIOL, V213, P2665, DOI 10.1242/jeb.043216; Hirons AC, 2001, CAN J ZOOL, V79, P1053, DOI 10.1139/z01-055; HYVARINEN H, 1989, J ZOOL, V218, P663, DOI 10.1111/j.1469-7998.1989.tb05008.x; Hyvarinen H., 1984, ACTA ZOOL FENN, V171, P17; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; King JE., 1983, SEALS WORLD BRIT MUS; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; LING J. K., 1966, AUSTRALIAN J ZOOL, V14, P855, DOI 10.1071/ZO9660855; Ling J. K., 1977, P387; Marshall CD, 1998, MAR MAMMAL SCI, V14, P274, DOI 10.1111/j.1748-7692.1998.tb00716.x; Marshall CD, 2006, ANAT REC PART A, V288A, P13, DOI 10.1002/ar.a.20273; Marshall CD, 2003, J ZOOL, V259, P245, DOI 10.1017/S0952836902003205; MILLER EH, 1979, CAN J ZOOL, V57, P140, DOI 10.1139/z79-011; Mutanen M, 2007, SYST ENTOMOL, V32, P371, DOI 10.1111/j.1365-3113.2006.00372.x; Newby T. C, 1970, J. Mammal., V51, P152, DOI 10.2307/1378544; Ognev SK, 1962, MAMMALS USSR ADJACEN, VIII; Parsons KJ, 2003, ENVIRON BIOL FISH, V67, P417, DOI 10.1023/A:1025895317253; Pauly D, 1998, ICES J MAR SCI, V55, P467, DOI 10.1006/jmsc.1997.0280; Pavlicev M, 2009, EVOL BIOL, V36, P339, DOI 10.1007/s11692-009-9066-7; Reep RL, 1998, MAR MAMMAL SCI, V14, P257, DOI 10.1111/j.1748-7692.1998.tb00715.x; RICE FL, 1986, J COMP NEUROL, V252, P154, DOI 10.1002/cne.902520203; Rice FL, 1997, J COMP NEUROL, V385, P149; RICE FL, 1986, J COMP NEUROL, V252, P186, DOI 10.1002/cne.902520205; Rohlf F.J., 2004, TPSDIG2; ROHLF FJ, 1993, EFAWIN; SCHEFFER VB, 1962, N AM FAUNA, V64, P1, DOI DOI 10.3996/NAFA.64.0001; Scheiner S., 2001, DESIGN ANAL ECOLOGIC; Schulte-Pelkum N, 2007, J EXP BIOL, V210, P781, DOI 10.1242/jeb.02708; WARTZOK D, 1992, CAN J ZOOL, V70, P1712, DOI 10.1139/z92-238; WATKINS WA, 1985, MAR MAMMAL SCI, V1, P219, DOI 10.1111/j.1748-7692.1985.tb00011.x; Wieskotten S, 2010, J EXP BIOL, V213, P3734, DOI 10.1242/jeb.047134; Wieskotten S, 2010, J EXP BIOL, V213, P2194, DOI 10.1242/jeb.041699; Wieskotten S, 2011, J EXP BIOL, V214, P1922, DOI 10.1242/jeb.053926	52	58	58	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34481	10.1371/journal.pone.0034481	http://dx.doi.org/10.1371/journal.pone.0034481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509310	Green Published, Green Submitted, gold			2022-12-27	WOS:000304805900038
J	Sali, A; Guerron, AD; Gordish-Dressman, H; Spurney, CF; Iantorno, M; Hoffman, EP; Nagaraju, K				Sali, Arpana; Guerron, Alfredo D.; Gordish-Dressman, Heather; Spurney, Christopher F.; Iantorno, Micaela; Hoffman, Eric P.; Nagaraju, Kanneboyina			Glucocorticoid-Treated Mice Are an Inappropriate Positive Control for Long-Term Preclinical Studies in the mdx Mouse	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; DEFLAZACORT TREATMENT; DEFICIENT CARDIOMYOPATHY; PREDNISONE; STRENGTH; THERAPY; DIAPHRAGM; FIBROSIS; MUSCLE; MODEL	Background: Dmd(mdx) (mdx) mice are used as a genetic and biochemical model of dystrophin deficiency. The long-term consequences of glucocorticoid (GC) treatment on dystrophin-deficient skeletal and heart muscle are not yet known. Here we used systematic phenotyping to assess the long-term consequences of GC treatment in mdx mice. Our investigation addressed not only the effects of GC on the disease phenotype but also the question of whether GCs can be used as a positive control for preclinical drug evaluations. Methods and Findings: We performed nine pre-clinical efficacy trials (treated N = 129, untreated N = 106) of different durations in 9-to-50-week-old dystrophic mdx mice over a 3-year time period using standardized methods. In all these trials, we used either 1 mg/kg body weight of prednisone or 5 mg/kg body weight of prednisolone as positive controls to compare the efficacy of various test drugs. Data from untreated controls and GC-treated mice in the various trials have been pooled and analyzed to assess the effects of GCs on dystrophin-deficient skeletal and cardiac muscles of mdx mice. Our results indicate that continuous GC treatment results in early (e.g., at 50 days) improvements in normalized parameters such as grip strength, motor coordination and maximal in vitro force contractions on isolated EDL muscle, but these initial benefits are followed by a progressive loss of muscle strength after 100 days. We also found a significant increase in heart fibrosis that is reflected in a significant deterioration in cardiac systolic function after 100 days of treatment. Conclusion: Continuous administration of prednisone to mdx mice initially improves skeletal muscle strength, but further therapy result in deterioration of muscle strength and cardiac function associated with enhanced cardiac fibrosis. These results suggest that GCs may not serve as an appropriate positive control for long-term mdx mouse preclinical trials.	[Sali, Arpana; Guerron, Alfredo D.; Gordish-Dressman, Heather; Iantorno, Micaela; Hoffman, Eric P.; Nagaraju, Kanneboyina] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Hoffman, Eric P.; Nagaraju, Kanneboyina] George Washington Univ, Sch Med & Hlth Sci, Dept Integrat Syst Biol, Washington, DC 20052 USA; [Spurney, Christopher F.] Childrens Natl Med Ctr, Div Cardiol, Washington, DC 20010 USA	Children's National Health System; George Washington University; Children's National Health System	Sali, A (corresponding author), Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA.	knagaraju@cnmcresearch.org	Cruz, Alfredo Daniel Guerron/V-5188-2019; Nagaraju, Kanneboyina/AAV-7684-2021; Nagaraju, Kanneboyina/ABA-6525-2021	Cruz, Alfredo Daniel Guerron/0000-0002-4632-1681; Hoffman, Eric/0000-0001-6470-5139	Department of Defense USAMRAA [W81XWH-05-1-0616]; Foundation to Eradicate Duchenne, Inc.; National Institutes of Health [R01-AR050478, 1U54HD053177-01A1]; National Center for Medical Rehabilitation Research/National Institute for Neurological Disorders and Stroke [2R24HD050846-06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050846] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U54HD053177] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR032082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050478] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD011171] Funding Source: NIH RePORTER	Department of Defense USAMRAA(United States Department of Defense); Foundation to Eradicate Duchenne, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Medical Rehabilitation Research/National Institute for Neurological Disorders and Stroke; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding to KN in part by the Department of Defense USAMRAA grant W81XWH-05-1-0616 (Mouse Drug Screening Core), the Foundation to Eradicate Duchenne, Inc., and National Institutes of Health grants R01-AR050478 (KN), and 1U54HD053177-01A1 (Wellstone Muscular Dystrophy Center, EPH). This work was also partially supported by the National Institutes of Health; National Center for Medical Rehabilitation Research/National Institute for Neurological Disorders and Stroke 2R24HD050846-06 (Integrated Molecular Core for Rehabilitation Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban B, 2005, AM J PHYS MED REHAB, V84, P843, DOI 10.1097/01.phm.0000184156.98671.d0; Bauer R, 2008, CARDIOVASC RES, V79, P652, DOI 10.1093/cvr/cvn131; Bauer R, 2009, EUR J HEART FAIL, V11, P463, DOI 10.1093/eurjhf/hfp028; Biggar WD, 2006, NEUROMUSCULAR DISORD, V16, P249, DOI 10.1016/j.nmd.2006.01.010; Biggar WD, 2001, J PEDIATR-US, V138, P45, DOI 10.1067/mpd.2001.109601; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; DESILVA S, 1987, ARCH NEUROL-CHICAGO, V44, P818, DOI 10.1001/archneur.1987.00520200022012; Freishtat RJ, 2010, J INVEST MED, V58, P19, DOI 10.2310/JIM.0b013e3181b91654; Frosk P, 2004, NEUROMUSCULAR DISORD, V14, P579; Golumbek PT, 2007, NEUROMUSCULAR DISORD, V17, P376, DOI 10.1016/j.nmd.2007.02.005; Granchelli JA, 2000, NEUROMUSCULAR DISORD, V10, P235, DOI 10.1016/S0960-8966(99)00126-1; GRIGGS RC, 1993, NEUROLOGY, V43, P520, DOI 10.1212/WNL.43.3_Part_1.520; Guerron AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011220; Hartel JV, 2001, MUSCLE NERVE, V24, P428, DOI 10.1002/1097-4598(200103)24:3<428::AID-MUS1018>3.3.CO;2-5; Houde S, 2008, PEDIATR NEUROL, V38, P200, DOI 10.1016/j.pediatrneurol.2007.11.001; HUDECKI MS, 1993, RES COMMUN CHEM PATH, V79, P45; Keeling RM, 2007, MUSCLE NERVE, V35, P43, DOI 10.1002/mus.20646; LEFAUCHEUR JP, 1995, ANAT REC, V242, P70, DOI 10.1002/ar.1092420109; Manzur AY, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003725.pub3; Markham LW, 2005, PEDIATR CARDIOL, V26, P768, DOI 10.1007/s00246-005-0909-4; Marques MJ, 2009, MUSCLE NERVE, V40, P466, DOI 10.1002/mus.21341; Rotundo IL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024729; Silversides CK, 2003, AM J CARDIOL, V91, P769, DOI 10.1016/S0002-9149(02)03429-X; Skrabek RQ, 2001, MUSCLE NERVE, V24, P192, DOI 10.1002/1097-4598(200102)24:2<192::AID-MUS40>3.0.CO;2-S; Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008; Spurney CF, 2009, MUSCLE NERVE, V39, P591, DOI 10.1002/mus.21211; WELLER B, 1991, MUSCLE NERVE, V14, P771, DOI 10.1002/mus.880140812; Wong BLY, 2002, J CHILD NEUROL, V17, P183, DOI 10.1177/088307380201700306; Yang LY, 1998, MUSCLE NERVE, V21, P394, DOI 10.1002/(SICI)1097-4598(199803)21:3<394::AID-MUS14>3.0.CO;2-#	29	47	48	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34204	10.1371/journal.pone.0034204	http://dx.doi.org/10.1371/journal.pone.0034204			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509280	gold, Green Published, Green Submitted			2022-12-27	WOS:000304805900018
J	Lau, BWM; Lee, JCD; Li, Y; Fung, SMY; Sang, YH; Shen, JG; Chang, RCC; So, KF				Lau, Benson Wui-Man; Lee, Jada Chia-Di; Li, Yue; Fung, Sophia Man-Yuk; Sang, Yan-Hua; Shen, Jiangang; Chang, Raymond Chuen-Chung; So, Kwok-Fai			Polysaccharides from Wolfberry Prevents Corticosterone-Induced Inhibition of Sexual Behavior and Increases Neurogenesis	PLOS ONE			English	Article							LYCIUM-BARBARUM POLYSACCHARIDES; RETINAL GANGLION-CELLS; POSTNATAL NEUROGENESIS; INDUCED DAMAGE; EXPOSURE; PROLIFERATION; MEDICINE; BRAIN	Lycium barbarum, commonly known as wolfberry, has been used as a traditional Chinese medicine for the treatment of infertility and sexual dysfunction. However, there is still a scarcity of experimental evidence to support the pro-sexual effect of wolfberry. The aim of this study is to determine the effect of Lycium barbarum polysaccharides (LBP) on male sexual behavior of rats. Here we report that oral feeding of LBP for 21 days significantly improved the male copulatory performance including increase of copulatory efficiency, increase of ejaculation frequency and shortening of ejaculation latency. Furthermore, sexual inhibition caused by chronic corticosterone was prevented by LBP. Simultaneously, corticosterone suppressed neurogenesis in subventricular zone and hippocampus in adult rats, which could be reversed by LBP. The neurogenic effect of LBP was also shown in vitro. Significant correlation was found between neurogenesis and sexual performance, suggesting that the newborn neurons are associated with reproductive successfulness. Blocking neurogenesis in male rats abolished the pro-sexual effect of LBP. Taken together, these results demonstrate the pro-sexual effect of LBP on normal and sexually-inhibited rats, and LBP may modulate sexual behavior by regulating neurogenesis.	[Lau, Benson Wui-Man; Lee, Jada Chia-Di; Fung, Sophia Man-Yuk; Sang, Yan-Hua; Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China; [Lau, Benson Wui-Man; Lee, Jada Chia-Di; Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Pokfulam, Hong Kong, Peoples R China; [Lau, Benson Wui-Man; Lee, Jada Chia-Di; Li, Yue; Shen, Jiangang; Chang, Raymond Chuen-Chung; So, Kwok-Fai] Univ Hong Kong, Fac Med, Res Ctr Heart Brain Hormone & Hth Aging, Pokfulam, Hong Kong, Peoples R China; [Li, Yue; Shen, Jiangang] Univ Hong Kong, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Chang, Raymond Chuen-Chung] Univ Hong Kong, LKS Fac Med, Dept Anat, Lab Neurodegenerat Dis, Pokfulam, Hong Kong, Peoples R China; [So, Kwok-Fai] Univ Hong Kong, Guangzhou, Guangdong, Peoples R China; [So, Kwok-Fai] Jinan Univ, Joint Lab Brain Funct & Hlth BFAH, Guangzhou, Guangdong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Jinan University	Lau, BWM (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Pokfulam, Hong Kong, Peoples R China.	hrmaskf@hkucc.hku.hk	Li, Kevin/AAX-1664-2020; Chang, Raymond Chuen-Chung/C-1107-2009	Li, Kevin/0000-0001-8198-9911; Chang, Raymond Chuen-Chung/0000-0001-8538-7993; LAU, Wui Man/0000-0002-4552-2780; So, Kwok-Fai/0000-0003-4039-4246	Azalea Endowment Fund; University of Hong Kong Alzheimer's Disease Research Network under Strategic Research Theme on Healthy Aging; Fundamental Research Funds for the Central Universities [09ykpy25, 09ykpy31]	Azalea Endowment Fund; University of Hong Kong Alzheimer's Disease Research Network under Strategic Research Theme on Healthy Aging; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the Azalea (1972) Endowment Fund, the University of Hong Kong Alzheimer's Disease Research Network under Strategic Research Theme on Healthy Aging and the Fundamental Research Funds for the Central Universities, no. 09ykpy25, 09ykpy31. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Amagase H, 2009, NUTR RES, V29, P19, DOI 10.1016/j.nutres.2008.11.005; Amstislavskaya TG, 2010, PHARMACOL BIOCHEM BE, V96, P211, DOI 10.1016/j.pbb.2010.05.007; Chan HC, 2007, EXP NEUROL, V203, P269, DOI 10.1016/j.expneurol.2006.05.031; Chang RCC, 2008, CELL MOL NEUROBIOL, V28, P643, DOI 10.1007/s10571-007-9181-x; Chen LP, 2011, NEURAL REGEN RES, V6, P1618, DOI 10.3969/j.issn.1673-5374.2011.21.003; Chen X, 2010, NEUROSCIENCE, V165, P705, DOI 10.1016/j.neuroscience.2009.11.007; Chiu K, 2010, J CELL BIOCHEM, V110, P311, DOI 10.1002/jcb.22539; DAS GD, 1971, BRAIN RES, V30, P323, DOI 10.1016/0006-8993(71)90082-5; DAS GD, 1970, BRAIN RES, V21, P122, DOI 10.1016/0006-8993(70)90026-0; Deng HB, 2003, BIOMED ENVIRON SCI, V16, P267; EVERITT BJ, 1990, NEUROSCI BIOBEHAV R, V14, P217, DOI 10.1016/S0149-7634(05)80222-2; Gan L, 2003, EUR J PHARMACOL, V471, P217, DOI 10.1016/S0014-2999(03)01827-2; Gheusi G, 2009, BEHAV BRAIN RES, V200, P315, DOI 10.1016/j.bbr.2009.02.006; Hawken PAR, 2009, BIOL REPROD, V80, P1146, DOI 10.1095/biolreprod.108.075341; Ho YS, 2007, BRAIN RES, V1158, P123, DOI 10.1016/j.brainres.2007.04.075; Ho YS, 2010, AGEING RES REV, V9, P354, DOI 10.1016/j.arr.2009.10.001; Ho YS, 2009, CELL MOL NEUROBIOL, V29, P1233, DOI 10.1007/s10571-009-9419-x; Huang LY, 2002, HORM BEHAV, V41, P343, DOI 10.1006/hbeh.2002.1767; Lau BWM, 2009, NEUROREPORT, V20, P371, DOI 10.1097/WNR.0b013e328324edcd; Lau BWM, 2011, J SEX MED, V8, P1390, DOI 10.1111/j.1743-6109.2010.02081.x; Lau BWM, 2011, CELL TRANSPLANT, V20, P21, DOI 10.3727/096368910X532765; Lau BW, 2010, CELL TRANSPLANT; Lee SH, 2011, NEURAL REGEN RES, V6, P2085, DOI 10.3969/j.issn.1673-5374.2011.27.001; Leuner B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011597; Li M, 2011, CHEMBIOCHEM, V12, P449, DOI 10.1002/cbic.201000570; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Luo Q, 2006, LIFE SCI, V79, P613, DOI 10.1016/j.lfs.2006.02.012; Luo Q, 2011, PHYTOTHER RES, V25, P694, DOI 10.1002/ptr.3314; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Niu AJ, 2008, INT J BIOL MACROMOL, V42, P447, DOI 10.1016/j.ijbiomac.2008.02.003; Slotnick B, 2001, TRENDS COGN SCI, V5, P216, DOI 10.1016/S1364-6613(00)01625-9; Smith MT, 2001, HORM BEHAV, V39, P11, DOI 10.1006/hbeh.2000.1630; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Wang YR, 2002, J ETHNOPHARMACOL, V82, P169, DOI 10.1016/S0378-8741(02)00169-1; Wen Jing, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P295; Yau SY, 2011, NEURAL REGEN RES, V6, P2645, DOI 10.3969/j.issn.1673-5374.2011.34.001; Yu MS, 2005, EXP GERONTOL, V40, P716, DOI 10.1016/j.exger.2005.06.010	38	44	45	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e33374	10.1371/journal.pone.0033374	http://dx.doi.org/10.1371/journal.pone.0033374			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523540	Green Published, gold			2022-12-27	WOS:000305345000009
J	Estronca, LMBB; Silva, JCP; Sampaio, JL; Shevchenko, A; Verkade, P; Vaz, ADN; Vaz, WLC; Vieira, OV				Estronca, Luis M. B. B.; Silva, Joao C. P.; Sampaio, Julio L.; Shevchenko, Andrej; Verkade, Paul; Vaz, Alfin D. N.; Vaz, Winchil L. C.; Vieira, Otilia V.			Molecular Etiology of Atherogenesis - In Vitro Induction of Lipidosis in Macrophages with a New LDL Model	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; PEROXIDATION PRODUCTS; OXIDIZED LDL; CHOLESTEROL; ACCUMULATION; METABOLISM; COMPLEXES; BETA(2)-GLYCOPROTEIN-I; THERMODYNAMICS; ASSOCIATION	Background: Atherosclerosis starts by lipid accumulation in the arterial intima and progresses into a chronic vascular inflammatory disease. A major atherogenic process is the formation of lipid-loaded macrophages in which a breakdown of the endolysomal pathway results in irreversible accumulation of cargo in the late endocytic compartments with a phenotype similar to several forms of lipidosis. Macrophages exposed to oxidized LDL exihibit this phenomenon in vitro and manifest an impaired degradation of internalized lipids and enhanced inflammatory stimulation. Identification of the specific chemical component(s) causing this phenotype has been elusive because of the chemical complexity of oxidized LDL. Methodology/Principal Findings: Lipid "core aldehydes'' are formed in oxidized LDL and exist in atherosclerotic plaques. These aldehydes are slowly oxidized in situ and (much faster) by intracellular aldehyde oxidizing systems to cholesteryl hemiesters. We show that a single cholesteryl hemiester incorporated into native, non-oxidized LDL induces a lipidosis phenotype with subsequent cell death in macrophages. Internalization of the cholesteryl hemiester via the native LDL vehicle induced lipid accumulation in a time-and concentration-dependent manner in "frozen'' endolysosomes. Quantitative shotgun lipidomics analysis showed that internalized lipid in cholesteryl hemiester-intoxicated cells remained largely unprocessed in those lipid-rich organelles. Conclusions/Significance: The principle elucidated with the present cholesteryl hemiester-containing native-LDL model, extended to other molecular components of oxidized LDL, will help in defining the molecular etiology and etiological hierarchy of atherogenic agents.	[Estronca, Luis M. B. B.; Silva, Joao C. P.; Vieira, Otilia V.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Sampaio, Julio L.; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Verkade, Paul] Univ Bristol, Sch Biochem, Bristol, Avon, England; [Verkade, Paul] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Vaz, Alfin D. N.] Pfizer Global Res & Dev, Pharmacokinet Dynam & Metab, Groton, CT USA; [Vaz, Winchil L. C.] Univ Coimbra, Dept Chem, Coimbra, Portugal	Universidade de Coimbra; Max Planck Society; University of Bristol; University of Bristol; Pfizer; Universidade de Coimbra	Estronca, LMBB (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal.	vieira@cnc.cj.uc.pt	Vieira, O V/C-4860-2013; Verkade, Paul/N-7240-2014; Sampaio, Julio/S-3810-2019; Vaz, Winchil/N-4320-2013; Vieira, Otilia V/O-8660-2017	Verkade, Paul/0000-0002-2497-1026; Vaz, Winchil/0000-0002-3797-4330; Vieira, Otilia V/0000-0003-4924-1780; Estronca, Luis/0000-0001-8417-8313; Sampaio, Julio/0000-0002-2881-7827	Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education (FCT) [PTDC/SAU/MII/66285/2006, PTDC/BIA-BCM/112138/2009]; FCT [SFRH/BPD/26843/2006]; Deutsche Forschungsgemeinschaft [TRR 83]; Virtual Liver grant from the Bundesministerium fur Bildung und Forschung [0315757]	Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Virtual Liver grant from the Bundesministerium fur Bildung und Forschung	This work was supported by the Research grant PTDC/SAU/MII/66285/2006 and PTDC/BIA-BCM/112138/2009 from the Foundation for Science and Technology of the Portuguese Ministry of Science and Higher Education (FCT). LE is a holder of postdoctoral fellowships from the FCT (Ref.: SFRH/BPD/26843/2006). Lipidomics analysis performed in the AS laboratory was supported by a TRR 83 grant from the Deutsche Forschungsgemeinschaft and Virtual Liver grant (Code/0315757) from the Bundesministerium fur Bildung und Forschung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames P.R., 2010, BR J DIABETES VASC D, V10, P292, DOI [10.1177/1474651410388057, DOI 10.1177/1474651410388057]; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Berliner JA, 2009, J LIPID RES, V50, pS207, DOI 10.1194/jlr.R800074-JLR200; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; BROWN MS, 1979, J CELL BIOL, V82, P597, DOI 10.1083/jcb.82.3.597; Choi SH, 2009, CIRC RES, V104, P1355, DOI 10.1161/CIRCRESAHA.108.192880; de Duve C, 1974, Acta Cardiol, VSuppl 20, P9; Dhaliwal BS, 2000, J LIPID RES, V41, P1658; ESTERBAUER H, 1987, J LIPID RES, V28, P495; Estronca LMBB, 2005, BIOPHYS J, V88, P557, DOI 10.1529/biophysj.104.047050; Estronca LMBB, 2007, BIOPHYS J, V93, P4244, DOI 10.1529/biophysj.107.112847; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Greaves DR, 2009, J LIPID RES, V50, pS282, DOI 10.1194/jlr.R800066-JLR200; Greco TP, 2010, AM J CLIN PATHOL, V133, P737, DOI 10.1309/AJCP88WVRDRDFBAS; Guest CB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000511; Hartvigsen K, 2009, J LIPID RES, V50, pS388, DOI 10.1194/jlr.R800100-JLR200; Heinecke JW, 1997, CURR OPIN LIPIDOL, V8, P268, DOI 10.1097/00041433-199710000-00005; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; HOFF HF, 1978, BIOCHEM BIOPH RES CO, V85, P1424, DOI 10.1016/0006-291X(78)91162-2; Hoppe G, 1997, J LIPID RES, V38, P1347; Ishimaru C, 2007, BIOCHEM BIOPH RES CO, V354, P619, DOI 10.1016/j.bbrc.2007.01.034; Jessup W, 2004, BIOCHEM SOC T, V32, P134, DOI 10.1042/BST0320134; KAMIDO H, 1995, J LIPID RES, V36, P1876; KAMIDO H, 1993, LIPIDS, V28, P331, DOI 10.1007/BF02536319; Kellner-Weibel G, 1999, ARTERIOSCL THROM VAS, V19, P1891, DOI 10.1161/01.ATV.19.8.1891; Kobayashi K, 2003, J LIPID RES, V44, P716, DOI 10.1194/jlr.M200329-JLR200; Kobayashi K, 2001, J LIPID RES, V42, P697; Levitan I, 2010, ANTIOXID REDOX SIGN, V13, P39, DOI 10.1089/ars.2009.2733; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Sandhoff R, 1999, J LIPID RES, V40, P126; Schmitz G, 2009, BBA-MOL CELL BIOL L, V1791, P524, DOI 10.1016/j.bbalip.2008.12.007; Schwudke D, 2007, ANAL CHEM, V79, P4083, DOI 10.1021/ac062455y; Siems W, 2010, ARCH BIOCHEM BIOPHYS, V503, P248, DOI 10.1016/j.abb.2010.08.018; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; SMITH EB, 1983, BIOCHIM BIOPHYS ACTA, V754, P249, DOI 10.1016/0005-2760(83)90139-X; Spiteller G, 1998, CHEM PHYS LIPIDS, V95, P105, DOI 10.1016/S0009-3084(98)00091-7; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; Steinberg D, 2010, ARTERIOSCL THROM VAS, V30, P2311, DOI 10.1161/ATVBAHA.108.179697; Steinberg D, 2009, J LIPID RES, V50, pS376, DOI 10.1194/jlr.R800087-JLR200; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tabas I, 1999, ANNU REV NUTR, V19, P123, DOI 10.1146/annurev.nutr.19.1.123; Vieira OV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002913; Vieira OV, 1996, J LIPID RES, V37, P2715; Wang J, 2005, CELL BIOL INT, V29, P393, DOI 10.1016/j.cellbi.2004.12.002; Yancey PG, 2002, MICROSC MICROANAL, V8, P81, DOI 10.1017/S1431927601020013; Yancey PG, 2001, J LIPID RES, V42, P317; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6	51	14	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34822	10.1371/journal.pone.0034822	http://dx.doi.org/10.1371/journal.pone.0034822			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514671	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600077
J	He, HJ; Su, JB; Shu, SY; Zhang, Y; Ao, Y; Liu, B; Feng, DR; Wang, JF; Wang, HB				He, Hanjie; Su, Jianbin; Shu, Shengying; Zhang, Yang; Ao, Ying; Liu, Bing; Feng, Dongru; Wang, Jinfa; Wang, Hongbin			Two Homologous Putative Protein Tyrosine Phosphatases, OsPFA-DSP2 and AtPFA-DSP4, Negatively Regulate the Pathogen Response in Transgenic Plants	PLOS ONE			English	Article							ARABIDOPSIS INNATE IMMUNITY; OXYGEN SPECIES NETWORK; TRANSCRIPTION FACTOR; FUNCTIONAL GENOMICS; DISEASE RESISTANCE; HYDROGEN-PEROXIDE; GENE-EXPRESSION; RICE; PHOSPHORYLATION; TISSUE	Protein phosphatases, together with protein kinases, regulate protein phosphorylation and dephosphorylation, and play critical roles in plant growth and biotic stress responses. However, little is known about the biological functions of plant protein tyrosine dual-specificity phosphatase (PFA-DSP) in biotic stresses. Here, we found that OsPFA-DSP2 was mainly expressed in calli, seedlings, roots, and young panicles, and localized in cytoplasm and nucleus. Ectopic overexpression of OsPFA-DSP2 in rice increased sensitivity to Magnaporthe grisea (M. grisea Z1 strain), inhibited the accumulation of hydrogen peroxide (H2O2) and suppressed the expression of pathogenesis-related (PR) genes after fungal infection. Interestingly, transgenic Arabidopsis plants overexpressing AtPFA-DSP4, which is homologous to OsPFA-DSP2, also exhibited sensitivity to Pseudomonas syringae pv. tomato DC3000 (Pst DC3000), reduced accumulation of H2O2 and decreased photosynthesic capacity after infection compared with Col-0. These results indicate that OsPFA-DSP2 and AtPFA-DSP4 act as negative regulators of the pathogen response in transgenic plants.	[He, Hanjie; Su, Jianbin; Shu, Shengying; Zhang, Yang; Ao, Ying; Liu, Bing; Feng, Dongru; Wang, Jinfa; Wang, Hongbin] Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ,Sch Life Sci, State Key Lab Biocontrol & Guangdong,Key Lab Plan, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	He, HJ (corresponding author), Sun Yat Sen Univ, Key Lab Gene Engn, Minist Educ,Sch Life Sci, State Key Lab Biocontrol & Guangdong,Key Lab Plan, Guangzhou 510275, Guangdong, Peoples R China.	wanghb@mail.sysu.edu.cn	Su, Jianbin/L-6647-2019	Wang, Hong-Bin/0000-0003-4957-0509	National Natural Science Foundation of China [30800600, 30970237]; Natural Science Foundation of Guangdong Province, People's Republic of China [8151027501000016]; Fundamental Research Funds for the Central Universities [10lgpy34]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, People's Republic of China(National Natural Science Foundation of Guangdong Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by grants from the National Natural Science Foundation of China (no. 30800600 and no. 30970237), the Natural Science Foundation of Guangdong Province, People's Republic of China (no. 8151027501000016) and the Fundamental Research Funds for the Central Universities (10lgpy34). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceti DJ, 2008, PROTEINS, V73, P241, DOI 10.1002/prot.22041; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Anderson JC, 2011, PLANT J, V67, P258, DOI 10.1111/j.1365-313X.2011.04588.x; Torres MA, 2010, PHYSIOL PLANTARUM, V138, P414, DOI 10.1111/j.1399-3054.2009.01326.x; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Bartels S, 2010, TRENDS PLANT SCI, V15, P322, DOI 10.1016/j.tplants.2010.04.003; Bartels S, 2009, PLANT CELL, V21, P2884, DOI 10.1105/tpc.109.067678; Brock AK, 2010, PLANT PHYSIOL, V153, P1098, DOI 10.1104/pp.110.156109; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fukuoka S, 2009, SCIENCE, V325, P998, DOI 10.1126/science.1175550; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Gupta R, 2002, PLANT CELL, V14, P2495, DOI 10.1105/tpc.005702; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Hirochika H, 1996, P NATL ACAD SCI USA, V93, P7783, DOI 10.1073/pnas.93.15.7783; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kato T, 2009, PLANT MOL BIOL, V70, P617, DOI 10.1007/s11103-009-9495-9; Kotchoni SO, 2006, J BIOSCIENCES, V31, P389, DOI 10.1007/BF02704112; Kovtun Y, 2000, P NATL ACAD SCI USA, V97, P2940, DOI 10.1073/pnas.97.6.2940; Lee JS, 2009, PLANT J, V57, P975, DOI 10.1111/j.1365-313X.2008.03741.x; Li YG, 2012, PLANT SCI, V188, P10, DOI 10.1016/j.plantsci.2012.02.005; Liu B, 2012, PLANT CELL REP, DOI [10.1007/s00299-012-1231-2, DOI 10.1007/S00299-012-1231-2]; Luan S, 2003, ANNU REV PLANT BIOL, V54, P63, DOI 10.1146/annurev.arplant.54.031902.134743; Lumbreras V, 2010, PLANT J, V63, P1017, DOI 10.1111/j.1365-313X.2010.04297.x; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Mellersh DG, 2002, PLANT J, V29, P257, DOI 10.1046/j.0960-7412.2001.01215.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Monroe-Augustus M, 2003, PLANT CELL, V15, P2979, DOI 10.1105/tpc.017046; Mullineaux P, 2002, CURR OPIN PLANT BIOL, V5, P43, DOI 10.1016/S1369-5266(01)00226-6; Nanda AK, 2010, J INTEGR PLANT BIOL, V52, P195, DOI 10.1111/j.1744-7909.2010.00933.x; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Park CJ, 2008, PLOS BIOL, V6, P1910, DOI 10.1371/journal.pbio.0060231; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Qin GZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021945; Quan LJ, 2008, J INTEGR PLANT BIOL, V50, P2, DOI 10.1111/j.1744-7909.2007.00599.x; Ribot C, 2008, J PLANT PHYSIOL, V165, P114, DOI 10.1016/j.jplph.2007.06.013; Roma-Mateo C, 2007, J MOL BIOL, V374, P899, DOI 10.1016/j.jmb.2007.10.008; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Swanson S, 2010, PHYSIOL PLANTARUM, V138, P384, DOI 10.1111/j.1399-3054.2009.01313.x; Toki S, 2006, PLANT J, V47, P969, DOI 10.1111/j.1365-313X.2006.02836.x; Torii KU, 1998, EMBO J, V17, P5577, DOI 10.1093/emboj/17.19.5577; Vilela B, 2010, PLANT SIGNAL BEHAV, V5, P1497, DOI 10.4161/psb.5.11.13645; Zhang Y, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-30	47	11	16	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34995	10.1371/journal.pone.0034995	http://dx.doi.org/10.1371/journal.pone.0034995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514699	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600105
J	Johnson, CJ; Aiken, JM; McKenzie, D; Samuel, MD; Pedersen, JA				Johnson, Chad J.; Aiken, Judd M.; McKenzie, Debbie; Samuel, Michael D.; Pedersen, Joel A.			Highly Efficient Amplification of Chronic Wasting Disease Agent by Protein Misfolding Cyclic Amplification with Beads (PMCAb)	PLOS ONE			English	Article							IN-VITRO AMPLIFICATION; WHITE-TAILED DEER; PRION PROTEIN; PRESYMPTOMATIC DETECTION; INFLUENCE SUSCEPTIBILITY; INFECTIOUS PRIONS; CWD PRIONS; POLYMORPHISMS; SCRAPIE; ELK	Protein misfolding cyclic amplification (PMCA) has emerged as an important technique for detecting low levels of pathogenic prion protein in biological samples. The method exploits the ability of the pathogenic prion protein to convert the normal prion protein to a proteinase K-resistant conformation. Inclusion of Teflon (R) beads in the PMCA reaction (PMCAb) has been previously shown to increase the sensitivity and robustness of detection for the 263 K and SSLOW strains of hamster-adapted prions. Here, we demonstrate that PMCAb with saponin dramatically increases the sensitivity of detection for chronic wasting disease (CWD) agent without compromising the specificity of the assay (i.e., no false positive results). Addition of Teflon (R) beads increased the robustness of the PMCA reaction, resulting in a decrease in the variability of PMCA results. Three rounds of serial PMCAb allowed detection of CWD agent from a 6.7 x 10(-13) dilution of 10% brain homogenate (1.3 fg of source brain). Titration of the same brain homogenate in transgenic mice expressing cervid prion protein (Tg(CerPrP)1536(+/-) mice) allowed detection of CWD agent from the 10(-6) dilution of 10% brain homogenate. PMCAb is, thus, more sensitive than bioassay in transgenic mice by a factor exceeding 10(5). Additionally, we are able to amplify CWD agent from brain tissue and lymph nodes of CWD-positive white-tailed deer having Prnp alleles associated with reduced disease susceptibility.	[Johnson, Chad J.; Pedersen, Joel A.] Univ Wisconsin, Environm Chem & Technol Program, Madison, WI 53706 USA; [Johnson, Chad J.; Pedersen, Joel A.] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA; [Aiken, Judd M.; McKenzie, Debbie] Univ Alberta, Ctr Prions & Prot Misfolding Dis, Edmonton, AB, Canada; [Samuel, Michael D.] Univ Wisconsin, US Geol Survey, Wisconsin Cooperat Wildlife Res Unit, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Alberta; United States Department of the Interior; United States Geological Survey; University of Wisconsin System; University of Wisconsin Madison	Johnson, CJ (corresponding author), Univ Wisconsin, Environm Chem & Technol Program, Madison, WI 53706 USA.	joelpedersen@wisc.edu	Pedersen, Joel A./L-4007-2019; McKenzie, Debbie/G-4459-2015	Pedersen, Joel A./0000-0002-3918-1860; McKenzie, Debbie/0000-0002-9291-6977; Aiken, Judd/0000-0001-6119-4521	NSF [DEB-0914484, CBET-0547484]; NIH [R01 NS060034]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060034] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NSF grants DEB-0914484 (MDS) and CBET-0547484 (JAP), NIH grant R01 NS060034 (JMA/JAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Angers RC, 2009, EMERG INFECT DIS, V15, P696, DOI 10.3201/eid1505.081458; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Browning SR, 2004, J VIROL, V78, P13345, DOI 10.1128/JVI.78.23.13345-13350.2004; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Gonzalez-Montalban N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001277; Gonzalez-Romero D, 2008, FEBS LETT, V582, P3161, DOI 10.1016/j.febslet.2008.08.003; Haley NJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004848; Johnson C, 2006, J GEN VIROL, V87, P2109, DOI 10.1099/vir.0.81615-0; Johnson CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017450; Kelly AC, 2008, PRION, V2, P28, DOI 10.4161/pri.2.1.6321; Kurt TD, 2007, J VIROL, V81, P9605, DOI 10.1128/JVI.00635-07; Meyerett C, 2008, VIROLOGY, V382, P267, DOI 10.1016/j.virol.2008.09.023; Murayama Y, 2007, NEUROSCI LETT, V413, P270, DOI 10.1016/j.neulet.2006.11.056; Naslavsky N, 1997, J BIOL CHEM, V272, P6324, DOI 10.1074/jbc.272.10.6324; O'Rourke KI, 1999, J GEN VIROL, V80, P2765, DOI 10.1099/0022-1317-80-10-2765; O'Rourke KI, 2004, J GEN VIROL, V85, P1339, DOI 10.1099/vir.0.79785-0; Pritzkow S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020384; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Robinson SJ, 2012, ECOL APPIN PRESS; Saa P, 2006, J BIOL CHEM, V281, P35245, DOI 10.1074/jbc.M603964200; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Tamguney G, 2009, NATURE, V461, P529, DOI 10.1038/nature08289; Thorne L, 2008, J GEN VIROL, V89, P3177, DOI 10.1099/vir.0.2008/004226-0; Wilson GA, 2009, J TOXICOL ENV HEAL A, V72, P1025, DOI 10.1080/15287390903084264	31	27	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35383	10.1371/journal.pone.0035383	http://dx.doi.org/10.1371/journal.pone.0035383			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514738	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600143
J	Laranjeiro, R; Alcobia, I; Neves, H; Gomes, AC; Saavedra, P; Carvalho, CC; Duarte, A; Cidadao, A; Parreira, L				Laranjeiro, Ricardo; Alcobia, Isabel; Neves, Helia; Gomes, Andreia C.; Saavedra, Pedro; Carvalho, Catarina C.; Duarte, Antonio; Cidadao, Antonio; Parreira, Leonor			The Notch Ligand Delta-Like 4 Regulates Multiple Stages of Early Hemato-Vascular Development	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ENDOTHELIAL-CELLS; HEMATOPOIETIC COMMITMENT; DEFINITIVE HEMATOPOIESIS; EXPRESSION DEFINES; COMMON PRECURSOR; DIFFERENTIATION; MOUSE; GENE; HEMANGIOBLAST	Background: In mouse embryos, homozygous or heterozygous deletions of the gene encoding the Notch ligand Dll4 result in early embryonic death due to major defects in endothelial remodeling in the yolk sac and embryo. Considering the close developmental relationship between endothelial and hematopoietic cell lineages, which share a common mesoderm-derived precursor, the hemangioblast, and many key regulatory molecules, we investigated whether Dll4 is also involved in the regulation of early embryonic hematopoiesis. Methodology/Principal Findings: Using Embryoid Bodies (EBs) derived from embryonic stem cells harboring hetero- or homozygous Dll4 deletions, we observed that EBs from both genotypes exhibit an abnormal endothelial remodeling in the vascular sprouts that arise late during EB differentiation, indicating that this in vitro system recapitulates the angiogenic phenotype of Dll4 mutant embryos. However, analysis of EB development at early time points revealed that the absence of Dll4 delays the emergence of mesoderm and severely reduces the number of blast-colony forming cells (BL-CFCs), the in vitro counterpart of the hemangioblast, and of endothelial cells. Analysis of colony forming units (CFU) in EBs and yolk sacs from Dll4(+/-) and Dll4(-/-) embryos, showed that primitive erythropoiesis is specifically affected by Dll4 insufficiency. In Dll4 mutant EBs, smooth muscle cells (SMCs) were seemingly unaffected and cardiomyocyte differentiation was increased, indicating that SMC specification is Dll4-independent while a normal dose of this Notch ligand is essential for the quantitative regulation of cardiomyogenesis. Conclusions/Significance: This study highlights a previously unnoticed role for Dll4 in the quantitative regulation of early hemato-vascular precursors, further indicating that it is also involved on the timely emergence of mesoderm in early embryogenesis.	[Laranjeiro, Ricardo; Alcobia, Isabel; Neves, Helia; Gomes, Andreia C.; Saavedra, Pedro; Cidadao, Antonio; Parreira, Leonor] Univ Lisbon, Fac Med, Unidade Biol Hematopoiese, Inst Histol & Biol Desenvolvimento, P-1699 Lisbon, Portugal; [Carvalho, Catarina C.; Duarte, Antonio] Univ Tecn Lisboa, Fac Med Vet, Ctr Interdisciplinar Invest Sanidade Anim, P-1100 Lisbon, Portugal; [Alcobia, Isabel; Carvalho, Catarina C.; Duarte, Antonio; Parreira, Leonor] Inst Gulbenkian Ciencias, Oeiras, Portugal	Universidade de Lisboa; Universidade de Lisboa; Instituto Gulbenkian de Ciencia	Laranjeiro, R (corresponding author), UCL, Dept Cell & Dev Biol, London, England.	a.cidadao@campus.ul.pt	Gomes, Andreia/AAC-9198-2020; Gomes, Andreia C/B-5905-2009; Neves, Helia/GZK-6450-2022; Laranjeiro, Ricardo/L-6300-2019; Saavedra, Pedro/AAE-2054-2019; Alcobia, Isabel/F-2081-2014; Laranjeiro, Ricardo/L-2985-2019; Parreira, Leonor/S-2304-2019; Neves, Helia/H-1990-2019; Duarte, Antonio/V-1178-2018	Gomes, Andreia/0000-0002-0567-064X; Gomes, Andreia C/0000-0002-0567-064X; Neves, Helia/0000-0002-6700-4976; Laranjeiro, Ricardo/0000-0001-7665-0833; Alcobia, Isabel/0000-0002-1861-4049; Neves, Helia/0000-0002-6700-4976; Duarte, Antonio/0000-0002-9255-3635; Parreira, Leonor/0000-0002-1970-9285; Cruz de Carvalho, Catarina/0000-0003-3376-7550	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PTDC/SAU-OBD/64165/2006]; FCT	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by Fundacao para a Ciencia e a Tecnologia (FCT), Portugal (grant PTDC/SAU-OBD/64165/2006) and conducted at the facilities of the Instituto de Histologia e Biologia do Desenvolvimento, Faculdade de Medicina, Universidade de Lisboa, and Instituto de Medicina Molecular, Lisboa. R. L. and P. S. are recipients of a research fellowship from FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcobia I, 2011, CELLS TISSUES ORGANS, V193, P239, DOI 10.1159/000320572; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Chen VC, 2008, NAT BIOTECHNOL, V26, P1169, DOI 10.1038/nbt.1497; Cheng X, 2008, DEVELOPMENT, V135, P3447, DOI 10.1242/dev.025916; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Choi K, 1998, DEVELOPMENT, V125, P725; Croce JC, 2010, DEVELOPMENT, V137, P83, DOI 10.1242/dev.044149; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; D'Souza SL, 2005, BLOOD, V105, P3862, DOI 10.1182/blood-2004-09-3611; Dando JS, 2005, STEM CELLS, V23, P550, DOI 10.1634/stemcells.2004-0205; Del Monte G, 2007, DEV DYNAM, V236, P2594, DOI 10.1002/dvdy.21246; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Ema M, 2003, GENE DEV, V17, P380, DOI 10.1101/gad.1049803; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; HAUB O, 1991, DEVELOPMENT, V112, P397; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Ishitobi H, 2011, DEVELOPMENT, V138, P5357, DOI 10.1242/dev.065565; Iso T, 2006, BIOCHEM BIOPH RES CO, V341, P708, DOI 10.1016/j.bbrc.2006.01.020; Jaffredo T, 2005, EXP HEMATOL, V33, P1029, DOI 10.1016/j.exphem.2005.06.005; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Kabrun N, 1997, DEVELOPMENT, V124, P2039; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Kubo A, 2005, BLOOD, V105, P4590, DOI 10.1182/blood-2004-10-4137; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Lacaud G, 2002, BLOOD, V100, P458, DOI 10.1182/blood-2001-12-0321; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lee D, 2008, CELL STEM CELL, V2, P497, DOI 10.1016/j.stem.2008.03.008; Li HW, 2009, BMC NEUROSCI, V10, DOI [10.1186/1471-2202-10-122, 10.1186/1471-2105-10-418]; Masumura T, 2009, ARTERIOSCL THROM VAS, V29, P2125, DOI 10.1161/ATVBAHA.109.193185; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nemir M, 2006, CIRC RES, V98, P1471, DOI 10.1161/01.RES.0000226497.52052.2a; Ohishi K, 2003, SEMIN CELL DEV BIOL, V14, P143, DOI 10.1016/S1084-9521(02)00183-0; Palis J, 2001, EXP HEMATOL, V29, P927, DOI 10.1016/S0301-472X(01)00669-5; Pitulescu ME, 2010, GENE DEV, V24, P2480, DOI 10.1101/gad.1973910; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Ramasamy SK, 2010, MOL CELL BIOL, V30, P1946, DOI 10.1128/MCB.01419-09; ROGERS MB, 1991, DEVELOPMENT, V113, P815; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Schroeder T, 2006, MECH DEVELOP, V123, P570, DOI 10.1016/j.mod.2006.05.002; Shin M, 2009, DEVELOPMENT, V136, P595, DOI 10.1242/dev.026906; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Suenobu S, 2002, BIOCHEM BIOPH RES CO, V293, P1124, DOI 10.1016/S0006-291X(02)00330-3; Sugimoto A, 2006, EXP HEMATOL, V34, P424, DOI 10.1016/j.exphem.2005.12.016; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang ZY, 2002, BLOOD, V99, P2740, DOI 10.1182/blood.V99.8.2740; WILKINSON DG, 1990, NATURE, V343, P657, DOI 10.1038/343657a0; Yue W, 2010, STEM CELLS DEV, V19, P1937, DOI 10.1089/scd.2010.0096	63	9	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34553	10.1371/journal.pone.0034553	http://dx.doi.org/10.1371/journal.pone.0034553			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514637	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600042
J	Yang, J; Cai, L; Huang, HY; Liu, BY; Wu, Q				Yang, Jing; Cai, Lei; Huang, Haiyan; Liu, Bingya; Wu, Qiang			Genetic Variations and Haplotype Diversity of the UGT1 Gene Cluster in the Chinese Population	PLOS ONE			English	Article							HUMAN UDP-GLUCURONOSYLTRANSFERASES; TAG SNP SELECTION; BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE-1; COMPARATIVE GENOMICS; PROTOCADHERIN-ALPHA; CRIGLER-NAJJAR; COMPLEX LOCUS; GENOTYPE DATA; IDENTIFICATION; EXPRESSION	Vertebrates require tremendous molecular diversity to defend against numerous small hydrophobic chemicals. UDP-glucuronosyltransferases (UGTs) are a large family of detoxification enzymes that glucuronidate xenobiotics and endobiotics, facilitating their excretion from the body. The UGT1 gene cluster contains a tandem array of variable first exons, each preceded by a specific promoter, and a common set of downstream constant exons, similar to the genomic organization of the protocadherin (Pcdh), immunoglobulin, and T-cell receptor gene clusters. To assist pharmacogenomics studies in Chinese, we sequenced nine first exons, promoter and intronic regions, and five common exons of the UGT1 gene cluster in a population sample of 253 unrelated Chinese individuals. We identified 101 polymorphisms and found 15 novel SNPs. We then computed allele frequencies for each polymorphism and reconstructed their linkage disequilibrium (LD) map. The UGT1 cluster can be divided into five linkage blocks: Block 9 (UGT1A9), Block 9/7/6 (UGT1A9, UGT1A7, and UGT1A6), Block 5 (UGT1A5), Block 4/3 (UGT1A4 and UGT1A3), and Block 39 UTR. Furthermore, we inferred haplotypes and selected their tagSNPs. Finally, comparing our data with those of three other populations of the HapMap project revealed ethnic specificity of the UGT1 genetic diversity in Chinese. These findings have important implications for future molecular genetic studies of the UGT1 gene cluster as well as for personalized medical therapies in Chinese.	[Yang, Jing; Cai, Lei; Huang, Haiyan; Liu, Bingya; Wu, Qiang] Shanghai Jiao Tong Univ, Inst Syst Biomed, Ctr Comparat Biomed, Key Lab Syst Biomed,Minist Educ, Shanghai 200030, Peoples R China; [Yang, Jing; Cai, Lei; Huang, Haiyan; Wu, Qiang] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst,Renji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yang, J (corresponding author), Shanghai Jiao Tong Univ, Inst Syst Biomed, Ctr Comparat Biomed, Key Lab Syst Biomed,Minist Educ, Shanghai 200030, Peoples R China.	qwu123@gmail.com	Liu, Bingya/GMW-5655-2022; Wu, Qiang/A-6751-2009; Cai, Lei/H-3972-2017	Wu, Qiang/0000-0003-3841-3591; Cai, Lei/0000-0002-5726-2971; Liu, Bingya/0000-0002-4406-3762	National Natural Science Foundation of China [30970669, 31171015]; Ministry of Science and Technology of China [2009CB918701]; Science and Technology Commission of Shanghai Municipality [09PJ1405300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants 30970669 and 31171015 from the National Natural Science Foundation of China, 2009CB918701 from the Ministry of Science and Technology of China, and 09PJ1405300 from the Science and Technology Commission of Shanghai Municipality. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaba K, 1998, BIOCHEM MOL BIOL INT, V46, P21; AONO S, 1993, BIOCHEM BIOPH RES CO, V197, P1239, DOI 10.1006/bbrc.1993.2610; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; BOSMA PJ, 1994, J BIOL CHEM, V269, P17960; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Carlini LE, 2005, CLIN CANCER RES, V11, P1226; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; CRIGLER JF, 1952, PEDIATRICS, V10, P169; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Finel M, 2005, J PHARMACOL EXP THER, V315, P1143, DOI 10.1124/jpet.105.091900; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Fujita KI, 2007, CANCER CHEMOTH PHARM, V60, P515, DOI 10.1007/s00280-006-0396-1; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gong QH, 2001, PHARMACOGENETICS, V11, P357, DOI 10.1097/00008571-200106000-00011; Guillemette C, 2000, PHARMACOGENETICS, V10, P629, DOI 10.1097/00008571-200010000-00006; Halperin E, 2005, BIOINFORMATICS, V21, pI195, DOI 10.1093/bioinformatics/bti1021; Huang CS, 2000, PHARMACOGENETICS, V10, P539, DOI 10.1097/00008571-200008000-00007; Huang HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009144; Innocenti F, 2006, PHARMACOGENOMICS, V7, P1211, DOI 10.2217/14622416.7.8.1211; Judson R, 2000, Pharmacogenomics, V1, P15, DOI 10.1517/14622416.1.1.15; Kadakol A, 2000, HUM MUTAT, V16, P297, DOI 10.1002/1098-1004(200010)16:4<297::AID-HUMU2>3.0.CO;2-Z; Laakkonen L, 2010, MOL PHARMACOL, V77, P931, DOI 10.1124/mol.109.063289; Li C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-69; Litman GW, 2007, CURR OPIN IMMUNOL, V19, P526, DOI 10.1016/j.coi.2007.07.001; Locuson CW, 2007, XENOBIOTICA, V37, P155, DOI 10.1080/00498250601129109; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Maitland ML, 2006, PHARMACOGENOMICS J, V6, P52, DOI 10.1038/sj.tpj.6500351; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Menard V, 2009, HUM MUTAT, V30, P1310, DOI 10.1002/humu.21054; Menard V, 2009, HUM MUTAT, V30, P677, DOI 10.1002/humu.20946; Miley MJ, 2007, J MOL BIOL, V369, P498, DOI 10.1016/j.jmb.2007.03.066; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Nagar S, 2004, PHARMACOGENETICS, V14, P487, DOI 10.1097/01.fpc.0000114771.78957.cb; Noonan JP, 2004, GENOME RES, V14, P354, DOI 10.1101/gr.2133704; Noonan JP, 2003, AM J HUM GENET, V72, P621, DOI 10.1086/368060; Owens IS, 2005, METHOD ENZYMOL, V400, P1, DOI 10.1016/S0076-6879(05)00001-7; Patana AS, 2007, MOL PHARMACOL, V72, P604, DOI 10.1124/mol.107.036871; RITTER JK, 1992, J BIOL CHEM, V267, P3257; Saeki M, 2006, PHARMACOGENOMICS J, V6, P63, DOI 10.1038/sj.tpj.6500335; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tasic B, 2002, MOL CELL, V10, P21, DOI 10.1016/S1097-2765(02)00578-6; Thomas SS, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9432; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Wang XZ, 2002, GENE DEV, V16, P1890, DOI 10.1101/gad.1004802; Wu Q, 2005, GENETICS, V169, P2179, DOI 10.1534/genetics.104.037606; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yamanaka H, 2004, PHARMACOGENETICS, V14, P329, DOI 10.1097/00008571-200405000-00008; Yea SS, 2008, THER DRUG MONIT, V30, P23, DOI 10.1097/FTD.0b013e3181633824; Zhang K, 2004, GENOME RES, V14, P908, DOI 10.1101/gr.1837404; Zhang T, 2004, GENOME RES, V14, P79, DOI 10.1101/gr.1225204; Zhou YY, 2009, NEONATOLOGY, V96, P150, DOI 10.1159/000209851; Zipursky SL, 2010, CELL, V143, P343, DOI 10.1016/j.cell.2010.10.009	53	5	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e33988	10.1371/journal.pone.0033988	http://dx.doi.org/10.1371/journal.pone.0033988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514612	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600017
J	Ding, M; Cao, X; Xu, HN; Fan, JK; Huang, HL; Yang, DQ; Li, YH; Wang, J; Li, RS; Liu, XY				Ding, Miao; Cao, Xin; Xu, Hai-neng; Fan, Jun-kai; Huang, Hong-ling; Yang, Dong-qin; Li, Yu-hua; Wang, Jian; Li, Runsheng; Liu, Xin-Yuan			Prostate Cancer-Specific and Potent Antitumor Effect of a DD3-Controlled Oncolytic Virus Harboring the PTEN Gene	PLOS ONE			English	Article							ADENOVIRUS-MEDIATED TRANSFER; INHIBITS CELL-GROWTH; REPLICATING ADENOVIRUS; GLIOBLASTOMA CELLS; IN-VITRO; EXPRESSION; THERAPY; PROMOTER; SUPPRESSION; CARCINOMA	Prostate cancer is a major health problem for men in Western societies. Here we report a Prostate Cancer-Specific Targeting Gene-Viro-Therapy (CTGVT-PCa), in which PTEN was inserted into a DD3-controlled oncolytic viral vector (OV) to form Ad.DD3.E1A.E1B(Delta 55)-(PTEN) or, briefly, Ad.DD3.D55-PTEN. The woodchuck post-transcriptional element (WPRE) was also introduced at the downstream of the E1A coding sequence, resulting in much higher expression of the E1A gene. DD3 is one of the most prostate cancer-specific genes and has been used as a clinical bio-diagnostic marker. PTEN is frequently inactivated in primary prostate cancers, which is crucial for prostate cancer progression. Therefore, the Ad.DD3.D55-PTEN has prostate cancer specific and potent antitumor effect. The tumor growth rate was almost completely inhibited with the final tumor volume after Ad.DD3.D55-PTEN treatment less than the initial volume at the beginning of Ad.DD3.D55-PTEN treatment, which shows the powerful antitumor effect of Ad.DD3.D55-PTEN on prostate cancer tumor growth. The CTGVT-PCa construct reported here killed all of the prostate cancer cell lines tested, such as DU145, 22RV1 and CL1, but had a reduced or no killing effect on all the non-prostate cancer cell lines tested. The mechanism of action of Ad. DD3.D55-PTEN was due to the induction of apoptosis, as detected by TUNEL assays and flow cytometry. The apoptosis was mediated by mitochondria-dependent and -independent pathways, as determined by caspase assays and mitochondrial membrane potential.	[Ding, Miao; Cao, Xin; Xu, Hai-neng; Huang, Hong-ling; Yang, Dong-qin; Liu, Xin-Yuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China; [Liu, Xin-Yuan] Zhejiang Sci Tech Univ, Coll Biol Sci, Xinyuan Inst Med & Biotechnol, Hangzhou, Zhejiang, Peoples R China; [Fan, Jun-kai] Univ Kentucky, Lucille P Markey Canc Ctr, Dept Mol & Cellular Biochem, Lexington, KY USA; [Li, Yu-hua; Wang, Jian; Li, Runsheng] Shanghai Inst Planned Parenthood Res, Key Lab Contracept Drugs & Devices NPFPC, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Zhejiang Sci-Tech University; University of Kentucky	Ding, M (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai, Peoples R China.	runshengli2007@gmail.com; xyliu@sibs.ac.cn	Li, yu/HHZ-5236-2022; Liu, Xinyuan/HDM-5505-2022; Xu, Haineng/A-4345-2016	Xu, Haineng/0000-0001-7195-4897	National Basic Research Program of China (973 Pro_ram) [2010CB529901]; Important National Science AMP; Technology Specific Project of Hepatitis and Hepatoma Related Program [2008ZX10002-023]; New Innovation Program [2009-ZX-09102-246]; Zhejiang Sci-Tech University [1016834-Y]; National Basic Research Program of China [2009CB941704]; Shanghai Municipal Committee of Science and Technology [09140903200, 09DJ1400400, 08140901700, 06ZR14072]	National Basic Research Program of China (973 Pro_ram)(National Basic Research Program of China); Important National Science AMP; Technology Specific Project of Hepatitis and Hepatoma Related Program; New Innovation Program; Zhejiang Sci-Tech University(Zhejiang Sci-Tech University); National Basic Research Program of China(National Basic Research Program of China); Shanghai Municipal Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by the National Basic Research Program of China (973 Pro_ram) (No. 2010CB529901) (X. Liu), Important National Science & Technology Specific Project of Hepatitis and Hepatoma Related Program (2008ZX10002-023) (X. Liu), New Innovation Program (2009-ZX-09102-246) (X. Liu), the Zhejiang Sci-Tech University grant (1016834-Y), the National Basic Research Program of China (2009CB941704) (R. Li), the Shanghai Municipal Committee of Science and Technology (09140903200, 09DJ1400400, 08140901700 and 06ZR14072) (R. Li). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERKNER KL, 1992, CURR TOP MICROBIOL, V158, P39; BERKNER KL, 1988, BIOTECHNIQUES, V6, P616; Bischoff JR, 1996, SCIENCE, V274, P373, DOI 10.1126/science.274.5286.373; Cheney IW, 1998, CANCER RES, V58, P2331; Cheng WS, 2006, CANCER GENE THER, V13, P13, DOI 10.1038/sj.cgt.7700881; Davies MA, 1999, CANCER RES, V59, P2551; Davies MA, 2002, CLIN CANCER RES, V8, P1904; de Kok JB, 2002, CANCER RES, V62, P2695; Denmeade SR, 2004, PROSTATE, V58, P211, DOI 10.1002/pros.10360; Evans J, 2011, NAT MED, V17, P268, DOI 10.1038/nm0311-268b; Fan JK, 2010, INT J CANCER, V127, P707, DOI 10.1002/ijc.25069; Gonzalez-Murillo A, 2009, HUM GENE THER, V21, P623; Gropp M, 2003, MOL THER, V7, P281, DOI 10.1016/S1525-0016(02)00047-3; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; Hang Y, 2005, WORLD J GASTROENTERO, V11, P2224, DOI 10.3748/wjg.v11.i15.2224; Huggins C, 2002, J UROLOGY, V168, P9, DOI 10.1016/S0022-5347(05)64820-3; Khuri FR, 2000, NAT MED, V6, P879, DOI 10.1038/78638; Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228; Kirn D, 2001, EXPERT OPIN BIOL TH, V1, P525, DOI 10.1517/14712598.1.3.525; Klarlund JK, 1997, SCIENCE, V275, P1927, DOI 10.1126/science.275.5308.1927; Klein R, 2006, GENE, V372, P153, DOI 10.1016/j.gene.2005.12.018; Kwabi-Addo B, 2001, P NATL ACAD SCI USA, V98, P11563, DOI 10.1073/pnas.201167798; Li E, 1998, J VIROL, V72, P8806, DOI 10.1128/JVI.72.11.8806-8812.1998; Li EG, 1998, J VIROL, V72, P2055, DOI 10.1128/JVI.72.3.2055-2061.1998; Li J, 1998, CANCER RES, V58, P5667; Li X, 2005, CANCER RES, V65, P1941, DOI 10.1158/0008-5472.CAN-04-3666; Loeb JE, 1999, HUM GENE THER, V10, P2295, DOI 10.1089/10430349950016942; Mastroyiannopoulos NP, 2005, EMBO REP, V6, P458, DOI 10.1038/sj.embor.7400390; McMenamin ME, 1999, CANCER RES, V59, P4291; Minaguchi T, 1999, CANCER RES, V59, P6063; Muthana M, 2011, CANCER RES, V71, P1805, DOI 10.1158/0008-5472.CAN-10-2349; O'Shea CC, 2005, CELL CYCLE, V4, P883, DOI 10.4161/cc.4.7.1791; Pellinen R, 2004, INT J ONCOL, V25, P1753; Qiu Zhen, 2004, Zhonghua Wai Ke Za Zhi, V42, P600; Qiu Zhen, 2007, Zhonghua Nan Ke Xue, V13, P201; Rosser CJ, 2004, CANCER GENE THER, V11, P273, DOI 10.1038/sj.cgt.7700673; Saito Y, 2003, GENE THER, V10, P1961, DOI 10.1038/sj.gt.3302100; Sakurada A, 1999, INT J ONCOL, V15, P1069; Sarkar D, 2007, CANCER RES, V67, P5434, DOI 10.1158/0008-5472.CAN-07-0195; Schmidt C, 2011, NAT BIOTECHNOL, V29, P295, DOI 10.1038/nbt0411-295; Skjoth IHE, 2006, INT J ONCOL, V28, P217; Tanaka M, 2000, ONCOGENE, V19, P5406, DOI 10.1038/sj.onc.1203918; Tanaka M, 2005, CANCER DETECT PREV, V29, P170, DOI 10.1016/j.cdp.2004.07.006; Teng DHF, 1997, CANCER RES, V57, P5221; Tso CL, 2000, CANCER J, V6, P220; Verhaegh GW, 2000, J BIOL CHEM, V275, P37496, DOI 10.1074/jbc.M006293200; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wolfert MA, 1996, HUM GENE THER, V7, P2123, DOI 10.1089/hum.1996.7.17-2123; Yu D, 2001, CANCER GENE THER, V8, P628, DOI 10.1038/sj.cgt.7700344; Zhang KJ, 2009, HUM GENE THER, V20, P818, DOI 10.1089/hum.2008.205; Zhang Q, 2004, CANCER RES, V64, P5390, DOI 10.1158/0008-5472.CAN-04-1229; Zhang YP, 1999, GENE THER, V6, P1438, DOI 10.1038/sj.gt.3300965; Zhang ZL, 2003, CELL RES, V13, P481, DOI 10.1038/sj.cr.7290191; Zhao LL, 2005, HUM GENE THER, V16, P845, DOI 10.1089/hum.2005.16.845; Zhou YA, 2010, BIOSCI BIOTECH BIOCH, V74, P736, DOI 10.1271/bbb.90787	55	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35153	10.1371/journal.pone.0035153	http://dx.doi.org/10.1371/journal.pone.0035153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509396	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336600089
J	Fessler, DMT; Holbrook, C; Snyder, JK				Fessler, Daniel M. T.; Holbrook, Colin; Snyder, Jeffrey K.			Weapons Make the Man (Larger): Formidability Is Represented as Size and Strength in Humans	PLOS ONE			English	Article							AGGRESSION	In order to determine how to act in situations of potential agonistic conflict, individuals must assess multiple features of a prospective foe that contribute to the foe's resource-holding potential, or formidability. Across diverse species, physical size and strength are key determinants of formidability, and the same is often true for humans. However, in many species, formidability is also influenced by other factors, such as sex, coalitional size, and, in humans, access to weaponry. Decision-making involving assessments of multiple features is enhanced by the use of a single summary variable that encapsulates the contributions of these features. Given both a) the phylogenetic antiquity of the importance of size and strength as determinants of formidability, and b) redundant experiences during development that underscore the contributions of size and strength to formidability, we hypothesize that size and strength constitute the conceptual dimensions of a representation used to summarize multiple diverse determinants of a prospective foe's formidability. Here, we test this hypothesis in humans by examining the effects of a potential foe's access to weaponry on estimations of that individual's size and strength. We demonstrate that knowing that an individual possesses a gun or a large kitchen knife leads observers to conceptualize him as taller, and generally larger and more muscular, than individuals who possess only tools or similarly mundane objects. We also document that such patterns are not explicable in terms of any actual correlation between gun ownership and physical size, nor can they be explained in terms of cultural schemas or other background knowledge linking particular objects to individuals of particular size and strength. These findings pave the way for a fuller understanding of the evolution of the cognitive systems whereby humans - and likely many other social vertebrates - navigate social hierarchies.	[Fessler, Daniel M. T.; Holbrook, Colin; Snyder, Jeffrey K.] Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA; [Fessler, Daniel M. T.; Holbrook, Colin; Snyder, Jeffrey K.] Univ Calif Los Angeles, Ctr Behav Evolut & Culture, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Fessler, DMT (corresponding author), Univ Calif Los Angeles, Dept Anthropol, Los Angeles, CA 90024 USA.	dfessler@anthro.ucla.edu	Fessler, Daniel/G-8485-2012		United States Air Force Office of Scientific Research [FA9550-10-1-0511]	United States Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the United States Air Force Office of Scientific Research under Award #FA9550-10-1-0511. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer J., 1988, BEHAV BIOL AGGRESSIO, DOI DOI 10.1046/J.1420-9101.1991.4030515.X; Archer J, 2007, PERS INDIV DIFFER, V43, P627, DOI 10.1016/j.paid.2007.01.005; Archer J, 2009, EVOL HUM BEHAV, V30, P315, DOI 10.1016/j.evolhumbehav.2009.03.003; Barkow J. H., 1989, DARWIN SEX STATUS BI, DOI 10.1002/AJPA.1330840213; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Clark JA, 2010, EMOT REV, V2, P397, DOI 10.1177/1754073910374663; Duguid MM, 2012, PSYCHOL SCI, V23, P36, DOI 10.1177/0956797611422915; Felson RB, 1996, CRIMINOLOGY, V34, P433, DOI 10.1111/j.1745-9125.1996.tb01214.x; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Hepburn L, 2007, INJURY PREV, V13, P15, DOI 10.1136/ip.2006.013607; Hess N, 2010, HUM NATURE-INT BIOS, V21, P330, DOI 10.1007/s12110-010-9094-0; HIGHAM PA, 1992, CAN J BEHAV SCI, V24, P404, DOI 10.1037/h0078723; Lieberman D, 2007, NATURE, V445, P727, DOI 10.1038/nature05510; Marsh AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005707; *NAT CTR HLTH STAT, 1994, DHHS PUBL; Sell A, 2009, P NATL ACAD SCI USA, V106, P15073, DOI 10.1073/pnas.0904312106; Sorokowski P, 2010, EUR J SOC PSYCHOL, V40, P1302, DOI 10.1002/ejsp.710; WILSON PR, 1968, J SOC PSYCHOL, V74, P97, DOI 10.1080/00224545.1968.9919806	18	67	67	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e32751	10.1371/journal.pone.0032751	http://dx.doi.org/10.1371/journal.pone.0032751			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TP	22509247	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600005
J	Tognini, P; Manno, I; Bonaccorsi, J; Cenni, MC; Sale, A; Maffei, L				Tognini, Paola; Manno, Ilaria; Bonaccorsi, Joyce; Cenni, Maria Cristina; Sale, Alessandro; Maffei, Lamberto			Environmental Enrichment Promotes Plasticity and Visual Acuity Recovery in Adult Monocular Amblyopic Rats	PLOS ONE			English	Article							CRITICAL-PERIOD; CORTEX; DEPRIVATION; EXPERIENCE; RESPONSES; VISION; EYE; INHIBITION; KITTENS; MOUSE	Loss of visual acuity caused by abnormal visual experience during development (amblyopia) is an untreatable pathology in adults. In some occasions, amblyopic patients loose vision in their better eye owing to accidents or illnesses. While this condition is relevant both for its clinical importance and because it represents a case in which binocular interactions in the visual cortex are suppressed, it has scarcely been studied in animal models. We investigated whether exposure to environmental enrichment (EE) is effective in triggering recovery of vision in adult amblyopic rats rendered monocular by optic nerve dissection in their normal eye. By employing both electrophysiological and behavioral assessments, we found a full recovery of visual acuity in enriched rats compared to controls reared in standard conditions. Moreover, we report that EE modulates the expression of GAD67 and BDNF. The non invasive nature of EE renders this paradigm promising for amblyopia therapy in adult monocular people.	[Tognini, Paola; Manno, Ilaria; Bonaccorsi, Joyce; Maffei, Lamberto] Scuola Normale Super Pisa, Neurobiol Lab, Pisa, Italy; [Tognini, Paola; Cenni, Maria Cristina; Sale, Alessandro; Maffei, Lamberto] Inst Neurosci CNR, Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Tognini, P (corresponding author), Scuola Normale Super Pisa, Neurobiol Lab, Pisa, Italy.	sale@in.cnr.it	Sale, Alessandro/K-7760-2016	Sale, Alessandro/0000-0001-7608-4456	Scuola Normale Superiore	Scuola Normale Superiore	The work has been supported by the grant "Progetto di Ateneo 2008 from the Scuola Normale Superiore" to AS and a Scuola Normale Superiore grant to LM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonini A, 1998, VISUAL NEUROSCI, V15, P401; Bavelier D, 2010, J NEUROSCI, V30, P14964, DOI 10.1523/JNEUROSCI.4812-10.2010; Berardi N, 2003, TRENDS NEUROSCI, V26, P369, DOI 10.1016/S0166-2236(03)00168-1; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; Cancedda L, 2004, J NEUROSCI, V24, P4840, DOI 10.1523/JNEUROSCI.0845-04.2004; CHAPMAN B, 1986, NATURE, V324, P154, DOI 10.1038/324154a0; El Mallah MK, 2000, BRIT J OPHTHALMOL, V84, P952, DOI 10.1136/bjo.84.9.952; Fronius M, 2005, GRAEF ARCH CLIN EXP, V243, P278, DOI 10.1007/s00417-004-1014-8; Gordon JA, 1996, J NEUROSCI, V16, P3274; HAMED LM, 1991, OPHTHALMOLOGY, V98, P247; He HY, 2007, NAT NEUROSCI, V10, P1134, DOI 10.1038/nn1965; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Holmes JM, 2006, LANCET, V367, P1343, DOI 10.1016/S0140-6736(06)68581-4; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kaneko M, 2008, NAT NEUROSCI, V11, P497, DOI 10.1038/nn2068; Levi DM, 2009, VISION RES, V49, P2535, DOI 10.1016/j.visres.2009.02.010; Lewis TL, 2005, DEV PSYCHOBIOL, V46, P163, DOI 10.1002/dev.20055; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Mitchell DE, 2001, P NATL ACAD SCI USA, V98, P11662, DOI 10.1073/pnas.201392698; Mitchell Donald E, 2002, Clin Exp Optom, V85, P5; Pizzorusso T, 2006, P NATL ACAD SCI USA, V103, P8517, DOI 10.1073/pnas.0602657103; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Restani L, 2009, NEURON, V64, P707, DOI 10.1016/j.neuron.2009.10.019; Sale A, 2007, NAT NEUROSCI, V10, P679, DOI 10.1038/nn1899; Sale A, 2009, TRENDS NEUROSCI, V32, P233, DOI 10.1016/j.tins.2008.12.004; SMITH DC, 1978, J COMP NEUROL, V178, P313, DOI 10.1002/cne.901780207; VEREECKEN EP, 1984, ARCH OPHTHALMOL-CHIC, V102, P220; WIESEL TN, 1965, J NEUROPHYSIOL, V28, P1060, DOI 10.1152/jn.1965.28.6.1060; WILSON ME, 1992, J PEDIATR OPHTHALMOL, V29, P100	29	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34815	10.1371/journal.pone.0034815	http://dx.doi.org/10.1371/journal.pone.0034815			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509358	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600059
J	Ziervogel, K; McKay, L; Rhodes, B; Osburn, CL; Dickson-Brown, J; Arnosti, C; Teske, A				Ziervogel, Kai; McKay, Luke; Rhodes, Benjamin; Osburn, Christopher L.; Dickson-Brown, Jennifer; Arnosti, Carol; Teske, Andreas			Microbial Activities and Dissolved Organic Matter Dynamics in Oil-Contaminated Surface Seawater from the Deepwater Horizon Oil Spill Site	PLOS ONE			English	Article							MARINE; BIODEGRADATION; BACTERIA	The Deepwater Horizon oil spill triggered a complex cascade of microbial responses that reshaped the dynamics of heterotrophic carbon degradation and the turnover of dissolved organic carbon (DOC) in oil contaminated waters. Our results from 21-day laboratory incubations in rotating glass bottles (roller bottles) demonstrate that microbial dynamics and carbon flux in oil-contaminated surface water sampled near the spill site two weeks after the onset of the blowout were greatly affected by activities of microbes associated with macroscopic oil aggregates. Roller bottles with oil-amended water showed rapid formation of oil aggregates that were similar in size and appearance compared to oil aggregates observed in surface waters near the spill site. Oil aggregates that formed in roller bottles were densely colonized by heterotrophic bacteria, exhibiting high rates of enzymatic activity (lipase hydrolysis) indicative of oil degradation. Ambient waters surrounding aggregates also showed enhanced microbial activities not directly associated with primary oil-degradation (beta-glucosidase; peptidase), as well as a twofold increase in DOC. Concurrent changes in fluorescence properties of colored dissolved organic matter (CDOM) suggest an increase in oil-derived, aromatic hydrocarbons in the DOC pool. Thus our data indicate that oil aggregates mediate, by two distinct mechanisms, the transfer of hydrocarbons to the deep sea: a microbially-derived flux of oil-derived DOC from sinking oil aggregates into the ambient water column, and rapid sedimentation of the oil aggregates themselves, serving as vehicles for oily particulate matter as well as oil aggregate-associated microbial communities.	[Ziervogel, Kai; McKay, Luke; Rhodes, Benjamin; Arnosti, Carol; Teske, Andreas] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA; [Osburn, Christopher L.; Dickson-Brown, Jennifer] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University	Ziervogel, K (corresponding author), Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA.	ziervoge@email.unc.edu	Teske, Andreas/AAQ-9577-2021	Ziervogel, Kai/0000-0002-4734-1369; Osburn, Christopher/0000-0002-9334-4202	NSF RAPID [OCE-1045115, OCE-0848703]; Division Of Ocean Sciences [0848703] Funding Source: National Science Foundation	NSF RAPID(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by NSF RAPID grant OCE-1045115. B.R. and C.A. were supported by OCE-0848703. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLDREDGE AL, 1988, LIMNOL OCEANOGR, V33, P339, DOI 10.4319/lo.1988.33.3.0339; Ammerman JW, 2000, MAR ECOL PROG SER, V201, P1, DOI 10.3354/meps201001; Arnosti C, 2011, ANNU REV MAR SCI, V3, P401, DOI 10.1146/annurev-marine-120709-142731; Atlas RM, 2011, ENVIRON SCI TECHNOL, V45, P6709, DOI 10.1021/es2013227; Camilli R, 2010, SCIENCE, V330, P201, DOI 10.1126/science.1195223; Coble PG, 2007, CHEM REV, V107, P402, DOI 10.1021/cr050350+; Diercks AR, 2010, P OCEANS 2010 MTS IE; Diercks AR, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045046; Federal Interagency Solutions Group, 2010, OIL BUDG CALC TECHN; Fingas M, 2003, MAR POLLUT BULL, V47, P369, DOI 10.1016/S0025-326X(03)00212-1; Gutierrez T, 2007, J APPL MICROBIOL, V103, P1716, DOI 10.1111/j.1365-2672.2007.03407.x; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Head IM, 2006, NAT REV MICROBIOL, V4, P173, DOI 10.1038/nrmicro1348; Hino S, 1997, J FERMENT BIOENG, V84, P528, DOI 10.1016/S0922-338X(97)81906-X; HOPPE HG, 1983, MAR ECOL PROG SER, V11, P299, DOI 10.3354/meps011299; Iwabuchi N, 2002, APPL ENVIRON MICROB, V68, P2337, DOI 10.1128/AEM.68.5.2337-2343.2002; Kasai Y, 2002, APPL ENVIRON MICROB, V68, P5625, DOI 10.1128/AEM.68.11.5625-5633.2002; Kessler JD, 2011, SCIENCE, V331, P312, DOI 10.1126/science.1199697; Murrell MC, 2003, AQUAT MICROB ECOL, V32, P239, DOI 10.3354/ame032239; Niu HB, 2011, ENVIRON MODEL ASSESS, V16, P61, DOI 10.1007/s10666-010-9228-0; NRC, 2003, OIL SEA; Operational Science Advisory Team (OSAT), 2010, SUMM REP FAT EFF REM; OSAT, 2010, SUMM REP SUBS SUBS O; PATTON JS, 1981, NATURE, V290, P235, DOI 10.1038/290235a0; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Ratzel A., 2011, ASSESSMENT FLOW RATE; Reddy CM, 2012, P NATL ACAD SCI USA, V109, P20229, DOI 10.1073/pnas.1101242108; Redmond MC, 2012, P NATL ACAD SCI USA, V109, P20292, DOI 10.1073/pnas.1108756108; SENESI N, 1991, SOIL SCI, V152, P259, DOI 10.1097/00010694-199110000-00004; SHANKS AL, 1989, MAR BIOL, V101, P463, DOI 10.1007/BF00541648; Stedmon CA, 2000, ESTUAR COAST SHELF S, V51, P267, DOI 10.1006/ecss.2000.0645; Unanue MA, 1998, FEMS MICROBIOL ECOL, V26, P325; Valentine DL, 2012, P NATL ACAD SCI USA, V109, P20286, DOI 10.1073/pnas.1108820109; Valentine DL, 2010, SCIENCE, V330, P208, DOI 10.1126/science.1196830; VELJI MI, 1986, CAN J MICROBIOL, V32, P121, DOI 10.1139/m86-024; WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242; Wysocki LA, 2006, ESTUAR COAST SHELF S, V69, P47, DOI 10.1016/j.ecss.2006.03.022; Ziervogel K, 2010, BIOGEOSCIENCES, V7, P1007, DOI 10.5194/bg-7-1007-2010	38	99	100	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34816	10.1371/journal.pone.0034816	http://dx.doi.org/10.1371/journal.pone.0034816			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509359	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336600060
J	Walker, RS; Wichmann, S; Mailund, T; Atkisson, CJ				Walker, Robert S.; Wichmann, Soren; Mailund, Thomas; Atkisson, Curtis J.			Cultural Phylogenetics of the Tupi Language Family in Lowland South America	PLOS ONE			English	Article							QUARTET DISTANCE; EVOLUTION; HISTORY; TREE; RESIDENCE; SUPPORT; CLASSIFICATION; TRANSMISSION; COMPLEXITY; STRATEGIES	Background: Recent advances in automated assessment of basic vocabulary lists allow the construction of linguistic phylogenies useful for tracing dynamics of human population expansions, reconstructing ancestral cultures, and modeling transition rates of cultural traits over time. Methods: Here we investigate the Tupi expansion, a widely-dispersed language family in lowland South America, with a distance-based phylogeny based on 40-word vocabulary lists from 48 languages. We coded 11 cultural traits across the diverse Tupi family including traditional warfare patterns, post-marital residence, corporate structure, community size, paternity beliefs, sibling terminology, presence of canoes, tattooing, shamanism, men's houses, and lip plugs. Results/Discussion: The linguistic phylogeny supports a Tupi homeland in west-central Brazil with subsequent major expansions across much of lowland South America. Consistently, ancestral reconstructions of cultural traits over the linguistic phylogeny suggest that social complexity has tended to decline through time, most notably in the independent emergence of several nomadic hunter-gatherer societies. Estimated rates of cultural change across the Tupi expansion are on the order of only a few changes per 10,000 years, in accord with previous cultural phylogenetic results in other language families around the world, and indicate a conservative nature to much of human culture.	[Walker, Robert S.; Atkisson, Curtis J.] Univ Missouri, Dept Anthropol, Columbia, MO 65211 USA; [Wichmann, Soren] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Mailund, Thomas] Aarhus Univ, Bioinformat Res Ctr, Aarhus, Denmark	University of Missouri System; University of Missouri Columbia; Max Planck Society; Aarhus University	Walker, RS (corresponding author), Univ Missouri, Dept Anthropol, 200 Swallow Hall, Columbia, MO 65211 USA.	walkerro@missouri.edu	Wichmann, Søren/H-6659-2016	Wichmann, Søren/0000-0002-3257-3087; Mailund, Thomas/0000-0001-6206-9239	Research Board and Arts and Science Alumni Organization Faculty Incentive Grants (University of Missouri)	Research Board and Arts and Science Alumni Organization Faculty Incentive Grants (University of Missouri)	Financial support was provided by Research Board and Arts and Science Alumni Organization Faculty Incentive Grants (University of Missouri) to Robert Walker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balee W, 2000, ETHNOHISTORY, V47, P399, DOI 10.1215/00141801-47-2-399; Bansal MS, 2011, THEOR COMPUT SCI, V412, P6634, DOI 10.1016/j.tcs.2011.08.027; Boas Franz, 1896, J AM FOLKLORE, V9, P1, DOI [10.2307/532988, DOI 10.2307/532988]; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Boyd R., 1997, HUMAN NATURE BIOL SO, P355; Brown CH, 2008, STUF-LANG TYPOL UNIV, V61, P285; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bryant D., 2005, EVOLUTION CULTURAL D, P67; Cabral Ana Suelly De Arruda Camara, 1995, THESIS U PITTSBURGH; Callegari-Jacques SM, 2011, AM J PHYS ANTHROPOL, V145, P371, DOI 10.1002/ajpa.21505; Christiansen C, 2006, ALGORITHM MOL BIOL, V1, DOI 10.1186/1748-7188-1-16; Cisco J, CULTURAL PHYLOGENETI; Collard M, 2006, EVOL HUM BEHAV, V27, P169, DOI 10.1016/j.evolhumbehav.2005.07.003; Crandall KA, 2004, SCIENCE, V306, P1144, DOI 10.1126/science.1106198; Critchlow DE, 1996, SYST BIOL, V45, P323, DOI 10.2307/2413567; Currie TE, 2011, PHILOS T R SOC B, V366, P1108, DOI 10.1098/rstb.2010.0318; Currie TE, 2010, NATURE, V467, P801, DOI 10.1038/nature09461; de Castro Eduardo Viveiros, 1992, ENEMYS POINT VIEW HU; Diamond J, 2001, ANTHR CONT PERSPECTI, P24; Dietrich W, 1990, MORE EVIDENCE IN S12; Dietrich W, 2009, 2 ENC LENG IND AM 2; Drude Sebastian, 2006, ESTUD HIST-URUGUAY, P11; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Dziebel G., 2007, GENIUS KINSHIP PHENO; ESTABROOK GF, 1985, SYST ZOOL, V34, P193, DOI 10.2307/2413326; Fortunato L, 2006, HUM NATURE-INT BIOS, V17, P355, DOI 10.1007/s12110-006-1000-4; Fortunato L, 2011, HUM BIOL, V83, P87, DOI 10.3378/027.083.0106; Fortunato L, 2011, HUM BIOL, V83, P107, DOI 10.3378/027.083.0107; Fortunato L, 2009, ORIG HUM BEHAV, V2, P235; Fortunato L, 2010, PHILOS T R SOC B, V365, P3913, DOI 10.1098/rstb.2010.0017; Gildea S, 2008, B MUSEU PARAENSE EMI, V2, P19; Gray J., 1999, WORLD CULTURES J, V10, P24; Gray RD, 2009, SCIENCE, V323, P479, DOI 10.1126/science.1166858; Gray RD, 2000, NATURE, V405, P1052, DOI 10.1038/35016575; Gray RD, 2003, NATURE, V426, P435, DOI 10.1038/nature02029; Gray RD, 2010, PHILOS T R SOC B, V365, P3923, DOI 10.1098/rstb.2010.0162; Gray Russell D., 2007, Biological Theory, V2, P360, DOI 10.1162/biot.2007.2.4.360; Greenhill SJ, 2010, P ROY SOC B-BIOL SCI, V277, P2443, DOI 10.1098/rspb.2010.0051; Greenhill SJ, 2009, P ROY SOC B-BIOL SCI, V276, P2299, DOI 10.1098/rspb.2008.1944; Harris Marvin, 1989, OUR KIND; Hemming J., 1978, RED GOLD CONQUEST BR; Henrich J, 2004, AM ANTIQUITY, V69, P197, DOI 10.2307/4128416; Holden C. J., 2005, EVOLUTION CULTURAL D, P217; Holden CJ, 2002, P ROY SOC B-BIOL SCI, V269, P793, DOI 10.1098/rspb.2002.1955; Holden CJ, 2003, P ROY SOC B-BIOL SCI, V270, P2425, DOI 10.1098/rspb.2003.2535; Holman EW, 2008, FOLIA LINGUIST, V42, P331, DOI 10.1515/FLIN.2008.331; Hostetler John, 1993, AMISH SOC, DOI 10.2307/539066; Jensen Cheryl., 1999, AMAZONIAN LANGUAGES, P125; Jordan F., 2007, THESIS U COLL LONDON; Jordan FM, 2009, P ROY SOC B-BIOL SCI, V276, P1957, DOI 10.1098/rspb.2009.0088; Klimek S, 1935, AM ANTHROPOL, V37, P71, DOI 10.1525/aa.1935.37.1.02a00070; KROEBER AL, 1948, ANTHROPOLOGY; Lemle Miriam., 1971, TUPI STUDIES, P107; LEWIS PM, 2009, ETHNOLOGUE LANGUAGES; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Lycett SJ, 2009, J HUM EVOL, V57, P337, DOI 10.1016/j.jhevol.2009.05.015; Macario KD, 2009, RADIOCARBON, V51, P937, DOI 10.1017/S0033822200034019; Mace R, 2005, TRENDS ECOL EVOL, V20, P116, DOI 10.1016/j.tree.2004.12.002; MACE R, 1994, CURR ANTHROPOL, V35, P549, DOI 10.1086/204317; Mace R, 2005, EVOLUTION CULTURAL D; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Mailund T, 2004, BIOINFORMATICS, V20, P1636, DOI 10.1093/bioinformatics/bth097; Matraux A, 1928, CIVILISATION MAT TRI; MELLO A. A. S., 2000, THESIS U FEDERAL SAN; Mello AAS, 2001, LINGUAS INDIGENAS BR, VI, P338; Mulder MB, 2006, EVOL ANTHROPOL, V15, P52, DOI 10.1002/evan.20088; Mulder MB, 2001, EVOL ANTHROPOL, V10, P99; Nelson-Sathi S, 2011, P ROY SOC B-BIOL SCI, V278, P1794, DOI 10.1098/rspb.2010.1917; Nielsen J, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-15; Noelli FS, 1998, ANTIQUITY, V72, P648, DOI 10.1017/S0003598X00087068; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Pagel M, 2005, EVOLUTION CULTURAL D, P235; Pagel M, 2009, NAT REV GENET, V10, P405, DOI 10.1038/nrg2560; Parks DH, 2009, GENOME RES, V19, P1896, DOI 10.1101/gr.095612.109; Pompei S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020109; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Rodrigues, 1986, LINGUAS BRASILEIRAS; Rodrigues, 1984, REV ANTROPOLOGIA, V27, P33; RODRIGUES AD, 1958, INT J AM LINGUIST, V24, P231, DOI 10.1086/464461; Rodrigues AD, 2001, LINGUAS INDIGENAS BR, VI, P327; Rodrigues Aryon Dall'Igna, 1985, S AM INDIAN LANGUAGE, P371; Rodrigues Aryon DallIgna, 1964, REV ANTROPOL, V12, P99; Rodrigues AryonD., 1997, DIACHRONICA, V14, P265, DOI DOI 10.1075/DIA.14.2.04ROD; Salzano FM, 2005, CURR ANTHROPOL, V46, pS121, DOI 10.1086/497667; Scheel-Ybert R, 2008, AN ACAD BRAS CIENC, V80, P763, DOI 10.1590/S0001-37652008000400015; Schleicher CharlesO., 1998, THESIS U WISCONSIN M; Shennen S., 2010, INNOVATION CULTURAL, P161; Steward Julian H., 1959, NATIVE PEOPLES S AM; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Temkin I, 2007, CURR ANTHROPOL, V48, P146, DOI 10.1086/510463; TERRELL J, 1988, ANTIQUITY, V62, P642, DOI 10.1017/S0003598X00075049; Walker RS, 2011, P ROY SOC B-BIOL SCI, V278, P1399, DOI 10.1098/rspb.2010.1942; Walker RS, 2010, P NATL ACAD SCI USA, V107, P19195, DOI 10.1073/pnas.1002598107; Wichmann S, 2010, PHYSICA A, V389, P3632, DOI 10.1016/j.physa.2010.05.011; Wichmann Soren, 2011, ASJP DATABASE VERSIO; [No title captured]; [No title captured]	99	42	43	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35025	10.1371/journal.pone.0035025	http://dx.doi.org/10.1371/journal.pone.0035025			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	959FE	22506065	Green Published, Green Submitted, gold			2022-12-27	WOS:000305297500072
J	Norgaard, T; Ebner, M; Dacke, M				Norgaard, Thomas; Ebner, Martin; Dacke, Marie			Animal or Plant: Which Is the Better Fog Water Collector?	PLOS ONE			English	Article							DESERT; BASKING	Occasional fog is a critical water source utilised by plants and animals in the Namib Desert. Fog basking beetles (Onymacris unguicularis, Tenebrionidae) and Namib dune bushman grass (Stipagrostris sabulicola, Poaceae) collect water directly from the fog. While the beetles position themselves optimally for fog water collection on dune ridges, the grass occurs predominantly at the dune base where less fog water is available. Differences in the fog-water collecting abilities in animals and plants have never been addressed. Here we place beetles and grass side-by-side in a fog chamber and measure the amount of water they collect over time. Based on the accumulated amount of water over a two hour period, grass is the better fog collector. However, in contrast to the episodic cascading water run-off from the grass, the beetles obtain water in a steady flow from their elytra. This steady trickle from the beetles' elytra to their mouth could ensure that even short periods of fog basking - while exposed to predators - will yield water. Up to now there is no indication of specialised surface properties on the grass leafs, but the steady run-off from the beetles could point to specific property adaptations of their elytra surface.	[Norgaard, Thomas; Dacke, Marie] Lund Univ, Dept Biol, Lund, Sweden; [Ebner, Martin] Univ Tubingen, Inst Geosci, Tubingen, Germany	Lund University; Eberhard Karls University of Tubingen	Norgaard, T (corresponding author), Lund Univ, Dept Biol, Lund, Sweden.	thomas.norgaard@biol.lu.se			Carl Tryggers Foundation	Carl Tryggers Foundation	The authors thank the Carl Tryggers Foundation for funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cereceda P, 2002, ATMOS RES, V64, P261, DOI 10.1016/S0169-8095(02)00097-2; Ebner M, 2011, J ARID ENVIRON, V75, P524, DOI 10.1016/j.jaridenv.2011.01.004; Gonser SG, 2012, PURE APPL GEOPHYS, V169, P821, DOI 10.1007/s00024-011-0270-x; Hamilton WJ, 2003, S AFR J SCI, V99, P181; HAMILTON WJ, 1976, NATURE, V262, P284, DOI 10.1038/262284a0; Henschel JR, 1998, 8 DRFN; Kidron GJ, 1999, AGR FOREST METEOROL, V96, P1, DOI 10.1016/S0168-1923(99)00043-X; LANCASTER J, 1984, Madoqua, V14, P5; Norgaard T, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-23; PIETRUSZKA RD, 1985, S AFR J SCI, V81, P682; ROBINSON MD, 1980, J ARID ENVIRON, V3, P183, DOI 10.1016/S0140-1963(18)31647-1; SEELY MK, 1979, OECOLOGIA, V42, P213, DOI 10.1007/BF00344858; SEELY MK, 1976, SCIENCE, V193, P484, DOI 10.1126/science.193.4252.484; Vogel S, 1994, LIFE MOVING FLUIDS; WARD JD, 1983, S AFR J SCI, V79, P175	15	24	26	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34603	10.1371/journal.pone.0034603	http://dx.doi.org/10.1371/journal.pone.0034603			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509331	Green Published, gold, Green Submitted			2022-12-27	WOS:000304805900054
J	Liu, JB; Chen, DW; Yao, Y; Yu, B; Mao, XB; He, J; Huang, ZQ; Zheng, P				Liu, Jingbo; Chen, Daiwen; Yao, Ying; Yu, Bing; Mao, Xiangbing; He, Jun; Huang, Zhiqing; Zheng, Ping			Intrauterine Growth Retardation Increases the Susceptibility of Pigs to High-Fat Diet-Induced Mitochondrial Dysfunction in Skeletal Muscle	PLOS ONE			English	Article							IMPAIRED OXIDATIVE-PHOSPHORYLATION; MTDNA COPY NUMBER; GENE-EXPRESSION; BIRTH-WEIGHT; INSULIN-RESISTANCE; RAT-LIVER; IN-UTERO; FETAL; RESTRICTION; ENZYMES	It has been recognized that there is a relationship between prenatal growth restriction and the development of metabolic-related diseases in later life, a process involved in mitochondrial dysfunction. In addition, intrauterine growth retardation (IUGR) increases the susceptibility of offspring to high-fat (HF) diet-induced metabolic syndrome. Recent findings suggested that HF feeding decreased mitochondrial oxidative capacity and impaired mitochondrial function in skeletal muscle. Therefore, we hypothesized that the long-term consequences of IUGR on mitochondrial biogenesis and function make the offspring more susceptible to HF diet-induced mitochondrial dysfunction. Normal birth weight (NBW), and IUGR pigs were allotted to control or HF diet in a completely randomized design, individually. After 4 weeks of feeding, growth performance and molecular pathways related to mitochondrial function were determined. The results showed that IUGR decreased growth performance and plasma insulin concentrations. In offspring fed a HF diet, IUGR was associated with enhanced plasma leptin levels, increased concentrations of triglyceride and malondialdehyde (MDA), and reduced glycogen and ATP contents in skeletal muscle. High fat diet-fed IUGR offspring exhibited decreased activities of lactate dehydrogenase (LDH) and glucose-6-phosphate dehydrogenase (G6PD). These alterations in metabolic traits of IUGR pigs were accompanied by impaired mitochondrial respiration function, reduced mitochondrial DNA (mtDNA) contents, and down-regulated mRNA expression levels of genes responsible for mitochondrial biogenesis and function. In conclusion, our results suggest that IUGR make the offspring more susceptible to HF diet-induced mitochondrial dysfunction.	[Liu, Jingbo; Chen, Daiwen; Yao, Ying; Yu, Bing; Mao, Xiangbing; He, Jun; Huang, Zhiqing; Zheng, Ping] Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China; [Liu, Jingbo; Chen, Daiwen; Yao, Ying; Yu, Bing; Mao, Xiangbing; He, Jun; Huang, Zhiqing; Zheng, Ping] Minist Educ, Key Lab Anim Dis Resistance Nutr, Beijing, Peoples R China	Sichuan Agricultural University	Liu, JB (corresponding author), Sichuan Agr Univ, Inst Anim Nutr, Yaan, Sichuan, Peoples R China.	dwchen@sicau.edu.cn			Program for Changjiang Scholars and Innovative Research Team in University, Ministry of Education of China [IRT0555-5]; earmarked fund for China Agriculture Research System [CARS-36]	Program for Changjiang Scholars and Innovative Research Team in University, Ministry of Education of China(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)Ministry of Education, China); earmarked fund for China Agriculture Research System	This work was supported by Program for Changjiang Scholars and Innovative Research Team in University, Ministry of Education of China (IRT0555-5), and the earmarked fund for China Agriculture Research System (CARS-36). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2000, THERIOGENOLOGY, V53, P555, DOI 10.1016/S0093-691X(99)00258-7; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Coupe B, 2009, AM J PHYSIOL-REG I, V297, pR813, DOI 10.1152/ajpregu.00201.2009; Crescenzo R, 2008, OBESITY, V16, P958, DOI 10.1038/oby.2008.10; Desai M, 2007, AM J OBSTET GYNECOL, V196; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Godfrey K, 2006, CURR OPIN OBSTET GYN, V16, P267, DOI DOI 10.1016/j.curobgyn.2006.07.004; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; Godfrey KM, 2000, AM J CLIN NUTR, V71, p1344S, DOI 10.1093/ajcn/71.5.1344s; Gondret F, 2005, LIVEST PROD SCI, V93, P137, DOI 10.1016/j.livprodsci.2004.09.009; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; He J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015110; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Hoeks J, 2008, FEBS LETT, V582, P510, DOI 10.1016/j.febslet.2008.01.013; IDE T, 1987, LIPIDS, V22, P6, DOI 10.1007/BF02534867; Iossa S, 2003, BRIT J NUTR, V90, P953, DOI 10.1079/BJN2003000968; Jacob S, 1999, DIABETES, V48, P1113, DOI 10.2337/diabetes.48.5.1113; Jorgensen W, 2009, AM J PHYSIOL-ENDOC M, V297, pE1349, DOI 10.1152/ajpendo.00505.2009; Kouba M, 1999, MEAT SCI, V52, P39, DOI 10.1016/S0309-1740(98)00146-6; Lane RH, 2001, PEDIATR RES, V50, P83, DOI 10.1203/00006450-200107000-00016; Lane RH, 1996, PEDIATR RES, V39, P390, DOI 10.1203/00006450-199603000-00003; Lee HK, 1998, DIABETES RES CLIN PR, V42, P161, DOI 10.1016/S0168-8227(98)00110-7; Lee YY, 2011, BRIT J NUTR, V106, P1198, DOI 10.1017/S0007114511001632; Lee YY, 2005, J NUTR BIOCHEM, V16, P195, DOI 10.1016/j.jnutbio.2004.11.002; Li ZY, 2011, BIOCHEM BIOPH RES CO, V414, P5, DOI 10.1016/j.bbrc.2011.09.046; Liu JB, 2011, ARCH ANIM NUTR, V65, P376, DOI 10.1080/1745039X.2011.594352; Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921; Merrifield CA, 2011, MOL BIOSYST, V7, P2577, DOI 10.1039/c1mb05023k; Morise A, 2011, BRIT J NUTR, V105, P1471, DOI 10.1017/S0007114510005386; Morris TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007271; Mortensen OH, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S38; Mortensen OH, 2010, PEDIATR RES, V67, P47, DOI 10.1203/PDR.0b013e3181c4735c; *NAT RES COUNC, 1996, GUID CAR US LAB AN; National Research Council, 1998, NUTR REQ SWIN, Vtenth; OGATA ES, 1990, PEDIATR RES, V27, P56, DOI 10.1203/00006450-199001000-00017; Park KS, 2003, J NUTR, V133, P3085, DOI 10.1093/jn/133.10.3085; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Peterside IE, 2003, AM J PHYSIOL-ENDOC M, V285, pE1258, DOI 10.1152/ajpendo.00437.2002; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poore KR, 2004, J PHYSIOL-LONDON, V558, P295, DOI 10.1113/jphysiol.2004.061390; POWELL SE, 1980, J ANIM SCI, V50, P860, DOI 10.2527/jas1980.505860x; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rueda-Clausen CF, 2011, DIABETES, V60, P507, DOI 10.2337/db10-1239; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scifres CM, 2009, J PHYSIOL-LONDON, V587, P3453, DOI 10.1113/jphysiol.2009.173252; Selak MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE130, DOI 10.1152/ajpendo.00322.2002; Serviddio G, 2007, REDOX REP, V12, P91, DOI 10.1179/135100007X162112; Serviddio G, 2010, J PHARMACOL EXP THER, V332, P922, DOI 10.1124/jpet.109.161612; Simmons Rebecca A, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P13, DOI 10.1097/MED.0b013e328013da5b; Sreekumar R, 2007, INDIAN J MED RES, V125, P399; Taylor PD, 2007, EXP PHYSIOL, V92, P287, DOI 10.1113/expphysiol.2005.032854; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Wu G, 2006, J ANIM SCI, V84, P2316, DOI 10.2527/jas.2006-156	57	41	45	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34835	10.1371/journal.pone.0034835	http://dx.doi.org/10.1371/journal.pone.0034835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523560	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345000032
J	Wang, W; Lundin, VF; Millan, I; Zeng, AN; Chen, XY; Yang, J; Allen, E; Chen, NN; Bach, G; Hsu, A; Maloney, MT; Kapur, M; Yang, Y				Wang, Wei; Lundin, Victor F.; Millan, Ivan; Zeng, Anne; Chen, Xinyu; Yang, Jie; Allen, Elizabeth; Chen, Ningna; Bach, Gillian; Hsu, Andrew; Maloney, Michael T.; Kapur, Mridu; Yang, Yanmin			Nemitin, a Novel Map8/Map1s Interacting Protein with Wd40 Repeats	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEIN-8; LIS1; DEGRADATION; DOMAIN; DYNEIN; TAU; 1S; 1B	In neurons, a highly regulated microtubule cytoskeleton is essential for many cellular functions. These include axonal transport, regional specialization and synaptic function. Given the critical roles of microtubule-associated proteins (MAPs) in maintaining and regulating microtubule stability and dynamics, we sought to understand how this regulation is achieved. Here, we identify a novel LisH/WD40 repeat protein, tentatively named nemitin (neuronal enriched MAP interacting protein), as a potential regulator of MAP8-associated microtubule function. Based on expression at both the mRNA and protein levels, nemitin is enriched in the nervous system. Its protein expression is detected as early as embryonic day 11 and continues through adulthood. Interestingly, when expressed in non-neuronal cells, nemitin displays a diffuse pattern with puncta, although at the ultrastructural level it localizes along the microtubule network in vivo in sciatic nerves. These results suggest that the association of nemitin to microtubules may require an intermediary protein. Indeed, co-expression of nemitin with microtubule-associated protein 8 (MAP8) results in nemitin losing its diffuse pattern, instead decorating microtubules uniformly along with MAP8. Together, these results imply that nemitin may play an important role in regulating the neuronal cytoskeleton through an interaction with MAP8.	[Wang, Wei; Lundin, Victor F.; Millan, Ivan; Zeng, Anne; Allen, Elizabeth; Chen, Ningna; Bach, Gillian; Hsu, Andrew; Maloney, Michael T.; Kapur, Mridu; Yang, Yanmin] Stanford Univ, Dept Neurol, Sch Med, Stanford, CA 94305 USA; [Chen, Xinyu; Yang, Jie] Shanghai Jiao Tong Univ, Sch Med, Dept Biochem & Cell Biol, Shanghai 200030, Peoples R China	Stanford University; Shanghai Jiao Tong University	Wang, W (corresponding author), Stanford Univ, Dept Neurol, Sch Med, Stanford, CA 94305 USA.	yanmin.yang@stanford.edu	Kapur, Mridu/M-2669-2019	Kapur, Mridu/0000-0002-3313-5038; Zeng, Anne/0000-0002-1452-2462	National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01NS060897]; Human Frontier Science Program Postdoctoral Fellowship; Regina Casper Stanford Graduate Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060897] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Human Frontier Science Program Postdoctoral Fellowship(Human Frontier Science Program); Regina Casper Stanford Graduate Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health/National Institute of Neurological Disorders and Stroke R01NS060897, a Human Frontier Science Program Postdoctoral Fellowship, and a Regina Casper Stanford Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, NATURE, V438, P224, DOI 10.1038/nature04256; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Dehmelt L, 2005, GENOME BIOL, V6; Ding JQ, 2006, HUM MOL GENET, V15, P1451, DOI 10.1093/hmg/ddl069; Ding JQ, 2006, BIOCHEM BIOPH RES CO, V339, P172, DOI 10.1016/j.bbrc.2005.10.199; Ding JQ, 2002, J CELL BIOL, V158, P427, DOI 10.1083/jcb.200202055; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; DOBYNS WB, 1993, JAMA-J AM MED ASSOC, V270, P2838, DOI 10.1001/jama.270.23.2838; Eriksson M, 2007, BIOCHEM BIOPH RES CO, V361, P127, DOI 10.1016/j.bbrc.2007.06.179; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hirokawa N, 1996, J CELL BIOL, V132, P667, DOI 10.1083/jcb.132.4.667; Iqbal K, 2009, ACTA NEUROPATHOL, V118, P53, DOI 10.1007/s00401-009-0486-3; Jorgensen ND, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008463; Kett LR, 2012, HUM MOL GENET, V21, P890, DOI 10.1093/hmg/ddr526; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; Mateja A, 2006, J MOL BIOL, V357, P621, DOI 10.1016/j.jmb.2006.01.002; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Orban-Nemeth Z, 2005, J BIOL CHEM, V280, P2257, DOI 10.1074/jbc.M408984200; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Su QN, 2004, NAT CELL BIOL, V6, P941, DOI 10.1038/ncb1169; Wang W, 2005, CURR BIOL, V15, P2050, DOI 10.1016/j.cub.2005.10.052; Xie R, 2011, J BIOL CHEM, V286, P10367, DOI 10.1074/jbc.M110.206532; Xu C, 2011, PROTEIN CELL, V2, P202, DOI 10.1007/s13238-011-1018-1; Yang YM, 1999, CELL, V98, P229, DOI 10.1016/S0092-8674(00)81017-X	24	7	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e33094	10.1371/journal.pone.0033094	http://dx.doi.org/10.1371/journal.pone.0033094			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523538	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345000007
J	Lee, JK; Bettencourt, R; Brenner, D; Le, TA; Barrett-Connor, E; Loomba, R				Lee, Jeffrey K.; Bettencourt, Ricki; Brenner, David; Le, Thuy-Anh; Barrett-Connor, Elizabeth; Loomba, Rohit			Association between Serum Interleukin-6 Concentrations and Mortality in Older Adults: The Rancho Bernardo Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; UNITED-STATES; CARDIOVASCULAR-DISEASE; SYSTEMIC INFLAMMATION; PARTIAL-HEPATECTOMY; LIVER INFLAMMATION; ALL-CAUSE; CANCER; RISK; IL-6	Background: Interleukin-6 (IL-6) may have a protective role in acute liver disease but a detrimental effect in chronic liver disease. It is unknown whether IL-6 is associated with risk of liver-related mortality in humans. Aims: To determine if IL-6 is associated with an increased risk of all-cause, cardiovascular disease (CVD), cancer, and liver-related mortality. Methods: A prospective cohort study included 1843 participants who attended a research visit in 1984-87. Multiple covariates were ascertained including serum IL-6. Multivariable-adjusted Cox proportional hazards regression analyses were used to examine the association between serum IL-6 as a continuous (log transformed) variable with all-cause, CVD, cancer, and liver-related mortality. Patients with prevalent CVD, cancer and liver disease were excluded for cause-specific mortality. Results: The mean (+/- standard deviation) age and body-mass-index (BMI) of participants was 68 (+/- 10.6) years and 25 (+/- 3.7) Kg/m(2), respectively. During the 25,802 person-years of follow-up, the cumulative all-cause, CVD, cancer, and liver-related mortality were 53.1% (N = 978), 25.5%, 11.3%, and 1.3%, respectively. The median (+/- IQR) length of follow-up was 15.3 +/- 10.6 years. In multivariable analyses, adjusted for age, sex, alcohol, BMI, diabetes, hypertension, total cholesterol, HDL, and smoking, one-SD increment in log-transformed serum IL-6 was associated with increased risk of all-cause, CVD, cancer, and liver-related mortality, with hazard ratios of 1.48 (95% CI, 1.33-1.64), 1.38 (95% CI, 1.16-1.65), 1.35 (95% CI, 1.02-1.79), and 1.88 (95% CI, 0.97-3.67), respectively. CRP adjustment attenuated the effects but the association between IL-6 and all-cause and CVD mortality remained statistically significant, independent of CRP levels. Conclusions: In community-dwelling older adults, serum IL-6 is associated with all-cause, CVD, cancer, and liver-related mortality.	[Lee, Jeffrey K.; Brenner, David; Le, Thuy-Anh; Loomba, Rohit] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Brenner, David; Le, Thuy-Anh; Loomba, Rohit] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA; [Bettencourt, Ricki; Barrett-Connor, Elizabeth; Loomba, Rohit] Univ Calif San Diego, Dept Family & Prevent Med, Div Epidemiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Lee, JK (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	roloomba@ucsd.edu	Bettencourt, Ricki/M-3531-2019; Loomba, Rohit/AAE-7831-2019	Loomba, Rohit/0000-0002-4845-9991; Brenner, David/0000-0003-2573-525X	American Gastroenterological Association Foundation - Sucampo - ASP Designated Research Award in Geriatric Gastroenterology; T. Franklin Williams Scholarship Award; Atlantic Philanthropies, Inc; John A. Hartford Foundation; Association of Specialty Professors; American Gastroenterological Association; University of California San Diego Digestive Diseases Research Development Center, United States PHS [DK080506]; National Institutes of Health/National Institute on Aging [AG07181, AG028507]; National Institute of Diabetes and Digestive and Kidney Diseases [DK31801];  [K23-DK090303]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202, K23DK090303, R01DK031801, R24DK080506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG007181, R01AG028507, R37AG007181] Funding Source: NIH RePORTER	American Gastroenterological Association Foundation - Sucampo - ASP Designated Research Award in Geriatric Gastroenterology; T. Franklin Williams Scholarship Award; Atlantic Philanthropies, Inc; John A. Hartford Foundation; Association of Specialty Professors; American Gastroenterological Association; University of California San Diego Digestive Diseases Research Development Center, United States PHS; National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported in part by the American Gastroenterological Association Foundation - Sucampo - ASP Designated Research Award in Geriatric Gastroenterology and by a T. Franklin Williams Scholarship Award, funding provided by: Atlantic Philanthropies, Inc, the John A. Hartford Foundation, the Association of Specialty Professors, and the American Gastroenterological Association and grant K23-DK090303 to RL, MD, MHSc. This research was funded in part with the support of the University of California San Diego Digestive Diseases Research Development Center, United States PHS grant #DK080506. This work was supported by the National Institutes of Health/National Institute on Aging grants AG07181 and AG028507, and the National Institute of Diabetes and Digestive and Kidney Diseases, grant DK31801. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2008, J GERONTOL A-BIOL, V63, P1209, DOI 10.1093/gerona/63.11.1209; Armstrong GL, 2006, ANN INTERN MED, V144, P705, DOI 10.7326/0003-4819-144-10-200605160-00004; BARRETTCONNOR E, 1982, AM J EPIDEMIOL, V115, P888, DOI 10.1093/oxfordjournals.aje.a113376; Baune BT, 2011, AGE, V33, P209, DOI 10.1007/s11357-010-9165-5; Blindenbacher A, 2003, HEPATOLOGY, V38, P674, DOI 10.1053/jhep.2003.50378; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Everhart JE, 2009, GASTROENTEROLOGY, V136, P1134, DOI 10.1053/j.gastro.2009.02.038; George DJ, 2005, CLIN CANCER RES, V11, P1815, DOI 10.1158/1078-0432.CCR-04-1560; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; He GB, 2011, CELL RES, V21, P159, DOI 10.1038/cr.2010.183; HILL DB, 1992, J LAB CLIN MED, V119, P547; Jin XL, 2006, HEPATOLOGY, V43, P474, DOI 10.1002/hep.21087; Jylha M, 2007, J GERONTOL A-BIOL, V62, P1016, DOI 10.1093/gerona/62.9.1016; Knupfer H, 2010, INT J COLORECTAL DIS, V25, P135, DOI 10.1007/s00384-009-0818-8; Kovalovich K, 2001, J BIOL CHEM, V276, P26605, DOI 10.1074/jbc.M100740200; Kugelmas M, 2003, HEPATOLOGY, V38, P413, DOI 10.1053/jhep.2003.50316; Laughlin GA, 2004, J CLIN ENDOCR METAB, V89, P114, DOI 10.1210/jc.2003-030967; Loomba R, 2009, ALIMENT PHARM THER, V30, P1137, DOI 10.1111/j.1365-2036.2009.04141.x; Maggio M, 2006, J GERONTOL A-BIOL, V61, P575, DOI 10.1093/gerona/61.6.575; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Papanicolaou DA, 1998, ANN INTERN MED, V128, P127, DOI 10.7326/0003-4819-128-2-199801150-00009; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Preti HA, 1997, ANN INTERN MED, V127, P186, DOI 10.7326/0003-4819-127-3-199708010-00002; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Ruhl CE, 2009, GASTROENTEROLOGY, V136, P477, DOI 10.1053/j.gastro.2008.10.052; Schieffer B, 2000, CIRCULATION, V101, P1372, DOI 10.1161/01.CIR.101.12.1372; Soresi M, 2006, WORLD J GASTROENTERO, V12, P2563, DOI 10.3748/wjg.v12.i16.2563; Stork S, 2006, AM J MED, V119, P519, DOI 10.1016/j.amjmed.2005.10.062; Sun ZL, 2003, GASTROENTEROLOGY, V125, P202, DOI 10.1016/S0016-5085(03)00696-6; Tiberio GAM, 2008, CYTOKINE, V42, P372, DOI 10.1016/j.cyto.2008.03.012; Trompet S, 2009, CLIN CANCER RES, V15, P7744, DOI 10.1158/1078-0432.CCR-09-2152; Volpato S, 2001, CIRCULATION, V103, P947; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x	36	55	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34218	10.1371/journal.pone.0034218	http://dx.doi.org/10.1371/journal.pone.0034218			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514624	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600029
J	Malm, S; Jusko, M; Eick, S; Potempa, J; Riesbeck, K; Blom, AM				Malm, Sven; Jusko, Monika; Eick, Sigrun; Potempa, Jan; Riesbeck, Kristian; Blom, Anna M.			Acquisition of Complement Inhibitor Serine Protease Factor I and Its Cofactors C4b-Binding Protein and Factor H by Prevotella intermedia	PLOS ONE			English	Article							FC-BINDING ACTIVITY; STAPHYLOCOCCUS-AUREUS; PORPHYROMONAS-GINGIVALIS; STREPTOCOCCUS-PNEUMONIAE; RHEUMATOID-ARTHRITIS; PERIODONTAL-DISEASES; CLUMPING FACTOR; SERUM; C3B; CLEAVAGE	Infection with the Gram-negative pathogen Prevotella intermedia gives rise to periodontitis and a growing number of studies implies an association of P. intermedia with rheumatoid arthritis. The serine protease Factor I (FI) is the central inhibitor of complement degrading complement components C3b and C4b in the presence of cofactors such as C4b-binding protein (C4BP) and Factor H (FH). Yet, the significance of complement inhibitor acquisition in P. intermedia infection and FI binding by Gram-negative pathogens has not been addressed. Here we show that P. intermedia isolates bound purified FI as well as FI directly from heat-inactivated human serum. FI bound to bacteria retained its serine protease activity as shown in degradation experiments with I-125-labeled C4b. Since FI requires cofactors for its activity we also investigated the binding of purified cofactors C4BP and FH and found acquisition of both proteins, which retained their activity in FI mediated degradation of C3b and C4b. We propose that FI binding by P. intermedia represents a new mechanism contributing to complement evasion by a Gram-negative bacterial pathogen associated with chronic diseases.	[Malm, Sven; Jusko, Monika; Blom, Anna M.] Lund Univ, Sect Med Prot Chem, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden; [Eick, Sigrun] Univ Bern, Lab Oral Microbiol, Dept Periodontol, Bern, Switzerland; [Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Dept Microbiol, Krakow, Poland; [Potempa, Jan] Univ Louisville, Sch Dent, Ctr Oral Hlth & Syst Dis, Louisville, KY 40292 USA; [Riesbeck, Kristian] Lund Univ, Dept Lab Med, Skane Univ Hosp, Malmo, Sweden	Lund University; Skane University Hospital; University of Bern; Jagiellonian University; University of Louisville; Lund University; Skane University Hospital	Malm, S (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Dept Mol Infect Biol, Sect Microbial Inflammat Res,Div Mol Inflammat Me, Borstel, Germany.	anna.blom@med.lu.se	Blom, Anna/AFS-7369-2022; Potempa, Jan/AAA-6850-2021; Blom, Anna/B-9607-2009	Blom, Anna/0000-0002-1348-1734; Riesbeck, Kristian/0000-0001-6274-6965; Potempa, Jan/0000-0002-3600-7461	Swedish Foundation for Strategic Research, Swedish Medical Research Council [K2009-68X-14928-06-3]; Foundation of Osterlund; Foundation of Kock; Foundation of King Gustav V's 80th Anniversary; Foundation of Knut and Alice Wallenberg; Foundation of Inga-Britt and Arne Lundberg; Skane University Hospital; Royal Physiographic Society in Lund; Greta and Johan Kock Foundation; Foundation for Polish Science (TEAM project) [DPS/424-329/10]; European Commission [FP7-HEALTH-2010-261460]; National Institutes of Health, United States [DE 09761]; Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficent of the structural funds from the European Union [POIG.02.01.00-12-064/08]	Swedish Foundation for Strategic Research, Swedish Medical Research Council; Foundation of Osterlund; Foundation of Kock; Foundation of King Gustav V's 80th Anniversary; Foundation of Knut and Alice Wallenberg(Knut & Alice Wallenberg Foundation); Foundation of Inga-Britt and Arne Lundberg; Skane University Hospital; Royal Physiographic Society in Lund; Greta and Johan Kock Foundation; Foundation for Polish Science (TEAM project); European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficent of the structural funds from the European Union	This work was supported by the Swedish Foundation for Strategic Research, Swedish Medical Research Council (K2009-68X-14928-06-3), Foundations of Osterlund, Kock, King Gustav V's 80th Anniversary, Knut and Alice Wallenberg, Inga-Britt and Arne Lundberg as well as research grants from the Skane University Hospital (to A. B.) and grants from the Royal Physiographic Society in Lund and the Greta and Johan Kock Foundation (to S. M.). JP acknowledges support from the Foundation for Polish Science (TEAM project DPS/424-329/10), the European Commission (FP7-HEALTH-2010-261460 "Gums&Joints''), and the National Institutes of Health (DE 09761, United States). The Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University is a beneficent of the structural funds from the European Union (grant no. POIG.02.01.00-12-064/08-"Molecular Biotechnology for Health''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aduse-Opoku J, 2000, MICROBIOL-UK, V146, P1933, DOI 10.1099/00221287-146-8-1933; Agarwal V, 2010, J BIOL CHEM, V285, P23484, DOI 10.1074/jbc.M110.142703; Asakawa R, 2003, MOL MICROBIOL, V50, P1125, DOI 10.1046/j.1365-2958.2003.03748.x; Blom AM, 2004, MOL IMMUNOL, V40, P1333, DOI 10.1016/j.molimm.2003.12.002; Blom AM, 2003, MOL IMMUNOL, V39, P547, DOI 10.1016/S0161-5890(02)00213-4; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; BOACKLE RJ, 1991, CRIT REV ORAL BIOL M, V2, P355, DOI 10.1177/10454411910020030401; Boon CJF, 2009, MOL IMMUNOL, V46, P1573, DOI 10.1016/j.molimm.2009.02.013; CATTERALL CF, 1987, BIOCHEM J, V242, P849, DOI 10.1042/bj2420849; CROSSLEY LG, 1980, BIOCHEM J, V191, P173, DOI 10.1042/bj1910173; Cunnion KM, 2005, J LAB CLIN MED, V146, P279, DOI 10.1016/j.lab.2005.07.001; Cunnion KM, 2004, INFECT IMMUN, V72, P2858, DOI 10.1128/IAI.72.5.2858-2863.2004; Cunnion KM, 2001, INFECT IMMUN, V69, P6796, DOI 10.1128/IAI.69.11.6796-6803.2001; DAHLBACK B, 1983, BIOCHEM J, V209, P847, DOI 10.1042/bj2090847; Darby I, 2001, PERIODONTOL 2000, V26, P33, DOI 10.1034/j.1600-0757.2001.2260103.x; de Cordoba SR, 2008, CLIN EXP IMMUNOL, V151, P1, DOI 10.1111/j.1365-2249.2007.03574.x; de Pablo P, 2008, J RHEUMATOL, V35, P70; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Feng HH, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/617509; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; FRANDSEN EVG, 1995, INT J SYST BACTERIOL, V45, P429, DOI 10.1099/00207713-45-3-429; Friberg N, 2008, J IMMUNOL, V181, P8624, DOI 10.4049/jimmunol.181.12.8624; Genco RJ, 2010, NAT REV CARDIOL, V7, P479, DOI 10.1038/nrcardio.2010.120; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; GRENIER D, 1994, CLIN DIAGN LAB IMMUN, V1, P247, DOI 10.1128/CDLI.1.2.247-249.1994; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Hair PS, 2008, J INFECT DIS, V198, P125, DOI 10.1086/588825; Hair PS, 2010, INFECT IMMUN, V78, P1717, DOI 10.1128/IAI.01065-09; Hamad OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012889; HESSING M, 1990, J IMMUNOL, V144, P204; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Krauss JL, 2010, PERIODONTOL 2000, V52, P141, DOI 10.1111/j.1600-0757.2009.00324.x; LABBE S, 1995, INFECT IMMUN, V63, P2785; Marcelino SL, 2010, ANAEROBE, V16, P629, DOI 10.1016/j.anaerobe.2010.08.007; Martinez-Martinez RE, 2009, J CLIN PERIODONTOL, V36, P1004, DOI 10.1111/j.1600-051X.2009.01496.x; McDowell JV, 2009, INFECT IMMUN, V77, P1417, DOI 10.1128/IAI.01544-08; MERI S, 1994, BIOCHEM BIOPH RES CO, V198, P52, DOI 10.1006/bbrc.1994.1008; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Nilsson SC, 2007, MOL IMMUNOL, V44, P1835, DOI 10.1016/j.molimm.2006.10.005; Nordstrom T, 2004, J IMMUNOL, V173, P4598, DOI 10.4049/jimmunol.173.7.4598; Okuda K, 1998, Bull Tokyo Dent Coll, V39, P7; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Popadiak K, 2007, J IMMUNOL, V178, P7242, DOI 10.4049/jimmunol.178.11.7242; Potempa M, 2008, J IMMUNOL, V181, P5537, DOI 10.4049/jimmunol.181.8.5537; Potempa M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000316; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; SCHENKEIN HA, 1977, J PERIODONTOL, V48, P772, DOI 10.1902/jop.1977.48.12.772; Sztukowska M, 2004, MOL MICROBIOL, V54, P1393, DOI 10.1111/j.1365-2958.2004.04357.x; Wann ER, 2000, J BIOL CHEM, V275, P13863, DOI 10.1074/jbc.275.18.13863; WINGROVE JA, 1992, J BIOL CHEM, V267, P18902	50	16	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34852	10.1371/journal.pone.0034852	http://dx.doi.org/10.1371/journal.pone.0034852			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514678	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600084
J	Marion, E; Prado, S; Cano, C; Babonneau, J; Ghamrawi, S; Marsollier, L				Marion, Estelle; Prado, Soizic; Cano, Camille; Babonneau, Jeremie; Ghamrawi, Sarah; Marsollier, Laurent			Photodegradation of the Mycobacterium ulcerans Toxin, Mycolactones: Considerations for Handling and Storage	PLOS ONE			English	Article							BURULI ULCER; MACROLIDE; PATHOGEN; PRODUCE	Background: Mycolactones are toxins secreted by M. ulcerans, the etiological agent of Buruli ulcer. These toxins, which are the main virulence factors of the bacilli, are responsible for skin lesions. Considering their specificity for M. ulcerans and their presence in skin lesions even at early stages, mycolactones are promising candidates for the development of a diagnostic tool for M. ulcerans infection. Stability of purified mycolactones towards light and heat has not yet been investigated, despite the importance of such parameters in the selection of strategies for a diagnosis tool development. In this context, the effects of UV, light and temperature on mycolactone stability and biological activity were studied. Methodology/Principal Findings: To investigate the effect of these physical parameters, mycolactones were exposed to different wavelengths in several solvents and temperatures. Structural changes and biological activity were monitored. Whilst high temperature had no effect on mycolactones, UV irradiation (UV-A, UV-B and UV-C) and sunlight exposure caused a considerable degradation, as revealed by LC-MS and NMR analysis, correlated with a loss of biological activity. Moreover, effect of UVs on mycolactone caused a photodegradation rather than a phototransformation due to the identification of degradation product. Conclusion/Significance: This study demonstrates the high sensitivity of mycolactones to UVs as such it defines instructions for storage and handling.	[Marion, Estelle; Cano, Camille; Babonneau, Jeremie; Marsollier, Laurent] Unite Inserm U892, Equipe 15, Nantes, France; [Marion, Estelle; Ghamrawi, Sarah; Marsollier, Laurent] Univ Angers, Grp Etud Interact Hote Pathogene, Angers, France; [Marion, Estelle; Ghamrawi, Sarah; Marsollier, Laurent] CHU Angers, Angers, France; [Prado, Soizic] Museum Natl Hist Nat Paris, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Museum National d'Histoire Naturelle (MNHN)	Marion, E (corresponding author), Unite Inserm U892, Equipe 15, Nantes, France.	stel.marion@yahoo.fr; laurent.marsollier@inserm.fr	Marsollier, Laurent/P-6178-2015; Marion, Estelle/G-3437-2016	Marion, Estelle/0000-0003-4917-9665; Laurent, Marsollier/0000-0001-5497-5995	Fondation Francaise Raoul Follereau; Institut National de la Sante et de la Recherche Medicale; Region Pays de Loire, Conseil General 49; Angers Loire Metropole	Fondation Francaise Raoul Follereau; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Region Pays de Loire, Conseil General 49(Region Pays de la Loire); Angers Loire Metropole(Region Pays de la Loire)	This work was supported by the Fondation Francaise Raoul Follereau, by the Institut National de la Sante et de la Recherche Medicale, by Region Pays de Loire, Conseil General 49, and Angers Loire Metropole. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammad Sadia, 2008, J Cosmet Dermatol, V7, P180, DOI 10.1111/j.1473-2165.2008.00386.x; Asiedu K, 1998, AM J TROP MED HYG, V59, P1015, DOI 10.4269/ajtmh.1998.59.1015; Asiedu K, 2000, BURULI ULCER MYCOBAC; Coutanceau E, 2005, CELL MICROBIOL, V7, P1187, DOI 10.1111/j.1462-5822.2005.00546.x; Etuaful S, 2005, ANTIMICROB AGENTS CH, V49, P3182, DOI 10.1128/AAC.49.8.3182-3186.2005; Fraga AG, 2011, INFECT IMMUN, V79, P421, DOI 10.1128/IAI.00820-10; George KM, 1998, INFECT IMMUN, V66, P587, DOI 10.1128/IAI.66.2.587-593.1998; George KM, 1999, SCIENCE, V283, P854, DOI 10.1126/science.283.5403.854; George KM, 2000, INFECT IMMUN, V68, P877, DOI 10.1128/IAI.68.2.877-883.2000; Gunawardana G, 1999, J AM CHEM SOC, V121, P6092, DOI 10.1021/ja990017l; Kim I, 2009, ENVIRON INT, V35, P793, DOI 10.1016/j.envint.2009.01.003; Liu RJ, 2010, J MASS SPECTROM, V45, P553, DOI 10.1002/jms.1741; Marion E, 2011, EMERG INFECT DIS, V17, P551, DOI 10.3201/eid1703.091859; Marsollier L, 2007, PLOS PATHOG, V3, P582, DOI 10.1371/journal.ppat.0030062; Mve-Obiang A, 2005, INFECT IMMUN, V73, P3307, DOI 10.1128/IAI.73.6.3307-3312.2005; Mve-Obiang A, 2003, INFECT IMMUN, V71, P774, DOI 10.1128/IAI.71.2.774-783.2003; Pahlevan AA, 1999, J IMMUNOL, V163, P3928; Pidot SJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000663; Ranger BS, 2006, INFECT IMMUN, V74, P6037, DOI 10.1128/IAI.00970-06; Smijs TGM, 2011, PHOTOCHEM PHOTOBIOL, V87, P2, DOI 10.1111/j.1751-1097.2010.00848.x; Spangenberg T, 2010, CHEM COMMUN, V46, P1410, DOI 10.1039/b924896j; Stienstra Y, 2005, TROP MED INT HEALTH, V10, P1251, DOI 10.1111/j.1365-3156.2005.01519.x; Stinear TP, 2004, P NATL ACAD SCI USA, V101, P1345, DOI 10.1073/pnas.0305877101; WorldHealthOrganization, 2004, WKLY EPIDEMIOL REC, V79, P145; Zhang JF, 2010, PEST MANAG SCI, V66, P248, DOI 10.1002/ps.1856; Zorraquino MA, 2011, J FOOD PROTECT, V74, P311, DOI 10.4315/0362-028X.JFP-10-297	26	26	27	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e33600	10.1371/journal.pone.0033600	http://dx.doi.org/10.1371/journal.pone.0033600			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514607	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600012
J	Wang, YQ; Gao, Y; Imsland, F; Gu, XR; Feng, CG; Liu, RR; Song, C; Tixier-Boichard, M; Gourichon, D; Li, QY; Chen, KW; Li, HF; Andersson, L; Hu, XX; Li, N				Wang, Yanqiang; Gao, Yu; Imsland, Freyja; Gu, Xiaorong; Feng, Chungang; Liu, Ranran; Song, Chi; Tixier-Boichard, Michele; Gourichon, David; Li, Qingyuan; Chen, Kuanwei; Li, Huifang; Andersson, Leif; Hu, Xiaoxiang; Li, Ning			The Crest Phenotype in Chicken Is Associated with Ectopic Expression of HOXC8 in Cranial Skin	PLOS ONE			English	Article							DOMINANT-WHITE; QUANTITATIVE TRAITS; LINKAGE MAP; GENE; HAIR; IDENTIFICATION; MORPHOLOGY; EVOLUTION; REVEALS; BRAIN	The Crest phenotype is characterised by a tuft of elongated feathers atop the head. A similar phenotype is also seen in several wild bird species. Crest shows an autosomal incompletely dominant mode of inheritance and is associated with cerebral hernia. Here we show, using linkage analysis and genome-wide association, that Crest is located on the E22C19W28 linkage group and that it shows complete association to the HOXC-cluster on this chromosome. Expression analysis of tissues from Crested and non-crested chickens, representing 26 different breeds, revealed that HOXC8, but not HOXC12 or HOXC13, showed ectopic expression in cranial skin during embryonic development. We propose that Crest is caused by a cis-acting regulatory mutation underlying the ectopic expression of HOXC8. However, the identification of the causative mutation(s) has to await until a method becomes available for assembling this chromosomal region. Crest is unfortunately located in a genomic region that has so far defied all attempts to establish a contiguous sequence.	[Wang, Yanqiang; Gao, Yu; Gu, Xiaorong; Feng, Chungang; Liu, Ranran; Song, Chi; Li, Qingyuan; Hu, Xiaoxiang; Li, Ning] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Imsland, Freyja; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Song, Chi; Chen, Kuanwei; Li, Huifang] Jiangsu Inst Poultry Sci, Yangzhou, Peoples R China; [Tixier-Boichard, Michele] AgroParisTech, INRA, Anim Genet & Integrat Biol UMR1313, Jouy En Josas, France; [Gourichon, David] INRA, PEAT UE1295, F-37380 Nouzilly, France; [Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, S-75007 Uppsala, Sweden	China Agricultural University; Uppsala University; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Swedish University of Agricultural Sciences	Wang, YQ (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	huxx@cau.edu.cn; ninglcau@cau.edu.cn	Gu, xiaorong/Q-7152-2016; Gao, Yu/AAU-9530-2021	Gu, xiaorong/0000-0001-5158-8009; Gao, Yu/0000-0002-4210-7338; Feng, Chungang/0000-0002-7031-4211; Imsland, Freyja/0000-0002-9452-5566	National Advanced Technology Research and Development Program of China [2011AA100301]; National Natural Science Foundation of China [U0831003]; State Key Laboratory of Agrobiotechnology [2011SKLAB02-3]; Program for New Century Excellent Talents in University [NCET-08-0527]	National Advanced Technology Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Agrobiotechnology; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was funded by the National Advanced Technology Research and Development Program of China (No. 2011AA100301), National Natural Science Foundation of China (Grant No. U0831003), grants from the State Key Laboratory of Agrobiotechnology (2011SKLAB02-3) and the Program for New Century Excellent Talents in University (NCET-08-0527). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels T, 2003, J EXP ZOOL PART B, V298B, P91, DOI 10.1002/jez.b.00028; Bradshaw MS, 1996, P NATL ACAD SCI USA, V93, P2426, DOI 10.1073/pnas.93.6.2426; Brandt AE, 1936, J HERED, V27, P79, DOI 10.1093/oxfordjournals.jhered.a104177; BROTHWELL D, 1979, J ARCHAEOL SCI, V6, P291, DOI 10.1016/0305-4403(79)90007-4; BURKE AC, 1995, DEVELOPMENT, V121, P333; Clamp M, 2003, NUCLEIC ACIDS RES, V31, P38, DOI 10.1093/nar/gkg083; Davenport CB, INHERITANCE POULTRY; Duboule D, 1998, GENE DEV, V12, P1, DOI 10.1101/gad.12.1.1; FISHER R. A., 1934, SCIENCE, V80, P288, DOI 10.1126/science.80.2074.288; Frahm HD, 1998, BRAIN BEHAV EVOLUT, V52, P292, DOI 10.1159/000006574; Frahm HD, 2001, POULTRY SCI, V80, P1249, DOI 10.1093/ps/80.9.1249; Gal E, 2010, J ARCHAEOL SCI, V37, P1065, DOI 10.1016/j.jas.2009.12.007; Gao Y, 2005, ANIM GENET, V36, P284, DOI 10.1111/j.1365-2052.2005.01302.x; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Green P, 1990, DOCUMENTATION CRI MA; Groenen MAM, 2000, GENOME RES, V10, P137; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hutt FB, 1940, J HERED, V31, P231, DOI 10.1093/oxfordjournals.jhered.a104892; Kanzler B, 1997, DEV DYNAM, V210, P274, DOI 10.1002/(SICI)1097-0177(199711)210:3<274::AID-AJA8>3.0.CO;2-D; Kerje S, 2004, GENETICS, V168, P1507, DOI 10.1534/genetics.104.027995; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Ladjali-Mohammedi K, 2001, CYTOGENET CELL GENET, V92, P157, DOI 10.1159/000056889; Lei H, 2006, P NATL ACAD SCI USA, V103, P10305, DOI 10.1073/pnas.0603552103; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lin CM, 2006, CURR OPIN CELL BIOL, V18, P730, DOI 10.1016/j.ceb.2006.10.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1; Ma L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-315; Mao YC, 2006, PHYSIOL GENOMICS, V28, P46, DOI 10.1152/physiolgenomics.00096.2006; Meyer A, 1999, CURR BIOL, V9, pR210, DOI 10.1016/S0960-9822(99)80131-6; Reid AI, 2002, INT J DEV BIOL, V46, P209; Richardson MK, 2007, CYTOGENET GENOME RES, V117, P110, DOI 10.1159/000103171; Romanov MN, 2004, WORLD POULTRY SCI J, V60, P19, DOI 10.1079/WPS20032; Sambrook J., 2001, MOL CLONING LAB MANU; Serebrovsky AS, 1928, J HERED, V19, P305, DOI 10.1093/oxfordjournals.jhered.a103005; Shang L, 2002, MECH DEVELOP, V113, P207, DOI 10.1016/S0925-4773(02)00022-9; Shashikant CS, 2007, J EXP ZOOL PART B, V308B, P242, DOI 10.1002/jez.b.21143; Suttle AD, 1932, J HERED, V23, P135, DOI 10.1093/oxfordjournals.jhered.a103583; Svingen T, 2006, HEREDITY, V97, P88, DOI 10.1038/sj.hdy.6800847; Tkatchenko AV, 2001, DEVELOPMENT, V128, P1547; Wallis JW, 2004, NATURE, V432, P761, DOI 10.1038/nature03030; Warren DC, 1936, AM NAT, V70, P379, DOI 10.1086/280676; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yu MK, 2002, NATURE, V420, P308, DOI 10.1038/nature01196	45	36	40	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34012	10.1371/journal.pone.0034012	http://dx.doi.org/10.1371/journal.pone.0034012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514613	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600018
J	Chen, L; Kasai, T; Li, YG; Sugii, Y; Jin, GL; Okada, M; Vaidyanath, A; Mizutani, A; Satoh, A; Kudoh, T; Hendrix, MJC; Salomon, DS; Fu, L; Seno, M				Chen, Ling; Kasai, Tomonari; Li, Yueguang; Sugii, Yuh; Jin, Guoliang; Okada, Masashi; Vaidyanath, Arun; Mizutani, Akifumi; Satoh, Ayano; Kudoh, Takayuki; Hendrix, Mary J. C.; Salomon, David S.; Fu, Li; Seno, Masaharu			A Model of Cancer Stem Cells Derived from Mouse Induced Pluripotent Stem Cells	PLOS ONE			English	Article							MICROENVIRONMENT SUPPRESSES; TUMORIGENIC PHENOTYPE; COPY NUMBER; TUMOR; GENERATION	Cancer stem cells (CSCs) are capable of continuous proliferation and self-renewal and are proposed to play significant roles in oncogenesis, tumor growth, metastasis and cancer recurrence. CSCs are considered derived from normal stem cells affected by the tumor microenvironment although the mechanism of development is not clear yet. In 2007, Yamanaka's group succeeded in generating Nanog mouse induced pluripotent stem (miPS) cells, in which green fluorescent protein (GFP) has been inserted into the 5'-untranslated region of the Nanog gene. Usually, iPS cells, just like embryonic stem cells, are considered to be induced into progenitor cells, which differentiate into various normal phenotypes depending on the normal niche. We hypothesized that CSCs could be derived from Nanog miPS cells in the conditioned culture medium of cancer cell lines, which is a mimic of carcinoma microenvironment. As a result, the Nanog miPS cells treated with the conditioned medium of mouse Lewis lung carcinoma acquired characteristics of CSCs, in that they formed spheroids expressing GFP in suspension culture, and had a high tumorigenicity in Balb/c nude mice exhibiting angiogenesis in vivo. In addition, these iPS-derived CSCs had a capacity of self-renewal and expressed the marker genes, Nanog, Rex1, Eras, Esg1 and Cripto, associated with stem cell properties and an undifferentiated state. Thus we concluded that a model of CSCs was originally developed from miPS cells and proposed the conditioned culture medium of cancer cell lines might perform as niche for producing CSCs. The model of CSCs and the procedure of their establishment will help study the genetic alterations and the secreted factors in the tumor microenvironment which convert miPS cells to CSCs. Furthermore, the identification of potentially bona fide markers of CSCs, which will help the development of novel anti-cancer therapies, might be possible though the CSC model.	[Chen, Ling; Kasai, Tomonari; Sugii, Yuh; Jin, Guoliang; Okada, Masashi; Vaidyanath, Arun; Mizutani, Akifumi; Kudoh, Takayuki; Seno, Masaharu] Okayama Univ, Grad Sch Nat Sci & Technol, Dept Med & Bioengn Sci, Okayama 7008530, Japan; [Chen, Ling] Japan Soc Promot Sci, Tokyo, Japan; [Chen, Ling] Tianjin Cent Hosp Gynecol Obstet, Dept Pathol, Tianjin, Peoples R China; [Li, Yueguang] Tianjin 4th Ctr Hosp, Dept Gen Surg, Tianjin, Peoples R China; [Satoh, Ayano] Okayama Univ, Multidisciplinary Div, Okayama 7008530, Japan; [Hendrix, Mary J. C.] Northwestern Univ, Feinberg Sch Med, Childrens Mem Res Ctr, Chicago, IL 60611 USA; [Salomon, David S.] NCI, Lab Mammary Biol & Tumorigenesis, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Fu, Li] Tianjin Med Univ, State Key Lab Breast Canc Res, Dept Breast Canc Pathol & Res Lab, Canc Hosp, Tianjin, Peoples R China	Okayama University; Japan Society for the Promotion of Science; Okayama University; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Tianjin Medical University	Chen, L (corresponding author), Okayama Univ, Grad Sch Nat Sci & Technol, Dept Med & Bioengn Sci, Okayama 7008530, Japan.	fulijyb@hotmail.com; mseno@cc.okayama-u.ac.jp	SENO, Masaharu/B-2092-2011; Satoh, Ayano/B-2423-2011	SENO, Masaharu/0000-0001-8547-6259; Satoh, Ayano/0000-0003-3736-1283; Vaidyanath, Arun/0000-0001-8824-9887	Ministry of Education, Culture, Sports, Science and Technology of Japan [21300179]; National Natural Science Foundation of China (Key Program) [30930038]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Natural Science Foundation of China (Key Program)(National Natural Science Foundation of China (NSFC))	This work was supported by Grant-in-Aid for Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 21300179, http://www.waseda.jp/rps/en/manual/kakenhi_honbun.html), and by National Natural Science Foundation of China (Key Program, Grant No. 30930038, http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DE, 2008, CANCER MICROENVIRON, V1, P13, DOI 10.1007/s12307-008-0004-5; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Baiocchi M, 2010, CURR OPIN PHARMACOL, V10, P380, DOI 10.1016/j.coph.2010.05.002; Bar J, 2009, ONCOGENE, V28, P933, DOI 10.1038/onc.2008.445; Booth BW, 2011, ONCOGENE, V30, P679, DOI 10.1038/onc.2010.439; Booth BW, 2008, P NATL ACAD SCI USA, V105, P14891, DOI 10.1073/pnas.0803214105; Boulanger CA, 2007, P NATL ACAD SCI USA, V104, P3871, DOI 10.1073/pnas.0611637104; Boulanger CA, 2009, CELL CYCLE, V8, P1127, DOI 10.4161/cc.8.8.8189; Costa FF, 2009, EPIGENOMICS-UK, V1, P387, DOI 10.2217/EPI.09.25; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gore A, 2011, NATURE, V629, P205; Hanley J, 2010, BRIT J HAEMATOL, V151, P16, DOI 10.1111/j.1365-2141.2010.08296.x; Hood JL, 2009, LAB INVEST, V89, P1317, DOI 10.1038/labinvest.2009.94; Huang SY, 2002, ONCOGENE, V21, P2504, DOI 10.1038/sj.onc.1205341; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Miyoshi N, 2010, SURG TODAY, V40, P608, DOI 10.1007/s00595-009-4106-6; Mlarotta LLC, 2009, CURR OPIN GENET DEV, V19, P44, DOI 10.1016/j.gde.2008.12.003; MORIMOTO J, 1987, IN VITRO CELL DEV B, V23, P755; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Niwa A, 2009, J CELL PHYSIOL, V221, P367, DOI 10.1002/jcp.21864; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Onorati M, 2010, MOL CELL NEUROSCI, V43, P287, DOI 10.1016/j.mcn.2009.12.002; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Pasi CE, 2011, CELL DEATH DIFFER, V18, P745, DOI 10.1038/cdd.2011.9; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Ruiz-Vela A, 2009, STEM CELL REV REP, V5, P319, DOI 10.1007/s12015-009-9096-7; Scaffidi P, 2011, NAT CELL BIOL, V13, P1051, DOI 10.1038/ncb2308; Shackleton M, 2010, SEMIN CANCER BIOL, V20, P85, DOI 10.1016/j.semcancer.2010.04.002; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tzukerman M, 2006, CANCER RES, V66, P3792, DOI 10.1158/0008-5472.CAN-05-3467; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Zhao RC, 2008, PHARMACOL THERAPEUT, V119, P74, DOI 10.1016/j.pharmthera.2008.04.008	40	84	93	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e33544	10.1371/journal.pone.0033544	http://dx.doi.org/10.1371/journal.pone.0033544			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511923	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338600009
J	Kawato, Y; Hirao, M; Ebina, K; Shi, K; Hashimoto, J; Honjo, Y; Yoshikawa, H; Myoui, A				Kawato, Yoshitaka; Hirao, Makoto; Ebina, Kosuke; Shi, Kenrin; Hashimoto, Jun; Honjo, Yui; Yoshikawa, Hideki; Myoui, Akira			Nkx3.2 Promotes Primary Chondrogenic Differentiation by Upregulating Col2a1 Transcription	PLOS ONE			English	Article							CHONDROCYTE DIFFERENTIATION; SOMITIC CHONDROGENESIS; GENE-EXPRESSION; AXIAL SKELETON; COLLAGEN GENE; SOX9; BINDING; ASSOCIATION; ACTIVATION; DYSPLASIA	Background: The Nkx3.2 transcription factor promotes chondrogenesis by forming a positive regulatory loop with a crucial chondrogenic transcription factor, Sox9. Previous studies have indicated that factors other than Sox9 may promote chondrogenesis directly, but these factors have not been identified. Here, we test the hypothesis that Nkx3.2 promotes chondrogenesis directly by Sox9-independent mechanisms and indirectly by previously characterized Sox9-dependent mechanisms. Methodology/Principal Findings: C3H10T1/2 pluripotent mesenchymal cells were cultured with bone morphogenetic protein 2 (BMP2) to induce endochondral ossification. Overexpression of wild-type Nkx3.2 (WT-Nkx3.2) upregulated glycosaminoglycan (GAG) production and expression of type II collagen alpha 1 (Col2a1) mRNA, and these effects were evident before WT-Nkx3.2-mediated upregulation of Sox9. RNAi-mediated inhibition of Nkx3.2 abolished GAG production and expression of Col2a1 mRNA. Dual luciferase reporter assays revealed that WT-Nkx3.2 upregulated Col2a1 enhancer activity in a dose-dependent manner in C3H10T1/2 cells and also in N1511 chondrocytes. In addition, WT-Nkx3.2 partially restored downregulation of GAG production, Col2 protein expression, and Col2a1 mRNA expression induced by Sox9 RNAi. ChIP assays revealed that Nkx3.2 bound to the Col2a1 enhancer element. Conclusions/Significance: Nkx3.2 promoted primary chondrogenesis by two mechanisms: Direct and Sox9-independent upregulation of Col2a1 transcription and upregulation of Sox9 mRNA expression under positive feedback system.	[Kawato, Yoshitaka; Ebina, Kosuke; Shi, Kenrin; Honjo, Yui; Yoshikawa, Hideki] Osaka Univ, Dept Orthopaed, Grad Sch Med, Suita, Osaka, Japan; [Hirao, Makoto; Hashimoto, Jun] Osaka Minami Med Ctr, Natl Hosp Org, Dept Orthopaed Surg, Kawachi Nagano, Osaka, Japan; [Myoui, Akira] Osaka Univ Hosp, Med Ctr Translat Res, Suita, Osaka, Japan	Osaka University; Osaka University	Kawato, Y (corresponding author), Osaka Univ, Dept Orthopaed, Grad Sch Med, Suita, Osaka, Japan.	k-ebina@umin.ac.jp	Myoui, Akira/E-8296-2010; Ebina, Kosuke/AAH-6171-2019		Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This work was supported by grants from the Japan Science and Technology Agency. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2000, GENES CELLS, V5, P499, DOI 10.1046/j.1365-2443.2000.00339.x; Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; Aszodi A, 1998, J CELL BIOL, V143, P1399, DOI 10.1083/jcb.143.5.1399; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Furumatsu T, 2005, J BIOL CHEM, V280, P35203, DOI 10.1074/jbc.M502409200; Furumatsu T, 2005, J BIOL CHEM, V280, P8343, DOI 10.1074/jbc.M413913200; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; Hellemans J, 2009, AM J HUM GENET, V85, P916, DOI 10.1016/j.ajhg.2009.11.005; Hirao M, 2006, J BIOL CHEM, V281, P31079, DOI 10.1074/jbc.M602296200; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Kamiya N, 2002, J BONE MINER RES, V17, P1832, DOI 10.1359/jbmr.2002.17.10.1832; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kim DW, 2003, J BIOL CHEM, V278, P27532, DOI 10.1074/jbc.M301461200; Kim IS, 1999, MECH DEVELOP, V80, P159, DOI 10.1016/S0925-4773(98)00210-X; Lefebvre V, 1996, MOL CELL BIOL, V16, P4512; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Lengner CJ, 2005, J BIOL CHEM, V280, P15872, DOI 10.1074/jbc.M411144200; Lettice LA, 1999, P NATL ACAD SCI USA, V96, P9695, DOI 10.1073/pnas.96.17.9695; Park M, 2007, NAT CELL BIOL, V9, P287, DOI 10.1038/ncb1538; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Tribioli C, 1999, DEVELOPMENT, V126, P5699; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; Yamashita S, 2009, EXP CELL RES, V315, P2231, DOI 10.1016/j.yexcr.2009.03.008; Zeng L, 2002, GENE DEV, V16, P1990, DOI 10.1101/gad.1008002	24	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34703	10.1371/journal.pone.0034703	http://dx.doi.org/10.1371/journal.pone.0034703			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511961	Green Submitted, gold, Green Published			2022-12-27	WOS:000305338600047
J	Li, RP; Zhou, GS				Li, Rong-Ping; Zhou, Guang-Sheng			A Temperature-Precipitation Based Leafing Model and Its Application in Northeast China	PLOS ONE			English	Article							BUD BURST; PHENOLOGICAL MODELS; DECIDUOUS FOREST; CLIMATE-CHANGE; TREES; BUDBURST; VARIABILITY; RESPONSES; GROWTH; PREDICT	Plant phenology models, especially leafing models, play critical roles in evaluating the impact of climate change on the primary production of temperate plants. Existing models based on temperature alone could not accurately simulate plant leafing in arid and semi-arid regions. The objective of the present study was to test the suitability of the existing temperature-based leafing models in arid and semi-arid regions, and to develop a temperature-precipitation based leafing model (TP), based on the long-term (i.e., 12-27 years) ground leafing observation data and meteorological data in Northeast China. The better simulation of leafing for all the plant species in Northeast China was given by TP with the fixed starting date (TPn) than with the parameterized starting date (TPm), which gave the smallest average root mean square error (RMSE) of 4.21 days. Tree leafing models were validated with independent data, and the coefficient of determination (R 2) was greater than 0.60 in 75% of the estimates by TP and the spring warming model (SW) with the fixed starting date. The average RMSE of herb leafing simulated by TPn was 5.03 days, much lower than other models (>9.51 days), while the average R-2 of TPn and TPm were 0.68 and 0.57, respectively, much higher than the other models (<0.22). It indicates that TPn is a universal model and more suitable for simulating leafing of trees and herbs than the prior models. Furthermore, water is an important factor determining herb leafing in arid and semi-arid temperate regions.	[Li, Rong-Ping; Zhou, Guang-Sheng] Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China; [Li, Rong-Ping] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Li, Rong-Ping] China Meteorol Adm, Inst Atmospher Environm, Shenyang, Peoples R China; [Zhou, Guang-Sheng] Chinese Acad Meteorol Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Meteorological Administration; Chinese Academy of Meteorological Sciences (CAMS)	Li, RP (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Vegetat & Environm Change, Beijing, Peoples R China.	gszhou@ibcas.ac.cn			State Key Development Program of Basic Research (SKDPBR) [2010CB951303]; Natural Science Foundation of China (NSFC) [90711001, 40625015]	State Key Development Program of Basic Research (SKDPBR); Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was jointly financed by State Key Development Program of Basic Research (SKDPBR) (2010CB951303), and the Natural Science Foundation of China (NSFC) (90711001, 40625015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CANNELL MGR, 1983, J APPL ECOL, V20, P951, DOI 10.2307/2403139; Chatfield C., 1988, PROBLEM SOLVING STAT; [陈效逑 CHEN Xiao-Qiu], 2009, [生态学报, Acta Ecologica Sinica], V29, P5280; China Meteorological Administration, 1993, NORMS AGR MET OBS; Chuine I, 2000, J THEOR BIOL, V207, P337, DOI 10.1006/jtbi.2000.2178; Chuine I, 1998, PLANT CELL ENVIRON, V21, P455, DOI 10.1046/j.1365-3040.1998.00299.x; Chuine I, 2000, GLOBAL CHANGE BIOL, V6, P943, DOI 10.1046/j.1365-2486.2000.00368.x; [邓振镛 Deng Zhenyong], 2010, [生态学报, Acta Ecologica Sinica], V30, P6278; Diekmann M, 1996, CAN J BOT, V74, P528, DOI 10.1139/b96-067; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; Guo Zhi-xing, 2010, Shengtaixue Zazhi, V29, P578; Hannerz M, 1999, CAN J FOREST RES, V29, P9, DOI 10.1139/cjfr-29-1-9; HANNINEN H, 1990, Acta Forestalia Fennica, V213, P1; Hanninen H., 1987, Silva Fennica, V21, P279; Hanninen H, 1989, TREES-STRUCT FUNCT, V3, P179, DOI 10.1007/BF00226654; Hogg EH, 2000, J CLIMATE, V13, P4229, DOI [10.1175/1520-0442(2000)013<4229:PFODFP>2.0.CO;2, 10.1175/1520-0442(2000)013&lt;4229:PFODFP&gt;2.0.CO;2]; HUNTER AF, 1992, J APPL ECOL, V29, P597, DOI 10.2307/2404467; Jolly WM, 2005, GLOBAL CHANGE BIOL, V11, P619, DOI 10.1111/j.1365-2486.2005.00930.x; KRAMER K, 1994, J APPL ECOL, V31, P172, DOI 10.2307/2404609; Kramer K, 2000, INT J BIOMETEOROL, V44, P67, DOI 10.1007/s004840000066; LANDSBERG JJ, 1974, ANN BOT-LONDON, V38, P1013, DOI 10.1093/oxfordjournals.aob.a084891; Larcher W., 1981, PHYSIOLOGICAL PLANT, P403; Li Rong-ping, 2010, Shengtaixue Zazhi, V29, P2317; Linkosalo T, 2008, TREE PHYSIOL, V28, P1873, DOI 10.1093/treephys/28.12.1873; Linkosalo T, 2006, TREE PHYSIOL, V26, P1249, DOI 10.1093/treephys/26.10.1249; LOGAN JA, 1988, ENVIRON ENTOMOL, V17, P359, DOI 10.1093/ee/17.2.359; Ma ZS, 2008, ANN ENTOMOL SOC AM, V101, P351, DOI 10.1603/0013-8746(2008)101[351:DAPMOR]2.0.CO;2; Molod A, 2003, J HYDROMETEOROL, V4, P810, DOI 10.1175/1525-7541(2003)004<0810:ANLAMS>2.0.CO;2; MURRAY MB, 1989, J APPL ECOL, V26, P693, DOI 10.2307/2404093; RICHARDSON E A, 1974, Hortscience, V9, P331; Running S.W., 1993, SCALING PHYSL PROCES, P141, DOI DOI 10.1016/B978-0-12-233440-5.50014-2; Sarvas R, 1972, ACTIVE PERIOD COMMUN, V76, P1; Schwartz MD, 1998, NATURE, V394, P839, DOI 10.1038/29670; THOMSON AJ, 1982, CAN J FOREST RES, V12, P448, DOI 10.1139/x82-069; White MA, 1997, GLOBAL BIOGEOCHEM CY, V11, P217, DOI 10.1029/97GB00330; White MA, 1999, INT J BIOMETEOROL, V42, P139, DOI 10.1007/s004840050097; Yuan WP, 2007, ECOL RES, V22, P784, DOI 10.1007/s11284-006-0318-z; ZIMMERMANN MH, 1964, PLANT PHYSIOL, V39, P568, DOI 10.1104/pp.39.4.568	39	25	29	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e33192	10.1371/journal.pone.0033192	http://dx.doi.org/10.1371/journal.pone.0033192			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509255	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336600009
J	Lu, L; Wu, Y; Qi, QB; Liu, C; Gan, W; Zhu, JW; Li, HX; Lin, X				Lu, Ling; Wu, Ying; Qi, Qibin; Liu, Chen; Gan, Wei; Zhu, Jingwen; Li, Huaixing; Lin, Xu			Associations of Type 2 Diabetes with Common Variants in PPARD and the Modifying Effect of Vitamin D among Middle-Aged and Elderly Chinese	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED-RECEPTOR; 25-HYDROXYVITAMIN D CONCENTRATION; SINGLE NUCLEOTIDE POLYMORPHISMS; DELTA-GENE; METABOLIC SYNDROME; RISK-FACTORS; GLUCOSE; TARGET; MEN; OBESITY	Background: Previous studies have identified that variants in peroxisome proliferator-activated receptor PPAR-delta (PPARD), a target gene of vitamin D, were significantly associated with fasting glucose and insulin sensitivity in European populations. This current study sought to determine (1) whether the genetic associations of PPARD variants with type 2 diabetes and its related traits could be replicated in Chinese Han population, and (2) whether the associations would be modified by the effect of vitamin D status. Methods and Findings: We genotyped 9 tag single nucleotide polymorphisms (SNPs) that cover the gene of PPARD (rs2267664, rs6902123, rs3798343, rs2267665, rs2267668, rs2016520, rs2299869, rs1053049, and rs9658056) and tested their associations with type 2 diabetes risk and its related traits, including fasting glucose, insulin and HbA1c in 3,210 Chinese Hans. Among the 9 PPARD tag SNPs, rs6902123 was significantly associated with risk of type 2 diabetes (odds ratio 1.75 [95%CI 1.22-2.53]; P = 0.0025) and combined type 2 diabetes and impaired fasting glucose (IFG) (odds ratio 1.47 [95%CI 1.12-1.92]; P = 0.0054). The minor C allele of rs6902123 was associated with increased levels of fasting glucose (P = 0.0316) and HbA1c (P = 0.0180). In addition, we observed that vitamin D modified the effect of rs6902123 on HbA1c (P for interaction = 0.0347). Conclusions/Significance: Our findings demonstrate that common variants in PPARD contribute to the risk of type 2 diabetes in Chinese Hans, and provided suggestive evidence of interaction between 25(OH) D levels and PPARD-rs6902123 on HbA1c.	[Lu, Ling] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Lu, L (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	lihx@sibs.ac.cn; xlin@sibs.ac.cn	Qi, Qibin/H-9055-2012		Chinese Academy of Sciences [2009KIP401, SIBS2008006, KSCX2-EW-R-10]; National Basic Research Program of China (973 Program) [2011CB504002, 2012CB524900]; National High Technology Research and Development Program (863 Program) [2009AA022704]; National Natural Science Foundation of China [30930081, 81021002]; INS Clinical Nutrition Research Center [CRC2010008]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Basic Research Program of China (973 Program)(National Basic Research Program of China); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); INS Clinical Nutrition Research Center	This study was funded by the research grants from the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (2009KIP401), National Basic Research Program of China (973 Program) (2011CB504002 and 2012CB524900), National High Technology Research and Development Program (863 Program) (2009AA022704), the Chief Scientist Program of Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences (SIBS2008006), the Knowledge Innovation Program Project of the Chinese Academy of Sciences (KSCX2-EW-R-10), the National Natural Science Foundation of China (30930081 and 81021002), and Research Program of INS Clinical Nutrition Research Center (CRC2010008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle Jens, 2006, Int J Med Sci, V3, P108; Andrulionyte L, 2006, DIABETES, V55, P2148, DOI 10.2337/db05-1629; Dunlop TW, 2005, J MOL BIOL, V349, P248, DOI 10.1016/j.jmb.2005.03.060; Fritz T, 2006, DIABETES-METAB RES, V22, P492, DOI 10.1002/dmrr.656; Grarup N, 2007, DIABETOLOGIA, V50, P1201, DOI 10.1007/s00125-007-0668-2; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hu C, 2006, DIABETIC MED, V23, P1307, DOI 10.1111/j.1464-5491.2006.02001.x; Kramer DK, 2005, DIABETES, V54, P1157, DOI 10.2337/diabetes.54.4.1157; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Levy JC, 1998, DIABETES CARE, V21, P2191, DOI 10.2337/diacare.21.12.2191; Lu L, 2009, DIABETES CARE, V32, P1278, DOI 10.2337/dc09-0209; Luquet S, 2004, BIOCHIMIE, V86, P833, DOI 10.1016/j.biochi.2004.09.024; Luquet S, 2005, BBA-MOL BASIS DIS, V1740, P313, DOI 10.1016/j.bbadis.2004.11.011; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Pittas AG, 2010, DIABETES CARE, V33, P2021, DOI 10.2337/dc10-0790; Riserus U, 2008, DIABETES, V57, P332, DOI 10.2337/db07-1318; Shin HD, 2004, DIABETES, V53, P847, DOI 10.2337/diabetes.53.3.847; Sigal RJ, 2006, DIABETES CARE, V29, P1433, DOI 10.2337/dc06-9910; Skogsberg J, 2003, ARTERIOSCL THROM VAS, V23, P637, DOI 10.1161/01.ATV.0000064383.88696.24; Skogsberg J, 2003, J INTERN MED, V254, P597, DOI 10.1111/j.1365-2796.2003.01236.x; Vanttinen M, 2005, DIABETES, V54, P3587, DOI 10.2337/diabetes.54.12.3587; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; World Health Organization Department of Noncommunicable Disease Surveillance, DEF DIAGN CLASS DIAB; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047	25	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34895	10.1371/journal.pone.0034895	http://dx.doi.org/10.1371/journal.pone.0034895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509365	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600065
J	Zheng, GH; Chen, HY; Xiong, SQ				Zheng, Guo-hua; Chen, Hai-ying; Xiong, Shang-quan			Polymorphisms of-174G > C and-572G > C in the Interleukin 6 (IL-6) Gene and Coronary Heart Disease Risk: A Meta-Analysis of 27 Research Studies	PLOS ONE			English	Article							G/C PROMOTER POLYMORPHISM; C-REACTIVE PROTEIN; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; NO ASSOCIATION; INFLAMMATORY MARKERS; SERUM INTERLEUKIN-6; ADHESION MOLECULES; BLOOD-PRESSURE; PLASMA-LEVELS	Objective: Elevated serum IL-6 level is a risk factor for coronary heart disease (CHD). The -174G>C and -572G>C polymorphisms in the IL-6 gene have previously been shown to modulate IL-6 levels. But the association between the -174G>C and -572G>C polymorphisms and the risk of CHD is still unclear. A meta-analysis of all eligible studies was carried out to clarify the role of IL-6 gene polymorphisms in CHD. Methods and Results: PubMed, EMBASE, Vip, CNKI and CBM-disc were searched for eligible articles in English and Chinese that were published before October 2010. 27 studies involving 11580 patients with CHD and 17103 controls were included. A meta-analysis was performed for the included articles using the RevMan 5.0 and Stata 10.0 softwares. Overall, the -174C allele was not significantly associated with CHD risk (ORs = 1.04, 95%CI = 0.98 to 1.10) when compared with the -174G allele in the additive model, and meta-analysis under other genetic models (dominant, recessive, CC versus GG, and GC versus GG) also did not reveal any significant association. On the contrary, the -572C allele was associated with a decreased risk of CHD when compared with the -572G allele (ORs = 0.79, 95%CI = 0.68 to 0.93). Furthermore, analyses under the recessive model (ORs = 0.69, 95% = 0.59 to 0.80) and the allele contrast model (genotype of CC versus GG, ORs = 0.49, 95% = 0.35 to 0.70) yielded similar results. However, statistical significance was not found when the meta-analysis was restricted to studies focusing on European populations, studies with large sample size, and cohort studies by using subgroup analysis. Conclusions: The -174G>C polymorphism in the IL-6 gene is not significantly associated with increased risks of CHD. However, The -572G>C polymorphism may contribute to CHD development. Future investigations with better study design and large number of subjects are needed.	[Zheng, Guo-hua; Chen, Hai-ying] Fujian Univ Tradit Chinese Med, Acad Integrat Med, Ctr Evidence Based Med, Fuzhou, Peoples R China; [Xiong, Shang-quan] Peoples Hosp Fujian Prov, Fuzhou, Peoples R China	Fujian University of Traditional Chinese Medicine	Zheng, GH (corresponding author), Fujian Univ Tradit Chinese Med, Acad Integrat Med, Ctr Evidence Based Med, Fuzhou, Peoples R China.	zhgh_1969@yahoo.com.cn	Zheng, Guo hua/E-8256-2013	Zheng, Guo hua/0000-0002-4229-7346	National Natural Science Foundation of China [81072726]; National Natural Science Foundation of China, Beijing, China; natural science foundation of Fujian province [2009J01163]; Fujian Provincial Department of Science & Technology, Fujian, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); natural science foundation of Fujian province(Natural Science Foundation of Fujian Province); Fujian Provincial Department of Science & Technology, Fujian, China	Funding was provided by the National Natural Science Foundation of China (www.nsfc.gov.cn, grant no. 81072726, National Natural Science Foundation of China, Beijing, China) and the natural science foundation of Fujian province (www.fjkjt.gov.cn, grant no. 2009J01163, Fujian Provincial Department of Science & Technology, Fujian, China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee I, 2009, J THROMB THROMBOLYS, V27, P88, DOI 10.1007/s11239-007-0184-8; Barton BE, 1996, MED RES REV, V16, P87, DOI 10.1002/(SICI)1098-1128(199601)16:1<87::AID-MED3>3.3.CO;2-5; Basso F, 2002, ARTERIOSCL THROM VAS, V22, P599, DOI 10.1161/01.ATV.0000013283.84306.1A; Bennermo M, 2004, ATHEROSCLEROSIS, V174, P157, DOI 10.1016/j.atherosclerosis.2004.01.019; Bennermo M, 2011, J INTERF CYTOK RES, V31, P259, DOI 10.1089/jir.2010.0036; Bennet AM, 2003, ATHEROSCLEROSIS, V171, P359, DOI 10.1016/j.atherosclerosis.2003.08.029; Berg KK, 2009, SCAND J IMMUNOL, V69, P36, DOI 10.1111/j.1365-3083.2008.02187.x; Blankenberg S, 2003, ATHEROSCLEROSIS, V170, P191, DOI 10.1016/S0021-9150(03)00097-2; Boiardi L, 2006, J RHEUMATOL, V33, P703; Brull DJ, 2001, ARTERIOSCL THROM VAS, V21, P1458, DOI 10.1161/hq0901.094280; Cesari M, 2003, AM J CARDIOL, V92, P522, DOI 10.1016/S0002-9149(03)00718-5; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Danesh J, 2000, BMJ-BRIT MED J, V321, P199, DOI 10.1136/bmj.321.7255.199; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; Fan WH, 2011, ORAL DIS, V17, P270, DOI 10.1111/j.1601-0825.2010.01736.x; Fishman D, 1998, J CLIN INVEST, V102, P1369, DOI 10.1172/JCI2629; Fu Hai-xia, 2006, Zhonghua Yixue Yichuanxue Zazhi, V23, P245; Fu Hai-xia, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P519; [付海霞 Fu Haixia], 2003, [中国动脉硬化杂志, Chinese Journal of Arteriosclerosis], V11, P557; Fu HX, 2006, CHIN J POSTGRAD MED, V29, P1; Gao CuiXiang, 2008, Journal of the Fourth Military Medical University, V29, P2183; Georges JL, 2001, J MOL MED, V79, P300, DOI 10.1007/s001090100209; Ghazouani L, 2010, CLIN BIOCHEM, V43, P1085, DOI 10.1016/j.clinbiochem.2010.05.005; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Humphries SE, 2001, EUR HEART J, V22, P2243, DOI 10.1053/euhj.2001.2678; Jenny NS, 2002, ARTERIOSCL THROM VAS, V22, P2066, DOI 10.1161/01.ATV.0000040224.49362.60; Jia Xing-Wang, 2007, Zhongguo Shi Yan Xue Ye Xue Za Zhi, V15, P1270; Jia XW, 2010, MED SCI MONITOR, V16, pCR103; Kelberman D, 2004, THROMB HAEMOSTASIS, V92, P1122, DOI 10.1160/TH04-04-0202; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; [李艳 Li Yan], 2005, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V28, P369; Libby P, 2004, AM J MED, V116, P9, DOI 10.1016/j.amjmed.2004.02.006; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Licastro F, 2004, MECH AGEING DEV, V125, P575, DOI 10.1016/j.mad.2004.06.008; Lieb W, 2004, INT J CARDIOL, V97, P205, DOI 10.1016/j.ijcard.2003.07.038; Liu YS, 2007, CHIN J CARDIOVASC RE, V15, P264; Lloyd-Jones D, 2009, CIRCULATION, V119, P480, DOI 10.1161/CIRCULATIONAHA.108.191259; Maitra A, 2008, THROMB HAEMOSTASIS, V99, P944, DOI 10.1160/TH07-11-0686; Malarstig A, 2007, THROMB RES, V119, P467, DOI 10.1016/j.thromres.2006.05.001; Nauck M, 2002, J MOL MED, V80, P507, DOI 10.1007/s00109-002-0354-2; Olomolaiye O, 1998, EUR J IMMUNOGENET, V25, P267, DOI 10.1111/j.1744-313X.1998.tb01147.x; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Pantsulaia I, 2002, CYTOKINE, V19, P138, DOI 10.1006/cyto.2002.1959; Park S, 2007, CORONARY ARTERY DIS, V18, P417, DOI 10.1097/MCA.0b013e328241d967; Petitti DB, 1994, METAANALYSIS DECISIO, P90; Ravaglia G, 2005, BIOGERONTOLOGY, V6, P415, DOI 10.1007/s10522-005-4908-x; Ridker PM, 2000, CIRCULATION, V101, P1767, DOI 10.1161/01.CIR.101.15.1767; Rios DLS, 2010, CYTOKINE, V50, P292, DOI 10.1016/j.cyto.2010.02.012; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sarecka-Hujar B, 2008, KARDIOL POL, V66, P1269; Sekuri C, 2007, CORONARY ARTERY DIS, V18, P333, DOI 10.1097/MCA.0b013e32820588ae; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Shanker Jayashree, 2010, Open Cardiovasc Med J, V4, P30, DOI 10.2174/1874192401004020030; Sie MPS, 2006, ARTERIOSCL THROM VAS, V26, P212, DOI 10.1161/01.ATV.0000194099.65024.17; Smith AJP, 2008, CLIN CHEM, V54, P841, DOI 10.1373/clinchem.2007.098608; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Tanaka C, 2005, HYPERTENS RES, V28, P35, DOI 10.1291/hypres.28.35; Terry CF, 2000, J BIOL CHEM, V275, P18138, DOI 10.1074/jbc.M000379200; Tzoulaki I, 2005, CIRCULATION, V112, P976, DOI 10.1161/CIRCULATIONAHA.104.513085; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; Wei Ye-sheng, 2006, Zhongguo Wei Zhong Bing Ji Jiu Yi Xue, V18, P233; Wei YS, 2005, CHIN J EMERG MED, V14, P636; Woods A, 2000, EUR HEART J, V21, P1574, DOI 10.1053/euhj.1999.2207; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Yanbaeva DG, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-23; Yang C, 2004, SICHUAN MED J, V25, P404; Zhang J, 2009, J MODEM STOMATO J, V123, P415	69	22	27	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34839	10.1371/journal.pone.0034839	http://dx.doi.org/10.1371/journal.pone.0034839			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509361	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600062
J	Geraud, C; Evdokimov, K; Straub, BK; Peitsch, WK; Demory, A; Dorflinger, Y; Schledzewski, K; Schmieder, A; Schemmer, P; Augustin, HG; Schirmacher, P; Goerdt, S				Geraud, Cyrill; Evdokimov, Konstantin; Straub, Beate K.; Peitsch, Wiebke K.; Demory, Alexandra; Doerflinger, Yvette; Schledzewski, Kai; Schmieder, Astrid; Schemmer, Peter; Augustin, Hellmut G.; Schirmacher, Peter; Goerdt, Sergij			Unique Cell Type-Specific Junctional Complexes in Vascular Endothelium of Human and Rat Liver Sinusoids	PLOS ONE			English	Article							ADHESION MOLECULE; KUPFFER CELLS; JAM FAMILY; LYMPH-NODE; EXPRESSION; HETEROGENEITY; PHENOTYPE; CIRRHOSIS; VESSELS; BLOOD	Liver sinusoidal endothelium is strategically positioned to control access of fluids, macromolecules and cells to the liver parenchyma and to serve clearance functions upstream of the hepatocytes. While clearance of macromolecular debris from the peripheral blood is performed by liver sinusoidal endothelial cells (LSECs) using a delicate endocytic receptor system featuring stabilin-1 and -2, the mannose receptor and CD32b, vascular permeability and cell trafficking are controlled by transcellular pores, i.e. the fenestrae, and by intercellular junctional complexes. In contrast to blood vascular and lymphatic endothelial cells in other organs, the junctional complexes of LSECs have not yet been consistently characterized in molecular terms. In a comprehensive analysis, we here show that LSECs express the typical proteins found in endothelial adherens junctions (AJ), i.e. VE-cadherin as well as alpha-, beta-, p120-catenin and plakoglobin. Tight junction (TJ) transmembrane proteins typical of endothelial cells, i.e. claudin-5 and occludin, were not expressed by rat LSECs while heterogenous immunreactivity for claudin-5 was detected in human LSECs. In contrast, junctional molecules preferentially associating with TJ such as JAM-A, B and C and zonula occludens proteins ZO-1 and ZO-2 were readily detected in LSECs. Remarkably, among the JAMs JAM-C was considerably over-expressed in LSECs as compared to lung microvascular endothelial cells. In conclusion, we show here that LSECs form a special kind of mixed-type intercellular junctions characterized by co-occurrence of endothelial AJ proteins, and of ZO-1 and -2, and JAMs. The distinct molecular architecture of the intercellular junctional complexes of LSECs corroborates previous ultrastructural findings and provides the molecular basis for further analyses of the endothelial barrier function of liver sinusoids under pathologic conditions ranging from hepatic inflammation to formation of liver metastasis.	[Geraud, Cyrill; Evdokimov, Konstantin; Peitsch, Wiebke K.; Demory, Alexandra; Doerflinger, Yvette; Schledzewski, Kai; Schmieder, Astrid; Goerdt, Sergij] Univ Heidelberg, Univ Med Ctr, Dept Dermatol Venereol & Allergol, D-6800 Mannheim, Germany; [Geraud, Cyrill; Evdokimov, Konstantin; Peitsch, Wiebke K.; Demory, Alexandra; Doerflinger, Yvette; Schledzewski, Kai; Schmieder, Astrid; Augustin, Hellmut G.; Goerdt, Sergij] Univ Heidelberg, Med Fac Mannheim, D-6800 Mannheim, Germany; [Geraud, Cyrill; Evdokimov, Konstantin; Peitsch, Wiebke K.; Demory, Alexandra; Doerflinger, Yvette; Schledzewski, Kai; Schmieder, Astrid; Goerdt, Sergij] Ctr Excellence Dermatol, Mannheim, Germany; [Straub, Beate K.; Schirmacher, Peter] Univ Heidelberg, Univ Clin Heidelberg, Dept Pathol, D-6800 Mannheim, Germany; [Schemmer, Peter] Univ Heidelberg, Dept Gen & Transplantat Surg, Heidelberg, Germany; [Augustin, Hellmut G.] German Canc Res Ctr, Joint Res Div Vasc Biol, D-6900 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Geraud, C (corresponding author), Univ Heidelberg, Univ Med Ctr, Dept Dermatol Venereol & Allergol, D-6800 Mannheim, Germany.	cyrill.geraud@umm.de	Augustin, Hellmut/AAA-5246-2020	Augustin, Hellmut/0000-0002-7173-4242; Straub, Beate/0000-0002-4857-1561; Evdokimov, Konstantin/0000-0003-1343-1355; Geraud, Cyrill/0000-0001-9432-6869	Deutsche Forschungsgemeinschaft [SFB-TRR23, SFB-TRR77]; Deutsche Krebshilfe [108626]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported in part by grants of Deutsche Forschungsgemeinschaft SFB-TRR23, project B1 (to SG) and SFB-TRR77, project C3 (to SG and HGA) and project B5 (to P. Schirmacher), and by a grant from the Deutsche Krebshilfe, project 108626 (to WKP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; ANDERSON ND, 1976, IMMUNOLOGY, V31, P455; Aurrand-Lions M, 2001, BLOOD, V98, P3699, DOI 10.1182/blood.V98.13.3699; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Braet Filip, 2002, Comp Hepatol, V1, P1, DOI 10.1186/1476-5926-1-1; Carreira CM, 2001, CANCER RES, V61, P8079; COUVELARD A, 1993, AM J PATHOL, V143, P738; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007; FREEMONT AJ, 1983, J ANAT, V136, P349; Geraud C, 2010, HEPATOLOGY, V52, P313, DOI 10.1002/hep.23618; Gouysse G, 2002, J HEPATOL, V37, P730, DOI 10.1016/S0168-8278(02)00282-9; Katsuno T, 2008, MOL BIOL CELL, V19, P2465, DOI 10.1091/mbc.E07-12-1215; Khandoga A, 2009, J HEPATOL, V50, P755, DOI 10.1016/j.jhep.2008.11.027; Klein D, 2008, HEPATOLOGY, V47, P1018, DOI 10.1002/hep.22084; Lalor PF, 2006, WORLD J GASTROENTERO, V12, P5429, DOI 10.3748/wjg.v12.i34.5429; Lalor PF, 1999, J CLIN PATHOL-MOL PA, V52, P214, DOI 10.1136/mp.52.4.214; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; Mandell KJ, 2005, ADV DRUG DELIVER REV, V57, P857, DOI 10.1016/j.addr.2005.01.005; March S, 2009, HEPATOLOGY, V50, P920, DOI 10.1002/hep.23085; Medina J, 2005, J HEPATOL, V42, P124, DOI 10.1016/j.jhep.2004.09.024; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Orlova VV, 2006, J EXP MED, V203, P2703, DOI 10.1084/jem.20051730; Palmeri D, 2000, J BIOL CHEM, V275, P19139, DOI 10.1074/jbc.M003189200; Paschos KA, 2009, CELL SIGNAL, V21, P665, DOI 10.1016/j.cellsig.2009.01.006; Perri RE, 2005, SIGNALING PATHWAYS IN LIVER DISEASES, P53, DOI 10.1007/3-540-27194-5_5; Pfeiffer F, 2008, EUR J IMMUNOL, V38, P2142, DOI 10.1002/eji.200838140; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Sakaguchi T, 2008, J SURG RES, V147, P123, DOI 10.1016/j.jss.2007.07.013; Scheiermann C, 2009, ARTERIOSCL THROM VAS, V29, P1509, DOI 10.1161/ATVBAHA.109.187559; Schledzewski K, 2011, J CLIN INVEST, V121, P703, DOI 10.1172/JCI44740; Seternes T, 2002, P NATL ACAD SCI USA, V99, P7594, DOI 10.1073/pnas.102173299; Si-Tayeb K, 2010, DEV CELL, V18, P175, DOI 10.1016/j.devcel.2010.01.011; SMEDSROD B, 1985, CELL TISSUE RES, V241, P639; STEINHOFF G, 1993, AM J PATHOL, V142, P481; TANUMA Y, 1983, ARCH HISTOL JAPON, V46, P401, DOI 10.1679/aohc.46.401; Tse D, 2010, SEMIN THROMB HEMOST, V36, P236, DOI 10.1055/s-0030-1253447; Tsukita S, 2009, ANN NY ACAD SCI, V1165, P44, DOI 10.1111/j.1749-6632.2009.04056.x; Vekemans K, 2005, WORLD J GASTROENTERO, V11, P5095, DOI 10.3748/wjg.v11.i33.5095; WISSE E, 1970, J ULTRA MOL STRUCT R, V31, P125, DOI 10.1016/S0022-5320(70)90150-4; WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427; WISSE E, 1972, J ULTRA MOL STRUCT R, V38, P528, DOI 10.1016/0022-5320(72)90089-5; Xu B, 2003, AM J PATHOL, V163, P1275, DOI 10.1016/S0002-9440(10)63487-6	46	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34206	10.1371/journal.pone.0034206	http://dx.doi.org/10.1371/journal.pone.0034206			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509281	Green Published, gold, Green Submitted			2022-12-27	WOS:000304805900019
J	Lovett, DH; Mahimkar, R; Raffai, RL; Cape, L; Maklashina, E; Cecchini, G; Karliner, JS				Lovett, David H.; Mahimkar, Rajeev; Raffai, Robert L.; Cape, Leslie; Maklashina, Elena; Cecchini, Gary; Karliner, Joel S.			A Novel Intracellular Isoform of Matrix Metalloproteinase-2 Induced by Oxidative Stress Activates Innate Immunity	PLOS ONE			English	Article							CONGESTIVE-HEART-FAILURE; KAPPA-B-ALPHA; ALTERNATIVE TRANSLATION; MYOCARDIAL-INFARCTION; REPERFUSION INJURY; START SITES; EXPRESSION; MITOCHONDRIA; DYSFUNCTION; PROTEIN	Background: Experimental and clinical evidence has pinpointed a critical role for matrix metalloproteinase-2 (MMP-2) in ischemic ventricular remodeling and systolic heart failure. Prior studies have demonstrated that transgenic expression of the full-length, 68 kDa, secreted form of MMP-2 induces severe systolic failure. These mice also had unexpected and severe mitochondrial structural abnormalities and dysfunction. We hypothesized that an additional intracellular isoform of MMP-2, which affects mitochondrial function is induced under conditions of systolic failure-associated oxidative stress. Methodology and Principal Findings: Western blots of cardiac mitochondria from the full length MMP-2 transgenics, ageing mice and a model of accelerated atherogenesis revealed a smaller 65 kDa MMP-2 isoform. Cultured cardiomyoblasts subjected to transient oxidative stress generated the 65 kDa MMP-2 isoform. The 65 kDa MMP-2 isoform was also induced by hypoxic culture of cardiomyoblasts. Genomic database analysis of the MMP-2 gene mapped transcriptional start sites and RNA transcripts induced by hypoxia or epigenetic modifiers within the first intron of the MMP-2 gene. Translation of these transcripts yields a 65 kDa N-terminal truncated isoform beginning at M-77, thereby deleting the signal sequence and inhibitory prodomain. Cellular trafficking studies demonstrated that the 65 kDa MMP-2 isoform is not secreted and is present in cytosolic and mitochondrial fractions, while the full length 68 kDa isoform was found only in the extracellular space. Expression of the 65 kDa MMP-2 isoform induced mitochondrial-nuclear stress signaling with activation of the pro-inflammatory NF-kappa B, NFAT and IRF transcriptional pathways. By microarray, the 65 kDa MMP-2 induces an innate immunity transcriptome, including viral stress response genes, innate immunity transcription factor IRF7, chemokines and pro-apoptosis genes. Conclusion: A novel N-terminal truncated intracellular isoform of MMP-2 is induced by oxidative stress. This isoform initiates a primary innate immune response that may contribute to progressive cardiac dysfunction in the setting of ischemia and systolic failure.	[Lovett, David H.; Mahimkar, Rajeev; Cape, Leslie; Karliner, Joel S.] Univ Calif San Francisco, Dept Med, San Francisco Dept, Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Raffai, Robert L.] Univ Calif San Francisco, Dept Surg, San Francisco Dept Vet Affairs Med Ctr, San Francisco, CA USA; [Maklashina, Elena; Cecchini, Gary] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco Dept Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Karliner, Joel S.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lovett, DH (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco Dept, Vet Affairs Med Ctr, San Francisco, CA 94143 USA.	david.lovett@va.gov			National Heart, Lung and Blood Institute [PO1-HL-68738, RO1-HL089871]; Department of Veterans Affairs [1101BX000593]; Department of Veterans Affairs Biomedical Laboratory Research and Development; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089871, P01HL068738] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061606] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001077, I01BX000593] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Department of Veterans Affairs(US Department of Veterans Affairs); Department of Veterans Affairs Biomedical Laboratory Research and Development(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Heart, Lung and Blood Institute Grant PO1-HL-68738 (Dr. Karliner and Dr. Lovett), a Department of Veterans Affairs Merit Review Award 1101BX000593 (Dr. Lovett), a Department of Veterans Affairs Biomedical Laboratory Research and Development Award (Dr. Cecchini) and a National Heart, Lung and Blood Institute Grant RO1-HL089871 (Dr. Raffai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MA, 2011, J CELL PHYS IN PRESS; Ali MAM, 2010, CIRCULATION, V122, P2039, DOI 10.1161/CIRCULATIONAHA.109.930222; Arnuthan G, 2002, ONCOGENE, V21, P7839, DOI 10.1038/sj.onc.1205983; Becker T, 2011, TRENDS BIOC IN PRESS; Bergman MR, 2007, AM J PHYSIOL-HEART C, V292, pH1847, DOI 10.1152/ajpheart.00434.2006; BERGMANN U, 1995, BIOCHEMISTRY-US, V34, P2819, DOI 10.1021/bi00009a011; Biswas G, 2003, J CELL BIOL, V161, P507, DOI 10.1083/jcb.200211104; Butler GS, 2009, BIOCHEMISTRY-US, V48, P10830, DOI 10.1021/bi901656f; Cauwe B, 2010, CRIT REV BIOCHEM MOL, V45, P351, DOI 10.3109/10409238.2010.501783; Chow AK, 2007, BRIT J PHARMACOL, V152, P189, DOI 10.1038/sj.bjp.0707344; Cogswell PC, 2003, J BIOL CHEM, V278, P2963, DOI 10.1074/jbc.M209995200; Coker ML, 1999, AM J PHYSIOL-HEART C, V277, pH777, DOI 10.1152/ajpheart.1999.277.2.H777; Cybulsky AV, 2005, J BIOL CHEM, V280, P24396, DOI 10.1074/jbc.M500729200; Dahi S, 2011, INT J EXP PATHOL, V92, P50, DOI 10.1111/j.1365-2613.2010.00744.x; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; George CX, 2009, J INTERF CYTOK RES, V29, P477, DOI 10.1089/jir.2009.0065; Ghosh JC, 2010, CANCER RES, V70, P8988, DOI 10.1158/0008-5472.CAN-10-2225; Gordon JW, 2011, CIRC RES, V108, P1122, DOI 10.1161/CIRCRESAHA.110.226928; Hayashidani S, 2003, AM J PHYSIOL-HEART C, V285, pH1229, DOI 10.1152/ajpheart.00207.2003; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hori M, 2009, CARDIOVASC RES, V81, P457, DOI 10.1093/cvr/cvn335; Jamaluddin M, 1998, J VIROL, V72, P4849, DOI 10.1128/JVI.72.6.4849-4857.1998; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kochetov AV, 2005, MOL GENET GENOMICS, V273, P491, DOI 10.1007/s00438-005-1152-7; Kochetov AV, 2005, BIOINFORMATICS, V21, P837, DOI 10.1093/bioinformatics/bti136; Koivunen E, 1999, NAT BIOTECHNOL, V17, P768, DOI 10.1038/11703; KRIECHBAUMER V, 2011, PROTOPLASMA IN PRESS; Lee JG, 2005, P NATL ACAD SCI USA, V102, P16345, DOI 10.1073/pnas.0508085102; Li HT, 2010, MOL CELL BIOCHEM, V337, P101, DOI 10.1007/s11010-009-0289-9; Liu QY, 2011, MOL CANCER THER, V10, P1113, DOI 10.1158/1535-7163.MCT-10-1010; Mahimkar R, 2009, CARDIOVASC PATHOL, V18, P253, DOI 10.1016/j.carpath.2008.08.001; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; McManus CJ, 2011, CURR OPIN GENET DEV; McMillan JI, 1996, J CLIN INVEST, V97, P1094, DOI 10.1172/JCI118502; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Niu JL, 2009, CLIN SCI, V117, P95, DOI 10.1042/CS20080581; Pannappan S, 2005, IMMUNITY AGEING, V2, P15; Powell DJ, 2008, CELL CYCLE, V7, P950, DOI 10.4161/cc.7.7.5626; Rattazzi M, 2003, J HYPERTENS, V21, P1787, DOI 10.1097/00004872-200310000-00002; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Sawicki G, 2005, CIRCULATION, V112, P544, DOI 10.1161/CIRCULATIONAHA.104.531616; Schulz R, 2007, ANNU REV PHARMACOL, V47, P211, DOI 10.1146/annurev.pharmtox.47.120505.105230; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Shirakabe A, 2010, INT HEART J, V51, P404, DOI 10.1536/ihj.51.404; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Stellas D, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-51; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Tsuchihara K, 2009, NUCLEIC ACIDS RES, V37, P2249, DOI 10.1093/nar/gkp066; Tsutamoto T, 1998, J AM COLL CARDIOL, V31, P391, DOI 10.1016/S0735-1097(97)00494-4; Turck J, 1996, J BIOL CHEM, V271, P15074, DOI 10.1074/jbc.271.25.15074; Tziakas DN, 2005, AM J CARDIOL, V96, P1449, DOI 10.1016/j.amjcard.2005.06.096; Wang HF, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-282; Wang WJ, 2002, CIRCULATION, V106, P1543, DOI 10.1161/01.CIR.0000028818.33488.7B; Watkins SJ, 2011, IN VITRO CELL DEV-AN, V47, P125, DOI 10.1007/s11626-010-9368-1; Will H, 1996, J BIOL CHEM, V271, P17119, DOI 10.1074/jbc.271.29.17119; Yamashita R, 2010, NUCLEIC ACIDS RES, V38, pD98, DOI 10.1093/nar/gkp1017; Yamazaki T, 2004, EUR J HEART FAIL, V6, P41, DOI 10.1016/j.ejheart.2003.05.002; Younce CW, 2010, BIOCHEM J, V426, P43, DOI 10.1042/BJ20090976; Zaidi M, 1999, EMBO J, V18, P522; Zamora M, 2004, J BIOL CHEM, V279, P38415, DOI 10.1074/jbc.M404928200; Zhang SW, 2005, CIRCULATION, V111, P3457, DOI 10.1161/CIRCULATIONAHA.104.523563; Zhou FF, 2011, FEBS J, V278, P403, DOI 10.1111/j.1742-4658.2010.07965.x; Zhou HZ, 2007, BIOCHEM BIOPH RES CO, V358, P189, DOI 10.1016/j.bbrc.2007.04.094; Zhou LM, 2006, CIRC RES, V98, P1177, DOI 10.1161/01.RES.0000220106.64661.71	67	75	78	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34177	10.1371/journal.pone.0034177	http://dx.doi.org/10.1371/journal.pone.0034177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509276	Green Published, Green Submitted, gold			2022-12-27	WOS:000304805900015
J	Lukianova-Hleb, EY; Ren, XY; Constantinou, PE; Danysh, BP; Shenefelt, DL; Carson, DD; Farach-Carson, MC; Kulchitsky, VA; Wu, XW; Wagner, DS; Lapotko, DO				Lukianova-Hleb, Ekaterina Y.; Ren, Xiaoyang; Constantinou, Pamela E.; Danysh, Brian P.; Shenefelt, Derek L.; Carson, Daniel D.; Farach-Carson, Mary C.; Kulchitsky, Vladimir A.; Wu, Xiangwei; Wagner, Daniel S.; Lapotko, Dmitri O.			RETRACTED: Improved Cellular Specificity of Plasmonic Nanobubbles versus Nanoparticles in Heterogeneous Cell Systems (Retracted article. See vol. 12, art no E0187820, 2017)	PLOS ONE			English	Article; Retracted Publication							SCATTERING SUBMICROSCOPIC PARTICLES; HIGHLY FLUORESCENT ANALOGS; GOLD NANOPARTICLES; DRUG-DELIVERY; PHOTOTHERMAL BUBBLES; BIOLOGICAL APPLICATIONS; OPTICAL-SCATTERING; NANO-THERMOLYSIS; LEUKEMIA-CELLS; TRACER LABELS	The limited specificity of nanoparticle (NP) uptake by target cells associated with a disease is one of the principal challenges of nanomedicine. Using the threshold mechanism of plasmonic nanobubble (PNB) generation and enhanced accumulation and clustering of gold nanoparticles in target cells, we increased the specificity of PNB generation and detection in target versus non-target cells by more than one order of magnitude compared to the specificity of NP uptake by the same cells. This improved cellular specificity of PNBs was demonstrated in six different cell models representing diverse molecular targets such as epidermal growth factor receptor, CD3 receptor, prostate specific membrane antigen and mucin molecule MUC1. Thus PNBs may be a universal method and nano-agent that overcome the problem of non-specific uptake of NPs by non-target cells and improve the specificity of NP-based diagnostics, therapeutics and theranostics at the cell level.	[Lukianova-Hleb, Ekaterina Y.; Constantinou, Pamela E.; Danysh, Brian P.; Shenefelt, Derek L.; Carson, Daniel D.; Farach-Carson, Mary C.; Wagner, Daniel S.; Lapotko, Dmitri O.] Rice Univ, Dept Biochem & Cell Biol, Houston, TX 77251 USA; [Ren, Xiaoyang; Wu, Xiangwei] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA; [Kulchitsky, Vladimir A.] Natl Acad Sci Belarus, Inst Physiol, Minsk, BELARUS; [Lapotko, Dmitri O.] Rice Univ, Dept Phys & Astron, Houston, TX USA	Rice University; University of Texas System; UTMD Anderson Cancer Center; National Academy of Sciences of Belarus (NASB); Institute of Physiology of the National Academy of Sciences of Belarus; Rice University	Lukianova-Hleb, EY (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	dl5@rice.edu	ren, xianyan/J-3165-2018; Wagner, Daniel S/C-9379-2009; Kulchitsky, Vladimir/AAS-1322-2021	Wagner, Daniel S/0000-0002-0595-2436; Danysh, Brian/0000-0001-6839-6337; Farach-Carson, Mary/0000-0002-4526-3088	National Institutes of Health [R01GM094816, P01 CA098912, S10RR026399 01]; MD Anderson Gynecologic Specialized Programs of Research Excellence (SPORE) in Uterine Cancer [2P50CA098258-06]; NATIONAL CANCER INSTITUTE [P50CA098258] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015961, S10RR026399] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094816] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MD Anderson Gynecologic Specialized Programs of Research Excellence (SPORE) in Uterine Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01GM094816 (DOL), P01 CA098912 (MCFC), MD Anderson Gynecologic Specialized Programs of Research Excellence (SPORE) in Uterine Cancer, Pilot Project Award 2P50CA098258-06 (DDC). Confocal microscopy was performed on equipment obtained through a Shared Instrumentation Grant from the National Institutes of Health (S10RR026399 01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson A. W., 1967, PHYS CHEM SURFACES; Anderson LJE, 2010, J CONTROL RELEASE, V144, P151, DOI 10.1016/j.jconrel.2010.02.012; ANDERSON RR, 1983, SCIENCE, V220, P524, DOI 10.1126/science.6836297; Bernardi RJ, 2008, J NEURO-ONCOL, V86, P165, DOI 10.1007/s11060-007-9467-3; Bohren C. F., 1998, ABSORPTION SCATTERIN; Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g; Braun GB, 2009, ACS NANO, V3, P2007, DOI 10.1021/nn900469q; Cai WB, 2008, NANOTECHNOL SCI APPL, V1, P17, DOI 10.2147/NSA.S3788; Chen WX, 2010, MOL CANCER THER, V9, P1028, DOI 10.1158/1535-7163.MCT-09-0829; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Cho KJ, 2008, CLIN CANCER RES, V14, P1310, DOI 10.1158/1078-0432.CCR-07-1441; De Gennes P.G., 2004, CAPILLARY WETTING PH; Dean J. A., 1999, LANGES HDB CHEM; El-Sayed IH, 2005, NANO LETT, V5, P829, DOI 10.1021/nl050074e; Francois L, 2001, PHYS CHEM CHEM PHYS, V3, P4965, DOI 10.1039/b106690k; Gregor PD, 2005, INT J CANCER, V116, P415, DOI 10.1002/ijc.21014; HAIGLER HT, 1979, J CELL BIOL, V81, P382, DOI 10.1083/jcb.81.2.382; Hauck TS, 2008, ADV MATER, V20, P3832, DOI 10.1002/adma.200800921; Hleb EY, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/35/355702; Hleb EY, 2008, NANOMEDICINE-UK, V3, P647, DOI 10.2217/17435889.3.5.647; Hleb EY, 2008, NANOMEDICINE-UK, V3, P797, DOI 10.2217/17435889.3.6.797; Hu M, 2006, CHEM SOC REV, V35, P1084, DOI 10.1039/b517615h; Huang XH, 2006, J AM CHEM SOC, V128, P2115, DOI 10.1021/ja057254a; Huschka R, 2010, NANO LETT, V10, P4117, DOI 10.1021/nl102293b; Hutson MS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.158104; Jain PK, 2008, ACCOUNTS CHEM RES, V41, P1578, DOI 10.1021/ar7002804; Khlebtsov NG, 2004, NATO SCI SER II-MATH, V161, P265; Khlebtsov NG, 2000, COLLOID J+, V62, P765, DOI 10.1023/A:1026643111821; Kim B, 2010, NAT NANOTECHNOL, V5, P465, DOI [10.1038/nnano.2010.58, 10.1038/NNANO.2010.58]; Kohli V, 2005, BIOTECHNOL BIOENG, V92, P889, DOI 10.1002/bit.20689; Kumar S, 2007, NANO LETT, V7, P1338, DOI 10.1021/nl070365i; Lapotko D, 2005, PROC SPIE, V5697, P82, DOI 10.1117/12.596372; Lapotko D, 2002, PHOTOCHEM PHOTOBIOL, V75, P519, DOI 10.1562/0031-8655(2002)075<0519:PMORSO>2.0.CO;2; Lapotko D, 2006, CANCER LETT, V239, P36, DOI 10.1016/j.canlet.2005.07.031; Lapotko Dmitri, 2011, Cancers (Basel), V3, P802, DOI 10.3390/cancers3010802; Lapotko D, 2009, OPT EXPRESS, V17, P2538, DOI 10.1364/OE.17.002538; Lapotko D, 2009, INT J HEAT MASS TRAN, V52, P1540, DOI 10.1016/j.ijheatmasstransfer.2008.08.010; Lapotko DO, 2007, NANOMEDICINE-UK, V2, P241, DOI 10.2217/17435889.2.2.241; Lapotko DO, 2006, LASER SURG MED, V38, P631, DOI 10.1002/lsm.20359; Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595; Li JL, 2009, CANCER LETT, V274, P319, DOI 10.1016/j.canlet.2008.09.024; Liang XJ, 2010, P NATL ACAD SCI USA, V107, P7449, DOI 10.1073/pnas.0909707107; Lin CP, 1998, APPL PHYS LETT, V72, P2800, DOI 10.1063/1.121462; Loo C, 2005, NANO LETT, V5, P709, DOI 10.1021/nl050127s; Lukianova-Hleb EY, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/8/085102; Lukianova-Hleb E, 2010, ACS NANO, V4, P2109, DOI 10.1021/nn1000222; Lukianova-Hleb EY, 2012, ADV MATER, V24, P3831, DOI 10.1002/adma.201103550; Lukianova-Hleb EY, 2012, LANGMUIR, V28, P4858, DOI 10.1021/la205132x; Lukianova-Hleb Ekaterina Y, 2011, J Nanomed Nanotechnol, V2, P1; Lukianova-Hleb EY, 2012, BIOMATERIALS, V33, P1821, DOI 10.1016/j.biomaterials.2011.11.015; Lukianova-Hleb EY, 2011, THERANOSTICS, V1, P3, DOI 10.7150/thno/v01p0003; Lukianova-Hleb EY, 2011, J CONTROL RELEASE, V152, P286, DOI 10.1016/j.jconrel.2011.02.006; Lukianova-Hleb EY, 2011, J SURG RES, V166, pE3, DOI 10.1016/j.jss.2010.10.039; Lukianova-Hleb EY, 2009, NANO LETT, V9, P2160, DOI 10.1021/nl9007425; Lukianova-Hleb E, 2009, LASER SURG MED, V41, P240, DOI 10.1002/lsm.20749; Mallidi S, 2009, NANO LETT, V9, P2825, DOI 10.1021/nl802929u; Mandal D, 2009, J MATER SCI-MATER M, V20, P347, DOI 10.1007/s10856-008-3588-x; Meng HA, 2010, ACS NANO, V4, P4539, DOI 10.1021/nn100690m; Mie G, 1908, ANN PHYS-BERLIN, V25, P377, DOI 10.1002/andp.19083300302; Neumann J, 2007, J APPL PHYS, V101, DOI 10.1063/1.2740348; O'Neal DP, 2004, CANCER LETT, V209, P171, DOI 10.1016/j.canlet.2004.02.004; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Paasonen L, 2007, J CONTROL RELEASE, V122, P86, DOI 10.1016/j.jconrel.2007.06.009; Paasonen L, 2010, J CONTROL RELEASE, V147, P136, DOI 10.1016/j.jconrel.2010.07.095; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Pissuwan D, 2011, J CONTROL RELEASE, V149, P65, DOI 10.1016/j.jconrel.2009.12.006; Pitsillides CM, 2003, BIOPHYS J, V84, P4023, DOI 10.1016/S0006-3495(03)75128-5; Prentice P, 2005, NAT PHYS, V1, P107, DOI 10.1038/nphys148; Prigodich AE, 2009, ACS NANO, V3, P2147, DOI 10.1021/nn9003814; Qin GT, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/15/155605; Sajja Hari Krishna, 2009, Curr Drug Discov Technol, V6, P43; Salmaso S, 2009, J MATER CHEM, V19, P1608, DOI 10.1039/b816603j; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Sokolov I, 2007, SMALL, V3, P419, DOI 10.1002/smll.200600319; Sokolov K, 2003, CANCER RES, V63, P1999; Stevenson D, 2006, OPT EXPRESS, V14, P7125, DOI 10.1364/OE.14.007125; Tong L, 2009, NANOMEDICINE-UK, V4, P265, DOI 10.2217/NNM.09.4; Vigderman L, 2012, ANGEW CHEM INT EDIT, V51, P636, DOI 10.1002/anie.201107304; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Vogel A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.038102; Wagner DS, 2010, BIOMATERIALS, V31, P7567, DOI 10.1016/j.biomaterials.2010.06.031; Wang F, 2011, ACS NANO, V5, P3679, DOI 10.1021/nn200007z; Wang LH, 2011, NAT PHOTONICS, V5, P183, DOI 10.1038/nphoton.2011.24; West JL, 2003, ANNU REV BIOMED ENG, V5, P285, DOI 10.1146/annurev.bioeng.5.011303.120723; Wu GH, 2009, METHOD ENZYMOL, V464, P279, DOI 10.1016/S0076-6879(09)64014-3; Yang LL, 2008, J BIOMED NANOTECHNOL, V4, P439, DOI 10.1166/jbn.2008.007; Yao CP, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2137321; Yao CP, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3253320; Yguerabide J, 1998, ANAL BIOCHEM, V262, P137, DOI 10.1006/abio.1998.2759; Yguerabide J, 1998, ANAL BIOCHEM, V262, P157, DOI 10.1006/abio.1998.2760	91	30	30	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34537	10.1371/journal.pone.0034537	http://dx.doi.org/10.1371/journal.pone.0034537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509318	Green Published, gold			2022-12-27	WOS:000304805900044
J	Yuan, QX; Tang, W; Zhang, XP; Hinson, JA; Liu, C; Osei, K; Wang, J				Yuan, Qingxin; Tang, Wei; Zhang, Xiaoping; Hinson, Jack A.; Liu, Chao; Osei, Kwame; Wang, Jie			Proinsulin Atypical Maturation and Disposal Induces Extensive Defects in Mouse Ins2(+/Akita) beta-Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; HUMAN PANCREATIC-ISLETS; INSULIN RELEASE; HIGH GLUCOSE; APOPTOSIS; MICE; GENE; PROTEIN; MUTATION; DEATH	Because of its low relative folding rate and plentiful manufacture in beta-cells, proinsulin maintains a homeostatic balance of natively and plentiful non-natively folded states (i.e., proinsulin homeostasis, PIHO) through the integration of maturation and disposal processes. PIHO is susceptible to genetic and environmental influences, and its disorder has been critically linked to defects in beta-cells in diabetes. To explore this hypothesis, we performed polymerase chain reaction (PCR), metabolic-labeling, immunoblotting, and histological studies to clarify what defects result from primary disorder of PIHO in model Ins2(+/Akita) beta-cells. We used T antigen-transformed Ins2(+/Akita) and control Ins2(+/+) beta-cells established from Akita and wild-type littermate mice. In Ins2(+/Akita) beta-cells, we found no apparent defect at the transcriptional and translational levels to contribute to reduced cellular content of insulin and its precursor and secreted insulin. Glucose response remained normal in proinsulin biosynthesis but was impaired for insulin secretion. The size and number of mature insulin granules were reduced, but the size/number of endoplasmic reticulum, Golgi, mitochondrion, and lysosome organelles and vacuoles were expanded/increased. Moreover, cell death increased, and severe oxidative stress, which manifested as increased reactive oxygen species, thioredoxin-interacting protein, and protein tyrosine nitration, occurred in Ins2(+/Akita) beta-cells and/or islets. These data show the first clear evidence that primary PIHO imbalance induces severe oxidative stress and impairs glucose-stimulated insulin release and beta-cell survival as well as producing other toxic consequences. The defects disclosed/clarified in model Ins2(+/Akita) beta-cells further support a role of the genetic and stress-susceptible PIHO disorder in b-cell failure and diabetes.	[Yuan, Qingxin; Tang, Wei; Zhang, Xiaoping; Osei, Kwame; Wang, Jie] Ohio State Univ, Dept Internal Med, Div Endocrinol Diabet & Metab, Columbus, OH 43210 USA; [Hinson, Jack A.] Univ Arkansas Med Sci, Dept Pharmacol & Toxicol, Little Rock, AR 72205 USA; [Liu, Chao; Wang, Jie] Nanjing Univ Chinese & Western Med, Div Endocrinol, Jiangsu Prov Hosp Integrat Chinese & Western Med, Nanjing, Jiangsu, Peoples R China	University System of Ohio; Ohio State University; University of Arkansas System; University of Arkansas Medical Sciences; Nanjing University of Chinese Medicine	Yuan, QX (corresponding author), Nanjing Med Univ, Nanjing, Jiangsu, Peoples R China.	jie.wang2@osumc.edu			Ohio State University	Ohio State University(Ohio State University)	This work was supported in part by the start-up fund, the Manuel Tzagournis Medical Research Award, and the William D. and Anna R. Cunningham Award from The Ohio State University (to JW). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker JM, 2007, J PEDIATR-US, V150, P31, DOI 10.1016/j.jpeds.2006.09.033; BOQUIST L, 1974, J CELL BIOL, V62, P77, DOI 10.1083/jcb.62.1.77; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; Butler PC, 2007, NAT CLIN PRACT ENDOC, V3, P758, DOI 10.1038/ncpendmet0647; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Del Guerra S, 2007, DIABETES-METAB RES, V23, P234, DOI 10.1002/dmrr.680; Del Prato S, 2002, DIABETES, V51, pS109, DOI 10.2337/diabetes.51.2007.S109; Deniaud A, 2008, ONCOGENE, V27, P285, DOI 10.1038/sj.onc.1210638; DIXIT PK, 1962, NATURE, V195, P388, DOI 10.1038/195388a0; Donath MY, 1999, DIABETES, V48, P738, DOI 10.2337/diabetes.48.4.738; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; Eisenbarth GS, 2010, DIABETES, V59, P759, DOI 10.2337/db09-1855; Federici M, 2001, DIABETES, V50, P1290, DOI 10.2337/diabetes.50.6.1290; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hanley SC, 2010, ENDOCRINOLOGY, V151, P1462, DOI 10.1210/en.2009-1277; HELLMAN B, 1969, DIABETOLOGIA, V5, P22, DOI 10.1007/BF01212214; Higa M, 1999, P NATL ACAD SCI USA, V96, P11513, DOI 10.1073/pnas.96.20.11513; Hinson JA, 2000, TOXICOL SCI, V53, P467, DOI 10.1093/toxsci/53.2.467; Hong EG, 2007, AM J PHYSIOL-ENDOC M, V293, pE1687, DOI 10.1152/ajpendo.00256.2007; Illi B, 2009, PHARMACOL THERAPEUT, V123, P344, DOI 10.1016/j.pharmthera.2009.05.003; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; Kahn SE, 2009, DIABETOLOGIA, V52, P1003, DOI 10.1007/s00125-009-1321-z; Kayo T, 1998, J CLIN INVEST, V101, P2112, DOI 10.1172/JCI1842; Ladriere L, 2010, J CLIN ENDOCR METAB, V95, P1442, DOI 10.1210/jc.2009-2322; LIKE AA, 1970, DIABETOLOGIA, V6, P216, DOI 10.1007/BF01212232; Liu M, 2010, TRENDS ENDOCRIN MET, V21, P652, DOI 10.1016/j.tem.2010.07.001; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Moritz W, 2002, FASEB J, V16, P745, DOI 10.1096/fj.01-0403fje; Nielsen K, 1999, DIABETES, V48, P2324, DOI 10.2337/diabetes.48.12.2324; Nozaki J, 2004, GENES CELLS, V9, P261, DOI 10.1111/j.1356-9597.2004.00721.x; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; PERMUTT MA, 1972, P NATL ACAD SCI USA, V69, P505, DOI 10.1073/pnas.69.2.505; Pick A, 1998, DIABETES, V47, P358, DOI 10.2337/diabetes.47.3.358; Rapoport T A, 1980, Ann N Y Acad Sci, V343, P111, DOI 10.1111/j.1749-6632.1980.tb47246.x; Rhodes CJ, 2005, SCIENCE, V307, P380, DOI 10.1126/science.1104345; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; STEINER DF, 2001, ENDOCRINOLOGY, P667; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; SuarezPinzon WL, 1997, DIABETES, V46, P907, DOI 10.2337/diabetes.46.5.907; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Unger RH, 2002, BBA-MOL CELL BIOL L, V1585, P202, DOI 10.1016/S1388-1981(02)00342-6; Van de Casteele M, 2003, BIOCHEM BIOPH RES CO, V312, P937, DOI 10.1016/j.bbrc.2003.11.013; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Wang J, 2006, P NATL ACAD SCI USA, V103, P10636, DOI 10.1073/pnas.0604194103; Wang J, 2011, BIOCHEM BIOPH RES CO, V411, P150, DOI 10.1016/j.bbrc.2011.06.119; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019446; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; Weiss MA, 2009, J BIOL CHEM, V284, P19159, DOI 10.1074/jbc.R109.009936; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Zhang XP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027647; Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745; Zuber C, 2004, FASEB J, V18, P917, DOI 10.1096/fj.03-1210fje	54	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e35098	10.1371/journal.pone.0035098	http://dx.doi.org/10.1371/journal.pone.0035098			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509386	Green Published, Green Submitted, gold			2022-12-27	WOS:000304805900065
J	Raz, S; Graham, JH; Cohen, A; de Bivort, BL; Grishkan, I; Nevo, E				Raz, Shmuel; Graham, John H.; Cohen, Ayelet; de Bivort, Benjamin L.; Grishkan, Isabella; Nevo, Eviatar			Growth and Asymmetry of Soil Microfungal Colonies from "Evolution Canyon," Lower Nahal Oren, Mount Carmel, Israel	PLOS ONE			English	Article							FLUCTUATING ASYMMETRY; DEVELOPMENTAL STABILITY; DROSOPHILA-MELANOGASTER; INTERSLOPE DIVERGENCE; VASCULAR PLANTS; BIODIVERSITY; PATTERNS; STRESS; SIZE; INSTABILITY	Background: Fluctuating asymmetry is a contentious indicator of stress in populations of animals and plants. Nevertheless, it is a measure of developmental noise, typically obtained by measuring asymmetry across an individual organism's left-right axis of symmetry. These individual, signed asymmetries are symmetrically distributed around a mean of zero. Fluctuating asymmetry, however, has rarely been studied in microorganisms, and never in fungi. Objective and Methods: We examined colony growth and random phenotypic variation of five soil microfungal species isolated from the opposing slopes of "Evolution Canyon," Mount Carmel, Israel. This canyon provides an opportunity to study diverse taxa inhabiting a single microsite, under different kinds and intensities of abiotic and biotic stress. The south-facing "African" slope of "Evolution Canyon" is xeric, warm, and tropical. It is only 200 m, on average, from the north-facing "European" slope, which is mesic, cool, and temperate. Five fungal species inhabiting both the south-facing "African" slope, and the north-facing "European" slope of the canyon were grown under controlled laboratory conditions, where we measured the fluctuating radial asymmetry and sizes of their colonies. Results: Different species displayed different amounts of radial asymmetry (and colony size). Moreover, there were highly significant slope by species interactions for size, and marginally significant ones for fluctuating asymmetry. There were no universal differences (i.e., across all species) in radial asymmetry and colony size between strains from "African" and "European" slopes, but colonies of Clonostachys rosea from the "African" slope were more asymmetric than those from the "European" slope. Conclusions and Significance: Our study suggests that fluctuating radial asymmetry has potential as an indicator of random phenotypic variation and stress in soil microfungi. Interaction of slope and species for both growth rate and asymmetry of microfungi in a common environment is evidence of genetic differences between the "African" and "European" slopes of "Evolution Canyon."	[Raz, Shmuel; Cohen, Ayelet; Grishkan, Isabella; Nevo, Eviatar] Univ Haifa, Inst Evolut, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Graham, John H.] Berry Coll, Dept Biol, Mt Berry, GA USA; [Raz, Shmuel; de Bivort, Benjamin L.] Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02138 USA	University of Haifa; Harvard University	Raz, S (corresponding author), Univ Haifa, Inst Evolut, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	razshmu@gmail.com	רז, שמואל/ABD-3478-2021	Graham, John/0000-0003-1974-132X				Ashford AE, 2002, PLANT SOIL, V244, P177, DOI 10.1023/A:1020271121683; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Carlile MJ, 1994, GROWING FUNGUS, P3; Clausen J., 1940, CARNEGIE I WASH PUBL, V1, P452; Cowart NM, 1999, INT J PLANT SCI, V160, P116, DOI 10.1086/314104; Davet P, 2000, DETECTION ISOLATION; Debat V, 2006, EVOLUTION, V60, P2529, DOI 10.1554/06-045.1; Derzhavets Elena, 1997, Drosophila Information Service, V80, P73; Domsch KH, 2007, COMPENDIUM SOIL FUNG; Ellanskaya IA, 1997, MICROBIOS, V92, P19; Freeman D. Carl, 2003, P367; Garcia D, 2010, FOOD MICROBIOL, V27, P909, DOI 10.1016/j.fm.2010.05.015; Graham JH, 2003, BIOL J LINN SOC, V80, P57, DOI 10.1046/j.1095-8312.2003.00220.x; GRAHAM JH, 1993, AM SOC TEST MATER, V1179, P136, DOI 10.1520/STP19239S; GRAHAM JH, 1985, EVOLUTION, V39, P104, DOI 10.1111/j.1558-5646.1985.tb04083.x; Graham JH, 2010, SYMMETRY-BASEL, V2, P466, DOI 10.3390/sym2020466; Grishkan I, 2000, ISRAEL J PLANT SCI, V48, P297, DOI 10.1560/LAJV-KKNY-F0HD-59KG; JONES JS, 1987, NATURE, V325, P298, DOI 10.1038/325298a0; Kennington WJ, 2003, EVOLUTION, V57, P932, DOI 10.1111/j.0014-3820.2003.tb00304.x; Lamb BC, 1998, GENETICS, V149, P87; Lavie B., 1993, Barley Genetics Newsletter, V23, P12; Leamy LJ, 2005, ANNU REV ECOL EVOL S, V36, P1, DOI 10.1146/annurev.ecolsys.36.102003.152640; Leamy LJ, 2002, EVOLUTION, V56, P642, DOI 10.1111/j.0014-3820.2002.tb01373.x; MATHER K, 1953, HEREDITY, V7, P297, DOI 10.1038/hdy.1953.41; Midgley GF, 1998, PLANT CELL ENVIRON, V21, P437, DOI 10.1046/j.1365-3040.1998.00274.x; MOLLER AP, 1994, J EVOLUTION BIOL, V7, P97, DOI 10.1046/j.1420-9101.1994.7010097.x; Nevo E, 1999, ISR J PLANT SCI, V47, P49, DOI 10.1080/07929978.1999.10676751; NEVO E, 1995, P ROY SOC B-BIOL SCI, V262, P149, DOI 10.1098/rspb.1995.0189; Nevo E, 1997, THEOR POPUL BIOL, V52, P231, DOI 10.1006/tpbi.1997.1330; Nevo E, 1996, ISR J ZOOL, V42, P395; Nevo E, 2001, P NATL ACAD SCI USA, V98, P6233, DOI 10.1073/pnas.101109298; Nevo E., 2009, TRENDS EVOL BIOL, V1, P3; Nevo E, 2006, ISR J ECOL EVOL, V52, P485; Palmer A. Richard, 2003, P279; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; PARSONS PA, 1992, HEREDITY, V68, P361, DOI 10.1038/hdy.1992.51; Pavlicek Tomas, 2003, Israel Journal of Earth Sciences, V52, P1, DOI 10.1560/QD0A-9T22-4FGL-FGH6; Pelabon C, 2004, EVOLUTION, V58, P504, DOI 10.1111/j.0014-3820.2004.tb01674.x; Polak M., 2003, CAUSES CONSEQUENCES; Rayner ADM, 1994, GROWING FUNGUS, P21; Raz S, 2011, BIOL J LINN SOC, V102, P786, DOI 10.1111/j.1095-8312.2011.01615.x; Raz S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005214; Ritchie F, 2006, MYCOL RES, V110, P725, DOI 10.1016/j.mycres.2006.04.008; Ritz K., 2004, Mycologist, V18, P52, DOI 10.1017/S0269915X04002010; Sangster TA, 2008, P NATL ACAD SCI USA, V105, P2963, DOI 10.1073/pnas.0712200105; Santos M, 2002, J EVOLUTION BIOL, V15, P720, DOI 10.1046/j.1420-9101.2002.00450.x; Singaravelan N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002993; VANVALEN L, 1962, EVOLUTION, V16, P125; Waddington C., 1957, STRATEGY GENES; Zakharov V.M., 1989, Soviet Scientific Reviews Section F Physiology and General Biology Reviews, V4, P1	50	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34689	10.1371/journal.pone.0034689	http://dx.doi.org/10.1371/journal.pone.0034689			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523554	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000025
J	Kim, SY; Kim, JY; Malik, S; Son, W; Kwon, KS; Kim, C				Kim, Sung Yun; Kim, Ji Young; Malik, Sumira; Son, Wonseok; Kwon, Ki-Sun; Kim, Changsoo			Negative Regulation of EGFR/MAPK Pathway by Pumilio in Drosophila melanogaster	PLOS ONE			English	Article							HUNCHBACK MESSENGER-RNA; SIGNALING PATHWAYS; EGF-RECEPTOR; TRANSLATIONAL REGULATOR; GENE-EXPRESSION; BINDING DOMAIN; CELL FATE; PROTEIN; KINASE; NANOS	In Drosophila melanogaster, specification of wing vein cells and sensory organ precursor (SOP) cells, which later give rise to a bristle, requires EGFR signaling. Here, we show that Pumilio (Pum), an RNA-binding translational repressor, negatively regulates EGFR signaling in wing vein and bristle development. We observed that loss of Pum function yielded extra wing veins and additional bristles. Conversely, overexpression of Pum eliminated wing veins and bristles. Heterozygotes for Pum produced no phenotype on their own, but greatly enhanced phenotypes caused by the enhancement of EGFR signaling. Conversely, over-expression of Pum suppressed the effects of ectopic EGFR signaling. Components of the EGFR signaling pathway are encoded by mRNAs that have Nanos Response Element (NRE)-like sequences in their 3'UTRs; NREs are known to bind Pum to confer regulation in other mRNAs. We show that these NRE-like sequences bind Pum and confer repression on a luciferase reporter in heterologous cells. Taken together, our evidence suggests that Pum functions as a negative regulator of EGFR signaling by directly targeting components of the pathway in Drosophila.	[Kim, Sung Yun; Kim, Ji Young; Malik, Sumira; Kim, Changsoo] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Yongbong Dong, Gwangju, South Korea; [Kim, Ji Young; Kwon, Ki-Sun] Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Taejon, South Korea; [Son, Wonseok] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Chonnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST)	Kim, SY (corresponding author), Ohio State Univ, Dept Mol Genet, 484 W 12Th Ave, Columbus, OH 43210 USA.	changgk@chonnam.ac.kr	Malik, Sumira/AIE-3977-2022	Malik, Sumira/0000-0001-5077-1493; Son, Wonseok/0000-0003-1623-1236	National Research Foundation of Korea [2011-0030133, 2011-0936]; Brain Korea (BK) 21 program	National Research Foundation of Korea(National Research Foundation of Korea); Brain Korea (BK) 21 program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported in part by grants to K.-S. Kwon (2011-0030133) and C. Kim (2011-0936) from the National Research Foundation of Korea and to S. Kim, J. Kim, and S. Malik from the Brain Korea (BK) 21 program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER DD, 1992, GENE DEV, V6, P2312, DOI 10.1101/gad.6.12a.2312; Bernstein DS, 2002, METHODS, V26, P123, DOI 10.1016/S1046-2023(02)00015-4; BODMER R, 1989, NEURON, V3, P21, DOI 10.1016/0896-6273(89)90112-8; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; BRUNNER D, 1994, CELL, V76, P875, DOI 10.1016/0092-8674(94)90362-X; Ciapponi L, 2001, GENE DEV, V15, P1540, DOI 10.1101/gad.886301; CLIFFORD RJ, 1989, GENETICS, V123, P771; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Culi J, 1998, GENE DEV, V12, P2036, DOI 10.1101/gad.12.13.2036; Culi J, 2001, DEVELOPMENT, V128, P299; Dean KA, 2002, TRENDS GENET, V18, P572, DOI 10.1016/S0168-9525(02)02792-0; DIAZBENJUMEA FJ, 1994, DEVELOPMENT, V120, P569; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Forbes A, 1998, DEVELOPMENT, V125, P679; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; Karim FD, 1998, DEVELOPMENT, V125, P1; Kim JY, 2010, J BIOL CHEM, V285, P4741, DOI 10.1074/jbc.M109.002014; Lee MH, 2007, PLOS GENET, V3, P2540, DOI 10.1371/journal.pgen.0030233; MACDONALD PM, 1992, DEVELOPMENT, V114, P221; Marenda DR, 2006, DEVELOPMENT, V133, P43, DOI 10.1242/dev.02168; Martin-Blanco E, 1999, DEVELOPMENT, V126, P5739; Martin-Blanco E, 1998, INT J DEV BIOL, V42, P363; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Na SY, 1999, J BIOL CHEM, V274, P28491, DOI 10.1074/jbc.274.40.28491; Nakao K, 1996, NEURON, V16, P275, DOI 10.1016/S0896-6273(00)80046-X; Oellers N, 1996, J BIOL CHEM, V271, P24939, DOI 10.1074/jbc.271.40.24939; Parisi M, 1999, GENETICS, V153, P235; PERRIMON N, 1994, CURR OPIN CELL BIOL, V6, P260, DOI 10.1016/0955-0674(94)90145-7; Prinz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000249; SAWAMOTO K, 1994, DEV BIOL, V164, P267, DOI 10.1006/dbio.1994.1197; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; Sonoda J, 1999, GENE DEV, V13, P2704, DOI 10.1101/gad.13.20.2704; STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585; STURTEVANT MA, 1993, GENE DEV, V7, P961, DOI 10.1101/gad.7.6.961; Wharton RP, 1998, MOL CELL, V1, P863, DOI 10.1016/S1097-2765(00)80085-4; Xiao CF, 2007, DEV NEUROBIOL, V67, P438, DOI 10.1002/dneu.20344; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Zamore PD, 1999, BIOCHEMISTRY-US, V38, P596, DOI 10.1021/bi982264s; zur Lage PI, 2004, DEV CELL, V7, P687, DOI 10.1016/j.devcel.2004.09.015	42	8	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34016	10.1371/journal.pone.0034016	http://dx.doi.org/10.1371/journal.pone.0034016			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514614	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341600019
J	Rupasov, VI; Lebedev, MA; Erlichman, JS; Linderman, M				Rupasov, Valery I.; Lebedev, Mikhail A.; Erlichman, Joseph S.; Linderman, Michael			Neuronal Variability during Handwriting: Lognormal Distribution	PLOS ONE			English	Article							RAPID HUMAN MOVEMENTS; KINEMATIC THEORY; REPRESENTATION; NOISE; PART	We examined time-dependent statistical properties of electromyographic (EMG) signals recorded from intrinsic hand muscles during handwriting. Our analysis showed that trial-to-trial neuronal variability of EMG signals is well described by the lognormal distribution clearly distinguished from the Gaussian (normal) distribution. This finding indicates that EMG formation cannot be described by a conventional model where the signal is normally distributed because it is composed by summation of many random sources. We found that the variability of temporal parameters of handwriting - handwriting duration and response time - is also well described by a lognormal distribution. Although, the exact mechanism of lognormal statistics remains an open question, the results obtained should significantly impact experimental research, theoretical modeling and bioengineering applications of motor networks. In particular, our results suggest that accounting for lognormal distribution of EMGs can improve biomimetic systems that strive to reproduce EMG signals in artificial actuators.	[Rupasov, Valery I.] Norconnect Inc, Dept Basic Res, Ogdensburg, NY USA; [Lebedev, Mikhail A.] Duke Univ, Dept Neurobiol, Durham, NC USA; [Erlichman, Joseph S.] St Lawrence Univ, Dept Biol, Canton, NY 13617 USA; [Linderman, Michael] Norconnect Inc, Dept Neuroeth, Ogdensburg, NY USA	Duke University; Saint Lawrence University	Rupasov, VI (corresponding author), Norconnect Inc, Dept Basic Res, Ogdensburg, NY USA.	mlinderman@acm.org	Lebedev, Mikhail A/H-5066-2016	Lebedev, Mikhail A/0000-0003-0355-8723	National Science Foundation [0848523, 1048430, 1048428]; National Instruments grant	National Science Foundation(National Science Foundation (NSF)); National Instruments grant	This work was supported by National Science Foundation grants 0848523 (IIP), 1048430 (RAHSS), 1048428 (RET) (Principal investigator: ML), and by National Instruments grant. www.nsf.gov. www.ni.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendat JS, 1968, MEASUREMENTS ANAL RA; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; Churchland MM, 2010, NAT NEUROSCI, V13, P369, DOI 10.1038/nn.2501; Djioua M., 2008, INT C FRONT HANDWR R, P112; Djioua M, 2011, P 15 BIENN C INT GRA, P90; Fagg AH, 2007, J NEUROSCI, V27, P11842, DOI 10.1523/JNEUROSCI.3516-07.2007; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Linderman M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006791; PLAMONDON R, 1995, BIOL CYBERN, V72, P295, DOI 10.1007/BF00202785; PLAMONDON R, 1995, BIOL CYBERN, V72, P309, DOI 10.1007/BF00202786; Plamondon R, 2003, BIOL CYBERN, V89, P126, DOI 10.1007/s00422-003-0407-9; PLAMONDON R, 1990, BIOL CYBERN, V63, P443, DOI 10.1007/BF00199576; Plamondon R, 1995, BIOL CYBERN, V78, P133; Santucci DM, 2005, EUR J NEUROSCI, V22, P1529, DOI 10.1111/j.1460-9568.2005.04320.x; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668	16	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34759	10.1371/journal.pone.0034759	http://dx.doi.org/10.1371/journal.pone.0034759			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514664	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341600070
J	Yadavalli, V; Jolley, CC; Malleda, C; Thangaraj, B; Fromme, P; Subramanyam, R				Yadavalli, Venkateswarlu; Jolley, Craig C.; Malleda, Chandramouli; Thangaraj, Balakumar; Fromme, Petra; Subramanyam, Rajagopal			Alteration of Proteins and Pigments Influence the Function of Photosystem I under Iron Deficiency from Chlamydomonas reinhardtii	PLOS ONE			English	Article							LIGHT-HARVESTING COMPLEX; MANGANESE SUPEROXIDE-DISMUTASE; PSI-LHCI; EXCITATION DYNAMICS; THYLAKOID MEMBRANES; SYNECHOCOCCUS-SP; SUPERCOMPLEX; CORE; ORGANIZATION; BINDING	Background: Iron is an essential micronutrient for all organisms because it is a component of enzyme cofactors that catalyze redox reactions in fundamental metabolic processes. Even though iron is abundant on earth, it is often present in the insoluble ferric [Fe (III)] state, leaving many surface environments Fe-limited. The haploid green alga Chlamydomonas reinhardtii is used as a model organism for studying eukaryotic photosynthesis. This study explores structural and functional changes in PSI-LHCI supercomplexes under Fe deficiency as the eukaryotic photosynthetic apparatus adapts to Fe deficiency. Results: 77K emission spectra and sucrose density gradient data show that PSI and LHCI subunits are affected under iron deficiency conditions. The visible circular dichroism (CD) spectra associated with strongly-coupled chlorophyll dimers increases in intensity. The change in CD signals of pigments originates from the modification of interactions between pigment molecules. Evidence from sucrose gradients and non-denaturing (green) gels indicates that PSI-LHCI levels were reduced after cells were grown for 72 h in Fe-deficient medium. Ultrafast fluorescence spectroscopy suggests that red-shifted pigments in the PSI-LHCI antenna were lost during Fe stress. Further, denaturing gel electrophoresis and immunoblot analysis reveals that levels of the PSI subunits PsaC and PsaD decreased, while PsaE was completely absent after Fe stress. The light harvesting complexes were also susceptible to iron deficiency, with Lhca1 and Lhca9 showing the most dramatic decreases. These changes in the number and composition of PSI-LHCI supercomplexes may be caused by reactive oxygen species, which increase under Fe deficiency conditions. Conclusions: Fe deficiency induces rapid reduction of the levels of photosynthetic pigments due to a decrease in chlorophyll synthesis. Chlorophyll is important not only as a light-harvesting pigment, but also has a structural role, particularly in the pigment-rich LHCI subunits. The reduced level of chlorophyll molecules inhibits the formation of large PSI-LHCI supercomplexes, further decreasing the photosynthetic efficiency.	[Yadavalli, Venkateswarlu; Malleda, Chandramouli] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India; [Jolley, Craig C.; Thangaraj, Balakumar; Fromme, Petra] Arizona State Univ, Ctr Bioenergy & Photosynth, Dept Chem & Biochem, Tempe, AZ USA; [Subramanyam, Rajagopal] Univ Hyderabad, Sch Life Sci, Dept Plant Sci, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad; Arizona State University; Arizona State University-Tempe; University of Hyderabad	Yadavalli, V (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India.	psrajagopal@yahoo.com	thangaraj, balakumar/M-7831-2015	Fromme, Petra/0000-0003-0953-4909	Council of Scientific and Industrial Research [38(1279)/11/EMR-II]; Department of Biotechnology [BT/PR11277/GBD/27/152/2008]; Department of Science and Technology [SR/SO/BB-34/2006, SR/FT/L-89/2006]; University of Hyderabad-Centre for Education and Research in Biology and Biotechnology; University Grand Commission, India; National Science Foundation [MCB-0417142]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); University of Hyderabad-Centre for Education and Research in Biology and Biotechnology; University Grand Commission, India; National Science Foundation(National Science Foundation (NSF))	This work was supported by Council of Scientific and Industrial Research (No. 38(1279)/11/EMR-II), and Department of Biotechnology (BT/PR11277/GBD/27/152/2008), Department of Science and Technology (SR/SO/BB-34/2006 and SR/FT/L-89/2006, FIST), University of Hyderabad-Centre for Education and Research in Biology and Biotechnology, University Grand Commission-special assistant programme, India to RS and the National Science Foundation under Grant No. MCB-0417142 to PF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; Andaluz S, 2006, PHOTOSYNTH RES, V89, P141, DOI 10.1007/s11120-006-9092-6; Banowetz GM, 2004, ANAL BIOCHEM, V332, P314, DOI 10.1016/j.ab.2004.06.015; BASSI R, 1987, EUR J BIOCHEM, V163, P221, DOI 10.1111/j.1432-1033.1987.tb10791.x; Batsmanova L M, 2008, Ukr Biokhim Zh (1999), V80, P101; BAUM JA, 1979, DIFFERENTIATION, V13, P133, DOI 10.1111/j.1432-0436.1979.tb01576.x; Beauchamp Charles, ANAL BIOCHEM, V44, P276, DOI [10.1016/0003-2697(71)90370-8, DOI 10.1016/0003-2697(71)90370-8]; Briat JF, 2007, CURR OPIN PLANT BIOL, V10, P276, DOI 10.1016/j.pbi.2007.04.003; Chang-Quan W, 2008, ACTA PHYSIOL PLANT, V30, P841, DOI 10.1007/s11738-008-0189-8; Chauhan D, 2011, BIOCHEMISTRY-US, V50, P686, DOI 10.1021/bi1009425; Chen CN, 1996, BOT BULL ACAD SINICA, V37, P107; CHITNIS PR, 1995, PHOTOSYNTH RES, V44, P23, DOI 10.1007/BF00018294; CHO HM, 1984, BIOPHYS J, V45, P455, DOI 10.1016/S0006-3495(84)84168-5; Coale KH, 1996, NATURE, V379, P621, DOI 10.1038/379621a0; Drazkiewicz M, 2007, CHEMOSPHERE, V67, P188, DOI 10.1016/j.chemosphere.2006.08.032; Fischer N, 1997, BIOCHEMISTRY-US, V36, P93, DOI 10.1021/bi962244v; Germano M, 2002, FEBS LETT, V525, P121, DOI 10.1016/S0014-5793(02)03100-9; Gibasiewicz K, 2005, J PHYS CHEM B, V109, P21180, DOI 10.1021/jp0530909; Gibasiewicz K, 2002, J PHYS CHEM B, V106, P6322, DOI [10.1021/jp014608l, 10.1021/jp0146081]; Gibasiewicz K, 2001, J PHYS CHEM B, V105, P11498, DOI 10.1021/jp012089g; Gobets B, 2001, BBA-BIOENERGETICS, V1507, P80, DOI 10.1016/S0005-2728(01)00203-1; GUIKEMA JA, 1984, PLANT PHYSIOL, V74, P90, DOI 10.1104/pp.74.1.90; HWANGSCHWEITZER RH, 1992, J LUMIN, V51, P99, DOI 10.1016/0022-2313(92)90022-2; Ihalainen JA, 2005, FEBS LETT, V579, P4787, DOI 10.1016/j.febslet.2005.06.091; Jeanjean R, 2008, BBA-BIOENERGETICS, V1777, P308, DOI 10.1016/j.bbabio.2007.11.009; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kargul J, 2003, J BIOL CHEM, V278, P16135, DOI 10.1074/jbc.M300262200; Kitayama K, 1999, J PHYCOL, V35, P136, DOI 10.1046/j.1529-8817.1999.3510136.x; LI N, 1991, BIOCHEMISTRY-US, V30, P7863, DOI 10.1021/bi00245a028; Li W, 2009, J INTEGR PLANT BIOL, V51, P279, DOI 10.1111/j.1744-7909.2008.00790.x; LUNEBERG J, 1994, FEBS LETT, V338, P197, DOI 10.1016/0014-5793(94)80364-1; Lynnes JA, 1998, PLANTA, V204, P360, DOI 10.1007/s004250050267; MARTIN JH, 1994, NATURE, V371, P123, DOI 10.1038/371123a0; Merchant SS, 2006, BBA-MOL CELL RES, V1763, P578, DOI 10.1016/j.bbamcr.2006.04.007; Moseley JL, 2002, EMBO J, V21, P6709, DOI 10.1093/emboj/cdf666; Msilini N, 2011, PHOTOSYNTH RES, V107, P247, DOI 10.1007/s11120-011-9628-2; Murakami A, 1997, PHOTOSYNTH RES, V53, P141, DOI 10.1023/A:1005818317797; Naumann B, 2005, J BIOL CHEM, V280, P20431, DOI 10.1074/jbc.M414486200; Naumann B, 2007, PROTEOMICS, V7, P3964, DOI 10.1002/pmic.200700407; OHOKA H, 1988, J BIOCHEM-TOKYO, V103, P962, DOI 10.1093/oxfordjournals.jbchem.a122394; PUSHNIK JC, 1982, J PLANT NUTR, V5, P311, DOI 10.1080/01904168209362960; Saenger W, 2002, CURR OPIN STRUC BIOL, V12, P244, DOI 10.1016/S0959-440X(02)00317-2; SARVARI E, 1994, ELECTROPHORESIS, V15, P1068, DOI 10.1002/elps.11501501159; Setif P, 2002, BBA-BIOENERGETICS, V1555, P204, DOI 10.1016/S0005-2728(02)00279-7; Singh AK, 2003, PLANT PHYSIOL, V132, P1825, DOI 10.1104/pp.103.024018; Sonoike K, 2011, PHYSIOL PLANTARUM, V142, P56, DOI 10.1111/j.1399-3054.2010.01437.x; Straus N.A., 1994, MOL BIOL CYANOBACTER, P731, DOI DOI 10.1007/978-94-011-0227-8_25; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; Subramanyam R, 2006, FEBS LETT, V580, P233, DOI 10.1016/j.febslet.2005.12.003; Subramanyam R, 2010, PROTOCOLS ALGAL RES, P138; Subramanyam R, 2010, PLANTA, V231, P913, DOI 10.1007/s00425-009-1097-x; Thangaraj B, 2011, BIOPHYS J, V100, P135, DOI 10.1016/j.bpj.2010.09.069; Timperio AM, 2007, J EXP BOT, V58, P3695, DOI 10.1093/jxb/erm219; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Varsano T, 2006, J BIOL CHEM, V281, P10305, DOI 10.1074/jbc.M511057200; Wollman FA, 1999, BBA-BIOENERGETICS, V1411, P21, DOI 10.1016/S0005-2728(99)00043-2; Yadavalli V, 2011, MOL BIOSYST, V7, P3143, DOI 10.1039/c1mb05218g; YU JP, 1995, PLANT MOL BIOL, V29, P331, DOI 10.1007/BF00043656	59	28	28	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35084	10.1371/journal.pone.0035084	http://dx.doi.org/10.1371/journal.pone.0035084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514709	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600115
J	Bobrowska, A; Donmez, G; Weiss, A; Guarente, L; Bates, G				Bobrowska, Anna; Donmez, Gizem; Weiss, Andreas; Guarente, Leonard; Bates, Gillian			SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington's Disease Phenotypes In Vivo	PLOS ONE			English	Article							R6/2 MOUSE MODEL; MUTANT HUNTINGTIN; GENE-EXPRESSION; TRANSGENIC MICE; DEACETYLASE; INHIBITORS; PROTEIN; DYSFUNCTION; AGGREGATION; INCLUSIONS	Huntington's disease (HD) is a devastating neurodegenerative disorder for which there are no disease-modifying treatments. The molecular pathogenesis of HD is complex and many mechanisms and cellular processes have been proposed as potential sites of therapeutic intervention. However, prior to embarking on drug development initiatives, it is essential that therapeutic targets can be validated in mammalian models of HD. Previous studies in invertebrate and cell culture HD models have suggested that inhibition of SIRT2 could have beneficial consequences on disease progression. SIRT2 is a NAD(+)-dependent deacetylase that has been proposed to deacetylate alpha-tubulin, histone H4 K16 and to regulate cholesterol biogenesis - a pathway which is dysregulated in HD patients and HD mouse models. We have utilized mice in which SIRT2 has been reduced or ablated to further explore the function of SIRT2 and to assess whether SIRT2 loss has a beneficial impact on disease progression in the R6/2 mouse model of HD. Surprisingly we found that reduction or loss of SIRT2 had no effect on the acetylation of alpha-tubulin or H4K16 or on cholesterol biosynthesis in the brains of wild type mice. Equally, genetic reduction or ablation of SIRT2 had no effect on HD progression as assessed by a battery of physiological and behavioural tests. Furthermore, we observed no change in aggregate load or levels of soluble mutant huntingtin transprotein. Intriguingly, neither the constitutive genetic loss nor acute pharmacological inhibition of SIRT2 affected the expression of cholesterol biosynthesis enzymes in the context of HD. Therefore, we conclude that SIRT2 inhibition does not modify disease progression in the R6/2 mouse model of HD and SIRT2 inhibition should not be prioritised as a therapeutic option for HD.	[Bobrowska, Anna; Bates, Gillian] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Donmez, Gizem; Guarente, Leonard] MIT, Paul F Glenn Lab, Cambridge, MA 02139 USA; [Donmez, Gizem; Guarente, Leonard] MIT, Dept Biol, Cambridge, MA USA; [Weiss, Andreas] Novartis Inst BioMed Res, Basel, Switzerland	University of London; King's College London; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Novartis	Bobrowska, A (corresponding author), Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England.	gillian.bates@kcl.ac.uk	Yalcin, Gizem Donmez/AAG-5056-2019; Bates, Gillian/E-1146-2012	Yalcin, Gizem Donmez/0000-0002-5121-8232; Bobrowska, Anna/0000-0002-5001-7981; Bates, Gillian/0000-0002-4041-6305	European Commission Marie Curie Initial Training Network Fellowship [215618]; American Parkinson's Disease Fellowship; Johnson and Johnson fellowship; CHDI Foundation through fee-for-service contract; Johnson and Johnson; CHDI Foundation	European Commission Marie Curie Initial Training Network Fellowship; American Parkinson's Disease Fellowship; Johnson and Johnson fellowship; CHDI Foundation through fee-for-service contract; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); CHDI Foundation	This work was supported by a European Commission Marie Curie Initial Training Network (215618) Fellowship (AB), an American Parkinson's Disease Fellowship (GD) and a Johnson and Johnson fellowship (GD). Part of this work was funded through fee-for-service contract research by the CHDI Foundation. (CHDI Foundation is a privately-funded not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease.) With the exception of this, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: AW is an employee of Novartis Pharma AG, Basel, and GD received a fellowship from Johnson and Johnson. The CHDI Foundation is a privately-funded not-for-profit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. BioFocus, Cerep, Cychem and Pharmidex provided reagents and data through a fee-for-service agreement for the CHDI Foundation. This declaration does not alter the authors' adherence to all PLoS ONE policies on sharing data and materials.	ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; BATES G, 2002, HUNTINGTONS DIS; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Benn CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005747; Bobrowska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020696; Cakir I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008322; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dryden SC, 2003, MOL CELL BIOL, V23, P3173, DOI 10.1128/MCB.23.9.3173-3185.2003; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hathorn T, 2011, NEUROBIOL DIS, V41, P43, DOI 10.1016/j.nbd.2010.08.017; Hockly E, 2006, NEUROBIOL DIS, V21, P228, DOI 10.1016/j.nbd.2005.07.007; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Hockly E, 2002, ANN NEUROL, V51, P235, DOI 10.1002/ana.10094; Inoue T, 2007, ONCOGENE, V26, P945, DOI 10.1038/sj.onc.1209857; Jeong H, 2012, NAT MED, V18, P159, DOI 10.1038/nm.2559; Jiang ML, 2012, NAT MED, V18, P153, DOI 10.1038/nm.2558; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Liang ZJ, 2010, J PHYS CHEM B, V114, P11927, DOI 10.1021/jp1054183; Luthi-Carter R, 2010, P NATL ACAD SCI USA, V107, P7927, DOI 10.1073/pnas.1002924107; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Maxwell MM, 2011, HUM MOL GENET, V20, P3986, DOI 10.1093/hmg/ddr326; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Moumne L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031080; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Nie Hui, 2011, Int J Physiol Pathophysiol Pharmacol, V3, P65; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000784; Novak Marianne J U, 2010, BMJ, V340, pc3109, DOI 10.1136/bmj.c3109; Novak MJU, 2011, INT REV NEUROBIOL, V98, P297, DOI 10.1016/B978-0-12-381328-2.00013-4; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Rosas HD, 2003, NEUROLOGY, V60, P1615, DOI 10.1212/01.WNL.0000065888.88988.6E; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Schilling G, 2007, J NEUROPATH EXP NEUR, V66, P313, DOI 10.1097/nen.0b013e318040b2c8; Valenza M, 2007, NEUROBIOL DIS, V28, P133, DOI 10.1016/j.nbd.2007.07.004; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Walker FO, 2007, SEMIN NEUROL, V27, P143, DOI 10.1055/s-2007-971176; Wang F, 2011, ONCOGENE; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009	60	96	98	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34805	10.1371/journal.pone.0034805	http://dx.doi.org/10.1371/journal.pone.0034805			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511966	Green Published, gold			2022-12-27	WOS:000305338600052
J	Rizvi, F; Heimann, T; O'Brien, WJ				Rizvi, Farhan; Heimann, Tom; O'Brien, William J.			Expression of NADPH Oxidase (NOX) 5 in Rabbit Corneal Stromal Cells	PLOS ONE			English	Article							MOLECULAR EVOLUTION; OXYGEN; FAMILY; SUPEROXIDE; ACTIVATION; MECHANISM; GENES; RAC1	Purpose: To determine whether NOX 5 is expressed in rabbit corneal stromal cells (RCSC). NADPH oxidases (NOXes) are enzymes that preferentially use NADPH as a substrate and generate superoxide. Several isoforms of NOXes function as multi-protein complexes while NOX5 and DUOXs do not require the accessory proteins for their activity and possess calcium binding EF hands. Methods: Human NOX5 primers were used to amplify the rabbit NOX5 by RT-PCR. Amplified product was sequenced to confirm its identity. The protein encoded by the NOX5 was identified by western blot analysis. NOX5 siRNA was used to reduce transcript, protein, and calcium stimulated activity. In silico analyses were performed to establish the putative structure, functions, and evolution of rabbit NOX5. Results: NOX activity was measured in RCSC with NADPH rather than NADH as a substrate. RT-PCR with NOX5 primers amplified 288 bp product using RCSC cDNA, which, when sequenced, confirmed its identity to human NOX5 mRNA. This sequence was used to predict the rabbit (Oryctolagus cuniculus) NOX5 gene. NOX5 siRNA reduced amounts of NOX5 mRNA in RCSC and reduced ionomycin stimulated superoxide production. A protein of about 65 to 70 kDa encoded by the NOX5 was detected by western blot analysis. In silico analysis predicted a putative rabbit NOX5 protein containing 801 amino acids. Motif searches predicted the presence of at least 3 putative EF-hands in N-terminus and a NOX domain in C terminal region. Conclusions: The data document that the NOX5 gene was expressed in cells of lagomorphs unlike rodents, making the rabbit an interesting model to study NOX5 functions. The activity of the rabbit NOX5 was calcium stimulated, a trait of NOX5 in general. NOX5 may also prove to be a useful genetic marker for studying the taxonomic position of lagomorphs and the Glires classification.	[Rizvi, Farhan; Heimann, Tom; O'Brien, William J.] Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA; [O'Brien, William J.] Med Coll Wisconsin, Dept Microbiol Mol Genet, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin	Rizvi, F (corresponding author), Med Coll Wisconsin, Dept Ophthalmol, Milwaukee, WI 53226 USA.	frizvi@mcw.edu			National Institutes of Health (NIH) [R01-EY017079, P30-EY02031, C06-RR016511]; Research to Prevent Blindness; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR016511] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY017079] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported in part by the National Institutes of Health (NIH) Grants R01-EY017079 and P30-EY02031 and an unrestricted grant from Research to Prevent Blindness. Research was conducted in facilities constructed in part by Construction Grant C06-RR016511 from the NIH. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambasta RK, 2006, FREE RADIC BIOL MED, V41, P203; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asher RJ, 2005, SCIENCE, V307, P1091, DOI 10.1126/science.1107808; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Basuroy S, 2011, AM J PHYSIOL-CELL PH, V300, pC256, DOI 10.1152/ajpcell.00272.2010; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bedard K, 2012, FREE RADICAL BIO MED, V52, P725, DOI 10.1016/j.freeradbiomed.2011.11.023; BelAiba RS, 2007, FREE RADICAL BIO MED, V42, P446, DOI 10.1016/j.freeradbiomed.2006.10.054; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Dean M, 2005, ANNU REV GENOM HUM G, V6, P123, DOI 10.1146/annurev.genom.6.080604.162122; Fulton DJR, 2009, ANTIOXID REDOX SIGN, V11, P2443, DOI [10.1089/ars.2009.2587, 10.1089/ARS.2009.2587]; He JK, 2010, DEV BIOL, V337, P157, DOI 10.1016/j.ydbio.2009.09.038; Hong J, 2011, AM J PHYSIOL-CELL PH, V301, pC413, DOI 10.1152/ajpcell.00027.2011; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Jagnandan D, 2007, J BIOL CHEM, V282, P6494, DOI 10.1074/jbc.M608966200; Kawahara T, 2008, MOL BIOL CELL, V19, P4020, DOI 10.1091/mbc.E07-12-1223; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-178; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Kawai YK, 2010, MAMM GENOME, V21, P320, DOI 10.1007/s00335-010-9263-9; Kawasaki H, 1998, BIOMETALS, V11, P277, DOI 10.1023/A:1009282307967; Kullberg M, 2006, MOL BIOL EVOL, V23, P1493, DOI 10.1093/molbev/msl027; Lambeth JD, 2007, FREE RADIC BIOL MED, V43, P320; Lyle AN, 2006, PHYSIOLOGY, V21, P269, DOI 10.1152/physiol.00004.2006; Lyle AN, 2009, CIRC RES, V105, P249, DOI 10.1161/CIRCRESAHA.109.193722; Martin-Garrido A, 2011, FREE RADICAL BIO MED, V50, P354, DOI 10.1016/j.freeradbiomed.2010.11.007; Meng D, 2008, CARDIOVASC RES, V80, P299, DOI 10.1093/cvr/cvn173; Nauseef WM, 2004, HISTOCHEM CELL BIOL, V122, P277, DOI 10.1007/s00418-004-0679-8; O'Brien WJ, 2009, MOL VIS, V15, P2535; O'Brien WJ, 2006, INVEST OPHTH VIS SCI, V47, P853, DOI 10.1167/iovs.05-1063; Rizvi F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018137; Saltzman MR, 2011, P NATL ACAD SCI USA, V108, P3876, DOI 10.1073/pnas.1011836108; Sedeek M, 2009, CURR OPIN NEPHROL HY, V18, P122, DOI 10.1097/MNH.0b013e32832923c3; Serrander L, 2007, BIOCHIMIE, V89, P1159, DOI 10.1016/j.biochi.2007.05.004; Tirone F, 2010, BIOCHEMISTRY-US, V49, P761, DOI 10.1021/bi901846y; Ushio-Fukai M, 2008, CANCER LETT, V266, P37, DOI 10.1016/j.canlet.2008.02.044; Ushio-Fukai Masuko, 2006, Sci STKE, V2006, pre8; Weissmann N, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-86; Williams RJP, 2006, BBA-MOL CELL RES, V1763, P1139, DOI 10.1016/j.bbamcr.2006.08.042; Ye J, 2011, CYTOGENET GENOME RES, V132, P41, DOI 10.1159/000317082; Zhang LL, 2011, BIOCHIMIE, V93, P457, DOI 10.1016/j.biochi.2010.11.001	41	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34440	10.1371/journal.pone.0034440	http://dx.doi.org/10.1371/journal.pone.0034440			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511941	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600027
J	Ahmad, MF; Yadav, B; Kumar, P; Puri, A; Mazumder, M; Ali, A; Gourinath, S; Muthuswami, R; Komath, SS				Ahmad, Mohammad Faiz; Yadav, Bhawna; Kumar, Pravin; Puri, Amrita; Mazumder, Mohit; Ali, Anwar; Gourinath, Samudrala; Muthuswami, Rohini; Komath, Sneha Sudha			The GPI Anchor Signal Sequence Dictates the Folding and Functionality of the Als5 Adhesin from Candida albicans	PLOS ONE			English	Article							AMYLOID-FORMING SEQUENCES; GENE FAMILY; PROTEINS; AGGREGATION; MORPHOGENESIS; BIOSYNTHESIS; VIRULENCE; PEPTIDES; REPEATS; PART	Background: Proteins destined to be Glycosylphosphatidylinositol (GPI) anchored are translocated into the ER lumen completely before the C-terminal GPI anchor attachment signal sequence (SS) is removed by the GPI-transamidase and replaced by a pre-formed GPI anchor precursor. Does the SS have a role in dictating the conformation and function of the protein as well? Methodology/Principal Findings: We generated two variants of the Als5 protein without and with the SS in order to address the above question. Using a combination of biochemical and biophysical techniques, we show that in the case of Als5, an adhesin of C. albicans, the C-terminal deletion of 20 amino acids (SS) results in a significant alteration in conformation and function of the mature protein. Conclusions/Significance: We propose that the locking of the conformation of the precursor protein in an alternate conformation from that of the mature protein is one probable strategy employed by the cell to control the behaviour and function of proteins intended to be GPI anchored during their transit through the ER.	[Ahmad, Mohammad Faiz; Yadav, Bhawna; Mazumder, Mohit; Gourinath, Samudrala; Muthuswami, Rohini; Komath, Sneha Sudha] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Ahmad, Mohammad Faiz; Ali, Anwar] Jamia Millia Islamia, Dept Chem, New Delhi 110025, India; [Kumar, Pravin] Univ Delhi, Dept Plant Mol Biol, New Delhi, India; [Puri, Amrita] Biotech Co, Invisible Sentinel, Philadelphia, PA USA	Jawaharlal Nehru University, New Delhi; Jamia Millia Islamia; University of Delhi	Ahmad, MF (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	sskomath@yahoo.com	Muthuswami, Rohini/Q-9841-2019; KOMATH, SNEHA SUDHA/AAE-6359-2020	Muthuswami, Rohini/0000-0002-0559-9484; KOMATH, SNEHA SUDHA/0000-0002-0491-7102; KUMAR, PRAVIN/0000-0002-6264-4157; mazumder, mohit/0000-0002-2593-725X	DBT-India [BT/PR10689/10/616/2008]; UGC-RNW [34-282/2008]; SLS LRE	DBT-India(Department of Biotechnology (DBT) India); UGC-RNW; SLS LRE	This work was supported in part by grants to SSK from DBT-India (grant number: BT/PR10689/10/616/2008) (URL: http://dbtindia.nic.in), UGC-RNW (grant number: 34-282/2008(SR)) (URL: http://www.ugc.ac.in/) and the SLS LRE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other external funding was received for this study.	Almeida A, 2009, BBA-MOL BASIS DIS, V1792, P874, DOI 10.1016/j.bbadis.2008.12.010; Alonso R, 2001, MICROBIOL-SGM, V147, P1971, DOI 10.1099/00221287-147-7-1971; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Dalley JA, 2003, BIOCHEM SOC T, V31, P1257; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Donohue DS, 2011, MOL MICROBIOL, V80, P1667, DOI 10.1111/j.1365-2958.2011.07676.x; Eisenhaber B, 2003, BIOESSAYS, V25, P367, DOI 10.1002/bies.10254; Feng QL, 2009, ACTA BIOCH BIOPH SIN, V41, P955, DOI 10.1093/abbs/gmp086; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Frank AT, 2010, EUKARYOT CELL, V9, P405, DOI 10.1128/EC.00235-09; Gaur NK, 1999, INFECT IMMUN, V67, P6040, DOI 10.1128/IAI.67.11.6040-6047.1999; Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9; Hoyer LL, 2008, MED MYCOL, V46, P1, DOI 10.1080/13693780701435317; JOST CR, 1991, BLOOD, V78, P3030; Klotz SA, 2004, INFECT IMMUN, V72, P2029, DOI 10.1128/IAI.72.4.2029-2034.2004; Klotz SA, 2007, MED MYCOL, V45, P363, DOI 10.1080/13693780701299333; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; London N, 2010, PROTEINS, V78, P3140, DOI 10.1002/prot.22785; Maeda Y, 2011, PROG LIPID RES, V50, P411, DOI 10.1016/j.plipres.2011.05.002; Martinez-Lopez R, 2004, MICROBIOL-SGM, V150, P3341, DOI 10.1099/mic.0.27320-0; Otoo HN, 2008, EUKARYOT CELL, V7, P776, DOI 10.1128/EC.00309-07; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Ramsook CB, 2010, EUKARYOT CELL, V9, P393, DOI 10.1128/EC.00068-09; Rauceo JM, 2006, EUKARYOT CELL, V5, P1664, DOI 10.1128/EC.00120-06; Rauceo JM, 2004, INFECT IMMUN, V72, P4948, DOI 10.1128/IAI.72.9.4948-4955.2004; Richard M, 2002, MOL MICROBIOL, V44, P841, DOI 10.1046/j.1365-2958.2002.02926.x; Richard ML, 2007, EUKARYOT CELL, V6, P119, DOI 10.1128/EC.00297-06; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Salgado PS, 2011, P NATL ACAD SCI USA, V108, P15775, DOI 10.1073/pnas.1103496108; Sheppard DC, 2004, J BIOL CHEM, V279, P30480, DOI 10.1074/jbc.M401929200; SINGH N, 1991, MOL CELL BIOL, V11, P2362, DOI 10.1128/MCB.11.5.2362; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yan R, 2010, BIOMOL NMR ASSIGN, V4, P187, DOI 10.1007/s12104-010-9243-8; Zhao XM, 2003, MICROBIOL-SGM, V149, P2947, DOI 10.1099/mic.0.26495-0	35	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35305	10.1371/journal.pone.0035305	http://dx.doi.org/10.1371/journal.pone.0035305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509405	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336600099
J	Rodrigues, J; Oliveira, GA; Kotsyfakis, M; Dixit, R; Molina-Cruz, A; Jochim, R; Barillas-Mury, C				Rodrigues, Janneth; Oliveira, Giselle A.; Kotsyfakis, Michalis; Dixit, Rajnikant; Molina-Cruz, Alvaro; Jochim, Ryan; Barillas-Mury, Carolina			An Epithelial Serine Protease, AgESP, Is Required for Plasmodium Invasion in the Mosquito Anopheles gambiae	PLOS ONE			English	Article							TIME BOMB MODEL; OOKINETE INVASION; MIDGUT CELLS; MALARIA PARASITES; SALIVARY-GLANDS; REAL-TIME; FALCIPARUM; STEPHENSI; VECTOR; SPOROZOITES	Background: Plasmodium parasites need to cross the midgut and salivary gland epithelia to complete their life cycle in the mosquito. However, our understanding of the molecular mechanism and the mosquito genes that participate in this process is still very limited. Methodology/Principal Findings: We identified an Anopheles gambiae epithelial serine protease (AgESP) that is constitutively expressed in the submicrovillar region of mosquito midgut epithelial cells and in the basal side of the salivary glands that is critical for Plasmodium parasites to cross these two epithelial barriers. AgESP silencing greatly reduces Plasmodium berghei and Plasmodium falciparum midgut invasion and prevents the transcriptional activation of gelsolin, a key regulator of actin remodeling and a reported Plasmodium agonist. AgESP expression is highly induced in midgut cells invaded by Plasmodium, suggesting that this protease also participates in the apoptotic response to invasion. In salivary gland epithelial cells, AgESP is localized on the basal side-the surface with which sporozoites interact. AgESP expression in the salivary gland is also induced in response to P. berghei and P. falciparum sporozoite invasion, and AgESP silencing significantly reduces the number of sporozoites that invade this organ. Conclusion: Our findings indicate that AgESP is required for Plasmodium parasites to effectively traverse the midgut and salivary gland epithelial barriers. Plasmodium parasites need to modify the actin cytoskeleton of mosquito epithelial cells to successfully complete their life cycle in the mosquito and AgESP appears to be a major player in the regulation of this process.	[Rodrigues, Janneth; Oliveira, Giselle A.; Kotsyfakis, Michalis; Dixit, Rajnikant; Molina-Cruz, Alvaro; Jochim, Ryan; Barillas-Mury, Carolina] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Rodrigues, J (corresponding author), Univ Washington, Dept Chem, Seattle, WA 98195 USA.	cbarillas@niaid.nih.gov	Dixit, Rajnikant/D-2566-2009; Kotsyfakis, Michail/G-9525-2014; Jochim, Ryan/C-6756-2013	Dixit, Rajnikant/0000-0002-3536-8329; Kotsyfakis, Michail/0000-0002-7526-1876; Oliveira, Giselle/0000-0002-5898-7843; Rodrigues, Janneth/0000-0001-9693-1958	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; Baton LA, 2004, PARASITOLOGY, V129, P663, DOI 10.1017/S0031182004005979; BILLINGSLEY PF, 1990, ANNU REV ENTOMOL, V35, P219, DOI 10.1146/annurev.en.35.010190.001251; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dana AN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-5; Ghosh A., 2011, P NATL ACAD SCI US; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Han YS, 2002, INSECT BIOCHEM MOLEC, V32, P1311, DOI 10.1016/S0965-1748(02)00093-0; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEIS JFGM, 1989, PARASITOL RES, V76, P13, DOI 10.1007/BF00931065; Muller HM, 1995, EXP PARASITOL, V81, P371, DOI 10.1006/expr.1995.1128; PIMENTA PF, 1994, J EUKARYOT MICROBIOL, V41, P608, DOI 10.1111/j.1550-7408.1994.tb01523.x; Pinto SB, 2008, CELL MICROBIOL, V10, P891, DOI 10.1111/j.1462-5822.2007.01091.x; RAWLINGS ND, 1994, METHOD ENZYMOL, V244, P19; Rodrigues J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-33; Shen Z, 2000, INSECT MOL BIOL, V9, P223, DOI 10.1046/j.1365-2583.2000.00188.x; Silacci P, 2004, CELL MOL LIFE SCI, V61, P2614, DOI 10.1007/s00018-004-4225-6; STERLING CR, 1973, J PARASITOL, V59, P593, DOI 10.2307/3278847; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Vlachou D, 2004, CELL MICROBIOL, V6, P671, DOI 10.1111/j.1462-5822.2004.00394.x; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Windbichler N, 2011, NATURE, V473, P212, DOI 10.1038/nature09937; World Health Organization, 2010, MAL FACT SHEET; ZOLG JW, 1982, J PARASITOL, V68, P1072, DOI 10.2307/3281094	29	18	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35210	10.1371/journal.pone.0035210	http://dx.doi.org/10.1371/journal.pone.0035210			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509400	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600093
J	Woo, HD; Kim, J				Woo, Hae Dong; Kim, Jeongseon			Global DNA Hypomethylation in Peripheral Blood Leukocytes as a Biomarker for Cancer Risk: A Meta-Analysis	PLOS ONE			English	Article							GENOMIC DNA; 5-METHYLCYTOSINE CONTENT; METHYLATION PATTERNS; LINE-1 METHYLATION; COLORECTAL ADENOMA; BLADDER-CANCER; BREAST-CANCER; CARCINOMA; DEMETHYLATION; TUMORS	Background: Good biomarkers for early detection of cancer lead to better prognosis. However, harvesting tumor tissue is invasive and cannot be routinely performed. Global DNA methylation of peripheral blood leukocyte DNA was evaluated as a biomarker for cancer risk. Methods: We performed a meta-analysis to estimate overall cancer risk according to global DNA hypomethylation levels among studies with various cancer types and analytical methods used to measure DNA methylation. Studies were systemically searched via PubMed with no language limitation up to July 2011. Summary estimates were calculated using a fixed effects model. Results: The subgroup analyses by experimental methods to determine DNA methylation level were performed due to heterogeneity within the selected studies (p<0.001, I-2: 80%). Heterogeneity was not found in the subgroup of %5-mC (p=0.393, I-2: 0%) and LINE-1 used same target sequence (p=0.097, I-2: 49%), whereas considerable variance remained in LINE-1 (p<0.001, I-2: 80%) and bladder cancer studies (p=0.016, I-2: 76%). These results suggest that experimental methods used to quantify global DNA methylation levels are important factors in the association study between hypomethylation levels and cancer risk. Overall, cancer risks of the group with the lowest DNA methylation levels were significantly higher compared to the group with the highest methylation levels [OR (95% CI): 1.48 (1.28-1.70)]. Conclusions: Global DNA hypomethylation in peripheral blood leukocytes may be a suitable biomarker for cancer risk. However, the association between global DNA methylation and cancer risk may be different based on experimental methods, and region of DNA targeted for measuring global hypomethylation levels as well as the cancer type. Therefore, it is important to select a precise and accurate surrogate marker for global DNA methylation levels in the association studies between global DNA methylation levels in peripheral leukocyte and cancer risk.	[Woo, Hae Dong; Kim, Jeongseon] Natl Canc Ctr, Canc Epidemiol Branch, Goyang Si, South Korea	National Cancer Center - Korea (NCC)	Woo, HD (corresponding author), Natl Canc Ctr, Canc Epidemiol Branch, Goyang Si, South Korea.	jskim@ncc.re.kr	KIM, JEONGSEON/AAA-4643-2022		National Cancer Center, Korea [1110300]	National Cancer Center, Korea	This work was supported by a grant from the National Cancer Center, Korea (no. 1110300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Cash HL, 2012, INT J CANCER, V130, P1151, DOI 10.1002/ijc.26098; Cho NY, 2009, VIRCHOWS ARCH, V454, P17, DOI 10.1007/s00428-008-0706-6; Cho YH, 2010, ANTICANCER RES, V30, P2489; Choi JY, 2009, CARCINOGENESIS, V30, P1889, DOI 10.1093/carcin/bgp143; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; Cravo M, 1996, GUT, V39, P434, DOI 10.1136/gut.39.3.434; Dahl C, 2003, BIOGERONTOLOGY, V4, P233, DOI 10.1023/A:1025103319328; Davis CD, 2004, EXP BIOL MED, V229, P988, DOI 10.1177/153537020422901002; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Eden A, 2003, SCIENCE, V300, P455, DOI 10.1126/science.1083557; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; FEINBERG AP, 1988, CANCER RES, V48, P1159; Fraga MF, 2002, ELECTROPHORESIS, V23, P1677, DOI 10.1002/1522-2683(200206)23:11&lt;1677::AID-ELPS1677&gt;3.0.CO;2-Z; GAMASOSA MA, 1983, NUCLEIC ACIDS RES, V11, P6883, DOI 10.1093/nar/11.19.6883; Gao Y, 2012, BRIT J CANCER, V106, P585, DOI 10.1038/bjc.2011.562; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hou LF, 2010, INT J CANCER, V127, P1866, DOI 10.1002/ijc.25190; Hsiung DT, 2007, CANCER EPIDEM BIOMAR, V16, P108, DOI 10.1158/1055-9965.EPI-06-0636; Issa JP, 2000, CURR TOP MICROBIOL, V249, P101; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Jones PA, 1996, CANCER RES, V56, P2463; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; KIM YI, 1994, CANCER, V74, P893, DOI 10.1002/1097-0142(19940801)74:3<893::AID-CNCR2820740316>3.0.CO;2-B; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; LAIRD PW, 1994, HUM MOL GENET, V3, P1487, DOI 10.1093/hmg/3.suppl_1.1487; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Liao LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027361; Lim U, 2008, GASTROENTEROLOGY, V134, P47, DOI 10.1053/j.gastro.2007.10.013; Lin CH, 2001, CANCER RES, V61, P4238; Liu L, 2003, MECH AGEING DEV, V124, P989, DOI 10.1016/j.mad.2003.08.001; Moore LE, 2008, LANCET ONCOL, V9, P359, DOI 10.1016/S1470-2045(08)70038-X; Nelson HH, 2011, ENVIRON HEALTH PERSP, V119, P1528, DOI 10.1289/ehp.1103423; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Phokaew C, 2008, NUCLEIC ACIDS RES, V36, P5704, DOI 10.1093/nar/gkn571; Poole C, 1999, AM J EPIDEMIOL, V150, P469, DOI 10.1093/oxfordjournals.aje.a010035; Pufulete M, 2003, GASTROENTEROLOGY, V124, P1240, DOI 10.1016/S0016-5085(03)00279-8; Qu GZ, 1999, MUTAT RES-FUND MOL M, V423, P91, DOI 10.1016/S0027-5107(98)00229-2; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Soares J, 1999, CANCER, V85, P112, DOI 10.1002/(SICI)1097-0142(19990101)85:1<112::AID-CNCR16>3.3.CO;2-K; Sterne J.A., 2008, SYSTEMATIC REV HLTH, P347, DOI DOI 10.1002/9780470693926.CH18; Suter CM, 2004, INT J COLORECTAL DIS, V19, P95, DOI 10.1007/s00384-003-0539-3; Vatolin S, 2005, CANCER RES, V65, P7751, DOI 10.1158/0008-5472.CAN-05-0858; Widschwendter M, 2006, CLIN CANCER RES, V12, P7205, DOI 10.1158/1078-0432.CCR-06-2531; Wilhelm CS, 2010, CLIN CANCER RES, V16, P1682, DOI 10.1158/1078-0432.CCR-09-2983; Woloszynska-Read A, 2011, CLIN CANCER RES, V17, P2170, DOI 10.1158/1078-0432.CCR-10-2315; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Zhu ZZ, 2011, CANCER CAUSE CONTROL, V22, P437, DOI 10.1007/s10552-010-9715-2	60	100	103	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34615	10.1371/journal.pone.0034615	http://dx.doi.org/10.1371/journal.pone.0034615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509334	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600040
J	Krishnamurthy, P; Silberberg, G; Lansner, A				Krishnamurthy, Pradeep; Silberberg, Gilad; Lansner, Anders			A Cortical Attractor Network with Martinotti Cells Driven by Facilitating Synapses	PLOS ONE			English	Article							GABAERGIC INTERNEURONS; DISYNAPTIC INHIBITION; SYNAPTIC MECHANISMS; NEURAL-NETWORKS; DYNAMICS; NEURONS; OSCILLATIONS; RAT; EXCITATION; MODEL	The population of pyramidal cells significantly outnumbers the inhibitory interneurons in the neocortex, while at the same time the diversity of interneuron types is much more pronounced. One acknowledged key role of inhibition is to control the rate and patterning of pyramidal cell firing via negative feedback, but most likely the diversity of inhibitory pathways is matched by a corresponding diversity of functional roles. An important distinguishing feature of cortical interneurons is the variability of the short-term plasticity properties of synapses received from pyramidal cells. The Martinotti cell type has recently come under scrutiny due to the distinctly facilitating nature of the synapses they receive from pyramidal cells. This distinguishes these neurons from basket cells and other inhibitory interneurons typically targeted by depressing synapses. A key aspect of the work reported here has been to pinpoint the role of this variability. We first set out to reproduce quantitatively based on in vitro data the di-synaptic inhibitory microcircuit connecting two pyramidal cells via one or a few Martinotti cells. In a second step, we embedded this microcircuit in a previously developed attractor memory network model of neocortical layers 2/3. This model network demonstrated that basket cells with their characteristic depressing synapses are the first to discharge when the network enters an attractor state and that Martinotti cells respond with a delay, thereby shifting the excitation-inhibition balance and acting to terminate the attractor state. A parameter sensitivity analysis suggested that Martinotti cells might, in fact, play a dominant role in setting the attractor dwell time and thus cortical speed of processing, with cellular adaptation and synaptic depression having a less prominent role than previously thought.	[Krishnamurthy, Pradeep; Lansner, Anders] Stockholm Univ, Dept Numer Anal & Comp Sci, S-10691 Stockholm, Sweden; [Silberberg, Gilad] Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, S-10401 Stockholm, Sweden; [Krishnamurthy, Pradeep; Lansner, Anders] Royal Inst Technol KTH, Dept Computat Biol, Sch Comp Sci & Commun, Stockholm, Sweden	Stockholm University; Karolinska Institutet; Royal Institute of Technology	Krishnamurthy, P (corresponding author), Stockholm Univ, Dept Numer Anal & Comp Sci, S-10691 Stockholm, Sweden.	ala@csc.kth.se	Silberberg, Gilad/A-1048-2012; Lansner, Anders/E-4824-2016	Silberberg, Gilad/0000-0001-9964-505X; Lansner, Anders/0000-0002-2358-7815	Swedish Science Council [VR-621-2004-3807]; VINNOVA (Swedish Government Agency for Innovation Systems); Swedish Foundation for Strategic Research (through the Stockholm Brain Institute); European Union (FACETS project) [FP6-2004-IST-FETPI-015879]	Swedish Science Council; VINNOVA (Swedish Government Agency for Innovation Systems)(Vinnova); Swedish Foundation for Strategic Research (through the Stockholm Brain Institute)(Swedish Foundation for Strategic Research); European Union (FACETS project)	This work was partly supported by grants from the Swedish Science Council (VR-621-2004-3807), VINNOVA (Swedish Government Agency for Innovation Systems), the Swedish Foundation for Strategic Research (through the Stockholm Brain Institute), and from the European Union (FACETS project, FP6-2004-IST-FETPI-015879). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Berger TK, 2009, J PHYSIOL-LONDON, V587, P5411, DOI 10.1113/jphysiol.2009.176552; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Buxhoeveden DP, 2002, BRAIN BEHAV EVOLUT, V60, P125, DOI 10.1159/000065935; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Connors BW, 2007, NAT NEUROSCI, V10, P808, DOI 10.1038/nn0707-808; Cossart R, 2003, NATURE, V423, P283, DOI 10.1038/nature01614; Deans MR, 2001, NEURON, V31, P477, DOI 10.1016/S0896-6273(01)00373-7; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Djurfeldt M, 2008, IBM J RES DEV, V52, P31, DOI 10.1147/rd.521.0031; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Fanselow EE, 2010, J NEUROPHYSIOL, V104, P596, DOI 10.1152/jn.00206.2010; Fransen E, 1998, NETWORK-COMP NEURAL, V9, P235, DOI 10.1088/0954-898X/9/2/006; Fuhrmann G, 2002, J NEUROPHYSIOL, V87, P140, DOI 10.1152/jn.00258.2001; Galarreta M, 2002, P NATL ACAD SCI USA, V99, P12438, DOI 10.1073/pnas.192159599; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Holcman D, 2006, PLOS COMPUT BIOL, V2, P174, DOI 10.1371/journal.pcbi.0020023; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Horn D, 1991, NEURAL COMPUT, V3, P510, DOI 10.1162/neco.1991.3.4.510; Johansson C, 2007, NEURAL COMPUT, V19, P1871, DOI 10.1162/neco.2007.19.7.1871; Kalisman N, 2003, BIOL CYBERN, V88, P210, DOI 10.1007/s00422-002-0377-3; Kapfer C, 2007, NAT NEUROSCI, V10, P743, DOI 10.1038/nn1909; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Knoblauch A, 2002, BIOL CYBERN, V87, P168, DOI 10.1007/s00422-002-0332-3; Liu BH, 2009, J NEUROSCI, V29, P10520, DOI 10.1523/JNEUROSCI.1915-09.2009; Lundqvist M, 2006, NETWORK-COMP NEURAL, V17, P253, DOI 10.1080/09548980600774619; Lundqvist M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000803; Ma WP, 2010, J NEUROSCI, V30, P14371, DOI 10.1523/JNEUROSCI.3248-10.2010; Mainen T.J., 1998, METHODS NEURONAL MOD, V2, P1; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Melamed O, 2008, J COMPUT NEUROSCI, V25, P308, DOI 10.1007/s10827-008-0080-z; Miesenbock G, 2009, SCIENCE, V326, P395, DOI 10.1126/science.1174520; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Pastrana E, 2011, NAT METHODS, V8, P24, DOI 10.1038/NMETH.F.323; Pospischil M, 2008, BIOL CYBERN, V99, P427, DOI 10.1007/s00422-008-0263-8; Reig R, 2006, CEREB CORTEX, V16, P688, DOI 10.1093/cercor/bhj014; Reig R, 2007, PLOS COMPUT BIOL, V2, P1; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4286; Silberberg G, 2004, J PHYSIOL-LONDON, V556, P19, DOI 10.1113/jphysiol.2004.060962; Silberberg G, 2008, CURRENT OPINION NEUR, V18, P1; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Tabak J, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001124; Thomson AM, 2002, CEREB CORTEX, V12, P936, DOI 10.1093/cercor/12.9.936; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Wang XJ, 2004, P NATL ACAD SCI USA, V101, P1368, DOI 10.1073/pnas.0305337101; Wang XJ, 1999, J NEUROSCI, V19, P9587; Wang XJ, 1996, J NEUROSCI, V16, P6402; Yamada WM, 1989, METHODS NEURONAL MOD, P97	62	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e30752	10.1371/journal.pone.0030752	http://dx.doi.org/10.1371/journal.pone.0030752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523533	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345000002
J	Garapati, UK; Suryanarayana, T				Garapati, Usha Kumari; Suryanarayana, Tangirala			Isolation of Two Strong Poly (U) Binding Proteins from Moderate Halophile Halomonas eurihalina and Their Identification as Cold Shock Proteins	PLOS ONE			English	Article							ESCHERICHIA-COLI; CSPA; FAMILY	Cold shock proteins (Csp) are known to be expressed in response to sudden decrease in temperature. They are thought to be involved in a number of cellular processes viz., RNA chaperone activity, translation, transcription, nucleoid condensation. During our studies on ribosomal protein S1 in moderate halophile Halomonas eurihalina, we observed the presence of two strong poly (U) binding proteins in abundance in cell extracts from cells grown under normal growth conditions. The proteins can be isolated in a single step using Poly (U) cellulose chromatography. The proteins were identified as major cold shock proteins belonging to Csp A family by MALDI-TOF and bioinformatic analysis. Csp 12 kDa was found in both exponential and stationary phases whereas Csp 8 kDa is found only in exponential phase.	[Garapati, Usha Kumari; Suryanarayana, Tangirala] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India	University of Hyderabad	Garapati, UK (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India.	tssl@uohyd.ernet.in			Indian Council of Medical Research (ICMR), New Delhi, India	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR))	We are thankful to Ms. Monica Kannan for her help during proteomic studies. We also thank the Proteomics Facility (CREBB) of School of Life Sciences, University of Hyderabad and DST-FIST facility of our department. Usha Kumari Garapati acknowledges the fellowship from Indian Council of Medical Research (ICMR), New Delhi, India.	Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; Brandi A, 1999, EMBO J, V18, P1653, DOI 10.1093/emboj/18.6.1653; Carmichael CG, 1975, J BIOL CHEM, V250, P6160; Ermolenko DN, 2002, CELL MOL LIFE SCI, V59, P1902, DOI 10.1007/PL00012513; Etchegaray JP, 1999, J BACTERIOL, V181, P1827, DOI 10.1128/JB.181.6.1827-1830.1999; Giaquinto L, 2007, J BACTERIOL, V189, P5738, DOI 10.1128/JB.00395-07; Graumann Peter L., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P203; Graumann PL, 1999, ARCH MICROBIOL, V171, P135, DOI 10.1007/s002030050690; Graumann PL, 1998, TRENDS BIOCHEM SCI, V23, P286, DOI 10.1016/S0968-0004(98)01255-9; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; Jiang WN, 1997, J BIOL CHEM, V272, P196; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MADJAR JJ, 1979, ANAL BIOCHEM, V92, P174, DOI 10.1016/0003-2697(79)90641-9; Metz LJ, 1974, ANAL BIOCHEM, V57, P200; MINKS MA, 1978, EUR J BIOCHEM, V82, P271, DOI 10.1111/j.1432-1033.1978.tb12020.x; Phadtare S, 1999, CURR OPIN MICROBIOL, V2, P175, DOI 10.1016/S1369-5274(99)80031-9; Phadtare S, 2010, RNA BIOL, V7, P788, DOI 10.4161/rna.7.6.13482; Phadtare S, 2009, J MOL MICROB BIOTECH, V17, P110, DOI 10.1159/000226587; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SURYANARAYANA T, 1983, BIOCHEMISTRY-US, V22, P2715, DOI 10.1021/bi00280a020; Thieringer HA, 1998, BIOESSAYS, V20, P49; THOMAS JO, 1975, P NATL ACAD SCI USA, V72, P2626, DOI 10.1073/pnas.72.7.2626; WOLFFE AP, 1992, NEW BIOL, V4, P290	23	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34409	10.1371/journal.pone.0034409	http://dx.doi.org/10.1371/journal.pone.0034409			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514631	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600036
J	Karaayvaz, M; Zhang, C; Liang, SR; Shroyer, KR; Ju, JF				Karaayvaz, Mihriban; Zhang, Cecilia; Liang, Sharon; Shroyer, Kenneth R.; Ju, Jingfang			Prognostic Significance of miR-205 in Endometrial Cancer	PLOS ONE			English	Article							MICRORNA EXPRESSION PROFILES; CELL-PROLIFERATION; DOWN-REGULATION; SMALL RNAS; CARCINOMA; PTEN; MUTATIONS; FEATURES; GROWTH; TUMORS	Purpose: microRNAs have emerged as key regulators of gene expression, and their altered expression has been associated with tumorigenesis and tumor progression. Thus, microRNAs have potential as both cancer biomarkers and/or potential novel therapeutic targets. Although accumulating evidence suggests the role of aberrant microRNA expression in endometrial carcinogenesis, there are still limited data available about the prognostic significance of microRNAs in endometrial cancer. The goal of this study is to investigate the prognostic value of selected key microRNAs in endometrial cancer by the analysis of archival formalin-fixed paraffin-embedded tissues. Experimental Design: Total RNAs were extracted from 48 paired normal and endometrial tumor specimens using Trizol based approach. The expression of miR-26a, let-7g, miR-21, miR-181b, miR-200c, miR-192, miR-215, miR-200c, and miR-205 were quantified by real time qRT-PCR expression analysis. Targets of the differentially expressed miRNAs were quantified using immunohistochemistry. Statistical analysis was performed by GraphPad Prism 5.0. Results: The expression levels of miR-200c (P<0.0001) and miR-205 (P<0.0001) were significantly increased in endometrial tumors compared to normal tissues. Kaplan-Meier survival analysis revealed that high levels of miR-205 expression were associated with poor patient overall survival (hazard ratio, 0.377; Logrank test, P = 0.028). Furthermore, decreased expression of a miR-205 target PTEN was detected in endometrial cancer tissues compared to normal tissues. Conclusion: miR-205 holds a unique potential as a prognostic biomarker in endometrial cancer.	[Karaayvaz, Mihriban; Shroyer, Kenneth R.; Ju, Jingfang] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Zhang, Cecilia] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Liang, Sharon] Hofstra Univ, Hofstra N Shore LIJ Sch Med, Dept Obstet Gynecol, Hempstead, NY 11550 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Hofstra University; Northwell Health	Karaayvaz, M (corresponding author), SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA.	jingfang.ju@stonybrookmedicine.edu		Ju, Jingfang/0000-0002-4821-7458; Karaayvaz, Mihriban/0000-0002-6264-2477	Stony Brook University Translational Research Laboratory [R01CA155019, R33CA147966]; NATIONAL CANCER INSTITUTE [R33CA147966, R01CA155019] Funding Source: NIH RePORTER	Stony Brook University Translational Research Laboratory; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Stony Brook University Translational Research Laboratory Start-up fund (Dr. Ju), R01CA155019 (Dr. Ju) and R33CA147966 (Dr. Ju). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffa R, 2009, J PATHOL, V219, P214, DOI 10.1002/path.2586; Bansal N, 2009, CANCER CONTROL, V16, P8, DOI 10.1177/107327480901600102; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Boren T, 2008, GYNECOL ONCOL, V110, P206, DOI 10.1016/j.ygyno.2008.03.023; Braun CJ, 2008, CANCER RES, V68, P10094, DOI 10.1158/0008-5472.CAN-08-1569; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chung TKH, 2012, INT J CANCER, V130, P1036, DOI 10.1002/ijc.26060; Chung TKH, 2009, INT J CANCER, V124, P1358, DOI 10.1002/ijc.24071; Cohn DE, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.02.051; Djordjevic B, 2012, MOD PATHOL; Feber A, 2008, J THORAC CARDIOV SUR, V135, P255, DOI 10.1016/j.jtcvs.2007.08.055; Gandellini P, 2009, CANCER RES, V69, P2287, DOI 10.1158/0008-5472.CAN-08-2894; Garg K, 2012, INT J GYNECOL PATHOL, V31, P48, DOI 10.1097/PGP.0b013e3182230d00; Ghodgaonkar MM, 2009, CELL DEATH DIFFER, V16, P858, DOI 10.1038/cdd.2009.15; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hiroki E, 2010, CANCER SCI, V101, P241, DOI 10.1111/j.1349-7006.2009.01385.x; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Kanamori Y, 2001, CLIN CANCER RES, V7, P892; Kong DH, 1997, NAT GENET, V17, P143, DOI 10.1038/ng1097-143; Kumar MS, 2008, P NATL ACAD SCI USA, V105, P3903, DOI 10.1073/pnas.0712321105; Ladeiro Y, 2008, HEPATOLOGY, V47, P1955, DOI 10.1002/hep.22256; Lou YH, 2010, INT J MOL MED, V26, P819, DOI 10.3892/ijmm_00000530; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu JA, 2011, CANCER RES, V71, P225, DOI 10.1158/0008-5472.CAN-10-1850; Macwhinnie N, 2004, INT J GYNECOL CANCER, V14, P938, DOI 10.1111/j.1048-891X.2004.14533.x; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Mhawech-Fauceglia P, 2010, AM J CLIN PATHOL, V133, P899, DOI 10.1309/AJCPQDQXJ4FNRFQB; Nakada C, 2008, J PATHOL, V216, P418, DOI 10.1002/path.2437; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Navarro F, 2010, J IMMUNOL, V184, P5939, DOI 10.4049/jimmunol.0902567; Oberli A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-9; Pallares J, 2005, MODERN PATHOL, V18, P719, DOI 10.1038/modpathol.3800347; Qu C, 2012, CELL CYCLE, V11; Ratner ES, 2010, GYNECOL ONCOL, V118, P251, DOI 10.1016/j.ygyno.2010.05.010; Risinger JI, 1997, CANCER RES, V57, P4736; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Snowdon J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022828; Tang FC, 2010, DIFFERENTIATION, V79, P141, DOI 10.1016/j.diff.2009.11.002; Tashiro H, 1997, CANCER RES, V57, P3935; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang SY, 2010, CLIN CANCER RES, V16, P4325, DOI 10.1158/1078-0432.CCR-09-2990	52	85	91	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35158	10.1371/journal.pone.0035158	http://dx.doi.org/10.1371/journal.pone.0035158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514717	Green Published, Green Accepted, gold			2022-12-27	WOS:000305341600123
J	Pilizota, T; Shaevitz, JW				Pilizota, Teuta; Shaevitz, Joshua W.			Fast, Multiphase Volume Adaptation to Hyperosmotic Shock by Escherichia coli	PLOS ONE			English	Article							MEDIATED WATER PERMEABILITY; PROTEIN-DNA INTERACTIONS; BETAINE CARRIER BETP; CORYNEBACTERIUM-GLUTAMICUM; ELECTRON-MICROSCOPY; OSMOTIC-STRESS; TURGOR; CELL; OSMOSENSOR; TRANSPORT	All living cells employ an array of different mechanisms to help them survive changes in extra cellular osmotic pressure. The difference in the concentration of chemicals in a bacterium's cytoplasm and the external environment generates an osmotic pressure that inflates the cell. It is thought that the bacterium Escherichia coli use a number of interconnected systems to adapt to changes in external pressure, allowing them to maintain turgor and live in surroundings that range more than two-hundred-fold in external osmolality. Here, we use fluorescence imaging to make the first measurements of cell volume changes over time during hyperosmotic shock and subsequent adaptation on a single cell level in vivo with a time resolution on the order of seconds. We directly observe two previously unseen phases of the cytoplasmic water efflux upon hyperosmotic shock. Furthermore, we monitor cell volume changes during the post-shock recovery and observe a two-phase response that depends on the shock magnitude. The initial phase of recovery is fast, on the order of 15-20 min and shows little cell-to-cell variation. For large sucrose shocks, a secondary phase that lasts several hours adds to the recovery. We find that cells are able to recover fully from shocks as high as 1 Osmol/kg using existing systems, but that for larger shocks, protein synthesis is required for full recovery.	[Pilizota, Teuta; Shaevitz, Joshua W.] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Shaevitz, Joshua W.] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA	Princeton University; Princeton University	Pilizota, T (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	shaevitz@princeton.edu		Pilizota, Teuta/0000-0002-2156-0221	Alfred P. Sloan Foundation; Pew Charitable Trusts; National Science Foundation [PHY-0844466]	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Pew Charitable Trusts; National Science Foundation(National Science Foundation (NSF))	This work was supported by awards from the Alfred P. Sloan Foundation, Pew Charitable Trusts and National Science Foundation Award PHY-0844466 to JWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allersma MW, 1998, BIOPHYS J, V74, P1074, DOI 10.1016/S0006-3495(98)74031-7; ASHA H, 1993, J BACTERIOL, V175, P4528, DOI 10.1128/JB.175.14.4528-4537.1993; BALDWIN WW, 1995, J BACTERIOL, V177, P235, DOI 10.1128/jb.177.1.235-237.1995; BAYER ME, 1967, J BACTERIOL, V93, P1104, DOI 10.1128/JB.93.3.1104-1112.1967; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; Calamita G, 1998, P NATL ACAD SCI USA, V95, P3627, DOI 10.1073/pnas.95.7.3627; Cayley DS, 2000, BIOPHYS J, V78, P1748, DOI 10.1016/S0006-3495(00)76726-9; Cayley S, 2004, J MOL RECOGNIT, V17, P488, DOI 10.1002/jmr.695; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Cayley S, 2003, BIOCHEMISTRY-US, V42, P12596, DOI 10.1021/bi0347297; CAYLEY S, 1992, J BACTERIOL, V174, P1586, DOI 10.1128/jb.174.5.1586-1595.1992; Corry B, 2008, BBA-BIOMEMBRANES, V1778, P1859, DOI 10.1016/j.bbamem.2007.06.022; COTAROBLES EH, 1963, J BACTERIOL, V85, P499, DOI 10.1128/JB.85.3.499-503.1963; COWIE DB, 1949, J CELL COMPAR PHYSL, V34, P243, DOI 10.1002/jcp.1030340205; Culham DE, 2003, BIOCHEMISTRY-US, V42, P410, DOI 10.1021/bi0264364; DECAD GM, 1976, J BACTERIOL, V128, P325, DOI 10.1128/JB.128.1.325-336.1976; Delamarche C, 1999, J BACTERIOL, V181, P4193, DOI 10.1128/JB.181.14.4193-4197.1999; Deng Y, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.158101; DINNIBIER U, 1988, ARCH MICROBIOL, V150, P348, DOI 10.1007/BF00408306; DUBOCHET J, 1983, J BACTERIOL, V155, P381, DOI 10.1128/JB.155.1.381-390.1983; HAHN F. E., 1955, J BACT, V69, P215; Hamann K, 2008, J BACTERIOL, V190, P2360, DOI 10.1128/JB.01635-07; KOCH AL, 1985, CAN J MICROBIOL, V31, P1071, DOI 10.1139/m85-204; Kolbe M, 2000, SCIENCE, V288, P1390, DOI 10.1126/science.288.5470.1390; Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05; Konopka MC, 2009, J BACTERIOL, V191, P231, DOI 10.1128/JB.00536-08; Korber DR, 1996, APPL ENVIRON MICROB, V62, P3939, DOI 10.1128/AEM.62.11.3939-3947.1996; Kralj JM, 2011, SCIENCE, V333, P345, DOI 10.1126/science.1204763; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Lo CJ, 2007, BIOPHYS J, V93, P294, DOI 10.1529/biophysj.106.095265; Mallo RC, 2006, J BACTERIOL, V188, P820, DOI 10.1128/JB.188.2.820-822.2006; MEURY J, 1985, EUR J BIOCHEM, V151, P613, DOI 10.1111/j.1432-1033.1985.tb09148.x; Mika JT, 2010, MOL MICROBIOL, V77, P200, DOI 10.1111/j.1365-2958.2010.07201.x; MILNER JL, 1988, J BIOL CHEM, V263, P14900; Morbach S, 2002, CHEMBIOCHEM, V3, P385, DOI 10.1002/1439-7633(20020503)3:5<384::AID-CBIC384>3.0.CO;2-H; Neuman KC, 2004, REV SCI INSTRUM, V75, P2787, DOI 10.1063/1.1785844; OHYAMA T, 1992, J BACTERIOL, V174, P2922, DOI 10.1128/JB.174.9.2922-2928.1992; Pilizota T, 2007, BIOPHYS J, V93, P264, DOI 10.1529/biophysj.106.091074; Racher KI, 1999, BIOCHEMISTRY-US, V38, P1676, DOI 10.1021/bi981279n; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P143, DOI 10.1016/S0968-0004(98)01196-7; Rubenhagen R, 2000, J BIOL CHEM, V275, P735, DOI 10.1074/jbc.275.2.735; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; SCHULTZ SG, 1961, J GEN PHYSIOL, V45, P355, DOI 10.1085/jgp.45.2.355; Soupene E, 2002, J BACTERIOL, V184, P4304, DOI 10.1128/JB.184.15.4304-4307.2002; Su J, 2009, INFECT IMMUN, V77, P667, DOI 10.1128/IAI.01027-08; SUTHERLAND L, 1986, J BACTERIOL, V168, P805, DOI 10.1128/jb.168.2.805-814.1986; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; Walter JM, 2007, P NATL ACAD SCI USA, V104, P2408, DOI 10.1073/pnas.0611035104; Wang SY, 2010, P NATL ACAD SCI USA, V107, P9182, DOI 10.1073/pnas.0911517107; Wood JM, 2007, METHOD ENZYMOL, V428, P77, DOI 10.1016/S0076-6879(07)28005-X; Wood Janet M, 2006, Sci STKE, V2006, ppe43; Yasuda R, 2001, NATURE, V410, P898, DOI 10.1038/35073513	52	48	52	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35205	10.1371/journal.pone.0035205	http://dx.doi.org/10.1371/journal.pone.0035205			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514721	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600127
J	Ma, GG; Eschbaumer, M; Said, A; Hoffmann, B; Beer, M; Osterrieder, N				Ma, Guanggang; Eschbaumer, Michael; Said, Abdelrahman; Hoffmann, Bernd; Beer, Martin; Osterrieder, Nikolaus			An Equine Herpesvirus Type 1 (EHV-1) Expressing VP2 and VP5 of Serotype 8 Bluetongue Virus (BTV-8) Induces Protection in a Murine Infection Model	PLOS ONE			English	Article							OUTER CAPSID PROTEINS; IMMUNE-RESPONSES; VACCINE; ANTIBODIES; RECOMBINATION; VECTOR; GENES; SHEEP; MICE	Bluetongue virus (BTV) can infect most species of domestic and wild ruminants causing substantial morbidity and mortality and, consequently, high economic losses. In 2006, an epizootic of BTV serotype 8 (BTV-8) started in northern Europe that caused significant disease in cattle and sheep before comprehensive vaccination was introduced two years later. Here, we evaluate the potential of equine herpesvirus type 1 (EHV-1), an alphaherpesvirus, as a novel vectored DIVA (differentiating infected from vaccinated animals) vaccine expressing VP2 of BTV-8 alone or in combination with VP5. The EHV-1 recombinant viruses stably expressed the transgenes and grew with kinetics that were identical to those of parental virus in vitro. After immunization of mice, a BTV-8-specific neutralizing antibody response was elicited. In a challenge experiment using a lethal dose of BTV-8, 100% of interferon-receptor-deficient (IFNAR 2/2) mice vaccinated with the recombinant EHV-1 carrying both VP2 and VP5, but not VP2 alone, survived. VP7 was not included in the vectored vaccines and was successfully used as a DIVA marker. In summary, we show that EHV-1 expressing BTV-8 VP2 and VP5 is capable of eliciting a protective immune response that is distinguishable from that after infection and as such may be an alternative for BTV vaccination strategies in which DIVA compatibility is of importance.	[Ma, Guanggang; Said, Abdelrahman; Osterrieder, Nikolaus] Free Univ Berlin, Inst Virol, Berlin, Germany; [Eschbaumer, Michael; Hoffmann, Bernd; Beer, Martin] Friedrich Loeffler Inst, Inst Virusdiagnost, Greifswald, Germany	Free University of Berlin; Friedrich Loeffler Institute	Ma, GG (corresponding author), Free Univ Berlin, Inst Virol, Berlin, Germany.	no.34@fu-berlin.de	Said, Abdelrahman/AAL-2522-2020; Ma, Guanggang/AAD-8256-2022	Osterrieder, Nikolaus/0000-0002-5313-2176; Eschbaumer, Michael/0000-0002-1104-0695; Said, Abdo/0000-0002-3960-6670	Freie Universitat Berlin; EPIZONE; European Union (EU) Network of Excellence for Epizootic Disease Diagnosis and Control [FOOD-CT-2006-016236]; EU Seventh Framework Programme project ORBIVAC [245266]	Freie Universitat Berlin; EPIZONE; European Union (EU) Network of Excellence for Epizootic Disease Diagnosis and Control; EU Seventh Framework Programme project ORBIVAC	The study was supported by unrestricted funds made available by Freie Universitat Berlin to NO. ME was supported by EPIZONE, the European Union (EU) Network of Excellence for Epizootic Disease Diagnosis and Control (FOOD-CT-2006-016236) and the EU Seventh Framework Programme project ORBIVAC (reference 245266). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G P, 1986, Prog Vet Microbiol Immunol, V2, P78; ALPAR OH, 2009, BLUETONGUE, P235; ANDERSON J, 1993, J VIROL METHODS, V43, P167, DOI 10.1016/0166-0934(93)90074-2; Barros SC, 2009, VET MICROBIOL, V137, P252, DOI 10.1016/j.vetmic.2009.01.033; Belhouchet M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025697; Boone JD, 2007, VACCINE, V25, P672, DOI 10.1016/j.vaccine.2006.08.025; Calvo-Pinilla E, 2009, VACCINE, V28, P437, DOI 10.1016/j.vaccine.2009.10.027; Calvo-Pinilla E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005171; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; DeMaula CD, 2000, VIRUS RES, V67, P59, DOI 10.1016/S0168-1702(00)00130-1; Eschbaumer M, 2009, VACCINE, V27, P4169, DOI 10.1016/j.vaccine.2009.04.056; Franceschi V, 2011, VACCINE, V29, P3074, DOI 10.1016/j.vaccine.2011.01.075; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; Hussey GS, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-23; Lobato ZIP, 1997, VET IMMUNOL IMMUNOP, V59, P293, DOI 10.1016/S0165-2427(97)00084-6; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; MEYER H, 1988, VET MICROBIOL, V18, P95, DOI 10.1016/0378-1135(88)90119-8; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Perrin A, 2007, VACCINE, V25, P6774, DOI 10.1016/j.vaccine.2007.06.052; Rosas C, 2008, VACCINE, V26, P2335, DOI 10.1016/j.vaccine.2008.02.064; Rosas CT, 2008, AM J TROP MED HYG, V78, P83, DOI 10.4269/ajtmh.2008.78.83; Rosas CT, 2007, VIRUS RES, V125, P69, DOI 10.1016/j.virusres.2006.12.009; Rosas CT, 2007, J GEN VIROL, V88, P748, DOI 10.1099/vir.0.82528-0; Rosas CT, 2006, EXPERT REV VACCINES, V5, P119, DOI 10.1586/14760584.5.1.119; Roy P, 2004, Vet Ital, V40, P594; ROY P, 1990, J VIROL, V64, P1998, DOI 10.1128/JVI.64.5.1998-2003.1990; Roy P, 2009, NAT REV MICROBIOL, V7, P120, DOI 10.1038/nrmicro2052; Rudolph J, 2002, VIROLOGY, V293, P356, DOI 10.1006/viro.2001.1277; Saegerman C, 2008, EMERG INFECT DIS, V14, P539, DOI 10.3201/eid1404.071441; Said A, 2011, VET MICROBIOL, V154, P113, DOI 10.1016/j.vetmic.2011.07.003; Savini Giovanni, 2007, Vet Ital, V43, P807; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; Tischer BK, 2010, METHODS MOL BIOL, V634, P421, DOI 10.1007/978-1-60761-652-8_30; Tischer BK, 2006, BIOTECHNIQUES, V40, P191, DOI 10.2144/000112096; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Trapp S, 2005, J VIROL, V79, P5445, DOI 10.1128/JVI.79.9.5445-5454.2005; Van de Walle GR, 2010, VACCINE, V28, P1048, DOI 10.1016/j.vaccine.2009.10.123; WadeEvans AM, 1996, VIROLOGY, V220, P227, DOI 10.1006/viro.1996.0306; Wackerlin R, 2010, VACCINE, V28, P4348, DOI 10.1016/j.vaccine.2010.04.055; Wong ET, 2002, GENE THER, V9, P337, DOI 10.1038/sj.gt.3301667; Zientara S, 2010, EXPERT REV VACCINES, V9, P989, DOI 10.1586/ERV.10.97	42	36	40	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34425	10.1371/journal.pone.0034425	http://dx.doi.org/10.1371/journal.pone.0034425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511939	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338600025
J	Sharma, MK; Sharma, R; Cao, PJ; Jenkins, J; Bartley, LE; Qualls, M; Grimwood, J; Schmutz, J; Rokhsar, D; Ronald, PC				Sharma, Manoj K.; Sharma, Rita; Cao, Peijian; Jenkins, Jerry; Bartley, Laura E.; Qualls, Morgan; Grimwood, Jane; Schmutz, Jeremy; Rokhsar, Daniel; Ronald, Pamela C.			A Genome-Wide Survey of Switchgrass Genome Structure and Organization	PLOS ONE			English	Article							ARTIFICIAL CHROMOSOME LIBRARY; SIMPLE SEQUENCE REPEATS; GC-CONTENT EVOLUTION; BAC LIBRARY; PANICUM-VIRGATUM; HIGHER-PLANTS; CONSTRUCTION; IDENTIFICATION; GENE; DNA	The perennial grass, switchgrass (Panicum virgatum L.), is a promising bioenergy crop and the target of whole genome sequencing. We constructed two bacterial artificial chromosome (BAC) libraries from the AP13 clone of switchgrass to gain insight into the genome structure and organization, initiate functional and comparative genomic studies, and assist with genome assembly. Together representing 16 haploid genome equivalents of switchgrass, each library comprises 101,376 clones with average insert sizes of 144 (HindIII-generated) and 110 kb (BstYI-generated). A total of 330,297 high quality BAC-end sequences (BES) were generated, accounting for 263.2 Mbp (16.4%) of the switchgrass genome. Analysis of the BES identified 279,099 known repetitive elements, >50,000 SSRs, and 2,528 novel repeat elements, named switchgrass repetitive elements (SREs). Comparative mapping of 47 full-length BAC sequences and 330K BES revealed high levels of synteny with the grass genomes sorghum, rice, maize, and Brachypodium. Our data indicate that the sorghum genome has retained larger microsyntenous regions with switchgrass besides high gene order conservation with rice. The resources generated in this effort will be useful for a broad range of applications.	[Sharma, Manoj K.; Sharma, Rita; Bartley, Laura E.; Ronald, Pamela C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Sharma, Manoj K.; Sharma, Rita; Bartley, Laura E.; Ronald, Pamela C.] Joint BioEnergy Inst, Emeryville, CA USA; [Cao, Peijian] China Tobacco Gene Res Ctr, Zhengzhou Tobacco Res Inst, Zhengzhou, Peoples R China; [Jenkins, Jerry; Qualls, Morgan; Grimwood, Jane; Schmutz, Jeremy] HudsonAlpha Inst Biotechnol, Huntsville, AL USA; [Jenkins, Jerry; Qualls, Morgan; Grimwood, Jane; Schmutz, Jeremy; Rokhsar, Daniel] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Rokhsar, Daniel] Univ Calif Berkeley, Berkeley, CA 94720 USA	University of California System; University of California Davis; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Zhengzhou Tobacco Research Institute of CNTC; HudsonAlpha Institute for Biotechnology; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Berkeley	Sharma, MK (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	pcronald@ucdavis.edu	Ronald, Pamela/AAK-7664-2020; Schmutz, Jeremy/N-3173-2013; Bartley, Laura/AAF-2217-2020; Cao, Peijian/U-6776-2019; Grimwood, Jane/ABD-5737-2021; Jenkins, Jerry/ABE-6479-2020; Sharma, Rita/G-2425-2017	Schmutz, Jeremy/0000-0001-8062-9172; Bartley, Laura/0000-0001-8610-7551; Jenkins, Jerry/0000-0002-7943-3997; Rokhsar, Daniel/0000-0002-8704-2224; Sharma, Manoj K./0000-0002-4768-8733	Office of Science of the United States Department of Energy [DE-AC02-05CH11231]; Office of Biological and Environmental Research of the United States DOE [DE-AC02-05CH11231]; United States Department of Agriculture National Institute of Food and Agriculture agreement [2011-67009-30153]	Office of Science of the United States Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research of the United States DOE(United States Department of Energy (DOE)); United States Department of Agriculture National Institute of Food and Agriculture agreement	This work was supported by the Office of Science of the United States Department of Energy under Contract No. DE-AC02-05CH11231 to the United States Department of Energy Joint Genome Institute, the Office of Biological and Environmental Research of the United States DOE contract No. DE-AC02-05CH11231 to the Joint BioEnergy Institute, and the United States Department of Agriculture National Institute of Food and Agriculture agreement No. 2011-67009-30153 to PCR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Blondon AF, 2005, THEOR APPL GENET, V110, P1363, DOI 10.1007/s00122-005-1924-9; Agarwal M, 2008, PLANT CELL REP, V27, P617, DOI 10.1007/s00299-008-0507-z; Ammiraju JSS, 2006, GENOME RES, V16, P140, DOI 10.1101/gr.3766306; Bailey TL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-179; Barow M, 2002, CYTOMETRY, V47, P1, DOI 10.1002/cyto.10030; Bennetzen JL, 2000, PLANT MOL BIOL, V42, P251, DOI 10.1023/A:1006344508454; Bennetzen JL, 2000, PLANT CELL, V12, P1021, DOI 10.1105/tpc.12.7.1021; Blanchard E.B., 2003, CURRENT PROTOCOLS BI, P3; Bouton Joe, 2008, P295, DOI 10.1007/978-0-387-70805-8_11; BUCKLER AJ, 1991, P NATL ACAD SCI USA, V88, P4005, DOI 10.1073/pnas.88.9.4005; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Cheung F, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-29; CLARKE L, 1976, CELL, V9, P91, DOI 10.1016/0092-8674(76)90055-6; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Devos KM, 2005, CURR OPIN PLANT BIOL, V8, P155, DOI 10.1016/j.pbi.2005.01.005; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Febrer M, 2007, GENOME, V50, P412, DOI 10.1139/G07-013; Feuillet C, 2002, ANN BOT-LONDON, V89, P3, DOI 10.1093/aob/mcf008; Fike JH, 2006, BIOMASS BIOENERG, V30, P198, DOI 10.1016/j.biombioe.2005.10.006; Flowers JM, 2008, CURR OPIN GENET DEV, V18, P565, DOI 10.1016/j.gde.2008.11.005; Fullerton SM, 2001, MOL BIOL EVOL, V18, P1139, DOI 10.1093/oxfordjournals.molbev.a003886; Galtier N, 2001, GENETICS, V159, P907; Gonzalez VM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-618; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Grandbastien Marie-Angle, 2004, Journal de la Societe de Biologie, V198, P425; Han YP, 2008, PLANT MOL BIOL, V67, P581, DOI 10.1007/s11103-008-9321-9; Hong CP, 2004, MOL GENET GENOMICS, V271, P709, DOI 10.1007/s00438-004-1021-9; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Huo NX, 2009, PLANT MOL BIOL, V70, P47, DOI 10.1007/s11103-009-9456-3; Huo NX, 2006, GENOME, V49, P1099, DOI 10.1139/G06-087; Jayashree B., 2006, In Silico Biology, V6, P607; Jeukens J, 2011, MOL ECOL RESOUR, V11, P541, DOI 10.1111/j.1755-0998.2011.02982.x; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kawabe A, 2003, GENES GENET SYST, V78, P343, DOI 10.1266/ggs.78.343; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Kolpakov R, 2003, NUCLEIC ACIDS RES, V31, P3672, DOI 10.1093/nar/gkg617; Lai JS, 2004, GENOME RES, V14, P1924, DOI 10.1101/gr.2701104; Liang HY, 2007, TREE GENET GENOMES, V3, P215, DOI 10.1007/s11295-006-0057-x; Luo MZ, 2003, METH MOL B, V236, P3; Marek LF, 1997, GENOME, V40, P420, DOI 10.1139/g97-056; McKay Sheldon J, 2010, Curr Protoc Bioinformatics, VChapter 9, DOI 10.1002/0471250953.bi0912s31; McLaughlin SB, 2005, BIOMASS BIOENERG, V28, P515, DOI 10.1016/j.biombioe.2004.05.006; Missaoui AM, 2005, THEOR APPL GENET, V110, P1372, DOI 10.1007/s00122-005-1935-6; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Musto H, 2004, FEBS LETT, V573, P73, DOI 10.1016/j.febslet.2004.07.056; Okada M, 2010, GENETICS, V185, P745, DOI 10.1534/genetics.110.113910; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Parrish DJ, 2005, CRIT REV PLANT SCI, V24, P423, DOI 10.1080/07352680500316433; Paterson AH, 2000, PLANT CELL, V12, P1523, DOI 10.1105/tpc.12.9.1523; Paterson AH, 1996, NAT GENET, V14, P380, DOI 10.1038/ng1296-380; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Rabinowicz PD, 2002, GENOME RES, V12, P1015, DOI 10.1101/gr.432502; Rampant PF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-292; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Sanderson MA, 1996, BIORESOURCE TECHNOL, V56, P83, DOI 10.1016/0960-8524(95)00176-X; Sanderson MA, 2006, CAN J PLANT SCI, V86, P1315, DOI 10.4141/P06-136; Saski CA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-369; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; SHERIDAN RP, 1992, PROTEINS, V14, P16, DOI 10.1002/prot.340140105; SHIZUYA H, 1992, P NATL ACAD SCI USA, V89, P8794, DOI 10.1073/pnas.89.18.8794; Smarda P, 2008, ANN BOT-LONDON, V101, P421, DOI 10.1093/aob/mcm307; Smit A, 1996, GREEN P REPEATMASKER; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, V25, p4.10.11, DOI 10.1002/0471250953.bi0410s25; Tobias CM, 2009, PLANT GENOME-US, V2, P5, DOI 10.3835/plantgenome2009.02.0004let; Tobias CM, 2008, PLANT GENOME-US, V1, P111, DOI 10.3835/plantgenome2008.08.0003; Tomkins JP, 1999, THEOR APPL GENET, V99, P419, DOI 10.1007/s001220051252; Tomkins JP, 2002, CROP SCI, V42, P928, DOI 10.2135/cropsci2002.0928; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Venter JC, 1996, NATURE, V381, P364, DOI 10.1038/381364a0; WANG GL, 1995, PLANT J, V7, P525, DOI 10.1046/j.1365-313X.1995.7030525.x; WOO SS, 1994, NUCLEIC ACIDS RES, V22, P4922, DOI 10.1093/nar/22.23.4922; Wright L.L., HIST PERSPECTIVE WHY	79	47	47	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e33892	10.1371/journal.pone.0033892	http://dx.doi.org/10.1371/journal.pone.0033892			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511929	Green Published, gold			2022-12-27	WOS:000305338600015
J	Bockl, K; Wild, J; Bredl, S; Kindsmuller, K; Kostler, J; Wagner, R				Boeckl, Katharina; Wild, Jens; Bredl, Simon; Kindsmueller, Kathrin; Koestler, Josef; Wagner, Ralf			Altering an Artificial Gagpolnef Polyprotein and Mode of ENV Co-Administration Affects the Immunogenicity of a Clade C HIV DNA Vaccine	PLOS ONE			English	Article							T-CELL RESPONSES; PHASE-I TRIAL; IMMUNE-RESPONSES; ENVELOPE PROTEIN; AIDS RESEARCH; NYVAC-C; VIRUS; EXPRESSION; INFECTION; IMMUNIZATION	HIV-1 candidate vaccines expressing an artificial polyprotein comprising Gag, Pol and Nef (GPN) and a secreted envelope protein (Env) were shown in recent Phase I/II clinical trials to induce high levels of polyfunctional T cell responses; however, Env-specific responses clearly exceeded those against Gag. Here, we assess the impact of the GPN immunogen design and variations in the formulation and vaccination regimen of a combined GPN/Env DNA vaccine on the T cell responses against the various HIV proteins. Subtle modifications were introduced into the GPN gene to increase Gag expression, modify the expression ratio of Gag to PolNef and support budding of virus-like particles. I. m. administration of the various DNA constructs into BALB/c mice resulted in an up to 10-fold increase in Gag- and Pol-specific IFN gamma(+) CD8(+) T cells compared to GPN. Co-administering Env with Gag or GPN derivatives largely abrogated Gag-specific responses. Alterations in the molar ratio of the DNA vaccines and spatially or temporally separated administration induced more balanced T cell responses. Whereas forced co-expression of Gag and Env from one plasmid induced predominantly Env-specific T cells responses, deletion of the only H-2(d) T cell epitope in Env allowed increased levels of Gag-specific T cells, suggesting competition at an epitope level. Our data demonstrate that the biochemical properties of an artificial polyprotein clearly influence the levels of antigen-specific T cells, and variations in formulation and schedule can overcome competition for the induction of these responses. These results are guiding the design of ongoing pre-clinical and clinical trials.	[Boeckl, Katharina; Wild, Jens; Bredl, Simon; Kindsmueller, Kathrin; Koestler, Josef; Wagner, Ralf] Univ Regensburg, Inst Med Microbiol, Regensburg, Germany; [Wagner, Ralf] Geneart AG Life Technol, Regensburg, Germany	University of Regensburg	Bockl, K (corresponding author), Univ Regensburg, Inst Med Microbiol, Regensburg, Germany.	ralf.wagner@klinik.uni-regensburg.de		Wild, Jens/0000-0001-9880-7897	Bill and Melinda Gates Foundation (CAVD - PTVDC); Bavarian Research Foundation	Bill and Melinda Gates Foundation (CAVD - PTVDC); Bavarian Research Foundation	This work was supported by Bill and Melinda Gates Foundation (CAVD - PTVDC Project; http://www.gatesfoundation.org) as well as Bavarian Research Foundation (Forprotect; http://www.forschungsstiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bart PA, 2008, VACCINE, V26, P3153, DOI 10.1016/j.vaccine.2008.03.083; Berglund P, 1997, AIDS RES HUM RETROV, V13, P1487, DOI 10.1089/aid.1997.13.1487; Bojak A, 2002, INTERVIROLOGY, V45, P275, DOI 10.1159/000067919; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Cohen J, 2007, SCIENCE, V318, P1048, DOI 10.1126/science.318.5853.1048; Cohen J, 2007, SCIENCE, V318, P28, DOI 10.1126/science.318.5847.28; Deml L, 2001, J VIROL, V75, P10991, DOI 10.1128/JVI.75.22.10991-11001.2001; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; HAFFAR O, 1990, J VIROL, V64, P2653, DOI 10.1128/JVI.64.6.2653-2659.1990; Harari A, 2008, J EXP MED, V205, P63, DOI 10.1084/jem.20071331; Harrer T, 1996, J IMMUNOL, V156, P2616; Hovav AH, 2009, J VIROL, V83, P10941, DOI 10.1128/JVI.00394-09; Ledford H, 2007, NATURE, V450, P325, DOI 10.1038/450325a; Lopez D, 2001, J IMMUNOL, V167, P4238, DOI 10.4049/jimmunol.167.8.4238; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; McCormack S, 2008, VACCINE, V26, P3162, DOI 10.1016/j.vaccine.2008.02.072; Mooij P, 2009, J VIROL, V83, P5881, DOI 10.1128/JVI.02345-08; Perreau M, 2011, J VIROL, V85, P9854, DOI 10.1128/JVI.00788-11; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Schmidt B, 2005, VIROLOGY, V343, P256, DOI 10.1016/j.virol.2005.09.059; Sellins K, 2005, MOL THER, V12, P451, DOI 10.1016/j.ymthe.2005.04.008; Staple DW, 2003, NUCLEIC ACIDS RES, V31, P4326, DOI 10.1093/nar/gkg654; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Toapanta FR, 2007, CURR HIV RES, V5, P199, DOI 10.2174/157016207780077057; Wagner R, 1999, J IMMUNOL, V162, P3727; WAGNER R, 1992, ARCH VIROL, V127, P117, DOI 10.1007/BF01309579; Wild J, 2009, VIRAL IMMUNOL, V22, P309, DOI 10.1089/vim.2009.0038; YUAN X, 1993, J VIROL, V67, P6387, DOI 10.1128/JVI.67.11.6387-6394.1993	30	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34723	10.1371/journal.pone.0034723	http://dx.doi.org/10.1371/journal.pone.0034723			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509350	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600053
J	Galesic, M; Garcia-Retamero, R				Galesic, Mirta; Garcia-Retamero, Rocio			The Risks We Dread: A Social Circle Account	PLOS ONE			English	Article							HUMAN LIFE; SIZE; JUDGMENTS; EVOLUTION; SHOW	What makes some risks dreadful? We propose that people are particularly sensitive to threats that could kill the number of people that is similar to the size of a typical human social circle. Although there is some variability in reported sizes of social circles, active contact rarely seems to be maintained with more than about 100 people. The loss of this immediate social group may have had survival consequences in the past and still causes great distress to people today. Therefore we hypothesize that risks that threaten a much larger number of people (e.g., 1000) will not be dreaded more than those that threaten to kill "only" the number of people typical for social circles. We found support for this hypothesis in 9 experiments using different risk scenarios, measurements of fear, and samples from different countries. Fear of risks killing 100 people was higher than fear of risks killing 10 people, but there was no difference in fear of risks killing 100 or 1000 people (Experiments 1-4, 7-9). Also in support of the hypothesis, the median number of deaths that would cause maximum level of fear was 100 (Experiments 5 and 6). These results are not a consequence of lack of differentiation between the numbers 100 and 1000 (Experiments 7 and 8), and are different from the phenomenon of "psychophysical numbing" that occurs in the context of altruistic behavior towards members of other communities rather than in the context of threat to one's own community (Experiment 9). We discuss several possible explanations of these findings. Our results stress the importance of considering social environments when studying people's understanding of and reactions to risks.	[Galesic, Mirta] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany; [Garcia-Retamero, Rocio] Univ Granada, Dept Expt Psychol, E-18071 Granada, Spain	Max Planck Society; University of Granada	Galesic, M (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany.	galesic@mpib-berlin.mpg.de	Galesic, Mirta/B-8327-2012	Galesic, Mirta/0000-0002-3537-8359; Garcia-Retamero, Rocio/0000-0001-9140-8519	Max Planck Society (Germany); projects "How to Improve Understanding of Risks about Health" [PSI2008-02019]; Ministry of Science and Innovation (Spain) [PSI2011-22954]; Ministry of Economy (Spain); Contextual and Psychological Factors Involved in Risk Behavior [P09-SEJ-4752]; Junta de Andalucia (Spain)	Max Planck Society (Germany)(Max Planck Society); projects "How to Improve Understanding of Risks about Health"; Ministry of Science and Innovation (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Economy (Spain)(Spanish Government); Contextual and Psychological Factors Involved in Risk Behavior; Junta de Andalucia (Spain)(Junta de AndaluciaEuropean Commission)	This research was supported by the Max Planck Society (Germany) and the projects "How to Improve Understanding of Risks about Health (PSI2008-02019)" funded by the Ministry of Science and Innovation (Spain), "Helping Doctors and Their Patients Make Decisions about Health (PSI2011-22954)" funded by the Ministry of Economy (Spain)," and "Contextual and Psychological Factors Involved in Risk Behavior" (P09-SEJ-4752) funded by the Junta de Andalucia (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1987, EVOLUTION HUMAN SOC; AVERILL JR, 1968, PSYCHOL BULL, V70, P721, DOI 10.1037/h0026824; Birnbaum MH, 1999, PSYCHOL METHODS, V4, P243, DOI 10.1037/1082-989X.4.3.243; BREWER DD, 1995, HUM NATURE-INT BIOS, V6, P379, DOI 10.1007/BF02734207; Cosmides L., 1992, ADAPTED MIND EVOLUTI, P163; Dunbar RIM, 2007, SCIENCE, V317, P1344, DOI 10.1126/science.1145463; DUNBAR RIM, 1993, BEHAV BRAIN SCI, V16, P681, DOI 10.1017/S0140525X00032325; Facebook, 2011, STAT; Fetherstonhaugh D, 1997, J RISK UNCERTAINTY, V14, P283, DOI 10.1023/A:1007744326393; Garcia-Retamero R, 2011, J EXP PSYCHOL-APPL, V17, P270, DOI 10.1037/a0023677; Garcia-Retamero R, 2011, PATIENT EDUC COUNS, V84, P245, DOI 10.1016/j.pec.2010.07.027; Garcia-Retamero R, 2009, AM J PUBLIC HEALTH, V99, P2196, DOI 10.2105/AJPH.2009.160234; Gigerenzer G, 2004, PSYCHOL SCI, V15, P286, DOI 10.1111/j.0956-7976.2004.00668.x; HASSAN FA, 1981, DEMOGRAPHIC ARCHAEOL; Hertwig R, 2005, J EXP PSYCHOL LEARN, V31, P621, DOI 10.1037/0278-7393.31.4.621; Hill KR, 2011, SCIENCE, V331, P1286, DOI 10.1126/science.1199071; Hill RA, 2003, HUM NATURE-INT BIOS, V14, P53, DOI 10.1007/s12110-003-1016-y; Hsee CK, 2004, J EXP PSYCHOL GEN, V133, P23, DOI 10.1037/0096-3445.133.1.23; Juslin P, 2000, PSYCHOL REV, V107, P384, DOI 10.1037//0033-295X.107.2.384; KILLWORTH PD, 1990, SOC NETWORKS, V12, P289, DOI 10.1016/0378-8733(90)90012-X; Kogut T, 2005, J BEHAV DECIS MAKING, V18, P157, DOI 10.1002/bdm.492; Krause J, 2002, LIVING GROUPS; Lee R. B., MAN HUNTER, P3; Lerner JS, 2001, J PERS SOC PSYCHOL, V81, P146, DOI 10.1037//0022-3514.81.1.146; Mason W, 2011, CONDUCTING BEHAV RES; McCarty C, 2001, HUM ORGAN, V60, P28, DOI 10.17730/humo.60.1.efx5t9gjtgmga73y; Olivola CY, 2009, P NATL ACAD SCI USA, V106, P22151, DOI 10.1073/pnas.0908980106; Pachur T, 2004, PROCEEDINGS OF THE TWENTY-SIXTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P1077; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Slovic P, 2007, JUDGM DECIS MAK, V2, P79; Small DA, 2007, ORGAN BEHAV HUM DEC, V102, P143, DOI 10.1016/j.obhdp.2006.01.005; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Sugiyama LS, 2004, AM J PHYS ANTHROPOL, V123, P371, DOI 10.1002/ajpa.10325; WANG XT, 1995, J BEHAV DECIS MAKING, V8, P279, DOI 10.1002/bdm.3960080405; Wang XT, 1996, ORGAN BEHAV HUM DEC, V68, P145, DOI 10.1006/obhd.1996.0095; Wang XT, 2001, RISKY T TRUST KINSHI, P47	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e32837	10.1371/journal.pone.0032837	http://dx.doi.org/10.1371/journal.pone.0032837			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TP	22509250	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336600007
J	Hockings, KJ; McLennan, MR				Hockings, Kimberley J.; McLennan, Matthew R.			From Forest to Farm: Systematic Review of Cultivar Feeding by Chimpanzees - Management Implications for Wildlife in Anthropogenic Landscapes	PLOS ONE			English	Article							NATIONAL-PARK; SEASONAL-VARIATION; PATTERNS; GUINEA; BOSSOU; AVAILABILITY; ELEPHANTS; RESERVE; HABITS; DAMAGE	Crop-raiding is a major source of conflict between people and wildlife globally, impacting local livelihoods and impeding conservation. Conflict mitigation strategies that target problematic wildlife behaviours such as crop-raiding are notoriously difficult to develop for large-bodied, cognitively complex species. Many crop-raiders are generalist feeders. In more ecologically specialised species crop-type selection is not random and evidence-based management requires a good understanding of species' ecology and crop feeding habits. Comprehensive species-wide studies of crop consumption by endangered wildlife are lacking but are important for managing human-wildlife conflict. We conducted a comprehensive literature search of crop feeding records by wild chimpanzees (Pan troglodytes), a ripe-fruit specialist. We assessed quantitatively patterns of crop selection in relation to species-specific feeding behaviour, agricultural exposure, and crop availability. Crop consumption by chimpanzees is widespread in tropical Africa. Chimpanzees were recorded to eat a considerable range of cultivars (51 plant parts from 36 species). Crop part selection reflected a species-typical preference for fruit. Crops widely distributed in chimpanzee range countries were eaten at more sites than sparsely distributed crops. We identified 'high' and 'low' conflict crops according to their attractiveness to chimpanzees, taking account of their importance as cash crops and/or staple foods to people. Most (86%) high conflict crops were fruits, compared to 13% of low conflict crops. Some widely farmed cash or staple crops were seldom or never eaten by chimpanzees. Information about which crops are most frequently consumed and which are ignored has enormous potential for aiding on-the-ground stakeholders (i.e. farmers, wildlife managers, and conservation and agricultural extension practitioners) develop sustainable wildlife management schemes for ecologically specialised and protected species in anthropogenic habitats. However, the economic and subsistence needs of local people, and the crop-raiding behaviour of sympatric wildlife, must be considered when assessing suitability of particular crops for conflict prevention and mitigation.	[Hockings, Kimberley J.] Univ Nova Lisboa, Dept Antropol, P-1200 Lisbon, Portugal; [Hockings, Kimberley J.] Ctr Res Anthropol CRIA, Lisbon, Portugal; [Hockings, Kimberley J.; McLennan, Matthew R.] Oxford Brookes Univ, Anthropol Ctr Conservat Environm & Dev, Oxford OX3 0BP, England	Universidade Nova de Lisboa; Oxford Brookes University	Hockings, KJ (corresponding author), Univ Nova Lisboa, Dept Antropol, P-1200 Lisbon, Portugal.	hock@fcsh.unl.pt		Hockings, Kimberley/0000-0002-6187-644X; McLennan, Matthew/0000-0002-5925-1483	Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/CS-ANT/121124/2010]; Leverhulme Trust [F/00 382/F]; Economic and Social Research Council, United Kingdom; Natural Environment Research Council, United Kingdom	Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Leverhulme Trust(Leverhulme Trust); Economic and Social Research Council, United Kingdom(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council, United Kingdom(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	KH was supported by a post-doctoral fellowship and research grant from Fundacao para a Ciencia e a Tecnologia, Portugal (PTDC/CS-ANT/121124/2010). MM's fieldwork was sponsored by the Leverhulme Trust (project ref. F/00 382/F) and the Economic and Social Research Council and the Natural Environment Research Council, United Kingdom. additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlet ME, 2007, INT J PEST MANAGE, V53, P237, DOI 10.1080/09670870701418994; Arlet Malgorzata E., 2010, African Primates, V7, P27; Beasley J. C., 2008, HUMAN WILDLIFE CONFL, V2, P36; Berger-Tal O, 2011, BEHAV ECOL, V22, P236, DOI 10.1093/beheco/arq224; Boesch C, 2000, CHIMPANZEES TAI FORE; Brickell C. D., 2009, SCRIPTA HORTICULTURA, V10; Brugiere D, 2009, FOLIA PRIMATOL, V80, P353, DOI 10.1159/000259335; Caldecott J.O., 2005, WORLD ATLAS GREAT AP; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Chancellor RL, 2012, INT J PRIMATOL, V33, P115, DOI 10.1007/s10764-011-9561-4; Chiyo PI, 2011, J APPL ECOL, V48, P788, DOI 10.1111/j.1365-2664.2011.01967.x; Cornell JE, 1999, RES METHODOLOGY SOCI, P285; Dunnett S, 1970, Bijdr. Dierk., V40, P148; Food and agriculture organization of the United Nations (FAO), 2010, SYST INT AGR CENS SU; Forthman Debra L., 2005, Special Topics in Primatology, V4, P420; Forthman Quick D.L., 1988, Bulletin de la Societe Herpetologique de France, V11, P25; Fuentes A, 2010, AM J PRIMATOL, V72, P841, DOI 10.1002/ajp.20844; Goodall J, 1986, CHIMPANZEES GOMBE, DOI DOI 10.1002/AJPA.1330730313; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; Ham R., 1998, NATIONWIDE CHI UNPUB; Hernandez-Aguilar RA, 2006, THESIS U SO CALIFORN; Hicks T.C., 2010, CHIMPANZEE MEGA CULT; Hill CM., 2002, ALBERTINE RIFT TECHN; Hockings K., 2009, BEST PRACTICE GUIDEL; Hockings KJ, 2010, AM J PRIMATOL, V72, P887, DOI 10.1002/ajp.20784; Hockings KJ, 2009, AM J PRIMATOL, V71, P636, DOI 10.1002/ajp.20698; Hockings KJ, 2011, PRIMATE CONSERV, V26; Hockings KJ, 2012, ORYX IN PRESS; Honda T, 2009, MAMM STUDY, V34, P13, DOI 10.3106/041.034.0103; Hoppe-Dominik B, 1991, PRIM REP, V31, P45; Hyeroba D, 2011, VET REC, V169, DOI 10.1136/vr.d4680; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; Kendall CI, 2011, ORYX, V45, P28, DOI 10.1017/S0030605310000359; King LE, 2009, AFR J ECOL, V47, P131, DOI 10.1111/j.1365-2028.2009.01114.x; Knight J., 2001, NATURAL ENEMIES PEOP; KORTLANDT A, 1962, SCI AM, V206, P128, DOI 10.1038/scientificamerican0562-128; Kortlandt A., 1967, P208; Leciak E, 2005, REV ECOL-TERRE VIE, V60, P179; Linkie M, 2007, ANIM CONSERV, V10, P127, DOI 10.1111/j.1469-1795.2006.00083.x; Lloyd JN, 2000, INVESTIGATION UNPUB; Madden F., 2006, POLICY MATTERS, V14, P180; McLennan MR, 2010, AM J PRIMATOL, V72, P907, DOI 10.1002/ajp.20839; McLennan Matthew R., 2008, Primate Conservation, V23, P45, DOI 10.1896/052.023.0105; McLennan MR, 2010, THESIS OXFORD BROOKE; Meijaard E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027491; Morgan David, 2006, P97; Moscovice LR, 2007, AM J PRIMATOL, V69, P487, DOI 10.1002/ajp.20350; Naughton-Treves L, 1998, J APPL ECOL, V35, P596, DOI 10.1046/j.1365-2664.1998.3540596.x; Naughton-Treves L, 2005, CONSERV BIOL SER, V9, P252; NISHIDA T, 1983, J HUM EVOL, V12, P467, DOI 10.1016/S0047-2484(83)80142-0; Nishida T., 1983, AFR STUD MONOGR, V3, P109, DOI DOI 10.14989/67987; NISHIDA T, 2008, PAN AFR NEWS, V15, P12; Nissen, 1931, COMP PSYCHOL MONOGR, V8, P1; Osborn FV, 2004, AFR J ECOL, V42, P322, DOI 10.1111/j.1365-2028.2004.00531.x; Parker GE, 2006, ORYX, V40, P343, DOI 10.1017/S0030605306000822; Paterson JD, 2005, COMMENSALISM CONFLIC; Rahm U., 1967, P195; Reynolds V, 2003, PRIMATES IN FRAGMENTS: ECOLOGY AND CONSERVATION, P309; Reynolds V., 2005, CHIMPANZEES BUDONGO; Rivera M., 2021, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2020-3.RLTS.T22678711A183481909.EN; SABATERPI J, 1979, Z TIERPSYCHOL, V50, P265; Sitati NW, 2003, J APPL ECOL, V40, P667, DOI 10.1046/j.1365-2664.2003.00828.x; Strum SC, 2010, INT J PRIMATOL, V31, P133, DOI 10.1007/s10764-009-9387-5; Sugiyama Yukimaru, 1992, African Study Monographs, V13, P127; SUKUMAR R, 1990, J TROP ECOL, V6, P33, DOI 10.1017/S0266467400004004; Thirgood S, 2008, J APPL ECOL, V45, P1550, DOI 10.1111/j.1365-2664.2008.01519.x; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; TUTIN CEG, 1993, AM J PRIMATOL, V30, P195, DOI 10.1002/ajp.1350300305; Woodroffe R., 2005, CONSERV BIOL; Wrangham RW, 1998, INT J PRIMATOL, V19, P949, DOI 10.1023/A:1020318102257; WRANGHAM RW, 1994, J TROP ECOL, V10, P355, DOI 10.1017/S0266467400008026; Yamagiwa Juichi, 1992, African Study Monographs, V13, P217; Yamakoshi G, 2011, PRIMATOL MONOGR, P35, DOI 10.1007/978-4-431-53921-6_5	73	67	68	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e33391	10.1371/journal.pone.0033391	http://dx.doi.org/10.1371/journal.pone.0033391			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509256	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336600010
J	Simpson, MIG; Woods, WP; Prendergast, G; Johnson, SR; Green, GGR				Simpson, Michael I. G.; Woods, William P.; Prendergast, Garreth; Johnson, Sam R.; Green, Gary G. R.			Stimulus Variability Affects the Amplitude of the Auditory Steady-State Response	PLOS ONE			English	Article							MODULATED TONES; FREQUENCY; CORTEX; BRAIN; POTENTIALS; AUDIOMETRY; HEARING; MODELS; SOUND; BIAS	In this study we investigate whether stimulus variability affects the auditory steady-state response (ASSR). We present cosinusoidal AM pulses as stimuli where we are able to manipulate waveform shape independently of the fixed repetition rate of 4 Hz. We either present sounds in which the waveform shape, the pulse-width, is fixed throughout the presentation or where it varies pseudo-randomly. Importantly, the average spectra of all the fixed-width AM stimuli are equal to the spectra of the mixed-width AM. Our null hypothesis is that the average ASSR to the fixed-width AM will not be significantly different from the ASSR to the mixed-width AM. In a region of interest beamformer analysis of MEG data, we compare the 4 Hz component of the ASSR to the mixed-width AM with the 4 Hz component of the ASSR to the pooled fixed-width AM. We find that at the group level, there is a significantly greater response to the variable mixed-width AM at the medial boundary of the Middle and Superior Temporal Gyri. Hence, we find that adding variability into AM stimuli increases the amplitude of the ASSR. This observation is important, as it provides evidence that analysis of the modulation waveform shape is an integral part of AM processing. Therefore, standard steady-state studies in audition, using sinusoidal AM, may not be sensitive to a key feature of acoustic processing.	[Simpson, Michael I. G.; Prendergast, Garreth; Johnson, Sam R.; Green, Gary G. R.] Univ York, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England; [Woods, William P.] Swinburne Univ Technol, Melbourne, Vic, Australia	University of York - UK; Swinburne University of Technology	Simpson, MIG (corresponding author), Univ York, York Neuroimaging Ctr, York YO10 5DD, N Yorkshire, England.	michael.simpson@ynic.york.ac.uk	Green, Gary GR/D-3543-2009	Green, Gary GR/0000-0003-1977-7509; Woods, William/0000-0001-6653-6105; Prendergast, Garreth/0000-0002-7255-6708	York Neuroimaging Centre, University of York	York Neuroimaging Centre, University of York	All authors are full-time employees of the University of York. This study was internally funded by the York Neuroimaging Centre, University of York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DA, 2008, J NEUROSCI, V28, P3958, DOI 10.1523/JNEUROSCI.0187-08.2008; Avants BB, 2008, MED IMAGE ANAL, V12, P26, DOI 10.1016/j.media.2007.06.004; Bartlett EL, 2005, J NEUROPHYSIOL, V94, P83, DOI 10.1152/jn.01124.2004; Boemio A, 2005, NAT NEUROSCI, V8, P389, DOI 10.1038/nn1409; Byrne AJ, 2011, J ACOUST SOC AM, V129, P593, DOI 10.1121/1.3531838; Chait M, 2007, J NEUROSCI, V27, P5207, DOI 10.1523/JNEUROSCI.0318-07.2007; Dimitrijevic Andrew, 2002, J Am Acad Audiol, V13, P205; Ewert SD, 2000, J ACOUST SOC AM, V108, P1181, DOI 10.1121/1.1288665; Georgeson MA, 2007, J VISION, V7, DOI 10.1167/7.13.7; Green GGR, 1974, J PHYSIOL-LONDON, V241, P29; HARI R, 1989, J ACOUST SOC AM, V86, P1033, DOI 10.1121/1.398093; Huang MX, 2004, BRAIN TOPOGR, V16, P139; Jenkinson M, 2005, 11 ANN M ORG HUM BRA; Johnson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022251; KAY RH, 1972, J PHYSIOL-LONDON, V225, P657, DOI 10.1113/jphysiol.1972.sp009962; Kozinska D, 2001, CLIN NEUROPHYSIOL, V112, P1553, DOI 10.1016/S1388-2457(01)00556-9; KUWADA S, 1986, HEARING RES, V21, P179, DOI 10.1016/0378-5955(86)90038-9; Lins OG, 1996, EAR HEARING, V17, P81, DOI 10.1097/00003446-199604000-00001; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; PATTERSON RD, 1994, J ACOUST SOC AM, V96, P1419, DOI 10.1121/1.410286; PATTERSON RD, 1994, J ACOUST SOC AM, V96, P1409, DOI 10.1121/1.410285; PICTON TW, 1987, J ACOUST SOC AM, V82, P165, DOI 10.1121/1.395560; Prendergast G, 2011, SPEECH COMMUN, V53, P903, DOI 10.1016/j.specom.2011.03.002; Prendergast G, 2010, EUR J NEUROSCI, V32, P1599, DOI 10.1111/j.1460-9568.2010.07423.x; QUENOUILLE MH, 1956, BIOMETRIKA, V43, P353; REES A, 1986, HEARING RES, V23, P123, DOI 10.1016/0378-5955(86)90009-2; Ross B, 2000, J ACOUST SOC AM, V108, P679, DOI 10.1121/1.429600; Scherf F, 2006, INT J AUDIOL, V45, P281, DOI 10.1080/14992020500485684; Simpson MIG, 2005, NEUROSCI LETT, V385, P195, DOI 10.1016/j.neulet.2005.05.043; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; TANSLEY BW, 1983, J ACOUST SOC AM, V74, P765, DOI 10.1121/1.389864; TUKEY JW, 1958, ANN MATH STAT, V29, P614; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Wojtczak M, 2005, J ACOUST SOC AM, V118, P3198, DOI 10.1121/1.2042970; [No title captured]	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34668	10.1371/journal.pone.0034668	http://dx.doi.org/10.1371/journal.pone.0034668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509343	Green Published, gold			2022-12-27	WOS:000304805900056
J	Deep, G; Gangar, SC; Rajamanickam, S; Raina, K; Gu, M; Agarwal, C; Oberlies, NH; Agarwal, R				Deep, Gagan; Gangar, Subhash Chander; Rajamanickam, Subapriya; Raina, Komal; Gu, Mallikarjuna; Agarwal, Chapla; Oberlies, Nicholas H.; Agarwal, Rajesh			Angiopreventive Efficacy of Pure Flavonolignans from Milk Thistle Extract against Prostate Cancer: Targeting VEGF-VEGFR Signaling	PLOS ONE			English	Article							CIRCULATING ENDOTHELIAL-CELLS; ANGIOGENESIS INHIBITORS; SILYBUM-MARIANUM; ISOSILYBIN-B; CYCLE ARREST; G(1) ARREST; IN-VIVO; GROWTH; SILIBININ; SILYMARIN	The role of neo-angiogenesis in prostate cancer (PCA) growth and metastasis is well established, but the development of effective and non-toxic pharmacological inhibitors of angiogenesis remains an unaccomplished goal. In this regard, targeting aberrant angiogenesis through non-toxic phytochemicals could be an attractive angiopreventive strategy against PCA. The rationale of the present study was to compare the anti-angiogenic potential of four pure diastereoisomeric flavonolignans, namely silybin A, silybin B, isosilybin A and isosilybin B, which we established previously as biologically active constituents in Milk Thistle extract. Results showed that oral feeding of these flavonolignans (50 and 100 mg/kg body weight) effectively inhibit the growth of advanced human PCA DU145 xenografts. Immunohistochemical analyses revealed that these flavonolignans inhibit tumor angiogenesis biomarkers (CD31 and nestin) and signaling molecules regulating angiogenesis (VEGF, VEGFR1, VEGFR2, phospho-Akt and HIF-1 alpha) without adversely affecting the vessel-count in normal tissues (liver, lung, and kidney) of tumor bearing mice. These flavonolignans also inhibited the microvessel sprouting from mouse dorsal aortas ex vivo, and the VEGF-induced cell proliferation, capillary-like tube formation and invasiveness of human umbilical vein endothelial cells (HUVEC) in vitro. Further studies in HUVEC showed that these diastereoisomers target cell cycle, apoptosis and VEGF-induced signaling cascade. Three dimensional growth assay as well as co-culture invasion and in vitro angiogenesis studies (with HUVEC and DU145 cells) suggested the differential effectiveness of the diastereoisomers toward PCA and endothelial cells. Overall, these studies elucidated the comparative anti-angiogenic efficacy of pure flavonolignans from Milk Thistle and suggest their usefulness in PCA angioprevention.	[Deep, Gagan; Gangar, Subhash Chander; Rajamanickam, Subapriya; Raina, Komal; Gu, Mallikarjuna; Agarwal, Chapla; Agarwal, Rajesh] Univ Colorado Denver, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA; [Deep, Gagan; Agarwal, Chapla; Agarwal, Rajesh] Univ Colorado Denver, Univ Colorado Canc Ctr, Aurora, CO USA; [Oberlies, Nicholas H.] Univ N Carolina, Dept Chem & Biochem, Greensboro, NC 27412 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of North Carolina; University of North Carolina Greensboro	Deep, G (corresponding author), Univ Colorado Denver, Skaggs Sch Pharm & Pharmaceut Sci, Aurora, CO USA.	Rajesh.Agarwal@ucdenver.edu	Deep, Gagan/H-1853-2012; Oberlies, Nicholas/D-8162-2011	Oberlies, Nicholas/0000-0002-0354-8464; Raina, Komal/0000-0003-0371-1070	NCI [CA102514, CA104286]; NATIONAL CANCER INSTITUTE [R01CA102514, P30CA046934, R01CA104286] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI R01 grants CA102514 and CA104286. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2006, ANTICANCER RES, V26, P4457; Airley RE, 2007, CHEMOTHERAPY, V53, P233, DOI 10.1159/000104457; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bicknell R, 2004, ANNU REV PHARMACOL, V44, P219, DOI 10.1146/annurev.pharmtox.44.101802.121650; Blanchet B, 2010, EXPERT OPIN DRUG SAF, V9, P275, DOI 10.1517/14740330903510608; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Cook KM, 2010, CA-CANCER J CLIN, V60, P222, DOI 10.3322/caac.20075; Davis-Searles PR, 2005, CANCER RES, V65, P4448, DOI 10.1158/0008-5472.CAN-04-4662; Deep G, 2008, ONCOGENE, V27, P3986, DOI 10.1038/onc.2008.45; Deep G, 2006, ONCOGENE, V25, P1053, DOI 10.1038/sj.onc.1209146; Deep G, 2008, INT J CANCER, V123, P2750, DOI 10.1002/ijc.23879; Deep G, 2008, INT J CANCER, V123, P41, DOI 10.1002/ijc.23485; Deep G, 2007, CARCINOGENESIS, V28, P1533, DOI 10.1093/carcin/bgm069; Deep G, 2011, CANCER PREV RES, V4, P1222, DOI 10.1158/1940-6207.CAPR-10-0370; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; George D, 2011, PROSTATE; Georgiou HD, 2008, NAT CLIN PRACT UROL, V5, P445, DOI 10.1038/ncpuro1188; Graf TN, 2007, PLANTA MED, V73, P1495, DOI 10.1055/s-2007-990239; Gu M, 2007, CANCER RES, V67, P3483, DOI 10.1158/0008-5472.CAN-06-3955; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hsieh AC, 2011, BRIT J CANCER, V105, P329, DOI 10.1038/bjc.2011.241; Hua KQ, 2009, ONCOL REP, V21, P893, DOI 10.3892/or_00000300; Huss WJ, 2001, CANCER RES, V61, P2736; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaur M, 2009, MOL CANCER THER, V8, P2366, DOI 10.1158/1535-7163.MCT-09-0304; Kim D, 2005, FRONT BIOSCI-LANDMRK, V10, P975, DOI 10.2741/1592; Kim NC, 2003, ORG BIOMOL CHEM, V1, P1684, DOI 10.1039/b300099k; Kroll DJ, 2007, INTEGR CANCER THER, V6, P110, DOI 10.1177/1534735407301825; Li HQ, 2008, BJU INT, V101, P884, DOI 10.1111/j.1464-410X.2007.07342.x; Li Y, 2010, MED RES REV, V30, P23, DOI 10.1002/med.20161; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Menakuru SR, 2008, BRIT J CANCER, V99, P1961, DOI 10.1038/sj.bjc.6604733; Mulder K, 2011, EXPERT OPIN BIOL TH, V11, P405, DOI 10.1517/14712598.2011.557657; Naumov GN, 2006, CELL CYCLE, V5, P1779, DOI 10.4161/cc.5.16.3018; Pang XF, 2009, CANCER RES, V69, P5893, DOI 10.1158/0008-5472.CAN-09-0755; Patan S, 2004, CANC TREAT, V117, P3; Samant RS, 2011, ONCOTARGET, V2, P122; Saunders WB, 2006, J CELL BIOL, V175, P179, DOI 10.1083/jcb.200603176; Singh RP, 2007, CARCINOGENESIS, V28, P2567, DOI 10.1093/carcin/bgm218; Singh RP, 2006, J NATL CANCER I, V98, P846, DOI 10.1093/jnci/djj231; Singh RP, 2005, ONCOGENE, V24, P1188, DOI 10.1038/sj.onc.1208276; Takenaga Keizo, 2011, Front Biosci (Landmark Ed), V16, P31; Tosetti F, 2002, FASEB J, V16, P2, DOI 10.1096/fj.01-0300rev; Yu EM, 2010, DISCOV MED, V10, P521; Zi XL, 1998, CLIN CANCER RES, V4, P1055	47	44	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34630	10.1371/journal.pone.0034630	http://dx.doi.org/10.1371/journal.pone.0034630			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514647	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600053
J	Elliot, AJ; Pazda, AD				Elliot, Andrew J.; Pazda, Adam D.			Dressed for Sex: Red as a Female Sexual Signal in Humans	PLOS ONE			English	Article							SELF-PRESENTATION; COLOR; BEHAVIOR; ATTRACTIVENESS; PERFORMANCE; SWELLINGS; COURTSHIP; INTERNET; SUCCESS; SKIN	Background: In many non-human primate species, a display of red by a female serves as a sexual signal to attract male conspecifics. Red is associated with sex and romance in humans, and women convey their sexual interest to men through a variety of verbal, postural, and behavioral means. In the present research, we investigate whether female red ornamentation in non-human primates has a human analog, whereby women use a behavioral display of red to signal their sexual interest to men. Methodology/Principal Findings: Three studies tested the hypothesis that women use red clothing to communicate sexual interest to men in profile pictures on dating websites. In Study 1, women who imagined being interested in casual sex were more likely to display red (but not other colors) on their anticipated web profile picture. In Study 2, women who indicated interest in casual sex were more likely to prominently display red (but not other colors) on their actual web profile picture. In Study 3, women on a website dedicated to facilitating casual sexual relationships were more likely to prominently exhibit red (but not other colors) than women on a website dedicated to facilitating marital relationships. Conclusions/Significance: These results establish a provocative parallel between women and non-human female primates in red signal coloration in the mating game. This research shows, for the first time, a functional use of color in women's sexual self-presentation, and highlights the need to extend research on color beyond physics, physiology, and preference to psychological functioning.	[Elliot, Andrew J.; Pazda, Adam D.] Univ Rochester, Dept Clin & Social Sci Psychol, Rochester, NY 14627 USA	University of Rochester	Elliot, AJ (corresponding author), Univ Rochester, Dept Clin & Social Sci Psychol, Rochester, NY 14627 USA.	andye@psych.rochester.edu	Elliot, Andrew J/D-1546-2013					ABBEY A, 1987, PSYCHOL WOMEN QUART, V11, P173, DOI 10.1111/j.1471-6402.1987.tb00782.x; Barber N, 1999, SEX ROLES, V40, P459, DOI 10.1023/A:1018823727012; Barelli C, 2007, HORM BEHAV, V51, P221, DOI 10.1016/j.yhbeh.2006.10.008; BIELERT C, 1989, J ZOOL, V219, P569, DOI 10.1111/j.1469-7998.1989.tb02601.x; Bock D R, 1985, MULTIVARIATE STAT ME; Campbell A, 2004, J SEX RES, V41, P16, DOI 10.1080/00224490409552210; Conley TD, 2011, J PERS SOC PSYCHOL, V100, P309, DOI 10.1037/a0022152; Couch D, 2008, QUAL HEALTH RES, V18, P268, DOI 10.1177/1049732307312832; Deschner T, 2004, HORM BEHAV, V46, P204, DOI 10.1016/j.yhbeh.2004.03.013; DIXSON AF, 1983, ADV STUD BEHAV, V13, P63, DOI 10.1016/S0065-3454(08)60286-7; DRAPER P, 1982, J ANTHROPOL RES, V38, P255, DOI 10.1086/jar.38.3.3629848; EDMONDS EM, 1984, B PSYCHONOMIC SOC, V22, P171; Elliot AJ, 2008, J PERS SOC PSYCHOL, V95, P1150, DOI 10.1037/0022-3514.95.5.1150; Elliot AJ, 2007, J EXP PSYCHOL GEN, V136, P154, DOI 10.1037/0096-3445.136.1.154; Elliot AJ, 2012, ADV EXP SOC PSYCHOL, V45, P61, DOI 10.1016/B978-0-12-394286-9.00002-0; Elliot AJ, 2010, J EXP PSYCHOL GEN, V139, P399, DOI 10.1037/a0019689; Fisher ML, 2004, P ROY SOC B-BIOL SCI, V271, pS283, DOI 10.1098/rsbl.2004.0160; Gamberale-Stille G, 2001, P ROY SOC B-BIOL SCI, V268, P2525, DOI 10.1098/rspb.2001.1814; Gerald Melissa S., 2003, Special Topics in Primatology, V3, P141; Gibbs JL, 2006, COMMUN RES, V33, P152, DOI 10.1177/0093650205285368; GIVENS DB, 1978, PSYCHIATRY, V41, P346, DOI 10.1080/00332747.1978.11023994; Grammer K, 2004, J SEX RES, V41, P66, DOI 10.1080/00224490409552214; GRAMMER K, 1990, J NONVERBAL BEHAV, V14, P209, DOI 10.1007/BF00989317; Haselton MG, 2003, J RES PERS, V37, P34, DOI 10.1016/S0092-6566(02)00529-9; Heino RD, 2010, J SOC PERS RELAT, V27, P427, DOI 10.1177/0265407510361614; Hendrie CA, 2009, BEHAVIOUR, V146, P1331, DOI 10.1163/156853909X427704; Hill RA, 2005, NATURE, V435, P293, DOI 10.1038/435293a; Hutchings J, 2004, COLOR RES APPL, V29, P57, DOI 10.1002/col.10212; Jobes G., 1962, DICT MYTHOLOGY FOLKL, VI-II; Kayser DN, 2010, EUR J SOC PSYCHOL, V40, P901, DOI 10.1002/ejsp.757; Lohmus M, 2009, ANN ZOOL FENN, V46, P75, DOI 10.5735/086.046.0108; Low BS., 1979, EVOLUTIONARY BIOL HU, P462; Meston CM, 2009, WHY WOMEN HAVE SEX P; Moore MM, 2010, J SEX RES, V47, P171, DOI 10.1080/00224490903402520; Morgan EM, 2010, COMPUT HUM BEHAV, V26, P883, DOI 10.1016/j.chb.2010.02.002; MUEHLENHARD CL, 1986, BEHAV THER, V17, P404, DOI 10.1016/S0005-7894(86)80071-5; Pazda AD, J EXP SOC PSYCHOL; Perper T., 1987, J SEX RES, V23, P455, DOI DOI 10.1080/00224498709551385; Roberts SC, 2010, EVOL PSYCHOL-US, V8, P350, DOI 10.1177/147470491000800304; Rozin P., 2015, EVOLUTIONARY PSYCHOL; Setchell JM, 2004, BEHAV ECOL, V15, P438, DOI 10.1093/beheco/arh027; Stallmann RR, 2000, PRIMATES, V41, P1, DOI 10.1007/BF02557457; Stephen ID, 2010, PERCEPTION, V39, P1104, DOI 10.1068/p6730; Stephen ID, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005083; Toma CL, 2010, COMMUN RES, V37, P335, DOI 10.1177/0093650209356437; Waitt C, 2006, AM J PRIMATOL, V68, P738, DOI 10.1002/ajp.20264; Whitty MT, 2008, COMPUT HUM BEHAV, V24, P1837, DOI 10.1016/j.chb.2008.02.009; Zanna M.P., 1982, CONSISTENCY SOCIAL B, P283	48	36	38	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34607	10.1371/journal.pone.0034607	http://dx.doi.org/10.1371/journal.pone.0034607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UT	22514643	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600049
J	Kamal, MZ; Mohammad, TAS; Krishnamoorthy, G; Rao, NM				Kamal, Md Zahid; Mohammad, Tabrez Anwar Shamim; Krishnamoorthy, G.; Rao, Nalam Madhusudhana			Role of Active Site Rigidity in Activity: MD Simulation and Fluorescence Study on a Lipase Mutant	PLOS ONE			English	Article							BACILLUS-SUBTILIS LIPASE; DIRECTED EVOLUTION; ENZYME CATALYSIS; CONFORMATIONAL DYNAMICS; DIHYDROFOLATE-REDUCTASE; AMYLOID PROTOFIBRILS; CRYSTAL-STRUCTURES; CHEMICAL STEP; PROTEIN; STABILITY	Relationship between stability and activity of enzymes is maintained by underlying conformational flexibility. In thermophilic enzymes, a decrease in flexibility causes low enzyme activity while in less stable proteins such as mesophiles and psychrophiles, an increase in flexibility is associated with enhanced enzyme activity. Recently, we identified a mutant of a lipase whose stability and activity were enhanced simultaneously. In this work, we probed the conformational dynamics of the mutant and the wild type lipase, particularly flexibility of their active site using molecular dynamic simulations and time-resolved fluorescence techniques. In contrast to the earlier observations, our data show that active site of the mutant is more rigid than wild type enzyme. Further investigation suggests that this lipase needs minimal reorganization/flexibility of active site residues during its catalytic cycle. Molecular dynamic simulations suggest that catalytically competent active site geometry of the mutant is relatively more preserved than wild type lipase, which might have led to its higher enzyme activity. Our study implies that widely accepted positive correlation between conformation flexibility and enzyme activity need not be stringent and draws attention to the possibility that high enzyme activity can still be accomplished in a rigid active site and stable protein structures. This finding has a significant implication towards better understanding of involvement of dynamic motions in enzyme catalysis and enzyme engineering through mutations in active site.	[Kamal, Md Zahid; Rao, Nalam Madhusudhana] CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India; [Mohammad, Tabrez Anwar Shamim] Ctr DNA Fingerprinting & Diagnost, Hyderabad, Andhra Pradesh, India; [Krishnamoorthy, G.] Tata Inst Fundamental Res, Dept Chem Sci, Mumbai 400005, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Tata Institute of Fundamental Research (TIFR)	Kamal, MZ (corresponding author), CSIR, Ctr Cellular & Mol Biol, Hyderabad, Andhra Pradesh, India.	madhu@ccmb.res.in	MOHAMMAD, TABREZ/AAN-7495-2020	MOHAMMAD, TABREZ/0000-0002-9553-7841	Council of Scientific and Industrial Research [NWP0044, CMM0021]	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	The work reported here was supported by the grants from the Council of Scientific and Industrial Research (NWP0044 and CMM0021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2004, J MOL BIOL, V341, P1271, DOI 10.1016/j.jmb.2004.06.059; Adamczyk AJ, 2011, P NATL ACAD SCI USA, V108, P14115, DOI 10.1073/pnas.1111252108; Ahmad S, 2008, J MOL BIOL, V381, P324, DOI 10.1016/j.jmb.2008.05.063; Ahmad S, 2009, PROTEIN SCI, V18, P1183, DOI 10.1002/pro.126; Akanuma S, 1998, PROTEIN SCI, V7, P698, DOI 10.1002/pro.5560070319; Benkovic SJ, 2008, BIOCHEMISTRY-US, V47, P3317, DOI 10.1021/bi800049z; Bhabha G, 2011, SCIENCE, V332, P234, DOI 10.1126/science.1198542; D'Amico S, 2003, J BIOL CHEM, V278, P7891, DOI 10.1074/jbc.M212508200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Droge MJ, 2006, CHEMBIOCHEM, V7, P149, DOI 10.1002/cbic.200500308; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Fraser JS, 2009, NATURE, V462, P669, DOI 10.1038/nature08615; Giver L, 1998, P NATL ACAD SCI USA, V95, P12809, DOI 10.1073/pnas.95.22.12809; Goel T, 2010, J PHYS CHEM B, V114, P8986, DOI 10.1021/jp912029m; Gribenko AV, 2009, P NATL ACAD SCI USA, V106, P2601, DOI 10.1073/pnas.0808220106; Gunasekaran K, 2007, J MOL BIOL, V365, P257, DOI 10.1016/j.jmb.2006.09.062; Gutteridge A, 2005, J MOL BIOL, V346, P21, DOI 10.1016/j.jmb.2004.11.013; Hammes-Schiffer S, 2006, ANNU REV BIOCHEM, V75, P519, DOI 10.1146/annurev.biochem.75.103004.142800; Hecky J, 2005, BIOCHEMISTRY-US, V44, P12640, DOI 10.1021/bi0501885; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hibbs RE, 2006, J BIOL CHEM, V281, P39708, DOI 10.1074/jbc.M604752200; Hollien J, 1999, P NATL ACAD SCI USA, V96, P13674, DOI 10.1073/pnas.96.24.13674; Jha A, 2009, J MOL BIOL, V393, P735, DOI 10.1016/j.jmb.2009.08.053; Kamal MZ, 2011, J MOL BIOL, V413, P726, DOI 10.1016/j.jmb.2011.09.002; Kamerlin SCL, 2010, PROTEINS, V78, P1339, DOI 10.1002/prot.22654; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Labeikovsky W, 2007, J MOL BIOL, V367, P1370, DOI 10.1016/j.jmb.2007.01.049; Lakshmikanth GS, 1999, BIOPHYS J, V77, P1100, DOI 10.1016/S0006-3495(99)76960-2; Lazaridis T, 1997, PROTEIN SCI, V6, P2589; Lehmann M, 2000, BBA-PROTEIN STRUCT M, V1543, P408, DOI 10.1016/S0167-4838(00)00238-7; Markwell M A, 1981, Methods Enzymol, V72, P296; McElheny D, 2005, P NATL ACAD SCI USA, V102, P5032, DOI 10.1073/pnas.0500699102; Miyazaki K, 2000, J MOL BIOL, V297, P1015, DOI 10.1006/jmbi.2000.3612; Mukhopadhyay S, 2006, J MOL BIOL, V358, P935, DOI 10.1016/j.jmb.2006.02.006; Papaleo E, 2008, FEBS LETT, V582, P1008, DOI 10.1016/j.febslet.2008.02.048; Pisliakov AV, 2009, P NATL ACAD SCI USA, V106, P17359, DOI 10.1073/pnas.0909150106; Richard P.Haugland, 2002, HDB FLUORESCENCENT P, P79; Smith AJT, 2008, J AM CHEM SOC, V130, P15361, DOI 10.1021/ja803213p; Tousignant A, 2004, CHEM BIOL, V11, P1037, DOI 10.1016/j.chembiol.2004.06.007; Van den Burg B, 1998, P NATL ACAD SCI USA, V95, P2056, DOI 10.1073/pnas.95.5.2056; VAN PG, 2001, J MOL BIOL, V309, P215; VARLEY PG, 1991, J MOL BIOL, V220, P531, DOI 10.1016/0022-2836(91)90028-5; Wolf-Watz M, 2004, NAT STRUCT MOL BIOL, V11, P945, DOI 10.1038/nsmb821; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406; Zhao HM, 1999, PROTEIN ENG, V12, P47, DOI 10.1093/protein/12.1.47	48	59	63	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35188	10.1371/journal.pone.0035188	http://dx.doi.org/10.1371/journal.pone.0035188			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514720	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600126
J	Chapple, DG; Birkett, A; Miller, KA; Daugherty, CH; Gleeson, DM				Chapple, David G.; Birkett, Alisha; Miller, Kimberly A.; Daugherty, Charles H.; Gleeson, Dianne M.			Phylogeography of the Endangered Otago Skink, Oligosoma otagense: Population Structure, Hybridisation and Genetic Diversity in Captive Populations	PLOS ONE			English	Article							SCINCIDAE SPECIES COMPLEX; NEW-ZEALAND BIOTA; SOUTH ISLAND; PHYLOGENETIC-RELATIONSHIPS; EVOLUTIONARY PROCESSES; TAXONOMIC REVISION; DNA-SEQUENCES; CONSERVATION; REPTILIA; DIVERSIFICATION	Climatic cooling and substantial tectonic activity since the late Miocene have had a pronounced influence on the evolutionary history of the fauna of New Zealand's South Island. However, many species have recently experienced dramatic range reductions due to habitat fragmentation and the introduction of mammalian predators and competitors. These anthropogenic impacts have been particularly severe in the tussock grasslands of the Otago region. The Otago skink (Oligosoma otagense), endemic to the region, is one of the most critically endangered vertebrates in New Zealand. We use mitochondrial DNA sequence data to investigate the evolutionary history of the Otago skink, examine its population genetic structure, and assess the level of genetic diversity in the individuals in the captive breeding program. Our data indicate that the Otago skink diverged from its closest relatives in the Miocene, consistent with the commencement of tectonic uplift of the Southern Alps. However, there is evidence for past introgression with the scree skink (O. waimatense) in the northern Otago-southern Canterbury region. The remnant populations in eastern Otago and western Otago are estimated to have diverged in the mid-Pliocene, with no haplotypes shared between these two regions. This divergence accounts for 95% of the genetic diversity in the species. Within both regions there is strong genetic structure among populations, although shared haplotypes are generally evident between adjacent localities. Although substantial genetic diversity is present in the captive population, all individuals originate from the eastern region and the majority had haplotypes that were not evident in the intensively managed populations at Macraes Flat. Our data indicate that eastern and western populations should continue to be regarded as separate management units. Knowledge of the genetic diversity of the breeding stock will act to inform the captive management of the Otago skink and contribute to a key recovery action for the species.	[Chapple, David G.; Miller, Kimberly A.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Chapple, David G.; Daugherty, Charles H.] Victoria Univ Wellington, Sch Biol Sci, Allan Wilson Ctr Mol Ecol & Evolut, Wellington, New Zealand; [Birkett, Alisha; Gleeson, Dianne M.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Birkett, Alisha; Gleeson, Dianne M.] Landcare Res, Ecol Genet Lab, Auckland, New Zealand	Monash University; Victoria University Wellington; University of Auckland; Landcare Research - New Zealand	Chapple, DG (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	David.Chapple@monash.edu	Chapple, David/B-9073-2008	Chapple, David/0000-0002-7720-6280; Gleeson, Dianne/0000-0002-5093-4405	Allan Wilson Centre for Molecular Ecology and Evolution; Victoria University of Wellington University Research Fund; New Zealand Department of Conservation [3785]; Ministry for Science and Innovation Outcome Based Investment (Sustaining and Restoring Biodiversity)	Allan Wilson Centre for Molecular Ecology and Evolution; Victoria University of Wellington University Research Fund; New Zealand Department of Conservation; Ministry for Science and Innovation Outcome Based Investment (Sustaining and Restoring Biodiversity)	This research was supported by funding to DGC and CHD from the Allan Wilson Centre for Molecular Ecology and Evolution, and the Victoria University of Wellington University Research Fund, and grants from the New Zealand Department of Conservation (Investigation Number 3785) and Ministry for Science and Innovation Outcome Based Investment (Sustaining and Restoring Biodiversity) to DMG. The funders had no role in study design, and analysis, decision to publish, or preparation of the manuscript. However, the New Zealand Department of Conservation did provide some tissue samples that were used in the study.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bell TP, 2008, ZOOTAXA, P57, DOI 10.11646/zootaxa.1882.1.3; Berry O, 2005, BIOL CONSERV, V123, P197, DOI 10.1016/j.biocon.2004.11.007; Bridle JR, 2007, TRENDS ECOL EVOL, V22, P140, DOI 10.1016/j.tree.2006.11.002; Bryson RW, 2008, COPEIA, P172, DOI 10.1643/CH-07-043; Chamberlain CP, 1999, CHEM GEOL, V155, P279, DOI 10.1016/S0009-2541(98)00165-X; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Chapple DG, 2008, BIOL J LINN SOC, V95, P388, DOI 10.1111/j.1095-8312.2008.01062.x; Chapple DG, 2008, J HERPETOL, V42, P437, DOI 10.1670/07-110.1; Chapple DG, 2008, NEW ZEAL J ZOOL, V35, P129, DOI 10.1080/03014220809510110; Chapple DG, 2007, NEW ZEAL J ZOOL, V34, P347, DOI 10.1080/03014220709510094; Chapple DG, 2011, ZOOTAXA, P1; Chapple DG, 2009, MOL PHYLOGENET EVOL, V52, P470, DOI 10.1016/j.ympev.2009.03.021; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coddington E. J., 1997, PAC CONSERV BIOL, V3, P379, DOI [10.1071/PC980379, DOI 10.1071/PC980379]; Connolly JD, 2008, BIOL CONSERV, V141, P1283, DOI 10.1016/j.biocon.2008.02.026; COOPER A, 1995, P ROY SOC B-BIOL SCI, V261, P293, DOI 10.1098/rspb.1995.0150; COOPER RA, 1993, TRENDS ECOL EVOL, V8, P429, DOI 10.1016/0169-5347(93)90004-9; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; CREE A, 1994, NEW ZEAL J ZOOL, V21, P351, DOI 10.1080/03014223.1994.9518005; Daugherty CH, ALLOZYME VARIA UNPUB; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duncan RP, 2001, NEW ZEAL J ECOL, V25, P35; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2004, MOL ECOL, V13, P853, DOI 10.1046/j.1365-294X.2003.02004.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Forstner MRJ, 1995, MOL PHYLOGENET EVOL, V4, P93, DOI 10.1006/mpev.1995.1010; Fu YX, 1997, GENETICS, V147, P915; GAGE M, 1980, LEGENDS ROCKS OUTLIN; Gaston KJ, 2003, STRUCTURE DYNAMICS G; Germano JM, 2007, J HERPETOL, V41, P179, DOI 10.1670/0022-1511(2007)41[179:MHRACE]2.0.CO;2; Gibbs G., 2006, GHOSTS GONDWANA HIST; Greaves SNJ, 2008, J BIOGEOGR, V35, P853, DOI 10.1111/j.1365-2699.2007.01848.x; Greaves SNJ, 2007, MOL PHYLOGENET EVOL, V45, P729, DOI 10.1016/j.ympev.2007.06.008; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; HARDY GS, 1977, NEW ZEAL J ZOOL, V4, P221, DOI 10.1080/03014223.1977.9517956; Hare KM, 2008, MOL PHYLOGENET EVOL, V46, P303, DOI 10.1016/j.ympev.2007.08.012; HARPENDING HC, 1994, HUM BIOL, V66, P591; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hitchmough RA, 2010, NEW ZEAL J ZOOL, V37, P203, DOI 10.1080/03014223.2010.496487; HOLM S, 1979, SCAND J STAT, V6, P65; Jennings WB, 2003, SYST BIOL, V52, P757, DOI 10.1080/10635150390250974; Jewell T., 2008, PHOTOGRAPHIC GUIDE R; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; Kumazawa Y, 1999, MOL BIOL EVOL, V16, P784, DOI 10.1093/oxfordjournals.molbev.a026163; Landis CA, 2008, GEOL MAG, V145, P173, DOI 10.1017/S0016756807004268; Lee DE, 2001, AUST J BOT, V49, P341, DOI 10.1071/BT00031; Liggins L, 2008, MOL ECOL, V17, P3668, DOI 10.1111/j.1365-294X.2008.03864.x; Liggins L, 2008, MOL ECOL, V17, P3290, DOI 10.1111/j.1365-294X.2008.03832.x; Macey JR, 1998, MOL PHYLOGENET EVOL, V10, P118, DOI 10.1006/mpev.1997.0478; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; MARKGRAF V, 1995, TRENDS ECOL EVOL, V10, P143, DOI 10.1016/S0169-5347(00)89023-0; McCann C., 1955, DOMINION MUSEUM B, V17; Miller KA, 2009, ANIM CONSERV, V12, P163, DOI 10.1111/j.1469-1795.2009.00236.x; Morgan-Richards M, 2009, J ROY SOC NEW ZEAL, V39, P15, DOI 10.1080/03014220909510561; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Newnham RM, 1999, PROG PHYS GEOG, V23, P567, DOI 10.1177/030913339902300406; Norbury DC, 1996, NEW ZEAL J ECOL, V20, P285; Norbury G, 2001, J APPL ECOL, V38, P1350, DOI 10.1046/j.0021-8901.2001.00685.x; Norbury G, 2006, GRAND OTAGO SKINK RE; Norbury G, 2009, NEW ZEAL J ECOL, V33, P24; O'Neill SB, 2008, MOL PHYLOGENET EVOL, V48, P1168, DOI 10.1016/j.ympev.2008.05.008; OCONNOR KF, 1982, NEW ZEAL J ECOL, V5, P97; Patterson GB, 1997, J ROY SOC NEW ZEAL, V27, P439, DOI 10.1080/03014223.1997.9517547; Patterson GB, 1992, DOC INTERNAL REPORT; Patterson GB, 2009, ZOOTAXA, P43, DOI 10.11646/zootaxa.2271.1.4; Pole M, 2003, J ROY SOC NEW ZEAL, V33, P415, DOI 10.1080/03014223.2003.9517737; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poulakakis N, 2005, MOL ECOL, V14, P2433, DOI 10.1111/j.1365-294X.2005.02588.x; Rambaut A, TRACER V1 5; Ray N, 2003, MOL BIOL EVOL, V20, P76, DOI 10.1093/molbev/msg009; Reardon JT, 2012, NZ J ECOLOG IN PRESS; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sadlier RA, 2004, J HERPETOL, V38, P320, DOI 10.1670/196-03A; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Schneider S, 1999, GENETICS, V152, P1079; Shoo LP, 2008, MOL PHYLOGENET EVOL, V48, P528, DOI 10.1016/j.ympev.2008.03.022; Sinervo B, 2010, SCIENCE, V328, P894, DOI 10.1126/science.1184695; Skinner A, 2011, J BIOGEOGR, V38, P1044, DOI 10.1111/j.1365-2699.2010.02471.x; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Towns DR, 2001, BIOL CONSERV, V99, P3, DOI 10.1016/S0006-3207(00)00184-1; TOWNS DR, 1994, NEW ZEAL J ZOOL, V21, P325, DOI 10.1080/03014223.1994.9518003; Wallis GP, 2009, MOL ECOL, V18, P3548, DOI 10.1111/j.1365-294X.2009.04294.x; Waters JM, 2001, EVOLUTION, V55, P1844; Whitaker A., 1995, OTAGO SKINK GRAND SK; Wilcox TP, 2002, MOL PHYLOGENET EVOL, V25, P361, DOI 10.1016/S1055-7903(02)00244-0; Wilson K. J., 2004, FLIGHT HUIA ECOLOGY; Worthy T. H., 2002, LOST WORLD MOA PREHI; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154	96	17	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34599	10.1371/journal.pone.0034599	http://dx.doi.org/10.1371/journal.pone.0034599			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511953	Green Published, gold			2022-12-27	WOS:000305338600039
J	Jylhava, J; Lyytikainen, LP; Kahonen, M; Hutri-Kahonen, N; Kettunen, J; Viikari, J; Raitakari, OT; Lehtimaki, T; Hurme, M				Jylhava, Juulia; Lyytikainen, Leo-Pekka; Kahonen, Mika; Hutri-Kahonen, Nina; Kettunen, Johannes; Viikari, Jorma; Raitakari, Olli T.; Lehtimaki, Terho; Hurme, Mikko			A Genome-Wide Association Study Identifies UGT1A1 as a Regulator of Serum Cell-Free DNA in Young Adults: The Cardiovascular Risk in Young Finns Study	PLOS ONE			English	Article							UDP-GLUCURONOSYLTRANSFERASE; EXTRACELLULAR DNA; BILIRUBIN LEVELS; CIRCULATING DNA; IN-VITRO; CLEARANCE; GENE; EXPRESSION; PROTEINS; CHROMATIN	Introduction: Circulating cell-free DNA (cf-DNA) is a useful indicator of cell death, and it can also be used to predict outcomes in various clinical disorders. Several innate immune mechanisms are known to be involved in eliminating DNA and chromatin-related material as part of the inhibition of potentially harmful autoimmune responses. However, the exact molecular mechanism underlying the clearance of circulating cf-DNA is currently unclear. Methods: To examine the mechanisms controlling serum levels of cf-DNA, we carried out a genome-wide association analysis (GWA) in a cohort of young adults (aged 24-39 years; n = 1841; 1018 women and 823 men) participating in the Cardiovascular Risk in Young Finns Study. Genotyping was performed with a custom-built Illumina Human 670 k BeadChip. The Quant-iT (TM) high sensitivity DNA assay was used to measure cf-DNA directly from serum. Results: The results revealed that 110 single nucleotide polymorphisms (SNPs) were associated with serum cf-DNA with genome-wide significance (p<5x10(-8)). All of these significant SNPs were localised to chromosome 2q37, near the UDP-glucuronosyltransferase 1 (UGT1) family locus, and the most significant SNPs localised within the UGT1 polypeptide A1 (UGT1A1) gene region. Conclusion: The UGT1A1 enzyme catalyses the detoxification of several drugs and the turnover of many xenobiotic and endogenous compounds by glucuronidating its substrates. These data indicate that UGT1A1-associated processes are also involved in the regulation of serum cf-DNA concentrations.	[Jylhava, Juulia; Hurme, Mikko] Univ Tampere, Dept Microbiol & Immunol, Sch Med, FIN-33101 Tampere, Finland; [Lyytikainen, Leo-Pekka] Univ Tampere, Dept Clin Chem, Sch Med, FIN-33101 Tampere, Finland; [Lehtimaki, Terho] Tampere Univ Hosp, Dept Clin Chem, FIN-33521 Tampere, Finland; [Kahonen, Mika] Univ Tampere, Dept Clin Physiol, FIN-33101 Tampere, Finland; [Hutri-Kahonen, Nina] Univ Tampere, Dept Pediat, FIN-33101 Tampere, Finland; [Hurme, Mikko] Tampere Univ Hosp, Dept Microbiol, Tampere, Finland; [Kettunen, Johannes] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Viikari, Jorma] Univ Turku, Dept Med, Turku, Finland; [Viikari, Jorma; Raitakari, Olli T.] Turku Univ Hosp, FIN-20520 Turku, Finland; [Raitakari, Olli T.] Univ Turku, Res Ctr Appl & Prevent Cardiovasc Med, Turku, Finland; [Raitakari, Olli T.] Univ Turku, Dept Clin Physiol, Turku, Finland	Tampere University; Tampere University; Tampere University; Tampere University Hospital; Tampere University; Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; University of Turku; University of Turku; University of Turku; University of Turku	Jylhava, J (corresponding author), Univ Tampere, Dept Microbiol & Immunol, Sch Med, FIN-33101 Tampere, Finland.	juulia.jylhava@uta.fi	Lyytikäinen, Leo-Pekka/C-8544-2016; Lehtimäki, Terho/AAD-1094-2022; Raitakari, Olli/AAQ-7389-2021	Lyytikäinen, Leo-Pekka/0000-0002-7200-5455; Lehtimäki, Terho/0000-0002-2555-4427; Jylhava, Juulia/0000-0003-0250-4491; Hurme, Mikko/0000-0002-8614-1044; Kahonen, Mika/0000-0002-4510-7341	Academy of Finland [126925, 121584, 124282, 129378, 117787, 41071]; Social Insurance Institution of Finland; Turku University Foundation; Finnish Cultural Foundation; Yrjo Jahnsson Foundation; Emil Aaltonen Foundation; Medical Research Fund of Tampere University Hospital [9M048]; Turku University Central Hospital Medical Fund; Juho Vainio Foundation; Finnish Foundation for Cardiovascular Research and Tampere Tuberculosis Foundation	Academy of Finland(Academy of Finland); Social Insurance Institution of Finland; Turku University Foundation; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Yrjo Jahnsson Foundation; Emil Aaltonen Foundation; Medical Research Fund of Tampere University Hospital; Turku University Central Hospital Medical Fund; Juho Vainio Foundation; Finnish Foundation for Cardiovascular Research and Tampere Tuberculosis Foundation	The Young Finns Study was financially supported by the Academy of Finland: grants no. 126925, 121584, 124282, 129378 (Salve), 117787 (Gendi), and 41071 (Skidi), the Social Insurance Institution of Finland, the Turku University Foundation, the Finnish Cultural Foundation, the Yrjo Jahnsson Foundation, the Emil Aaltonen Foundation (T.L.), Medical Research Fund of Tampere University Hospital (grant no. 9M048), the Turku University Central Hospital Medical Fund, the Juho Vainio Foundation, and the Finnish Foundation for Cardiovascular Research and Tampere Tuberculosis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atamaniuk J, 2011, NEPHROL DIAL TRANSPL; Aulchenko YS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-134; Barbier O, 2000, DRUG METAB DISPOS, V28, P497; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Botezatu I, 2000, CLIN CHEM, V46, P1078; BURKI E, 1948, OPHTHALMOLOGICA, V115, P241; Burlingame RW, 1996, J IMMUNOL, V156, P4783; Choi JJ, 2005, IMMUNOLOGY, V115, P55, DOI 10.1111/j.1365-2567.2005.02130.x; Decker P, 2005, J IMMUNOL, V174, P3326, DOI 10.4049/jimmunol.174.6.3326; Du Clos TW, 1999, CLIN EXP IMMUNOL, V117, P403; EMLEN W, 1984, CLIN EXP IMMUNOL, V56, P185; Fenton KA, 2007, ANN NY ACAD SCI, V1108, P104, DOI 10.1196/annals.1422.012; Garcia-Olmo D, 2001, ANN NY ACAD SCI, V945, P265; Gauthier VJ, 1996, J IMMUNOL, V156, P1151; Hofmann T, 2010, GENES NUTR, V5, P309, DOI 10.1007/s12263-010-0170-1; Hong AL, 2007, DRUG METAB DISPOS, V35, P1254, DOI 10.1124/dmd.106.014183; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Johnson AD, 2009, HUM MOL GENET, V18, P2700, DOI 10.1093/hmg/ddp202; Kawashima A, 2011, ENDOCRINOLOGY, V152, P1702, DOI 10.1210/en.2010-1132; Lee TH, 2001, TRANSFUSION, V41, P276, DOI 10.1046/j.1537-2995.2001.41020276.x; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lin JP, 2009, ATHEROSCLEROSIS, V206, P228, DOI 10.1016/j.atherosclerosis.2009.02.039; Litvack ML, 2010, INNATE IMMUN-LONDON, V16, P191, DOI 10.1177/1753425910369271; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Nakamura A, 2008, DRUG METAB DISPOS, V36, P1461, DOI 10.1124/dmd.108.021428; Nishimura Y, 2007, BBA-GEN SUBJECTS, V1770, P1557, DOI 10.1016/j.bbagen.2007.07.011; Ohta Y, 2005, HEPATOL RES, V31, P241, DOI 10.1016/j.hepres.2004.12.007; Peters DL, 2011, CLIN CHIM ACTA, V412, P806, DOI 10.1016/j.cca.2011.01.026; Pisetsky DS, 2007, AUTOIMMUNITY, V40, P281, DOI 10.1080/08916930701358826; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raitakari OT, 2008, INT J EPIDEMIOL, V37, P1220, DOI 10.1093/ije/dym225; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Strassburg CP, 2000, J BIOL CHEM, V275, P36164, DOI 10.1074/jbc.M002180200; Teo YY, 2007, BIOINFORMATICS, V23, P2741, DOI 10.1093/bioinformatics/btm443; Tong YK, 2006, CLIN CHIM ACTA, V363, P187, DOI 10.1016/j.cccn.2005.05.048; Tsang JCH, 2007, PATHOLOGY, V39, P197, DOI 10.1080/00313020701230831; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Umetani N, 2006, ANN NY ACAD SCI, V1075, P299, DOI 10.1196/annals.1368.040; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512	42	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e35426	10.1371/journal.pone.0035426	http://dx.doi.org/10.1371/journal.pone.0035426			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511988	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338600074
J	Kieffer, TL; De Meyer, S; Bartels, DJ; Sullivan, JC; Zhang, EZ; Tigges, A; Dierynck, I; Spanks, J; Dorrian, J; Jiang, M; Adiwijaya, B; Ghys, A; Beumont, M; Kauffman, RS; Adda, N; Jacobson, IM; Sherman, KE; Zeuzem, S; Kwong, AD; Picchio, G				Kieffer, Tara L.; De Meyer, Sandra; Bartels, Doug J.; Sullivan, James C.; Zhang, Eileen Z.; Tigges, Ann; Dierynck, Inge; Spanks, Joan; Dorrian, Jennifer; Jiang, Min; Adiwijaya, Bambang; Ghys, Anne; Beumont, Maria; Kauffman, Robert S.; Adda, Nathalie; Jacobson, Ira M.; Sherman, Kenneth E.; Zeuzem, Stefan; Kwong, Ann D.; Picchio, Gaston			Hepatitis C Viral Evolution in Genotype 1 Treatment-Naive and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials	PLOS ONE			English	Article							TERM-FOLLOW-UP; PROTEASE INHIBITOR; RESISTANT VARIANTS; VIRUS; RIBAVIRIN; PEGINTERFERON; COMBINATION; VX-950; RETREATMENT; DISCOVERY	Background: In patients with genotype 1 chronic hepatitis C infection, telaprevir (TVR) in combination with peginterferon and ribavirin (PR) significantly increased sustained virologic response (SVR) rates compared with PR alone. However, genotypic changes could be observed in TVR-treated patients who did not achieve an SVR. Methods: Population sequence analysis of the NS3N4A region was performed in patients who did not achieve SVR with TVR-based treatment. Results: Resistant variants were observed after treatment with a telaprevir-based regimen in 12% of treatment-naive patients (ADVANCE; T12PR arm), 6% of prior relapsers, 24% of prior partial responders, and 51% of prior null responder patients (REALIZE, T12PR48 arms). NS3 protease variants V36M, R155K, and V36M+R155K emerged frequently in patients with genotype 1a and V36A, T54A, and A156S/T in patients with genotype 1b. Lower-level resistance to telaprevir was conferred by V36A/M, T54A/S, R155K/T, and A156S variants; and higher-level resistance to telaprevir was conferred by A156T and V36M+R155K variants. Virologic failure during telaprevir treatment was more common in patients with genotype 1a and in prior PR nonresponder patients and was associated with higher-level telaprevir-resistant variants. Relapse was usually associated with wild-type or lower-level resistant variants. After treatment, viral populations were wild-type with a median time of 10 months for genotype 1a and 3 weeks for genotype 1b patients. Conclusions: A consistent, subtype-dependent resistance profile was observed in patients who did not achieve an SVR with telaprevir-based treatment. The primary role of TVR is to inhibit wild-type virus and variants with lower-levels of resistance to telaprevir. The complementary role of PR is to clear any remaining telaprevir-resistant variants, especially higher-level telaprevir-resistant variants. Resistant variants are detectable in most patients who fail to achieve SVR, but their levels decline over time after treatment.	[Kieffer, Tara L.; Bartels, Doug J.; Sullivan, James C.; Zhang, Eileen Z.; Tigges, Ann; Spanks, Joan; Dorrian, Jennifer; Jiang, Min; Adiwijaya, Bambang; Kauffman, Robert S.; Adda, Nathalie; Kwong, Ann D.] Vertex Pharmaceut Inc, Cambridge, MA USA; [De Meyer, Sandra; Dierynck, Inge; Ghys, Anne; Beumont, Maria] Janssen Infect Dis BVBA, Beerse, Belgium; [Jacobson, Ira M.] Weill Cornell Med Coll, New York, NY USA; [Sherman, Kenneth E.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Zeuzem, Stefan] Goethe Univ Frankfurt, Med Ctr, Frankfurt, Germany; [Picchio, Gaston] Janssen Res & Dev, Titusville, NJ USA	Vertex Pharmaceuticals; Cornell University; University System of Ohio; University of Cincinnati; Goethe University Frankfurt; Johnson & Johnson; Janssen Pharmaceuticals	Kieffer, TL (corresponding author), Vertex Pharmaceut Inc, Cambridge, MA USA.	tara_kieffer@vrtx.com	Zeuzem, Stefan/AAE-7435-2019		Vertex Pharmaceuticals Incorporated; Janssen Pharmaceuticals, Inc.; Abbott; Anadys Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Gilead Sciences; GlobeImmune; Human Genome Sciences; Novartis; Pharmasset; Pfizer; Roche/Genentech; Sanofi-Aventis; Schering-Plough/Merck; Tibotec; ZymoGenetics; Genentech; Gilead; Merck; Vertex Pharmaceuticals; Achillion; Bayer; Santaris	Vertex Pharmaceuticals Incorporated(Vertex Pharmaceuticals); Janssen Pharmaceuticals, Inc.(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Abbott(Abbott Laboratories); Anadys Pharmaceuticals; Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); GlobeImmune; Human Genome Sciences(GlaxoSmithKline); Novartis(Novartis); Pharmasset; Pfizer(Pfizer); Roche/Genentech(Roche HoldingGenentech); Sanofi-Aventis(Sanofi-Aventis); Schering-Plough/Merck(Merck & CompanySchering Plough Corporation); Tibotec; ZymoGenetics; Genentech(Roche HoldingGenentech); Gilead(Gilead Sciences); Merck(Merck & Company); Vertex Pharmaceuticals(Vertex Pharmaceuticals); Achillion; Bayer(Bayer AG); Santaris	This study was funded by Vertex Pharmaceuticals Incorporated (www.vrtx.com) and Janssen Pharmaceuticals, Inc. (http://www.janssenpharmaceuticalsinc.com/). No other funding sources were used.; The authors have read the journal's policy and have the following conflicts: TLK, DJB, JCS, EZZ, AT, JS, JD, MJ, RSK, NA, and ADK are employees and stock owners of Vertex Pharmaceuticals Incorporated. BA was an employee of Vertex Pharmaceuticals at the time this research was performed, is a current Vertex stock owner, and is a current employee of Merrimack Pharmaceuticals. SDM, ID, AG, MB, and GP are employees of Janssen Pharmaceuticals and stock owners of Johnson & Johnson. IMJ has received consulting and lecture fees from Abbott, Anadys Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlobeImmune, Human Genome Sciences, Novartis, Pharmasset, Pfizer, Roche/Genentech, Sanofi-Aventis, Schering-Plough/Merck, Tibotec, Vertex Pharmaceuticals Incorporated, and ZymoGenetics; and grant/research support from Anadys Pharmaceuticals, Boehringer Ingelheim, Gilead Sciences, GlobeImmune, Human Genome Sciences, Novartis, Pharmasset, Roche/Genentech, Schering-Plough/Merck, Tibotec, and Vertex Pharmaceuticals Incorporated. KES has received grant/research support from Anadys Pharmaceuticals, Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Gilead, Merck, Pharmasset, Schering-Plough and Vertex Pharmaceuticals; and is an Advisory or Review Committee Member for Bristol-Myers Squibb, Merck, Pfizer, Fibrogen, Genentech, Tibotec, and Vertex Pharmaceuticals. SZ has received consulting/lecture fees from Abbott, Achillion, Anadys Pharmaceuticals, Bayer, Bristol-Myers Squibb, Gilead Sciences, Human Genome Sciences, Novartis, Pharmasset, Roche/Genentech, Santaris, Schering-Plough/Merck, Tibotec and Vertex Pharmaceuticals. None of the aforementioned commercial grant/research support was used for this specific study. Telaprevir was used in this study and is a drug that was co-developed by Vertex and Johnson. There are no other patents, products in development, or other marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Bartels DJ, 2008, J INFECT DIS, V198, P800, DOI 10.1086/591141; de Bruijne J, 2010, ANT C AMST NETH; De Meyer S, 2011, J HEPATOL, V54, pS475, DOI 10.1016/S0168-8278(11)61204-X; Hezode C, 2009, NEW ENGL J MED, V360, P1839, DOI 10.1056/NEJMoa0807650; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Janssen-Cilag Beerse Belgium, 2011, JANSS CIL BEERS BELG; Kieffer TL, 2010, REV ANTIVIRAL THERAP, V5, P6; Kwong AD, 2011, NAT BIOTECHNOL, V29, P993, DOI 10.1038/nbt.2020; Lin C, 2004, J BIOL CHEM, V279, P17508, DOI 10.1074/jbc.M313020200; Lin K, 2006, ANTIMICROB AGENTS CH, V50, P1813, DOI 10.1128/AAC.50.5.1813-1822.2006; Locarnini S, 2004, SEMIN LIVER DIS, V24, P3, DOI 10.1055/s-2004-828672; Marcellin P, 2011, GASTROENTEROLOGY, V140, P459, DOI 10.1053/j.gastro.2010.10.046; McHutchison JG, 2010, NEW ENGL J MED, V362, P1647; McHutchison JG, 2009, NEW ENGL J MED, V361, P1516; McHutchison JG, 2010, NEW ENGL J MED, V362, P1292, DOI 10.1056/NEJMoa0908014; McHutchison JG, 2009, NEW ENGL J MED, V360, P1827, DOI 10.1056/NEJMoa0806104; Muir AJ, 2011, HEPATOLOGY, V54, P1538, DOI 10.1002/hep.24549; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; OGATA N, 1991, P NATL ACAD SCI USA, V88, P3392, DOI 10.1073/pnas.88.8.3392; Perni RB, 2006, ANTIMICROB AGENTS CH, V50, P899, DOI 10.1128/AAC.50.3.899-909.2006; Ray SC, 2009, MANDELL DOUGLAS BENN, P2157; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Sarrazin C, 2007, GASTROENTEROLOGY, V132, P1767, DOI 10.1053/j.gastro.2007.02.037; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Siliciano JD, 2004, J ANTIMICROB CHEMOTH, V54, P6, DOI 10.1093/jac/dkh292; Sullivan JC, 2011, J HEPATOL, V54, pS4, DOI 10.1016/S0168-8278(11)60010-X; Thomas XV, 2011, J HEPATOL, V54, pS490, DOI 10.1016/S0168-8278(11)61244-0; Vertex Pharmaceuticals Incorporated Cambridge MA, 2011, INCIVEK US PROD INS; Vertex Pharmaceuticals Incorporated Cambridge MA, 2011, INCIVEK CAN PROD MON; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086; Zeuzem S, 2010, HEPATOLOGY, V52, p436A; Zhang EZ, 2008, HEPATOLOGY, V48, p1138A	33	78	80	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34372	10.1371/journal.pone.0034372	http://dx.doi.org/10.1371/journal.pone.0034372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511937	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338600023
J	Coriat, R; Lecler, A; Lamarque, D; Deyra, J; Roche, H; Nizou, C; Berretta, O; Mesnard, B; Bouygues, M; Soupison, A; Monnin, JL; Podevin, P; Cassaz, C; Sautereau, D; Prat, F; Chaussade, S				Coriat, Romain; Lecler, Augustin; Lamarque, Dominique; Deyra, Jacques; Roche, Herve; Nizou, Catherine; Berretta, Olivier; Mesnard, Bruno; Bouygues, Martin; Soupison, Alain; Monnin, Jean-Luc; Podevin, Philippe; Cassaz, Carole; Sautereau, Denis; Prat, Frederic; Chaussade, Stanislas			Quality Indicators for Colonoscopy Procedures: A Prospective Multicentre Method for Endoscopy Units	PLOS ONE			English	Article							ADENOMA DETECTION RATE; COLORECTAL-CANCER; INCOMPLETE COLONOSCOPY; RISK; TRANSMISSION; PREVENTION; INTERVAL; RATES	Background and Aims: Healthcare professionals are required to conduct quality control of endoscopy procedures, and yet there is no standardised method for assessing quality. The topic of the present study was to validate the applicability of the procedure in daily practice, giving physicians the ability to define areas for continuous quality improvement. Methods: In ten endoscopy units in France, 200 patients per centre undergoing colonoscopy were enrolled in the study. An evaluation was carried out based on a prospectively developed checklist of 10 quality-control indicators including five dependent upon and five independent of the colonoscopy procedure. Results: Of the 2000 procedures, 30% were done at general hospitals, 20% at university hospitals, and 50% in private practices. The colonoscopies were carried out for a valid indication for 95.9% (range 92.5-100). Colon preparation was insufficient in 3.7% (range 1-10.5). Colonoscopies were successful in 95.3% (range 81-99). Adenoma detection rate was 0.31 (range 0.17-0.45) in successful colonoscopies. Conclusion: This tool for evaluating the quality of colonoscopy procedures in healthcare units is based on standard endoscopy and patient criteria. It is an easy and feasible procedure giving the ability to detect suboptimal practice and differences between endoscopy-units. It will enable individual units to assess the quality of their colonoscopy techniques.	[Coriat, Romain; Lecler, Augustin; Prat, Frederic; Chaussade, Stanislas] GHU Ouest, Hop Cochin, Serv Gastroenterol, Paris, France; [Coriat, Romain; Lamarque, Dominique; Cassaz, Carole; Prat, Frederic; Chaussade, Stanislas] Univ Paris 05, Paris, France; [Lamarque, Dominique; Cassaz, Carole] GHU Ouest, Hop Hotel Dieu, Serv Gastroenterol, Paris, France; [Deyra, Jacques] URC Cochin, Unite Rech Clin, Paris, France; [Roche, Herve] Hop Prive Versailles, Versailles, France; [Nizou, Catherine] Hop Instruct Armees Begin, Serv Gastroenterol, St Mande, France; [Berretta, Olivier] Clin Chirurg Chelles, Chelles, France; [Mesnard, Bruno] Ctr Hosp Tourcoing, Serv Gastroenterol, Tourcoing, France; [Bouygues, Martin] Clin Pre, Le Mans, France; [Soupison, Alain] Ctr Hosp William Morey, Serv Gastroenterol, Chalon Sur Saone, France; [Monnin, Jean-Luc] Clin Med Chirurg, St Jean De Vedas, France; [Podevin, Philippe] Ctr Hosp Provins, Serv Gastroenterol, Provins, France; [Sautereau, Denis] Hop Univ, Serv Gastroenterol, Limoges, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; CHU Limoges	Coriat, R (corresponding author), GHU Ouest, Hop Cochin, Serv Gastroenterol, Paris, France.	romain.coriat@cch.aphp.fr	Coriat, Romain/O-7902-2017	Lecler, Augustin/0000-0001-7869-1815	Societe Nationale Francaise de Gastro-Enterologie (SNFGE)	Societe Nationale Francaise de Gastro-Enterologie (SNFGE)	This study was supported by a Societe Nationale Francaise de Gastro-Enterologie 2009 grant (SNFGE) for research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aminalai A, 2010, AM J GASTROENTEROL; ANAES, 2005, ONCOLOGIE, V7, P70; Baxter NN, 2009, ANN INTERN MED, V150, P1, DOI 10.7326/0003-4819-150-1-200901060-00306; Benson M, 2010, AM J GASTROENTEROL; Brenner H, 2011, GUT; Brenner H, 2011, ANN INTERN MED, V154, P22, DOI 10.7326/0003-4819-154-1-201101040-00004; Bressler B, 2004, GASTROENTEROLOGY, V127, P452, DOI 10.1053/j.gastro.2004.05.032; Bressler B, 2007, GASTROENTEROLOGY, V132, P96, DOI 10.1053/j.gastro.2006.10.027; Bronowicki JP, 1997, NEW ENGL J MED, V337, P237, DOI 10.1056/NEJM199707243370404; Church J, 2008, DIS COLON RECTUM, V51, P520, DOI 10.1007/s10350-008-9239-y; Cooper GS, 2007, GASTROENTEROLOGY, V132, P2588, DOI 10.1053/j.gastro.2007.04.028; Coriat R, 2009, GASTROEN CLIN BIOL, V33, P103, DOI 10.1016/j.gcb.2008.04.038; Crispin A, 2009, ENDOSCOPY, V41, P1018, DOI 10.1055/s-0029-1215214; de Pedro-Cuesta J, 2011, J NEUROL NEUROSUR PS, V82, P204, DOI 10.1136/jnnp.2009.188425; EIDE TJ, 1986, INT J CANCER, V38, P173, DOI 10.1002/ijc.2910380205; Fatima H, 2010, GASTROINTEST ENDOSC, V71, P1244, DOI 10.1016/j.gie.2009.11.053; Harewood GC, 2003, GASTROINTEST ENDOSC, V58, P76, DOI 10.1067/mge.2003.294; Harris JK, 2007, SCAND J GASTROENTERO, V42, P126, DOI 10.1080/00365520600815647; Huffman M, 2010, GASTROINTEST ENDOSC, V72, P516, DOI 10.1016/j.gie.2010.03.1125; JEMAL A, 2010, CA CANC J CLIN; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; Lieberman D, 2006, NEW ENGL J MED, V355, P2588, DOI 10.1056/NEJMe068254; Millan MS, 2008, DIS COLON RECTUM, V51, P1217, DOI 10.1007/s10350-008-9315-3; Minoli G, 1999, ENDOSCOPY, V31, P522; Neerincx M, 2010, ENDOSCOPY, V42, P730, DOI 10.1055/s-0030-1255523; Pabby A, 2005, GASTROINTEST ENDOSC, V61, P385, DOI 10.1016/S0016-5107(04)02765-8; Pickhardt PJ, 2004, ANN INTERN MED, V141, P352, DOI 10.7326/0003-4819-141-5-200409070-00009; Rex DK, 2006, GASTROINTEST ENDOSC, V63, pS16, DOI 10.1016/j.gie.2006.02.021; Rex DK, 2002, AM J GASTROENTEROL, V97, P1296, DOI 10.1016/S0002-9270(02)04168-0; Rex DK, 2000, GASTROINTEST ENDOSC, V51, P33, DOI 10.1016/S0016-5107(00)70383-X; Rex DK, 2006, AM J GASTROENTEROL, V101, P2866, DOI 10.1111/j.1572-0241.2006.00905.x; Robertson DJ, 2005, GASTROENTEROLOGY, V129, P34, DOI 10.1053/j.gastro.2005.05.012; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Shah HA, 2007, GASTROENTEROLOGY, V132, P2297, DOI 10.1053/j.gastro.2007.03.032; Singh H, 2006, JAMA-J AM MED ASSOC, V295, P2366, DOI 10.1001/jama.295.20.2366; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701	39	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e33957	10.1371/journal.pone.0033957	http://dx.doi.org/10.1371/journal.pone.0033957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509267	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336600017
J	Covey, TM; Kaur, S; Ong, TT; Proffitt, KD; Wu, YH; Tan, P; Virshup, DM				Covey, Tracy M.; Kaur, Simran; Ong, Tina Tan; Proffitt, Kyle D.; Wu, Yonghui; Tan, Patrick; Virshup, David M.			PORCN Moonlights in a Wnt-Independent Pathway That Regulates Cancer Cell Proliferation	PLOS ONE			English	Article							FOCAL DERMAL HYPOPLASIA; POLARITY GENE PORCUPINE; SECRETION; PROTEINS; EXPRESSION; APOPTOSIS; HOMOLOG; LIGANDS; GROWTH	Porcupine (PORCN) is a membrane-bound O-acyl transferase that is required for the palmitoylation of Wnt proteins, and that is essential in diverse Wnt pathways for Wnt-Wntless (WLS) binding, Wnt secretion, and Wnt signaling activity. We tested if PORCN was required for the proliferation of transformed cells. Knockdown of PORCN by multiple independent siRNAs results in a cell growth defect in a subset of epithelial cancer cell lines. The growth defect is transformation-dependent in human mammary epithelial (HMEC) cells. Additionally, inducible PORCN knockdown by two independent shRNAs markedly reduces the growth of established MDA-MB-231 cancers in orthotopic xenografts in immunodeficient mice. Unexpectedly, the proliferation defect resulting from loss of PORCN occurs in a Wnt-independent manner, as it is rescued by re-expression of catalytically inactive PORCN, and is not seen after RNAi-mediated knockdown of the Wnt carrier protein WLS, nor after treatment with the PORCN inhibitor IWP. Consistent with a role in a Wnt-independent pathway, knockdown of PORCN regulates a distinct set of genes that are not altered by other inhibitors of Wnt signaling. PORCN protein thus appears to moonlight in a novel signaling pathway that is rate-limiting for cancer cell growth and tumorigenesis independent of its enzymatic function in Wnt biosynthesis and secretion.	[Covey, Tracy M.; Kaur, Simran; Ong, Tina Tan; Proffitt, Kyle D.; Wu, Yonghui; Tan, Patrick; Virshup, David M.] Duke NUS Grad Med Sch, Singapore, Singapore; [Virshup, David M.] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Virshup, David M.] Duke Univ, Dept Pediat, Durham, NC 27706 USA	National University of Singapore; National University of Singapore; Duke University	Covey, TM (corresponding author), Duke NUS Grad Med Sch, Singapore, Singapore.	david.virshup@duke-nus.edu.sg	Wu, Yonghui/HGA-8662-2022; Virshup, David M/C-1449-2009	Virshup, David M/0000-0001-6976-850X; Kaur, Simran/0000-0003-1510-928X; Wu, Yonghui/0000-0003-1655-510X	Duke-NUS; Singapore Translational Research (STaR) Investigator Award; Agency for Science, Technology and Research, Singapore; Ministry of Health, Singapore	Duke-NUS; Singapore Translational Research (STaR) Investigator Award; Agency for Science, Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR)); Ministry of Health, Singapore(Ministry of Health-Singapore)	This research was supported by the Duke-NUS Signature Research Program and the Singapore Translational Research (STaR) Investigator Award (to DMV) funded by the Agency for Science, Technology and Research, Singapore, and the Ministry of Health, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barrott JJ, 2011, P NATL ACAD SCI USA, V108, P12752, DOI 10.1073/pnas.1006437108; Bartling B, 2010, INT J ONCOL, V36, P1015, DOI 10.3892/ijo_00000582; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Benhaj K, 2006, ONCOL REP, V15, P701; Biechele S, 2011, DEV BIOL, V355, P275, DOI 10.1016/j.ydbio.2011.04.029; Caricasole A, 2002, GENE, V288, P147, DOI 10.1016/S0378-1119(02)00467-5; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen Z, 2008, ONCOGENE, V27, P3483, DOI 10.1038/sj.onc.1211006; Ching W, 2006, CELL, V125, P432, DOI 10.1016/j.cell.2006.04.018; Coombs GS, 2008, CURR DRUG TARGETS, V9, P513, DOI 10.2174/138945008784911796; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Cox BJ, 2010, GENOME RES, V20, P1154, DOI 10.1101/gr.105106.110; Doubravska L, 2011, CELL SIGNAL, V23, P837, DOI 10.1016/j.cellsig.2011.01.007; Froyen G, 2009, CLIN GENET, V76, P535, DOI 10.1111/j.1399-0004.2009.01248.x; Fu JA, 2011, DEV DYNAM, V240, P365, DOI 10.1002/dvdy.22541; Galli LM, 2007, DEVELOPMENT, V134, P3339, DOI 10.1242/dev.02881; Galli LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026636; Grzeschik KH, 2007, NAT GENET, V39, P833, DOI 10.1038/ng2052; He B, 2004, NEOPLASIA, V6, P7, DOI 10.1016/S1476-5586(04)80048-4; Herr P, 2011, DEV BIOL; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Matsuda Y, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2317; McCulloch MWB, 2009, BIOORGAN MED CHEM, V17, P2189, DOI 10.1016/j.bmc.2008.10.077; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; RAJAGOPALAN S, 1994, SCIENCE, V263, P387, DOI 10.1126/science.8278814; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; Wang XL, 2007, NAT GENET, V39, P836, DOI 10.1038/ng2057; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; WITHEILER J, 1972, J BIOL CHEM, V247, P2217; Yang W, 2011, NATURE; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	38	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34532	10.1371/journal.pone.0034532	http://dx.doi.org/10.1371/journal.pone.0034532			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509316	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336600033
J	Cuevasanta, E; Denicola, A; Alvarez, B; Moller, MN				Cuevasanta, Ernesto; Denicola, Ana; Alvarez, Beatriz; Moeller, Matias N.			Solubility and Permeation of Hydrogen Sulfide in Lipid Membranes	PLOS ONE			English	Article							NITRIC-OXIDE; BILAYER-MEMBRANES; CARBON-DIOXIDE; DRUG DISCOVERY; PERMEABILITY; DIFFUSION; TRANSPORT; OXYGEN; NEUROMODULATOR; RULE	Hydrogen sulfide (H2S) is mainly known for its toxicity but has recently been shown to be produced endogenously in mammalian tissues and to be associated with physiological regulatory functions. To better understand the role of biomembranes in modulating its biological distribution and effects; we measured the partition coefficient of (HS)-S-2 in models of biological membranes. The partition coefficients were found to be 2.1 +/- 0.2, 1.9 +/- 0.5 and 2.0 +/- 0.6 in n-octanol, hexane and dilauroylphosphatidylcholine liposome membranes relative to water, respectively (25 degrees C). This two-fold higher concentration of H2S in the membrane translates into a rapid membrane permeability, P-m = 3 cm s(-1). We used a mathematical model in three dimensions to gain insight into the diffusion of total sulfide in tissues. This model shows that the sphere of action of sulfide produced by a single cell expands to involve more than 200 neighboring cells, and that the resistance imposed by lipid membranes has a significant effect on the diffusional spread of sulfide at pH 7.4, increasing local concentrations. These results support the role of hydrogen sulfide as a paracrine signaling molecule and reveal advantageous pharmacokinetic properties for its therapeutic applications.	[Cuevasanta, Ernesto; Alvarez, Beatriz] Univ Republica, Fac Ciencias, Lab Enzimol, Montevideo, Uruguay; [Cuevasanta, Ernesto; Denicola, Ana; Alvarez, Beatriz; Moeller, Matias N.] Univ Republica, Ctr Free Rad & Biomed Res, Montevideo, Uruguay; [Denicola, Ana; Moeller, Matias N.] Univ Republica, Fac Ciencias, Lab Fisicoquim Biol, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Cuevasanta, E (corresponding author), Univ Republica, Fac Ciencias, Lab Enzimol, Montevideo, Uruguay.	beatriz.alvarez@fcien.edu.uy; mmoller@fcien.edu.uy		Moller, Matias N./0000-0002-3486-8217; Alvarez, Beatriz/0000-0001-6911-3132; Denicola, Ana/0000-0002-5181-9708	CSIC (Universidad de la Republica, Uruguay); ANII (Uruguay) [BE_INI_2008_55]	CSIC (Universidad de la Republica, Uruguay); ANII (Uruguay)	This work was supported by grants from CSIC (Universidad de la Republica, Uruguay, to Dr. Alvarez and Dr. Denicola). Dr. Cuevasanta was supported by a fellowship from ANII (BE_INI_2008_55, Uruguay). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1996, J NEUROSCI, V16, P1066; BATTINO R, 1983, J PHYS CHEM REF DATA, V12, P163, DOI 10.1063/1.555680; Calvert JW, CIRCULATION, V122, P11; Carballal S, 2011, FREE RADICAL BIO MED, V50, P196, DOI 10.1016/j.freeradbiomed.2010.10.705; Carslaw HS, 1959, USE SOURCES SINKS CA; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Cotton F, 1988, ADV INORG CHEM RAD, P620; Elrod JW, 2007, P NATL ACAD SCI USA, V104, P15560, DOI 10.1073/pnas.0705891104; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; GUTKNECHT J, 1981, BIOCHIM BIOPHYS ACTA, V641, P183, DOI 10.1016/0005-2736(81)90582-4; Kerns EH, 2001, J PHARM SCI-US, V90, P1838, DOI 10.1002/jps.1134; Lancaster JR, 1997, NITRIC OXIDE-BIOL CH, V1, P18, DOI 10.1006/niox.1996.0112; LANCASTER JR, 1994, P NATL ACAD SCI USA, V91, P8137, DOI 10.1073/pnas.91.17.8137; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu XP, 1998, P NATL ACAD SCI USA, V95, P2175, DOI 10.1073/pnas.95.5.2175; MALINSKI T, 1993, BIOCHEM BIOPH RES CO, V193, P1076, DOI 10.1006/bbrc.1993.1735; Mathai JC, 2009, P NATL ACAD SCI USA, V106, P16633, DOI 10.1073/pnas.0902952106; Missner A, 2008, J BIOL CHEM, V283, P25340, DOI 10.1074/jbc.M800096200; Missner A, 2009, CHEMPHYSCHEM, V10, P1405, DOI 10.1002/cphc.200900270; Molinspiration, 2011, CALC MOL PROP BIOACT; Moller M, 2005, J BIOL CHEM, V280, P8850, DOI 10.1074/jbc.M413699200; Moller MN, 2007, IUBMB LIFE, V59, P243, DOI 10.1080/15216540701311147; Moller MN, 2007, CHEM RES TOXICOL, V20, P709, DOI 10.1021/tx700010h; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; National Institute of Standards and Technology, 2011, NIST CHEM; NEW RRC, LIPOSOMES PRACTICAL, P1; PETERSEN LC, 1977, BIOCHIM BIOPHYS ACTA, V460, P299, DOI 10.1016/0005-2728(77)90216-X; REIFFENSTEIN RJ, 1992, ANNU REV PHARMACOL, V32, P109, DOI 10.1146/annurev.pa.32.040192.000545; Sander R, 1999, COMPILATION HENRYS L; Saparov SM, 2006, BIOPHYS J, V90, pL86, DOI 10.1529/biophysj.106.084343; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; SIEGEL LM, 1965, ANAL BIOCHEM, V11, P126, DOI 10.1016/0003-2697(65)90051-5; SIMON SA, 1980, BIOCHIM BIOPHYS ACTA, V596, P352, DOI 10.1016/0005-2736(80)90122-4; Subczynski WK, 1996, FREE RADICAL RES, V24, P343, DOI 10.3109/10715769609088032; TAMIMI A, 1994, J CHEM ENG DATA, V39, P330, DOI 10.1021/je00014a031; WALTER A, 1986, J MEMBRANE BIOL, V90, P207, DOI 10.1007/BF01870127; Whitfield NL, 2008, AM J PHYSIOL-REG I, V294, pR1930, DOI 10.1152/ajpregu.00025.2008; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	39	97	100	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34562	10.1371/journal.pone.0034562	http://dx.doi.org/10.1371/journal.pone.0034562			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509322	gold, Green Submitted, Green Published			2022-12-27	WOS:000305336600036
J	Dahlman, KB; Parker, JS; Shamu, T; Hieronymus, H; Chapinski, C; Carver, B; Chang, K; Hannon, GJ; Sawyers, CL				Dahlman, Kimberly Brown; Parker, Joel S.; Shamu, Tambudzai; Hieronymus, Haley; Chapinski, Caren; Carver, Brett; Chang, Kenneth; Hannon, Gregory J.; Sawyers, Charles L.			Modulators of Prostate Cancer Cell Proliferation and Viability Identified by Short-Hairpin RNA Library Screening	PLOS ONE			English	Article							ANDROGEN RECEPTOR; ANTITUMOR-ACTIVITY; PATHWAY; DOCETAXEL; MITOXANTRONE; PREDNISONE; ACTIVATION; PTEN/MMAC1; INACTIVATION; ANTIANDROGEN	There is significant need to identify novel prostate cancer drug targets because current hormone therapies eventually fail, leading to a drug-resistant and fatal disease termed castration-resistant prostate cancer. To functionally identify genes that, when silenced, decrease prostate cancer cell proliferation or induce cell death in combination with antiandrogens, we employed an RNA interference-based short hairpin RNA barcode screen in LNCaP human prostate cancer cells. We identified and validated four candidate genes (AKT1, PSMC1, STRADA, and TTK) that impaired growth when silenced in androgen receptor positive prostate cancer cells and enhanced the antiproliferative effects of antiandrogens. Inhibition of AKT with a pharmacologic inhibitor also induced apoptosis when combined with antiandrogens, consistent with recent evidence for PI3K and AR pathway crosstalk in prostate cancer cells. Recovery of hairpins targeting a known prostate cancer pathway validates the utility of shRNA library screening in prostate cancer as a broad strategy to identify new candidate drug targets.	[Dahlman, Kimberly Brown; Shamu, Tambudzai; Hieronymus, Haley; Chapinski, Caren; Sawyers, Charles L.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Carver, Brett] Mem Sloan Kettering Canc Ctr, Dept Urol, New York, NY 10021 USA; [Parker, Joel S.] Express Anal Inc, Durham, NC USA; [Chang, Kenneth; Hannon, Gregory J.] Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Hannon, Gregory J.; Sawyers, Charles L.] Howard Hughes Med Inst, Chevy Chase, MD USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Dahlman, KB (corresponding author), Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	sawyersc@mskcc.org	Hannon, Gregory/AAB-3568-2019; Sawyers, Charles/G-5327-2016; Parker, Joel/AAG-1108-2019	Shamu, Tambudzai/0000-0001-8944-8079	AACR-Amgen, Inc.; Prostate Cancer Foundation; Howard Hughes Medical Institute; National Cancer Institute; NATIONAL CANCER INSTITUTE [P30CA045508, P30CA016086] Funding Source: NIH RePORTER	AACR-Amgen, Inc.; Prostate Cancer Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by AACR-Amgen, Inc. Fellowship in Clinical and Translational Research(KBD); Prostate Cancer Foundation (www.pcf.org) (BSC); Howard Hughes Medical Institute(www.hhmi.org) (CLS); National Cancer Institute(www.cancer.gov) (CLS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CLS is a co-inventor of MDV3100 and owns stock in Medivation. KBD was supported by AACR-Amgen, Inc. while this work was being performed. JSP is employed by Expression Analysis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The remaining authors have declared that no competing interests exist.	Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Agoulnik IU, 2006, J CELL BIOCHEM, V99, P362, DOI 10.1002/jcb.20811; Antonarakis ES, 2010, CANCER LETT, V291, P1, DOI 10.1016/j.canlet.2009.08.012; Balk SP, 2002, UROLOGY, V60, P132, DOI 10.1016/S0090-4295(02)01593-5; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Cairns P, 1997, CANCER RES, V57, P4997; Carver BS, 2011, CANCER CELL, V19, P575, DOI 10.1016/j.ccr.2011.04.008; Chen CD, 2004, NAT MED, V10, P33, DOI 10.1038/nm972; Chen Y, 2008, CURR OPIN PHARMACOL, V8, P440, DOI 10.1016/j.coph.2008.07.005; Cinar B, 2007, J BIOL CHEM, V282, P29584, DOI 10.1074/jbc.M703310200; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; de Bono JS, 2010, LANCET, V376, P1147, DOI 10.1016/S0140-6736(10)61389-X; Ghosh PM, 2005, ENDOCR-RELAT CANCER, V12, P119, DOI 10.1677/erc.1.00835; Institute NC, 2010, PROST CANC; Janssen A, 2009, P NATL ACAD SCI USA, V106, P19108, DOI 10.1073/pnas.0904343106; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Lin JQ, 1999, CANCER RES, V59, P2891; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Petrylak DP, 2004, NEW ENGL J MED, V351, P1513, DOI 10.1056/NEJMoa041318; Rathkopf D, 2010, CLIN CANC RES; Reid AHM, 2010, J CLIN ONCOL, V28, P1489, DOI 10.1200/JCO.2009.24.6819; Sarker D, 2009, CLIN CANCER RES, V15, P4799, DOI 10.1158/1078-0432.CCR-08-0125; Scher HI, 2010, LANCET, V375, P1437, DOI 10.1016/S0140-6736(10)60172-9; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Silva JM, 2008, SCIENCE, V319, P617, DOI 10.1126/science.1149185; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Suzuki H, 1998, CANCER RES, V58, P204; Tannock IF, 2004, NEW ENGL J MED, V351, P1502, DOI 10.1056/NEJMoa040720; Taplin ME, 2007, NAT CLIN PRACT ONCOL, V4, P236, DOI 10.1038/ncponc0765; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Trials.gov C, 2010, SAF PHARM PROOF OF C; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Wang Y, 2007, ONCOGENE, V26, P6061, DOI 10.1038/sj.onc.1210435; Whang YE, 1998, P NATL ACAD SCI USA, V95, P5246, DOI 10.1073/pnas.95.9.5246	38	18	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34414	10.1371/journal.pone.0034414	http://dx.doi.org/10.1371/journal.pone.0034414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509301	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000305336600031
J	Huang, M; Li, H; Zhang, L; Gao, F; Wang, P; Hu, Y; Yan, SH; Zhao, L; Zhang, Q; Tan, JJ; Liu, XC; He, SB; Li, LJ				Huang, Min; Li, Hui; Zhang, Lu; Gao, Fei; Wang, Pu; Hu, Yong; Yan, Shihan; Zhao, Lin; Zhang, Qi; Tan, Junjun; Liu, Xincheng; He, Shibin; Li, Lijia			Plant 45S rDNA Clusters Are Fragile Sites and Their Instability Is Associated with Epigenetic Alterations	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; POLYMERASE-II TRANSCRIPTION; DOUBLE-STRAND BREAKS; EXTENDED DNA FIBERS; ACTINOMYCIN-D; CHROMATIN DECONDENSATION; CELL-CYCLE; MITOSIS; REPLICATION; CHROMOSOMES	Our previous study demonstrated that 45S ribosomal DNA (45S rDNA) clusters were chromosome fragile sites expressed spontaneously in Lolium. In this study, fragile phenotypes of 45S rDNA were observed under aphidicolin (APH) incubation in several plant species. Further actinomycin D (ActD) treatment showed that transcriptional stress might interfere with chromatin packaging, resulting in 45S rDNA fragile expression. These data identified 45S rDNA sites as replication-dependent as well as transcription-dependent fragile sites in plants. In the presence of ActD, a dramatic switch to an open chromatin conformation and accumulated incomplete 59 end of the external transcribed spacer (5'ETS) transcripts were observed, accompanied by decreased DNA methylation, decreased levels of histone H3, and increased histone acetylation and levels of H3K4me2, suggesting that these epigenetic alterations are associated with failure of 45S rDNA condensation. Furthermore, the finding that gamma-H2AX was accumulated at 45S rDNA sites following ActD treatment suggested that the DNA damage signaling pathway was associated with the appearance of 45S rDNA fragile phenotypes. Our data provide a link between 45S rDNA transcription and chromatin-packaging defects and open the door for further identifying the molecular mechanism involved.	[Huang, Min; Li, Hui; Zhang, Lu; Gao, Fei; Wang, Pu; Hu, Yong; Yan, Shihan; Zhao, Lin; Zhang, Qi; Tan, Junjun; Liu, Xincheng; He, Shibin; Li, Lijia] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China	Wuhan University	Huang, M (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	ljli@whu.edu.cn		Yan, Shihan/0000-0001-9814-769X	National Natural Science Foundation of China [30870261, 31171186]; Research Fund for the Doctoral Program of Higher Education [20090141110031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by the National Natural Science Foundation of China (nos. 30870261 and 31171186) and the Research Fund for the Doctoral Program of Higher Education (no. 20090141110031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPELS R, 1980, CHROMOSOMA, V78, P293, DOI 10.1007/BF00327389; Arlt MF, 2003, CYTOGENET GENOME RES, V100, P92, DOI 10.1159/000072843; Arlt MF, 2004, MOL CELL BIOL, V24, P6701, DOI 10.1128/mcb.24.15.6701-6709.2004; BUTLER DK, 1992, GENETICS, V131, P581; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cazaux B, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-124; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; Dillon LW, 2010, CURR GENOMICS, V11, P326, DOI 10.2174/138920210791616699; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Espada J, 2007, NUCLEIC ACIDS RES, V35, P2191, DOI 10.1093/nar/gkm118; FUKUEI K, 1977, PLANT CELL PHYSIOL, V18, P173; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; Glover TW, 2006, CANCER LETT, V232, P4, DOI 10.1016/j.canlet.2005.08.032; GLOVER TW, 1984, HUM GENET, V67, P136, DOI 10.1007/BF00272988; Haaf T, 1996, EXP CELL RES, V224, P163, DOI 10.1006/excr.1996.0124; HADJIOLOVA KV, 1995, EUR J BIOCHEM, V228, P605, DOI 10.1111/j.1432-1033.1995.tb20300.x; Hanson RE, 1996, CHROMOSOMA, V105, P55, DOI 10.1007/BF02510039; Haring M, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-11; Hernandez-Verdun D, 2006, HISTOCHEM CELL BIOL, V125, P127, DOI 10.1007/s00418-005-0046-4; Ho CY, 2010, J CELL BIOCHEM, V110, P725, DOI 10.1002/jcb.22583; HOWELL WM, 1980, EXPERIENTIA, V36, P1014, DOI 10.1007/BF01953855; Hu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022132; Huang J, 2009, PROTOPLASMA, V236, P59, DOI 10.1007/s00709-009-0051-x; Huang J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002167; Huebner K, 2001, NAT REV CANCER, V1, P214, DOI 10.1038/35106058; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; Jasencakova Z, 2000, PLANT CELL, V12, P2087, DOI 10.1105/tpc.12.11.2087; JAXEL C, 1988, BIOCHEMISTRY-US, V27, P95, DOI 10.1021/bi00401a016; Kobayashi T, 2006, GENES GENET SYST, V81, P155, DOI 10.1266/ggs.81.155; Kruhlak MJ, 2006, J CELL BIOL, V172, P823, DOI 10.1083/jcb.200510015; Lemoine FJ, 2008, MOL CELL BIOL, V28, P5359, DOI 10.1128/MCB.02084-07; Li LJ, 2005, CYTOM PART A, V63A, P114, DOI 10.1002/cyto.a.20111; Li LJ, 1998, HEREDITAS, V129, P101, DOI 10.1111/j.1601-5223.1998.00101.x; Li LJ, 2001, THEOR APPL GENET, V102, P658, DOI 10.1007/s001220051694; Li Y, 2005, PLANT J, V41, P346, DOI 10.1111/j.1365-313X.2004.02301.x; Li ZJ, 1998, J VIROL, V72, P4183, DOI 10.1128/JVI.72.5.4183-4191.1998; Li ZY, 2006, BIOCELL, V30, P27; Lim KY, 2000, CHROMOSOMA, V109, P161; Liu B, 2009, J GENET GENOMICS, V36, P519, DOI 10.1016/S1673-8527(08)60143-5; Matyasek R, 2007, GENETICS, V176, P2509, DOI 10.1534/genetics.107.072751; McGowan PO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002085; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Merz K, 2008, GENE DEV, V22, P1190, DOI 10.1101/gad.466908; Mischo HE, 2005, J BIOL CHEM, V280, P9586, DOI 10.1074/jbc.M411444200; OHNUKI Y, 1968, CHROMOSOMA, V25, P402, DOI 10.1007/BF02327721; PATHAK S, 1975, CHROMOSOMA, V50, P79; PEACOCK WJ, 1981, P NATL ACAD SCI-BIOL, V78, P4490, DOI 10.1073/pnas.78.7.4490; Probst AV, 2004, PLANT CELL, V16, P1021, DOI 10.1105/tpc.018754; Ragland RL, 2008, GENE CHROMOSOME CANC, V47, P860, DOI 10.1002/gcc.20591; ROBERTFORTEL I, 1993, CHROMOSOMA, V102, P146, DOI 10.1007/BF00387729; Roussel P, 1996, J CELL BIOL, V133, P235, DOI 10.1083/jcb.133.2.235; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; SCHUBERT I, 1985, CHROMOSOMA, V92, P143, DOI 10.1007/BF00328466; Seijo JG, 2004, AM J BOT, V91, P1294, DOI 10.3732/ajb.91.9.1294; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Siroky J, 2003, CHROMOSOMA, V112, P116, DOI 10.1007/s00412-003-0251-7; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Taketa S, 2005, ANN BOT-LONDON, V96, P23, DOI 10.1093/aob/mci147; Thomas HM, 2001, CHROMOSOME RES, V9, P585, DOI 10.1023/A:1012499303514; Thomas HM, 1996, CHROMOSOME RES, V4, P486, DOI 10.1007/BF02261775; Toledo F, 2000, NUCLEIC ACIDS RES, V28, P4805, DOI 10.1093/nar/28.23.4805; Tsagkogeorga G, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-187; Wang YH, 2006, CANCER LETT, V232, P70, DOI 10.1016/j.canlet.2005.07.040; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Yang F, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-178; Yu AD, 1998, HUM MOL GENET, V7, P609, DOI 10.1093/hmg/7.4.609	69	31	33	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35139	10.1371/journal.pone.0035139	http://dx.doi.org/10.1371/journal.pone.0035139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509394	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336600087
J	Martinelli, N; Girelli, D; Cigolini, D; Sandri, M; Ricci, G; Rocca, G; Olivieri, O				Martinelli, Nicola; Girelli, Domenico; Cigolini, Davide; Sandri, Marco; Ricci, Giorgio; Rocca, Giampaolo; Olivieri, Oliviero			Access Rate to the Emergency Department for Venous Thromboembolism in Relationship with Coarse and Fine Particulate Matter Air Pollution	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; EXPOSURE; PARTICLES; RISK; ATHEROSCLEROSIS; INFLAMMATION; VARIABILITY; DYSFUNCTION; MORTALITY	Particulate matter (PM) air pollution has been associated with cardiovascular and respiratory disease. Recent studies have proposed also a link with venous thromboembolism (VTE) risk. This study was aimed to evaluate the possible influence of air pollution-related changes on the daily flux of patients referring to the Emergency Department (ED) for VTE, dissecting the different effects of coarse and fine PM. From July 1(st), 2007, to June 30(th), 2009, data about ED accesses for VTE and about daily concentrations of PM air pollution in Verona district (Italy) were collected. Coarse PM (PM10-2.5) was calculated by subtracting the finest PM2.5 from the whole PM10. During the index period a total of 302 accesses for VTE were observed (135 males and 167 females; mean age 68.3 +/- 16.7 years). In multiple regression models adjusted for other atmospheric parameters PM10-2.5, but not PM2.5, concentrations were positively correlated with VTE (beta-coefficient = 0.237; P = 0.020). During the days with high levels of PM10-2.5 (>= 75(th) percentile) there was an increased risk of ED accesses for VTE (OR 1.69 with 95%CI 1.13-2.53). By analysing days of exposure using distributed lag non-linear models, the increase of VTE risk was limited to PM10-2.5 peaks in the short-term period. Consistently with these results, in another cohort of subjects without active thrombosis (n = 102) an inverse correlation between PM10-2.5 and prothrombin time was found (R = -0.247; P = 0.012). Our results suggest that short-time exposure to high concentrations of PM10-2.5 may favour an increased rate of ED accesses for VTE through the induction of a prothrombotic state.	[Martinelli, Nicola; Girelli, Domenico; Cigolini, Davide; Sandri, Marco; Olivieri, Oliviero] Univ Verona, Dept Med, Sect Internal Med, I-37100 Verona, Italy; [Ricci, Giorgio; Rocca, Giampaolo] Hosp Verona, Emergency Dept, Verona, Italy	University of Verona	Martinelli, N (corresponding author), Univ Verona, Dept Med, Sect Internal Med, I-37100 Verona, Italy.	oliviero.olivieri@univr.it	Girelli, Domenico/B-1183-2008; Martinelli, Nicola/J-5622-2016; Olivieri, Oliviero/A-9126-2008; Sandri, Marco/L-2875-2013	Girelli, Domenico/0000-0001-9684-1899; Martinelli, Nicola/0000-0001-6465-5119; Olivieri, Oliviero/0000-0001-8209-9056; Sandri, Marco/0000-0002-1422-5695				Baccarelli A, 2007, J THROMB HAEMOST, V5, P252, DOI 10.1111/j.1538-7836.2007.02300.x; Baccarelli A, 2008, ARCH INTERN MED, V168, P920, DOI 10.1001/archinte.168.9.920; Baccarelli A, 2009, CIRCULATION, V119, P3118, DOI 10.1161/CIRCULATIONAHA.108.836163; Becker S, 2002, TOXICOL IN VITRO, V16, P209, DOI 10.1016/S0887-2333(02)00015-2; Brook RD, 2004, CIRCULATION, V109, P2655, DOI 10.1161/01.CIR.0000128587.30041.C8; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brook RD, 2009, HYPERTENSION, V54, P659, DOI 10.1161/HYPERTENSIONAHA.109.130237; Brunekreef B, 2005, EUR RESPIR J, V26, P309, DOI 10.1183/09031936.05.00001805; Chahine T, 2007, ENVIRON HEALTH PERSP, V115, P1617, DOI 10.1289/ehp.10318; Chuang KJ, 2007, AM J RESP CRIT CARE, V176, P370, DOI 10.1164/rccm.200611-1627OC; Dales RE, 2010, J THROMB HAEMOST, V8, P669, DOI 10.1111/j.1538-7836.2010.03760.x; Dales R, 2007, INT ARCH OCC ENV HEA, V81, P159, DOI 10.1007/s00420-007-0199-7; Dentali F, 2011, THROMB HAEMOSTASIS, V106, P439, DOI 10.1160/TH11-02-0116; DOCKERY DW, 1993, NEW ENGL J MED, V329, P1753, DOI 10.1056/NEJM199312093292401; Franchini M, 2007, J THROMB HAEMOST, V5, P2169, DOI 10.1111/j.1538-7836.2007.02750.x; Franchini M, 2011, BLOOD, V118, P2405, DOI 10.1182/blood-2011-04-343111; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Ghio AJ, 2003, INHAL TOXICOL, V15, P1465, DOI 10.1080/08958370390249111; Ghio AJ, 2000, AM J RESP CRIT CARE, V162, P981, DOI 10.1164/ajrccm.162.3.9911115; Gilmour PS, 2005, OCCUP ENVIRON MED, V62, P164, DOI 10.1136/oem.2004.014951; Hoffmann B, 2007, CIRCULATION, V116, P489, DOI 10.1161/CIRCULATIONAHA.107.693622; Hsiao WLW, 2000, MUTAT RES-GEN TOX EN, V471, P45; Kan H, 2011, J THROMB HAEMOST, V9, P672, DOI 10.1111/j.1538-7836.2011.04210.x; Kilinc E, 2011, J THROMB HAEMOST, V9, P1359, DOI 10.1111/j.1538-7836.2011.04280.x; Lucking AJ, 2008, EUR HEART J, V29, P3043, DOI 10.1093/eurheartj/ehn464; Mannucci PM, 2010, J THROMB HAEMOST, V8, P659, DOI 10.1111/j.1538-7836.2010.03804.x; Mills NL, 2005, CIRCULATION, V112, P3930, DOI 10.1161/CIRCULATIONAHA.105.588962; Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9; Nemmar Abderrahim, 2006, Clin Occup Environ Med, V5, P865; POPE CA, 1995, AM J RESP CRIT CARE, V151, P669, DOI 10.1164/ajrccm/151.3_Pt_1.669; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Roux AVD, 2008, AM J EPIDEMIOL, V167, P667, DOI 10.1093/aje/kwm359; Shi T, 2003, OCCUP ENVIRON MED, V60, P315, DOI 10.1136/oem.60.5.315; Shih RA, 2011, ENVIRON HEALTH PERSP, V119, P326, DOI 10.1289/ehp.1002256; Sun QH, 2010, CIRCULATION, V121, P2755, DOI 10.1161/CIRCULATIONAHA.109.893461; Venkataraman C, 1999, INHAL TOXICOL, V11, P151, DOI 10.1080/089583799197221; Wilson WE, 1997, J AIR WASTE MANAGE, V47, P1238, DOI 10.1080/10473289.1997.10464074; Zeger SL, 2000, ENVIRON HEALTH PERSP, V108, P419, DOI 10.2307/3454382; Zeka A, 2006, INT J EPIDEMIOL, V35, P1347, DOI 10.1093/ije/dyl132	40	38	39	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34831	10.1371/journal.pone.0034831	http://dx.doi.org/10.1371/journal.pone.0034831			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509360	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336600061
J	Pezzoli, D; Olimpieri, F; Malloggi, C; Bertini, S; Volonterio, A; Candiani, G				Pezzoli, Daniele; Olimpieri, Francesca; Malloggi, Chiara; Bertini, Sabrina; Volonterio, Alessandro; Candiani, Gabriele			Chitosan-Graft-Branched Polyethylenimine Copolymers: Influence of Degree of Grafting on Transfection Behavior	PLOS ONE			English	Article							MOLECULAR-WEIGHT POLYETHYLENIMINE; GENE DELIVERY-SYSTEM; IN-VITRO; CATIONIC POLYMERS; DNA CONDENSATION; EFFICIENCY; TOXICITY; VIVO; POLY(ETHYLENIMINE); COMPLEXES	Background: Successful non-viral gene delivery currently requires compromises to achieve useful transfection levels while minimizing toxicity. Despite high molecular weight (MW) branched polyethylenimine (bPEI) is considered the gold standard polymeric transfectant, it suffers from high cytotoxicity. Inversely, its low MW counterpart is less toxic and effective in transfection. Moreover, chitosan is a highly biocompatible and biodegradable polymer but characterized by very low transfection efficiency. In this scenario, a straightforward approach widely exploited to develop effective transfectants relies on the synthesis of chitosan-graft-low MW bPEIs (Chi-g-bPEI(x)) but, despite the vast amount of work that has been done in developing promising polymeric assemblies, the possible influence of the degree of grafting on the overall behavior of copolymers for gene delivery has been largely overlooked. Methodology/Principal Findings: With the aim of providing a comprehensive evaluation of the pivotal role of the degree of grafting in modulating the overall transfection effectiveness of copolymeric vectors, we have synthesized seven Chi-g-bPEIx derivatives with a variable amount of bPEI grafts (minimum: 0.6%; maximum: 8.8%). Along the Chi-g-bPEI(x) series, the higher the degree of grafting, the greater the zeta-potential and the cytotoxicity of the resulting polyplexes. Most important, in all cell lines tested the intermediate degree of grafting of 2.7% conferred low cytotoxicity and higher transfection efficiency compared to other Chi-g-bPEI(x) copolymers. We emphasize that, in transfection experiments carried out in primary articular chondrocytes, Chi-g-bPEI(2.7%) was as effective as and less cytotoxic than the gold standard 25 kDa bPEI. Conclusions/Significance: This work underlines for the first time the pivotal role of the degree of grafting in modulating the overall transfection effectiveness of Chi-g-bPEI(x) copolymers. Crucially, we have demonstrated that, along the copolymer series, the fine tuning of the degree of grafting directly affected the overall charge of polyplexes and, altogether, had a direct effect on cytotoxicity.	[Pezzoli, Daniele; Candiani, Gabriele] Consorzio Interuniv Nazl Sci & Tecnol Mat INSTM, Unita Politecn Milano, Milan, Italy; [Olimpieri, Francesca; Malloggi, Chiara; Volonterio, Alessandro; Candiani, Gabriele] Politecn Milan, Dept Chem Mat & Chem Engn Giulio Natta, I-20133 Milan, Italy; [Bertini, Sabrina] Ist Ric Chim & Biochim G Ronzoni, Milan, Italy	Polytechnic University of Milan; Polytechnic University of Milan	Pezzoli, D (corresponding author), Consorzio Interuniv Nazl Sci & Tecnol Mat INSTM, Unita Politecn Milano, Milan, Italy.	alessandro.volonterio@polimi.it; gabriele.candiani@polimi.it	Candiani, Gabriele/A-9744-2009; Pezzoli, Daniele/J-4308-2012; volonterio, alessandro/J-1869-2012; Malloggi, Chiara/S-7540-2017	Candiani, Gabriele/0000-0003-0575-068X; Pezzoli, Daniele/0000-0002-6780-6979; volonterio, alessandro/0000-0002-0125-0744; Malloggi, Chiara/0000-0002-0122-9224	Politecnico di Milano; Italian Ministry for Education, University and Research (MIUR) - FIRB [RBFR08XH0H]	Politecnico di Milano; Italian Ministry for Education, University and Research (MIUR) - FIRB(Ministry of Education, Universities and Research (MIUR))	This work was partly supported by the Politecnico di Milano, 5xmille Junior, "SURGES" Project (to Dr. Candiani, Dr. Volonterio) and by the Italian Ministry for Education, University and Research (MIUR) - FIRB Futuro in Ricerca 2008, Grant RBFR08XH0H (to Dr. Candiani). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner A, 2008, CURR PHARM DESIGN, V14, P3603, DOI 10.2174/138161208786898815; Anderson DG, 2005, MOL THER, V11, P426, DOI 10.1016/j.ymthe.2004.11.015; Aravindan L, 2009, INT J PHARMACEUT, V378, P201, DOI 10.1016/j.ijpharm.2009.05.052; BARANOVSKII VY, 1988, VYSOKOMOL SOEDIN B, V30, P627; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Breunig M, 2007, P NATL ACAD SCI USA, V104, P14454, DOI 10.1073/pnas.0703882104; Candiani G, 2008, INT J ARTIF ORGANS, V31, P490, DOI 10.1177/039139880803100604; Candiani G, 2008, J GENE MED, V10, P637, DOI 10.1002/jgm.1186; Candiani G, 2007, CHEMMEDCHEM, V2, P292, DOI 10.1002/cmdc.200600267; Candiani G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013430; Erbacher P, 1999, J GENE MED, V1, P210; Erbacher P, 1998, PHARMACEUT RES, V15, P1332, DOI 10.1023/A:1011981000671; Gao JQ, 2010, INT J PHARMACEUT, V387, P286, DOI 10.1016/j.ijpharm.2009.12.033; Glodde M, 2006, BIOMACROMOLECULES, V7, P347, DOI 10.1021/bm050726t; Godbey WT, 2001, BIOMATERIALS, V22, P471, DOI 10.1016/S0142-9612(00)00203-9; Godbey WT, 1999, J BIOMED MATER RES, V45, P268, DOI 10.1002/(SICI)1097-4636(19990605)45:3<268::AID-JBM15>3.0.CO;2-Q; Godbey WT, 1999, J CONTROL RELEASE, V60, P149, DOI 10.1016/S0168-3659(99)00090-5; Goldman CK, 1997, NAT BIOTECHNOL, V15, P462, DOI 10.1038/nbt0597-462; He CB, 2010, BIOMATERIALS, V31, P3657, DOI 10.1016/j.biomaterials.2010.01.065; Illum L, 1998, PHARM RES-DORDR, V15, P1326; Intra J, 2008, J CONTROL RELEASE, V130, P129, DOI 10.1016/j.jconrel.2008.04.014; Jeong JH, 2001, J CONTROL RELEASE, V73, P391, DOI 10.1016/S0168-3659(01)00310-8; Jiang HL, 2007, GENE THER, V14, P1389, DOI 10.1038/sj.gt.3302997; Jiang HL, 2007, J CONTROL RELEASE, V117, P273, DOI 10.1016/j.jconrel.2006.10.025; Jiang HL, 2009, BIOMATERIALS, V30, P5844, DOI 10.1016/j.biomaterials.2009.07.017; Jiang HL, 2009, INT J PHARMACEUT, V375, P133, DOI 10.1016/j.ijpharm.2009.03.033; Koping-Hoggard M, 2001, GENE THER, V8, P1108, DOI 10.1038/sj.gt.3301492; Kunath K, 2003, J CONTROL RELEASE, V89, P113, DOI 10.1016/S0168-3659(03)00076-2; Li ZT, 2010, CARBOHYD POLYM, V80, P254, DOI 10.1016/j.carbpol.2009.11.021; Lu B, 2008, BIOMACROMOLECULES, V9, P2594, DOI 10.1021/bm8004676; Luedtke NW, 2003, J AM CHEM SOC, V125, P12374, DOI 10.1021/ja0360135; Lv HT, 2006, J CONTROL RELEASE, V114, P100, DOI 10.1016/j.jconrel.2006.04.014; Merdan T, 2002, ADV DRUG DELIVER REV, V54, P715, DOI 10.1016/S0169-409X(02)00046-7; Pandita D, 2011, BIOMACROMOLECULES, V12, P472, DOI 10.1021/bm1012647; Petersen H, 2002, MACROMOLECULES, V35, P9854, DOI 10.1021/ma025625r; Petersen H, 2002, BIOMACROMOLECULES, V3, P926, DOI 10.1021/bm025539z; Pezzoli D, 2010, DRUG DISCOV TODAY, V15, P1102, DOI 10.1016/j.drudis.2010.09.408; Ping Y, 2011, BIOMATERIALS, V32, P8328, DOI 10.1016/j.biomaterials.2011.07.038; Pouton CW, 1998, J CONTROL RELEASE, V53, P289, DOI 10.1016/S0168-3659(98)00015-7; Qin CQ, 2002, INT J BIOL MACROMOL, V31, P111, DOI 10.1016/S0141-8130(02)00064-8; Schipper NGM, 1996, PHARMACEUT RES, V13, P1686, DOI 10.1023/A:1016444808000; Shukla GC, 2011, ACS NANO, V5, P3405, DOI 10.1021/nn200989r; von Harpe A, 2000, J CONTROL RELEASE, V69, P309, DOI 10.1016/S0168-3659(00)00317-5; Wang X, 2010, PHARMAZIE, V65, P572, DOI 10.1691/ph.2010.9422; Welter JF, 2004, METH MOLEC MED, V100, P129; Wong K, 2006, BIOCONJUGATE CHEM, V17, P152, DOI 10.1021/bc0501597; Zipper H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh101	47	38	39	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34711	10.1371/journal.pone.0034711	http://dx.doi.org/10.1371/journal.pone.0034711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509349	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336600052
J	Vercken, E; Wellenreuther, M; Svensson, EI; Mauroy, B				Vercken, Elodie; Wellenreuther, Maren; Svensson, Erik I.; Mauroy, Benjamin			Don't Fall Off the Adaptation Cliff: When Asymmetrical Fitness Selects for Suboptimal Traits	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; LITTER SIZE; CLUTCH-SIZE; JENSENS INEQUALITY; POPULATION DIVERGENCE; SEXUAL SELECTION; BROOD SIZE; TRADE-OFFS; REPRODUCTION; MANIPULATION	The cliff-edge hypothesis introduces the counterintuitive idea that the trait value associated with the maximum of an asymmetrical fitness function is not necessarily the value that is selected for if the trait shows variability in its phenotypic expression. We develop a model of population dynamics to show that, in such a system, the evolutionary stable strategy depends on both the shape of the fitness function around its maximum and the amount of phenotypic variance. The model provides quantitative predictions of the expected trait value distribution and provides an alternative quantity that should be maximized ("genotype fitness") instead of the classical fitness function ("phenotype fitness"). We test the model's predictions on three examples: (1) litter size in guinea pigs, (2) sexual selection in damselflies, and (3) the geometry of the human lung. In all three cases, the model's predictions give a closer match to empirical data than traditional optimization theory models. Our model can be extended to most ecological situations, and the evolutionary conditions for its application are expected to be common in nature.	[Vercken, Elodie] INRA, UMR ISA 1355, Inst Sophia Agrobiotech, Sophia Antipolis, France; [Wellenreuther, Maren; Svensson, Erik I.] Lund Univ, Dept Biol, Lund, Sweden; [Mauroy, Benjamin] Univ Nice Sophia Antipolis, CNRS, UMR 7351, Lab JA Dieudonne, Nice, France	INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Lund University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Cote d'Azur	Vercken, E (corresponding author), INRA, UMR ISA 1355, Inst Sophia Agrobiotech, Sophia Antipolis, France.	elodie.vercken@sophia.inra.fr	Svensson, Erik/E-8324-2010; Wellenreuther, Maren/AAD-8360-2021	Svensson, Erik/0000-0001-9006-016X; Wellenreuther, Maren/0000-0002-2764-8291	Institut National de la Recherche Agronomique; Centre National de la Recherche Scientifique	Institut National de la Recherche Agronomique; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Institut National de la Recherche Agronomique and the Centre National de la Recherche Scientifique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUTIN S, 1988, J ANIM ECOL, V57, P455, DOI 10.2307/4917; BOYCE MS, 1987, ECOLOGY, V68, P142, DOI 10.2307/1938814; BOYD IL, 1995, J ANIM ECOL, V64, P505, DOI 10.2307/5653; Burns JK, 2004, BEHAV BRAIN SCI, V27, P868, DOI 10.1017/S0140525X0436019X; CHARNOV EL, 1984, FLA ENTOMOL, V67, P5, DOI 10.2307/3494101; DeWitt TJ, 1997, TRENDS ECOL EVOL, V12, P443, DOI 10.1016/S0169-5347(97)85747-3; Drake JM, 2005, P ROY SOC B-BIOL SCI, V272, P1823, DOI 10.1098/rspb.2005.3148; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; Fairbairn Daphne J., 2001, P29; Falconer D. S., 1981, INTRO QUANTITATIVE G; Fisher RA, 1930, GENETICAL THEORY NAT; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; FOX GA, 1993, EVOL ECOL, V7, P1, DOI 10.1007/BF01237731; Freedberg S, 2007, J EVOLUTION BIOL, V20, P213, DOI 10.1111/j.1420-9101.2006.01209.x; Hansen TF, 2006, AM NAT, V168, P168, DOI 10.1086/505768; HARE JF, 1992, J MAMMAL, V73, P449, DOI 10.2307/1382083; Humphries MM, 2000, ECOLOGY, V81, P2867, DOI 10.2307/177347; Koivula M, 2003, ECOLOGY, V84, P398, DOI 10.1890/0012-9658(2003)084[0398:CORITW]2.0.CO;2; LACK D, 1947, IBIS, V89, P302, DOI 10.1111/j.1474-919X.1947.tb04155.x; Lajus Dmitry L., 2003, P343; LESSELLS CM, 1986, J ANIM ECOL, V55, P669, DOI 10.2307/4747; Martin TL, 2008, AM NAT, V171, pE102, DOI 10.1086/527502; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; Mazer Susan J., 2001, P16; MILLAR JS, 1977, EVOLUTION, V31, P370, DOI 10.2307/2407759; Mock D. W., 1998, EVOLUTION SIBLING RI; MOLLER AP, 1991, FUNCT ECOL, V5, P351, DOI 10.2307/2389806; Morris DW, 1996, J ANIM ECOL, V65, P43, DOI 10.2307/5698; MORRIS DW, 1992, EVOLUTION, V46, P1848, DOI 10.1111/j.1558-5646.1992.tb01173.x; MOUNTFORD MD, 1968, J ANIM ECOL, V37, P363, DOI 10.2307/2953; Nesse R.M., 1996, WHY WE GET SICK NEW; Nesse RM, 2004, BEHAV BRAIN SCI, V27, P862, DOI 10.1017/S0140525X04300191; PARKER GA, 1990, NATURE, V348, P27, DOI 10.1038/348027a0; Pasztor L, 2000, TRENDS ECOL EVOL, V15, P117, DOI 10.1016/S0169-5347(99)01801-7; PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9; REAL LA, 1992, ECOLOGY, V73, P1227, DOI 10.2307/1940671; Risch TS, 2007, ECOLOGY, V88, P306, DOI 10.1890/06-0249; RISCH TS, 1995, ECOLOGY, V76, P1643, DOI 10.2307/1938165; Roff Derek A., 1992; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Ruppel G, 2005, PRACHTLIBELLEN EUROP; Ruusila V, 2000, J ZOOL, V252, P79, DOI 10.1017/S0952836900009092; Siva-Jothy MT, 1999, BEHAVIOUR, V136, P1365, DOI 10.1163/156853999500776; Smallwood PD, 1996, AM ZOOL, V36, P392; SMITH CC, 1974, AM NAT, V108, P499, DOI 10.1086/282929; SMITH JM, 1978, ANNU REV ECOL SYST, V9, P31, DOI 10.1146/annurev.es.09.110178.000335; Stearns S.C., 1992, pi; Stearns SC, 2002, P NATL ACAD SCI USA, V99, P10229, DOI 10.1073/pnas.172388999; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Stearns SC, 2008, EVOLUTION HLTH DIS; Svensson EI, 2004, HEREDITY, V93, P423, DOI 10.1038/sj.hdy.6800519; Svensson EI, 2007, AM NAT, V170, P101, DOI 10.1086/518181; Svensson EI, 2006, EVOLUTION, V60, P1242; Turnbull LA, 2008, ECOL LETT, V11, P1037, DOI 10.1111/j.1461-0248.2008.01214.x; VAN NOORDWIJK AJ, 1986, AM NAT, V128, P137, DOI 10.1086/284547; Weibel E.R., 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WHITLOCK MC, 1995, EVOLUTION, V49, P252, DOI 10.1111/j.1558-5646.1995.tb02237.x; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; Wilson AJ, 2006, PLOS BIOL, V4, P1270, DOI 10.1371/journal.pbio.0040216; Wilson WG, 2003, AM NAT, V162, P220, DOI 10.1086/376584; Wright S, 1932, P 6 INT C GEN, P355; YOSHIMURA J, 1992, B MATH BIOL, V54, P445, DOI 10.1007/BF02464843; Yoshimura J, 1996, RES POPUL ECOL, V38, P165, DOI 10.1007/BF02515724	64	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34889	10.1371/journal.pone.0034889	http://dx.doi.org/10.1371/journal.pone.0034889			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509364	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600064
J	Berger-Tal, O; Avgar, T				Berger-Tal, Oded; Avgar, Tal			The Glass is Half-Full: Overestimating the Quality of a Novel Environment is Advantageous	PLOS ONE			English	Article							EXPLORATORY-BEHAVIOR; BAYESIAN BIRDS; PREDATION RISK; MODEL; DECISIONS; ECOLOGY; RULES; HOME; ESTABLISHMENT; EXPLOITATION	According to optimal foraging theory, foraging decisions are based on the forager's current estimate of the quality of its environment. However, in a novel environment, a forager does not possess information regarding the quality of the environment, and may make a decision based on a biased estimate. We show, using a simple simulation model, that when facing uncertainty in heterogeneous environments it is better to overestimate the quality of the environment (to be an "optimist") than underestimate it, as optimistic animals learn the true value of the environment faster due to higher exploration rate. Moreover, we show that when the animal has the capacity to remember the location and quality of resource patches, having a positively biased estimate of the environment leads to higher fitness gains than having an unbiased estimate, due to the benefits of exploration. Our study demonstrates how a simple model of foraging with incomplete information, derived directly from optimal foraging theory, can produce well documented complex space-use patterns of exploring animals.	[Berger-Tal, Oded] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, IL-84105 Beer Sheva, Israel; [Avgar, Tal] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	Ben Gurion University; University of Guelph	Berger-Tal, O (corresponding author), Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, IL-84105 Beer Sheva, Israel.	bergerod@bgu.ac.il	Avgar, Tal/J-6305-2012; Berger-Tal, Oded/P-9189-2014; Avgar, Tal/W-9520-2019; Berger-Tal, Oded/P-1670-2019	Berger-Tal, Oded/0000-0002-7396-456X; Avgar, Tal/0000-0002-8764-6976; Berger-Tal, Oded/0000-0002-7396-456X	Israel Academy of Sciences and Humanities; Natural Sciences Natural Sciences and Engineering Research Council	Israel Academy of Sciences and Humanities; Natural Sciences Natural Sciences and Engineering Research Council	Dr. Berger-Tal is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities. Dr. Avgar is supported by a Natural Sciences Natural Sciences and Engineering Research Council Vanier fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMS MV, 1989, ECOLOGY, V70, P999, DOI 10.2307/1941368; ABRAMS PA, 1994, AM NAT, V144, P317, DOI 10.1086/285677; Avni R, 2008, ANIM COGN, V11, P311, DOI 10.1007/s10071-007-0119-y; Beauchamp G, 2000, J THEOR BIOL, V207, P21, DOI 10.1006/jtbi.2000.2153; BERNSTEIN C, 1988, J ANIM ECOL, V57, P1007, DOI 10.2307/5108; Borger L, 2008, ECOL LETT, V11, P637, DOI 10.1111/j.1461-0248.2008.01182.x; BOUSKILA A, 1992, AM NAT, V139, P161, DOI 10.1086/285318; BROWN JS, 1988, BEHAV ECOL SOCIOBIOL, V22, P37, DOI 10.1007/BF00395696; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Burns CE, 2005, BEHAV ECOL, V16, P898, DOI 10.1093/beheco/ari070; Burt W. H., 1943, Journal of Mammalogy, V24, P346, DOI 10.2307/1374834; BUSH RR, 1951, PSYCHOL REV, V58, P313, DOI 10.1037/h0054388; Caughley G., 1976, P94; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Crook DA, 2004, CAN J FISH AQUAT SCI, V61, P2183, DOI 10.1139/F04-151; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Delgado MD, 2009, BEHAV ECOL SOCIOBIOL, V64, P35, DOI 10.1007/s00265-009-0815-5; Dukas R, 2008, ETHOLOGY, V114, P1195, DOI 10.1111/j.1439-0310.2008.01565.x; Egas M, 2001, ECOL LETT, V4, P190, DOI 10.1046/j.1461-0248.2001.00219.x; Eliassen S, 2007, OIKOS, V116, P513, DOI 10.1111/j.2006.0030-1299.15462.x; Eliassen S, 2009, AM NAT, V174, P478, DOI 10.1086/605370; Giraldeau LA, 1999, TRENDS ECOL EVOL, V14, P102, DOI 10.1016/S0169-5347(98)01542-0; Glymour C., 1981, THEORY EVIDENCE; Gottert T, 2010, MAMMALIA, V74, P35, DOI 10.1515/MAMM.2010.012; Green RF, 2006, OIKOS, V112, P274; GREEN RF, 1980, THEOR POPUL BIOL, V18, P244, DOI 10.1016/0040-5809(80)90051-9; Holling C. S., 1959, Canadian Entomologist, V91, P385; Johnson DDP, 2011, NATURE, V477, P317, DOI 10.1038/nature10384; JOHNSON ML, 1989, CAN J ZOOL, V67, P2325, DOI 10.1139/z89-326; Kacelnik A., 1985, P189; Lange A, 2009, J THEOR BIOL, V259, P503, DOI 10.1016/j.jtbi.2009.03.020; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; McNamara JM, 2006, OIKOS, V112, P243, DOI 10.1111/j.0030-1299.2006.14228.x; McNamara JM, 2011, ECOL LETT, V14, P58, DOI 10.1111/j.1461-0248.2010.01556.x; Mettke-Hofmann C, 2002, ETHOLOGY, V108, P249, DOI 10.1046/j.1439-0310.2002.00773.x; METZGAR LH, 1967, J MAMMAL, V48, P387, DOI 10.2307/1377771; Miller Richard, 1987, FACT METHOD EXPLANAT; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; OATEN A, 1977, THEOR POPUL BIOL, V12, P263, DOI 10.1016/0040-5809(77)90046-6; Ohashi K, 2005, BEHAV ECOL, V16, P592, DOI 10.1093/beheco/ari031; Olsson O, 2006, OIKOS, V112, P260, DOI 10.1111/j.0030-1299.2006.13548.x; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Radespiel U, 2003, BEHAVIOUR, V140, P301, DOI 10.1163/156853903321826648; Russell JC, 2010, ANIM BEHAV, V79, P159, DOI 10.1016/j.anbehav.2009.10.020; Rutz C, 2006, P ROY SOC B-BIOL SCI, V273, P579, DOI 10.1098/rspb.2005.3353; Selonen V, 2006, J ANIM ECOL, V75, P1440, DOI 10.1111/j.1365-2656.2006.01168.x; Stamps JA, 1999, Q REV BIOL, V74, P291, DOI 10.1086/393163; Stephens D., 2007, FORAGING BEHAV ECOLO; STEPHENS DW, 1987, THEOR POPUL BIOL, V32, P15, DOI 10.1016/0040-5809(87)90036-0; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Thomson JD, 1997, BEHAV ECOL, V8, P199, DOI 10.1093/beheco/8.2.199; Van Moorter B, 2009, OIKOS, V118, P641, DOI 10.1111/j.1600-0706.2008.17003.x; Wajnberg E, 2006, BEHAV ECOL SOCIOBIOL, V60, P1, DOI 10.1007/s00265-005-0131-7; Welton NJ, 2003, THEOR POPUL BIOL, V64, P417, DOI 10.1016/S0040-5809(03)00097-2	54	29	29	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34578	10.1371/journal.pone.0034578	http://dx.doi.org/10.1371/journal.pone.0034578			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509326	Green Published, Green Submitted, gold			2022-12-27	WOS:000304805900049
J	Cartier, AE; Ubhi, K; Spencer, B; Vazquez-Roque, RA; Kosberg, KA; Fourgeaud, L; Kanayson, P; Patrick, C; Rockenstein, E; Patrick, GN; Masliah, E				Cartier, Anna E.; Ubhi, Kiren; Spencer, Brian; Vazquez-Roque, Ruben A.; Kosberg, Kori Ann; Fourgeaud, Lawrence; Kanayson, Priya; Patrick, Christina; Rockenstein, Edward; Patrick, Gentry N.; Masliah, Eliezer			Differential Effects of UCHL1 Modulation on Alpha-Synuclein in PD-Like Models of Alpha-Synucleinopathy	PLOS ONE			English	Article							CHAPERONE-MEDIATED AUTOPHAGY; TERMINAL HYDROLASE L1; PARKINSONS-DISEASE SUSCEPTIBILITY; LEWY BODY; SUBCELLULAR-LOCALIZATION; SEQUESTOSOME 1/P62; GAMMA-SYNUCLEIN; 2 PARTS; DEGRADATION; PROTEIN	Parkinson's disease (PD) is a progressive neurodegenerative disorder caused by genetic and environmental factors. Abnormal accumulation and aggregation of alpha-synuclein (a-syn) within neurons, and mutations in the a-syn and UCH-L1 genes have been shown to play a role in the pathogenesis of PD. In light of recent reports suggesting an interaction between a-synuclein and UCH-L1, we investigated the effects of UCH-L1 inhibition on a-syn distribution and expression levels in primary neurons and hippocampal tissues derived from non transgenic (non tg) and a-syn over expressing tg mice. We show that suppression of UCH-L1 activity increased a-syn levels in control, non tg neurons, and resulted in a concomitant accumulation of presynaptic a-syn in these neurons. In contrast, blocking UCH-L1 activity in a-syn over expressing neurons decreased a-syn levels, and enhanced its synaptic clearance. In vitro studies verified the LDN-induced inhibition of UCH-L1 had minimal effect on LC3 (a marker of autophagy) in control cells, in cells over expressing a-syn UCH-L1 inhibition resulted in increased LC3 activity. These findings suggest a possible differential role of UCH-L1 function under normal and pathological conditions. Furthermore, in the context of a-syn-induced pathology, modulation of UCH-L1 activity could serve as a therapeutic tool to enhance the autophagy pathway and induce clearance of the observed accumulated/aggregated a-syn species in the PD brain.	[Cartier, Anna E.; Ubhi, Kiren; Spencer, Brian; Kosberg, Kori Ann; Kanayson, Priya; Patrick, Christina; Rockenstein, Edward; Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Sch Med, Dept Pathol, La Jolla, CA 92093 USA; [Vazquez-Roque, Ruben A.] Inst Politecn Nacl, Dept Fisiol, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico; [Fourgeaud, Lawrence] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Cartier, Anna E.; Patrick, Gentry N.] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; Instituto Politecnico Nacional - Mexico; Salk Institute; University of California System; University of California San Diego	Cartier, AE (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA.	emasliah@ucsd.edu	Vazquez Roque, Ruben/L-5757-2013	Vazquez Roque, Ruben/0000-0002-2712-5714	National Institutes of Heath [AG18840, AG5131, AG022074, AG03197, AG010435]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005131, R37AG018440, P01AG022074, P01AG010435] Funding Source: NIH RePORTER	National Institutes of Heath(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by National Institutes of Heath grants AG18840, AG5131, AG022074, AG03197, AG010435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2008, CURR OPIN NEUROL, V21, P676, DOI 10.1097/WCO.0b013e3283168df0; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Cartier AE, 2009, J NEUROSCI, V29, P7857, DOI 10.1523/JNEUROSCI.1817-09.2009; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Cookson MR, 2008, EXP NEUROL, V209, P5, DOI 10.1016/j.expneurol.2007.05.022; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Healy DG, 2006, ANN NEUROL, V59, P627, DOI 10.1002/ana.20757; Hutter CM, 2008, EUR J NEUROL, V15, P134, DOI 10.1111/j.1468-1331.2007.02012.x; Ichimura Y, 2008, AUTOPHAGY, V4, P1063, DOI 10.4161/auto.6826; Kabuta T, 2008, J BIOL CHEM; Kabuta T, 2008, J BIOL CHEM, V283, P23731, DOI 10.1074/jbc.M801918200; Kabuta T, 2008, AUTOPHAGY, V4, P827, DOI 10.4161/auto.6560; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; Klein C, 2007, NEUROLOGY, V69, P2093, DOI 10.1212/01.wnl.0000271880.27321.a7; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Liu YC, 2003, CHEM BIOL, V10, P837, DOI 10.1016/j.chembiol.2003.08.010; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Liu ZH, 2009, P NATL ACAD SCI USA, V106, P4635, DOI 10.1073/pnas.0806474106; Maraganore DM, 1999, NEUROLOGY, V53, P1858, DOI 10.1212/WNL.53.8.1858; McKeith IG, 2004, PARKINSONISM RELAT D, V10, pS15, DOI 10.1016/j.parkreldis.2003.12.005; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; Meredith GE, 2002, BRAIN RES, V956, P156, DOI 10.1016/S0006-8993(02)03514-X; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Osaka H, 2003, HUM MOL GENET, V12, P1945, DOI 10.1093/hmg/ddg211; Pan TH, 2008, BRAIN, V131, P1969, DOI 10.1093/brain/awm318; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; POLLANEN MS, 1993, J NEUROPATH EXP NEUR, V52, P183, DOI 10.1097/00005072-199305000-00001; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Rockenstein E, 2005, J NEUROSCI RES, V80, P247, DOI 10.1002/jnr.20446; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; ROEDER LM, 1982, J NEUROSCI RES, V8, P671, DOI 10.1002/jnr.490080412; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Satoh J, 2001, J NEUROL SCI, V189, P113, DOI 10.1016/S0022-510X(01)00555-X; Scott DA, 2010, J NEUROSCI, V30, P8083, DOI 10.1523/JNEUROSCI.1091-10.2010; Seibenhener ML, 2007, FEBS LETT, V581, P175, DOI 10.1016/j.febslet.2006.12.027; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Setsuie R, 2007, NEUROCHEM INT, V50, P119, DOI 10.1016/j.neuint.2006.07.015; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Specht CG, 2005, MOL CELL NEUROSCI, V28, P326, DOI 10.1016/j.mcn.2004.09.017; Spencer B, 2009, J NEUROSCI, V29, P13578, DOI 10.1523/JNEUROSCI.4390-09.2009; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tanida I, 2004, J BIOL CHEM, V279, P47704, DOI 10.1074/jbc.M407016200; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Wang YL, 2004, BRAIN RES, V1019, P1, DOI 10.1016/j.brainres.2004.05.023; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Wooten MW, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/62079; Xilouri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005515	61	52	52	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34713	10.1371/journal.pone.0034713	http://dx.doi.org/10.1371/journal.pone.0034713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514658	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600064
J	Lelievre, J; Almela, MJ; Lozano, S; Miguel, C; Franco, V; Leroy, D; Herreros, E				Lelievre, Joel; Jesus Almela, Maria; Lozano, Sonia; Miguel, Celia; Franco, Virginia; Leroy, Didier; Herreros, Esperanza			Activity of Clinically Relevant Antimalarial Drugs on Plasmodium falciparum Mature Gametocytes in an ATP Bioluminescence "Transmission Blocking" Assay	PLOS ONE			English	Article							IN-VITRO ACTIVITY; METHYLENE-BLUE; QUANTITATIVE ASSESSMENT; HEMOGLOBIN DEGRADATION; MALARIA PARASITES; INVITRO ACTIVITY; PRIMAQUINE; ARTESUNATE; CULTURE; STAGE	Background: Current anti-malarial drugs have been selected on the basis of their activity against the symptom-causing asexual blood stage of the parasite. Which of these drugs also target gametocytes, in the sexual stage responsible for disease transmission, remains unknown. Blocking transmission is one of the main strategies in the eradication agenda and requires the identification of new molecules that are active against gametocytes. However, to date, the main limitation for measuring the effect of molecules against mature gametocytes on a large scale is the lack of a standardized and reliable method. Here we provide an efficient method to produce and purify mature gametocytes in vitro. Based on this new procedure, we developed a robust, affordable, and sensitive ATP bioluminescence-based assay. We then assessed the activity of 17 gold-standard anti-malarial drugs on Plasmodium late stage gametocytes. Methods and Findings: Difficulties in producing large amounts of gametocytes have limited progress in the development of malaria transmission blocking assays. We improved the method established by Ifediba and Vanderberg to obtain viable, mature gametocytes en masse, whatever the strain used. We designed an assay to determine the activity of antimalarial drugs based on the intracellular ATP content of purified stage IV-V gametocytes after 48 h of drug exposure in 96/384-well microplates. Measurements of drug activity on asexual stages and cytotoxicity on HepG2 cells were also obtained to estimate the specificity of the active drugs. Conclusions: The work described here represents another significant step towards determination of the activity of new molecules on mature gametocytes of any strain with an automated assay suitable for medium/high-throughput screening. Considering that the biology of the forms involved in the sexual and asexual stages is very different, a screen of our 2 million-compound library may allow us to discover novel anti-malarial drugs to target gametocyte-specific metabolic pathways.	[Lelievre, Joel; Jesus Almela, Maria; Lozano, Sonia; Miguel, Celia; Franco, Virginia; Herreros, Esperanza] GlaxoSmithKline R&D, Malaria Discovery Performance Unit, Madrid, Spain; [Leroy, Didier] Med Malaria Venture, Geneva, Switzerland	GlaxoSmithKline	Lelievre, J (corresponding author), GlaxoSmithKline R&D, Malaria Discovery Performance Unit, Tres Cantos Med Dev Campus, Madrid, Spain.	Joel.l.lelievre@gsk.com; esperanza.a.herreros@gsk.com	Herreros, Esperanza/GQH-7182-2022		GSK	GSK(GlaxoSmithKline)	The authors have read the journal's policy and have the following conflicts: JL SL MJA EH CM are employees of GlaxoSmithKline (GSK) and work was funded by GSK under a general research program. DL is employee of Medicines for Malaria Venture (MMV). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. Neither GSK nor MMV have influenced or biased the content of this work.	Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Adjuik M, 2004, LANCET, V363, P9, DOI 10.1016/S0140-6736(03)15162-8; Akoachere M, 2005, ANTIMICROB AGENTS CH, V49, P4592, DOI 10.1128/AAC.49.11.4592-4597.2005; BASCO LK, 1992, AM J TROP MED HYG, V47, P521, DOI 10.4269/ajtmh.1992.47.521; BASCO LK, 1992, BRIT J CLIN PHARMACO, V33, P517, DOI 10.1111/j.1365-2125.1992.tb04081.x; Benoit-Vical F, 2007, ANTIMICROB AGENTS CH, V51, P1463, DOI 10.1128/AAC.00967-06; Biswas S, 2001, J Postgrad Med, V47, P240; Bregani ER, 2000, PANMINERVA MED, V42, P197; Buchholz K, 2011, J INFECT DIS, V203, P1445, DOI 10.1093/infdis/jir037; Butcher GA, 1997, INT J PARASITOL, V27, P975, DOI 10.1016/S0020-7519(97)00079-9; Butcher GA, 2003, AM J TROP MED HYG, V68, P111, DOI 10.4269/ajtmh.2003.68.111; Chavalitshewinkoon-Petmitr Porntip, 2000, Parasitology International, V48, P275, DOI 10.1016/S1383-5769(99)00028-8; Chevalley S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-49; Chotivanich K, 2006, ANTIMICROB AGENTS CH, V50, P1927, DOI 10.1128/AAC.01472-05; Coulibaly B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005318; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Czesny B, 2009, ANTIMICROB AGENTS CH, V53, P4080, DOI 10.1128/AAC.00088-09; Delves M, 2012, PLOS MED IN PRESS; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; EKONG RM, 1990, BIOCHEM PHARMACOL, V40, P297, DOI 10.1016/0006-2952(90)90691-D; Fivelman QL, 2007, MOL BIOCHEM PARASIT, V154, P119, DOI 10.1016/j.molbiopara.2007.04.008; GUPTA SK, 1985, J PROTOZOOL, V32, P91, DOI 10.1111/j.1550-7408.1985.tb03020.x; Hawley SR, 1998, ANTIMICROB AGENTS CH, V42, P682, DOI 10.1128/AAC.42.3.682; Hoppe HC, 2004, ANTIMICROB AGENTS CH, V48, P2370, DOI 10.1128/AAC.48.7.2370-2378.2004; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; Kurth F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-79; LANNERS HN, 1991, PARASITOL RES, V77, P478, DOI 10.1007/BF00928413; Mann VH, 1996, INT J PARASITOL, V26, P117, DOI 10.1016/0020-7519(95)00073-9; Moore LR, 2006, FASEB J, V20, P747, DOI 10.1096/fj.05-5122fje; Mungthin M, 1998, ANTIMICROB AGENTS CH, V42, P2973, DOI 10.1128/AAC.42.11.2973; O'Neill PM, 2003, J MED CHEM, V46, P4933, DOI 10.1021/jm030796n; Peatey CL, 2009, J INFECT DIS, V200, P1518, DOI 10.1086/644645; Peatey CL, 2011, MOL BIOCH PARASITOL; Price RN, 1996, LANCET, V347, P1654, DOI 10.1016/S0140-6736(96)91488-9; Pukrittayakamee S, 2004, ANTIMICROB AGENTS CH, V48, P1329, DOI 10.1128/AAC.48.4.1329-1334.2004; RIECKMANN KH, 1968, B WORLD HEALTH ORGAN, V38, P625; Ringwald P, 1996, AM J TROP MED HYG, V55, P254, DOI 10.4269/ajtmh.1996.55.254; Shimizu S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-73; Silvestrini F, 2005, MOL BIOCHEM PARASIT, V143, P100, DOI 10.1016/j.molbiopara.2005.04.015; SINDEN RE, 1979, PARASITOLOGY, V79, P277, DOI 10.1017/S003118200005335X; SMALLEY ME, 1977, PARASITOLOGY, V74, P1, DOI 10.1017/S0031182000047478; Souri E, 2002, IRAN J PHARM THERAPE, P17; SQUATRITO RC, 1995, GYNECOL ONCOL, V58, P101, DOI 10.1006/gyno.1995.1190; Talman AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009156; Tanaka TQ, 2011, MOL BIOCHEM PARASIT, V177, P160, DOI 10.1016/j.molbiopara.2011.02.005; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; VANDERBERG JP, 1977, B WORLD HEALTH ORGAN, V55, P377; VANHUYSSEN W, 1993, TROP MED PARASITOL, V44, P329; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	49	111	111	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35019	10.1371/journal.pone.0035019	http://dx.doi.org/10.1371/journal.pone.0035019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514702	gold, Green Published			2022-12-27	WOS:000305341600108
J	Ma, WT; Hu, JM				Ma, Wentao; Hu, Jiming			Computer Simulation on the Cooperation of Functional Molecules during the Early Stages of Evolution	PLOS ONE			English	Article							PREBIOTIC EVOLUTION; DARWINIAN SELECTION; EUTECTIC PHASE; RNA WORLD; WATER-ICE; ORIGIN; REPLICATORS; MODELS; COEXISTENCE; RIBOZYMES	It is very likely that life began with some RNA (or RNA-like) molecules, self-replicating by base-pairing and exhibiting enzyme-like functions that favored the self-replication. Different functional molecules may have emerged by favoring their own self-replication at different aspects. Then, a direct route towards complexity/efficiency may have been through the coexistence/cooperation of these molecules. However, the likelihood of this route remains quite unclear, especially because the molecules would be competing for limited common resources. By computer simulation using a Monte-Carlo model (with "micro-resolution'' at the level of nucleotides and membrane components), we show that the coexistence/cooperation of these molecules can occur naturally, both in a naked form and in a protocell form. The results of the computer simulation also lead to quite a few deductions concerning the environment and history in the scenario. First, a naked stage (with functional molecules catalyzing template-replication and metabolism) may have occurred early in evolution but required high concentration and limited dispersal of the system (e. g., on some mineral surface); the emergence of protocells enabled a "habitat-shift'' into bulk water. Second, the protocell stage started with a substage of "pseudo-protocells'', with functional molecules catalyzing template-replication and metabolism, but still missing the function involved in the synthesis of membrane components, the emergence of which would lead to a subsequent "true-protocell'' substage. Third, the initial unstable membrane, composed of prebiotically available fatty acids, should have been superseded quite early by a more stable membrane (e. g., composed of phospholipids, like modern cells). Additionally, the membrane-takeover probably occurred at the transition of the two substages of the protocells. The scenario described in the present study should correspond to an episode in early evolution, after the emergence of single "genes'', but before the appearance of a "chromosome'' with linked genes.	[Ma, Wentao] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Hu, Jiming] Wuhan Univ, Coll Chem & Mol Sci, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University	Ma, WT (corresponding author), Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	mwt@whu.edu.cn			National Natural Science Foundation of China [31170958, 30870660, 20927003, 90913013]; National 973 Basic Research Program of China [2010CB530500, 2010CB530503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China)	The study was supported by the National Natural Science Foundation of China (No. 31170958, 30870660, 20927003, 90913013) and the National 973 Basic Research Program of China (No. 2010CB530500, 2010CB530503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACEVEDO OL, 1986, NATURE, V321, P790, DOI 10.1038/321790a0; Bada JL, 2002, SCIENCE, V296, P1982, DOI 10.1126/science.1069487; Bartel DP, 1999, TRENDS CELL BIOL, V9, pM9, DOI 10.1016/S0962-8924(99)01669-4; Biondi E, 2007, GENE, V389, P10, DOI 10.1016/j.gene.2006.09.002; Branciamore S, 2009, J MOL EVOL, V69, P458, DOI 10.1007/s00239-009-9278-6; Budin I, 2011, P NATL ACAD SCI USA, V108, P5249, DOI 10.1073/pnas.1100498108; Chen IA, 2004, SCIENCE, V305, P1474, DOI 10.1126/science.1100757; Chen IA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002170; Chen X, 2007, CHEM BIODIVERS, V4, P633, DOI 10.1002/cbdv.200790055; Czaran T., 2000, GEOMETRY ECOLOGICAL, P116, DOI [10.1017/cbo9780511525537.009, DOI 10.1017/CBO9780511525537.009]; Dawkins Richard, 1976, SELFISH GENE; De Lucrezia D, 2007, ORIGINS LIFE EVOL B, V37, P379, DOI 10.1007/s11084-007-9098-x; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465, DOI 10.1007/BF00623322; Ertem G, 2004, ORIGINS LIFE EVOL B, V34, P549, DOI 10.1023/B:ORIG.0000043130.49790.a7; Ferris JP, 2002, ORIGINS LIFE EVOL B, V32, P311, DOI 10.1023/A:1020543312109; Ferris JP, 1996, NATURE, V381, P59, DOI 10.1038/381059a0; Fontanari JF, 2006, J THEOR BIOL, V239, P247, DOI 10.1016/j.jtbi.2005.08.039; Franchi M, 2005, GENE, V346, P205, DOI 10.1016/j.gene.2004.11.002; Franchi M, 2004, ORIGINS LIFE EVOL B, V34, P133, DOI 10.1023/B:ORIG.0000009834.81642.cb; GANTI T, 1975, BIOSYSTEMS, V7, P15, DOI 10.1016/0303-2647(75)90038-6; Ganti T., 1974, Biologia, Hungary, V22, P17; GILBERT W, 1986, NATURE, V319, P618, DOI 10.1038/319618a0; GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Hogeweg P, 2003, ORIGINS LIFE EVOL B, V33, P375, DOI 10.1023/A:1025754907141; Janas T, 2006, COLD SPRING HARB MON, V43, P207; Joyce GF, 2002, NATURE, V418, P214, DOI 10.1038/418214a; Kazakov SA, 2006, RNA, V12, P446, DOI 10.1261/rna.2123506; Konnyu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020931; Konnyu B, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-267; KRUGER K, 1982, CELL, V31, P147, DOI 10.1016/0092-8674(82)90414-7; Lifson S, 2001, J THEOR BIOL, V212, P107, DOI 10.1006/jtbi.2001.2361; Ma W, 2007, RNA, V13, P2012, DOI 10.1261/rna.658507; Ma WT, 2010, ASTROBIOLOGY, V10, P437, DOI 10.1089/ast.2009.0385; Ma WT, 2010, BIOSYSTEMS, V99, P201, DOI 10.1016/j.biosystems.2009.11.003; Mansy SS, 2008, NATURE, V454, P122, DOI 10.1038/nature07018; Mansy SS, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002188; Monnard PA, 2001, ORIGINS LIFE EVOL B, V31, P147, DOI 10.1023/A:1006769503968; Monnard PA, 2008, CHEM BIODIVERS, V5, P1521, DOI 10.1002/cbdv.200890141; Monnard PA, 2008, J INORG BIOCHEM, V102, P1104, DOI 10.1016/j.jinorgbio.2008.01.026; Munteanu A, 2007, PHILOS T R SOC B, V362, P1847, DOI 10.1098/rstb.2007.2077; Powner MW, 2009, NATURE, V459, P239, DOI 10.1038/nature08013; Rasmussen S, 2004, SCIENCE, V303, P963, DOI 10.1126/science.1093669; Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464; Robertson MP, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003608; Sacerdote MG, 2005, P NATL ACAD SCI USA, V102, P6004, DOI 10.1073/pnas.0408440102; Scheuring I, 2003, ORIGINS LIFE EVOL B, V33, P319, DOI 10.1023/A:1025742505324; Scheuring I, 2001, J THEOR BIOL, V212, P99, DOI 10.1006/jtbi.2001.2360; Schrum JP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002212; Silvestre DGM, 2005, EUR PHYS J B, V47, P423, DOI 10.1140/epjb/e2005-00346-5; SMITH JM, 1993, J THEOR BIOL, V164, P437, DOI 10.1006/jtbi.1993.1165; Szabo P, 2002, NATURE, V420, P340, DOI 10.1038/nature01187; Szathmary E, 2005, TOP CURR CHEM, V259, P167, DOI 10.1007/tcc001; Szathmary E, 2005, NATURE, V433, P469, DOI 10.1038/433469a; SZATHMARY E, 1987, J THEOR BIOL, V128, P463, DOI 10.1016/S0022-5193(87)80191-1; Szathmary E, 2006, PHILOS T R SOC B, V361, P1761, DOI 10.1098/rstb.2006.1912; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Takeuchi N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000542; Takeuchi N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-33; Trinks H, 2005, ORIGINS LIFE EVOL B, V35, P429, DOI 10.1007/s11084-005-5009-1; Vlassov AV, 2005, J MOL EVOL, V61, P264, DOI 10.1007/s00239-004-0362-7; Vlassov AV, 2004, NUCLEIC ACIDS RES, V32, P2966, DOI 10.1093/nar/gkh601; WALDE P, 1994, J AM CHEM SOC, V116, P7541, DOI 10.1021/ja00096a010; Yarus M, 1999, CURR OPIN CHEM BIOL, V3, P260, DOI 10.1016/S1367-5931(99)80041-6; Zintzaras E, 2002, J THEOR BIOL, V217, P167, DOI 10.1006/jtbi.2002.3026; Zintzaras E, 2010, J THEOR BIOL, V267, P605, DOI 10.1016/j.jtbi.2010.09.011	66	20	21	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35454	10.1371/journal.pone.0035454	http://dx.doi.org/10.1371/journal.pone.0035454			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514745	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600150
J	Murakami, N; Bolton, DC; Kida, E; Xie, W; Hwang, YW				Murakami, Noriko; Bolton, David C.; Kida, Elizabeth; Xie, Wen; Hwang, Yu-Wen			Phosphorylation by Dyrk1A of Clathrin Coated Vesicle-Associated Proteins: Identification of the Substrate Proteins and the Effects of Phosphorylation	PLOS ONE			English	Article							MICROTUBULE-ASSOCIATED PROTEINS; DOWN-SYNDROME; DUAL-SPECIFICITY; MEDIATED ENDOCYTOSIS; KINASE 1A; TYROSINE PHOSPHORYLATION; DYNAMIC INSTABILITY; REGULATED KINASE; CRITICAL REGION; SH3 DOMAIN	Dyrk1A phosphorylated multiple proteins in the clathrin-coated vesicle (CCV) preparations obtained from rat brains. Mass spectrometric analysis identified MAP1A, MAP2, AP180, and alpha- and beta-adaptins as the phosphorylated proteins in the CCVs. Each protein was subsequently confirmed by [P-32]-labeling and immunological methods. The Dyrk1A-mediated phosphorylation released the majority of MAP1A and MAP2 and enhanced the release of AP180 and adaptin subunits from the CCVs. Furthermore, Dyrk1A displaced adaptor proteins physically from CCVs in a kinase-concentration dependent manner. The clathrin heavy chain release rate, in contrast, was not affected by Dyrk1A. Surprisingly, the Dyrk1A-mediated phosphorylation of alpha- and beta-adaptins led to dissociation of the AP2 complex, and released only beta-adaptin from the CCVs. AP180 was phosphorylated by Dyrk1A also in the membrane-free fractions, but alpha- and beta-adaptins were not. Dyrk1A was detected in the isolated CCVs and was co-localized with clathrin in neurons from mouse brain sections and from primary cultured rat hippocampus. Previously, we proposed that Dyrk1A inhibits the onset of clathrin-mediated endocytosis in neurons by phosphorylating dynamin 1, amphiphysin 1, and synaptojanin 1. Current results suggest that besides the inhibition, Dyrk1A promotes the uncoating process of endocytosed CCVs.	[Murakami, Noriko; Xie, Wen; Hwang, Yu-Wen] New York State Inst Basic Res Dev Disabil, Lab Mol Regulat, Staten Isl, NY 10314 USA; [Bolton, David C.] New York State Inst Basic Res Dev Disabil, Lab Mol Struct & Funct, Mass Spectrometry Facil, Dept Mol Biol, Staten Isl, NY 10314 USA; [Kida, Elizabeth] New York State Inst Basic Res Dev Disabil, Dept Dev Neurobiol, Staten Isl, NY 10314 USA	Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities	Murakami, N (corresponding author), New York State Inst Basic Res Dev Disabil, Lab Mol Regulat, 1050 Forest Hill Rd, Staten Isl, NY 10314 USA.	noriko.murakami@opwdd.ny.gov			New York State Office of Mental Retardation and Developmental Disabilities	New York State Office of Mental Retardation and Developmental Disabilities	This work was supported by the New York State Office of Mental Retardation and Developmental Disabilities. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adayev T, 2007, BIOCHEMISTRY-US, V46, P7614, DOI 10.1021/bi700251n; Adayev T, 2006, BIOCHEM BIOPH RES CO, V351, P1060, DOI 10.1016/j.bbrc.2006.10.169; Adayev T, 2006, BIOCHEMISTRY-US, V45, P12011, DOI 10.1021/bi060632j; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; CAMPBELL C, 1984, BIOCHEMISTRY-US, V23, P4420, DOI 10.1021/bi00314a028; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; Chen-Hwang MC, 2002, J BIOL CHEM, V277, P17597, DOI 10.1074/jbc.M111101200; Clayton EL, 2010, NAT NEUROSCI, V13, P845, DOI 10.1038/nn.2571; Conner SD, 2005, J BIOL CHEM, V280, P21539, DOI 10.1074/jbc.M502462200; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Cousin MA, 2001, J NEUROCHEM, V76, P105, DOI 10.1046/j.1471-4159.2001.00049.x; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; Dowjat WK, 2007, NEUROSCI LETT, V413, P77, DOI 10.1016/j.neulet.2006.11.026; Eisenberg E, 2007, TRAFFIC, V8, P640, DOI 10.1111/j.1600-0854.2007.00568.x; Epstein CJ, 2006, NATURE, V441, P582, DOI 10.1038/441582a; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Greener T, 2000, J BIOL CHEM, V275, P1365, DOI 10.1074/jbc.275.2.1365; Guimera J, 1999, GENOMICS, V57, P407, DOI 10.1006/geno.1999.5775; Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hammerle B, 2003, EUR J NEUROSCI, V17, P2277, DOI 10.1046/j.1460-9568.2003.02665.x; Hao WH, 1999, J BIOL CHEM, V274, P22785, DOI 10.1074/jbc.274.32.22785; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Himpel S, 2000, J BIOL CHEM, V275, P2431, DOI 10.1074/jbc.275.4.2431; Himpel S, 2001, BIOCHEM J, V359, P497, DOI 10.1042/0264-6021:3590497; HORIO T, 1986, NATURE, V321, P605, DOI 10.1038/321605a0; Huang Y, 2004, BIOCHEMISTRY-US, V43, P10173, DOI 10.1021/bi036060+; Hussain NK, 2003, J BIOL CHEM, V278, P28823, DOI 10.1074/jbc.M300995200; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Kentrup H, 1996, J BIOL CHEM, V271, P3488; Kida E, 2011, NEUROSCIENCE, V195, P112, DOI 10.1016/j.neuroscience.2011.08.028; Kim Y, 2010, NEUROSIGNALS, V18, P164, DOI 10.1159/000321994; Kirchhausen T, 1999, ANNU REV CELL DEV BI, V15, P705, DOI 10.1146/annurev.cellbio.15.1.705; KORENBERG JR, 1994, P NATL ACAD SCI USA, V91, P4997, DOI 10.1073/pnas.91.11.4997; Korolchuk VI, 2005, J BIOL CHEM, V280, P40796, DOI 10.1074/jbc.M508988200; Korolchuk VI, 2002, TRAFFIC, V3, P428, DOI 10.1034/j.1600-0854.2002.30606.x; KOWALSKI RJ, 1993, J BIOL CHEM, V268, P9847; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; MURAKAMI, 2009, BIOCHEMISTRY-US, V48, P9297; Murakami N, 2006, J BIOL CHEM, V281, P23712, DOI 10.1074/jbc.M513497200; OLMSTED JB, 1986, ANNU REV CELL BIOL, V2, P421, DOI 10.1146/annurev.cb.02.110186.002225; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; PEDROTTI B, 1994, BIOCHEMISTRY-US, V33, P12463, DOI 10.1021/bi00207a013; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; PRYER NK, 1992, J CELL SCI, V103, P965; Raich WB, 2003, GENETICS, V163, P571; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Scales TME, 2009, J CELL SCI, V122, P2424, DOI 10.1242/jcs.040162; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Tassone F, 1999, J NEURAL TRANSM-SUPP, P179; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Tejedor FJ, 2011, FEBS J, V278, P223, DOI 10.1111/j.1742-4658.2010.07954.x; Umeda A, 2000, EUR J CELL BIOL, V79, P336, DOI 10.1078/S0171-9335(04)70037-0; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; USAMI M, 1984, BIOCHIM BIOPHYS ACTA, V798, P306, DOI 10.1016/0304-4165(84)90103-X; Wegiel J, 2004, BRAIN RES, V1010, P69, DOI 10.1016/j.brainres.2004.03.008; Wilde A, 1999, CELL, V96, P677, DOI 10.1016/S0092-8674(00)80578-4	65	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34845	10.1371/journal.pone.0034845	http://dx.doi.org/10.1371/journal.pone.0034845			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514676	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600082
J	Van der Velden, J; Janssen-Heininger, YMW; Mandalapu, S; Scheller, EV; Kolls, JK; Alcorn, JF				Van der Velden, Jos; Janssen-Heininger, Yvonne M. W.; Mandalapu, Sivanarayna; Scheller, Erich V.; Kolls, Jay K.; Alcorn, John F.			Differential Requirement for c-Jun N-terminal Kinase 1 in Lung Inflammation and Host Defense	PLOS ONE			English	Article							BRONCHIAL EPITHELIAL-CELLS; ESCHERICHIA-COLI INFECTION; ACTIVATED PROTEIN-KINASE; SMOOTH-MUSCLE-CELLS; NH2-TERMINAL KINASE; SIGNAL-TRANSDUCTION; IMMUNE-RESPONSE; GENE-EXPRESSION; NEUTROPHIL RECRUITMENT; MAP KINASES	The c-Jun N-terminal kinase (JNK) - 1 pathway has been implicated in the cellular response to stress in many tissues and models. JNK1 is known to play a role in a variety of signaling cascades, including those involved in lung disease pathogenesis. Recently, a role for JNK1 signaling in immune cell function has emerged. The goal of the present study was to determine the role of JNK1 in host defense against both bacterial and viral pneumonia, as well as the impact of JNK1 signaling on IL-17 mediated immunity. Wild type (WT) and JNK1 -/- mice were challenged with Escherichia coli, Staphylococcus aureus, or Influenza A. In addition, WT and JNK1 -/- mice and epithelial cells were stimulated with IL-17A. The impact of JNK1 deletion on pathogen clearance, inflammation, and histopathology was assessed. JNK1 was required for clearance of E. coli, inflammatory cell recruitment, and cytokine production. Interestingly, JNK1 deletion had only a small impact on the host response to S. aureus. JNK1 -/- mice had decreased Influenza A burden in viral pneumonia, yet displayed worsened morbidity. Finally, JNK1 was required for IL-17A mediated induction of inflammatory cytokines and antimicrobial peptides both in epithelial cells and the lung. These data identify JNK1 as an important signaling molecule in host defense and demonstrate a pathogen specific role in disease. Manipulation of the JNK1 pathway may represent a novel therapeutic target in pneumonia.	[Van der Velden, Jos; Janssen-Heininger, Yvonne M. W.] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Mandalapu, Sivanarayna; Scheller, Erich V.; Alcorn, John F.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA; [Kolls, Jay K.] UPMC, Childrens Hosp Pittsburgh, RK Mellon Fdn Inst, Pittsburgh, PA USA	University of Vermont; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Van der Velden, J (corresponding author), Univ Vermont, Dept Pathol, Burlington, VT 05405 USA.	john.alcorn@chp.edu	Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304; van der Velden, Jos/0000-0002-2451-3180	Parker B. Francis Foundation Fellowship; Children's Hospital of Pittsburgh Research Advisory Committee Start-up Award [R01 HL085464, R37 HL079142]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL079142, R01HL085464] Funding Source: NIH RePORTER	Parker B. Francis Foundation Fellowship; Children's Hospital of Pittsburgh Research Advisory Committee Start-up Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a Parker B. Francis Foundation Fellowship (JFA), Children's Hospital of Pittsburgh Research Advisory Committee Start-up Award (JFA), R01 HL085464 (YJH), R37 HL079142 (JKK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn JF, 2008, J CELL SCI, V121, P1036, DOI 10.1242/jcs.019455; Alcorn JF, 2009, AM J RESP CELL MOL, V40, P422, DOI 10.1165/rcmb.2008-0174OC; Balamayooran G, 2011, INFECT IMMUN, V79, P2567, DOI 10.1128/IAI.00067-11; Balamayooran T, 2011, INFECT IMMUN, V79, P4588, DOI 10.1128/IAI.05641-11; Baranova IN, 2008, J IMMUNOL, V181, P7147, DOI 10.4049/jimmunol.181.10.7147; Cheon IS, 2008, MOL IMMUNOL, V45, P1665, DOI 10.1016/j.molimm.2007.10.001; Christiansen D, 2012, ADV EXP MED BIOL, V946, P237, DOI 10.1007/978-1-4614-0106-3_14; Conze D, 2002, J EXP MED, V195, P811, DOI 10.1084/jem.20011508; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; Cuzick A, 2006, INFECT IMMUN, V74, P4104, DOI 10.1128/IAI.02045-05; de Haij S, 2005, J AM SOC NEPHROL, V16, P1603, DOI 10.1681/ASN.2004090781; Desmet EA, 2010, VIROLOGY, V400, P224, DOI 10.1016/j.virol.2010.02.001; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Hayashi S, 2008, RESPIROLOGY, V13, P203, DOI 10.1111/j.1440-1843.2007.01204.x; Jeyaseelan S, 2007, J IMMUNOL, V178, P3153, DOI 10.4049/jimmunol.178.5.3153; Jia JH, 2006, INFECT IMMUN, V74, P6557, DOI 10.1128/IAI.00591-06; Kawaguchi M, 2002, J BIOL CHEM, V277, P15229, DOI 10.1074/jbc.C100641200; Kawaguchi M, 2001, J ALLERGY CLIN IMMUN, V108, P804, DOI 10.1067/mai.2001.119027; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; Kujime K, 2000, J IMMUNOL, V164, P3222, DOI 10.4049/jimmunol.164.6.3222; Liu WC, 2009, J BIOL CHEM, V284, P24006, DOI 10.1074/jbc.M109.025528; Ludwig S, 2002, J VIROL, V76, P11166, DOI 10.1128/JVI.76.21.11166-11171.2002; Ludwig S, 2001, J BIOL CHEM, V276, P10990, DOI 10.1074/jbc.M009902200; Lui XY, 2010, J GEN VIROL, V91, P1439, DOI 10.1099/vir.0.018465-0; Ma XY, 2010, J IMMUNOL, V184, P4898, DOI 10.4049/jimmunol.1000142; Mehrotra S, 2007, J LEUKOCYTE BIOL, V81, P539, DOI 10.1189/jlb.0706479; Prause O, 2009, PULM PHARMACOL THER, V22, P199, DOI 10.1016/j.pupt.2008.12.005; Rahman MS, 2006, J IMMUNOL, V177, P4064, DOI 10.4049/jimmunol.177.6.4064; Rincon M, 2003, IMMUNOL REV, V192, P131, DOI 10.1034/j.1600-065X.2003.00019.x; Rincon M, 2009, IMMUNOL REV, V228, P212, DOI 10.1111/j.1600-065X.2008.00744.x; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Shahrara S, 2010, J IMMUNOL, V184, P4479, DOI 10.4049/jimmunol.0901942; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Sivick KE, 2010, J IMMUNOL, V184, P2065, DOI 10.4049/jimmunol.0902386; Velden J L AJ, 2011, AM J RESP CELL MOL B, V44, P571, DOI DOI 10.1165/RCMB.2009-02820C; Wang J, 2007, AM J PHYSIOL-LUNG C, V292, pL1495, DOI 10.1152/ajplung.00452.2006; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Wiehler S, 2007, AM J PHYSIOL-LUNG C, V293, pL505, DOI 10.1152/ajplung.00066.2007; Wu WX, 2010, VIROLOGY, V396, P178, DOI 10.1016/j.virol.2009.10.016; Wuyts WA, 2005, J HEART LUNG TRANSPL, V24, P875, DOI 10.1016/j.healun.2004.05.003; Yagi Y, 2007, J GASTROENTEROL, V42, P746, DOI 10.1007/s00535-007-2091-3; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Ye P, 2001, AM J RESP CELL MOL, V25, P335, DOI 10.1165/ajrcmb.25.3.4424; Zhou Y, 2007, CYTOKINE, V38, P157, DOI 10.1016/j.cyto.2007.06.002	48	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34638	10.1371/journal.pone.0034638	http://dx.doi.org/10.1371/journal.pone.0034638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514650	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341600056
J	Bonnin, RA; Poirel, L; Carattoli, A; Nordmann, P				Bonnin, Remy A.; Poirel, Laurent; Carattoli, Alessandra; Nordmann, Patrice			Characterization of an IncFII Plasmid Encoding NDM-1 from Escherichia coli ST131	PLOS ONE			English	Article							ACINETOBACTER-BAUMANNII; BETA-LACTAMASE; BLA(NDM-1); EMERGENCE; ACQUISITION; STRAIN	Background: The current spread of the gene encoding the metallo-beta-lactamase NDM-1 in Enterobacteriaceae is linked to a variety of surrounding genetic structures and plasmid scaffolds. Methodology: The whole sequence of plasmid pGUE-NDM carrying the bla(NDM-1) gene was determined by high-density pyrosequencing and a genomic comparative analysis with other bla(NDM-1)-negative IncFII was performed. Principal Findings: Plasmid pGUE-NDM replicating in Escherichia coli confers resistance to many antibiotic molecules including beta-lactams, aminoglycosides, trimethoprim, and sulfonamides. It is 87,022 bp in-size and carries the two beta-lactamase genes bla(NDM-1) and bla(OXA-1), together with three aminoglycoside resistance genes aacA4, aadA2, and aacC2. Comparative analysis of the multidrug resistance locus contained a module encompassing the bla(NDM-1) gene that is actually conserved among different structures identified in other enterobacterial isolates. This module was constituted by the bla(NDM-1) gene, a fragment of insertion sequence ISAba125 and a bleomycin resistance encoding gene. Significance: This is the first characterized bla(NDM-1)-carrying IncFII-type plasmid. Such association between the bla(NDM-1) gene and an IncFII-type plasmid backbone is extremely worrisome considering that this plasmid type is known to spread efficiently, as examplified with the worldwide dissemination of bla(CTX-M-15)-borne IncFII plasmids.	[Bonnin, Remy A.; Poirel, Laurent; Nordmann, Patrice] Hop Bicetre, AP HP, Fac Med, Serv Bacteriol Virol,INSERM U914 Emerging Resista, Paris, France; [Bonnin, Remy A.; Poirel, Laurent; Nordmann, Patrice] Univ Paris 11, Paris, France; [Carattoli, Alessandra] Ist Super Sanita, Dept Infect Parasit & Imunnomediated Dis, I-00161 Rome, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Istituto Superiore di Sanita (ISS)	Bonnin, RA (corresponding author), Hop Bicetre, AP HP, Fac Med, Serv Bacteriol Virol,INSERM U914 Emerging Resista, Paris, France.	nordmann.patrice@bct.aphp.fr	Carattoli, Alessandra/A-1324-2009; Poirel, Laurent/ABE-6736-2020	Carattoli, Alessandra/0000-0002-6120-6526; Poirel, Laurent/0000-0001-5160-5286; Bonnin, Remy A./0000-0002-2307-3232	INSERM (Institut National de la Sante et de la Recherche Medicale France) [U914]; Ministere de l'Education Nationale et de la Recherche [UPRES-EA3539]; Universite Paris XI, Paris, France; European Community (TEMPOtest-QC) [HEALTH-2009-241742]	INSERM (Institut National de la Sante et de la Recherche Medicale France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Ministere de l'Education Nationale et de la Recherche; Universite Paris XI, Paris, France; European Community (TEMPOtest-QC)(European Commission)	This work was funded mostly by a grant from the INSERM (Institut National de la Sante et de la Recherche Medicale France) (U914), by a grant-in-aid of the Ministere de l'Education Nationale et de la Recherche (UPRES-EA3539), Universite Paris XI, Paris, France, and by a grant of the European Community (TEMPOtest-QC, HEALTH-2009-241742). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyd DA, 2004, ANTIMICROB AGENTS CH, V48, P3758, DOI 10.1128/AAC.48.10.3758-3764.2004; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2012, ANTIMICROB AGENTS CH, V56, P783, DOI 10.1128/AAC.05116-11; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Ho PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017989; Jovcic B, 2011, ANTIMICROB AGENTS CH, V55, P3929, DOI 10.1128/AAC.00226-11; Karthikeyan K, 2010, J ANTIMICROB CHEMOTH, V65, P2253, DOI 10.1093/jac/dkq273; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lartigue MF, 2006, ANTIMICROB AGENTS CH, V50, P1282, DOI 10.1128/AAC.50.4.1282-1286.2006; Livermore DM, 2011, LANCET INFECT DIS, V11, P164, DOI 10.1016/S1473-3099(11)70048-2; Nordmann P, 2011, TRENDS MICROBIOL, V19, P588, DOI 10.1016/j.tim.2011.09.005; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Osborn AM, 2000, MICROBIOL-UK, V146, P2267, DOI 10.1099/00221287-146-9-2267; Pfeifer Y, 2011, J ANTIMICROB CHEMOTH, V66, P1998, DOI 10.1093/jac/dkr256; Poirel L, 2012, ANTIMICROB AGENTS CH, V56, P1087, DOI 10.1128/AAC.05620-11; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P4224, DOI 10.1128/AAC.00165-11; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P1821, DOI 10.1128/AAC.01761-10; Poirel L, 2011, J ANTIMICROB CHEMOTH, V66, P304, DOI 10.1093/jac/dkq428; Poirel L, 2010, LANCET INFECT DIS, V10, P832, DOI 10.1016/S1473-3099(10)70279-6; Rogers BA, 2011, J ANTIMICROB CHEMOTH, V66, P1, DOI 10.1093/jac/dkq415; Sekizuka T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025334; Toleman MA, 2006, MICROBIOL MOL BIOL R, V70, P296, DOI 10.1128/MMBR.00048-05; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Woodford N, 2009, ANTIMICROB AGENTS CH, V53, P4472, DOI 10.1128/AAC.00688-09; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	28	95	96	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34752	10.1371/journal.pone.0034752	http://dx.doi.org/10.1371/journal.pone.0034752			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511964	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338600050
J	Dong, WP; Liu, J; Yu, J; Wang, L; Zhou, SL				Dong, Wenpan; Liu, Jing; Yu, Jing; Wang, Ling; Zhou, Shiliang			Highly Variable Chloroplast Markers for Evaluating Plant Phylogeny at Low Taxonomic Levels and for DNA Barcoding	PLOS ONE			English	Article							MATK; EVOLUTION; SEQUENCES; MULTIPLE; REGIONS; UTILITY; GENE; RBCL; TORTOISE; GENOMES	Background: At present, plant molecular systematics and DNA barcoding techniques rely heavily on the use of chloroplast gene sequences. Because of the relatively low evolutionary rates of chloroplast genes, there are very few choices suitable for molecular studies on angiosperms at low taxonomic levels, and for DNA barcoding of species. Methodology/Principal Findings: We scanned the entire chloroplast genomes of 12 genera to search for highly variable regions. The sequence data of 9 genera were from GenBank and 3 genera were of our own. We identified nearly 5% of the most variable loci from all variable loci in the chloroplast genomes of each genus, and then selected 23 loci that were present in at least three genera. The 23 loci included 4 coding regions, 2 introns, and 17 intergenic spacers. Of the 23 loci, the most variable (in order from highest variability to lowest) were intergenic regions ycf1-a, trnK, rpl32-trnL, and trnH-psbA, followed by trn(SUGA)-trnG(UCC), petA-psbJ, rps16-trnQ, ndhC-trnV, ycf1-b, ndhF, rpoB-trnC, psbE-petL, and rbcL-accD. Three loci, trnS(UGA)-trnG(UCC), trnT-psbD, and trnW-psaJ, showed very high nucleotide diversity per site (p values) across three genera. Other loci may have strong potential for resolving phylogenetic and species identification problems at the species level. The loci accD-psaI, rbcL-accD, rpl32-trnL, rps16-trnQ, and ycf1 are absent from some genera. To amplify and sequence the highly variable loci identified in this study, we designed primers from their conserved flanking regions. We tested the applicability of the primers to amplify target sequences in eight species representing basal angiosperms, monocots, eudicots, rosids, and asterids, and confirmed that the primers amplified the desired sequences of these species. Significance/Conclusions: Chloroplast genome sequences contain regions that are highly variable. Such regions are the first consideration when screening the suitable loci to resolve closely related species or genera in phylogenetic analyses, and for DNA barcoding.	[Dong, Wenpan; Liu, Jing; Yu, Jing; Zhou, Shiliang] Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China; [Dong, Wenpan; Wang, Ling] NE Forestry Univ, Coll Landscape Architecture, Harbin, Peoples R China; [Liu, Jing; Yu, Jing] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS; Northeast Forestry University - China; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Dong, WP (corresponding author), Chinese Acad Sci, Inst Bot, State Key Lab Systemat & Evolutionary Bot, Beijing, Peoples R China.	slzhou@ibcas.ac.cn	董, 文攀/D-1297-2015; Dong, Wenpan/C-8167-2013	Dong, Wenpan/0000-0002-8371-3246	National Natural Science Foundation of China [30930010, 30872062]; Research Fund for the Large-scale Scientific Facilities of the Chinese Academy of Sciences [2009-LSF-GBOWS-01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Large-scale Scientific Facilities of the Chinese Academy of Sciences	This study was supported by National Natural Science Foundation of China (30930010, 30872062) and the Research Fund for the Large-scale Scientific Facilities of the Chinese Academy of Sciences (Grant No. 2009-LSF-GBOWS-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Borsch T, 2009, PLANT SYST EVOL, V282, P169, DOI 10.1007/s00606-009-0210-8; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Doyle J. J., 1987, PHYTOCHEM B, P11; Dunning LT, 2010, BOT J LINN SOC, V164, P1, DOI 10.1111/j.1095-8339.2010.01071.x; Erixon P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001386; Hilu KW, 2008, MOL PHYLOGENET EVOL, V48, P1120, DOI 10.1016/j.ympev.2008.05.021; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Li JH, 2008, J SYST EVOL, V46, P341, DOI 10.3724/SP.J.1002.2008.08025; Kanamoto H., 2005, PLANT BIOTECHNOL-NAR, V22, P231; Kelchner SA, 2000, ANN MO BOT GARD, V87, P482, DOI 10.2307/2666142; Kim KJ, 2005, MOL CELLS, V19, P104; KIM KJ, 1995, P NATL ACAD SCI USA, V92, P10379, DOI 10.1073/pnas.92.22.10379; Korall P, 2007, AM J BOT, V94, P873, DOI 10.3732/ajb.94.5.873; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HL, 2007, MOL BIOL EVOL, V24, P1161, DOI 10.1093/molbev/msm036; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Lu LT, 1986, FLORA REIPUBLICAE PO, V38; Muller KF, 2006, MOL PHYLOGENET EVOL, V41, P99, DOI 10.1016/j.ympev.2006.06.017; Neubig KM, 2010, AM J BOT, V97, pE52, DOI 10.3732/ajb.1000128; Neubig KM, 2009, PLANT SYST EVOL, V277, P75, DOI 10.1007/s00606-008-0105-0; Newmaster S G, 2008, Mol Ecol Resour, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Peterson PM, 2010, MOL PHYLOGENET EVOL, V55, P580, DOI 10.1016/j.ympev.2010.01.018; Quan X, 2011, J SYST EVOL, V49, P138, DOI 10.1111/j.1759-6831.2010.00112.x; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533; Wilson CA, 2009, SYST BOT, V34, P277, DOI 10.1600/036364409788606316; Gao X, 2008, J SYST EVOL, V46, P315, DOI 10.3724/SP.J.1002.2008.08007; Yang Zhen-Yan, 2010, Acta Botanica Yunnanica, V32, P393, DOI 10.3724/SP.J.1143.2010.10070; Yu J, 2011, J SYST EVOL, V49, P176, DOI 10.1111/j.1759-6831.2011.00134.x; Zhang JM, 2009, SCI CHINA SER C, V52, P568, DOI 10.1007/s11427-009-0069-5; Zhao Li-Jia, 2010, Acta Botanica Yunnanica, V32, P239, DOI 10.3724/SP.J.1143.2010.09234; Zuo YJ, 2011, PLANTA MED, V77, P182, DOI 10.1055/s-0030-1250166	46	361	392	8	150	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e35071	10.1371/journal.pone.0035071	http://dx.doi.org/10.1371/journal.pone.0035071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511980	Green Published, gold			2022-12-27	WOS:000305338600066
J	Du, C; Zhang, CY; Li, Z; Biswas, MHU; Balaji, KC				Du, Cheng; Zhang, Chuanyou; Li, Zhuo; Biswas, Md. Helal Uddin; Balaji, K. C.			Beta-Catenin Phosphorylated at Threonine 120 Antagonizes Generation of Active Beta-Catenin by Spatial Localization in trans-Golgi Network	PLOS ONE			English	Article							PROTEIN-KINASE D1; HUMAN PROSTATE-CANCER; ALPHA-CATENIN; E-CADHERIN; BONE METASTASIS; C-MU; ACTIVATION; EXPRESSION; ADHESION; PATHWAY	The stability and subcellular localization of beta-catenin, a protein that plays a major role in cell adhesion and proliferation, is tightly regulated by multiple signaling pathways. While aberrant activation of beta-catenin signaling has been implicated in cancers, the biochemical identity of transcriptionally active beta-catenin (ABC), commonly known as unphosphorylated serine 37 (S37) and threonine 41 (T41) beta-catenin, remains elusive. Our current study demonstrates that ABC transcriptional activity is influenced by phosphorylation of T120 by Protein Kinase D1 (PKD1). Whereas the nuclear beta-catenin from PKD1-low prostate cancer cell line C4-2 is unphosphorylated S37/T41/T120 with high transcription activity, the nuclear beta-catenin from PKD1-overexpressing C4-2 cells is highly phosphorylated at T120, S37 and T41 with low transcription activity, implying that accumulation of nuclear beta-catenin alone cannot be simply used as a read-out for Wnt activation. In human normal prostate tissue, the phosphorylated T120 beta-catenin is mainly localized to the trans-Golgi network (TGN, 22/30, 73%), and this pattern is significantly altered in prostate cancer (14/197, 7.1%), which is consistent with known down regulation of PKD1 in prostate cancer. These in vitro and in vivo data unveil a previously unrecognized post-translational modification of ABC through T120 phosphorylation by PKD1, which alters subcellular localization and transcriptional activity of beta-catenin. Our results support the view that beta-catenin signaling activity is regulated by spatial compartmentation and post-translational modifications and protein level of beta-catenin alone is insufficient to count signaling activity.	[Du, Cheng; Zhang, Chuanyou; Li, Zhuo; Biswas, Md. Helal Uddin] Univ Massachusetts, Dept Surg, Sch Med, Worcester, MA 01605 USA; [Balaji, K. C.] Wake Forest Univ, Dept Urol, Winston Salem, NC 27109 USA; [Balaji, K. C.] Wake Forest Univ, Inst Regenerat Med, Winston Salem, NC 27109 USA	University of Massachusetts System; University of Massachusetts Worcester; Wake Forest University; Wake Forest University	Du, C (corresponding author), Univ Massachusetts, Dept Surg, Sch Med, Worcester, MA 01605 USA.	cheng.du@umassmed.edu; kbalaji@wakehealth.edu	Du, Cheng/F-1569-2013	Du, Cheng/0000-0002-8882-2513	University of Massachusetts Medical School	University of Massachusetts Medical School	This work is supported by funding from University of Massachusetts Medical School to KCB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1996, J BIOL CHEM, V271, P1520, DOI 10.1074/jbc.271.3.1520; Alcaraz C, 1990, J Vet Diagn Invest, V2, P191; Bek S, 2002, J CELL SCI, V115, P4743, DOI 10.1242/jcs.00154; Chesire DR, 2003, ENDOCR-RELAT CANCER, V10, P537, DOI 10.1677/erc.0.0100537; Chesire DR, 2002, ONCOGENE, V21, P8453, DOI 10.1038/sj.onc.1206049; Dai JL, 2008, CANCER RES, V68, P5785, DOI 10.1158/0008-5472.CAN-07-6541; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Du C, 2010, CANCER RES, V70, P7810, DOI 10.1158/0008-5472.CAN-09-4481; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Faux MC, PLOS ONE, V5; Fielitz J, 2008, P NATL ACAD SCI USA, V105, P3059, DOI 10.1073/pnas.0712265105; Graham TA, 2000, CELL, V103, P885, DOI 10.1016/S0092-8674(00)00192-6; Hendriksen J, 2008, J CELL SCI, V121, P1793, DOI 10.1242/jcs.025536; Jaggi M, 2005, UROL ONCOL-SEMIN ORI, V23, P402, DOI 10.1016/j.urolonc.2005.03.024; Jaggi M, 2005, CANCER RES, V65, P483; Jaggi M, 2003, BIOCHEM BIOPH RES CO, V307, P254, DOI 10.1016/S0006-291X(03)01161-6; Jaggi M, 2009, CANC RES; Jaggi M, 2008, MOL CANCER THER, V7, P2703, DOI 10.1158/1535-7163.MCT-08-0119; Jaggi M, 2007, FRONT BIOSCI-LANDMRK, V12, P3757, DOI 10.2741/2349; Kim JH, 2005, NATURE, V434, P921, DOI 10.1038/nature03452; Kim M, 2008, CARCINOGENESIS, V29, P629, DOI 10.1093/carcin/bgm291; Maher MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010184; Maher MT, 2009, J CELL BIOL, V186, P219, DOI 10.1083/jcb.200811108; Maher MT, PLOS ONE, V5; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Pokutta S, 2000, MOL CELL, V5, P533, DOI 10.1016/S1097-2765(00)80447-5; Sharlow ER, 2008, J BIOL CHEM, V283, P33516, DOI 10.1074/jbc.M805358200; THALMANN GN, 1994, CANCER RES, V54, P2577; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; van Noort M, 2007, BLOOD, V110, P2778, DOI 10.1182/blood-2007-05-092445; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Verras M, 2006, CANCER LETT, V237, P22, DOI 10.1016/j.canlet.2005.06.004; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Whitaker HC, 2008, PROSTATE, V68, P1196, DOI 10.1002/pros.20780; Yang FJ, 2002, J BIOL CHEM, V277, P11336, DOI 10.1074/jbc.M111962200; Yardy GW, 2009, EUR UROL, V56, P486, DOI 10.1016/j.eururo.2008.05.029; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x	37	19	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e33830	10.1371/journal.pone.0033830	http://dx.doi.org/10.1371/journal.pone.0033830			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511927	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338600013
J	Ghosh, J; Joshi, G; Pradhan, S; Mittal, B				Ghosh, Jayashri; Joshi, Gunjan; Pradhan, Sunil; Mittal, Balraj			Potential Role of Aromatase over Estrogen Receptor Gene Polymorphisms in Migraine Susceptibility: A Case Control Study from North India	PLOS ONE			English	Article							BREAST-CANCER RISK; BETA GENE; ASSOCIATION; VARIANTS; ALPHA; ESR1; PROGESTERONE; PREVALENCE; HAPLOTYPES	Background: The present study was undertaken to find out the role of estrogen pathway related gene polymorphisms in susceptibility to migraine in Northern Indian population. Aromatase, CYP19A1 (rs10046 and rs4646); estrogen receptors, ESR1 (rs2234693, rs1801132, rs2228480 and rs9340799) and ESR2 (rs1271572 and rs1256049) polymorphisms were selected for the present study. Methodology/Principal Findings: The patients were recruited in two cohorts - primary (207) and replicative (127) along with 200 healthy controls and genotyped for various polymorphisms. Logistic regression analysis was applied for statistical analyses. The results were validated in the replicative cohort and pooled by meta analysis using Fisher's and Mantel-Haenszel test. Furthermore, Benjamini - Hochberg false discovery rate test was used to correct for multiple comparisons. CYP19A1 rs10046 and CYP19A1 rs4646 polymorphisms were found to confer risk and protective effect, respectively. Out of four ESR1 polymorphisms, only rs2234693 variant allele was significantly associated in migraine with aura. No significant associations were observed for ESR2 polymorphisms. Significant haplotypes were identified for CYP19A1 and ESR1 polymorphisms. Gene-gene interactions of genotypes as well as haplotypes were observed for CYP19A1-ESR1 showing both risk and protective combinations. Conclusion: We strongly suggest CYP19A1 polymorphisms to be the major contributing factors in migraine susceptibility instead of genetic variants of estrogen receptors.	[Ghosh, Jayashri; Joshi, Gunjan; Mittal, Balraj] Sanjay Gandhi Postgrad Inst Med Sci, Dept Genet, Lucknow, Uttar Pradesh, India; [Pradhan, Sunil] Sanjay Gandhi Postgrad Inst Med Sci, Dept Neurol, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Ghosh, J (corresponding author), Sanjay Gandhi Postgrad Inst Med Sci, Dept Genet, Lucknow, Uttar Pradesh, India.	bml_pgi@yahoo.com	Pradhan, Sunil/Y-9202-2018	Pradhan, Sunil/0000-0003-3324-3626	Indian Council of Medical Research (ICMR) [54/6/2006-BMS]; Council of Scientific and Industrial Research (CSIR), New Delhi, India [09/590(0141)/2008-EMR-I]	Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by Indian Council of Medical Research (ICMR) [Number 54/6/2006-BMS] and Council of Scientific and Industrial Research (CSIR) [File number 09/590(0141)/2008-EMR-I], New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell DW, 2007, INT J CANCER, V121, P2661, DOI 10.1002/ijc.23026; Bolay H, 2011, HEADACHE, V51, P891, DOI 10.1111/j.1526-4610.2011.01903.x; Colomer R, 2008, CLIN CANCER RES, V14, P811, DOI 10.1158/1078-0432.CCR-07-1923; Colson NJ, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-12; Colson NJ, 2004, NEUROGENETICS, V5, P129, DOI 10.1007/s10048-004-0181-4; Corominas R, 2009, EUR J NEUROL, V16, P413, DOI 10.1111/j.1468-1331.2008.02499.x; Cox DG, 2008, INT J CANCER, V122, P387, DOI 10.1002/ijc.23127; De Castro F, 2005, JNCI-J NATL CANCER I, V97, P152, DOI 10.1093/jnci/dji029; Dunning AM, 2004, JNCI-J NATL CANCER I, V96, P936, DOI 10.1093/jnci/djh167; Eikermann-Haerter K, 2009, ANN NEUROL, V66, P564, DOI 10.1002/ana.21779; Haiman CA, 2007, CANCER RES, V67, P1893, DOI 10.1158/0008-5472.CAN-06-4123; Iwase H, 1996, CANCER LETT, V108, P179, DOI 10.1016/S0304-3835(96)04406-0; Joshi G, 2010, CEPHALALGIA, V30, P311, DOI 10.1111/j.1468-2982.2009.01967.x; Kaunisto MA, 2006, CEPHALALGIA, V26, P1462, DOI 10.1111/j.1468-2982.2006.01228.x; LEHRER S, 1993, HYPERTENSION, V21, P439, DOI 10.1161/01.HYP.21.4.439; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Oterino A, 2006, NEUROREPORT, V17, P61, DOI 10.1097/01.wnr.0000192735.85287.f4; Oterino A, 2008, HEADACHE, V48, P1438, DOI 10.1111/j.1526-4610.2008.01294.x; Piccioli P, 2008, CLIN CHEM, V54, P227, DOI 10.1373/clinchem.2007.095703; Puri V, 2006, CEPHALALGIA, V26, P33, DOI 10.1111/j.1468-2982.2005.00987.x; Puri V, 2005, NEUROPEPTIDES, V39, P409, DOI 10.1016/j.npep.2005.04.002; Rexrode KM, 2007, CLIN CHEM, V53, P1749, DOI 10.1373/clinchem.2007.091454; Schurks M, 2010, CEPHALALGIA, V30, P1306, DOI 10.1177/0333102410364155; Schuit SCE, 2005, EUR J ENDOCRINOL, V153, P327, DOI 10.1530/eje.1.01973; Sheffield RE, 1998, HEADACHE, V38, P595, DOI 10.1046/j.1526-4610.1998.3808595.x; Shimodaira Masanori, 2008, Int J Med Sci, V5, P29; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; SOMERVILLE BW, 1971, NEUROLOGY, V21, P853, DOI 10.1212/WNL.21.8.853; STEWART WF, 1994, NEUROLOGY, V44, P17; Sundarrajan C, 2001, J CLIN ENDOCR METAB, V86, P135, DOI 10.1210/jc.86.1.135; van Meurs JBJ, 2003, HUM MOL GENET, V12, P1745, DOI 10.1093/hmg/ddg176; Zhang LN, 2009, BREAST CANCER RES TR, V114, P327, DOI 10.1007/s10549-008-9998-0; Zofkova I, 2002, STEROIDS, V67, P815, DOI 10.1016/S0039-128X(02)00034-X	33	17	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34828	10.1371/journal.pone.0034828	http://dx.doi.org/10.1371/journal.pone.0034828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511967	gold, Green Submitted, Green Published			2022-12-27	WOS:000305338600053
J	Kitahara, CM; Platz, EA; Ladenson, PW; Mondul, AM; Menke, A; de Gonzalez, AB				Kitahara, Cari M.; Platz, Elizabeth A.; Ladenson, Paul W.; Mondul, Alison M.; Menke, Andy; de Gonzalez, Amy Berrington			Body Fatness and Markers of Thyroid Function among US Men and Women	PLOS ONE			English	Article							RESTING ENERGY-EXPENDITURE; CORONARY-HEART-DISEASE; MASS INDEX; SERUM TSH; SUBCLINICAL HYPOTHYROIDISM; OBESE WOMEN; WEIGHT-LOSS; FREE T4; ABDOMINAL ADIPOSITY; EUTHYROID SUBJECTS	Background: We evaluated the association of central versus overall adiposity on levels of thyroid stimulating hormone (TSH), free triiodothyronine (fT(3)), and free thyroxine (fT(4)) among euthyroid subjects taken from a cross-sectional, representative sample of the adult non-institutionalized U. S. population. Methods: The National Health and Nutrition Examination Survey 2007-2008 included 1,623 men and 1,491 women who were 20 years and older, with no history of thyroid or liver disease, kidney failure, diabetes, or thyroid function-altering prescription medication use (based on self-report), and having TSH, fT(3), and fT(4) levels between 0.5-4.49 mIU/L, 2.5-3.9 pg/mL, and 0.6-1.6 ng/dL, respectively. Associations between body mass index (BMI) and waist circumference (measures of overall and central adiposity, respectively) and TSH, fT(3), and fT(4) levels were estimated using multivariable linear regression models stratified by sex and adjusted for age, race, smoking status, and alcohol intake. Results: An increase in serum TSH levels was observed for every 1-quartile increase in BMI in euthyroid men (3.8% [95% CI 0.8%, 6.8%]) and euthyroid women (4.0% [95% CI 1.6%, 6.5%]). Similar, albeit slightly weaker, associations were observed with waist circumference. We also found increases in fT(3) levels with every 1-quartile increase in BMI (1.0% in men and 1.3% in women) and waist circumference (1.2% in men and 1.2% in women). No associations were observed with fT(4). Conclusions: Our results provide support that BMI and waist circumference are positively associated with levels of serum TSH and f T-3 but not fT(4) among euthyroid adults. Longitudinal studies are needed to define the temporality of these associations and their potential health implications.	[Kitahara, Cari M.; Platz, Elizabeth A.; Menke, Andy] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Kitahara, Cari M.; Mondul, Alison M.; de Gonzalez, Amy Berrington] NCI, NIH, Div Canc Epidemiol & Genet, Rockville, MD USA; [Ladenson, Paul W.] Johns Hopkins Med Inst, Dept Med, Div Endocrinol & Metab, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Medicine	Kitahara, CM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	kitaharac@mail.nih.gov	de gonzalez, amy berrington/L-7017-2017; Kitahara, Cari M/R-8267-2016	de gonzalez, amy berrington/0000-0002-7332-8387; Kitahara, Cari M/0000-0001-6416-4432; Mondul, Alison/0000-0002-8843-1416	Intramural Research Program of the National Cancer Institute, National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIACP010219] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah A, 2010, DIABETES RES CLIN PR, V89, P309, DOI 10.1016/j.diabres.2010.04.012; AlAdsani H, 1997, J CLIN ENDOCR METAB, V82, P1118, DOI 10.1210/jc.82.4.1118; [Anonymous], 1995, PHYS STAT US INT ANT; Asvold BO, 2009, J CLIN ENDOCR METAB, V94, P5023, DOI 10.1210/jc.2009-1180; Bastemir M, 2007, SWISS MED WKLY, V137, P431; Belin RM, 2004, J CLIN ENDOCR METAB, V89, P6077, DOI 10.1210/jc.2004-0431; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Caldwell KL, 2011, THYROID, V21, P419, DOI 10.1089/thy.2010.0077; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; Centers for Disease Control and Prevention, 2007 2008 PUBL DAT G; Centers for Disease Control and Prevention. National Center for Health Statistics. National Health and Nutrition Examination Survey [Internet], 2007 2008 LAB METH; Dall'Asta C, 2010, OBESITY, V18, P854, DOI 10.1038/oby.2009.320; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; De Pergola G, 2007, CLIN ENDOCRINOL, V67, P265, DOI 10.1111/j.1365-2265.2007.02874.x; Diez JJ, 2011, EXP CLIN ENDOCR DIAB, V119, P144, DOI 10.1055/s-0030-1265133; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Fox CS, 2008, ARCH INTERN MED, V168, P587, DOI 10.1001/archinte.168.6.587; Hak AE, 2000, ANN INTERN MED, V132, P270, DOI 10.7326/0003-4819-132-4-200002150-00004; Iacobellis G, 2005, CLIN ENDOCRINOL, V62, P487, DOI 10.1111/j.1365-2265.2005.02247.x; Ibrahim MM, 2010, OBES REV, V11, P11, DOI 10.1111/j.1467-789X.2009.00623.x; Iglesias P, 2007, CYTOKINE, V40, P61, DOI 10.1016/j.cyto.2007.10.001; Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225; Kok P, 2005, J CLIN ENDOCR METAB, V90, P4659, DOI 10.1210/jc.2005-0920; Makepeace AE, 2008, CLIN ENDOCRINOL, V69, P648, DOI 10.1111/j.1365-2265.2008.03239.x; Manji N, 2006, CLIN ENDOCRINOL, V64, P125, DOI 10.1111/j.1365-2265.2006.02433.x; Nguyen DM, 2010, GASTROENTEROL CLIN N, V39, P1, DOI 10.1016/j.gtc.2009.12.014; Nyrnes A, 2006, INT J OBESITY, V30, P100, DOI 10.1038/sj.ijo.0803112; Onur S, 2005, EUR J ENDOCRINOL, V152, P179, DOI 10.1530/eje.1.01850; Reinehr T, 2006, J CLIN ENDOCR METAB, V91, P3088, DOI 10.1210/jc.2006-0095; Reinehr T, 2010, MOL CELL ENDOCRINOL, V316, P165, DOI 10.1016/j.mce.2009.06.005; Rexrode KM, 1998, JAMA-J AM MED ASSOC, V280, P1843, DOI 10.1001/jama.280.21.1843; Rodondi N, 2010, JAMA-J AM MED ASSOC, V304, P1365, DOI 10.1001/jama.2010.1361; Rotondi M, 2009, EUR J ENDOCRINOL, V160, P403, DOI 10.1530/EJE-08-0734; Shon Ho Sang, 2008, Korean Journal of Internal Medicine, V23, P53, DOI 10.3904/kjim.2008.23.2.53; Strazzullo P, 2010, STROKE, V41, pE418, DOI 10.1161/STROKEAHA.109.576967; Wang YF, 2005, AM J CLIN NUTR, V81, P555; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	37	117	120	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34979	10.1371/journal.pone.0034979	http://dx.doi.org/10.1371/journal.pone.0034979			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511976	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600062
J	Dhaliwal, A; Maldonado, M; Lin, C; Segura, T				Dhaliwal, Anandika; Maldonado, Maricela; Lin, Clayton; Segura, Tatiana			Cellular Cytoskeleton Dynamics Modulates Non-Viral Gene Delivery through RhoGTPases	PLOS ONE			English	Article							RHO-FAMILY GTPASES; BINDING PROTEIN RHO; ACTIN CYTOSKELETON; CYCLE PROGRESSION; CDC42 GTPASES; ADHESION; CELLS; INTERNALIZATION; ENDOCYTOSIS; ACTIVATION	Although it is well accepted that the constituents of the cellular microenvironment modulate a myriad of cellular processes, including cell morphology, cytoskeletal dynamics and uptake pathways, the underlying mechanism of how these pathways influence non-viral gene transfer have not been studied. Transgene expression is increased on fibronectin (Fn) coated surfaces as a consequence of increased proliferation, cell spreading and active engagement of clathrin endocytosis pathway. RhoGTPases mediate the crosstalk between the cell and Fn, and regulate cellular processes involving filamentous actin, in-response to cellular interaction with Fn. Here the role of RhoGTPases specifically Rho, Rac and Cdc42 in modulation of non-viral gene transfer in mouse mesenchymal stem (mMSCs) plated in a fibronectin microenvironment was studied. More than 90% decrease in transgene expression was observed after inactivation of RhoGTPases using difficile toxin B (TcdB) and C3 transferase. Expression of dominant negative RhoA (RhoAT19N), Rac1(Rac1T17N) and Cdc42 (Cdc42T17N) also significantly reduced polyplex uptake and transgene expression. Interactions of cells with Fn lead to activation of RhoGTPases. However, further activation of RhoA, Rac1 and Cdc42 by expression of constitutively active genes (RhoAQ63L, Rac1Q61L and Cdc42Q61L) did not further enhance transgene expression in mMSCs, when plated on Fn. In contrast, activation of RhoA, Rac1 and Cdc42 by expression of constitutively active genes for cells plated on collagen I, which by itself did not increase RhoGTPase activation, resulted in enhanced transgene expression. Our study shows that RhoGTPases regulate internalization and effective intracellular processing of polyplexes that results in efficient gene transfer.	[Dhaliwal, Anandika; Segura, Tatiana] Univ Calif Los Angeles, Biomed Engn Interdept Program, Los Angeles, CA 90095 USA; [Maldonado, Maricela; Lin, Clayton; Segura, Tatiana] Univ Calif Los Angeles, Chem & Biomol Engn Dept, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Dhaliwal, A (corresponding author), Univ Calif Los Angeles, Biomed Engn Interdept Program, Los Angeles, CA 90095 USA.	tsegura@ucla.edu			National Institutes of Health [R21EB009516, CA-16042, AI-28697]; JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB009516] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was provided by National Institutes of Health R21EB009516, Understanding the Role of the Extracellular Matrix on Non-Viral Gene Transfer (www.nih.gov). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We sincerely appreciate the co-operation and valuable advice rendered by all the members of the Segura Lab, especially Yuguo Lei, Quinn Ng, Sean Anderson, Talar Tokatlian, Shiva Gojggini and Jonathan Lam. Flow cytometry was performed in the UCLA Jonsson Comprehensive Cancer Center (JCCC) and Center for AIDS Research Flow Cytometry Core Facility that is supported by National Institutes of Health awards CA-16042 and AI-28697, and by the JCCC, the UCLA AIDS Institute, and the David Geffen School of Medicine at UCLA.	Aktories K, 2005, CURR TOP MICROBIOL, V291, P113; Aktories K, 1997, J CLIN INVEST, V99, P827, DOI 10.1172/JCI119245; Arthur WT, 2002, BIOL RES, V35, P239, DOI 10.4067/S0716-97602002000200016; Bengali Z, 2007, J GENE MED, V9, P668, DOI 10.1002/jgm.1058; BENYA RV, 1994, MOL PHARMACOL, V46, P495; Boudreau J, 1999, BIOCHEM J, V339, P481, DOI 10.1042/0264-6021:3390481; Bourdoulous S, 1998, J CELL BIOL, V143, P267, DOI 10.1083/jcb.143.1.267; Burnham CAD, 2007, FEMS MICROBIOL LETT, V272, P8, DOI 10.1111/j.1574-6968.2007.00768.x; Defilippi P, 1999, MICROSC RES TECHNIQ, V47, P67, DOI 10.1002/(SICI)1097-0029(19991001)47:1<67::AID-JEMT7>3.3.CO;2-G; Dhaliwal A, 2011, SOFT MATTER; Dhaliwal A, 2010, ACTA BIOMATER, V6, P3436, DOI 10.1016/j.actbio.2010.03.038; Ellis S, 2000, TRENDS CELL BIOL, V10, P85, DOI 10.1016/S0962-8924(99)01710-9; Garrett WS, 2000, CELL, V102, P325, DOI 10.1016/S0092-8674(00)00038-6; Genth H, 2008, INT J BIOCHEM CELL B, V40, P592, DOI 10.1016/j.biocel.2007.12.014; Hassani Z, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm152; Kanematsu T, 2007, J NEUROCHEM, V101, P898, DOI 10.1111/j.1471-4159.2006.04399.x; Kazmierczak BI, 2001, CELL MICROBIOL, V3, P85, DOI 10.1046/j.1462-5822.2001.00091.x; Khatiwala CB, 2009, J BONE MINER RES, V24, P886, DOI [10.1359/jbmr.081240, 10.1359/JBMR.081240]; Kim SJ, 2002, CELL SIGNAL, V14, P205, DOI 10.1016/S0898-6568(01)00244-3; Kircheis R, 2001, ADV DRUG DELIVER REV, V53, P341, DOI 10.1016/S0169-409X(01)00202-2; Koivusalo M, 2010, J CELL BIOL, V188, P547, DOI 10.1083/jcb.200908086; Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392; Koo BK, 2006, J MOL BIOL, V355, P651, DOI 10.1016/j.jmb.2005.09.087; Kopatz I, 2004, J GENE MED, V6, P769, DOI 10.1002/jgm.558; Lamaze C, 1996, NATURE, V382, P177, DOI 10.1038/382177a0; Li E, 1998, J VIROL, V72, P8806, DOI 10.1128/JVI.72.11.8806-8812.1998; Li S, 2000, GENE THER, V7, P31, DOI 10.1038/sj.gt.3301110; Morgan MR, 2007, NAT REV MOL CELL BIO, V8, P957, DOI 10.1038/nrm2289; Mostafavi-Pour Z, 2003, J CELL BIOL, V161, P155, DOI 10.1083/jcb.200210176; Ng T, 1999, EMBO J, V18, P3909, DOI 10.1093/emboj/18.14.3909; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Pan J, 2005, J CELL PHYSIOL, V202, P536, DOI 10.1002/jcp.20151; Perlstein I, 2003, GENE THER, V10, P1420, DOI 10.1038/sj.gt.3302043; Plautz SA, 2011, MOL THER, V19, P2144, DOI 10.1038/mt.2011.161; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Ren XD, 1996, MOL BIOL CELL, V7, P435, DOI 10.1091/mbc.7.3.435; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2001, TRAFFIC, V2, P303, DOI 10.1034/j.1600-0854.2001.002005303.x; Schmidt A, 1998, ANNU REV CELL DEV BI, V14, P305, DOI 10.1146/annurev.cellbio.14.1.305; Schoenwaelder SM, 1999, J BIOL CHEM, V274, P14359, DOI 10.1074/jbc.274.20.14359; Subauste MC, 2000, J BIOL CHEM, V275, P9725, DOI 10.1074/jbc.275.13.9725; Tkachenko E, 2004, J CELL SCI, V117, P3189, DOI 10.1242/jcs.01190; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Tosello-Trampont AC, 2003, J BIOL CHEM, V278, P49911, DOI 10.1074/jbc.M306079200; Uchimura E, 2005, NEUROSCI LETT, V378, P40, DOI 10.1016/j.neulet.2004.12.018; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Wang B, 2005, LANGMUIR, V21, P1290, DOI 10.1021/la048388p; ZHANG SJ, 1995, J BIOL CHEM, V270, P23934, DOI 10.1074/jbc.270.41.23934	51	21	22	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35046	10.1371/journal.pone.0035046	http://dx.doi.org/10.1371/journal.pone.0035046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509380	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600076
J	Hobson, KA; Van Wilgenburg, SL; Wassenaar, LI; Larson, K				Hobson, Keith A.; Van Wilgenburg, Steven L.; Wassenaar, Leonard I.; Larson, Keith			Linking Hydrogen (delta H-2) Isotopes in Feathers and Precipitation: Sources of Variance and Consequences for Assignment to Isoscapes	PLOS ONE			English	Article							STABLE-ISOTOPES; MIGRATORY CONNECTIVITY; LESSER SCAUP; BIRDS; ORIGINS; TRACKING; POPULATIONS; DISPERSAL; GROUNDS; DESIGN	Background: Tracking small migrant organisms worldwide has been hampered by technological and recovery limitations and sampling bias inherent in exogenous markers. Naturally occurring stable isotopes of H (delta H-2) in feathers provide an alternative intrinsic marker of animal origin due to the predictable spatial linkage to underlying hydrologically driven flow of H isotopes into foodwebs. This approach can assess the likelihood that a migrant animal originated from a given location(s) within a continent but requires a robust algorithm linking H isotopes in tissues of interest to an appropriate hydrological isotopic spatio-temporal pattern, such as weighted-annual rainfall. However, a number of factors contribute to or alter expected isotopic patterns in animals. We present results of an extensive investigation into taxonomic and environmental factors influencing feather delta H-2 patterns across North America. Principal Findings: Stable isotope data were measured from 544 feathers from 40 species and 140 known locations. For delta H-2, the most parsimonious model explaining 83% of the isotopic variance was found with amount-weighted growing-season precipitation delta H-2, foraging substrate and migratory strategy. Conclusions/Significance: This extensive H isotopic analysis of known-origin feathers of songbirds in North America and elsewhere reconfirmed the strong coupling between tissue delta H-2 and global hydrologic delta H-2 patterns, and accounting for variance associated with foraging substrate and migratory strategy, can be used in conservation and research for the purpose of assigning birds and other species to their approximate origin.	[Hobson, Keith A.; Van Wilgenburg, Steven L.; Wassenaar, Leonard I.] Environm Canada, Saskatoon, SK, Canada; [Larson, Keith] Lund Univ, Dept Zool, Lund, Scania, Sweden	Environment & Climate Change Canada; Lund University; Scania	Hobson, KA (corresponding author), Environm Canada, Saskatoon, SK, Canada.	Keith.Hobson@ec.gc.ca	Hobson, Keith/Q-9306-2019; Larson, Keith/G-5585-2010; Wassenaar, Leonard/AAY-7081-2020	Larson, Keith/0000-0001-7089-524X; Wassenaar, Leonard/0000-0001-5532-0771; Van Wilgenburg, Steven/0000-0002-6742-4567	Turner Foundation; Environmental Protection Agency [R827109-01-0, R 833778]; National Science Foundation [DEB-9726425, IRCEB- 9977072]; National Science Foundation-National Institute of Health [EF- 0430146]; NIAID CEIRS Center for Rapid Influenza Surveillance and Research [HHSN266200700009C]; National Institute of Allergy and Infectious Diseases [EID-1R01AI074059-01]; Environment Canada; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074059] Funding Source: NIH RePORTER	Turner Foundation; Environmental Protection Agency(United States Environmental Protection Agency); National Science Foundation(National Science Foundation (NSF)); National Science Foundation-National Institute of Health(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID CEIRS Center for Rapid Influenza Surveillance and Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Environment Canada(CGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The collection and curation of the majority of feathers used in this study and housed at UCLA's Center for Tropical Research was made possible by grants from the Turner Foundation, the Environmental Protection Agency (R827109-01-0 and R 833778), the National Science Foundation (DEB-9726425 and IRCEB- 9977072), the National Science Foundation-National Institute of Health Ecology of Infectious Diseases Program (grant number EF- 0430146), the NIAID CEIRS Center for Rapid Influenza Surveillance and Research (Contract Number: HHSN266200700009C), and the National Institute of Allergy and Infectious Diseases (grant number EID-1R01AI074059-01). Isotope analyses were funded by grants to KAH and LIW from Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachler E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009566; Birchall J, 2005, J ANIM ECOL, V74, P877, DOI 10.1111/j.1365-2656.2005.00979.x; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bump JK, 2007, P ROY SOC B-BIOL SCI, V274, P2471, DOI 10.1098/rspb.2007.0700; Burnham K. P., 2002, MULTIMODEL SELECTION; Chamberlain CP, 1997, OECOLOGIA, V109, P132, DOI 10.1007/s004420050067; Clark I., 1997, ENV ISOTOPES HYDROGE; Clark RG, 2006, CAN J ZOOL, V84, P1395, DOI 10.1139/Z06-135; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; Desante DF, 1995, J APPL STAT, V22, P935, DOI 10.1080/02664769524720; Dunn EH, 2006, AVIAN CONSERV ECOL, V1; Ellsworth PZ, 2007, PLANT SOIL, V291, P93, DOI 10.1007/s11104-006-9177-1; Farmer A, 2008, OECOLOGIA, V158, P183, DOI 10.1007/s00442-008-1143-6; Fraser KC, 2010, THESIS U NEW BRUNSWI; Greenwood JL, 2011, CONDOR, V113, P555, DOI 10.1525/cond.2011.100213; Hobson KA, 2005, AUK, V122, P1037, DOI 10.1642/0004-8038(2005)122[1037:SIATDO]2.0.CO;2; Hobson KA, 2004, CONDOR, V106, P905, DOI 10.1650/7545; Hobson KA, 2004, CONDOR, V106, P732, DOI 10.1650/7631; Hobson KA, 1997, OECOLOGIA, V109, P142, DOI 10.1007/s004420050068; Hobson KA, 2008, TERR ECOL SER, V2, P45, DOI 10.1016/S1936-7961(07)00003-6; Hobson KA, 2008, TERR ECOL SER, V2, P1, DOI 10.1016/S1936-7961(07)00001-2; Hobson KA, 2011, J ORNITHOL, V152, P49, DOI 10.1007/s10336-011-0653-x; Hobson KA, 2010, CONDOR, V112, P778, DOI 10.1525/cond.2010.100146; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Hobson KA, 2009, J APPL ECOL, V46, P572, DOI 10.1111/j.1365-2664.2009.01651.x; Howell S. N, 1997, IDENTIFICATION GUIDE; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Kelly JF, 2002, OECOLOGIA, V130, P216, DOI 10.1007/s004420100789; Lott CA, 2006, AUK, V123, P822, DOI 10.1642/0004-8038(2006)123[822:AGATET]2.0.CO;2; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; Newton I, 2006, J AVIAN BIOL, V37, P431, DOI 10.1111/j.0908-8857.2006.03840.x; Pietsch SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024601; Poole A., 2005, BIRDS N AM ONLINE; Popa-Lisseanu AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030388; Powell LA, 2006, CAN J ZOOL, V84, P1331, DOI 10.1139/Z06-114; Rocque DA, 2006, J ORNITHOL, V147, P395, DOI 10.1007/s10336-006-0068-2; Rocque DA, 2009, J ORNITHOL, V150, P931, DOI 10.1007/s10336-009-0433-z; ROLSHAUSEN G, 2009, CURR BIOL, V19, P1; Royle JA, 2004, ECOL APPL, V14, P1780; Rubenstein DR, 2002, SCIENCE, V295, P1062, DOI 10.1126/science.1067124; Smith AD, 2009, AUK, V126, P41, DOI 10.1525/auk.2009.08009; Stutchbury BJM, 2009, SCIENCE, V323, P896, DOI 10.1126/science.1166664; Van Wilgenburg SL, 2011, ISOMAP JOB 5986 ISOS; Van Wilgenburg Steven L., 2012, Endangered Species Research, V16, P17, DOI 10.3354/esr00383; Van Wilgenburg SL, 2011, ECOL APPL, V21, P1340, DOI 10.1890/09-2047.1; Wassenaar L. I., 2003, ISOT ENVIRON HEALT S, V39, P1; Webster Michael S., 2005, P199; Wunder MB, 2008, TERR ECOL SER, V2, P107, DOI 10.1016/S1936-7961(07)00005-X; Wunder MB, 2009, AUK, V126, P922, DOI 10.1525/auk.2009.126.4.2	49	114	118	0	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35137	10.1371/journal.pone.0035137	http://dx.doi.org/10.1371/journal.pone.0035137			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509393	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600086
J	Pan, XN; Gillies, M; Barker, C; Clark, DM; Slater, M				Pan, Xueni; Gillies, Marco; Barker, Chris; Clark, David M.; Slater, Mel			Socially Anxious and Confident Men Interact with a Forward Virtual Woman: An Experimental Study	PLOS ONE			English	Article							REALITY EXPOSURE THERAPY; PUBLIC-SPEAKING ANXIETY; FEAR; PHOBIA; ENVIRONMENTS; BEHAVIOR	Background: Male volunteers entered an immersive virtual reality that depicted a party, where they were approached by a lone virtual woman who initiated a conversation. The goal was to study how socially anxious and socially confident men would react to this event. Interest focused on whether the socially anxious participants would exhibit sustained anxiety during the conversation or whether this would diminish over time, and differ from the responses of the more socially confident men. Methodology: The scenario was a party with five virtual characters, four sitting at a distance from the participant and talking amongst themselves and one lone woman standing closer. The woman approached the participant, introduced herself and initiated a conversation that was first about mundane matters and then became more personal and intimate. Participants were men who were either relatively socially confident (18) or socially anxious in their relationships with women (18). A second experimental factor was whether or not the other four characters occasionally looked towards the participant. There was a post-trial questionnaire about social anxiety in relation to the experience, and skin conductance and ECG physiological measures were recorded. Our expectation was that the socially anxious participants would show greater anxiety throughout. Conclusions: Compared to baseline readings both socially confident and socially anxious groups on average showed signs of significantly increased stress at the initial approach of the virtual woman. The stress then diminished once the conversation entered into the mundane phase and then did not significantly change. Comparing pre- and post-questionnaire anxiety scores there was no change for the more confident participants but a significant decrease in average score amongst the anxious group. The methodology of placing socially anxious participants in a virtual reality where they can gain experience of how to act in a stressful situation promises a novel way forward for treating social anxiety.	[Pan, Xueni; Slater, Mel] UCL, Dept Comp Sci, London, England; [Gillies, Marco] Univ London, Dept Comp, London, England; [Barker, Chris] UCL, Dept Clin Educ & Hlth Psychol, London, England; [Clark, David M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Slater, Mel] Univ Barcelona, ICREA, EVENT Lab, Fac Psicol, Barcelona, Spain	University of London; University College London; University of London; University of London; University College London; University of Oxford; ICREA; University of Barcelona	Pan, XN (corresponding author), UCL, Dept Comp Sci, London, England.	melslater@ub.edu	Barker, Chris/C-2193-2008; Pan, Xueni/B-4307-2013; Slater, Mel/M-5210-2014	Barker, Chris/0000-0002-9268-9356; Pan, Xueni/0000-0002-1282-1469; Slater, Mel/0000-0002-6223-0050; Clark, David/0000-0002-8173-6022	EPSRC (Engineering and Physical Sciences Research Council), UK [EP/D505542/1, EP/F032420/1]; European Sixth Framework Program, Future and Emerging Technologies (FET) [27731]; European Research Council (ERC) [227985]; ICREA Funding Source: Custom; EPSRC [EP/F032420/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/D505542/1, EP/F032420/1] Funding Source: researchfish	EPSRC (Engineering and Physical Sciences Research Council), UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Sixth Framework Program, Future and Emerging Technologies (FET); European Research Council (ERC)(European Research Council (ERC)); ICREA(ICREA); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research was funded under the following projects: Empathic avatars: input, processing and output of emotional state (EPSRC (Engineering and Physical Sciences Research Council), UK) EP/D505542/1; Visual and Behavioural Fidelity of Virtual Humans with Applications to Bystander Intervention in Violent Emergencies (EPSRC, UK) EP/F032420/1 (http://www.epsrc.ac.uk); PRESENCCIA funded under the European Sixth Framework Program, Future and Emerging Technologies (FET), Contract Number 27731 (http://cordis.europa.eu/fp7/ict/programme/fet_en.html); and TRAVERSE funded by the European Research Council (ERC) (under the Advanced Grant scheme), grant agreement number 227985. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2003, COGN BEHAV PRACT, V10, P240, DOI 10.1016/S1077-7229(03)80036-6; Anderson PL, 2005, DEPRESS ANXIETY, V22, P156, DOI 10.1002/da.20090; Bailenson JN, 2007, HUM-COMPUT INTERACT, V22, P325; BIGGER JT, 1995, CIRCULATION, V91, P1936, DOI 10.1161/01.CIR.91.7.1936; Blascovich J, 2002, PSYCHOL INQ, V13, P103, DOI 10.1207/S15327965PLI1302_01; Botella C, 2000, BEHAV THER, V31, P583, DOI 10.1016/S0005-7894(00)80032-5; Botella C, 1998, BEHAV RES THER, V36, P239, DOI 10.1016/S0005-7967(97)10006-7; Boucsein W., 1992, ELECTRODERMAL ACTIVI; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Burger JM, 2009, AM PSYCHOL, V64, P1, DOI 10.1037/a0010932; Clark D. M., 1995, SOCIAL PHOBIA DIAGNO, V41, P68, DOI DOI 10.1016/S0005-7967(97)00022-3; CRUZNEIRA C, 1992, COMMUN ACM, V35, P64, DOI 10.1145/129888.129892; Emmelkamp PMG, 2002, BEHAV RES THER, V40, P509, DOI 10.1016/S0005-7967(01)00023-7; EWING DJ, 1984, BRIT HEART J, V52, P396; Garcia-Lopez LJ, 2008, EUR J PSYCHOL ASSESS, V24, P150, DOI 10.1027/1015-5759.24.3.150; Garcia-Palacios A, 2002, BEHAV RES THER, V40, P983, DOI 10.1016/S0005-7967(01)00068-7; Grillon H, 2006, P 6 INT C DIS VIRT R, V1-8, P1; Harris SR, 2002, CYBERPSYCHOL BEHAV, V5, P543, DOI 10.1089/109493102321018187; Herbelin B., 2002, 8 INT C VIRT SYST MU; HODGES LF, 1995, COMPUTER, V28, P27, DOI 10.1109/2.391038; Hoffman HG, 2003, INT J HUM-COMPUT INT, V16, P283, DOI 10.1207/S15327590IJHC1602_08; James LK, 2003, CYBERPSYCHOL BEHAV, V6, P237, DOI 10.1089/109493103322011515; Klinger E, 2005, CYBERPSYCHOL BEHAV, V8, P76, DOI 10.1089/cpb.2005.8.76; Lee JM, 2002, CYBERPSYCHOL BEHAV, V5, P191, DOI 10.1089/109493102760147169; Meyerbroker K, 2010, DEPRESS ANXIETY, V27, P933, DOI 10.1002/da.20734; North M. M., 1998, International Journal of Virtual Reality, V3, P2; North MM, 1996, PRESENCE-TELEOP VIRT, V5, P346, DOI 10.1162/pres.1996.5.3.346; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Pan X., 2007, PRES 10 ANN INT WORK; Pan XN, 2008, LECT NOTES COMPUT SC, V5208, P89; Pertaub DP, 2002, PRESENCE-TELEOP VIRT, V11, P68, DOI 10.1162/105474602317343668; Powers MB, 2008, J ANXIETY DISORD, V22, P561, DOI 10.1016/j.janxdis.2007.04.006; Rothbaum BO, 2002, J CONSULT CLIN PSYCH, V70, P428, DOI 10.1037//0022-006X.70.2.428; ROTHBAUM BO, 1995, BEHAV THER, V26, P547, DOI 10.1016/S0005-7894(05)80100-5; Rothbaum BO, 2000, J CONSULT CLIN PSYCH, V68, P1020, DOI 10.1037/0022-006X.68.6.1020; Roy S, 2003, CYBERPSYCHOL BEHAV, V6, P411, DOI 10.1089/109493103322278808; Sanchez-Vives MV, 2005, NAT REV NEUROSCI, V6, P332, DOI 10.1038/nrn1651; Slater M, 1999, IEEE COMPUT GRAPH, V19, P6, DOI 10.1109/38.749116; Slater M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000039; Slater M, 2006, PRESENCE-VIRTUAL AUG, V15, P553, DOI 10.1162/pres.15.5.553; Slater M, 2006, CYBERPSYCHOL BEHAV, V9, P627, DOI 10.1089/cpb.2006.9.627; Slater M, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778829; Slater M, 2009, PHILOS T R SOC B, V364, P3549, DOI 10.1098/rstb.2009.0138; Slater M, 2009, IEEE COMPUT GRAPH, V29, P76, DOI 10.1109/MCG.2009.55; Taelman J, 2009, INFLUENCE MENTAL STR; Turner S. M., 1989, PSYCHOL ASSESSMENT J, V1, P35, DOI [10.1037/1040-3590.1.1.35, DOI 10.1037/1040-3590.1.1.35]	46	56	56	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e32931	10.1371/journal.pone.0032931	http://dx.doi.org/10.1371/journal.pone.0032931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TP	22509251	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000305336600008
J	Xu, Z; Zhang, YL; Song, C; Wu, LL; Gao, HW				Xu, Zhen; Zhang, Ya-Lei; Song, Cao; Wu, Ling-Ling; Gao, Hong-Wen			Interactions of Hydroxyapatite with Proteins and Its Toxicological Effect to Zebrafish Embryos Development	PLOS ONE			English	Article							ZINC-OXIDE NANOPARTICLES; CYTOCHROME-C; BIOLOGICAL TOXICITY; IN-VITRO; ADSORPTION; NANO; NANOMATERIALS; TIO2; PARTICLES; STABILITY	The increased application of nanomaterials has raised the level of public concern regarding possible toxicities caused by exposure to nanostructures. The interactions of nanosized hydroxyapatite (HA) with cytochrome c and hemoglobin were investigated by zeta-potential, UV-vis, fluorescence and circular dichroism. The experimental results indicated that the interactions were formed via charge attraction and hydrogen bond and obeyed Langmuir adsorption isotherm. The two functional proteins bridged between HA particles to aggregate into the coralloid form, where change of the secondary structure of proteins occurred. From effects of nanosized HA, SiO2 and TiO2 particles on the zebrafish embryos development, they were adsorbed on the membrane surface confirmed by the electronic scanning microscopy. Nano-HA aggregated into the biggest particles around the membrane protein and then caused a little toxicity to development of zebrafish embryos. The SiO2 particles were distributed throughout the outer surface and caused jam of membrane passage, delay of the hatching time and axial malformation. Maybe owing to the oxygen free radical activity, TiO2 caused some serious deformity characters in the cardiovascular system.	[Xu, Zhen; Song, Cao; Gao, Hong-Wen] Tongji Univ, Coll Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China; [Zhang, Ya-Lei; Wu, Ling-Ling] Tongji Univ, Educ Minist China, Key Lab Yangtze River Environm, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Xu, Z (corresponding author), Tongji Univ, Coll Environm Sci & Engn, State Key Lab Pollut Control & Resource Reuse, Shanghai 200092, Peoples R China.	zhangyl@tongji.edu.cn; EMSL@tongji.edu.cn	Wu, Ling/GZN-2235-2022	Zhang, Yalei/0000-0002-3254-8965	Foundation of State Key Laboratory of Pollution Control and Resource Reuse (Tongji University) [PCRRK11003]; Natural Science Foundation of China [41101499]; Key Laboratory Foundation of Education Ministry of China [YRWEY1008]	Foundation of State Key Laboratory of Pollution Control and Resource Reuse (Tongji University); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory Foundation of Education Ministry of China	This work was supported financially by The Foundation of State Key Laboratory of Pollution Control and Resource Reuse (Tongji University) (Grant No. PCRRK11003), Natural Science Foundation of China (41101499) and Key Laboratory Foundation of Education Ministry of China (YRWEY1008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai W, 2010, J NANOPART RES, V12, P1645, DOI 10.1007/s11051-009-9740-9; Bar-Ilan O, 2009, SMALL, V5, P1897, DOI 10.1002/smll.200801716; Chen YNTFF, 2008, AMINO ACIDS, V36, P399; Dhawan A, 2009, NANOTOXICOLOGY, V3, P1, DOI 10.1080/17435390802578595; Donaldson K, 2001, ENVIRON HEALTH PERSP, V109, P523, DOI 10.2307/3454663; Dunford R, 1997, FEBS LETT, V418, P87, DOI 10.1016/S0014-5793(97)01356-2; Dwivedi PD, 2009, NANOTOXICOLOGY, V3, P19, DOI 10.1080/17435390802604276; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Gao HW, 1999, ASIAN J CHEM, V11, P1556; Giacomelli CE, 1997, J COLLOID INTERF SCI, V188, P387, DOI 10.1006/jcis.1996.4750; Hu HY, 1999, PROG BIOCHEM BIOPHYS, V26, P9; Kang JH, 2006, B KOREAN CHEM SOC, V27, P1891; Kim NH, 2004, B KOREAN CHEM SOC, V25, P1889; Kreyling WG, 2006, J NANOPART RES, V8, P543, DOI 10.1007/s11051-005-9068-z; Krishna ADS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007240; Larsericsdotter H, 2005, J COLLOID INTERF SCI, V289, P26, DOI 10.1016/j.jcis.2005.03.064; Li BG, 2007, RARE METAL MAT ENG, V36, P124; Li L, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-16; Motskin M, 2009, BIOMATERIALS, V30, P3307, DOI 10.1016/j.biomaterials.2009.02.044; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Nezu T, 2008, DENT MATER J, V27, P573, DOI 10.4012/dmj.27.573; Osmond MJ, 2010, NANOTOXICOLOGY, V4, P15, DOI 10.3109/17435390903502028; Qin LL, 2010, INT J PHARMACEUT, V388, P223, DOI 10.1016/j.ijpharm.2009.12.044; Roddick-Lanzilotta AD, 1998, LANGMUIR, V14, P6479, DOI 10.1021/la980425n; Roperto S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010299; Shang W, 2009, SMALL, V5, P470, DOI 10.1002/smll.200800995; Skulachev VP, 1998, FEBS LETT, V423, P275, DOI 10.1016/S0014-5793(98)00061-1; Song C, 2011, TOXICOL SCI, V122, P395, DOI 10.1093/toxsci/kfr131; Srinivasan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019036; Stone V, 2007, IEEE T NANOBIOSCI, V6, P331, DOI 10.1109/TNB.2007.909005; Turkmen D, 2006, INT J BIOL MACROMOL, V38, P126, DOI 10.1016/j.ijbiomac.2006.01.018; Uysal A, 2008, ANAL CHIM ACTA, V625, P110, DOI 10.1016/j.aca.2008.07.010; Wang B, 2007, CHEM RES CHINESE U, V23, P254, DOI 10.1016/S1005-9040(07)60054-3; Wang YQ, 2008, COLLOID SURFACE B, V65, P190, DOI 10.1016/j.colsurfb.2008.04.001; Watanabe A, 2009, FISHERIES SCI, V75, P225, DOI 10.1007/s12562-008-0004-x; Xu Z, 2010, J HAZARD MATER, V180, P375, DOI 10.1016/j.jhazmat.2010.04.042; Xu Z, 2010, ENVIRON SCI POLLUT R, V17, P798, DOI 10.1007/s11356-009-0153-1; Yeo MK, 2008, B KOREAN CHEM SOC, V29, P1179; Yeo MK, 2009, KOREAN J CHEM ENG, V26, P711, DOI 10.1007/s11814-009-0119-5; Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014; Zhao JF, 2010, J EXP NANOSCI, V5, P447, DOI 10.1080/17458081003628931; Zhou SL, 2009, AQUAT TOXICOL, V95, P339, DOI 10.1016/j.aquatox.2009.10.006	42	31	31	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e32818	10.1371/journal.pone.0032818	http://dx.doi.org/10.1371/journal.pone.0032818			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509249	Green Published, gold, Green Submitted			2022-12-27	WOS:000305336600006
J	Zhang, YG; Wu, SP; Xia, YL; Chen, D; Petrof, EO; Claud, EC; Hsu, W; Sun, J				Zhang, Yong-guo; Wu, Shaoping; Xia, Yinglin; Chen, Di; Petrof, Elaine O.; Claud, Erika C.; Hsu, Wei; Sun, Jun			Axin1 Prevents Salmonella Invasiveness and Inflammatory Response in Intestinal Epithelial Cells	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; NF-KAPPA-B; BETA-CATENIN; NEGATIVE REGULATOR; JNK ACTIVATION; DISEASE; KINASE; EXPRESSION; INTERACTS; GSK-3-BETA	Background: Axin1 and its homolog Axin2 are scaffold proteins essential for regulating Wnt signaling. Axin-dependent regulation of Wnt is important for various developmental processes and human diseases. However, the involvement of Axin1 and Axin2 in host defense and inflammation remains to be determined. Methods/Principal Findings: Here, we report that Axin1, but not Axin2, plays an essential role in host-pathogen interaction mediated by the Wnt pathway. Pathogenic Salmonella colonization greatly reduces the level of Axin1 in intestinal epithelial cells. This reduction is regulated at the posttranslational level in early onset of the bacterial infection. Further analysis reveals that the DIX domain and Ser614 of Axin1 are necessary for the Salmonella-mediated modulation through ubiquitination and SUMOylation. Conclusion/Significance: Axin1 apparently has a preventive effect on bacterial invasiveness and inflammatory response during the early stages of infection. The results suggest a distinct biological function of Axin1 and Axin2 in infectious disease and intestinal inflammation while they are functionally equivalent in developmental settings.	[Zhang, Yong-guo; Wu, Shaoping; Chen, Di; Sun, Jun] Rush Univ, Dept Biochem, Med Ctr, Chicago, IL 60612 USA; [Xia, Yinglin] Univ Rochester, Dept Biostat & Computat Biol, Rochester, NY USA; [Petrof, Elaine O.] Queens Univ, Dept Med, GI Dis Res Unit, Kingston, ON K7L 3N6, Canada; [Petrof, Elaine O.] Queens Univ, Dept Med, Div Infect Dis, Kingston, ON K7L 3N6, Canada; [Claud, Erika C.] Univ Chicago, Med Ctr, Dept Pediat & Med, Chicago, IL 60637 USA; [Hsu, Wei] Univ Rochester, Ctr Oral Biol, Dept Biomed Genet, Rochester, NY USA; [Hsu, Wei] Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY USA; [Sun, Jun] Univ Rochester, Dept Med, Div Gastroenterol & Hepatol, Rochester, NY USA	Rush University; University of Rochester; Queens University - Canada; Queens University - Canada; University of Chicago; University of Chicago Medical Center; University of Rochester; University of Rochester; University of Rochester	Zhang, YG (corresponding author), Rush Univ, Dept Biochem, Med Ctr, Chicago, IL 60612 USA.	jun_sun@rush.edu	Chen, Di/AAJ-3665-2021; Sun, Jun/S-7440-2019; Hsu, Wei/ABG-6856-2021	Sun, Jun/0000-0001-7465-3133; Hsu, Wei/0000-0001-6738-6030	National Institutes of Health [KO1 DK075386, 1R03DK089010-01, CA106308, DE015654]; American Cancer Society [RSG-09-075-01-MBC]; New York State's Empire State Stem Cell Board [N09G-279]; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA106308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055915] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK089010, K01DK075386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); New York State's Empire State Stem Cell Board; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health(KO1 DK075386 and 1R03DK089010-01), the American Cancer Society (RSG-09-075-01-MBC), and the Innovative, Developmental or Exploratory Activities (IDEA) award from New York State's Empire State Stem Cell Board (N09G-279) to Jun Sun. Wei Hsu is supported by NIH grants CA106308 and DE015654 and an Idea Award from the Department of Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Du FY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000595; Duan YL, 2007, LAB INVEST, V87, P613, DOI 10.1038/labinvest.3700545; Hsu W, 2001, J CELL BIOL, V155, P1055, DOI 10.1083/jcb.200107066; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Jones RM, 2008, CELL HOST MICROBE, V3, P233, DOI 10.1016/j.chom.2008.02.016; Julius MA, 2000, BIOCHEM BIOPH RES CO, V276, P1162, DOI 10.1006/bbrc.2000.3607; Kim MJ, 2008, FASEB J, V22, P3785, DOI 10.1096/fj.08-113910; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li QX, 2009, NAT CELL BIOL, V11, P1128, DOI 10.1038/ncb1927; Liao AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002369; Liu X, 2011, AM J PHYSL GASTROINT; Liu X, 2011, INFLAMM BOWEL DIS; Liu XY, 2010, FEBS LETT, V584, P911, DOI 10.1016/j.febslet.2010.01.024; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Luo W, 2005, J BIOL CHEM, V280, P5054, DOI 10.1074/jbc.M412340200; Luo W, 2003, J BIOL CHEM, V278, P37451, DOI 10.1074/jbc.M305277200; Mai M, 1999, GENOMICS, V55, P341, DOI 10.1006/geno.1998.5650; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; MCCORMICK BA, 1993, J CELL BIOL, V123, P895, DOI 10.1083/jcb.123.4.895; MILLER SI, 1990, J BACTERIOL, V172, P2485, DOI 10.1128/jb.172.5.2485-2490.1990; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Patel JC, 2005, TRENDS PHARMACOL SCI, V26, P564, DOI 10.1016/j.tips.2005.09.005; Rui HL, 2002, J BIOL CHEM, V277, P42981, DOI 10.1074/jbc.M208099200; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Schaale K, 2010, EUR J CELL BIOL; Sen M, 2008, J IMMUNOL, V181, P4441, DOI 10.4049/jimmunol.181.7.4441; Sun J, 2005, AM J PHYSIOL-GASTR L, V289, pG129, DOI 10.1152/ajpgi.00515.2004; Sun J, 2004, AM J PHYSIOL-GASTR L, V287, pG220, DOI 10.1152/ajpgi.00498.2003; Wehkamp J, 2007, J IMMUNOL, V179, P3109, DOI 10.4049/jimmunol.179.5.3109; Wu SP, 2010, AM J PATHOL, V177, P686, DOI 10.2353/ajpath.2010.090998; Wu SP, 2010, AM J PHYSIOL-GASTR L, V298, pG784, DOI 10.1152/ajpgi.00526.2009; Xie R, 2010, GENESIS; Yamamoto H, 1998, MOL CELL BIOL, V18, P2867, DOI 10.1128/MCB.18.5.2867; Ye ZD, 2007, AM J PATHOL, V171, P882, DOI 10.2353/ajpath.2007.070220; You J, 2008, DIGEST DIS SCI, V53, P1013, DOI 10.1007/s10620-007-9973-3; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Yu HMI, 2007, MECH DEVELOP, V124, P146, DOI 10.1016/j.mod.2006.10.002; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang Y, 2000, J BIOL CHEM, V275, P25008, DOI 10.1074/jbc.M002491200	44	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34942	10.1371/journal.pone.0034942	http://dx.doi.org/10.1371/journal.pone.0034942			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509369	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600067
J	Collison, KS; Makhoul, NJ; Zaidi, MZ; Saleh, SM; Andres, B; Inglis, A; Al-Rabiah, R; Al-Mohanna, FA				Collison, Kate S.; Makhoul, Nadine J.; Zaidi, Marya Z.; Saleh, Soad M.; Andres, Bernard; Inglis, Angela; Al-Rabiah, Rana; Al-Mohanna, Futwan A.			Gender Dimorphism in Aspartame-Induced Impairment of Spatial Cognition and Insulin Sensitivity	PLOS ONE			English	Article							GLUTAMATERGIC SYNAPTIC-TRANSMISSION; DETAILED BEHAVIORAL-ANALYSIS; LONG-TERM POTENTIATION; WATER MAZE ACQUISITION; GENETIC MOUSE MODEL; MONOSODIUM GLUTAMATE; PHENYLALANINE-HYDROXYLASE; CLASSIC PHENYLKETONURIA; PLACENTAL-TRANSFER; RECEPTOR FUNCTION	Previous studies have linked aspartame consumption to impaired retention of learned behavior in rodents. Prenatal exposure to aspartame has also been shown to impair odor-associative learning in guinea pigs; and recently, aspartame-fed hyperlipidemic zebrafish exhibited weight gain, hyperglycemia and acute swimming defects. We therefore investigated the effects of chronic lifetime exposure to aspartame, commencing in utero, on changes in blood glucose parameters, spatial learning and memory in C57BL/6J mice. Morris Water Maze (MWM) testing was used to assess learning and memory, and a random-fed insulin tolerance test was performed to assess glucose homeostasis. Pearson correlation analysis was used to investigate the associations between body characteristics and MWM performance outcome variables. At 17 weeks of age, male aspartame-fed mice exhibited weight gain, elevated fasting glucose levels and decreased insulin sensitivity compared to controls (P<0.05). Females were less affected, but had significantly raised fasting glucose levels. During spatial learning trials in the MWM (acquisition training), the escape latencies of male aspartame-fed mice were consistently higher than controls, indicative of learning impairment. Thigmotactic behavior and time spent floating directionless was increased in aspartame mice, who also spent less time searching in the target quadrant of the maze (P<0.05). Spatial learning of female aspartame-fed mice was not significantly different from controls. Reference memory during a probe test was affected in both genders, with the aspartame-fed mice spending significantly less time searching for the former location of the platform. Interestingly, the extent of visceral fat deposition correlated positively with non-spatial search strategies such as floating and thigmotaxis, and negatively with time spent in the target quadrant and swimming across the location of the escape platform. These data suggest that lifetime exposure to aspartame, commencing in utero, may affect spatial cognition and glucose homeostasis in C57BL/6J mice, particularly in males.	[Collison, Kate S.; Makhoul, Nadine J.; Zaidi, Marya Z.; Saleh, Soad M.; Andres, Bernard; Inglis, Angela; Al-Rabiah, Rana; Al-Mohanna, Futwan A.] King Faisal Specialist Hosp & Res Ctr, Dept Cell Biol, Cell Biol & Diabet Res Unit, Riyadh 11211, Saudi Arabia; [Al-Mohanna, Futwan A.] Al Faisal Univ, Sch Med, Riyadh, Saudi Arabia	King Faisal Specialist Hospital & Research Center; Alfaisal University	Collison, KS (corresponding author), King Faisal Specialist Hosp & Res Ctr, Dept Cell Biol, Cell Biol & Diabet Res Unit, Riyadh 11211, Saudi Arabia.	kate@kfshrc.edu.sa		Zaidi, Marya/0000-0002-0652-0184	National Comprehensive Plan for Science and Technology, Kingdom of Saudi Arabia [08-MED490-20]	National Comprehensive Plan for Science and Technology, Kingdom of Saudi Arabia	This work was funded with support the National Comprehensive Plan for Science and Technology, Kingdom of Saudi Arabia (#08-MED490-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Salam OM, 2011, NEUROTOX RES    0806; Andreazzi AE, 2009, J ENDOCRINOL, V201, P351, DOI 10.1677/JOE-08-0312; ARAI T, 1992, RES VET SCI, V53, P247, DOI 10.1016/0034-5288(92)90117-K; Benice TS, 2006, NEUROSCIENCE, V137, P413, DOI 10.1016/j.neuroscience.2005.08.029; Blanco M, 2006, AM J NEURORADIOL, V27, P452; Blau N, 2010, LANCET, V376, P1417, DOI 10.1016/S0140-6736(10)60961-0; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Brunner R L, 1979, Neurobehav Toxicol, V1, P79; Cabib S, 2003, BEHAV GENET, V33, P301, DOI 10.1023/A:1023498508987; Cain DP, 1996, BEHAV NEUROSCI, V110, P86, DOI 10.1037/0735-7044.110.1.86; Christian B, 2004, PHARMACOL BIOCHEM BE, V78, P121, DOI 10.1016/j.pbb.2004.02.017; Collison KS, 2010, PHYSIOL BEHAV, V99, P334, DOI 10.1016/j.physbeh.2009.11.010; Cox DJ, 2005, DIABETES CARE, V28, P71, DOI 10.2337/diacare.28.1.71; CURI CMON, 1991, BIOCHEM INT, V24, P927; Devan BD, 1999, J NEUROSCI, V19, P2789; DHONDT JL, 1979, MECH AGEING DEV, V10, P219, DOI 10.1016/0047-6374(79)90035-6; DOWEDWARDS DL, 1989, NEUROTOXICOL TERATOL, V11, P413, DOI 10.1016/0892-0362(89)90015-9; Dubovicky M, 1999, PHARMACOL BIOCHEM BE, V64, P681, DOI 10.1016/S0091-3057(99)00166-5; Ercal N, 2002, FREE RADICAL BIO MED, V32, P906, DOI 10.1016/S0891-5849(02)00781-5; FAO/WHO, 1988, WHO FOOD ADD SER, V22, P97; Faust DM, 1996, MOL CELL BIOL, V16, P3125; Ferland Annie, 2007, Diabetes Care, V30, pe59, DOI 10.2337/dc06-1888; Fowler SP, 2008, OBESITY, V16, P1894, DOI 10.1038/oby.2008.284; Gassio R, 2005, DEV MED CHILD NEUROL, V47, P443, DOI 10.1017/S0012162205000861; GIBBS ME, 1987, NEUROSCI BIOBEHAV R, V11, P331, DOI 10.1016/S0149-7634(87)80018-0; Glushakov AV, 2005, BRAIN, V128, P300, DOI 10.1093/brain/awh354; Glushakov AV, 2003, J NEUROSCI RES, V72, P116, DOI 10.1002/jnr.10569; Glushakov AV, 2002, MOL PSYCHIATR, V7, P359, DOI 10.1038/sj.mp.4000976; GRIFFIN RF, 1973, AM J HUM GENET, V25, P646; Hermanussen M, 2006, EUR J CLIN NUTR, V60, P25, DOI 10.1038/sj.ejcn.1602263; Hlinak Z, 2005, NEUROTOXICOL TERATOL, V27, P465, DOI 10.1016/j.ntt.2005.03.006; HOSTETTE.G, 1967, J COMP PHYSIOL PSYCH, V63, P105, DOI 10.1037/h0024144; Humphries P, 2008, EUR J CLIN NUTR, V62, P451, DOI 10.1038/sj.ejcn.1602866; ISHII H, 1981, TOXICOLOGY, V21, P91, DOI 10.1016/0300-483X(81)90119-0; IZQUIERDO I, 1994, FASEB J, V8, P1139, DOI 10.1096/fasebj.8.14.7958619; JAGENBURG R, 1977, CLIN CHEM, V23, P1654; Janus C, 2004, LEARN MEMORY, V11, P337, DOI 10.1101/lm.70104; Janzen D, 2010, MOL GENET METAB, V99, pS47, DOI 10.1016/j.ymgme.2009.10.009; Jurdak N, 2008, NUTR NEUROSCI, V11, P48, DOI 10.1179/147683008X301333; Kim JY, 2011, FOOD CHEM TOXICOL, V49, P2899, DOI 10.1016/j.fct.2011.08.001; Levy HL, 1999, P NATL ACAD SCI USA, V96, P1811, DOI 10.1073/pnas.96.5.1811; Liang LL, 2011, NEUROREPORT, V22, P617, DOI 10.1097/WNR.0b013e3283495acc; MacDonald J F, 1990, Adv Exp Med Biol, V268, P27; MAHALIK MP, 1984, RES COMMUN PSYCH PSY, V9, P385; MAITER D, 1991, ENDOCRINOLOGY, V128, P1100; Martynyuk AE, 2005, MOL GENET METAB, V86, pS34, DOI 10.1016/j.ymgme.2005.06.014; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Matyskova R, 2008, PHYSIOL RES, V57, P727, DOI 10.33549/physiolres.931274; Mazzola PN, 2011, METAB BRAIN DIS, V26, P291, DOI 10.1007/s11011-011-9264-8; MCANULTY PA, 1989, FUND APPL TOXICOL, V13, P296, DOI 10.1016/0272-0590(89)90265-0; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; NEMEROFF CB, 1978, DEV NEUROSCI-BASEL, V1, P102, DOI 10.1159/000112561; nouye M, 1973, CONGENIT ANOM, V13, P235; OLNEY JW, 1970, NATURE, V227, P609, DOI 10.1038/227609b0; Park CH, 2000, TOXICOL LETT, V115, P117, DOI 10.1016/S0378-4274(00)00188-0; Peruzzo B, 2000, EXP BRAIN RES, V132, P10, DOI 10.1007/s002219900289; POTTS WJ, 1980, J ENVIRON PATHOL TOX, V3, P341; PUESCHEL SM, 1982, OBSTET GYNECOL, V59, P182; REMKE H, 1988, EXP PATHOL-JENA, V33, P223, DOI 10.1016/S0232-1513(88)80076-8; REYNOLDS WA, 1976, J TOXICOL ENV HEALTH, V2, P471, DOI 10.1080/15287397609529448; Riedel G, 2003, BEHAV BRAIN RES, V140, P1, DOI 10.1016/S0166-4328(02)00272-3; Saucier D, 1996, BEHAV NEUROSCI, V110, P103, DOI 10.1037/0735-7044.110.1.103; Scriver C.R., 1995, METABOLIC MOL BASIS, V7th ed, P1015; Scriver CR, 1996, CIBA F SYMP, V197, P73; STEGINK LD, 1979, METABOLISM, V28, P669, DOI 10.1016/0026-0495(79)90021-0; STEGINK LD, 1981, J NUTR, V111, P1688; STEGINK LD, 1990, METABOLISM, V39, P1076, DOI 10.1016/0026-0495(90)90169-D; STOKES AF, 1991, AVIAT SPACE ENVIR MD, V62, P648; TILSON HA, 1991, NEUROTOXICOL TERATOL, V13, P27, DOI 10.1016/0892-0362(91)90024-Q; TOURIAN A, 1972, BIOCHIM BIOPHYS ACTA, V279, P484, DOI 10.1016/0304-4165(72)90170-5; Whalley LJ, 2004, AGEING RES REV, V3, P369, DOI 10.1016/j.arr.2004.05.001; Wolfer DP, 1998, NEWS PHYSIOL SCI, V13, P118, DOI 10.1152/physiologyonline.1998.13.3.118; Wolff M, 2002, BEHAV BRAIN RES, V136, P463, DOI 10.1016/S0166-4328(02)00192-4; Yaffe K, 2007, CURR ALZHEIMER RES, V4, P123, DOI 10.2174/156720507780362191; Yang Qing, 2010, Yale Journal of Biology and Medicine, V83, P101; YEH GC, 1990, MOL PHARMACOL, V38, P14; YOKOGOSHI H, 1984, AM J CLIN NUTR, V40, P1; Yu TX, 1997, BRAIN RES, V747, P195, DOI 10.1016/S0006-8993(96)01181-X; Zagreda L, 1999, J NEUROSCI, V19, P6175, DOI 10.1523/JNEUROSCI.19-14-06175.1999	80	32	34	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e31570	10.1371/journal.pone.0031570	http://dx.doi.org/10.1371/journal.pone.0031570			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509243	Green Published, Green Submitted, gold			2022-12-27	WOS:000304805900001
J	Hwang, JY; Park, J; Kang, BJ; Lubow, DJ; Chu, D; Farkas, DL; Shung, KK; Medina-Kauwe, LK				Hwang, Jae Youn; Park, Jinhyoung; Kang, Bong Jin; Lubow, David J.; Chu, David; Farkas, Daniel L.; Shung, K. Kirk; Medina-Kauwe, Lali K.			Multimodality Imaging In Vivo for Preclinical Assessment of Tumor-Targeted Doxorubicin Nanoparticles	PLOS ONE			English	Article							NONVIRAL GENE DELIVERY; AD5 PENTON PROTEINS; HUMAN BREAST; CELL-GROWTH; CANCER; ULTRASOUND; APOPTOSIS; INHIBITION; SYSTEMS; DEATH	This study presents a new multimodal imaging approach that includes high-frequency ultrasound, fluorescence intensity, confocal, and spectral imaging to improve the preclinical evaluation of new therapeutics in vivo. Here we use this approach to assess in vivo the therapeutic efficacy of the novel chemotherapy construct, HerDox during and after treatment. HerDox is comprised of doxorubicin non-covalently assembled in a viral-like particle targeted to HER2+ tumor cells, causing tumor cell death at over 10-fold lower dose compared to the untargeted drug, while sparing the heart. Whereas our initial proof-of-principle studies on HerDox used tumor growth/shrinkage rates as a measure of therapeutic efficacy, here we show that multimodal imaging deployed during and after treatment can supplement traditional modes of tumor monitoring to further characterize the particle in tissues of treated mice. Specifically, we show here that tumor cell apoptosis elicited by HerDox can be monitored in vivo during treatment using high frequency ultrasound imaging, while in situ confocal imaging of excised tumors shows that HerDox indeed penetrated tumor tissue and can be detected at the subcellular level, including in the nucleus, via Dox fluorescence. In addition, ratiometric spectral imaging of the same tumor tissue enables quantitative discrimination of HerDox fluorescence from autofluorescence in situ. In contrast to standard approaches of preclinical assessment, this new method provides multiple/complementary information that may shorten the time required for initial evaluation of in vivo efficacy, thus potentially reducing the time and cost for translating new drug molecules into the clinic.	[Hwang, Jae Youn; Lubow, David J.; Chu, David; Farkas, Daniel L.; Medina-Kauwe, Lali K.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Park, Jinhyoung; Kang, Bong Jin; Farkas, Daniel L.; Shung, K. Kirk] Univ So Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA; [Medina-Kauwe, Lali K.] Univ Calif Los Angeles, Dept Med, Geffen Sch Med, Los Angeles, CA 90024 USA	Cedars Sinai Medical Center; University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Hwang, JY (corresponding author), Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA.	hwangjy@cshs.org	Park, Jinhyoung/G-1374-2013	Medina-Kauwe, Lali/0000-0002-9807-5523	NIH [R21 CA116014, R01 CA140995, R01 CA129822, R01-HL79976, P41-EB2182]; Department of Defense (DoD) [BC050662]; Susan G. Komen Breast Cancer foundation [BCTR0201194]; Donna and Jesse Garber Award; NATIONAL CANCER INSTITUTE [R01CA129822, R21CA116014, R01CA140995] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079976] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002182] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense (DoD)(United States Department of Defense); Susan G. Komen Breast Cancer foundation(Susan G. Komen Breast Cancer Foundation); Donna and Jesse Garber Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by grants from the NIH (R21 CA116014, R01 CA140995, and R01 CA129822 to LKMK/R01-HL79976 and P41-EB2182 to K.K. Shung), the Department of Defense (DoD) (BC050662), the Susan G. Komen Breast Cancer foundation (BCTR0201194), the Donna and Jesse Garber Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agadjanian H, 2012, NANOMEDICINE-UK, V7, P335, DOI [10.2217/NNM.11.104, 10.2217/nnm.11.104]; Agadjanian H, 2009, P NATL ACAD SCI USA, V106, P6105, DOI 10.1073/pnas.0901531106; Bhushan KR, 2008, J AM CHEM SOC, V130, P17648, DOI 10.1021/ja807099s; Brand S, 2009, ULTRASOUND MED BIOL, V35, P482, DOI 10.1016/j.ultrasmedbio.2008.09.014; Cai W, 2008, EUR J NUCL MED MOL I, V35, P186, DOI 10.1007/s00259-007-0560-9; Cherry SR, 2006, ANNU REV BIOMED ENG, V8, P35, DOI 10.1146/annurev.bioeng.8.061505.095728; Cruz LJ, 2011, MOL PHARMACEUT, V8, P520, DOI 10.1021/mp100356k; Czarnota GJ, 1999, BRIT J CANCER, V81, P520, DOI 10.1038/sj.bjc.6690724; Gregory CW, 2005, CLIN CANCER RES, V11, P1704, DOI 10.1158/1078-0432.CCR-04-1158; Hennings L, 2009, INT J HYPERTHER, V25, P355, DOI 10.1080/02656730902964357; Hsu AR, 2007, J NUCL MED, V48, P445; Hwang J.Y., 2011, MOL IMAGING BIOL; Hwang JY, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3589299; JESCHKE M, 1995, INT J CANCER, V60, P730, DOI 10.1002/ijc.2910600527; Kelly KA, 2005, CIRC RES, V96, P327, DOI 10.1161/01.RES.0000155722.17881.dd; Kim J, 2009, CHEM SOC REV, V38, P372, DOI 10.1039/b709883a; Lecchi M, 2007, Q J NUCL MED MOL IM, V51, P111; Lewis GD, 1996, CANCER RES, V56, P1457; Medarova Z, 2006, NAT PROTOC, V1, P429, DOI 10.1038/nprot.2006.63; Medina-Kauwe LK, 2001, GENE THER, V8, P795, DOI 10.1038/sj.gt.3301448; Medina-Kauwe LK, 2001, GENE THER, V8, P1753, DOI 10.1038/sj.gt.3301583; Mulder WJM, 2009, ANGIOGENESIS, V12, P17, DOI 10.1007/s10456-008-9124-2; Nahrendorf M, 2009, ARTERIOSCL THROM VAS, V29, P1444, DOI 10.1161/ATVBAHA.109.193086; Petrovsky A, 2003, CANCER RES, V63, P1936; Stell A, 2007, Q J NUCL MED MOL IM, V51, P127; Sun L, 2007, IEEE T ULTRASON FERR, V54, P1648, DOI 10.1109/TUFFC.2007.436; van der Horst EH, 2005, INT J CANCER, V113, P689, DOI 10.1002/ijc.20643; Vanderheyden JL, 2009, Q J NUCL MED MOL IM, V53, P374; Vlad RM, 2011, METHODS MOL BIOL, V682, P165, DOI 10.1007/978-1-60327-409-8_13; Vlad RM, 2010, MED PHYS, V37, P4288, DOI 10.1118/1.3459020; Waerzeggers Y, 2008, MOL IMAGING, V7, P77, DOI 10.2310/7290.2008.0010; Wei HJ, 2004, SPECTROSC SPECT ANAL, V24, P524; Wessels JT, 2007, CYTOM PART A, V71A, P542, DOI 10.1002/cyto.a.20419; Zaidi H, 2009, J MED PHYS, V34, P122, DOI 10.4103/0971-6203.54844	34	27	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34463	10.1371/journal.pone.0034463	http://dx.doi.org/10.1371/journal.pone.0034463			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509306	Green Published, gold, Green Submitted			2022-12-27	WOS:000304805900034
J	McGraw, KL; Fuhler, GM; Johnson, JO; Clark, JA; Caceres, GC; Sokol, L; List, AF				McGraw, Kathy L.; Fuhler, Gwenny M.; Johnson, Joseph O.; Clark, Justine A.; Caceres, Gisela C.; Sokol, Lubomir; List, Alan F.			Erythropoietin Receptor Signaling Is Membrane Raft Dependent	PLOS ONE			English	Article							LIPID RAFTS; LYMPHOCYTE FUNCTION; ACTIVATION; GTPASES; STAT5; EXPRESSION; EXPANSION; KINASE; CELLS; PLAY	Upon erythropoietin (Epo) engagement, Epo-receptor (R) homodimerizes to activate JAK2 and Lyn, which phosphorylate STAT5. Although recent investigations have identified key negative regulators of Epo-R signaling, little is known about the role of membrane localization in controlling receptor signal fidelity. Here we show a critical role for membrane raft (MR) microdomains in creation of discrete signaling platforms essential for Epo-R signaling. Treatment of UT7 cells with Epo induced MR assembly and coalescence. Confocal microscopy showed that raft aggregates significantly increased after Epo stimulation (mean, 4.3 +/- 1.4(SE) vs. 25.6 +/- 3.2 aggregates/cell; p <= 0.001), accompanied by a >3-fold increase in cluster size (p <= 0.001). Raft fraction immunoblotting showed Epo-R translocation to MR after Epo stimulation and was confirmed by fluorescence microscopy in Epo stimulated UT7 cells and primary erythroid bursts. Receptor recruitment into MR was accompanied by incorporation of JAK2, Lyn, and STAT5 and their activated forms. Raft disruption by cholesterol depletion extinguished Epo induced Jak2, STAT5, Akt and MAPK phosphorylation in UT7 cells and erythroid progenitors. Furthermore, inhibition of the Rho GTPases Rac1 or RhoA blocked receptor recruitment into raft fractions, indicating a role for these GTPases in receptor trafficking. These data establish a critical role for MR in recruitment and assembly of Epo-R and signal intermediates into discrete membrane signaling units.	[McGraw, Kathy L.; Clark, Justine A.; Caceres, Gisela C.; Sokol, Lubomir; List, Alan F.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Malignant Hematol, Tampa, FL 33682 USA; [McGraw, Kathy L.] Univ S Florida, Canc Biol PhD Program, Tampa, FL USA; [Fuhler, Gwenny M.] Univ Med Ctr Rotterdam, Dept Gasteroenterol & Hepatol, Erasmus MC, Rotterdam, Netherlands; [Johnson, Joseph O.] Univ S Florida, H Lee Moffitt Canc Ctr, Analyt Microscopy Core Facil, Tampa, FL 33682 USA	H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Erasmus University Rotterdam; Erasmus MC; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	McGraw, KL (corresponding author), Univ S Florida, H Lee Moffitt Canc Ctr, Dept Malignant Hematol, Tampa, FL 33682 USA.	Alan.List@moffitt.org	Fuhler, Gwenny/AAC-7122-2019	Fuhler, Gwenny/0000-0001-9221-4855; LIST, ALAN/0000-0002-1647-2972	WES Foundation; Dutch Cancer Society [EMCR 2010-4737]; National Cancer Institute/National Institutes of Health [5R01CA13107604]; NATIONAL CANCER INSTITUTE [R01CA131076, P30CA076292] Funding Source: NIH RePORTER	WES Foundation; Dutch Cancer Society(KWF Kankerbestrijding); National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	GMF was financially supported by the WES Foundation and the Dutch Cancer Society (EMCR 2010-4737). This work was also funded by the National Cancer Institute/National Institutes of Health grant 5R01CA13107604 and a generous donation from Martin Schaffel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellamy WT, 2001, BLOOD, V97, P1427, DOI 10.1182/blood.V97.5.1427; Chin H, 1998, BLOOD, V91, P3734; Elliott S, 2006, BLOOD, V107, P1892, DOI 10.1182/blood-2005-10-4066; Elliott S, 2010, J IMMUNOL METHODS, V352, P126, DOI 10.1016/j.jim.2009.10.006; Fuhler GM, 2004, J LEUKOCYTE BIOL, V76, P254, DOI 10.1189/jlb.0204071; Fuhler GM, 2007, J LEUKOCYTE BIOL, V81, P449, DOI 10.1189/jlb.0506311; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Harder KW, 2004, BLOOD, V104, P3901, DOI 10.1182/blood-2003-12-4396; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hillyard DZ, 2004, ATHEROSCLEROSIS, V175, P305, DOI 10.1016/j.atherosclerosis.2004.03.018; Hoefsloot LH, 1997, BLOOD, V89, P1690, DOI 10.1182/blood.V89.5.1690.1690_1690_1700; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Ingley E, 2005, ONCOGENE, V24, P336, DOI 10.1038/sj.onc.1208199; Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204; Ji P, 2010, HAEMATOL-HEMATOL J, V95, P2, DOI 10.3324/haematol.2009.015511; Jury EC, 2006, J IMMUNOL, V177, P7416, DOI 10.4049/jimmunol.177.10.7416; Kabouridis PS, 2008, FEBS LETT, V582, P3711, DOI 10.1016/j.febslet.2008.10.006; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kalfa TA, 2010, HAEMATOL-HEMATOL J, V95, P27, DOI 10.3324/haematol.2009.006239; Karur VG, 2006, BLOOD, V108, P1524, DOI 10.1182/blood-2005-09-008243; Langlet C, 2000, CURR OPIN IMMUNOL, V12, P250, DOI 10.1016/S0952-7915(00)00084-4; Liang K, 2010, CANCER CELL, V18, P423, DOI 10.1016/j.ccr.2010.10.025; Murphy SC, 2007, BLOOD, V110, P2132, DOI 10.1182/blood-2007-04-083873; Rane SG, 2002, ONCOGENE, V21, P3334, DOI 10.1038/sj.onc.1205398; Rentero C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002262; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sinclair AM, 2010, BLOOD, V115, P4264, DOI 10.1182/blood-2009-10-248666; Swift S, 2010, BLOOD, V115, P4254, DOI 10.1182/blood-2009-10-248674; Tilbrook PA, 1997, EMBO J, V16, P1610, DOI 10.1093/emboj/16.7.1610; WITTHUHN BA, 1993, CELL, V74, P227, DOI 10.1016/0092-8674(93)90414-L; Wojchowski DM, 1999, EXP CELL RES, V253, P143, DOI 10.1006/excr.1999.4673; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4	33	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34477	10.1371/journal.pone.0034477	http://dx.doi.org/10.1371/journal.pone.0034477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509308	gold, Green Published, Green Submitted			2022-12-27	WOS:000304805900036
J	Thampi, P; Rao, HV; Mitter, SK; Cai, J; Mao, HY; Li, H; Seo, S; Qi, XP; Lewin, AS; Romano, C; Boulton, ME				Thampi, Prajitha; Rao, Haripriya Vittal; Mitter, Sayak K.; Cai, Jun; Mao, Haoyu; Li, Hong; Seo, Soojung; Qi, Xiaoping; Lewin, Alfred S.; Romano, Carl; Boulton, Michael E.			The 5HT(1a) Receptor Agonist 8-Oh DPAT Induces Protection from Lipofuscin Accumulation and Oxidative Stress in the Retinal Pigment Epithelium	PLOS ONE			English	Article							BAY X 3702; MITOCHONDRIAL-DNA DAMAGE; GLOBAL CEREBRAL-ISCHEMIA; FUNDUS AUTOFLUORESCENCE; SEROTONIN(1A) RECEPTOR; MACULAR DEGENERATION; GEOGRAPHIC ATROPHY; IN-VIVO; PROTEIN-KINASE; MOUSE MODEL	Age-related macular degeneration (AMD), a major cause of blindness in the elderly, is associated with oxidative stress, lipofuscin accumulation and retinal degeneration. The aim of this study was to determine if a 5-HT1A receptor agonist can reduce lipofuscin accumulation, reduce oxidative damage and prevent retinal cell loss both in vitro and in vivo. Autophagy-derived and photoreceptor outer segment (POS)-derived lipofuscin formation was assessed using FACS analysis and confocal microscopy in cultured retinal pigment epithelial (RPE) cells in the presence or absence of the 5-HT1A receptor agonist, 8-OH DPAT. 8-OH DPAT treatment resulted in a dose-dependent reduction in both autophagy-and POS-derived lipofuscin compared to control. Reduction in autophagy-induced lipofuscin was sustained for 4 weeks following removal of the drug. The ability of 8-OH DPAT to reduce oxidative damage following exposure to 200 mu M H2O2 was assessed. 8-OH DPAT reduced superoxide generation and increased mitochondrial superoxide dismutase (MnSOD) levels and the ratio of reduced glutathione to the oxidized form of glutathione in H2O2-treated cells compared to controls and protected against H2O2-initiated lipid peroxidation, nitrotyrosine levels and mitochondrial damage. SOD2 knockdown mice, which have an AMD-like phenotype, received daily subcutaneous injections of either saline, 0.5 or 5.0 mg/kg 8-OH DPAT and were evaluated at monthly intervals. Systemic administration of 8-OH DPAT improved the electroretinogram response in SOD2 knockdown eyes of mice compared to knockdown eyes receiving vehicle control. There was a significant increase in the ONL thickness in mice treated with 8-OH DPAT at 4 months past the time of MnSOD knockdown compared to untreated controls together with a 60% reduction in RPE lipofuscin. The data indicate that 5-HT1A agonists can reduce lipofuscin accumulation and protect the retina from oxidative damage and mitochondrial dysfunction. 5-HT1A receptor agonists may have potential as therapeutic agents in the treatment of retinal degenerative disease.	[Thampi, Prajitha; Rao, Haripriya Vittal; Mitter, Sayak K.; Cai, Jun; Qi, Xiaoping; Boulton, Michael E.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA; [Mao, Haoyu; Li, Hong; Seo, Soojung; Lewin, Alfred S.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Romano, Carl] Alcon Labs Inc, Retina Res, Ft Worth, TX 76101 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Novartis; Alcon	Thampi, P (corresponding author), Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32610 USA.	meboulton@ufl.edu		Lewin, Alfred/0000-0002-4192-9727	National Institutes of Health [EY019688]; Alcon Labs, Inc; NATIONAL EYE INSTITUTE [P30EY021721, R01EY019688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alcon Labs, Inc(Novartis); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by National Institutes of Health grant EY019688 (MEB) and a grant from Alcon Labs, Inc (MEB & ASL). CR is an employee of Alcon Labs, Inc. and contributed to the study design and preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adayev T, 1999, J NEUROCHEM, V72, P1489, DOI 10.1046/j.1471-4159.1999.721489.x; Ahlemeyer B, 1997, BRAIN RES, V777, P179; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Bezard E, 2006, NEUROBIOL DIS, V23, P77, DOI 10.1016/j.nbd.2006.02.003; Boulton M, 2004, PHOTOCH PHOTOBIO SCI, V3, P759, DOI 10.1039/b400108g; BOULTON M, 1989, INVEST OPHTH VIS SCI, V30, P82; Boulton M. E., 2009, FUNDUS AUTOFLUORESCE, P14; BOULTON ME, 1983, EXP EYE RES, V37, P307, DOI 10.1016/0014-4835(83)90166-5; Brizee K, 1981, AGE PIGMENTS, P317; BRUNK UT, 1992, MUTAT RES, V275, P395, DOI 10.1016/0921-8734(92)90042-N; Burke JM, 1998, INVEST OPHTH VIS SCI, V39, P1478; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018076; Collier RJ, 2011, INVEST OPHT IN PRESS; Collier RJ, 2011, INVEST OPHTH VIS SCI, V52, P2118, DOI 10.1167/iovs.10-6304; Curcio CA, 1996, INVEST OPHTH VIS SCI, V37, P1236; Druse MJ, 2006, BRAIN RES, V1092, P79, DOI 10.1016/j.brainres.2006.02.065; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Godley BF, 2005, J BIOL CHEM, V280, P21061, DOI 10.1074/jbc.M502194200; Hageman GS, 1999, MOL VIS, V5; Holz FG, 2001, INVEST OPHTH VIS SCI, V42, P1051; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Hsiung SC, 2005, J NEUROCHEM, V95, P1653, DOI 10.1111/j.1471-4159.2005.03496.x; Jarrett SG, 2005, FREE RADICAL BIO MED, V38, P1382, DOI 10.1016/j.freeradbiomed.2005.02.003; Justilien V, 2007, INVEST OPHTH VIS SCI, V48, P4407, DOI 10.1167/iovs.07-0432; Kline AE, 2002, NEUROSCI LETT, V333, P179, DOI 10.1016/S0304-3940(02)01101-1; Kukley M, 2001, NEUROSCIENCE, V107, P405, DOI 10.1016/S0306-4522(01)00369-4; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P3521, DOI 10.1167/iovs.10-6163; Liu YL, 2006, AM J RESP CELL MOL, V34, P182, DOI 10.1165/rcmb.2005-0163OC; Lois N, 2002, AM J OPHTHALMOL, V133, P341, DOI 10.1016/S0002-9394(01)01404-0; Madhavan L, 2003, J PHARMACOL EXP THER, V304, P913, DOI 10.1124/jpet.102.044370; Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102; de Freitas RLM, 2010, BRAIN RES BULL, V81, P505, DOI 10.1016/j.brainresbull.2009.09.014; Nash MS, 1997, INVEST OPHTH VIS SCI, V38, P510; Oosterink BJ, 2003, NEUROREPORT, V14, P57, DOI 10.1097/00001756-200301200-00011; PERUCHE B, 1994, J NEURAL TRANSM-PARK, V8, P73, DOI 10.1007/BF02250918; PIERA MJ, 1995, ARCH INT PHARMACOD T, V329, P347; Pucadyil TJ, 2005, CELL MOL NEUROBIOL, V25, P553, DOI 10.1007/s10571-005-3969-3; Radu RA, 2005, INVEST OPHTH VIS SCI, V46, P4393, DOI 10.1167/iovs.05-0820; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; Ramos AJ, 2004, BRAIN RES, V1030, P201, DOI 10.1016/j.brainres.2004.10.019; Rojo AI, 2004, J NEUROSCI, V24, P7324, DOI 10.1523/JNEUROSCI.2111-04.2004; Schmitz-Valckenberg S, 2004, INVEST OPHTH VIS SCI, V45, P4470, DOI 10.1167/iovs.03-1311; Semkova I, 1998, EUR J PHARMACOL, V359, P251, DOI 10.1016/S0014-2999(98)00634-7; Solbach U, 1997, RETINA-J RET VIT DIS, V17, P385; Sparrow JR, 2005, EXP EYE RES, V80, P595, DOI 10.1016/j.exer.2005.01.007; Suchanek B, 1998, EUR J PHARMACOL, V355, P95, DOI 10.1016/S0014-2999(98)00469-5; Sullivan NR, 2005, N-S ARCH PHARMACOL, V371, P18, DOI 10.1007/s00210-004-1005-7; Timmers A, 2001, MOL VIS, V7, P131; Torup L, 2000, EUR J PHARMACOL, V395, P137, DOI 10.1016/S0014-2999(00)00175-8; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; von Ruckmann A, 1999, GRAEF ARCH CLIN EXP, V237, P1, DOI 10.1007/s004170050186; vonRuckmann A, 1997, ARCH OPHTHALMOL-CHIC, V115, P609, DOI 10.1001/archopht.1997.01100150611006; Wassell J, 1998, INVEST OPHTH VIS SCI, V39, P1487; Wihlmark U, 1996, APMIS, V104, P272, DOI 10.1111/j.1699-0463.1996.tb00717.x; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Zhou JL, 2005, EXP EYE RES, V80, P567, DOI 10.1016/j.exer.2004.11.009	56	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34468	10.1371/journal.pone.0034468	http://dx.doi.org/10.1371/journal.pone.0034468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509307	Green Submitted, Green Published, gold			2022-12-27	WOS:000304805900035
J	Ivanek, R; Osterberg, J; Gautam, R; Lewerin, SS				Ivanek, Renata; Osterberg, Julia; Gautam, Raju; Lewerin, Susanna Sternberg			Salmonella Fecal Shedding and Immune Responses are Dose- and Serotype- Dependent in Pigs	PLOS ONE			English	Article							ANTIBODY-RESPONSES; MULTISTATE MODELS; RISK-FACTORS; TIME-COURSE; TYPHIMURIUM; TRANSMISSION; ENTERICA; FEED; HERD; EXCRETION	Despite the public health importance of Salmonella infection in pigs, little is known about the associated dynamics of fecal shedding and immunity. In this study, we investigated the transitions of pigs through the states of Salmonella fecal shedding and immune response post-Salmonella inoculation as affected by the challenge dose and serotype. Continuous-time multistate Markov models were developed using published experimental data. The model for shedding had four transient states, of which two were shedding (continuous and intermittent shedding) and two non-shedding (latency and intermittent non-shedding), and one absorbing state representing permanent cessation of shedding. The immune response model had two transient states representing responses below and above the seroconversion level. The effects of two doses [low (0.65 x 10(6) CFU/pig) and high (0.65 x 10(9) CFU/pig)] and four serotypes (Salmonella Yoruba, Salmonella Cubana, Salmonella Typhimurium, and Salmonella Derby) on the models' transition intensities were evaluated using a proportional intensities model. Results indicated statistically significant effects of the challenge dose and serotype on the dynamics of shedding and immune response. The time spent in the specific states was also estimated. Continuous shedding was on average 10-26 days longer, while intermittent non-shedding was 2-4 days shorter, in pigs challenged with the high compared to low dose. Interestingly, among pigs challenged with the high dose, the continuous and intermittent shedding states were on average up to 10-17 and 3-4 days longer, respectively, in pigs infected with S. Cubana compared to the other three serotypes. Pigs challenged with the high dose of S. Typhimurium or S. Derby seroconverted on average up to 8-11 days faster compared to the low dose. These findings highlight that Salmonella fecal shedding and immune response following Salmonella challenge are dose-and serotype-dependent and that the detection of specific Salmonella strains and immune responses in pigs are time-sensitive.	[Ivanek, Renata; Gautam, Raju] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA; [Osterberg, Julia] Swedish Natl Vet Inst, Dept Anim Hlth & Antimicrobial Strategies, Uppsala, Sweden; [Lewerin, Susanna Sternberg] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden	Texas A&M University System; Texas A&M University College Station; National Veterinary Institute SVA; Swedish University of Agricultural Sciences	Ivanek, R (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Integrat Biosci, College Stn, TX 77843 USA.	rivanek@cvm.tamu.edu	Lewerin, Susanna Sternberg/C-1621-2015; Ivanek, Renata/B-9005-2009	Lewerin, Susanna Sternberg/0000-0001-7907-8377; Ivanek, Renata/0000-0001-6348-4709	National Science Foundation [NSF-EF-0913367]; Direct For Biological Sciences [0913042, 0913367] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the National Science Foundation grant NSF-EF-0913367 to RI funded under the American Recovery and Reinvestment Act of 2009. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahnson PB, 2006, PREV VET MED, V76, P249, DOI 10.1016/j.prevetmed.2006.05.009; Boqvist S, 2003, ACTA VET SCAND, V44, P181, DOI 10.1186/1751-0147-44-181; Callaway T. R., 2006, Current Issues in Intestinal Microbiology, V7, P65; Centers for Disease Control and Prevention (CDC), 2006, REP FOODB DIS OUTBR; Charles SD, 2000, SWINE HEALTH PROD, V8, P107; Doyle ME, 2009, WHITE PAPER HUMAN IL; Doyle P.M., 1997, FOOD MICROBIOLOGY FU, P171; Eriksson Erik, 2007, BMC Vet Res, V3, P21, DOI 10.1186/1746-6148-3-21; FEDORKACRAY PJ, 1994, VET MICROBIOL, V41, P333, DOI 10.1016/0378-1135(94)90029-9; Garcia-Feliz C, 2009, PREV VET MED, V91, P130, DOI 10.1016/j.prevetmed.2009.05.011; GENTLEMAN RC, 1994, STAT MED, V13, P805, DOI 10.1002/sim.4780130803; Gill J, 2004, SOCIOL METHOD RES, V33, P54, DOI 10.1177/0049124103262681; Gray JT, 1996, AM J VET RES, V57, P313; Hendriksen SWM, 2004, EMERG INFECT DIS, V10, P2225, DOI 10.3201/eid1012.040286; Hougaard P, 1999, LIFETIME DATA ANAL, V5, P239, DOI 10.1023/A:1009672031531; Huston CL, 2002, J AM VET MED ASSOC, V220, P650, DOI 10.2460/javma.2002.220.650; Ivanek R, 2004, J FOOD PROTECT, V67, P2403, DOI 10.4315/0362-028X-67.11.2403; Ivaneka R, 2007, J THEOR BIOL, V245, P44, DOI 10.1016/j.jtbi.2006.09.031; Jackson C, 2010, MULTISTATE MARKOV HI; Jackson Christopher, 2007, MULTISTATE MODELLING; Jensen AN, 2006, APPL ENVIRON MICROB, V72, P1833, DOI 10.1128/AEM.72.3.1833-1842.2006; KALBFLEISCH JD, 1985, J AM STAT ASSOC, V80, P863, DOI 10.2307/2288545; KAY R, 1986, BIOMETRICS, V42, P855, DOI 10.2307/2530699; Korsak N, 2006, INT J FOOD MICROBIOL, V108, P246, DOI 10.1016/j.ijfoodmicro.2005.09.013; Machado LM, 2007, COMPUT METH PROG BIO, V86, P131, DOI 10.1016/j.cmpb.2007.01.010; MALMQVIST M, 1995, ACTA VET SCAND, V36, P21; MARSHALL G, 1995, STAT MED, V14, P1975, DOI 10.1002/sim.4780141804; Molla B, 2010, APPL ENVIRON MICROB, V76, P7188, DOI 10.1128/AEM.01169-10; Nielsen B, 1995, VET MICROBIOL, V47, P205, DOI 10.1016/0378-1135(95)00113-1; Osterberg J, 2008, VET REC, V162, P580, DOI 10.1136/vr.162.18.580; Osterberg J, 2006, ACTA VET SCAND, V47, P13, DOI 10.1186/1751-0147-47-13; Osterberg J, 2009, VET REC, V165, P404, DOI 10.1136/vr.165.14.404; Osterberg J, 2001, BERL MUNCH TIERARZTL, V114, P331; Osterberg J, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-30; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Radke BR, 2003, PREV VET MED, V59, P241, DOI 10.1016/S0167-5877(03)00103-X; Rccourt J, 1997, FOOD MICROBIOLOGY FU, P337; Sanchez J, 2007, PREV VET MED, V81, P148, DOI 10.1016/j.prevetmed.2007.04.005; Scherer K, 2008, J FOOD PROTECT, V71, P699, DOI 10.4315/0362-028X-71.4.699; Taormina PJ, 1999, EMERG INFECT DIS, V5, P626, DOI 10.3201/eid0505.990503; van Winsen RL, 2001, VET MICROBIOL, V80, P267, DOI 10.1016/S0378-1135(01)00313-3; WHO (World Health Organization), 2005, DRUG RES SALM	42	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34660	10.1371/journal.pone.0034660	http://dx.doi.org/10.1371/journal.pone.0034660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523553	Green Published, gold, Green Submitted			2022-12-27	WOS:000305345000023
J	Stier, AC; Gil, MA; McKeon, CS; Lemer, S; Leray, M; Mills, SC; Osenberg, CW				Stier, Adrian C.; Gil, Michael A.; McKeon, C. Seabird; Lemer, Sarah; Leray, Matthieu; Mills, Suzanne C.; Osenberg, Craig W.			Housekeeping Mutualisms: Do More Symbionts Facilitate Host Performance?	PLOS ONE			English	Article							ANTAGONISTIC INTERACTIONS; COMMUNITY STRUCTURE; SEDIMENT-REJECTION; CORALS; GROWTH; COMPETITION; MECHANISMS; CRUSTACEA; BRACHYURA; BEHAVIOR	Mutualisms often involve one host supporting multiple symbionts, whose identity, density and intraguild interactions can influence the nature of the mutualism and performance of the host. However, the implications of multiple co-occurring symbionts on services to a host have rarely been quantified. In this study, we quantified effects of decapod symbionts on removal of sediment from their coral host. Our field survey showed that all common symbionts typically occur as pairs and never at greater abundances. Two species, the crab Trapezia serenei and the shrimp Alpheus lottini, were most common and co-occurred more often than expected by chance. We conducted a mesocosm experiment to test for effects of decapod identity and density on sediment removal. Alone, corals removed 10% of sediment, but removal increased to 30% and 48% with the presence of two and four symbionts, respectively. Per-capita effects of symbionts were independent of density and identity. Our results suggest that symbiont density is restricted by intraspecific competition. Thus, increased sediment removal from a coral host can only be achieved by increasing the number of species of symbionts on that coral, even though these species are functionally equivalent. Symbiont diversity plays a key role, not through added functionality but by overcoming density limitation likely imposed by intraspecific mating systems.	[Stier, Adrian C.; Gil, Michael A.; McKeon, C. Seabird; Osenberg, Craig W.] Univ Florida, Dept Biol, Gainesville, FL 32610 USA; [Lemer, Sarah; Leray, Matthieu; Mills, Suzanne C.] Univ Perpignan, Lab Excellence CORAIL, USR 3278, CNRS,EPHE,CBETM, F-66025 Perpignan, France; [McKeon, C. Seabird] Smithsonian Marine Stn, Smithsonian Inst Marine Sci Network, Ft Pierce, FL USA	State University System of Florida; University of Florida; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Perpignan Via Domitia; Smithsonian Institution; Smithsonian National Museum of Natural History	Stier, AC (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32610 USA.	adrian.stier@gmail.com	Mills, Suzanne/K-5538-2012; Osenberg, Craig/M-9904-2013	Mills, Suzanne/0000-0001-8948-3384; McKeon, Seabird/0000-0001-7261-8094; Leray, Matthieu/0000-0002-7327-1878; Stier, Adrian/0000-0002-4704-4145; Osenberg, Craig/0000-0003-1918-7904; Lemer, Sarah/0000-0003-0048-7296	Partnership University Fund of the French American Cultural Exchange (Ocean Bridges Program); National Science Foundation [OCE-1130359, DGE-0802270]; Division Of Ocean Sciences [1130359] Funding Source: National Science Foundation	Partnership University Fund of the French American Cultural Exchange (Ocean Bridges Program); National Science Foundation(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Financial support was provided by the Partnership University Fund of the French American Cultural Exchange (Ocean Bridges Program, http://facecouncil.org/puf/) and the National Science Foundation (Grant No. OCE-1130359; and a Graduate Research Fellowship awarded to Dr. Gil, Grant No. DGE-0802270) for financial support. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele L.G., 1976, Journal Biogeogr, V3, P35; Altshuler DL, 1999, OECOLOGIA, V119, P600, DOI 10.1007/s004420050825; BILLICK I, 1994, ECOLOGY, V75, P1529, DOI 10.2307/1939614; BOUCHER DH, 1982, ANNU REV ECOL SYST, V13, P315, DOI 10.1146/annurev.es.13.110182.001531; Bracken MES, 2007, ECOLOGY, V88, P2211, DOI 10.1890/06-0881.1; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Caley MJ, 2001, ECOLOGY, V82, P2001; CASTRO P, 1978, MAR BIOL, V46, P237, DOI 10.1007/BF00390685; Crowley PH, 2011, TRENDS ECOL IN PRESS, DOI [10.1016/j.tree.2011.1007.1011, DOI 10.1016/J.TREE.2011.1007.1011]; DODGE RE, 1974, NATURE, V247, P574, DOI 10.1038/247574a0; Domenech J, 2004, FOREST ECOL MANAG, V194, P293, DOI 10.1016/j.foreco.2004.02.026; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; GLYNN PW, 1983, MAR BIOL LETT, V4, P105; Goheen JR, 2010, CURR BIOL, V20, P1768, DOI 10.1016/j.cub.2010.08.015; Gomulkiewicz R, 2003, AM NAT, V162, pS80, DOI 10.1086/378705; Griffen BD, 2006, OECOLOGIA, V148, P702, DOI 10.1007/s00442-006-0414-3; Hay ME, 2004, ANNU REV ECOL EVOL S, V35, P175, DOI 10.1146/annurev.ecolsys.34.011802.132357; HUBBARD DK, 1985, B MAR SCI, V36, P325; Hubbard J.A.E.B., 1972, Geologische Rundschau, V62, P598; HUBER ME, 1986, MAR ECOL PROG SER, V30, P21, DOI 10.3354/meps030021; HUBER ME, 1987, J CRUSTACEAN BIOL, V7, P238, DOI 10.2307/1548604; Jonsson LM, 2001, OIKOS, V93, P353, DOI 10.1034/j.1600-0706.2001.930301.x; LASKER HR, 1980, J EXP MAR BIOL ECOL, V47, P77, DOI 10.1016/0022-0981(80)90139-2; Loreau M, 2004, OIKOS, V104, P606, DOI 10.1111/j.0030-1299.2004.12685.x; McKeon CS, 2011, OECOLOGIA IN PRESS; McKeon CS, 2010, DIVERSITY TROPICAL M; Morris WF, 2007, ECOLOGY, V88, P1021, DOI 10.1890/06-0442; Oliveira RS, 2005, CHEMOSPHERE, V60, P1462, DOI 10.1016/j.chemosphere.2005.01.038; Palmer TM, 2003, AM NAT, V162, pS63, DOI 10.1086/378682; Palmer TM, 2008, SCIENCE, V319, P192, DOI 10.1126/science.1151579; Patton W.K., 1974, SYMBIOSIS SEA, P210; Pratchett MS, 2001, MAR ECOL PROG SER, V214, P111, DOI 10.3354/meps214111; Raine NE, 2004, ECOL ENTOMOL, V29, P345, DOI 10.1111/j.0307-6946.2004.00608.x; Rypien KL, 2010, ENVIRON MICROBIOL, V12, P28, DOI 10.1111/j.1462-2920.2009.02027.x; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; Stachowicz JJ, 2005, ECOLOGY, V86, P2418, DOI 10.1890/04-0819; STAFFORDSMITH MG, 1992, AUST J MAR FRESH RES, V43, P683, DOI 10.1071/MF9920683; Stanton ML, 2003, AM NAT, V162, pS10, DOI 10.1086/378646; Stewart HL, 2006, CORAL REEFS, V25, P609, DOI 10.1007/s00338-006-0132-7; Stier AC, 2010, CORAL REEFS, V29, P1019, DOI 10.1007/s00338-010-0663-9; Vance-Chalcraft HD, 2007, ECOLOGY, V88, P2689, DOI 10.1890/06-1869.1; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	42	27	28	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e32079	10.1371/journal.pone.0032079	http://dx.doi.org/10.1371/journal.pone.0032079			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523536	Green Submitted, Green Published, gold			2022-12-27	WOS:000305345000005
J	Heymann, EW; Luttmann, K; Michalczyk, IM; Saboya, PPP; Ziegenhagen, B; Bialozyt, R				Heymann, Eckhard W.; Luettmann, Kathrin; Michalczyk, Inga M.; Pinedo Saboya, Pedro Pablo; Ziegenhagen, Birgit; Bialozyt, Ronald			DNA Fingerprinting Validates Seed Dispersal Curves from Observational Studies in the Neotropical Legume Parkia	PLOS ONE			English	Article							SAGUINUS-FUSCICOLLIS; SPATIAL-PATTERNS; MONKEYS; TAMARINS; ECOLOGY; IDENTIFICATION; LEGUMINOSAE; FRUGIVORES; PRIMATES; DISTANCE	Background: Determining the distances over which seeds are dispersed is a crucial component for examining spatial patterns of seed dispersal and their consequences for plant reproductive success and population structure. However, following the fate of individual seeds after removal from the source tree till deposition at a distant place is generally extremely difficult. Here we provide a comparison of observationally and genetically determined seed dispersal distances and dispersal curves in a Neotropical animal-plant system. Methodology/Principal Findings: In a field study on the dispersal of seeds of three Parkia (Fabaceae) species by two Neotropical primate species, Saguinus fuscicollis and Saguinus mystax, in Peruvian Amazonia, we observationally determined dispersal distances. These dispersal distances were then validated through DNA fingerprinting, by matching DNA from the maternally derived seed coat to DNA from potential source trees. We found that dispersal distances are strongly rights-kewed, and that distributions obtained through observational and genetic methods and fitted distributions do not differ significantly from each other. Conclusions/Significance: Our study showed that seed dispersal distances can be reliably estimated through observational methods when a strict criterion for inclusion of seeds is observed. Furthermore, dispersal distances produced by the two primate species indicated that these primates fulfil one of the criteria for efficient seed dispersers. Finally, our study demonstrated that DNA extraction methods so far employed for temperate plant species can be successfully used for hard-seeded tropical plants.	[Heymann, Eckhard W.; Luettmann, Kathrin] Deutsch Primatenzentrum GmbH, Abt Verhaltensokol & Soziobiol, Gottingen, Germany; [Michalczyk, Inga M.; Ziegenhagen, Birgit; Bialozyt, Ronald] Univ Marburg, AG Nat Schutzbiol, Marburg, Germany; [Michalczyk, Inga M.] Mobile DNAnal, Ebsdorfergrund, Germany; [Pinedo Saboya, Pedro Pablo] Univ Nacl Amazonia Peruana, Fac Ciencias Forestales, Iquitos, Peru	Deutsches Primatenzentrum (DPZ); Philipps University Marburg; Universidad Nacional de la Amazonia Peruana	Heymann, EW (corresponding author), Deutsch Primatenzentrum GmbH, Abt Verhaltensokol & Soziobiol, Gottingen, Germany.	eheyman@gwdg.de	Heymann, Eckhard W./I-2422-2014; Bialozyt, Ronald B/I-2021-2014	Heymann, Eckhard W./0000-0002-4259-8018; Bialozyt, Ronald B/0000-0003-0101-9443	Deutsche Forschungsgemeinschaft [HE 1870/15-1, HE 1870/15-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding provided by the Deutsche Forschungsgemeinschaft, grant no. HE 1870/15-1 and HE 1870/15-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowler M, 2011, INT J PRIMATOL, V32, P1109, DOI 10.1007/s10764-011-9527-6; Chapman Colin A., 1995, Evolutionary Anthropology, V4, P74, DOI 10.1002/evan.1360040303; Culot L, 2009, THESIS U LIEGE LIEGE; Culot L, 2010, INT J PRIMATOL, V31, P553, DOI 10.1007/s10764-010-9413-7; Dew JL, 2008, CAM S BIO EVOL ANTHR, V55, P155; Dumolin S, 1995, THEOR APPL GENET, V91, P1253, DOI 10.1007/BF00220937; ENCARNACION F, 1985, Candollea, V40, P237; Feldmann Marianne, 2000, Ecotropica (Bonn), V6, P207; Godoy JA, 2001, MOL ECOL, V10, P2275, DOI 10.1046/j.0962-1083.2001.01342.x; HEYMANN EW, 1995, J ZOOL, V237, P211, DOI 10.1111/j.1469-7998.1995.tb02759.x; Heymann EW, 2000, BIOL REV, V75, P169, DOI 10.1017/S0006323199005460; Holbrook K. M., 2007, Seed dispersal: theory and its application in a changing world, P300, DOI 10.1079/9781845931650.0300; Holbrook KM, 2000, OECOLOGIA, V125, P249, DOI 10.1007/s004420000445; HOPKINS HC, 1984, J ECOL, V72, P1, DOI 10.2307/2260003; HOPKINS HC, 1983, TROPICAL RAIN FOREST, P197; Hopkins HCF., 1986, FLORA NEOTROP, V43, P1; Jordano P, 2007, P NATL ACAD SCI USA, V104, P3278, DOI 10.1073/pnas.0606793104; Jordano P., 2007, Seed dispersal: theory and its application in a changing world, P229, DOI 10.1079/9781845931650.0229; KINZEY WG, 1993, INT J PRIMATOL, V14, P207, DOI 10.1007/BF02192632; Knogge C, 2003, FOLIA PRIMATOL, V74, P33, DOI 10.1159/000068392; Komsta L, 2011, MOMENTS MOMENTS CUMU; Leins P., 2008, BLUTE FRUCHT MORPHOL, V2; LUCKOW M, 1995, AM J BOT, V82, P1300, DOI 10.2307/2446253; Luettmann K, 2010, AM J BOT, V97, pE34, DOI 10.3732/ajb.1000096; Nathan R, 2000, TRENDS ECOL EVOL, V15, P278, DOI 10.1016/S0169-5347(00)01874-7; Neill DA, 2009, NOVON, V19, P204, DOI 10.3417/2007152; Oliveira ACM, 2000, J TROP ECOL, V16, P709, DOI 10.1017/S0266467400001668; Peakall R., 2006, GENALEX 6 GENETIC AN; Peres CA, 2000, J TROP ECOL, V16, P287, DOI 10.1017/S0266467400001413; Pritchard JK, 2000, GENETICS, V155, P945; Reinehr A, 2010, SAMENAUSBREITUNG LEO; SCHUPP EW, 1993, VEGETATIO, V108, P15; Sezen UU, 2009, P ROY SOC B-BIOL SCI, V276, P2037, DOI 10.1098/rspb.2008.1793; Soulsbury CD, 2007, CONSERV GENET, V8, P733, DOI 10.1007/s10592-006-9194-x; Stevenson PR, 2000, AM J PRIMATOL, V50, P275, DOI 10.1002/(SICI)1098-2345(200004)50:4&lt;275::AID-AJP4&gt;3.0.CO;2-K; Sun C, 1997, OECOLOGIA, V112, P94, DOI 10.1007/s004420050288; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tsuji Y, 2010, J TROP ECOL, V26, P115, DOI 10.1017/S0266467409990290; Valenta K, 2010, BIOTROPICA, V42, P223, DOI 10.1111/j.1744-7429.2009.00551.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vasquez Martinez R, 1997, FLORULA RESERVAS BIO; Venables W., 2003, MODERN APPL STAT S; Wang BC, 2002, TRENDS ECOL EVOL, V17, P379, DOI 10.1016/S0169-5347(02)02541-7; Wehncke EV, 2007, J TROP ECOL, V23, P519, DOI 10.1017/S0266467407004257; Wehncke EV, 2003, J ECOL, V91, P677, DOI 10.1046/j.1365-2745.2003.00798.x; Wenny DG, 2000, ECOL MONOGR, V70, P331, DOI 10.1890/0012-9615(2000)070[0331:SDSPAS]2.0.CO;2; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751; Ziegenhagen B., 1993, Plant Molecular Biology Reporter, V11, P117, DOI 10.1007/BF02670469; Ziegenhagen B, 2003, TREES-STRUCT FUNCT, V17, P345, DOI 10.1007/s00468-002-0244-9	50	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35480	10.1371/journal.pone.0035480	http://dx.doi.org/10.1371/journal.pone.0035480			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514748	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600153
J	Suzuki, T; Shioya, T; Murayama, T; Sugihara, M; Odagiri, F; Nakazato, Y; Nishizawa, H; Chugun, A; Sakurai, T; Daida, H; Morimoto, S; Kurebayashi, N				Suzuki, Takeshi; Shioya, Takao; Murayama, Takashi; Sugihara, Masami; Odagiri, Fuminori; Nakazato, Yuji; Nishizawa, Hiroto; Chugun, Akihito; Sakurai, Takashi; Daida, Hiroyuki; Morimoto, Sachio; Kurebayashi, Nagomi			Multistep Ion Channel Remodeling and Lethal Arrhythmia Precede Heart Failure in a Mouse Model of Inherited Dilated Cardiomyopathy	PLOS ONE			English	Article							GENE-EXPRESSION; VENTRICULAR REPOLARIZATION; K+ CURRENTS; MUTATIONS; ARRHYTHMOGENESIS; REFRACTORINESS; HYPERTROPHY; TRANSIENTS; DELETION; DEFECTS	Background: Patients with inherited dilated cardiomyopathy (DCM) frequently die with severe heart failure (HF) or die suddenly with arrhythmias, although these symptoms are not always observed at birth. It remains unclear how and when HF and arrhythmogenic changes develop in these DCM mutation carriers. In order to address this issue, properties of the myocardium and underlying gene expressions were studied using a knock-in mouse model of human inherited DCM caused by a deletion mutation Delta K210 in cardiac troponinT. Methodology/Principal Findings: By 1 month, DCM mice had already enlarged hearts, but showed no symptoms of HF and a much lower mortality than at 2 months or later. At around 2 months, some would die suddenly with no clear symptoms of HF, whereas at 3 months, many of the survivors showed evident symptoms of HF. In isolated left ventricular myocardium (LV) from 2 month-mice, spontaneous activity frequently occurred and action potential duration (APD) was prolonged. Transient outward (I-to) and ultrarapid delayed rectifier K+ (I-Kur) currents were significantly reduced in DCM myocytes. Correspondingly, down-regulation of Kv4.2, Kv1.5 and KChIP2 was evident in mRNA and protein levels. In LVs at 3-months, more frequent spontaneous activity, greater prolongation of APD and further down-regulation in above K+ channels were observed. At 1 month, in contrast, infrequent spontaneous activity and down-regulation of Kv4.2, but not Kv1.5 or KChIP2, were observed. Conclusions/Significance: Our results suggest that at least three steps of electrical remodeling occur in the hearts of DCM model mice, and that the combined down-regulation of Kv4.2, Kv1.5 and KChIP2 prior to the onset of HF may play an important role in the premature sudden death in this DCM model. DCM mice at 1 month or before, on the contrary, are associated with low risk of death in spite of inborn disorder and enlarged heart.	[Suzuki, Takeshi; Murayama, Takashi; Sugihara, Masami; Odagiri, Fuminori; Nishizawa, Hiroto; Chugun, Akihito; Sakurai, Takashi; Kurebayashi, Nagomi] Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Pharmacol, Bunkyo Ku, Tokyo, Japan; [Suzuki, Takeshi; Sugihara, Masami; Odagiri, Fuminori; Nakazato, Yuji; Nishizawa, Hiroto; Daida, Hiroyuki] Juntendo Univ, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo, Japan; [Shioya, Takao] Saga Univ, Dept Physiol, Fac Med, Saga 840, Japan; [Morimoto, Sachio] Kyushu Univ, Dept Clin Pharmacol, Fac Med Sci, Fukuoka 812, Japan	Juntendo University; Juntendo University; Saga University; Kyushu University	Suzuki, T (corresponding author), Juntendo Univ, Grad Sch Med, Dept Cellular & Mol Pharmacol, Bunkyo Ku, Tokyo, Japan.	nagomik@juntendo.ac.jp		Morimoto, Sachio/0000-0001-9171-3636	"High Technology Research Center'' Project for Private Universities: matching fund Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation; Vehicle Racing Commemorative Foundation; Institute of Seizon and Life Sciences;  [8590241];  [23136514]	"High Technology Research Center'' Project for Private Universities: matching fund Ministry of Education, Culture, Sports, Science and Technology of Japan; Uehara Memorial Foundation(Uehara Memorial Foundation); Vehicle Racing Commemorative Foundation; Institute of Seizon and Life Sciences; ; 	This work was supported by a Grant-in Aid (#18590241 and #23136514) and a "High Technology Research Center'' Project for Private Universities: matching fund subsidy from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to NK). The authors also thank the Uehara Memorial Foundation, the Vehicle Racing Commemorative Foundation (to NK) and the Institute of Seizon and Life Sciences for financial support (to SM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baartscheer A, 2003, CARDIOVASC RES, V58, P99, DOI 10.1016/S0008-6363(02)00854-4; Baker LC, 2000, CIRC RES, V86, P396, DOI 10.1161/01.RES.86.4.396; Borlak J, 2003, FASEB J, V17, P1592, DOI 10.1096/fj.02-0889com; Brouillette J, 2004, J PHYSIOL-LONDON, V559, P777, DOI 10.1113/jphysiol.2004.063446; Brunet S, 2004, J PHYSIOL-LONDON, V559, P103, DOI 10.1113/jphysiol.2004.063347; Chang AN, 2005, HEART FAIL REV, V10, P225, DOI 10.1007/s10741-005-5252-6; Costantini DL, 2005, CELL, V123, P347, DOI 10.1016/j.cell.2005.08.004; Coughlin SS, 1997, J NATL MED ASSOC, V89, P277; DEC GW, 1994, NEW ENGL J MED, V331, P1564, DOI 10.1056/NEJM199412083312307; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; FUSTER V, 1981, AM J CARDIOL, V47, P525, DOI 10.1016/0002-9149(81)90534-8; Gramlich M, 2009, J MOL CELL CARDIOL, V47, P352, DOI 10.1016/j.yjmcc.2009.04.014; Grandy SA, 2007, AM J PHYSIOL-HEART C, V293, pH2168, DOI 10.1152/ajpheart.00521.2007; Guo WN, 2005, CIRC RES, V97, P1342, DOI 10.1161/01.RES.0000196559.63223.aa; Guo WN, 1999, J PHYSIOL-LONDON, V521, P587, DOI 10.1111/j.1469-7793.1999.00587.x; Haghighi K, 2006, P NATL ACAD SCI USA, V103, P1388, DOI 10.1073/pnas.0510519103; Harrell MD, 2007, PHYSIOL GENOMICS, V28, P273, DOI 10.1152/physiolgenomics.00163.2006; Janse MJ, 2004, CARDIOVASC RES, V61, P208, DOI 10.1016/j.cardiores.2003.11.018; Janse MJ, 2003, PROG BIOPHYS MOL BIO, V82, P187, DOI 10.1016/S0079-6107(03)00015-4; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Kaprielian R, 1999, J PHYSIOL-LONDON, V517, P229, DOI 10.1111/j.1469-7793.1999.0229z.x; Knollmann BC, 2000, J PHYSIOL-LONDON, V525, P483, DOI 10.1111/j.1469-7793.2000.t01-1-00483.x; Kurebayashi N, 2004, AM J PHYSIOL-CELL PH, V287, pC1646, DOI 10.1152/ajpcell.00200.2004; Kurebayashi N, 2008, AM J PHYSIOL-CELL PH, V294, pC1419, DOI 10.1152/ajpcell.00413.2007; Kuwahara K, 2003, EMBO J, V22, P6310, DOI 10.1093/emboj/cdg601; London B, 2001, CIRC RES, V88, P940, DOI 10.1161/hh0901.090929; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; McCauley MD, 2009, DIS MODEL MECH, V2, P563, DOI 10.1242/dmm.002840; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Morimoto S, 2008, CARDIOVASC RES, V77, P659, DOI 10.1093/cvr/cvm084; Mounkes LC, 2005, HUM MOL GENET, V14, P2167, DOI 10.1093/hmg/ddi221; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Nishizawa H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007069; Otten E, 2010, NETH HEART J, V18, P478, DOI 10.1007/BF03091819; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Rivard K, 2009, AM J PHYSIOL-HEART C, V296, pH704, DOI 10.1152/ajpheart.00337.2008; Roden DM, 2006, J INTERN MED, V259, P59, DOI 10.1111/j.1365-2796.2005.01589.x; Sabir IN, 2007, PFLUG ARCH EUR J PHY, V454, P209, DOI 10.1007/s00424-007-0217-3; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Shioya T, 2007, J PHYSIOL SCI, V57, P327, DOI 10.2170/physiolsci.RP010107; Sugihara M, 2011, J PHARM SCI; Suzuki M, 2001, CIRC RES, V88, P570, DOI 10.1161/01.RES.88.6.570; Tomaselli GF, 1999, CARDIOVASC RES, V42, P270, DOI 10.1016/S0008-6363(99)00017-6; Waldeyer C, 2009, BASIC RES CARDIOL, V104, P523, DOI 10.1007/s00395-009-0019-1; Wang YY, 2010, CARDIOVASC RES, V87, P636, DOI 10.1093/cvr/cvq133; Wu TJ, 1998, J AM COLL CARDIOL, V32, P187, DOI 10.1016/S0735-1097(98)00184-3; Xu Q, 2010, J MOL CELL CARDIOL, V48, P899, DOI 10.1016/j.yjmcc.2010.03.005; Zhan DY, 2009, CARDIOVASC RES, V84, P64, DOI 10.1093/cvr/cvp168	50	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35353	10.1371/journal.pone.0035353	http://dx.doi.org/10.1371/journal.pone.0035353			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514734	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600139
J	Belleannee, C; Calvo, E; Thimon, V; Cyr, DG; Legare, C; Garneau, L; Sullivan, R				Belleannee, Clemence; Calvo, Ezequiel; Thimon, Veronique; Cyr, Daniel G.; Legare, Christine; Garneau, Louis; Sullivan, Robert			Role of MicroRNAs in Controlling Gene Expression in Different Segments of the Human Epididymis	PLOS ONE			English	Article							LOOP RT-PCR; LUMINAL FLUID; PROTEINS; RNA; RAT; TRANSCRIPTOME; BARRIER; ADULT; IDENTIFICATION; SPERMATOZOA	Background: The molecular mechanisms implicated in regionalized gene expression in the human epididymis have not yet been fully elucidated. Interestingly, more than 200 microRNAs (miRNAs) have been identified in the human epididymis and could be involved in the regulation of mRNA stability and post-transcriptional expression in this organ. Methods: Using a miRNA microarray approach, we investigated the correlation between miRNA signatures and gene expression profiles found in three distinct regions (caput, corpus and cauda) of human epididymides from 3 donors. In silico prediction of transcript miRNA targets was performed using TargetScan and Miranda software's. FHCE1 immortalized epididymal cell lines were cotransfected with mimic microRNAs and plasmid constructs containing the 3'UTR of predicted target genes downstream of the luciferase gene. Results: We identified 35 miRNAs differentially expressed in the distinct segments of the epididymis (fold change >= 2, P-value <= 0.01). Among these miRNAs, miR-890, miR-892a, miR-892b, miR-891a, miR-891b belonging to the same epididymis-enriched cluster located on the X chromosome, are significantly more expressed in the corpus and cauda regions than in the caput. Interestingly, a strong negative correlation (r = -0,89, P-value <= 0.001) was found between the pattern of expression of miR-892b and its potential mRNA target Esrrg (Estrogen Related Receptor Gamma) and with miR-145 and Cldn10 mRNA (r = -0,92, P-value <= 0.001). We confirmed that miR-145 and miR-892b inhibit the expression of the luciferase reporter via Cldn10 and Esrrg 39 UTRs, respectively. Conclusion: Our study shows that the expression of miRNAs is segmented along the human epididymis and correlates with the pattern of target gene expression in different regions. Therefore, epididymal miRNAs may be in control of the maintenance of gene expression profile in the epididymis, which dictates segment-specific secretion of proteins and establishes physiological compartments that directly or indirectly affect sperm maturation and fertility.	[Belleannee, Clemence; Legare, Christine; Garneau, Louis; Sullivan, Robert] Univ Laval, Ctr Rech CHUQ, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Belleannee, Clemence; Legare, Christine; Garneau, Louis; Sullivan, Robert] Univ Laval, Fac Med, Dept Obstet Gynecol, Quebec City, PQ G1K 7P4, Canada; [Calvo, Ezequiel; Sullivan, Robert] Univ Laval, Dept Mol Med, Quebec City, PQ G1K 7P4, Canada; [Calvo, Ezequiel; Sullivan, Robert] Univ Laval, Lab Endocrinol & Gen, CHUL Res Ctr, Quebec City, PQ G1K 7P4, Canada; [Cyr, Daniel G.] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ, Canada	Laval University; Laval University; Laval University; Laval University; University of Quebec; Institut national de la recherche scientifique (INRS)	Belleannee, C (corresponding author), Univ Laval, Ctr Rech CHUQ, Fac Med, Quebec City, PQ G1K 7P4, Canada.	clemence.belleannee@crchuq.ulaval.ca; robert.sullivan@crchul.ulaval.ca	Cyr, Daniel/AIC-9460-2022	Belleannee, Clemence/0000-0001-9284-9420	Canadian Institutes of Health Research (CIHR) [IC090473]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (CIHR) grant # IC090473 to Dr. Robert Sullivan (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belleannee C, 2011, PROTEOMICS, V11, P1952, DOI 10.1002/pmic.201000662; Belleannee C, 2011, J PROTEOMICS, V74, P59, DOI 10.1016/j.jprot.2010.07.013; Berry R, 2011, HUM MOL GENET, V20, P917, DOI 10.1093/hmg/ddq530; Chaurand P, 2003, PROTEOMICS, V3, P2221, DOI 10.1002/pmic.200300474; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; CORNWALL GA, 1995, J ANDROL, V16, P379; CORNWALL GA, 1990, BIOL REPROD, V43, P121, DOI 10.1095/biolreprod43.1.121; Cyr DG, 2007, ASIAN J ANDROL, V9, P463, DOI 10.1111/j.1745-7262.2007.00308.x; CYR DG, 1995, MICROSC RES TECHNIQ, V30, P54, DOI 10.1002/jemt.1070300105; Dacheux JL, 2006, MOL CELL ENDOCRINOL, V250, P36, DOI 10.1016/j.mce.2005.12.022; Dacheux JL, 2009, MOL CELL ENDOCRINOL, V306, P45, DOI 10.1016/j.mce.2009.03.007; Dube E, 2007, BIOL REPROD, V76, P1034, DOI 10.1095/biolreprod.106.059246; Dube E, 2010, BIOL REPROD, V83, P584, DOI 10.1095/biolreprod.110.084459; Dube E, 2010, BIOL REPROD, V82, P1119, DOI 10.1095/biolreprod.109.083196; Dube E, 2008, BIOL REPROD, V78, P342, DOI 10.1095/biolreprod.107.062760; Frenette G, 2002, BIOL REPROD, V67, P308, DOI 10.1095/biolreprod67.1.308; Guyonnet B, 2011, J ANDROL, V32, P651, DOI 10.2164/jandrol.111.013086; Guyonnet B, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-369; Hamzeh M, 2011, J ENDOCRINOL, V209, P55, DOI 10.1530/JOE-10-0223; Hess RA, 2000, REV REPROD, V5, P84; HINTON BT, 1981, J REPROD FERTIL, V63, P95, DOI 10.1530/jrf.0.0630095; Huppunen J, 2004, MOL CELL ENDOCRINOL, V219, P151, DOI 10.1016/j.mce.2004.01.002; Jelinsky SA, 2007, BIOL REPROD, V76, P561, DOI 10.1095/biolreprod.106.057323; Jervis KM, 2002, EXP GERONTOL, V37, P897, DOI 10.1016/S0531-5565(02)00024-4; Johnston DS, 2005, BIOL REPROD, V73, P404, DOI 10.1095/biolreprod.105.039719; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; KRULL N, 1993, MOL REPROD DEV, V34, P16, DOI 10.1002/mrd.1080340104; Lan ZJ, 1998, BIOL REPROD, V58, P197, DOI 10.1095/biolreprod58.1.197; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li JJ, 2010, MOL BIOL EVOL, V27, P671, DOI 10.1093/molbev/msp284; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Nam S, 2009, NUCLEIC ACIDS RES, V37, pW356, DOI 10.1093/nar/gkp294; OLSON GE, 1985, J ANDROL, V6, P20; Papaioannou MD, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M900587-MCP200; Papaioannou MD, 2010, J ANDROL, V31, P26, DOI 10.2164/jandrol.109.008128; Papaioannou MD, 2009, DEV BIOL, V326, P250, DOI 10.1016/j.ydbio.2008.11.011; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Robaire B, 2011, J ANDROL, V32, P592, DOI 10.2164/jandrol.111.014266; Rodriguez CM, 2001, REPRODUCTION, V122, P41, DOI 10.1530/reprod/122.1.41; Romero Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025241; Ruike Y, 2008, J HUM GENET, V53, P515, DOI 10.1007/s10038-008-0279-x; Saez F, 2003, J ANDROL, V24, P149; Shahab SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022508; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Sullivan R, 2007, ASIAN J ANDROL, V9, P483, DOI 10.1111/j.1745-7262.2007.00281.x; Syntin P, 1996, BIOL REPROD, V55, P956, DOI 10.1095/biolreprod55.5.956; Tang FC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj009; Tang XL, 2004, J MOL MED, V82, P383, DOI 10.1007/s00109-004-0535-2; Thimon V, 2007, MOL HUM REPROD, V13, P691, DOI 10.1093/molehr/gam051; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Van Itallie CM, 2006, AM J PHYSIOL-RENAL, V291, pF1288, DOI 10.1152/ajprenal.00138.2006; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Varkonyi-Gasic E, 2010, METHODS MOL BIOL, V631, P109, DOI 10.1007/978-1-60761-646-7_10; Vasudevan S, 2011, WILEY INTERDISCIP RE, V2011; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; VEERAMACHANENI DNR, 1990, J ANDROL, V11, P140; Wang YP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-218; Zhang JS, 2010, ACTA BIOCH BIOPH SIN, V42, P145, DOI 10.1093/abbs/gmp116	65	77	78	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34996	10.1371/journal.pone.0034996	http://dx.doi.org/10.1371/journal.pone.0034996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511979	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338600065
J	Hoxha, E; Boda, E; Montarolo, F; Parolisi, R; Tempia, F				Hoxha, Eriola; Boda, Enrica; Montarolo, Francesca; Parolisi, Roberta; Tempia, Filippo			Excitability and Synaptic Alterations in the Cerebellum of APP/PS1 Mice	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; INDUCED NEURONAL DYSFUNCTION; GAMMA-AMINOBUTYRIC ACID; ALZHEIMERS-DISEASE; PURKINJE-CELLS; A-BETA; SECRETED OLIGOMERS; HOMOVANILLIC-ACID; SENILE-DEMENTIA; MOUSE MODELS	In Alzheimer's disease (AD), the severity of cognitive symptoms is better correlated with the levels of soluble amyloid-beta (A beta) rather than with the deposition of fibrillar Ab in amyloid plaques. In APP/PS1 mice, a murine model of AD, at 8 months of age the cerebellum is devoid of fibrillar A beta, but dosage of soluble A beta(1-42), the form which is more prone to aggregation, showed higher levels in this structure than in the forebrain. Aim of this study was to investigate the alterations of intrinsic membrane properties and of synaptic inputs in Purkinje cells (PCs) of the cerebellum, where only soluble A beta is present. PCs were recorded by whole-cell patch-clamp in cerebellar slices from wild-type and APP/PS1 mice. In APP/PS1 PCs, evoked action potential discharge showed enhanced frequency adaptation and larger afterhyperpolarizations, indicating a reduction of the intrinsic membrane excitability. In the miniature GABAergic postsynaptic currents, the largest events were absent in APP/PS1 mice and the interspike intervals distribution was shifted to the left, but the mean amplitude and frequency were normal. The ryanodine-sensitive multivescicular release was not altered and the postsynaptic responsiveness to a GABA(A) agonist was intact. Climbing fiber postsynaptic currents were normal but their short-term plasticity was reduced in a time window of 100-800 ms. Parallel fiber postsynaptic currents and their short-term plasticity were normal. These results indicate that, in the cerebellar cortex, chronically elevated levels of soluble A beta(1-42) are associated with alterations of the intrinsic excitability of PCs and with alterations of the release of GABA from interneurons and of glutamate from climbing fibers, while the release of glutamate from parallel fibers and all postsynaptic mechanisms are preserved. Thus, soluble A beta(1-42) causes, in PCs, multiple functional alterations, including an impairment of intrinsic membrane properties and synapse-specific deficits, with differential consequences even in different subtypes of glutamatergic synapses.	[Hoxha, Eriola; Boda, Enrica; Montarolo, Francesca; Parolisi, Roberta; Tempia, Filippo] Univ Turin, NICO, Turin, Italy; [Tempia, Filippo] Univ Turin, Natl Inst Neurosci Italy INN, Turin, Italy	University of Turin; University of Turin	Hoxha, E (corresponding author), Univ Turin, NICO, Turin, Italy.	filippo.tempia@unito.it	Boda, Enrica/AFM-7909-2022; Hoxha, Eriola/N-1752-2017; Tempia, Filippo/A-5883-2012; Montarolo, F/K-3331-2018	Hoxha, Eriola/0000-0002-4452-889X; Tempia, Filippo/0000-0003-2778-0943; Montarolo, F/0000-0002-3633-8746; Parolisi, Roberta/0000-0002-1948-7766; BODA, Enrica/0000-0002-1006-2577	Ministero dell'Istruzione; Universita e Ricerca scientifica (PRIN); Regione Piemonte (Ricerca Scientifica Applicata) [A183, A74]; Ricerca Sanitaria Finalizzata; Compagnia di San Paolo; Fondazione Cassa di Risparmio di Torino (Progetto Alfieri bando); Fondazione Cassa di Risparmio di Torino (Progetto Lagrange)	Ministero dell'Istruzione(Ministry of Education, Universities and Research (MIUR)); Universita e Ricerca scientifica (PRIN); Regione Piemonte (Ricerca Scientifica Applicata)(Regione Piemonte); Ricerca Sanitaria Finalizzata(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Finalizzata (MOH-RF)); Compagnia di San Paolo(Compagnia di San Paolo); Fondazione Cassa di Risparmio di Torino (Progetto Alfieri bando); Fondazione Cassa di Risparmio di Torino (Progetto Lagrange)	The experiments were supported by grants (to Dr. Tempia) from: Ministero dell'Istruzione, Universita e Ricerca scientifica (PRIN-2007), Regione Piemonte (Ricerca Scientifica Applicata 2004 projects A183 and A74 and Ricerca Sanitaria Finalizzata 2007), Compagnia di San Paolo, Fondazione Cassa di Risparmio di Torino (Progetto Alfieri bando 2007). Dr. Boda is recipient of a fellowship from Fondazione Cassa di Risparmio di Torino (Progetto Lagrange). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe KH, 2010, NEURON, V66, P631, DOI 10.1016/j.neuron.2010.04.031; BAREGGI SR, 1982, ARCH NEUROL-CHICAGO, V39, P709, DOI 10.1001/archneur.1982.00510230035010; Bas O, 2009, ANN ANAT, V191, P186, DOI 10.1016/j.aanat.2008.12.003; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; DAVIES P, 1980, NATURE, V288, P279, DOI 10.1038/288279a0; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; HARDY J, 1987, NEUROSCI LETT, V73, P192, DOI 10.1016/0304-3940(87)90016-4; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; Hashimoto M, 2010, ACTA NEUROPATHOL, V119, P543, DOI 10.1007/s00401-010-0661-6; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Yun SH, 2006, NEUROSCI LETT, V403, P162, DOI 10.1016/j.neulet.2006.04.065; Jin M, 2011, P NATL ACAD SCI USA, V108, P5819, DOI 10.1073/pnas.1017033108; Kaczorowski CC, 2011, NEUROBIOL AGING, V32, P1452, DOI 10.1016/j.neurobiolaging.2009.09.003; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Mavroudis IA, 2010, AM J ALZHEIMERS DIS, V25, P585, DOI 10.1177/1533317510382892; McKay BE, 2005, J NEUROSCI, V25, P1481, DOI 10.1523/JNEUROSCI.3523-04.2005; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Raji CA, 2009, NEUROLOGY, V73, P1899, DOI 10.1212/WNL.0b013e3181c3f293; Sacco T, 2006, MOL CELL NEUROSCI, V33, P170, DOI 10.1016/j.mcn.2006.07.006; Seidl R, 2001, N-S ARCH PHARMACOL, V363, P139, DOI 10.1007/s002100000346; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Williams SR, 2002, J PHYSIOL-LONDON, V539, P469, DOI 10.1113/jphysiol.2001.013136; ZIMMER R, 1984, ARCH NEUROL-CHICAGO, V41, P602, DOI 10.1001/archneur.1984.04210080010005	44	30	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34726	10.1371/journal.pone.0034726	http://dx.doi.org/10.1371/journal.pone.0034726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511962	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338600048
J	Liu, Y; Wang, B; Cui, P; Li, LB; Xue, JY; Yu, J; Qiu, YL				Liu, Yang; Wang, Bin; Cui, Peng; Li, Libo; Xue, Jia-Yu; Yu, Jun; Qiu, Yin-Long			The Mitochondrial Genome of the Lycophyte Huperzia squarrosa: The Most Archaic Form in Vascular Plants	PLOS ONE			English	Article							TRANSCRIPTION INITIATION SITES; COMPLETE NUCLEOTIDE-SEQUENCE; LAND PLANTS; GREEN-ALGA; EVOLUTION; DNA; CHLOROPLAST; GENES; CONTAINS; TOOL	Mitochondrial genomes have maintained some bacterial features despite their residence within eukaryotic cells for approximately two billion years. One of these features is the frequent presence of polycistronic operons. In land plants, however, it has been shown that all sequenced vascular plant chondromes lack large polycistronic operons while bryophyte chondromes have many of them. In this study, we provide the completely sequenced mitochondrial genome of a lycophyte, from Huperzia squarrosa, which is a member of the sister group to all other vascular plants. The genome, at a size of 413,530 base pairs, contains 66 genes and 32 group II introns. In addition, it has 69 pseudogene fragments for 24 of the 40 proteinand rRNA-coding genes. It represents the most archaic form of mitochondrial genomes of all vascular plants. In particular, it has one large conserved gene cluster containing up to 10 ribosomal protein genes, which likely represents a polycistronic operon but has been disrupted and greatly reduced in the chondromes of other vascular plants. It also has the least rearranged gene order in comparison to the chondromes of other vascular plants. The genome is ancestral in vascular plants in several other aspects: the gene content resembling those of charophytes and most bryophytes, all introns being cis-spliced, a low level of RNA editing, and lack of foreign DNA of chloroplast or nuclear origin.	[Liu, Yang; Wang, Bin; Li, Libo; Xue, Jia-Yu; Qiu, Yin-Long] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Cui, Peng; Yu, Jun] Chinese Acad Sci, CAS Key Lab Genome Sci & Informat, Beijing Inst Genom, Beijing, Peoples R China; [Xue, Jia-Yu] Nanjing Univ, Sch Life Sci, Nanjing, Jiangsu, Peoples R China	University of Michigan System; University of Michigan; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Nanjing University	Liu, Y (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA.	ylqiu@umich.edu	li, li/HII-4157-2022; li, li/GPX-3938-2022; LI, LI/GVS-5344-2022; Wang, Bin/A-8639-2013; liu, yang/H-6324-2011; Li, Li/AEM-3636-2022	Wang, Bin/0000-0003-2481-735X; Xue, Jia-Yu/0000-0002-7128-9935; Liu, Yang/0000-0002-5942-839X	National Science Foundation (NSF) [DEB 0531689, 0332298]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by National Science Foundation (NSF) grants DEB 0531689 and 0332298 to YQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2002, P NATL ACAD SCI USA, V99, P9905, DOI 10.1073/pnas.042694899; Allen JO, 2007, GENETICS, V177, P1173, DOI 10.1534/genetics.107.073312; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alverson AJ, 2011, PLANT CELL, V23, P2499, DOI 10.1105/tpc.111.087189; Alverson AJ, 2010, MOL BIOL EVOL, V27, P1436, DOI 10.1093/molbev/msq029; ANDRE C, 1992, TRENDS GENET, V8, P128, DOI 10.1016/0168-9525(92)90370-J; Banks JA, 2011, SCIENCE, V332, P960, DOI 10.1126/science.1203810; BINDER S, 1993, J BIOL CHEM, V268, P7849; Binder S, 2003, PHILOS T R SOC B, V358, P181, DOI 10.1098/rstb.2002.1179; Boore JL, 1999, NUCLEIC ACIDS RES, V27, P1767, DOI 10.1093/nar/27.8.1767; Chang SX, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-497; Chaw SM, 2008, MOL BIOL EVOL, V25, P603, DOI 10.1093/molbev/msn009; Dombrovska O, 2004, MOL PHYLOGENET EVOL, V32, P246, DOI 10.1016/j.ympev.2003.12.013; Doyle J. J., 1987, PHYTOCHEM B, P11; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Faircloth BC, 2008, MOL ECOL RESOUR, V8, P92, DOI 10.1111/j.1471-8286.2007.01884.x; Fey J, 1999, BIOCHEM BIOPH RES CO, V256, P409, DOI 10.1006/bbrc.1999.0349; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Gray MW, 2004, ANNU REV GENET, V38, P477, DOI 10.1146/annurev.genet.37.110801.142526; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Green, 1990, FAMILIES GENERA VASC, V1, P31, DOI [10.1007/978-3-662-02604-5_10, DOI 10.1007/978-3-662-02604-5_10]; Grewe F, 2011, NUCLEIC ACIDS RES, V39, P2890, DOI 10.1093/nar/gkq1227; Grewe F, 2009, NUCLEIC ACIDS RES, V37, P5093, DOI 10.1093/nar/gkp532; Groth-Malonek M, 2007, INT J PLANT SCI, V168, P709, DOI 10.1086/513472; Guo XY, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000449; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Hecht J, 2011, GENOME BIOL EVOL, V3, P344, DOI 10.1093/gbe/evr027; HIESEL R, 1994, P NATL ACAD SCI USA, V91, P634, DOI 10.1073/pnas.91.2.634; Jermy AC, 1990, FAMILIES GENERA VASC, V1, DOI DOI 10.1007/978-3-662-02604-5_; Knoop V, 2004, CURR GENET, V46, P123, DOI 10.1007/s00294-004-0522-8; Kuhn K, 2005, NUCLEIC ACIDS RES, V33, P337, DOI 10.1093/nar/gki179; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lang BF, 1997, NATURE, V387, P493, DOI 10.1038/387493a0; Leitch IJ, 2005, ANN BOT-LONDON, V95, P207, DOI 10.1093/aob/mci014; Lenz H, 2010, CURR GENET, V56, P189, DOI 10.1007/s00294-009-0283-5; Li LB, 2009, J MOL EVOL, V68, P665, DOI 10.1007/s00239-009-9240-7; Liu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025836; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Malek O, 1998, RNA, V4, P1599, DOI 10.1017/S1355838298981262; MICHEL F, 1983, EMBO J, V2, P33, DOI 10.1002/j.1460-2075.1983.tb01376.x; Mower JP, 2006, MOL GENET GENOMICS, V276, P285, DOI 10.1007/s00438-006-0139-3; MULLIGAN RM, 1988, MOL GEN GENET, V211, P373, DOI 10.1007/BF00425688; ODA K, 1992, J MOL BIOL, V223, P1, DOI 10.1016/0022-2836(92)90708-R; Paquin B, 1997, CURR GENET, V31, P380, DOI 10.1007/s002940050220; Podlaha O, 2010, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0005118.pub2, DOI 10.1002/9780470015902.A0005118.PUB2]; Qiu Y-L, 2012, J SYST EVOL IN PRESS; Qiu YL, 2006, P NATL ACAD SCI USA, V103, P15511, DOI 10.1073/pnas.0603335103; Qiu YL, 2004, J MOL EVOL, V59, P80, DOI 10.1007/s00239-004-2606-y; RAUBESON LA, 1992, SCIENCE, V255, P1697, DOI 10.1126/science.255.5052.1697; Rodriguez-Moreno L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-424; SCHUSTER W, 1994, ANNU REV PLANT PHYS, V45, P61, DOI 10.1146/annurev.pp.45.060194.000425; Sloan DB, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001241; SMALL I, 1989, CELL, V58, P69, DOI 10.1016/0092-8674(89)90403-0; Sugiyama Y, 2005, MOL GENET GENOMICS, V272, P603, DOI 10.1007/s00438-004-1075-8; Terasawa K, 2007, MOL BIOL EVOL, V24, P699, DOI 10.1093/molbev/msl198; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian XJ, 2006, PLANT PHYSIOL, V140, P401, DOI 10.1104/pp.105.070060; Turmel M, 2003, PLANT CELL, V15, P1888, DOI 10.1105/tpc.013169; Turmel M, 2002, P NATL ACAD SCI USA, V99, P11275, DOI 10.1073/pnas.162203299; Turmel M, 2002, MOL BIOL EVOL, V19, P24, DOI 10.1093/oxfordjournals.molbev.a003979; Turmel M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-137; Unseld M, 1997, NAT GENET, V15, P57, DOI 10.1038/ng0197-57; Wahrmund U, 2008, J MOL EVOL, V66, P621, DOI 10.1007/s00239-008-9114-4; Wang B, 2009, CURR GENET, V55, P601, DOI 10.1007/s00294-009-0273-7; Wang W, 2006, PLANT CELL, V18, P1791, DOI 10.1105/tpc.106.041905; Wolf PG, 2005, GENE, V350, P117, DOI 10.1016/j.gene.2005.01.018; Xue JY, 2010, CURR GENET, V56, P53, DOI 10.1007/s00294-009-0279-1; Qiu YL, 2008, J SYST EVOL, V46, P287, DOI [10.3724/SP.J.1002.2008.08035, 10.1111/j.1439-0469.2008.00465.x]; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003	71	25	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e35168	10.1371/journal.pone.0035168	http://dx.doi.org/10.1371/journal.pone.0035168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511984	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338600070
J	Iori, E; Vinci, B; Murphy, E; Marescotti, MC; Avogaro, A; Ahluwalia, A				Iori, Elisabetta; Vinci, Bruna; Murphy, Ellen; Marescotti, Maria Cristina; Avogaro, Angelo; Ahluwalia, Arti			Glucose and Fatty Acid Metabolism in a 3 Tissue In-Vitro Model Challenged with Normo- and Hyperglycaemia	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; MODULAR BIOREACTOR; ENDOTHELIAL-CELLS; INTRACELLULAR LACTATE; HUMAN ADIPOCYTES; LIVER-DISEASE; HEPG2 CELLS; E-SELECTIN	Nutrient balance in the human body is maintained through systemic signaling between different cells and tissues. Breaking down this circuitry to its most basic elements and reconstructing the metabolic network in-vitro provides a systematic method to gain a better understanding of how cross-talk between the organs contributes to the whole body metabolic profile and of the specific role of each different cell type. To this end, a 3-way connected culture of hepatocytes, adipose tissue and endothelial cells representing a simplified model of energetic substrate metabolism in the visceral region was developed. The 3-way culture was shown to maintain glucose and fatty acid homeostasis in-vitro. Subsequently it was challenged with insulin and high glucose concentrations to simulate hyperglycaemia. The aim was to study the capacity of the 3-way culture to maintain or restore normal circulating glucose concentrations in response to insulin and to investigate the effects these conditions on other metabolites involved in glucose and lipid metabolism. The results show that the system's metabolic profile changes dramatically in the presence of high concentrations of glucose, and that these changes are modulated by the presence of insulin. Furthermore, we observed an increase in E-selectin levels in hyperglycaemic conditions and increased IL-6 concentrations in insulin-free-hyperglycaemic conditions, indicating, respectively, endothelial injury and proinflammatory stress in the challenged 3-way system.	[Iori, Elisabetta; Murphy, Ellen; Marescotti, Maria Cristina; Avogaro, Angelo] Univ Padua, Dept Clin & Expt Med, Div Metab Dis, Padua, Italy; [Vinci, Bruna; Ahluwalia, Arti] Univ Pisa, Ctr Interdipartimentale Ric E Piaggio, Pisa, Italy; [Vinci, Bruna; Ahluwalia, Arti] CNR, Inst Clin Physiol, I-56100 Pisa, Italy	University of Padua; University of Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Iori, E (corresponding author), Univ Padua, Dept Clin & Expt Med, Div Metab Dis, Padua, Italy.	arti.ahluwalia@centropiaggio.unipi.it	Avogaro, Angelo/S-3808-2016	Ahluwalia, Arti/0000-0001-5370-6750				AbuLebdeh HS, 1996, BAILLIERE CLIN ENDOC, V10, P589, DOI 10.1016/S0950-351X(96)80741-5; Armani A, 2010, J CELL BIOCHEM, V110, P564, DOI 10.1002/jcb.22598; Arner P, 2002, DIABETES-METAB RES, V18, pS5, DOI 10.1002/dmrr.254; Avogaro A, 1996, J ENDOCRINOL INVEST, V19, P99, DOI 10.1007/BF03349844; Avogaro A, 1996, J CLIN INVEST, V98, P108, DOI 10.1172/JCI118754; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; Buechler C, 2011, WORLD J GASTROENTERO, V17, P2801, DOI 10.3748/wjg.v17.i23.2801; Chen TC, 2011, J BIOL CHEM, V286, P25564, DOI 10.1074/jbc.M111.230540; Drew BG, 2009, CIRCULATION, V119, P2103, DOI 10.1161/CIRCULATIONAHA.108.843219; Du ZY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020917; Fadini GP, 2011, DIABETES OBES METAB, V13, P718, DOI 10.1111/j.1463-1326.2011.01396.x; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; Getty-Kaushik L, 2005, OBES RES, V13, P2058, DOI 10.1038/oby.2005.255; GROSS R, 1984, J ENDOCRINOL, V102, P381, DOI 10.1677/joe.0.1020381; GRUNDY SM, 1990, DM-DIS MON, V36, P641; Guo W, 2006, AM J PHYSIOL-GASTR L, V290, pG528, DOI 10.1152/ajpgi.00386.2005; Guzzardi MA, 2011, TISSUE ENG PT A, V17, P1635, DOI [10.1089/ten.tea.2010.0541, 10.1089/ten.TEA.2010.0541]; Guzzardi MA, 2009, TISSUE ENG PT A, V15, P3635, DOI 10.1089/ten.TEA.2008.0695; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Harrington EO, 2006, LUNG, V184, P259, DOI 10.1007/s00408-005-2589-5; Lee DE, 2009, AM J PHYSIOL-ENDOC M, V296, pE1210, DOI 10.1152/ajpendo.00015.2009; Lee Y, 2011, DIABETES, V60, P391, DOI 10.2337/db10-0426; LIMA FB, 1991, ENDOCRINOLOGY, V128, P2415, DOI 10.1210/endo-128-5-2415; LLOYD B, 1978, CLIN CHEM, V24, P1724; Mazzei D, 2010, BIOTECHNOL BIOENG, V106, P127, DOI 10.1002/bit.22671; Meerarani P, 2006, CURR MOL MED, V6, P501, DOI 10.2174/156652406778018680; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; MILLER TB, 1973, J BIOL CHEM, V248, P3483; MOUSSALLI C, 1986, DIABETES, V35, P759, DOI 10.2337/diabetes.35.7.759; Nakajima K, 2000, J BIOL CHEM, V275, P20880, DOI 10.1074/jbc.M905410199; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; NONOGAKI K, 1995, ENDOCRINOLOGY, V136, P2143, DOI 10.1210/en.136.5.2143; Nozawa F, 2000, J SURG RES, V94, P153, DOI 10.1006/jsre.2000.6002; Opie LH, 1988, J CARDIOVASCULAR S1, pS31; Qureshi K, 2007, WORLD J GASTROENTERO, V13, P3540, DOI 10.3748/wjg.v13.i26.3540; Sbrana T, 2011, NEW TECHNOLOGIES TOX; Sell H, 2006, TRENDS ENDOCRIN MET, V17, P416, DOI 10.1016/j.tem.2006.10.010; Stouthard JML, 1996, BIOCHEM BIOPH RES CO, V220, P241, DOI 10.1006/bbrc.1996.0389; Szkudelski T, 2000, PHYSIOL RES, V49, P213; Turato C, 2010, LAB INVEST, V90, P1016, DOI 10.1038/labinvest.2010.55; Vicennati V, 2002, INT J OBESITY, V26, P905, DOI 10.1038/sj.ijo.0802035; Vinci B, 2012, BIOTECHNOL J, V7, P117, DOI 10.1002/biot.201100177; Vinci B, 2011, BIOTECHNOL J, V6, P554, DOI 10.1002/biot.201000326; Vinci B, 2010, BIOTECHNOL J, V5, P618, DOI 10.1002/biot.201000009; Vinci B, 2010, BIOTECHNOL J, V5, P232, DOI 10.1002/biot.200900074; Vozzi F, 2011, BIOTECHNOL BIOENG, V108, P2129, DOI 10.1002/bit.23164; Wang PYT, 2008, NATURE, V452, P1012, DOI 10.1038/nature06852; Wang ZC, 2006, BIOCHEM BIOPH RES CO, V345, P976, DOI 10.1016/j.bbrc.2006.04.173	48	46	46	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34704	10.1371/journal.pone.0034704	http://dx.doi.org/10.1371/journal.pone.0034704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509346	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336600050
J	Lin, CW; Hsieh, YS; Hsin, CH; Su, CW; Lin, CH; Wei, LH; Yang, SF; Chien, MH				Lin, Chiao-Wen; Hsieh, Yih-Shou; Hsin, Chung-Han; Su, Chun-Wen; Lin, Chien-Huang; Wei, Lin-Hung; Yang, Shun-Fa; Chien, Ming-Hsien			Effects of NFKB1 and NFKBIA Gene Polymorphisms on Susceptibility to Environmental Factors and the Clinicopathologic Development of Oral Cancer	PLOS ONE			English	Article							NF-KAPPA-B; SQUAMOUS-CELL CARCINOMAS; DIFFERENTIAL EXPRESSION; FUNCTIONAL POLYMORPHISM; PROMOTER POLYMORPHISMS; RISK; PROGRESSION; TUMOR; ASSOCIATION; TAIWAN	Background: Oral cancer, which is the fourth most common cancer in Taiwanese men, is associated with environmental carcinogens. The possibility that genetic predisposition in nuclear factor-kappa B (NF-kappa B)-signaling pathways activation is linked to the development of oral squamous cell carcinoma (OSCC) requires investigation. The current study examines associations between polymorphisms within promoter regions of NFKB1 encoding NF-kappa B1 and NFKBIA encoding IkappaBalpha (I kappa beta alpha) with both the susceptibility to develop OSCC and the clinicopathological characteristics of the tumors. Methodology/Principal Findings: Genetic polymorphisms of NFKB1 and NFKBIA were analyzed by a real-time polymerase chain reaction (real-time PCR) for 462 patients with oral cancer and 520 non-cancer controls. We found that NFKB1 -94 ATGG1/ATGG2, -94 ATGG2/ATGG2, and the combination of -94 ATGG1/ATGG2 and ATGG2/ATGG2 genotypes NFKBIA -826 T (CT+TT) and -881 G (AG+GG) allelic carriages, were more prevalent in OSCC patients than in non-cancer participants. Moreover, we found that NFKB1 or NFKBIA gene polymorphisms seem to be related to susceptibility to develop oral cancer linked to betel nut and tobacco consumption. Finally, patients with oral cancer who had at least one -519 T allele of the NFKBIA gene were at higher risk for developing distant metastasis (P<.05), compared with those patients CC homozygotes. Conclusions: Our results suggest that NFKB1 -94 ATTG2, NFKBIA -826 T, and -881 G alleles are associated with oral carcinogenesis. The combination of NFKB1 or NFKBIA gene polymorphisms and environmental carcinogens appears related to an increased risk of oral cancer. More importantly, the genetic polymorphism of NFKBIA -519 might be a predictive factor for the distal metastasis of OSCC in Taiwanese.	[Lin, Chiao-Wen; Hsieh, Yih-Shou] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Lin, Chiao-Wen; Hsieh, Yih-Shou; Yang, Shun-Fa] Chung Shan Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Hsin, Chung-Han] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Hsin, Chung-Han] Chung Shan Med Univ Hosp, Dept Otolaryngol, Taichung, Taiwan; [Su, Chun-Wen; Yang, Shun-Fa] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lin, Chien-Huang] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Wei, Lin-Hung] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Wan Fang Hosp, Taipei, Taiwan; [Chien, Ming-Hsien] Taipei Med Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Taipei Medical University; National Taiwan University; National Taiwan University Hospital; Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University	Lin, CW (corresponding author), Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan.	mhchien1976@gmail.com	Yang, Shun-Fa/AAN-1519-2020	Yang, Shun-Fa/0000-0002-0365-7927; Wei, Lin-Hung/0000-0001-8789-0859; Lin, Chien-Huang/0000-0002-0916-8737	Taipei Medical University [TMU99-AE1-B05]	Taipei Medical University	This study was supported by a grant from Taipei Medical University (grant no. TMU99-AE1-B05 to Dr. Chien). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah A, 2003, GENES IMMUN, V4, P450, DOI 10.1038/sj.gene.6364001; Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Bharti AC, 2002, BIOCHEM PHARMACOL, V64, P883, DOI 10.1016/S0006-2952(02)01154-1; Biolchini F, 2005, Minerva Stomatol, V54, P405; Bu H, 2007, J CANCER RES CLIN, V133, P859, DOI 10.1007/s00432-007-0228-7; Califano J, 1996, CANCER RES, V56, P2488; Chang ET, 2009, CANCER EPIDEM BIOMAR, V18, P976, DOI 10.1158/1055-9965.EPI-08-1130; Chung TT, 2011, CARCINOGENESIS, V32, P1063, DOI 10.1093/carcin/bgr083; Curran JE, 2002, CANCER LETT, V188, P103, DOI 10.1016/S0304-3835(02)00460-3; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Dong QG, 2002, ONCOGENE, V21, P6510, DOI 10.1038/sj.onc.1205848; Edge SB., 2010, AJCC CANC STAGING MA, V7, P111; Gao JF, 2007, SCAND J GASTROENTERO, V42, P345, DOI 10.1080/00365520600880856; Gilmore Thomas D, 2003, Cancer Treat Res, V115, P241; He YC, 2009, CARCINOGENESIS, V30, P1916, DOI 10.1093/carcin/bgp226; Huang SF, 2009, ORAL ONCOL, V45, P16, DOI 10.1016/j.oraloncology.2008.03.006; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Jordan RCK, 1996, ORAL ONCOL, V32B, P394, DOI 10.1016/S0964-1955(96)00033-4; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Lai KC, 2006, MUTAT RES-FUND MOL M, V599, P66, DOI 10.1016/j.mrfmmm.2006.01.005; Lin MH, 2004, ARCH TOXICOL, V78, P167, DOI 10.1007/s00204-003-0524-1; Lin PY, 2008, J ORAL PATHOL MED, V37, P18, DOI 10.1111/j.1600-0714.2007.0057.x; Lin SC, 2005, INT J CANCER, V116, P526, DOI 10.1002/ijc.21104; Lin SC, 2006, CANCER LETT, V243, P47, DOI 10.1016/j.canlet.2005.11.019; Lo SS, 2009, SURGERY, V145, P280, DOI 10.1016/j.surg.2008.11.001; Mishra A, 2006, INT J CANCER, V119, P2840, DOI 10.1002/ijc.22262; Nagaraj NS, 2006, TOXICOL LETT, V165, P182, DOI 10.1016/j.toxlet.2006.03.008; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nakao S, 2009, ARCH ORAL BIOL, V54, P251, DOI 10.1016/j.archoralbio.2008.11.006; Pacifico F, 2006, BIOCHEM PHARMACOL, V72, P1142, DOI 10.1016/j.bcp.2006.07.032; Pikarsky E, 2004, NATURE, V431, P461, DOI 10.1038/nature02924; Shastry BS, 2002, J HUM GENET, V47, P561, DOI 10.1007/s100380200086; Spink CF, 2007, CANCER LETT, V246, P92, DOI 10.1016/j.canlet.2006.02.001; Sun XF, 2007, HISTOL HISTOPATHOL, V22, P1387, DOI 10.14670/HH-22.1387; Vairaktaris E, 2007, EJSO-EUR J SURG ONC, V33, P504, DOI 10.1016/j.ejso.2006.11.002; Whiteside ST, 1997, SEMIN CANCER BIOL, V8, P75, DOI 10.1006/scbi.1997.0058; Wu HJ, 2005, J TOXICOL ENV HEAL A, V68, P1511, DOI 10.1080/15287390590967478; Yang JM, 2007, CANCER RES, V67, P3127, DOI 10.1158/0008-5472.CAN-06-3547; Yen CY, 2008, J ORAL PATHOL MED, V37, P271, DOI 10.1111/j.1600-0714.2007.00608.x; Zhang P, 2009, CANCER GENET CYTOGEN, V191, P73, DOI 10.1016/j.cancergencyto.2009.01.017; Zhou B, 2010, ANN ONCOL, V21, P506, DOI 10.1093/annonc/mdp507	42	31	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35078	10.1371/journal.pone.0035078	http://dx.doi.org/10.1371/journal.pone.0035078			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509384	Green Submitted, Green Published, gold			2022-12-27	WOS:000305336600080
J	Shen, YY; Lim, BK; Liu, HQ; Liu, J; Irwin, DM; Zhang, YP				Shen, Yong-Yi; Lim, Burton K.; Liu, He-Qun; Liu, Jie; Irwin, David M.; Zhang, Ya-Ping			Multiple Episodes of Convergence in Genes of the Dim Light Vision Pathway in Bats	PLOS ONE			English	Article							HOMEOBOX GENE; PHYLOGENETIC ANALYSIS; POSITIVE SELECTION; ECHOLOCATING BATS; BRANCH-SITE; EVOLUTION; CRX; ROD; MUTATIONS; LIKELIHOOD	The molecular basis of the evolution of phenotypic characters is very complex and is poorly understood with few examples documenting the roles of multiple genes. Considering that a single gene cannot fully explain the convergence of phenotypic characters, we choose to study the convergent evolution of rod vision in two divergent bats from a network perspective. The Old World fruit bats (Pteropodidae) are non-echolocating and have binocular vision, whereas the sheath-tailed bats (Emballonuridae) are echolocating and have monocular vision; however, they both have relatively large eyes and rely more on rod vision to find food and navigate in the night. We found that the genes CRX, which plays an essential role in the differentiation of photoreceptor cells, SAG, which is involved in the desensitization of the photoactivated transduction cascade, and the photoreceptor gene RH, which is directly responsible for the perception of dim light, have undergone parallel sequence evolution in two divergent lineages of bats with larger eyes (Pteropodidae and Emballonuroidea). The multiple convergent events in the network of genes essential for rod vision is a rare phenomenon that illustrates the importance of investigating pathways and networks in the evolution of the molecular basis of phenotypic convergence.	[Shen, Yong-Yi; Liu, He-Qun; Liu, Jie; Zhang, Ya-Ping] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Shen, Yong-Yi; Zhang, Ya-Ping] Yunnan Univ, Lab Conservat & Utilizat Bioresources, Kunming, Peoples R China; [Lim, Burton K.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Liu, He-Qun; Liu, Jie] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Irwin, David M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Irwin, David M.] Univ Toronto, Banting & Best Diabet Ctr, Toronto, ON M5G 1L5, Canada	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan University; Royal Ontario Museum; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Toronto; University of Toronto	Shen, YY (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	zhangyp@mail.kiz.ac.cn	Shen, Yongyi/GWU-8031-2022; Lim, Burton/A-1148-2011	Irwin, David/0000-0001-6131-4933; Lim, Burton/0000-0002-0884-0421	National Basic Research Program of China (973 Program) [2007CB411600]; National Natural Science Foundation of China [30621092, 31172080]; Bureau of Science and Technology of Yunnan Province; ROM Governors	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bureau of Science and Technology of Yunnan Province; ROM Governors	This work was supported by National Basic Research Program of China (973 Program, 2007CB411600), National Natural Science Foundation of China (30621092 and 31172080), Bureau of Science and Technology of Yunnan Province, and research grants from the ROM Governors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Acharya KK, 1998, BEHAV PROCESS, V44, P59, DOI 10.1016/S0376-6357(98)00028-X; Baron G., 1996, COMP NEUROBIOLOGY CH, V2; Bloomfield SA, 2001, PROG RETIN EYE RES, V20, P351, DOI 10.1016/S1350-9462(00)00031-8; Castoe TA, 2009, P NATL ACAD SCI USA, V106, P8986, DOI 10.1073/pnas.0900233106; Corbo JC, 2010, GENOME RES, V20, P1512, DOI 10.1101/gr.109405.110; Ding KY, 2005, MOL BIOL EVOL, V22, P148, DOI 10.1093/molbev/msh266; Eklof J, 2003, ANIM BEHAV, V66, P949, DOI 10.1006/anbe.2003.2272; Eklof J, 2002, MAMM BIOL, V67, P42, DOI 10.1078/1616-5047-00004; Eklof J, 2003, VISION ECHOLOCATING; Endler JA, 2005, BIOL J LINN SOC, V86, P405, DOI 10.1111/j.1095-8312.2005.00540.x; Fernald RD, 2006, SCIENCE, V313, P1914, DOI 10.1126/science.1127889; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Fure A, 2006, LONDON NATURALIST, V85, P1; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harmon LJ, 2005, EVOLUTION, V59, P409; Heesy CP, 2001, J HUM EVOL, V40, P111, DOI 10.1006/jhev.2000.0447; HUANG SK, 1992, CELL TISSUE RES, V267, P493, DOI 10.1007/BF00319371; Huelsenbeck J. P., 2001, MRBAYES BAYESIAN INF, P754; Isashiki Y, 1999, BRIT J OPHTHALMOL, V83, P1197; Jones G, 2010, CURR BIOL, V20, pR62, DOI 10.1016/j.cub.2009.11.059; Kay RF, 2000, AM J PHYS ANTHROPOL, V113, P235, DOI 10.1002/1096-8644(200010)113:2<235::AID-AJPA7>3.0.CO;2-9; Kim TJ, 2008, MOL CELLS, V26, P373; Larhammar D, 2009, PHILOS T R SOC B, V364, P2867, DOI 10.1098/rstb.2009.0077; Lee MSY, 1998, BIOL J LINN SOC, V65, P369, DOI 10.1111/j.1095-8312.1998.tb01148.x; Li G, 2008, P NATL ACAD SCI USA, V105, P13959, DOI 10.1073/pnas.0802097105; LI WH, 1985, MOL BIOL EVOL, V2, P150; Li Y, 2010, CURR BIOL, V20, pR55, DOI 10.1016/j.cub.2009.11.042; Liu Y, 2010, CURR BIOL, V20, pR53, DOI 10.1016/j.cub.2009.11.058; Liu Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026618; Luft S, 2003, NATURWISSENSCHAFTEN, V90, P84, DOI 10.1007/s00114-002-0393-0; Nozawa M, 2009, P NATL ACAD SCI USA, V106, P6700, DOI 10.1073/pnas.0901855106; Phillips CJ, 2000, THEORETICAL CONSIDER; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rivolta C, 2001, HUM MUTAT, V18, P488, DOI 10.1002/humu.1226; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Schnitzler HU, 1998, ECHOLOCATING BATS SE, P183; Shen YY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008838; Shichida Y, 2009, PHILOS T R SOC B, V364, P2881, DOI 10.1098/rstb.2009.0051; Simmons Nancy B., 1998, Bulletin of the American Museum of Natural History, V235, P1; Sohocki MM, 1998, AM J HUM GENET, V63, P1307, DOI 10.1086/302101; Speakman JR, 2001, MAMMAL REV, V31, P111, DOI 10.1046/j.1365-2907.2001.00082.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teeling EC, 2000, NATURE, V403, P188, DOI 10.1038/35003188; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wiens JJ, 2003, SYST BIOL, V52, P501, DOI 10.1080/10635150390218222; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; YOKOYAMA S, 1993, MOL BIOL EVOL, V10, P527; Yokoyama S, 2008, ANNU REV GENOM HUM G, V9, P259, DOI 10.1146/annurev.genom.9.081307.164228; Zhang JZ, 1997, MOL BIOL EVOL, V14, P527, DOI 10.1093/oxfordjournals.molbev.a025789	55	9	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34564	10.1371/journal.pone.0034564	http://dx.doi.org/10.1371/journal.pone.0034564			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509324	Green Submitted, gold, Green Published			2022-12-27	WOS:000305336600037
J	Stidsen, JV; Khorooshi, R; Rahbek, MKU; Kirketerp-Moller, KL; Hansen, PBL; Bie, P; Kejling, K; Mandrup, S; Hawgood, S; Nielsen, O; Nielsen, CH; Owens, T; Holmskov, U; Sorensen, GL				Stidsen, Jacob V.; Khorooshi, Reza; Rahbek, Martin K. U.; Kirketerp-Moller, Katrine L.; Hansen, Pernille B. L.; Bie, Peter; Kejling, Karin; Mandrup, Susanne; Hawgood, Samuel; Nielsen, Ole; Nielsen, Claus H.; Owens, Trevor; Holmskov, Uffe; Sorensen, Grith L.			Surfactant Protein D Deficiency in Mice Is Associated with Hyperphagia, Altered Fat Deposition, Insulin Resistance, and Increased Basal Endotoxemia	PLOS ONE			English	Article							FOOD-INTAKE; PATHOLOGICAL RESEARCH; INNATE IMMUNITY; GUT MICROBIOTA; ADIPOSE-TISSUE; BODY-WEIGHT; OBESITY; LUNG; SERUM; INFLAMMATION	Pulmonary surfactant protein D (SP-D) is a host defence lectin of the innate immune system that enhances clearance of pathogens and modulates inflammatory responses. Recently it has been found that systemic SP-D is associated with metabolic disturbances and that SP-D deficient mice are mildly obese. However, the mechanism behind SP-D's role in energy metabolism is not known. Here we report that SP-D deficient mice had significantly higher ad libitum energy intake compared to wild-type mice and unchanged energy expenditure. This resulted in accumulation but also redistribution of fat tissue. Blood pressure was unchanged. The change in energy intake was unrelated to the basal levels of hypothalamic Proopiomelanocortin (POMC) and Agouti-related peptide (AgRP) gene expression. Neither short time systemic, nor intracereberoventricular SP-D treatment altered the hypothalamic signalling or body weight accumulation. In ad libitum fed animals, serum leptin, insulin, and glucose were significantly increased in mice deficient in SP-D, and indicative of insulin resistance. However, restricted diets eliminated all metabolic differences except the distribution of body fat. SP-D deficiency was further associated with elevated levels of systemic bacterial lipopolysaccharide. In conclusion, our findings suggest that lack of SP-D mediates modulation of food intake not directly involving hypothalamic regulatory pathways. The resulting accumulation of adipose tissue was associated with insulin resistance. The data suggest SP-D as a regulator of energy intake and body composition and an inhibitor of metabolic endotoxemia. SP-D may play a causal role at the crossroads of inflammation, obesity, and insulin resistance.	[Stidsen, Jacob V.; Rahbek, Martin K. U.; Kirketerp-Moller, Katrine L.; Hansen, Pernille B. L.; Bie, Peter; Kejling, Karin; Holmskov, Uffe; Sorensen, Grith L.] Univ So Denmark, Inst Mol Med, Odense, Denmark; [Khorooshi, Reza; Owens, Trevor] Univ So Denmark, Inst Mol Med, Dept Neurobiol Res, Odense, Denmark; [Mandrup, Susanne] Univ So Denmark, Dept Biochem & Mol Biol, Odense, Denmark; [Hawgood, Samuel] Univ Calif San Francisco, Sch Med, San Francisco, CA USA; [Nielsen, Claus H.] Odense Univ Hosp, Dept Pathol, DK-5000 Odense, Denmark; [Nielsen, Claus H.] Copenhagen Univ Hosp, Rigshosp, Inst Inflammat Res, Copenhagen, Denmark	University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; University of California System; University of California San Francisco; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen	Stidsen, JV (corresponding author), Univ So Denmark, Inst Mol Med, Odense, Denmark.	glsorensen@health.sdu.dk	Holmskov, Uffe/AAA-3056-2022; Stidsen, Jacob/ABC-9420-2020	Holmskov, Uffe/0000-0002-2391-9445; Stidsen, Jacob/0000-0003-2711-5927; Nielsen, Claus Henrik/0000-0001-7543-9016; Rahbek, Martin Torp/0000-0001-7506-3426; Hansen, Pernille B. Laerkegaard/0000-0003-0661-1665; Mandrup, Susanne/0000-0002-0961-5787; Owens, Trevor/0000-0001-9315-6036; Sorensen, Grith Lykke/0000-0002-5273-1097; Kirketerp-Moller, Katrine Lindequist/0000-0002-3795-7207; Khorooshi, Reza/0000-0002-6164-4972	Danish Medical Research Council; Novo-Nordic Foundation; Lundbeck Foundation; Fonden til Laegevidenskabens Fremme; Danish Heart Foundation; European Union [QLK2 CT2000 00325]; Benzon Foundation; Augustinus Foundation; Becket Foundation; Lundbeck Foundation [R5-2006-446] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo-Nordic Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); Fonden til Laegevidenskabens Fremme; Danish Heart Foundation; European Union(European Commission); Benzon Foundation; Augustinus Foundation; Becket Foundation; Lundbeck Foundation(Lundbeckfonden)	This work was supported by grants from the Danish Medical Research Council, the Novo-Nordic Foundation, The Lundbeck Foundation, Fonden til Laegevidenskabens Fremme, the Danish Heart Foundation, European Union Contract Number QLK2 CT2000 00325, The Benzon Foundation, The Augustinus Foundation, and the Becket Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2002, DIABETES, V51, P2099, DOI 10.2337/diabetes.51.7.2099; Akiyama J, 2002, J HISTOCHEM CYTOCHEM, V50, P993, DOI 10.1177/002215540205000713; Andersen H, 2011, ACTA PHYSIOL, V203, P197, DOI 10.1111/j.1748-1716.2010.02218.x; Atochina-Vasserman EN, 2007, J IMMUNOL, V179, P8090, DOI 10.4049/jimmunol.179.12.8090; Aye T, 2010, J HISTOCHEM CYTOCHEM, V58, P369, DOI 10.1369/jhc.2009.954909; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Breslow MJ, 1999, AM J PHYSIOL-ENDOC M, V276, pE443, DOI 10.1152/ajpendo.1999.276.3.E443; Brouwer E., 1965, EAAP PUB, V11, P441, DOI DOI 10.4236/NS.2011.312129; Brown LM, 2006, PHYSIOL BEHAV, V89, P687, DOI 10.1016/j.physbeh.2006.08.008; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; CHWALIBOG A, 1992, J ANIM PHYSIOL AN N, V68, P123, DOI 10.1111/j.1439-0396.1992.tb00652.x; Conterno L, 2011, GENES NUTR, V6, P241, DOI 10.1007/s12263-011-0230-1; Creutzberg EC, 2003, EUR RESPIR J, V22, p76S, DOI 10.1183/09031936.03.00004610; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fernandez-Real JM, 2008, TRENDS ENDOCRIN MET, V19, P10, DOI 10.1016/j.tem.2007.10.004; Frisard MI, 2010, AM J PHYSIOL-ENDOC M, V298, pE988, DOI 10.1152/ajpendo.00307.2009; Fujita M, 2005, CYTOKINE, V31, P25, DOI 10.1016/j.cyto.2005.02.006; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; Hamdy O, 2006, CURR DIABETES REV, V2, P367, DOI 10.2174/1573399810602040367; Hansen S, 2008, J IMMUNOL METHODS, V330, P75, DOI 10.1016/j.jim.2007.11.001; Hartshorn KL, 1998, AM J PHYSIOL-LUNG C, V274, pL958, DOI 10.1152/ajplung.1998.274.6.L958; Hill J, 2011, EUR HEART J, V32, P1918, DOI 10.1093/eurheartj/ehr124; Honda K, 2007, NEUROSCI LETT, V423, P153, DOI 10.1016/j.neulet.2007.07.004; Ikegami M, 2001, AM J PHYSIOL-LUNG C, V281, pL697, DOI 10.1152/ajplung.2001.281.3.L697; Khorooshi R, 2010, J IMMUNOL, V185, P1258, DOI 10.4049/jimmunol.0901753; Layden BT, 2010, J ENDOCRINOL, V207, P265, DOI 10.1677/JOE-10-0298; Leinninger GM, 2009, INT J OBESITY, V33, pS14, DOI 10.1038/ijo.2009.66; Leth-Larsen R, 2005, J IMMUNOL, V174, P1532, DOI 10.4049/jimmunol.174.3.1532; Leth-Larsen R, 2003, CLIN IMMUNOL, V108, P29, DOI 10.1016/S1521-6616(03)00042-1; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Madsen J, 2000, J IMMUNOL, V164, P5866, DOI 10.4049/jimmunol.164.11.5866; Mancuso P, 2010, J APPL PHYSIOL, V108, P722, DOI 10.1152/japplphysiol.00781.2009; Fernandez-Real JM, 2010, DIABETES CARE, V33, P847, DOI 10.2337/dc09-0542; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ohya M, 2006, BIOCHEMISTRY-US, V45, P8657, DOI 10.1021/bi060176z; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Onat A, 2011, CLIN CHIM ACTA; Paxinox G, MOUSE BRAIN STEREOTA; Reed JA, 2005, J CLIN INVEST, V115, P3035, DOI 10.1172/JCI25681; Sano H, 2000, J BIOL CHEM, V275, P22442, DOI 10.1074/jbc.M001107200; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Sorensen GL, 2006, SCAND J IMMUNOL, V64, P633, DOI 10.1111/j.1365-3083.2006.01853.x; Sorensen GL, 2006, AM J PHYSIOL-LUNG C, V290, pL1010, DOI 10.1152/ajplung.00487.2005; Sorensen GL, 2006, AM J PHYSIOL-HEART C, V290, pH2286, DOI 10.1152/ajpheart.01105.2005; Sorensen GL, 2009, MOL IMMUNOL, V46, P3060, DOI 10.1016/j.molimm.2009.06.005; Sorensen GL, 2007, IMMUNOBIOLOGY, V212, P381, DOI 10.1016/j.imbio.2007.01.003; Stahlman MT, 2002, J HISTOCHEM CYTOCHEM, V50, P651, DOI 10.1177/002215540205000506; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Tilg H, 2008, CLIN SCI, V114, P275, DOI 10.1042/CS20070196; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; von Eyben FE, 2003, INT J OBESITY, V27, P941, DOI 10.1038/sj.ijo.0802309; Wannamethee SG, 2010, DIABETES CARE, V33, P1990, DOI 10.2337/dc10-0324; Weide K, 2003, PHYSIOL GENOMICS, V13, P47, DOI 10.1152/physiolgenomics.00129.2002; Williams KW, 2011, EUR J PHARMACOL, V660, P2, DOI 10.1016/j.ejphar.2010.11.042; Wouters EFM, 2002, CHEST, V121, p127S, DOI 10.1378/chest.121.5_suppl.127S; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wu HX, 2003, J CLIN INVEST, V111, P1589, DOI 10.1172/JCI200316889; Yamazoe M, 2008, J BIOL CHEM, V283, P35878, DOI 10.1074/jbc.M807268200; Yoshida M, 2006, RESPIROLOGY, V11, pS37, DOI 10.1111/j.1440-1843.2006.00806.x; Yoshida M, 2009, LAB INVEST, V89, P760, DOI 10.1038/labinvest.2009.34; Zeyda M, 2007, IMMUNOL LETT, V112, P61, DOI 10.1016/j.imlet.2007.07.003; Zhang MX, 2011, BIOMED ENVIRON SCI, V24, P12, DOI 10.3967/0895-3988.2011.01.002; Zhao XM, 2007, SCAND J IMMUNOL, V66, P71, DOI 10.1111/j.1365-3083.2007.01943.x	70	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e35066	10.1371/journal.pone.0035066	http://dx.doi.org/10.1371/journal.pone.0035066			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509382	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600078
J	Lopez-Dee, ZP; Chittur, SV; Patel, B; Stanton, R; Wakeley, M; Lippert, B; Menaker, A; Eiche, B; Terry, R; Gutierrez, LS				Lopez-Dee, Zenaida P.; Chittur, Sridar V.; Patel, Bhumi; Stanton, Rebecca; Wakeley, Michelle; Lippert, Brittany; Menaker, Anastasya; Eiche, Bethany; Terry, Robert; Gutierrez, Linda S.			Thrombospondin-1 Type 1 Repeats in a Model of Inflammatory Bowel Disease: Transcript Profile and Therapeutic Effects	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TUMOR-GROWTH; CROHNS-DISEASE; PROTEIN; COLON; SERGLYCIN; COLITIS; IDENTIFICATION; PROTEOGLYCAN; ANGIOGENESIS	Thrombospondin-1 (TSP-1) is a matricellular protein with regulatory functions in inflammation and cancer. The type 1 repeats (TSR) domains of TSP-1 have been shown to interact with a wide range of proteins that result in the anti-angiogenic and anti-tumor properties of TSP-1. To ascertain possible functions and evaluate potential therapeutic effects of TSRs in inflammatory bowel disease, we conducted clinical, histological and microarray analyses on a mouse model of induced colitis. We used dextran sulfate sodium (DSS) to induce colitis in wild-type (WT) mice for 7 days. Simultaneously, mice were injected with either saline or one form of TSP-1 derived recombinant proteins, containing either (1) the three type 1 repeats of the TSP-1 (3TSR), (2) the second type 1 repeat (TSR2), or (3) TSR2 with the RFK sequence (TSR2+RFK). Total RNA isolated from the mice colons were processed and hybridized to mouse arrays. Array data were validated by real-time qPCR and immunohistochemistry. Histological and disease indices reveal that the mice treated with the TSRs show different patterns of leukocytic infiltration and that 3TSR treatment was the most effective in decreasing inflammation in DSS-induced colitis. Transcriptional profiling revealed differentially expressed (DE) genes, with the 3TSR-treated mice showing the least deviation from the WT-water controls. In conclusion, this study shows that 3TSR treatment is effective in attenuating the inflammatory response to DSS injury. In addition, the transcriptomics work unveils novel genetic data that suggest beneficial application of the TSR domains in inflammatory bowel disease.	[Lopez-Dee, Zenaida P.; Patel, Bhumi; Stanton, Rebecca; Wakeley, Michelle; Lippert, Brittany; Menaker, Anastasya; Eiche, Bethany; Terry, Robert; Gutierrez, Linda S.] Wilkes Univ, Dept Biol, Wilkes Barre, PA 18766 USA; [Chittur, Sridar V.] SUNY Albany, Ctr Funct Genom, Rensselaer, NY USA	Wilkes University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Lopez-Dee, ZP (corresponding author), Commonwealth Med Coll, Dept Basic Sci, Scranton, PA USA.	linda.gutierrez@wilkes.edu	/W-2676-2019		National Institutes of Health [DK067901-12 02]; Howard Hughes Medical Institute [52006328]; Wilkes Mentoring grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R15DK067901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Wilkes Mentoring grant; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK067901-12 02), the Howard Hughes Medical Institute (grant # 52006328) and a Wilkes Mentoring grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2000, DEV DYNAM, V218, P280; Amsterdam A, 2011, INT J ONCOL, V39, P1165, DOI 10.3892/ijo.2011.1123; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Carlson CB, 2008, CELL MOL LIFE SCI, V65, P672, DOI 10.1007/s00018-007-7484-1; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Feagins LA, 2010, INFLAMM BOWEL DIS, V16, P1963, DOI 10.1002/ibd.21281; Garcia MI, 2009, DEV BIOL, V331, P58, DOI 10.1016/j.ydbio.2009.04.020; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Gove ME, 2009, J LEUKOCYTE BIOL, V85, P491, DOI 10.1189/jlb.0808508; Hagiwara K, 2003, J IMMUNOL, V170, P1973, DOI 10.4049/jimmunol.170.4.1973; Haviv F, 2005, J MED CHEM, V48, P2838, DOI 10.1021/jm0401560; Hsu Kenneth, 2009, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V8, P290; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Isenberg JS, 2009, NAT REV CANCER, V9, P182, DOI 10.1038/nrc2561; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; LAWLER J, 1986, J CELL BIOL, V103, P1635, DOI 10.1083/jcb.103.5.1635; LAWLER J, 1986, BLOOD, V67, P1197; Li YX, 2010, GROWTH HORM IGF RES, V20, P391, DOI 10.1016/j.ghir.2010.09.005; Marquez L, 2011, GUT; Miao WM, 2001, CANCER RES, V61, P7830; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Moldobaeva A, 2010, MICROVASC RES, V80, P18, DOI 10.1016/j.mvr.2010.01.011; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Papp M, 2007, DIGEST DIS SCI, V52, P1279, DOI 10.1007/s10620-006-9615-1; Petersson J, 2007, AM J PHYSIOL-GASTR L, V293, pG1281, DOI 10.1152/ajpgi.00357.2007; Pilka ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007113; Punekar S, 2008, PATHOBIOLOGY, V75, P9, DOI 10.1159/000113790; Ren B, 2009, CANCER RES, V69, P3856, DOI 10.1158/0008-5472.CAN-08-2940; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Santiago JL, 2008, DIABETOLOGIA, V51, P1653, DOI 10.1007/s00125-008-1070-4; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schick BP, 2001, BLOOD, V97, P449, DOI 10.1182/blood.V97.2.449; Short SM, 2005, J CELL BIOL, V168, P643, DOI 10.1083/jcb.200407060; Simantov R, 2005, MATRIX BIOL, V24, P27, DOI 10.1016/j.matbio.2004.11.005; Simantov R, 2003, FRONT BIOSCI-LANDMRK, V8, pS874, DOI 10.2741/1168; Sipione S, 2006, J IMMUNOL, V177, P5051, DOI 10.4049/jimmunol.177.8.5051; Sunahori K, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1939; Swidsinski A, 2009, J PHYSIOL PHARMACOL, V60, P61; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P969, DOI 10.1016/j.biocel.2003.12.011; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Yasui Yumiko, 2009, J Carcinog, V8, P10, DOI 10.4103/1477-3163.51851; Yee KO, 2004, AM J PATHOL, V165, P541, DOI 10.1016/S0002-9440(10)63319-6; Zernichow L, 2006, J BIOL CHEM, V281, P26792, DOI 10.1074/jbc.M512889200; Zhang XF, 2005, CLIN CANCER RES, V11, P2337, DOI 10.1158/1078-0432.CCR-04-1900; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649	47	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34590	10.1371/journal.pone.0034590	http://dx.doi.org/10.1371/journal.pone.0034590			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509329	Green Published, Green Submitted, gold			2022-12-27	WOS:000304805900052
J	Sun, J; Zhou, M; Mao, ZT; Li, CX				Sun, Jie; Zhou, Meng; Mao, Zhitao; Li, Chuanxing			Characterization and Evolution of microRNA Genes Derived from Repetitive Elements and Duplication Events in Plants	PLOS ONE			English	Article							ARABIDOPSIS; GENOME; IDENTIFICATION; FAMILIES; RESOURCE; CONSERVATION; PRECURSORS; SEQUENCES; ORIGIN; MIRNAS	MicroRNAs (miRNAs) are a major class of small non-coding RNAs that act as negative regulators at the post-transcriptional level in animals and plants. In this study, all known miRNAs in four plant species (Arabidopsis thaliana, Populus trichocarpa, Oryza sativa and Sorghum bicolor) have been analyzed, using a combination of computational and comparative genomic approaches, to systematically identify and characterize the miRNAs that were derived from repetitive elements and duplication events. The study provides a complete mapping, at the genome scale, of all the miRNAs found on repetitive elements in the four test plant species. Significant differences between repetitive element-related miRNAs and non-repeat-derived miRNAs were observed for many characteristics, including their location in protein-coding and intergenic regions in genomes, their conservation in plant species, sequence length of their hairpin precursors, base composition of their hairpin precursors and the minimum free energy of their hairpin structures. Further analysis showed that a considerable number of miRNA families in the four test plant species arose from either tandem duplication events, segmental duplication events or a combination of the two. However, comparative analysis suggested that the contribution made by these two duplication events differed greatly between the perennial tree species tested and the other three annual species. The expansion of miRNA families in A. thaliana, O. sativa and S. bicolor are more likely to occur as a result of tandem duplication events than from segmental duplications. In contrast, genomic segmental duplications contributed significantly more to the expansion of miRNA families in P. trichocarpa than did tandem duplication events. Taken together, this study has successfully characterized miRNAs derived from repetitive elements and duplication events at the genome scale and provides comprehensive knowledge and deeper insight into the origins and evolution of miRNAs in plants.	[Sun, Jie; Zhou, Meng; Mao, Zhitao; Li, Chuanxing] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	Harbin Medical University	Sun, J (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	biofomeng@hotmail.com	Zhou, Meng/G-7674-2011	Zhou, Meng/0000-0001-9987-9024; Li, Chuan-Xing/0000-0003-2189-5010; Sun, Jie/0000-0002-0932-7195	Foundation of Harbin Medical University [WLD-QN1107]	Foundation of Harbin Medical University	This work was partially supported by the Foundation of Harbin Medical University(WLD-QN1107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arabidopsis Genome Initiative, 2000, Nature (London), V408, P796, DOI 10.1038/35048692; Barakat Abdelali, 2007, BMC Genomics, V8, P481, DOI 10.1186/1471-2164-8-481; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; De Felippes FF, 2008, RNA, V14, P2455, DOI 10.1261/rna.1149408; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Friedman R, 2001, GENOME RES, V11, P373, DOI 10.1101/gr.155801; Gazzani S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-62; Guddeti S, 2005, CELL RES, V15, P631, DOI 10.1038/sj.cr.7290333; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Jiang DH, 2006, CELL RES, V16, P507, DOI 10.1038/sj.cr.7310062; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li AL, 2007, CELL RES, V17, P212, DOI 10.1038/sj.cr.7310113; Li Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019212; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Mendes ND, 2009, NUCLEIC ACIDS RES, V37, P2419, DOI 10.1093/nar/gkp145; Merchan F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r136; Mica E, 2006, J EXP BOT, V57, P2601, DOI 10.1093/jxb/erl013; Ni M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-329; Nozawa M, 2010, GENOME BIOL EVOL, V2, P180, DOI 10.1093/gbe/evq009; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Piriyapongsa J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000203; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yuan ZD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017666; Yuan ZD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-346; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang LF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000716; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507; Zhou FF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-14; Zhou M, 2011, FEBS J, V278, P929, DOI 10.1111/j.1742-4658.2011.08008.x	43	34	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34092	10.1371/journal.pone.0034092	http://dx.doi.org/10.1371/journal.pone.0034092			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523544	Green Submitted, gold, Green Published			2022-12-27	WOS:000305345000013
J	Calvo-Pinilla, E; Navasa, N; Anguita, J; Ortego, J				Calvo-Pinilla, Eva; Navasa, Nicolas; Anguita, Juan; Ortego, Javier			Multiserotype Protection Elicited by a Combinatorial Prime-Boost Vaccination Strategy against Bluetongue Virus	PLOS ONE			English	Article							IMMUNE-RESPONSES; DENDRITIC CELLS; INFECTION; VACCINES; SHEEP; PROTEINS; PATHOGENESIS; EXPRESSION; GENERATION; DEFICIENT	Bluetongue virus (BTV) belongs to the genus Orbivirus within the family Reoviridae. The development of vector-based vaccines expressing conserved protective antigens results in increased immune activation and could reduce the number of multiserotype vaccinations required, therefore providing a cost-effective product. Recent recombinant DNA technology has allowed the development of novel strategies to develop marker and safe vaccines against BTV. We have now engineered naked DNAs and recombinant modified vaccinia virus Ankara (rMVA) expressing VP2, VP7 and NS1 proteins from BTV-4. IFNAR((-/-)) mice inoculated with DNA/rMVA-VP2,-VP7-NS1 in an heterologous prime boost vaccination strategy generated significant levels of antibodies specific of VP2, VP7, and NS1, including those with neutralizing activity against BTV-4. In addition, vaccination stimulated specific CD8(+) T cell responses against these three BTV proteins. Importantly, the vaccine combination expressing NS1, VP2 and VP7 proteins of BTV-4, elicited sterile protection against a lethal dose of homologous BTV-4 infection. Remarkably, the vaccine induced cross-protection against lethal doses of heterologous BTV-8 and BTV-1 suggesting that the DNA/rMVA-VP2,-VP7,-NS1 marker vaccine is a promising multiserotype vaccine against BTV.	[Calvo-Pinilla, Eva; Ortego, Javier] INIA, CISA, Valdeolmos Madrid, Spain; [Navasa, Nicolas; Anguita, Juan] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Calvo-Pinilla, E (corresponding author), INIA, CISA, Valdeolmos Madrid, Spain.	ortego@inia.es	Anguita, Juan/D-5432-2011; Ortego, Javier/M-6810-2019; CALVO-PINILLA, EVA/L-5348-2014; ortego, javier/K-6020-2014; navasa, nicolas/AAB-2997-2019	Anguita, Juan/0000-0003-2061-7182; Ortego, Javier/0000-0002-4275-7277; CALVO-PINILLA, EVA/0000-0002-4667-4081; ortego, javier/0000-0002-4275-7277; 	Comision Interministerial de Ciencia y Tecnologia (CICYT) [AGL2008-00646/GAN, AGL2011-23506/GAN]; Integrating Activities 7th European Union program [228394-NADIR]; European Union Network of Excellence EPIZONE [FOOD-CT-2006-016236]	Comision Interministerial de Ciencia y Tecnologia (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Integrating Activities 7th European Union program; European Union Network of Excellence EPIZONE(European Commission)	This work was supported by grants AGL2008-00646/GAN and AGL2011-23506/GAN from the Comision Interministerial de Ciencia y Tecnologia (CICYT), 228394-NADIR-Integrating Activities 7th European Union program, and the European Union Network of Excellence EPIZONE (Contract No FOOD-CT-2006-016236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREW M, 1995, VET IMMUNOL IMMUNOP, V47, P311, DOI 10.1016/0165-2427(94)05410-T; BARRATTBOYES SM, 1995, J AM VET MED ASSOC, V206, P1322; Boone JD, 2007, VACCINE, V25, P672, DOI 10.1016/j.vaccine.2006.08.025; Calvo-Pinilla E, 2010, J GEN VIROL, V91, P2821, DOI 10.1099/vir.0.024117-0; Calvo-Pinilla E, 2009, VACCINE, V28, P437, DOI 10.1016/j.vaccine.2009.10.027; Calvo-Pinilla E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005171; Caporale M, 2011, J VIROL, V85, P11479, DOI 10.1128/JVI.05226-11; Castillo-Olivares J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016503; de Diego ACP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026666; De Temmerman ML, 2011, DRUG DISCOV TODAY, V16, P569, DOI 10.1016/j.drudis.2011.04.006; Demento SL, 2011, TRENDS BIOTECHNOL, V29, P294, DOI 10.1016/j.tibtech.2011.02.004; Eschbaumer M, 2011, VET MICROBIOL; GIBBS EPJ, 1994, COMP IMMUNOL MICROB, V17, P207, DOI 10.1016/0147-9571(94)90044-2; Gomez CE, 2011, CURR GENE THER, V11, P189; Guerra S, 2007, J VIROL, V81, P8707, DOI 10.1128/JVI.00444-07; Hanke T, 2002, VACCINE, V21, P108, DOI 10.1016/S0264-410X(02)00403-6; Hemati B, 2009, J VIROL, V83, P8789, DOI 10.1128/JVI.00626-09; HEWAT EA, 1992, J STRUCT BIOL, V108, P35, DOI 10.1016/1047-8477(92)90005-U; Janardhana V, 1999, RES VET SCI, V67, P213, DOI 10.1053/rvsc.1999.0306; JEGGO MH, 1984, RES VET SCI, V36, P81, DOI 10.1016/S0034-5288(18)32007-1; JEGGO MH, 1984, IMMUNOLOGY, V52, P403; JEGGO MH, 1982, IMMUNOLOGY, V45, P629; JEGGO MH, 1984, RES VET SCI, V37, P368, DOI 10.1016/S0034-5288(18)31885-X; Lobato ZIP, 1997, VET IMMUNOL IMMUNOP, V59, P293, DOI 10.1016/S0165-2427(97)00084-6; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; Matsuo E, 2011, J VIROL, V85, P10213, DOI 10.1128/JVI.05412-11; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; Perrin A, 2007, VACCINE, V25, P6774, DOI 10.1016/j.vaccine.2007.06.052; Romito M, 1999, ONDERSTEPOORT J VET, V66, P139; Rosenberg AS, 2006, AAPS J, V8, pE501, DOI 10.1208/aapsj080359; Roy P, 1996, INTERVIROLOGY, V39, P62, DOI 10.1159/000150476; ROY P, 1994, VACCINE, V12, P805, DOI 10.1016/0264-410X(94)90289-5; Savini G, 2008, COMP IMMUNOL MICROB, V31, P101, DOI 10.1016/j.cimid.2007.07.006; Schwartz-Cornil I, 2008, VET RES, V39, DOI 10.1051/vetres:2008023; Stott J.L., 1990, CURR TOP MICROBIOL, V162, P163, DOI 10.1007/978-3-642-75247-6_7; TAKAMATSU H, 1989, IMMUNOLOGY, V66, P258; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Umeshappa CS, 2010, VACCINE, V28, P2522, DOI 10.1016/j.vaccine.2010.01.039; Veronesi E, 2009, VACCINE; Veronesi E, 2010, VACCINE, V28, P1397, DOI 10.1016/j.vaccine.2009.10.107; WadeEvans AM, 1996, VIROLOGY, V220, P227, DOI 10.1006/viro.1996.0306	41	47	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34735	10.1371/journal.pone.0034735	http://dx.doi.org/10.1371/journal.pone.0034735			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514660	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600066
J	Fretwell, PT; LaRue, MA; Morin, P; Kooyman, GL; Wienecke, B; Ratcliffe, N; Fox, AJ; Fleming, AH; Porter, C; Trathan, PN				Fretwell, Peter T.; LaRue, Michelle A.; Morin, Paul; Kooyman, Gerald L.; Wienecke, Barbara; Ratcliffe, Norman; Fox, Adrian J.; Fleming, Andrew H.; Porter, Claire; Trathan, Phil N.			An Emperor Penguin Population Estimate: The First Global, Synoptic Survey of a Species from Space	PLOS ONE			English	Article							CLIMATE; RESPONSES; COLONIES	Our aim was to estimate the population of emperor penguins (Aptenodytes fosteri) using a single synoptic survey. We examined the whole continental coastline of Antarctica using a combination of medium resolution and Very High Resolution (VHR) satellite imagery to identify emperor penguin colony locations. Where colonies were identified, VHR imagery was obtained in the 2009 breeding season. The remotely-sensed images were then analysed using a supervised classification method to separate penguins from snow, shadow and guano. Actual counts of penguins from eleven ground truthing sites were used to convert these classified areas into numbers of penguins using a robust regression algorithm. We found four new colonies and confirmed the location of three previously suspected sites giving a total number of emperor penguin breeding colonies of 46. We estimated the breeding population of emperor penguins at each colony during 2009 and provide a population estimate of similar to 238,000 breeding pairs (compared with the last previously published count of 135,000-175,000 pairs). Based on published values of the relationship between breeders and non-breeders, this translates to a total population of similar to 595,000 adult birds. There is a growing consensus in the literature that global and regional emperor penguin populations will be affected by changing climate, a driver thought to be critical to their future survival. However, a complete understanding is severely limited by the lack of detailed knowledge about much of their ecology, and importantly a poor understanding of their total breeding population. To address the second of these issues, our work now provides a comprehensive estimate of the total breeding population that can be used in future population models and will provide a baseline for long-term research.	[Fretwell, Peter T.; Ratcliffe, Norman; Fox, Adrian J.; Fleming, Andrew H.; Trathan, Phil N.] British Antarctic Survey, Cambridge CB3 0ET, England; [LaRue, Michelle A.; Morin, Paul; Porter, Claire] Univ Minnesota, Polar Geospatial Ctr, Minneapolis, MN USA; [Kooyman, Gerald L.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Wienecke, Barbara] Australian Antarctic Div, Hobart, Tas, Australia	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego; Scripps Institution of Oceanography; Australian Antarctic Division	Fretwell, PT (corresponding author), British Antarctic Survey, Cambridge CB3 0ET, England.	ptf@bas.ac.uk		Chiaradia, Andre/0000-0002-6178-4211; , gerald/0000-0002-8872-2950	National Science Foundation (NSF) [1043681, 0944220]; BAS; UK Overseas Territories Fund [BAT601]; NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	National Science Foundation (NSF)(National Science Foundation (NSF)); BAS; UK Overseas Territories Fund; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors would like to acknowledge and thank funding and provision of imagery from the National Science Foundation (NSF-#1043681 and #0944220) which funded the U.S. component of this work. Imagery for the UK analysis was funded by the BAS Ecosystems/predators work package and UK Overseas Territories Fund (BAT601). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley D, 2010, ECOL MONOGR, V80, P49, DOI 10.1890/08-2289.1; Ainley D, 2010, MAR MAMMAL SCI, V26, P482, DOI 10.1111/j.1748-7692.2009.00337.x; Ainley DG, 2005, ANTARCT SCI, V17, P171, DOI 10.1017/S0954102005002567; Barber-Meyer SM, 2008, ANTARCT SCI, V20, P3, DOI 10.1017/S0954102007000673; Barber-Meyer SM, 2007, POLAR BIOL, V30, P1565, DOI 10.1007/s00300-007-0317-8; Barbraud C, 2001, NATURE, V411, P183, DOI 10.1038/35075554; Barbraud C, 2011, ANTARCT SCI, V23, P461, DOI 10.1017/S0954102011000356; Bracegirdle TJ, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008933; Condy P. R., 1979, S AFRICAN J ANTARCTI, V9, P29; Forcada J, 2009, GLOBAL CHANGE BIOL, V15, P1618, DOI 10.1111/j.1365-2486.2009.01909.x; Fretwell PT, 2009, GLOBAL ECOL BIOGEOGR, V18, P543, DOI 10.1111/j.1466-8238.2009.00467.x; Gelman A., 2007, DATA ANAL USING REGR; Gilbert C, 2006, PHYSIOL BEHAV, V88, P479, DOI 10.1016/j.physbeh.2006.04.024; Hempel G, 1987, BERICHTE POLARFORSCH, V39, P227, DOI DOI 10.2312/BZP_0039_1987; Horne RSC, 1983, ANARE RES NOTES, V9, P8; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Jenouvrier S, 2009, P NATL ACAD SCI USA, V106, P1844, DOI 10.1073/pnas.0806638106; Jouventin P., 1975, P435; Kato Akiko, 2004, Polar Bioscience, V17, P117; Kato Akiko, 1999, Polar Bioscience, V12, P36; Lea Mary-Anne, 2005, Marine Ornithology, V33, P59; Ledenev V. G., 1965, SOVIET ANTARCTIC EXP, V3, P107; Luna Perez JC, 1963, VISITA ROQUERIA PING, V70; Martinez I., 1992, HDB BIRDS WORLD, V1; Massom RA, 2010, POLAR SCI, V4, P149, DOI 10.1016/j.polar.2010.05.001; Melick David8, 1995, Polar Record, V31, P426; Sanchez RD, 2004, 20041379 USGS; Stammerjohn SE, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004269; Todd Frank S., 2004, Marine Ornithology, V32, P193; Trathan PN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014738; Turner J., 2009, ANTARCTIC CLIMATE CH; Vaughan DG, 2003, CLIMATIC CHANGE, V60, P243, DOI 10.1023/A:1026021217991; Wienecke B, 2011, POLAR BIOL, V34, P153, DOI 10.1007/s00300-010-0882-0; Wienecke B, 2010, POLAR REC, V46, P271, DOI 10.1017/S0032247409990283; Wienecke B, 2009, POLAR REC, V45, P304, DOI 10.1017/S0032247409008341; Williams T.D., 1995, PENGUINS; Woehler E.J., 1991, International Council for Bird Preservation Technical Publication, V11, P279; Woehler EJ, 1993, DISTRIBUTION ABUNDAN; Yeates G.W., 1975, P397	39	181	197	3	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e33751	10.1371/journal.pone.0033751	http://dx.doi.org/10.1371/journal.pone.0033751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514609	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000305341600014
J	Lopez-Marques, RL; Poulsen, LR; Palmgren, MG				Lopez-Marques, Rosa L.; Poulsen, Lisbeth R.; Palmgren, Michael G.			A Putative Plant Aminophospholipid Flippase, the Arabidopsis P4 ATPase ALA1, Localizes to the Plasma Membrane following Association with a beta-Subunit	PLOS ONE			English	Article							H+-ATPASE; PHOSPHOLIPID ASYMMETRY; ENDOPLASMIC-RETICULUM; LIPID TRANSLOCATION; CELLULAR MEMBRANES; EUKARYOTIC CELLS; YEAST; PROTEIN; GOLGI; EXPRESSION	Plasma membranes in eukaryotic cells display asymmetric lipid distributions with aminophospholipids concentrated in the inner leaflet and sphingolipids in the outer leaflet. This unequal distribution of lipids between leaflets is, amongst several proposed functions, hypothesized to be a prerequisite for endocytosis. P4 ATPases, belonging to the P-type ATPase superfamily of pumps, are involved in establishing lipid asymmetry across plasma membranes, but P4 ATPases have not been identified in plant plasma membranes. Here we report that the plant P4 ATPase ALA1, which previously has been connected with cold tolerance of Arabidopsis thaliana, is targeted to the plasma membrane and does so following association in the endoplasmic reticulum with an ALIS protein beta-subunit.	[Lopez-Marques, Rosa L.; Poulsen, Lisbeth R.; Palmgren, Michael G.] Univ Copenhagen, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Dept Plant Biol & Biotechnol, Frederiksberg, Denmark	Danmarks Grundforskningsfond; University of Copenhagen	Lopez-Marques, RL (corresponding author), Univ Copenhagen, Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Dept Plant Biol & Biotechnol, Frederiksberg, Denmark.	rlo@life.ku.dk	Poulsen, Lisbeth Rosager/AAP-1301-2020; Palmgren, Michael/A-9808-2013; Marques, Rosa Laura Lopez/AAI-8071-2020; Lopez-Marques, Rosa L/F-8536-2014; Poulsen, Lisbeth R/I-1843-2014	Palmgren, Michael/0000-0002-9982-6114; Marques, Rosa Laura Lopez/0000-0002-5663-7903; Lopez-Marques, Rosa L/0000-0002-5663-7903; Poulsen, Lisbeth R/0000-0002-9133-3358	Danish National Research Foundation through the PUMPKIN Center of Excellence; Danish Council for Independent Research | Natural Sciences (FNU) [10-083406]; Danish Government's Globalisation Fund	Danish National Research Foundation through the PUMPKIN Center of Excellence; Danish Council for Independent Research | Natural Sciences (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council); Danish Government's Globalisation Fund	This work was supported by the Danish National Research Foundation through the PUMPKIN Center of Excellence (MGP), The Danish Council for Independent Research | Natural Sciences (FNU, project number 10-083406) (RLLM), and by The Danish Government's Globalisation Fund (LRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Burgers PMJ, 1999, METHODS, V18, P349, DOI 10.1006/meth.1999.0796; CAPIEAUX E, 1989, J BIOL CHEM, V264, P7437; CERBON J, 1995, BBA-BIOMEMBRANES, V1235, P100, DOI 10.1016/0005-2736(94)00311-C; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001; Devaux PF, 2006, CHEM PHYS LIPIDS, V141, P119, DOI 10.1016/j.chemphyslip.2006.02.007; Diaz C, 1996, J MEMBRANE BIOL, V151, P1, DOI 10.1007/s002329900051; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Gomes E, 2000, PLANT CELL, V12, P2441, DOI 10.1105/tpc.12.12.2441; Graber JH, 2002, NUCLEIC ACIDS RES, V30, P1851, DOI 10.1093/nar/30.8.1851; Hill WG, 1999, J GEN PHYSIOL, V114, P405, DOI 10.1085/jgp.114.3.405; Hua ZL, 2002, MOL BIOL CELL, V13, P3162, DOI 10.1091/mbc.E02-03-0172; IGARASHI K, 1995, J BIOL CHEM, V270, P29075, DOI 10.1074/jbc.270.49.29075; Jacquot A, 2012, J BIOL CHEM, V287, P13249, DOI 10.1074/jbc.M111.313916; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Krylov AV, 2001, J GEN PHYSIOL, V118, P333, DOI 10.1085/jgp.118.4.333; Larsson C., 1990, The plant plasma membrane., P1; Leventis PA, 2010, ANNU REV BIOPHYS, V39, P407, DOI 10.1146/annurev.biophys.093008.131234; Lopez-Marques RL, 2010, MOL BIOL CELL, V21, P791, DOI 10.1091/mbc.E09-08-0656; MONK BC, 1991, J BIOL CHEM, V266, P18097; Nakano K, 2008, MOL BIOL CELL, V19, P1783, DOI 10.1091/mbc.E07-07-0646; Natarajan P, 2009, NAT CELL BIOL, V11, P1421, DOI 10.1038/ncb1989; OPARKA KJ, 1994, NEW PHYTOL, V126, P571, DOI 10.1111/j.1469-8137.1994.tb02952.x; OPDENKAMP JAF, 1979, ANNU REV BIOCHEM, V48, P47, DOI 10.1146/annurev.bi.48.070179.000403; Paulusma CC, 2008, HEPATOLOGY, V47, P268, DOI 10.1002/hep.21950; Perez-Victoria FJ, 2006, DRUG RESIST UPDATE, V9, P26, DOI 10.1016/j.drup.2006.04.001; Perez-Victoria FJ, 2003, J BIOL CHEM, V278, P49965, DOI 10.1074/jbc.M308352200; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Pomorski T, 2001, SEMIN CELL DEV BIOL, V12, P139, DOI 10.1006/scdb.2000.0231; Poulsen LR, 2008, PLANT CELL, V20, P658, DOI 10.1105/tpc.107.054767; ROSE AB, 1990, METHOD ENZYMOL, V185, P234; ROTHMAN JE, 1977, SCIENCE, V195, P743, DOI 10.1126/science.402030; Sapperstein SK, 1996, J CELL BIOL, V132, P755, DOI 10.1083/jcb.132.5.755; Serrano R, 1991, MOL CELLULAR BIOL YE, P523; Takeda Y, 2001, BBA-BIOMEMBRANES, V1513, P38, DOI 10.1016/S0005-2736(01)00342-X; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; TROTTER PJ, 1994, BBA-LIPID LIPID MET, V1213, P241, DOI 10.1016/0005-2760(94)00073-5; Verhulst PM, 2010, HEPATOLOGY, V51, P2049, DOI 10.1002/hep.23586; Verkleij AJ, 2000, J MEMBRANE BIOL, V178, P1, DOI 10.1007/s002320010009; VILLALBA JM, 1992, J BIOL CHEM, V267, P12341; Xu P, 2009, J CELL SCI, V122, P2866, DOI 10.1242/jcs.047423	44	29	30	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e33042	10.1371/journal.pone.0033042	http://dx.doi.org/10.1371/journal.pone.0033042			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514601	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600006
J	Tse, H; Chan, WM; Li, KSM; Lau, SKP; Woo, PCY; Yuen, KY				Tse, Herman; Chan, Wan-Mui; Li, Kenneth S. M.; Lau, Susanna K. P.; Woo, Patrick C. Y.; Yuen, Kwok-Yung			Discovery and Genomic Characterization of a Novel Bat Sapovirus with Unusual Genomic Features and Phylogenetic Position	PLOS ONE			English	Article							NUCLEOTIDE COMPOSITION; CODON USAGE; MOLECULAR CHARACTERIZATION; GENOTYPE ANALYSIS; CALICIVIRUS; VIRUS; GASTROENTERITIS; CORONAVIRUS; INFECTIONS; IDENTIFICATION	Sapovirus is a genus of caliciviruses that are known to cause enteric disease in humans and animals. There is considerable genetic diversity among the sapoviruses, which are classified into different genogroups based on phylogenetic analysis of the full-length capsid protein sequence. While several mammalian species, including humans, pigs, minks, and dogs, have been identified as animal hosts for sapoviruses, there were no reports of sapoviruses in bats in spite of their biological diversity. In this report, we present the results of a targeted surveillance study in different bat species in Hong Kong. Five of the 321 specimens from the bat species, Hipposideros pomona, were found to be positive for sapoviruses by RT-PCR. Complete or nearly full-length genome sequences of approximately 7.7 kb in length were obtained for three strains, which showed similar organization of the genome compared to other sapoviruses. Interestingly, they possess many genomic features atypical of most sapoviruses, like high G+C content and minimal CpG suppression. Phylogenetic analysis of the viral proteins suggested that the bat sapovirus descended from an ancestral sapovirus lineage and is most closely related to the porcine sapoviruses. Codon usage analysis showed that the bat sapovirus genome has greater codon usage bias relative to other sapovirus genomes. In summary, we report the discovery and genomic characterization of the first bat calicivirus, which appears to have evolved under different conditions after early divergence from other sapovirus lineages.	[Tse, Herman; Chan, Wan-Mui; Li, Kenneth S. M.; Lau, Susanna K. P.; Woo, Patrick C. Y.; Yuen, Kwok-Yung] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Tse, Herman; Lau, Susanna K. P.; Woo, Patrick C. Y.; Yuen, Kwok-Yung] Univ Hong Kong, Res Ctr Infect & Immun, Hong Kong, Hong Kong, Peoples R China; [Tse, Herman; Lau, Susanna K. P.; Woo, Patrick C. Y.; Yuen, Kwok-Yung] State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Tse, H (corresponding author), Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China.	kyyuen@hkucc.hku.hk	Lau, Susanna Kar Pui/AAJ-6848-2020; Woo, Patrick Chiu Yat/C-4449-2009	Lau, Susanna Kar Pui/0000-0002-1383-7374; Woo, Patrick Chiu Yat/0000-0001-9401-1832; Yuen, Kwok-yung/0000-0002-2083-1552	Research Grant Council; University of Hong Kong; Tung Wah Group of Hospitals Fund for Research in Infectious Diseases; HKSAR Research Fund for the Control of Infectious Diseases of the Health, Welfare and Food Bureau; Shaw Foundation; Hong Kong Police Force	Research Grant Council(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong); Tung Wah Group of Hospitals Fund for Research in Infectious Diseases; HKSAR Research Fund for the Control of Infectious Diseases of the Health, Welfare and Food Bureau; Shaw Foundation; Hong Kong Police Force	This work is partly supported by the Research Grant Council; University Development Fund, The University of Hong Kong; The Tung Wah Group of Hospitals Fund for Research in Infectious Diseases; the HKSAR Research Fund for the Control of Infectious Diseases of the Health, Welfare and Food Bureau; and the Shaw Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Director Alan Chi-Kong Wong, Siu-Fai Leung, Chik-Chuen Lay, Ping-Man So and K. F. Chan [HKSAR Department of Agriculture, Fisheries, and Conservation (AFCD)] and Hong Kong Police Force for facilitation and support; Chung-Tong Shek, Cynthia S. M. Chan and Joseph W. K. So from AFCD for their excellent technical assistance and collection of animal specimens. Photos and ecological information of the bats roosting sites are reproduced with kind permission from AFCD. Views expressed in this paper are those of the authors only, and may not represent the opinion of the AFCD or the Government of the HKSAR. We are grateful for the generous support of Mr Hui Hoy and Mr Hui Ming in the genomic sequencing platform.	Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Atmar RL, 2001, CLIN MICROBIOL REV, V14, P15, DOI 10.1128/CMR.14.1.15-37.2001; Bank-Wolf BR, 2010, VET MICROBIOL, V140, P204, DOI 10.1016/j.vetmic.2009.08.021; Berke T, 2000, ARCH VIROL, V145, P1421, DOI 10.1007/s007050070099; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; CHIBA S, 1979, J MED VIROL, V4, P249, DOI 10.1002/jmv.1890040402; Chiba S, 2000, J INFECT DIS, V181, pS303, DOI 10.1086/315574; Clarke IN, 2000, J INFECT DIS, V181, pS309, DOI 10.1086/315575; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Di Martino B, 2011, VET MICROBIOL, V153, P367, DOI 10.1016/j.vetmic.2011.05.034; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ElHefnawi M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-44; Etherington GJ, 2005, BIOINFORMATICS, V21, P278, DOI 10.1093/bioinformatics/bth500; Farkas T, 2008, J VIROL, V82, P5408, DOI 10.1128/JVI.00070-08; Farkas T, 2010, J GEN VIROL, V91, P734, DOI 10.1099/vir.0.015263-0; Greenbaum BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005969; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo M, 2001, ARCH VIROL, V146, P479, DOI 10.1007/s007050170157; Hansman GS, 2008, VIRUS RES, V137, P261, DOI 10.1016/j.virusres.2008.07.002; Kaplon J, 2011, EMERG INFECT DIS, V17, P1120, DOI [10.3201/eid1706.100038, 10.3201/eid/1706.100038]; Kapoor A, 2010, J VIROL, V84, P10322, DOI 10.1128/JVI.00601-10; KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994; Khamrin P, 2007, J MED VIROL, V79, P1921, DOI 10.1002/jmv.21004; Kim KH, 2011, APPL ENVIRON MICROB, V77, P7663, DOI 10.1128/AEM.00289-11; L'Homme Y, 2010, ARCH VIROL, V155, P839, DOI 10.1007/s00705-010-0651-y; L'Homme Y, 2009, VIRUS GENES, V39, P66, DOI 10.1007/s11262-009-0360-3; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau SKP, 2007, VIROLOGY, V367, P428, DOI 10.1016/j.virol.2007.06.009; Lau SKP, 2011, J VIROL, V85, P8819, DOI 10.1128/JVI.02364-10; Lau SKP, 2010, J VIROL, V84, P11385, DOI 10.1128/JVI.01121-10; Lau SKP, 2010, VIROLOGY, V404, P106, DOI 10.1016/j.virol.2010.03.049; Lau SKP, 2010, J VIROL, V84, P2808, DOI 10.1128/JVI.02219-09; Li LL, 2011, J GEN VIROL, V92, P2534, DOI 10.1099/vir.0.034611-0; Li LL, 2011, J VIROL, V85, P9909, DOI 10.1128/JVI.05026-11; Lobo FP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006282; Logan C, 2008, FUTURE VIROL, V3, P61, DOI 10.2217/17460794.3.1.61; Martella V, 2008, EMERG INFECT DIS, V14, P1306, DOI 10.3201/eid1408.080062; Martella V, 2007, EMERG INFECT DIS, V13, P1071, DOI 10.3201/eid1307.070268; Monica B, 2007, J MED VIROL, V79, P544, DOI 10.1002/jmv.20862; Novembre JA, 2002, MOL BIOL EVOL, V19, P1390, DOI 10.1093/oxfordjournals.molbev.a004201; Oka T, 2005, J VIROL, V79, P7283, DOI 10.1128/JVI.79.12.7283-7290.2005; Oka T, 2006, J GEN VIROL, V87, P3329, DOI 10.1099/vir.0.81799-0; Pang XLL, 2009, J INFECT DIS, V199, P547, DOI 10.1086/596210; Percival S, 2004, MICROBIOLOGY WATERBO, P433; Rima BK, 1997, J GEN VIROL, V78, P2859, DOI 10.1099/0022-1317-78-11-2859; Rockx B, 2002, CLIN INFECT DIS, V35, P246, DOI 10.1086/341408; Scipioni A, 2008, VET J, V178, P32, DOI 10.1016/j.tvjl.2007.11.012; Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1; Smiley JR, 2002, J VIROL, V76, P10089, DOI 10.1128/JVI.76.20.10089-10098.2002; Supek F, 2004, BIOINFORMATICS, V20, P2329, DOI 10.1093/bioinformatics/bth238; Svraka S, 2010, J CLIN MICROBIOL, V48, P2191, DOI 10.1128/JCM.02427-09; Tam CC, 2011, GUT; Tse H, 2011, J GEN VIROL, V92, P1888, DOI 10.1099/vir.0.030817-0; Tse H, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-491; Wilson D. E., 2005, MAMMAL SPECIES WORLD; Wolf S, 2011, ARCH VIROL, V156, P1143, DOI 10.1007/s00705-011-0964-5; Wong S, 2007, REV MED VIROL, V17, P67, DOI 10.1002/rmv.520; Woo PCY, 2006, VIROLOGY, V351, P180, DOI 10.1016/j.virol.2006.02.041; Woo PCY, 2010, J GEN VIROL, V91, P2433, DOI 10.1099/vir.0.021717-0; Woo PCY, 2009, J VIROL, V83, P908, DOI 10.1128/JVI.01977-08; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9	62	36	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34987	10.1371/journal.pone.0034987	http://dx.doi.org/10.1371/journal.pone.0034987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514697	Green Published, Green Submitted, gold			2022-12-27	WOS:000305341600103
J	Zhou, ZH; Chen, TN; Arora, K; Hyams, K; Kozlowski, S				Zhou, Zhao-Hua; Chen, Trina; Arora, Kamalpreet; Hyams, Kenneth; Kozlowski, Steven			Complement C1 Esterase Inhibitor Levels Linked to Infections and Contaminated Heparin-Associated Adverse Events	PLOS ONE			English	Article							OVERSULFATED CHONDROITIN SULFATE; KALLIKREIN-KININ SYSTEM; HUMAN-PLASMA KALLIKREIN; C1-INHIBITOR DEFICIENCY; ACQUIRED ANGIOEDEMA; LUPUS-ERYTHEMATOSUS; CLINICAL EVENTS; ACTIVATION; HEREDITARY; INSIGHTS	Activation of kinin-kallikrein and complement pathways by oversulfated-chondroitin-sulfate (OSCS) has been linked with recent heparin-associated adverse clinical events. Given the fact that the majority of patients who received contaminated heparin did not experience an adverse event, it is of particular importance to determine the circumstances that increase the risk of a clinical reaction. In this study, we demonstrated by both the addition and affinity depletion of C1inh from normal human plasma, that the level of C1inh in the plasma has a great impact on the OSCS-induced kallikrein activity and its kinetics. OSCS-induced kallikrein activity was dramatically increased after C1inh was depleted, while the addition of C1inh completely attenuated kallikrein activity. In addition, actual clinical infection can lead to increased C1inh levels. Plasma from patients with sepsis had higher average levels of functional C1inh and decreased OSCS-induced kallikrein activity. Lastly, descriptive data on adverse event reports suggest cases likely to be associated with contaminated heparin are inversely correlated with infection. Our data suggest that low C1inh levels can be a risk factor and high levels can be protective. The identification of risk factors for contact system-mediated adverse events may allow for patient screening and clinical development of prophylaxis and treatments.	[Zhou, Zhao-Hua; Chen, Trina; Arora, Kamalpreet; Kozlowski, Steven] US FDA, Div Monoclonal Antibodies, Off Pharmaceut Sci, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [Hyams, Kenneth; Kozlowski, Steven] US FDA, Off Biol Prod, Off Pharmaceut Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Zhou, ZH (corresponding author), US FDA, Div Monoclonal Antibodies, Off Pharmaceut Sci, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA.	Steven.Kozlowski@fda.hhs.gov	Zhou, Zhaohua/AGR-4892-2022		United States Food and Drug Administration (FDA); FDA/Center for Drug Evaluation and Research	United States Food and Drug Administration (FDA); FDA/Center for Drug Evaluation and Research	This research was supported by the Intramural Research Program of the United States Food and Drug Administration (FDA) and FDA/Center for Drug Evaluation and Research Critical Path Funds. The views expressed in this manuscript represent the opinions of the authors, and do not necessarily represent the official views of the FDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen A O, 1980, Adv Shock Res, V4, P1; Adam A, 2010, BIOMATERIALS, V31, P5741, DOI 10.1016/j.biomaterials.2010.03.074; Agostoni A, 2004, J ALLERGY CLIN IMMUN, V114, pS51, DOI 10.1016/j.jaci.2004.06.047; Beltrami L, 2006, EXPERT OPIN DRUG SAF, V5, P643, DOI 10.1517/14740338.5.5.643; Blanch A, 2006, J ALLERGY CLIN IMMUN, V118, P1330, DOI 10.1016/j.jaci.2006.07.035; Blossom DB, 2008, NEW ENGL J MED, V359, P2674, DOI 10.1056/NEJMoa0806450; Bryant J. W., 2009, Cardiovascular & Hematological Agents in Medicinal Chemistry, V7, P234; Charles SC, 2005, ADVERSE EVENTS STRES; Cugno M, 2009, ALLERGY, V64, P254, DOI 10.1111/j.1398-9995.2008.01859.x; Cugno M, 2009, TRENDS MOL MED, V15, P69, DOI 10.1016/j.molmed.2008.12.001; Deis JN, 2008, TRANSF MORB MORT C I, V2; Emonts M, 2007, FEMS IMMUNOL MED MIC, V50, P330, DOI 10.1111/j.1574-695X.2007.00250.x; Guerrini M, 2008, NAT BIOTECHNOL, V26, P669, DOI 10.1038/nbt1407; Hack CE, 2012, ALLERGY, V67, P123, DOI 10.1111/j.1398-9995.2011.02716.x; Hagman R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008039; Han ED, 2002, J CLIN INVEST, V109, P1057, DOI 10.1172/JCI200214211; JOHNSON AM, 1971, SCIENCE, V173, P553, DOI 10.1126/science.173.3996.553; Joseph K, 2009, J ALLERGY CLIN IMMUN, V124, P143, DOI 10.1016/j.jaci.2009.02.006; KALTER ES, 1985, J INFECT DIS, V151, P1019, DOI 10.1093/infdis/151.6.1019; Kaplan AP, 2010, MOL IMMUNOL, V47, P2161, DOI 10.1016/j.molimm.2010.05.010; Kemp SF, 2008, ALLERGENS ALLERGEN I, P477; Kishimoto TK, 2008, NEW ENGL J MED, V358, P2457, DOI 10.1056/NEJMoa0803200; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; Lahiri M, 2007, ANN ACAD MED SINGAP, V36, P142; Levi M, 2006, AM J MED, V119, pE3, DOI 10.1016/j.amjmed.2005.09.018; Li BZ, 2009, BIOCHEM PHARMACOL, V78, P292, DOI 10.1016/j.bcp.2009.04.012; LOESCHER A, 1988, BRIT J ORAL MAX SURG, V26, P129, DOI 10.1016/0266-4356(88)90007-1; Martinez-Barricarte R, 2010, J CLIN INVEST, V120, P3702, DOI 10.1172/JCI43343; MARTINEZBROTONS F, 1987, THROMB HAEMOSTASIS, V58, P709; McLean-Tooke A, 2007, J CLIN PATHOL, V60, P565, DOI 10.1136/jcp.2006.041350; McMahon AW, 2010, PHARMACOEPIDEMIOL DR; Meszaros T, 2010, LUPUS, V19, P634, DOI 10.1177/0961203309357059; Molinaro G, 2002, J PHARMACOL EXP THER, V303, P232, DOI 10.1124/jpet.102.038067; Morris JA, 2003, ANN SURG, V237, P844, DOI 10.1097/00000658-200306000-00013; MUNKVAD S, 1990, CLIN CHEM, V36, P737; Nikpoor B, 2005, EXPERT OPIN PHARMACO, V6, P1851, DOI 10.1517/14656566.6.11.1851; NUIJENS JH, 1989, J CLIN INVEST, V84, P443, DOI 10.1172/JCI114185; Schwartz LB, 2008, NEW ENGL J MED, V358, P2505, DOI 10.1056/NEJMe0803599; SKIDGEL RA, 1992, J CARDIOVASC PHARM, V20, pS4, DOI 10.1097/00005344-199200209-00003; Stiller B, 2001, INTENS CARE MED, V27, P193, DOI 10.1007/s001340000704; Tami C, 2008, BIOMATERIALS, V29, P4808, DOI 10.1016/j.biomaterials.2008.08.024; VANDERGRAAF F, 1983, BIOCHEMISTRY-US, V22, P4860, DOI 10.1021/bi00289a037; Wuillemin WA, 1997, J IMMUNOL, V159, P1953; Yip J, 1992, Australas J Dermatol, V33, P35, DOI 10.1111/j.1440-0960.1992.tb00050.x; Zhou ZH, 2007, CELL HOST MICROBE, V1, P51, DOI 10.1016/j.chom.2007.01.002	45	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34978	10.1371/journal.pone.0034978	http://dx.doi.org/10.1371/journal.pone.0034978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514695	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600101
J	Decker, C; Olu, K; Cunha, RL; Arnaud-Haond, S				Decker, Carole; Olu, Karine; Cunha, Regina L.; Arnaud-Haond, Sophie			Phylogeny and Diversification Patterns among Vesicomyid Bivalves	PLOS ONE			English	Article							DEEP-SEA CLAMS; EVOLUTIONARY RELATIONSHIPS; HYDROTHERMAL VENT; CHEMOAUTOTROPHIC BACTERIA; COMMUNITY STRUCTURE; WOODEN STEPS; MOLLUSCA; GENUS; RECORD; MODEL	Vesicomyid bivalves are among the most abundant and diverse symbiotic taxa in chemosynthetic-based ecosystems: more than 100 different vesicomyid species have been described so far. In the present study, we investigated the phylogenetic positioning of recently described vesicomyid species from the Gulf of Guinea and their western Atlantic and Pacific counterparts using mitochondrial DNA sequence data. The maximum-likelihood (ML) tree provided limited support for the recent taxonomic revision of vesicomyids based on morphological criteria; nevertheless, most of the newly sequenced specimens did not cluster with their morphological conspecifics. Moreover, the observed lack of geographic clustering suggests the occurrence of independent radiations followed by worldwide dispersal. Ancestral character state reconstruction showed a significant correlation between the characters "depth'' and "habitat'' and the reconstructed ML phylogeny suggesting possible recurrent events of 'stepwise speciation' from shallow to deep waters in different ocean basins. This is consistent with genus or species bathymetric segregation observed from recent taxonomic studies. Altogether, our results highlight the need for ongoing re-evaluation of the morphological characters used to identify vesicomyid bivalves.	[Decker, Carole; Olu, Karine; Arnaud-Haond, Sophie] IFREMER, REM EEP LEP, Lab Environm Profond, Plouzane, France; [Cunha, Regina L.] Univ Algarve, Ctr Marine Sci, CCMAR CIMAR, Faro, Portugal	Ifremer; Universidade do Algarve	Decker, C (corresponding author), IFREMER, REM EEP LEP, Lab Environm Profond, Plouzane, France.	carole.decker@ifremer.fr	Cunha, Regina L/M-3463-2013; Castilho, Rita/B-6185-2008; Arnaud-Haond, Sophie/B-2479-2008	Cunha, Regina L/0000-0002-4275-9723; Castilho, Rita/0000-0003-0727-3688; Arnaud-Haond, Sophie/0000-0001-5814-8452; Olu, Karine/0000-0002-4906-4131	ANR Deep Oases project for scientific collaborations [ANR06BDV005]; German Research Foundation Research Center Ocean Margins/Center for Marine Environmental Sciences at the University Bremen for the Meteor cruises	ANR Deep Oases project for scientific collaborations(French National Research Agency (ANR)); German Research Foundation Research Center Ocean Margins/Center for Marine Environmental Sciences at the University Bremen for the Meteor cruises	This work was done with the support of the ANR Deep Oases (ANR06BDV005) project for scientific collaborations and of the German Research Foundation Research Center Ocean Margins/Center for Marine Environmental Sciences at the University Bremen for the Meteor cruises. No other current external funding sources have been obtained for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Baco AR, 1999, MAR ECOL PROG SER, V182, P137, DOI 10.3354/meps182137; BENNETT BA, 1994, MAR ECOL PROG SER, V108, P205, DOI 10.3354/meps108205; Bockel B., 2008, REPORT PRELIMINARY R; CAVANAUGH CM, 1983, NATURE, V302, P58, DOI 10.1038/302058a0; Cordes EE, 2007, DEEP-SEA RES PT I, V54, P637, DOI 10.1016/j.dsr.2007.01.001; CRADDOCK C, 1995, MAR BIOL, V121, P477, DOI 10.1007/BF00349456; Distel DL, 2000, NATURE, V403, P725, DOI 10.1038/35001667; Drummond A. J., 2009, GENEIOUS V4 6; FIALAMEDIONI A, 1990, COMP PHYSIOL, V5, P49; FIALAMEDIONI A, 1988, OCEANOL ACTA, V11, P185; FISHER CR, 1990, REV AQUAT SCI, V2, P399; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fujikura Katsunori, 2000, Venus the Japanese Journal of Malacology, V59, P103; Gaudron SM, 2010, MAR ENVIRON RES, V70, P1, DOI 10.1016/j.marenvres.2010.02.002; Genio L, 2008, J SHELLFISH RES, V27, P53, DOI 10.2983/0730-8000(2008)27[53:NROBMC]2.0.CO;2; Goffredi SK, 2003, MAR BIOL, V142, P311, DOI 10.1007/s00227-002-0941-3; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Kojima S, 2004, MOL PHYLOGENET EVOL, V32, P396, DOI 10.1016/j.ympev.2004.02.016; Kojima Shigeaki, 1995, Journal of Oceanography, V51, P257, DOI 10.1007/BF02236528; Kojima S, 2006, ZOOL SCI, V23, P835, DOI 10.2108/zsj.23.835; Kojima Shigeaki, 1995, Venus the Japanese Journal of Malacology, V54, P153; Krylova Elena M., 2006, Archiv fuer Molluskenkunde, V135, P231; Krylova EM, 2006, J MOLLUS STUD, V72, P359, DOI 10.1093/mollus/eyl022; Krylova EM, 2011, ZOOSYSTEMA, V33, P83, DOI 10.5252/z2011n1a4; Krylova EM, 2010, J MOLLUS STUD, V76, P107, DOI 10.1093/mollus/eyp052; Krylova EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009957; Little CTS, 2003, TRENDS ECOL EVOL, V18, P582, DOI 10.1016/j.tree.2003.08.009; Maddison W.P., 2001, MACCLADE 4 VERSION 4; McArthur AG, 1998, GEOL SOC SPEC PUBL, V148, P271, DOI 10.1144/GSL.SP.1998.148.01.15; Mikkelsen PM, 2006, ZOOL J LINN SOC-LOND, V148, P439, DOI 10.1111/j.1096-3642.2006.00262.x; Okutani Takashi, 2009, Venus (Tokyo), V68, P15; Olu K, 2008, ZOOSTYSTEMA; Olu K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011967; Olu-Le Roy K, 2007, DEEP-SEA RES PT I, V54, P1890, DOI 10.1016/j.dsr.2007.07.004; Peek AS, 2000, J MOL EVOL, V50, P141, DOI 10.1007/s002399910016; Peek AS, 1997, MAR BIOL, V130, P151, DOI 10.1007/s002270050234; Peek AS, 1998, P NATL ACAD SCI USA, V95, P9962, DOI 10.1073/pnas.95.17.9962; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Salas C, 2002, SARSIA, V86, P333; Samadi S, 2007, CR BIOL, V330, P446, DOI 10.1016/j.crvi.2007.04.001; Sibuet M, 1998, DEEP-SEA RES PT II, V45, P517, DOI 10.1016/S0967-0645(97)00074-X; Sturany R., 1896, DENKSCHRIFTEN MATHEM, V63, P1; Thiele J., 1931, VALDIVIA, V21, P159; TUNNICLIFFE V, 1991, OCEANOGR MAR BIOL, V29, P319; von Cosel R, 2009, DEEP-SEA RES PT II, V56, P2350, DOI 10.1016/j.dsr2.2009.04.016; VRIJENHOEK RC, 1994, DEEP-SEA RES PT I, V41, P1171, DOI 10.1016/0967-0637(94)90039-6	48	40	44	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e33359	10.1371/journal.pone.0033359	http://dx.doi.org/10.1371/journal.pone.0033359			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511920	Green Published, gold			2022-12-27	WOS:000305338600006
J	Li, YF; He, RR; Tsoi, B; Li, XD; Li, WX; Abe, K; Kurihara, H				Li, Yi-Fang; He, Rong-Rong; Tsoi, Bun; Li, Xiao-Di; Li, Wei-Xi; Abe, Keiichi; Kurihara, Hiroshi			Anti-Stress Effects of Carnosine on Restraint-Evoked Immunocompromise in Mice through Spleen Lymphocyte Number Maintenance	PLOS ONE			English	Article							GLUCOCORTICOID-INDUCED APOPTOSIS; HUMAN-DIPLOID FIBROBLASTS; BRAIN HISTAMINE; NATURAL-KILLER; HISTIDINE-DECARBOXYLASE; IMMUNE FUNCTION; BALB/C MICE; STRESS; DEATH; BLOOD	Carnosine (beta-alanyl-L-histidine), a naturally occurring dipeptide, has been characterized as a putative neurotransmitter and serves as a reservoir for brain histamine, which could act on histaminergic neurons system to relieve stress-induced damages. However, understanding of the role of carnosine in stress-evoked immunocompromise is limited. In this study, results showed that when mice were subjected to restraint stress, spleen index and the number of spleen lymphocytes including Natural Killer (NK) cells were obviously decreased. Results also demonstrated that restraint stress decreased the cytotoxic activity of NK cells per spleen (LU10/spleen) while the activity of a single NK cell (LU10/10(6) cells) was not changed. However, oral administration of carnosine (150 and 300 mg/kg) increased spleen index and number of spleen lymphocytes (including NK cells), and elevated the cytotoxic activity of NK cells per spleen in restraint-stressed mice. These results indicated that carnosine ameliorated stress-evoked immunocompromise through spleen lymphocyte number maintenance. Carnosine was further found to reduce stress-induced elevation of plasma corticosterone level. On the other hand, results showed that carnosine and RU486 (a glucocorticoids receptor antagonist) treatment prevented the reduction in mitochondrion membrane potential and the release of mitochondrial cytochrome c into cytoplasm, increased Bcl-2/Bax mRNA ratio, as well as decreased terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL)-positive cells in spleen lymphocytes of stressed mice. The results above suggested that the maintenance of spleen lymphocyte number by carnosine was related with the inhibition of lymphocytes apoptosis caused by glucocorticoids overflow. The stimulation of lymphocyte proliferation by carnosine also contributed to the maintenance of spleen lymphocyte number in stressed mice. In view of the elevated histamine level, the anti-stress effects of carnosine on restraint-evoked immunocompromise might be via carnosine-histamine metabolic pathway. Taken together, carnosine maintained spleen lymphocyte number by inhibiting lymphocyte apoptosis and stimulating lymphocyte proliferation, thus prevented immunocompromise in restraint-stressed mice.	[Li, Yi-Fang; He, Rong-Rong; Tsoi, Bun; Li, Xiao-Di; Li, Wei-Xi; Kurihara, Hiroshi] Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Guangzhou, Guangdong, Peoples R China; [He, Rong-Rong; Abe, Keiichi; Kurihara, Hiroshi] Jinan Univ, BRANDS Fdn, Hlth Sci Res Ctr, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University	Li, YF (corresponding author), Jinan Univ, Inst Tradit Chinese Med & Nat Prod, Guangzhou, Guangdong, Peoples R China.	Hiroshi_Kurihara@163.com	Tsoi, Bun/C-7395-2014; Li, WeiXi/AAM-5381-2021; Tsoi, Bun/P-4173-2019; Tsoi, Bun/AAH-9135-2019	Tsoi, Bun/0000-0002-7033-1732; Tsoi, Bun/0000-0002-7033-1732; Tsoi, Bun/0000-0003-4958-4222; HE, Rong-Rong/0000-0001-5505-5672; Li, Xiaodi/0000-0002-7109-6770	Fundamental Research Funds for the Central Universities of China [21611396, 21611316]; NSFC of China [81102485]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); NSFC of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for the Central Universities of China (no. 21611396 and 21611316) and by NSFC of China (no. 81102485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral JD, 2009, CURR MED CHEM, V16, P3886; ARIF A J, 1989, Indian Journal of Malariology, V26, P173; Berthiaume F, 1999, TISSUE ENG, V5, P499, DOI 10.1089/ten.1999.5.499; Boldizsar F, 2006, IMMUNOBIOLOGY, V211, P785, DOI 10.1016/j.imbio.2006.06.005; BONNEAU RH, 1991, BRAIN BEHAV IMMUN, V5, P170, DOI 10.1016/0889-1591(91)90015-3; Corona C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017971; Cuzzocrea S, 2007, AM J PHYSIOL-LUNG C, V292, pL1095, DOI 10.1152/ajplung.00283.2006; Fleisher-Berkovich S, 2009, PEPTIDES, V30, P1306, DOI 10.1016/j.peptides.2009.04.003; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; HANNA N, 1980, J NATL CANCER I, V65, P801, DOI 10.1093/jnci/65.4.801; Hatanaka K, 2001, LIFE SCI, V69, P155, DOI 10.1016/S0024-3205(01)01106-7; He RR, 2009, J PHARMACOL SCI, V111, P117, DOI 10.1254/jphs.09090FP; He RR, 2009, BIOL PHARM BULL, V32, P247, DOI 10.1248/bpb.32.247; Hipkiss AR, 2002, ANN NY ACAD SCI, V959, P285, DOI 10.1111/j.1749-6632.2002.tb02100.x; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Holliday R, 1996, BRIT J CANCER, V73, P966, DOI 10.1038/bjc.1996.189; Hyland P, 2000, MECH AGEING DEV, V121, P203; Ito C, 2000, BIOMED PHARMACOTHER, V54, P263, DOI 10.1016/S0753-3322(00)80069-4; Jan TR, 2007, INT IMMUNOPHARMACOL, V7, P773, DOI 10.1016/j.intimp.2007.01.015; Janssen B, 2005, DIABETES, V54, P2320, DOI 10.2337/diabetes.54.8.2320; Kozan R, 2008, BRAIN RES, V1239, P249, DOI 10.1016/j.brainres.2008.08.019; Kurihara H, 2002, LIFE SCI, V70, P2509, DOI 10.1016/S0024-3205(02)01522-9; Kurihara H, 2009, FOOD SCI TECHNOL RES, V15, P179, DOI 10.3136/fstr.15.179; Lee YT, 2005, EUR J PHARMACOL, V513, P145, DOI 10.1016/j.ejphar.2005.02.010; Lu YQ, 2010, BIOSCI BIOTECH BIOCH, V74, P1276, DOI 10.1271/bbb.90950; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; MAZURKIEWICZKWILECKI IM, 1978, PHARMACOL BIOCHEM BE, V9, P465, DOI 10.1016/0091-3057(78)90042-4; McFarland GA, 1999, EXP GERONTOL, V34, P35, DOI 10.1016/S0531-5565(98)00056-4; MCFARLAND GA, 1994, EXP CELL RES, V212, P167, DOI 10.1006/excr.1994.1132; Miller DB, 2002, METABOLISM, V51, P5, DOI 10.1053/meta.2002.33184; Otani H, 2008, NEUROSCI LETT, V445, P166, DOI 10.1016/j.neulet.2008.09.008; Pariante CM, 1997, PSYCHOTHER PSYCHOSOM, V66, P199, DOI 10.1159/000289135; Piriou L, 2000, CYTOMETRY, V41, P289, DOI 10.1002/1097-0320(20001201)41:4<289::AID-CYTO7>3.0.CO;2-5; Planey SL, 2002, J BIOL CHEM, V277, P42188, DOI 10.1074/jbc.M205085200; Planey SL, 2000, BIOCHEM BIOPH RES CO, V279, P307, DOI 10.1006/bbrc.2000.3922; REDDY WJ, 1962, J BIOL CHEM, V237, P705; SAKAI N, 1991, LIFE SCI, V48, P2397, DOI 10.1016/0024-3205(91)90373-J; Shi YF, 2003, BRAIN BEHAV IMMUN, V17, pS18; Silberman DM, 2002, INT IMMUNOPHARMACOL, V2, P487, DOI 10.1016/S1567-5769(01)00190-4; Silverman AJ, 2000, J NEUROSCI, V20, P401, DOI 10.1523/JNEUROSCI.20-01-00401.2000; Soliman Kawther, 2003, J Egypt Soc Parasitol, V33, P663; Tan KML, 1998, CLIN LAB HAEMATOL, V20, P239, DOI 10.1046/j.1365-2257.1998.00123.x; Van de Kar LD, 1999, FRONT NEUROENDOCRIN, V20, P1, DOI 10.1006/frne.1998.0172; Vizuete ML, 2000, J NEUROCHEM, V75, P540, DOI 10.1046/j.1471-4159.2000.0750540.x; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; WOODWARD CJH, 1987, J CHROMATOGR-BIOMED, V419, P280, DOI 10.1016/0378-4347(87)80287-6; Yang EV, 2002, INT IMMUNOPHARMACOL, V2, P315, DOI 10.1016/S1567-5769(01)00182-5; ZAMZAMI N, 1995, J EXP MED, V181, P1661, DOI 10.1084/jem.181.5.1661; Zapp JA, 1938, J BIOL CHEM, V126, P19; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016212; Zhu YY, 2007, NEUROSCI LETT, V416, P211, DOI 10.1016/j.neulet.2007.01.075; Zorrilla EP, 2001, BRAIN BEHAV IMMUN, V15, P199, DOI 10.1006/brbi.2000.0597	52	38	39	3	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e33190	10.1371/journal.pone.0033190	http://dx.doi.org/10.1371/journal.pone.0033190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511917	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600003
J	Munguia, M; Rahbek, C; Rangel, TF; Diniz, JAF; Araujo, MB				Munguia, Mariana; Rahbek, Carsten; Rangel, Thiago F.; Diniz-Filho, Jose Alexandre F.; Araujo, Miguel B.			Equilibrium of Global Amphibian Species Distributions with Climate	PLOS ONE			English	Article							LATITUDINAL VARIATION; ENVELOPE MODELS; RANGE; BIODIVERSITY; DIVERSITY; UNCERTAINTY; TEMPERATURE; POPULATIONS; PREDICTION; SPECIATION	A common assumption in bioclimatic envelope modeling is that species distributions are in equilibrium with contemporary climate. A number of studies have measured departures from equilibrium in species distributions in particular regions, but such investigations were never carried out for a complete lineage across its entire distribution. We measure departures of equilibrium with contemporary climate for the distributions of the world amphibian species. Specifically, we fitted bioclimatic envelopes for 5544 species using three presence-only models. We then measured the proportion of the modeled envelope that is currently occupied by the species, as a metric of equilibrium of species distributions with climate. The assumption was that the greater the difference between modeled bioclimatic envelope and the occupied distribution, the greater the likelihood that species distribution would not be at equilibrium with contemporary climate. On average, amphibians occupied 30% to 57% of their potential distributions. Although patterns differed across regions, there were no significant differences among lineages. Species in the Neotropic, Afrotropics, Indo-Malay, and Palaearctic occupied a smaller proportion of their potential distributions than species in the Nearctic, Madagascar, and Australasia. We acknowledge that our models underestimate non equilibrium, and discuss potential reasons for the observed patterns. From a modeling perspective our results support the view that at global scale bioclimatic envelope models might perform similarly across lineages but differently across regions.	[Munguia, Mariana; Araujo, Miguel B.] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, E-28006 Madrid, Spain; [Munguia, Mariana] Univ Nacl Autonoma Mexico, Inst Biol, Dept Zool, Mexico City 04510, DF, Mexico; [Rahbek, Carsten; Araujo, Miguel B.] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Rangel, Thiago F.; Diniz-Filho, Jose Alexandre F.] Univ Fed Goias, ICB, Dept Ecol, Goiania, Go, Brazil; [Araujo, Miguel B.] Univ Evora, CIBIO, Catedra Rui Nabeiro Biodiversidade, Evora, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universidad Nacional Autonoma de Mexico; University of Copenhagen; Universidade Federal de Goias; University of Evora	Munguia, M (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolut, E-28006 Madrid, Spain.	maraujo@mncn.csic.es	Rahbek, Carsten/D-9372-2013; Diniz-Filho, José Alexandre Felizola/D-9405-2013; Rahbek, Carsten/L-1129-2013; Rangel, Thiago F/H-8708-2012; Araújo, Miguel B/B-6117-2008	Diniz-Filho, José Alexandre Felizola/0000-0002-0967-9684; Rahbek, Carsten/0000-0003-4585-0300; Rangel, Thiago F/0000-0002-2001-7382; Araújo, Miguel B/0000-0002-5107-7265; Munguia-Carrara, Mariana/0000-0003-3514-3397	Consejo Nacional de Ciencia y Tecnologia through Posgrado en Ciencias Biologicas, Universidad Nacional Autonoma de Mexico; Banco Bilbao Vizcaya Argentaria Foundation BIOIMPACTO project; Foundation for Science and Technology Range Shift project; Rui Nabeiro Chair of Biodiversity; Spanish Research Council; Danish National Science Foundation	Consejo Nacional de Ciencia y Tecnologia through Posgrado en Ciencias Biologicas, Universidad Nacional Autonoma de Mexico; Banco Bilbao Vizcaya Argentaria Foundation BIOIMPACTO project; Foundation for Science and Technology Range Shift project; Rui Nabeiro Chair of Biodiversity; Spanish Research Council; Danish National Science Foundation(Danmarks Grundforskningsfond)	MM was funded by the Consejo Nacional de Ciencia y Tecnologia through Posgrado en Ciencias Biologicas, Universidad Nacional Autonoma de Mexico. MBA, MM, JAFDF, and TFR received support from the Banco Bilbao Vizcaya Argentaria Foundation BIOIMPACTO project. MBA receives support from the Foundation for Science and Technology Range Shift project, the Rui Nabeiro Chair of Biodiversity, and the Spanish Research Council. CR and MBA also acknowledge support from the Danish National Science Foundation, while JAFDF and TFR thank the "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico'', and "Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior'' for continuous support in the development of computer programs for species distribution modeling. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ECOLOGICAL NICHES GE; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2005, ECOGRAPHY, V28, P693, DOI 10.1111/j.2005.0906-7590.04253.x; Araujo MB, 2008, ECOGRAPHY, V31, P8, DOI 10.1111/j.2007.0906-7590.05318.x; Araujo MB, 2006, SCIENCE, V313, P1396, DOI 10.1126/science.1131758; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Araujo MB, 2011, ECOGRAPHY, V34, P897, DOI 10.1111/j.1600-0587.2011.06919.x; Baselga A, 2012, J BIOGEOGR, V39, P760, DOI 10.1111/j.1365-2699.2011.02612.x; Baselga A, 2010, J BIOGEOGR, V37, P1842, DOI 10.1111/j.1365-2699.2010.02341.x; Bernardo J, 2006, BIOL LETTERS, V2, P135, DOI 10.1098/rsbl.2005.0417; Bonn A, 2001, ECOGRAPHY, V24, P483, DOI 10.1034/j.1600-0587.2001.d01-204.x; Botkin D, 2007, BIOSCIENCE IN PRESS; BROWN JH, 1989, SCIENCE, V243, P1145, DOI 10.1126/science.243.4895.1145; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; FEDER ME, 1976, J COMP PHYSIOL, V110, P197, DOI 10.1007/BF00689308; Feder ME, 1977, J EXP ZOOL, V204, P403; Hijmans R., 2005, WORLDCLIM; Kadmon R, 2003, ECOL APPL, V13, P853, DOI 10.1890/1051-0761(2003)013[0853:ASAOFA]2.0.CO;2; Kearney MR, 2010, CONSERV LETT, V3, P203, DOI 10.1111/j.1755-263X.2010.00097.x; Kozak KH, 2007, P ROY SOC B-BIOL SCI, V274, P2995, DOI 10.1098/rspb.2007.1106; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martin PR, 2004, EVOLUTION, V58, P938; Monahan WB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007921; Morin X, 2006, ECOL LETT, V9, P185, DOI 10.1111/j.1461-0248.2005.00864.x; Munguia M, 2008, J BIOGEOGR, V35, P1879; Nix H. A., 1986, ATLAS ELAPID SNAKES, V7, P4; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Pearson RG, 2006, J BIOGEOGR, V33, P1704, DOI 10.1111/j.1365-2699.2006.01460.x; RANGEL TFL, 2009, BIOENSEMBLES 1 0 SOF; Sclater P. L., 1858, J P LINNEAN SOC ZOOL, V2, P130, DOI [10.1111/j.1096-3642, DOI 10.1111/J.1096-3642.1858.TB02549.X]; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Stockwell DRB, 2002, ECOL MODEL, V148, P1, DOI 10.1016/S0304-3800(01)00388-X; Svenning JC, 2004, ECOL LETT, V7, P565, DOI 10.1111/j.1461-0248.2004.00614.x; Thuiller W, 2004, ECOGRAPHY, V27, P165, DOI 10.1111/j.0906-7590.2004.03673.x; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Vences M, 2008, HYDROBIOLOGIA, V595, P569, DOI 10.1007/s10750-007-9032-2; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Wallace A. R., 1876, GEOGRAPHICAL DISTRIB, P1; Wiens JJ, 2006, AM NAT, V168, P579, DOI 10.1086/507882	44	43	47	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34420	10.1371/journal.pone.0034420	http://dx.doi.org/10.1371/journal.pone.0034420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511938	gold, Green Published, Green Submitted			2022-12-27	WOS:000305338600024
J	Bhullar, K; Waglechner, N; Pawlowski, A; Koteva, K; Banks, ED; Johnston, MD; Barton, HA; Wright, GD				Bhullar, Kirandeep; Waglechner, Nicholas; Pawlowski, Andrew; Koteva, Kalinka; Banks, Eric D.; Johnston, Michael D.; Barton, Hazel A.; Wright, Gerard D.			Antibiotic Resistance Is Prevalent in an Isolated Cave Microbiome	PLOS ONE			English	Article							MOLECULAR PHYLOGENETIC ANALYSIS; BACTERIAL-RESISTANCE; MULTIDRUG-RESISTANCE; RESISTOME; COMMUNITY; LECHUGUILLA; DIVERSITY; EVOLUTION; RESERVOIR; PLASMIDS	Antibiotic resistance is a global challenge that impacts all pharmaceutically used antibiotics. The origin of the genes associated with this resistance is of significant importance to our understanding of the evolution and dissemination of antibiotic resistance in pathogens. A growing body of evidence implicates environmental organisms as reservoirs of these resistance genes; however, the role of anthropogenic use of antibiotics in the emergence of these genes is controversial. We report a screen of a sample of the culturable microbiome of Lechuguilla Cave, New Mexico, in a region of the cave that has been isolated for over 4 million years. We report that, like surface microbes, these bacteria were highly resistant to antibiotics; some strains were resistant to 14 different commercially available antibiotics. Resistance was detected to a wide range of structurally different antibiotics including daptomycin, an antibiotic of last resort in the treatment of drug resistant Gram-positive pathogens. Enzyme-mediated mechanisms of resistance were also discovered for natural and semi-synthetic macrolide antibiotics via glycosylation and through a kinase-mediated phosphorylation mechanism. Sequencing of the genome of one of the resistant bacteria identified a macrolide kinase encoding gene and characterization of its product revealed it to be related to a known family of kinases circulating in modern drug resistant pathogens. The implications of this study are significant to our understanding of the prevalence of resistance, even in microbiomes isolated from human use of antibiotics. This supports a growing understanding that antibiotic resistance is natural, ancient, and hard wired in the microbial pangenome.	[Bhullar, Kirandeep; Waglechner, Nicholas; Pawlowski, Andrew; Koteva, Kalinka; Wright, Gerard D.] McMaster Univ, Dept Biochem & Biomed Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Johnston, Michael D.; Barton, Hazel A.] Univ Akron, Dept Biol, Akron, OH 44325 USA	McMaster University; University System of Ohio; University of Akron	Bhullar, K (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.	wrightge@mcmaster.ca	Wright, G/ABB-7666-2021	Barton, Hazel/0000-0001-8585-9997; Pawlowski, Andrew/0000-0001-6270-8395; Koteva, Kalinka/0000-0002-6446-9567; Wright, Gerard/0000-0002-9129-7131	Canada Research Chairs; Canadian Institutes of Health Research [MT-13536]; National Science Foundation [NSF0643462]	Canada Research Chairs(Canada Research ChairsCGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Foundation(National Science Foundation (NSF))	This research was supported by the Canada Research Chairs program (GDW), a Canadian Institutes of Health Research Operating Grant (MT-13536 to GDW), the National Science Foundation Microbial interactions and Processes Program (NSF0643462 to HAB) and a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship to KB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2009, DNA CELL BIOL, V28, P109, DOI 10.1089/dna.2008.0812; Baltz RH, 2008, CURR OPIN PHARMACOL, V8, P557, DOI 10.1016/j.coph.2008.04.008; Barlow M, 2002, J MOL EVOL, V55, P314, DOI 10.1007/s00239-002-2328-y; Barton H, 2011, TREATISE GE IN PRESS; Barton HA, 2004, GEOMICROBIOL J, V21, P11, DOI 10.1080/01490450490253428; Barton HA, 2007, INT J SPELEOL, V36, P93, DOI 10.5038/1827-806X.36.2.5; Bolam DN, 2007, P NATL ACAD SCI USA, V104, P5336, DOI 10.1073/pnas.0607897104; Brown MG, 2009, MICROB ECOL, V57, P484, DOI 10.1007/s00248-008-9431-6; Canaveras JC, 2001, GEOMICROBIOL J, V18, P223; Chelius MK, 2004, GEOMICROBIOL J, V21, P123, DOI 10.1080/01490450490266389; Chesneau O, 2007, FEMS MICROBIOL LETT, V269, P317, DOI 10.1111/j.1574-6968.2007.00643.x; Chevreux B., 1999, GERMAN C BIOINFORMAT, V99, P45; Cirz RT, 2005, PLOS BIOL, V3, P1024, DOI 10.1371/journal.pbio.0030176; CLSI, 2018, METHODS DILUTION ANT; CUNNINGHAM KI, 1995, ENVIRON GEOL, V25, P2, DOI 10.1007/BF01061824; D'Costa VM, 2007, CURR OPIN MICROBIOL, V10, P481, DOI 10.1016/j.mib.2007.08.009; D'Costa VM, 2011, NATURE, V477, P457, DOI 10.1038/nature10388; D'Costa VM, 2006, SCIENCE, V311, P374, DOI 10.1126/science.1120800; D'Costa VM, 2011, ANTIMICROB IN PRESS; DAVIS CE, 1970, NEW ENGL J MED, V282, P117, DOI 10.1056/NEJM197001152820302; Davis DG., 2000, J CAVE KARST STUD, V62, P147; Donato JJ, 2010, APPL ENV MICROBIOL; DuChene H. R., 2006, 57 ANN FALL FIELD C, P211; Fisher JF, 2005, CHEM REV, V105, P395, DOI 10.1021/cr030102i; Hall BG, 2004, DRUG RESIST UPDATE, V7, P111, DOI 10.1016/j.drup.2004.02.003; Hill CA, 2000, SPELEOGENESIS EVOLUT, P309; HUGHES VM, 1983, NATURE, V302, P725, DOI 10.1038/302725a0; Johnston M, 2011, P AM SOC MICR GEN M, p[N149, 1795]; Jurado V, 2006, INT J SYST EVOL MICR, V56, P2583, DOI 10.1099/ijs.0.64397-0; Kadavy DR, 2000, APPL ENVIRON MICROB, V66, P4615, DOI 10.1128/AEM.66.11.4615-4619.2000; Kaufmann BB, 2010, MOL CELL, V37, P297, DOI 10.1016/j.molcel.2010.01.027; Knapp CW, 2010, ENVIRON SCI TECHNOL, V44, P580, DOI 10.1021/es901221x; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; KONO M, 1992, FEMS MICROBIOL LETT, V97, P89; Lapidus A, 2009, STAND GENOMIC SCI, V1, P3, DOI 10.4056/sigs.492; Leclercq R, 2002, CLIN INFECT DIS, V34, P482, DOI 10.1086/324626; Morar M, 2010, ANNU REV GENET, V44, P25, DOI 10.1146/annurev-genet-102209-163517; Murray IA, 1997, ANTIMICROB AGENTS CH, V41, P1; Nguyen MCP, 2009, EMERG INFECT DIS, V15, P1648, DOI 10.3201/eid1510.090696; Noguchi N, 1996, FEMS MICROBIOL LETT, V144, P197, DOI 10.1016/0378-1097(96)00362-X; Northup DE, 2003, ENVIRON MICROBIOL, V5, P1071, DOI 10.1046/j.1462-2920.2003.00500.x; O'Brien J, 2011, CURR OPIN BIOTECH, V22, P552, DOI 10.1016/j.copbio.2011.03.010; Polyak V.J., 2000, J CAVE KARST STUD, V62, P72; Polyak VJ, 1998, SCIENCE, V279, P1919, DOI 10.1126/science.279.5358.1919; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Shakya T, 2010, ANTIMICROB AGENTS CH, V54, P1909, DOI 10.1128/AAC.01570-09; Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950; Thaller MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008989; Thuy DT, 2011, J ANTIMICROB CHEMOTH, V66, P531, DOI 10.1093/jac/dkq496; Toth M, 2010, J AM CHEM SOC, V132, P816, DOI 10.1021/ja908850p; Wright GD, 2005, ADV DRUG DELIVER REV, V57, P1451, DOI 10.1016/j.addr.2005.04.002; Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Wright GD, 2010, EXPERT OPIN DRUG DIS, V5, P779, DOI 10.1517/17460441.2010.497535	53	390	416	5	188	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34953	10.1371/journal.pone.0034953	http://dx.doi.org/10.1371/journal.pone.0034953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509370	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336600068
J	Cocco, E; Sardu, C; Pieroni, E; Valentini, M; Murru, R; Costa, G; Tranquilli, S; Frau, J; Coghe, G; Carboni, N; Floris, M; Contu, P; Marrosu, MG				Cocco, Eleonora; Sardu, Claudia; Pieroni, Enrico; Valentini, Maria; Murru, Raffaele; Costa, Gianna; Tranquilli, Stefania; Frau, Jessica; Coghe, Giancarlo; Carboni, Nicola; Floris, Matteo; Contu, Paolo; Marrosu, Maria Giovanna			HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; DIAGNOSTIC-CRITERIA; CRYSTAL-STRUCTURE; TRANSGENIC MICE; ASSOCIATION; DISEASE; MOLECULES; ALLELES; LOCUS; RISK	Introduction: Genetic predisposition to multiple sclerosis (MS) in Sardinia (Italy) has been associated with five DRB1*-DQB1* haplotypes of the human leukocyte antigen (HLA). Given the complexity of these associations, an in-depth re-analysis was performed with the specific aims of confirming the haplotype associations; establishing the independence of the associated haplotypes; and assessing patients' genotypic risk of developing MS. Methods and Results: A transmission disequilibrium test (TDT) of the DRB1*-DQB1* haplotypes in 943 trio families, confirmed a higher than expected transmission rate (over-transmission) of the *13:03-*03:01 (OR = 2.9, P = 7.6 x 10(-3)), *04:05-*03:01 (OR = 2.4, P = 4.4 x 10(-6)) and *03:01-*02:01 (OR = 2.1, P = 1.0 x 10(-15)) haplotype. In contrast, the *16:01-*05:02 (OR = 0.5, P = 5.4 x 10(-11)) and the *15:02-*06:01 (OR = 0.3, P = 1.5 x 10(-3)) haplotypes exhibited a lower than expected transmission rate (under-transmission). The independence of the transmission of each positively and negatively associated haplotype was confirmed relative to all positively associated haplotypes, and to the negatively associated *16:01-*05:02 haplotype. In patients, carriage of two predisposing haplotypes, or of protective haplotypes, respectively increased or decreased the patient's risk of developing MS. The risk of MS followed a multiplicative model of genotypes, which was, in order of decreasing ORs: *04:05-*0301/*03:01-*02:01 (OR = 4.5); *03:01-*02:01/*03:01-*02:01 (OR = 4.1); and the *16:01-* 05:02/*16:01-*0502 (OR = 0.2) genotypes. Analysis of DRB1 and DQB1 protein chain residues showed that the Val/Gly residue at position 86 of the DRB1 chain was the only difference between the protective *16:01-*15:02 alleles and the predisposing *15:01 one. Similarly, the Ala/Val residue at position 38 of the DQB1 chain differentiated the positively associated *06:02 allele and the negatively associated *05:02, *06:01 alleles. Conclusions: These findings show that the association of specific, independent DRB1*-DQB1* haplotypes confers susceptibility or resistance to MS in the MS-prone Sardinian population. The data also supports a functional role for specific residues of the DRB1 and DQB1 proteins in predisposing patients to MS.	[Cocco, Eleonora; Sardu, Claudia; Murru, Raffaele; Costa, Gianna; Tranquilli, Stefania; Frau, Jessica; Coghe, Giancarlo; Carboni, Nicola; Contu, Paolo; Marrosu, Maria Giovanna] Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Cagliari, Italy; [Pieroni, Enrico; Valentini, Maria; Floris, Matteo] CRS4, Cagliari, Italy	University of Cagliari	Cocco, E (corresponding author), Univ Cagliari, Dept Publ Hlth Clin & Mol Med, Cagliari, Italy.	gmarrosu@unica.it	Frau, Jessica/AAC-1622-2019; Floris, Matteo/ABH-1274-2020; Contu, Paolo/I-2409-2019; Cocco, Eleonora/G-5064-2012	Floris, Matteo/0000-0003-4385-9336; Cocco, Eleonora/0000-0002-3878-8820; pieroni, enrico/0000-0002-4246-6963; Valentini, Maria/0000-0002-4288-8621; MURRU, RAFFAELE/0000-0001-8830-5084; Marrosu, Maria Giovanna/0000-0003-2334-2081; Contu, Paolo/0000-0002-5511-0923	Ministero dell'Istruzione, dell'Universita e della Ricerca	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This work was supported by grant project by a grant by "Ministero dell'Istruzione, dell'Universita e della Ricerca" (call: PRIN 2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN M, 1994, HUM IMMUNOL, V39, P41, DOI 10.1016/0198-8859(94)90099-X; Ballerini C, 2004, J NEUROIMMUNOL, V150, P178, DOI 10.1016/j.jneuroim.2004.01.015; Barcellos LF, 2003, AM J HUM GENET, V72, P710, DOI 10.1086/367781; Barcellos LF, 2006, HUM MOL GENET, V15, P2813, DOI 10.1093/hmg/ddl223; Brassat D, 2005, NEUROLOGY, V64, P361, DOI 10.1212/01.WNL.0000149765.71212.0A; Chao MJ, 2009, HUM MOL GENET, V18, P261, DOI 10.1093/hmg/ddn353; Cocco E, 2011, MULT SCLER J, V17, P1282, DOI 10.1177/1352458511408754; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; CONGIA M, 1994, HUM IMMUNOL, V40, P138, DOI 10.1016/0198-8859(94)90059-0; Cordell HJ, 2004, GENET EPIDEMIOL, V26, P167, DOI 10.1002/gepi.10307; Dean G, 2008, NEUROLOGY, V70, P101, DOI 10.1212/01.wnl.0000284598.98525.d7; DEMOTZ S, 1993, EUR J IMMUNOL, V23, P425, DOI 10.1002/eji.1830230219; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; FOGDELL A, 1995, TISSUE ANTIGENS, V46, P333, DOI 10.1111/j.1399-0039.1995.tb02503.x; Granieri E, 2000, NEUROLOGY, V55, P842, DOI 10.1212/WNL.55.6.842; JERSILD C, 1972, LANCET, V1, P1240; Koeleman BPC, 2004, GENES IMMUN, V5, P381, DOI 10.1038/sj.gene.6364106; Kwon OJ, 1999, ARCH NEUROL-CHICAGO, V56, P555, DOI 10.1001/archneur.56.5.555; Lampis R, 2000, TISSUE ANTIGENS, V56, P515, DOI 10.1034/j.1399-0039.2000.560605.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Luckey D, 2011, J AUTOIMMUN, V37, P122, DOI 10.1016/j.jaut.2011.05.001; Madsen LS, 1999, NAT GENET, V23, P343, DOI 10.1038/15525; Mangalam AK, 2008, ADV IMMUNOL, V97, P65, DOI 10.1016/S0065-2776(08)00002-3; Marrosu MG, 2001, HUM MOL GENET, V10, P2907, DOI 10.1093/hmg/10.25.2907; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Modin H, 2004, AM J HUM GENET, V74, P1321, DOI 10.1086/420977; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; PAYAMI H, 1989, AM J HUM GENET, V45, P541; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Quarsten H, 1998, INT IMMUNOL, V10, P1229, DOI 10.1093/intimm/10.8.1229; Ramagopalan SV, 2007, PLOS GENET, V3, P1607, DOI 10.1371/journal.pgen.0030150; Robinson J, 2003, NUCLEIC ACIDS RES, V31, P311, DOI [10.1093/nar/gkg070, 10.1093/nar/GKG070]; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sawcer S, 2008, BRAIN, V131, P3118, DOI 10.1093/brain/awn081; Siebold C, 2004, P NATL ACAD SCI USA, V101, P1999, DOI 10.1073/pnas.0308458100; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Teutsch SM, 1999, HUM IMMUNOL, V60, P715, DOI 10.1016/S0198-8859(99)00033-6; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Traherne JA, 2008, INT J IMMUNOGENET, V35, P179, DOI 10.1111/j.1744-313X.2008.00765.x; VOGT AB, 1994, J IMMUNOL, V153, P1665; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100	46	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e33972	10.1371/journal.pone.0033972	http://dx.doi.org/10.1371/journal.pone.0033972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509268	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600018
J	Rooker, JR; Simms, JR; Wells, RJD; Holt, SA; Holt, GJ; Graves, JE; Furey, NB				Rooker, Jay R.; Simms, Jeff R.; Wells, R. J. David; Holt, Scott A.; Holt, G. Joan; Graves, John E.; Furey, Nathan B.			Distribution and Habitat Associations of Billfish and Swordfish Larvae across Mesoscale Features in the Gulf of Mexico	PLOS ONE			English	Article							SAILFISH ISTIOPHORUS-PLATYPTERUS; MARLIN TETRAPTURUS-ALBIDUS; ATLANTIC BLUEFIN TUNA; MAKAIRA-NIGRICANS; XIPHIAS-GLADIUS; THUNNUS-THYNNUS; LIFE-HISTORY; FISH LARVAE; OCEAN; SARGASSUM	Ichthyoplankton surveys were conducted in surface waters of the northern Gulf of Mexico (NGoM) over a three-year period (2006-2008) to determine the relative value of this region as early life habitat of sailfish (Istiophorus platypterus), blue marlin (Makaira nigricans), white marlin (Kajikia albida), and swordfish (Xiphias gladius). Sailfish were the dominant billfish collected in summer surveys, and larvae were present at 37.5% of the stations sampled. Blue marlin and white marlin larvae were present at 25.0% and 4.6% of the stations sampled, respectively, while swordfish occurred at 17.2% of the stations. Areas of peak production were detected and maximum density estimates for sailfish (22.09 larvae 1000 m(-2)) were significantly higher than the three other species: blue marlin (9.62 larvae 1000 m(-2)), white marlin (5.44 larvae 1000 m(-2)), and swordfish (4.67 larvae 1000 m(-2)). The distribution and abundance of billfish and swordfish larvae varied spatially and temporally, and several environmental variables (sea surface temperature, salinity, sea surface height, distance to the Loop Current, current velocity, water depth, and Sargassum biomass) were deemed to be influential variables in generalized additive models (GAMs). Mesoscale features in the NGoM affected the distribution and abundance of billfish and swordfish larvae, with densities typically higher in frontal zones or areas proximal to the Loop Current. Habitat suitability of all four species was strongly linked to physicochemical attributes of the water masses they inhabited, and observed abundance was higher in slope waters with lower sea surface temperature and higher salinity. Our results highlight the value of the NGoM as early life habitat of billfishes and swordfish, and represent valuable baseline data for evaluating anthropogenic effects (i.e., Deepwater Horizon oil spill) on the Atlantic billfish and swordfish populations.	[Rooker, Jay R.; Simms, Jeff R.; Wells, R. J. David; Furey, Nathan B.] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; [Rooker, Jay R.; Simms, Jeff R.; Furey, Nathan B.] Texas A&M Univ, Dept Wildlife & Fisheries Sci, College Stn, TX 77843 USA; [Holt, Scott A.; Holt, G. Joan] Univ Texas Austin, Univ Texas Marine Sci Inst, Port Aransas, TX USA; [Graves, John E.] Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA	Texas A&M University System; Texas A&M University System; Texas A&M University College Station; University of Texas System; University of Texas Austin; William & Mary; Virginia Institute of Marine Science	Rooker, JR (corresponding author), Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA.	rookerj@tamug.edu	Furey, Nathan/J-4862-2012; Rooker, Jay/M-3197-2013; Fennell, Hannah/AAI-1408-2019	Furey, Nathan/0000-0002-8584-7889; Rooker, Jay/0000-0002-5934-7688; 	National Marine Fisheries Service (Southeast Fisheries Science Center); McDaniel Charitable Foundation	National Marine Fisheries Service (Southeast Fisheries Science Center); McDaniel Charitable Foundation	This work was supported by the National Marine Fisheries Service (Southeast Fisheries Science Center) and the McDaniel Charitable Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2010, R LANG ENV STAT COMP; Arocha F, 2009, FISH RES, V95, P98, DOI 10.1016/j.fishres.2008.08.010; Baum JK, 2009, J ANIM ECOL, V78, P699, DOI 10.1111/j.1365-2656.2009.01531.x; Bellido JM, 2008, HYDROBIOLOGIA, V612, P171, DOI 10.1007/s10750-008-9481-2; Biggs DC, 1997, FISH B-NOAA, V95, P369; Bjorkstedt EP, 2002, MAR ECOL PROG SER, V242, P215, DOI 10.3354/meps242215; Brinson AA, 2006, B MAR SCI, V79, P635; Brodeur RD, 2008, MAR ECOL PROG SER, V366, P187, DOI 10.3354/meps07539; Casazza TL, 2008, FISH B-NOAA, V106, P348; Cowen RK, 2006, SCIENCE, V311, P522, DOI 10.1126/science.1122039; Davis RW, 2002, DEEP-SEA RES PT I, V49, P121, DOI 10.1016/S0967-0637(01)00035-8; deSylva DP, 1997, B MAR SCI, V60, P668; Die DJ, 2006, B MAR SCI, V79, P529; Govoni JJ, 2003, FISH B-NOAA, V101, P778; GOVONI JJ, 1992, CONT SHELF RES, V12, P1265, DOI 10.1016/0278-4343(92)90063-P; Grimes CB, 1996, MAR FRESHWATER RES, V47, P191, DOI 10.1071/MF9960191; Hanisko DS, 2007, AM FISH S S, V60, P285; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hernandez FJ, 2010, FISH B-NOAA, V108, P193; Hoolihan JP, 2005, MAR BIOL, V146, P1015, DOI 10.1007/s00227-004-1488-2; Horodysky AZ, 2007, FISH OCEANOGR, V16, P240, DOI 10.1111/j.1365-2419.2007.00419.x; Hurst TP, 2002, CAN J FISH AQUAT SCI, V59, P787, DOI 10.1139/F02-051; ICCAT (International Commission for the Conservation of Atlantic Tunas), 2006, SCRS2006013 ICCAT, P1; Idrisi N, 2003, MAR FRESHW BEHAV PHY, V36, P51, DOI 10.1080/1023624021000054299; Ingram GW, 2010, AQUAT LIVING RESOUR, V23, P35, DOI 10.1051/alr/2009053; Kerr LA, 2010, ECOL APPL, V20, P497, DOI 10.1890/08-1382.1; Kraus RT, 2011, MAR BIOL, V158, P699, DOI 10.1007/s00227-010-1593-3; LAMADRIDROSE Y, 1988, MAR ENVIRON RES, V25, P175, DOI 10.1016/0141-1136(88)90002-5; Lochmann SE, 1997, CAN J FISH AQUAT SCI, V54, P1461, DOI 10.1139/cjfas-54-7-1461; Luthy SA, 2005, FISH B-NOAA, V103, P588; Lynch PD, 2011, SUSTAINABLE FISHERIES: MULTI-LEVEL APPROACHES TO A GLOBAL PROBLEM, P197; Maggini R, 2006, J BIOGEOGR, V33, P1729, DOI 10.1111/j.1365-2699.2006.01465.x; Mueter FJ, 2006, PROG OCEANOGR, V68, P152, DOI 10.1016/j.pocean.2006.02.012; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Nakamura I, 1985, FAO FISH SYNOPSIS, V5; Nash RDM, 2005, FISH OCEANOGR, V14, P279, DOI 10.1111/j.1365-2419.2005.00336.x; Neilson John D., 2007, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V61, P25; Okazaki Y, 2002, MAR FRESHWATER RES, V53, P403, DOI 10.1071/MF01115; Olney J.E., 2006, EARLY STAGES ATLANTI, P1019; Orbesen E.S., 2008, U S National Marine Fisheries Service Marine Fisheries Review, V70, P14; Ortiz M, 2003, MAR FRESHWATER RES, V54, P489, DOI 10.1071/MF02028; Oschlies A, 1998, NATURE, V394, P266, DOI 10.1038/28373; Paris CB, 2005, MAR ECOL PROG SER, V296, P93, DOI 10.3354/meps296093; Paris CB, 2004, LIMNOL OCEANOGR, V49, P1964, DOI 10.4319/lo.2004.49.6.1964; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pinnegar JK, 2000, ENVIRON CONSERV, V27, P179, DOI 10.1017/S0376892900000205; Planque B, 2007, FISH OCEANOGR, V16, P16, DOI 10.1111/j.1365-2419.2006.00411.x; Poisson F, 2009, AQUAT LIVING RESOUR, V22, P59, DOI 10.1051/alr/2009012; Post JT, 1997, B MAR SCI, V60, P1026; Prince ED, 2005, FISH B-NOAA, V103, P659; Ralston S, 2003, FISH B-NOAA, V101, P129; RICHARDS W. J., 1974, P INT BILLF S KAIL K, P62; Richardson DE, 2010, PROG OCEANOGR, V86, P8, DOI 10.1016/j.pocean.2010.04.005; Richardson DE, 2009, PROG OCEANOGR, V82, P252, DOI 10.1016/j.pocean.2009.07.003; Richardson DE, 2009, FISH OCEANOGR, V18, P402, DOI 10.1111/j.1365-2419.2009.00520.x; Rooker JR, 2006, MAR ECOL PROG SER, V313, P249, DOI 10.3354/meps313249; Sandman A, 2008, J MARINE SYST, V74, pS86, DOI 10.1016/j.jmarsys.2008.03.028; Sedberry GR, 2001, MAR BIOL, V139, P355; Serafy J.E., 2004, MAR FISH REV, V66, P9; Serafy JE, 2003, MAR FRESHWATER RES, V54, P299, DOI 10.1071/MF01273; Siddon EC, 2011, MAR ECOL PROG SER, V426, P225, DOI 10.3354/meps09009; Simms JR, 2010, FISH B-NOAA, V108, P478; Somarakis S, 2007, MAR BIOL, V152, P1143, DOI 10.1007/s00227-007-0761-6; Sundblad G, 2009, ESTUAR COAST SHELF S, V83, P90, DOI 10.1016/j.ecss.2009.03.025; Teo SLH, 2007, MAR BIOL, V151, P1, DOI 10.1007/s00227-006-0447-5; Waite AM, 2007, DEEP-SEA RES PT II, V54, P981, DOI 10.1016/j.dsr2.2007.03.001; Wells RJD, 2004, B MAR SCI, V74, P81; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2008, J R STAT SOC B, V70, P495, DOI 10.1111/j.1467-9868.2007.00646.x; Wood SN, 2000, J ROY STAT SOC B, V62, P413, DOI 10.1111/1467-9868.00240; Wright PJ, 2009, FISH FISH, V10, P283, DOI 10.1111/j.1467-2979.2008.00322.x; Zimmerman RA, 1999, J GEOPHYS RES-OCEANS, V104, P5251, DOI 10.1029/1998JC900072	74	76	76	4	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34180	10.1371/journal.pone.0034180	http://dx.doi.org/10.1371/journal.pone.0034180			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509277	Green Published, gold			2022-12-27	WOS:000305336600022
J	Wang, SQ; Shi, DQ; Long, YP; Liu, J; Yang, WC				Wang, Si-Qi; Shi, Dong-Qiao; Long, Yan-Ping; Liu, Jie; Yang, Wei-Cai			GAMETOPHYTE DEFECTIVE 1, a Putative Subunit of RNases P/MRP, Is Essential for Female Gametogenesis and Male Competence in Arabidopsis	PLOS ONE			English	Article							PRECURSOR RIBOSOMAL-RNA; CELL-CYCLE PROGRESSION; CARTILAGE-HAIR HYPOPLASIA; ESSENTIAL PROTEIN SUBUNIT; POLLEN-TUBE GUIDANCE; RIBONUCLEASE-P; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; PROCESSING ENZYME; ESCHERICHIA-COLI	RNA biogenesis, including biosynthesis and maturation of rRNA, tRNA and mRNA, is a fundamental process that is critical for cell growth, division and differentiation. Previous studies showed that mutations in components involved in RNA biogenesis resulted in abnormalities in gametophyte and leaf development in Arabidopsis. In eukaryotes, RNases P/MRP (RNase mitochondrial RNA processing) are important ribonucleases that are responsible for processing of tRNA, and transcription of small non-coding RNAs. Here we report that Gametophyte Defective 1 (GAF1), a gene encoding a predicted protein subunit of RNases P/MRP, AtRPP30, plays a role in female gametophyte development and male competence. Embryo sacs were arrested at stages ranging from FG1 to FG7 in gaf1 mutant, suggesting that the progression of the gametophytic division during female gametogenesis was impaired in gaf1 mutant. In contrast, pollen development was not affected in gaf1. However, the fitness of the mutant pollen tube was weaker than that of the wild-type, leading to reduced transmission through the male gametes. GAF1 is featured as a typical RPP30 domain protein and interacts physically with AtPOP5, a homologue of RNases P/MRP subunit POP5 of yeast. Together, our data suggest that components of the RNases P/MRP family, such as RPP30, play important roles in gametophyte development and function in plants.	[Wang, Si-Qi; Shi, Dong-Qiao; Long, Yan-Ping; Liu, Jie; Yang, Wei-Cai] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Mol Dev Biol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Wang, SQ (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, State Key Lab Mol Dev Biol, Beijing, Peoples R China.	dqshi@genetics.ac.cn; wcyang@genetics.ac.cn	Yang, Wei-Cai/AAX-7879-2021; Long, Yanping/Z-1281-2018	Yang, Wei-Cai/0000-0003-0252-7079; Long, Yanping/0000-0003-4512-0594	National Science Foundation of China [30870227, 30921003]; Ministry of Science and Technology [2007CB108702]; Chinese Academy of Sciences [KSCX2-EW-Q-24-01]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Science Foundation of China (grant no. 30870227 and 30921003), Ministry of Science and Technology (grant no. 2007CB108702) and Chinese Academy of Sciences (grant no. KSCX2-EW-Q-24-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MP, 1980, STAIN TECHNOL, V55, P13, DOI 10.3109/10520298009067890; ALIFANO P, 1994, GENE DEV, V8, P3021, DOI 10.1101/gad.8.24.3021; Aspinall TV, 2007, NUCLEIC ACIDS RES, V35, P6439, DOI 10.1093/nar/gkm553; Bechtold N, 1998, METH MOL B, V82, P259; Bonafe L, 2002, CLIN GENET, V61, P146, DOI 10.1034/j.1399-0004.2002.610210.x; Byrne ME, 2009, TRENDS PLANT SCI, V14, P512, DOI 10.1016/j.tplants.2009.06.009; Cai T, 2002, GENETICS, V161, P1029; Chen YH, 2007, PLANT CELL, V19, P3563, DOI 10.1105/tpc.107.053967; Christensen CA, 1997, SEX PLANT REPROD, V10, P49, DOI 10.1007/s004970050067; Chu S, 1997, RNA, V3, P382; CHU S, 1994, P NATL ACAD SCI USA, V91, P659, DOI 10.1073/pnas.91.2.659; CLAYTON DA, 1994, P NATL ACAD SCI USA, V91, P4615, DOI 10.1073/pnas.91.11.4615; Clayton DA, 2001, NATURE, V410, P29, DOI 10.1038/35065191; Coury DA, 2007, SEX PLANT REPROD, V20, P87, DOI 10.1007/s00497-007-0046-8; Dichtl B, 1997, EMBO J, V16, P417, DOI 10.1093/emboj/16.2.417; Ding YH, 2006, PLANT CELL, V18, P815, DOI 10.1105/tpc.105.039495; Drews GN, 1998, PLANT CELL, V10, P5, DOI 10.1105/tpc.10.1.5; Eder PS, 1997, P NATL ACAD SCI USA, V94, P1101, DOI 10.1073/pnas.94.4.1101; Esakova O, 2010, RNA, V16, P1725, DOI 10.1261/rna.2214510; FORSTER AC, 1990, SCIENCE, V249, P783, DOI 10.1126/science.1697102; Gill T, 2006, J CELL BIOL, V173, P35, DOI 10.1083/jcb.200512025; Gill T, 2004, MOL CELL BIOL, V24, P945, DOI 10.1128/MCB.24.3.945-953.2004; GOLD HA, 1989, SCIENCE, V245, P1377, DOI 10.1126/science.2476849; GOLD HA, 1988, P NATL ACAD SCI USA, V85, P5483, DOI 10.1073/pnas.85.15.5483; Gross-Hardt R, 2007, PLOS BIOL, V5, P494, DOI 10.1371/journal.pbio.0050047; Grossniklaus U, 1998, SEMIN CELL DEV BIOL, V9, P227, DOI 10.1006/scdb.1997.0214; GUERRIERTAKADA C, 1984, SCIENCE, V223, P285, DOI 10.1126/science.6199841; Harscoet E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012829; Hartmann E, 2003, TRENDS GENET, V19, P561, DOI 10.1016/j.tig.2003.08.007; Houser-Scott F, 2002, P NATL ACAD SCI USA, V99, P2684, DOI 10.1073/pnas.052586299; Huang CK, 2010, PLANT CELL PHYSIOL, V51, P694, DOI 10.1093/pcp/pcq045; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jarrous N, 2007, NUCLEIC ACIDS RES, V35, P3519, DOI 10.1093/nar/gkm071; Jiang LX, 2005, PLANT CELL, V17, P584, DOI 10.1105/tpc.104.027631; Jiang TJ, 2001, P NATL ACAD SCI USA, V98, P920, DOI 10.1073/pnas.021561498; Li N, 2009, PLANT PHYSIOL, V151, P1486, DOI 10.1104/pp.109.142414; Li Y, 2004, J MOL BIOL, V339, P31, DOI 10.1016/j.jmb.2004.03.041; Li Y, 2003, P NATL ACAD SCI USA, V100, P13213, DOI 10.1073/pnas.2235589100; Lindahl L, 2009, RNA, V15, P1407, DOI 10.1261/rna.1302909; Liu M, 2010, J INTEGR PLANT BIOL, V52, P817, DOI 10.1111/j.1744-7909.2010.00972.x; Liu M, 2009, J INTEGR PLANT BIOL, V51, P261, DOI 10.1111/j.1744-7909.2008.00783.x; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Lygerou Z, 1996, EMBO J, V15, P5936, DOI 10.1002/j.1460-2075.1996.tb00980.x; Ma Hong, 2005, Annu Rev Plant Biol, V56, P393, DOI 10.1146/annurev.arplant.55.031903.141717; McCormick S, 2004, PLANT CELL, V16, pS142, DOI 10.1105/tpc.016659; MCCORMICK S, 1993, PLANT CELL, V5, P1265, DOI 10.1105/tpc.5.10.1265; Moll C, 2008, PLANT J, V56, P913, DOI 10.1111/j.1365-313X.2008.03650.x; Nicholson A, NUCL ACIDS MOL BIOL, P319; Papdi C, 2008, PLANT PHYSIOL, V147, P528, DOI 10.1104/pp.108.116897; PECKMILLER KA, 1991, J MOL BIOL, V221, P1; Perederina A, 2011, RNA, V17, P1922, DOI 10.1261/rna.2855511; Piccinelli P, 2005, NUCLEIC ACIDS RES, V33, P4485, DOI 10.1093/nar/gki756; Reiner R, 2006, GENE DEV, V20, P1621, DOI 10.1101/gad.386706; Ridanpaa M, 2003, J MED GENET, V40, P741, DOI 10.1136/jmg.40.10.741; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Rosenblad MA, 2006, NUCLEIC ACIDS RES, V34, P5145, DOI 10.1093/nar/gkl626; Schippers JHM, 2010, PLANT SCI, V179, P307, DOI 10.1016/j.plantsci.2010.06.012; SCHMITT ME, 1994, GENE DEV, V8, P2617, DOI 10.1101/gad.8.21.2617; Shi DQ, 2011, CURR OPIN PLANT BIOL, V14, P74, DOI 10.1016/j.pbi.2010.09.001; Shi DQ, 2005, PLANT CELL, V17, P2340, DOI 10.1105/tpc.105.033563; Shimizu KK, 2008, PLANT CELL PHYSIOL, V49, P1478, DOI 10.1093/pcp/pcn130; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Stolc V, 1998, P NATL ACAD SCI USA, V95, P6716, DOI 10.1073/pnas.95.12.6716; Stolc V, 1997, GENE DEV, V11, P2926, DOI 10.1101/gad.11.21.2926; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Sundaresan V, 2010, DEVELOPMENT, V137, P179, DOI 10.1242/dev.030346; Thiel CT, 2005, AM J HUM GENET, V77, P795, DOI 10.1086/497708; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; van Eenennaam H, 2001, J BIOL CHEM, V276, P31635, DOI 10.1074/jbc.M103399200; Walker SC, 2006, CRIT REV BIOCHEM MOL, V41, P77, DOI 10.1080/10409230600602634; WEBB MC, 1990, SEX PLANT REPROD, V3, P244, DOI 10.1007/BF00202882; Welting TJM, 2004, NUCLEIC ACIDS RES, V32, P2138, DOI 10.1093/nar/gkh539; Wilusz JE, 2008, CELL, V135, P919, DOI 10.1016/j.cell.2008.10.012; Wuest SE, 2010, CURR BIOL, V20, P506, DOI 10.1016/j.cub.2010.01.051; Xiao SH, 2002, ANNU REV BIOCHEM, V71, P165, DOI 10.1146/annurev.biochem.71.110601.135352; Yang WC, 1999, GENE DEV, V13, P2108, DOI 10.1101/gad.13.16.2108; Yang WC, 2010, ANNU REV PLANT BIOL, V61, P89, DOI 10.1146/annurev-arplant-042809-112203; Yao Y, 2008, DEVELOPMENT, V135, P1325, DOI 10.1242/dev.017913	78	11	12	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e33595	10.1371/journal.pone.0033595	http://dx.doi.org/10.1371/journal.pone.0033595			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509260	gold, Green Published, Green Submitted			2022-12-27	WOS:000305336600013
J	Zhu, M; Yu, XB; Choo, B; Qu, QM; Jia, LT; Zhao, WJ; Qiao, T; Lu, J				Zhu, Min; Yu, Xiaobo; Choo, Brian; Qu, Qingming; Jia, Liantao; Zhao, Wenjin; Qiao, Tuo; Lu, Jing			Fossil Fishes from China Provide First Evidence of Dermal Pelvic Girdles in Osteichthyans	PLOS ONE			English	Article							PAIRED FINS; DEVONIAN PERIOD; PECTORAL FIN; BONY FISHES; PALEONTOLOGY; CHARACTERS; EVOLUTION; OSTEOSTRACAN; VERTEBRATES; BRAINCASE	Background: The pectoral and pelvic girdles support paired fins and limbs, and have transformed significantly in the diversification of gnathostomes or jawed vertebrates (including osteichthyans, chondrichthyans, acanthodians and placoderms). For instance, changes in the pectoral and pelvic girdles accompanied the transition of fins to limbs as some osteichthyans (a clade that contains the vast majority of vertebrates - bony fishes and tetrapods) ventured from aquatic to terrestrial environments. The fossil record shows that the pectoral girdles of early osteichthyans (e. g., Lophosteus, Andreolepis, Psarolepis and Guiyu) retained part of the primitive gnathostome pectoral girdle condition with spines and/or other dermal components. However, very little is known about the condition of the pelvic girdle in the earliest osteichthyans. Living osteichthyans, like chondrichthyans (cartilaginous fishes), have exclusively endoskeletal pelvic girdles, while dermal pelvic girdle components (plates and/or spines) have so far been found only in some extinct placoderms and acanthodians. Consequently, whether the pectoral and pelvic girdles are primitively similar in osteichthyans cannot be adequately evaluated, and phylogeny-based inferences regarding the primitive pelvic girdle condition in osteichthyans cannot be tested against available fossil evidence. Methodology/Principal Findings: Here we report the first discovery of spine-bearing dermal pelvic girdles in early osteichthyans, based on a new articulated specimen of Guiyu oneiros from the Late Ludlow (Silurian) Kuanti Formation, Yunnan, as well as a re-examination of the previously described holotype. We also describe disarticulated pelvic girdles of Psarolepis romeri from the Lochkovian (Early Devonian) Xitun Formation, Yunnan, which resemble the previously reported pectoral girdles in having integrated dermal and endoskeletal components with polybasal fin articulation. Conclusions/Significance: The new findings reveal hitherto unknown similarity in pectoral and pelvic girdles among early osteichthyans, and provide critical information for studying the evolution of pelvic girdles in osteichthyans and other gnathostomes.	[Zhu, Min; Yu, Xiaobo; Choo, Brian; Qu, Qingming; Jia, Liantao; Zhao, Wenjin; Qiao, Tuo; Lu, Jing] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China; [Yu, Xiaobo] Kean Univ, Dept Biol Sci, Union, NJ USA; [Qu, Qingming] Uppsala Univ, Subdept Evolutionary Organismal Biol, Dept Physiol & Dev Biol, Uppsala, Sweden	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Uppsala University	Zhu, M (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing, Peoples R China.	zhumin@ivpp.ac.cn	Yu, Xiaobo/G-7160-2011; min, zhu/AAL-6712-2021; Zhu, Min/E-8728-2012; Qiao, Tuo/AAJ-6317-2021; Qu, Qingming/R-7194-2016	Yu, Xiaobo/0000-0001-9600-7888; Zhu, Min/0000-0002-4786-0898; Qiao, Tuo/0000-0002-0488-7265; Qu, Qingming/0000-0002-8291-8493; Zhao, Wenjin/0000-0002-9649-2171; Choo, Brian/0000-0002-9983-0762	Chinese Academy of Sciences [KZCX2-YW-156]; MST of China [2012CB821902]; National Nature Science Foundation of China [40930208]; CAS/SAFEA	Chinese Academy of Sciences(Chinese Academy of Sciences); MST of China(Ministry of Science and Technology, China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAS/SAFEA(Chinese Academy of Sciences)	Funding was provided by the Chinese Academy of Sciences (KZCX2-YW-156), the Major Basic Research Projects (2012CB821902) of MST of China, the National Nature Science Foundation of China (40930208), and the CAS/SAFEA International Partnership Program for Creative Research Teams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg PE, 1999, NATURE, V397, P564, DOI 10.1038/17484; Basden AM, 2000, NATURE, V403, P185, DOI 10.1038/35003183; Basden AM, 2001, J VERTEBR PALEONTOL, V21, P754, DOI 10.1671/0272-4634(2001)021[0754:APANFT]2.0.CO;2; Botella H, 2007, NATURE, V448, P583, DOI 10.1038/nature05989; Brazeau MD, 2009, NATURE, V457, P305, DOI 10.1038/nature07436; Chang MM, 2000, NATURE, V403, P152, DOI 10.1038/35003093; Coates MI, 2003, THEOR BIOSCI, V122, P266; Coates MI, 2002, EVOL DEV, V4, P390, DOI 10.1046/j.1525-142X.2002.02026.x; Coates MI, 2009, NATURE, V458, P413, DOI 10.1038/458413a; Denison RH, 1979, ACANTHODII; FOREY PL, 1980, PROC R SOC SER B-BIO, V208, P369, DOI 10.1098/rspb.1980.0056; Friedman M, 2007, J SYST PALAEONTOL, V5, P289, DOI 10.1017/S1477201907002052; Friedman M, 2010, J VERTEBR PALEONTOL, V30, P36, DOI 10.1080/02724630903409071; Gardiner B.G., 1984, Bulletin of the British Museum (Natural History) Geology, V37, P173; Gardiner B.G., 1984, Journal of Vertebrate Paleontology, V4, P379; Goujet D., 1973, Palaeontographica Abt A, V143, P73; GROSS W, 1969, LETHAIA, V2, P15, DOI 10.1111/j.1502-3931.1969.tb01249.x; GROSS W, 1968, LETHAIA, V1, P184, DOI 10.1111/j.1502-3931.1968.tb01736.x; Janvier P, 2004, J VERTEBR PALEONTOL, V24, P773, DOI 10.1671/0272-4634(2004)024[0773:CCITPF]2.0.CO;2; Janvier P., 1978, Eesti NSV Teaduste Akadeemia Toimetised Geoloogia, V27, P88; Janvier P., 1996, EARLY VERTEBRATES; Jarvik E., 1944, K SVENSKA VETENSKAPSAKAD HANDL, V21, P1; Johanson Z, 2002, LETHAIA, V35, P169, DOI 10.1080/002411602320184024; Johanson Z, 2010, J EXP ZOOL PART B, V314B, P347, DOI 10.1002/jez.b.21343; Long J.A., 1988, Memoir of the Association of Australasian Palaeontologists, V7, P65; Long John A., 1997, Geodiversitas, V19, P515; Maisey JG, 2009, J VERTEBR PALEONTOL, V29, P14, DOI 10.1671/039.029.0130; Miles RS, 1973, GEOLOGY, V24, P111; Miller RF, 2003, NATURE, V425, P501, DOI 10.1038/nature02001; Min Z, 1997, LETHAIA, V30, P293; Qiao T, 2010, SCI CHINA EARTH SCI, V53, P1836, DOI 10.1007/s11430-010-4089-6; Qu QM, 2010, 3 INT PAL C; ROSEN D E, 1981, Bulletin of the American Museum of Natural History, V167, P159; SCHULTZE H-P, 1968, Bulletin of the British Museum (Natural History) Geology, V16, P343; Schultze H-P, 2004, RIGA ACTA U LATVIENS, V679, P57; Schultze HP, 2001, SYST ASSOC SPEC VOL, V61, P315; STENSIO ERIK, 1959, K SVENSKA VETENSKAPSAKAD HANDL, V8, P1; Wake MH, HYMANS COMP VERTEBRA; Young GC, 2008, J VERTEBR PALEONTOL, V28, P626, DOI 10.1671/0272-4634(2008)28[626:TROADP]2.0.CO;2; Young GC, 2010, ANNU REV EARTH PL SC, V38, P523, DOI 10.1146/annurev-earth-040809-152507; Yu X, 2010, BCAS PALEOICHTHYOLOG, V24, P71; Yu XB, 1998, J VERTEBR PALEONTOL, V18, P261, DOI 10.1080/02724634.1998.10011055; Zhao Wen-Jin, 2010, Palaeoworld, V19, P4, DOI 10.1016/j.palwor.2009.11.007; Zhu M, 1999, NATURE, V397, P607, DOI 10.1038/17594; Zhu M, 2006, NATURE, V441, P77, DOI 10.1038/nature04563; Zhu M, 2002, NATURE, V418, P767, DOI 10.1038/nature00871; Zhu M, 2001, NATURE, V410, P81, DOI 10.1038/35065078; Zhu M, 2012, BIOL LETTERS, V8, P453, DOI 10.1098/rsbl.2011.1033; Zhu M, 2009, BIOL LETTERS, V5, P372, DOI 10.1098/rsbl.2008.0784; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855	50	15	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e35103	10.1371/journal.pone.0035103	http://dx.doi.org/10.1371/journal.pone.0035103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509388	gold, Green Published, Green Submitted			2022-12-27	WOS:000304805900066
J	Corten, R				Corten, Rense			Composition and Structure of a Large Online Social Network in the Netherlands	PLOS ONE			English	Article							FRIENDS; SITES	Limitations in data collection have long been an obstacle in research on friendship networks. Most earlier studies use either a sample of ego-networks, or complete network data on a relatively small group (e.g., a single organization). The rise of online social networking services such as Friendster and Facebook, however, provides researchers with opportunities to study friendship networks on a much larger scale. This study uses complete network data from Hyves, a popular online social networking service in the Netherlands, comprising over eight million members and over 400 million online friendship relations. In the first study of its kind for the Netherlands, I examine the structure of this network in terms of the degree distribution, characteristic path length, clustering, and degree assortativity. Results indicate that this network shares features of other large complex networks, but also deviates in other respects. In addition, a comparison with other online social networks shows that these networks show remarkable similarities.	Univ Utrecht, ICS, Dept Sociol, Utrecht, Netherlands	Utrecht University	Corten, R (corresponding author), Univ Utrecht, ICS, Dept Sociol, Utrecht, Netherlands.	r.corten@uu.nl	Corten, Rense/D-7090-2013	Corten, Rense/0000-0001-8154-9393	Netherlands Organisation for Scientific Research [446-09-023]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by a "Rubicon" grant (number 446-09-023) from the Netherlands Organisation for Scientific Research (www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson E, 1997, ORGAN SCI, V8, P289, DOI 10.1287/orsc.8.3.289; Ahn YY, 2007, P 16 INT C WORLD WID, DOI [DOI 10.1145/1242572.1242685, 10.1145/1242572.1242685]; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Boyd DM, 2007, J COMPUT-MEDIAT COMM, V13, P210, DOI 10.1111/j.1083-6101.2007.00393.x; Caverlee J, 2008, P INT C WEBL SOC MED; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; comScore, 2011, NETH RANKS 1 WORLDW; Ellison N, 2006, J COMPUT-MEDIAT COMM, V11; Faloutsos M, 1999, COMP COMM R, V29, P251, DOI 10.1145/316194.316229; Gjoka M, 2010, IEEE INFOCOM SER, DOI 10.1109/infcom.2010.5462078; Holme P, 2004, SOC NETWORKS, V26, P155, DOI 10.1016/j.socnet.2004.01.007; Jackson MO, 2007, AM ECON REV, V97, P890, DOI 10.1257/aer.97.3.890; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Kumar R, 2010, LINK MINING: MODELS, ALGORITHMS, AND APPLICATIONS, P337, DOI 10.1007/978-1-4419-6515-8_13; Leskovec J., 2008, THESIS CARNEGIE MELL; Leskovec J., 2008, P 14 ACM SIGKDD INT, P462, DOI DOI 10.1145/1401890.1401948; Leskovec J., 2008, P 17 INT C WORLD WID, P915, DOI [10.1145/1367497.1367620, DOI 10.1145/1367497.1367620]; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; McPherson M, 2006, AM SOCIOL REV, V71, P353, DOI 10.1177/000312240607100301; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Mislove A, 2007, IMC'07: PROCEEDINGS OF THE 2007 ACM SIGCOMM INTERNET MEASUREMENT CONFERENCE, P29; Newman M, STRUCTURE DYNAMICS N; Newman MEJ, 2003, LECT NOTES PHYS, V625, P66; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Parsons ECM, 2003, AQUAT CONSERV, V13, P397, DOI 10.1002/aqc.582; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Scott J., 2000, SOCIAL STRUCTURE, V2nd; Statistics Netherlands, 2010, STATL TAB 7461BEV BE; Subrahmanyam K, 2008, J APPL DEV PSYCHOL, V29, P420, DOI 10.1016/j.appdev.2008.07.003; Tauro SL, 2001, GLOB TELECOMM CONF, P1667, DOI 10.1109/GLOCOM.2001.965863; van Deursen AJ, 2010, TRENDRAPPORT COMPUTE; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DJ, 2004, ANNU REV SOCIOL, V30, P243, DOI 10.1146/annurev.soc.30.020404.104342; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wilson C, 2009, EUROSYS'09: PROCEEDINGS OF THE FOURTH EUROSYS CONFERENCE, P205; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	37	19	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e34760	10.1371/journal.pone.0034760	http://dx.doi.org/10.1371/journal.pone.0034760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959VO	22523557	gold, Green Published, Green Submitted			2022-12-27	WOS:000305345000028
J	Wineinger, NE; Tiwari, HK				Wineinger, Nathan E.; Tiwari, Hemant K.			The Impact of Errors in Copy Number Variation Detection Algorithms on Association Results	PLOS ONE			English	Article							MISSING HERITABILITY; GENOME-WIDE	The inaccuracy of copy number variation (CNV) detection on single nucleotide polymorphism (SNP) arrays has recently been brought to attention. Such high error rates will undoubtedly have ramifications on downstream association testing. We examined this effect for a wide range of scenarios and found a noticeable decrease in power for error rates typical of CNV calling algorithms. We compared power using CNV calls to the log relative ratio and found the latter to be superior when error rates are moderate to large or when the CNV size is small. It is our recommendation that CNV researchers use intensity measurements as an alternative to CNV calls in these scenarios.	[Wineinger, Nathan E.; Tiwari, Hemant K.] Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA; [Wineinger, Nathan E.] Scripps Hlth, Scripps Translat Sci Inst, La Jolla, CA USA	University of Alabama System; University of Alabama Birmingham; Scripps Research Institute	Wineinger, NE (corresponding author), Univ Alabama Birmingham, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA.	wineinger.nathan@scrippshealth.org			Marie and Emmett Carmichael Scholarship; Scripps Health; National Institutes of Health (NIH) [T32HL079888]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL079888] Funding Source: NIH RePORTER	Marie and Emmett Carmichael Scholarship; Scripps Health; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by the Marie and Emmett Carmichael Scholarship, Scripps Health, and by National Institutes of Health (NIH) grant T32HL079888 (Dr. Tiwari). The opinions expressed herein are those of the authors and not necessarily those of the NIH or any organization with which the authors are affiliated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Baross A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-368; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Glessner JT, 2010, AM J HUM GENET, V87, P661, DOI 10.1016/j.ajhg.2010.09.014; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Gordon D, 2005, J CLIN INVEST, V115, P1408, DOI 10.1172/JCI24756; Kang SJ, 2004, GENET EPIDEMIOL, V26, P132, DOI 10.1002/gepi.10301; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Winchester Laura, 2009, Briefings in Functional Genomics & Proteomics, V8, P353, DOI 10.1093/bfgp/elp017; Zhang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014511	16	9	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2012	7	4							e32396	10.1371/journal.pone.0032396	http://dx.doi.org/10.1371/journal.pone.0032396			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959VO	22523537	Green Published, Green Submitted, gold			2022-12-27	WOS:000305345000006
J	Bonner, F; Borg, N; Burghoff, S; Schrader, J				Boenner, Florian; Borg, Nadine; Burghoff, Sandra; Schrader, Juergen			Resident Cardiac Immune Cells and Expression of the Ectonucleotidase Enzymes CD39 and CD73 after Ischemic Injury	PLOS ONE			English	Article							ATP-DIPHOSPHOHYDROLASE ACTIVITY; DENDRITIC CELLS; INFLAMMATORY RESPONSE; TARGETED DISRUPTION; REPERFUSION INJURY; ADENOSINE; RECEPTORS; MACROPHAGES; ACTIVATION; ADULT	Background: The ectoenzymes CD39 and CD73 are expressed by a broad range of immune cells and promote the extracellular degradation of nucleotides to anti-inflammatory adenosine. This study explored the abundance of CD73 and CD39 on circulating and resident cardiac leukocytes and coronary endothelial cells under control conditions and in response to inflammation following myocardial ischemia and reperfusion (I/R). Methods and Results: A method was elaborated to permit FACS analysis of non-myocardial cells (resident leukocytes, coronary endothelium and CD31(-) CD45(-) cells) of the unstressed heart. Under control conditions the murine heart contained 2.3x10(3) resident leukocytes/mg tissue, the most prominent fraction being antigen-presenting mononuclear cells (CD11b(+) CD11c(+) F4/80(+) MHCII+) followed by B-cells, monocytes and T-cells. CD73 was highly expressed on circulating and resident cardiac lymphoid cells with little expression on myeloid cells, while the opposite was true for CD39. Cardiomyocytes and erythrocytes do not measurably express CD39/CD73 and CD39 dominates on coronary endothelium. Three days after I/R, CD73 was significantly upregulated on invading granulocytes (2.8-fold) and T-cells (1.5-fold). Compared with coronary endothelial cells, CD73 associated with leukocytes comprised 2/3 of the total cardiac CD73. Conclusion: Our study suggests that extracellular ATP formed during I/R is preferentially degraded by CD39 present on myeloid cells, while the formation of immunosuppressive adenosine is mainly catalysed by CD73 present on granulocytes and lymphoid cells. Upregulated CD73 on granulocytes and T-cells infiltrating the injured heart is consistent with the existence of an autocrine adenosinergic loop which may promote the healing process.	[Boenner, Florian; Borg, Nadine; Burghoff, Sandra; Schrader, Juergen] Univ Dusseldorf, Dept Mol Cardiol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Bonner, F (corresponding author), Univ Dusseldorf, Dept Mol Cardiol, D-40225 Dusseldorf, Germany.	schrader@uni-duesseldorf.de			Deutsche Forschungsgemeinschaft [SFB612]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft SFB612 (http://www.uni-duesseldorf.de/home/Fakultaeten/Medizin/SFB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arciero JC, 2008, AM J PHYSIOL-HEART C, V295, pH1562, DOI 10.1152/ajpheart.00261.2008; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Bulloch K, 2008, J COMP NEUROL, V508, P687, DOI 10.1002/cne.21668; Candinas D, 1996, THROMB HAEMOSTASIS, V76, P807; Devey L, 2009, MOL THER, V17, P65, DOI 10.1038/mt.2008.237; Elliott MR, 2009, NATURE, V461, P282, DOI 10.1038/nature08296; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2006, CIRC RES, V99, P1100, DOI 10.1161/01.RES.0000250174.31269.70; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Fiset C, 1997, J PHYSIOL-LONDON, V504, P557, DOI 10.1111/j.1469-7793.1997.557bd.x; Frangogiannis NG, 2008, PHARMACOL RES, V58, P88, DOI 10.1016/j.phrs.2008.06.007; Fredholm BB, 2007, PROG NEUROBIOL, V83, P263, DOI 10.1016/j.pneurobio.2007.07.005; Gachet C, 2006, ANNU REV PHARMACOL, V46, P277, DOI 10.1146/annurev.pharmtox.46.120604.141207; Galkina E, 2006, J EXP MED, V203, P1273, DOI 10.1084/jem.20052205; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Henttinen T, 2003, J BIOL CHEM, V278, P24888, DOI 10.1074/jbc.M300779200; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Junger WG, 2011, NAT REV IMMUNOL, V11, P201, DOI 10.1038/nri2938; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; Levesque SA, 2010, EUR J IMMUNOL, V40, P1473, DOI 10.1002/eji.200939741; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nahrendorf M, 2010, CIRCULATION, V121, P2437, DOI 10.1161/CIRCULATIONAHA.109.916346; Novobrantseva TI, 2005, J CLIN INVEST, V115, P3072, DOI 10.1172/JCI24798; Ochoa MT, 2008, J INVEST DERMATOL, V128, P2225, DOI 10.1038/jid.2008.56; Pellegatti P, 2005, MOL BIOL CELL, V16, P3659, DOI 10.1091/mbc.E05-03-0222; Praetorius HA, 2009, PURINERG SIGNAL, V5, P433, DOI 10.1007/s11302-009-9146-2; Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; Romio M, 2011, AM J PHYSIOL-CELL PH, V301, pC530, DOI 10.1152/ajpcell.00385.2010; SALMON JE, 1990, J IMMUNOL, V145, P2235; Save S, 2011, INFECT IMMUN, V79, P3431, DOI 10.1128/IAI.05005-11; Schenk U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160583; Serra S, 2011, BLOOD, V118, P6141, DOI 10.1182/blood-2011-08-374728; Soos TJ, 2006, KIDNEY INT, V70, P591, DOI 10.1038/sj.ki.5001567; Tadagavadi RK, 2010, J AM SOC NEPHROL, V21, P53, DOI 10.1681/ASN.2009040407; van den Borne SWM, 2010, NAT REV CARDIOL, V7, P30, DOI 10.1038/nrcardio.2009.199; Wong CW, 2006, NAT MED, V12, P950, DOI 10.1038/nm1441; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429	44	78	81	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34730	10.1371/journal.pone.0034730	http://dx.doi.org/10.1371/journal.pone.0034730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514659	gold, Green Published			2022-12-27	WOS:000305341600065
J	De Boni, R; Silva, PLD; Bastos, FI; Pechansky, F; de Vasconcellos, MTL				De Boni, Raquel; do Nascimento Silva, Pedro Luis; Bastos, Francisco Inacio; Pechansky, Flavio; Leite de Vasconcellos, Mauricio Teixeira			Reaching the Hard-to-Reach: A Probability Sampling Method for Assessing Prevalence of Driving under the Influence after Drinking in Alcohol Outlets	PLOS ONE			English	Article							YOUNG-ADULTS; DRUG-USE; DENSITY; CONSUMPTION; BEHAVIORS; RISK; POPULATIONS; AVAILABILITY; NIGHTLIFE; ACCIDENTS	Drinking alcoholic beverages in places such as bars and clubs may be associated with harmful consequences such as violence and impaired driving. However, methods for obtaining probabilistic samples of drivers who drink at these places remain a challenge - since there is no a priori information on this mobile population - and must be continually improved. This paper describes the procedures adopted in the selection of a population-based sample of drivers who drank at alcohol selling outlets in Porto Alegre, Brazil, which we used to estimate the prevalence of intention to drive under the influence of alcohol. The sampling strategy comprises a stratified three-stage cluster sampling: 1) census enumeration areas (CEA) were stratified by alcohol outlets (AO) density and sampled with probability proportional to the number of AOs in each CEA; 2) combinations of outlets and shifts (COS) were stratified by prevalence of alcohol-related traffic crashes and sampled with probability proportional to their squared duration in hours; and, 3) drivers who drank at the selected COS were stratified by their intention to drive and sampled using inverse sampling. Sample weights were calibrated using a post-stratification estimator. 3,118 individuals were approached and 683 drivers interviewed, leading to an estimate that 56.3% (SE = 3,5%) of the drivers intended to drive after drinking in less than one hour after the interview. Prevalence was also estimated by sex and broad age groups. The combined use of stratification and inverse sampling enabled a good trade-off between resource and time allocation, while preserving the ability to generalize the findings. The current strategy can be viewed as a step forward in the efforts to improve surveys and estimation for hard-to-reach, mobile populations.	[De Boni, Raquel; Pechansky, Flavio] Univ Fed Rio Grande do Sul, Ctr Drug & Alcohol Res, Porto Alegre, RS, Brazil; [De Boni, Raquel; Pechansky, Flavio] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [do Nascimento Silva, Pedro Luis; Leite de Vasconcellos, Mauricio Teixeira] Brazilian Geog & Stat Inst, Natl Sch Stat, Rio De Janeiro, Brazil; [Bastos, Francisco Inacio] Fundacao Oswaldo Cruz, Dept Hlth Informat, Rio De Janeiro, Brazil; [Leite de Vasconcellos, Mauricio Teixeira] Fundacao Oswaldo Cruz, Evandro Chagas Clin Res Inst, Rio De Janeiro, Brazil	Universidade Federal do Rio Grande do Sul; Escola Nacional de Ciencias Estatisticas (ENCE); Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	De Boni, R (corresponding author), Univ Fed Rio Grande do Sul, Ctr Drug & Alcohol Res, Porto Alegre, RS, Brazil.	raqueldeboni@gmail.com	DE BONI, RAQUEL BRANDINI/D-4212-2013; Pechansky, Flavio/P-1629-2014	DE BONI, RAQUEL BRANDINI/0000-0002-2455-5997; Pechansky, Flavio/0000-0002-1994-9983; Bastos, Francisco/0000-0001-5970-8896	National Secretariat for Alcohol and Drug Policies [SENAD TC 004/2007]; FIPE/HCPA (Hospital de Clinicas de Porto Alegre) [GPPG 006-012]	National Secretariat for Alcohol and Drug Policies; FIPE/HCPA (Hospital de Clinicas de Porto Alegre)	The study was funded by National Secretariat for Alcohol and Drug Policies (SENAD TC 004/2007) and FIPE/HCPA (Hospital de Clinicas de Porto Alegre) (GPPG 006-012). FIB has long-term support from FAPERJ (Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro) for analyses on alcohol misuse and related harms. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JP, 1997, ALCOHOL CLIN EXP RES, V21, P613, DOI 10.1111/j.1530-0277.1997.tb03811.x; Babor TF, 2003, ALCOHOL NO ORDINARY; Bellis MA, 2010, SUBST ABUSE TREAT PR, V5, DOI 10.1186/1747-597X-5-5; Caetano R, 2006, ADDICTION, V101, P149, DOI [10.1111/j.1360-0443.2006.01334.x, 10.1111/j.1360-0443.2005.01334.x]; Calafat A, 2009, TRAFFIC INJ PREV, V10, P162, DOI 10.1080/15389580802597054; Campbell CA, 2009, AM J PREV MED, V37, P556, DOI 10.1016/j.amepre.2009.09.028; Chou SP, 2006, DRUG ALCOHOL DEPEN, V83, P137, DOI 10.1016/j.drugalcdep.2005.11.001; Cochran WG., 1963, SAMPLING TECHNIQUES; COLON I, 1983, AM J DRUG ALCOHOL AB, V9, P325, DOI 10.3109/00952998209002634; De Boni R, 2011, ACCID ANAL IN PRESS; De Boni R, 2010, ICADTS T2010 C OSL; De Boni R, 2008, REV SAUDE PUBL, V42; Duailibi S, 2007, REV SAUDE PUBL, V41, P1058, DOI 10.1590/S0034-89102006005000045; Fernandes M, 2010, ETHICAL LEGAL METHOD, P24; Furr-Holden D, 2006, DRUG ALCOHOL DEPEN, V85, P83, DOI 10.1016/j.drugalcdep.2006.03.012; GIBB KA, 1984, ANN EMERG MED, V13, P516, DOI 10.1016/S0196-0644(84)80517-X; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Goldim JR, 2011, CURR OPIN PSYCHIATR, V24, P181, DOI 10.1097/YCO.0b013e32834593bc; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; Gruenewald PJ, 2010, J STUD ALCOHOL DRUGS, V71, P237, DOI 10.15288/jsad.2010.71.237; Gruenewald PJ, 2002, J STUD ALCOHOL, V63, P460, DOI 10.15288/jsa.2002.63.460; Gruenewald PJ, 2002, ALCOHOL RES HEALTH, V26, P42; HALDANE JBS, 1945, BIOMETRIKA, V33, P222, DOI 10.1093/biomet/33.3.222; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Hingson R, 2003, ALCOHOL RES HEALTH, V27, P63; Laranjeira R, 2002, REV SAUDE PUBL, V36, P455, DOI 10.1590/S0034-89102002000400011; Laranjeira R, 2010, REV BRAS PSIQUIATR, V32, P231, DOI 10.1590/S1516-44462009005000012; Livingston M, 2007, DRUG ALCOHOL REV, V26, P557, DOI 10.1080/09595230701499191; lobal Road Safety P, 2007, ASS SIT CHOOS PRIOR, P26; Lomba L, 2009, ADICCIONES, V21, P309, DOI 10.20882/adicciones.222; Lumley T., 2010, COMPLEX SURVEYS GUID, DOI [10.1002/9780470580066, DOI 10.1002/9780470580066]; MacKellar D, 1996, PUBLIC HEALTH REP, V111, P138; Meliker JR, 2004, ACCIDENT ANAL PREV, V36, P1129, DOI 10.1016/j.aap.2004.06.002; Mendez E.B., 1999, VERSAO BRASILEIRA AU; Miller BA, 2009, J SUBST USE, V14, P19, DOI 10.1080/14659890802305887; Muhib FB, 2001, PUBLIC HEALTH REP, V116, P216, DOI 10.1093/phr/116.S1.216; Parsons JT, 2008, J DRUG ISSUES, V38, P1061, DOI 10.1177/002204260803800407; Pechansky F, 2009, REV BRAS PSIQUIATR, V31, P125, DOI 10.1590/S1516-44462009000200008; Ponce JD, 2011, ACCIDENT ANAL PREV, V43, P782, DOI 10.1016/j.aap.2010.10.025; Popova S, 2009, ALCOHOL ALCOHOLISM, V44, P500, DOI 10.1093/alcalc/agp054; Razatos G, 2005, FORENSIC SCI INT, V153, P17, DOI 10.1016/j.forsciint.2005.04.030; Modelli Manoel Eugenio dos Santos, 2008, Rev. Saúde Pública, V42, P350, DOI 10.1590/S0034-89102008005000012; Sarndal C.-E., 1992, MODEL ASSISTED SURVE; SCRIBNER RA, 1994, J STUD ALCOHOL, V55, P447, DOI 10.15288/jsa.1994.55.447; Shults RA, 2001, AM J PREV MED, V21, P66, DOI 10.1016/S0749-3797(01)00381-6; Siliquini R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-205; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; SUDMAN S, 1988, SCIENCE, V240, P991, DOI 10.1126/science.240.4855.991; Thompson SK, 2002, DRUG ALCOHOL DEPEN, V68, pS57; Treno AJ, 2003, ALCOHOL CLIN EXP RES, V27, P835, DOI 10.1097/01.ALC.0000067979.85714.22; Truong KD, 2009, AM J PUBLIC HEALTH, V99, P264, DOI 10.2105/AJPH.2007.122077; Valente TW, 2010, SOCIAL NETWORKS HLTH, DOI DOI 10.1093/ACPROF:OSO/9780195301014.001.0001/ACPROF-9780195301014; VANOERS JAM, 1993, J STUD ALCOHOL, V54, P739, DOI 10.15288/jsa.1993.54.739; Voas RB, 2006, EVALUATION REV, V30, P44, DOI 10.1177/0193841X05277285; Wells BE, 2010, AM J DRUG ALCOHOL AB, V36, P39, DOI 10.3109/00952990903544836; World Health Organization, 2011, GLOB STAT REP ALC HL; Zador PL, 2000, J STUD ALCOHOL, V61, P387, DOI 10.15288/jsa.2000.61.387	57	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34104	10.1371/journal.pone.0034104	http://dx.doi.org/10.1371/journal.pone.0034104			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UT	22514620	gold, Green Published			2022-12-27	WOS:000305341600025
J	Hosseinpoor, AR; Williams, JS; Amin, A; de Carvalho, IA; Beard, J; Boerma, T; Kowal, P; Naidoo, N; Chatterji, S				Hosseinpoor, Ahmad Reza; Williams, Jennifer Stewart; Amin, Avni; de Carvalho, Islene Araujo; Beard, John; Boerma, Ties; Kowal, Paul; Naidoo, Nirmala; Chatterji, Somnath			Social Determinants of Self-Reported Health in Women and Men: Understanding the Role of Gender in Population Health	PLOS ONE			English	Article							RATED HEALTH; DECOMPOSITION; DIFFERENTIALS; DISCRIMINATION; INEQUALITY; MORBIDITY; MORTALITY; BEHAVIOR	Background: Women and men share similar health challenges yet women report poorer health. The study investigates the social determinants of self-reported health in women and men, and male-female differences in health. Methods: Data on 103154 men and 125728 women were analysed from 57 countries in the World Health Survey 2002-2004. Item Response Theory was used to construct a composite measure of health. Associations between health and determinants were assessed using multivariate linear regression. Blinder-Oaxaca decomposition partitioned the inequality in health between women and men into an "explained" component that arises because men and women differ in social and economic characteristics, and an "unexplained" component due to the differential effects of these characteristics. Decomposition was repeated for 18 countries in the World Health Organization (WHO) African region and 19 countries in the WHO European region. Results: Women's health was significantly lower than men's. Health was associated with education, household economic status, employment, and marital status after controlling for age. In the pooled analysis decomposition showed that 30% of the inequality was "explained", of which almost 75% came from employment, education, marital status. The differential effects of being in paid employment increased the inequality. When countries in Africa and Europe were compared, the "explained" component (31% and 39% respectively) was largely attributed to the social determinants in the African countries and to women's longevity in the European countries. Being in paid employment had a greater positive effect on the health of males in both regions. Conclusions: Ways in which age and the social determinants contribute to the poorer health status of women compared with men varies between groups of countries. This study highlights the need for action to address social structures, institutional discrimination and harmful gender norms and roles that differently influence health with ageing.	[Hosseinpoor, Ahmad Reza; Boerma, Ties; Kowal, Paul; Naidoo, Nirmala; Chatterji, Somnath] World Hlth Org, Dept Hlth Stat & Informat Syst, Geneva, Switzerland; [Williams, Jennifer Stewart; Kowal, Paul] Univ Newcastle, Res Ctr Gender Hlth & Ageing, Fac Hlth, Newcastle, NSW 2300, Australia; [Amin, Avni; de Carvalho, Islene Araujo; Beard, John] World Hlth Org, Dept Gender Women & Hlth, Geneva, Switzerland	World Health Organization; University of Newcastle; World Health Organization	Hosseinpoor, AR (corresponding author), World Hlth Org, Dept Hlth Stat & Informat Syst, Geneva, Switzerland.	hosseinpoora@who.int	Hosseinpoor, Ahmad Reza/AFP-8422-2022; Beard, John R/K-9621-2014; CHATTERJI, Somnath/ABE-6832-2020; Beard, John/AAI-4592-2021	Hosseinpoor, Ahmad Reza/0000-0001-7322-672X; Beard, John R/0000-0002-8557-0242; Beard, John/0000-0002-8557-0242; Stewart Williams, Jennifer/0000-0001-6533-0762; Kowal, Paul/0000-0002-6314-8753; Naidoo, Navindhra/0000-0001-9142-3751	World Health Organization; United States of America, National Institutes of Health [1 R01 AG034479-01A1]; NATIONAL INSTITUTE ON AGING [R01AG034479] Funding Source: NIH RePORTER	World Health Organization(World Health Organization); United States of America, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by World Health Organization as well as the United States of America, National Institutes of Health grant 1 R01 AG034479-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulraheem IS, 2007, ANN AFR MED, V6, P58, DOI 10.4103/1596-3519.55715; [Anonymous], 2008, CLOS GAP GEN HLTH EQ; Asfar, 2007, BMC PUBLIC HLTH; Avila-Burgos L, 2005, SAUDI MED J, V26, P1617; Ayuso-Mateos JL, 2010, BRIT J PSYCHIAT, V196, P365, DOI 10.1192/bjp.bp.109.071191; Chatterji S, 2008, HEALTH AFFAIR, V27, P1052, DOI 10.1377/hlthaff.27.4.1052; COTTON J, 1988, REV ECON STAT, V70, P236, DOI 10.2307/1928307; Ferguson B, 2003, HLTH SYSTEMS PERFORM; Frankenberg E, 2004, J HEALTH SOC BEHAV, V45, P441, DOI 10.1177/002214650404500406; Gakidou E, 2007, JAMA-J AM MED ASSOC, V298, P1876, DOI 10.1001/jama.298.16.1876; Hosseinpoor AR, 2005, B WORLD HEALTH ORGAN, V83, P837; Jann B, 2008, STATA J, V8, P453, DOI 10.1177/1536867X0800800401; Kaleta D, 2008, INT J OCCUP MED ENV, V21, P227, DOI 10.2478/v10001-008-0023-y; Koch-Weser S, 2006, J HEALTH CARE POOR U, V17, P133, DOI 10.1353/hpu.2006.0076; Krochalk PC, 2008, AUSTRALAS J AGEING, V27, P26, DOI 10.1111/j.1741-6612.2007.00269.x; Liu H, 2008, J HEALTH SOC BEHAV, V49, P239, DOI 10.1177/002214650804900301; Mendoza-Sassi RA, 2007, CAD SAUDE PUBLICA, V23, P341, DOI 10.1590/S0102-311X2007000200010; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; NEUMARK D, 1988, J HUM RESOUR, V23, P279, DOI 10.2307/145830; Oaxaca RL, 1973, INT ECON REV, V14, P693; REIMERS CW, 1983, REV ECON STAT, V65, P570, DOI 10.2307/1935925; Sen G, 2008, Glob Public Health, V3 Suppl 1, P1, DOI 10.1080/17441690801900795; Sen G., 2007, UNEQUAL UNFAIR INEFF; Szwarcwald Célia Landmann, 2005, Cad. Saúde Pública, V21, pS54, DOI 10.1590/S0102-311X2005000700007; UN Women, 2010, CONS COSTS; Ustun T, 2003, HLTH SYSTEMS PERFORM; WHO (World Health Organization), 2010, EQ SOC DET PUBL HLTH; Williams JAS, 2009, SOC SCI MED, V69, P1072, DOI 10.1016/j.socscimed.2009.07.012; Wilson M, 2006, HEALTH EDUC RES, V21, P19, DOI 10.1093/her/cyl053; World Bank, 2011, WORLD DEVELOPMENT REPORT 2011: CONFLICT, SECURITY AND DEVELOPMENT, P1, DOI 10.1596/978-0-8213-8439-8; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1	31	76	78	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34799	10.1371/journal.pone.0034799	http://dx.doi.org/10.1371/journal.pone.0034799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UT	22514667	Green Published, gold			2022-12-27	WOS:000305341600073
J	Muentener, P; Bonawitz, E; Horowitz, A; Schulz, L				Muentener, Paul; Bonawitz, Elizabeth; Horowitz, Alexandra; Schulz, Laura			Mind the Gap: Investigating Toddlers' Sensitivity to Contact Relations in Predictive Events	PLOS ONE			English	Article							GOAL ATTRIBUTION; INFANTS; CAUSALITY; PERCEPTION; CHILDREN; OBJECTS; AGENT	Toddlers readily learn predictive relations between events (e.g., that event A predicts event B). However, they intervene on A to try to cause B only in a few contexts: When a dispositional agent initiates the event or when the event is described with causal language. The current studies look at whether toddlers' failures are due merely to the difficulty of initiating interventions or to more general constraints on the kinds of events they represent as causal. Toddlers saw a block slide towards a base, but an occluder prevented them from seeing whether the block contacted the base; after the block disappeared behind the occluder, a toy connected to the base did or did not activate. We hypothesized that if toddlers construed the events as causal, they would be sensitive to the contact relations between the participants in the predictive event. In Experiment 1, the block either moved spontaneously (no dispositional agent) or emerged already in motion (a dispositional agent was potentially present). Toddlers were sensitive to the contact relations only when a dispositional agent was potentially present. Experiment 2 confirmed that toddlers inferred a hidden agent was present when the block emerged in motion. In Experiment 3, the block moved spontaneously, but the events were described either with non-causal ("here's my block") or causal ("the block can make it go") language. Toddlers were sensitive to the contact relations only when given causal language. These findings suggest that dispositional agency and causal language facilitate toddlers' ability to represent causal relationships.	[Muentener, Paul; Schulz, Laura] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Bonawitz, Elizabeth] Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; [Horowitz, Alexandra] Stanford Univ, Dept Psychol, Palo Alto, CA 94304 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; Stanford University	Muentener, P (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	pmuenten@mit.edu			John Templeton Foundation [12667]; James S. McDonnell Foundation; National Science Foundation [0744213]	John Templeton Foundation; James S. McDonnell Foundation; National Science Foundation(National Science Foundation (NSF))	This research was supported by grants from the John Templeton Foundation (# 12667) and the James S. McDonnell Foundation Causal Learning Collaborative to LS, as well as an National Science Foundation Career Award (# 0744213) to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILLARGEON R, 1990, COGNITION, V36, P255, DOI 10.1016/0010-0277(90)90059-S; Ball W. A., 1973, M SOC RES CHILD DEV; Blakemore SJ, 2001, NEUROREPORT, V12, P3741, DOI 10.1097/00001756-200112040-00027; Bonawitz EB, 2010, COGNITION, V115, P104, DOI 10.1016/j.cognition.2009.12.001; Bullock M., 1982, DEV PSYCHOL TIME; Csibra G, 1999, COGNITION, V72, P237, DOI 10.1016/S0010-0277(99)00039-6; DIAMOND A, 1989, EXP BRAIN RES, V74, P24; Glymour Clark, 2001, CAUSATION PREDICTION; Gopnik A, 2004, PSYCHOL REV, V111, P3, DOI 10.1037/0033-295X.111.1.3; Gopnik A, 2004, TRENDS COGN SCI, V8, P371, DOI 10.1016/j.tics.2004.06.005; Gopnik A., 2007, CAUSAL LEARNING; Haith M, 1998, INFANT BEHAV DEV, V21, P167, DOI 10.1016/S0163-6383(98)90001-7; Johnson S, 1998, DEVELOPMENTAL SCI, V1, P233, DOI 10.1111/1467-7687.00036; Kidd C, 2010, P 32 ANN M COGN SCI; Kotovsky L, 2000, DEVELOPMENTAL SCI, V3, P344, DOI 10.1111/1467-7687.00129; LESLIE AM, 1987, COGNITION, V25, P265, DOI 10.1016/S0010-0277(87)80006-9; LESLIE AM, 1984, PERCEPTION, V13, P287, DOI 10.1068/p130287; Luo YY, 2009, COGNITIVE PSYCHOL, V58, P441, DOI 10.1016/j.cogpsych.2008.11.001; Meltzoff A, 2007, HARV U PRESRCD M CAM; MELTZOFF AN, 1995, DEV PSYCHOL, V31, P838, DOI 10.1037/0012-1649.31.5.838; Michotte A, 1947, PERCEPTION CAUSALITY; Movellan JR, 2002, 2ND INTERNATIONAL CONFERENCE ON DEVELOPMENT AND LEARNING, PROCEEDINGS, P34, DOI 10.1109/DEVLRN.2002.1011728; Muentener P, 2012, LANG LEARN DEV, V8, P61, DOI 10.1080/15475441.2011.616455; Muentener P, 2010, COGNITIVE PSYCHOL, V61, P63, DOI 10.1016/j.cogpsych.2010.02.001; Munakata Y, 2001, TRENDS COGN SCI, V5, P309, DOI 10.1016/S1364-6613(00)01682-X; OAKES LM, 1990, COGNITIVE DEV, V5, P193, DOI 10.1016/0885-2014(90)90026-P; Saxe R, 2005, PSYCHOL SCI, V16, P995, DOI 10.1111/j.1467-9280.2005.01649.x; Saxe R, 2007, DEV PSYCHOL, V43, P149, DOI 10.1037/0012-1649.43.1.149; Saxe R, 2006, ACTA PSYCHOL, V123, P144, DOI 10.1016/j.actpsy.2006.05.005; Schlottmann A, 1999, PERCEPTION, V28, P1105, DOI 10.1068/p2767; Schlottmann A, 2000, TRENDS COGN SCI, V4, P441, DOI 10.1016/S1364-6613(00)01555-2; Schlottmann A, 2010, DEVELOPMENTAL SCI, V13, P1, DOI 10.1111/j.1467-7687.2009.00854.x; Schlottmann A, 2009, J EXP CHILD PSYCHOL, V103, P87, DOI 10.1016/j.jecp.2008.09.003; Scholl BJ, 2000, TRENDS COGN SCI, V4, P299, DOI 10.1016/S1364-6613(00)01506-0; Schulz L, 2007, CAUSAL LEARNING; Schulz LE, 2007, DEVELOPMENTAL SCI, V10, P322, DOI 10.1111/j.1467-7687.2007.00587.x; Shimizu YA, 2004, DEVELOPMENTAL SCI, V7, P425, DOI 10.1111/j.1467-7687.2004.00362.x; SHULTZ TR, 1982, MONOGR SOC RES CHILD, V47, P1, DOI 10.2307/1165893; Sperber D., 1995, CAUSAL COGNITION MUL; Thelen E., 1994, DYNAMIC SYSTEMS APPR; Woodward A, 1993, P 15 ANN M COGN SCI; Woodward J., 2007, CAUSAL LEARNING PSYC, P19, DOI DOI 10.1093/ACPROF:OSO/9780195176803.003.0002; Woodward James, 2005, MAKING THINGS HAPPEN	44	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34061	10.1371/journal.pone.0034061	http://dx.doi.org/10.1371/journal.pone.0034061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959UT	22514616	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600021
J	Roesler, J; Segerer, F; Morbach, H; Kleinert, S; Thieme, S; Rosen-Wolff, A; Liese, JG				Roesler, Joachim; Segerer, Florian; Morbach, Henner; Kleinert, Stefan; Thieme, Sebastian; Roesen-Wolff, Angela; Liese, Johannes G.			P67-phox (NCF2) Lacking Exons 11 and 12 Is Functionally Active and Leads to an Extremely Late Diagnosis of Chronic Granulomatous Disease (CGD)	PLOS ONE			English	Article							NADPH OXIDASE; EUROPEAN EXPERIENCE; INTERFERON-GAMMA; GENE; P67(PHOX); REGION; PROPHYLAXIS; INFECTION; MUTATION	Two brothers in their fifties presented with a medical history of suspected fungal allergy, allergic bronchopulmonary aspergillosis, alveolitis, and invasive aspergillosis and pulmonary fistula, respectively. Eventually, after a delay of 50 years, chronic granulomatous disease (CGD) was diagnosed in the index patient. We found a new splice mutation in the NCF2 (p67-phox) gene, c.1000+2T -> G, that led to several splice products one of which lacked exons 11 and 12. This deletion was in frame and allowed for remarkable residual NADPH oxidase activity as determined by transduction experiments using a retroviral vector. We conclude that p67-phox which lacks the 34 amino acids encoded by the two exons can still exert considerable functional activity. This activity can partially explain the long-term survival of the patients without adequate diagnosis and treatment, but could not prevent progressing lung damage.	[Roesler, Joachim; Thieme, Sebastian; Roesen-Wolff, Angela] Univ Hosp Carl Gustav Carus, Dept Pediat, Dresden, Germany; [Segerer, Florian; Morbach, Henner; Liese, Johannes G.] Univ Hosp Wuerzburg, Dept Pediat, Wurzburg, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of Wurzburg	Roesler, J (corresponding author), Univ Hosp Carl Gustav Carus, Dept Pediat, Dresden, Germany.	roeslerj@rcs.urz.tu-dresden.de		Kleinert, Stefan/0000-0002-2588-7547				Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897; Condino-Neto A, 2000, BLOOD, V95, P3548, DOI 10.1182/blood.V95.11.3548.011k36_3548_3554; Foster CB, 1998, J CLIN INVEST, V102, P2146, DOI 10.1172/JCI5084; Gentsch M, 2010, HUM MUTAT, V31, P151, DOI 10.1002/humu.21156; Grizot S, 2001, J BIOL CHEM, V276, P21627, DOI 10.1074/jbc.M100893200; Isman-Nelkenbaum G, 2011, CLIN EXP DERMATOL; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-178; Kuhns DB, 2010, NEW ENGL J MED, V363, P2600, DOI 10.1056/NEJMoa1007097; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Leto Thomas L., 2007, V412, P365, DOI 10.1007/978-1-59745-467-4_24; Liese J, 2000, J PEDIATR-US, V137, P687, DOI 10.1067/mpd.2000.109112; Liese JG, 1996, LANCET, V347, P220, DOI 10.1016/S0140-6736(96)90403-1; Lun A, 2002, CLIN CHEM, V48, P780; MARGOLIS DM, 1990, J INFECT DIS, V162, P723, DOI 10.1093/infdis/162.3.723; Mauch L, 2007, CLIN CHEM, V53, P890, DOI 10.1373/clinchem.2006.083444; Mizuki K, 2005, ARCH BIOCHEM BIOPHYS, V444, P185, DOI 10.1016/j.abb.2005.10.012; MOUY R, 1994, J PEDIATR-US, V125, P998, DOI 10.1016/S0022-3476(05)82023-2; Roesler J, 2000, BLOOD, V95, P2150, DOI 10.1182/blood.V95.6.2150; Roesler J, 2005, J EVAL CLIN PRACT, V11, P513, DOI 10.1111/j.1365-2753.2005.00584.x; Roesler J, 2002, BLOOD, V100, P4381, DOI 10.1182/blood-2001-12-0165; Roos D, 2010, BLOOD CELL MOL DIS, V45, P246, DOI 10.1016/j.bcmd.2010.07.012; Roos D, 2010, BLOOD CELL MOL DIS, V44, P291, DOI 10.1016/j.bcmd.2010.01.009; Rosen-Wolff A, 2001, ANN HEMATOL, V80, P113, DOI 10.1007/s002770000230; Ryser MF, 2007, EXPERT OPIN BIOL TH, V7, P1799, DOI 10.1517/14712598.7.12.1799; SCHAPIRO BL, 1991, NEW ENGL J MED, V325, P1786, DOI 10.1056/NEJM199112193252506; Schuetz C, 2006, EUR J PEDIAT; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Seger RA, 2002, BLOOD, V100, P4344, DOI 10.1182/blood-2002-02-0583; Seger RA, 2010, IMMUNOL ALLERGY CLIN, V30, P195, DOI 10.1016/j.iac.2010.01.003; The International Chronic Granulomatous Disease Cooperative Study Group, 1991, N ENGL J MED, V324, P509; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Yamada M, 2000, BRIT J HAEMATOL, V108, P511, DOI 10.1046/j.1365-2141.2000.01857.x	33	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34296	10.1371/journal.pone.0034296	http://dx.doi.org/10.1371/journal.pone.0034296			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514628	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600033
J	Ruan, JB; Ouyang, H; Amaya, MF; Ravichandran, M; Loppnau, P; Min, JR; Zang, JY				Ruan, Jianbin; Ouyang, Hui; Amaya, Maria F.; Ravichandran, Mani; Loppnau, Peter; Min, Jinrong; Zang, Jianye			Structural Basis of the Chromodomain of Cbx3 Bound to Methylated Peptides from Histone H1 and G9a	PLOS ONE			English	Article							HETEROCHROMATIN PROTEIN-1; DNA METHYLATION; HP1; COMPLEX; RECOGNITION; BINDING; H3; SPECIFICITY; METHYLTRANSFERASE; TRANSCRIPTION	Background: HP1 proteins are highly conserved heterochromatin proteins, which have been identified to be structural adapters assembling a variety of macromolecular complexes involved in regulation of gene expression, chromatin remodeling and heterochromatin formation. Much evidence shows that HP1 proteins interact with numerous proteins including methylated histones, histone methyltransferases and so on. Cbx3 is one of the paralogues of HP1 proteins, which has been reported to specifically recognize trimethylated histone H3K9 mark, and a consensus binding motif has been defined for the Cbx3 chromodomain. Methodology/Principal Findings: Here, we found that the Cbx3 chromodomain can bind to H1K26me2 and G9aK185me3 with comparable binding affinities compared to H3K9me3. We also determined the crystal structures of the human Cbx3 chromodomain in complex with dimethylated histone H1K26 and trimethylated G9aK185 peptides, respectively. The complex structures unveil that the Cbx3 chromodomain specifically bind methylated histone H1K26 and G9aK185 through a conserved mechanism. Conclusions/Significance: The Cbx3 chromodomain binds with comparable affinities to all of the methylated H3K9, H1K26 and G9aK185 peptides. It is suggested that Cbx3 may regulate gene expression via recognizing both histones and nonhistone proteins.	[Ruan, Jianbin; Zang, Jianye] Univ Sci & Technol China, Hefei Natl Lab Phys Sci, Hefei 230026, Anhui, Peoples R China; [Ruan, Jianbin; Zang, Jianye] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Ruan, Jianbin; Zang, Jianye] Chinese Acad Sci, Key Lab Struct Biol, Hefei, Anhui, Peoples R China; [Ouyang, Hui; Amaya, Maria F.; Ravichandran, Mani; Loppnau, Peter; Min, Jinrong] Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada; [Min, Jinrong] Univ Toronto, Dept Physiol, Toronto, ON, Canada	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Toronto; Structural Genomics Consortium; University of Toronto	Ruan, JB (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci, Hefei 230026, Anhui, Peoples R China.	jr.min@utoronto.ca; zangjy@ustc.edu.cn	Zang, Jianye/E-5228-2013; Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130; Ruan, Jianbin/0000-0001-5843-8273	Chinese Ministry of Science and Technology [2009CB825502]; National Natural Science Foundation of China [31171241, 30970576]; "100 Talents Program'' of the Chinese Academy of Sciences; Structural Genomics Consortium [1097737]; Canadian Institutes for Health Research; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institute; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "100 Talents Program'' of the Chinese Academy of Sciences(Chinese Academy of Sciences); Structural Genomics Consortium(University of Toronto); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institute(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome Trust)	This work was supported by the grant from the Chinese Ministry of Science and Technology (No. 2009CB825502), the grants from National Natural Science Foundation of China (Nos. 31171241 and 30970576) and "100 Talents Program'' of the Chinese Academy of Sciences to JZ. This research was also supported by the Structural Genomics Consortium, a registered charity (number 1097737) [that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institute, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research] and the Wellcome Trust to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsztein AM, 1998, J CELL BIOL, V143, P1763, DOI 10.1083/jcb.143.7.1763; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Canzio D, 2011, MOL CELL, V41, P67, DOI 10.1016/j.molcel.2010.12.016; Chin HG, 2007, NUCLEIC ACIDS RES, V35, P7313, DOI 10.1093/nar/gkm726; Cowell IG, 2002, CHROMOSOMA, V111, P22, DOI 10.1007/s00412-002-0182-8; Daujat S, 2005, J BIOL CHEM, V280, P38090, DOI 10.1074/jbc.C500229200; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Eissenberg JC, 2000, CURR OPIN GENET DEV, V10, P204, DOI 10.1016/S0959-437X(00)00058-7; El Gazzar M, 2008, J BIOL CHEM, V283, P32198, DOI 10.1074/jbc.M803446200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Fujita N, 2003, J BIOL CHEM, V278, P24132, DOI 10.1074/jbc.M302283200; Garcia BA, 2004, J PROTEOME RES, V3, P1219, DOI 10.1021/pr0498887; Haldar S, 2011, J BIOL CHEM, V286, P9308, DOI 10.1074/jbc.M110.143198; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Honda S, 2008, MOL CELL BIOL, V28, P6044, DOI 10.1128/MCB.00823-08; Huang Y, 2006, STRUCTURE, V14, P703, DOI 10.1016/j.str.2006.01.007; Inoue A, 2008, MUTAT RES-GEN TOX EN, V657, P48, DOI 10.1016/j.mrgentox.2008.08.010; Izzo A, 2008, BIOL CHEM, V389, P333, DOI 10.1515/BC.2008.037; Jones DO, 2000, BIOESSAYS, V22, P124, DOI 10.1002/(SICI)1521-1878(200002)22:2&lt;124::AID-BIES4&gt;3.0.CO;2-E; Kaustov L, 2011, J BIOL CHEM, V286, P521, DOI 10.1074/jbc.M110.191411; Kim H, 2011, NUCLEIC ACIDS RES, V39, P8329, DOI 10.1093/nar/gkr529; Kiyomitsu T, 2010, J CELL BIOL, V188, P791, DOI 10.1083/jcb.200908096; Kourmouli N, 2000, EMBO J, V19, P6558, DOI 10.1093/emboj/19.23.6558; Kuzmichev A, 2004, MOL CELL, V14, P183, DOI 10.1016/S1097-2765(04)00185-6; Kwon SH, 2011, BIOESSAYS, V33, P280, DOI 10.1002/bies.201000138; Li J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025104; Lu AP, 2009, J PROTEOME RES, V8, P4207, DOI 10.1021/pr9000652; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nielsen AL, 2001, MOL CELL, V7, P729, DOI 10.1016/S1097-2765(01)00218-0; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PARO R, 1991, P NATL ACAD SCI USA, V88, P263, DOI 10.1073/pnas.88.1.263; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Piacentini L, 2010, FLY, V4, P299, DOI 10.4161/fly.4.4.13261; Shareef MM, 2001, MOL BIOL CELL, V12, P1671, DOI 10.1091/mbc.12.6.1671; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Xu C, 2008, STRUCTURE, V16, P1740, DOI 10.1016/j.str.2008.08.008; Xu C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1237; Xu C, 2010, P NATL ACAD SCI USA, V107, P19266, DOI 10.1073/pnas.1008937107; Yamamoto K, 2003, BIOCHEM BIOPH RES CO, V301, P287, DOI 10.1016/S0006-291X(02)03021-8; Yap KL, 2011, BIOCHEMISTRY-US, V50, P1966, DOI 10.1021/bi101885m; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983	48	25	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35376	10.1371/journal.pone.0035376	http://dx.doi.org/10.1371/journal.pone.0035376			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514736	gold, Green Published, Green Submitted			2022-12-27	WOS:000305341600141
J	Snell-Rood, EC; Moczek, AP				Snell-Rood, Emilie C.; Moczek, Armin P.			Insulin Signaling as a Mechanism Underlying Developmental Plasticity: The Role of FOXO in a Nutritional Polyphenism	PLOS ONE			English	Article							ALTERNATIVE REPRODUCTIVE TACTICS; ONTHOPHAGUS-TAURUS COLEOPTERA; HORN LENGTH DIMORPHISM; DIVISION-OF-LABOR; BODY-SIZE; LIFE-SPAN; DROSOPHILA-MELANOGASTER; SEXUAL-DIMORPHISM; STATIC ALLOMETRY; GENE-EXPRESSION	We investigated whether insulin signaling, known to mediate physiological plasticity in response to changes in nutrition, also facilitates discrete phenotypic responses such as polyphenisms. We test the hypothesis that the gene FOXO - which regulates growth arrest under nutrient stress - mediates a nutritional polyphenism in the horned beetle, Onthophagus nigriventris. Male beetles in the genus Onthophagus vary their mating strategy with body size: large males express horns and fight for access to females while small males invest heavily in genitalia and sneak copulations with females. Given that body size and larval nutrition are linked, we predicted that 1) FOXO expression would differentially scale with body size (nutritional status) between males and females, and 2) manipulation of FOXO expression would affect the nutritional polyphenism in horns and genitalia. First, we found that FOXO expression varied with body size in a tissue-and sex-specific manner, being more highly expressed in the abdominal tissue of large (horned) males, in particular in regions associated with genitalia development. Second, we found that knockdown of FOXO through RNA-interference resulted in the growth of relatively larger copulatory organs compared to control-injected individuals and significant, albeit modest, increases in relative horn length. Our results support the hypothesis that FOXO expression in the abdominal tissue limits genitalia growth, and provides limited support for the hypothesis that FOXO regulates relative horn length through direct suppression of horn growth. Both results support the idea that tissue-specific FOXO expression may play a general role in regulating scaling relationships in nutritional polyphenisms by signaling traits to be relatively smaller.	[Snell-Rood, Emilie C.; Moczek, Armin P.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Snell-Rood, Emilie C.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Indiana University System; Indiana University Bloomington; University of Minnesota System; University of Minnesota Twin Cities	Snell-Rood, EC (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	emilies@umn.edu			NIH NRSA [F32GM083830]; National Science Foundation [IOS 0820411, IOS 0718522]; METACyt Initiative of Indiana University; Lilly Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM083830] Funding Source: NIH RePORTER	NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); METACyt Initiative of Indiana University; Lilly Endowment; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ESR was supported by NIH NRSA F32GM083830. Additional support was provided by National Science Foundation grant IOS 0820411 and IOS 0718522 to APM. The Center for Genomics and Bioinformatics (where qPCR analyses were run) is funded in part by the METACyt Initiative of Indiana University, which is funded in part through a major grant from the Lilly Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Aubin-Horth N, 2004, EVOLUTION, V58, P136; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Becker T, 2010, NATURE, V463, P369, DOI 10.1038/nature08698; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Bonduriansky R, 2007, AM NAT, V169, P9, DOI 10.1086/510214; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Corona M, 2007, P NATL ACAD SCI USA, V104, P7128, DOI 10.1073/pnas.0701909104; de Azevedo SV, 2008, J INSECT PHYSIOL, V54, P1064, DOI 10.1016/j.jinsphys.2008.04.009; De Moed GH, 1999, J EVOLUTION BIOL, V12, P852, DOI 10.1046/j.1420-9101.1999.00103.x; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Eberhard WG, 2009, EVOLUTION, V63, P48, DOI 10.1111/j.1558-5646.2008.00528.x; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Emlen DJ, 2006, HEREDITY, V97, P179, DOI 10.1038/sj.hdy.6800868; Emlen DJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P335, DOI 10.1007/s002650050393; Emlen DJ, 1999, J INSECT PHYSIOL, V45, P45, DOI 10.1016/S0022-1910(98)00096-1; EMLEN DJ, 1994, P ROY SOC B-BIOL SCI, V256, P131, DOI 10.1098/rspb.1994.0060; Emlen DJ, 2001, SCIENCE, V291, P1534, DOI 10.1126/science.1056607; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Gershman B, 2007, PHYSIOL GENOMICS, V29, P24, DOI 10.1152/physiolgenomics.00061.2006; Giannakou ME, 2004, SCIENCE, V305, P361, DOI 10.1126/science.1098219; Gilbert S. F., 2009, ECOLOGICAL DEV BIOL; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Harvey KF, 2008, J CELL BIOL, V180, P691, DOI 10.1083/jcb.200710100; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Iga M, 2011, PEPTIDES, V32, P531, DOI 10.1016/j.peptides.2010.10.033; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Kijimoto T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-504; Kramer Jamie M, 2003, BMC Dev Biol, V3, P5, DOI 10.1186/1471-213X-3-5; LABARBERA M, 1989, ANNU REV ECOL SYST, V20, P97, DOI 10.1146/annurev.es.20.110189.000525; MCARDLE BH, 1988, CAN J ZOOL, V66, P2329, DOI 10.1139/z88-348; McCairns RJS, 2010, EVOLUTION, V64, P1029, DOI 10.1111/j.1558-5646.2009.00886.x; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Miyakawa H, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-45; Moczek AP, 2003, EVOL DEV, V5, P259, DOI 10.1046/j.1525-142X.2003.03033.x; Moczek AP, 2005, EVOL DEV, V7, P175, DOI 10.1111/j.1525-142X.2005.05020.x; Moczek AP, 2000, ANIM BEHAV, V59, P459, DOI 10.1006/anbe.1999.1342; Moczek AP, 2004, AM NAT, V163, P184, DOI 10.1086/381741; Moczek AP, 2002, EVOL DEV, V4, P252, DOI 10.1046/j.1525-142X.2002.02014.x; Moczek AP, 1999, J EVOLUTION BIOL, V12, P27, DOI 10.1046/j.1420-9101.1999.00004.x; Moczek AP, 2006, AM NAT, V168, P711, DOI 10.1086/509051; Moczek AP, 2006, DEV GENES EVOL, V216, P655, DOI 10.1007/s00427-006-0087-2; Moczek AP, 2009, P NATL ACAD SCI USA, V106, P8992, DOI 10.1073/pnas.0809668106; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; Nijhout HF, 2002, P NATL ACAD SCI USA, V99, P15446, DOI 10.1073/pnas.242548399; O'Donnell S, 1998, ANNU REV ENTOMOL, V43, P323, DOI 10.1146/annurev.ento.43.1.323; Oostra V, 2011, P ROY SOC B-BIOL SCI, V278, P789, DOI 10.1098/rspb.2010.1560; Parthasarathy R, 2011, INSECT BIOCHEM MOLEC, V41, P294, DOI 10.1016/j.ibmb.2011.01.006; Parzer HF, 2008, EVOLUTION, V62, P2423, DOI 10.1111/j.1558-5646.2008.00448.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Shafiei M, 2001, PHYSIOL ENTOMOL, V26, P173, DOI 10.1046/j.1365-3032.2001.00231.x; Shingleton AW, 2007, BIOESSAYS, V29, P536, DOI 10.1002/bies.20584; Shingleton AW, 2005, PLOS BIOL, V3, P1607, DOI 10.1371/journal.pbio.0030289; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; Simmons LW, 1999, P ROY SOC B-BIOL SCI, V266, P145, DOI 10.1098/rspb.1999.0614; Smith CR, 2008, NAT REV GENET, V9, P735, DOI 10.1038/nrg2429; Snell-Rood EC, 2013, ANIMAL CONTESTS, P178; Snell-Rood EC, 2011, EVOLUTION, V65, P231, DOI 10.1111/j.1558-5646.2010.01106.x; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Tang HY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002373; Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Toth AL, 2007, SCIENCE, V318, P441, DOI 10.1126/science.1146647; van der Heide LP, 2004, BIOCHEM J, V380, P297, DOI 10.1042/BJ20040167; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang H, 2009, P NATL ACAD SCI USA, V106, P19617, DOI 10.1073/pnas.0905083106	74	48	48	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e34857	10.1371/journal.pone.0034857	http://dx.doi.org/10.1371/journal.pone.0034857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514679	Green Submitted, gold, Green Published			2022-12-27	WOS:000305341600085
J	Wang, Q; Feng, H; Zheng, PL; Shen, BR; Chen, L; Liu, L; Liu, X; Hao, QS; Wang, SC; Chen, JG; Teng, JL				Wang, Qiao; Feng, Hui; Zheng, Pengli; Shen, Birong; Chen, Liang; Liu, Lin; Liu, Xiao; Hao, Qingsong; Wang, Shunchang; Chen, Jianguo; Teng, Junlin			The Intracellular Transport and Secretion of Calumenin-1/2 in Living Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; CYTOPLASMIC DYNEIN; SARCOPLASMIC-RETICULUM; CA2+-BINDING PROTEIN; GOLGI TRANSPORT; COATED VESICLES; BULK FLOW; KINESIN; ER; MEMBRANE	Calumenin isoforms 1 and 2 (calu-1/2), encoded by the CALU gene, belong to the CREC protein family. Calu-1/2 proteins are secreted into the extracellular space, but the secretory process and regulatory mechanism are largely unknown. Here, using a time-lapse imaging system, we visualized the intracellular transport and secretory process of calu-1/2-EGFP after their translocation into the ER lumen. Interestingly, we observed that an abundance of calu-1/2-EGFP accumulated in cellular processes before being released into the extracellular space, while only part of calu-1/2-EGFP proteins were secreted directly after attaching to the cell periphery. Moreover, we found the secretion of calu-1/2-EGFP required microtubule integrity, and that calu-1/2-EGFP-containing vesicles were transported by the motor proteins Kif5b and cytoplasmic dynein. Finally, we determined the export signal of calu-1/2-EGFP (amino acid positions 20-46) and provided evidence that the asparagine at site 131 was indispensable for calu-1/2-EGFP stabilization. Taken together, we provide a detailed picture of the intracellular transport of calu-1/2-EGFP, which facilitates our understanding of the secretory mechanism of calu-1/2.	[Wang, Qiao; Feng, Hui; Zheng, Pengli; Shen, Birong; Chen, Liang; Liu, Lin; Liu, Xiao; Hao, Qingsong; Wang, Shunchang; Chen, Jianguo; Teng, Junlin] Peking Univ, State Key Lab Biomembrane & Membrane Bioengn, Minist Educ, Coll Life Sci, Beijing 100871, Peoples R China; [Wang, Qiao; Feng, Hui; Zheng, Pengli; Shen, Birong; Chen, Liang; Liu, Lin; Liu, Xiao; Hao, Qingsong; Wang, Shunchang; Chen, Jianguo; Teng, Junlin] Peking Univ, Key Lab Cell Proliferat & Differentiat, Minist Educ, Coll Life Sci, Beijing 100871, Peoples R China; [Chen, Jianguo] Peking Univ, Ctr Theoret Biol, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Wang, Q (corresponding author), Peking Univ, State Key Lab Biomembrane & Membrane Bioengn, Minist Educ, Coll Life Sci, Beijing 100871, Peoples R China.	junlinteng@pku.edu.cn	Chen, Liangyi/F-1352-2010	Chen, Liangyi/0000-0003-1270-7321; Wang, Qiao/0000-0001-6416-1733; Zheng, Pengli/0000-0002-3797-4023	Major State Basic Research Development Program of China (973 Program) [2010CB833705]; National Natural Science Foundation of China [30971433, 31071177]	Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Major State Basic Research Development Program of China (973 Program)(2010CB833705) and the National Natural Science Foundation of China (30971433, 31071177). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki Y, 2007, EMBO J, V26, P1475, DOI 10.1038/sj.emboj.7601609; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; BURGOYNE RD, 1987, BIOSCIENCE REP, V7, P281, DOI 10.1007/BF01121449; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Ding C, 2009, J CELL SCI, V122, P2820, DOI 10.1242/jcs.048777; Fu W, J CELL SCI, V123, P3645; Grigoriev I, 2008, CURR BIOL, V18, P177, DOI 10.1016/j.cub.2007.12.050; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Hansen GAW, 2009, MOL CELL BIOCHEM, V320, P25, DOI 10.1007/s11010-008-9895-1; HENDRICKS AG, 2010, CURR BIOL; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485; Honore B, 2000, FEBS LETT, V466, P11, DOI 10.1016/S0014-5793(99)01780-9; Honore B, 2009, BIOESSAYS, V31, P262, DOI 10.1002/bies.200800186; Hseu MJ, 1999, FEBS LETT, V445, P440, DOI 10.1016/S0014-5793(99)00177-5; Jaulin F, 2007, DEV CELL, V13, P511, DOI 10.1016/j.devcel.2007.08.001; Jung DH, 2006, BIOCHEM BIOPH RES CO, V343, P34, DOI 10.1016/j.bbrc.2006.02.115; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Lansbergen G, 2006, DEV CELL, V11, P21, DOI 10.1016/j.devcel.2006.05.012; Li HH, 2006, J CELL SCI, V119, P4452, DOI 10.1242/jcs.03219; Malkus P, 2002, J CELL BIOL, V159, P915, DOI 10.1083/jcb.200208074; Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X; MEYER DI, 1979, FEBS LETT, V101, P129, DOI 10.1016/0014-5793(79)81310-1; Mili S, 2008, NATURE, V453, P115, DOI 10.1038/nature06888; Ostergaard M, 2006, PROTEOMICS, V6, P3509, DOI 10.1002/pmic.200500686; Polishchuk EV, 2003, MOL BIOL CELL, V14, P4470, DOI 10.1091/mbc.E03-01-0033; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Sahoo SK, 2008, MOL CELLS, V26, P265; Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025; SAMSON F, 1979, J PHARMACOL EXP THER, V208, P411; Setou M, 2002, NATURE, V417, P83, DOI 10.1038/nature743; Tsukumo Y, 2009, J BIOL CHEM, V284, P27500, DOI 10.1074/jbc.M109.021592; van der Voet M, 2009, NAT CELL BIOL, V11, P269, DOI 10.1038/ncb1834; Vorum H, 2000, FEBS LETT, V465, P129, DOI 10.1016/S0014-5793(99)01734-2; Vorum H, 1999, EXP CELL RES, V248, P473, DOI 10.1006/excr.1999.4431; Vorum H, 1998, BBA-PROTEIN STRUCT M, V1386, P121, DOI 10.1016/S0167-4838(98)00089-2; Wajih N, 2004, J BIOL CHEM, V279, P25276, DOI 10.1074/jbc.M401645200; Wang Q, 2010, CELL RES; Wang QA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013252; Wang QA, 2010, CELL RES, V20, P713, DOI 10.1038/cr.2010.47; Wang XF, 2009, P NATL ACAD SCI USA, V106, P21288, DOI 10.1073/pnas.0908151106; Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206; WIELAND FT, 1987, CELL, V50, P289, DOI 10.1016/0092-8674(87)90224-8; Wozniak MJ, 2006, EMBO J, V25, P5457, DOI 10.1038/sj.emboj.7601427; Wozniak MJ, 2009, J CELL SCI, V122, P1979, DOI 10.1242/jcs.041962; Yabe D, 1998, GENOMICS, V49, P331, DOI 10.1006/geno.1998.5245; Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232	55	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35344	10.1371/journal.pone.0035344	http://dx.doi.org/10.1371/journal.pone.0035344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514732	Green Published, gold, Green Submitted			2022-12-27	WOS:000305341600137
J	Wu, YF; Qi, XM; Gong, LK; Xing, GZ; Chen, M; Miao, LL; Yao, J; Suzuki, T; Furihata, C; Luan, Y; Ren, J				Wu, Yuanfeng; Qi, Xinming; Gong, Likun; Xing, Guozhen; Chen, Min; Miao, Lingling; Yao, Jun; Suzuki, Takayoshi; Furihata, Chie; Luan, Yang; Ren, Jin			Identification of BC005512 as a DNA Damage Responsive Murine Endogenous Retrovirus of GLN Family Involved in Cell Growth Regulation	PLOS ONE			English	Article							MUTATION ASSAY; MOLECULAR-MECHANISMS; ORGAN VARIATION; HEPG2 CELLS; RAT-LIVER; GENOTOXICITY; EXPRESSION; MICE; CANCER; P53	Genotoxicity assessment is of great significance in drug safety evaluation, and microarray is a useful tool widely used to identify genotoxic stress responsive genes. In the present work, by using oligonucleotide microarray in an in vivo model, we identified an unknown gene BC005512 (abbreviated as BC, official full name: cDNA sequence BC005512), whose expression in mouse liver was specifically induced by seven well-known genotoxins (GTXs), but not by non-genotoxins (NGTXs). Bioinformatics revealed that BC was a member of the GLN family of murine endogenous retrovirus (ERV). However, the relationship to genotoxicity and the cellular function of GLN are largely unknown. Using NIH/3T3 cells as an in vitro model system and quantitative real-time PCR, BC expression was specifically induced by another seven GTXs, covering diverse genotoxicity mechanisms. Additionally, dose-response and linear regression analysis showed that expression level of BC in NIH/3T3 cells strongly correlated with DNA damage, measured using the alkaline comet assay,. While in p53 deficient L5178Y cells, GTXs could not induce BC expression. Further functional studies using RNA interference revealed that down-regulation of BC expression induced G1/S phase arrest, inhibited cell proliferation and thus suppressed cell growth in NIH/3T3 cells. Together, our results provide the first evidence that BC005512, a member from GLN family of murine ERV, was responsive to DNA damage and involved in cell growth regulation. These findings could be of great value in genotoxicity predictions and contribute to a deeper understanding of GLN biological functions.	[Wu, Yuanfeng; Qi, Xinming; Gong, Likun; Xing, Guozhen; Chen, Min; Miao, Lingling; Yao, Jun; Luan, Yang; Ren, Jin] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab New Drug Res, Ctr Drug Safety Evaluat & Res, Shanghai 200031, Peoples R China; [Suzuki, Takayoshi] Natl Inst Hlth Sci, Div Cellular & Gene Therapy Prod, Tokyo, Japan; [Furihata, Chie] Aoyama Gakuin Univ, Sch Sci & Engn, Dept Chem & Biol Sci, Tokyo, Kanagawa 150, Japan	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; National Institute of Health Sciences - Japan; Aoyama Gakuin University	Wu, YF (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab New Drug Res, Ctr Drug Safety Evaluat & Res, Shanghai 200031, Peoples R China.	yluan@cdser.simm.ac.cn; jren@cdser.simm.ac.cn	Miao, Lingling/X-6143-2019; wu, yuanfeng/GVU-6762-2022; Wu, Yuanfeng/O-2920-2014; SUZUKI, TAKAYOSHI/ABA-2386-2020	Miao, Lingling/0000-0003-3674-2885; Wu, Yuanfeng/0000-0001-6390-3635; SUZUKI, TAKAYOSHI/0000-0002-2261-5263	National Natural Science Foundation of China [20807045/B070701]; National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program", China [2009ZX09301-001, 2008ZX09305-007, 2009ZX09501-033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program", China	This work was supported by National Natural Science Foundation of China (No. 20807045/B070701), and National Science and Technology Major Project "Key New Drug Creation and Manufacturing Program", China (No. 2009ZX09301-001, 2008ZX09305-007 and 2009ZX09501-033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; [Anonymous], 1996, ENV MOL MUTAGEN, V28, P363; ANTOCCIA A, 1993, MUTAT RES, V287, P93, DOI 10.1016/0027-5107(93)90148-9; Balada E, 2009, REV MED VIROL, V19, P273, DOI 10.1002/rmv.622; Baldwin E. L., 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P363, DOI 10.2174/1568011054222364; Bates S, 1996, ONCOGENE, V13, P1103; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Boeke J. D., 1997, P343; Choy W.N., 2001, GENETIC TOXICOLOGY C, P93; DRAGANI TA, 1987, CANCER RES, V47, P795; Dupressoir A, 2009, P NATL ACAD SCI USA, V106, P12127, DOI 10.1073/pnas.0902925106; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ellinger-Ziegelbauer H, 2005, MUTAT RES-FUND MOL M, V575, P61, DOI 10.1016/j.mrfmmm.2005.02.004; Ellinger-Ziegelbauer H, 2009, TOXICOL LETT, V186, P36, DOI 10.1016/j.toxlet.2008.08.017; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Goodsell DS, 2006, ONCOLOGIST, V11, P316, DOI 10.1634/theoncologist.11-3-316; Hastwell PW, 2006, MUTAT RES-GEN TOX EN, V607, P160, DOI 10.1016/j.mrgentox.2006.04.011; Hendriks G, 2012, TOXICOL SCI, V125, P285, DOI 10.1093/toxsci/kfr281; Hendriks G, 2011, MUTAT RES-FUND MOL M, V709-10, P49, DOI 10.1016/j.mrfmmm.2011.02.013; Hohenadl C, 1999, J INVEST DERMATOL, V113, P587, DOI 10.1046/j.1523-1747.1999.00728.x; Honma M, 1999, MUTAGENESIS, V14, P23, DOI 10.1093/mutage/14.1.23; HSIEH LL, 1987, CANCER RES, V47, P3421; ITIN A, 1986, J VIROL, V59, P301, DOI 10.1128/JVI.59.2.301-307.1986; Kirkland D, 2008, MUTAT RES-GEN TOX EN, V654, P114, DOI 10.1016/j.mrgentox.2008.05.002; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LATOUR I, 1995, FEBS LETT, V373, P299, DOI 10.1016/0014-5793(95)01065-M; Leavitt SA, 2008, MUTAGENESIS, V23, P445, DOI 10.1093/mutage/gen033; LI JP, 1990, NATURE, V343, P762, DOI 10.1038/343762a0; Magkoufopoulou C, 2011, MUTAGENESIS, V26, P593, DOI 10.1093/mutage/ger021; OBATA MM, 1988, J VIROL, V62, P4381, DOI 10.1128/JVI.62.11.4381-4386.1988; Ohsawa K, 2000, MUTAT RES-GEN TOX EN, V471, P113, DOI 10.1016/S1383-5718(00)00120-0; Okada N, 1997, MUTAGENESIS, V12, P179, DOI 10.1093/mutage/12.3.179; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Ponferrada VG, 2003, ARCH VIROL, V148, P659, DOI 10.1007/s00705-002-0960-x; Ribet D, 2008, J VIROL, V82, P4413, DOI 10.1128/JVI.02141-07; Rink SM, 1996, CHEM RES TOXICOL, V9, P382, DOI 10.1021/tx950156q; Ruprecht K, 2008, CELL MOL LIFE SCI, V65, P3366, DOI 10.1007/s00018-008-8496-1; SACKETT DL, 1993, BIOCHEMISTRY-US, V32, P13560, DOI 10.1021/bi00212a023; SALMON ED, 1984, CELL MOTIL CYTOSKEL, V4, P155, DOI 10.1002/cm.970040302; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Scott DJ, 2011, TOXICOLOGY, V290, P50, DOI 10.1016/j.tox.2011.08.015; Storer RD, 1997, MUTAT RES-FUND MOL M, V373, P157, DOI 10.1016/S0027-5107(96)00227-8; Suzuki T, 1999, MUTAT RES-GEN TOX EN, V444, P259, DOI 10.1016/S1383-5718(99)00104-7; Suzuki T, 1996, ENVIRON MOL MUTAGEN, V28, P348; Thomas RS, 2007, TOXICOL SCI, V96, P40, DOI 10.1093/toxsci/kfl171; TSICHLIS PN, 1991, P NATL ACAD SCI USA, V88, P4611, DOI 10.1073/pnas.88.11.4611; Van Hummelen P, 2010, MUTAT RES-REV MUTAT, V705, P165, DOI 10.1016/j.mrrev.2010.04.007; Wang T, 2007, P NATL ACAD SCI USA, V104, P18613, DOI 10.1073/pnas.0703637104; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Westerink WMA, 2010, MUTAT RES-GEN TOX EN, V696, P21, DOI 10.1016/j.mrgentox.2009.12.007; Yelamos J, 2006, EMBO J, V25, P4350, DOI 10.1038/sj.emboj.7601301	55	8	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35010	10.1371/journal.pone.0035010	http://dx.doi.org/10.1371/journal.pone.0035010			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	22514700	Green Submitted, Green Published, gold			2022-12-27	WOS:000305341600106
J	Chen, ZY; Zeng, DY; Hu, YT; He, YW; Pan, N; Ding, JP; Cao, ZJ; Liu, ML; Li, WX; Yi, H; Jiang, L; Wu, YL				Chen, Zong-Yun; Zeng, Dan-Yun; Hu, You-Tian; He, Ya-Wen; Pan, Na; Ding, Jiu-Ping; Cao, Zhi-Jian; Liu, Mai-Li; Li, Wen-Xin; Yi, Hong; Jiang, Ling; Wu, Ying-Liang			Structural and Functional Diversity of Acidic Scorpion Potassium Channel Toxins	PLOS ONE			English	Article							K+ CHANNEL; THERAPEUTIC TARGET; NMR STRUCTURE; HIGH-AFFINITY; MAXI-K; INHIBITOR; VENOM; CHARYBDOTOXIN; PEPTIDE; KV1.3	Background: Although the basic scorpion K+ channel toxins (KTxs) are well-known pharmacological tools and potential drug candidates, characterization the acidic KTxs still has the great significance for their potential selectivity towards different K+ channel subtypes. Unfortunately, research on the acidic KTxs has been ignored for several years and progressed slowly. Principal Findings: Here, we describe the identification of nine new acidic KTxs by cDNA cloning and bioinformatic analyses. Seven of these toxins belong to three new alpha-KTx subfamilies (alpha-KTx28, alpha-KTx29, and alpha-KTx30), and two are new members of the known kappa-KTx2 subfamily. ImKTx104 containing three disulfide bridges, the first member of the alpha-KTx28 subfamily, has a low sequence homology with other known KTxs, and its NMR structure suggests ImKTx104 adopts a modified cystine-stabilized alpha-helix-loop-beta-sheet (CS-alpha/beta) fold motif that has no apparent alpha-helixs and beta-sheets, but still stabilized by three disulfide bridges. These newly described acidic KTxs exhibit differential pharmacological effects on potassium channels. Acidic scorpion toxin ImKTx104 was the first peptide inhibitor found to affect KCNQ1 channel, which is insensitive to the basic KTxs and is strongly associated with human cardiac abnormalities. ImKTx104 selectively inhibited KCNQ1 channel with a K-d of 11.69 mu M, but was less effective against the basic KTxs-sensitive potassium channels. In addition to the ImKTx104 toxin, HeTx204 peptide, containing a cystine-stabilized alpha-helix-loop-helix (CS-alpha/alpha) fold scaffold motif, blocked both Kv1.3 and KCNQ1 channels. StKTx23 toxin, with a cystine-stabilized alpha-helix-loop-beta-sheet (CS-alpha/beta) fold motif, could inhibit Kv1.3 channel, but not the KCNQ1 channel. Conclusions/Significance: These findings characterize the structural and functional diversity of acidic KTxs, and could accelerate the development and clinical use of acidic KTxs as pharmacological tools and potential drugs.	[Chen, Zong-Yun; Hu, You-Tian; He, Ya-Wen; Cao, Zhi-Jian; Li, Wen-Xin; Yi, Hong; Wu, Ying-Liang] Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China; [Zeng, Dan-Yun; Liu, Mai-Li; Jiang, Ling] Chinese Acad Sci, Wuhan Ctr Magnet Resonance, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan Inst Phys & Math, Wuhan, Peoples R China; [Pan, Na; Ding, Jiu-Ping] Huazhong Univ Sci & Technol, Key Lab Mol Biophys, Minist Educ, Coll Life Sci & Technol, Wuhan 430074, Hubei, Peoples R China	Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Huazhong University of Science & Technology	Chen, ZY (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Peoples R China.	whu_rette@yahoo.com.cn; lingjiang@wipm.ac.cn; ylwu@whu.edu.cn	Liu, Maili/A-8543-2011; Hu, Youtian/G-5408-2014	Liu, Maili/0000-0002-9359-915X; 	National Basic Research Program of China [2010CB529800, 2009CB918600]; China Postdoctoral Science Special Foundation [201003496]; National Natural Sciences Foundation of China [30530140, 31071942, 30900265, 30973636, 90813017]; Hubei Province Natural Sciences Foundation of China [2009CDA076]	National Basic Research Program of China(National Basic Research Program of China); China Postdoctoral Science Special Foundation; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Province Natural Sciences Foundation of China	This work was supported by grants from the National Basic Research Program of China (2010CB529800 and 2009CB918600), the China Postdoctoral Science Special Foundation (number 201003496), and the National Natural Sciences Foundation of China (number 30530140, 31071942, 30900265, 30973636, and 90813017), the Hubei Province Natural Sciences Foundation of China (number 2009CDA076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev YA, 2008, J BIOL CHEM, V283, P23914, DOI 10.1074/jbc.M800776200; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; Blanc E, 1997, PROTEINS, V29, P359, DOI 10.1002/(SICI)1097-0134(199711)29:3&lt;359::AID-PROT9&gt;3.0.CO;2-5; Camargos TS, 2011, PEPTIDES, V32, P1509, DOI 10.1016/j.peptides.2011.05.017; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Castle NA, 2003, MOL PHARMACOL, V63, P409, DOI 10.1124/mol.63.2.409; Chagot B, 2005, BIOCHEM J, V388, P263, DOI 10.1042/BJ20041705; Chen HJ, 2003, NEURON, V40, P15, DOI 10.1016/S0896-6273(03)00570-1; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; Gao YD, 2003, PROTEINS, V52, P146, DOI 10.1002/prot.10341; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Han S, 2008, J BIOL CHEM, V283, P19058, DOI 10.1074/jbc.M802054200; Han S, 2010, J PROTEOME RES, V9, P3118, DOI 10.1021/pr100027k; He QY, 2008, NUCLEIC ACIDS RES, V36, pD293, DOI 10.1093/nar/gkm832; Huys I, 2004, J BIOL CHEM, V279, P2781, DOI 10.1074/jbc.M311029200; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LAMBERT P, 1990, BIOCHEM BIOPH RES CO, V170, P684, DOI 10.1016/0006-291X(90)92145-P; Lecomte C, 2000, J PEPT RES, V55, P246, DOI 10.1034/j.1399-3011.2000.00170.x; Liu J, 2009, PEPTIDES, V30, P675, DOI 10.1016/j.peptides.2008.11.015; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ma YB, 2010, PROTEOMICS, V10, P2471, DOI 10.1002/pmic.200900763; Ma YB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-290; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MASSEFSKI W, 1991, SCIENCE, V252, P631, DOI 10.1126/science.252.5006.631.b; Mosbah A, 2000, PROTEINS, V40, P436, DOI 10.1002/1097-0134(20000815)40:3&lt;436::AID-PROT90&gt;3.0.CO;2-9; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Olamendi-Portugal T, 2005, TOXICON, V46, P418, DOI 10.1016/j.toxicon.2005.06.001; Ramu Y, 2008, P NATL ACAD SCI USA, V105, P10774, DOI 10.1073/pnas.0802850105; RomiLebrun R, 1997, EUR J BIOCHEM, V245, P457, DOI 10.1111/j.1432-1033.1997.00457.x; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Saucedo AL, 2012, J BIOL CHEM; Schroeder N, 2002, FEBS LETT, V527, P298, DOI 10.1016/S0014-5793(02)03256-8; Smith JJ, 2011, P NATL ACAD SCI USA, V108, P10478, DOI 10.1073/pnas.1103501108; Srinivasan KN, 2002, J BIOL CHEM, V277, P30040, DOI 10.1074/jbc.M111258200; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Whittemore NA, 2005, BIOCHEMISTRY-US, V44, P4434, DOI 10.1021/bi048292u; Wu G, 2000, BIOCHEM BIOPH RES CO, V276, P1148, DOI 10.1006/bbrc.2000.3435; Wu YL, 2004, BIOPHYS J, V87, P105, DOI 10.1529/biophysj.103.039156; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Yi H, 2007, J PROTEOME RES, V6, P611, DOI 10.1021/pr060368g; Yin SJ, 2008, J PROTEOME RES, V7, P4890, DOI 10.1021/pr800494a; Yin SJ, 2008, PEPTIDES, V29, P1514, DOI 10.1016/j.peptides.2008.04.021; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zhang M, 2003, BIOPHYS J, V84, P3022, DOI 10.1016/S0006-3495(03)70028-9; Zhao ZH, 2009, ANTIMICROB AGENTS CH, V53, P3472, DOI 10.1128/AAC.01436-08; Zhu SY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002832	50	26	39	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e35154	10.1371/journal.pone.0035154	http://dx.doi.org/10.1371/journal.pone.0035154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511981	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600067
J	Day, CA; Kenworthy, AK				Day, Charles A.; Kenworthy, Anne K.			Mechanisms Underlying the Confined Diffusion of Cholera Toxin B-Subunit in Intact Cell Membranes	PLOS ONE			English	Article							SINGLE-MOLECULE TRACKING; GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE; ACTIN POLYMERIZATION; ATP DEPLETION; 3T3-L1 ADIPOCYTES; GANGLIOSIDE GM1; RAFT PROTEINS; K-RAS; DYNAMICS	Multivalent glycolipid binding toxins such as cholera toxin have the capacity to cluster glycolipids, a process thought to be important for their functional uptake into cells. In contrast to the highly dynamic properties of lipid probes and many lipid-anchored proteins, the B-subunit of cholera toxin (CTxB) diffuses extremely slowly when bound to its glycolipid receptor GM(1) in the plasma membrane of living cells. In the current study, we used confocal FRAP to examine the origins of this slow diffusion of the CTxB/GM(1) complex at the cell surface, relative to the behavior of a representative GPI-anchored protein, transmembrane protein, and fluorescent lipid analog. We show that the diffusion of CTxB is impeded by actin-and ATP-dependent processes, but is unaffected by caveolae. At physiological temperature, the diffusion of several cell surface markers is unchanged in the presence of CTxB, suggesting that binding of CTxB to membranes does not alter the organization of the plasma membrane in a way that influences the diffusion of other molecules. Furthermore, diffusion of the B-subunit of another glycolipid-binding toxin, Shiga toxin, is significantly faster than that of CTxB, indicating that the confined diffusion of CTxB is not a simple function of its ability to cluster glycolipids. By identifying underlying mechanisms that control CTxB dynamics at the cell surface, these findings help to delineate the fundamental properties of toxin-receptor complexes in intact cell membranes.	[Day, Charles A.; Kenworthy, Anne K.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA; [Kenworthy, Anne K.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [Kenworthy, Anne K.] Vanderbilt Univ, Sch Med, Chem & Phys Biol Program, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Day, CA (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37212 USA.	Anne.kenworthy@vanderbilt.edu		Day, Charles A/0000-0001-6277-2004; Kenworthy, Anne/0000-0001-6567-9059	NIH [RO1 GM073846]; Vanderbilt Molecular Biophysics training grant [NIH T32 GM08320]; Vanderbilt Discovery Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320, R01GM073846] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Molecular Biophysics training grant; Vanderbilt Discovery Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH RO1 GM073846, the Vanderbilt Molecular Biophysics training grant (NIH T32 GM08320), and a Vanderbilt Discovery Grant. The funding sources had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler J, 2010, NAT METHODS, V7, P170, DOI 10.1038/nmeth0310-170; Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Atkinson SJ, 2004, J BIOL CHEM, V279, P5194, DOI 10.1074/jbc.M306973200; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; Badizadegan K, 2004, AM J PHYSIOL-CELL PH, V287, pC1453, DOI 10.1152/ajpcell.00189.2004; Blank N, 2007, IMMUNOL CELL BIOL, V85, P378, DOI 10.1038/sj.icb.7100045; Chen Y, 2006, J CELL BIOL, V175, P169, DOI 10.1083/jcb.200512116; Chen Y, 2009, J CELL SCI, V122, P3966, DOI 10.1242/jcs.049346; Day CA, 2009, BBA-BIOMEMBRANES, V1788, P245, DOI 10.1016/j.bbamem.2008.10.024; Drake KR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009806; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Frick M, 2007, CURR BIOL, V17, P462, DOI 10.1016/j.cub.2007.01.069; Fujita A, 2009, BBA-MOL CELL BIOL L, V1791, P388, DOI 10.1016/j.bbalip.2009.01.008; Gomez GA, 2007, FEBS J, V274, P2210, DOI 10.1111/j.1742-4658.2007.05758.x; Gonzalez-Munoz E, 2009, ENDOCRINOLOGY, V150, P3493, DOI 10.1210/en.2008-1520; Goodwin JS, 2005, BIOPHYS J, V89, P1398, DOI 10.1529/biophysj.104.055640; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Guo L, 2010, J BIOL CHEM, V285, P25438, DOI 10.1074/jbc.M110.119933; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Hansen GH, 2005, BIOCHEMISTRY-US, V44, P873, DOI 10.1021/bi047959+; Hebbar S, 2008, J LIPID RES, V49, P1077, DOI 10.1194/jlr.M700543-JLR200; Herget-Rosenthal S, 2001, AM J PHYSIOL-CELL PH, V281, pC1858, DOI 10.1152/ajpcell.2001.281.6.C1858; HINSHAW DB, 1993, AM J PHYSIOL, V264, pC1171, DOI 10.1152/ajpcell.1993.264.5.C1171; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Johannes L, 2010, CELL, V142, P507, DOI 10.1016/j.cell.2010.08.007; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kang M, 2009, BIOPHYS J, V97, P1501, DOI 10.1016/j.bpj.2009.06.017; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kenworthy AK, 2007, LIPID RAFTS; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Kusumi A, 1996, CURR OPIN CELL BIOL, V8, P566, DOI 10.1016/S0955-0674(96)80036-6; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Langhorst MF, 2007, FEBS LETT, V581, P4697, DOI 10.1016/j.febslet.2007.08.074; Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Ling H, 1998, BIOCHEMISTRY-US, V37, P1777, DOI 10.1021/bi971806n; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2011, NAT CHEM BIOL, V7, P260, DOI 10.1038/nchembio.551; Mahfoud R, 2010, J BIOL CHEM, V285, P36049, DOI 10.1074/jbc.M110.110189; Marguet D, 2006, EMBO J, V25, P3446, DOI 10.1038/sj.emboj.7601204; Meder D, 2006, P NATL ACAD SCI USA, V103, P329, DOI 10.1073/pnas.0509885103; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Mueller V, 2011, BIOPHYS J, V101, P1651, DOI 10.1016/j.bpj.2011.09.006; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Pang H, 2004, J CELL SCI, V117, P1421, DOI 10.1242/jcs.01009; PARTON RG, 1994, J HISTOCHEM CYTOCHEM, V42, P155, DOI 10.1177/42.2.8288861; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pina DG, 2005, TOXICON, V45, P389, DOI 10.1016/j.toxicon.2004.12.014; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; Plowman SJ, 2005, P NATL ACAD SCI USA, V102, P15500, DOI 10.1073/pnas.0504114102; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Romer W, 2010, CELL, V140, P540, DOI 10.1016/j.cell.2010.01.010; Sahl SJ, 2010, P NATL ACAD SCI USA, V107, P6829, DOI 10.1073/pnas.0912894107; Schnitzer JE, 1996, SCIENCE, V274, P239, DOI 10.1126/science.274.5285.239; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shvartsman DE, 2003, J CELL BIOL, V163, P879, DOI 10.1083/jcb.200308142; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Steffensen R, 2000, J BIOL CHEM, V275, P16723, DOI 10.1074/jbc.M000728200; Suzuki KGN, 2007, J CELL BIOL, V177, P731, DOI 10.1083/jcb.200609175; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Tetaud C, 2003, J BIOL CHEM, V278, P45200, DOI 10.1074/jbc.M303868200; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Umemura YM, 2008, BIOPHYS J, V95, P435, DOI 10.1529/biophysj.107.123018; van Zanten TS, 2010, P NATL ACAD SCI USA, V107, P15437, DOI 10.1073/pnas.1003876107; vanDeurs B, 1996, J CELL SCI, V109, P1655; Watkins EB, 2011, P NATL ACAD SCI USA, V108, P6975, DOI 10.1073/pnas.1014579108; Wolf AA, 2008, INFECT IMMUN, V76, P1476, DOI 10.1128/IAI.01286-07; Yanagisawa M, 2006, GLYCOBIOLOGY, V16, p19G, DOI 10.1093/glycob/cwl003; Zhang DW, 2009, J CELL SCI, V122, P3715, DOI 10.1242/jcs.051557	77	41	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34923	10.1371/journal.pone.0034923	http://dx.doi.org/10.1371/journal.pone.0034923			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511973	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338600059
J	Chu, SH; Lee, MK; Ahn, KY; Im, JA; Park, MS; Lee, DC; Jeon, JY; Lee, JW				Chu, Sang Hui; Lee, Mi Kyung; Ahn, Ki Yong; Im, Jee-Aee; Park, Min Soo; Lee, Duk-Chul; Jeon, Justin Y.; Lee, Ji Won			Chemerin and Adiponectin Contribute Reciprocally to Metabolic Syndrome	PLOS ONE			English	Article							ADIPOGENESIS; POPULATION; ADIPOKINE; PEPTIDES; PROTEIN; OBESITY; CELLS	Obesity and metabolic syndrome (MetS) are considered chronic inflammatory states. Chemerin, a novel adipokine, may play an important role in linking MetS and inflammation. We investigated the association of chemerin with inflammatory markers and with characteristics of MetS in apparently healthy overweight and obese adults. We studied 92 adults; 59 men and 33 women whose average body mass index (BMI) was 28.15 +/- 5.08 kg/m(2). Anthropometric parameters, insulin resistance indices, lipid profiles, and inflammatory markers including high sensitivity C-reactive protein (hsCRP), pentraxin 3 (PTX3), adiponectin, and chemerin were measured. Controlling for age, gender, and BMI, serum chemerin level was positively correlated with body fat and serum triglyceride, and negatively correlated with adiponectin and high density lipoprotein cholesterol (HDL- C), and was not correlated with altered hsCRP or PTX3 levels. Among the low, moderate and high chemerin groups, high chemerin individuals are more likely to have lower HDL-C. Conversely, individuals in the low adiponectin group are more likely to have lower HDL-C and show more MetS phenotypic traits than moderate and high adiponectin subjects. To determine the relationships of chemerin and adiponectin to MetS and its components, participants were stratified into four groups based on their chemerin and adiponectin levels (high chemerin/high adiponectin, high chemerin/low adiponectin, low chemerin/high adiponectin, or low chemerin/low adiponectin). Participants who were in the high chemerin/low adiponectin group more likely to have dyslipidemia and MetS (OR: 5.79, 95% CI:1.00-33.70) compared to the other three group. Our findings suggest that chemerin and adiponectin may reciprocally participate in the development of MetS.	[Chu, Sang Hui] Yonsei Univ, Coll Nursing, Dept Clin Nursing Sci, Nursing Policy & Res Inst,Biobehav Res Ctr, Seoul 120749, South Korea; [Lee, Mi Kyung; Ahn, Ki Yong; Jeon, Justin Y.] Yonsei Univ, Dept Sport & Leisure Studies, Seoul 120749, South Korea; [Im, Jee-Aee] INTOTO Inc, Sport & Med Res Ctr, Seoul, South Korea; [Park, Min Soo] Yonsei Univ, Coll Med, Severance Hosp, Dept Pediat,Clin Trial Ctr, Seoul 120749, South Korea; [Lee, Duk-Chul; Lee, Ji Won] Yonsei Univ, Coll Med, Severance Hosp, Dept Family Med, Seoul 120749, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Chu, SH (corresponding author), Yonsei Univ, Coll Nursing, Dept Clin Nursing Sci, Nursing Policy & Res Inst,Biobehav Res Ctr, Seoul 120749, South Korea.	jjeon@yonsei.ac.kr; indi5645@yuhs.ac		LEE, JI WON/0000-0002-2666-4249; Jeon, Justin/0000-0001-7978-4271; Lee, Duk Chul/0000-0001-9166-1813; Park, Min Soo/0000-0002-4395-9938; CHU, Sang Hui/0000-0001-6877-5599	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2009-0070217]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2009-0070217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abderrahim-Ferkoune A, 2003, J LIPID RES, V44, P994, DOI 10.1194/jlr.M200382-JLR200; Bozaoglu K, 2007, ENDOCRINOLOGY, V148, P4687, DOI 10.1210/en.2007-0175; Bozaoglu K, 2009, J CLIN ENDOCR METAB, V94, P3085, DOI 10.1210/jc.2008-1833; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Getz GS, 2010, CURR PHARM DESIGN, V16, P3173; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Kralisch S, 2009, REGUL PEPTIDES, V154, P102, DOI 10.1016/j.regpep.2009.02.010; Kutzleb C, 2005, CURR PROTEIN PEPT SC, V6, P265, DOI 10.2174/1389203054065419; Muruganandan S, 2011, J BIOL CHEM, V286, P23982, DOI 10.1074/jbc.M111.220491; Parlee SD, 2010, ENDOCRINOLOGY, V151, P2590, DOI 10.1210/en.2009-0794; Ress C, 2010, EUR J CLIN INVEST, V40, P277, DOI 10.1111/j.1365-2362.2010.02255.x; Shin HY, 2011, CLIN ENDOCR IN PRESS; Stanley TL, 2011, J CLIN ENDOCR METAB, V96, pE146, DOI 10.1210/jc.2010-1170; Stejskal D, 2008, BIOMED PAP, V152, P217, DOI 10.5507/bp.2008.033; Takahashi M, 2011, SCI REPORTS, V123, P1; Tan BK, 2009, DIABETES, V58, P1971, DOI 10.2337/db08-1528; Tonjes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013911; Trujillo ME, 2005, J INTERN MED, V257, P167, DOI 10.1111/j.1365-2796.2004.01426.x; Vernochet C, 2010, ENDOCRINOLOGY, V151, P586, DOI 10.1210/en.2009-1057; Weigert J, 2010, CLIN ENDOCRINOL, V72, P342, DOI 10.1111/j.1365-2265.2009.03664.x; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Yamauchi T, 2008, INT J OBESITY, V32, pS13, DOI 10.1038/ijo.2008.233; Yilmaz Y, 2011, SCAND J GASTROENTERO, V46, P91, DOI 10.3109/00365521.2010.516452; Yoshimura T, 2008, J EXP MED, V205, P2187, DOI 10.1084/jem.20081736; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200	27	83	86	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2012	7	4							e34710	10.1371/journal.pone.0034710	http://dx.doi.org/10.1371/journal.pone.0034710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TP	22509348	Green Published, Green Submitted, gold			2022-12-27	WOS:000305336600051
J	Caprioli, M; Ambrosini, R; Boncoraglio, G; Gatti, E; Romano, A; Romano, M; Rubolini, D; Gianfranceschi, L; Saino, N				Caprioli, Manuela; Ambrosini, Roberto; Boncoraglio, Giuseppe; Gatti, Emanuele; Romano, Andrea; Romano, Maria; Rubolini, Diego; Gianfranceschi, Luca; Saino, Nicola			Clock Gene Variation Is Associated with Breeding Phenology and Maybe under Directional Selection in the Migratory Barn Swallow	PLOS ONE			English	Article							CLIMATE-CHANGE; LATITUDINAL CLINE; HIRUNDO-RUSTICA; PHENOTYPIC PLASTICITY; MOLECULAR ANALYSIS; REPRODUCTION; EVOLUTION; TIME; POLYMORPHISM; TEMPERATURE	Background: In diverse taxa, photoperiodic responses that cause seasonal physiological and behavioural shifts are controlled by genes, including the vertebrate Clock orthologues, that encode for circadian oscillator mechanisms. While the genetic network behind circadian rhythms is well described, relatively few reports exist of the phenological consequences of and selection on Clock genes in the wild. Here, we investigated variation in breeding phenology in relation to Clock genetic diversity in a long-distance migratory bird, the barn swallow (Hirundo rustica). Methodology/Principal Findings: In a sample of 922 adult barn swallows from a single population breeding in Italy we found one very common (Q(7)) and three rare (Q(5), Q(6), Q(8)) length variants of a functionally significant polyglutamine repeat. Rare (2.9%) Q(7)/Q(8) heterozygous females, but not males, bred significantly later than common (91.5%) Q(7)/Q(7) females, consistent with the expectation that 'long' alleles cause late breeding, as observed in a resident population of another bird species. Because breeding date depends on arrival date from migration, present results suggest that the association between breeding date and Clock might be mediated by migration phenology. In addition, fecundity selection appears to be operating against Q(7)/Q(8) because late migrating/breeding swallows have fewer clutches per season, and late breeding has additional negative selection effects via reduced offspring longevity. Genotype frequencies varied marginally non-significantly with age, as Q(7)/Q(8) frequency showed a 4-fold reduction in old individuals. This result suggests negative viability selection against Q(7)/Q(8), possibly mediated by costs of late breeding. Conclusions/Significance: This is the first study of migratory birds showing an association between breeding phenology and Clock genotype and suggesting that negative selection occurs on a phenologically deviant genotype. Low polymorphism at Clock may constrain microevolutionary phenological response to changing climate, and may thus contribute to the decline of barn swallow populations.	[Caprioli, Manuela; Boncoraglio, Giuseppe; Romano, Andrea; Romano, Maria; Rubolini, Diego; Saino, Nicola] Univ Milan, Dipartimento Biol, Milan, Italy; [Ambrosini, Roberto] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Milan, Italy; [Gatti, Emanuele; Gianfranceschi, Luca] Univ Milan, Dipartimento Sci Biomol & Biotecnol, Milan, Italy	University of Milan; University of Milano-Bicocca; University of Milan	Caprioli, M (corresponding author), Univ Milan, Dipartimento Biol, Milan, Italy.	nicola.saino@unimi.it	Gianfranceschi, Luca/D-3166-2012; Rubolini, Diego/F-2851-2011; Romano, Andrea/B-3930-2012; Romano, Andrea/A-2780-2017; Ambrosini, Roberto/F-3188-2012	Gianfranceschi, Luca/0000-0002-7644-5968; Rubolini, Diego/0000-0003-2703-5783; Romano, Andrea/0000-0002-0945-6018; Ambrosini, Roberto/0000-0002-7148-1468; Saino, Nicola/0000-0002-0230-3967				Abraham U, 2002, EUR J NEUROSCI, V16, P429, DOI 10.1046/j.1460-9568.2002.02102.x; Ambrosini R, 2002, ECOL LETT, V5, P640, DOI 10.1046/j.1461-0248.2002.00363.x; Ambrosini R, 2012, BIRD CONSERV INT, V22, P411, DOI 10.1017/S0959270912000056; Ambrosini R, 2011, CLIM RES, V50, P43, DOI 10.3354/cr01034; Ambrosini R, 2011, BIRD STUDY, V58, P495, DOI 10.1080/00063657.2011.609883; Bailey MJ, 2002, FEBS LETT, V513, P169, DOI 10.1016/S0014-5793(02)02276-7; Ball GF, 2008, PHILOS T R SOC B, V363, P231, DOI 10.1098/rstb.2007.2137; BirdLife International, 2004, BIRDL CONSERV SER, V12; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Bradshaw WE, 2001, J INSECT PHYSIOL, V47, P809, DOI 10.1016/S0022-1910(01)00054-3; Caro SP, 2009, FUNCT ECOL, V23, P172, DOI 10.1111/j.1365-2435.2008.01486.x; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Chong NW, 2000, J BIOL CHEM, V275, P32991, DOI 10.1074/jbc.M005671200; Clutton-Brock T. H., 1988, REPROD SUCCESS; Coppack T, 2001, OECOLOGIA, V128, P181, DOI 10.1007/s004420100652; COSTA R, 1992, P ROY SOC B-BIOL SCI, V250, P43, DOI 10.1098/rspb.1992.0128; Cramp S, 1998, COMPLETE BIRDS W PAL; Crick HQP, 1999, NATURE, V399, P423, DOI 10.1038/20839; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dor R, 2012, ECOL EVOL, V2, P95, DOI 10.1002/ece3.73; Dor R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028843; Dvornyk V, 2003, P NATL ACAD SCI USA, V100, P2495, DOI 10.1073/pnas.0130099100; Fidler AE, 2003, COMP BIOCHEM PHYS B, V136, P861, DOI 10.1016/S1096-4959(03)00276-8; Hall JC, 2003, ADV GENET, V48, P1, DOI 10.1016/S0065-2660(03)48000-0; Johnsen A, 2007, MOL ECOL, V16, P4867, DOI 10.1111/j.1365-294X.2007.03552.x; Knudsen E, 2011, BIOL REV, V86, P928, DOI 10.1111/j.1469-185X.2011.00179.x; Kyriacou CP, 2007, J EVOLUTION BIOL, V20, P1649, DOI 10.1111/j.1420-9101.2007.01352.x; Liedvogel M, 2010, J AVIAN BIOL, V41, P543, DOI 10.1111/j.1600-048X.2010.05055.x; Liedvogel M, 2009, MOL ECOL, V18, P2444, DOI 10.1111/j.1365-294X.2009.04204.x; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; McCleery RH, 1998, NATURE, V391, P30, DOI 10.1038/34073; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Moller AP, 2007, BEHAV ECOL, V18, P62, DOI 10.1093/beheco/arl051; Moller AP, 2001, J APPL ECOL, V38, P378, DOI 10.1046/j.1365-2664.2001.00593.x; Moller AP., 1994, SEXUAL SELECTION BAR; MOller AP, 2010, EFFECTS CLIMATE CHAN; Mueller JC, 2011, P ROY SOC B-BIOL SCI, V278, P2848, DOI 10.1098/rspb.2010.2567; Murton RK, 1977, AVIAN BREEDING CYCLE; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nunes MV, 1999, J BIOL RHYTHM, V14, P84, DOI 10.1177/074873049901400202; Nussey DH, 2007, J EVOLUTION BIOL, V20, P831, DOI 10.1111/j.1420-9101.2007.01300.x; O'Malley KG, 2008, GENETICA, V132, P87, DOI 10.1007/s10709-007-9151-8; O'Malley KG, 2008, P ROY SOC B-BIOL SCI, V275, P2813, DOI 10.1098/rspb.2008.0524; O'Malley KG, 2010, P ROY SOC B-BIOL SCI, V277, P3703, DOI 10.1098/rspb.2010.0762; Okano T, 2001, GENES CELLS, V6, P825, DOI 10.1046/j.1365-2443.2001.00462.x; PRICE T, 1988, SCIENCE, V240, P798, DOI 10.1126/science.3363360; Pulido F, 2003, AVIAN MIGRATION, P53; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Saino N, 1999, J ANIM ECOL, V68, P999, DOI 10.1046/j.1365-2656.1999.00350.x; Saino N, 2004, FUNCT ECOL, V18, P50, DOI 10.1046/j.0269-8463.2004.00808.x; Saino N, 2012, J ANIM ECOL IN PRESS; Saino N, 2008, EVOL ECOL, V22, P659, DOI 10.1007/s10682-007-9189-1; Saino N, 2008, GLOBAL CHANGE BIOL, V14, P250, DOI 10.1111/j.1365-2486.2007.01488.x; Saino N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019593; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Sharp PJ, 2005, ANN NY ACAD SCI, V1040, P189, DOI 10.1196/annals.1327.024; Sheldon BC, 2003, EVOLUTION, V57, P406; Teplitsky C, 2011, J EVOLUTION BIOL, V24, P2025, DOI 10.1111/j.1420-9101.2011.02342.x; Turner A., 2006, BARN SWALLOW; Verboven N, 1998, OIKOS, V81, P511, DOI 10.2307/3546771; Vitaterna MH, 2006, P NATL ACAD SCI USA, V103, P9327, DOI 10.1073/pnas.0603601103; WILLIAMS DA, 1976, BIOMETRIKA, V63, P33, DOI 10.2307/2335081; Yamamoto K, 2001, NEUROSCI LETT, V313, P13, DOI 10.1016/S0304-3940(01)02227-3; Yoshimura T, 2000, MOL BRAIN RES, V78, P207, DOI 10.1016/S0169-328X(00)00091-7	65	56	57	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 10	2012	7	4							e35140	10.1371/journal.pone.0035140	http://dx.doi.org/10.1371/journal.pone.0035140			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959FE	22506071	Green Submitted, gold, Green Published			2022-12-27	WOS:000305297500079
J	Miquel, E; Cassina, A; Martinez-Palma, L; Bolatto, C; Trias, E; Gandelman, M; Radi, R; Barbeito, L; Cassina, P				Miquel, Ernesto; Cassina, Adriana; Martinez-Palma, Laura; Bolatto, Carmen; Trias, Emiliano; Gandelman, Mandi; Radi, Rafael; Barbeito, Luis; Cassina, Patricia			Modulation of Astrocytic Mitochondrial Function by Dichloroacetate Improves Survival and Motor Performance in Inherited Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							MOUSE MODEL; SUPEROXIDE-DISMUTASE; DISEASE PROGRESSION; NEURON DEGENERATION; NRF2 ACTIVATION; RAT MODEL; PYRUVATE; ALS; MICE; DYSFUNCTION	Mitochondrial dysfunction is one of the pathogenic mechanisms that lead to neurodegeneration in Amyotrophic Lateral Sclerosis (ALS). Astrocytes expressing the ALS-linked SOD1(G93A) mutation display a decreased mitochondrial respiratory capacity associated to phenotypic changes that cause them to induce motor neuron death. Astrocyte-mediated toxicity can be prevented by mitochondria-targeted antioxidants, indicating a critical role of mitochondria in the neurotoxic phenotype. However, it is presently unknown whether drugs currently used to stimulate mitochondrial metabolism can also modulate ALS progression. Here, we tested the disease-modifying effect of dichloroacetate (DCA), an orphan drug that improves the functional status of mitochondria through the stimulation of the pyruvate dehydrogenase complex activity (PDH). Applied to astrocyte cultures isolated from rats expressing the SOD1(G93A) mutation, DCA reduced phosphorylation of PDH and improved mitochondrial coupling as expressed by the respiratory control ratio (RCR). Notably, DCA completely prevented the toxicity of SOD1(G93A) astrocytes to motor neurons in coculture conditions. Chronic administration of DCA (500 mg/L) in the drinking water of mice expressing the SOD1(G93A) mutation increased survival by 2 weeks compared to untreated mice. Systemic DCA also normalized the reduced RCR value measured in lumbar spinal cord tissue of diseased SOD1(G93A) mice. A remarkable effect of DCA was the improvement of grip strength performance at the end stage of the disease, which correlated with a recovery of the neuromuscular junction area in extensor digitorum longus muscles. Systemic DCA also decreased astrocyte reactivity and preventedmotor neuron loss in SOD1(G93A) mice. Taken together, our results indicate that improvement of the mitochondrial redox status by DCA leads to a disease-modifying effect, further supporting the therapeutic potential of mitochondria-targeted drugs in ALS.	[Miquel, Ernesto; Martinez-Palma, Laura; Bolatto, Carmen; Gandelman, Mandi; Cassina, Patricia] Univ Republica, Fac Med, Dept Histol & Embriol, Montevideo, Uruguay; [Cassina, Adriana; Radi, Rafael] Univ Republica, Dept Bioquim, Fac Med, Montevideo, Uruguay; [Cassina, Adriana; Radi, Rafael; Barbeito, Luis; Cassina, Patricia] Univ Republica, CEINBIO, Fac Med, Montevideo, Uruguay; [Trias, Emiliano] Inst Invest Biol Clemente Estable, Montevideo, Uruguay; [Barbeito, Luis] Inst Pasteur Montevideo, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Miquel, E (corresponding author), Univ Republica, Fac Med, Dept Histol & Embriol, Montevideo, Uruguay.	pcassina@fmed.edu.uy	gandelman, mandi/V-7659-2019; Miquel, Ernesto/O-2912-2018	gandelman, mandi/0000-0003-2697-0390; Miquel, Ernesto/0000-0002-4407-3661; Martinez-Palma, Laura/0000-0002-1094-5409; Barbeito, Luis/0000-0002-3047-232X; Trias, Emiliano/0000-0001-7187-511X	Amyotrophic Lateral Sclerosis Association (ALSA) [1734]; Comision Sectorial de Investigacion Cientifica-Universidad de la Republica, Uruguay (CSIC); Agencia Nacional de Investigacion e Innovacion, Uruguay (ANII); Programa para el Desarrollo de las Ciencias Basicas, Uruguay (PEDECIBA); ANII	Amyotrophic Lateral Sclerosis Association (ALSA); Comision Sectorial de Investigacion Cientifica-Universidad de la Republica, Uruguay (CSIC); Agencia Nacional de Investigacion e Innovacion, Uruguay (ANII); Programa para el Desarrollo de las Ciencias Basicas, Uruguay (PEDECIBA); ANII	This work was supported by grants from Amyotrophic Lateral Sclerosis Association (ALSA, www.alsa.org), Grant # 1734 to PC; Comision Sectorial de Investigacion Cientifica-Universidad de la Republica, Uruguay (CSIC, www.csic.edu.uy) and Agencia Nacional de Investigacion e Innovacion, Uruguay (ANII, www.anii.org.uy) to RR and Programa para el Desarrollo de las Ciencias Basicas, Uruguay (PEDECIBA, www.pedeciba.edu.uy). EM is recipient of a fellowship from ANII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEMAYOR E, 1984, J NEUROCHEM, V42, P38, DOI 10.1111/j.1471-4159.1984.tb09694.x; Almeida A, 2010, P NATL ACAD SCI USA, V107, P738, DOI 10.1073/pnas.0913668107; Alves CJ, 2011, BRAIN RES, V1394, P90, DOI 10.1016/j.brainres.2011.02.060; Andreassen OA, 2001, ANN NEUROL, V50, P112, DOI 10.1002/ana.1085; Arciuch VGA, 2009, ADV DRUG DELIVER REV, V61, P1234, DOI 10.1016/j.addr.2009.04.025; Arciuch VGA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007523; Arnold S, 2012, J STEROID BIOCH MOL; Barbeito AG, 2010, NEUROBIOL DIS, V37, P574, DOI 10.1016/j.nbd.2009.11.007; Blasco H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013223; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Burhans WC, 2009, FREE RADICAL BIO MED, V47, P1282, DOI 10.1016/j.freeradbiomed.2009.05.026; Cassina P, 2002, J NEUROSCI RES, V67, P21, DOI 10.1002/jnr.10107; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cudkowicz ME, 2002, NEUROLOGY, V59, P729, DOI 10.1212/WNL.59.5.729; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Diaz-Amarilla P, 2011, P NATL ACAD SCI USA, V108, P18126, DOI 10.1073/pnas.1110689108; Dupuis L, 2004, NEURODEGENER DIS, V1, P245, DOI 10.1159/000085063; Dupuis L, 2009, CURR OPIN PHARMACOL, V9, P341, DOI 10.1016/j.coph.2009.03.007; Esposito E, 2007, BRAIN RES, V1168, P90, DOI 10.1016/j.brainres.2007.06.095; Gnaiger E, 2007, MITOCHONDRIAL PATHWA; Gong YH, 2000, J NEUROSCI, V20, P660, DOI 10.1523/JNEUROSCI.20-02-00660.2000; Groeneveld GJ, 2004, BRAIN RES, V1021, P128, DOI 10.1016/j.brainres.2004.06.024; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hassoun EA, 2011, TOXICOL ENVIRON CHEM, V93, P332, DOI 10.1080/02772248.2010.509602; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; Heiman-Patterson TD, 2011, AMYOTROPH LATERAL SC, V12, P79, DOI 10.3109/17482968.2010.550626; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Itoh Y, 2003, P NATL ACAD SCI USA, V100, P4879, DOI 10.1073/pnas.0831078100; Kawamata H, 2010, MECH AGEING DEV, V131, P517, DOI 10.1016/j.mad.2010.05.003; Kirkinezos IG, 2003, ANN NEUROL, V53, P804, DOI 10.1002/ana.10597; Knoechel TR, 2006, BIOCHEMISTRY-US, V45, P402, DOI 10.1021/bi051402s; Kumar A, 2010, CLIN CHIM ACTA, V411, P563, DOI 10.1016/j.cca.2010.01.016; Levine JB, 1999, GLIA, V28, P215; Mahoney DJ, 2004, MUSCLE NERVE, V29, P656, DOI 10.1002/mus.20004; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Mattiazzi M, 2002, J BIOL CHEM, V277, P29626, DOI 10.1074/jbc.M203065200; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Morten KJ, 1998, NEUROLOGY, V51, P1331, DOI 10.1212/WNL.51.5.1331; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Naumenko N, 2011, FRONT CELL NEUROSCI, V5, DOI 10.3389/fncel.2011.00026; Park JH, 2007, NEUROSCI LETT, V413, P265, DOI 10.1016/j.neulet.2006.11.058; Seth P, 2011, NEOPLASIA, V13, P60, DOI 10.1593/neo.101020; Stacpoole PW, 2006, PEDIATRICS, V117, P1519, DOI 10.1542/peds.2005-1226; STACPOOLE PW, 1989, METABOLISM, V38, P1124, DOI 10.1016/0026-0495(89)90051-6; Suzuki M, 2007, AMYOTROPH LATERAL SC, V8, P20, DOI 10.1080/17482960600982447; Trieu VN, 1999, BIOCHEM BIOPH RES CO, V258, P685, DOI 10.1006/bbrc.1999.0577; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Vargas MR, 2006, J NEUROCHEM, V97, P687, DOI 10.1111/j.1471-4159.2006.03742.x; Vargas MR, 2005, J BIOL CHEM, V280, P25571, DOI 10.1074/jbc.M501920200; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wilson Jeffrey S, 2003, Vasc Endovascular Surg, V37, P191, DOI 10.1177/153857440303700306; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047	54	73	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34776	10.1371/journal.pone.0034776	http://dx.doi.org/10.1371/journal.pone.0034776			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509356	Green Published, Green Submitted, gold			2022-12-27	WOS:000304805900059
J	Shu, HW; Liu, TT; Chan, HI; Liu, YM; Wu, KM; Shu, HY; Tsai, SF; Hsiao, KJ; Hu, WS; Ng, WV				Shu, Hung-Wei; Liu, Tze-Tze; Chan, Huang-I; Liu, Yen-Ming; Wu, Keh-Ming; Shu, Hung-Yu; Tsai, Shih-Feng; Hsiao, Kwang-Jen; Hu, Wensi S.; Ng, Wailap Victor			Complexity of the Mycoplasma fermentans M64 Genome and Metabolic Essentiality and Diversity among Mycoplasmas	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POLYMERASE-CHAIN-REACTION; CHRONIC-FATIGUE-SYNDROME; REACTION-BASED ASSAY; BACILLUS-SUBTILIS; RNA-POLYMERASE; RESPIRATORY PATHWAYS; ESCHERICHIA-COLI; DNA-REPLICATION; DELTA-SUBUNIT	Recently, the genomes of two Mycoplasma fermentans strains, namely M64 and JER, have been completely sequenced. Gross comparison indicated that the genome of M64 is significantly bigger than the other strain and the difference is mainly contributed by the repetitive sequences including seven families of simple and complex transposable elements ranging from 973 to 23,778 bps. Analysis of these repeats resulted in the identification of a new distinct family of Integrative Conjugal Elements of M. fermentans, designated as ICEF-III. Using the concept of "reaction connectivity", the metabolic capabilities in M. fermentans manifested by the complete and partial connected biomodules were revealed. A comparison of the reported M. pulmonis, M. arthritidis, M. genitalium, B. subtilis, and E. coli essential genes and the genes predicted from the M64 genome indicated that more than 73% of the Mycoplasmas essential genes are preserved in M. fermentans. Further examination of the highly and partly connected reactions by a novel combinatorial phylogenetic tree, metabolic network, and essential gene analysis indicated that some of the pathways (e. g. purine and pyrimidine metabolisms) with partial connected reactions may be important for the conversions of intermediate metabolites. Taken together, in light of systems and network analyses, the diversity among the Mycoplasma species was manifested on the variations of their limited metabolic abilities during evolution.	[Shu, Hung-Wei; Hu, Wensi S.; Ng, Wailap Victor] Natl Yang Ming Univ, Inst Biotechnol Med, Dept Biotechnol, Lab Sci Med, Taipei 112, Taiwan; [Liu, Tze-Tze; Wu, Keh-Ming; Shu, Hung-Yu; Tsai, Shih-Feng] Natl Yang Ming Univ, Genome Res Ctr, Taipei 112, Taiwan; [Chan, Huang-I; Ng, Wailap Victor] Natl Yang Ming Univ, Inst Biomed Informat, Taipei 112, Taiwan; [Liu, Yen-Ming; Tsai, Shih-Feng] Natl Yang Ming Univ, Dept Life Sci, Inst Genome Sci, Taipei 112, Taiwan; [Tsai, Shih-Feng] Natl Hlth Res Inst, Div Mol & Genome Med, Zhunan Town, Miaoli County, Taiwan; [Hsiao, Kwang-Jen] Taipei Vet Gen Hosp, Dept Med Res & Educ, Taipei, Taiwan; [Hsiao, Kwang-Jen] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; Taipei Veterans General Hospital; Taipei City Hospital	Shu, HW (corresponding author), Natl Yang Ming Univ, Inst Biotechnol Med, Dept Biotechnol, Lab Sci Med, Taipei 112, Taiwan.	huws@ym.edu.tw; wvng@ym.edu.tw	Tsai, Shih-Feng/E-3997-2010	Shu, Hung-Yu/0000-0002-2213-9324	National Science Council [96-2628-B-010-003-MY3]; Aim for the Top University; Ministry of Education in Taiwan, Republic of China	National Science Council(Ministry of Science and Technology, Taiwan); Aim for the Top University(Ministry of Education, Taiwan); Ministry of Education in Taiwan, Republic of China	This work was supported by Grant 96-2628-B-010-003-MY3 from the National Science Council and intramural funding from the Aim for the Top University Grant awarded to National Yang Ming University from the Ministry of Education in Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth J G, 2000, HIV Med, V1, P219, DOI 10.1046/j.1468-1293.2000.00032.x; Ainsworth JG, 2000, J INFECTION, V40, P138, DOI 10.1016/S0163-4453(00)80005-5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BAKER TA, 1992, ANNU REV GENET, V26, P447; Barker EN, 2011, J BACTERIOL, V193, P2060, DOI 10.1128/JB.00076-11; BASEMAN JB, 1982, J BACTERIOL, V151, P1514, DOI 10.1128/JB.151.3.1514-1522.1982; BEECHAM HJ, 1991, LANCET, V338, P1014, DOI 10.1016/0140-6736(91)91874-T; BLANCHARD A, 1993, CLIN INFECT DIS, V17, pS272, DOI 10.1093/clinids/17.Supplement_1.S272; Brown DR, 2011, J BACTERIOL, V193, P2892, DOI 10.1128/JB.00309-11; Calcutt MJ, 2002, J BACTERIOL, V184, P6929, DOI 10.1128/JB.184.24.6929-6941.2002; Calcutt MJ, 1999, J BACTERIOL, V181, P7597, DOI 10.1128/JB.181.24.7597-7607.1999; Calderon-Copete SP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S7; Chambaud I, 2001, NUCLEIC ACIDS RES, V29, P2145, DOI 10.1093/nar/29.10.2145; Chingbingyong MI, 1996, ARCH ORAL BIOL, V41, P311, DOI 10.1016/0003-9969(96)84556-0; Choppa PC, 1998, MOL CELL PROBE, V12, P301, DOI 10.1006/mcpr.1998.0186; Chu LJ, 2011, J PROTEOME RES; Cultrera R, 1998, J MED MICROBIOL, V47, P983, DOI 10.1099/00222615-47-11-983; Dallo SF, 2000, MICROB PATHOGENESIS, V29, P301, DOI 10.1006/mpat.2000.0395; DAWSON MS, 1993, ARCH PATHOL LAB MED, V117, P511; de Saro FJL, 1999, J BIOL CHEM, V274, P15953, DOI 10.1074/jbc.274.22.15953; Dybvig K, 2008, INFECT IMMUN, V76, P4000, DOI 10.1128/IAI.00516-08; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; French CT, 2008, MOL MICROBIOL, V69, P67, DOI 10.1111/j.1365-2958.2008.06262.x; Gilroy CB, 2001, RHEUMATOLOGY, V40, P1355, DOI 10.1093/rheumatology/40.12.1355; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Guell M, 2009, SCIENCE, V326, P1268, DOI 10.1126/science.1176951; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haier J, 1999, RHEUMATOLOGY, V38, P504, DOI 10.1093/rheumatology/38.6.504; HAWKINS RE, 1992, J INFECT DIS, V165, P581, DOI 10.1093/infdis/165.3.581; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; Hu WS, 1998, CURR MICROBIOL, V37, P1, DOI 10.1007/s002849900327; Hu WSS, 2001, FEMS MICROBIOL LETT, V198, P159, DOI 10.1111/j.1574-6968.2001.tb10636.x; Ishida N, 2009, CURR MICROBIOL, V58, P535, DOI 10.1007/s00284-009-9362-6; Iyama K, 1996, MICROBIOL IMMUNOL, V40, P907, DOI 10.1111/j.1348-0421.1996.tb01159.x; Jaffe JD, 2004, GENOME RES, V14, P1447, DOI 10.1101/gr.2674004; Johnson S, 2000, J CLIN MICROBIOL, V38, P90; Jones AL, 2003, INFECT IMMUN, V71, P4011, DOI 10.1128/IAI.71.7.4011-4017.2003; KAWAUCHI Y, 1982, MOL GEN GENET, V188, P7, DOI 10.1007/BF00332989; Kitzerow A, 1999, J MED MICROBIOL, V48, P485, DOI 10.1099/00222615-48-5-485; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Kraft M, 1998, AM J RESP CRIT CARE, V158, P998, DOI 10.1164/ajrccm.158.3.9711092; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; LAMPE M, 1988, GENE, V67, P13, DOI 10.1016/0378-1119(88)90003-0; Liu W, 2010, J BACTERIOL, V192, P5844, DOI 10.1128/JB.00946-10; Messick JB, 2011, J BACTERIOL, V193, P2068, DOI 10.1128/JB.00133-11; Minion FC, 2004, J BACTERIOL, V186, P7123, DOI 10.1128/JB.186.21.7123-7133.2004; MONTAGNIER L, 1993, CLIN INFECT DIS, V17, pS309; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Neimark H, 2001, INT J SYST EVOL MICR, V51, P891, DOI 10.1099/00207713-51-3-891; Papazisi L, 2003, MICROBIOL-SGM, V149, P2307, DOI 10.1099/mic.0.26427-0; Pereyre S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000677; PETERSON SN, 1993, J BACTERIOL, V175, P7918, DOI 10.1128/JB.175.24.7918-7930.1993; Pettersson B, 2000, INT J SYST EVOL MICR, V50, P291, DOI 10.1099/00207713-50-1-291; Pitcher D, 1998, FEMS MICROBIOL LETT, V160, P101, DOI 10.1111/j.1574-6968.1998.tb12898.x; Pollack JD, 2002, FRONT BIOSCI-LANDMRK, V7, pD1762, DOI 10.2741/pollack; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rechnitzer H, 2011, MICROBIOL-SGM, V157, P760, DOI 10.1099/mic.0.043208-0; Rikihisa Y, 1997, J CLIN MICROBIOL, V35, P823, DOI 10.1128/JCM.35.4.823-829.1997; Roske K, 2004, MOL MICROBIOL, V52, P1703, DOI 10.1111/j.1365-2958.2004.04087.x; Sasaki Y, 2002, NUCLEIC ACIDS RES, V30, P5293, DOI 10.1093/nar/gkf667; SASAKI Y, 1994, MICROB PATHOGENESIS, V17, P131, DOI 10.1006/mpat.1994.1059; Shibata K, 1999, MICROBIOL IMMUNOL, V43, P521, DOI 10.1111/j.1348-0421.1999.tb02437.x; Shu HW, 2011, J BACTERIOL, V193, P4302, DOI 10.1128/JB.05228-11; Sirand-Pugnet P, 2007, PLOS GENET, V3, P744, DOI 10.1371/journal.pgen.0030075; SMITH SL, 1963, J BACTERIOL, V86, P893, DOI 10.1128/JB.86.5.893-897.1963; Snider J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-216; TAYLORROBINSON D, 1993, CLIN INFECT DIS, V17, pS302, DOI 10.1093/clinids/17.Supplement_1.S302; VANDEMAR.PJ, 1967, ANN NY ACAD SCI, V143, P77; Vasconcelos ATR, 2005, J BACTERIOL, V187, P5568, DOI 10.1128/JB.187.16.5568-5577.2005; Vojdani A, 1998, FEMS IMMUNOL MED MIC, V22, P355; Watanabe T, 1998, FEMS IMMUNOL MED MIC, V22, P241, DOI 10.1111/j.1574-695X.1998.tb01212.x; Watson SP, 1998, MICROBIOL-UK, V144, P3159, DOI 10.1099/00221287-144-11-3159; WEISBURG WG, 1989, J BACTERIOL, V171, P6455, DOI 10.1128/jb.171.12.6455-6467.1989; Westberg J, 2004, GENOME RES, V14, P221, DOI 10.1101/gr.1673304; Wise KS, 2011, INFECT IMMUN, V79, P982, DOI 10.1128/IAI.00726-10; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263	78	4	5	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e32940	10.1371/journal.pone.0032940	http://dx.doi.org/10.1371/journal.pone.0032940			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509252	Green Published, gold, Green Submitted			2022-12-27	WOS:000304805900004
J	Su, YF; Yang, TH; Huang, HT; Liu, LF; Hwang, JL				Su, Yee-Fun; Yang, Tsunghan; Huang, Hoting; Liu, Leroy F.; Hwang, Jaulang			Phosphorylation of Ubc9 by Cdk1 Enhances SUMOylation Activity	PLOS ONE			English	Article							UBIQUITIN-CONJUGATING ENZYME; HUMAN TOPOISOMERASE-I; MAMMALIAN-CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; CHROMOSOME SEGREGATION; PROTEIN SUMOYLATION; SUMO MODIFICATION; YEAST; MITOSIS; KINASE	Increasing evidence has pointed to an important role of SUMOylation in cell cycle regulation, especially for M phase. In the current studies, we have obtained evidence through in vitro studies that the master M phase regulator CDK1/cyclin B kinase phosphorylates the SUMOylation machinery component Ubc9, leading to its enhanced SUMOylation activity. First, we show that CDK1/cyclin B, but not many other cell cycle kinases such as CDK2/cyclin E, ERK1, ERK2, PKA and JNK2/SAPK1, specifically enhances SUMOylation activity. Second, CDK1/cyclin B phosphorylates the SUMOylation machinery component Ubc9, but not SAE1/SAE2 or SUMO1. Third, CDK1/cyclin B-phosphorylated Ubc9 exhibits increased SUMOylation activity and elevated accumulation of the Ubc9-SUMO1 thioester conjugate. Fourth, CDK1/cyclin B enhances SUMOylation activity through phosphorylation of Ubc9 at serine 71. These studies demonstrate for the first time that the cell cycle-specific kinase CDK1/cyclin B phosphorylates a SUMOylation machinery component to increase its overall SUMOylation activity, suggesting that SUMOylation is part of the cell cycle program orchestrated by CDK1 through Ubc9.	[Su, Yee-Fun; Hwang, Jaulang] Natl Def Med Ctr, Grad Inst Life Sci, Taiwan Int Grad Program, Mol & Cell Biol Program, Taipei, Taiwan; [Su, Yee-Fun; Yang, Tsunghan; Huang, Hoting; Hwang, Jaulang] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Liu, Leroy F.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ 08854 USA	National Defense Medical Center; Academia Sinica - Taiwan; Rutgers State University New Brunswick; Rutgers State University Medical Center	Su, YF (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taiwan Int Grad Program, Mol & Cell Biol Program, Taipei, Taiwan.	jaulangh@imb.sinica.edu.tw		Liu, Leroy/0000-0001-9396-763X	National Science Council in Taiwan [NSC98-2311-B-001-008-MY3]; Institute of Molecular Biology, Academia Sinica; National Institutes of Health [CA39662]; NATIONAL CANCER INSTITUTE [R01CA039662] Funding Source: NIH RePORTER	National Science Council in Taiwan(Ministry of Science and Technology, Taiwan); Institute of Molecular Biology, Academia Sinica(Academia Sinica - Taiwan); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the National Science Council in Taiwan NSC98-2311-B-001-008-MY3 (to JH) (http://web1.nsc.gov.tw/mp.aspx?mp=7), Institute of Molecular Biology, Academia Sinica (no grant number) (to JH) (http://www.imb.sinica.edu.tw/en/), and National Institutes of Health CA39662 (to LFL) (http://grants.nih.gov/grants/guide/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHODAIRY F, 1995, J CELL SCI, V108, P475; Azuma Y, 2003, J CELL BIOL, V163, P477, DOI 10.1083/jcb.200304088; Azuma Y, 2005, EMBO J, V24, P2172, DOI 10.1038/sj.emboj.7600700; Bachant J, 2002, MOL CELL, V9, P1169, DOI 10.1016/S1097-2765(02)00543-9; Biggins S, 2001, GENETICS, V159, P453; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Chen TY, 2000, APPL MICROBIOL BIOT, V53, P558, DOI 10.1007/s002530051657; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Fernandez-Miranda G, 2010, J CELL SCI, V123, P2823, DOI 10.1242/jcs.065565; Gaiddon C, 2003, J BIOL CHEM, V278, P27421, DOI 10.1074/jbc.M300251200; Hackbarth JS, 2008, J BIOL CHEM, V283, P16711, DOI 10.1074/jbc.M802246200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Hsiao HH, 2009, MOL CELL PROTEOMICS, V8, P2664, DOI 10.1074/mcp.M900087-MCP200; HWONG CL, 1989, J BIOL CHEM, V264, P14923; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Kimura K, 2001, J BIOL CHEM, V276, P5417, DOI 10.1074/jbc.C000873200; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Ledl A, 2005, ONCOGENE, V24, P3810, DOI 10.1038/sj.onc.1208539; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Matic I, 2008, J PROTEOME RES, V7, P4050, DOI 10.1021/pr800368m; Munarriz E, 2004, MOL CELL BIOL, V24, P10593, DOI 10.1128/MCB.24.24.10593-10610.2004; Nacerddine K, 2005, DEV CELL, V9, P769, DOI 10.1016/j.devcel.2005.10.007; Nowak M, 2006, MOL BIOL CELL, V17, P5324, DOI 10.1091/mbc.E06-05-0413; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; SEUFERT W, 1995, NATURE, V373, P78, DOI 10.1038/373078a0; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Yang ML, 2006, J BIOL CHEM, V281, P8264, DOI 10.1074/jbc.M510364200	33	44	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34250	10.1371/journal.pone.0034250	http://dx.doi.org/10.1371/journal.pone.0034250			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	22509284	gold, Green Published, Green Submitted			2022-12-27	WOS:000304805900021
J	Tian, J; Ban, XQ; Zeng, H; He, JS; Chen, YX; Wang, YW				Tian, Jun; Ban, Xiaoquan; Zeng, Hong; He, Jingsheng; Chen, Yuxin; Wang, Youwei			The Mechanism of Antifungal Action of Essential Oil from Dill (Anethum graveolens L.) on Aspergillus flavus	PLOS ONE			English	Article							IN-VITRO; MITOCHONDRIAL ATPASE; COLORIMETRIC ASSAY; ERGOSTEROL CONTENT; CANDIDA; SUSCEPTIBILITY; QUANTITATION; FLUCONAZOLE; APOPTOSIS; CELLS	The essential oil extracted from the seeds of dill (Anethum graveolens L.) was demonstrated in this study as a potential source of an eco-friendly antifungal agent. To elucidate the mechanism of the antifungal action further, the effect of the essential oil on the plasma membrane and mitochondria of Aspergillus flavus was investigated. The lesion in the plasma membrane was detected through flow cytometry and further verified through the inhibition of ergosterol synthesis. The essential oil caused morphological changes in the cells of A. flavus and a reduction in the ergosterol quantity. Moreover, mitochondrial membrane potential (MMP), acidification of external medium, and mitochondrial ATPase and dehydrogenase activities were detected. The reactive oxygen species (ROS) accumulation was also examined through fluorometric assay. Exposure to dill oil resulted in an elevation of MMP, and in the suppression of the glucose-induced decrease in external pH at 4 mu l/ml. Decreased ATPase and dehydrogenase activities in A. flavus cells were also observed in a dose-dependent manner. The above dysfunctions of the mitochondria caused ROS accumulation in A. flavus. A reduction in cell viability was prevented through the addition of L-cysteine, which indicates that ROS is an important mediator of the antifungal action of dill oil. In summary, the antifungal activity of dill oil results from its ability to disrupt the permeability barrier of the plasma membrane and from the mitochondrial dysfunction-induced ROS accumulation in A. flavus.	[Tian, Jun; Ban, Xiaoquan; Zeng, Hong; He, Jingsheng; Chen, Yuxin; Wang, Youwei] Wuhan Univ, Key Lab Combinatorial Biosynth & Drug Discovery, Minist Educ, Sch Pharmaceut Sci,Inst Tradit Chinese Med & Nat, Wuhan 430072, Peoples R China	Wuhan University	Tian, J (corresponding author), Wuhan Univ, Key Lab Combinatorial Biosynth & Drug Discovery, Minist Educ, Sch Pharmaceut Sci,Inst Tradit Chinese Med & Nat, Wuhan 430072, Peoples R China.	wyw@whu.edu.cn		Tian, Jun/0000-0003-2371-3153	National Mega Project on Major Drug Development [2011ZX09401-302]; Commonweal Specialized Research Fund of China Agriculture [201103016]; Natural Science Foundation of Hubei Province of China [2010CBB02301]; Fundamental Research Funds for the Central Universities [20103010101000185]	National Mega Project on Major Drug Development; Commonweal Specialized Research Fund of China Agriculture; Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Mega Project on Major Drug Development (2011ZX09401-302), the Commonweal Specialized Research Fund of China Agriculture (201103016), the Key Program of Natural Science Foundation of Hubei Province of China (2010CBB02301), and the Fundamental Research Funds for the Central Universities (20103010101000185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; Arthington-Skaggs BA, 2000, ANTIMICROB AGENTS CH, V44, P2081, DOI 10.1128/AAC.44.8.2081-2085.2000; Arthington-Skaggs BA, 2002, ANTIMICROB AGENTS CH, V46, P2477, DOI 10.1128/AAC.46.8.2477-2481.2002; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Balietti M, 2005, BIOGERONTOLOGY, V6, P95, DOI 10.1007/s10522-005-3463-9; BAUER KD, 1993, ANN NY ACAD SCI, V677, P59, DOI 10.1111/j.1749-6632.1993.tb38765.x; Benhar M, 2001, MOL CELL BIOL, V21, P6913, DOI 10.1128/MCB.21.20.6913-6926.2001; Bonini MG, 2006, FREE RADICAL BIO MED, V40, P968, DOI 10.1016/j.freeradbiomed.2005.10.042; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND MD, 1994, BBA-BIOENERGETICS, V1187, P132, DOI 10.1016/0005-2728(94)90099-X; BUTTKE TM, 1993, J IMMUNOL METHODS, V157, P233, DOI 10.1016/0022-1759(93)90092-L; Cardile V, 2009, J ETHNOPHARMACOL, V126, P265, DOI 10.1016/j.jep.2009.08.034; Castelli MV, 2005, BIOCHEM PHARMACOL, V70, P82, DOI 10.1016/j.bcp.2005.04.016; Cheng JJ, 2003, MOL CELL BIOL, V23, P163, DOI 10.1128/MCB.23.1.163-177.2003; Cleveland TE, 2009, TRENDS BIOTECHNOL, V27, P151, DOI 10.1016/j.tibtech.2008.11.008; Cox SD, 2000, J APPL MICROBIOL, V88, P170, DOI 10.1046/j.1365-2672.2000.00943.x; Deak E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007673; Denning DW, 2003, CLIN INFECT DIS, V37, pS265, DOI 10.1086/376526; Editorial Committee of National Chinese Medical Manage Bureau, 1999, CHIN HERB, V15; GRUBMEYER C, 1982, J BIOL CHEM, V257, P2092; Helmerhorst EJ, 2001, P NATL ACAD SCI USA, V98, P14637, DOI 10.1073/pnas.141366998; Jeong SY, 2008, BMB REP, V41, P11, DOI 10.1146/annurev-genet-102108-134850; Kaim G, 1999, EMBO J, V18, P4118, DOI 10.1093/emboj/18.15.4118; Kang K, 2010, MYCOPATHOLOGIA, V170, P391, DOI 10.1007/s11046-010-9341-2; KELLY SL, 1995, BIOCHEM BIOPH RES CO, V207, P910, DOI 10.1006/bbrc.1995.1272; Kobayashi D, 2002, ANTIMICROB AGENTS CH, V46, P3113, DOI 10.1128/AAC.46.10.3113-3117.2002; Leiter E, 2005, ANTIMICROB AGENTS CH, V49, P2445, DOI 10.1128/AAC.49.6.2445-2453.2005; Lunde CS, 2000, ANTIMICROB AGENTS CH, V44, P1943, DOI 10.1128/AAC.44.7.1943-1953.2000; Maertens J, 2004, CLIN INFECT DIS, V39, P1563, DOI 10.1086/423381; Manavathu EK, 1999, ANTIMICROB AGENTS CH, V43, P2950, DOI 10.1128/AAC.43.12.2950; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P3402, DOI 10.1128/JCM.39.9.3402-3408.2001; Mello EO, 2011, CURR MICROBIOL, V62, P1209, DOI 10.1007/s00284-010-9847-3; Monsefi M, 2006, PHYTOTHER RES, V20, P865, DOI 10.1002/ptr.1959; Pinto E, 2006, J MED MICROBIOL, V55, P1367, DOI 10.1099/jmm.0.46443-0; Pinto E, 2009, J MED MICROBIOL, V58, P1454, DOI 10.1099/jmm.0.010538-0; Pozniakovsky AI, 2005, J CELL BIOL, V168, P257, DOI 10.1083/jcb.200408145; Qi GF, 2010, PEPTIDES, V31, P1978, DOI 10.1016/j.peptides.2010.08.003; Rafii F, 2007, CHEMOTHERAPY, V53, P21, DOI 10.1159/000098246; RODRIGUEZ RJ, 1985, BIOCHIM BIOPHYS ACTA, V837, P336, DOI 10.1016/0005-2760(85)90057-8; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; ROWLANDS RT, 1974, MOL GEN GENET, V132, P73, DOI 10.1007/BF00268232; Simbula G, 1997, AM J PHYSIOL-CELL PH, V273, pC479, DOI 10.1152/ajpcell.1997.273.2.C479; SQUIRE RA, 1981, SCIENCE, V214, P877, DOI 10.1126/science.7302565; Starkov AA, 2003, J NEUROCHEM, V86, P1101, DOI 10.1046/j.1471-4159.2003.01908.x; Tang XQ, 2005, BRAIN RES, V1057, P57, DOI 10.1016/j.brainres.2005.07.072; Tian J, 2012, FOOD CHEM, V130, P520, DOI 10.1016/j.foodchem.2011.07.061; Tian J, 2011, FOOD CONTROL, V22, P1992, DOI 10.1016/j.foodcont.2011.05.018; Varma J, 2001, INT J FOOD MICROBIOL, V68, P207, DOI 10.1016/S0168-1605(01)00506-2; White TC, 1998, CLIN MICROBIOL REV, V11, P382, DOI 10.1128/CMR.11.2.382; Williams JH, 2004, AM J CLIN NUTR, V80, P1106, DOI 10.1093/ajcn/80.5.1106; Wu XZ, 2009, BBA-GEN SUBJECTS, V1790, P770, DOI 10.1016/j.bbagen.2009.05.002; Yan L, 2009, J ANTIMICROB CHEMOTH, V64, P764, DOI 10.1093/jac/dkp273; Yazdanparast R, 2001, CYTOBIOS, V105, P185; Zeng H, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/659704; Zorov DB, 1997, BIOSCIENCE REP, V17, P507, DOI 10.1023/A:1027304122259	56	205	239	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2012	7	1							e30147	10.1371/journal.pone.0030147	http://dx.doi.org/10.1371/journal.pone.0030147			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	907XU	22272289	Green Submitted, Green Published, gold			2022-12-27	WOS:000301454400067
J	Conte, V; Ulrich, F; Baum, B; Munoz, J; Veldhuis, J; Brodland, W; Miodownik, M				Conte, Vito; Ulrich, Florian; Baum, Buzz; Munoz, Jose; Veldhuis, Jim; Brodland, Wayne; Miodownik, Mark			A Biomechanical Analysis of Ventral Furrow Formation in the Drosophila Melanogaster Embryo	PLOS ONE			English	Article							GASTRULATION; MECHANICS; FORCES	The article provides a biomechanical analysis of ventral furrow formation in the Drosophila melanogaster embryo. Ventral furrow formation is the first large-scale morphogenetic movement in the fly embryo. It involves deformation of a uniform cellular monolayer formed following cellularisation, and has therefore long been used as a simple system in which to explore the role of mechanics in force generation. Here we use a quantitative framework to carry out a systematic perturbation analysis to determine the role of each of the active forces observed. The analysis confirms that ventral furrow invagination arises from a combination of apical constriction and apical-basal shortening forces in the mesoderm, together with a combination of ectodermal forces. We show that the mesodermal forces are crucial for invagination: the loss of apical constriction leads to a loss of the furrow, while the mesodermal radial shortening forces are the primary cause of the internalisation of the future mesoderm as the furrow rises. Ectodermal forces play a minor but significant role in furrow formation: without ectodermal forces the furrow is slower to form, does not close properly and has an aberrant morphology. Nevertheless, despite changes in the active mesodermal and ectodermal forces lead to changes in the timing and extent of furrow, invagination is eventually achieved in most cases, implying that the system is robust to perturbation and therefore over-determined.	[Conte, Vito] Inst Bioengn Catalonia, Barcelona, Spain; [Ulrich, Florian] New York Hosp, Skirball Inst Biomol Med, New York, NY 10021 USA; [Baum, Buzz] UCL, Med Res Council Lab Mol Cell Biol, London, England; [Munoz, Jose] Univ Politecn Cataluna, Lab Calcul Numer, Dept Appl Math 3, Barcelona, Spain; [Veldhuis, Jim; Brodland, Wayne] Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada; [Brodland, Wayne] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Miodownik, Mark] UCL, Dept Mech Engn, London, England	Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; NewYork-Presbyterian Hospital; University of London; University College London; Universitat Politecnica de Catalunya; University of Waterloo; University of Waterloo; University of London; University College London	Conte, V (corresponding author), Inst Bioengn Catalonia, Barcelona, Spain.	m.miodownik@ucl.ac.uk	Klenk, Jochen/C-2164-2012; Becker, Clemens/ABI-5405-2020; Chiari, Lorenzo/N-7622-2015; Klenk, Jochen/R-3614-2019; Munoz, Jose J/B-2475-2009; Aminian, Kamiar/H-4568-2011; Conte, Vito/I-1194-2015	Chiari, Lorenzo/0000-0002-2318-4370; Klenk, Jochen/0000-0002-5987-447X; Munoz, Jose J/0000-0002-0083-3673; Aminian, Kamiar/0000-0002-6582-5375; Conte, Vito/0000-0002-7439-2866; Baum, Buzz/0000-0002-9201-6186	Human Frontiers Science Program (HFSP); Natural Sciences and Engineering Research Council of Canada (NSERC); Engineering and Physical Science Research Council of UK; Royal Society; New Jersey Commission of Cancer Research (NJCCR); Cancer Research UK; EPSRC [EP/I00159X/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/02495] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I00159X/2] Funding Source: researchfish; Medical Research Council [MC_CF12266] Funding Source: researchfish	Human Frontiers Science Program (HFSP)(Human Frontier Science Program); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Engineering and Physical Science Research Council of UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); New Jersey Commission of Cancer Research (NJCCR); Cancer Research UK(Cancer Research UK); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding to WB and JV was provided by the Human Frontiers Science Program (HFSP); to WB and SN by the Natural Sciences and Engineering Research Council of Canada (NSERC); to MM and VC by the Engineering and Physical Science Research Council of UK; to BB from the Royal Society and Cancer Research UK; and to FU by the New Jersey Commission of Cancer Research (NJCCR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allena R, 2010, J MECH BEHAV BIOMED, V3, P313, DOI 10.1016/j.jmbbm.2010.01.001; Bittig T, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/6/063001; Brodland GW, 2010, P NATL ACAD SCI USA, V107, P22111, DOI 10.1073/pnas.1006591107; Butler LC, 2009, NAT CELL BIOL, V11, P859, DOI 10.1038/ncb1894; Chen XG, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015003; CLAUSI DA, 1993, DEVELOPMENT, V118, P1013; Conte V, 2008, J MECH BEHAV BIOMED, V1, P188, DOI 10.1016/j.jmbbm.2007.10.002; Conte V, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016010; Costa M, 1993, DEV DROSOPHILA MELAN; Cranston PG, 2010, ANN BIOMED ENG, V38, P2937, DOI 10.1007/s10439-010-9998-1; DAVIDSON LA, 1995, DEVELOPMENT, V121, P2005; Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009; Gregor T, 2005, P NATL ACAD SCI USA, V102, P18403, DOI 10.1073/pnas.0509483102; Hutson MS, 2009, BIOPHYS J, V97, P3075, DOI 10.1016/j.bpj.2009.09.034; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; Lecuit T, 2002, DEV CELL, V2, P425, DOI 10.1016/S1534-5807(02)00141-7; Leptin M, 1999, EMBO J, V18, P3187, DOI 10.1093/emboj/18.12.3187; LEPTIN M, 1990, DEVELOPMENT, V110, P73; Leptin M, 1995, ANNU REV CELL DEV BI, V11, P189; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; Munoz JJ, 2007, J BIOMECH, V40, P1372, DOI 10.1016/j.jbiomech.2006.05.006; Munoz JJ, 2010, BIOMECH MODEL MECHAN, V9, P451, DOI 10.1007/s10237-009-0187-9; ODELL GM, 1981, DEV BIOL, V85, P446, DOI 10.1016/0012-1606(81)90276-1; Pouille PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000098; Pouille PA, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015005; Roth S., 2004, P105; Schunn C.D., 2005, PSYCHOLOGIE KOGNITIO, P115; Sherrard K, 2010, CURR BIOL, V20, P1499, DOI 10.1016/j.cub.2010.06.075; SWEETON D, 1991, DEVELOPMENT, V112, P775; Tamulonis C, 2011, DEV BIOL, V351, P217, DOI 10.1016/j.ydbio.2010.10.017; Zhou J, 2009, DEVELOPMENT, V136, P677, DOI 10.1242/dev.026211; Zienkiewicz OC, 2005, FINITE ELEMENT METHOD FOR FLUID DYNAMICS, 6TH EDITION, P1	32	359	364	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34473	10.1371/journal.pone.0034473	http://dx.doi.org/10.1371/journal.pone.0034473			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511944	Green Published, Green Submitted, gold			2022-12-27	WOS:000305338600030
J	Wu, B; Miao, YF; Bai, YR; Ye, M; Xu, YJ; Chen, HF; Shen, JF; Qiu, YM				Wu, Bin; Miao, Yifeng; Bai, Yongrui; Ye, Min; Xu, Yuejuan; Chen, Huafeng; Shen, Jinfang; Qiu, Yongming			Subgroup Economic Analysis for Glioblastoma in a Health Resource-Limited Setting	PLOS ONE			English	Article							HIGH-GRADE GLIOMA; RECURRENT GLIOBLASTOMA; ADJUVANT TEMOZOLOMIDE; COST-EFFECTIVENESS; MALIGNANT GLIOMAS; RADIOTHERAPY; THERAPY; CHEMOTHERAPY; MULTIFORME; BEVACIZUMAB	Background: The aim of this research was to evaluate the economic outcomes of radiotherapy (RT), temozolomide (TMZ) and nitrosourea (NT) strategies for glioblastoma patients with different prognostic factors. Methodology/Principal Findings: A Markov model was developed to track monthly patient transitions. Transition probabilities and utilities were derived primarily from published reports. Costs were estimated from the perspective of the Chinese healthcare system. The survival data with different prognostic factors were simulated using Weibull survival models. Costs over a 5-year period and quality-adjusted life years (QALYs) were estimated. Probabilistic sensitivity and one-way analyses were performed. The baseline analysis in the overall cohort showed that the TMZ strategy increased the cost and QALY relative to the RT strategy by $ 25,328.4 and 0.29, respectively; and the TMZ strategy increased the cost and QALY relative to the NT strategy by $ 23,906.5 and 0.25, respectively. Therefore, the incremental cost effectiveness ratio (ICER) per additional QALY of the TMZ strategy, relative to the RT strategy and the NT strategy, amounts to $ 87,940.6 and $ 94,968.3, respectively. Subgroups with more favorable prognostic factors achieved more health benefits with improved ICERs. Probabilistic sensitivity analyses confirmed that the TMZ strategy was not cost-effective. In general, the results were most sensitive to the cost of TMZ, which indicates that better outcomes could be achieved by decreasing the cost of TMZ. Conclusions/Significance: In health resource-limited settings, TMZ is not a cost-effective option for glioblastoma patients. Selecting patients with more favorable prognostic factors increases the likelihood of cost-effectiveness.	[Wu, Bin; Chen, Huafeng; Shen, Jinfang] Shanghai Jiao Tong Univ, Sch Med, Dept Pharm, Clin Outcomes & Econ Grp,Renji Hosp, Shanghai 200030, Peoples R China; [Miao, Yifeng] Nanjing Med Univ, Wuxi Peoples Hosp 2, Ctr Neurosci, Shanghai, Peoples R China; [Bai, Yongrui] Shanghai Jiao Tong Univ, Sch Med, Dept Radiotherapy, Renji Hosp, Shanghai 200030, Peoples R China; [Ye, Min] Shanghai Jiao Tong Univ, Sch Med, Dept Oncol, Renji Hosp, Shanghai 200030, Peoples R China; [Xu, Yuejuan] South East Univ, Sch Med, Dept Oncol, Hosp Nanjing 2, Nanjing, Jiangsu, Peoples R China; [Qiu, Yongming] Shanghai Jiao Tong Univ, Sch Med, Dept Neurosurg, Renji Hosp, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Nanjing Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Southeast University - China; Shanghai Jiao Tong University	Wu, B (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Pharm, Clin Outcomes & Econ Grp,Renji Hosp, Shanghai 200030, Peoples R China.	qiuzhoub@sina.com	Ma, Yimian/AAD-8777-2019	Ma, Yimian/0000-0003-2466-7697; Yuan, lichai/0000-0002-6413-8848	project of building hospital clinical key disciplines [RJ.4101307]; Shanghai government [0952nm03900]	project of building hospital clinical key disciplines; Shanghai government	This work was supported by a project of building hospital clinical key disciplines (NO. RJ.4101307) and a grant from Shanghai government (NO. 0952nm03900). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afra D, 2002, LANCET, V359, P1011; Aoki T, 2006, J NEUROSURG, V105, P385, DOI 10.3171/jns.2006.105.3.385; Chamberlain M, 2011, EXPERT REV NEUROTHER, V11, P519, DOI [10.1586/ERN.11.30, 10.1586/ern.11.30]; Chamberlain MC, 2010, J NEURO-ONCOL, V96, P259, DOI 10.1007/s11060-009-9957-6; Eichler HG, 2004, VALUE HEALTH, V7, P518, DOI 10.1111/j.1524-4733.2004.75003.x; Garside R, 2007, Health Technol Assess, V11, piii; Garside R, 2007, HEALTH TECHNOL ASSES, V11, P221; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hu Y M, 1999, Sheng Li Xue Bao, V51, P45; Lamers LM, 2008, CANCER-AM CANCER SOC, V112, P1337, DOI 10.1002/cncr.23297; Mangiola A, 2010, EXPERT REV NEUROTHER, V10, P507, DOI [10.1586/ern.09.158, 10.1586/ERN.09.158]; Mason WP, 2005, NAT CLIN PRACT NEURO, V1, P88, DOI 10.1038/ncpneuro0045; Moen MD, 2010, DRUGS, V70, P181, DOI 10.2165/11203890-000000000-00000; Mrugala MM, 2008, NAT CLIN PRACT ONCOL, V5, P476, DOI 10.1038/ncponc1155; Nishikawa R, 2010, NEUROL MED-CHIR, V50, P713, DOI 10.2176/nmc.50.713; Remak E, 2008, J CLIN ONCOL, V26, P3995, DOI 10.1200/JCO.2007.13.2662; Schmidt F, 2006, NEUROLOGY, V66, P587, DOI 10.1212/01.wnl.0000197792.73656.c2; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Uyl-de Groot Carin A, 2009, Expert Rev Pharmacoecon Outcomes Res, V9, P235, DOI 10.1586/erp.09.15; Vordermark D, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-247; Wasserfallen JB, 2005, NEURO-ONCOLOGY, V7, P189, DOI 10.1215/S1152851704000687; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wolff JEA, 2008, J NEURO-ONCOL, V88, P57, DOI 10.1007/s11060-008-9533-5	24	59	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34588	10.1371/journal.pone.0034588	http://dx.doi.org/10.1371/journal.pone.0034588			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511951	Green Submitted, Green Published, gold			2022-12-27	WOS:000305338600037
J	Long, LE; Chesworth, R; Huang, XF; Wong, A; Spiro, A; McGregor, IS; Arnold, JC; Karl, T				Long, Leonora E.; Chesworth, Rose; Huang, Xu-Feng; Wong, Alexander; Spiro, Adena; McGregor, Iain S.; Arnold, Jonathon C.; Karl, Tim			Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice	PLOS ONE			English	Article							SUPERIOR TEMPORAL GYRUS; PREPULSE INHIBITION; SOCIAL-INTERACTION; BASE-LINE; RECEPTORS; DELTA(9)-TETRAHYDROCANNABINOL; DELTA-9-TETRAHYDROCANNABINOL; GENE; RAT; BEHAVIOR	The cannabis constituent cannabidiol (CBD) possesses anxiolytic and antipsychotic properties. We have previously shown that transmembrane domain neuregulin 1 mutant (Nrg1 TM HET) mice display altered neurobehavioural responses to the main psychoactive constituent of cannabis, Delta(9)-tetrahydrocannabinol. Here we investigated whether Nrg1 TM HET mice respond differently to CBD and whether CBD reverses schizophrenia-related phenotypes expressed by these mice. Adult male Nrg1 TM HET and wild type-like littermates (WT) received vehicle or CBD (1, 50 or 100 mg/kg i.p.) for 21 days. During treatment and 48 h after withdrawal we measured behaviour, whole blood CBD concentrations and autoradiographic receptor binding. Nrg1 HET mice displayed locomotor hyperactivity, PPI deficits and reduced 5-HT2A receptor binding density in the substantia nigra, but these phenotypes were not reversed by CBD. However, long-term CBD (50 and 100 mg/kg) selectively enhanced social interaction in Nrg1 TM HET mice. Furthermore, acute CBD (100 mg/kg) selectively increased PPI in Nrg1 TM HET mice, although tolerance to this effect was manifest upon repeated CBD administration. Long-term CBD (50 mg/kg) also selectively increased GABA(A) receptor binding in the granular retrosplenial cortex in Nrg1 TM HET mice and reduced 5-HT2A binding in the substantia nigra in WT mice. Nrg1 appears necessary for CBD-induced anxiolysis since only WT mice developed decreased anxiety-related behaviour with repeated CBD treatment. Altered pharmacokinetics in mutant mice could not explain our findings since no genotype differences existed in CBD blood concentrations. Here we demonstrate that Nrg1 modulates acute and long-term neurobehavioural effects of CBD, which does not reverse the schizophrenia-relevant phenotypes.	[Long, Leonora E.; Chesworth, Rose; Huang, Xu-Feng; Arnold, Jonathon C.; Karl, Tim] Schizophrenia Res Inst, Darlinghurst, NSW, Australia; [Long, Leonora E.; Chesworth, Rose; Karl, Tim] Neurosci Res Australia, Randwick, NSW, Australia; [Long, Leonora E.; Karl, Tim] Univ New S Wales, Sydney, NSW, Australia; [Huang, Xu-Feng] Univ Wollongong, Sch Hlth Sci, Ctr Translat Neurosci, Wollongong, NSW, Australia; [Wong, Alexander; Spiro, Adena; Arnold, Jonathon C.] Univ Sydney, Dept Pharmacol, Sydney, NSW 2006, Australia; [McGregor, Iain S.; Arnold, Jonathon C.] Brain & Mind Res Inst, Sydney, NSW, Australia; [McGregor, Iain S.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of Wollongong; University of Sydney; University of Sydney; University of Sydney	Long, LE (corresponding author), Schizophrenia Res Inst, Darlinghurst, NSW, Australia.	jonathon.arnold@sydney.edu.au; t.karl@neura.edu.au	Wong, Alexander/GZM-2929-2022; Huang, Xu-Feng/H-7408-2015; Huang, Xu-Feng/D-6053-2013; Karl, Tim/E-2088-2011; Arnold, Jonathon C/ACF-5231-2022; Long, Leonora/D-2576-2010	Wong, Alexander/0000-0002-5295-2797; Huang, Xu-Feng/0000-0002-5895-2253; Huang, Xu-Feng/0000-0002-5895-2253; Karl, Tim/0000-0001-9904-8482; Long, Leonora/0000-0002-1759-4138; Chesworth, Rose/0000-0002-3758-9598; Arnold, Jonathon/0000-0002-0159-9997; mcgregor, iain/0000-0002-9307-7159	National Health and Medical Research Council (NHMRC) [493301, 568752]; Schizophrenia Research Institute; NSW Health; Baxter Charitable Foundation; Alma Hazel Eddy Trust; National Alliance for Research on Schizophrenia and Depression	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Schizophrenia Research Institute; NSW Health; Baxter Charitable Foundation; Alma Hazel Eddy Trust; National Alliance for Research on Schizophrenia and Depression(NARSAD)	This work was supported by the National Health and Medical Research Council (NHMRC, project grant 493301) and by the Schizophrenia Research Institute, utilising infrastructure funding from NSW Health, the Baxter Charitable Foundation and the Alma Hazel Eddy Trust. TK is funded by a NHMRC career development award (568752). TK and JCA are also supported by the National Alliance for Research on Schizophrenia and Depression (Young Investigator Awards). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert L, 2006, GENES BRAIN BEHAV, V5, P423, DOI 10.1111/j.1601-183X.2005.00178.x; Bergamaschi MM, 2011, NEUROPSYCHOPHARMACOL, V36, P1219, DOI 10.1038/npp.2011.6; Bhattacharyya S, 2010, NEUROPSYCHOPHARMACOL, V35, P764, DOI 10.1038/npp.2009.184; Bisogno T, 2001, BRIT J PHARMACOL, V134, P845, DOI 10.1038/sj.bjp.0704327; Boucher AA, 2007, NEUROSCIENCE, V149, P861, DOI 10.1016/j.neuroscience.2007.08.020; Boucher AA, 2007, PSYCHOPHARMACOLOGY, V192, P325, DOI 10.1007/s00213-007-0721-3; Boucher AA, 2011, INT J NEUROPSYCHOPH, V14, P631, DOI 10.1017/S146114571000091X; Braff DL, 2001, PSYCHOPHARMACOLOGY, V156, P234, DOI 10.1007/s002130100810; Campos AC, 2008, PSYCHOPHARMACOLOGY, V199, P223, DOI 10.1007/s00213-008-1168-x; Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026; Cato MA, 2004, J COGNITIVE NEUROSCI, V16, P167, DOI 10.1162/089892904322984481; CORBETT R, 1991, PSYCHOPHARMACOLOGY, V104, P312, DOI 10.1007/BF02246029; Crippa JAD, 2004, NEUROPSYCHOPHARMACOL, V29, P417, DOI 10.1038/sj.npp.1300340; Dean B, 2008, SCHIZOPHR RES, V99, P341, DOI 10.1016/j.schres.2007.10.013; Deiana S, 2012, PSYCHOPHARMACOLOGY, V219, P859, DOI 10.1007/s00213-011-2415-0; DENENBERG VH, 1969, ANN NY ACAD SCI, V159, P852, DOI 10.1111/j.1749-6632.1969.tb12983.x; Deng C, 2006, EXP BRAIN RES, V168, P587, DOI 10.1007/s00221-005-0290-9; Deng Chao, 2007, Neurosci Bull, V23, P341, DOI 10.1007/s12264-007-0051-9; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Duffy L, 2010, NEUROSCIENCE, V170, P800, DOI 10.1016/j.neuroscience.2010.07.042; El-Alfy AT, 2010, PHARMACOL BIOCHEM BE, V95, P434, DOI 10.1016/j.pbb.2010.03.004; Ellenbroek BA, 2000, BEHAV PHARMACOL, V11, P223, DOI 10.1097/00008877-200006000-00006; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; File SE, 2003, EUR J PHARMACOL, V463, P35, DOI 10.1016/S0014-2999(03)01273-1; Frisher M, 2005, J EPIDEMIOL COMMUN H, V59, P847, DOI 10.1136/jech.2004.030833; Fusar-Poli P, 2009, ARCH GEN PSYCHIAT, V66, P95, DOI 10.1001/archgenpsychiatry.2008.519; Geyer MA, 2003, CURR PROTOC NEUROSCI; Gomes FV, 2011, PSYCHOPHARMACOLOGY, V213, P465, DOI 10.1007/s00213-010-2036-z; Gunasekaran N, 2009, BRIT J PHARMACOL, V158, P1330, DOI 10.1111/j.1476-5381.2009.00399.x; Gururajan A, 2011, BEHAV BRAIN RES, V222, P299, DOI 10.1016/j.bbr.2011.03.053; Han M, 2009, NEUROSCIENCE, V164, P1754, DOI 10.1016/j.neuroscience.2009.09.041; Kang K, 2009, PROG NEURO-PSYCHOPH, V33, P867, DOI 10.1016/j.pnpbp.2009.04.010; Karl T, 2007, GENES BRAIN BEHAV, V6, P677, DOI 10.1111/j.1601-183X.2006.00298.x; Karl T, 2011, BEHAV BRAIN RES, V223, P336, DOI 10.1016/j.bbr.2011.04.051; Karschner EL, 2010, ANAL BIOANAL CHEM, V397, P603, DOI 10.1007/s00216-010-3599-6; Keene CS, 2008, BEHAV NEUROSCI, V122, P1070, DOI 10.1037/a0012895; Klein C, 2011, PSYCHOPHARM IN PRESS; Koethe D, 2009, PSYCHOPHARMACOLOGY, V206, P551, DOI 10.1007/s00213-009-1591-7; Koethe D, 2009, BRIT J PSYCHIAT, V194, P371, DOI 10.1192/bjp.bp.108.053843; KREUZ DS, 1973, SCIENCE, V179, P391, DOI 10.1126/science.179.4071.391; Long LE, 2006, NEUROPSYCHOPHARMACOL, V31, P795, DOI 10.1038/sj.npp.1300838; Long LE, 2010, INT J NEUROPSYCHOPH, V13, P861, DOI 10.1017/S1461145709990605; Long LE, 2010, PSYCHOPHARMACOLOGY, V211, P277, DOI 10.1007/s00213-010-1896-6; Malone DT, 2009, PHARMACOL BIOCHEM BE, V93, P91, DOI 10.1016/j.pbb.2009.04.010; MARTIN WR, 1963, PSYCHOPHARMACOLOGIA, V4, P247, DOI 10.1007/BF00408180; McLaren J, 2008, ADDICTION, V103, P1100, DOI 10.1111/j.1360-0443.2008.02230.x; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Moreira FA, 2005, EUR J PHARMACOL, V512, P199, DOI 10.1016/j.ejphar.2005.02.040; Moreira FA, 2006, PROG NEURO-PSYCHOPH, V30, P1466, DOI 10.1016/j.pnpbp.2006.06.004; Nadulski T, 2005, J ANAL TOXICOL, V29, P782, DOI 10.1093/jat/29.8.782; Newell KA, 2007, J NEURAL TRANSM, V114, P995, DOI 10.1007/s00702-007-0668-x; O'Tuathaigh CMP, 2007, NEUROSCIENCE, V147, P18, DOI 10.1016/j.neuroscience.2007.03.051; O'Tuathaigh CMP, 2008, PROG NEURO-PSYCHOPH, V32, P462, DOI 10.1016/j.pnpbp.2007.09.018; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Petitet F, 1998, LIFE SCI, V63, pPL1, DOI 10.1016/S0024-3205(98)00238-0; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Porras G, 2002, NEUROPSYCHOPHARMACOL, V26, P311, DOI 10.1016/S0893-133X(01)00333-5; Powell CM, 2006, BIOL PSYCHIAT, V59, P1198, DOI 10.1016/j.biopsych.2006.05.008; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; SCHMIDT CJ, 1992, EUR J PHARMACOL, V223, P65, DOI 10.1016/0014-2999(92)90819-P; Schwarcz G, 2009, J CLIN PSYCHOPHARM, V29, P255, DOI 10.1097/JCP.0b013e3181a6bc3b; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Thomas A, 2007, BRIT J PHARMACOL, V150, P613, DOI 10.1038/sj.bjp.0707133; van den Buuse M, 2009, INT J NEUROPSYCHOPH, V12, P1383, DOI 10.1017/S1461145709000388; Yee BK, 2004, NEUROPSYCHOPHARMACOL, V29, P1865, DOI 10.1038/sj.npp.1300480; Zanelati TV, 2010, BRIT J PHARMACOL, V159, P122, DOI 10.1111/j.1476-5381.2009.00521.x; Zuardi AW, 2006, J PSYCHOPHARMACOL, V20, P683, DOI 10.1177/0269881106060967; ZUARDI AW, 1982, PSYCHOPHARMACOLOGY, V76, P245, DOI 10.1007/BF00432554	68	73	74	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 3	2012	7	4							e34129	10.1371/journal.pone.0034129	http://dx.doi.org/10.1371/journal.pone.0034129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	952PZ	23272167	gold, Green Submitted, Green Published			2022-12-27	WOS:000304805900013
J	Liu, HB; Liu, SB; Li, Y; Wang, XH; Xue, WJ; Ge, GQ; Luo, XH				Liu, Hongbao; Liu, Shuibing; Li, Yang; Wang, Xiaohong; Xue, Wujun; Ge, Guanqun; Luo, Xiaohui			The Role of SDF-1-CXCR4/CXCR7 Axis in the Therapeutic Effects of Hypoxia-Preconditioned Mesenchymal Stem Cells for Renal Ischemia/Reperfusion Injury	PLOS ONE			English	Article							MARROW STROMAL CELLS; ACUTE KIDNEY INJURY; BONE-MARROW; CXCR4; MIGRATION; EXPRESSION; REPAIR; DIFFERENTIATION; MOBILIZATION; CONTRIBUTES	In vitro hypoxic preconditioning (HP) of mesenchymal stem cells (MSCs) could ameliorate their viability and tissue repair capabilities after transplantation into the injured tissue through yet undefined mechanisms. There is also experimental evidence that HP enhances the expression of both stromal-derived factor-1 (SDF-1) receptors, CXCR4 and CXCR7, which are involved in migration and survival of MSCs in vitro, but little is known about their role in the in vivo therapeutic effectiveness of MSCs in renal ischemia/reperfusion (I/R) injury. Here, we evaluated the role of SDF-1-CXCR4/CXCR7 pathway in regulating chemotaxis, viability and paracrine actions of HP-MSCs in vitro and in vivo. Compared with normoxic preconditioning (NP), HP not only improved MSC chemotaxis and viability but also stimulated secretion of proangiogenic and mitogenic factors. Importantly, both CXCR4 and CXCR7 were required for the production of paracrine factors by HP-MSCs though the former was only responsible for chemotaxis while the latter was for viability. SDF-1 alpha expression was upregulated in postischemic kidneys. After 24 h systemical administration following I/R, HP-MSCs but not NP-MSCs were selectively recruited to ischemic kidneys and this improved recruitment was abolished by neutralization of CXCR4, but not CXCR7. Furthermore, the increased recruitment of HP-MSCs was associated with enhanced functional recovery, accelerated mitogenic response, and reduced apoptotic cell death. In addition, neutralization of either CXCR4 or CXCR7 impaired the improved therapeutic potential of HP-MSCs. These results advance our knowledge about SDF-1-CXCR4/CXCR7 axis as an attractive target pathway for improving the beneficial effects of MSC-based therapies for renal I/R.	[Liu, Hongbao] Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Peoples R China; [Liu, Shuibing] Fourth Mil Med Univ, Sch Pharm, Dept Pharmacol, Xian 710032, Peoples R China; [Li, Yang; Wang, Xiaohong; Xue, Wujun; Ge, Guanqun; Luo, Xiaohui] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Renal Transplant, Xian 710049, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Xi'an Jiaotong University	Liu, HB (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Nephrol, Xian 710032, Peoples R China.	xjsnlhb@yahoo.com.cn; xjsnxwj@126.com	Li, Yuan/GXV-1310-2022; Li, Yang/GWM-7879-2022; li, yong/HDN-3885-2022	Liu, Hui/0000-0002-4548-2002; Liu, Hongbao/0000-0002-1283-4956	National Nature Science Foundation of China [81000309, 30900277]; Natural Science Basis Research Plan in Shaanxi Province of China [2009K12-02]; Major Scientific and Technological Special Projects of Shaanxi Province of China [2007ZDKG-67]; Youth Foundation of First Affiliated Hospital, Medical College, Xi'an Jiaotong University [2011YK.20]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basis Research Plan in Shaanxi Province of China; Major Scientific and Technological Special Projects of Shaanxi Province of China; Youth Foundation of First Affiliated Hospital, Medical College, Xi'an Jiaotong University	This work was supported by grants from National Nature Science Foundation of China (Nos. 81000309 and 30900277), Natural Science Basis Research Plan in Shaanxi Province of China (No: 2009K12-02), Major Scientific and Technological Special Projects of Shaanxi Province of China (No. 2007ZDKG-67) and Youth Foundation of the First Affiliated Hospital, Medical College, Xi'an Jiaotong University (No. 2011YK.20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019029; Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Bi B, 2007, J AM SOC NEPHROL, V18, P2486, DOI 10.1681/ASN.2007020140; Bussolati B, 2012, AM J PHYSIOL-RENAL, V302, pF116, DOI 10.1152/ajprenal.00184.2011; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chacko SM, 2009, AM J PHYSIOL-HEART C, V296, pH1263, DOI 10.1152/ajpheart.01311.2008; Chen YT, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-51; Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374; Das R, 2010, TISSUE ENG PART B-RE, V16, P159, DOI 10.1089/ten.TEB.2009.0296; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; Gao H, 2009, STEM CELLS, V27, P857, DOI 10.1002/stem.23; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Grayson WL, 2006, J CELL PHYSIOL, V207, P331, DOI 10.1002/jcp.20571; Grenz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014812; Guo JK, 2010, ANNU REV PHYSIOL, V72, P357, DOI 10.1146/annurev.physiol.010908.163245; Gupta S, 2010, AM J PHYSIOL-RENAL, V298, pF209, DOI 10.1152/ajprenal.00451.2009; Honczarenko M, 2006, STEM CELLS, V24, P1030, DOI 10.1634/stemcells.2005-0319; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Humphreys BD, 2008, ANNU REV MED, V59, P311, DOI 10.1146/annurev.med.59.061506.154239; Hung SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000416; Jayakumar C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026776; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kanazawa H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019195; Kentrup D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026419; Kubo M, 2009, J CELL PHYSIOL, V220, P508, DOI 10.1002/jcp.21803; Lameire N, 2006, NAT CLIN PRACT NEPHR, V2, P364, DOI 10.1038/ncpneph0218; Li B, 2010, CIRCULATION, V121, P2211, DOI 10.1161/CIRCULATIONAHA.109.928796; Li KH, 2010, STEM CELLS DEV, V19, P1267, DOI 10.1089/scd.2009.0196; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Mias C, 2008, STEM CELLS, V26, P1749, DOI 10.1634/stemcells.2007-1000; Mitra AK, 2009, J CELL MOL MED, V13, P177, DOI 10.1111/j.1582-4934.2008.00311.x; Morishita Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023267; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Sachse A, 2007, J AM SOC NEPHROL, V18, P2439, DOI 10.1681/ASN.2007020149; Schietke RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031034; Schley G, 2011, J AM SOC NEPHROL, V22, P2004, DOI 10.1681/ASN.2010121249; Shi MX, 2007, HAEMATOLOGICA, V92, P897, DOI 10.3324/haematol.10669; Shi RZ, 2008, BIOCHEM BIOPH RES CO, V376, P247, DOI 10.1016/j.bbrc.2008.09.004; Singh P, 2012, J AM SOC NEPHROL; Son BR, 2006, STEM CELLS, V24, P1254, DOI 10.1634/stemcells.2005-0271; Stokman G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014386; Tang JM, 2011, CARDIOVASC RES, V91, P402, DOI 10.1093/cvr/cvr053; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Togel F, 2007, AM J PHYSIOL-RENAL, V292, pF1626, DOI 10.1152/ajprenal.00339.2006; Wang JA, 2008, ACTA PHARMACOL SIN, V29, P74, DOI 10.1111/j.1745-7254.2008.00716.x; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Wu HL, 2010, J AM SOC NEPHROL, V21, P1878, DOI 10.1681/ASN.2009101048; Wu J, 2010, AM J PATHOL, V176, P2163, DOI 10.2353/ajpath.2010.090386; Wu Y, 2011, STEM CELL REV; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Zhang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029876	57	178	199	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2012	7	4							e34608	10.1371/journal.pone.0034608	http://dx.doi.org/10.1371/journal.pone.0034608			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TZ	22511954	Green Published, gold, Green Submitted			2022-12-27	WOS:000305338600040
J	Kim, M; Yoon, S; Lee, S; Ha, SA; Kim, HK; Kim, JW; Chung, J				Kim, Minsoo; Yoon, Soomin; Lee, Sukmook; Ha, Seon Ah; Kim, Hyun Kee; Kim, Jin Woo; Chung, Junho			Gremlin-1 Induces BMP-Independent Tumor Cell Proliferation, Migration, and Invasion	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN; ANTAGONIST GREMLIN-1; DRM/GREMLIN; CANCER; EXPRESSION; CARCINOMA; DAN	Gremlin-1, a bone morphogenetic protein (BMP) antagonist, is overexpressed in various cancerous tissues but its role in carcinogenesis has not been established. Here, we report that gremlin-1 binds various cancer cell lines and this interaction is inhibited by our newly developed gremlin-1 antibody, GRE1. Gremlin-1 binding to cancer cells was unaffected by the presence of BMP-2, BMP-4, and BMP-7. In addition, the binding was independent of vascular endothelial growth factor receptor-2 (VEGFR2) expression on the cell surface. Addition of gremlin-1 to A549 cells induced a fibroblast-like morphology and decreased E-cadherin expression. In a scratch wound healing assay, A549 cells incubated with gremlin-1 or transfected with gremlin-1 showed increased migration, which was inhibited in the presence of the GRE1 antibody. Gremlin-1 transfected A549 cells also exhibited increased invasiveness as well as an increased growth rate. These effects were also inhibited by the addition of the GRE1 antibody. In conclusion, this study demonstrates that gremlin-1 directly interacts with cancer cells in a BMP- and VEGFR2-independent manner and can induce cell migration, invasion, and proliferation.	[Kim, Minsoo; Yoon, Soomin; Chung, Junho] Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea; [Kim, Minsoo] Seoul Natl Univ, Coll Med, Dept Canc Biol, Seoul, South Korea; [Kim, Minsoo; Chung, Junho] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Lee, Sukmook] Scripps Korea Antibody Inst, Chuncheon Si, Gangwon Do, South Korea; [Ha, Seon Ah; Kim, Jin Woo] Catholic Univ Korea, Coll Med, Mol Genet Lab, Seoul, South Korea; [Kim, Hyun Kee; Kim, Jin Woo] Catholic Univ Korea, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Catholic University of Korea; Catholic University of Korea	Kim, M (corresponding author), Seoul Natl Univ, Coll Med, Dept Biochem & Mol Biol, Seoul, South Korea.	jjhchung@snu.ac.kr	Chung, Junho/J-2792-2012		Korea Biotech R&D Group of Next-generation growth engine project of the Ministry of Education, Science and Technology, Republic of Korea [2011K000737]	Korea Biotech R&D Group of Next-generation growth engine project of the Ministry of Education, Science and Technology, Republic of Korea	This research was supported by a grant (2011K000737) from Korea Biotech R&D Group of Next-generation growth engine project of the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobinac D, 2005, CROAT MED J, V46, P389; Chen B, 2004, J IMMUNOL, V173, P5914, DOI 10.4049/jimmunol.173.10.5914; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chung L, 2004, FASEB J, V18, pA345, DOI 10.1096/fj.03-0586fje; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Kim K, 2007, BIOCHEM BIOPH RES CO, V354, P115, DOI 10.1016/j.bbrc.2006.12.164; Koli K, 2006, AM J PATHOL, V169, P61, DOI 10.2353/ajpath.2006.051263; Lappin DWP, 2000, CURR OPIN NEPHROL HY, V9, P469, DOI 10.1097/00041552-200009000-00002; Lee MS, 2008, HYBRIDOMA, V27, P18, DOI 10.1089/hyb.2007.0532; Li XL, 2009, CANCER CHEMOTH PHARM, V64, P1097, DOI 10.1007/s00280-009-0966-0; Lu MM, 2001, DEV DYNAM, V222, P667, DOI 10.1002/dvdy.1231; Merino R, 1999, DEVELOPMENT, V126, P5515; Mitola S, 2010, BLOOD, V116, P3677, DOI 10.1182/blood-2010-06-291930; Namkoong H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-74; Park S, 2010, CLIN CHIM ACTA, V411, P1238, DOI 10.1016/j.cca.2010.04.027; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Rosso O, 2007, MOL CANCER RES, V5, P1246, DOI 10.1158/1541-7786.MCR-07-0060; Sha GH, 2009, FERTIL STERIL, V91, P350, DOI 10.1016/j.fertnstert.2007.12.007; Shi W, 2001, AM J PHYSIOL-LUNG C, V280, pL1030, DOI 10.1152/ajplung.2001.280.5.L1030; Singh A, 2010, CYTOKINE GROWTH F R, V21, P299, DOI 10.1016/j.cytogfr.2010.06.003; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Stanley E, 1998, MECH DEVELOP, V77, P173, DOI 10.1016/S0925-4773(98)00139-7; Sun JP, 2006, J BIOL CHEM, V281, P29349, DOI 10.1074/jbc.M603833200; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Topol LZ, 2000, J BIOL CHEM, V275, P8785, DOI 10.1074/jbc.275.12.8785; Topol LZ, 2000, CYTOGENET CELL GENET, V89, P79, DOI 10.1159/000015568; Topol LZ, 1997, MOL CELL BIOL, V17, P4801, DOI 10.1128/MCB.17.8.4801	27	102	114	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2012	7	4							e35100	10.1371/journal.pone.0035100	http://dx.doi.org/10.1371/journal.pone.0035100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UT	23118971	gold, Green Submitted, Green Published			2022-12-27	WOS:000305341600118
J	Bagala, F; Becker, C; Cappello, A; Chiari, L; Aminian, K; Hausdorff, JM; Zijlstra, W; Klenk, J				Bagala, Fabio; Becker, Clemens; Cappello, Angelo; Chiari, Lorenzo; Aminian, Kamiar; Hausdorff, Jeffrey M.; Zijlstra, Wiebren; Klenk, Jochen			Evaluation of Accelerometer-Based Fall Detection Algorithms on Real-World Falls	PLOS ONE			English	Article							TRIAXIAL ACCELEROMETER; OLDER-ADULTS; COMMUNITY; SYSTEM; PEOPLE; IMPACT; RISK	Despite extensive preventive efforts, falls continue to be a major source of morbidity and mortality among elders. Real-time detection of falls and their urgent communication to a telecare center may enable rapid medical assistance, thus increasing the sense of security of the elderly and reducing some of the negative consequences of falls. Many different approaches have been explored to automatically detect a fall using inertial sensors. Although previously published algorithms report high sensitivity (SE) and high specificity (SP), they have usually been tested on simulated falls performed by healthy volunteers. We recently collected acceleration data during a number of real-world falls among a patient population with a high-fall-risk as part of the SensAction-AAL European project. The aim of the present study is to bechmark the performance of thirteen published fall-detection algorithms when they are applied to the database of 29 real-world fall. To the best of our knowledge, this is the first systematic comparison of fall detection algorithms tested on real-world falls. We found that the SP average of the thirteen algorithms, was (mean +/- std) 83.0%+/- 30.3% (maximum value = 98%). The SE was considerably lower (SE = 57.0%+/- 27.3%, maximum value = 82.8%), much lower than the values obtained on simulated falls. The number of false alarms generated by the algorithms during 1-day monitoring of there representative fallers ranged from 3 to 85. The factors that affect the performance of the published algorithms, when they are applied to the real-world falls, are also discussed. These findings indicate the importance of testing fall-detection algorithms in real-life conditions in order to produce more effective automated alarm systems with higher acceptance. Further, the present results support the idea that a large, shared real-world fall database could, potentially, provide an enhanced understanding of the fall process and the information needed to design and evaluate a high-performance fall detector.	[Bagala, Fabio; Cappello, Angelo; Chiari, Lorenzo] Univ Bologna, Dept Elect Comp Sci & Syst, Bologna, Italy; [Becker, Clemens; Klenk, Jochen] Robert Bosch Krankenhaus, Dept Clin Gerontol, Stuttgart, Germany; [Aminian, Kamiar] Ecole Polytech Fed Lausanne, Lab Movement Anal & Measuremnt, CH-1015 Lausanne, Switzerland; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Sourasky Med Ctr, Lab Gait & Neurodynam,Movement Disorders Unit, IL-69978 Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, IL-69978 Tel Aviv, Israel; [Zijlstra, Wiebren] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, NL-9713 AV Groningen, Netherlands	University of Bologna; Bosch; Robert Bosch Krankenhaus; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Groningen	Bagala, F (corresponding author), Univ Bologna, Dept Elect Comp Sci & Syst, Bologna, Italy.	fabio.bagala@unibo.it	Klenk, Jochen/C-2164-2012; Becker, Clemens/ABI-5405-2020; Chiari, Lorenzo/N-7622-2015; Klenk, Jochen/R-3614-2019; Munoz, Jose J/B-2475-2009; Aminian, Kamiar/H-4568-2011; Conte, Vito/I-1194-2015	Chiari, Lorenzo/0000-0002-2318-4370; Klenk, Jochen/0000-0002-5987-447X; Munoz, Jose J/0000-0002-0083-3673; Aminian, Kamiar/0000-0002-6582-5375; Conte, Vito/0000-0002-7439-2866; Baum, Buzz/0000-0002-9201-6186	European Union [045622, 288940]; EPSRC [EP/I00159X/2] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/B/02495] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/I00159X/2] Funding Source: researchfish; Medical Research Council [MC_CF12266] Funding Source: researchfish	European Union(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results has been partly funded by the European Union under grant agreements n. 045622 (FP6/2002-06; SensAction-AAL project) and n. 288940 (FP7/2007-13; FARSEEING project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwan M, 2006, P ICTTA 06 DAM SYR A, P23; Anderson Derek, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P6388; Benocci M, 2010, MICROELECTRON J, V41, P703, DOI 10.1016/j.mejo.2010.06.014; Bourke AK, 2007, GAIT POSTURE, V26, P194, DOI 10.1016/j.gaitpost.2006.09.012; Bourke AK, 2010, J BIOMECH, V43, P3051, DOI 10.1016/j.jbiomech.2010.07.005; Bourke AK, 2008, IEEE ENG MED BIO, P2844, DOI 10.1109/IEMBS.2008.4649795; Boyle J, 2008, IEEE ENG MED BIO, P1274, DOI 10.1109/IEMBS.2008.4649396; Chen J, P 27 IEEE EMBS ANN I, P3551; Culhane KM, 2004, CLIN REHABIL, V18, P335, DOI 10.1191/0269215504cr734oa; Degen T, 2003, SEVENTH IEEE INTERNATIONAL SYMPOSIUM ON WEARABLE COMPUTERS, PROCEEDINGS, P184, DOI 10.1109/ISWC.2003.1241410; Diaz A, 2004, P ANN INT IEEE EMBS, V26, P2180; Doughty K, 2000, J TELEMED TELECARE, V6, P150, DOI 10.1258/1357633001934483; Golbe L, 2005, NEURODEGENER DIS, P663; Gurley RJ, 1996, NEW ENGL J MED, V334, P1710, DOI 10.1056/NEJM199606273342606; Hauer K, 2006, AGE AGEING, V35, P5, DOI 10.1093/ageing/afi218; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hori T., 2005, P 7 INT C ENT INF SY, P110; Huang B, 2008, 2008 7TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION, VOLS 1-23, P3619, DOI 10.1109/WCICA.2008.4593501; Hwang JY, 2004, P ANN INT IEEE EMBS, V26, P2204; Jia N, FALL DETECTION APPL; Jiangpeng Dai, 2010, 2010 8th IEEE International Conference on Pervasive Computing and Communications Workshops (PERCOM Workshops), P292, DOI 10.1109/PERCOMW.2010.5470652; Kangas M, 2011, GAIT POSTUR IN PRESS; Kangas M, 2008, GAIT POSTURE, V28, P285, DOI 10.1016/j.gaitpost.2008.01.003; Karantonis DM, 2006, IEEE T INF TECHNOL B, V10, P156, DOI 10.1109/TITB.2005.856864; KING MB, 1995, J AM GERIATR SOC, V43, P1146, DOI 10.1111/j.1532-5415.1995.tb07017.x; Klenk J, 2011, MED ENG PHYS, V33, P368, DOI 10.1016/j.medengphy.2010.11.003; Lee RYW, 2011, AGE AGEING, V40, P690, DOI [10.1093/ageing/afr050, 10.1155/2011/653570]; Lee YS, 2009, 11TH INTERNATIONAL CONFERENCE ON ADVANCED COMMUNICATION TECHNOLOGY, VOLS I-III, PROCEEDINGS,, P2308; Lee Y, 2007, P ANN INT IEEE EMBS, P2315, DOI 10.1109/IEMBS.2007.4352789; Li Q, 2009, SIXTH INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P138, DOI [10.1109/P3644.45, 10.1109/BSN.2009.46]; Lin CW, P 16 ICCCN AUG 13 16, P1172; Lindemann U, 2005, MED BIOL ENG COMPUT, V43, P548, DOI 10.1007/BF02351026; Lindemann U, 2010, MOVEMENT DISORD, V25, P1040, DOI 10.1002/mds.23023; Litvak D, 2008, IEEE ENG MED BIO, P4632, DOI 10.1109/IEMBS.2008.4650245; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Lord R, 2001, FALLS OLDER PEOPLE R; MALLINSON WJW, 1985, AGE AGEING, V14, P174, DOI 10.1093/ageing/14.3.174; Nait-Charif H, 2004, INT C PATT RECOG, P323, DOI 10.1109/ICPR.2004.1333768; NEVITT MC, 1989, JAMA-J AM MED ASSOC, V261, P2663, DOI 10.1001/jama.261.18.2663; Nicolai S, 2010, Z GERONTOL GERIATR, V43, P224, DOI 10.1007/s00391-010-0125-6; Noury N, 2007, P ANN INT IEEE EMBS, P1663, DOI 10.1109/IEMBS.2007.4352627; Noury N, 2003, P ANN INT IEEE EMBS, V25, P3286, DOI 10.1109/IEMBS.2003.1280846; Noury N, 2008, IRBM, V29, P340, DOI 10.1016/j.irbm.2008.08.002; Nyan MN, 2006, MED ENG PHYS, V28, P842, DOI 10.1016/j.medengphy.2005.11.008; Nyan MN, 2008, J BIOMECH, V41, P3475, DOI 10.1016/j.jbiomech.2008.08.009; Perolle G., 2006, P MEDETEL, P65; Porter Eileen J, 2005, J Gerontol Nurs, V31, P26; Rapp K, 2012, J AM MED DIR ASSOC, V13, DOI 10.1016/j.jamda.2011.06.011; ROUSH RE, 1995, SOUTHERN MED J, V88, P917, DOI 10.1097/00007611-199509000-00006; Schrag A, 1999, LANCET, V354, P1771, DOI 10.1016/S0140-6736(99)04137-9; Sixsmith A, 2004, IEEE PERVAS COMPUT, V3, P42, DOI 10.1109/MPRV.2004.1316817; Sposaro F, 2009, IEEE ENG MED BIO, P6119, DOI 10.1109/IEMBS.2009.5334912; Tamura T, 2009, IEEE T INF TECHNOL B, V13, P910, DOI 10.1109/TITB.2009.2033673; TINETTI ME, 1993, JAMA-J AM MED ASSOC, V269, P65, DOI 10.1001/jama.269.1.65; Vass DC, 2010, TRIALS, V10, P83; VELLAS B, 1987, AGE AGEING, V16, P189, DOI 10.1093/ageing/16.3.189; WILD D, 1981, BRIT MED J, V282, P266, DOI 10.1136/bmj.282.6260.266; Williams G, P 20 IEEE EMBS ANN I, P1151; Wu G, 2000, J BIOMECH, V33, P1497, DOI 10.1016/S0021-9290(00)00117-2; Zigel Y, 2009, IEEE T BIO-MED ENG, V56, P2858, DOI 10.1109/TBME.2009.2030171	60	359	364	7	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2012	7	5			1				e37062	10.1371/journal.pone.0037062	http://dx.doi.org/10.1371/journal.pone.0037062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UR	22511944	Green Published, gold			2022-12-27	WOS:000305341300060
J	Lin, HP; Jiang, SS; Chuu, CP				Lin, Hui-Ping; Jiang, Shih Sheng; Chuu, Chih-Pin			Caffeic Acid Phenethyl Ester Causes p21(Cip1) Induction, Akt Signaling Reduction, and Growth Inhibition in PC-3 Human Prostate Cancer Cells	PLOS ONE			English	Article							ANDROGEN RECEPTOR; IN-VITRO; DOWN-REGULATION; PROTEIN-KINASE; TRANSCRIPTION FACTOR; LUNG ADENOCARCINOMA; UP-REGULATION; KAPPA-B; APOPTOSIS; PHOSPHORYLATION	Caffeic acid phenethyl ester (CAPE) treatment suppressed proliferation, colony formation, and cell cycle progression in PC-3 human prostate cancer cells. CAPE decreased protein expression of cyclin D1, cyclin E, SKP2, c-Myc, Akt1, Akt2, Akt3, total Akt, mTOR, Bcl-2, Rb, as well as phosphorylation of Rb, ERK1/2, Akt, mTOR, GSK3 alpha, GSK3 beta, PDK1; but increased protein expression of KLF6 and p21(Cip1). Microarray analysis indicated that pathways involved in cellular movement, cell death, proliferation, and cell cycle were affected by CAPE. Co-treatment of CAPE with chemotherapeutic drugs vinblastine, paclitaxol, and estramustine indicated synergistic suppression effect. CAPE administration may serve as a potential adjuvant therapy for prostate cancer.	[Lin, Hui-Ping; Chuu, Chih-Pin] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan; [Lin, Hui-Ping; Jiang, Shih Sheng; Chuu, Chih-Pin] Natl Hlth Res Inst, Translat Ctr Glandular Malignancies, Miaoli, Taiwan; [Jiang, Shih Sheng] Natl Hlth Res Inst, Natl Inst Canc Res, Miaoli, Taiwan; [Chuu, Chih-Pin] China Med Univ, Grad Program Aging, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; China Medical University Taiwan	Lin, HP (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan.	cpchuu@nhri.org.tw	Chuu, Chih-Pin/B-1086-2010; Jiang, Shih Sheng/J-9671-2019; Jiang, Shih Sheng/C-6187-2011; Chuu, Chih-Pin/N-6697-2019	Jiang, Shih Sheng/0000-0003-1909-437X; Lin, Hua/0000-0001-5001-5567	National Health Research Institutes [CS-100-PP-12]; National Science Council, NSC in Taiwan [NSC 99-2320-B-400-015-MY3]; Department of Health [DOH100-TD-C-111-014]; Protein Chemistry Core Facility of Core Instrument Center in NHRI; Taiwan Bioinformatics Institute by NSC [NSC100-2319-B-400-001]	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, NSC in Taiwan(Ministry of Science and Technology, Taiwan); Department of Health; Protein Chemistry Core Facility of Core Instrument Center in NHRI; Taiwan Bioinformatics Institute by NSC	This work was supported by CS-100-PP-12 (National Health Research Institutes) and NSC 99-2320-B-400-015-MY3 (National Science Council, NSC) in Taiwan for CPC, as well as DOH100-TD-C-111-014 (Department of Health) for SSJ and CPC. We thank support from Protein Chemistry Core Facility of Core Instrument Center in NHRI and Taiwan Bioinformatics Institute Core Facility of the National Core Facility Program for Biotechnology by NSC (NSC100-2319-B-400-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alao JP, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-24; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Bektic J, 2005, PROSTATE, V64, P332, DOI 10.1002/pros.20243; BHIMANI RS, 1993, CANCER RES, V53, P4528; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Celli N, 2007, J AGR FOOD CHEM, V55, P3398, DOI 10.1021/jf063477o; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Chen YJ, 2001, J AGR FOOD CHEM, V49, P5615, DOI 10.1021/jf0107252; Chuu CP, 2007, J BIOMED SCI, V14, P543, DOI 10.1007/s11373-007-9160-8; Chuu CP, 2007, BIOCHEM BIOPH RES CO, V357, P341, DOI 10.1016/j.bbrc.2007.03.116; Chuu CP, 2011, CANCER SCI, V102, P2022, DOI 10.1111/j.1349-7006.2011.02043.x; Chuu CP, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-63; Chuu CP, 2010, ANTICANCER RES, V30, P3643; Chuu CP, 2009, CANCER LETT, V275, P86, DOI 10.1016/j.canlet.2008.10.001; Coffer PJ, 1998, BIOCHEM J, V335, P1; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Ding H, 2003, BIOCHEM BIOPH RES CO, V305, P950, DOI 10.1016/S0006-291X(03)00873-8; Duchene J, 2007, J IMMUNOL, V179, P4849, DOI 10.4049/jimmunol.179.7.4849; ELLEDGE SJ, 1994, CURR OPIN CELL BIOL, V6, P847, DOI 10.1016/0955-0674(94)90055-8; Frescas D, 2008, NAT REV CANCER, V8, P438, DOI 10.1038/nrc2396; Gao H, 2005, J BIOL CHEM, V280, P10988, DOI 10.1074/jbc.M412720200; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Gilligan T, 2002, UROLOGY, V60, P94, DOI 10.1016/S0090-4295(02)01583-2; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; HARPER JW, 1993, CELL, V75, P805; He YJ, 2006, WORLD J GASTROENTERO, V12, P4981, DOI 10.3748/wjg.v12.i31.4981; Heliez C, 2003, ONCOGENE, V22, P3260, DOI 10.1038/sj.onc.1206409; Hellerstedt BA, 2002, CA-CANCER J CLIN, V52, P154, DOI 10.3322/canjclin.52.3.154; Ho HC, 2009, CELL MOL BIOL, V55, P1161, DOI 10.1170/132; Horiguchi-Yamada J, 2002, ANTICANCER RES, V22, P3827; Huggins C, 1941, ARCH SURG-CHICAGO, V43, P15; Ibrahim T, 2010, CANCER-AM CANCER SOC, V116, P1406, DOI 10.1002/cncr.24896; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jiang SS, 2010, CLIN CANCER RES, V16, P4363, DOI 10.1158/1078-0432.CCR-10-0138; Jin SQ, 2000, J BIOL CHEM, V275, P16602, DOI 10.1074/jbc.M000284200; Katsuki Y, 2008, BIOCHEM BIOPH RES CO, V368, P808, DOI 10.1016/j.bbrc.2008.02.010; Keller ET, 2001, CANCER METAST REV, V20, P333, DOI 10.1023/A:1015599831232; Kolomeichuk SN, 2008, MOL PHARMACOL, V73, P128, DOI 10.1124/mol.108.039750; Kreisberg JI, 2004, CANCER RES, V64, P5232, DOI 10.1158/0008-5472.CAN-04-0272; Kuo HC, 2006, CANCER LETT, V234, P199, DOI 10.1016/j.canlet.2005.03.046; Lebedeva I, 2000, CANCER RES, V60, P6052; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Liu QY, 1997, CLIN CANCER RES, V3, P2039; Liu RH, 2009, CANCER RES, V69, P2252, DOI 10.1158/0008-5472.CAN-08-3717; Majumder PK, 2005, ONCOGENE, V24, P7465, DOI 10.1038/sj.onc.1209096; Malhotra S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020293; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McEleny K, 2004, BJU INT, V94, P402, DOI 10.1111/j.1464-410X.2004.04936.x; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; PIENTA KJ, 1993, J UROLOGY, V149, P1622, DOI 10.1016/S0022-5347(17)36463-7; Pinto AC, 2011, PROSTATE, V71, P81, DOI 10.1002/pros.21224; Polin L, 1997, INVEST NEW DRUG, V15, P99, DOI 10.1023/A:1005856605726; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki T, 2010, BIOCHEM BIOPH RES CO, V399, P79, DOI 10.1016/j.bbrc.2010.07.045; Schutyser E, 2000, J IMMUNOL, V165, P4470, DOI 10.4049/jimmunol.165.8.4470; Shankar S, 2005, PROSTATE, V62, P165, DOI 10.1002/pros.20126; Shigeoka Y, 2004, J CANCER RES CLIN, V130, P146, DOI 10.1007/s00432-003-0520-0; Wang LC, 2010, CLIN EXP IMMUNOL, V160, P223, DOI 10.1111/j.1365-2249.2009.04067.x; Watabe M, 2004, J BIOL CHEM, V279, P6017, DOI 10.1074/jbc.M306040200; Williams JF, 2000, PROSTATE, V44, P275, DOI 10.1002/1097-0045(20000901)44:4<275::AID-PROS3>3.0.CO;2-9; WOLPE SD, 1989, P NATL ACAD SCI USA, V86, P612, DOI 10.1073/pnas.86.2.612; Yagi A, 2003, J CELL BIOCHEM, V90, P1242, DOI 10.1002/jcb.10711; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao HC, 2000, EXP CELL RES, V258, P92, DOI 10.1006/excr.2000.4906; Zhao H, 2010, CYTOM PART A, V77A, P999, DOI 10.1002/cyto.a.20983; Zimmers TA, 2008, J CANCER RES CLIN, V134, P753, DOI 10.1007/s00432-007-0336-4	70	308	321	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 7	2012	7	2							e31286	10.1371/journal.pone.0031286	http://dx.doi.org/10.1371/journal.pone.0031286			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	917MF	22506074	Green Published, gold, Green Submitted			2022-12-27	WOS:000302180600033
J	Chen, L; Huang, LZ; Min, DH; Phillips, A; Wang, SQ; Madgwick, PJ; Parry, MAJ; Hu, YG				Chen, Liang; Huang, Linzhou; Min, Donghong; Phillips, Andy; Wang, Shiqiang; Madgwick, Pippa J.; Parry, Martin A. J.; Hu, Yin-Gang			Development and Characterization of a New TILLING Population of Common Bread Wheat (Triticum aestivum L.)	PLOS ONE			English	Article							CHEMICALLY-INDUCED MUTATIONS; DETECT INDUCED MUTATIONS; GENE-FUNCTION; INSERTIONAL MUTAGENESIS; FUNCTIONAL GENOMICS; POINT MUTATIONS; INDUCED MUTANTS; DISCOVERY; RESOURCE; RICE	Mutagenesis is an important tool in crop improvement. However, the hexaploid genome of wheat (Triticum aestivum L.) presents problems in identifying desirable genetic changes based on phenotypic screening due to gene redundancy. TILLING (Targeting Induced Local Lesions IN Genomes), a powerful reverse genetic strategy that allows the detection of induced point mutations in individuals of the mutagenized populations, can address the major challenge of linking sequence information to the biological function of genes and can also identify novel variation for crop breeding. Wheat is especially well-suited for TILLING due to the high mutation densities tolerated by polyploids. However, only a few wheat TILLING populations are currently available in the world, which is far from satisfying the requirement of researchers and breeders in different growing environments. In addition, current TILLING screening protocols require costly fluorescence detection systems, limiting their use, especially in developing countries. We developed a new TILLING resource comprising 2610 M-2 mutants in a common wheat cultivar 'Jinmai 47'. Numerous phenotypes with altered morphological and agronomic traits were observed from the M-2 and M-3 lines in the field. To simplify the procedure and decrease costs, we use unlabeled primers and either non-denaturing polyacrylamide gels or agarose gels for mutation detection. The value of this new resource was tested using PCR with RAPD and Intron-spliced junction (ISJ) primers, and also TILLING in three selected candidate genes, in 300 and 512 mutant lines, revealing high mutation densities of 1/34 kb by RAPD/ISJ analysis and 1/47 kb by TILLING. In total, 31 novel alleles were identified in the 3 targeted genes and confirmed by sequencing. The results indicate that this mutant population represents a useful resource for the wheat research community. We hope that the use of this reverse genetics resource will provide novel allelic diversity for wheat improvement and functional genomics.	[Chen, Liang; Huang, Linzhou; Min, Donghong; Wang, Shiqiang; Hu, Yin-Gang] NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Phillips, Andy; Madgwick, Pippa J.; Parry, Martin A. J.] Rothamsted Res, Dept Plant Sci, Ctr Crop Genet Improvement, Harpenden, Herts, England; NW A&F Univ, Inst Water Saving Agr Arid Reg China, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Northwest A&F University - China	Hu, YG (corresponding author), NW A&F Univ, Coll Agron, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.	huyingang@nwsuaf.edu.cn	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	Ministry of Science and Technology [2006AA100201, 2006AA100223, 2006CB708208]; 111 Program of Introducing Talents of Discipline to Universities P. R. China [111-2-16]; ACIAR Project of Australia [CIM/2005/111]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); 111 Program of Introducing Talents of Discipline to Universities P. R. China; ACIAR Project of Australia(Australian Ctr Intl Agr Res); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the sub-project of the 863 Program (2006AA100201, 2006AA100223), the pre-phase project of the 973 Program (2006CB708208) of the Ministry of Science and Technology, and the 111 Program of Introducing Talents of Discipline to Universities (111-2-16), P. R. China, as well as the ACIAR Project (CIM/2005/111) of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich C, 1993, PLANT MOL BIOL REP, V11, P128, DOI DOI 10.1007/BF02670471; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I; Bentley A, 2000, GENETICS, V156, P1169; Bibi S, 2009, PAK J BOT, V41, P1022; Caldwell DG, 2004, PLANT J, V40, P143, DOI 10.1111/j.1365-313X.2004.02190.x; Chawade A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-86; Chen LA, 2011, AUST J CROP SCI, V5, P318; Chua NH, 2006, CURR OPIN BIOTECH, V17, P103, DOI 10.1016/j.copbio.2006.03.002; Cooper JL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-9; Dahmani-Mardas F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015776; Dong CM, 2009, PLANT GENOME-US, V2, P39, DOI 10.3835/plantgenome2008.10.0012; Eversole K, 2009, ANN WHEAT N IN PRESS, P55; Fox JL, 2004, NAT BIOTECHNOL, V22, P1062, DOI 10.1038/nbt0904-1062; Fu DL, 2007, TRANSGENIC RES, V16, P689, DOI 10.1007/s11248-007-9150-7; Gonzalez FG, 2005, EUPHYTICA, V146, P253, DOI 10.1007/s10681-005-9021-3; Gottwald Sven, 2009, BMC Res Notes, V2, P258, DOI 10.1186/1756-0500-2-258; Greene EA, 2003, GENETICS, V164, P731; HALLORAN GM, 1982, ANN BOT-LONDON, V49, P115, DOI 10.1093/oxfordjournals.aob.a086220; Henikoff S, 2004, PLANT PHYSIOL, V135, P630, DOI 10.1104/pp.104.041061; Hirochika H, 2001, CURR OPIN PLANT BIOL, V4, P118, DOI 10.1016/S1369-5266(00)00146-1; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jeon JS, 2000, PLANT J, V22, P561, DOI 10.1046/j.1365-313x.2000.00767.x; Knoll JE, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-81; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCallum CM, 2000, PLANT PHYSIOL, V123, P439, DOI 10.1104/pp.123.2.439; MERRIL CR, 1984, ELECTROPHORESIS, V5, P289, DOI 10.1002/elps.1150050509; Minoia Silvia, 2010, BMC Res Notes, V3, P69, DOI 10.1186/1756-0500-3-69; Muth J, 2008, PLANT BIOTECHNOL J, V6, P576, DOI 10.1111/j.1467-7652.2008.00340.x; Naghavi Mohammad Reza, 2004, Iranian Journal of Biotechnology, V2, P195; Nomura T, 2005, P NATL ACAD SCI USA, V102, P16490, DOI 10.1073/pnas.0505156102; Oleykowski CA, 1998, NUCLEIC ACIDS RES, V26, P4597, DOI 10.1093/nar/26.20.4597; Parry MAJ, 2009, J EXP BOT, V60, P2817, DOI 10.1093/jxb/erp189; Piron F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011313; Przetakiewicz J, 2002, CELL MOL BIOL LETT, V7, P671; Raghavan C, 2007, MOL BREEDING, V19, P87, DOI 10.1007/s11032-006-9046-x; Rothe N, 2010, THESIS KANSASS STATE; Sabetta W, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-20; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Slafer GA, 1996, FIELD CROP RES, V46, P1, DOI 10.1016/0378-4290(95)00081-X; SONG WN, 1995, GENET RESOUR CROP EV, V42, P273, DOI 10.1007/BF02431262; Stephenson P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-62; Suzuki T, 2008, MOL GENET GENOMICS, V279, P213, DOI 10.1007/s00438-007-0293-2; Talame V, 2008, PLANT BIOTECHNOL J, V6, P477, DOI 10.1111/j.1467-7652.2008.00341.x; Till B. J., 2007, GENOMICS ASSISTED CR, P333; Till BJ, 2003, METH MOL B, V236, P205; Till BJ, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-19; Till Bradley J., 2004, BMC Plant Biology, V4, P12, DOI 10.1186/1471-2229-4-12; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Wang N, 2008, NEW PHYTOL, V180, P751, DOI 10.1111/j.1469-8137.2008.02619.x; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; Wu JL, 2005, PLANT MOL BIOL, V59, P85, DOI 10.1007/s11103-004-5112-0; Xin ZG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-103	53	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 23	2012	7	7							e41570	10.1371/journal.pone.0041570	http://dx.doi.org/10.1371/journal.pone.0041570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	977TM	22844501	Green Published, gold, Green Submitted			2022-12-27	WOS:000306687700113
J	Chen, L; Ma, YL; Kim, EY; Yu, W; Schwartz, RJ; Qian, L; Wang, J				Chen, Li; Ma, Yanlin; Kim, Eun Young; Yu, Wei; Schwartz, Robert J.; Qian, Ling; Wang, Jun			Conditional Ablation of Ezh2 in Murine Hearts Reveals Its Essential Roles in Endocardial Cushion Formation, Cardiomyocyte Proliferation and Survival	PLOS ONE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; CARDIAC DEVELOPMENT; TRANSCRIPTION FACTOR; MOUSE DEVELOPMENT; NOTCH ACTIVATION; GENE-EXPRESSION; OUTFLOW-TRACT; BHLH FACTORS; CELL FATE; METHYLATION	Ezh2 is a histone trimethyltransferase that silences genes mainly via catalyzing trimethylation of histone 3 lysine 27 (H3K27Me3). The role of Ezh2 as a regulator of gene silencing and cell proliferation in cancer development has been extensively investigated; however, its function in heart development during embryonic cardiogenesis has not been well studied. In the present study, we used a genetically modified mouse system in which Ezh2 was specifically ablated in the mouse heart. We identified a wide spectrum of cardiovascular malformations in the Ezh2 mutant mice, which collectively led to perinatal death. In the Ezh2 mutant heart, the endocardial cushions (ECs) were hypoplastic and the endothelial-to-mesenchymal transition (EMT) process was impaired. The hearts of Ezh2 mutant mice also exhibited decreased cardiomyocyte proliferation and increased apoptosis. We further identified that the Hey2 gene, which is important for cardiomyocyte proliferation and cardiac morphogenesis, is a downstream target of Ezh2. The regulation of Hey2 expression by Ezh2 may be independent of Notch signaling activity. Our work defines an indispensible role of the chromatin remodeling factor Ezh2 in normal cardiovascular development.	[Chen, Li; Kim, Eun Young; Qian, Ling; Wang, Jun] Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA; [Ma, Yanlin] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Kim, Eun Young] Univ Texas Hlth Sci Ctr Houston, Program Genes & Dev, Houston, TX USA; [Yu, Wei; Schwartz, Robert J.] Univ Houston, Dept Biochem & Mol Biol, Houston, TX USA	Texas Heart Institute; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Texas System; University of Texas Health Science Center Houston; University of Houston System; University of Houston	Chen, L (corresponding author), Texas Heart Inst, Basic Res Labs, Dept Stem Cell Engn, Houston, TX 77025 USA.	junwang@heart.thi.tmc.edu	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	American Heart Association; National Health Institute; American Heart Association Southern Central Affiliate; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	American Heart Association(American Heart Association); National Health Institute; American Heart Association Southern Central Affiliate; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by grants from the American Heart Association to JW. JW is also supported by a P30 grant from the National Health Institute as a Newly Independent Investigator (NII). LC is supported by a Postdoctoral Fellowship from the American Heart Association Southern Central Affiliate. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2004, P NATL ACAD SCI USA, V101, P6502, DOI 10.1073/pnas.0401711101; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brutsaert DL, 2003, PHYSIOL REV, V83, P59, DOI 10.1152/physrev.00017.2002; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chase A, 2011, CLIN CANCER RES, V17, P2613, DOI 10.1158/1078-0432.CCR-10-2156; Conerly ML, 2011, GENE DEV, V25, P997, DOI 10.1101/gad.2054311; Curry CL, 2005, ONCOGENE, V24, P6333, DOI 10.1038/sj.onc.1208783; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Diez H, 2007, EXP CELL RES, V313, P1, DOI 10.1016/j.yexcr.2006.09.009; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Donovan J, 2002, CURR BIOL, V12, P1605, DOI 10.1016/S0960-9822(02)01149-1; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Ezhkova E, 2011, GENE DEV, V25, P485, DOI 10.1101/gad.2019811; Fischer A, 2007, NUCLEIC ACIDS RES, V35, P4583, DOI 10.1093/nar/gkm477; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fussbroich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021651; Gessler M, 2002, CURR BIOL, V12, P1601, DOI 10.1016/S0960-9822(02)01150-8; Gordadze AV, 2001, J VIROL, V75, P5899, DOI 10.1128/JVI.75.13.5899-5912.2001; Han P, 2011, CIRC RES, V108, P378, DOI 10.1161/CIRCRESAHA.110.224287; Harrelson Z, 2004, DEVELOPMENT, V131, P5041, DOI 10.1242/dev.01378; High FA, 2008, NAT REV GENET, V9, P49, DOI 10.1038/nrg2279; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kim EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020803; Lee ST, 2011, MOL CELL, V43, P798, DOI 10.1016/j.molcel.2011.08.011; Leimeister C, 2000, DEV BIOL, V227, P91, DOI 10.1006/dbio.2000.9884; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Li X, 2009, AM J PATHOL, V175, P1246, DOI 10.2353/ajpath.2009.090042; Liu W, 2004, P NATL ACAD SCI USA, V101, P4489, DOI 10.1073/pnas.0308466101; Liu YG, 2010, AM J PHYSIOL-HEART C, V298, pH2082, DOI 10.1152/ajpheart.00747.2009; Ma Q, 2008, DEV BIOL, V323, P98, DOI 10.1016/j.ydbio.2008.08.013; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Niessen K, 2008, CIRC RES, V102, P1169, DOI 10.1161/CIRCRESAHA.108.174318; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Person AD, 2005, INT REV CYTOL, V243, P287, DOI 10.1016/S0074-7696(05)43005-3; Riising EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002704; Rutenberg JB, 2006, DEVELOPMENT, V133, P4381, DOI 10.1242/dev.02607; Sakata Y, 2006, J MOL CELL CARDIOL, V40, P267, DOI 10.1016/j.yjmcc.2005.09.006; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Shirai M, 2009, P NATL ACAD SCI USA, V106, P18604, DOI 10.1073/pnas.0900635106; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; van Weerd JH, 2011, CARDIOVASC RES, V91, P203, DOI 10.1093/cvr/cvr138; Wang J, 2008, J BIOL CHEM, V283, P23235, DOI 10.1074/jbc.M709748200; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang J, 2011, WIRES SYST BIOL MED, V3, P446, DOI 10.1002/wsbm.130; Wang J, 2011, BIRTH DEFECTS RES A, V91, P468, DOI 10.1002/bdra.20816; Wilkinson FH, 2006, P NATL ACAD SCI USA, V103, P19296, DOI 10.1073/pnas.0603564103; Wu JC, 2004, CURR PROB CARDIOLOGY, V29, P641, DOI 10.1016/j.cpcardiol.2004.04.003; Wu SC, 2011, J BIOL CHEM, V286, P28511, DOI 10.1074/jbc.M111.240515; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180	61	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 1	2012	7	2							e31005	10.1371/journal.pone.0031005	http://dx.doi.org/10.1371/journal.pone.0031005			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	914UG	22844501	Green Published, Green Submitted, gold			2022-12-27	WOS:000301977500025
J	Chen, LC; Hsu, C; Chiueh, CC; Lee, WS				Chen, Li-Ching; Hsu, Chin; Chiueh, Chuang Chin; Lee, Wen-Sen			Ferrous Citrate Up-Regulates the NOS2 through Nuclear Translocation of NF kappa B Induced by Free Radicals Generation in Mouse Cerebral Endothelial Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TRANSIENT FOREBRAIN ISCHEMIA; SUBARACHNOID HEMORRHAGE; OXIDATIVE STRESS; BRAIN-INJURY; PUTATIVE ROLE; IRON; ACTIVATION; EXPRESSION; FERRITIN	Previous studies indicate that the inducible nitric oxide synthase 2 (NOS2) of the brain vascular tissue in experimental subarachnoid hemorrhage (SAH) rats is a critical factor for inducing cerebral vasospasm. However, the underlying molecular mechanisms remain to be elucidated. Here, we applied ferrous citrate (FC) complexes to the primary cultured mouse cerebral endothelial cell (CEC) to mimic the SAH conditions and to address the issue how SAH-induced NOS2 up-regulation. Using immunocytochemical staining technique, we demonstrated that NOS2 was expressed in the cultured CEC. Treatment of the CEC with FC induced increases of the intracellular level of ROS, nuclear factor kappa-light-chain-enhancer of activated B cells (NF kappa B) nuclear translocation as well as NF kappa B binding onto the NOS promoter, and the levels of NOS2 mRNA and protein. These effects were abolished by pre-treatment of the cell with N-Acetyl-Cysteine (NAC), a reactive oxygen species (ROS) scavenger. In the present study, two previously predicted NFkB binding sites were confirmed in the NOS2 promoter within the range of -1529 bp to -1516 bp and -1224 bp to -1210 bp. Interestingly, both NF kappa B binding sites are involved in the FC-activated NOS2 transcriptional activity; the binding site located at -1529 bp to -1516 bp played a greater role than the other binding site located at -1224 bp to -1210 bp in the mouse CEC. These findings highlight the molecular mechanism underlying FC-induced up-regulation of NOS2 in the mouse CEC.	[Chen, Li-Ching; Lee, Wen-Sen] Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan; [Hsu, Chin] Kaohsiung Med Univ, Dept Physiol, Kaohsiung, Taiwan; [Chiueh, Chuang Chin] Taipei Med Univ, Shuang Ho Hosp, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ, Dept Physiol, Sch Med, Taipei, Taiwan; [Lee, Wen-Sen] Taipei Med Univ Hosp, Canc Res Ctr, Taipei, Taiwan	Taipei Medical University; Kaohsiung Medical University; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Lee, WS (corresponding author), Taipei Med Univ, Grad Inst Med Sci, Sch Med, Taipei, Taiwan.	wslee@tmu.edu.tw	Chen, Lei/A-2275-2011	Chen, Lei/0000-0003-3068-1583; Parry, Martin/0000-0002-4477-672X; cai, yudong/0000-0001-5664-7979	National Science Council of Taiwan [NSC-101-2320-B-038-005, NSC-101-2629-B-037-001, NSC-95-2320-B-037-032-MY2, NSC97-2314-B-037-039-MY2, NSC-95-2320-B-038-027-MY2]; Biotechnology and Biological Sciences Research Council [BBS/E/C/00004820, BBS/E/C/00005202, BBS/E/C/00004952, BB/E025161/1, BB/I000607/1] Funding Source: researchfish	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by research grants from the National Science Council of Taiwan (NSC-101-2320-B-038-005 and NSC-101-2629-B-037-001 to W. S. L.; NSC-95-2320-B-037-032-MY2 and NSC97-2314-B-037-039-MY2 to C. H.; NSC-95-2320-B-038-027-MY2 to C. C. C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aladag MA, 2009, NEUROCHEM RES, V34, P1935, DOI 10.1007/s11064-009-9979-7; ALLEN DR, 1994, ARCH BIOCHEM BIOPHYS, V315, P235, DOI 10.1006/abbi.1994.1495; Amberg GC, 2010, CIRC RES, V107, P1002, DOI 10.1161/CIRCRESAHA.110.217018; Asehnoune K, 2004, J IMMUNOL, V172, P2522, DOI 10.4049/jimmunol.172.4.2522; Ayer RE, 2008, ACTA NEUROCHIR SUPPL, V104, P33; Berra L V, 2007, J Neurosurg Sci, V51, P1; BIEMOND P, 1988, FREE RADICAL BIO MED, V4, P185, DOI 10.1016/0891-5849(88)90026-3; Bishop GM, 2001, BRAIN RES, V907, P175, DOI 10.1016/S0006-8993(01)02303-4; Chen LC, 2009, J AGR FOOD CHEM, V57, P7331, DOI 10.1021/jf901477g; Chen TY, 2010, STROKE, V41, P160, DOI 10.1161/STROKEAHA.109.562850; Chiueh CC, 2001, PEDIATR NEUROL, V25, P138, DOI 10.1016/S0887-8994(01)00266-1; Chiueh CC, 2000, NEUROTOX RES, V2, P293, DOI 10.1007/BF03033799; Defrere S, 2008, MOL HUM REPROD, V14, P377, DOI 10.1093/molehr/gan033; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Du WL, 2005, CHEST, V128, p556S, DOI 10.1378/chest.128.6_suppl.556S; Dumont AS, 2003, NEUROSURGERY, V53, P123, DOI 10.1227/01.NEU.0000068863.37133.9E; Gaasch JA, 2007, NEUROCHEM RES, V32, P1196, DOI 10.1007/s11064-007-9290-4; Hanggi D, 2006, ACTA NEUROCHIR, V148, P605, DOI 10.1007/s00701-005-0721-1; Ho PY, 2006, MOL CANCER THER, V5, P3130, DOI 10.1158/1535-7163.MCT-06-0457; Horky LL, 1998, J NEUROSURG, V88, P298, DOI 10.3171/jns.1998.88.2.0298; Hua Y, 2007, STROKE, V38, P759, DOI 10.1161/01.STR.0000247868.97078.10; Ishimaru H, 1996, BRAIN RES, V726, P23, DOI 10.1016/0006-8993(96)00294-6; Janjua Nazli, 2003, Curr Opin Crit Care, V9, P113, DOI 10.1097/00075198-200304000-00006; Jaramillo M, 2003, J IMMUNOL, V171, P4243, DOI 10.4049/jimmunol.171.8.4243; KONDO Y, 1995, J CEREBR BLOOD F MET, V15, P216, DOI 10.1038/jcbfm.1995.27; Lin CL, 2006, J NEUROSURG, V104, P298, DOI 10.3171/jns.2006.104.2.298; Lopez-Ongil S, 1998, BRIT J PHARMACOL, V124, P447, DOI 10.1038/sj.bjp.0701847; Mills E, 2010, FUTURE MED CHEM, V2, P51, DOI 10.4155/FMC.09.140; MOHANAKUMAR KP, 1994, ANN NY ACAD SCI, V738, P392; MORRIS SM, 1994, AM J PHYSIOL, V266, pE829, DOI 10.1152/ajpendo.1994.266.6.E829; Ong WY, 2005, REPROD NUTR DEV, V45, P647, DOI 10.1051/rnd:2005051; Ortego M, 2005, J CARDIOVASC PHARM, V45, P468, DOI 10.1097/01.fjc.0000159042.50488.e5; Osuka K, 2009, J NEUROTRAUM, V26, P1157, DOI 10.1089/neu.2008-0836; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Ql WN, 2004, MICROSURG, V24, P316, DOI 10.1002/micr.20030; Rauhala P, 1998, FREE RADICAL BIO MED, V24, P1065, DOI 10.1016/S0891-5849(97)00386-9; Regunathan S, 2003, ANN NY ACAD SCI, V1009, P20, DOI 10.1196/annals.1304.002; Shih HC, 2006, STROKE, V37, P3025, DOI 10.1161/01.STR.0000249008.18669.5a; Sorond FA, 2000, ANTIOXID REDOX SIGN, V2, P421, DOI 10.1089/15230860050192206; Taylor BS, 2001, PROG INFLAM RES, P1; Taylor BS, 2000, SHOCK, V13, P413, DOI 10.1097/00024382-200006000-00001; Van Bergen P, 1999, FREE RADICAL RES, V31, P631, DOI 10.1080/10715769900301201; Vijay A, 2006, NEUROL RES, V28, P759, DOI 10.1179/016164106X152034; West KA, 2003, J CLIN INVEST, V111, P81, DOI 10.1172/JCI200316147; Wilkinson DS, 2005, MOL CELL BIOL, V25, P1200, DOI 10.1128/MCB.25.3.1200-1212.2005; Won SM, 2011, EXP MOL MED, V43, P121, DOI 10.3858/emm.2011.43.2.020; Wong J M, 1995, Adv Pharmacol, V34, P155; Xu J, 2000, STROKE, V31, P1744, DOI 10.1161/01.STR.31.7.1744; Young HM, 1997, HISTOCHEM CELL BIOL, V107, P19, DOI 10.1007/s004180050085; Zhen JH, 2008, AM J HYPERTENS, V21, P28, DOI 10.1038/ajh.2007.14	51	254	259	6	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2012	7	9							e46239	10.1371/journal.pone.0046239	http://dx.doi.org/10.1371/journal.pone.0046239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	022PZ	22844501	Green Submitted, gold, Green Published			2022-12-27	WOS:000309973900115
